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Personal Care and Consumer Product Chemicals and Metabolites







































































122 N,N-Diethyl-meta -toluamide (DEET)
CAS No. 134-62-3
124 3-(Diethylcarbamoyl) benzoic acid (DCBA)
CAS No. 858981-15-4




























Insect Repellent and Metabolites
Carbamate Pesticide Metabolites
Organochlorine Pesticide Metabolites
Organophosphorus Insecticides: Specific Metabolites
Organophosphorus Insecticides: Dialkyl Phosphate Metabolites
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176 trans -3-(2,2-Dichlorovinyl)-2,2-dimethylcyclopropane carboxylic acid
CAS No. 55701-05-8









196 Inorganic-related Arsenic Species
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269 Manganese
CAS No. 8075-39-6


























332 Perfluorobutane sulfonic acid (PFBuS)
CAS No. 375-73-5
335 Perfluorodecanoic acid (PFDeA)
CAS No. 335-76-2
338 Perfluorododecanoic acid (PFDoA)
CAS No. 307-55-1
341 Perfluoroheptanoic acid (PFHpA)
CAS No. 375-85-9
344 Perfluorohexane sulfonic acid (PFHxS)
CAS No. 355-46-4
347 Perfluorononanoic acid (PFNA)
CAS No. 375-95-1
350 Perfluorooctanoic acid (PFOA)
CAS No. 335-67-1
353 n -Perfluorooctanoic acid (n -PFOA)
354 Branched Perfluorooctanoic isomers (Sb-PFOA)
355 Perfluorooctane sulfonic acid (PFOS)
CAS No. 1763-23-1
358 n -Perfluorooctane sulfonic acid (n -PFOS)
359 Perfluoromethylheptane sulfonic acid isomers (Sm-PFOS)
Perchlorate and Other Anions
Perfluoroalkyl and Polyfluoroalkyl Substances: Surfactants
_________________________________________________________________________________________________
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360 Perfluorooctane sulfonamide (PFOSA)
CAS No. 754-91-6
363 2-(N-Ethyl-perfluorooctane sulfonamido) acetic acid (Et-PFOSA-AcOH)
CAS No. 2991-50-6
366 2-(N-Methyl-perfluorooctane sulfonamido) acetic acid (Me-PFOSA-AcOH)
CAS No. 2355-31-9
369 Perfluoroundecanoic acid (PFUA)
CAS No. 2058-94-8
372 Mono-benzyl phthalate (MBzP)
CAS No. 2528-16-7
378 Mono-n -butyl phthalate (MnBP)
CAS No. 131-70-4
384 Mono-isobutyl phthalate (MiBP)
CAS No. 30833-53-5
390 Mono-cyclohexyl phthalate (MCHP)
CAS No. 7517-36-4
394 Mono-ethyl phthalate (MEP)
CAS No. 863029-89-4
400 Mono-2-ethylhexyl phthalate (MEHP)
CAS No. 4376-20-9
406 Mono-(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP)
CAS No. 40321-99-1
412 Mono-(2-ethyl-5-oxohexyl) phthalate (MEOHP)
CAS No. 40321-98-0
418 Mono-(2-ethyl-5-carboxypentyl) phthalate (MECPP)
CAS No. 40809-41-4
422 Mono-(carboxynonyl) phthalate (MCNP)
CAS No. 1373125-93-9
426 Mono-isononyl phthalate (MiNP)
CAS No. 297182-83-3
432 Mono-(carboxyoctyl) phthalate (MCOP)
CAS No. Di-isononyl phthalate (DNP)
436 Mono-methyl phthalate (MMP)
CAS No. 4376-18-5
442 Mono-(3-carboxypropyl) phthalate (MCPP)
CAS No. 66851-46-5
448 Mono-n -octyl phthalate (MOP)
CAS No. 5393-19-1












Phthalate and Phthalate Alternative Metabolites
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545 1,2-Dichlorobenzene (o -Dichlorobenzene)
CAS No. 95-50-1








Polycyclic Aromatic Hydrocarbon Metabolites
Volatile Organic Compounds (VOCs)
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Volatile Organic Compound (VOC) Metabolites
_________________________________________________________________________________________________







































623 3- and 4-Methylhippuric acid
CAS No. 27115-49-7, 27115-50-0
625 Appendix C
631 Appendix D
1 Special Analysis of Pooled Samples for Select Chemicals
Volume Two
Special Analysis of Pooled Samples for Select Chemicals
Appendices
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61 2,2',4’-Tribromodiphenyl ether (BDE 17)
CAS No. 147217-75-2
64 2,4,4’-Tribromodiphenyl ether (BDE 28)
CAS No. 41318-75-6
67 2,2’,4,4’-Tetrabromodiphenyl ether (BDE 47)
CAS No. 5436-43-1
70 2,3',4,4'-Tetrabromodiphenyl ether (BDE 66)
CAS No. 189084-61-5
73 2,2’,3,4,4’-Pentabromodiphenyl ether (BDE 85)
CAS No. 182346-21-0
76 2,2’,4,4’,5-Pentabromodiphenyl ether (BDE 99)
CAS No. 60328-60-9
79 2,2’,4,4’,6-Pentabromodiphenyl ether (BDE 100)
CAS No. 189084-64-8
82 2,2’,4,4’,5,5’-Hexabromodiphenyl ether (BDE 153)
CAS No. 68631-49-2
85 2,2’,4,4’,5,6’-Hexabromodiphenyl ether (BDE 154)
CAS No. 207122-15-4
88 2,2’,3,4,4’,5’,6-Heptabromodiphenyl ether (BDE 183)
CAS No. 207122-16-5
91 2,2',3,3',4,4',5,5',6,6'-Decabromodiphenyl ether (BDE 209)
CAS No. 1163-19-5
93 2,2’,4,4’,5,5’-Hexabromobiphenyl (PBB 153)
CAS No. 59080-40-9
96 1,2,3,4,6,7,8-Heptachlorodibenzo-p -dioxin (HpCDD) 
Organochlorine Pesticides and Metabolites (Pooled Samples after 2004)
Polybrominated Diphenyl Ethers and PBB 153 (Pooled Samples after 2004)
Polychlorinated Dibenzo-p -dioxins (Pooled Samples after 2004)
_________________________________________________________________________________________________
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102 1,2,3,4,7,8-Hexachlorodibenzo-p -dioxin (HxCDD)
CAS No. 39227-28-6
108 1,2,3,6,7,8-Hexachlorodibenzo-p -dioxin (HxCDD) 
CAS No. 57653-85-7
114 1,2,3,7,8,9-Hexachlorodibenzo-p -dioxin (HxCDD) 
CAS No. 19408-74-3
120 1,2,3,4,6,7,8,9-Octachlorodibenzo-p -dioxin (OCDD) 
CAS No. 3268-87-9
126 1,2,3,7,8-Pentachlorodibenzo-p -dioxin (PeCDD) 
CAS No. 40321-76-4
132 2,3,7,8-Tetrachlorodibenzo-p -dioxin (TCDD)  
CAS No. 1746-01-6




150 1,2,3,4,7,8-Hexachlorodibenzofuran (HxCDF) 
CAS No. 70648-26-9
156 1,2,3,6,7,8-Hexachlorodibenzofuran (HxCDF) 
CAS No. 57117-44-9
162 1,2,3,7,8,9-Hexachlorodibenzofuran (HxCDF) 
CAS No. 72918-21-9
168 2,3,4,6,7,8-Hexachlorodibenzofuran (HxCDF) 
CAS No. 60851-34-5
174 1,2,3,4,6,7,8,9-Octachlorodibenzofuran (OCDF) 
CAS No. 39001-02-0
180 1,2,3,7,8-Pentachlorodibenzofuran (PeCDF) 
CAS No. 57117-41-6
186 2,3,4,7,8-Pentachlorodibenzofuran (PeCDF) 
CAS No. 57117-31-4
192 2,3,7,8-Tetrachlorodibenzofuran (TCDF) 
CAS No. 51207-31-9
198 3,4,4',5-Tetrachlorobiphenyl (PCB 81) 
CAS No. 70362-50-4
204 3,3',4,4',5-Pentachlorobiphenyl (PCB 126) 
CAS No. 57465-28-8
210 3,3',4,4',5,5'-Hexachlorobiphenyl (PCB 169) 
CAS No. 32774-16-6
216 2,3,3',4,4'-Pentachlorobiphenyl (PCB 105)
CAS No. 32598-14-4
222 2,3,3',4,4'-Pentachlorobiphenyl (PCB 114)
CAS No. 74472-37-0
226 2,3',4,4',5-Pentachlorobiphenyl (PCB 118)
CAS No. 31508-00-6
232 2',3,4,4',5-Pentachlorobiphenyl (PCB 123)
CAS No. 65510-44-3
236 2,3,3',4,4',5-Hexachlorobiphenyl (PCB 156)
CAS No. 38380-08-4
Polychlorinated Dibenzofurans (Pooled Samples after 2004)
Dioxin-like Polychlorinated Biphenyls: coplanar PCBs (Pooled Samples after 2004)
Dioxin-like Polychlorinated Biphenyls: mono-ortho -substituted PCBs (Pooled Samples after 2004)
_________________________________________________________________________________________________
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242 2,3,3',4,4',5'-Hexachlorobiphenyl (PCB 157)
CAS No. 69782-90-7
248 2,3',4,4',5,5'-Hexachlorobiphenyl (PCB 167)
CAS No. 52663-72-6
254 2,3,3’,4,4’,5,5’-Heptachlorobiphenyl (PCB 189)
CAS No. 39635-31-9
260 2,4,4'-Trichlorobiphenyl (PCB 28)
CAS No. 7012-37-5
266 2,2'3,5'-Tetrachloro biphenyl (PCB 44)
CAS No. 41464-39-5
272 2,2',4,5'-Tetrachloro biphenyl (PCB 49)
CAS No. 41464-40-8
278 2,2',5,5'-Tetrachlorobiphenyl (PCB 52)
CAS No. 35693-99-3
284 2,3',4,4'-Tetrachlorobiphenyl (PCB 66)
CAS No. 33025-41-1
290 2,4,4',5-Tetrachlorobiphenyl (PCB 74)
CAS No. 32690-93-0
296 2,2',3,4,5'-Pentachlorobiphenyl (PCB 87)
CAS No. 41464-51-1
302 2,2',4,4',5-Pentachlorobiphenyl (PCB 99)
CAS No. 38380-02-8
308 2,2',4,5,5'-Pentachlorobiphenyl (PCB 101)
CAS No. 37680-73-2
314 2,3,3’,4’,6-Pentachlorobiphenyl (PCB 110)
CAS No. 74472-35-8
320 2,2',3,3',4,4'-Hexachlorobiphenyl (PCB 128)
CAS No. 38380-07-3
326 2,2',3,4,4',5' and 2,3,3’,4,4’,6-Hexachlorobiphenyl (PCB 138 & 158)
CAS No. 52712-04-6 and 74472-42-7
332 2,2',3,4',5,5'-Hexachlorobiphenyl (PCB 146)
CAS No. 51908-16-8
338 2,2’,3,4’,5’,6-Hexachlorobiphenyl (PCB 149)
CAS No. 38380-04-0
344 2,2’,3,5,5’,6-Hexachlorobiphenyl (PCB 151)
CAS No. 52663-63-5
350 2,2',4,4',5,5'-Hexachlorobiphenyl (PCB 153)
CAS No. 35065-27-1
356 2,2',3,3',4,4',5-Heptachlorobiphenyl (PCB 170)
CAS No. 35065-30-6
362 2,2',3,3',4,5,5'-Heptachlorobiphenyl (PCB 172)
CAS No. 52663-74-8
368 2,2',3,3',4,5',6'-Heptachlorobiphenyl (PCB 177)
CAS No. 40186-70-7
374 2,2',3,3',5,5',6-Heptachlorobiphenyl (PCB 178)
CAS No. 52663-67-9
380 2,2',3,4,4',5,5'-Heptachlorobiphenyl (PCB 180)
CAS No. 35065-29-3
386 2,2',3,4,4',5',6-Heptachlorobiphenyl (PCB 183)
CAS No. 52663-69-1
392 2,2',3,4',5,5',6-Heptachlorobiphenyl (PCB 187)
CAS No. 52663-68-0
Polychlorinated Biphenyls: Non-Dioxin-Like (Pooled Samples after 2004)
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398 2,2’,3,3’,4,4’,5,5’-Octachlorobiphenyl (PCB 194)
CAS No. 35694-08-7
404 2,2’,3,3’,4,4’,5,6-Octachlorobiphenyl (PCB 195)
CAS No. 52663-78-2
410 2,2’,3,3’,4,4’,5,6’ and 2,2’,3,4,4’,5,5’,6-Octachlorobiphenyl (PCB 196 & 203)
CAS No. 42740-50-1 and 52663-76-0
416 2,2’,3,3’,4,5,5’,6-Octachlorobiphenyl (PCB 199)
CAS No. 52663-73-7
422 2,2’,3,3’,4,4’,5,5’,6-Nonachlorobiphenyl (PCB 206)
CAS No. 40186-72-9
428 2,2',3,3',4,4',5,5',6,6'-Decachlorobiphenyl (PCB 209)
CAS No. 2051-24-3






































Metals and Metalloids (Special Sample: Adult Smokers & Nonsmokers)
Exposure to Chemicals Found in Cigarette Smoke in U.S. Adults
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Perchlorate and Other Anions (Special Sample: Adult Smokers & Nonsmokers)
Polycyclic Aromatic Hydrocarbon Metabolites (Adult Cigarette Smokers & Nonsmokers: Special Sample)
Volatile Organic Compound (VOC) Metabolites (Special Sample: Adult Smokers & Nonsmokers)
_________________________________________________________________________________________________































555 3- & 4-Methylhippuric acid
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Fourth National Report on Human Exposure to Environmental Chemicals, 
Updated Tables, January 2017 
The Fourth Report on Human Exposure to Environmental Chemicals, Updated Tables, January 
2017 (abbreviated as Updated Tables, January 2017) is cumulative, containing the nationally 
representative biomonitoring data presented in each of the previous National Reports on Human 
Exposure to Environmental Chemicals and each of the previous Updated Tables. The earliest 
biomonitoring data included is from 1999-2000. 
Starting with this release, the Updated Tables have expanded to two volumes. Volume One 
provides data for the general U.S. population and includes recently released data from 
NHANES 2005-2006, 2007-2008, 2009-2010, and 2013-2014. Volume Two provides data for 
chemicals previously measured in individual samples but currently measured in pooled samples 
and includes recently released data from NHANES 2005-2006 and 2007-2008 using the 
corrected NHANES sampling weights. Volume Two also provides data for the special sample of 
adult cigarette smokers and nonsmokers, including recently released data from NHANES 2013-
2014. Of note, the age for eligibility in the special sample decreased from 20 years and older in 
NHANES 2011-2012 to 18 years and older beginning in NHANES 2013-2014 (NHANES 
lowered the age for asking the smoking questions in 2013).  
The Updated Tables, January 2017 provides data for 308 chemicals, of which 20 are new and 
96 have updated data since the Updated Tables, February 2015. A link to a Biomonitoring 
Summary providing information about a specific chemical or chemical group is provided at the 
bottom of many of the data tables. Several chemicals also have a link to a factsheet about the 
chemical or chemical group. Two appendices have been updated to include information 
pertinent to these chemicals and the other chemicals included in the Updated Tables (Appendix 
C. Limit of Detection Table; Appendix D. References for Biomonitoring Methods).
A complete list of the chemicals included in this Updated Tables is posted on the Report 
website: Chemicals in the Fourth Report: Updated Tables, January 2017. The Updated Tables, 
January 2017 provides updated data for 207 chemicals since the publication of the Fourth 
Report, new data for 96 chemicals, and Fourth Report data for 5 chemicals that are no longer 
measured.  
The Report website is the best resource for updates of available data 
(http://www.cdc.gov/exposurereport). The Fourth National Report on Human Exposure to 
Environmental Chemicals, 2009, at this website contains details of the Data Sources and Data 
Analysis, Interpretation of Report Data, and Chemical and Toxicological Information that pertain 
to the Updated Tables. 
_________________________________________________________________________________________________
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What’s New and Different?  
The Updated Tables, January 2017, include chemicals that have results available from the 
NHANES survey periods 2005-2006, 2007-2008, 2009-2010, and 2013-2014. No new 2011-
2012 data were released for this Updated Tables. New chemicals measured for the first time 
include the herbicide atrazine and five of its metabolites, the insect repellent DEET and two of 
its metabolites, triclocarban, branched and linear isomers of both PFOS and PFOA, and six 
blood VOCs: 1,1,1,2-tetrachloroethane; 1,2,3-trichloropropane; 1,2-dibromoethane; furan; 
isopropylbenzene (cumene); and nitromethane. A new chemical group created in 2013-2014 is 
the Personal Care and Consumer Product Chemicals and Metabolites, which reflects the 
chemical uses and combines three previous groups: Environmental Phenols, Parabens, and 
Other Pesticide Metabolites. The chemical group previously called Perfluorinated Compounds: 
Surfactants has been renamed as Perfluoroalkyl and Polyfluoroalkyl Substances: Surfactants. 
Chemicals with updated data in this release are  
• adducts of hemoglobin (acrylamide and glycidamide); 
• blood VOCs, including disinfection by-products; 
• urinary PBA, benzophenone-3, triclosan, four parabens, 2,4-dichlorophenol, and 2,5-
dichlorophenol;  
• whole blood metals and mercury species; 
• serum metals; 
• urinary metals and arsenic species;  
• urinary perchlorate, nitrate, and thiocyanate; 
• serum perfluoroalkyl and polyfluoroalkyl substances (PFAS);  
• urinary polycyclic aromatic hydrocarbon metabolites;  
• serum polychlorinated dibenzo-p-dioxins (pooled); 
• serum polychlorinated dibenzofurans (pooled); 
• serum dioxin-like polychlorinated biphenyls: coplanar PCBs (pooled).  
CAS Registry Numbers (CAS Nos.)  
With this Updated Tables, we are including CAS registry numbers in the Table of Contents 
placed along with the chemical name. Not all chemicals have a CAS No. assigned, and there is 
no number for chemicals that have values calculated from two or more species (e.g., arsenic) or 
isomers (e.g., PFOS, PFOA). 
Updated Tables in Two Volumes 
In this release, we have expanded the Updated Tables to two volumes, each as a separate 
PDF. This change was made because the file size of the single PDF had become so large that it 
could not easily be shared or sent as an attachment. Volume One contains data tables for most 
of the chemicals measured in the U.S. general population. Volume Two contains data tables for 
the persistent organic pollutants and pesticides previously measured in individual samples and 
are currently measured in pooled samples. Volume Two also contains data tables for the 
special sample of adult cigarette smokers and nonsmokers, including recently released data 
_________________________________________________________________________________________________
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from NHANES 2013-2014. We anticipate that future Updated Tables will continue to be 
presented in two volumes. 
PFOS and PFOA Results for NHANES 2013-2014 
Starting in 2013, we began measuring linear and branched isomers of both PFOS and PFOA 
and no longer measure total PFOS or PFOA. The isomers of each chemical represent more 
than 95% of what was previously reported as PFOS and PFOA. PFOS and PFOA were 
calculated by summing the linear and branched isomers for each participant before applying the 
appropriate sample weight. Because the 2013-2014 values are a calculated sum, there is no 
limit of detection (LOD) for PFOS and PFOA. Data tables for each of the four isomers also are 
presented. See Calculation of PFOS and PFOA as the Sum of the Isomers for more details. The 
2013-2014 PFOS and PFOA results can be used to compare with previous measurements and 
to examine trends in the general U.S. population.  
NHANES 2005-2006 Urine VOC Metabolite Data Were Withdrawn 
The NHANES 2005-2006 urine VOC metabolite data were withdrawn in January 2016 because 
of a systematic bias in several analytes. We have removed the data tables that were previously 
presented using those data. Once the data are revised and re-posted, we will again present 
data tables for these chemicals.  
With the exception of one analyte, t,t-muconic acid, a metabolite of benzene, the NHANES 
2011-2012 data were not affected and those data tables are included in this Updated Tables. 
The data for t,t-muconic acid was withdrawn for NHANES 2011-2012 because of recently 
identified analytical issues that could not be resolved. 
Chemicals No Longer Being Reported 
Results for several chemicals are no longer reported in the Updated Tables because their 
concentrations have been largely undetectable in previous survey periods. These chemicals are 
atrazine and five atrazine metabolites (measured in 2007-2008), and two PFAS chemicals: 
PFOSA (also referred to as FOSA) and Et-PFOSA-AcOH (also referred to as EtFOSA). 
For the information in this section, “What’s New and Different,” contained in previous releases of 
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Calculation of Urinary Inorganic-related Arsenic Species 
In this Updated Tables, we present updated data for the urinary inorganic-related arsenic 
species. The values are calculated using results for each NHANES survey period for the 
following four arsenic species: arsenic (V) acid, arsenous (III) acid, dimethylarsinic acid (DMA), 
and monomethylarsonic acid (MMA). The sum of the four species is calculated for each 
individual NHANES participant. If the value of a species is less than the limit of detection (LOD), 
then the imputed value is used. The imputed value is calculated as the LOD divided by the 
square root of 2 (Hornung and Reed, 1990) and imputed values are provided in the NHANES 
public release file. If all four arsenic species are reported as less than the LOD, then the sum 
will be the sum of the four imputed values. 
The geometric means, selected percentiles, and confidence intervals are calculated using sums 
with detectable values of 60 percent or higher. If the detection frequency for a category is less 
than 60 percent, this is indicated by an asterisk (*). There is no LOD for the inorganic-related 
arsenic species because the values are calculated, rather than measured. 
 
Reference: Hornung RW, Reed LD. 1990. Estimation of average concentration in the presence 
of nondetectable values. Appl Occup Environ Hyg 5(1):46-51. 
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Calculation of PFOS and PFOA as the Sum of the Isomers 
In this Updated Tables, January 2017, we report NHANES 2013-2014 results for both serum 
PFOS and PFOA as the sum of their respective isomers. This is because in 2013 we began 
measuring separately linear and branched isomers of both PFOS and PFOA and no longer 
measure total PFOS or PFOA. This calculated sum of PFOS (or PFOA) isomers is comparable 
to the total PFOS (or PFOA) reported before. Production of PFOS and PFOA employed 
electrochemical fluorination (ECF) or fluorotelomerization. ECF used from the 1950s until the 
early 2000s yielded branched and linear isomers. In contrast, fluorotelomerization produced 
almost exclusively linear compounds. Measurement of the two types of isomers may be 
informative because branched isomers may be eliminated from the body more rapidly than 
linear isomers (Benskin et al, 2009a). In addition, separate measurements may provide 
information that is helpful for evaluating exposure source contributions (Benskin et al, 2010, 
2009b). 
The value of PFOS is calculated as the sum of branched PFOS isomers 
(perfluoromethylheptane sulfonate isomers, Sm-PFOS) plus the linear isomer (n-PFOS). PFOA 
is calculated as the sum of branched PFOA isomers (Sb-PFOA) plus the linear isomer (n-
PFOA). For each chemical (PFOS and PFOA), the sum of the branched and linear isomers is 
calculated for each individual NHANES participant. If the value for any isomer is below the limit 
of detection (LOD), then the imputed value is used. The imputed value is calculated as the LOD 
divided by the square root of 2 (Hornung and Reed, 1990) and imputed values are provided in 
the NHANES public release file. If both isomers for calculating either PFOS or PFOA are 
reported as less than the LOD, then two imputed values are summed. These calculated PFOA 
and PFOS results can be used to compare with previous measurements and examine trends in 
the U.S. population. 
The geometric means, selected percentiles, and confidence intervals are calculated using sums 
with detectable values of 60 percent or higher. If the detection frequency for a category is less 
than 60 percent, this is indicated by an asterisk (*).  Because the 2013-2014 values for PFOA 
and PFOS are a calculated sum, there is no limit of detection (LOD) for either of these two 
chemicals. 
The branched isomers of PFOS (Sm-PFOS) and PFOA (Sb-PFOA) are a mixture of isomers. 
The isomers known to be included in Sm-PFOS are perfluoro-3-methylheptane sulfonate, 
perfluoro-4-methylheptane sulfonate, perfluoro-5-methylheptane sulfonate, and perfluoro-6-
methylheptane sulfonate. The isomers known to be included in Sb-PFOA are perfluoro-3-
methylheptanoic acid, perfluoro-4-methyheptanoic acid, perfluoro-5-methyheptanoic acid, 
perfluoro-6-methyheptanoic acid, perfluoro-4,4-dimethylhexanoic acid, perfluoro-5,5-
dimethylhexanoic acid, perfluoro-3,5-dimethylhexanoic acid, and perfluoro-4,5-dimethylhexanoic 
acid. The linear isomers of PFOS (n-PFOS) and PFOA (n-PFOA) are single chemicals. Data 
tables are also presented for each of the four isomers that were measured.  
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nondetectable values. Appl Occup Environ Hyg 5(1):46-51. 
 
_________________________________________________________________________________________________
Fourth National Report on Human Exposure to Environmental Chemicals, Updated Tables, January 2017 Volume One Page 6
Acrylamide (2003 - 2006) 
 
Geometric mean and selected percentiles of hemoglobin adduct concentrations (in pmol/g hemoglobin) for the U.S. population 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 61.2 (58.1-64.4) 54.8 (52.8-57.7) 79.1 (73.5-85.6) 141 (124-155) 192 (168-217) 7101 
 05-06 61.6 (58.1-65.4) 54.8 (52.8-56.8) 79.1 (75.1-86.1) 165 (151-178) 221 (204-246) 7857 
Age group        
3-5 years 03-04 59.4 (53.6-65.7) 58.6 (51.7-64.9) 75.7 (63.4-83.6) 90.6 (81.9-105) 108 (86.2-118) 350 
 05-06 59.1 (55.8-62.6) 63.6 (58.6-66.4) 74.4 (73.2-76.3) 90.3 (80.8-100) 102 (87.3-121) 483 
6-11 years 03-04 58.6 (56.1-61.2) 57.3 (55.2-59.7) 71.0 (67.4-76.3) 86.8 (81.2-91.4) 98.8 (91.0-104) 769 
 05-06 56.1 (53.9-58.5) 57.1 (54.8-59.9) 67.8 (65.3-69.8) 78.8 (74.9-86.8) 93.8 (81.1-103) 924 
12-19 years 03-04 57.4 (54.4-60.5) 54.5 (52.1-57.4) 70.7 (65.6-75.7) 100 (89.2-114) 132 (115-151) 1889 
 05-06 56.4 (52.5-60.6) 53.1 (50.7-55.8) 69.5 (66.2-73.1) 112 (98.0-127) 162 (131-221) 1977 
20-59 years 03-04 66.2 (62.2-70.6) 57.9 (54.6-61.1) 96.1 (83.6-108) 163 (147-191) 223 (194-243) 2570 
 05-06 66.8 (62.1-71.9) 56.4 (53.7-59.8) 101 (87.1-118) 196 (177-210) 257 (222-298) 3066 
60 years and older 03-04 50.1 (47.9-52.3) 46.5 (44.0-49.2) 61.0 (57.6-66.0) 96.1 (88.0-108) 141 (120-152) 1523 
 05-06 52.5 (49.4-55.7) 47.8 (45.0-49.6) 65.9 (60.2-71.6) 136 (112-156) 184 (167-198) 1407 
Gender        
Males 03-04 63.9 (60.2-67.9) 57.0 (53.7-60.1) 85.5 (79.2-93.7) 152 (139-175) 220 (189-237) 3509 
 05-06 65.7 (61.5-70.1) 57.5 (55.1-60.4) 91.5 (80.9-101) 183 (163-208) 246 (213-277) 3826 
Females 03-04 58.7 (55.9-61.5) 53.4 (51.8-55.9) 73.9 (69.5-80.6) 126 (111-142) 164 (147-191) 3592 
 05-06 58.1 (54.6-61.7) 52.8 (50.9-54.7) 73.1 (68.3-78.2) 146 (131-160) 199 (182-211) 4031 
Race/ethnicity        
Mexican Americans 03-04 61.7 (58.7-64.9) 57.4 (54.4-60.4) 73.0 (69.2-77.3) 101 (95.0-115) 149 (125-179) 1792 
 05-06 57.2 (54.0-60.7) 54.8 (51.4-58.2) 70.2 (67.2-73.7) 94.0 (86.2-104) 130 (110-148) 2035 
Non-Hispanic blacks 03-04 63.8 (57.3-71.1) 57.1 (52.1-64.1) 86.5 (74.6-104) 156 (120-203) 218 (172-271) 1874 
 05-06 58.1 (53.5-63.2) 54.2 (52.4-55.7) 82.3 (74.0-95.4) 170 (147-189) 226 (198-259) 2061 
Non-Hispanic whites 03-04 62.4 (59.0-66.0) 55.3 (53.0-58.6) 82.2 (75.4-89.1) 146 (129-163) 197 (172-223) 2994 
 05-06 63.9 (59.8-68.3) 55.4 (53.0-58.5) 83.8 (76.5-94.9) 177 (160-194) 228 (208-258) 3153 
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Glycidamide (2003 - 2006) 
 
Geometric mean and selected percentiles of hemoglobin adduct concentrations (in pmol/g hemoglobin) for the U.S. population 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 59.3 (56.7-62.1) 59.9 (57.6-62.5) 85.9 (81.6-90.5) 130 (120-141) 167 (153-181) 7278 
 05-06 50.4 (46.9-54.1) 49.4 (46.5-52.4) 71.3 (67.1-75.6) 109 (98.4-120) 142 (130-151) 7740 
Age group        
3-5 years 03-04 71.6 (66.9-76.7) 71.1 (66.9-78.9) 94.7 (87.3-101) 118 (103-126) 126 (119-135) 411 
 05-06 66.7 (61.5-72.2) 72.9 (65.9-76.3) 89.4 (82.8-96.8) 107 (104-113) 120 (109-129) 482 
6-11 years 03-04 74.1 (70.3-78.2) 75.0 (70.9-77.9) 95.6 (90.4-103) 121 (112-134) 141 (126-157) 784 
 05-06 58.2 (55.4-61.2) 59.6 (57.3-61.8) 73.7 (70.0-77.5) 90.8 (81.3-99.8) 106 (93.8-113) 907 
12-19 years 03-04 55.4 (51.1-60.1) 59.2 (56.1-62.1) 79.2 (72.7-86.7) 113 (94.9-138) 146 (123-169) 1931 
 05-06 48.2 (45.1-51.6) 47.3 (44.8-49.3) 64.1 (60.5-67.9) 92.0 (82.8-103) 123 (103-149) 1944 
20-59 years 03-04 62.5 (59.4-65.8) 60.9 (58.7-64.4) 90.7 (84.4-98.2) 143 (130-159) 187 (169-204) 2623 
 05-06 52.3 (47.9-57.1) 50.1 (46.3-54.2) 74.5 (69.5-80.9) 121 (107-134) 154 (140-179) 3025 
60 years and older 03-04 45.5 (42.8-48.3) 46.8 (44.8-49.3) 65.2 (63.5-66.9) 96.4 (90.0-103) 129 (111-141) 1529 
 05-06 40.9 (38.1-44.0) 39.5 (37.4-42.7) 56.7 (51.1-63.8) 88.7 (75.7-103) 118 (103-133) 1382 
Gender        
Males 03-04 59.5 (56.9-62.3) 59.4 (56.8-61.8) 87.1 (82.5-92.3) 136 (123-148) 174 (157-197) 3604 
 05-06 50.8 (46.9-55.0) 49.4 (46.1-53.2) 74.5 (70.2-78.8) 113 (102-127) 148 (131-165) 3761 
Females 03-04 59.1 (56.0-62.5) 60.4 (57.5-64.0) 85.0 (80.2-90.0) 125 (116-135) 159 (143-175) 3674 
 05-06 50.0 (46.7-53.6) 49.2 (46.5-52.3) 68.3 (63.9-73.2) 101 (93.8-114) 136 (125-145) 3979 
Race/ethnicity        
Mexican Americans 03-04 64.7 (61.2-68.4) 65.4 (61.1-70.1) 87.4 (81.5-94.4) 118 (110-129) 152 (135-170) 1841 
 05-06 50.3 (46.5-54.4) 50.7 (46.8-54.8) 66.1 (61.6-70.5) 86.6 (80.6-95.8) 106 (98.1-114) 2022 
Non-Hispanic blacks 03-04 53.8 (51.1-56.7) 56.0 (52.4-59.7) 83.0 (75.2-91.5) 121 (108-140) 159 (129-204) 1954 
 05-06 42.3 (38.9-46.0) 44.1 (41.7-45.9) 64.0 (60.3-67.8) 99.9 (87.2-109) 129 (117-140) 2008 
Non-Hispanic whites 03-04 61.1 (57.6-64.9) 60.7 (57.9-64.2) 87.5 (83.0-93.5) 136 (124-149) 172 (157-194) 3044 
 05-06 52.5 (48.5-56.9) 50.7 (46.8-55.0) 74.5 (69.9-80.1) 115 (102-129) 147 (134-160) 3110 
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Serum Cotinine (1999 – 2010) 
Metabolite of nicotine (component of tobacco smoke) 
Geometric mean and selected percentiles of serum concentrations (in ng/mL) for the ***non-smoking U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 * .060 (<LOD-.080) .240 (.190-.302) 1.02 (.770-1.28) 1.96 (1.60-2.62) 5999 
 01-02** .062 (.050-.077) < LOD .160 (.120-.220) .930 (.740-1.17) 2.20 (1.83-2.44) 6819 
 03-04 .071 (.057-.089) .050 (.040-.070) .210 (.140-.310) .990 (.740-1.30) 2.17 (1.81-2.54) 6320 
 05-06 .054 (.047-.061) .040 (.030-.040) .120 (.100-.150) .630 (.460-.870) 1.47 (1.15-1.92) 6347 
 07-08 .057 (.048-.068) .040 (.030-.040) .130 (.100-.180) .760 (.550-1.09) 1.81 (1.45-2.43) 6197 
 09-10 .041 (.037-.046) .030 (.020-.030) .070 (.070-.090) .450 (.350-.580) 1.29 (1.04-1.61) 6678 
Age group        
3-11 years 99-00 .164 (.115-.234) .110 (.066-.188) .500 (.260-1.16) 1.88 (.997-3.44) 3.44 (1.42-4.79) 1174 
 01-02** .110 (.076-.160) .070 (<LOD-.130) .570 (.310-1.00) 2.23 (1.63-2.78) 3.23 (2.53-4.01) 1415 
 03-04 .137 (.088-.213) .120 (.060-.220) .620 (.310-1.20) 2.04 (1.38-2.94) 3.35 (2.12-4.68) 1252 
 05-06 .078 (.062-.097) .050 (.040-.070) .220 (.160-.350) 1.22 (.880-1.82) 2.42 (1.63-3.46) 1296 
 07-08 .095 (.067-.136) .060 (.040-.100) .380 (.170-.840) 1.67 (1.10-2.54) 2.81 (2.26-3.54) 1337 
 09-10 .060 (.047-.075) .040 (.030-.050) .160 (.110-.250) .920 (.560-1.58) 2.15 (1.35-3.00) 1355 
12-19 years 99-00 .163 (.142-.187) .110 (.080-.163) .540 (.428-.660) 1.66 (1.50-1.95) 2.62 (2.09-3.39) 1773 
 01-02** .086 (.059-.126) .050 (<LOD-.110) .350 (.190-.580) 1.53 (1.09-2.12) 3.12 (2.47-3.99) 1902 
 03-04 .110 (.087-.139) .080 (.060-.120) .510 (.350-.670) 1.55 (1.21-1.93) 2.68 (1.96-4.02) 1783 
 05-06 .074 (.060-.092) .050 (.040-.060) .230 (.150-.350) 1.16 (.860-1.69) 2.26 (1.69-2.72) 1714 
 07-08 .081 (.061-.106) .050 (.030-.070) .350 (.170-.550) 1.25 (.930-1.99) 2.54 (2.04-2.94) 934 
 09-10 .056 (.044-.072) .030 (.020-.040) .130 (.080-.230) .980 (.510-1.80) 2.49 (1.31-3.65) 1042 
20 years and older 99-00 * .050 (<LOD-.061) .167 (.140-.193) .630 (.533-.820) 1.50 (1.28-1.66) 3052 
 01-02** .052 (<LOD-.063) < LOD .110 (.090-.150) .630 (.470-.790) 1.42 (1.14-1.89) 3502 
 03-04 .058 (.047-.071) .040 (.030-.050) .140 (.100-.200) .630 (.480-.840) 1.54 (1.26-1.92) 3285 
 05-06 .047 (.042-.053) .030 (.030-.040) .100 (.080-.120) .440 (.310-.620) 1.14 (.870-1.41) 3337 
 07-08 .049 (.043-.057) .030 (.030-.040) .100 (.080-.120) .490 (.390-.640) 1.37 (.970-1.70) 3926 
 09-10 .037 (.034-.040) .020 (.020-.030) .070 (.060-.070) .310 (.240-.390) .990 (.700-1.24) 4281 
Gender        
Males 99-00 .124 (.106-.145) .080 (.060-.110) .308 (.220-.410) 1.20 (.950-1.49) 2.39 (1.66-3.22) 2789 
 01-02** .075 (.059-.094) .050 (<LOD-.070) .230 (.160-.320) 1.17 (.960-1.49) 2.44 (2.23-2.99) 3152 
 03-04 .087 (.070-.108) .060 (.040-.080) .280 (.190-.360) 1.23 (.910-1.68) 2.63 (2.09-3.19) 2937 
 05-06 .064 (.055-.074) .040 (.040-.050) .150 (.120-.190) .720 (.550-1.07) 1.85 (1.42-2.24) 2922 
 07-08 .068 (.056-.081) .040 (.040-.050) .170 (.120-.240) 1.07 (.690-1.39) 2.52 (1.84-2.92) 2948 
 09-10 .046 (.042-.051) .030 (.030-.030) .080 (.070-.100) .550 (.410-.700) 1.60 (1.19-2.38) 3181 
Females 99-00 * < LOD .180 (.148-.230) .850 (.600-1.14) 1.85 (1.33-2.45) 3210 
 01-02** .053 (<LOD-.066) < LOD .120 (.090-.180) .710 (.540-.990) 1.77 (1.32-2.20) 3667 
 03-04 .060 (.047-.077) .040 (.030-.060) .160 (.110-.260) .860 (.580-1.15) 1.76 (1.32-2.22) 3383 
 05-06 .047 (.040-.054) .030 (.030-.040) .100 (.070-.130) .510 (.300-.830) 1.23 (1.04-1.52) 3425 
 07-08 .050 (.042-.059) .030 (.030-.040) .110 (.080-.150) .630 (.400-.900) 1.40 (1.09-1.87) 3249 
 09-10 .037 (.033-.042) .020 (.020-.030) .070 (.050-.080) .380 (.270-.570) 1.03 (.720-1.61) 3497 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 05-06, 07-08, and 09-10 are 0.05, 0.05, 0.015, 0.015, 0.015, and 0.015 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample.  
* Not calculated: proportion of results below limit of detection was too high to provide a valid result. 
**In the 2001-2002 survey period, 83% of measurements had an LOD of 0.015 ng/mL, and 17% had an LOD of 0.05 ng/mL. 
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Serum Cotinine (1999 – 2010) 
Metabolite of nicotine (component of tobacco smoke) 
Geometric mean and selected percentiles of serum concentrations (in ng/mL) for the ***non-smoking 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 * < LOD .140 (.110-.180) .506 (.370-.726) 1.21 (.900-1.70) 2241 
 01-02** .060 (<LOD-.084) < LOD .160 (.080-.310) .730 (.480-1.19) 2.12 (1.19-2.96) 1878 
 03-04 .054 (.043-.068) .030 (.020-.050) .120 (.080-.180) .690 (.430-1.00) 2.65 (1.87-3.57) 1707 
 05-06 .047 (.038-.059) .030 (.020-.040) .100 (.070-.150) .500 (.370-.730) 1.54 (.830-2.49) 1807 
 07-08 .044 (.033-.057) .030 (.020-.040) .080 (.060-.120) .480 (.290-.880) 1.59 (1.00-3.07) 1412 
 09-10 .038 (.032-.045) .020 (.020-.030) .060 (.050-.080) .360 (.230-.640) 1.35 (.710-2.25) 1615 
Non-Hispanic blacks 99-00 .175 (.153-.201) .131 (.111-.150) .505 (.400-.625) 1.43 (1.21-1.75) 2.34 (1.84-3.50) 1333 
 01-02** .164 (.137-.197) .130 (.110-.160) .580 (.450-.770) 1.77 (1.55-2.05) 3.15 (2.50-4.30) 1602 
 03-04 .144 (.104-.198) .120 (.080-.180) .520 (.350-.770) 1.54 (1.20-2.14) 2.77 (2.18-3.54) 1704 
 05-06 .114 (.085-.153) .080 (.060-.120) .440 (.240-.690) 1.42 (.900-2.03) 2.45 (1.70-3.70) 1630 
 07-08 .094 (.079-.112) .060 (.050-.090) .320 (.250-.390) 1.19 (.980-1.46) 2.37 (1.75-2.88) 1244 
 09-10 .095 (.074-.122) .070 (.050-.090) .320 (.210-.540) 1.33 (.900-2.05) 2.85 (1.97-3.60) 1129 
Non-Hispanic whites 99-00 * .050 (<LOD-.073) .216 (.154-.312) .950 (.621-1.40) 1.92 (1.48-3.02) 1950 
 01-02** .052 (<LOD-.068) < LOD .120 (.090-.180) .800 (.570-1.11) 1.88 (1.48-2.30) 2847 
 03-04 .066 (.050-.087) .040 (.030-.070) .180 (.120-.300) .920 (.620-1.32) 2.01 (1.70-2.49) 2500 
 05-06 .049 (.042-.056) .030 (.030-.040) .100 (.080-.130) .530 (.330-.800) 1.27 (.980-1.62) 2404 
 07-08 .056 (.043-.073) .040 (.030-.050) .130 (.080-.240) .750 (.440-1.27) 1.70 (1.24-2.54) 2485 
 09-10 .037 (.033-.043) .020 (.020-.030) .070 (.050-.080) .350 (.240-.560) 1.06 (.780-1.60) 2743 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 05-06, 07-08, and 09-10 are 0.05, 0.05, 0.015, 0.015, 0.015, and 0.015 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
*Not calculated: proportion of results below limit of detection was too high to provide a valid result. 
**In the 2001-2002 survey period, 83% of measurements had an LOD of 0.015 ng/mL, and 17% had an LOD of 0.05 ng/mL. 
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Serum Cotinine (2011 - 2012) 
Metabolite of nicotine (component of tobacco smoke) 
Geometric mean and selected percentiles of serum concentrations (in ng/mL) for the **non-smoking U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * .020 (.018-.023) .059 (.049-.072) .356 (.263-.500) 1.30 (.882-1.60) 6108 
Age group        
3-11 years 11-12 .058 (.045-.074) .031 (.024-.045) .172 (.100-.313) 1.02 (.627-1.94) 2.49 (1.56-3.36) 1348 
12-19 years 11-12 .049 (.040-.061) .025 (.020-.037) .147 (.083-.235) .711 (.520-1.06) 1.47 (1.05-2.29) 990 
20 years and older 11-12 * .019 (.016-.020) .047 (.040-.053) .210 (.176-.263) .835 (.566-1.38) 3770 
Gender        
Males 11-12 .041 (.037-.045) .023 (.020-.026) .076 (.065-.095) .530 (.397-.715) 1.76 (1.35-2.42) 2903 
Females 11-12 * .019 (.016-.021) .048 (.040-.059) .244 (.189-.314) .819 (.572-1.31) 3205 
Race/ethnicity        
Mexican Americans 11-12 .033 (.027-.042) .021 (.016-.027) .055 (.040-.081) .230 (.106-.386) .668 (.349-2.07) 886 
Non-Hispanic blacks 11-12 .076 (.054-.107) .045 (.032-.071) .259 (.127-.513) 1.10 (.678-2.02) 2.86 (1.46-4.20) 1576 
Non-Hispanic whites 11-12 * .017 (<LOD-.020) .048 (.039-.061) .277 (.207-.363) 1.10 (.627-1.50) 1841 
All Hispanics 11-12 .033 (.028-.040) .021 (.017-.026) .054 (.041-.074) .233 (.123-.387) .834 (.377-2.37) 1587 
Asians 11-12 .030 (.026-.035) .023 (.020-.027) .046 (.037-.058) .123 (.083-.201) .308 (.201-.594) 878 
Limit of detection (LOD, see Data Analysis section) for Survey year 11-12 is 0.015. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result. 
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Urinary NNAL (4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol) (2007 – 2010) 
Metabolite of (4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone) (NNK) 
Geometric mean and selected percentiles of urine concentrations (in pg/mL) for the **non-smoking U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 07-08 * < LOD 2.80 (2.20-3.70) 11.1 (8.80-14.4) 24.5 (18.0-30.4) 5212 
 09-10 * < LOD 1.90 (1.60-2.40) 7.30 (6.40-8.50) 16.7 (13.9-19.6) 6067 
Age group        
6-11 years 07-08 * 1.30 (.600-2.60) 8.50 (4.70-13.8) 31.4 (17.5-49.8) 60.6 (37.1-75.7) 875 
 09-10 * .600 (<LOD-1.00) 3.10 (2.20-5.00) 15.5 (10.4-22.8) 29.3 (18.1-59.4) 937 
12-19 years 07-08 * 1.20 (.600-2.10) 5.00 (3.80-9.20) 20.0 (11.9-27.5) 39.1 (20.6-60.9) 843 
 09-10 * .900 (<LOD-1.50) 3.70 (2.70-5.20) 12.5 (6.90-25.5) 29.1 (13.9-51.4) 1004 
20 years and older 07-08 * < LOD 2.10 (1.70-2.50) 8.20 (6.90-9.80) 16.6 (13.9-21.5) 3494 
 09-10 * < LOD 1.60 (1.30-1.90) 6.10 (5.10-6.90) 13.1 (10.7-15.8) 4126 
Gender        
Males 07-08 * < LOD 3.80 (3.00-4.50) 12.6 (10.6-15.0) 27.5 (18.9-38.1) 2463 
 09-10 * < LOD 2.40 (1.90-3.00) 8.30 (7.20-9.90) 19.3 (15.2-22.5) 2903 
Females 07-08 * < LOD 2.10 (1.50-2.90) 9.70 (7.10-13.6) 21.6 (16.6-28.0) 2749 
 09-10 * < LOD 1.60 (1.30-1.90) 6.50 (4.70-8.80) 14.0 (10.7-19.0) 3164 
Race/ethnicity        
Mexican Americans 07-08 * < LOD 2.00 (1.20-3.10) 6.90 (4.90-9.00) 13.9 (10.8-17.3) 1206 
 09-10 * < LOD 1.60 (1.20-2.20) 4.90 (3.70-7.00) 11.1 (5.70-18.4) 1476 
Non-Hispanic blacks 07-08 * .800 (<LOD-1.90) 4.90 (3.60-6.30) 14.0 (11.6-17.2) 26.1 (18.5-33.2) 1057 
 09-10 1.81 (1.30-2.54) 1.40 (<LOD-2.40) 5.90 (3.80-8.10) 18.9 (11.7-26.1) 34.0 (18.9-61.9) 1004 
Non-Hispanic whites 07-08 * < LOD 2.80 (1.90-4.10) 11.9 (8.20-17.7) 27.5 (19.6-35.4) 2047 
 09-10 * < LOD 1.80 (1.40-2.40) 6.80 (5.40-8.40) 15.2 (11.9-19.3) 2514 
Limit of detection (LOD, see Data Analysis section) for Survey years 07-08 and 09-10 are 0.6 and 0.6 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result.  
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Urinary NNAL (4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol) (2011 - 2012) 
Metabolite of (4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone) (NNK) 
Geometric mean and selected percentiles of urine concentrations (in pg/mL) for the **non-smoking U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * .800 (.700-.900) 2.30 (2.00-2.60) 7.40 (6.10-8.90) 15.7 (11.7-21.0) 5486 
Age group        
6-11 years 11-12 1.91 (1.57-2.32) 1.30 (1.10-1.70) 5.10 (3.80-7.30) 21.1 (11.5-31.9) 36.7 (20.1-60.2) 955 
12-19 years 11-12 1.53 (1.35-1.73) 1.30 (1.10-1.40) 3.10 (2.20-4.30) 10.8 (7.60-14.4) 19.3 (13.2-27.0) 949 
20 years and older 11-12 * .700 (.600-.900) 2.00 (1.80-2.20) 5.70 (4.80-6.80) 11.7 (10.0-14.9) 3582 
Gender        
Males 11-12 1.32 (1.23-1.41) 1.00 (.900-1.10) 2.80 (2.40-3.10) 9.80 (7.60-11.2) 19.5 (13.5-26.4) 2616 
Females 11-12 * .700 (.600-.800) 1.90 (1.70-2.20) 5.70 (4.60-7.20) 12.4 (9.00-18.5) 2870 
Race/ethnicity        
Mexican Americans 11-12 1.12 (.956-1.30) .900 (.700-1.20) 1.90 (1.50-2.50) 5.30 (3.70-7.40) 9.50 (7.70-15.0) 775 
Non-Hispanic blacks 11-12 1.98 (1.57-2.48) 1.60 (1.30-2.10) 5.10 (3.30-8.70) 15.9 (9.40-28.8) 30.4 (18.5-46.7) 1393 
Non-Hispanic whites 11-12 * .800 (.600-.900) 2.10 (1.80-2.40) 6.70 (5.30-8.50) 14.4 (11.4-20.4) 1679 
Asians 11-12 * .600 (<LOD-.700) 1.20 (1.00-1.50) 2.80 (1.90-3.80) 5.00 (3.40-6.80) 814 
Limit of detection (LOD, see Data Analysis section) for Survey year 11-12 is 0.6. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result.  
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Urinary NNAL (4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol) (creatinine corrected) (2007 – 2010) 
Metabolite of (4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone) (NNK) 
Geometric mean and selected percentiles of urine concentrations (in pg/mg of creatinine) for the **non-smoking U.S. population 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 07-08 * < LOD 2.79 (2.31-3.50) 10.3 (7.36-14.0) 20.5 (16.4-27.5) 5210 
 09-10 * < LOD 2.05 (1.88-2.28) 6.40 (5.71-7.41) 14.6 (11.5-17.3) 6066 
Age group        
6-11 years 07-08 * 2.15 (1.38-3.22) 10.7 (5.95-17.9) 38.3 (21.2-57.1) 60.9 (46.4-72.1) 875 
 09-10 * 1.19 (<LOD-1.52) 4.25 (2.88-6.37) 19.2 (11.0-28.8) 37.2 (22.9-53.0) 936 
12-19 years 07-08 * 1.14 (.710-1.75) 4.40 (2.59-7.36) 14.2 (10.5-23.1) 29.2 (15.6-41.9) 841 
 09-10 * 1.05 (<LOD-1.26) 3.08 (1.96-4.37) 10.0 (6.02-15.2) 20.7 (12.3-30.2) 1004 
20 years and older 07-08 * < LOD 2.34 (2.00-2.73) 6.82 (5.49-8.65) 15.1 (11.8-17.7) 3494 
 09-10 * < LOD 1.84 (1.71-2.00) 5.21 (4.57-6.07) 11.4 (8.42-14.1) 4126 
Gender        
Males 07-08 * < LOD 2.98 (2.39-3.71) 10.5 (7.57-12.9) 20.9 (15.7-29.0) 2462 
 09-10 * < LOD 2.00 (1.86-2.25) 6.61 (6.00-7.83) 15.1 (11.7-19.8) 2902 
Females 07-08 * < LOD 2.67 (2.14-3.37) 9.87 (6.79-14.9) 20.0 (15.7-27.9) 2748 
 09-10 * < LOD 2.09 (1.82-2.36) 6.15 (4.88-8.21) 12.7 (9.26-17.3) 3164 
Race/ethnicity        
Mexican Americans 07-08 * < LOD 2.16 (1.55-3.00) 5.91 (4.32-8.30) 13.3 (8.36-17.9) 1205 
 09-10 * < LOD 1.73 (1.36-2.11) 5.00 (3.72-6.84) 10.0 (6.79-14.7) 1476 
Non-Hispanic blacks 07-08 * .960 (<LOD-1.42) 3.70 (2.50-5.31) 11.5 (9.18-14.2) 20.8 (14.5-28.8) 1056 
 09-10 1.40 (.982-2.01) 1.21 (<LOD-2.06) 3.96 (2.78-5.99) 12.2 (7.29-20.3) 23.4 (14.3-35.4) 1003 
Non-Hispanic whites 07-08 * < LOD 2.93 (2.22-4.00) 11.4 (7.22-17.1) 23.9 (17.1-32.0) 2047 
 09-10 * < LOD 1.96 (1.82-2.15) 6.09 (5.00-7.83) 14.7 (10.0-18.2) 2514 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result.  
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Urinary NNAL (4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol) (creatinine corrected) (2011 - 2012) 
Metabolite of (4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone) (NNK) 
Geometric mean and selected percentiles of urine concentrations (in pg/mg of creatinine) for the **non-smoking U.S. population 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * 1.06 (1.00-1.14) 2.47 (2.14-2.72) 6.57 (5.24-8.25) 14.3 (11.7-18.4) 5483 
Age group        
6-11 years 11-12 2.57 (2.13-3.10) 1.91 (1.60-2.47) 5.93 (4.21-8.49) 23.5 (13.7-31.6) 39.1 (23.5-59.0) 954 
12-19 years 11-12 1.45 (1.31-1.60) 1.14 (1.05-1.25) 3.40 (2.50-3.99) 9.14 (5.71-13.4) 18.4 (12.2-22.2) 949 
20 years and older 11-12 * 1.00 (.938-1.08) 2.12 (1.91-2.42) 5.00 (4.26-6.18) 10.5 (8.56-13.0) 3580 
Gender        
Males 11-12 1.19 (1.10-1.29) .984 (.909-1.05) 2.38 (2.08-2.68) 7.36 (5.60-9.33) 15.2 (11.5-21.4) 2615 
Females 11-12 * 1.18 (1.04-1.30) 2.48 (2.17-2.86) 5.67 (4.69-8.21) 13.5 (10.3-18.0) 2868 
Race/ethnicity        
Mexican Americans 11-12 1.15 (.985-1.35) 1.03 (.860-1.22) 1.94 (1.67-2.35) 4.72 (3.51-6.74) 9.93 (6.46-15.9) 775 
Non-Hispanic blacks 11-12 1.50 (1.18-1.91) 1.31 (1.02-1.63) 3.70 (2.36-6.09) 11.5 (6.69-19.0) 19.7 (11.5-33.7) 1392 
Non-Hispanic whites 11-12 * 1.04 (.984-1.14) 2.47 (2.06-2.79) 5.94 (5.14-7.72) 16.1 (11.5-18.9) 1677 
Asians 11-12 * .972 (<LOD-1.17) 1.82 (1.56-2.24) 3.57 (2.86-4.79) 5.71 (4.29-8.57) 814 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result. 
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Blood Bromodichloromethane (2001 - 2008) 
 
Geometric mean and selected percentiles of whole blood concentrations (in pg/mL) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 01-02 2.21 (1.65-2.97) 2.30 (1.56-3.21) 4.63 (3.24-6.20) 8.45 (5.86-12.0) 12.0 (7.68-19.2) 785 
 03-04 1.50 (1.20-1.86) 1.40 (1.10-1.90) 3.40 (2.60-4.20) 6.20 (5.30-7.00) 9.50 (7.00-12.0) 1322 
 05-06 1.41 (1.09-1.83) 1.30 (.880-1.80) 3.00 (2.10-4.40) 6.30 (4.30-9.70) 10.0 (6.80-14.0) 3139 
 07-08 1.52 (1.24-1.86) 1.42 (1.05-1.90) 3.13 (2.50-4.20) 6.42 (4.70-8.30) 9.59 (7.05-14.6) 2982 
Age group        
12-19 years 05-06 1.23 (.954-1.58) 1.00 (.620-1.60) 2.80 (1.70-4.10) 5.50 (4.10-7.20) 8.20 (6.20-12.0) 932 
 07-08 1.49 (1.19-1.86) 1.26 (.910-1.88) 3.10 (2.42-4.05) 6.20 (4.13-8.52) 9.02 (6.20-15.0) 482 
20-59 years 01-02 2.21 (1.65-2.97) 2.30 (1.56-3.21) 4.63 (3.24-6.20) 8.45 (5.86-12.0) 12.0 (7.68-19.2) 785 
 03-04 1.50 (1.20-1.86) 1.40 (1.10-1.90) 3.40 (2.60-4.20) 6.20 (5.30-7.00) 9.50 (7.00-12.0) 1322 
 05-06 1.45 (1.11-1.89) 1.30 (.900-1.90) 3.10 (2.10-4.60) 6.40 (4.30-10.0) 11.0 (6.90-14.0) 1537 
 07-08 1.60 (1.28-2.01) 1.56 (1.13-2.04) 3.33 (2.61-4.43) 6.90 (4.94-9.29) 11.0 (7.39-15.6) 1607 
60 years and older 05-06 1.43 (.996-2.05) 1.40 (.850-2.00) 3.20 (1.60-5.90) 6.50 (3.20-15.0) 9.70 (5.00-18.0) 670 
 07-08 1.28 (1.07-1.53) 1.20 (.870-1.59) 2.60 (1.90-3.41) 4.88 (3.67-6.50) 7.39 (5.70-8.80) 893 
Gender        
Males 01-02 2.19 (1.60-3.00) 2.31 (1.63-3.21) 4.64 (3.21-6.08) 7.96 (5.74-15.3) 13.0 (6.93-20.5) 382 
 03-04 1.48 (1.18-1.85) 1.40 (.940-2.00) 3.40 (2.60-4.30) 6.60 (5.40-7.20) 11.0 (7.20-14.0) 650 
 05-06 1.39 (1.07-1.80) 1.20 (.830-1.70) 3.00 (2.00-4.30) 6.50 (4.30-10.0) 11.0 (6.80-16.0) 1489 
 07-08 1.52 (1.24-1.87) 1.50 (1.03-1.95) 3.23 (2.59-4.20) 6.72 (4.80-9.02) 11.0 (7.31-15.9) 1487 
Females 01-02 2.24 (1.66-3.01) 2.28 (1.49-3.24) 4.63 (3.09-7.01) 8.62 (5.26-12.9) 11.1 (7.68-25.0) 403 
 03-04 1.51 (1.21-1.90) 1.50 (1.10-1.90) 3.30 (2.50-4.20) 6.10 (4.69-7.30) 7.80 (6.40-12.0) 672 
 05-06 1.44 (1.10-1.88) 1.30 (.900-1.90) 3.10 (2.10-4.60) 6.20 (4.20-9.40) 9.40 (6.30-13.0) 1650 
 07-08 1.51 (1.22-1.87) 1.40 (1.01-1.92) 3.03 (2.42-4.10) 6.20 (4.60-7.82) 8.31 (6.80-12.9) 1495 
Race/ethnicity        
Mexican Americans 01-02 3.28 (2.29-4.68) 3.32 (2.19-4.70) 6.81 (3.71-10.4) 10.8 (8.24-14.7) 14.7 (11.1-20.5) 227 
 03-04 1.65 (1.15-2.38) 1.60 (.820-2.80) 3.50 (2.60-4.90) 7.30 (4.50-10.0) 10.0 (7.30-11.0) 244 
 05-06 1.95 (1.19-3.18) 1.90 (1.00-3.70) 4.40 (2.10-9.10) 9.10 (4.80-17.0) 14.0 (7.50-22.0) 771 
 07-08 1.61 (1.27-2.03) 1.57 (1.08-2.20) 3.44 (2.42-4.50) 5.93 (4.70-8.15) 8.90 (6.80-13.2) 574 
Non-Hispanic blacks 01-02 2.32 (1.82-2.94) 2.50 (1.56-3.55) 4.57 (3.60-5.56) 8.69 (5.63-9.49) 10.0 (5.89-13.5) 130 
 03-04 1.56 (1.15-2.13) 1.70 (1.10-2.20) 2.90 (2.15-3.80) 5.10 (3.80-6.60) 6.60 (4.90-13.0) 290 
 05-06 1.74 (1.27-2.37) 1.70 (1.00-2.70) 3.80 (2.70-4.80) 6.40 (4.50-8.90) 8.70 (6.60-11.0) 817 
 07-08 1.72 (1.42-2.08) 1.70 (1.30-2.21) 3.29 (2.80-4.01) 5.78 (4.70-7.30) 7.49 (6.03-9.70) 593 
Non-Hispanic whites 01-02 2.02 (1.42-2.87) 2.16 (1.36-3.09) 4.34 (2.92-6.01) 7.33 (4.72-15.3) 11.1 (6.01-26.1) 365 
 03-04 1.42 (1.11-1.81) 1.30 (.850-1.90) 3.30 (2.30-4.40) 6.20 (5.20-7.20) 9.80 (6.70-13.0) 684 
 05-06 1.29 (.989-1.67) 1.10 (.710-1.70) 2.70 (1.80-4.10) 5.80 (4.00-8.60) 9.40 (6.20-14.0) 1318 
 07-08 1.45 (1.11-1.87) 1.32 (.917-1.90) 3.03 (2.23-4.30) 6.50 (4.20-9.29) 9.59 (6.30-15.3) 1347 
Limit of detection (LOD, see Data Analysis section) for Survey years 01-02, 03-04, 05-06, and 07-08 are 0.233, 0.62, 0.62, and 0.62, respectively. 
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Blood Dibromochloromethane (Chlorodibromomethane) (2001 - 2008) 
 
Geometric mean and selected percentiles of whole blood concentrations (in pg/mL) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 01-02 .867 (.521-1.44) .780 (.340-1.90) 2.61 (1.22-4.38) 5.46 (3.53-9.71) 8.96 (5.04-12.9) 781 
 03-04 * < LOD 1.30 (1.00-1.80) 3.60 (2.70-4.80) 7.20 (4.80-8.60) 1333 
 05-06 * < LOD 1.40 (.870-2.40) 4.30 (2.40-7.40) 7.80 (4.60-13.0) 3122 
 07-08 * .775 (<LOD-1.05) 1.90 (1.36-2.73) 4.29 (3.20-6.13) 7.14 (5.54-9.52) 2998 
Age group        
12-19 years 05-06 * < LOD 1.30 (.750-2.50) 4.10 (2.60-5.50) 6.50 (4.10-11.0) 925 
 07-08 * .760 (<LOD-1.06) 2.09 (1.30-3.05) 4.50 (3.09-7.22) 8.32 (5.39-14.4) 484 
20-59 years 01-02 .867 (.521-1.44) .780 (.340-1.90) 2.61 (1.22-4.38) 5.46 (3.53-9.71) 8.96 (5.04-12.9) 781 
 03-04 * < LOD 1.30 (1.00-1.80) 3.60 (2.70-4.80) 7.20 (4.80-8.60) 1333 
 05-06 * < LOD 1.40 (.860-2.30) 4.10 (2.40-7.10) 7.80 (4.20-14.0) 1526 
 07-08 * .846 (<LOD-1.15) 2.07 (1.50-2.92) 4.75 (3.40-6.60) 7.99 (5.80-10.5) 1617 
60 years and older 05-06 * < LOD 1.60 (.780-4.00) 5.10 (1.30-13.0) 7.90 (2.20-20.0) 671 
 07-08 * .630 (<LOD-.874) 1.40 (.918-2.28) 3.40 (2.16-4.63) 4.86 (3.79-5.50) 897 
Gender        
Males 01-02 .850 (.481-1.50) .730 (.300-2.25) 2.66 (.960-4.38) 4.77 (3.33-9.20) 8.06 (4.31-14.6) 371 
 03-04 * < LOD 1.30 (1.00-1.90) 3.70 (2.70-5.70) 7.20 (5.20-8.60) 657 
 05-06 * < LOD 1.40 (.830-2.30) 4.40 (2.30-7.80) 8.30 (4.30-14.0) 1487 
 07-08 * .762 (<LOD-1.10) 2.10 (1.38-2.87) 4.30 (3.30-6.50) 7.50 (5.66-10.5) 1496 
Females 01-02 .884 (.550-1.42) .820 (.340-1.69) 2.54 (1.37-4.31) 6.30 (3.28-10.1) 9.91 (5.02-13.0) 410 
 03-04 * < LOD 1.30 (1.00-1.80) 3.60 (2.50-4.80) 6.60 (3.80-9.20) 676 
 05-06 * < LOD 1.50 (.920-2.50) 4.20 (2.20-7.80) 7.20 (4.10-14.0) 1635 
 07-08 * .776 (<LOD-1.04) 1.80 (1.34-2.62) 4.25 (2.88-6.07) 6.40 (4.91-9.70) 1502 
Race/ethnicity        
Mexican Americans 01-02 1.61 (.843-3.06) 1.49 (.670-3.99) 4.59 (1.93-8.89) 9.26 (5.21-12.1) 12.0 (9.63-16.1) 233 
 03-04 1.20 (.963-1.50) 1.10 (.810-1.40) 2.30 (1.50-4.10) 5.20 (3.80-6.90) 7.70 (5.20-11.0) 256 
 05-06 1.25 (.774-2.02) .950 (<LOD-1.70) 2.50 (1.00-7.40) 7.40 (2.50-19.0) 13.0 (5.80-21.0) 759 
 07-08 1.54 (1.09-2.18) 1.38 (.864-2.10) 3.20 (1.79-5.80) 7.70 (3.35-13.0) 9.81 (7.10-18.2) 574 
Non-Hispanic blacks 01-02 1.03 (.505-2.09) .930 (.530-2.03) 2.03 (.770-7.06) 4.22 (2.01-10.5) 8.09 (2.80-16.5) 128 
 03-04 * < LOD .970 (.650-1.60) 1.90 (1.20-3.20) 3.20 (1.80-5.20) 288 
 05-06 * .620 (<LOD-.820) 1.30 (1.00-1.90) 3.40 (2.10-4.90) 5.50 (4.10-7.10) 822 
 07-08 .979 (.752-1.27) .811 (<LOD-1.12) 1.60 (1.02-2.70) 3.28 (2.18-5.67) 5.67 (3.05-8.50) 593 
Non-Hispanic whites 01-02 .736 (.413-1.31) .640 (<LOD-1.93) 2.49 (.870-4.27) 4.57 (3.00-7.12) 6.98 (4.27-11.1) 357 
 03-04 * < LOD 1.30 (.950-1.80) 3.30 (2.50-4.60) 6.60 (3.70-9.20) 685 
 05-06 * < LOD 1.30 (.710-2.30) 4.10 (2.30-7.10) 7.70 (4.60-11.0) 1311 
 07-08 * .665 (<LOD-1.02) 1.79 (1.09-2.88) 3.95 (2.60-5.78) 6.03 (4.02-9.80) 1358 
Limit of detection (LOD, see Data Analysis section) for Survey years 01-02, 03-04, 05-06, and 07-08 are 0.271, 0.62, 0.62, and 0.62, respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Blood Tribromomethane (Bromoform) (2001 - 2008) 
 
Geometric mean and selected percentiles of whole blood concentrations (in pg/mL) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 01-02 1.57 (1.07-2.31) 1.39 (.960-2.02) 2.78 (1.76-4.63) 6.05 (2.92-29.2) 15.5 (3.68-85.4) 774 
 03-04 * < LOD 1.80 (<LOD-2.80) 3.74 (2.30-7.10) 6.40 (3.60-14.0) 1310 
 05-06 * < LOD 1.20 (<LOD-1.60) 2.70 (2.00-4.00) 5.20 (3.10-7.60) 3016 
 07-08 * < LOD < LOD 2.51 (1.90-3.34) 5.20 (3.54-7.44) 2994 
Age group        
12-19 years 05-06 * < LOD 1.20 (<LOD-1.60) 2.40 (1.70-4.40) 4.80 (2.80-7.10) 892 
 07-08 * < LOD 1.11 (<LOD-1.29) 2.80 (1.90-4.77) 6.69 (3.50-7.88) 484 
20-59 years 01-02 1.57 (1.07-2.31) 1.39 (.960-2.02) 2.78 (1.76-4.63) 6.05 (2.92-29.2) 15.5 (3.68-85.4) 774 
 03-04 * < LOD 1.80 (<LOD-2.80) 3.74 (2.30-7.10) 6.40 (3.60-14.0) 1310 
 05-06 * < LOD 1.20 (<LOD-1.60) 2.90 (1.90-4.20) 5.20 (3.10-8.80) 1478 
 07-08 * < LOD < LOD 2.73 (1.93-3.74) 6.48 (3.74-7.98) 1614 
60 years and older 05-06 * < LOD 1.28 (<LOD-2.10) 2.60 (2.30-3.50) 4.70 (3.00-7.70) 646 
 07-08 * < LOD < LOD 1.78 (1.33-2.72) 3.24 (2.16-4.91) 896 
Gender        
Males 01-02 1.49 (.944-2.34) 1.29 (.850-1.98) 2.65 (1.49-5.05) 6.12 (2.26-33.9) 14.9 (2.79-69.9) 374 
 03-04 * < LOD 1.90 (<LOD-2.87) 4.00 (2.40-6.80) 6.50 (4.00-13.0) 645 
 05-06 * < LOD 1.16 (<LOD-1.60) 2.70 (1.90-4.00) 5.00 (3.10-7.60) 1424 
 07-08 * < LOD < LOD 2.40 (1.71-3.51) 6.00 (3.23-8.49) 1494 
Females 01-02 1.67 (1.17-2.39) 1.46 (1.05-2.21) 2.86 (1.89-4.57) 5.69 (3.30-27.5) 22.2 (5.09-49.6) 400 
 03-04 * < LOD 1.72 (<LOD-2.65) 3.20 (1.93-7.70) 6.10 (3.10-31.0) 665 
 05-06 * < LOD 1.23 (1.00-1.60) 2.70 (1.90-4.20) 5.20 (3.10-8.80) 1592 
 07-08 * < LOD < LOD 2.57 (1.90-3.40) 4.88 (3.55-7.30) 1500 
Race/ethnicity        
Mexican Americans 01-02 2.34 (1.15-4.77) 1.66 (.990-3.38) 4.03 (1.42-36.5) 28.3 (4.39-49.2) 40.8 (31.5-57.9) 234 
 03-04 * 1.60 (<LOD-3.10) 3.30 (<LOD-9.40) 7.60 (3.60-14.0) 11.0 (5.60-210) 242 
 05-06 * < LOD 1.60 (1.04-3.20) 4.00 (2.40-5.90) 5.90 (4.30-8.30) 721 
 07-08 * < LOD 2.82 (1.23-6.70) 6.80 (2.93-11.0) 9.54 (6.10-15.7) 574 
Non-Hispanic blacks 01-02 1.51 (.857-2.67) 1.47 (.780-3.15) 2.58 (1.39-4.64) 4.34 (2.57-8.48) 6.27 (3.28-15.2) 121 
 03-04 * < LOD 1.60 (<LOD-2.30) 2.50 (1.80-3.20) 3.20 (2.40-6.10) 289 
 05-06 * < LOD 1.10 (<LOD-1.30) 2.00 (1.70-2.40) 3.40 (2.30-4.30) 796 
 07-08 * < LOD < LOD 1.54 (<LOD-3.54) 3.07 (1.47-7.20) 592 
Non-Hispanic whites 01-02 1.47 (.980-2.22) 1.29 (.840-2.06) 2.58 (1.51-4.91) 5.69 (2.84-21.2) 11.0 (3.30-69.9) 362 
 03-04 * < LOD 1.70 (<LOD-2.90) 3.50 (2.00-7.70) 5.90 (3.30-21.0) 680 
 05-06 * < LOD 1.20 (<LOD-1.60) 2.80 (2.00-3.90) 5.40 (3.10-9.90) 1271 
 07-08 * < LOD < LOD 1.90 (1.33-2.97) 3.51 (1.93-7.81) 1355 
Limit of detection (LOD, see Data Analysis section) for Survey years 01-02, 03-04, 05-06, and 07-08 are 0.596, 1.5, 1.0, and 1.0, respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Blood Trichloromethane (Chloroform) (2001 - 2008) 
 
Geometric mean and selected percentiles of whole blood concentrations (in pg/mL) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 01-02 16.6 (13.0-21.1) 16.1 (11.9-22.2) 31.7 (23.9-40.4) 55.5 (44.5-68.6) 72.1 (57.3-105) 744 
 03-04 10.2 (8.56-12.2) 10.0 (8.50-13.0) 20.0 (17.0-24.0) 35.0 (29.0-40.0) 50.0 (37.0-65.0) 1222 
 05-06 10.1 (9.09-11.3) 9.90 (8.90-11.0) 19.0 (17.0-21.0) 36.0 (31.0-41.0) 54.0 (46.0-64.0) 3111 
 07-08 6.63 (5.30-8.30) 6.56 (4.87-8.83) 14.6 (11.0-19.4) 27.7 (22.0-37.0) 41.8 (33.0-54.1) 2754 
Age group        
12-19 years 05-06 9.22 (8.20-10.4) 9.10 (8.10-10.0) 17.0 (14.0-20.0) 33.0 (27.0-40.0) 46.0 (36.0-64.0) 913 
 07-08 5.95 (4.69-7.53) 5.33 (3.92-7.98) 12.5 (8.56-19.0) 25.5 (17.6-48.3) 47.6 (26.0-56.8) 440 
20-59 years 01-02 16.6 (13.0-21.1) 16.1 (11.9-22.2) 31.7 (23.9-40.4) 55.5 (44.5-68.6) 72.1 (57.3-105) 744 
 03-04 10.2 (8.56-12.2) 10.0 (8.50-13.0) 20.0 (17.0-24.0) 35.0 (29.0-40.0) 50.0 (37.0-65.0) 1222 
 05-06 10.5 (9.29-11.8) 10.0 (8.90-12.0) 20.0 (18.0-22.0) 37.0 (31.0-44.0) 55.0 (46.0-71.0) 1529 
 07-08 6.89 (5.37-8.83) 6.78 (5.00-9.53) 15.1 (11.2-20.8) 29.0 (23.3-38.3) 42.0 (34.2-55.8) 1503 
60 years and older 05-06 9.71 (8.25-11.4) 9.60 (8.20-11.0) 19.0 (14.0-22.0) 35.0 (27.0-40.0) 46.0 (39.0-59.0) 669 
 07-08 6.25 (5.24-7.46) 6.34 (4.64-8.30) 14.0 (11.0-17.2) 24.8 (19.5-33.0) 36.0 (25.4-48.6) 811 
Gender        
Males 01-02 16.8 (12.0-23.5) 16.1 (11.0-24.8) 34.3 (22.4-48.7) 57.0 (39.9-76.4) 75.2 (54.5-156) 358 
 03-04 10.1 (8.43-12.1) 10.0 (7.90-14.0) 20.0 (17.0-25.0) 36.8 (29.0-49.0) 53.0 (36.8-69.0) 599 
 05-06 9.94 (8.80-11.2) 9.80 (8.50-11.0) 19.0 (17.0-22.0) 38.0 (33.0-44.0) 54.0 (46.0-67.0) 1483 
 07-08 6.54 (5.25-8.14) 6.32 (4.85-8.43) 14.2 (11.0-19.1) 29.0 (21.9-37.6) 41.8 (31.8-59.2) 1376 
Females 01-02 16.4 (13.4-20.1) 16.6 (12.0-21.5) 29.2 (24.0-36.5) 53.5 (38.4-68.9) 69.5 (53.3-104) 386 
 03-04 10.4 (8.41-12.7) 10.0 (8.40-13.0) 20.0 (16.0-23.9) 33.0 (26.0-40.0) 46.0 (35.0-65.0) 623 
 05-06 10.4 (9.24-11.6) 10.0 (9.10-11.0) 19.0 (17.0-21.0) 32.0 (29.0-39.0) 52.0 (41.0-67.0) 1628 
 07-08 6.73 (5.29-8.55) 6.73 (4.80-9.35) 15.0 (11.0-19.7) 26.9 (21.5-37.7) 42.0 (31.4-54.0) 1378 
Race/ethnicity        
Mexican Americans 01-02 17.0 (10.5-27.6) 14.5 (10.0-32.7) 35.1 (18.6-57.6) 60.7 (41.5-100) 93.0 (49.7-243) 223 
 03-04 9.17 (7.45-11.3) 9.30 (7.60-11.0) 19.0 (15.0-24.0) 34.0 (24.0-44.4) 44.4 (30.0-59.0) 225 
 05-06 10.3 (8.59-12.5) 10.0 (7.60-14.0) 20.0 (17.0-22.0) 36.0 (30.0-41.0) 47.0 (41.0-64.0) 740 
 07-08 5.87 (4.20-8.19) 5.23 (3.50-7.80) 13.0 (7.76-20.0) 30.3 (15.8-49.2) 45.9 (23.4-89.7) 504 
Non-Hispanic blacks 01-02 19.1 (12.9-28.1) 20.9 (9.28-37.4) 38.4 (27.7-46.0) 55.9 (45.5-69.8) 68.9 (51.9-74.0) 116 
 03-04 11.8 (9.54-14.6) 12.0 (8.90-15.0) 20.0 (15.0-30.0) 35.0 (28.0-59.0) 61.0 (34.0-100) 272 
 05-06 11.9 (9.78-14.4) 12.0 (9.10-15.0) 22.0 (19.0-26.0) 39.0 (31.0-47.0) 55.0 (46.0-70.0) 822 
 07-08 8.00 (6.22-10.3) 8.60 (6.20-11.0) 15.7 (12.0-20.0) 28.0 (22.3-37.0) 39.6 (34.5-46.6) 585 
Non-Hispanic whites 01-02 15.6 (12.0-20.2) 15.2 (11.2-20.5) 26.8 (20.4-39.5) 53.5 (35.3-72.1) 69.5 (53.5-105) 348 
 03-04 9.84 (8.09-12.0) 10.0 (8.10-13.0) 20.0 (16.0-23.0) 33.8 (27.0-40.0) 47.0 (35.0-67.0) 630 
 05-06 9.87 (8.79-11.1) 9.70 (8.80-11.0) 19.0 (16.0-21.0) 34.0 (29.0-43.0) 53.0 (45.0-67.0) 1318 
 07-08 6.45 (4.95-8.40) 6.30 (4.16-9.23) 14.9 (10.1-21.0) 27.7 (21.0-40.0) 41.8 (31.0-58.9) 1226 
Limit of detection (LOD, see Data Analysis section) for Survey years 01-02, 03-04, 05-06, and 07-08 are 2.37, 2.11, 2.1, and 2.1, respectively. 
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Urinary Benzophenone-3 (2003 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 22.9 (18.1-28.9) 18.1 (15.5-23.2) 94.0 (67.5-123) 370 (225-570) 1040 (698-1390) 2517 
 05-06 19.4 (16.5-22.8) 14.1 (12.5-17.5) 68.8 (54.5-87.2) 433 (294-597) 1150 (936-1510) 2548 
 07-08 18.3 (13.7-24.3) 14.3 (10.7-19.8) 64.1 (42.8-116) 365 (223-524) 801 (471-2080) 2604 
 09-10 22.3 (18.0-27.7) 16.4 (12.7-20.5) 81.2 (55.0-126) 493 (320-742) 1750 (931-3120) 2749 
Age group        
6-11 years 03-04 21.2 (16.4-27.3) 17.2 (14.9-25.9) 66.7 (38.7-102) 158 (106-246) 246 (154-618) 314 
 05-06 21.2 (14.3-31.3) 19.4 (11.7-26.1) 58.8 (40.5-102) 259 (115-433) 852 (355-2200) 356 
 07-08 24.1 (15.0-38.7) 17.2 (11.8-25.0) 79.9 (32.9-168) 392 (129-1610) 1410 (165-43600) 389 
 09-10 21.7 (15.6-30.2) 14.6 (12.0-19.7) 52.7 (27.2-119) 470 (80.7-1900) 1570 (153-6440) 415 
12-19 years 03-04 22.9 (18.0-29.3) 20.1 (16.1-25.1) 67.1 (45.2-93.8) 170 (137-240) 407 (183-717) 715 
 05-06 21.2 (15.8-28.4) 14.9 (12.1-21.4) 64.3 (39.7-95.3) 227 (130-382) 633 (252-1260) 702 
 07-08 21.5 (16.0-28.8) 15.0 (11.9-21.3) 59.3 (36.7-111) 214 (113-613) 613 (206-1350) 401 
 09-10 23.3 (16.6-32.5) 16.6 (13.1-19.7) 62.3 (35.1-129) 423 (184-843) 988 (550-2670) 420 
20 years and older 03-04 23.1 (18.0-29.6) 18.1 (14.7-23.3) 109 (72.1-140) 450 (315-733) 1220 (769-1750) 1488 
 05-06 19.0 (16.5-21.8) 13.5 (12.0-16.3) 70.9 (55.2-87.2) 543 (390-638) 1200 (954-1690) 1490 
 07-08 17.3 (13.0-23.0) 13.7 (10.0-19.5) 64.1 (41.5-117) 371 (240-516) 801 (516-1790) 1814 
 09-10 22.3 (17.9-27.7) 16.5 (12.3-22.5) 86.7 (63.1-129) 505 (339-760) 1890 (1240-3170) 1914 
Gender        
Males 03-04 16.8 (13.2-21.3) 13.7 (11.4-16.8) 55.3 (33.2-86.6) 178 (134-324) 567 (238-1350) 1229 
 05-06 14.6 (10.8-19.7) 11.8 (8.80-15.9) 43.4 (31.0-68.8) 227 (103-552) 909 (479-1190) 1270 
 07-08 11.9 (8.84-16.0) 9.40 (7.70-12.3) 37.6 (22.6-54.7) 172 (79.9-376) 471 (208-1410) 1294 
 09-10 15.3 (12.7-18.6) 12.2 (10.0-15.2) 52.8 (33.9-72.6) 223 (129-332) 610 (318-1270) 1399 
Females 03-04 30.7 (23.7-39.8) 26.0 (20.2-34.1) 137 (106-172) 596 (403-769) 1340 (776-1790) 1288 
 05-06 25.5 (21.7-29.9) 17.9 (14.3-23.1) 129 (82.9-166) 638 (478-900) 1410 (945-2620) 1278 
 07-08 27.6 (20.4-37.3) 25.6 (17.5-33.9) 117 (72.6-211) 535 (361-757) 1260 (643-2280) 1310 
 09-10 32.0 (23.7-43.3) 23.0 (16.4-29.8) 148 (73.3-260) 1020 (540-1800) 3200 (1760-4400) 1350 
Race/ethnicity        
Mexican Americans 03-04 16.5 (10.9-25.1) 11.9 (8.50-18.3) 45.5 (25.9-78.2) 178 (76.4-412) 412 (178-2180) 613 
 05-06 14.3 (10.7-19.1) 10.2 (7.40-14.1) 45.6 (24.1-75.7) 214 (166-313) 635 (337-1090) 637 
 07-08 12.1 (9.49-15.3) 9.90 (7.70-12.4) 32.6 (25.0-48.3) 142 (85.0-268) 409 (214-778) 531 
 09-10 17.2 (13.7-21.6) 12.5 (10.5-14.5) 41.9 (30.2-57.4) 351 (248-546) 1130 (493-2140) 566 
Non-Hispanic blacks 03-04 12.8 (9.38-17.4) 10.2 (7.40-14.4) 34.3 (22.8-50.6) 127 (90.8-176) 247 (143-499) 652 
 05-06 12.4 (9.77-15.6) 9.40 (7.30-11.8) 33.0 (22.3-46.5) 208 (115-291) 556 (269-1060) 678 
 07-08 8.55 (6.75-10.8) 7.40 (5.00-9.70) 25.5 (17.5-34.5) 117 (66.8-217) 422 (195-786) 597 
 09-10 14.0 (10.9-18.1) 8.90 (7.30-10.5) 30.9 (21.9-50.5) 276 (143-437) 705 (320-3000) 516 
Non-Hispanic whites 03-04 27.7 (20.3-37.8) 24.4 (16.8-32.0) 121 (83.6-162) 507 (316-769) 1340 (733-2070) 1092 
 05-06 21.6 (18.5-25.2) 16.0 (13.5-19.0) 82.4 (64.2-114) 552 (392-754) 1370 (945-2050) 1038 
 07-08 23.1 (15.0-35.5) 18.7 (11.0-33.7) 101 (47.4-206) 459 (241-749) 1160 (487-2620) 1077 
 09-10 26.1 (19.0-35.9) 21.1 (14.6-29.7) 94.9 (59.8-186) 610 (325-1240) 2130 (934-3820) 1206 
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Urinary Benzophenone-3 (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 23.2 (17.2-31.3) 18.7 (13.6-27.0) 83.8 (50.8-142) 461 (290-861) 1200 (861-1610) 2489 
 13-14 25.2 (20.4-31.2) 21.0 (16.8-25.3) 87.9 (72.7-102) 417 (269-642) 1210 (853-1760) 2686 
Age group        
6-11 years 11-12 18.7 (12.3-28.2) 13.2 (8.20-20.8) 55.4 (28.0-108) 336 (134-653) 657 (236-1270) 396 
 13-14 26.0 (16.5-40.9) 19.2 (14.4-30.0) 77.6 (39.0-206) 363 (171-720) 824 (271-1840) 409 
12-19 years 11-12 27.8 (15.4-50.2) 21.6 (10.8-42.1) 109 (34.0-255) 433 (159-1160) 1120 (261-1990) 388 
 13-14 29.2 (23.3-36.4) 26.2 (19.7-36.4) 87.2 (57.8-137) 261 (167-504) 537 (269-1340) 462 
20 years and older 11-12 23.1 (17.8-30.0) 19.2 (14.4-27.0) 83.8 (52.8-137) 482 (305-805) 1250 (975-1640) 1705 
 13-14 24.6 (19.7-30.6) 20.1 (16.0-24.7) 90.6 (73.4-102) 482 (294-801) 1360 (875-2740) 1815 
Gender        
Males 11-12 17.2 (12.1-24.5) 16.0 (9.40-23.6) 50.2 (40.1-78.7) 295 (141-448) 594 (301-1360) 1259 
 13-14 19.0 (15.8-22.9) 16.8 (14.4-19.8) 55.0 (46.4-63.1) 231 (176-259) 576 (340-864) 1285 
Females 11-12 31.0 (22.7-42.2) 22.2 (16.0-34.1) 137 (79.9-243) 781 (467-1220) 1720 (1260-2290) 1230 
 13-14 32.9 (24.9-43.5) 26.2 (19.4-37.2) 120 (94.9-195) 733 (447-1230) 1950 (1200-3460) 1401 
Race/ethnicity        
Mexican Americans 11-12 16.8 (10.5-26.8) 13.4 (7.20-25.2) 46.1 (25.2-115) 305 (111-644) 885 (305-1740) 316 
 13-14 25.9 (20.5-32.7) 19.0 (15.0-24.2) 69.3 (44.1-86.6) 256 (204-538) 893 (518-1230) 438 
Non-Hispanic blacks 11-12 14.5 (11.4-18.5) 10.9 (8.00-14.1) 41.4 (28.8-59.5) 316 (192-433) 895 (475-1270) 665 
 13-14 10.9 (7.48-15.8) 9.60 (6.60-13.1) 26.9 (19.6-39.9) 104 (60.3-205) 448 (118-1070) 609 
Non-Hispanic whites 11-12 26.8 (17.8-40.5) 22.2 (14.8-36.5) 101 (52.8-216) 512 (255-1130) 1230 (805-1830) 813 
 13-14 29.7 (22.7-38.8) 24.9 (19.5-32.9) 108 (94.0-131) 523 (340-853) 1470 (1150-2860) 988 
All Hispanics 11-12 21.2 (15.2-29.4) 16.3 (10.6-22.7) 57.9 (38.2-126) 408 (261-684) 1020 (527-1610) 571 
 13-14 28.2 (23.8-33.4) 20.1 (16.5-23.9) 81.5 (64.7-98.3) 415 (219-824) 1120 (738-1780) 690 
Asians 11-12 16.7 (10.5-26.5) 11.9 (7.30-21.1) 66.4 (37.6-122) 486 (157-1350) 1640 (770-2780) 352 
 13-14 18.6 (12.4-28.0) 17.0 (8.30-26.8) 64.2 (36.1-107) 254 (114-532) 532 (283-1770) 289 
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Urinary Benzophenone-3 (creatinine corrected) (2003 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 22.2 (17.6-28.0) 16.2 (12.7-21.6) 82.0 (58.7-108) 415 (283-577) 1080 (686-1600) 2514 
 05-06 18.9 (15.8-22.6) 13.5 (11.2-16.8) 60.4 (47.6-81.4) 445 (346-553) 1210 (794-1970) 2548 
 07-08 18.4 (13.9-24.4) 13.5 (10.2-17.8) 67.9 (45.2-117) 338 (215-584) 935 (525-1800) 2604 
 09-10 23.3 (18.7-29.1) 16.1 (12.8-19.8) 79.1 (52.2-124) 579 (355-1040) 2340 (1380-3010) 2749 
Age group        
6-11 years 03-04 25.8 (19.5-34.1) 22.4 (14.4-33.7) 84.6 (41.0-131) 171 (132-365) 427 (171-710) 314 
 05-06 23.3 (15.9-34.1) 17.5 (11.6-28.3) 67.7 (39.7-105) 249 (106-631) 868 (264-2080) 356 
 07-08 29.7 (19.0-46.6) 19.3 (12.4-32.3) 103 (51.1-159) 442 (133-1550) 1430 (187-29100) 389 
 09-10 28.3 (20.4-39.4) 18.8 (14.7-21.1) 53.9 (33.2-132) 565 (104-3410) 1780 (253-8230) 415 
12-19 years 03-04 17.2 (13.7-21.5) 12.9 (10.4-16.5) 43.6 (29.5-57.7) 136 (91.7-239) 350 (173-646) 713 
 05-06 15.8 (11.6-21.6) 12.1 (9.16-17.0) 42.5 (28.6-58.7) 164 (101-438) 625 (225-956) 702 
 07-08 16.7 (12.4-22.4) 12.1 (8.57-17.6) 55.7 (30.4-74.8) 211 (88.2-505) 505 (163-902) 401 
 09-10 18.7 (13.4-26.1) 13.6 (10.1-19.7) 39.9 (25.5-91.6) 412 (89.8-750) 1240 (629-2540) 420 
20 years and older 03-04 22.8 (17.8-29.1) 16.2 (12.7-21.9) 93.2 (66.0-130) 491 (361-700) 1330 (880-1880) 1487 
 05-06 19.0 (16.3-22.2) 13.4 (11.2-16.2) 64.2 (49.3-87.0) 509 (406-628) 1480 (816-2200) 1490 
 07-08 17.7 (13.3-23.6) 12.6 (9.93-17.5) 67.7 (44.1-127) 362 (249-584) 960 (581-1970) 1814 
 09-10 23.6 (18.8-29.5) 16.3 (12.7-20.2) 83.6 (58.3-146) 602 (364-1230) 2470 (1350-3080) 1914 
Gender        
Males 03-04 13.6 (10.8-17.1) 10.3 (8.36-12.9) 40.0 (24.9-62.5) 169 (93.3-316) 381 (229-685) 1228 
 05-06 11.7 (8.74-15.8) 9.43 (6.72-12.5) 31.9 (19.7-49.4) 176 (77.1-406) 553 (317-948) 1270 
 07-08 10.0 (7.37-13.7) 7.50 (5.74-10.0) 28.7 (18.5-47.3) 142 (65.8-225) 332 (181-960) 1294 
 09-10 13.7 (11.4-16.6) 10.7 (8.53-12.7) 44.6 (29.7-57.4) 186 (123-287) 420 (287-1230) 1399 
Females 03-04 35.5 (27.1-46.4) 28.2 (20.2-37.0) 144 (101-224) 686 (491-1130) 1850 (1220-2580) 1286 
 05-06 30.0 (25.3-35.6) 20.9 (17.0-29.0) 129 (88.0-175) 707 (527-912) 1880 (1150-2770) 1278 
 07-08 33.0 (25.0-43.7) 26.2 (19.1-41.1) 156 (90.2-235) 617 (385-935) 1500 (746-2710) 1310 
 09-10 38.6 (28.1-53.0) 25.7 (17.5-35.2) 161 (76.3-378) 1580 (955-2410) 3250 (2540-4640) 1350 
Race/ethnicity        
Mexican Americans 03-04 15.1 (9.44-24.0) 11.1 (6.95-16.0) 40.7 (18.3-85.8) 158 (87.4-362) 595 (118-1860) 612 
 05-06 12.9 (10.2-16.2) 8.63 (6.16-12.5) 32.1 (23.1-51.8) 216 (135-408) 948 (441-1220) 637 
 07-08 11.8 (8.87-15.6) 8.97 (7.00-12.4) 33.6 (26.0-43.2) 154 (93.4-249) 413 (217-932) 531 
 09-10 17.1 (13.4-21.7) 12.2 (9.64-14.5) 40.4 (26.4-60.3) 288 (155-603) 1310 (441-2180) 566 
Non-Hispanic blacks 03-04 8.78 (6.49-11.9) 6.80 (5.27-9.00) 19.7 (13.5-33.4) 79.8 (46.8-139) 185 (79.8-536) 651 
 05-06 8.69 (7.02-10.8) 6.29 (5.52-7.78) 21.2 (14.5-34.5) 118 (74.9-245) 448 (208-876) 678 
 07-08 6.65 (5.24-8.42) 5.09 (4.15-6.10) 17.8 (13.2-24.2) 86.6 (57.5-122) 297 (113-903) 597 
 09-10 10.2 (8.12-12.7) 6.46 (5.40-7.67) 23.1 (15.5-38.2) 160 (79.9-396) 653 (305-1580) 516 
Non-Hispanic whites 03-04 28.3 (20.6-38.8) 22.0 (14.6-32.7) 116 (73.5-175) 510 (380-760) 1330 (852-2410) 1091 
 05-06 22.7 (19.4-26.7) 16.2 (13.0-19.7) 77.3 (56.5-106) 538 (406-679) 1500 (828-2430) 1038 
 07-08 24.1 (15.6-37.2) 18.1 (11.0-30.0) 103 (53.6-198) 494 (227-960) 1170 (522-2710) 1077 
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Urinary Benzophenone-3 (creatinine corrected) (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 26.4 (19.3-36.2) 18.8 (13.3-27.3) 102 (57.8-162) 613 (330-1020) 1680 (1010-2500) 2487 
 13-14 25.2 (20.5-31.0) 19.8 (15.7-24.7) 79.8 (66.2-103) 467 (299-603) 1190 (847-1810) 2684 
Age group        
6-11 years 11-12 26.9 (17.9-40.2) 18.8 (13.0-28.6) 67.8 (37.8-135) 552 (138-1010) 1010 (297-1670) 395 
 13-14 32.8 (21.5-50.1) 28.8 (16.7-45.7) 90.0 (46.9-189) 401 (152-868) 868 (432-1700) 409 
12-19 years 11-12 27.1 (14.2-51.8) 16.7 (8.69-44.3) 102 (29.9-331) 631 (117-3050) 1720 (331-3900) 388 
 13-14 23.7 (17.8-31.4) 21.6 (15.8-28.7) 63.0 (49.1-86.2) 221 (116-440) 506 (221-647) 462 
20 years and older 11-12 26.3 (19.8-34.8) 19.8 (13.9-26.6) 107 (68.1-156) 640 (371-957) 1890 (1080-2500) 1704 
 13-14 24.7 (20.3-30.0) 18.8 (15.2-23.1) 82.3 (69.5-102) 529 (317-790) 1420 (915-2660) 1813 
Gender        
Males 11-12 16.1 (11.3-22.8) 11.9 (8.77-18.1) 48.8 (31.6-84.5) 237 (120-442) 716 (267-1030) 1258 
 13-14 15.9 (13.2-19.3) 13.8 (10.9-17.5) 44.0 (33.1-58.5) 181 (146-229) 432 (299-532) 1284 
Females 11-12 42.7 (30.6-59.5) 30.1 (19.7-49.4) 186 (107-374) 1150 (771-1910) 2720 (1660-4230) 1229 
 13-14 38.9 (29.2-51.8) 29.7 (21.3-39.9) 153 (83.6-242) 905 (603-1250) 2550 (1440-3500) 1400 
Race/ethnicity        
Mexican Americans 11-12 18.9 (12.4-29.0) 13.8 (8.75-22.0) 45.3 (23.5-132) 369 (132-820) 1030 (371-2330) 316 
 13-14 26.4 (20.2-34.4) 18.2 (15.6-23.2) 59.1 (40.6-82.7) 296 (122-1090) 1180 (473-2130) 438 
Non-Hispanic blacks 11-12 11.3 (8.82-14.5) 7.48 (6.04-9.49) 27.6 (18.0-42.1) 269 (159-376) 747 (376-1010) 665 
 13-14 8.02 (5.57-11.5) 6.43 (4.68-8.60) 16.9 (11.6-24.7) 93.5 (51.1-204) 332 (144-818) 609 
Non-Hispanic whites 11-12 32.6 (21.1-50.4) 25.5 (15.3-41.1) 128 (70.8-248) 793 (334-1320) 1970 (1030-3500) 811 
 13-14 31.2 (24.5-39.6) 25.3 (20.1-31.5) 115 (77.3-159) 569 (432-765) 1270 (871-2550) 987 
All Hispanics 11-12 23.7 (17.6-32.0) 15.9 (11.4-21.7) 65.0 (38.6-132) 425 (265-916) 1850 (784-2330) 571 
 13-14 28.0 (23.2-33.7) 18.8 (16.3-22.5) 66.8 (50.9-84.5) 338 (190-1020) 1380 (974-2740) 690 
Asians 11-12 22.3 (14.3-34.9) 14.2 (8.24-27.8) 73.1 (41.6-153) 624 (282-1640) 1860 (641-4410) 352 
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Urinary Bisphenol A (2003 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 2.64 (2.38-2.94) 2.80 (2.50-3.10) 5.50 (5.00-6.20) 10.6 (9.40-12.0) 16.0 (14.4-17.2) 2517 
 05-06 1.90 (1.79-2.02) 2.00 (1.90-2.00) 3.70 (3.50-3.90) 7.00 (6.40-7.60) 11.5 (10.0-13.6) 2548 
 07-08 2.08 (1.92-2.26) 2.10 (1.90-2.30) 4.10 (3.60-4.60) 7.70 (6.80-8.70) 13.0 (10.0-15.6) 2604 
 09-10 1.83 (1.72-1.94) 1.90 (1.70-2.00) 3.50 (3.30-3.80) 6.60 (6.00-7.20) 9.60 (8.50-11.3) 2749 
Age group        
6-11 years 03-04 3.55 (2.95-4.29) 3.80 (2.70-5.00) 6.90 (6.00-8.30) 12.6 (9.50-15.1) 16.0 (11.5-23.3) 314 
 05-06 2.86 (2.52-3.24) 2.70 (2.30-2.90) 5.00 (4.40-5.80) 13.5 (9.30-16.8) 22.8 (13.6-34.6) 356 
 07-08 2.48 (2.21-2.77) 2.40 (1.90-3.00) 4.50 (3.70-5.50) 7.60 (6.30-9.50) 13.4 (8.80-17.8) 389 
 09-10 1.81 (1.55-2.10) 1.70 (1.50-2.00) 3.40 (3.00-4.00) 6.50 (4.30-9.70) 9.20 (6.50-15.1) 415 
12-19 years 03-04 3.74 (3.31-4.22) 4.30 (3.60-4.60) 7.80 (6.50-9.00) 13.5 (11.8-15.2) 16.5 (15.2-20.9) 715 
 05-06 2.42 (2.18-2.68) 2.40 (2.10-2.70) 4.30 (3.90-5.20) 8.40 (6.50-10.8) 11.9 (10.7-14.8) 702 
 07-08 2.45 (2.14-2.80) 2.40 (2.10-2.60) 4.40 (3.60-5.50) 9.70 (7.30-11.9) 12.2 (9.70-19.0) 401 
 09-10 2.11 (1.86-2.40) 2.20 (1.90-2.40) 3.80 (3.20-4.50) 6.90 (4.70-10.8) 11.1 (6.90-21.0) 420 
20 years and older 03-04 2.41 (2.15-2.72) 2.60 (2.30-2.80) 5.10 (4.50-5.70) 9.50 (8.10-11.3) 15.2 (12.4-18.1) 1488 
 05-06 1.75 (1.62-1.89) 1.80 (1.70-2.00) 3.40 (3.10-3.70) 6.40 (5.80-7.50) 10.7 (8.80-12.1) 1490 
 07-08 1.99 (1.82-2.18) 2.00 (1.80-2.30) 3.90 (3.40-4.60) 7.40 (6.60-8.50) 13.2 (9.10-15.7) 1814 
 09-10 1.79 (1.67-1.93) 1.80 (1.60-2.00) 3.50 (3.30-3.70) 6.50 (6.00-7.20) 9.60 (8.30-11.3) 1914 
Gender        
Males 03-04 2.92 (2.63-3.24) 3.20 (2.70-3.60) 6.10 (5.40-6.60) 10.4 (9.50-11.6) 16.0 (12.7-17.6) 1229 
 05-06 2.09 (1.92-2.28) 2.10 (2.00-2.30) 3.70 (3.40-4.20) 7.70 (6.80-9.30) 12.8 (10.1-15.8) 1270 
 07-08 2.20 (2.01-2.41) 2.10 (1.90-2.40) 4.00 (3.60-4.70) 8.10 (6.70-9.70) 14.0 (8.70-20.8) 1294 
 09-10 1.94 (1.82-2.07) 1.90 (1.70-2.00) 3.70 (3.40-4.10) 6.90 (5.90-7.90) 10.9 (8.40-13.5) 1399 
Females 03-04 2.41 (2.11-2.75) 2.50 (2.20-2.80) 5.00 (4.20-6.20) 10.6 (8.70-12.5) 15.9 (13.5-20.1) 1288 
 05-06 1.74 (1.55-1.95) 1.80 (1.60-2.00) 3.70 (3.10-4.00) 6.20 (5.80-7.60) 10.4 (7.70-14.7) 1278 
 07-08 1.97 (1.80-2.16) 2.00 (1.80-2.20) 4.10 (3.60-4.60) 7.40 (6.80-8.20) 12.0 (9.60-14.1) 1310 
 09-10 1.73 (1.60-1.87) 1.80 (1.60-2.00) 3.40 (3.20-3.70) 6.50 (5.60-7.10) 9.20 (8.00-11.2) 1350 
Race/ethnicity        
Mexican Americans 03-04 2.58 (2.15-3.08) 2.60 (2.10-3.20) 5.20 (4.40-6.50) 9.90 (7.30-13.9) 15.4 (10.2-19.7) 613 
 05-06 2.05 (1.75-2.40) 2.00 (1.70-2.40) 3.60 (3.00-4.20) 6.90 (5.40-10.1) 12.2 (8.00-15.6) 637 
 07-08 2.09 (1.94-2.26) 2.00 (1.80-2.30) 3.80 (3.30-4.30) 7.10 (6.10-8.60) 11.7 (7.70-14.6) 531 
 09-10 1.92 (1.69-2.19) 2.10 (1.80-2.30) 3.50 (3.10-4.10) 6.50 (5.20-7.50) 9.00 (6.90-16.2) 566 
Non-Hispanic blacks 03-04 4.24 (3.73-4.82) 4.30 (3.80-5.10) 8.20 (7.10-9.80) 14.2 (11.7-16.9) 20.6 (14.9-25.2) 652 
 05-06 2.50 (2.25-2.77) 2.70 (2.30-3.00) 4.60 (4.00-5.00) 8.00 (6.80-9.30) 11.3 (8.90-14.2) 678 
 07-08 2.66 (2.38-2.97) 2.80 (2.60-3.10) 5.40 (4.40-6.40) 9.10 (7.50-10.4) 13.3 (10.0-15.1) 597 
 09-10 2.51 (2.22-2.83) 2.60 (2.30-3.00) 4.40 (3.80-5.00) 7.30 (6.10-8.80) 10.3 (7.90-13.6) 516 
Non-Hispanic whites 03-04 2.51 (2.26-2.79) 2.70 (2.50-3.00) 5.20 (4.70-5.80) 9.60 (8.30-10.9) 15.1 (12.6-16.7) 1092 
 05-06 1.76 (1.62-1.91) 1.80 (1.60-2.00) 3.50 (3.20-3.80) 6.80 (5.90-7.60) 11.0 (8.80-13.7) 1038 
 07-08 2.06 (1.87-2.27) 2.00 (1.80-2.30) 4.00 (3.40-4.70) 7.80 (6.70-8.90) 13.7 (9.80-16.1) 1077 
 09-10 1.73 (1.60-1.87) 1.70 (1.60-1.90) 3.40 (3.10-3.70) 6.40 (5.40-7.60) 9.20 (8.20-11.2) 1206 
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Urinary Bisphenol A (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 1.51 (1.41-1.62) 1.40 (1.30-1.60) 3.00 (2.70-3.30) 5.60 (4.90-6.50) 9.40 (7.70-11.2) 2489 
 13-14 1.28 (1.20-1.36) 1.30 (1.20-1.40) 2.50 (2.40-2.70) 4.90 (4.10-5.60) 7.70 (6.80-8.30) 2686 
Age group        
6-11 years 11-12 1.58 (1.41-1.78) 1.50 (1.30-1.70) 3.10 (2.60-3.50) 6.70 (5.10-8.00) 8.70 (6.20-21.4) 396 
 13-14 1.43 (1.30-1.59) 1.40 (1.30-1.60) 2.90 (2.30-3.40) 4.40 (4.10-5.20) 8.00 (5.20-10.2) 409 
12-19 years 11-12 1.69 (1.42-2.00) 1.70 (1.30-2.10) 3.30 (2.80-4.00) 6.90 (4.80-7.90) 10.0 (7.10-13.0) 388 
 13-14 1.28 (1.16-1.41) 1.20 (1.10-1.40) 2.40 (1.90-2.70) 4.60 (3.30-5.20) 6.80 (5.20-8.10) 462 
20 years and older 11-12 1.48 (1.35-1.61) 1.40 (1.20-1.60) 2.90 (2.50-3.30) 5.40 (4.70-6.30) 9.30 (7.30-12.2) 1705 
 13-14 1.26 (1.18-1.35) 1.30 (1.20-1.40) 2.50 (2.40-2.80) 4.90 (4.10-6.00) 7.80 (6.80-8.60) 1815 
Gender        
Males 11-12 1.64 (1.49-1.81) 1.50 (1.40-1.70) 3.20 (2.70-3.70) 6.00 (5.00-7.70) 9.50 (7.80-11.2) 1259 
 13-14 1.43 (1.30-1.58) 1.40 (1.30-1.60) 2.80 (2.40-3.20) 5.30 (4.30-6.60) 8.30 (6.80-10.3) 1285 
Females 11-12 1.39 (1.25-1.55) 1.30 (1.20-1.50) 2.80 (2.40-3.20) 5.20 (4.30-6.30) 8.50 (6.50-13.4) 1230 
 13-14 1.15 (1.05-1.26) 1.20 (1.10-1.30) 2.30 (2.00-2.60) 4.20 (3.80-5.20) 7.20 (5.60-8.10) 1401 
Race/ethnicity        
Mexican Americans 11-12 1.45 (1.30-1.63) 1.40 (1.20-1.60) 2.80 (2.30-3.10) 5.00 (4.20-6.50) 7.70 (5.90-9.70) 316 
 13-14 1.28 (1.06-1.53) 1.30 (1.00-1.70) 2.50 (2.10-2.80) 4.10 (3.50-4.90) 5.60 (4.60-7.30) 438 
Non-Hispanic blacks 11-12 2.12 (1.88-2.38) 2.00 (1.80-2.40) 4.10 (3.40-4.60) 7.10 (5.70-8.10) 11.4 (8.10-14.3) 665 
 13-14 1.83 (1.62-2.07) 1.90 (1.50-2.20) 3.60 (3.20-4.10) 6.80 (5.70-7.80) 9.80 (7.70-12.9) 609 
Non-Hispanic whites 11-12 1.46 (1.34-1.58) 1.30 (1.20-1.50) 2.90 (2.50-3.20) 5.40 (4.60-6.60) 8.90 (6.90-13.4) 813 
 13-14 1.22 (1.13-1.31) 1.30 (1.10-1.40) 2.40 (2.20-2.70) 4.40 (3.90-5.90) 7.40 (6.40-8.30) 988 
All Hispanics 11-12 1.48 (1.25-1.74) 1.40 (1.20-1.70) 2.80 (2.20-3.40) 5.70 (4.20-7.30) 9.10 (6.50-14.1) 571 
 13-14 1.31 (1.18-1.46) 1.30 (1.10-1.50) 2.60 (2.20-2.80) 4.10 (3.70-4.70) 6.10 (4.90-7.50) 690 
Asians 11-12 1.03 (.863-1.23) .900 (.800-1.10) 1.80 (1.50-2.20) 4.00 (2.40-6.40) 7.30 (3.90-11.9) 352 
 13-14 .782 (.646-.948) .800 (.700-.900) 1.40 (1.00-1.80) 2.40 (1.80-3.30) 3.60 (2.40-12.1) 289 
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Urinary Bisphenol A (creatinine corrected) (2003 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 2.58 (2.36-2.82) 2.50 (2.31-2.80) 4.29 (3.88-4.75) 7.67 (6.62-8.66) 11.2 (9.78-12.4) 2514 
 05-06 1.86 (1.79-1.92) 1.71 (1.64-1.79) 3.01 (2.86-3.20) 5.73 (5.29-6.36) 9.70 (8.31-10.9) 2548 
 07-08 2.10 (1.95-2.25) 1.95 (1.84-2.03) 3.45 (3.02-3.83) 6.09 (5.10-7.45) 10.0 (7.48-13.2) 2604 
 09-10 1.91 (1.79-2.04) 1.76 (1.67-1.84) 3.06 (2.80-3.33) 5.33 (4.68-6.06) 8.03 (6.94-10.0) 2749 
Age group        
6-11 years 03-04 4.32 (3.63-5.14) 4.29 (3.63-5.23) 7.14 (5.83-9.56) 12.2 (9.84-14.8) 15.7 (12.2-23.2) 314 
 05-06 3.14 (2.79-3.54) 2.80 (2.55-3.06) 5.04 (4.46-5.71) 15.6 (8.15-22.4) 24.6 (19.9-48.5) 356 
 07-08 3.05 (2.73-3.41) 2.69 (2.38-3.12) 5.06 (4.33-5.60) 11.9 (6.30-17.4) 20.8 (12.7-26.3) 389 
 09-10 2.36 (2.09-2.65) 2.18 (2.00-2.53) 3.70 (3.14-4.29) 5.97 (4.57-9.15) 9.57 (6.52-13.7) 415 
12-19 years 03-04 2.80 (2.52-3.11) 2.74 (2.35-3.22) 4.74 (4.21-5.09) 7.79 (6.41-8.87) 11.8 (8.05-14.2) 713 
 05-06 1.80 (1.67-1.95) 1.65 (1.50-1.76) 2.73 (2.41-2.98) 5.71 (4.07-7.50) 8.52 (6.94-12.2) 702 
 07-08 1.90 (1.72-2.10) 1.69 (1.50-2.00) 2.94 (2.38-3.60) 5.10 (4.17-6.82) 7.72 (5.32-13.9) 401 
 09-10 1.70 (1.47-1.95) 1.60 (1.34-1.88) 2.63 (2.11-3.58) 4.47 (3.76-6.19) 6.71 (4.40-17.8) 420 
20 years and older 03-04 2.39 (2.17-2.64) 2.36 (2.15-2.59) 3.93 (3.44-4.33) 6.64 (5.97-7.74) 10.0 (9.01-11.4) 1487 
 05-06 1.75 (1.67-1.84) 1.64 (1.56-1.75) 2.84 (2.67-3.08) 5.38 (4.89-5.87) 8.54 (7.58-9.77) 1490 
 07-08 2.04 (1.90-2.20) 1.92 (1.79-2.03) 3.36 (2.91-3.78) 6.02 (4.88-7.48) 9.32 (7.48-12.1) 1814 
 09-10 1.90 (1.76-2.05) 1.76 (1.66-1.84) 3.04 (2.76-3.24) 5.33 (4.67-6.11) 8.00 (6.97-10.0) 1914 
Gender        
Males 03-04 2.38 (2.15-2.63) 2.31 (2.08-2.70) 4.19 (3.81-4.64) 7.10 (6.41-8.28) 9.94 (9.06-11.7) 1228 
 05-06 1.68 (1.57-1.80) 1.56 (1.45-1.64) 2.73 (2.43-3.14) 5.27 (4.64-6.04) 8.40 (6.81-11.4) 1270 
 07-08 1.85 (1.71-2.01) 1.77 (1.57-1.91) 2.97 (2.59-3.33) 5.41 (4.47-7.51) 9.52 (6.29-13.4) 1294 
 09-10 1.74 (1.62-1.87) 1.60 (1.48-1.72) 2.76 (2.53-2.96) 5.00 (4.16-5.86) 7.50 (6.22-9.00) 1399 
Females 03-04 2.78 (2.50-3.08) 2.68 (2.40-2.94) 4.41 (3.81-5.15) 7.93 (6.48-10.2) 12.4 (9.29-18.2) 1286 
 05-06 2.04 (1.95-2.14) 1.85 (1.76-2.02) 3.21 (2.98-3.39) 6.47 (5.51-7.50) 9.86 (8.62-11.8) 1278 
 07-08 2.36 (2.17-2.57) 2.14 (1.98-2.33) 3.77 (3.43-4.31) 6.67 (5.41-7.83) 10.5 (7.45-15.2) 1310 
 09-10 2.09 (1.92-2.27) 1.93 (1.80-2.15) 3.33 (2.94-3.84) 5.49 (4.87-6.74) 8.80 (6.47-12.5) 1350 
Race/ethnicity        
Mexican Americans 03-04 2.34 (2.02-2.71) 2.38 (2.00-2.65) 3.85 (3.24-4.55) 7.09 (5.00-9.04) 10.9 (8.50-14.3) 612 
 05-06 1.84 (1.66-2.04) 1.62 (1.45-1.84) 2.99 (2.56-3.60) 6.00 (4.51-8.00) 10.3 (6.84-14.9) 637 
 07-08 2.04 (1.86-2.24) 1.88 (1.72-2.11) 3.33 (2.96-3.95) 5.68 (5.05-6.59) 8.90 (6.30-11.8) 531 
 09-10 1.91 (1.71-2.13) 1.76 (1.67-1.87) 3.13 (2.63-3.57) 5.51 (4.72-6.97) 8.71 (5.86-14.4) 566 
Non-Hispanic blacks 03-04 2.92 (2.58-3.32) 2.95 (2.51-3.27) 4.90 (4.07-6.13) 8.64 (7.53-9.63) 11.9 (10.2-13.3) 651 
 05-06 1.76 (1.62-1.90) 1.68 (1.53-1.92) 2.82 (2.67-3.04) 4.56 (3.85-5.43) 6.81 (5.00-9.27) 678 
 07-08 2.06 (1.91-2.23) 2.03 (1.83-2.25) 3.24 (2.86-3.78) 5.71 (5.15-6.54) 8.59 (6.54-10.9) 597 
 09-10 1.82 (1.65-2.01) 1.70 (1.56-1.89) 2.90 (2.39-3.17) 4.94 (4.02-6.03) 6.74 (5.95-8.09) 516 
Non-Hispanic whites 03-04 2.58 (2.37-2.81) 2.55 (2.32-2.80) 4.30 (3.93-4.67) 7.58 (6.32-8.87) 11.0 (9.34-12.4) 1091 
 05-06 1.85 (1.75-1.96) 1.70 (1.60-1.82) 3.08 (2.78-3.31) 5.80 (5.13-6.72) 9.77 (7.87-11.5) 1038 
 07-08 2.15 (1.97-2.35) 1.97 (1.84-2.11) 3.50 (3.04-3.95) 6.44 (5.04-8.00) 10.9 (7.47-14.5) 1077 









Fourth National Report on Human Exposure to Environmental Chemicals, Updated Tables, January 2017 Volume One Page 26
Urinary Bisphenol A (creatinine corrected) (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 1.72 (1.61-1.84) 1.58 (1.46-1.71) 2.86 (2.62-3.01) 4.62 (4.12-5.65) 8.24 (6.47-11.0) 2487 
 13-14 1.28 (1.18-1.39) 1.21 (1.11-1.32) 2.12 (1.92-2.33) 3.88 (3.46-4.24) 5.09 (4.65-5.96) 2684 
Age group        
6-11 years 11-12 2.27 (1.97-2.62) 2.00 (1.78-2.16) 3.33 (2.93-3.75) 7.94 (4.71-12.4) 14.0 (6.45-47.5) 395 
 13-14 1.81 (1.68-1.96) 1.80 (1.52-2.03) 3.10 (2.63-3.46) 4.48 (4.00-4.96) 7.03 (5.00-9.92) 409 
12-19 years 11-12 1.64 (1.44-1.87) 1.48 (1.13-1.98) 2.88 (2.21-3.23) 4.50 (3.37-8.16) 8.74 (3.57-18.4) 388 
 13-14 1.04 (.887-1.21) .932 (.809-1.19) 1.71 (1.33-2.03) 2.69 (2.28-3.33) 3.99 (3.29-4.67) 462 
20 years and older 11-12 1.68 (1.57-1.80) 1.55 (1.43-1.68) 2.75 (2.54-3.00) 4.55 (4.00-5.39) 7.73 (5.73-10.0) 1704 
 13-14 1.27 (1.16-1.39) 1.21 (1.11-1.30) 2.09 (1.90-2.31) 3.88 (3.33-4.37) 5.09 (4.58-5.97) 1813 
Gender        
Males 11-12 1.54 (1.40-1.69) 1.37 (1.20-1.59) 2.55 (2.21-2.94) 4.38 (3.75-6.00) 8.24 (6.01-11.0) 1258 
 13-14 1.20 (1.11-1.31) 1.12 (.988-1.25) 1.95 (1.78-2.24) 3.75 (3.25-4.29) 4.91 (4.42-7.02) 1284 
Females 11-12 1.91 (1.76-2.08) 1.75 (1.57-1.97) 2.93 (2.73-3.24) 4.94 (4.27-6.24) 8.13 (6.00-11.1) 1229 
 13-14 1.36 (1.23-1.51) 1.28 (1.17-1.43) 2.25 (2.03-2.48) 3.94 (3.27-4.48) 5.18 (4.50-6.07) 1400 
Race/ethnicity        
Mexican Americans 11-12 1.64 (1.49-1.80) 1.46 (1.32-1.64) 2.70 (2.34-3.01) 4.50 (3.45-7.00) 7.37 (4.76-11.4) 316 
 13-14 1.30 (1.16-1.45) 1.27 (1.05-1.57) 2.25 (1.97-2.50) 3.57 (3.04-3.98) 4.25 (3.93-4.83) 438 
Non-Hispanic blacks 11-12 1.65 (1.48-1.84) 1.50 (1.30-1.71) 2.63 (2.11-3.17) 4.82 (3.82-6.24) 7.23 (5.98-10.7) 665 
 13-14 1.35 (1.25-1.46) 1.32 (1.13-1.46) 2.17 (1.96-2.35) 3.89 (3.24-4.27) 5.00 (4.40-6.01) 609 
Non-Hispanic whites 11-12 1.77 (1.64-1.92) 1.64 (1.49-1.78) 2.90 (2.65-3.08) 4.60 (4.05-6.00) 9.00 (6.11-12.3) 811 
 13-14 1.28 (1.14-1.44) 1.21 (1.06-1.38) 2.13 (1.85-2.42) 3.94 (3.33-4.56) 5.60 (4.65-6.53) 987 
All Hispanics 11-12 1.66 (1.44-1.90) 1.47 (1.28-1.70) 2.80 (2.39-3.14) 4.82 (3.67-7.00) 7.69 (5.76-9.62) 571 
 13-14 1.30 (1.19-1.43) 1.25 (1.09-1.42) 2.20 (1.92-2.47) 3.61 (3.13-3.98) 4.54 (4.03-4.89) 690 
Asians 11-12 1.38 (1.25-1.52) 1.32 (1.16-1.40) 2.11 (1.84-2.50) 4.04 (2.80-6.25) 7.42 (4.38-12.1) 352 
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Urinary 4-tert-Octylphenol (2005 – 2010)‡ 
 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 05-06 * < LOD < LOD < LOD .200 (<LOD-.300) 2548 
 07-08 * < LOD < LOD < LOD .300 (.200-.300) 2604 
 09-10 * < LOD < LOD .200 (<LOD-.300) .300 (.300-.400) 2749 
Age group        
6-11 years 05-06 * < LOD < LOD < LOD .300 (.200-.300) 356 
 07-08 * < LOD < LOD .200 (<LOD-.300) .300 (.200-.400) 389 
 09-10 * < LOD < LOD .300 (<LOD-.400) .400 (.300-.600) 415 
12-19 years 05-06 * < LOD < LOD < LOD .200 (<LOD-.400) 702 
 07-08 * < LOD < LOD < LOD .300 (<LOD-.400) 401 
 09-10 * < LOD < LOD .300 (.200-.300) .300 (.300-.400) 420 
20 years and older 05-06 * < LOD < LOD < LOD .200 (<LOD-.300) 1490 
 07-08 * < LOD < LOD < LOD .300 (.200-.400) 1814 
 09-10 * < LOD < LOD < LOD .300 (.200-.400) 1914 
Gender        
Males 05-06 * < LOD < LOD < LOD .200 (<LOD-.300) 1270 
 07-08 * < LOD < LOD < LOD .300 (.200-.400) 1294 
 09-10 * < LOD < LOD .200 (<LOD-.300) .300 (.300-.400) 1399 
Females 05-06 * < LOD < LOD < LOD < LOD 1278 
 07-08 * < LOD < LOD < LOD .300 (.200-.300) 1310 
 09-10 * < LOD < LOD .200 (<LOD-.300) .300 (.200-.400) 1350 
Race/ethnicity        
Mexican Americans 05-06 * < LOD < LOD < LOD .300 (<LOD-.800) 637 
 07-08 * < LOD < LOD < LOD .300 (.200-.300) 531 
 09-10 * < LOD < LOD < LOD .300 (<LOD-.500) 566 
Non-Hispanic blacks 05-06 * < LOD < LOD < LOD .200 (<LOD-.400) 678 
 07-08 * < LOD < LOD .200 (<LOD-.300) .300 (.200-.500) 597 
 09-10 * < LOD < LOD .300 (.200-.400) .500 (.400-.600) 516 
Non-Hispanic whites 05-06 * < LOD < LOD < LOD .200 (<LOD-.300) 1038 
 07-08 * < LOD < LOD < LOD .200 (.200-.300) 1077 
 09-10 * < LOD < LOD .200 (<LOD-.300) .300 (.300-.400) 1206 
Limit of detection (LOD, see Data Analysis section) for Survey years 05-06, 07-08, and 09-10 are 0.2, 0.2, and 0.2 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result.  
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Urinary 4-tert-Octylphenol (creatinine corrected) (2005 – 2010)‡ 
 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 05-06 * < LOD < LOD < LOD .560 (<LOD-.620) 2548 
 07-08 * < LOD < LOD < LOD .670 (.560-.880) 2604 
 09-10 * < LOD < LOD .470 (<LOD-.500) .640 (.580-.680) 2749 
Age group        
6-11 years 05-06 * < LOD < LOD < LOD .410 (.350-.610) 356 
 07-08 * < LOD < LOD .440 (<LOD-.540) .600 (.420-.930) 389 
 09-10 * < LOD < LOD .560 (<LOD-.670) .740 (.640-.830) 415 
12-19 years 05-06 * < LOD < LOD < LOD .450 (<LOD-.560) 702 
 07-08 * < LOD < LOD < LOD .420 (<LOD-.540) 401 
 09-10 * < LOD < LOD .360 (.270-.440) .450 (.340-.560) 420 
20 years and older 05-06 * < LOD < LOD < LOD .580 (<LOD-.670) 1490 
 07-08 * < LOD < LOD < LOD .700 (.580-.930) 1814 
 09-10 * < LOD < LOD < LOD .640 (.580-.700) 1914 
Gender        
Males 05-06 * < LOD < LOD < LOD .390 (<LOD-.440) 1270 
 07-08 * < LOD < LOD < LOD .510 (.390-.600) 1294 
 09-10 * < LOD < LOD .380 (<LOD-.420) .480 (.450-.610) 1399 
Females 05-06 * < LOD < LOD < LOD < LOD 1278 
 07-08 * < LOD < LOD < LOD .880 (.670-1.08) 1310 
 09-10 * < LOD < LOD .540 (<LOD-.580) .700 (.640-.880) 1350 
Race/ethnicity        
Mexican Americans 05-06 * < LOD < LOD < LOD .480 (<LOD-.740) 637 
 07-08 * < LOD < LOD < LOD .520 (.440-.610) 531 
 09-10 * < LOD < LOD < LOD .560 (<LOD-.750) 566 
Non-Hispanic blacks 05-06 * < LOD < LOD < LOD .320 (<LOD-.400) 678 
 07-08 * < LOD < LOD .320 (<LOD-.410) .460 (.340-.610) 597 
 09-10 * < LOD < LOD .300 (.250-.330) .440 (.320-.560) 516 
Non-Hispanic whites 05-06 * < LOD < LOD < LOD .610 (<LOD-.670) 1038 
 07-08 * < LOD < LOD < LOD .700 (.560-.930) 1077 
 09-10 * < LOD < LOD .500 (<LOD-.560) .670 (.580-.740) 1206 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result.  
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Urinary Triclocarban (2013 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 13-14 * < LOD .200 (.200-.200) 2.20 (1.20-4.10) 13.4 (8.00-24.5) 2686 
Age group        
6-11 years 13-14 * < LOD < LOD .300 (.200-.500) .900 (.400-5.50) 409 
12-19 years 13-14 * < LOD .200 (.100-.200) .900 (.400-1.90) 2.60 (1.40-9.40) 462 
20 years and older 13-14 * < LOD .200 (.200-.300) 3.40 (1.80-7.00) 17.9 (10.0-30.8) 1815 
Gender        
Males 13-14 * < LOD .200 (.200-.400) 3.50 (1.60-9.90) 31.9 (13.9-47.6) 1285 
Females 13-14 * < LOD .200 (.100-.200) 1.70 (.600-3.50) 7.50 (3.50-12.9) 1401 
Race/ethnicity        
Mexican Americans 13-14 * < LOD .100 (<LOD-.200) .600 (.200-3.30) 3.30 (.400-16.3) 438 
Non-Hispanic blacks 13-14 .397 (.295-.536) .200 (.100-.300) 1.10 (.700-2.00) 11.3 (6.00-17.9) 27.0 (11.7-67.9) 609 
Non-Hispanic whites 13-14 * < LOD .200 (.100-.200) 2.00 (.800-4.50) 14.8 (7.10-32.5) 988 
All Hispanics 13-14 * < LOD .100 (<LOD-.200) .600 (.300-2.10) 4.40 (1.10-9.40) 690 
Asians 13-14 * < LOD .100 (<LOD-.100) .500 (.200-1.40) 2.20 (.800-7.80) 289 
Limit of detection (LOD, see Data Analysis section) for Survey year 13-14 is 0.1. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Triclocarban (creatinine corrected) (2013 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 13-14 * < LOD .275 (.248-.306) 1.96 (1.00-4.17) 14.6 (8.93-21.3) 2684 
Age group        
6-11 years 13-14 * < LOD < LOD .413 (.323-.725) .778 (.389-7.77) 409 
12-19 years 13-14 * < LOD .200 (.146-.248) .559 (.380-.888) 1.97 (.769-8.70) 462 
20 years and older 13-14 * < LOD .292 (.261-.333) 3.20 (1.67-7.07) 17.6 (10.7-22.9) 1813 
Gender        
Males 13-14 * < LOD .250 (.185-.306) 3.00 (1.07-9.86) 21.3 (13.7-28.3) 1284 
Females 13-14 * < LOD .292 (.250-.357) 1.65 (.700-4.17) 9.33 (4.17-14.9) 1400 
Race/ethnicity        
Mexican Americans 13-14 * < LOD .200 (<LOD-.292) .559 (.292-1.35) 1.35 (.444-21.5) 438 
Non-Hispanic blacks 13-14 .293 (.220-.391) .172 (.127-.235) .741 (.513-1.11) 7.90 (2.41-19.3) 23.9 (10.8-28.9) 609 
Non-Hispanic whites 13-14 * < LOD .278 (.233-.333) 2.06 (.800-7.12) 15.4 (9.87-22.6) 987 
All Hispanics 13-14 * < LOD .192 (<LOD-.233) .617 (.351-1.35) 4.48 (1.24-10.6) 690 
Asians 13-14 * < LOD .217 (<LOD-.250) .625 (.379-1.67) 3.06 (.769-12.1) 288 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary Triclosan (2003 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 13.0 (11.6-14.6) 9.20 (7.90-10.9) 47.4 (38.2-58.4) 249 (188-304) 461 (383-522) 2517 
 05-06 18.5 (16.1-21.3) 15.1 (11.8-18.5) 76.2 (57.9-97.6) 334 (279-402) 655 (573-739) 2548 
 07-08 15.3 (13.5-17.4) 12.1 (10.2-13.8) 57.2 (46.1-65.9) 225 (176-288) 494 (371-615) 2604 
 09-10 14.5 (12.6-16.6) 10.7 (8.80-12.6) 51.2 (39.4-67.7) 238 (200-284) 483 (398-569) 2749 
Age group        
6-11 years 03-04 8.16 (6.20-10.8) 6.00 (4.00-8.50) 20.7 (14.3-31.6) 123 (36.4-163) 157 (113-380) 314 
 05-06 12.8 (9.89-16.7) 10.3 (8.30-17.2) 35.4 (23.9-65.8) 97.6 (67.4-181) 246 (99.5-462) 356 
 07-08 11.8 (7.57-18.2) 9.80 (6.70-13.9) 27.7 (14.8-52.2) 98.5 (40.5-364) 296 (67.4-826) 389 
 09-10 10.9 (9.35-12.8) 9.90 (7.10-11.9) 28.3 (22.1-35.5) 95.5 (71.5-117) 200 (114-474) 415 
12-19 years 03-04 14.5 (11.0-19.1) 10.3 (8.20-13.1) 39.0 (26.5-86.4) 304 (134-566) 655 (310-890) 715 
 05-06 18.8 (14.9-23.8) 15.4 (11.0-21.0) 67.5 (45.3-100) 330 (174-461) 566 (389-707) 702 
 07-08 18.2 (13.8-23.8) 13.8 (9.40-20.1) 63.2 (38.7-110) 296 (144-395) 401 (308-853) 401 
 09-10 11.7 (9.89-13.8) 8.80 (7.30-10.9) 30.2 (24.3-40.6) 165 (56.7-289) 301 (220-431) 420 
20 years and older 03-04 13.6 (12.0-15.3) 9.60 (8.20-11.5) 51.7 (39.6-65.7) 261 (198-317) 472 (406-522) 1488 
 05-06 19.3 (16.4-22.6) 15.5 (11.8-19.4) 84.3 (61.0-114) 366 (289-462) 738 (583-864) 1490 
 07-08 15.4 (13.7-17.3) 12.3 (10.1-14.4) 60.1 (48.5-69.0) 225 (185-286) 504 (378-573) 1814 
 09-10 15.5 (12.9-18.5) 11.1 (8.60-14.2) 61.8 (41.8-86.0) 262 (214-327) 544 (415-621) 1914 
Gender        
Males 03-04 16.2 (13.4-19.6) 11.7 (9.30-14.8) 84.9 (50.6-111) 317 (231-433) 574 (461-716) 1229 
 05-06 21.3 (17.6-25.7) 17.6 (11.9-23.2) 103 (69.9-143) 446 (366-488) 738 (601-873) 1270 
 07-08 15.2 (12.9-17.9) 12.3 (9.50-15.3) 60.6 (45.8-72.8) 236 (159-338) 467 (367-636) 1294 
 09-10 14.8 (12.7-17.4) 10.9 (8.60-13.3) 55.1 (40.4-77.5) 243 (214-295) 455 (327-600) 1399 
Females 03-04 10.6 (9.29-12.1) 7.60 (6.10-9.10) 33.2 (27.1-39.4) 144 (96.5-250) 380 (258-430) 1288 
 05-06 16.2 (13.9-18.8) 12.6 (10.1-15.6) 58.7 (41.5-81.9) 226 (169-304) 513 (310-773) 1278 
 07-08 15.5 (12.6-18.9) 12.0 (9.90-14.1) 52.1 (37.1-74.4) 210 (133-367) 504 (285-648) 1310 
 09-10 14.2 (12.0-16.8) 10.5 (8.70-12.6) 50.0 (34.4-63.8) 235 (149-302) 488 (332-661) 1350 
Race/ethnicity        
Mexican Americans 03-04 14.6 (10.6-20.1) 8.80 (5.40-17.5) 65.4 (32.8-127) 357 (225-456) 597 (372-992) 613 
 05-06 26.7 (21.2-33.7) 18.7 (13.5-25.5) 196 (99.4-269) 668 (475-759) 866 (750-1180) 637 
 07-08 17.1 (12.9-22.6) 11.8 (8.40-17.8) 67.4 (42.5-106) 358 (208-474) 556 (363-856) 531 
 09-10 14.9 (12.2-18.3) 10.2 (8.20-12.8) 54.7 (33.3-86.5) 345 (260-494) 691 (443-1180) 566 
Non-Hispanic blacks 03-04 14.4 (11.4-18.2) 11.1 (8.70-16.1) 37.6 (30.2-58.0) 203 (87.5-341) 450 (254-750) 652 
 05-06 17.3 (13.3-22.4) 14.0 (10.4-19.0) 59.2 (37.7-98.3) 258 (138-460) 541 (273-1190) 678 
 07-08 13.7 (11.7-16.1) 11.3 (8.80-13.9) 41.4 (28.9-49.6) 150 (93.5-265) 480 (190-757) 597 
 09-10 12.8 (10.8-15.0) 9.30 (7.70-11.7) 34.3 (24.0-44.6) 168 (88.4-263) 451 (202-959) 516 
Non-Hispanic whites 03-04 12.9 (11.2-14.9) 9.20 (7.40-11.0) 49.2 (37.8-63.4) 245 (163-334) 461 (383-527) 1092 
 05-06 17.5 (14.9-20.6) 15.1 (10.9-19.0) 74.3 (54.1-90.3) 288 (231-366) 569 (462-693) 1038 
 07-08 15.0 (12.6-17.7) 12.3 (9.80-14.5) 59.6 (41.9-73.4) 197 (147-266) 408 (296-537) 1077 
 09-10 14.0 (11.8-16.7) 10.5 (8.30-12.9) 51.7 (33.1-79.2) 216 (174-266) 431 (301-565) 1206 
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Urinary Triclosan (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 11.8 (10.6-13.1) 7.10 (6.10-7.90) 41.6 (30.2-59.5) 267 (207-332) 553 (429-722) 2489 
 13-14 9.78 (9.01-10.6) 6.30 (5.70-7.20) 33.9 (29.1-39.1) 172 (138-208) 379 (324-431) 2686 
Age group        
6-11 years 11-12 7.18 (5.73-9.01) 5.00 (3.40-7.30) 17.2 (10.4-21.8) 77.6 (28.9-184) 184 (78.7-393) 396 
 13-14 8.24 (6.70-10.1) 6.10 (4.80-8.00) 22.9 (15.3-33.5) 73.8 (52.7-96.0) 124 (91.2-204) 409 
12-19 years 11-12 10.1 (7.70-13.3) 5.80 (4.70-7.50) 25.5 (15.1-38.9) 156 (73.5-286) 489 (171-1550) 388 
 13-14 7.96 (6.81-9.31) 6.00 (4.80-7.40) 19.7 (15.4-25.3) 85.7 (37.2-183) 224 (122-325) 462 
20 years and older 11-12 12.7 (11.2-14.4) 7.60 (6.40-8.50) 57.4 (37.0-75.8) 298 (243-388) 594 (437-845) 1705 
 13-14 10.3 (9.32-11.3) 6.40 (5.60-7.50) 39.3 (32.4-48.5) 203 (147-270) 420 (350-529) 1815 
Gender        
Males 11-12 11.6 (10.1-13.1) 6.40 (5.30-7.50) 41.6 (28.1-58.7) 320 (211-388) 566 (392-722) 1259 
 13-14 9.95 (8.75-11.3) 6.40 (5.20-8.50) 34.7 (29.3-40.6) 172 (126-215) 372 (297-479) 1285 
Females 11-12 12.0 (10.2-14.0) 7.60 (6.20-8.60) 42.2 (25.7-75.8) 242 (188-286) 545 (380-855) 1230 
 13-14 9.63 (8.41-11.0) 6.20 (5.60-7.10) 31.7 (24.9-42.5) 173 (112-240) 384 (302-528) 1401 
Race/ethnicity        
Mexican Americans 11-12 12.6 (8.98-17.8) 7.20 (4.70-11.7) 47.6 (21.9-82.7) 411 (151-628) 628 (393-1250) 316 
 13-14 8.65 (5.55-13.5) 5.20 (2.60-12.2) 31.9 (15.4-68.0) 191 (79.5-346) 488 (180-822) 438 
Non-Hispanic blacks 11-12 10.5 (9.08-12.2) 6.70 (5.70-8.40) 29.9 (22.4-40.0) 169 (106-278) 475 (278-718) 665 
 13-14 8.34 (7.54-9.23) 5.50 (4.40-6.60) 24.9 (18.9-32.6) 145 (68.6-209) 304 (204-509) 609 
Non-Hispanic whites 11-12 11.7 (10.0-13.7) 7.00 (5.60-8.00) 44.6 (24.4-75.8) 248 (184-392) 552 (365-759) 813 
 13-14 10.0 (8.95-11.3) 6.40 (5.60-8.00) 34.7 (29.2-43.1) 148 (122-210) 350 (253-438) 988 
All Hispanics 11-12 13.4 (11.6-15.5) 7.50 (6.40-9.30) 48.3 (33.2-75.5) 411 (264-518) 861 (536-1040) 571 
 13-14 9.14 (6.95-12.0) 6.00 (3.70-9.50) 29.6 (17.9-44.3) 208 (131-325) 583 (325-737) 690 
Asians 11-12 11.7 (7.75-17.8) 7.30 (3.80-15.1) 42.9 (18.6-125) 274 (117-433) 453 (235-636) 352 
 13-14 11.5 (9.24-14.3) 6.20 (4.30-9.10) 71.5 (25.2-121) 294 (212-428) 594 (384-740) 289 
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Urinary Triclosan (creatinine corrected) (2003 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 12.7 (11.5-14.1) 9.48 (8.22-10.4) 43.9 (33.8-60.6) 212 (172-241) 368 (294-463) 2514 
 05-06 18.0 (16.0-20.3) 13.0 (11.5-16.1) 73.2 (57.3-91.6) 304 (240-364) 532 (434-674) 2548 
 07-08 15.5 (13.7-17.5) 12.4 (10.6-14.2) 50.4 (40.2-59.8) 233 (171-300) 443 (330-559) 2604 
 09-10 15.1 (13.2-17.4) 10.9 (9.41-12.4) 49.4 (37.0-67.3) 256 (191-322) 454 (352-557) 2749 
Age group        
6-11 years 03-04 9.93 (7.43-13.3) 7.55 (4.72-13.4) 25.1 (15.3-35.6) 116 (39.9-236) 236 (115-336) 314 
 05-06 14.1 (10.8-18.5) 13.5 (7.97-18.5) 38.6 (26.0-54.1) 108 (62.4-169) 241 (108-598) 356 
 07-08 14.5 (9.47-22.1) 13.0 (8.00-17.5) 33.1 (17.5-72.4) 132 (52.7-331) 331 (131-599) 389 
 09-10 14.2 (12.4-16.4) 12.0 (8.84-15.0) 37.1 (27.0-47.3) 129 (89.1-155) 300 (148-469) 415 
12-19 years 03-04 10.9 (8.32-14.2) 7.45 (5.48-10.7) 31.8 (21.9-61.1) 193 (90.7-318) 356 (169-580) 713 
 05-06 14.0 (11.0-17.8) 11.1 (8.68-13.6) 51.0 (33.0-73.4) 193 (125-306) 385 (203-739) 702 
 07-08 14.1 (11.0-18.1) 11.0 (7.87-14.4) 50.2 (27.1-78.8) 206 (95.3-293) 378 (238-571) 401 
 09-10 9.38 (7.86-11.2) 7.71 (5.71-9.21) 23.2 (17.3-29.3) 153 (63.0-201) 247 (166-379) 420 
20 years and older 03-04 13.4 (12.0-15.1) 10.0 (8.89-11.4) 50.0 (36.0-73.8) 224 (186-272) 385 (308-506) 1487 
 05-06 19.3 (16.9-22.0) 13.7 (11.6-17.0) 86.1 (64.0-109) 343 (262-411) 581 (440-718) 1490 
 07-08 15.8 (14.0-17.8) 12.6 (10.7-14.5) 52.3 (43.8-64.6) 244 (186-309) 484 (336-568) 1814 
 09-10 16.4 (13.7-19.6) 11.5 (9.63-14.8) 57.1 (38.4-80.2) 279 (202-364) 504 (372-601) 1914 
Gender        
Males 03-04 13.2 (11.3-15.6) 9.21 (6.86-12.1) 73.1 (45.8-85.9) 237 (175-294) 384 (294-506) 1228 
 05-06 17.1 (14.1-20.7) 12.4 (10.0-18.5) 82.6 (58.2-109) 308 (232-368) 472 (355-721) 1270 
 07-08 12.8 (10.9-15.0) 10.0 (8.12-13.0) 45.7 (32.1-57.3) 191 (132-241) 330 (253-456) 1294 
 09-10 13.3 (11.3-15.7) 9.21 (7.40-11.7) 43.9 (33.5-67.4) 230 (178-276) 345 (276-429) 1399 
Females 03-04 12.2 (10.6-14.2) 9.54 (8.45-10.4) 32.3 (26.2-46.6) 182 (138-217) 336 (225-480) 1286 
 05-06 19.0 (16.1-22.6) 13.8 (11.7-16.7) 64.0 (47.6-89.8) 301 (209-434) 619 (418-898) 1278 
 07-08 18.5 (15.6-22.0) 14.4 (12.4-16.8) 55.3 (38.5-77.0) 300 (182-435) 571 (359-729) 1310 
 09-10 17.1 (14.6-20.1) 12.3 (10.7-14.8) 50.6 (37.0-71.3) 300 (187-422) 556 (422-668) 1350 
Race/ethnicity        
Mexican Americans 03-04 13.3 (9.38-18.8) 9.18 (5.45-13.9) 66.7 (28.8-112) 292 (151-432) 453 (263-1150) 612 
 05-06 24.1 (19.3-29.9) 17.6 (13.3-22.8) 154 (96.4-242) 440 (379-601) 736 (601-818) 637 
 07-08 16.6 (12.2-22.6) 12.6 (8.51-16.5) 60.1 (39.6-80.3) 325 (182-475) 637 (368-828) 531 
 09-10 14.8 (12.1-18.2) 9.38 (7.63-12.4) 45.4 (32.2-110) 352 (244-458) 578 (402-737) 566 
Non-Hispanic blacks 03-04 9.94 (7.92-12.5) 7.74 (5.50-10.0) 30.2 (25.6-37.3) 132 (78.0-213) 260 (127-513) 651 
 05-06 12.2 (9.47-15.6) 9.50 (7.64-11.8) 41.0 (23.3-77.4) 179 (106-243) 352 (203-674) 678 
 07-08 10.6 (8.91-12.7) 8.34 (6.47-10.1) 28.6 (22.3-36.7) 120 (71.0-203) 266 (151-407) 597 
 09-10 9.23 (7.62-11.2) 6.62 (5.63-8.18) 22.7 (16.9-29.1) 136 (63.6-240) 356 (180-689) 516 
Non-Hispanic whites 03-04 13.3 (11.6-15.1) 9.82 (8.11-11.5) 47.0 (34.3-67.7) 213 (160-272) 358 (276-480) 1091 
 05-06 18.4 (16.0-21.2) 13.5 (11.6-17.0) 73.4 (56.8-97.0) 282 (231-343) 472 (367-699) 1038 
 07-08 15.6 (13.1-18.7) 13.0 (10.7-14.8) 50.4 (35.9-65.9) 222 (129-303) 418 (262-586) 1077 
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Urinary Triclosan (creatinine corrected) (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 13.4 (11.8-15.1) 8.39 (6.79-10.0) 49.3 (37.4-57.5) 309 (229-404) 642 (508-788) 2487 
 13-14 9.83 (9.00-10.7) 6.90 (6.27-7.65) 29.9 (25.1-34.4) 173 (138-207) 358 (292-425) 2684 
Age group        
6-11 years 11-12 10.3 (8.18-12.9) 6.70 (5.62-9.06) 22.4 (16.3-31.7) 103 (54.5-153) 235 (113-333) 395 
 13-14 10.4 (8.61-12.6) 8.97 (6.62-11.5) 23.4 (18.4-36.1) 78.1 (57.0-125) 184 (81.2-268) 409 
12-19 years 11-12 9.84 (7.85-12.4) 5.83 (4.95-7.23) 26.3 (19.0-37.8) 182 (65.0-399) 421 (182-647) 388 
 13-14 6.46 (5.24-7.96) 5.11 (4.39-5.93) 15.7 (10.0-21.8) 53.6 (33.2-105) 153 (102-289) 462 
20 years and older 11-12 14.4 (12.4-16.7) 9.06 (7.41-11.2) 54.3 (43.9-75.0) 364 (246-514) 660 (536-817) 1704 
 13-14 10.4 (9.44-11.4) 7.17 (6.32-8.26) 34.4 (29.3-41.6) 202 (162-234) 408 (296-531) 1813 
Gender        
Males 11-12 10.8 (9.49-12.2) 6.40 (5.24-8.53) 37.4 (26.8-49.4) 226 (153-309) 536 (311-656) 1258 
 13-14 8.36 (7.44-9.41) 5.74 (4.80-6.67) 26.7 (22.6-31.8) 143 (111-195) 296 (216-426) 1284 
Females 11-12 16.5 (13.8-19.6) 10.8 (8.44-12.7) 53.3 (44.2-75.0) 381 (273-539) 746 (614-900) 1229 
 13-14 11.5 (10.0-13.1) 8.08 (6.70-9.23) 34.4 (25.1-42.2) 205 (150-253) 419 (294-573) 1400 
Race/ethnicity        
Mexican Americans 11-12 14.2 (10.4-19.5) 8.29 (6.10-12.4) 62.5 (31.8-111) 399 (163-536) 536 (271-900) 316 
 13-14 8.82 (5.50-14.1) 6.08 (3.08-13.4) 25.5 (15.9-61.3) 147 (68.8-340) 425 (142-659) 438 
Non-Hispanic blacks 11-12 8.18 (7.09-9.44) 5.52 (4.66-6.27) 21.5 (16.7-29.9) 130 (74.3-222) 365 (229-461) 665 
 13-14 6.16 (5.30-7.15) 4.27 (3.52-4.93) 16.7 (12.7-21.3) 107 (66.1-125) 218 (116-284) 609 
Non-Hispanic whites 11-12 14.2 (12.1-16.7) 8.95 (6.79-11.7) 51.9 (39.1-69.1) 311 (180-569) 675 (508-817) 811 
 13-14 10.6 (9.78-11.5) 7.78 (6.67-9.09) 33.0 (26.4-40.2) 178 (128-215) 339 (247-420) 987 
All Hispanics 11-12 15.0 (13.0-17.3) 8.58 (6.52-11.4) 70.8 (40.8-98.6) 449 (320-514) 647 (506-913) 571 
 13-14 9.07 (6.64-12.4) 6.08 (3.75-11.0) 24.7 (17.0-55.6) 197 (114-322) 462 (322-619) 690 
Asians 11-12 15.7 (10.2-24.2) 10.5 (6.05-17.4) 51.8 (23.6-142) 333 (127-609) 575 (381-719) 352 
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Urinary Butyl paraben (2005 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 05-06 * < LOD 1.30 (.800-1.80) 6.60 (4.80-10.7) 19.6 (16.4-26.7) 2548 
 07-08 * < LOD 1.10 (.900-1.50) 9.00 (6.20-11.4) 20.9 (15.2-30.1) 2604 
 09-10 * < LOD .600 (.500-.800) 5.10 (3.40-8.10) 17.1 (10.5-29.4) 2749 
Age group        
6-11 years 05-06 * < LOD .400 (.200-.600) 1.90 (.800-5.80) 7.50 (1.70-18.5) 356 
 07-08 * < LOD .300 (.200-.500) 1.30 (.900-1.70) 3.80 (1.00-114) 389 
 09-10 * < LOD .300 (<LOD-.400) .900 (.500-1.70) 2.20 (1.30-5.10) 415 
12-19 years 05-06 * .200 (<LOD-.400) .900 (.600-1.80) 9.60 (4.10-16.1) 24.6 (14.5-33.4) 702 
 07-08 * < LOD .800 (.600-1.40) 6.20 (2.50-11.5) 15.8 (6.20-33.2) 401 
 09-10 * < LOD .500 (.400-.900) 5.70 (1.40-15.7) 18.6 (5.70-39.0) 420 
20 years and older 05-06 * < LOD 1.70 (1.00-2.20) 6.80 (4.80-11.7) 20.5 (15.8-28.3) 1490 
 07-08 * < LOD 1.50 (1.00-1.90) 9.80 (6.70-13.4) 24.6 (16.5-32.0) 1814 
 09-10 * < LOD .700 (.500-1.00) 6.00 (3.70-10.0) 18.7 (11.9-35.1) 1914 
Gender        
Males 05-06 * < LOD .300 (<LOD-.300) 1.10 (.600-2.00) 3.20 (1.90-5.50) 1270 
 07-08 * < LOD .200 (.200-.300) 1.00 (.700-1.50) 3.60 (2.00-7.20) 1294 
 09-10 * < LOD < LOD .800 (.500-1.20) 2.70 (1.50-12.0) 1399 
Females 05-06 .904 (.760-1.07) .500 (.400-.700) 3.70 (2.90-4.80) 17.4 (11.7-20.8) 34.9 (28.2-41.1) 1278 
 07-08 .926 (.825-1.04) .500 (.400-.700) 3.90 (3.00-4.70) 17.9 (12.1-20.5) 34.8 (25.2-52.1) 1310 
 09-10 * .300 (.200-.400) 1.80 (1.30-2.30) 11.3 (6.60-18.8) 31.8 (17.7-49.4) 1350 
Race/ethnicity        
Mexican Americans 05-06 * .200 (<LOD-.300) 1.10 (.700-2.30) 11.3 (6.40-15.6) 27.3 (16.5-35.9) 637 
 07-08 * < LOD .900 (.500-1.30) 6.80 (3.50-13.2) 22.7 (13.2-30.7) 531 
 09-10 * < LOD .900 (.400-1.30) 8.30 (4.50-13.8) 18.8 (13.8-35.1) 566 
Non-Hispanic blacks 05-06 * .300 (.200-.400) 2.10 (1.00-3.50) 9.10 (4.40-25.0) 31.8 (10.1-82.6) 678 
 07-08 * .200 (<LOD-.300) 1.10 (.700-1.70) 7.10 (4.20-9.90) 20.0 (8.90-31.3) 597 
 09-10 * < LOD .500 (.300-.900) 3.10 (1.40-7.30) 9.00 (5.60-16.7) 516 
Non-Hispanic whites 05-06 * < LOD 1.00 (.700-1.80) 5.80 (4.00-9.00) 17.7 (11.7-25.9) 1038 
 07-08 * < LOD 1.20 (.800-1.60) 9.10 (5.00-13.3) 19.6 (12.1-32.0) 1077 
 09-10 * < LOD .700 (.500-.900) 4.90 (2.70-9.20) 17.7 (9.20-34.5) 1206 
Limit of detection (LOD, see Data Analysis section) for Survey years 05-06, 07-08, and 09-10 are 0.2, 0.2, and 0.2 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Butyl paraben (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * < LOD .300 (.200-.400) 2.50 (1.60-3.40) 7.70 (4.50-11.4) 2489 
 13-14 * < LOD .200 (.100-.200) 1.30 (.800-1.70) 4.40 (2.70-6.10) 2686 
Age group        
6-11 years 11-12 * < LOD < LOD .700 (.300-1.00) 1.50 (1.00-1.90) 396 
 13-14 * < LOD < LOD .300 (.200-.500) .600 (.300-1.30) 409 
12-19 years 11-12 * < LOD .300 (<LOD-.400) .900 (.500-1.60) 1.90 (1.10-7.10) 388 
 13-14 * < LOD .200 (.100-.200) 1.20 (.500-1.90) 5.90 (1.70-26.7) 462 
20 years and older 11-12 * < LOD .400 (.300-.500) 3.30 (2.20-5.50) 8.90 (5.50-13.9) 1705 
 13-14 * < LOD .200 (.100-.300) 1.50 (.900-2.20) 4.90 (2.70-7.40) 1815 
Gender        
Males 11-12 * < LOD < LOD .400 (.200-.500) 1.30 (.500-2.40) 1259 
 13-14 * < LOD < LOD .200 (.100-.200) .400 (.300-.700) 1285 
Females 11-12 * < LOD .900 (.600-1.40) 5.90 (3.40-10.4) 13.4 (9.30-24.5) 1230 
 13-14 * < LOD .500 (.400-.800) 2.90 (1.90-4.90) 8.40 (4.90-15.3) 1401 
Race/ethnicity        
Mexican Americans 11-12 * < LOD .300 (<LOD-.400) 1.80 (1.40-5.90) 10.0 (3.20-13.7) 316 
 13-14 * < LOD .200 (.100-.300) 1.60 (.500-4.40) 7.10 (2.10-21.2) 438 
Non-Hispanic blacks 11-12 * < LOD .200 (<LOD-.300) 1.60 (1.00-2.50) 4.70 (2.50-8.10) 665 
 13-14 * < LOD .100 (<LOD-.200) .800 (.500-1.70) 3.20 (1.70-5.50) 609 
Non-Hispanic whites 11-12 * < LOD .300 (.200-.500) 2.60 (1.50-4.60) 8.00 (4.10-13.0) 813 
 13-14 * < LOD .200 (.100-.200) 1.20 (.700-1.70) 3.20 (1.80-5.60) 988 
All Hispanics 11-12 * < LOD .300 (<LOD-.400) 2.60 (1.30-7.00) 10.2 (3.40-21.5) 571 
 13-14 * < LOD .200 (.100-.300) 1.90 (.700-4.30) 9.00 (3.20-20.7) 690 
Asians 11-12 * < LOD .400 (<LOD-1.10) 3.10 (1.40-7.70) 12.0 (4.80-20.5) 352 
 13-14 * < LOD .200 (<LOD-.500) 2.90 (1.10-10.0) 18.4 (5.60-26.1) 289 
Limit of detection (LOD, see Data Analysis section) for Survey years 11-12 and 13-14 are 0.2 and 0.1, respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Butyl paraben (creatinine corrected) (2005 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 05-06 * < LOD 1.16 (.910-1.62) 7.82 (6.26-11.2) 21.2 (16.8-27.3) 2548 
 07-08 * < LOD 1.16 (.880-1.59) 9.83 (6.51-13.5) 23.1 (18.1-30.4) 2604 
 09-10 * < LOD .710 (.610-.930) 5.58 (3.55-10.0) 18.0 (10.2-27.6) 2749 
Age group        
6-11 years 05-06 * < LOD .440 (.370-.660) 1.65 (1.00-5.29) 7.92 (1.64-30.5) 356 
 07-08 * < LOD .540 (.410-.720) 1.24 (.920-2.80) 5.91 (.930-76.0) 389 
 09-10 * < LOD .530 (<LOD-.630) 1.36 (.740-1.89) 2.74 (1.56-6.58) 415 
12-19 years 05-06 * .190 (<LOD-.250) .690 (.490-1.20) 6.67 (3.60-11.2) 18.7 (9.52-28.9) 702 
 07-08 * < LOD .670 (.450-.930) 3.70 (1.80-7.41) 9.64 (6.00-18.7) 401 
 09-10 * < LOD .550 (.420-.790) 3.75 (1.21-11.9) 13.8 (3.75-23.7) 420 
20 years and older 05-06 * < LOD 1.49 (1.06-1.96) 9.07 (6.55-14.8) 25.5 (17.9-30.4) 1490 
 07-08 * < LOD 1.52 (1.04-2.21) 12.4 (8.35-15.1) 27.5 (21.2-36.8) 1814 
 09-10 * < LOD .830 (.640-1.19) 7.06 (3.79-11.9) 22.0 (13.1-31.2) 1914 
Gender        
Males 05-06 * < LOD .290 (<LOD-.350) .830 (.570-1.16) 2.28 (1.43-2.91) 1270 
 07-08 * < LOD .290 (.260-.340) .830 (.620-1.36) 2.40 (1.56-4.85) 1294 
 09-10 * < LOD < LOD .700 (.560-1.09) 2.50 (1.18-5.87) 1399 
Females 05-06 1.06 (.914-1.24) .750 (.600-.860) 4.44 (3.01-6.26) 19.8 (13.5-25.7) 34.7 (26.9-42.7) 1278 
 07-08 1.11 (.984-1.25) .670 (.550-.920) 4.44 (3.02-6.12) 20.6 (14.6-25.9) 39.4 (28.1-77.7) 1310 
 09-10 * .450 (.420-.520) 2.17 (1.67-3.10) 13.5 (8.75-22.5) 28.2 (18.4-45.7) 1350 
Race/ethnicity        
Mexican Americans 05-06 * .240 (<LOD-.290) 1.20 (.760-1.68) 9.15 (5.36-15.2) 20.3 (15.8-29.2) 637 
 07-08 * < LOD .810 (.610-1.07) 8.57 (3.28-12.0) 23.0 (12.7-29.5) 531 
 09-10 * < LOD .930 (.570-1.76) 8.01 (4.77-10.5) 17.0 (10.5-27.1) 566 
Non-Hispanic blacks 05-06 * .220 (.180-.270) 1.46 (.750-2.64) 8.18 (3.65-17.9) 21.0 (10.9-51.3) 678 
 07-08 * .220 (<LOD-.280) .900 (.570-1.27) 5.21 (3.13-6.18) 12.1 (6.14-21.4) 597 
 09-10 * < LOD .390 (.270-.590) 2.63 (.890-4.71) 7.00 (3.26-11.9) 516 
Non-Hispanic whites 05-06 * < LOD 1.12 (.850-1.65) 6.93 (5.21-9.91) 20.9 (15.4-27.3) 1038 
 07-08 * < LOD 1.18 (.810-2.09) 10.7 (6.32-14.8) 26.8 (15.1-40.4) 1077 
 09-10 * < LOD .780 (.620-1.13) 6.34 (3.44-12.6) 20.8 (9.12-33.2) 1206 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary Butyl paraben (creatinine corrected) (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * < LOD .560 (.476-.667) 3.50 (2.00-4.55) 10.0 (6.26-13.5) 2487 
 13-14 * < LOD .250 (.202-.318) 1.54 (.952-2.22) 4.39 (3.25-6.96) 2684 
Age group        
6-11 years 11-12 * < LOD < LOD .825 (.737-1.12) 1.56 (.825-2.44) 395 
 13-14 * < LOD < LOD .411 (.326-.538) .714 (.467-.984) 409 
12-19 years 11-12 * < LOD .378 (<LOD-.588) 1.35 (.588-2.21) 2.21 (1.50-7.45) 388 
 13-14 * < LOD .194 (.159-.233) 1.02 (.484-1.88) 4.00 (1.74-12.1) 462 
20 years and older 11-12 * < LOD .609 (.500-.789) 4.02 (2.58-6.28) 12.2 (7.04-17.9) 1704 
 13-14 * < LOD .269 (.208-.382) 1.74 (1.15-2.63) 5.42 (3.42-8.95) 1813 
Gender        
Males 11-12 * < LOD < LOD .583 (.424-.824) 1.35 (.778-2.25) 1258 
 13-14 * < LOD < LOD .225 (.179-.280) .417 (.304-.583) 1284 
Females 11-12 * < LOD 1.56 (1.08-2.00) 8.19 (5.33-12.1) 17.6 (11.8-30.8) 1229 
 13-14 * < LOD .690 (.411-1.11) 3.42 (2.41-4.87) 10.2 (6.22-13.4) 1400 
Race/ethnicity        
Mexican Americans 11-12 * < LOD .533 (<LOD-.660) 3.48 (1.30-4.33) 7.45 (3.50-19.2) 316 
 13-14 * < LOD .247 (.189-.350) 1.71 (.811-5.00) 10.6 (1.87-25.4) 438 
Non-Hispanic blacks 11-12 * < LOD .298 (<LOD-.378) 1.43 (.875-1.93) 3.47 (1.93-6.72) 665 
 13-14 * < LOD .146 (<LOD-.189) .583 (.368-1.16) 2.86 (1.19-3.25) 609 
Non-Hispanic whites 11-12 * < LOD .606 (.500-.778) 3.78 (2.08-5.63) 11.5 (5.39-15.7) 811 
 13-14 * < LOD .259 (.200-.368) 1.54 (.778-2.33) 4.03 (2.50-6.09) 987 
All Hispanics 11-12 * < LOD .526 (<LOD-.700) 3.50 (1.53-6.88) 13.7 (6.54-19.2) 571 
 13-14 * < LOD .250 (.219-.309) 1.73 (.896-3.92) 10.3 (3.56-14.3) 690 
Asians 11-12 * < LOD .824 (<LOD-1.30) 6.28 (2.03-12.3) 14.9 (7.89-18.8) 352 
 13-14 * < LOD .440 (<LOD-.606) 3.46 (1.43-13.0) 23.6 (5.45-38.4) 288 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary Ethyl paraben (2005 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 05-06 * < LOD 4.80 (3.40-6.00) 26.2 (19.4-31.9) 57.2 (40.3-83.4) 2548 
 07-08 * < LOD 5.40 (3.80-6.90) 29.3 (21.9-42.4) 72.1 (54.6-91.8) 2604 
 09-10 * 1.10 (<LOD-1.20) 6.60 (4.90-8.30) 37.6 (24.4-51.3) 82.6 (60.3-119) 2749 
Age group        
6-11 years 05-06 * < LOD < LOD 2.60 (1.70-4.70) 9.90 (2.80-30.7) 356 
 07-08 * < LOD 1.70 (1.10-2.60) 4.60 (2.30-36.7) 35.6 (2.60-282) 389 
 09-10 * < LOD 1.50 (1.20-1.80) 3.70 (2.50-5.30) 11.5 (4.50-18.4) 415 
12-19 years 05-06 * < LOD 2.30 (1.30-3.20) 11.3 (7.90-24.1) 38.0 (17.7-122) 702 
 07-08 * < LOD 3.00 (2.30-4.90) 23.0 (7.30-60.3) 60.3 (12.5-159) 401 
 09-10 * < LOD 3.50 (2.10-5.90) 33.8 (19.4-49.6) 83.2 (34.5-284) 420 
20 years and older 05-06 * < LOD 5.90 (4.60-8.10) 30.4 (22.3-38.6) 69.5 (48.1-89.5) 1490 
 07-08 * 1.10 (<LOD-1.40) 6.20 (4.60-9.20) 34.7 (22.8-50.4) 77.4 (51.4-120) 1814 
 09-10 * 1.30 (1.10-1.50) 8.40 (6.00-10.6) 45.0 (29.1-60.3) 91.4 (62.6-129) 1914 
Gender        
Males 05-06 * < LOD 1.90 (1.20-3.00) 8.90 (5.80-13.7) 25.2 (15.7-29.2) 1270 
 07-08 * < LOD 2.40 (1.50-3.00) 11.2 (6.60-15.3) 28.3 (15.3-42.8) 1294 
 09-10 * < LOD 2.20 (1.90-2.70) 10.4 (7.40-19.1) 36.4 (19.1-61.3) 1399 
Females 05-06 * 1.30 (<LOD-2.20) 10.0 (7.50-13.2) 42.7 (32.3-62.8) 98.7 (74.7-147) 1278 
 07-08 * 1.80 (1.40-2.50) 10.1 (6.90-16.5) 62.0 (38.2-80.8) 123 (78.5-259) 1310 
 09-10 3.84 (3.35-4.41) 2.00 (1.60-2.40) 15.4 (12.5-18.4) 62.4 (45.7-78.7) 138 (92.2-211) 1350 
Race/ethnicity        
Mexican Americans 05-06 * < LOD 3.70 (1.90-6.10) 24.0 (11.6-37.7) 55.6 (40.3-120) 637 
 07-08 * < LOD 4.10 (2.90-5.90) 23.6 (12.8-30.1) 48.3 (31.0-65.2) 531 
 09-10 * < LOD 4.30 (2.60-7.70) 31.0 (21.5-46.3) 65.5 (46.3-92.2) 566 
Non-Hispanic blacks 05-06 * 1.00 (<LOD-1.50) 5.70 (3.70-9.80) 31.3 (20.4-52.1) 92.3 (41.5-166) 678 
 07-08 * 1.00 (<LOD-1.50) 7.90 (3.90-15.8) 39.9 (24.0-63.4) 97.2 (58.3-256) 597 
 09-10 3.62 (3.11-4.22) 1.90 (1.60-2.40) 11.1 (8.10-17.5) 58.6 (33.8-93.7) 166 (66.0-297) 516 
Non-Hispanic whites 05-06 * < LOD 4.80 (3.10-6.10) 24.0 (15.5-32.3) 54.7 (36.4-86.8) 1038 
 07-08 * 1.00 (<LOD-1.30) 5.20 (3.50-7.10) 27.2 (18.0-40.8) 67.1 (42.8-98.1) 1077 
 09-10 * 1.10 (<LOD-1.20) 6.50 (4.50-8.50) 37.5 (22.7-52.7) 78.7 (49.7-138) 1206 
Limit of detection (LOD, see Data Analysis section) for Survey years 05-06, 07-08, and 09-10 are 1.0, 1.0, and 1.0 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Ethyl paraben (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * < LOD 5.10 (4.00-7.10) 33.6 (24.6-42.9) 68.8 (52.1-106) 2489 
 13-14 * < LOD 5.30 (4.50-6.50) 33.5 (25.5-46.4) 77.0 (66.4-97.9) 2686 
Age group        
6-11 years 11-12 * < LOD < LOD 3.40 (1.70-6.90) 6.90 (3.40-17.4) 396 
 13-14 * < LOD 1.30 (1.00-1.70) 5.60 (2.90-8.40) 10.7 (6.60-17.3) 409 
12-19 years 11-12 * < LOD 2.00 (1.10-3.10) 9.60 (5.50-14.0) 21.5 (9.60-69.2) 388 
 13-14 * < LOD 2.40 (1.60-3.40) 15.6 (6.60-29.3) 48.7 (19.4-83.4) 462 
20 years and older 11-12 * < LOD 7.20 (5.50-10.0) 41.1 (33.4-51.0) 86.5 (58.0-140) 1705 
 13-14 * 1.10 (<LOD-1.30) 6.90 (5.50-8.60) 43.3 (32.2-53.4) 84.8 (70.5-114) 1815 
Gender        
Males 11-12 * < LOD 2.20 (1.60-2.90) 10.0 (6.10-18.9) 31.2 (18.9-39.8) 1259 
 13-14 * < LOD 2.40 (1.80-3.10) 8.50 (6.00-14.4) 34.0 (15.6-62.8) 1285 
Females 11-12 * 1.60 (1.10-2.60) 12.9 (9.40-17.5) 58.2 (45.4-68.8) 145 (86.5-153) 1230 
 13-14 * 1.60 (1.20-2.30) 12.5 (8.60-17.8) 58.7 (46.4-72.9) 110 (81.5-149) 1401 
Race/ethnicity        
Mexican Americans 11-12 * < LOD 4.40 (2.40-6.40) 22.0 (12.9-35.5) 45.4 (22.4-171) 316 
 13-14 * < LOD 4.20 (2.60-7.70) 32.6 (16.7-53.4) 70.6 (52.5-123) 438 
Non-Hispanic blacks 11-12 * 1.50 (1.10-2.00) 8.00 (5.80-12.8) 55.4 (33.4-79.7) 106 (82.8-139) 665 
 13-14 * 1.40 (1.10-1.90) 6.80 (4.90-9.20) 48.8 (29.9-77.0) 115 (77.0-230) 609 
Non-Hispanic whites 11-12 * < LOD 4.60 (3.50-9.10) 33.6 (21.6-45.4) 62.6 (42.9-132) 813 
 13-14 * < LOD 5.20 (3.90-6.50) 29.2 (17.8-46.4) 68.5 (48.7-86.6) 988 
All Hispanics 11-12 * < LOD 4.50 (3.00-5.80) 24.4 (15.2-34.6) 55.9 (27.1-115) 571 
 13-14 * < LOD 5.50 (3.70-8.70) 35.5 (23.9-53.4) 90.4 (62.5-123) 690 
Asians 11-12 * < LOD 4.90 (3.40-8.30) 39.4 (16.0-59.1) 92.4 (43.4-186) 352 
 13-14 * < LOD 6.00 (2.70-11.3) 52.1 (27.4-75.0) 99.9 (65.5-174) 289 
Limit of detection (LOD, see Data Analysis section) for Survey years 11-12 and 13-14 are 1.0 and 1.0, respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Ethyl paraben (creatinine corrected) (2005 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 05-06 * < LOD 4.61 (3.39-6.30) 27.1 (19.1-34.0) 66.5 (46.5-84.2) 2548 
 07-08 * < LOD 5.56 (4.31-7.56) 32.7 (22.5-50.2) 80.0 (53.2-117) 2604 
 09-10 * 1.65 (<LOD-1.82) 6.11 (4.90-7.96) 36.6 (28.0-47.2) 94.6 (67.3-127) 2749 
Age group        
6-11 years 05-06 * < LOD < LOD 4.18 (1.91-10.2) 13.5 (4.18-29.0) 356 
 07-08 * < LOD 2.54 (1.82-3.30) 6.13 (3.26-34.3) 34.3 (3.30-207) 389 
 09-10 * < LOD 2.37 (1.97-3.09) 5.00 (3.74-6.67) 10.1 (6.11-27.3) 415 
12-19 years 05-06 * < LOD 1.94 (1.29-2.65) 10.9 (3.57-20.2) 32.0 (14.1-57.8) 702 
 07-08 * < LOD 2.93 (1.93-3.97) 12.9 (4.60-37.9) 37.9 (8.79-110) 401 
 09-10 * < LOD 3.11 (2.22-5.94) 26.2 (13.0-33.9) 52.4 (28.8-177) 420 
20 years and older 05-06 * < LOD 6.36 (4.63-7.92) 32.4 (23.7-46.0) 76.8 (57.3-97.9) 1490 
 07-08 * 1.58 (<LOD-1.97) 6.97 (4.94-10.9) 38.5 (24.8-61.9) 94.1 (53.6-146) 1814 
 09-10 * 1.82 (1.61-2.13) 8.08 (5.92-10.7) 43.7 (33.1-56.0) 106 (78.1-137) 1914 
Gender        
Males 05-06 * < LOD 1.82 (1.48-2.15) 6.38 (3.55-9.95) 15.5 (10.2-22.3) 1270 
 07-08 * < LOD 2.14 (1.67-3.03) 8.61 (5.54-12.4) 21.7 (11.7-32.7) 1294 
 09-10 * < LOD 2.45 (2.22-2.92) 8.63 (6.14-13.7) 28.8 (14.4-43.2) 1399 
Females 05-06 * 2.09 (<LOD-2.60) 12.7 (8.45-16.2) 57.3 (40.7-75.2) 107 (82.9-141) 1278 
 07-08 * 2.63 (2.09-3.55) 13.9 (9.09-22.5) 66.1 (40.9-95.1) 130 (78.8-203) 1310 
 09-10 4.63 (4.13-5.19) 2.90 (2.47-3.43) 16.8 (13.7-22.0) 71.9 (53.4-98.8) 173 (121-227) 1350 
Race/ethnicity        
Mexican Americans 05-06 * < LOD 3.49 (2.09-5.23) 23.6 (11.8-33.2) 68.5 (32.1-107) 637 
 07-08 * < LOD 4.44 (2.86-5.81) 22.5 (15.9-27.2) 47.7 (26.7-74.2) 531 
 09-10 * < LOD 4.40 (3.09-6.31) 30.0 (16.0-36.9) 59.1 (36.9-87.2) 566 
Non-Hispanic blacks 05-06 * .970 (<LOD-1.14) 4.48 (2.90-6.07) 22.0 (14.1-36.8) 47.5 (33.7-106) 678 
 07-08 * 1.18 (<LOD-1.47) 6.37 (3.20-10.9) 38.8 (16.5-53.1) 90.7 (42.6-172) 597 
 09-10 2.62 (2.14-3.21) 1.57 (1.20-2.05) 7.35 (5.15-9.97) 44.9 (22.0-75.0) 98.8 (60.0-162) 516 
Non-Hispanic whites 05-06 * < LOD 4.73 (3.38-6.58) 27.5 (16.2-38.4) 70.6 (46.0-91.2) 1038 
 07-08 * 1.48 (<LOD-1.82) 5.71 (3.74-8.97) 32.3 (20.0-53.6) 75.7 (40.5-121) 1077 
 09-10 * 1.79 (<LOD-2.03) 6.63 (4.84-9.18) 37.7 (27.7-53.4) 114 (62.8-164) 1206 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary Ethyl paraben (creatinine corrected) (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * < LOD 6.57 (5.32-8.80) 39.5 (28.4-50.6) 87.7 (63.6-121) 2487 
 13-14 * < LOD 5.41 (4.31-6.33) 36.6 (26.5-47.5) 99.3 (69.5-129) 2684 
Age group        
6-11 years 11-12 * < LOD < LOD 5.92 (3.74-7.50) 7.95 (6.51-17.8) 395 
 13-14 * < LOD 2.45 (2.03-2.96) 6.30 (3.94-9.44) 12.4 (7.02-26.6) 409 
12-19 years 11-12 * < LOD 2.53 (1.81-3.83) 11.1 (6.70-14.5) 20.5 (11.9-44.1) 388 
 13-14 * < LOD 2.24 (1.83-2.81) 11.8 (4.44-15.7) 36.1 (13.2-73.2) 462 
20 years and older 11-12 * < LOD 9.17 (6.69-12.5) 46.4 (34.7-64.8) 110 (71.5-146) 1704 
 13-14 * 1.57 (<LOD-1.84) 6.97 (5.76-8.73) 47.0 (35.1-63.1) 113 (76.0-169) 1813 
Gender        
Males 11-12 * < LOD 2.45 (2.07-2.94) 8.76 (5.32-14.2) 23.2 (13.2-33.1) 1258 
 13-14 * < LOD 2.17 (1.78-2.63) 7.89 (5.23-12.5) 26.6 (13.8-41.0) 1284 
Females 11-12 * 2.96 (2.37-4.08) 18.9 (12.5-27.6) 81.9 (55.6-121) 146 (115-181) 1229 
 13-14 * 2.54 (2.09-3.05) 14.5 (10.3-20.8) 73.2 (51.8-104) 167 (104-221) 1400 
Race/ethnicity        
Mexican Americans 11-12 * < LOD 4.73 (3.29-8.92) 25.4 (14.2-33.9) 45.4 (32.6-121) 316 
 13-14 * < LOD 4.85 (3.13-8.28) 33.9 (16.4-60.9) 75.8 (30.0-319) 438 
Non-Hispanic blacks 11-12 * 1.39 (1.06-1.75) 6.98 (4.74-8.92) 40.2 (24.8-55.3) 79.3 (61.1-135) 665 
 13-14 * 1.20 (1.05-1.39) 5.13 (3.53-7.24) 30.6 (18.4-38.8) 77.2 (38.8-129) 609 
Non-Hispanic whites 11-12 * < LOD 7.20 (4.88-10.4) 40.1 (26.4-63.5) 93.8 (58.4-131) 811 
 13-14 * < LOD 5.25 (3.95-6.33) 36.6 (22.0-51.9) 87.1 (51.9-162) 987 
All Hispanics 11-12 * < LOD 5.03 (3.74-7.13) 31.6 (13.2-54.0) 60.2 (43.6-121) 571 
 13-14 * < LOD 6.55 (3.94-8.72) 35.1 (26.6-56.1) 103 (56.1-135) 690 
Asians 11-12 * < LOD 7.21 (4.46-13.6) 48.9 (26.3-78.9) 100 (50.4-149) 352 
 13-14 * < LOD 7.52 (3.33-14.6) 65.9 (36.9-105) 116 (80.6-191) 288 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary Methyl paraben (2005 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 05-06 56.4 (46.9-67.9) 63.5 (47.9-74.5) 216 (168-282) 560 (432-777) 974 (827-1110) 2548 
 07-08 60.1 (49.6-72.8) 59.8 (47.5-73.3) 204 (171-253) 544 (444-675) 902 (746-1100) 2604 
 09-10 57.1 (51.0-63.9) 55.1 (46.7-62.6) 213 (179-259) 621 (546-716) 1010 (919-1170) 2749 
Age group        
6-11 years 05-06 33.5 (25.6-43.8) 25.0 (19.4-35.3) 86.7 (61.5-153) 289 (238-868) 1560 (389-2090) 356 
 07-08 35.2 (25.0-49.6) 30.1 (19.6-38.5) 94.0 (46.6-214) 340 (218-527) 651 (430-995) 389 
 09-10 33.9 (27.4-41.9) 26.5 (20.4-33.3) 79.4 (59.0-126) 415 (163-849) 873 (477-1230) 415 
12-19 years 05-06 53.8 (43.9-66.0) 53.5 (39.4-65.7) 192 (163-264) 491 (380-720) 901 (571-1210) 702 
 07-08 64.9 (50.3-83.8) 66.3 (48.0-96.7) 221 (180-276) 521 (424-789) 971 (574-1390) 401 
 09-10 53.9 (40.9-70.9) 56.5 (39.4-75.6) 176 (122-291) 716 (399-934) 984 (805-1210) 420 
20 years and older 05-06 60.3 (48.7-74.7) 70.0 (57.1-85.3) 225 (177-322) 602 (439-814) 974 (827-1110) 1490 
 07-08 63.0 (51.8-76.7) 64.0 (51.4-79.8) 210 (172-267) 558 (447-678) 916 (743-1190) 1814 
 09-10 61.0 (53.5-69.6) 59.1 (50.6-72.6) 239 (188-276) 625 (566-711) 1010 (909-1270) 1914 
Gender        
Males 05-06 29.8 (24.8-35.8) 23.7 (19.5-29.4) 97.6 (78.1-121) 299 (229-355) 491 (385-743) 1270 
 07-08 33.6 (27.3-41.3) 27.4 (20.8-39.9) 93.5 (71.0-137) 312 (260-407) 598 (460-734) 1294 
 09-10 31.7 (27.6-36.4) 25.3 (20.6-30.6) 94.0 (76.8-122) 366 (275-482) 727 (569-919) 1399 
Females 05-06 104 (80.8-135) 137 (93.0-168) 356 (279-427) 842 (660-974) 1110 (956-1330) 1278 
 07-08 105 (90.2-123) 116 (95.2-139) 315 (248-424) 683 (558-901) 1140 (917-1420) 1310 
 09-10 100 (87.9-114) 106 (90.9-125) 349 (271-405) 812 (696-931) 1230 (1010-1550) 1350 
Race/ethnicity        
Mexican Americans 05-06 78.2 (61.0-100) 86.3 (64.7-121) 301 (233-349) 742 (474-896) 1100 (896-1170) 637 
 07-08 80.5 (66.0-98.2) 87.0 (63.4-117) 283 (222-348) 630 (533-791) 1030 (773-1240) 531 
 09-10 82.9 (68.6-100) 85.5 (73.0-99.8) 293 (231-385) 821 (536-1120) 1580 (855-2360) 566 
Non-Hispanic blacks 05-06 174 (133-229) 216 (150-306) 616 (465-789) 1180 (1010-1480) 1690 (1210-2880) 678 
 07-08 152 (135-171) 159 (135-194) 483 (421-552) 1080 (938-1350) 1720 (1210-2700) 597 
 09-10 191 (171-213) 223 (170-288) 678 (533-849) 1470 (1220-2010) 2340 (1650-2750) 516 
Non-Hispanic whites 05-06 43.8 (36.7-52.3) 44.3 (36.7-58.2) 165 (132-209) 412 (320-520) 806 (485-974) 1038 
 07-08 48.9 (39.9-59.9) 47.6 (37.8-62.0) 158 (129-198) 430 (301-557) 671 (524-921) 1077 
 09-10 43.5 (39.4-48.1) 41.3 (33.5-47.7) 150 (127-176) 463 (361-557) 757 (619-888) 1206 
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Urinary Methyl paraben (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 40.3 (35.4-46.0) 39.0 (32.4-47.8) 172 (149-198) 471 (401-593) 841 (692-975) 2489 
 13-14 48.1 (43.0-53.8) 41.7 (34.5-50.4) 167 (151-186) 445 (404-509) 819 (663-918) 2686 
Age group        
6-11 years 11-12 18.5 (15.7-21.9) 13.8 (11.2-17.7) 58.6 (43.8-78.2) 217 (155-363) 549 (329-983) 396 
 13-14 28.6 (21.4-38.1) 22.7 (17.8-30.3) 62.1 (43.5-100) 260 (150-408) 542 (290-878) 409 
12-19 years 11-12 26.3 (19.0-36.5) 17.0 (9.80-31.2) 121 (62.4-219) 538 (376-667) 772 (609-996) 388 
 13-14 40.5 (32.7-50.1) 32.0 (25.2-41.7) 147 (89.6-193) 452 (309-725) 942 (612-1220) 462 
20 years and older 11-12 46.8 (41.3-53.1) 48.9 (37.8-61.0) 188 (158-231) 477 (409-611) 870 (676-1070) 1705 
 13-14 52.2 (46.0-59.3) 46.8 (37.8-57.3) 179 (163-201) 457 (417-525) 823 (663-918) 1815 
Gender        
Males 11-12 23.2 (19.2-28.1) 17.3 (12.5-23.4) 81.9 (65.7-119) 312 (224-396) 575 (401-822) 1259 
 13-14 31.1 (26.8-36.2) 24.4 (20.1-29.8) 77.2 (67.2-94.6) 273 (230-328) 561 (408-740) 1285 
Females 11-12 68.6 (59.0-79.9) 76.9 (67.5-89.2) 248 (201-309) 637 (493-819) 972 (772-1190) 1230 
 13-14 72.8 (63.6-83.4) 73.9 (61.0-94.1) 248 (217-276) 583 (490-680) 904 (801-1070) 1401 
Race/ethnicity        
Mexican Americans 11-12 43.9 (31.5-61.2) 44.9 (26.2-68.1) 192 (111-302) 529 (328-912) 1080 (471-1740) 316 
 13-14 62.1 (49.2-78.4) 57.4 (45.1-84.0) 230 (154-341) 518 (361-725) 915 (535-1530) 438 
Non-Hispanic blacks 11-12 123 (100-152) 155 (115-199) 450 (341-579) 934 (819-1110) 1390 (1020-1990) 665 
 13-14 111 (96.1-129) 110 (86.4-143) 375 (313-482) 927 (709-1180) 1430 (1020-2040) 609 
Non-Hispanic whites 11-12 31.0 (26.9-35.8) 30.0 (23.4-36.4) 130 (96.8-160) 372 (269-453) 603 (453-772) 813 
 13-14 37.9 (32.8-43.7) 32.5 (28.3-39.0) 123 (94.3-153) 328 (267-391) 573 (422-711) 988 
All Hispanics 11-12 50.1 (40.5-62.1) 46.0 (39.5-59.4) 203 (130-301) 666 (406-1080) 1170 (766-2100) 571 
 13-14 61.9 (52.2-73.3) 60.0 (49.0-73.5) 221 (161-291) 539 (417-702) 842 (639-1070) 690 
Asians 11-12 36.1 (29.2-44.5) 37.1 (24.6-57.4) 140 (97.9-175) 395 (259-509) 692 (461-1030) 352 
 13-14 45.0 (37.9-53.5) 38.9 (30.5-53.0) 168 (118-197) 384 (271-475) 663 (393-914) 289 
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Urinary Methyl paraben (creatinine corrected) (2005 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 05-06 55.0 (46.8-64.6) 58.8 (47.0-73.4) 221 (170-264) 527 (426-685) 902 (753-995) 2548 
 07-08 60.6 (49.8-73.8) 61.0 (45.3-83.2) 228 (188-288) 538 (439-645) 820 (694-1000) 2604 
 09-10 59.6 (53.5-66.3) 57.7 (52.3-68.5) 232 (195-262) 544 (468-632) 887 (734-1020) 2749 
Age group        
6-11 years 05-06 36.8 (27.9-48.7) 26.9 (21.0-36.6) 108 (55.9-164) 259 (195-753) 1540 (313-2510) 356 
 07-08 43.4 (31.3-60.2) 33.1 (21.8-55.0) 118 (62.3-197) 424 (218-668) 817 (558-1020) 389 
 09-10 44.2 (35.7-54.6) 32.3 (26.5-42.9) 110 (67.6-158) 483 (258-722) 849 (535-1080) 415 
12-19 years 05-06 40.1 (33.7-47.8) 41.7 (31.5-56.3) 160 (129-178) 362 (280-428) 549 (434-656) 702 
 07-08 50.5 (40.1-63.7) 52.8 (36.6-78.1) 167 (111-245) 336 (292-395) 475 (376-623) 401 
 09-10 43.3 (33.5-55.9) 43.5 (27.5-68.6) 168 (123-221) 399 (292-558) 632 (425-890) 420 
20 years and older 05-06 60.5 (50.5-72.5) 69.6 (51.5-90.9) 251 (189-320) 602 (462-729) 930 (788-1010) 1490 
 07-08 64.7 (52.9-79.2) 69.7 (51.1-92.5) 256 (209-316) 576 (450-710) 865 (697-1130) 1814 
 09-10 64.6 (57.0-73.3) 71.2 (56.6-84.7) 251 (217-287) 566 (495-673) 924 (753-1060) 1914 
Gender        
Males 05-06 23.9 (20.6-27.8) 21.1 (17.4-25.3) 72.1 (58.0-89.5) 209 (160-260) 368 (262-498) 1270 
 07-08 28.3 (22.8-35.0) 23.5 (17.2-33.2) 80.7 (56.9-111) 257 (181-318) 444 (386-558) 1294 
 09-10 28.4 (25.1-32.2) 23.3 (19.3-26.9) 77.7 (59.6-105) 260 (212-370) 516 (412-633) 1399 
Females 05-06 123 (99.3-152) 147 (111-196) 377 (319-445) 788 (676-910) 1050 (937-1290) 1278 
 07-08 126 (109-145) 160 (134-182) 374 (325-422) 734 (576-879) 1040 (835-1260) 1310 
 09-10 121 (107-137) 146 (125-162) 359 (307-426) 745 (606-890) 1080 (924-1390) 1350 
Race/ethnicity        
Mexican Americans 05-06 70.3 (57.1-86.7) 85.8 (67.2-106) 249 (191-303) 515 (431-656) 870 (656-1080) 637 
 07-08 78.5 (63.6-97.0) 96.2 (59.4-127) 293 (245-370) 627 (541-728) 831 (729-963) 531 
 09-10 82.3 (71.1-95.2) 95.2 (76.0-113) 284 (237-337) 623 (459-899) 1130 (657-2120) 566 
Non-Hispanic blacks 05-06 122 (93.0-161) 161 (98.2-225) 377 (334-462) 792 (581-1100) 1220 (916-1590) 678 
 07-08 118 (105-133) 134 (111-155) 356 (311-403) 757 (573-882) 1030 (847-1290) 597 
 09-10 138 (118-163) 165 (127-203) 403 (356-498) 928 (729-1120) 1350 (1080-1680) 516 
Non-Hispanic whites 05-06 46.1 (39.0-54.4) 45.6 (34.5-59.7) 170 (142-234) 447 (339-706) 814 (640-995) 1038 
 07-08 51.0 (40.5-64.2) 46.7 (35.8-66.3) 191 (154-230) 481 (383-614) 747 (574-966) 1077 
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Urinary Methyl paraben (creatinine corrected) (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 46.0 (41.3-51.3) 47.9 (36.9-61.7) 203 (179-228) 494 (399-571) 797 (632-993) 2487 
 13-14 48.2 (43.1-53.9) 41.8 (35.5-49.1) 180 (145-205) 410 (379-460) 653 (585-697) 2684 
Age group        
6-11 years 11-12 26.4 (22.8-30.7) 19.4 (14.6-23.8) 69.9 (53.0-113) 282 (182-458) 644 (354-1220) 395 
 13-14 36.1 (28.0-46.5) 28.2 (20.9-36.5) 72.7 (50.9-122) 263 (160-564) 588 (341-881) 409 
12-19 years 11-12 25.7 (19.3-34.2) 17.1 (11.8-33.4) 100 (53.2-175) 335 (213-545) 609 (450-773) 388 
 13-14 32.9 (27.7-39.0) 24.3 (18.1-33.8) 99.5 (75.3-145) 339 (234-412) 495 (377-655) 462 
20 years and older 11-12 53.4 (47.7-59.8) 64.9 (53.2-75.2) 228 (199-250) 523 (429-623) 815 (669-1110) 1704 
 13-14 52.6 (46.6-59.4) 47.5 (38.7-58.5) 199 (170-229) 429 (390-476) 666 (591-781) 1813 
Gender        
Males 11-12 21.8 (18.3-26.0) 16.2 (12.5-21.1) 74.1 (57.1-93.3) 250 (181-321) 450 (327-560) 1258 
 13-14 26.1 (22.9-29.8) 18.4 (16.6-22.2) 61.3 (52.1-74.0) 215 (172-284) 411 (323-479) 1284 
Females 11-12 94.5 (83.1-108) 119 (101-136) 309 (259-356) 682 (571-805) 1090 (797-1300) 1229 
 13-14 86.5 (74.1-101) 90.5 (72.2-125) 266 (237-307) 564 (506-614) 828 (665-998) 1400 
Race/ethnicity        
Mexican Americans 11-12 49.5 (37.0-66.2) 50.5 (32.5-79.7) 200 (133-298) 496 (316-982) 1090 (484-2160) 316 
 13-14 63.3 (46.8-85.5) 67.9 (45.6-96.0) 229 (146-317) 570 (360-764) 883 (578-1130) 438 
Non-Hispanic blacks 11-12 96.1 (79.4-116) 117 (88.0-157) 341 (274-382) 696 (626-842) 1090 (879-1190) 665 
 13-14 82.0 (75.2-89.5) 84.6 (65.8-100) 251 (211-289) 584 (521-672) 924 (655-1120) 609 
Non-Hispanic whites 11-12 37.8 (33.1-43.2) 33.4 (25.7-47.6) 177 (141-208) 425 (321-556) 719 (544-833) 811 
 13-14 39.9 (34.5-46.2) 31.8 (26.4-38.7) 139 (104-182) 357 (294-404) 560 (444-640) 987 
All Hispanics 11-12 56.1 (46.3-68.0) 57.1 (47.2-75.2) 217 (160-332) 577 (456-813) 1090 (662-1490) 571 
 13-14 61.4 (49.8-75.7) 60.8 (51.7-74.6) 227 (179-270) 542 (390-637) 774 (570-1070) 690 
Asians 11-12 48.3 (39.5-59.2) 54.9 (31.6-79.8) 198 (167-238) 473 (344-600) 840 (528-1170) 352 
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Urinary n-Propyl paraben (2005 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 05-06 7.91 (6.41-9.77) 8.70 (5.90-12.4) 48.9 (36.6-64.8) 160 (129-200) 299 (237-354) 2548 
 07-08 7.59 (6.22-9.26) 7.60 (5.70-10.6) 44.1 (34.1-55.6) 144 (115-196) 268 (231-290) 2604 
 09-10 6.97 (5.96-8.16) 6.40 (5.10-8.00) 44.3 (38.6-50.3) 153 (133-183) 297 (233-334) 2749 
Age group        
6-11 years 05-06 3.41 (2.43-4.77) 2.50 (1.60-4.30) 11.1 (7.10-21.0) 47.5 (30.0-91.9) 125 (55.8-383) 356 
 07-08 3.61 (2.39-5.44) 3.50 (1.90-6.00) 13.7 (7.60-22.8) 49.1 (21.7-99.6) 99.6 (80.4-120) 389 
 09-10 3.28 (2.58-4.17) 2.70 (2.00-4.00) 10.2 (7.00-14.0) 42.9 (28.2-61.6) 114 (56.8-239) 415 
12-19 years 05-06 8.16 (5.70-11.7) 8.40 (5.00-13.9) 46.4 (24.1-68.5) 165 (96.7-222) 310 (201-361) 702 
 07-08 8.85 (6.73-11.6) 7.90 (5.30-12.0) 49.2 (31.1-62.2) 193 (100-234) 271 (195-314) 401 
 09-10 7.01 (5.13-9.58) 7.90 (4.40-11.0) 39.7 (24.8-57.8) 153 (78.1-299) 367 (136-694) 420 
20 years and older 05-06 8.67 (6.83-11.0) 11.2 (7.70-14.4) 55.6 (41.2-75.6) 172 (130-233) 302 (237-367) 1490 
 07-08 8.04 (6.56-9.84) 8.40 (6.10-11.9) 48.8 (38.3-61.1) 152 (118-202) 272 (232-312) 1814 
 09-10 7.58 (6.28-9.15) 7.50 (5.30-9.90) 48.9 (42.6-58.0) 166 (139-199) 298 (251-334) 1914 
Gender        
Males 05-06 2.96 (2.33-3.77) 2.30 (1.60-3.10) 13.8 (9.00-18.0) 51.7 (39.7-70.9) 125 (77.2-185) 1270 
 07-08 3.02 (2.47-3.71) 2.30 (1.70-3.30) 12.6 (8.40-17.4) 56.4 (38.9-89.5) 140 (98.1-209) 1294 
 09-10 2.77 (2.26-3.40) 2.00 (1.40-2.60) 11.4 (7.70-15.4) 57.3 (44.6-67.8) 134 (86.1-184) 1399 
Females 05-06 20.4 (16.0-25.9) 29.1 (21.6-37.5) 93.0 (75.7-129) 254 (193-318) 357 (318-395) 1278 
 07-08 18.4 (15.7-21.5) 23.3 (20.5-26.1) 76.3 (62.9-100) 210 (164-269) 312 (271-363) 1310 
 09-10 16.9 (14.6-19.4) 20.2 (17.0-25.9) 83.3 (70.0-92.4) 227 (171-295) 361 (297-502) 1350 
Race/ethnicity        
Mexican Americans 05-06 10.6 (8.08-13.8) 12.1 (7.00-17.5) 65.9 (43.5-93.3) 247 (174-293) 389 (293-453) 637 
 07-08 7.82 (5.98-10.2) 7.00 (4.20-12.9) 52.1 (36.9-64.1) 146 (105-201) 217 (161-401) 531 
 09-10 8.94 (7.25-11.0) 8.70 (5.70-13.3) 58.9 (45.7-68.5) 182 (117-299) 451 (269-911) 566 
Non-Hispanic blacks 05-06 26.8 (21.5-33.3) 34.7 (28.3-44.2) 125 (89.5-165) 331 (236-411) 531 (367-730) 678 
 07-08 21.3 (18.4-24.7) 28.6 (21.8-34.8) 85.4 (70.8-96.9) 222 (176-282) 410 (277-506) 597 
 09-10 26.1 (21.8-31.3) 29.9 (23.4-39.5) 129 (87.4-167) 322 (229-503) 572 (369-654) 516 
Non-Hispanic whites 05-06 6.21 (5.02-7.68) 6.00 (4.60-9.10) 35.7 (28.4-49.6) 130 (92.1-157) 229 (156-318) 1038 
 07-08 6.49 (5.05-8.33) 6.10 (4.50-9.20) 36.8 (26.9-47.5) 129 (91.3-196) 251 (190-290) 1077 
 09-10 5.34 (4.55-6.27) 4.40 (3.60-5.70) 35.6 (26.1-44.3) 128 (92.4-141) 235 (170-300) 1206 
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Urinary n-Propyl paraben (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 5.39 (4.69-6.19) 4.70 (3.80-5.90) 28.5 (24.5-34.1) 126 (94.0-142) 200 (163-278) 2489 
 13-14 5.74 (5.06-6.50) 4.80 (3.90-5.70) 33.7 (27.1-41.1) 120 (106-130) 224 (193-284) 2686 
Age group        
6-11 years 11-12 2.20 (1.81-2.68) 1.40 (1.20-1.80) 6.40 (4.80-11.8) 28.1 (17.9-53.4) 77.7 (41.3-185) 396 
 13-14 2.96 (2.20-3.99) 2.40 (1.80-2.80) 7.60 (5.90-15.4) 44.7 (28.5-75.6) 113 (45.3-213) 409 
12-19 years 11-12 3.69 (2.77-4.92) 2.80 (1.80-4.20) 14.7 (9.50-23.4) 81.8 (51.5-151) 208 (122-357) 388 
 13-14 5.15 (3.89-6.83) 3.10 (2.40-4.90) 24.5 (12.5-54.0) 119 (90.5-147) 217 (139-299) 462 
20 years and older 11-12 6.29 (5.45-7.25) 6.20 (4.80-8.50) 35.4 (29.2-43.2) 135 (98.1-151) 213 (163-323) 1705 
 13-14 6.27 (5.51-7.12) 5.70 (4.40-7.20) 39.2 (31.3-43.2) 126 (112-161) 235 (202-304) 1815 
Gender        
Males 11-12 2.44 (1.99-2.98) 1.70 (1.40-2.10) 8.90 (6.70-12.0) 46.5 (28.0-80.6) 137 (65.8-258) 1259 
 13-14 2.61 (2.20-3.09) 1.70 (1.30-2.20) 9.20 (6.20-13.3) 49.8 (37.1-65.8) 128 (94.0-175) 1285 
Females 11-12 11.6 (10.0-13.4) 13.8 (12.4-16.3) 54.7 (48.6-67.2) 151 (141-175) 252 (183-323) 1230 
 13-14 12.2 (10.6-14.1) 13.5 (10.3-18.2) 57.0 (50.1-67.6) 179 (143-203) 329 (230-376) 1401 
Race/ethnicity        
Mexican Americans 11-12 6.15 (3.98-9.52) 6.50 (2.60-11.1) 30.0 (22.7-57.5) 181 (70.4-312) 312 (146-1060) 316 
 13-14 7.76 (5.55-10.8) 6.00 (3.60-14.0) 45.0 (29.7-57.4) 124 (80.7-184) 195 (137-342) 438 
Non-Hispanic blacks 11-12 16.4 (14.1-19.1) 18.0 (13.4-23.1) 61.1 (49.9-82.9) 183 (147-225) 340 (221-477) 665 
 13-14 15.4 (13.1-18.0) 15.7 (10.8-20.3) 71.8 (58.2-86.4) 249 (187-305) 396 (344-430) 609 
Non-Hispanic whites 11-12 4.14 (3.57-4.79) 3.30 (2.50-4.20) 21.0 (15.3-30.8) 94.6 (70.3-135) 163 (137-202) 813 
 13-14 4.46 (3.78-5.27) 3.40 (2.70-4.20) 23.8 (17.4-32.2) 98.3 (78.6-120) 202 (130-241) 988 
All Hispanics 11-12 6.87 (5.42-8.71) 6.70 (3.80-9.30) 33.6 (26.1-50.4) 181 (95.3-273) 333 (236-556) 571 
 13-14 7.73 (6.26-9.56) 6.20 (4.40-10.4) 45.0 (35.7-54.1) 127 (112-157) 207 (165-324) 690 
Asians 11-12 5.07 (4.06-6.34) 5.50 (3.40-7.70) 27.0 (22.3-37.2) 95.8 (63.6-143) 169 (123-292) 352 
 13-14 4.42 (3.71-5.27) 3.90 (2.20-8.10) 28.8 (19.3-41.1) 77.8 (60.6-120) 158 (95.5-209) 289 








Fourth National Report on Human Exposure to Environmental Chemicals, Updated Tables, January 2017 Volume One Page 49
Urinary n-Propyl paraben (creatinine corrected) (2005 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 05-06 7.71 (6.40-9.30) 8.27 (5.87-11.3) 52.9 (41.6-66.1) 161 (140-178) 263 (226-288) 2548 
 07-08 7.65 (6.22-9.40) 8.00 (5.34-11.6) 50.0 (39.5-59.8) 138 (115-168) 235 (199-293) 2604 
 09-10 7.28 (6.30-8.41) 6.67 (5.35-8.50) 45.1 (37.3-53.5) 155 (128-187) 253 (223-300) 2749 
Age group        
6-11 years 05-06 3.75 (2.67-5.26) 2.70 (1.89-4.43) 11.5 (8.07-16.0) 52.1 (22.9-100) 121 (55.5-352) 356 
 07-08 4.45 (3.03-6.53) 3.50 (1.79-6.85) 16.5 (8.82-28.8) 59.1 (28.6-94.4) 98.4 (65.0-139) 389 
 09-10 4.27 (3.34-5.47) 3.33 (2.41-4.62) 12.0 (8.52-16.6) 46.1 (27.5-108) 143 (72.5-243) 415 
12-19 years 05-06 6.08 (4.36-8.49) 5.44 (3.03-10.5) 33.0 (20.7-48.7) 116 (81.9-161) 175 (140-239) 702 
 07-08 6.88 (5.30-8.94) 5.68 (3.51-9.90) 33.2 (26.7-46.5) 103 (87.2-112) 132 (105-235) 401 
 09-10 5.64 (4.17-7.62) 5.19 (3.53-9.03) 32.9 (20.4-42.4) 107 (57.6-217) 218 (101-397) 420 
20 years and older 05-06 8.70 (7.08-10.7) 10.8 (7.39-15.2) 63.2 (49.7-80.5) 178 (152-198) 270 (236-293) 1490 
 07-08 8.26 (6.70-10.2) 9.91 (6.15-12.6) 57.9 (47.3-69.1) 161 (127-199) 273 (212-312) 1814 
 09-10 8.03 (6.74-9.56) 8.27 (6.10-10.8) 55.5 (43.5-66.0) 164 (136-200) 270 (232-314) 1914 
Gender        
Males 05-06 2.38 (1.92-2.95) 1.84 (1.42-2.46) 9.52 (6.79-12.8) 40.5 (31.1-51.5) 90.8 (56.8-125) 1270 
 07-08 2.55 (2.06-3.15) 1.74 (1.40-2.53) 10.7 (5.99-15.4) 44.7 (29.0-66.1) 112 (77.4-144) 1294 
 09-10 2.48 (2.05-3.00) 1.71 (1.35-2.25) 8.85 (6.12-14.2) 40.3 (33.8-57.6) 105 (74.5-143) 1399 
Females 05-06 23.9 (19.9-28.8) 34.9 (26.9-46.6) 114 (101-132) 235 (193-263) 306 (277-342) 1278 
 07-08 22.0 (18.7-25.8) 30.4 (25.2-36.3) 93.3 (80.8-110) 199 (161-245) 302 (271-370) 1310 
 09-10 20.4 (17.8-23.3) 25.7 (21.8-30.7) 97.1 (81.8-115) 223 (191-248) 334 (295-389) 1350 
Race/ethnicity        
Mexican Americans 05-06 9.49 (7.29-12.4) 11.0 (6.69-16.4) 55.2 (44.9-79.6) 186 (147-271) 329 (194-441) 637 
 07-08 7.63 (5.72-10.2) 6.60 (4.10-13.4) 47.9 (39.5-66.7) 162 (123-187) 273 (187-304) 531 
 09-10 8.87 (7.42-10.6) 7.97 (5.87-12.8) 54.7 (42.3-73.8) 184 (140-269) 325 (221-575) 566 
Non-Hispanic blacks 05-06 18.8 (15.2-23.3) 23.6 (19.0-30.8) 83.7 (61.8-105) 217 (169-255) 318 (242-377) 678 
 07-08 16.6 (14.1-19.5) 22.9 (18.0-27.2) 64.2 (51.4-73.3) 141 (117-172) 254 (169-311) 597 
 09-10 18.9 (15.2-23.5) 21.1 (18.2-27.7) 80.9 (59.5-109) 200 (151-249) 301 (223-376) 516 
Non-Hispanic whites 05-06 6.53 (5.32-8.02) 6.45 (3.96-9.11) 47.4 (32.6-65.3) 146 (119-184) 241 (184-278) 1038 
 07-08 6.77 (5.14-8.93) 5.81 (3.94-10.5) 45.4 (32.2-61.4) 132 (105-172) 215 (169-295) 1077 
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Urinary n-Propyl paraben (creatinine corrected) (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 6.16 (5.42-6.99) 5.35 (3.97-7.07) 36.7 (31.1-42.2) 129 (105-162) 215 (183-321) 2487 
 13-14 5.74 (5.10-6.46) 4.75 (3.81-5.91) 36.7 (30.3-41.9) 124 (99.0-148) 222 (186-253) 2684 
Age group        
6-11 years 11-12 3.18 (2.62-3.87) 2.09 (1.58-3.16) 9.11 (5.71-12.2) 37.0 (19.8-53.1) 116 (43.6-202) 395 
 13-14 3.74 (2.84-4.94) 2.73 (1.75-4.00) 10.9 (7.00-18.3) 40.5 (24.4-98.6) 153 (52.1-271) 409 
12-19 years 11-12 3.60 (2.75-4.70) 2.46 (1.93-3.52) 14.9 (9.36-24.9) 69.8 (32.3-130) 133 (75.6-202) 388 
 13-14 4.18 (3.24-5.39) 2.82 (2.03-4.46) 20.7 (9.86-39.0) 76.0 (56.4-102) 118 (94.2-197) 462 
20 years and older 11-12 7.17 (6.22-8.27) 7.28 (5.23-9.77) 45.7 (38.1-51.6) 152 (117-183) 258 (190-365) 1704 
 13-14 6.30 (5.61-7.08) 5.71 (4.40-7.22) 41.8 (35.9-47.8) 138 (112-166) 231 (199-259) 1813 
Gender        
Males 11-12 2.29 (1.90-2.75) 1.38 (1.21-1.67) 7.39 (6.02-9.39) 46.2 (28.5-72.7) 94.5 (57.3-190) 1258 
 13-14 2.19 (1.87-2.56) 1.35 (1.17-1.59) 7.42 (5.24-8.93) 42.2 (32.3-52.2) 110 (78.9-141) 1284 
Females 11-12 16.0 (13.9-18.4) 20.9 (16.7-25.7) 74.7 (62.3-88.7) 185 (164-213) 345 (239-426) 1229 
 13-14 14.4 (12.1-17.2) 17.5 (13.2-22.3) 65.9 (56.9-82.9) 198 (152-226) 281 (237-338) 1400 
Race/ethnicity        
Mexican Americans 11-12 6.93 (4.57-10.5) 7.19 (3.71-10.9) 40.5 (24.4-75.9) 159 (90.0-236) 315 (159-536) 316 
 13-14 7.90 (5.27-11.9) 6.75 (3.60-16.0) 52.7 (30.9-67.2) 134 (89.0-205) 231 (158-284) 438 
Non-Hispanic blacks 11-12 12.8 (11.3-14.4) 13.9 (11.3-18.0) 54.5 (43.4-65.7) 140 (105-185) 207 (166-333) 665 
 13-14 11.4 (10.0-12.9) 10.8 (7.87-13.9) 56.0 (44.6-67.6) 137 (108-186) 233 (191-274) 609 
Non-Hispanic whites 11-12 5.06 (4.35-5.88) 3.20 (2.50-5.06) 31.1 (27.3-37.1) 120 (88.2-164) 213 (164-345) 811 
 13-14 4.69 (4.01-5.48) 3.58 (2.66-4.63) 29.2 (22.9-36.2) 112 (81.6-158) 212 (165-259) 987 
All Hispanics 11-12 7.70 (5.99-9.90) 7.47 (5.00-10.1) 51.5 (35.2-72.9) 162 (119-196) 318 (185-473) 571 
 13-14 7.67 (5.91-9.97) 6.40 (4.71-10.3) 46.5 (35.4-61.9) 139 (109-205) 240 (173-285) 690 
Asians 11-12 6.80 (5.47-8.45) 6.90 (3.41-13.7) 46.5 (35.6-59.5) 136 (94.4-188) 222 (168-304) 352 
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Urinary 2,4-Dichlorophenol (2003 – 2010) 
Metabolite of other chlorophenols 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 1.04 (.895-1.21) .900 (.800-1.10) 2.70 (2.30-3.10) 8.80 (6.60-11.9) 21.3 (14.1-29.5) 2525 
 05-06 .945 (.791-1.13) .800 (.700-1.00) 2.00 (1.60-2.40) 4.90 (3.90-6.30) 11.9 (7.00-20.4) 2548 
 07-08 .970 (.852-1.11) .800 (.700-.900) 1.80 (1.50-2.30) 5.10 (3.80-7.60) 12.6 (9.00-18.1) 2604 
 09-10 .803 (.729-.885) .700 (.700-.800) 1.50 (1.40-1.70) 4.00 (3.30-5.00) 8.80 (6.40-15.7) 2749 
Age group        
6-11 years 03-04 1.01 (.796-1.28) .800 (.600-1.20) 2.30 (1.70-3.20) 7.70 (3.80-20.1) 23.5 (9.40-31.0) 314 
 05-06 1.01 (.879-1.15) .800 (.800-1.10) 2.00 (1.60-2.30) 4.90 (3.30-6.60) 9.80 (6.30-17.6) 356 
 07-08 1.04 (.778-1.39) .900 (.700-1.20) 1.80 (1.20-2.80) 5.90 (2.90-10.1) 11.4 (6.60-20.7) 389 
 09-10 .975 (.768-1.24) .700 (.600-.900) 1.80 (1.40-2.30) 5.00 (3.20-8.40) 14.2 (4.40-90.9) 415 
12-19 years 03-04 1.27 (.971-1.67) 1.10 (.800-1.50) 3.40 (2.50-5.00) 13.6 (6.10-25.5) 31.5 (14.5-85.0) 722 
 05-06 1.18 (.997-1.39) 1.00 (.900-1.20) 2.50 (2.00-3.10) 5.50 (4.00-8.30) 13.9 (7.10-33.6) 702 
 07-08 1.19 (.989-1.44) 1.10 (.800-1.40) 2.60 (2.00-3.00) 5.60 (3.10-10.8) 11.6 (5.70-36.5) 401 
 09-10 .967 (.794-1.18) .800 (.700-.900) 1.60 (1.40-2.70) 5.80 (3.70-10.1) 14.4 (7.10-24.8) 420 
20 years and older 03-04 1.01 (.874-1.17) .900 (.700-1.10) 2.60 (2.20-3.00) 8.50 (6.60-10.4) 19.4 (12.2-27.0) 1489 
 05-06 .907 (.737-1.12) .800 (.600-1.00) 2.00 (1.50-2.40) 4.90 (3.70-6.40) 11.1 (6.50-20.9) 1490 
 07-08 .932 (.820-1.06) .800 (.700-.900) 1.70 (1.40-2.20) 5.00 (3.80-7.60) 13.2 (9.20-18.1) 1814 
 09-10 .764 (.699-.836) .700 (.600-.700) 1.40 (1.30-1.60) 3.60 (3.10-4.50) 8.00 (5.60-13.9) 1914 
Gender        
Males 03-04 1.22 (1.02-1.45) 1.10 (.800-1.50) 3.00 (2.50-3.50) 9.40 (6.80-13.9) 22.7 (13.6-40.9) 1231 
 05-06 1.16 (.973-1.37) 1.00 (.900-1.20) 2.40 (2.00-2.80) 5.50 (4.40-7.90) 12.9 (7.30-25.3) 1270 
 07-08 1.06 (.943-1.19) .900 (.800-1.00) 1.90 (1.60-2.20) 5.40 (3.90-8.20) 13.6 (10.1-18.1) 1294 
 09-10 .879 (.789-.979) .800 (.700-.800) 1.60 (1.40-1.80) 4.00 (3.20-5.70) 10.4 (5.20-18.4) 1399 
Females 03-04 .896 (.754-1.07) .800 (.600-.900) 2.30 (2.00-2.70) 8.10 (5.70-11.1) 19.8 (12.0-27.5) 1294 
 05-06 .779 (.637-.954) .700 (.500-.800) 1.50 (1.30-2.10) 4.30 (2.80-6.20) 9.40 (5.40-19.6) 1278 
 07-08 .893 (.750-1.06) .700 (.600-.800) 1.80 (1.20-2.50) 4.70 (3.10-8.00) 11.9 (7.60-18.6) 1310 
 09-10 .737 (.659-.824) .600 (.600-.700) 1.40 (1.30-1.70) 4.00 (3.00-5.50) 7.80 (5.80-15.8) 1350 
Race/ethnicity        
Mexican Americans 03-04 1.94 (1.46-2.56) 1.70 (1.20-2.10) 4.50 (2.80-9.30) 26.9 (12.7-52.1) 66.0 (47.5-84.2) 617 
 05-06 1.97 (1.49-2.59) 1.60 (1.20-2.10) 5.00 (3.30-6.60) 20.9 (8.80-39.7) 46.5 (21.9-79.5) 637 
 07-08 1.59 (.969-2.60) 1.20 (.600-2.60) 4.20 (2.10-9.50) 13.4 (7.90-29.6) 38.0 (16.4-74.0) 531 
 09-10 1.25 (.860-1.81) .900 (.700-1.30) 2.70 (1.60-4.30) 11.3 (4.30-26.3) 29.1 (7.60-76.3) 566 
Non-Hispanic blacks 03-04 2.42 (1.92-3.06) 2.20 (1.70-2.70) 7.40 (4.00-9.60) 20.8 (11.2-38.3) 49.2 (24.0-69.7) 636 
 05-06 2.45 (1.93-3.12) 2.10 (1.70-2.40) 5.20 (3.90-7.40) 20.3 (10.6-36.9) 42.6 (21.3-129) 678 
 07-08 1.73 (1.49-2.01) 1.40 (1.10-1.60) 3.70 (2.90-4.90) 17.8 (9.70-25.8) 37.7 (24.6-56.8) 597 
 09-10 1.54 (1.06-2.23) 1.20 (.800-2.00) 3.10 (2.10-4.80) 12.4 (4.30-46.4) 35.2 (7.80-107) 516 
Non-Hispanic whites 03-04 .837 (.698-1.00) .700 (.600-.900) 2.10 (1.70-2.60) 6.20 (4.00-8.80) 13.4 (8.60-22.0) 1077 
 05-06 .734 (.610-.883) .700 (.500-.900) 1.40 (1.20-1.80) 3.10 (2.70-3.90) 5.30 (4.30-7.90) 1038 
 07-08 .817 (.732-.911) .700 (.600-.800) 1.50 (1.20-1.80) 3.10 (2.60-4.40) 6.40 (4.60-8.80) 1077 
 09-10 .651 (.594-.712) .600 (.500-.700) 1.30 (1.10-1.40) 2.80 (2.20-3.50) 5.60 (3.80-7.40) 1206 
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Urinary 2,4-Dichlorophenol (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 .695 (.619-.781) .600 (.600-.700) 1.30 (1.10-1.60) 3.50 (2.80-4.40) 9.00 (5.60-13.0) 2489 
 13-14 .669 (.603-.743) .600 (.500-.700) 1.30 (1.20-1.40) 3.00 (2.70-3.50) 6.40 (4.80-11.5) 2686 
Age group        
6-11 years 11-12 .672 (.558-.810) .600 (.400-.700) 1.10 (1.00-1.40) 3.60 (1.90-5.50) 11.3 (4.10-23.2) 396 
 13-14 .773 (.646-.925) .700 (.600-.900) 1.20 (1.10-1.60) 2.90 (2.10-4.80) 8.90 (3.30-21.8) 409 
12-19 years 11-12 .711 (.591-.857) .600 (.500-.800) 1.30 (1.00-1.50) 3.30 (2.10-5.80) 9.00 (4.10-13.0) 388 
 13-14 .668 (.576-.775) .600 (.500-.700) 1.10 (.900-1.40) 2.40 (1.70-4.40) 7.30 (3.10-13.8) 462 
20 years and older 11-12 .695 (.613-.789) .600 (.500-.700) 1.30 (1.10-1.60) 3.50 (2.80-4.60) 9.00 (5.20-13.1) 1705 
 13-14 .659 (.593-.732) .600 (.500-.700) 1.30 (1.20-1.40) 3.10 (2.70-3.50) 6.20 (4.90-10.8) 1815 
Gender        
Males 11-12 .717 (.641-.802) .600 (.600-.700) 1.30 (1.10-1.60) 3.20 (2.20-4.40) 7.10 (4.60-10.6) 1259 
 13-14 .708 (.637-.786) .600 (.600-.700) 1.30 (1.10-1.60) 2.90 (2.60-3.30) 6.20 (4.10-11.3) 1285 
Females 11-12 .675 (.581-.784) .600 (.500-.700) 1.20 (1.00-1.60) 3.80 (2.80-6.00) 11.1 (4.90-24.3) 1230 
 13-14 .635 (.553-.729) .600 (.500-.700) 1.20 (1.10-1.40) 3.10 (2.50-4.10) 7.60 (4.40-12.3) 1401 
Race/ethnicity        
Mexican Americans 11-12 .895 (.720-1.11) .800 (.600-1.00) 1.80 (1.30-2.60) 6.60 (3.50-10.5) 14.5 (7.40-27.0) 316 
 13-14 .807 (.609-1.07) .600 (.400-1.00) 1.70 (1.10-2.90) 4.00 (3.00-12.2) 14.6 (3.90-49.9) 438 
Non-Hispanic blacks 11-12 1.23 (.965-1.57) .900 (.800-1.20) 2.20 (1.60-3.30) 6.90 (4.20-14.8) 25.0 (8.40-53.6) 665 
 13-14 1.11 (.791-1.54) .800 (.700-1.10) 2.00 (1.40-3.30) 8.20 (3.00-28.2) 23.5 (6.50-81.9) 609 
Non-Hispanic whites 11-12 .577 (.514-.647) .500 (.500-.600) 1.00 (.900-1.20) 2.50 (1.70-3.70) 4.90 (3.30-9.40) 813 
 13-14 .588 (.525-.659) .500 (.500-.600) 1.10 (1.00-1.30) 2.60 (2.30-2.90) 4.60 (3.10-5.50) 988 
All Hispanics 11-12 .981 (.760-1.27) .800 (.600-1.00) 2.10 (1.30-3.10) 6.10 (3.90-13.0) 15.9 (7.00-42.0) 571 
 13-14 .786 (.641-.965) .600 (.500-.800) 1.60 (1.20-2.10) 3.50 (3.10-7.80) 12.4 (4.20-26.1) 690 
Asians 11-12 .621 (.478-.807) .500 (.400-.700) 1.10 (.800-1.60) 3.60 (1.70-7.10) 11.1 (3.50-17.7) 352 
 13-14 .567 (.435-.738) .500 (.300-.700) 1.20 (.800-1.60) 2.70 (1.70-5.80) 7.30 (2.50-58.9) 289 
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Urinary 2,4-Dichlorophenol (creatinine corrected) (2003 – 2010) 
Metabolite of other chlorophenols 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 1.02 (.873-1.18) .880 (.770-1.00) 2.19 (1.84-2.73) 7.39 (5.00-9.83) 15.4 (11.1-20.9) 2522 
 05-06 .922 (.798-1.06) .750 (.660-.880) 1.58 (1.33-1.86) 4.00 (3.00-5.71) 8.90 (5.98-16.6) 2548 
 07-08 .978 (.867-1.10) .790 (.700-.880) 1.63 (1.36-1.89) 4.00 (3.14-5.63) 11.7 (6.82-18.9) 2604 
 09-10 .838 (.757-.929) .680 (.630-.740) 1.33 (1.18-1.58) 3.48 (2.77-4.55) 8.17 (5.44-14.3) 2749 
Age group        
6-11 years 03-04 1.23 (.965-1.56) 1.03 (.750-1.45) 2.39 (1.82-3.36) 9.29 (3.98-16.5) 20.9 (12.9-38.1) 314 
 05-06 1.11 (.950-1.29) .970 (.800-1.08) 1.74 (1.38-2.19) 4.38 (3.33-7.80) 10.9 (5.12-23.3) 356 
 07-08 1.28 (1.00-1.63) 1.06 (.750-1.40) 2.06 (1.44-3.21) 4.49 (3.13-9.27) 11.2 (5.70-24.4) 389 
 09-10 1.27 (.986-1.64) .930 (.820-1.20) 2.03 (1.54-2.94) 5.89 (3.50-11.0) 15.9 (5.71-121) 415 
12-19 years 03-04 .954 (.725-1.26) .790 (.660-1.00) 2.08 (1.44-3.75) 8.02 (4.72-12.5) 14.8 (8.02-40.0) 720 
 05-06 .878 (.765-1.01) .700 (.600-.800) 1.65 (1.22-1.93) 3.92 (2.90-4.82) 8.28 (4.82-15.9) 702 
 07-08 .927 (.776-1.11) .790 (.640-1.00) 1.51 (1.14-2.22) 3.81 (2.38-5.92) 10.3 (4.28-21.8) 401 
 09-10 .778 (.656-.921) .580 (.510-.690) 1.18 (.970-1.40) 3.38 (2.11-6.27) 7.38 (3.39-19.4) 420 
20 years and older 03-04 1.00 (.863-1.16) .870 (.770-1.00) 2.17 (1.80-2.69) 7.16 (4.88-9.01) 15.0 (10.6-20.8) 1488 
 05-06 .909 (.774-1.07) .740 (.650-.870) 1.55 (1.25-1.89) 4.00 (2.84-6.19) 8.80 (5.71-16.8) 1490 
 07-08 .958 (.847-1.08) .770 (.670-.880) 1.60 (1.32-1.85) 3.98 (3.14-5.59) 12.1 (8.15-18.9) 1814 
 09-10 .810 (.735-.892) .670 (.620-.730) 1.27 (1.11-1.56) 3.33 (2.65-4.23) 7.64 (5.16-12.3) 1914 
Gender        
Males 03-04 .995 (.850-1.17) .900 (.730-1.06) 2.23 (1.82-2.82) 6.84 (4.54-9.01) 13.7 (9.29-21.8) 1230 
 05-06 .927 (.814-1.06) .770 (.670-.880) 1.60 (1.36-1.86) 4.12 (3.08-5.45) 8.90 (5.19-16.6) 1270 
 07-08 .891 (.808-.984) .720 (.660-.790) 1.44 (1.29-1.67) 4.00 (2.97-5.30) 9.96 (6.82-13.4) 1294 
 09-10 .788 (.706-.879) .620 (.580-.660) 1.25 (1.06-1.48) 3.66 (2.52-5.47) 7.69 (4.84-16.9) 1399 
Females 03-04 1.03 (.845-1.27) .870 (.770-1.00) 2.17 (1.73-2.73) 8.00 (4.57-12.1) 17.2 (11.1-23.7) 1292 
 05-06 .916 (.770-1.09) .740 (.640-.880) 1.56 (1.19-1.96) 3.91 (2.66-6.50) 8.93 (5.53-23.7) 1278 
 07-08 1.07 (.910-1.26) .850 (.720-1.00) 1.75 (1.43-2.29) 4.07 (3.13-7.65) 14.4 (6.50-26.8) 1310 
 09-10 .890 (.789-1.00) .740 (.660-.850) 1.41 (1.24-1.67) 3.39 (2.76-4.52) 8.79 (5.16-14.8) 1350 
Race/ethnicity        
Mexican Americans 03-04 1.76 (1.30-2.38) 1.33 (1.04-1.74) 3.85 (2.29-8.81) 23.8 (10.6-51.6) 71.4 (30.8-88.8) 616 
 05-06 1.77 (1.38-2.27) 1.25 (.990-1.73) 3.79 (2.70-5.35) 16.6 (6.75-31.8) 38.1 (23.8-55.3) 637 
 07-08 1.55 (.925-2.60) 1.18 (.630-2.28) 3.33 (1.93-6.50) 14.2 (5.65-30.6) 33.1 (16.6-60.0) 531 
 09-10 1.24 (.860-1.78) .910 (.630-1.28) 2.03 (1.43-3.90) 11.0 (3.54-26.4) 26.4 (10.2-93.5) 566 
Non-Hispanic blacks 03-04 1.66 (1.28-2.16) 1.47 (1.06-1.96) 4.14 (2.46-7.31) 14.9 (7.93-20.1) 22.9 (16.7-45.0) 635 
 05-06 1.72 (1.39-2.14) 1.32 (1.11-1.56) 3.28 (2.33-5.35) 14.9 (7.40-28.1) 37.0 (15.0-83.4) 678 
 07-08 1.34 (1.14-1.59) .990 (.800-1.17) 2.36 (1.85-3.12) 13.1 (5.70-23.3) 33.8 (22.7-41.1) 597 
 09-10 1.11 (.739-1.67) .890 (.630-1.19) 2.07 (1.25-3.87) 8.37 (2.99-22.0) 22.0 (7.05-83.1) 516 
Non-Hispanic whites 03-04 .864 (.721-1.03) .780 (.690-.890) 1.86 (1.54-2.23) 5.08 (3.58-8.00) 10.8 (6.84-18.2) 1076 
 05-06 .772 (.660-.904) .670 (.580-.790) 1.25 (1.07-1.56) 2.78 (2.11-3.52) 4.82 (3.33-8.62) 1038 
 07-08 .853 (.765-.950) .730 (.660-.810) 1.36 (1.14-1.67) 2.97 (2.53-3.33) 5.16 (3.84-9.38) 1077 
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Urinary 2,4-Dichlorophenol (creatinine corrected) (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 .791 (.706-.886) .614 (.560-.690) 1.29 (1.08-1.48) 3.33 (2.67-4.57) 8.10 (5.65-11.2) 2487 
 13-14 .668 (.611-.730) .556 (.510-.595) 1.13 (1.03-1.29) 2.73 (2.26-3.33) 5.96 (4.41-8.38) 2684 
Age group        
6-11 years 11-12 .964 (.807-1.15) .741 (.620-.851) 1.38 (1.07-1.61) 3.51 (2.22-7.36) 12.4 (5.13-34.9) 395 
 13-14 .977 (.833-1.14) .800 (.698-.909) 1.52 (1.20-1.94) 3.41 (2.22-6.60) 9.68 (4.48-23.7) 409 
12-19 years 11-12 .693 (.582-.825) .545 (.465-.678) 1.15 (.875-1.50) 2.73 (1.96-4.00) 4.82 (3.06-9.75) 388 
 13-14 .542 (.472-.623) .439 (.385-.519) .833 (.678-1.13) 1.72 (1.31-3.08) 4.10 (2.45-5.27) 462 
20 years and older 11-12 .790 (.694-.898) .610 (.556-.675) 1.30 (1.07-1.54) 3.33 (2.55-4.77) 8.33 (5.75-11.3) 1704 
 13-14 .661 (.600-.728) .538 (.495-.588) 1.14 (.991-1.31) 2.77 (2.22-3.47) 5.96 (4.39-8.53) 1813 
Gender        
Males 11-12 .670 (.594-.756) .538 (.462-.609) 1.08 (.903-1.27) 2.89 (2.10-3.46) 5.65 (4.26-7.63) 1258 
 13-14 .595 (.550-.642) .496 (.455-.538) 1.03 (.906-1.12) 2.41 (2.11-2.77) 4.39 (3.06-7.65) 1284 
Females 11-12 .928 (.816-1.06) .714 (.634-.833) 1.45 (1.27-1.76) 4.02 (3.06-6.37) 11.2 (6.37-18.1) 1229 
 13-14 .747 (.667-.836) .616 (.560-.676) 1.29 (1.11-1.43) 3.29 (2.37-4.15) 7.69 (4.69-12.6) 1400 
Race/ethnicity        
Mexican Americans 11-12 1.01 (.856-1.19) .788 (.620-1.04) 1.67 (1.50-2.14) 5.94 (3.50-9.36) 14.7 (6.16-33.3) 316 
 13-14 .823 (.614-1.10) .632 (.452-.864) 1.43 (.938-2.29) 6.25 (2.45-12.0) 13.5 (6.32-37.3) 438 
Non-Hispanic blacks 11-12 .959 (.766-1.20) .737 (.588-.851) 1.56 (1.18-2.34) 5.26 (3.00-15.0) 19.9 (6.61-40.7) 665 
 13-14 .815 (.617-1.08) .576 (.500-.704) 1.40 (.952-2.30) 5.32 (2.37-14.7) 15.4 (4.69-51.3) 609 
Non-Hispanic whites 11-12 .700 (.609-.805) .563 (.519-.619) 1.08 (.885-1.33) 2.89 (1.79-3.78) 5.75 (3.27-9.67) 811 
 13-14 .615 (.557-.679) .521 (.476-.570) 1.05 (.906-1.24) 2.22 (1.88-2.78) 3.64 (3.01-5.71) 987 
All Hispanics 11-12 1.10 (.919-1.31) .870 (.700-1.12) 2.00 (1.54-2.72) 5.70 (3.96-9.26) 14.7 (6.37-43.5) 571 
 13-14 .780 (.628-.970) .629 (.508-.774) 1.30 (.980-1.98) 4.48 (3.03-6.81) 11.1 (6.16-23.8) 690 
Asians 11-12 .832 (.629-1.10) .667 (.513-.952) 1.42 (1.01-2.12) 3.50 (2.31-7.82) 8.00 (3.50-17.0) 352 
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Urinary 2,5-Dichlorophenol (2003 – 2010) 
Metabolite of 1,4-Dichlorobenzene (Paradichlorobenzene) and other chlorophenols 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 12.9 (10.1-16.3) 10.5 (8.00-14.2) 40.9 (29.8-54.7) 190 (133-282) 705 (342-1330) 2525 
 05-06 9.55 (6.67-13.7) 8.10 (5.60-11.5) 26.4 (19.0-36.6) 111 (69.9-166) 332 (175-794) 2548 
 07-08 9.04 (7.22-11.3) 6.60 (5.50-8.30) 25.7 (19.2-34.7) 131 (90.2-222) 473 (296-753) 2604 
 09-10 6.10 (4.94-7.53) 4.70 (3.70-5.90) 18.4 (13.3-26.0) 101 (68.0-146) 301 (168-618) 2749 
Age group        
6-11 years 03-04 12.5 (8.22-18.9) 9.10 (5.60-17.4) 42.1 (21.7-83.9) 161 (111-626) 928 (249-1640) 314 
 05-06 10.5 (8.29-13.4) 7.80 (5.90-10.6) 28.1 (17.8-40.2) 104 (55.4-226) 336 (189-785) 356 
 07-08 9.31 (6.20-14.0) 6.50 (4.60-10.9) 23.3 (12.2-45.6) 151 (61.1-306) 464 (222-934) 389 
 09-10 7.19 (4.36-11.8) 4.80 (2.70-9.90) 30.4 (12.4-50.7) 146 (63.7-368) 503 (103-4940) 415 
12-19 years 03-04 16.9 (11.1-26.0) 11.5 (8.20-20.6) 49.9 (26.8-94.0) 233 (94.5-1060) 1080 (287-3970) 722 
 05-06 11.9 (8.47-16.8) 9.60 (6.40-16.7) 36.0 (22.3-54.4) 127 (89.9-160) 459 (160-894) 702 
 07-08 11.3 (8.78-14.5) 7.40 (6.20-9.10) 30.1 (18.5-52.6) 193 (66.7-448) 611 (254-1560) 401 
 09-10 8.01 (5.53-11.6) 4.80 (3.50-8.80) 24.9 (19.1-42.7) 191 (61.2-368) 526 (243-1140) 420 
20 years and older 03-04 12.3 (9.97-15.3) 10.4 (8.00-14.0) 40.5 (30.1-49.2) 181 (141-250) 583 (316-924) 1489 
 05-06 9.12 (6.15-13.5) 7.80 (5.20-11.5) 24.9 (17.3-35.3) 110 (62.9-183) 327 (159-852) 1490 
 07-08 8.71 (6.83-11.1) 6.60 (5.10-8.70) 24.6 (18.8-34.5) 124 (95.9-186) 452 (286-672) 1814 
 09-10 5.75 (4.77-6.92) 4.60 (3.70-5.70) 16.9 (12.7-23.1) 88.4 (66.4-117) 266 (156-450) 1914 
Gender        
Males 03-04 14.9 (11.8-18.8) 12.5 (9.00-16.5) 40.5 (30.7-54.5) 152 (120-259) 631 (259-1950) 1231 
 05-06 12.0 (8.55-16.7) 9.90 (7.80-13.8) 29.0 (21.8-40.5) 114 (71.7-200) 396 (175-916) 1270 
 07-08 10.9 (8.86-13.4) 8.30 (6.30-9.90) 29.4 (23.2-39.6) 139 (100-248) 546 (311-727) 1294 
 09-10 7.09 (5.68-8.85) 5.30 (4.40-6.70) 21.9 (15.2-33.5) 103 (63.3-191) 311 (133-736) 1399 
Females 03-04 11.2 (8.51-14.7) 8.50 (6.30-12.0) 42.8 (26.0-64.2) 212 (141-364) 732 (371-1100) 1294 
 05-06 7.69 (5.17-11.4) 5.90 (3.90-9.40) 21.1 (14.3-35.7) 110 (60.5-183) 317 (141-794) 1278 
 07-08 7.57 (5.70-10.1) 5.50 (4.40-7.30) 20.6 (13.9-31.8) 118 (57.4-268) 442 (213-838) 1310 
 09-10 5.28 (4.17-6.69) 3.90 (3.00-5.10) 16.7 (12.1-22.1) 99.5 (58.2-156) 287 (158-591) 1350 
Race/ethnicity        
Mexican Americans 03-04 30.1 (19.2-47.2) 23.7 (14.7-39.8) 103 (57.4-156) 841 (282-2040) 2370 (2040-3710) 617 
 05-06 32.2 (22.2-46.7) 23.0 (14.9-37.1) 120 (69.6-228) 867 (298-1320) 1630 (916-3650) 637 
 07-08 22.2 (9.88-49.8) 16.4 (5.40-60.7) 104 (35.2-364) 566 (313-1710) 1920 (672-3460) 531 
 09-10 13.0 (5.80-29.1) 10.3 (3.30-26.2) 53.6 (19.4-199) 361 (124-900) 998 (247-3700) 566 
Non-Hispanic blacks 03-04 54.0 (35.9-81.2) 43.9 (26.2-65.6) 159 (97.0-338) 817 (342-2330) 2330 (887-3730) 636 
 05-06 43.9 (33.2-58.1) 33.2 (25.3-47.6) 161 (79.9-255) 722 (360-1370) 1700 (886-6440) 678 
 07-08 27.4 (21.3-35.2) 18.5 (13.2-26.7) 102 (61.9-147) 682 (364-943) 1490 (933-1870) 597 
 09-10 23.0 (13.0-40.8) 17.3 (8.00-42.7) 82.7 (38.6-168) 443 (119-2180) 1240 (273-4940) 516 
Non-Hispanic whites 03-04 8.94 (7.15-11.2) 7.80 (6.30-9.40) 25.9 (19.3-36.6) 115 (61.8-171) 255 (148-522) 1077 
 05-06 6.19 (4.18-9.17) 5.90 (3.80-9.20) 15.7 (11.4-21.9) 43.7 (31.2-73.1) 105 (62.2-166) 1038 
 07-08 6.24 (5.04-7.74) 5.10 (4.20-6.20) 15.4 (12.2-19.9) 49.8 (37.0-90.2) 142 (103-294) 1077 
 09-10 4.10 (3.22-5.21) 3.30 (2.60-4.40) 10.9 (8.10-15.5) 45.5 (29.0-82.7) 124 (79.3-215) 1206 
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Urinary 2,5-Dichlorophenol (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 4.21 (3.15-5.62) 3.10 (2.30-3.90) 13.4 (9.40-18.9) 69.9 (40.9-117) 213 (121-404) 2489 
 13-14 2.78 (2.15-3.59) 1.80 (1.40-2.50) 7.50 (5.30-11.4) 37.7 (23.8-58.0) 148 (78.4-266) 2686 
Age group        
6-11 years 11-12 3.45 (2.11-5.64) 2.30 (1.60-3.30) 9.20 (4.40-21.2) 69.1 (27.8-168) 369 (99.9-986) 396 
 13-14 2.90 (1.98-4.24) 2.00 (1.30-3.00) 8.20 (4.30-14.9) 29.6 (19.7-73.8) 123 (38.0-438) 409 
12-19 years 11-12 4.15 (2.43-7.10) 3.20 (1.60-8.00) 14.0 (7.30-28.8) 55.7 (28.6-209) 236 (71.2-468) 388 
 13-14 2.72 (1.75-4.24) 2.10 (1.30-3.30) 6.00 (3.80-14.0) 21.7 (10.6-77.7) 77.7 (21.7-315) 462 
20 years and older 11-12 4.31 (3.21-5.78) 3.20 (2.30-4.10) 14.2 (9.40-19.2) 71.4 (39.5-118) 198 (118-408) 1705 
 13-14 2.78 (2.20-3.51) 1.80 (1.40-2.40) 7.80 (5.50-11.5) 42.7 (25.2-61.2) 169 (87.2-308) 1815 
Gender        
Males 11-12 4.42 (3.38-5.78) 3.30 (2.40-4.50) 13.2 (9.40-20.8) 55.5 (37.1-106) 194 (99.8-341) 1259 
 13-14 2.96 (2.31-3.80) 2.00 (1.50-2.60) 7.20 (5.20-11.5) 36.1 (23.1-52.6) 175 (77.6-250) 1285 
Females 11-12 4.01 (2.86-5.61) 2.80 (2.00-3.70) 13.9 (9.20-17.7) 83.3 (42.4-124) 352 (117-614) 1230 
 13-14 2.61 (1.96-3.48) 1.70 (1.30-2.50) 7.80 (5.20-11.9) 38.3 (21.6-63.8) 136 (63.2-376) 1401 
Race/ethnicity        
Mexican Americans 11-12 5.92 (3.36-10.4) 4.00 (2.20-8.40) 21.2 (14.2-42.7) 178 (58.4-341) 362 (119-1130) 316 
 13-14 4.60 (2.78-7.61) 2.70 (1.40-6.30) 14.5 (6.70-29.2) 90.5 (32.9-486) 584 (85.3-1840) 438 
Non-Hispanic blacks 11-12 16.6 (10.4-26.2) 13.4 (8.80-19.4) 47.9 (24.9-100) 227 (108-569) 759 (341-2480) 665 
 13-14 9.58 (5.03-18.2) 7.20 (3.90-14.2) 27.6 (15.6-70.7) 175 (51.4-874) 843 (150-3710) 609 
Non-Hispanic whites 11-12 2.78 (2.13-3.63) 2.00 (1.60-2.50) 7.40 (5.40-9.70) 34.4 (18.1-67.6) 112 (52.1-178) 813 
 13-14 1.95 (1.54-2.46) 1.40 (1.10-1.90) 4.70 (3.30-6.50) 19.0 (12.8-25.9) 53.7 (25.2-131) 988 
All Hispanics 11-12 7.96 (4.50-14.1) 6.30 (3.20-14.9) 29.1 (16.0-66.7) 196 (84.1-399) 536 (194-1630) 571 
 13-14 4.26 (2.84-6.40) 2.80 (1.50-5.00) 11.8 (7.20-22.4) 77.7 (42.7-236) 420 (112-807) 690 
Asians 11-12 3.77 (2.17-6.53) 2.40 (1.40-5.40) 13.0 (5.40-43.4) 86.8 (38.6-160) 378 (86.8-810) 352 
 13-14 2.66 (1.64-4.32) 1.70 (1.20-2.90) 6.20 (3.30-18.5) 50.3 (13.0-154) 154 (38.7-2450) 289 
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Urinary 2,5-Dichlorophenol (creatinine corrected) (2003 – 2010) 
Metabolite of 1,4-Dichlorobenzene (Paradichlorobenzene) and other chlorophenols 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 12.5 (10.1-15.6) 9.29 (7.25-12.5) 34.4 (26.8-45.4) 141 (100-251) 578 (313-851) 2522 
 05-06 9.31 (6.70-12.9) 7.32 (5.33-10.2) 20.4 (14.8-30.5) 89.3 (54.9-176) 292 (176-640) 2548 
 07-08 9.12 (7.35-11.3) 6.24 (5.00-7.77) 24.2 (17.2-30.3) 109 (70.8-175) 409 (234-745) 2604 
 09-10 6.36 (5.07-7.99) 4.12 (3.31-5.16) 16.2 (11.7-22.8) 80.2 (59.5-127) 269 (144-505) 2749 
Age group        
6-11 years 03-04 15.2 (9.93-23.1) 10.6 (5.87-26.7) 44.7 (28.9-80.0) 183 (95.3-617) 830 (330-2150) 314 
 05-06 11.6 (8.90-15.1) 8.00 (5.95-12.6) 24.7 (16.8-37.8) 129 (55.8-242) 419 (151-709) 356 
 07-08 11.5 (7.95-16.5) 7.70 (5.41-11.7) 29.5 (19.6-50.9) 131 (59.9-239) 420 (170-1110) 389 
 09-10 9.36 (5.65-15.5) 6.25 (4.09-9.60) 33.9 (12.6-65.0) 177 (66.1-496) 536 (111-5950) 415 
12-19 years 03-04 12.7 (8.50-18.9) 9.05 (6.17-13.3) 34.8 (18.6-67.0) 177 (67.0-516) 549 (187-2120) 720 
 05-06 8.88 (6.34-12.4) 6.91 (4.15-11.1) 23.4 (17.7-30.0) 78.0 (58.5-112) 279 (112-659) 702 
 07-08 8.79 (6.81-11.4) 5.56 (4.42-7.50) 20.9 (13.8-34.9) 130 (41.8-251) 353 (158-799) 401 
 09-10 6.44 (4.40-9.42) 4.05 (2.34-8.69) 19.4 (11.6-37.7) 121 (49.3-218) 257 (119-1180) 420 
20 years and older 03-04 12.2 (10.1-14.8) 9.13 (7.25-12.4) 32.7 (26.7-42.9) 140 (103-203) 552 (283-838) 1488 
 05-06 9.15 (6.43-13.0) 7.29 (5.29-10.0) 19.6 (14.2-30.4) 90.7 (48.5-197) 274 (163-701) 1490 
 07-08 8.94 (7.07-11.3) 6.15 (4.93-8.00) 24.3 (16.6-30.6) 101 (70.0-162) 422 (234-729) 1814 
 09-10 6.09 (4.97-7.45) 3.97 (3.27-4.78) 14.7 (11.0-20.5) 72.5 (56.6-97.2) 261 (141-446) 1914 
Gender        
Males 03-04 12.2 (9.73-15.3) 9.65 (7.23-12.7) 32.7 (25.3-39.1) 108 (79.0-183) 358 (161-1080) 1230 
 05-06 9.60 (7.17-12.9) 8.11 (5.95-10.5) 20.5 (15.9-28.2) 74.9 (50.5-141) 249 (137-534) 1270 
 07-08 9.17 (7.63-11.0) 6.24 (5.22-7.81) 25.5 (19.7-32.4) 110 (70.7-167) 353 (234-572) 1294 
 09-10 6.36 (5.04-8.02) 4.21 (3.36-4.97) 16.7 (11.7-24.0) 83.2 (53.7-141) 280 (111-727) 1399 
Females 03-04 12.9 (9.91-16.8) 8.95 (6.98-13.2) 37.1 (26.7-56.9) 209 (124-362) 660 (408-940) 1292 
 05-06 9.04 (6.18-13.2) 6.60 (4.56-10.4) 20.4 (14.1-33.8) 104 (55.8-199) 309 (149-933) 1278 
 07-08 9.07 (6.91-11.9) 6.08 (4.71-8.04) 22.4 (14.7-30.6) 107 (59.2-216) 509 (185-908) 1310 
 09-10 6.37 (4.92-8.25) 4.10 (3.09-5.69) 15.6 (11.3-22.1) 77.1 (53.3-148) 267 (151-481) 1350 
Race/ethnicity        
Mexican Americans 03-04 27.3 (17.4-42.9) 17.8 (9.86-36.3) 79.8 (45.8-138) 809 (196-2110) 2200 (1250-2480) 616 
 05-06 29.0 (20.5-41.0) 18.6 (12.9-27.3) 99.4 (61.6-165) 675 (296-1400) 1680 (718-2720) 637 
 07-08 21.6 (9.44-49.6) 16.4 (5.09-58.9) 83.9 (30.8-281) 572 (182-1490) 1490 (700-2220) 531 
 09-10 12.9 (5.78-28.8) 9.12 (3.38-26.7) 45.0 (17.3-236) 460 (105-1000) 1000 (380-2800) 566 
Non-Hispanic blacks 03-04 37.1 (24.3-56.7) 27.4 (17.5-47.7) 103 (63.8-216) 609 (248-1210) 1240 (627-2430) 635 
 05-06 30.9 (23.6-40.3) 20.5 (17.3-29.1) 104 (57.7-180) 480 (294-1080) 1480 (515-3100) 678 
 07-08 21.3 (16.2-27.9) 14.6 (10.2-19.7) 64.6 (48.0-101) 529 (217-884) 1130 (793-1560) 597 
 09-10 16.7 (9.19-30.2) 12.5 (6.74-22.0) 58.9 (22.3-106) 349 (92.6-878) 878 (277-3890) 516 
Non-Hispanic whites 03-04 9.24 (7.48-11.4) 7.14 (5.67-8.76) 24.8 (18.7-31.7) 79.7 (50.2-141) 216 (124-516) 1076 
 05-06 6.52 (4.51-9.43) 5.60 (3.86-8.51) 14.1 (10.7-19.7) 40.2 (28.4-61.6) 110 (47.3-224) 1038 
 07-08 6.52 (5.26-8.07) 4.89 (3.95-6.20) 14.4 (11.4-19.2) 53.2 (40.1-75.9) 131 (82.5-249) 1077 







Fourth National Report on Human Exposure to Environmental Chemicals, Updated Tables, January 2017 Volume One Page 58
Urinary 2,5-Dichlorophenol (creatinine corrected) (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 4.80 (3.65-6.32) 3.19 (2.38-4.43) 11.4 (7.97-17.9) 66.4 (39.9-125) 215 (145-342) 2487 
 13-14 2.77 (2.12-3.62) 1.82 (1.43-2.40) 6.80 (4.62-9.72) 32.2 (21.9-45.5) 108 (58.4-270) 2684 
Age group        
6-11 years 11-12 5.01 (3.10-8.09) 3.02 (2.00-5.00) 10.6 (5.53-21.7) 98.1 (32.9-166) 377 (125-1180) 395 
 13-14 3.66 (2.50-5.36) 2.41 (1.62-3.54) 9.73 (5.25-15.6) 37.6 (16.9-110) 172 (70.4-615) 409 
12-19 years 11-12 4.04 (2.51-6.52) 2.41 (1.54-5.34) 12.1 (5.67-27.6) 47.9 (26.3-99.5) 157 (55.1-324) 388 
 13-14 2.21 (1.44-3.40) 1.53 (.915-2.52) 5.16 (2.63-12.0) 22.7 (12.2-38.9) 54.2 (21.7-236) 462 
20 years and older 11-12 4.90 (3.67-6.56) 3.33 (2.50-4.51) 11.5 (8.04-18.0) 70.3 (38.8-136) 226 (145-342) 1704 
 13-14 2.78 (2.15-3.59) 1.81 (1.44-2.29) 6.67 (4.62-9.47) 32.6 (21.1-51.0) 126 (58.4-325) 1813 
Gender        
Males 11-12 4.15 (3.14-5.49) 2.87 (2.14-4.13) 9.73 (6.88-16.1) 52.8 (31.4-106) 157 (125-233) 1258 
 13-14 2.49 (1.93-3.22) 1.69 (1.23-2.22) 5.49 (4.18-8.11) 27.4 (19.6-45.8) 88.7 (58.4-160) 1284 
Females 11-12 5.53 (4.14-7.37) 3.39 (2.57-5.00) 13.1 (8.84-19.5) 90.1 (45.2-147) 331 (145-557) 1229 
 13-14 3.07 (2.30-4.09) 1.96 (1.52-2.54) 8.22 (5.07-11.9) 33.8 (21.7-56.2) 140 (50.4-374) 1400 
Race/ethnicity        
Mexican Americans 11-12 6.67 (4.04-11.0) 4.85 (2.25-8.69) 22.4 (12.6-37.6) 189 (49.2-249) 383 (213-981) 316 
 13-14 4.68 (2.72-8.06) 2.47 (1.36-5.71) 14.5 (7.24-25.0) 91.8 (26.9-559) 559 (89.0-1330) 438 
Non-Hispanic blacks 11-12 12.9 (8.32-19.9) 9.41 (6.35-15.1) 34.5 (18.1-75.0) 174 (83.7-567) 744 (236-1790) 665 
 13-14 7.07 (3.87-12.9) 5.62 (2.55-10.4) 21.2 (10.0-54.1) 128 (32.7-527) 415 (103-2580) 609 
Non-Hispanic whites 11-12 3.40 (2.57-4.49) 2.36 (1.76-3.19) 6.96 (4.70-9.67) 34.5 (16.4-80.1) 126 (55.3-232) 811 
 13-14 2.03 (1.53-2.69) 1.48 (1.13-1.91) 4.15 (2.96-6.34) 18.2 (10.6-32.5) 45.8 (26.0-86.3) 987 
All Hispanics 11-12 8.92 (5.45-14.6) 6.55 (3.50-13.8) 28.8 (16.6-53.6) 184 (97.2-266) 383 (213-1240) 571 
 13-14 4.23 (2.77-6.47) 2.50 (1.41-5.07) 11.5 (6.84-18.7) 84.6 (32.2-226) 401 (135-993) 690 
Asians 11-12 5.05 (2.93-8.69) 2.99 (1.74-7.04) 15.3 (6.51-45.6) 106 (58.7-177) 236 (97.5-632) 352 
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Urinary ortho-Phenylphenol (2003 – 2010) ‡ 
 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * .100 (<LOD-.200) .300 (.200-.400) .500 (.400-.700) .800 (.600-1.10) 2525 
 05-06 * < LOD < LOD .300 (.200-.400) .500 (.400-.800) 2548 
 07-08 * < LOD < LOD .100 (.100-.200) .300 (.200-.400) 2604 
 09-10 * < LOD < LOD .300 (.300-.400) .500 (.500-.600) 2749 
Age group        
6-11 years 03-04 .180 (.158-.206) .200 (.200-.200) .300 (.300-.400) .600 (.500-.800) .800 (.500-1.30) 314 
 05-06 * < LOD .100 (<LOD-.200) .500 (.300-1.10) 1.30 (.700-1.90) 356 
 07-08 * < LOD < LOD .300 (.200-.500) .600 (.300-1.00) 389 
 09-10 * < LOD .200 (<LOD-.300) .400 (.300-.700) .600 (.400-1.20) 415 
12-19 years 03-04 .175 (.149-.206) .200 (.100-.200) .400 (.300-.500) .600 (.500-.800) .900 (.700-1.30) 722 
 05-06 * < LOD < LOD .300 (.200-.500) .600 (.500-.800) 702 
 07-08 * < LOD < LOD .100 (.100-.200) .300 (.200-.600) 401 
 09-10 * < LOD .200 (<LOD-.300) .400 (.300-.500) .600 (.500-.900) 420 
20 years and older 03-04 * .100 (<LOD-.100) .300 (.200-.400) .500 (.400-.700) .800 (.600-1.10) 1489 
 05-06 * < LOD < LOD .300 (.100-.400) .500 (.400-.800) 1490 
 07-08 * < LOD < LOD .100 (<LOD-.200) .300 (.200-.400) 1814 
 09-10 * < LOD < LOD .300 (.300-.400) .500 (.400-.500) 1914 
Gender        
Males 03-04 * .100 (<LOD-.200) .400 (.300-.400) .600 (.500-.700) .800 (.600-1.00) 1231 
 05-06 * < LOD < LOD .300 (.200-.400) .500 (.400-.900) 1270 
 07-08 * < LOD < LOD .100 (<LOD-.200) .300 (.200-.500) 1294 
 09-10 * < LOD < LOD .300 (.300-.400) .500 (.500-.700) 1399 
Females 03-04 * .100 (<LOD-.200) .300 (.200-.400) .500 (.400-.700) .800 (.600-1.20) 1294 
 05-06 * < LOD < LOD .300 (.200-.400) .500 (.400-.800) 1278 
 07-08 * < LOD < LOD .100 (<LOD-.200) .300 (.200-.500) 1310 
 09-10 * < LOD < LOD .300 (.300-.400) .500 (.400-.500) 1350 
Race/ethnicity        
Mexican Americans 03-04 .191 (.150-.245) .200 (.100-.300) .400 (.300-.600) .700 (.500-1.10) 1.10 (.600-1.60) 617 
 05-06 * < LOD < LOD .400 (.100-.900) .800 (.400-3.20) 637 
 07-08 * < LOD < LOD .100 (<LOD-.300) .400 (.200-1.10) 531 
 09-10 * < LOD < LOD .300 (.200-.400) .400 (.300-.900) 566 
Non-Hispanic blacks 03-04 * .100 (<LOD-.200) .400 (.300-.400) .600 (.500-.800) 1.00 (.600-1.40) 636 
 05-06 * < LOD < LOD .400 (.300-.500) .500 (.400-.700) 678 
 07-08 * < LOD < LOD .200 (<LOD-.300) .400 (.200-.600) 597 
 09-10 * < LOD .200 (<LOD-.300) .400 (.300-.600) .700 (.500-.800) 516 
Non-Hispanic whites 03-04 * .100 (<LOD-.100) .300 (.200-.400) .500 (.400-.700) .800 (.600-1.00) 1077 
 05-06 * < LOD < LOD .300 (.100-.400) .500 (.300-1.10) 1038 
 07-08 * < LOD < LOD .100 (<LOD-.200) .300 (.200-.500) 1077 
 09-10 * < LOD < LOD .300 (.300-.400) .500 (.400-.600) 1206 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, 07-08 and 09-10 are 0.1, 0.1, 0.1, and 0.2 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result.  






Fourth National Report on Human Exposure to Environmental Chemicals, Updated Tables, January 2017 Volume One Page 60
Urinary ortho-Phenylphenol (creatinine corrected) (2003 – 2010) ‡ 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * .150 (<LOD-.170) .320 (.270-.380) .670 (.500-.800) .950 (.750-1.31) 2522 
 05-06 * < LOD < LOD .370 (.310-.410) .600 (.470-.750) 2548 
 07-08 * < LOD < LOD .290 (.250-.330) .470 (.400-.520) 2604 
 09-10 * < LOD < LOD .560 (.480-.640) .820 (.700-.910) 2749 
Age group        
6-11 years 03-04 .219 (.189-.255) .230 (.170-.280) .400 (.330-.540) .760 (.530-.860) .880 (.760-1.90) 314 
 05-06 * < LOD .180 (<LOD-.240) .590 (.430-.930) 1.94 (.710-2.94) 356 
 07-08 * < LOD < LOD .390 (.240-.660) .660 (.390-1.31) 389 
 09-10 * < LOD .410 (<LOD-.480) .820 (.560-1.06) 1.22 (.850-1.56) 415 
12-19 years 03-04 .131 (.110-.156) .140 (.100-.160) .270 (.230-.340) .490 (.400-.690) .790 (.550-1.30) 720 
 05-06 * < LOD < LOD .280 (.220-.320) .410 (.330-.710) 702 
 07-08 * < LOD < LOD .190 (.170-.250) .330 (.240-.470) 401 
 09-10 * < LOD .250 (<LOD-.300) .420 (.300-.550) .550 (.390-1.20) 420 
20 years and older 03-04 * .140 (<LOD-.170) .320 (.260-.370) .670 (.500-.800) 1.00 (.740-1.38) 1488 
 05-06 * < LOD < LOD .370 (.300-.410) .540 (.430-.710) 1490 
 07-08 * < LOD < LOD .300 (<LOD-.330) .470 (.390-.520) 1814 
 09-10 * < LOD < LOD .560 (.480-.640) .820 (.700-.880) 1914 
Gender        
Males 03-04 * .130 (<LOD-.150) .290 (.240-.340) .570 (.430-.740) .880 (.720-1.06) 1230 
 05-06 * < LOD < LOD .280 (.200-.350) .470 (.350-.670) 1270 
 07-08 * < LOD < LOD .220 (<LOD-.250) .350 (.300-.440) 1294 
 09-10 * < LOD < LOD .440 (.360-.540) .670 (.510-.850) 1399 
Females 03-04 * .170 (<LOD-.200) .350 (.280-.440) .700 (.500-.940) 1.07 (.730-1.57) 1292 
 05-06 * < LOD < LOD .430 (.370-.500) .700 (.500-1.03) 1278 
 07-08 * < LOD < LOD .350 (<LOD-.440) .500 (.440-.580) 1310 
 09-10 * < LOD < LOD .640 (.570-.700) .930 (.780-1.17) 1350 
Race/ethnicity        
Mexican Americans 03-04 .174 (.132-.229) .170 (.120-.240) .440 (.280-.590) .770 (.560-1.09) 1.11 (.770-1.72) 616 
 05-06 * < LOD < LOD .370 (.210-.670) .740 (.390-1.71) 637 
 07-08 * < LOD < LOD .250 (<LOD-.290) .430 (.320-.910) 531 
 09-10 * < LOD < LOD .420 (.370-.560) .680 (.560-.880) 566 
Non-Hispanic blacks 03-04 * .110 (<LOD-.130) .250 (.200-.310) .530 (.380-.650) .770 (.600-1.02) 635 
 05-06 * < LOD < LOD .290 (.220-.370) .440 (.380-.540) 678 
 07-08 * < LOD < LOD .210 (<LOD-.250) .330 (.250-.640) 597 
 09-10 * < LOD .220 (<LOD-.240) .370 (.310-.450) .570 (.440-.860) 516 
Non-Hispanic whites 03-04 * .150 (<LOD-.180) .330 (.260-.390) .690 (.470-.830) 1.00 (.740-1.38) 1076 
 05-06 * < LOD < LOD .390 (.320-.430) .610 (.470-.880) 1038 
 07-08 * < LOD < LOD .300 (<LOD-.370) .470 (.390-.580) 1077 
 09-10 * < LOD < LOD .610 (.520-.700) .870 (.700-.940) 1206 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result. 
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Urinary Ethylene thiourea (2003 - 2008) 
Metabolite of Several Dithiocarbamate Fungicides 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD .310 (<LOD-.560) 2169 
 05-06 * < LOD < LOD .600 (<LOD-1.08) 1.34 (.900-1.75) 2585 
 07-08 * < LOD < LOD < LOD .430 (<LOD-.960) 2571 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD < LOD 280 
 05-06 * < LOD < LOD .830 (<LOD-1.53) 1.55 (.960-3.11) 342 
 07-08 * < LOD < LOD < LOD .610 (<LOD-1.17) 382 
12-19 years 03-04 * < LOD < LOD < LOD .600 (<LOD-.920) 622 
 05-06 * < LOD < LOD .580 (<LOD-1.11) 1.34 (.660-2.23) 698 
 07-08 * < LOD < LOD < LOD .440 (<LOD-.970) 387 
20-59 years 03-04 * < LOD < LOD < LOD .310 (<LOD-.580) 827 
 05-06 * < LOD < LOD .750 (.500-1.18) 1.42 (1.05-1.75) 1072 
 07-08 * < LOD < LOD < LOD .510 (<LOD-1.19) 1169 
60 years and older 03-04 * < LOD < LOD < LOD < LOD 440 
 05-06 * < LOD < LOD < LOD .360 (<LOD-.780) 473 
 07-08 * < LOD < LOD < LOD < LOD 633 
Gender        
Males 03-04 * < LOD < LOD < LOD .360 (<LOD-.530) 1056 
 05-06 * < LOD < LOD .940 (.530-1.19) 1.51 (1.08-2.09) 1219 
 07-08 * < LOD < LOD < LOD .430 (<LOD-1.05) 1289 
Females 03-04 * < LOD < LOD < LOD < LOD 1113 
 05-06 * < LOD < LOD .370 (<LOD-.890) .950 (.500-1.58) 1366 
 07-08 * < LOD < LOD < LOD .410 (<LOD-.960) 1282 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 495 
 05-06 * < LOD < LOD .440 (<LOD-.960) 1.12 (.650-1.76) 686 
 07-08 * < LOD < LOD < LOD .340 (<LOD-.630) 491 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD .480 (<LOD-1.06) 607 
 05-06 * < LOD < LOD 1.37 (.790-2.05) 2.22 (1.37-3.77) 695 
 07-08 * < LOD < LOD < LOD .630 (<LOD-2.42) 570 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD .330 (<LOD-.560) 925 
 05-06 * < LOD < LOD .570 (<LOD-1.02) 1.18 (.940-1.42) 998 
 07-08 * < LOD < LOD < LOD .300 (<LOD-.750) 1084 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, and 07-08 are 0.1, 0.24, and 0.21 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Ethylene thiourea (creatinine corrected) (2003 - 2008) 
Metabolite of Several Dithiocarbamate Fungicides 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD .434 (<LOD-.538) 2167 
 05-06 * < LOD < LOD .792 (<LOD-1.06) 1.32 (1.06-1.58) 2585 
 07-08 * < LOD < LOD < LOD .789 (<LOD-1.00) 2569 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD < LOD 280 
 05-06 * < LOD < LOD 1.04 (<LOD-1.36) 2.36 (1.16-3.12) 342 
 07-08 * < LOD < LOD < LOD .974 (<LOD-1.50) 382 
12-19 years 03-04 * < LOD < LOD < LOD .423 (<LOD-.700) 621 
 05-06 * < LOD < LOD .582 (<LOD-.893) .967 (.680-1.58) 698 
 07-08 * < LOD < LOD < LOD .417 (<LOD-.652) 385 
20-59 years 03-04 * < LOD < LOD < LOD .425 (<LOD-.506) 826 
 05-06 * < LOD < LOD .892 (.708-1.21) 1.36 (1.21-1.78) 1072 
 07-08 * < LOD < LOD < LOD .789 (<LOD-1.31) 1169 
60 years and older 03-04 * < LOD < LOD < LOD < LOD 440 
 05-06 * < LOD < LOD < LOD 1.00 (<LOD-1.21) 473 
 07-08 * < LOD < LOD < LOD < LOD 633 
Gender        
Males 03-04 * < LOD < LOD < LOD .350 (<LOD-.467) 1055 
 05-06 * < LOD < LOD .783 (.634-1.04) 1.28 (1.05-1.45) 1219 
 07-08 * < LOD < LOD < LOD .529 (<LOD-.652) 1288 
Females 03-04 * < LOD < LOD < LOD < LOD 1112 
 05-06 * < LOD < LOD .827 (<LOD-1.21) 1.33 (1.00-2.01) 1366 
 07-08 * < LOD < LOD < LOD .938 (<LOD-1.25) 1281 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 494 
 05-06 * < LOD < LOD .748 (<LOD-1.17) 1.33 (.837-1.89) 686 
 07-08 * < LOD < LOD < LOD .714 (<LOD-1.10) 490 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD .368 (<LOD-.619) 607 
 05-06 * < LOD < LOD 1.02 (.649-1.74) 1.84 (1.04-2.50) 695 
 07-08 * < LOD < LOD < LOD .652 (<LOD-1.34) 569 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD .434 (<LOD-.583) 924 
 05-06 * < LOD < LOD .773 (<LOD-1.04) 1.25 (.968-1.48) 998 
 07-08 * < LOD < LOD < LOD .750 (<LOD-.882) 1084 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary Pentachlorophenol (2003 - 2004) 
Also a Metabolite of Several Organochlorine Insecticides 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD 1.12 (.570-1.58) 2.57 (2.08-2.99) 3.63 (2.98-4.61) 2354 
Age group        
6-11 years 03-04 * < LOD 1.57 (.970-2.25) 3.23 (2.12-5.67) 5.67 (2.94-6.38) 290 
12-19 years 03-04 * < LOD 1.36 (.760-1.99) 2.88 (2.08-3.53) 3.80 (3.06-6.38) 674 
20-59 years 03-04 * < LOD .980 (<LOD-1.50) 2.40 (1.73-2.79) 3.11 (2.75-3.65) 889 
60 years and older 03-04 * < LOD 1.14 (.540-1.74) 2.76 (2.17-3.60) 4.77 (3.29-5.88) 501 
Gender        
Males 03-04 * < LOD 1.32 (.720-2.05) 2.79 (2.46-3.40) 4.58 (3.50-5.49) 1147 
Females 03-04 * < LOD .880 (<LOD-1.41) 2.12 (1.71-2.74) 3.20 (2.44-3.84) 1207 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD 1.73 (.640-3.38) 2.44 (1.73-3.84) 550 
Non-Hispanic blacks 03-04 * < LOD 1.46 (1.11-1.93) 2.79 (2.22-3.65) 4.06 (3.20-4.77) 610 
Non-Hispanic whites 03-04 * < LOD 1.17 (.580-1.74) 2.66 (2.06-3.23) 3.69 (2.99-5.17) 1039 
Limit of detection (LOD, see Data Analysis section) for Survey year 03-04 is 0.5. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Pentachlorophenol (creatinine corrected) (2003 - 2004) 
Also a Metabolite of Several Organochlorine Insecticides 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD 1.22 (1.01-1.52) 2.30 (1.84-2.77) 3.44 (2.69-3.96) 2352 
Age group        
6-11 years 03-04 * < LOD 1.75 (1.38-2.69) 3.72 (2.50-4.96) 4.96 (3.59-10.6) 290 
12-19 years 03-04 * < LOD 1.11 (.800-1.28) 1.67 (1.31-2.65) 2.76 (1.64-3.89) 673 
20-59 years 03-04 * < LOD 1.10 (<LOD-1.31) 1.99 (1.66-2.59) 2.92 (2.20-3.81) 888 
60 years and older 03-04 * < LOD 1.65 (1.30-1.99) 2.64 (2.14-3.50) 4.15 (2.92-4.90) 501 
Gender        
Males 03-04 * < LOD 1.10 (.825-1.38) 1.93 (1.62-2.65) 3.23 (2.06-4.94) 1146 
Females 03-04 * < LOD 1.37 (<LOD-1.74) 2.50 (2.13-2.98) 3.50 (2.79-4.07) 1206 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD 1.54 (1.01-2.69) 2.33 (1.40-4.62) 549 
Non-Hispanic blacks 03-04 * < LOD .919 (.679-1.25) 1.88 (1.42-2.77) 2.94 (2.21-3.76) 610 
Non-Hispanic whites 03-04 * < LOD 1.35 (1.08-1.64) 2.42 (1.94-3.18) 3.54 (2.77-4.78) 1038 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary Propylene thiourea (2003 - 2008) 
Metabolite of Propineb 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 2456 
 05-06 * < LOD < LOD < LOD < LOD 2628 
 07-08 * < LOD < LOD < LOD < LOD 2573 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD < LOD 305 
 05-06 * < LOD < LOD < LOD < LOD 349 
 07-08 * < LOD < LOD < LOD < LOD 382 
12-19 years 03-04 * < LOD < LOD < LOD < LOD 702 
 05-06 * < LOD < LOD < LOD < LOD 718 
 07-08 * < LOD < LOD < LOD < LOD 387 
20-59 years 03-04 * < LOD < LOD < LOD < LOD 926 
 05-06 * < LOD < LOD < LOD < LOD 1086 
 07-08 * < LOD < LOD < LOD < LOD 1170 
60 years and older 03-04 * < LOD < LOD < LOD < LOD 523 
 05-06 * < LOD < LOD < LOD < LOD 475 
 07-08 * < LOD < LOD < LOD < LOD 634 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 1209 
 05-06 * < LOD < LOD < LOD < LOD 1246 
 07-08 * < LOD < LOD < LOD < LOD 1289 
Females 03-04 * < LOD < LOD < LOD < LOD 1247 
 05-06 * < LOD < LOD < LOD < LOD 1382 
 07-08 * < LOD < LOD < LOD < LOD 1284 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 598 
 05-06 * < LOD < LOD < LOD < LOD 693 
 07-08 * < LOD < LOD < LOD < LOD 493 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 637 
 05-06 * < LOD < LOD < LOD < LOD 720 
 07-08 * < LOD < LOD < LOD < LOD 570 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 1062 
 05-06 * < LOD < LOD < LOD < LOD 1006 
 07-08 * < LOD < LOD < LOD < LOD 1084 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, and 07-08 are 0.1, 0.37, and 0.36 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Propylene thiourea (creatinine corrected) (2003 - 2008) 
Metabolite of Propineb 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 2454 
 05-06 * < LOD < LOD < LOD < LOD 2628 
 07-08 * < LOD < LOD < LOD < LOD 2571 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD < LOD 305 
 05-06 * < LOD < LOD < LOD < LOD 349 
 07-08 * < LOD < LOD < LOD < LOD 382 
12-19 years 03-04 * < LOD < LOD < LOD < LOD 701 
 05-06 * < LOD < LOD < LOD < LOD 718 
 07-08 * < LOD < LOD < LOD < LOD 385 
20-59 years 03-04 * < LOD < LOD < LOD < LOD 925 
 05-06 * < LOD < LOD < LOD < LOD 1086 
 07-08 * < LOD < LOD < LOD < LOD 1170 
60 years and older 03-04 * < LOD < LOD < LOD < LOD 523 
 05-06 * < LOD < LOD < LOD < LOD 475 
 07-08 * < LOD < LOD < LOD < LOD 634 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 1208 
 05-06 * < LOD < LOD < LOD < LOD 1246 
 07-08 * < LOD < LOD < LOD < LOD 1288 
Females 03-04 * < LOD < LOD < LOD < LOD 1246 
 05-06 * < LOD < LOD < LOD < LOD 1382 
 07-08 * < LOD < LOD < LOD < LOD 1283 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 597 
 05-06 * < LOD < LOD < LOD < LOD 693 
 07-08 * < LOD < LOD < LOD < LOD 492 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 637 
 05-06 * < LOD < LOD < LOD < LOD 720 
 07-08 * < LOD < LOD < LOD < LOD 569 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 1061 
 05-06 * < LOD < LOD < LOD < LOD 1006 
 07-08 * < LOD < LOD < LOD < LOD 1084 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 






Fourth National Report on Human Exposure to Environmental Chemicals, Updated Tables, January 2017 Volume One Page 67
Urinary Atrazine (2007 - 2008)‡ 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 07-08 * < LOD < LOD < LOD < LOD 2588 
Age group        
6-11 years 07-08 * < LOD < LOD < LOD < LOD 384 
12-19 years 07-08 * < LOD < LOD < LOD < LOD 390 
20-59 years 07-08 * < LOD < LOD < LOD < LOD 1179 
60 years and older 07-08 * < LOD < LOD < LOD < LOD 635 
Gender        
Males 07-08 * < LOD < LOD < LOD < LOD 1294 
Females 07-08 * < LOD < LOD < LOD < LOD 1294 
Race/ethnicity        
Mexican Americans 07-08 * < LOD < LOD < LOD < LOD 501 
Non-Hispanic blacks 07-08 * < LOD < LOD < LOD < LOD 573 
Non-Hispanic whites 07-08 * < LOD < LOD < LOD < LOD 1085 
Limit of detection (LOD, see Data Analysis section) for Survey year 07-08 is 0.5. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result.  




Fourth National Report on Human Exposure to Environmental Chemicals, Updated Tables, January 2017 Volume One Page 68
Urinary Atrazine (creatinine corrected) (2007 - 2008)‡ 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 07-08 * < LOD < LOD < LOD < LOD 2586 
Age group        
6-11 years 07-08 * < LOD < LOD < LOD < LOD 384 
12-19 years 07-08 * < LOD < LOD < LOD < LOD 388 
20-59 years 07-08 * < LOD < LOD < LOD < LOD 1179 
60 years and older 07-08 * < LOD < LOD < LOD < LOD 635 
Gender        
Males 07-08 * < LOD < LOD < LOD < LOD 1293 
Females 07-08 * < LOD < LOD < LOD < LOD 1293 
Race/ethnicity        
Mexican Americans 07-08 * < LOD < LOD < LOD < LOD 500 
Non-Hispanic blacks 07-08 * < LOD < LOD < LOD < LOD 572 
Non-Hispanic whites 07-08 * < LOD < LOD < LOD < LOD 1085 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result. 
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Urinary Atrazine mercapturate (2007 - 2008)‡ 
Metabolite of Atrazine 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 07-08 * < LOD < LOD < LOD < LOD 2588 
Age group        
6-11 years 07-08 * < LOD < LOD < LOD < LOD 384 
12-19 years 07-08 * < LOD < LOD < LOD < LOD 390 
20-59 years 07-08 * < LOD < LOD < LOD < LOD 1179 
60 years and older 07-08 * < LOD < LOD < LOD < LOD 635 
Gender        
Males 07-08 * < LOD < LOD < LOD < LOD 1294 
Females 07-08 * < LOD < LOD < LOD < LOD 1294 
Race/ethnicity        
Mexican Americans 07-08 * < LOD < LOD < LOD < LOD 501 
Non-Hispanic blacks 07-08 * < LOD < LOD < LOD < LOD 573 
Non-Hispanic whites 07-08 * < LOD < LOD < LOD < LOD 1085 
Limit of detection (LOD, see Data Analysis section) for Survey year 07-08 is 0.5. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result.  
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Urinary Atrazine mercapturate (creatinine corrected) (2007 - 2008)‡ 
Metabolite of Atrazine 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 07-08 * < LOD < LOD < LOD < LOD 2586 
Age group        
6-11 years 07-08 * < LOD < LOD < LOD < LOD 384 
12-19 years 07-08 * < LOD < LOD < LOD < LOD 388 
20-59 years 07-08 * < LOD < LOD < LOD < LOD 1179 
60 years and older 07-08 * < LOD < LOD < LOD < LOD 635 
Gender        
Males 07-08 * < LOD < LOD < LOD < LOD 1293 
Females 07-08 * < LOD < LOD < LOD < LOD 1293 
Race/ethnicity        
Mexican Americans 07-08 * < LOD < LOD < LOD < LOD 500 
Non-Hispanic blacks 07-08 * < LOD < LOD < LOD < LOD 572 
Non-Hispanic whites 07-08 * < LOD < LOD < LOD < LOD 1085 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result. 
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Urinary Desethyl atrazine (2007 - 2008)‡ 
Metabolite of Atrazine 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 07-08 * < LOD < LOD < LOD < LOD 2482 
Age group        
6-11 years 07-08 * < LOD < LOD < LOD < LOD 360 
12-19 years 07-08 * < LOD < LOD < LOD < LOD 382 
20-59 years 07-08 * < LOD < LOD < LOD < LOD 1129 
60 years and older 07-08 * < LOD < LOD < LOD < LOD 611 
Gender        
Males 07-08 * < LOD < LOD < LOD < LOD 1234 
Females 07-08 * < LOD < LOD < LOD < LOD 1248 
Race/ethnicity        
Mexican Americans 07-08 * < LOD < LOD < LOD < LOD 462 
Non-Hispanic blacks 07-08 * < LOD < LOD < LOD < LOD 563 
Non-Hispanic whites 07-08 * < LOD < LOD < LOD < LOD 1048 
Limit of detection (LOD, see Data Analysis section) for Survey year 07-08 is 0.25. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result.  
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Urinary Desethyl atrazine (creatinine corrected) (2007 - 2008)‡ 
Metabolite of Atrazine 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 07-08 * < LOD < LOD < LOD < LOD 2480 
Age group        
6-11 years 07-08 * < LOD < LOD < LOD < LOD 360 
12-19 years 07-08 * < LOD < LOD < LOD < LOD 380 
20-59 years 07-08 * < LOD < LOD < LOD < LOD 1129 
60 years and older 07-08 * < LOD < LOD < LOD < LOD 611 
Gender        
Males 07-08 * < LOD < LOD < LOD < LOD 1233 
Females 07-08 * < LOD < LOD < LOD < LOD 1247 
Race/ethnicity        
Mexican Americans 07-08 * < LOD < LOD < LOD < LOD 461 
Non-Hispanic blacks 07-08 * < LOD < LOD < LOD < LOD 562 
Non-Hispanic whites 07-08 * < LOD < LOD < LOD < LOD 1048 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result. 
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Urinary Desisopropyl atrazine (2007 - 2008)‡ 
Metabolite of Atrazine 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 07-08 * < LOD < LOD < LOD < LOD 2445 
Age group        
6-11 years 07-08 * < LOD < LOD < LOD < LOD 367 
12-19 years 07-08 * < LOD < LOD < LOD < LOD 361 
20-59 years 07-08 * < LOD < LOD < LOD < LOD 1113 
60 years and older 07-08 * < LOD < LOD < LOD < LOD 604 
Gender        
Males 07-08 * < LOD < LOD < LOD < LOD 1224 
Females 07-08 * < LOD < LOD < LOD < LOD 1221 
Race/ethnicity        
Mexican Americans 07-08 * < LOD < LOD < LOD < LOD 493 
Non-Hispanic blacks 07-08 * < LOD < LOD < LOD < LOD 537 
Non-Hispanic whites 07-08 * < LOD < LOD < LOD < LOD 1010 
Limit of detection (LOD, see Data Analysis section) for Survey year 07-08 is 0.25. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result.  
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Urinary Desisopropyl atrazine (creatinine corrected) (2007 - 2008)‡ 
Metabolite of Atrazine 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 07-08 * < LOD < LOD < LOD < LOD 2444 
Age group        
6-11 years 07-08 * < LOD < LOD < LOD < LOD 367 
12-19 years 07-08 * < LOD < LOD < LOD < LOD 360 
20-59 years 07-08 * < LOD < LOD < LOD < LOD 1113 
60 years and older 07-08 * < LOD < LOD < LOD < LOD 604 
Gender        
Males 07-08 * < LOD < LOD < LOD < LOD 1223 
Females 07-08 * < LOD < LOD < LOD < LOD 1221 
Race/ethnicity        
Mexican Americans 07-08 * < LOD < LOD < LOD < LOD 492 
Non-Hispanic blacks 07-08 * < LOD < LOD < LOD < LOD 537 
Non-Hispanic whites 07-08 * < LOD < LOD < LOD < LOD 1010 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result. 
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Urinary Desisopropyl atrazine mercapturate (2007 – 2008)‡ 
Metabolite of Atrazine 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 07-08 * < LOD < LOD < LOD < LOD 2480 
Age group        
6-11 years 07-08 * < LOD < LOD < LOD < LOD 366 
12-19 years 07-08 * < LOD < LOD < LOD < LOD 372 
20-59 years 07-08 * < LOD < LOD < LOD < LOD 1135 
60 years and older 07-08 * < LOD < LOD < LOD < LOD 607 
Gender        
Males 07-08 * < LOD < LOD < LOD < LOD 1233 
Females 07-08 * < LOD < LOD < LOD < LOD 1247 
Race/ethnicity        
Mexican Americans 07-08 * < LOD < LOD < LOD < LOD 486 
Non-Hispanic blacks 07-08 * < LOD < LOD < LOD < LOD 531 
Non-Hispanic whites 07-08 * < LOD < LOD < LOD < LOD 1039 
Limit of detection (LOD, see Data Analysis section) for Survey year 07-08 is 0.1. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result. 
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Urinary Desisopropyl atrazine mercapturate (creatinine corrected) (2007 – 2008)‡ 
Metabolite of Atrazine 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 07-08 * < LOD < LOD < LOD < LOD 2478 
Age group        
6-11 years 07-08 * < LOD < LOD < LOD < LOD 366 
12-19 years 07-08 * < LOD < LOD < LOD < LOD 370 
20-59 years 07-08 * < LOD < LOD < LOD < LOD 1135 
60 years and older 07-08 * < LOD < LOD < LOD < LOD 607 
Gender        
Males 07-08 * < LOD < LOD < LOD < LOD 1232 
Females 07-08 * < LOD < LOD < LOD < LOD 1246 
Race/ethnicity        
Mexican Americans 07-08 * < LOD < LOD < LOD < LOD 485 
Non-Hispanic blacks 07-08 * < LOD < LOD < LOD < LOD 530 
Non-Hispanic whites 07-08 * < LOD < LOD < LOD < LOD 1039 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result. 
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Urinary Diaminochloroatrazine (2007 - 2008)‡ 
Metabolite of Atrazine 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 07-08 * < LOD < LOD < LOD < LOD 2588 
Age group        
6-11 years 07-08 * < LOD < LOD < LOD < LOD 384 
12-19 years 07-08 * < LOD < LOD < LOD < LOD 390 
20-59 years 07-08 * < LOD < LOD < LOD < LOD 1179 
60 years and older 07-08 * < LOD < LOD < LOD < LOD 635 
Gender        
Males 07-08 * < LOD < LOD < LOD < LOD 1294 
Females 07-08 * < LOD < LOD < LOD < LOD 1294 
Race/ethnicity        
Mexican Americans 07-08 * < LOD < LOD < LOD < LOD 501 
Non-Hispanic blacks 07-08 * < LOD < LOD < LOD < LOD 573 
Non-Hispanic whites 07-08 * < LOD < LOD < LOD < LOD 1085 
Limit of detection (LOD, see Data Analysis section) for Survey year 07-08 is 0.5. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result.  
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Urinary Diaminochloroatrazine (creatinine corrected) (2007 - 2008)‡ 
Metabolite of Atrazine 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 07-08 * < LOD < LOD < LOD < LOD 2586 
Age group        
6-11 years 07-08 * < LOD < LOD < LOD < LOD 384 
12-19 years 07-08 * < LOD < LOD < LOD < LOD 388 
20-59 years 07-08 * < LOD < LOD < LOD < LOD 1179 
60 years and older 07-08 * < LOD < LOD < LOD < LOD 635 
Gender        
Males 07-08 * < LOD < LOD < LOD < LOD 1293 
Females 07-08 * < LOD < LOD < LOD < LOD 1293 
Race/ethnicity        
Mexican Americans 07-08 * < LOD < LOD < LOD < LOD 500 
Non-Hispanic blacks 07-08 * < LOD < LOD < LOD < LOD 572 
Non-Hispanic whites 07-08 * < LOD < LOD < LOD < LOD 1085 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result. 
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Urinary 2,4-Dichlorophenoxyacetic acid (1999 - 2010)‡ 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 * < LOD < LOD < LOD < LOD 1977 
 01-02 * < LOD .220 (<LOD-.310) .690 (.560-.880) 1.26 (1.01-1.36) 2903 
 03-04 .245 (.210-.286) .230 (.180-.320) .580 (.490-.660) 1.10 (.910-1.34) 1.71 (1.41-2.37) 2488 
 07-08 * < LOD .550 (.530-.590) 1.06 (.940-1.19) 1.60 (1.38-1.79) 2587 
 09-10 .308 (.275-.345) .280 (.250-.320) .530 (.470-.600) .930 (.810-1.08) 1.43 (1.12-2.02) 2747 
Age group        
6-11 years 99-00 * < LOD < LOD < LOD 1.30 (<LOD-2.40) 477 
 01-02 * < LOD .310 (.210-.400) .740 (.550-1.13) 1.55 (1.00-2.21) 546 
 03-04 .266 (.214-.332) .290 (.200-.390) .670 (.440-.920) 1.03 (.890-1.40) 1.88 (1.01-2.54) 309 
 07-08 * < LOD .720 (.630-.860) 1.44 (1.15-1.64) 1.93 (1.62-2.84) 385 
 09-10 .385 (.330-.449) .350 (.290-.440) .670 (.510-.780) 1.20 (.860-1.58) 1.59 (1.36-2.77) 386 
12-19 years 99-00 * < LOD < LOD < LOD 1.10 (<LOD-1.60) 677 
 01-02 * < LOD .250 (<LOD-.420) .690 (.440-1.16) 1.24 (.690-1.66) 797 
 03-04 .256 (.212-.310) .260 (.180-.380) .580 (.470-.710) 1.04 (.890-1.31) 1.66 (1.20-2.97) 714 
 07-08 * < LOD .590 (.530-.670) 1.29 (.790-1.97) 2.38 (1.46-2.73) 390 
 09-10 .301 (.248-.366) .280 (.240-.330) .490 (.420-.620) .900 (.660-1.05) 1.12 (.880-2.88) 401 
20-59 years 99-00 * < LOD < LOD < LOD < LOD 823 
 01-02 * < LOD .210 (<LOD-.310) .690 (.540-.910) 1.27 (.930-1.49) 1070 
 03-04 .239 (.205-.279) .220 (.170-.300) .570 (.480-.640) .980 (.840-1.35) 1.55 (1.25-2.50) 937 
 07-08 * < LOD .530 (.490-.570) .970 (.800-1.17) 1.36 (1.22-1.78) 1179 
 09-10 .288 (.259-.319) .270 (.230-.310) .500 (.440-.560) .870 (.740-1.04) 1.33 (1.05-1.69) 1309 
60 years and older 01-02 * < LOD < LOD .560 (.390-.870) 1.26 (.690-1.78) 490 
 03-04 .248 (.205-.301) .210 (.130-.320) .560 (.470-.680) 1.36 (1.07-1.90) 2.42 (1.66-3.67) 528 
 07-08 * < LOD .560 (.530-.640) 1.02 (.840-1.12) 1.46 (1.10-2.11) 633 
 09-10 .349 (.294-.414) .300 (.230-.390) .590 (.510-.720) 1.11 (.810-1.57) 2.08 (1.16-5.40) 651 
Gender        
Males 99-00 * < LOD < LOD < LOD 1.10 (<LOD-1.80) 962 
 01-02 * < LOD .330 (.220-.490) .890 (.690-1.17) 1.49 (1.26-2.03) 1364 
 03-04 .276 (.240-.317) .290 (.210-.370) .630 (.540-.740) 1.22 (.960-1.42) 2.12 (1.42-2.73) 1218 
 07-08 * < LOD .610 (.580-.650) 1.26 (1.05-1.38) 2.11 (1.68-2.41) 1292 
 09-10 .347 (.298-.404) .320 (.270-.370) .580 (.500-.690) 1.05 (.810-1.47) 1.82 (1.12-4.14) 1343 
Females 99-00 * < LOD < LOD < LOD < LOD 1015 
 01-02 * < LOD < LOD .470 (.360-.620) .890 (.670-1.21) 1539 
 03-04 .219 (.181-.264) .190 (.110-.280) .490 (.400-.630) .980 (.860-1.33) 1.48 (1.31-2.27) 1270 
 07-08 * < LOD .500 (.460-.540) .870 (.790-1.01) 1.28 (1.12-1.42) 1295 
 09-10 .275 (.250-.303) .260 (.220-.300) .480 (.440-.540) .860 (.740-.950) 1.14 (.970-1.39) 1404 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 07-08 and 09-10 are 0.952, 0.2, and 0.1, 0.4 and 0.15 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample.  
* Not calculated: proportion of results below limit of detection was too high to provide a valid result. 
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Urinary 2,4-Dichlorophenoxyacetic acid (1999 - 2010) ‡ 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 * < LOD < LOD < LOD < LOD 695 
 01-02 * < LOD .250 (<LOD-.330) .730 (.610-.890) 1.20 (.960-1.36) 743 
 03-04 .313 (.256-.383) .340 (.260-.440) .730 (.610-.840) 1.42 (1.02-1.52) 1.81 (1.23-3.53) 606 
 07-08 * < LOD .520 (.470-.590) .860 (.790-1.00) 1.46 (.950-2.22) 500 
 09-10 .276 (.240-.318) .250 (.210-.300) .470 (.410-.570) .840 (.680-1.08) 1.23 (.830-2.02) 602 
Non-Hispanic blacks 99-00 * < LOD < LOD < LOD 1.20 (<LOD-1.70) 520 
 01-02 * < LOD < LOD .560 (.420-.890) 1.06 (.790-1.48) 743 
 03-04 * .190 (<LOD-.290) .510 (.380-.630) .910 (.750-1.22) 1.31 (.990-1.98) 648 
 07-08 * < LOD .580 (.530-.630) 1.05 (.910-1.20) 1.49 (1.23-1.97) 574 
 09-10 .284 (.251-.321) .260 (.240-.290) .460 (.390-.540) .790 (.620-1.03) 1.11 (.790-1.81) 504 
Non-Hispanic whites 99-00 * < LOD < LOD < LOD < LOD 589 
 01-02 * < LOD .240 (<LOD-.360) .730 (.560-.980) 1.30 (1.01-1.66) 1201 
 03-04 .254 (.211-.306) .240 (.180-.360) .590 (.470-.720) 1.17 (.930-1.41) 2.00 (1.40-2.51) 1076 
 07-08 * < LOD .560 (.540-.600) 1.12 (.940-1.29) 1.61 (1.36-2.16) 1083 
 09-10 .328 (.281-.382) .300 (.250-.370) .570 (.480-.680) .980 (.830-1.20) 1.57 (1.14-2.77) 1200 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 07-08 and 07-08 are 0.952, 0.2, and 0.1, 0.4 and 0.15 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result. 
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Urinary 2,4-Dichlorophenoxyacetic acid (creatinine corrected) (1999 - 2010)‡ 
 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 * < LOD < LOD < LOD < LOD 1977 
 01-02 * < LOD .378 (<LOD-.412) .700 (.635-.778) 1.12 (1.03-1.26) 2901 
 03-04 .241 (.203-.287) .253 (.206-.290) .500 (.423-.610) 1.03 (.855-1.28) 1.85 (1.42-2.50) 2486 
 07-08 * < LOD .737 (.667-.779) 1.28 (1.17-1.40) 1.84 (1.65-2.12) 2585 
 09-10 .321 (.286-.360) .301 (.272-.329) .500 (.458-.573) .983 (.846-1.19) 1.55 (1.30-2.12) 2747 
Age group        
6-11 years 99-00 * < LOD < LOD < LOD 1.32 (<LOD-2.24) 477 
 01-02 * < LOD .485 (.378-.679) 1.13 (.825-1.35) 1.41 (1.27-1.73) 546 
 03-04 .323 (.249-.421) .320 (.250-.440) .744 (.500-1.06) 1.30 (.990-2.55) 2.55 (1.23-5.16) 309 
 07-08 * < LOD .970 (.817-1.24) 1.65 (1.47-1.85) 2.96 (1.65-6.18) 385 
 09-10 .521 (.444-.610) .478 (.411-.531) .792 (.674-1.06) 1.52 (1.21-1.74) 2.20 (1.53-3.02) 386 
12-19 years 99-00 * < LOD < LOD < LOD .593 (<LOD-1.05) 677 
 01-02 * < LOD .275 (<LOD-.376) .483 (.328-.662) .662 (.517-.918) 796 
 03-04 .193 (.160-.232) .205 (.157-.250) .419 (.328-.460) .709 (.540-.925) 1.23 (.837-2.35) 713 
 07-08 * < LOD .555 (.475-.651) .908 (.778-1.05) 1.56 (.950-2.79) 388 
 09-10 .258 (.212-.314) .256 (.200-.299) .358 (.320-.439) .706 (.439-1.05) 1.05 (.579-3.27) 401 
20-59 years 99-00 * < LOD < LOD < LOD < LOD 823 
 01-02 * < LOD .378 (<LOD-.412) .667 (.593-.778) 1.08 (.806-1.29) 1070 
 03-04 .227 (.188-.274) .242 (.196-.278) .452 (.397-.545) .923 (.708-1.20) 1.48 (1.14-2.43) 936 
 07-08 * < LOD .667 (.588-.769) 1.17 (1.04-1.34) 1.65 (1.43-2.33) 1179 
 09-10 .288 (.259-.321) .276 (.250-.309) .458 (.418-.507) .860 (.750-.962) 1.36 (1.00-1.88) 1309 
60 years and older 01-02 * < LOD < LOD .824 (.583-1.10) 1.34 (1.00-2.16) 489 
 03-04 .301 (.248-.366) .310 (.237-.385) .657 (.510-.866) 1.54 (1.16-1.95) 3.00 (1.95-6.36) 528 
 07-08 * < LOD .860 (.781-.903) 1.53 (1.27-1.72) 1.96 (1.60-2.33) 633 
 09-10 .414 (.356-.480) .354 (.306-.407) .667 (.548-.812) 1.41 (.983-1.99) 2.87 (1.49-4.49) 651 
Gender        
Males 99-00 * < LOD < LOD < LOD .667 (<LOD-1.16) 962 
 01-02 * < LOD .336 (.272-.412) .652 (.560-.825) 1.14 (.979-1.39) 1364 
 03-04 .227 (.189-.271) .238 (.194-.276) .473 (.412-.564) .941 (.767-1.23) 1.80 (1.09-2.79) 1217 
 07-08 * < LOD .596 (.538-.670) 1.14 (.980-1.24) 1.63 (1.47-2.15) 1291 
 09-10 .309 (.266-.359) .282 (.242-.323) .481 (.413-.554) 1.01 (.707-1.57) 1.80 (1.06-3.88) 1343 
Females 99-00 * < LOD < LOD < LOD < LOD 1015 
 01-02 * < LOD < LOD .711 (.631-.809) 1.10 (.933-1.26) 1537 
 03-04 .256 (.213-.308) .263 (.212-.311) .522 (.435-.645) 1.14 (.900-1.42) 1.85 (1.42-2.64) 1269 
 07-08 * < LOD .854 (.757-.903) 1.47 (1.23-1.58) 1.91 (1.65-2.33) 1294 
 09-10 .334 (.302-.369) .319 (.288-.355) .533 (.475-.611) .953 (.862-1.10) 1.40 (1.21-1.55) 1404 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
*Not calculated: proportion of results below limit of detection was too high to provide a valid result. 
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Urinary 2,4-Dichlorophenoxyacetic acid (creatinine corrected) (1999 - 2010) ‡ 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 * < LOD < LOD < LOD < LOD 695 
 01-02 * < LOD .350 (<LOD-.386) .720 (.583-.840) 1.08 (.778-1.56) 743 
 03-04 .287 (.223-.371) .309 (.194-.459) .593 (.463-.771) 1.08 (.833-1.36) 1.54 (1.17-3.19) 605 
 07-08 * < LOD .622 (.571-.691) 1.15 (.903-1.43) 1.74 (1.37-2.33) 499 
 09-10 .289 (.255-.326) .282 (.255-.300) .434 (.392-.495) .781 (.565-1.11) 1.30 (.733-2.63) 602 
Non-Hispanic blacks 99-00 * < LOD < LOD < LOD .593 (<LOD-1.19) 520 
 01-02 * < LOD < LOD .467 (.349-.583) .778 (.552-.975) 742 
 03-04 * .140 (<LOD-.194) .304 (.264-.356) .629 (.461-.815) .970 (.719-1.50) 648 
 07-08 * < LOD .509 (.457-.596) .966 (.875-1.07) 1.33 (1.12-1.75) 573 
 09-10 .215 (.192-.240) .195 (.180-.218) .344 (.314-.400) .628 (.489-.822) 1.06 (.714-1.38) 504 
Non-Hispanic whites 99-00 * < LOD < LOD < LOD < LOD 589 
 01-02 * < LOD .412 (<LOD-.455) .769 (.667-.894) 1.25 (1.05-1.40) 1200 
 03-04 .263 (.213-.326) .269 (.226-.318) .539 (.434-.665) 1.13 (.941-1.46) 2.34 (1.54-2.73) 1075 
 07-08 * < LOD .780 (.737-.871) 1.36 (1.17-1.55) 2.00 (1.60-2.49) 1083 
 09-10 .357 (.308-.414) .328 (.288-.384) .547 (.485-.644) 1.10 (.897-1.40) 1.79 (1.35-3.02) 1200 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result. 
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Urinary 2,4,5-Trichlorophenoxyacetic acid (1999 - 2010)‡ 
 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 * < LOD < LOD < LOD < LOD 1814 
 01-02 * < LOD < LOD < LOD < LOD 3047 
 03-04 * < LOD < LOD < LOD .140 (<LOD-.210) 2416 
 07-08 * < LOD < LOD < LOD < LOD 2588 
 09-10 * < LOD < LOD < LOD < LOD 2747 
Age group        
6-11 years 99-00 * < LOD < LOD < LOD < LOD 430 
 01-02 * < LOD < LOD < LOD < LOD 580 
 03-04 * < LOD < LOD < LOD .110 (<LOD-.160) 303 
 07-08 * < LOD < LOD < LOD < LOD 385 
 09-10 * < LOD < LOD < LOD < LOD 386 
12-19 years 99-00 * < LOD < LOD < LOD < LOD 618 
 01-02 * < LOD < LOD < LOD < LOD 831 
 03-04 * < LOD < LOD < LOD .140 (<LOD-.190) 701 
 07-08 * < LOD < LOD < LOD < LOD 390 
 09-10 * < LOD < LOD < LOD < LOD 401 
20-59 years 99-00 * < LOD < LOD < LOD < LOD 766 
 01-02 * < LOD < LOD < LOD < LOD 1127 
 03-04 * < LOD < LOD < LOD .160 (<LOD-.250) 908 
 07-08 * < LOD < LOD < LOD < LOD 1180 
 09-10 * < LOD < LOD < LOD < LOD 1309 
60 years and older 01-02 * < LOD < LOD < LOD < LOD 509 
 03-04 * < LOD < LOD < LOD .140 (<LOD-.230) 504 
 07-08 * < LOD < LOD < LOD < LOD 633 
 09-10 * < LOD < LOD < LOD < LOD 651 
Gender        
Males 99-00 * < LOD < LOD < LOD < LOD 891 
 01-02 * < LOD < LOD < LOD < LOD 1428 
 03-04 * < LOD < LOD < LOD .140 (<LOD-.210) 1184 
 07-08 * < LOD < LOD < LOD < LOD 1293 
 09-10 * < LOD < LOD < LOD < LOD 1343 
Females 99-00 * < LOD < LOD < LOD < LOD 923 
 01-02 * < LOD < LOD < LOD < LOD 1619 
 03-04 * < LOD < LOD < LOD .150 (<LOD-.230) 1232 
 07-08 * < LOD < LOD < LOD < LOD 1295 
 09-10 * < LOD < LOD < LOD < LOD 1404 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 07-08 and 09-10 are 1.2, 0.1, and 0.1, 0.1 and 0.1 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample.  
* Not calculated: proportion of results below limit of detection was too high to provide a valid result.  
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Urinary 2,4,5-Trichlorophenoxyacetic acid (1999 - 2010) ‡ 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 * < LOD < LOD < LOD < LOD 652 
 01-02 * < LOD < LOD < LOD < LOD 766 
 03-04 * < LOD < LOD .120 (<LOD-.340) .200 (<LOD-.390) 605 
 07-08 * < LOD < LOD < LOD < LOD 500 
 09-10 * < LOD < LOD < LOD < LOD 602 
Non-Hispanic blacks 99-00 * < LOD < LOD < LOD < LOD 483 
 01-02 * < LOD < LOD < LOD < LOD 776 
 03-04 * < LOD < LOD < LOD < LOD 641 
 07-08 * < LOD < LOD < LOD < LOD 574 
 09-10 * < LOD < LOD < LOD < LOD 504 
Non-Hispanic whites 99-00 * < LOD < LOD < LOD < LOD 531 
 01-02 * < LOD < LOD < LOD < LOD 1281 
 03-04 * < LOD < LOD < LOD .150 (<LOD-.230) 1013 
 07-08 * < LOD < LOD < LOD < LOD 1084 
 09-10 * < LOD < LOD < LOD < LOD 1200 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 07-08 and 07-08 are 1.2, 0.1, and 0.1, 0.1 and 0.1 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result.  
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Urinary 2,4,5-Trichlorophenoxyacetic acid (creatinine corrected) (1999 - 2010)‡ 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 * < LOD < LOD < LOD < LOD 1814 
 01-02 * < LOD < LOD < LOD < LOD 3045 
 03-04 * < LOD < LOD < LOD .333 (<LOD-.412) 2414 
 07-08 * < LOD < LOD < LOD < LOD 2586 
 09-10 * < LOD < LOD < LOD < LOD 2747 
Age group        
6-11 years 99-00 * < LOD < LOD < LOD < LOD 430 
 01-02 * < LOD < LOD < LOD < LOD 580 
 03-04 * < LOD < LOD < LOD .318 (<LOD-.368) 303 
 07-08 * < LOD < LOD < LOD < LOD 385 
 09-10 * < LOD < LOD < LOD < LOD 386 
12-19 years 99-00 * < LOD < LOD < LOD < LOD 618 
 01-02 * < LOD < LOD < LOD < LOD 830 
 03-04 * < LOD < LOD < LOD .226 (<LOD-.269) 700 
 07-08 * < LOD < LOD < LOD < LOD 388 
 09-10 * < LOD < LOD < LOD < LOD 401 
20-59 years 99-00 * < LOD < LOD < LOD < LOD 766 
 01-02 * < LOD < LOD < LOD < LOD 1127 
 03-04 * < LOD < LOD < LOD .350 (<LOD-.438) 907 
 07-08 * < LOD < LOD < LOD < LOD 1180 
 09-10 * < LOD < LOD < LOD < LOD 1309 
60 years and older 01-02 * < LOD < LOD < LOD < LOD 508 
 03-04 * < LOD < LOD < LOD .368 (<LOD-.538) 504 
 07-08 * < LOD < LOD < LOD < LOD 633 
 09-10 * < LOD < LOD < LOD < LOD 651 
Gender        
Males 99-00 * < LOD < LOD < LOD < LOD 891 
 01-02 * < LOD < LOD < LOD < LOD 1428 
 03-04 * < LOD < LOD < LOD .253 (<LOD-.350) 1183 
 07-08 * < LOD < LOD < LOD < LOD 1292 
 09-10 * < LOD < LOD < LOD < LOD 1343 
Females 99-00 * < LOD < LOD < LOD < LOD 923 
 01-02 * < LOD < LOD < LOD < LOD 1617 
 03-04 * < LOD < LOD < LOD .432 (<LOD-.500) 1231 
 07-08 * < LOD < LOD < LOD < LOD 1294 
 09-10 * < LOD < LOD < LOD < LOD 1404 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result. 
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Urinary 2,4,5-Trichlorophenoxyacetic acid (creatinine corrected) (1999 - 2010) ‡ 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 * < LOD < LOD < LOD < LOD 652 
 01-02 * < LOD < LOD < LOD < LOD 766 
 03-04 * < LOD < LOD .200 (<LOD-.333) .333 (<LOD-.467) 604 
 07-08 * < LOD < LOD < LOD < LOD 499 
 09-10 * < LOD < LOD < LOD < LOD 602 
Non-Hispanic blacks 99-00 * < LOD < LOD < LOD < LOD 483 
 01-02 * < LOD < LOD < LOD < LOD 775 
 03-04 * < LOD < LOD < LOD < LOD 641 
 07-08 * < LOD < LOD < LOD < LOD 573 
 09-10 * < LOD < LOD < LOD < LOD 504 
Non-Hispanic whites 99-00 * < LOD < LOD < LOD < LOD 531 
 01-02 * < LOD < LOD < LOD < LOD 1280 
 03-04 * < LOD < LOD < LOD .350 (<LOD-.438) 1012 
 07-08 * < LOD < LOD < LOD < LOD 1084 
 09-10 * < LOD < LOD < LOD < LOD 1200 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result. 
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Urinary Bensulfuron-methyl (2003 – 2008) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 2355 
 05-06 * < LOD < LOD < LOD < LOD 2634 
 07-08 * < LOD < LOD < LOD < LOD 2494 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD < LOD 286 
 05-06 * < LOD < LOD < LOD < LOD 350 
 07-08 * < LOD < LOD < LOD < LOD 374 
12-19 years 03-04 * < LOD < LOD < LOD < LOD 671 
 05-06 * < LOD < LOD < LOD < LOD 718 
 07-08 * < LOD < LOD < LOD < LOD 381 
20 years and older 03-04 * < LOD < LOD < LOD < LOD 1398 
 05-06 * < LOD < LOD < LOD < LOD 1566 
 07-08 * < LOD < LOD < LOD < LOD 1739 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 1150 
 05-06 * < LOD < LOD < LOD < LOD 1247 
 07-08 * < LOD < LOD < LOD < LOD 1240 
Females 03-04 * < LOD < LOD < LOD < LOD 1205 
 05-06 * < LOD < LOD < LOD < LOD 1387 
 07-08 * < LOD < LOD < LOD < LOD 1254 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 567 
 05-06 * < LOD < LOD < LOD < LOD 697 
 07-08 * < LOD < LOD < LOD < LOD 477 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 617 
 05-06 * < LOD < LOD < LOD < LOD 720 
 07-08 * < LOD < LOD < LOD < LOD 558 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 1018 
 05-06 * < LOD < LOD < LOD < LOD 1007 
 07-08 * < LOD < LOD < LOD < LOD 1053 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, and 07-08 are 0.05, 0.05, and 0.05 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Bensulfuron-methyl (creatinine corrected) (2003 – 2008) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 2353 
 05-06 * < LOD < LOD < LOD < LOD 2634 
 07-08 * < LOD < LOD < LOD < LOD 2492 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD < LOD 286 
 05-06 * < LOD < LOD < LOD < LOD 350 
 07-08 * < LOD < LOD < LOD < LOD 374 
12-19 years 03-04 * < LOD < LOD < LOD < LOD 670 
 05-06 * < LOD < LOD < LOD < LOD 718 
 07-08 * < LOD < LOD < LOD < LOD 379 
20 years and older 03-04 * < LOD < LOD < LOD < LOD 1397 
 05-06 * < LOD < LOD < LOD < LOD 1566 
 07-08 * < LOD < LOD < LOD < LOD 1739 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 1149 
 05-06 * < LOD < LOD < LOD < LOD 1247 
 07-08 * < LOD < LOD < LOD < LOD 1239 
Females 03-04 * < LOD < LOD < LOD < LOD 1204 
 05-06 * < LOD < LOD < LOD < LOD 1387 
 07-08 * < LOD < LOD < LOD < LOD 1253 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 566 
 05-06 * < LOD < LOD < LOD < LOD 697 
 07-08 * < LOD < LOD < LOD < LOD 476 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 617 
 05-06 * < LOD < LOD < LOD < LOD 720 
 07-08 * < LOD < LOD < LOD < LOD 557 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 1017 
 05-06 * < LOD < LOD < LOD < LOD 1007 
 07-08 * < LOD < LOD < LOD < LOD 1053 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary Chlorsulfuron (2003 – 2008) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 2100 
 05-06 * < LOD < LOD < LOD < LOD 2419 
 07-08 * < LOD < LOD < LOD < LOD 2566 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD < LOD 259 
 05-06 * < LOD < LOD < LOD < LOD 314 
 07-08 * < LOD < LOD < LOD < LOD 380 
12-19 years 03-04 * < LOD < LOD < LOD < LOD 601 
 05-06 * < LOD < LOD < LOD < LOD 653 
 07-08 * < LOD < LOD < LOD < LOD 386 
20 years and older 03-04 * < LOD < LOD < LOD < LOD 1240 
 05-06 * < LOD < LOD < LOD < LOD 1452 
 07-08 * < LOD < LOD < LOD < LOD 1800 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 1031 
 05-06 * < LOD < LOD < LOD < LOD 1151 
 07-08 * < LOD < LOD < LOD < LOD 1285 
Females 03-04 * < LOD < LOD < LOD < LOD 1069 
 05-06 * < LOD < LOD < LOD < LOD 1268 
 07-08 * < LOD < LOD < LOD < LOD 1281 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 506 
 05-06 * < LOD < LOD < LOD < LOD 633 
 07-08 * < LOD < LOD < LOD < LOD 491 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 568 
 05-06 * < LOD < LOD < LOD < LOD 658 
 07-08 * < LOD < LOD < LOD < LOD 570 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 894 
 05-06 * < LOD < LOD < LOD < LOD 940 
 07-08 * < LOD < LOD < LOD < LOD 1081 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, and 07-08 are 0.06, 0.06, and 0.06 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Chlorsulfuron (creatinine corrected) (2003 – 2008) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 2098 
 05-06 * < LOD < LOD < LOD < LOD 2419 
 07-08 * < LOD < LOD < LOD < LOD 2564 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD < LOD 259 
 05-06 * < LOD < LOD < LOD < LOD 314 
 07-08 * < LOD < LOD < LOD < LOD 380 
12-19 years 03-04 * < LOD < LOD < LOD < LOD 600 
 05-06 * < LOD < LOD < LOD < LOD 653 
 07-08 * < LOD < LOD < LOD < LOD 384 
20 years and older 03-04 * < LOD < LOD < LOD < LOD 1239 
 05-06 * < LOD < LOD < LOD < LOD 1452 
 07-08 * < LOD < LOD < LOD < LOD 1800 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 1030 
 05-06 * < LOD < LOD < LOD < LOD 1151 
 07-08 * < LOD < LOD < LOD < LOD 1284 
Females 03-04 * < LOD < LOD < LOD < LOD 1068 
 05-06 * < LOD < LOD < LOD < LOD 1268 
 07-08 * < LOD < LOD < LOD < LOD 1280 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 505 
 05-06 * < LOD < LOD < LOD < LOD 633 
 07-08 * < LOD < LOD < LOD < LOD 490 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 568 
 05-06 * < LOD < LOD < LOD < LOD 658 
 07-08 * < LOD < LOD < LOD < LOD 569 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 893 
 05-06 * < LOD < LOD < LOD < LOD 940 
 07-08 * < LOD < LOD < LOD < LOD 1081 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary Ethametsulfuron-methyl (2003 – 2008) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 2321 
 05-06 * < LOD < LOD < LOD < LOD 2634 
 07-08 * < LOD < LOD < LOD < LOD 2458 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD < LOD 294 
 05-06 * < LOD < LOD < LOD < LOD 350 
 07-08 * < LOD < LOD < LOD < LOD 366 
12-19 years 03-04 * < LOD < LOD < LOD < LOD 671 
 05-06 * < LOD < LOD < LOD < LOD 718 
 07-08 * < LOD < LOD < LOD < LOD 381 
20 years and older 03-04 * < LOD < LOD < LOD < LOD 1356 
 05-06 * < LOD < LOD < LOD < LOD 1566 
 07-08 * < LOD < LOD < LOD < LOD 1711 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 1132 
 05-06 * < LOD < LOD < LOD < LOD 1247 
 07-08 * < LOD < LOD < LOD < LOD 1218 
Females 03-04 * < LOD < LOD < LOD < LOD 1189 
 05-06 * < LOD < LOD < LOD < LOD 1387 
 07-08 * < LOD < LOD < LOD < LOD 1240 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 590 
 05-06 * < LOD < LOD < LOD < LOD 697 
 07-08 * < LOD < LOD < LOD < LOD 468 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 608 
 05-06 * < LOD < LOD < LOD < LOD 720 
 07-08 * < LOD < LOD < LOD < LOD 534 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 974 
 05-06 * < LOD < LOD < LOD < LOD 1007 
 07-08 * < LOD < LOD < LOD < LOD 1052 
Limit of detection (LOD, see Data Analysis section) for Survey year 03-04, 05-06, and 07-08 are 0.1, 0.1, and 0.1 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Ethametsulfuron-methyl (creatinine corrected) (2003 – 2008) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 2319 
 05-06 * < LOD < LOD < LOD < LOD 2634 
 07-08 * < LOD < LOD < LOD < LOD 2456 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD < LOD 294 
 05-06 * < LOD < LOD < LOD < LOD 350 
 07-08 * < LOD < LOD < LOD < LOD 366 
12-19 years 03-04 * < LOD < LOD < LOD < LOD 670 
 05-06 * < LOD < LOD < LOD < LOD 718 
 07-08 * < LOD < LOD < LOD < LOD 379 
20 years and older 03-04 * < LOD < LOD < LOD < LOD 1355 
 05-06 * < LOD < LOD < LOD < LOD 1566 
 07-08 * < LOD < LOD < LOD < LOD 1711 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 1131 
 05-06 * < LOD < LOD < LOD < LOD 1247 
 07-08 * < LOD < LOD < LOD < LOD 1217 
Females 03-04 * < LOD < LOD < LOD < LOD 1188 
 05-06 * < LOD < LOD < LOD < LOD 1387 
 07-08 * < LOD < LOD < LOD < LOD 1239 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 589 
 05-06 * < LOD < LOD < LOD < LOD 697 
 07-08 * < LOD < LOD < LOD < LOD 467 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 608 
 05-06 * < LOD < LOD < LOD < LOD 720 
 07-08 * < LOD < LOD < LOD < LOD 533 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 973 
 05-06 * < LOD < LOD < LOD < LOD 1007 
 07-08 * < LOD < LOD < LOD < LOD 1052 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary Foramsulfuron (2003 – 2008) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 2255 
 05-06 * < LOD < LOD < LOD < LOD 2534 
 07-08 * < LOD < LOD < LOD < LOD 2423 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD < LOD 283 
 05-06 * < LOD < LOD < LOD < LOD 334 
 07-08 * < LOD < LOD < LOD < LOD 364 
12-19 years 03-04 * < LOD < LOD < LOD < LOD 653 
 05-06 * < LOD < LOD < LOD < LOD 688 
 07-08 * < LOD < LOD < LOD < LOD 364 
20 years and older 03-04 * < LOD < LOD < LOD < LOD 1319 
 05-06 * < LOD < LOD < LOD < LOD 1512 
 07-08 * < LOD < LOD < LOD < LOD 1695 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 1097 
 05-06 * < LOD < LOD < LOD < LOD 1203 
 07-08 * < LOD < LOD < LOD < LOD 1205 
Females 03-04 * < LOD < LOD < LOD < LOD 1158 
 05-06 * < LOD < LOD < LOD < LOD 1331 
 07-08 * < LOD < LOD < LOD < LOD 1218 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 587 
 05-06 * < LOD < LOD < LOD < LOD 632 
 07-08 * < LOD < LOD < LOD < LOD 487 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 584 
 05-06 * < LOD < LOD < LOD < LOD 711 
 07-08 * < LOD < LOD < LOD < LOD 523 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 935 
 05-06 * < LOD < LOD < LOD < LOD 990 
 07-08 * < LOD < LOD < LOD < LOD 1004 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, and 07-08 are 0.05, 0.05, and 0.05 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Foramsulfuron (creatinine corrected) (2003 – 2008) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 2253 
 05-06 * < LOD < LOD < LOD < LOD 2534 
 07-08 * < LOD < LOD < LOD < LOD 2421 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD < LOD 283 
 05-06 * < LOD < LOD < LOD < LOD 334 
 07-08 * < LOD < LOD < LOD < LOD 364 
12-19 years 03-04 * < LOD < LOD < LOD < LOD 652 
 05-06 * < LOD < LOD < LOD < LOD 688 
 07-08 * < LOD < LOD < LOD < LOD 362 
20 years and older 03-04 * < LOD < LOD < LOD < LOD 1318 
 05-06 * < LOD < LOD < LOD < LOD 1512 
 07-08 * < LOD < LOD < LOD < LOD 1695 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 1096 
 05-06 * < LOD < LOD < LOD < LOD 1203 
 07-08 * < LOD < LOD < LOD < LOD 1204 
Females 03-04 * < LOD < LOD < LOD < LOD 1157 
 05-06 * < LOD < LOD < LOD < LOD 1331 
 07-08 * < LOD < LOD < LOD < LOD 1217 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 586 
 05-06 * < LOD < LOD < LOD < LOD 632 
 07-08 * < LOD < LOD < LOD < LOD 486 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 584 
 05-06 * < LOD < LOD < LOD < LOD 711 
 07-08 * < LOD < LOD < LOD < LOD 522 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 934 
 05-06 * < LOD < LOD < LOD < LOD 990 
 07-08 * < LOD < LOD < LOD < LOD 1004 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary Halosulfuron (2003 – 2008)  
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 2356 
 05-06 * < LOD < LOD < LOD < LOD 2485 
 07-08 * < LOD < LOD < LOD < LOD 2530 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD < LOD 291 
 05-06 * < LOD < LOD < LOD < LOD 331 
 07-08 * < LOD < LOD < LOD < LOD 377 
12-19 years 03-04 * < LOD < LOD < LOD < LOD 672 
 05-06 * < LOD < LOD < LOD < LOD 679 
 07-08 * < LOD < LOD < LOD < LOD 385 
20 years and older 03-04 * < LOD < LOD < LOD < LOD 1393 
 05-06 * < LOD < LOD < LOD < LOD 1475 
 07-08 * < LOD < LOD < LOD < LOD 1768 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 1148 
 05-06 * < LOD < LOD < LOD < LOD 1184 
 07-08 * < LOD < LOD < LOD < LOD 1261 
Females 03-04 * < LOD < LOD < LOD < LOD 1208 
 05-06 * < LOD < LOD < LOD < LOD 1301 
 07-08 * < LOD < LOD < LOD < LOD 1269 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 592 
 05-06 * < LOD < LOD < LOD < LOD 650 
 07-08 * < LOD < LOD < LOD < LOD 485 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 609 
 05-06 * < LOD < LOD < LOD < LOD 694 
 07-08 * < LOD < LOD < LOD < LOD 565 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 1005 
 05-06 * < LOD < LOD < LOD < LOD 950 
 07-08 * < LOD < LOD < LOD < LOD 1068 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, and 07-08 are 0.1, 0.1, and 0.1 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Halosulfuron (creatinine corrected) (2003 – 2008) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 2354 
 05-06 * < LOD < LOD < LOD < LOD 2485 
 07-08 * < LOD < LOD < LOD < LOD 2528 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD < LOD 291 
 05-06 * < LOD < LOD < LOD < LOD 331 
 07-08 * < LOD < LOD < LOD < LOD 377 
12-19 years 03-04 * < LOD < LOD < LOD < LOD 671 
 05-06 * < LOD < LOD < LOD < LOD 679 
 07-08 * < LOD < LOD < LOD < LOD 383 
20 years and older 03-04 * < LOD < LOD < LOD < LOD 1392 
 05-06 * < LOD < LOD < LOD < LOD 1475 
 07-08 * < LOD < LOD < LOD < LOD 1768 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 1147 
 05-06 * < LOD < LOD < LOD < LOD 1184 
 07-08 * < LOD < LOD < LOD < LOD 1260 
Females 03-04 * < LOD < LOD < LOD < LOD 1207 
 05-06 * < LOD < LOD < LOD < LOD 1301 
 07-08 * < LOD < LOD < LOD < LOD 1268 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 591 
 05-06 * < LOD < LOD < LOD < LOD 650 
 07-08 * < LOD < LOD < LOD < LOD 484 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 609 
 05-06 * < LOD < LOD < LOD < LOD 694 
 07-08 * < LOD < LOD < LOD < LOD 564 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 1004 
 05-06 * < LOD < LOD < LOD < LOD 950 
 07-08 * < LOD < LOD < LOD < LOD 1068 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary Mesosulfuron-methyl (2003 – 2008) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 2427 
 05-06 * < LOD < LOD < LOD < LOD 2634 
 07-08 * < LOD < LOD < LOD < LOD 2494 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD < LOD 302 
 05-06 * < LOD < LOD < LOD < LOD 350 
 07-08 * < LOD < LOD < LOD < LOD 372 
12-19 years 03-04 * < LOD < LOD < LOD < LOD 694 
 05-06 * < LOD < LOD < LOD < LOD 718 
 07-08 * < LOD < LOD < LOD < LOD 371 
20 years and older 03-04 * < LOD < LOD < LOD < LOD 1431 
 05-06 * < LOD < LOD < LOD < LOD 1566 
 07-08 * < LOD < LOD < LOD < LOD 1751 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 1189 
 05-06 * < LOD < LOD < LOD < LOD 1247 
 07-08 * < LOD < LOD < LOD < LOD 1245 
Females 03-04 * < LOD < LOD < LOD < LOD 1238 
 05-06 * < LOD < LOD < LOD < LOD 1387 
 07-08 * < LOD < LOD < LOD < LOD 1249 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 596 
 05-06 * < LOD < LOD < LOD < LOD 697 
 07-08 * < LOD < LOD < LOD < LOD 465 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 634 
 05-06 * < LOD < LOD < LOD < LOD 720 
 07-08 * < LOD < LOD < LOD < LOD 554 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 1039 
 05-06 * < LOD < LOD < LOD < LOD 1007 
 07-08 * < LOD < LOD < LOD < LOD 1059 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, and 07-08 are 0.06, 0.06, and 0.06 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 2425 
 05-06 * < LOD < LOD < LOD < LOD 2634 
 07-08 * < LOD < LOD < LOD < LOD 2492 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD < LOD 302 
 05-06 * < LOD < LOD < LOD < LOD 350 
 07-08 * < LOD < LOD < LOD < LOD 372 
12-19 years 03-04 * < LOD < LOD < LOD < LOD 693 
 05-06 * < LOD < LOD < LOD < LOD 718 
 07-08 * < LOD < LOD < LOD < LOD 369 
20 years and older 03-04 * < LOD < LOD < LOD < LOD 1430 
 05-06 * < LOD < LOD < LOD < LOD 1566 
 07-08 * < LOD < LOD < LOD < LOD 1751 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 1188 
 05-06 * < LOD < LOD < LOD < LOD 1247 
 07-08 * < LOD < LOD < LOD < LOD 1244 
Females 03-04 * < LOD < LOD < LOD < LOD 1237 
 05-06 * < LOD < LOD < LOD < LOD 1387 
 07-08 * < LOD < LOD < LOD < LOD 1248 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 595 
 05-06 * < LOD < LOD < LOD < LOD 697 
 07-08 * < LOD < LOD < LOD < LOD 464 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 634 
 05-06 * < LOD < LOD < LOD < LOD 720 
 07-08 * < LOD < LOD < LOD < LOD 553 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 1038 
 05-06 * < LOD < LOD < LOD < LOD 1007 
 07-08 * < LOD < LOD < LOD < LOD 1059 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary Metsulfuron-methyl (2003 – 2008) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 2360 
 05-06 * < LOD < LOD < LOD < LOD 2634 
 07-08 * < LOD < LOD < LOD < LOD 2494 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD < LOD 297 
 05-06 * < LOD < LOD < LOD < LOD 350 
 07-08 * < LOD < LOD < LOD < LOD 373 
12-19 years 03-04 * < LOD < LOD < LOD < LOD 675 
 05-06 * < LOD < LOD < LOD < LOD 718 
 07-08 * < LOD < LOD < LOD < LOD 374 
20 years and older 03-04 * < LOD < LOD < LOD < LOD 1388 
 05-06 * < LOD < LOD < LOD < LOD 1566 
 07-08 * < LOD < LOD < LOD < LOD 1747 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 1152 
 05-06 * < LOD < LOD < LOD < LOD 1247 
 07-08 * < LOD < LOD < LOD < LOD 1246 
Females 03-04 * < LOD < LOD < LOD < LOD 1208 
 05-06 * < LOD < LOD < LOD < LOD 1387 
 07-08 * < LOD < LOD < LOD < LOD 1248 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 595 
 05-06 * < LOD < LOD < LOD < LOD 697 
 07-08 * < LOD < LOD < LOD < LOD 470 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 596 
 05-06 * < LOD < LOD < LOD < LOD 720 
 07-08 * < LOD < LOD < LOD < LOD 538 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 1013 
 05-06 * < LOD < LOD < LOD < LOD 1007 
 07-08 * < LOD < LOD < LOD < LOD 1066 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, and 07-08 are 0.05, 0.05, and 0.05 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 2358 
 05-06 * < LOD < LOD < LOD < LOD 2634 
 07-08 * < LOD < LOD < LOD < LOD 2492 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD < LOD 297 
 05-06 * < LOD < LOD < LOD < LOD 350 
 07-08 * < LOD < LOD < LOD < LOD 373 
12-19 years 03-04 * < LOD < LOD < LOD < LOD 674 
 05-06 * < LOD < LOD < LOD < LOD 718 
 07-08 * < LOD < LOD < LOD < LOD 372 
20 years and older 03-04 * < LOD < LOD < LOD < LOD 1387 
 05-06 * < LOD < LOD < LOD < LOD 1566 
 07-08 * < LOD < LOD < LOD < LOD 1747 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 1151 
 05-06 * < LOD < LOD < LOD < LOD 1247 
 07-08 * < LOD < LOD < LOD < LOD 1245 
Females 03-04 * < LOD < LOD < LOD < LOD 1207 
 05-06 * < LOD < LOD < LOD < LOD 1387 
 07-08 * < LOD < LOD < LOD < LOD 1247 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 594 
 05-06 * < LOD < LOD < LOD < LOD 697 
 07-08 * < LOD < LOD < LOD < LOD 469 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 596 
 05-06 * < LOD < LOD < LOD < LOD 720 
 07-08 * < LOD < LOD < LOD < LOD 537 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 1012 
 05-06 * < LOD < LOD < LOD < LOD 1007 
 07-08 * < LOD < LOD < LOD < LOD 1066 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 2322 
 05-06 * < LOD < LOD < LOD < LOD 2570 
 07-08 * < LOD < LOD < LOD < LOD 2422 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD < LOD 296 
 05-06 * < LOD < LOD < LOD < LOD 341 
 07-08 * < LOD < LOD < LOD < LOD 363 
12-19 years 03-04 * < LOD < LOD < LOD < LOD 666 
 05-06 * < LOD < LOD < LOD < LOD 699 
 07-08 * < LOD < LOD < LOD < LOD 364 
20 years and older 03-04 * < LOD < LOD < LOD < LOD 1360 
 05-06 * < LOD < LOD < LOD < LOD 1530 
 07-08 * < LOD < LOD < LOD < LOD 1695 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 1131 
 05-06 * < LOD < LOD < LOD < LOD 1222 
 07-08 * < LOD < LOD < LOD < LOD 1210 
Females 03-04 * < LOD < LOD < LOD < LOD 1191 
 05-06 * < LOD < LOD < LOD < LOD 1348 
 07-08 * < LOD < LOD < LOD < LOD 1212 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 589 
 05-06 * < LOD < LOD < LOD < LOD 656 
 07-08 * < LOD < LOD < LOD < LOD 486 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 601 
 05-06 * < LOD < LOD < LOD < LOD 719 
 07-08 * < LOD < LOD < LOD < LOD 524 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 980 
 05-06 * < LOD < LOD < LOD < LOD 993 
 07-08 * < LOD < LOD < LOD < LOD 1007 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, and 07-08 are 0.1, 0.1, and 0.1 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 2320 
 05-06 * < LOD < LOD < LOD < LOD 2570 
 07-08 * < LOD < LOD < LOD < LOD 2420 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD < LOD 296 
 05-06 * < LOD < LOD < LOD < LOD 341 
 07-08 * < LOD < LOD < LOD < LOD 363 
12-19 years 03-04 * < LOD < LOD < LOD < LOD 665 
 05-06 * < LOD < LOD < LOD < LOD 699 
 07-08 * < LOD < LOD < LOD < LOD 362 
20 years and older 03-04 * < LOD < LOD < LOD < LOD 1359 
 05-06 * < LOD < LOD < LOD < LOD 1530 
 07-08 * < LOD < LOD < LOD < LOD 1695 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 1130 
 05-06 * < LOD < LOD < LOD < LOD 1222 
 07-08 * < LOD < LOD < LOD < LOD 1209 
Females 03-04 * < LOD < LOD < LOD < LOD 1190 
 05-06 * < LOD < LOD < LOD < LOD 1348 
 07-08 * < LOD < LOD < LOD < LOD 1211 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 588 
 05-06 * < LOD < LOD < LOD < LOD 656 
 07-08 * < LOD < LOD < LOD < LOD 485 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 601 
 05-06 * < LOD < LOD < LOD < LOD 719 
 07-08 * < LOD < LOD < LOD < LOD 523 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 979 
 05-06 * < LOD < LOD < LOD < LOD 993 
 07-08 * < LOD < LOD < LOD < LOD 1007 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 2355 
 05-06 * < LOD < LOD < LOD < LOD 2634 
 07-08 * < LOD < LOD < LOD < LOD 2540 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD < LOD 290 
 05-06 * < LOD < LOD < LOD < LOD 350 
 07-08 * < LOD < LOD < LOD < LOD 379 
12-19 years 03-04 * < LOD < LOD < LOD < LOD 672 
 05-06 * < LOD < LOD < LOD < LOD 718 
 07-08 * < LOD < LOD < LOD < LOD 381 
20 years and older 03-04 * < LOD < LOD < LOD < LOD 1393 
 05-06 * < LOD < LOD < LOD < LOD 1566 
 07-08 * < LOD < LOD < LOD < LOD 1780 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 1150 
 05-06 * < LOD < LOD < LOD < LOD 1247 
 07-08 * < LOD < LOD < LOD < LOD 1269 
Females 03-04 * < LOD < LOD < LOD < LOD 1205 
 05-06 * < LOD < LOD < LOD < LOD 1387 
 07-08 * < LOD < LOD < LOD < LOD 1271 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 579 
 05-06 * < LOD < LOD < LOD < LOD 697 
 07-08 * < LOD < LOD < LOD < LOD 487 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 616 
 05-06 * < LOD < LOD < LOD < LOD 720 
 07-08 * < LOD < LOD < LOD < LOD 567 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 1018 
 05-06 * < LOD < LOD < LOD < LOD 1007 
 07-08 * < LOD < LOD < LOD < LOD 1076 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, and 07-08 are 0.06, 0.06, and 0.06 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 2353 
 05-06 * < LOD < LOD < LOD < LOD 2634 
 07-08 * < LOD < LOD < LOD < LOD 2538 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD < LOD 290 
 05-06 * < LOD < LOD < LOD < LOD 350 
 07-08 * < LOD < LOD < LOD < LOD 379 
12-19 years 03-04 * < LOD < LOD < LOD < LOD 671 
 05-06 * < LOD < LOD < LOD < LOD 718 
 07-08 * < LOD < LOD < LOD < LOD 379 
20 years and older 03-04 * < LOD < LOD < LOD < LOD 1392 
 05-06 * < LOD < LOD < LOD < LOD 1566 
 07-08 * < LOD < LOD < LOD < LOD 1780 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 1149 
 05-06 * < LOD < LOD < LOD < LOD 1247 
 07-08 * < LOD < LOD < LOD < LOD 1268 
Females 03-04 * < LOD < LOD < LOD < LOD 1204 
 05-06 * < LOD < LOD < LOD < LOD 1387 
 07-08 * < LOD < LOD < LOD < LOD 1270 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 578 
 05-06 * < LOD < LOD < LOD < LOD 697 
 07-08 * < LOD < LOD < LOD < LOD 486 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 616 
 05-06 * < LOD < LOD < LOD < LOD 720 
 07-08 * < LOD < LOD < LOD < LOD 566 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 1017 
 05-06 * < LOD < LOD < LOD < LOD 1007 
 07-08 * < LOD < LOD < LOD < LOD 1076 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 2250 
 05-06 * < LOD < LOD < LOD < LOD 2455 
 07-08 * < LOD < LOD < LOD < LOD 2422 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD < LOD 285 
 05-06 * < LOD < LOD < LOD < LOD 327 
 07-08 * < LOD < LOD < LOD < LOD 356 
12-19 years 03-04 * < LOD < LOD < LOD < LOD 627 
 05-06 * < LOD < LOD < LOD < LOD 665 
 07-08 * < LOD < LOD < LOD < LOD 376 
20 years and older 03-04 * < LOD < LOD < LOD < LOD 1338 
 05-06 * < LOD < LOD < LOD < LOD 1463 
 07-08 * < LOD < LOD < LOD < LOD 1690 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 1107 
 05-06 * < LOD < LOD < LOD < LOD 1160 
 07-08 * < LOD < LOD < LOD < LOD 1207 
Females 03-04 * < LOD < LOD < LOD < LOD 1143 
 05-06 * < LOD < LOD < LOD < LOD 1295 
 07-08 * < LOD < LOD < LOD < LOD 1215 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 574 
 05-06 * < LOD < LOD < LOD < LOD 667 
 07-08 * < LOD < LOD < LOD < LOD 456 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 556 
 05-06 * < LOD < LOD < LOD < LOD 661 
 07-08 * < LOD < LOD < LOD < LOD 549 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 975 
 05-06 * < LOD < LOD < LOD < LOD 938 
 07-08 * < LOD < LOD < LOD < LOD 1030 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, and 07-08 are 0.07, 0.07, and 0.07 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Primisulfuron-methyl (creatinine corrected) (2003 – 2008) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 2249 
 05-06 * < LOD < LOD < LOD < LOD 2455 
 07-08 * < LOD < LOD < LOD < LOD 2420 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD < LOD 285 
 05-06 * < LOD < LOD < LOD < LOD 327 
 07-08 * < LOD < LOD < LOD < LOD 356 
12-19 years 03-04 * < LOD < LOD < LOD < LOD 626 
 05-06 * < LOD < LOD < LOD < LOD 665 
 07-08 * < LOD < LOD < LOD < LOD 374 
20 years and older 03-04 * < LOD < LOD < LOD < LOD 1338 
 05-06 * < LOD < LOD < LOD < LOD 1463 
 07-08 * < LOD < LOD < LOD < LOD 1690 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 1107 
 05-06 * < LOD < LOD < LOD < LOD 1160 
 07-08 * < LOD < LOD < LOD < LOD 1206 
Females 03-04 * < LOD < LOD < LOD < LOD 1142 
 05-06 * < LOD < LOD < LOD < LOD 1295 
 07-08 * < LOD < LOD < LOD < LOD 1214 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 573 
 05-06 * < LOD < LOD < LOD < LOD 667 
 07-08 * < LOD < LOD < LOD < LOD 455 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 556 
 05-06 * < LOD < LOD < LOD < LOD 661 
 07-08 * < LOD < LOD < LOD < LOD 548 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 975 
 05-06 * < LOD < LOD < LOD < LOD 938 
 07-08 * < LOD < LOD < LOD < LOD 1030 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary Prosulfuron (2003 – 2008) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 2247 
 05-06 * < LOD < LOD < LOD < LOD 2461 
 07-08 * < LOD < LOD < LOD < LOD 2566 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD < LOD 284 
 05-06 * < LOD < LOD < LOD < LOD 326 
 07-08 * < LOD < LOD < LOD < LOD 380 
12-19 years 03-04 * < LOD < LOD < LOD < LOD 640 
 05-06 * < LOD < LOD < LOD < LOD 676 
 07-08 * < LOD < LOD < LOD < LOD 386 
20 years and older 03-04 * < LOD < LOD < LOD < LOD 1323 
 05-06 * < LOD < LOD < LOD < LOD 1459 
 07-08 * < LOD < LOD < LOD < LOD 1800 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 1100 
 05-06 * < LOD < LOD < LOD < LOD 1165 
 07-08 * < LOD < LOD < LOD < LOD 1285 
Females 03-04 * < LOD < LOD < LOD < LOD 1147 
 05-06 * < LOD < LOD < LOD < LOD 1296 
 07-08 * < LOD < LOD < LOD < LOD 1281 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 589 
 05-06 * < LOD < LOD < LOD < LOD 673 
 07-08 * < LOD < LOD < LOD < LOD 491 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 565 
 05-06 * < LOD < LOD < LOD < LOD 677 
 07-08 * < LOD < LOD < LOD < LOD 570 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 940 
 05-06 * < LOD < LOD < LOD < LOD 924 
 07-08 * < LOD < LOD < LOD < LOD 1081 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, and 07-08 are 0.05, 0.05, and 0.05 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Prosulfuron (creatinine corrected) (2003 – 2008) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 2245 
 05-06 * < LOD < LOD < LOD < LOD 2461 
 07-08 * < LOD < LOD < LOD < LOD 2564 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD < LOD 284 
 05-06 * < LOD < LOD < LOD < LOD 326 
 07-08 * < LOD < LOD < LOD < LOD 380 
12-19 years 03-04 * < LOD < LOD < LOD < LOD 639 
 05-06 * < LOD < LOD < LOD < LOD 676 
 07-08 * < LOD < LOD < LOD < LOD 384 
20 years and older 03-04 * < LOD < LOD < LOD < LOD 1322 
 05-06 * < LOD < LOD < LOD < LOD 1459 
 07-08 * < LOD < LOD < LOD < LOD 1800 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 1099 
 05-06 * < LOD < LOD < LOD < LOD 1165 
 07-08 * < LOD < LOD < LOD < LOD 1284 
Females 03-04 * < LOD < LOD < LOD < LOD 1146 
 05-06 * < LOD < LOD < LOD < LOD 1296 
 07-08 * < LOD < LOD < LOD < LOD 1280 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 588 
 05-06 * < LOD < LOD < LOD < LOD 673 
 07-08 * < LOD < LOD < LOD < LOD 490 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 565 
 05-06 * < LOD < LOD < LOD < LOD 677 
 07-08 * < LOD < LOD < LOD < LOD 569 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 939 
 05-06 * < LOD < LOD < LOD < LOD 924 
 07-08 * < LOD < LOD < LOD < LOD 1081 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary Rimsulfuron (2003 – 2008) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 2284 
 05-06 * < LOD < LOD < LOD < LOD 2593 
 07-08 * < LOD < LOD < LOD < LOD 2530 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD < LOD 279 
 05-06 * < LOD < LOD < LOD < LOD 346 
 07-08 * < LOD < LOD < LOD < LOD 376 
12-19 years 03-04 * < LOD < LOD < LOD < LOD 654 
 05-06 * < LOD < LOD < LOD < LOD 706 
 07-08 * < LOD < LOD < LOD < LOD 383 
20 years and older 03-04 * < LOD < LOD < LOD < LOD 1351 
 05-06 * < LOD < LOD < LOD < LOD 1541 
 07-08 * < LOD < LOD < LOD < LOD 1771 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 1110 
 05-06 * < LOD < LOD < LOD < LOD 1224 
 07-08 * < LOD < LOD < LOD < LOD 1271 
Females 03-04 * < LOD < LOD < LOD < LOD 1174 
 05-06 * < LOD < LOD < LOD < LOD 1369 
 07-08 * < LOD < LOD < LOD < LOD 1259 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 561 
 05-06 * < LOD < LOD < LOD < LOD 675 
 07-08 * < LOD < LOD < LOD < LOD 463 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 592 
 05-06 * < LOD < LOD < LOD < LOD 715 
 07-08 * < LOD < LOD < LOD < LOD 568 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 985 
 05-06 * < LOD < LOD < LOD < LOD 998 
 07-08 * < LOD < LOD < LOD < LOD 1080 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, and 07-08 are 0.05, 0.05, and 0.05 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Rimsulfuron (creatinine corrected) (2003 – 2008) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 2282 
 05-06 * < LOD < LOD < LOD < LOD 2593 
 07-08 * < LOD < LOD < LOD < LOD 2528 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD < LOD 279 
 05-06 * < LOD < LOD < LOD < LOD 346 
 07-08 * < LOD < LOD < LOD < LOD 376 
12-19 years 03-04 * < LOD < LOD < LOD < LOD 653 
 05-06 * < LOD < LOD < LOD < LOD 706 
 07-08 * < LOD < LOD < LOD < LOD 381 
20 years and older 03-04 * < LOD < LOD < LOD < LOD 1350 
 05-06 * < LOD < LOD < LOD < LOD 1541 
 07-08 * < LOD < LOD < LOD < LOD 1771 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 1109 
 05-06 * < LOD < LOD < LOD < LOD 1224 
 07-08 * < LOD < LOD < LOD < LOD 1270 
Females 03-04 * < LOD < LOD < LOD < LOD 1173 
 05-06 * < LOD < LOD < LOD < LOD 1369 
 07-08 * < LOD < LOD < LOD < LOD 1258 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 560 
 05-06 * < LOD < LOD < LOD < LOD 675 
 07-08 * < LOD < LOD < LOD < LOD 462 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 592 
 05-06 * < LOD < LOD < LOD < LOD 715 
 07-08 * < LOD < LOD < LOD < LOD 567 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 984 
 05-06 * < LOD < LOD < LOD < LOD 998 
 07-08 * < LOD < LOD < LOD < LOD 1080 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary Sulfometuron-methyl (2003 – 2008) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 2067 
 05-06 * < LOD < LOD < LOD < LOD 2598 
 07-08 * < LOD < LOD < LOD < LOD 2458 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD < LOD 252 
 05-06 * < LOD < LOD < LOD < LOD 345 
 07-08 * < LOD < LOD < LOD < LOD 352 
12-19 years 03-04 * < LOD < LOD < LOD < LOD 587 
 05-06 * < LOD < LOD < LOD < LOD 710 
 07-08 * < LOD < LOD < LOD < LOD 373 
20 years and older 03-04 * < LOD < LOD < LOD < LOD 1228 
 05-06 * < LOD < LOD < LOD < LOD 1543 
 07-08 * < LOD < LOD < LOD < LOD 1733 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 1007 
 05-06 * < LOD < LOD < LOD < LOD 1233 
 07-08 * < LOD < LOD < LOD < LOD 1226 
Females 03-04 * < LOD < LOD < LOD < LOD 1060 
 05-06 * < LOD < LOD < LOD < LOD 1365 
 07-08 * < LOD < LOD < LOD < LOD 1232 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 441 
 05-06 * < LOD < LOD < LOD < LOD 697 
 07-08 * < LOD < LOD < LOD < LOD 454 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 569 
 05-06 * < LOD < LOD < LOD < LOD 698 
 07-08 * < LOD < LOD < LOD < LOD 557 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 916 
 05-06 * < LOD < LOD < LOD < LOD 996 
 07-08 * < LOD < LOD < LOD < LOD 1045 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, and 07-08 are 0.05, 0.05, and 0.05 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Sulfometuron-methyl (creatinine corrected) (2003 – 2008) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 2065 
 05-06 * < LOD < LOD < LOD < LOD 2598 
 07-08 * < LOD < LOD < LOD < LOD 2456 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD < LOD 252 
 05-06 * < LOD < LOD < LOD < LOD 345 
 07-08 * < LOD < LOD < LOD < LOD 352 
12-19 years 03-04 * < LOD < LOD < LOD < LOD 586 
 05-06 * < LOD < LOD < LOD < LOD 710 
 07-08 * < LOD < LOD < LOD < LOD 371 
20 years and older 03-04 * < LOD < LOD < LOD < LOD 1227 
 05-06 * < LOD < LOD < LOD < LOD 1543 
 07-08 * < LOD < LOD < LOD < LOD 1733 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 1006 
 05-06 * < LOD < LOD < LOD < LOD 1233 
 07-08 * < LOD < LOD < LOD < LOD 1225 
Females 03-04 * < LOD < LOD < LOD < LOD 1059 
 05-06 * < LOD < LOD < LOD < LOD 1365 
 07-08 * < LOD < LOD < LOD < LOD 1231 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 440 
 05-06 * < LOD < LOD < LOD < LOD 697 
 07-08 * < LOD < LOD < LOD < LOD 453 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 569 
 05-06 * < LOD < LOD < LOD < LOD 698 
 07-08 * < LOD < LOD < LOD < LOD 556 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 915 
 05-06 * < LOD < LOD < LOD < LOD 996 
 07-08 * < LOD < LOD < LOD < LOD 1045 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary Sulfosulfuron (2003 – 2008) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 2391 
 05-06 * < LOD < LOD < LOD < LOD 2593 
 07-08 * < LOD < LOD < LOD < LOD 2530 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD < LOD 294 
 05-06 * < LOD < LOD < LOD < LOD 344 
 07-08 * < LOD < LOD < LOD < LOD 377 
12-19 years 03-04 * < LOD < LOD < LOD < LOD 681 
 05-06 * < LOD < LOD < LOD < LOD 708 
 07-08 * < LOD < LOD < LOD < LOD 385 
20 years and older 03-04 * < LOD < LOD < LOD < LOD 1416 
 05-06 * < LOD < LOD < LOD < LOD 1541 
 07-08 * < LOD < LOD < LOD < LOD 1768 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 1170 
 05-06 * < LOD < LOD < LOD < LOD 1230 
 07-08 * < LOD < LOD < LOD < LOD 1261 
Females 03-04 * < LOD < LOD < LOD < LOD 1221 
 05-06 * < LOD < LOD < LOD < LOD 1363 
 07-08 * < LOD < LOD < LOD < LOD 1269 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 594 
 05-06 * < LOD < LOD < LOD < LOD 673 
 07-08 * < LOD < LOD < LOD < LOD 485 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 617 
 05-06 * < LOD < LOD < LOD < LOD 719 
 07-08 * < LOD < LOD < LOD < LOD 565 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 1026 
 05-06 * < LOD < LOD < LOD < LOD 997 
 07-08 * < LOD < LOD < LOD < LOD 1068 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, and 07-08 are 0.1, 0.1, and 0.1 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 2389 
 05-06 * < LOD < LOD < LOD < LOD 2593 
 07-08 * < LOD < LOD < LOD < LOD 2528 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD < LOD 294 
 05-06 * < LOD < LOD < LOD < LOD 344 
 07-08 * < LOD < LOD < LOD < LOD 377 
12-19 years 03-04 * < LOD < LOD < LOD < LOD 680 
 05-06 * < LOD < LOD < LOD < LOD 708 
 07-08 * < LOD < LOD < LOD < LOD 383 
20 years and older 03-04 * < LOD < LOD < LOD < LOD 1415 
 05-06 * < LOD < LOD < LOD < LOD 1541 
 07-08 * < LOD < LOD < LOD < LOD 1768 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 1169 
 05-06 * < LOD < LOD < LOD < LOD 1230 
 07-08 * < LOD < LOD < LOD < LOD 1260 
Females 03-04 * < LOD < LOD < LOD < LOD 1220 
 05-06 * < LOD < LOD < LOD < LOD 1363 
 07-08 * < LOD < LOD < LOD < LOD 1268 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 593 
 05-06 * < LOD < LOD < LOD < LOD 673 
 07-08 * < LOD < LOD < LOD < LOD 484 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 617 
 05-06 * < LOD < LOD < LOD < LOD 719 
 07-08 * < LOD < LOD < LOD < LOD 564 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 1025 
 05-06 * < LOD < LOD < LOD < LOD 997 
 07-08 * < LOD < LOD < LOD < LOD 1068 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary Thifensulfuron-methyl (2003 – 2008) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 2355 
 05-06 * < LOD < LOD < LOD < LOD 2634 
 07-08 * < LOD < LOD < LOD < LOD 2495 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD < LOD 291 
 05-06 * < LOD < LOD < LOD < LOD 350 
 07-08 * < LOD < LOD < LOD < LOD 370 
12-19 years 03-04 * < LOD < LOD < LOD < LOD 677 
 05-06 * < LOD < LOD < LOD < LOD 718 
 07-08 * < LOD < LOD < LOD < LOD 375 
20 years and older 03-04 * < LOD < LOD < LOD < LOD 1387 
 05-06 * < LOD < LOD < LOD < LOD 1566 
 07-08 * < LOD < LOD < LOD < LOD 1750 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 1145 
 05-06 * < LOD < LOD < LOD < LOD 1247 
 07-08 * < LOD < LOD < LOD < LOD 1252 
Females 03-04 * < LOD < LOD < LOD < LOD 1210 
 05-06 * < LOD < LOD < LOD < LOD 1387 
 07-08 * < LOD < LOD < LOD < LOD 1243 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 566 
 05-06 * < LOD < LOD < LOD < LOD 697 
 07-08 * < LOD < LOD < LOD < LOD 479 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 616 
 05-06 * < LOD < LOD < LOD < LOD 720 
 07-08 * < LOD < LOD < LOD < LOD 542 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 1022 
 05-06 * < LOD < LOD < LOD < LOD 1007 
 07-08 * < LOD < LOD < LOD < LOD 1056 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, and 07-08 are 0.08, 0.08, and 0.08 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Thifensulfuron-methyl (creatinine corrected) (2003 – 2008) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 2353 
 05-06 * < LOD < LOD < LOD < LOD 2634 
 07-08 * < LOD < LOD < LOD < LOD 2493 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD < LOD 291 
 05-06 * < LOD < LOD < LOD < LOD 350 
 07-08 * < LOD < LOD < LOD < LOD 370 
12-19 years 03-04 * < LOD < LOD < LOD < LOD 676 
 05-06 * < LOD < LOD < LOD < LOD 718 
 07-08 * < LOD < LOD < LOD < LOD 373 
20 years and older 03-04 * < LOD < LOD < LOD < LOD 1386 
 05-06 * < LOD < LOD < LOD < LOD 1566 
 07-08 * < LOD < LOD < LOD < LOD 1750 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 1144 
 05-06 * < LOD < LOD < LOD < LOD 1247 
 07-08 * < LOD < LOD < LOD < LOD 1251 
Females 03-04 * < LOD < LOD < LOD < LOD 1209 
 05-06 * < LOD < LOD < LOD < LOD 1387 
 07-08 * < LOD < LOD < LOD < LOD 1242 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 565 
 05-06 * < LOD < LOD < LOD < LOD 697 
 07-08 * < LOD < LOD < LOD < LOD 478 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 616 
 05-06 * < LOD < LOD < LOD < LOD 720 
 07-08 * < LOD < LOD < LOD < LOD 541 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 1021 
 05-06 * < LOD < LOD < LOD < LOD 1007 
 07-08 * < LOD < LOD < LOD < LOD 1056 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary Triasulfuron (2003 – 2008) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 2250 
 05-06 * < LOD < LOD < LOD < LOD 2557 
 07-08 * < LOD < LOD < LOD < LOD 2530 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD < LOD 278 
 05-06 * < LOD < LOD < LOD < LOD 341 
 07-08 * < LOD < LOD < LOD < LOD 378 
12-19 years 03-04 * < LOD < LOD < LOD < LOD 643 
 05-06 * < LOD < LOD < LOD < LOD 695 
 07-08 * < LOD < LOD < LOD < LOD 385 
20 years and older 03-04 * < LOD < LOD < LOD < LOD 1329 
 05-06 * < LOD < LOD < LOD < LOD 1521 
 07-08 * < LOD < LOD < LOD < LOD 1767 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 1101 
 05-06 * < LOD < LOD < LOD < LOD 1210 
 07-08 * < LOD < LOD < LOD < LOD 1265 
Females 03-04 * < LOD < LOD < LOD < LOD 1149 
 05-06 * < LOD < LOD < LOD < LOD 1347 
 07-08 * < LOD < LOD < LOD < LOD 1265 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 549 
 05-06 * < LOD < LOD < LOD < LOD 677 
 07-08 * < LOD < LOD < LOD < LOD 488 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 580 
 05-06 * < LOD < LOD < LOD < LOD 713 
 07-08 * < LOD < LOD < LOD < LOD 547 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 973 
 05-06 * < LOD < LOD < LOD < LOD 968 
 07-08 * < LOD < LOD < LOD < LOD 1073 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, and 07-08 are 0.07, 0.07, and 0.07 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Triasulfuron (creatinine corrected) (2003 – 2008) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 2248 
 05-06 * < LOD < LOD < LOD < LOD 2557 
 07-08 * < LOD < LOD < LOD < LOD 2528 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD < LOD 278 
 05-06 * < LOD < LOD < LOD < LOD 341 
 07-08 * < LOD < LOD < LOD < LOD 378 
12-19 years 03-04 * < LOD < LOD < LOD < LOD 642 
 05-06 * < LOD < LOD < LOD < LOD 695 
 07-08 * < LOD < LOD < LOD < LOD 383 
20 years and older 03-04 * < LOD < LOD < LOD < LOD 1328 
 05-06 * < LOD < LOD < LOD < LOD 1521 
 07-08 * < LOD < LOD < LOD < LOD 1767 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 1100 
 05-06 * < LOD < LOD < LOD < LOD 1210 
 07-08 * < LOD < LOD < LOD < LOD 1264 
Females 03-04 * < LOD < LOD < LOD < LOD 1148 
 05-06 * < LOD < LOD < LOD < LOD 1347 
 07-08 * < LOD < LOD < LOD < LOD 1264 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 548 
 05-06 * < LOD < LOD < LOD < LOD 677 
 07-08 * < LOD < LOD < LOD < LOD 487 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 580 
 05-06 * < LOD < LOD < LOD < LOD 713 
 07-08 * < LOD < LOD < LOD < LOD 546 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 972 
 05-06 * < LOD < LOD < LOD < LOD 968 
 07-08 * < LOD < LOD < LOD < LOD 1073 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary Triflusulfuron-methyl (2003 – 2008) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 2427 
 05-06 * < LOD < LOD < LOD < LOD 2562 
 07-08 * < LOD < LOD < LOD < LOD 2494 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD < LOD 302 
 05-06 * < LOD < LOD < LOD < LOD 340 
 07-08 * < LOD < LOD < LOD < LOD 374 
12-19 years 03-04 * < LOD < LOD < LOD < LOD 694 
 05-06 * < LOD < LOD < LOD < LOD 702 
 07-08 * < LOD < LOD < LOD < LOD 381 
20 years and older 03-04 * < LOD < LOD < LOD < LOD 1431 
 05-06 * < LOD < LOD < LOD < LOD 1520 
 07-08 * < LOD < LOD < LOD < LOD 1739 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 1189 
 05-06 * < LOD < LOD < LOD < LOD 1216 
 07-08 * < LOD < LOD < LOD < LOD 1240 
Females 03-04 * < LOD < LOD < LOD < LOD 1238 
 05-06 * < LOD < LOD < LOD < LOD 1346 
 07-08 * < LOD < LOD < LOD < LOD 1254 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 596 
 05-06 * < LOD < LOD < LOD < LOD 693 
 07-08 * < LOD < LOD < LOD < LOD 477 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 634 
 05-06 * < LOD < LOD < LOD < LOD 699 
 07-08 * < LOD < LOD < LOD < LOD 558 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 1039 
 05-06 * < LOD < LOD < LOD < LOD 972 
 07-08 * < LOD < LOD < LOD < LOD 1053 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, and 07-08 are 0.05, 0.05, and 0.05 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Triflusulfuron-methyl (creatinine corrected) (2003 -2008) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 2425 
 05-06 * < LOD < LOD < LOD < LOD 2562 
 07-08 * < LOD < LOD < LOD < LOD 2492 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD < LOD 302 
 05-06 * < LOD < LOD < LOD < LOD 340 
 07-08 * < LOD < LOD < LOD < LOD 374 
12-19 years 03-04 * < LOD < LOD < LOD < LOD 693 
 05-06 * < LOD < LOD < LOD < LOD 702 
 07-08 * < LOD < LOD < LOD < LOD 379 
20 years and older 03-04 * < LOD < LOD < LOD < LOD 1430 
 05-06 * < LOD < LOD < LOD < LOD 1520 
 07-08 * < LOD < LOD < LOD < LOD 1739 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 1188 
 05-06 * < LOD < LOD < LOD < LOD 1216 
 07-08 * < LOD < LOD < LOD < LOD 1239 
Females 03-04 * < LOD < LOD < LOD < LOD 1237 
 05-06 * < LOD < LOD < LOD < LOD 1346 
 07-08 * < LOD < LOD < LOD < LOD 1253 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 595 
 05-06 * < LOD < LOD < LOD < LOD 693 
 07-08 * < LOD < LOD < LOD < LOD 476 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 634 
 05-06 * < LOD < LOD < LOD < LOD 699 
 07-08 * < LOD < LOD < LOD < LOD 557 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 1038 
 05-06 * < LOD < LOD < LOD < LOD 972 
 07-08 * < LOD < LOD < LOD < LOD 1053 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary N,N-diethyl-meta-toluamide (DEET) (2007 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 07-08 * < LOD < LOD < LOD < LOD 2565 
 09-10 * < LOD < LOD < LOD < LOD 2744 
Age group        
6-11 years 07-08 * < LOD < LOD < LOD < LOD 380 
 09-10 * < LOD < LOD < LOD < LOD 386 
12-19 years 07-08 * < LOD < LOD < LOD < LOD 386 
 09-10 * < LOD < LOD < LOD < LOD 400 
20-59 years 07-08 * < LOD < LOD < LOD < LOD 1169 
 09-10 * < LOD < LOD < LOD < LOD 1307 
60 years and older 07-08 * < LOD < LOD < LOD < LOD 630 
 09-10 * < LOD < LOD < LOD < LOD 651 
Gender        
Males 07-08 * < LOD < LOD < LOD < LOD 1286 
 09-10 * < LOD < LOD < LOD < LOD 1343 
Females 07-08 * < LOD < LOD < LOD < LOD 1279 
 09-10 * < LOD < LOD < LOD < LOD 1401 
Race/ethnicity        
Mexican Americans 07-08 * < LOD < LOD < LOD < LOD 499 
 09-10 * < LOD < LOD < LOD < LOD 600 
Non-Hispanic blacks 07-08 * < LOD < LOD < LOD < LOD 570 
 09-10 * < LOD < LOD < LOD < LOD 504 
Non-Hispanic whites 07-08 * < LOD < LOD < LOD < LOD 1071 
 09-10 * < LOD < LOD < LOD < LOD 1199 
Limit of detection (LOD, see Data Analysis section) for Survey year 07-08 and 09-10 are 0.089 and 0.089. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary N,N-diethyl-meta-toluamide (DEET) (creatinine corrected) (2007 – 2010)  
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 07-08 * < LOD < LOD < LOD < LOD 2563 
 09-10 * < LOD < LOD < LOD < LOD 2744 
Age group        
6-11 years 07-08 * < LOD < LOD < LOD < LOD 380 
 09-10 * < LOD < LOD < LOD < LOD 386 
12-19 years 07-08 * < LOD < LOD < LOD < LOD 384 
 09-10 * < LOD < LOD < LOD < LOD 400 
20-59 years 07-08 * < LOD < LOD < LOD < LOD 1169 
 09-10 * < LOD < LOD < LOD < LOD 1307 
60 years and older 07-08 * < LOD < LOD < LOD < LOD 630 
 09-10 * < LOD < LOD < LOD < LOD 651 
Gender        
Males 07-08 * < LOD < LOD < LOD < LOD 1285 
 09-10 * < LOD < LOD < LOD < LOD 1343 
Females 07-08 * < LOD < LOD < LOD < LOD 1278 
 09-10 * < LOD < LOD < LOD < LOD 1401 
Race/ethnicity        
Mexican Americans 07-08 * < LOD < LOD < LOD < LOD 498 
 09-10 * < LOD < LOD < LOD < LOD 600 
Non-Hispanic blacks 07-08 * < LOD < LOD < LOD < LOD 569 
 09-10 * < LOD < LOD < LOD < LOD 504 
Non-Hispanic whites 07-08 * < LOD < LOD < LOD < LOD 1071 
 09-10 * < LOD < LOD < LOD < LOD 1199 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary 3-(Diethylcarbamoyl) benzoic acid (DCBA) (2007 - 2010) 
Metabolite of DEET 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 07-08 3.50 (2.64-4.64) 2.37 (1.88-3.10) 9.14 (5.61-14.5) 33.9 (20.5-53.1) 79.2 (37.9-145) 2538 
 09-10 4.54 (3.35-6.15) 3.40 (2.31-4.95) 13.8 (8.63-20.6) 51.9 (31.1-108) 165 (57.8-464) 2735 
Age group        
6-11 years 07-08 4.44 (3.73-5.29) 3.44 (2.70-5.87) 12.7 (9.54-15.9) 42.0 (24.2-70.4) 79.7 (44.9-114) 378 
 09-10 6.44 (3.72-11.1) 5.35 (2.58-8.86) 18.5 (8.15-37.9) 83.8 (28.4-439) 316 (41.2-3970) 385 
12-19 years 07-08 5.26 (3.47-7.98) 4.37 (2.68-5.98) 13.1 (6.81-25.8) 35.4 (20.4-71.2) 71.2 (30.7-700) 380 
 09-10 6.58 (4.49-9.66) 4.63 (2.82-8.64) 18.9 (10.7-33.6) 87.8 (32.9-186) 186 (31.1-1130) 398 
20-59 years 07-08 3.33 (2.56-4.35) 2.23 (1.83-2.90) 7.95 (5.05-14.5) 30.8 (17.4-53.1) 75.6 (39.3-131) 1157 
 09-10 4.39 (3.29-5.86) 3.33 (2.23-4.95) 14.0 (8.36-20.9) 51.4 (32.6-95.8) 138 (52.9-280) 1300 
60 years and older 07-08 2.78 (1.75-4.42) 1.64 (.936-3.06) 6.15 (3.08-16.9) 34.7 (16.3-75.4) 103 (32.4-200) 623 
 09-10 3.42 (2.39-4.91) 2.13 (1.45-4.00) 9.63 (5.33-17.1) 35.4 (19.7-63.8) 103 (43.2-346) 652 
Gender        
Males 07-08 4.15 (2.88-6.00) 2.90 (2.13-4.34) 11.3 (6.63-19.7) 37.7 (20.7-82.0) 112 (34.7-556) 1269 
 09-10 5.58 (3.94-7.90) 4.39 (2.67-6.24) 18.7 (10.8-30.6) 78.3 (37.3-174) 199 (96.2-525) 1340 
Females 07-08 2.97 (2.32-3.80) 2.06 (1.64-2.59) 6.84 (4.41-10.8) 30.8 (15.0-40.8) 52.6 (36.4-103) 1269 
 09-10 3.73 (2.79-4.98) 2.76 (1.87-4.24) 9.91 (6.35-15.9) 36.2 (22.4-70.4) 94.9 (40.2-278) 1395 
Race/ethnicity        
Mexican Americans 07-08 3.70 (2.57-5.33) 3.26 (1.87-5.17) 9.63 (5.93-17.6) 28.0 (14.7-69.1) 69.1 (27.5-133) 490 
 09-10 2.63 (1.61-4.28) 2.03 (.932-4.71) 7.35 (4.22-14.5) 23.1 (12.5-48.2) 48.9 (26.0-94.3) 599 
Non-Hispanic blacks 07-08 4.36 (3.18-5.96) 3.54 (2.24-6.04) 10.3 (6.78-17.4) 31.9 (19.3-51.6) 62.4 (40.4-103) 562 
 09-10 3.91 (2.85-5.35) 3.22 (2.24-4.75) 9.53 (5.88-14.4) 23.4 (18.0-33.4) 38.4 (29.1-60.5) 497 
Non-Hispanic whites 07-08 3.47 (2.35-5.14) 2.22 (1.65-3.19) 9.12 (4.82-17.0) 36.5 (17.7-82.0) 86.9 (32.9-356) 1064 
 09-10 5.48 (3.83-7.84) 4.31 (2.64-6.25) 17.7 (10.5-28.4) 67.9 (32.6-195) 200 (63.8-832) 1199 
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Urinary 3-(Diethylcarbamoyl) benzoic acid (DCBA) (creatinine corrected) (2007 - 2010) 
Metabolite of DEET 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 07-08 3.60 (2.79-4.65) 2.79 (2.14-3.55) 8.55 (5.49-13.2) 27.3 (17.8-47.9) 70.8 (34.1-170) 2537 
 09-10 4.74 (3.48-6.46) 3.35 (2.30-5.26) 12.9 (8.53-20.6) 44.6 (28.3-86.3) 131 (47.0-405) 2735 
Age group        
6-11 years 07-08 5.64 (4.72-6.75) 4.84 (3.65-5.78) 14.2 (10.7-19.8) 47.7 (34.2-55.1) 88.6 (47.9-182) 378 
 09-10 8.72 (5.03-15.1) 6.42 (4.02-11.6) 23.5 (13.2-36.7) 75.4 (28.6-673) 365 (46.2-4980) 385 
12-19 years 07-08 4.08 (2.81-5.93) 2.96 (2.14-5.36) 11.0 (6.38-16.0) 24.3 (14.8-53.4) 53.4 (19.3-345) 379 
 09-10 5.65 (3.76-8.50) 3.76 (2.56-6.22) 16.5 (7.29-31.7) 68.6 (25.3-182) 154 (25.3-1270) 398 
20-59 years 07-08 3.34 (2.61-4.27) 2.73 (1.99-3.46) 7.57 (4.92-12.1) 24.8 (14.9-44.7) 57.8 (30.9-117) 1157 
 09-10 4.41 (3.25-5.97) 2.98 (2.11-5.32) 11.7 (7.71-19.6) 39.1 (24.7-82.6) 112 (51.3-228) 1300 
60 years and older 07-08 3.42 (2.33-5.02) 2.47 (1.45-3.64) 7.33 (4.25-16.8) 33.8 (15.9-86.0) 93.3 (34.2-244) 623 
 09-10 4.06 (2.95-5.59) 2.68 (2.10-3.96) 10.8 (6.79-15.9) 37.7 (22.2-51.1) 108 (42.7-393) 652 
Gender        
Males 07-08 3.46 (2.46-4.87) 2.72 (1.76-3.73) 8.68 (5.34-14.4) 27.8 (16.9-69.4) 87.0 (27.8-403) 1269 
 09-10 4.97 (3.49-7.08) 3.29 (2.14-5.94) 14.7 (9.13-24.0) 60.0 (28.5-134) 185 (74.8-433) 1340 
Females 07-08 3.74 (2.99-4.68) 2.88 (2.27-3.63) 8.55 (5.36-13.2) 27.2 (16.2-46.3) 54.8 (34.2-117) 1268 
 09-10 4.54 (3.40-6.05) 3.35 (2.39-4.67) 11.8 (7.55-18.4) 35.3 (24.2-53.4) 77.6 (36.7-252) 1395 
Race/ethnicity        
Mexican Americans 07-08 3.79 (2.57-5.58) 3.60 (1.99-5.96) 9.91 (6.55-16.9) 27.8 (15.0-60.6) 60.6 (24.4-107) 490 
 09-10 2.74 (1.75-4.28) 2.03 (1.12-5.18) 7.57 (3.92-14.0) 23.3 (13.6-31.8) 37.4 (23.6-90.5) 599 
Non-Hispanic blacks 07-08 3.33 (2.46-4.49) 2.74 (1.91-3.76) 7.07 (4.88-11.9) 22.5 (12.6-45.1) 53.9 (28.7-103) 561 
 09-10 2.98 (2.26-3.94) 2.41 (1.70-3.37) 6.73 (4.34-9.46) 16.5 (13.0-20.4) 30.6 (19.4-51.1) 497 
Non-Hispanic whites 07-08 3.78 (2.69-5.32) 2.82 (2.05-4.02) 8.70 (5.23-14.9) 30.7 (16.7-57.2) 76.9 (26.7-432) 1064 
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Urinary N,N-Diethyl-3-(hydroxymethyl) benzamide (DHMB) (2007 - 2010) 
Metabolite of DEET 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 07-08 * < LOD < LOD .229 (<LOD-.525) .780 (.326-1.51) 2562 
 09-10 * < LOD < LOD .455 (.162-.956) 1.34 (.644-3.10) 2736 
Age group        
6-11 years 07-08 * < LOD < LOD .275 (.168-.433) .640 (.264-2.64) 380 
 09-10 * < LOD < LOD .655 (<LOD-2.93) 2.82 (.205-24.6) 385 
12-19 years 07-08 * < LOD < LOD .356 (<LOD-.879) .665 (.165-8.14) 386 
 09-10 * < LOD < LOD .472 (<LOD-1.59) 1.20 (.201-4.11) 398 
20-59 years 07-08 * < LOD < LOD .188 (<LOD-.413) .767 (.335-1.30) 1167 
 09-10 * < LOD < LOD .498 (.172-.956) 1.34 (.729-2.29) 1304 
60 years and older 07-08 * < LOD < LOD .256 (<LOD-.787) .787 (.194-1.81) 629 
 09-10 * < LOD < LOD .257 (.106-.512) .840 (.521-2.46) 649 
Gender        
Males 07-08 * < LOD < LOD .325 (.091-.909) 1.05 (.249-4.86) 1283 
 09-10 * < LOD < LOD .744 (.323-1.43) 1.81 (.946-3.94) 1339 
Females 07-08 * < LOD < LOD .165 (<LOD-.326) .512 (.256-.968) 1279 
 09-10 * < LOD < LOD .220 (<LOD-.521) .796 (.329-2.05) 1397 
Race/ethnicity        
Mexican Americans 07-08 * < LOD < LOD .216 (.092-.509) .509 (.207-.989) 499 
 09-10 * < LOD < LOD .228 (<LOD-.504) .507 (.223-.866) 598 
Non-Hispanic blacks 07-08 * < LOD < LOD .310 (.091-.470) .640 (.378-1.29) 567 
 09-10 * < LOD < LOD .135 (<LOD-.292) .449 (.212-.884) 503 
Non-Hispanic whites 07-08 * < LOD < LOD .255 (<LOD-.861) .884 (.225-4.84) 1071 
 09-10 * < LOD < LOD .644 (.182-1.34) 1.89 (.770-5.34) 1195 
Limit of detection (LOD, see Data Analysis section) for Survey year 07-08 and 09-10 are 0.083 and 0.083. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary N,N-Diethyl-3-(hydroxymethyl) benzamide (DHMB) (creatinine corrected) (2007 - 2010) 
Metabolite of DEET 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 07-08 * < LOD < LOD .331 (<LOD-.452) .628 (.393-1.32) 2560 
 09-10 * < LOD < LOD .449 (.300-.720) 1.13 (.548-2.41) 2736 
Age group        
6-11 years 07-08 * < LOD < LOD .370 (.289-.524) .831 (.347-1.37) 380 
 09-10 * < LOD < LOD .572 (<LOD-3.40) 3.12 (.370-18.4) 385 
12-19 years 07-08 * < LOD < LOD .253 (<LOD-.555) .544 (.191-1.76) 384 
 09-10 * < LOD < LOD .436 (<LOD-.869) .869 (.246-8.42) 398 
20-59 years 07-08 * < LOD < LOD .331 (<LOD-.441) .582 (.441-.866) 1167 
 09-10 * < LOD < LOD .468 (.300-.702) 1.10 (.572-1.79) 1304 
60 years and older 07-08 * < LOD < LOD .394 (<LOD-.701) 1.01 (.389-2.48) 629 
 09-10 * < LOD < LOD .395 (.315-.489) .875 (.548-2.41) 649 
Gender        
Males 07-08 * < LOD < LOD .300 (.176-.826) .866 (.304-3.33) 1282 
 09-10 * < LOD < LOD .524 (.280-1.39) 1.45 (.718-3.16) 1339 
Females 07-08 * < LOD < LOD .341 (<LOD-.393) .572 (.419-.734) 1278 
 09-10 * < LOD < LOD .419 (<LOD-.488) .723 (.458-1.85) 1397 
Race/ethnicity        
Mexican Americans 07-08 * < LOD < LOD .315 (.203-.446) .467 (.337-.720) 498 
 09-10 * < LOD < LOD .297 (<LOD-.401) .415 (.299-.718) 598 
Non-Hispanic blacks 07-08 * < LOD < LOD .234 (.175-.411) .487 (.315-1.05) 566 
 09-10 * < LOD < LOD .221 (<LOD-.262) .362 (.246-.648) 503 
Non-Hispanic whites 07-08 * < LOD < LOD .343 (<LOD-.583) .826 (.349-2.99) 1071 
 09-10 * < LOD < LOD .531 (.305-1.36) 1.59 (.524-5.83) 1195 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary Carbofuranphenol (1999 - 2004) 
Metabolite of Benfuracarb, Carbofuran, Carbosulfan, and Furathiocar 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 * < LOD < LOD < LOD .770 (<LOD-1.30) 1994 
 01-02 * < LOD < LOD < LOD < LOD 3030 
 03-04 * < LOD < LOD < LOD < LOD 2390 
Age group        
6-11 years 99-00 * < LOD < LOD < LOD .450 (<LOD-2.20) 482 
 01-02 * < LOD < LOD < LOD < LOD 578 
 03-04 * < LOD < LOD < LOD < LOD 293 
12-19 years 99-00 * < LOD < LOD < LOD .570 (<LOD-1.20) 681 
 01-02 * < LOD < LOD < LOD < LOD 827 
 03-04 * < LOD < LOD < LOD < LOD 684 
20-59 years 99-00 * < LOD < LOD < LOD .840 (<LOD-1.50) 831 
 01-02 * < LOD < LOD < LOD < LOD 1125 
 03-04 * < LOD < LOD < LOD < LOD 902 
60 years and older 01-02 * < LOD < LOD < LOD < LOD 500 
 03-04 * < LOD < LOD < LOD < LOD 511 
Gender        
Males 99-00 * < LOD < LOD < LOD .740 (<LOD-1.50) 973 
 01-02 * < LOD < LOD < LOD < LOD 1423 
 03-04 * < LOD < LOD < LOD < LOD 1164 
Females 99-00 * < LOD < LOD < LOD .840 (<LOD-1.50) 1021 
 01-02 * < LOD < LOD < LOD < LOD 1607 
 03-04 * < LOD < LOD < LOD < LOD 1226 
Race/ethnicity        
Mexican Americans 99-00 * < LOD < LOD .590 (<LOD-2.00) 1.90 (<LOD-5.10) 696 
 01-02 * < LOD < LOD < LOD < LOD 765 
 03-04 * < LOD < LOD < LOD < LOD 568 
Non-Hispanic blacks 99-00 * < LOD < LOD < LOD .550 (<LOD-1.60) 521 
 01-02 * < LOD < LOD < LOD < LOD 770 
 03-04 * < LOD < LOD < LOD < LOD 613 
Non-Hispanic whites 99-00 * < LOD < LOD < LOD .740 (<LOD-1.50) 603 
 01-02 * < LOD < LOD < LOD < LOD 1272 
 03-04 * < LOD < LOD < LOD < LOD 1054 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, and 03-04 are 0.4, 0.4, and 0.4 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Carbofuranphenol (creatinine corrected) (1999 - 2004) 
Metabolite of Benfuracarb, Carbofuran, Carbosulfan, and Furathiocar 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 * < LOD < LOD < LOD .778 (<LOD-1.00) 1994 
 01-02 * < LOD < LOD < LOD < LOD 3029 
 03-04 * < LOD < LOD < LOD < LOD 2388 
Age group        
6-11 years 99-00 * < LOD < LOD < LOD .988 (<LOD-2.80) 482 
 01-02 * < LOD < LOD < LOD < LOD 578 
 03-04 * < LOD < LOD < LOD < LOD 293 
12-19 years 99-00 * < LOD < LOD < LOD .482 (<LOD-.853) 681 
 01-02 * < LOD < LOD < LOD < LOD 826 
 03-04 * < LOD < LOD < LOD < LOD 683 
20-59 years 99-00 * < LOD < LOD < LOD .875 (<LOD-1.06) 831 
 01-02 * < LOD < LOD < LOD < LOD 1125 
 03-04 * < LOD < LOD < LOD < LOD 901 
60 years and older 01-02 * < LOD < LOD < LOD < LOD 500 
 03-04 * < LOD < LOD < LOD < LOD 511 
Gender        
Males 99-00 * < LOD < LOD < LOD .667 (<LOD-1.08) 973 
 01-02 * < LOD < LOD < LOD < LOD 1423 
 03-04 * < LOD < LOD < LOD < LOD 1163 
Females 99-00 * < LOD < LOD < LOD .881 (<LOD-1.13) 1021 
 01-02 * < LOD < LOD < LOD < LOD 1606 
 03-04 * < LOD < LOD < LOD < LOD 1225 
Race/ethnicity        
Mexican Americans 99-00 * < LOD < LOD .778 (<LOD-1.94) 1.83 (<LOD-4.16) 696 
 01-02 * < LOD < LOD < LOD < LOD 765 
 03-04 * < LOD < LOD < LOD < LOD 567 
Non-Hispanic blacks 99-00 * < LOD < LOD < LOD .700 (<LOD-1.08) 521 
 01-02 * < LOD < LOD < LOD < LOD 769 
 03-04 * < LOD < LOD < LOD < LOD 613 
Non-Hispanic whites 99-00 * < LOD < LOD < LOD .737 (<LOD-.929) 603 
 01-02 * < LOD < LOD < LOD < LOD 1272 
 03-04 * < LOD < LOD < LOD < LOD 1053 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary 2-Isopropoxyphenol (1999 - 2004) 
Metabolite of Propoxur 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 * < LOD < LOD < LOD < LOD 1917 
 01-02 * < LOD < LOD < LOD < LOD 2994 
 03-04 * < LOD < LOD < LOD < LOD 2387 
Age group        
6-11 years 99-00 * < LOD < LOD < LOD < LOD 456 
 01-02 * < LOD < LOD < LOD < LOD 574 
 03-04 * < LOD < LOD < LOD < LOD 295 
12-19 years 99-00 * < LOD < LOD < LOD < LOD 655 
 01-02 * < LOD < LOD < LOD < LOD 820 
 03-04 * < LOD < LOD < LOD < LOD 686 
20-59 years 99-00 * < LOD < LOD < LOD < LOD 806 
 01-02 * < LOD < LOD < LOD < LOD 1109 
 03-04 * < LOD < LOD < LOD < LOD 900 
60 years and older 01-02 * < LOD < LOD < LOD < LOD 491 
 03-04 * < LOD < LOD < LOD < LOD 506 
Gender        
Males 99-00 * < LOD < LOD < LOD < LOD 936 
 01-02 * < LOD < LOD < LOD < LOD 1406 
 03-04 * < LOD < LOD < LOD < LOD 1161 
Females 99-00 * < LOD < LOD < LOD < LOD 981 
 01-02 * < LOD < LOD < LOD < LOD 1588 
 03-04 * < LOD < LOD < LOD < LOD 1226 
Race/ethnicity        
Mexican Americans 99-00 * < LOD < LOD < LOD < LOD 664 
 01-02 * < LOD < LOD < LOD < LOD 762 
 03-04 * < LOD < LOD < LOD < LOD 594 
Non-Hispanic blacks 99-00 * < LOD < LOD < LOD < LOD 500 
 01-02 * < LOD < LOD < LOD < LOD 770 
 03-04 * < LOD < LOD < LOD < LOD 601 
Non-Hispanic whites 99-00 * < LOD < LOD < LOD < LOD 585 
 01-02 * < LOD < LOD < LOD < LOD 1241 
 03-04 * < LOD < LOD < LOD < LOD 1041 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, and 03-04 are 1.1, 0.4, and 0.4 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary 2-Isopropoxyphenol (creatinine corrected) (1999 - 2004) 
Metabolite of Propoxur 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 * < LOD < LOD < LOD < LOD 1917 
 01-02 * < LOD < LOD < LOD < LOD 2993 
 03-04 * < LOD < LOD < LOD < LOD 2385 
Age group        
6-11 years 99-00 * < LOD < LOD < LOD < LOD 456 
 01-02 * < LOD < LOD < LOD < LOD 574 
 03-04 * < LOD < LOD < LOD < LOD 295 
12-19 years 99-00 * < LOD < LOD < LOD < LOD 655 
 01-02 * < LOD < LOD < LOD < LOD 819 
 03-04 * < LOD < LOD < LOD < LOD 685 
20-59 years 99-00 * < LOD < LOD < LOD < LOD 806 
 01-02 * < LOD < LOD < LOD < LOD 1109 
 03-04 * < LOD < LOD < LOD < LOD 899 
60 years and older 01-02 * < LOD < LOD < LOD < LOD 491 
 03-04 * < LOD < LOD < LOD < LOD 506 
Gender        
Males 99-00 * < LOD < LOD < LOD < LOD 936 
 01-02 * < LOD < LOD < LOD < LOD 1406 
 03-04 * < LOD < LOD < LOD < LOD 1160 
Females 99-00 * < LOD < LOD < LOD < LOD 981 
 01-02 * < LOD < LOD < LOD < LOD 1587 
 03-04 * < LOD < LOD < LOD < LOD 1225 
Race/ethnicity        
Mexican Americans 99-00 * < LOD < LOD < LOD < LOD 664 
 01-02 * < LOD < LOD < LOD < LOD 762 
 03-04 * < LOD < LOD < LOD < LOD 593 
Non-Hispanic blacks 99-00 * < LOD < LOD < LOD < LOD 500 
 01-02 * < LOD < LOD < LOD < LOD 769 
 03-04 * < LOD < LOD < LOD < LOD 601 
Non-Hispanic whites 99-00 * < LOD < LOD < LOD < LOD 585 
 01-02 * < LOD < LOD < LOD < LOD 1241 
 03-04 * < LOD < LOD < LOD < LOD 1040 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary 2,4,5-Trichlorophenol (2003 – 2010)‡ 
Metabolite of Several Organochlorine Insecticides 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD .100 (.100-.100) .200 (.200-.300) .400 (.300-.400) 2525 
 05-06 * < LOD .100 (.100-.200) .300 (.200-.300) .400 (.300-.500) 2548 
 07-08 * < LOD .100 (<LOD-.100) .200 (.200-.200) .300 (.200-.300) 2604 
 09-10 * < LOD < LOD .200 (.200-.200) .300 (.200-.300) 2749 
Age group        
6-11 years 03-04 * < LOD .100 (.100-.200) .200 (.200-.300) .300 (.200-.500) 314 
 05-06 * < LOD .100 (.100-.200) .300 (.200-.400) .400 (.300-.500) 356 
 07-08 * < LOD .100 (<LOD-.100) .200 (.100-.300) .300 (.200-.500) 389 
 09-10 * < LOD < LOD .200 (.100-.200) .200 (.200-.300) 415 
12-19 years 03-04 * < LOD .100 (.100-.200) .200 (.200-.300) .300 (.200-.500) 722 
 05-06 * < LOD .100 (.100-.200) .300 (.200-.300) .400 (.300-.500) 702 
 07-08 * < LOD .100 (<LOD-.100) .200 (.100-.200) .200 (.200-.500) 401 
 09-10 * < LOD .100 (<LOD-.100) .200 (.200-.300) .300 (.200-.500) 420 
20 years and older 03-04 * < LOD .100 (.100-.100) .300 (.200-.300) .400 (.300-.500) 1489 
 05-06 * < LOD .100 (.100-.200) .300 (.200-.300) .400 (.300-.500) 1490 
 07-08 * < LOD .100 (<LOD-.100) .200 (.200-.300) .300 (.200-.400) 1814 
 09-10 * < LOD < LOD .200 (.200-.200) .300 (.200-.300) 1914 
Gender        
Males 03-04 * < LOD .100 (.100-.100) .200 (.200-.300) .400 (.300-.400) 1231 
 05-06 * < LOD .100 (.100-.200) .200 (.200-.300) .400 (.300-.500) 1270 
 07-08 * < LOD .100 (<LOD-.100) .200 (.200-.200) .300 (.200-.300) 1294 
 09-10 * < LOD < LOD .200 (.200-.200) .300 (.200-.300) 1399 
Females 03-04 * < LOD .100 (.100-.200) .200 (.200-.300) .400 (.300-.400) 1294 
 05-06 * < LOD .100 (.100-.200) .300 (.200-.400) .500 (.300-.500) 1278 
 07-08 * < LOD .100 (<LOD-.100) .200 (.200-.300) .300 (.200-.400) 1310 
 09-10 * < LOD .100 (<LOD-.100) .200 (.200-.200) .300 (.200-.300) 1350 
Race/ethnicity        
Mexican Americans 03-04 * < LOD .100 (<LOD-.200) .200 (.200-.300) .300 (.200-.400) 617 
 05-06 * < LOD .100 (<LOD-.200) .300 (.200-.300) .400 (.300-.500) 637 
 07-08 * < LOD < LOD .200 (.100-.200) .200 (.200-.300) 531 
 09-10 * < LOD < LOD .100 (<LOD-.200) .200 (.100-.300) 566 
Non-Hispanic blacks 03-04 * < LOD .200 (.100-.200) .300 (.200-.500) .400 (.300-.700) 636 
 05-06 * < LOD .200 (.100-.200) .300 (.200-.400) .500 (.300-.500) 678 
 07-08 * < LOD .100 (.100-.200) .200 (.200-.300) .400 (.300-.500) 597 
 09-10 * < LOD .100 (<LOD-.100) .200 (.200-.200) .200 (.200-.300) 516 
Non-Hispanic whites 03-04 * < LOD .100 (.100-.100) .200 (.200-.300) .400 (.300-.400) 1077 
 05-06 * < LOD .100 (.100-.200) .300 (.200-.300) .400 (.300-.600) 1038 
 07-08 * < LOD .100 (<LOD-.100) .200 (.200-.300) .300 (.200-.400) 1077 
 09-10 * < LOD < LOD .200 (.200-.200) .300 (.200-.300) 1206 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, 07-08 and 09-10 are 0.1, 0.1, 0.1, and 0.1 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result.  






Fourth National Report on Human Exposure to Environmental Chemicals, Updated Tables, January 2017 Volume One Page 132
Urinary 2,4,5-Trichlorophenol (creatinine corrected) (2003 – 2010)‡ 
Metabolite of Several Organochlorine Insecticides 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD .170 (.160-.180) .280 (.260-.310) .370 (.330-.420) 2522 
 05-06 * < LOD .160 (.150-.180) .290 (.260-.320) .410 (.360-.450) 2548 
 07-08 * < LOD .150 (<LOD-.160) .280 (.230-.320) .390 (.330-.470) 2604 
 09-10 * < LOD < LOD .260 (.240-.280) .350 (.320-.390) 2749 
Age group        
6-11 years 03-04 * < LOD .180 (.150-.230) .290 (.250-.320) .370 (.310-.540) 314 
 05-06 * < LOD .180 (.140-.200) .310 (.210-.450) .450 (.320-.610) 356 
 07-08 * < LOD .180 (<LOD-.190) .270 (.210-.390) .430 (.270-.580) 389 
 09-10 * < LOD < LOD .320 (.240-.350) .390 (.320-.470) 415 
12-19 years 03-04 * < LOD .120 (.100-.140) .200 (.170-.220) .240 (.220-.280) 720 
 05-06 * < LOD .120 (.110-.130) .210 (.180-.240) .290 (.240-.330) 702 
 07-08 * < LOD .100 (<LOD-.120) .170 (.150-.210) .250 (.170-.310) 401 
 09-10 * < LOD .110 (<LOD-.130) .190 (.150-.250) .280 (.190-.380) 420 
20 years and older 03-04 * < LOD .180 (.160-.180) .290 (.270-.320) .390 (.350-.470) 1488 
 05-06 * < LOD .170 (.150-.190) .300 (.260-.330) .410 (.370-.470) 1490 
 07-08 * < LOD .150 (<LOD-.180) .290 (.230-.350) .410 (.340-.500) 1814 
 09-10 * < LOD < LOD .270 (.240-.280) .350 (.320-.410) 1914 
Gender        
Males 03-04 * < LOD .130 (.110-.150) .230 (.190-.260) .320 (.270-.350) 1230 
 05-06 * < LOD .130 (.120-.140) .220 (.190-.240) .310 (.260-.360) 1270 
 07-08 * < LOD .110 (<LOD-.120) .190 (.180-.230) .300 (.230-.340) 1294 
 09-10 * < LOD < LOD .210 (.190-.230) .280 (.240-.330) 1399 
Females 03-04 * < LOD .200 (.180-.210) .320 (.290-.350) .440 (.350-.510) 1292 
 05-06 * < LOD .210 (.180-.230) .350 (.300-.410) .470 (.410-.550) 1278 
 07-08 * < LOD .190 (<LOD-.230) .330 (.280-.410) .470 (.370-.580) 1310 
 09-10 * < LOD .180 (<LOD-.190) .300 (.280-.330) .420 (.330-.470) 1350 
Race/ethnicity        
Mexican Americans 03-04 * < LOD .140 (<LOD-.150) .240 (.200-.280) .330 (.280-.460) 616 
 05-06 * < LOD .140 (<LOD-.160) .240 (.190-.320) .350 (.290-.380) 637 
 07-08 * < LOD < LOD .210 (.180-.250) .270 (.240-.320) 531 
 09-10 * < LOD < LOD .190 (<LOD-.230) .290 (.220-.330) 566 
Non-Hispanic blacks 03-04 * < LOD .120 (.100-.150) .230 (.170-.290) .310 (.230-.390) 635 
 05-06 * < LOD .110 (.100-.140) .210 (.170-.260) .320 (.260-.360) 678 
 07-08 * < LOD .120 (.100-.140) .200 (.170-.250) .290 (.230-.420) 597 
 09-10 * < LOD .090 (<LOD-.110) .160 (.130-.200) .220 (.160-.380) 516 
Non-Hispanic whites 03-04 * < LOD .180 (.160-.190) .290 (.260-.320) .370 (.340-.440) 1076 
 05-06 * < LOD .180 (.160-.190) .300 (.270-.350) .410 (.360-.500) 1038 
 07-08 * < LOD .160 (<LOD-.190) .300 (.250-.360) .440 (.330-.510) 1077 
 09-10 * < LOD < LOD .280 (.250-.320) .370 (.330-.410) 1206 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result.  
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Urinary 2,4,6-Trichlorophenol (2003 – 2010) ‡ 
Metabolite of Several Organochlorine Insecticides 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD .500 (<LOD-.600) 1.00 (.800-1.20) 1.40 (1.20-1.80) 2525 
 05-06 * < LOD .600 (<LOD-.700) 1.00 (.800-1.20) 1.40 (1.20-1.80) 2548 
 07-08 * < LOD < LOD .800 (.700-.900) 1.20 (1.00-1.30) 2604 
 09-10 * < LOD .500 (<LOD-.600) .800 (.700-.900) 1.10 (1.00-1.40) 2749 
Age group        
6-11 years 03-04 * < LOD .600 (.500-.700) 1.10 (.800-1.40) 1.90 (1.10-3.10) 314 
 05-06 * < LOD .700 (.600-.900) 1.30 (1.00-2.30) 2.70 (1.30-5.40) 356 
 07-08 * < LOD .600 (<LOD-.700) 1.10 (.900-1.40) 1.60 (1.30-2.10) 389 
 09-10 * < LOD .500 (<LOD-.600) .900 (.700-1.20) 1.30 (.900-2.20) 415 
12-19 years 03-04 * < LOD .600 (.500-.800) 1.20 (.900-1.70) 1.80 (1.50-2.10) 722 
 05-06 * < LOD .600 (<LOD-.800) 1.00 (.800-1.30) 1.30 (1.20-1.70) 702 
 07-08 * < LOD .600 (<LOD-.700) .800 (.700-1.10) 1.10 (.800-1.70) 401 
 09-10 * < LOD .600 (<LOD-.700) .900 (.700-1.30) 1.30 (.900-1.90) 420 
20 years and older 03-04 * < LOD .500 (<LOD-.600) 1.00 (.800-1.10) 1.30 (1.10-1.70) 1489 
 05-06 * < LOD .600 (<LOD-.700) 1.00 (.800-1.20) 1.30 (1.20-1.80) 1490 
 07-08 * < LOD < LOD .800 (.700-.900) 1.10 (.900-1.30) 1814 
 09-10 * < LOD < LOD .800 (.700-.900) 1.10 (1.00-1.20) 1914 
Gender        
Males 03-04 * < LOD .600 (<LOD-.600) 1.00 (.800-1.10) 1.30 (1.10-1.80) 1231 
 05-06 * < LOD .600 (<LOD-.800) 1.10 (.900-1.30) 1.60 (1.20-2.00) 1270 
 07-08 * < LOD .500 (<LOD-.600) .900 (.700-1.00) 1.20 (1.10-1.40) 1294 
 09-10 * < LOD < LOD .800 (.700-.900) 1.10 (1.00-1.20) 1399 
Females 03-04 * < LOD .500 (<LOD-.600) 1.10 (.900-1.20) 1.40 (1.10-2.00) 1294 
 05-06 * < LOD .500 (<LOD-.600) .900 (.800-1.20) 1.30 (1.10-1.70) 1278 
 07-08 * < LOD < LOD .800 (.700-.900) 1.10 (.900-1.40) 1310 
 09-10 * < LOD .500 (<LOD-.600) .800 (.700-1.00) 1.10 (.900-1.60) 1350 
Race/ethnicity        
Mexican Americans 03-04 * < LOD .700 (.600-.800) 1.20 (1.10-1.60) 1.80 (1.30-2.00) 617 
 05-06 * < LOD .600 (.500-.700) 1.00 (.800-1.20) 1.30 (1.20-1.70) 637 
 07-08 * < LOD < LOD .700 (.700-.900) 1.00 (.900-1.20) 531 
 09-10 * < LOD .500 (<LOD-.600) .900 (.700-1.10) 1.10 (.900-1.30) 566 
Non-Hispanic blacks 03-04 * < LOD .900 (.700-1.00) 1.40 (1.10-1.90) 2.00 (1.50-2.70) 636 
 05-06 * < LOD .800 (.700-1.10) 1.50 (1.20-1.90) 2.20 (1.60-3.30) 678 
 07-08 * < LOD .600 (.500-.600) 1.00 (.900-1.10) 1.30 (1.10-1.60) 597 
 09-10 * < LOD .700 (.600-.800) 1.10 (.900-1.30) 1.50 (1.20-2.00) 516 
Non-Hispanic whites 03-04 * < LOD < LOD .800 (.700-1.00) 1.20 (1.00-1.50) 1077 
 05-06 * < LOD .500 (<LOD-.700) .900 (.700-1.30) 1.30 (1.10-1.80) 1038 
 07-08 * < LOD < LOD .800 (.700-.900) 1.20 (1.00-1.40) 1077 
 09-10 * < LOD < LOD .700 (.600-.900) 1.00 (.800-1.30) 1206 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, 07-08 and 09-10 are 0.5, 0.5, 0.5, and 0.5 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result.  
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Urinary 2,4,6-Trichlorophenol (creatinine corrected) (2003 – 2010)‡ 
Metabolite of Several Organochlorine Insecticides 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD .710 (<LOD-.780) 1.25 (1.17-1.35) 1.75 (1.59-2.06) 2522 
 05-06 * < LOD .720 (<LOD-.760) 1.27 (1.17-1.38) 1.75 (1.59-1.94) 2548 
 07-08 * < LOD < LOD 1.25 (1.06-1.42) 1.75 (1.52-2.19) 2604 
 09-10 * < LOD .710 (<LOD-.760) 1.21 (1.13-1.35) 1.67 (1.55-1.84) 2749 
Age group        
6-11 years 03-04 * < LOD .920 (.850-1.13) 1.59 (1.22-1.91) 2.11 (1.46-4.55) 314 
 05-06 * < LOD .880 (.740-1.06) 1.59 (1.21-2.06) 2.50 (1.61-5.20) 356 
 07-08 * < LOD .900 (<LOD-.930) 1.46 (1.14-1.67) 2.33 (1.52-2.92) 389 
 09-10 * < LOD .850 (<LOD-1.03) 1.59 (1.17-1.74) 1.85 (1.67-2.33) 415 
12-19 years 03-04 * < LOD .580 (.510-.660) .970 (.830-1.10) 1.21 (1.09-1.49) 720 
 05-06 * < LOD .550 (<LOD-.630) .970 (.690-1.17) 1.40 (1.08-1.59) 702 
 07-08 * < LOD .550 (<LOD-.610) .830 (.730-1.03) 1.30 (.930-1.48) 401 
 09-10 * < LOD .590 (<LOD-.700) .970 (.690-1.23) 1.23 (.920-1.66) 420 
20 years and older 03-04 * < LOD .710 (<LOD-.770) 1.25 (1.17-1.35) 1.75 (1.59-2.00) 1488 
 05-06 * < LOD .730 (<LOD-.780) 1.30 (1.17-1.40) 1.75 (1.57-2.06) 1490 
 07-08 * < LOD < LOD 1.30 (1.06-1.46) 1.84 (1.52-2.33) 1814 
 09-10 * < LOD < LOD 1.21 (1.13-1.35) 1.67 (1.52-1.94) 1914 
Gender        
Males 03-04 * < LOD .560 (<LOD-.600) .920 (.820-1.10) 1.30 (1.17-1.46) 1230 
 05-06 * < LOD .600 (<LOD-.650) 1.00 (.850-1.13) 1.43 (1.25-1.59) 1270 
 07-08 * < LOD .530 (<LOD-.600) .930 (.830-1.06) 1.46 (1.18-1.59) 1294 
 09-10 * < LOD < LOD .980 (.850-1.12) 1.33 (1.13-1.59) 1399 
Females 03-04 * < LOD .900 (<LOD-.960) 1.59 (1.35-1.75) 2.19 (1.75-2.63) 1292 
 05-06 * < LOD .850 (<LOD-.970) 1.46 (1.30-1.67) 2.06 (1.67-2.50) 1278 
 07-08 * < LOD < LOD 1.46 (1.23-1.75) 2.19 (1.67-2.50) 1310 
 09-10 * < LOD .850 (<LOD-.920) 1.46 (1.30-1.59) 2.06 (1.62-2.33) 1350 
Race/ethnicity        
Mexican Americans 03-04 * < LOD .760 (.600-.900) 1.15 (.970-1.38) 1.59 (1.18-2.42) 616 
 05-06 * < LOD .650 (.570-.700) 1.03 (.860-1.19) 1.46 (1.11-1.94) 637 
 07-08 * < LOD < LOD 1.05 (.910-1.17) 1.35 (1.13-1.57) 531 
 09-10 * < LOD .690 (<LOD-.760) 1.00 (.900-1.33) 1.67 (1.13-2.18) 566 
Non-Hispanic blacks 03-04 * < LOD .600 (.560-.640) .950 (.800-1.10) 1.34 (1.06-1.67) 635 
 05-06 * < LOD .630 (.540-.740) 1.03 (.830-1.49) 1.59 (1.13-2.07) 678 
 07-08 * < LOD .520 (.470-.620) 1.00 (.830-1.13) 1.40 (1.13-1.52) 597 
 09-10 * < LOD .560 (.490-.610) .830 (.750-.950) 1.17 (.920-1.52) 516 
Non-Hispanic whites 03-04 * < LOD < LOD 1.30 (1.17-1.46) 1.75 (1.59-2.11) 1076 
 05-06 * < LOD .760 (<LOD-.830) 1.35 (1.25-1.50) 1.79 (1.60-2.06) 1038 
 07-08 * < LOD < LOD 1.35 (1.13-1.52) 1.84 (1.52-2.50) 1077 
 09-10 * < LOD < LOD 1.30 (1.18-1.46) 1.73 (1.59-2.06) 1206 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result. 
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Urinary Acephate (2003 - 2008) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 2491 
 05-06 * < LOD < LOD < LOD < LOD 2546 
 07-08 * < LOD < LOD < LOD < LOD 2505 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD < LOD 309 
 05-06 * < LOD < LOD < LOD < LOD 343 
 07-08 * < LOD < LOD < LOD < LOD 374 
12-19 years 03-04 * < LOD < LOD < LOD < LOD 715 
 05-06 * < LOD < LOD < LOD < LOD 696 
 07-08 * < LOD < LOD < LOD < LOD 375 
20-59 years 03-04 * < LOD < LOD < LOD < LOD 939 
 05-06 * < LOD < LOD < LOD < LOD 1050 
 07-08 * < LOD < LOD < LOD < LOD 1134 
60 years and older 03-04 * < LOD < LOD < LOD < LOD 528 
 05-06 * < LOD < LOD < LOD < LOD 457 
 07-08 * < LOD < LOD < LOD < LOD 622 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 1221 
 05-06 * < LOD < LOD < LOD < LOD 1205 
 07-08 * < LOD < LOD < LOD < LOD 1250 
Females 03-04 * < LOD < LOD < LOD < LOD 1270 
 05-06 * < LOD < LOD < LOD < LOD 1341 
 07-08 * < LOD < LOD < LOD < LOD 1255 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 608 
 05-06 * < LOD < LOD < LOD < LOD 666 
 07-08 * < LOD < LOD < LOD < LOD 476 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 647 
 05-06 * < LOD < LOD < LOD < LOD 698 
 07-08 * < LOD < LOD < LOD < LOD 551 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 1077 
 05-06 * < LOD < LOD < LOD < LOD 979 
 07-08 * < LOD < LOD < LOD < LOD 1062 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, and 07-08 are 0.1, 0.25, and 0.27 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Acephate (creatinine corrected) (2003 - 2008) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 2489 
 05-06 * < LOD < LOD < LOD < LOD 2546 
 07-08 * < LOD < LOD < LOD < LOD 2503 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD < LOD 309 
 05-06 * < LOD < LOD < LOD < LOD 343 
 07-08 * < LOD < LOD < LOD < LOD 374 
12-19 years 03-04 * < LOD < LOD < LOD < LOD 714 
 05-06 * < LOD < LOD < LOD < LOD 696 
 07-08 * < LOD < LOD < LOD < LOD 373 
20-59 years 03-04 * < LOD < LOD < LOD < LOD 938 
 05-06 * < LOD < LOD < LOD < LOD 1050 
 07-08 * < LOD < LOD < LOD < LOD 1134 
60 years and older 03-04 * < LOD < LOD < LOD < LOD 528 
 05-06 * < LOD < LOD < LOD < LOD 457 
 07-08 * < LOD < LOD < LOD < LOD 622 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 1220 
 05-06 * < LOD < LOD < LOD < LOD 1205 
 07-08 * < LOD < LOD < LOD < LOD 1249 
Females 03-04 * < LOD < LOD < LOD < LOD 1269 
 05-06 * < LOD < LOD < LOD < LOD 1341 
 07-08 * < LOD < LOD < LOD < LOD 1254 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 607 
 05-06 * < LOD < LOD < LOD < LOD 666 
 07-08 * < LOD < LOD < LOD < LOD 475 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 647 
 05-06 * < LOD < LOD < LOD < LOD 698 
 07-08 * < LOD < LOD < LOD < LOD 550 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 1076 
 05-06 * < LOD < LOD < LOD < LOD 979 
 07-08 * < LOD < LOD < LOD < LOD 1062 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary Dimethoate (2003 - 2008) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 2455 
 05-06 * < LOD < LOD < LOD < LOD 2628 
 07-08 * < LOD < LOD < LOD < LOD 2573 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD < LOD 306 
 05-06 * < LOD < LOD < LOD < LOD 349 
 07-08 * < LOD < LOD < LOD < LOD 382 
12-19 years 03-04 * < LOD < LOD < LOD < LOD 708 
 05-06 * < LOD < LOD < LOD < LOD 718 
 07-08 * < LOD < LOD < LOD < LOD 388 
20-59 years 03-04 * < LOD < LOD < LOD < LOD 922 
 05-06 * < LOD < LOD < LOD < LOD 1087 
 07-08 * < LOD < LOD < LOD < LOD 1170 
60 years and older 03-04 * < LOD < LOD < LOD < LOD 519 
 05-06 * < LOD < LOD < LOD < LOD 474 
 07-08 * < LOD < LOD < LOD < LOD 633 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 1197 
 05-06 * < LOD < LOD < LOD < LOD 1245 
 07-08 * < LOD < LOD < LOD < LOD 1290 
Females 03-04 * < LOD < LOD < LOD < LOD 1258 
 05-06 * < LOD < LOD < LOD < LOD 1383 
 07-08 * < LOD < LOD < LOD < LOD 1283 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 605 
 05-06 * < LOD < LOD < LOD < LOD 693 
 07-08 * < LOD < LOD < LOD < LOD 493 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 629 
 05-06 * < LOD < LOD < LOD < LOD 719 
 07-08 * < LOD < LOD < LOD < LOD 570 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 1068 
 05-06 * < LOD < LOD < LOD < LOD 1007 
 07-08 * < LOD < LOD < LOD < LOD 1084 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, and 07-08 are 0.1, 0.25, and 0.1 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Dimethoate (creatinine corrected) (2003 - 2008) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 2453 
 05-06 * < LOD < LOD < LOD < LOD 2628 
 07-08 * < LOD < LOD < LOD < LOD 2571 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD < LOD 306 
 05-06 * < LOD < LOD < LOD < LOD 349 
 07-08 * < LOD < LOD < LOD < LOD 382 
12-19 years 03-04 * < LOD < LOD < LOD < LOD 707 
 05-06 * < LOD < LOD < LOD < LOD 718 
 07-08 * < LOD < LOD < LOD < LOD 386 
20-59 years 03-04 * < LOD < LOD < LOD < LOD 921 
 05-06 * < LOD < LOD < LOD < LOD 1087 
 07-08 * < LOD < LOD < LOD < LOD 1170 
60 years and older 03-04 * < LOD < LOD < LOD < LOD 519 
 05-06 * < LOD < LOD < LOD < LOD 474 
 07-08 * < LOD < LOD < LOD < LOD 633 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 1196 
 05-06 * < LOD < LOD < LOD < LOD 1245 
 07-08 * < LOD < LOD < LOD < LOD 1289 
Females 03-04 * < LOD < LOD < LOD < LOD 1257 
 05-06 * < LOD < LOD < LOD < LOD 1383 
 07-08 * < LOD < LOD < LOD < LOD 1282 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 604 
 05-06 * < LOD < LOD < LOD < LOD 693 
 07-08 * < LOD < LOD < LOD < LOD 492 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 629 
 05-06 * < LOD < LOD < LOD < LOD 719 
 07-08 * < LOD < LOD < LOD < LOD 569 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 1067 
 05-06 * < LOD < LOD < LOD < LOD 1007 
 07-08 * < LOD < LOD < LOD < LOD 1084 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary Methamidophos (2003 - 2008) 
Also a metabolite of Acephate 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 2379 
 05-06 * < LOD < LOD < LOD < LOD 2591 
 07-08 * < LOD < LOD < LOD < LOD 2573 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD < LOD 295 
 05-06 * < LOD < LOD < LOD < LOD 346 
 07-08 * < LOD < LOD < LOD < LOD 382 
12-19 years 03-04 * < LOD < LOD < LOD < LOD 683 
 05-06 * < LOD < LOD < LOD < LOD 710 
 07-08 * < LOD < LOD < LOD < LOD 388 
20-59 years 03-04 * < LOD < LOD < LOD < LOD 893 
 05-06 * < LOD < LOD < LOD < LOD 1070 
 07-08 * < LOD < LOD < LOD < LOD 1169 
60 years and older 03-04 * < LOD < LOD < LOD < LOD 508 
 05-06 * < LOD < LOD < LOD < LOD 465 
 07-08 * < LOD < LOD < LOD < LOD 634 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 1171 
 05-06 * < LOD < LOD < LOD < LOD 1232 
 07-08 * < LOD < LOD < LOD < LOD 1290 
Females 03-04 * < LOD < LOD < LOD < LOD 1208 
 05-06 * < LOD < LOD < LOD < LOD 1359 
 07-08 * < LOD < LOD < LOD < LOD 1283 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 564 
 05-06 * < LOD < LOD < LOD < LOD 688 
 07-08 * < LOD < LOD < LOD < LOD 492 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 631 
 05-06 * < LOD < LOD < LOD < LOD 717 
 07-08 * < LOD < LOD < LOD < LOD 571 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 1034 
 05-06 * < LOD < LOD < LOD < LOD 979 
 07-08 * < LOD < LOD < LOD < LOD 1084 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, and 07-08 are 0.1, 0.37, and 0.41 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Methamidophos (creatinine corrected) (2003 - 2008) 
Also a metabolite of Acephate 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 2377 
 05-06 * < LOD < LOD < LOD < LOD 2591 
 07-08 * < LOD < LOD < LOD < LOD 2571 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD < LOD 295 
 05-06 * < LOD < LOD < LOD < LOD 346 
 07-08 * < LOD < LOD < LOD < LOD 382 
12-19 years 03-04 * < LOD < LOD < LOD < LOD 682 
 05-06 * < LOD < LOD < LOD < LOD 710 
 07-08 * < LOD < LOD < LOD < LOD 386 
20-59 years 03-04 * < LOD < LOD < LOD < LOD 892 
 05-06 * < LOD < LOD < LOD < LOD 1070 
 07-08 * < LOD < LOD < LOD < LOD 1169 
60 years and older 03-04 * < LOD < LOD < LOD < LOD 508 
 05-06 * < LOD < LOD < LOD < LOD 465 
 07-08 * < LOD < LOD < LOD < LOD 634 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 1170 
 05-06 * < LOD < LOD < LOD < LOD 1232 
 07-08 * < LOD < LOD < LOD < LOD 1289 
Females 03-04 * < LOD < LOD < LOD < LOD 1207 
 05-06 * < LOD < LOD < LOD < LOD 1359 
 07-08 * < LOD < LOD < LOD < LOD 1282 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 563 
 05-06 * < LOD < LOD < LOD < LOD 688 
 07-08 * < LOD < LOD < LOD < LOD 491 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 631 
 05-06 * < LOD < LOD < LOD < LOD 717 
 07-08 * < LOD < LOD < LOD < LOD 570 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 1033 
 05-06 * < LOD < LOD < LOD < LOD 979 
 07-08 * < LOD < LOD < LOD < LOD 1084 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary Omethoate (2003 - 2008) 
Metabolite of Dimethoate 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 2455 
 05-06 * < LOD < LOD < LOD < LOD 2628 
 07-08 * < LOD < LOD < LOD < LOD 2574 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD < LOD 303 
 05-06 * < LOD < LOD < LOD < LOD 349 
 07-08 * < LOD < LOD < LOD < LOD 382 
12-19 years 03-04 * < LOD < LOD < LOD < LOD 707 
 05-06 * < LOD < LOD < LOD < LOD 718 
 07-08 * < LOD < LOD < LOD < LOD 388 
20-59 years 03-04 * < LOD < LOD < LOD < LOD 923 
 05-06 * < LOD < LOD < LOD < LOD 1086 
 07-08 * < LOD < LOD < LOD < LOD 1170 
60 years and older 03-04 * < LOD < LOD < LOD < LOD 522 
 05-06 * < LOD < LOD < LOD < LOD 475 
 07-08 * < LOD < LOD < LOD < LOD 634 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 1207 
 05-06 * < LOD < LOD < LOD < LOD 1245 
 07-08 * < LOD < LOD < LOD < LOD 1290 
Females 03-04 * < LOD < LOD < LOD < LOD 1248 
 05-06 * < LOD < LOD < LOD < LOD 1383 
 07-08 * < LOD < LOD < LOD < LOD 1284 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 606 
 05-06 * < LOD < LOD < LOD < LOD 693 
 07-08 * < LOD < LOD < LOD < LOD 493 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 637 
 05-06 * < LOD < LOD < LOD < LOD 719 
 07-08 * < LOD < LOD < LOD < LOD 571 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 1055 
 05-06 * < LOD < LOD < LOD < LOD 1007 
 07-08 * < LOD < LOD < LOD < LOD 1084 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, and 07-08 are 0.1, 0.14, and 0.1 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Omethoate (creatinine corrected) (2003 - 2008) 
Metabolite of Dimethoate 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 2453 
 05-06 * < LOD < LOD < LOD < LOD 2628 
 07-08 * < LOD < LOD < LOD < LOD 2572 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD < LOD 303 
 05-06 * < LOD < LOD < LOD < LOD 349 
 07-08 * < LOD < LOD < LOD < LOD 382 
12-19 years 03-04 * < LOD < LOD < LOD < LOD 706 
 05-06 * < LOD < LOD < LOD < LOD 718 
 07-08 * < LOD < LOD < LOD < LOD 386 
20-59 years 03-04 * < LOD < LOD < LOD < LOD 922 
 05-06 * < LOD < LOD < LOD < LOD 1086 
 07-08 * < LOD < LOD < LOD < LOD 1170 
60 years and older 03-04 * < LOD < LOD < LOD < LOD 522 
 05-06 * < LOD < LOD < LOD < LOD 475 
 07-08 * < LOD < LOD < LOD < LOD 634 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 1206 
 05-06 * < LOD < LOD < LOD < LOD 1245 
 07-08 * < LOD < LOD < LOD < LOD 1289 
Females 03-04 * < LOD < LOD < LOD < LOD 1247 
 05-06 * < LOD < LOD < LOD < LOD 1383 
 07-08 * < LOD < LOD < LOD < LOD 1283 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 605 
 05-06 * < LOD < LOD < LOD < LOD 693 
 07-08 * < LOD < LOD < LOD < LOD 492 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 637 
 05-06 * < LOD < LOD < LOD < LOD 719 
 07-08 * < LOD < LOD < LOD < LOD 570 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 1054 
 05-06 * < LOD < LOD < LOD < LOD 1007 
 07-08 * < LOD < LOD < LOD < LOD 1084 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary Malathion dicarboxylic acid (1999 - 2010) 
Metabolite of Malathion 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 * < LOD < LOD < LOD < LOD 1920 
 07-08 * < LOD < LOD .980 (.900-1.08) 1.65 (1.44-1.94) 2581 
 09-10 * < LOD < LOD .990 (.830-1.09) 2.05 (1.64-2.33) 2742 
Age group        
6-11 years 99-00 * < LOD < LOD < LOD 2.80 (<LOD-5.50) 453 
 07-08 * < LOD .510 (<LOD-.640) 1.26 (.810-2.13) 2.32 (1.43-3.55) 383 
 09-10 * < LOD < LOD 1.10 (.580-1.59) 1.80 (1.15-3.73) 385 
12-19 years 99-00 * < LOD < LOD < LOD < LOD 660 
 07-08 * < LOD < LOD 1.09 (.740-1.40) 1.59 (1.14-1.94) 390 
 09-10 * < LOD < LOD 1.08 (.520-1.41) 1.60 (1.00-3.37) 400 
20-59 years 99-00 * < LOD < LOD < LOD < LOD 807 
 07-08 * < LOD < LOD .900 (.770-1.01) 1.41 (1.14-1.65) 1177 
 09-10 * < LOD < LOD .910 (.710-1.10) 2.23 (1.65-2.57) 1307 
60 years and older 07-08 * < LOD .500 (<LOD-.580) 1.37 (.980-1.73) 3.29 (1.48-7.45) 631 
 09-10 * < LOD < LOD 1.03 (.830-1.25) 1.63 (1.34-3.34) 650 
Gender        
Males 99-00 * < LOD < LOD < LOD < LOD 937 
 07-08 * < LOD < LOD 1.05 (.930-1.23) 1.90 (1.55-2.46) 1290 
 09-10 * < LOD < LOD .950 (.720-1.19) 1.85 (1.22-2.86) 1341 
Females 99-00 * < LOD < LOD < LOD < LOD 983 
 07-08 * < LOD < LOD .860 (.660-1.13) 1.52 (1.13-1.91) 1291 
 09-10 * < LOD < LOD 1.00 (.720-1.29) 2.19 (1.64-2.63) 1401 
Race/ethnicity        
Mexican Americans 99-00 * < LOD < LOD < LOD < LOD 680 
 07-08 * < LOD < LOD .740 (.550-1.01) 1.12 (.900-1.52) 500 
 09-10 * < LOD < LOD .790 (.540-1.05) 1.29 (.920-1.94) 600 
Non-Hispanic blacks 99-00 * < LOD < LOD < LOD < LOD 498 
 07-08 * < LOD < LOD .670 (.540-.810) 1.06 (.860-1.34) 573 
 09-10 * < LOD < LOD .630 (<LOD-.880) 1.33 (.880-1.80) 504 
Non-Hispanic whites 99-00 * < LOD < LOD < LOD < LOD 580 
 07-08 * < LOD < LOD 1.08 (.900-1.29) 1.84 (1.55-2.47) 1079 
 09-10 * < LOD < LOD 1.09 (.910-1.30) 2.33 (1.81-2.87) 1197 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 07-08, and 09-10 are 2.64, 0.5, and 0.5 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Malathion dicarboxylic acid (creatinine corrected) (1999 - 2010) 
Metabolite of Malathion 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 * < LOD < LOD < LOD < LOD 1920 
 07-08 * < LOD < LOD 1.46 (1.30-1.71) 2.19 (1.85-2.72) 2579 
 09-10 * < LOD < LOD 1.52 (1.40-1.65) 2.50 (2.13-2.94) 2742 
Age group        
6-11 years 99-00 * < LOD < LOD < LOD 3.74 (<LOD-5.50) 453 
 07-08 * < LOD .946 (<LOD-1.14) 1.85 (1.55-2.27) 2.84 (1.85-5.11) 383 
 09-10 * < LOD < LOD 1.75 (1.25-2.19) 2.25 (1.94-6.25) 385 
12-19 years 99-00 * < LOD < LOD < LOD < LOD 660 
 07-08 * < LOD < LOD .982 (.761-1.21) 1.46 (1.06-1.80) 388 
 09-10 * < LOD < LOD .946 (.833-1.25) 1.49 (.946-3.41) 400 
20-59 years 99-00 * < LOD < LOD < LOD < LOD 807 
 07-08 * < LOD < LOD 1.35 (1.21-1.52) 1.96 (1.71-2.69) 1177 
 09-10 * < LOD < LOD 1.53 (1.40-1.67) 2.56 (2.06-3.26) 1307 
60 years and older 07-08 * < LOD 1.06 (<LOD-1.17) 2.06 (1.64-2.72) 3.58 (2.19-8.63) 631 
 09-10 * < LOD < LOD 1.62 (1.40-1.94) 2.52 (2.19-3.28) 650 
Gender        
Males 99-00 * < LOD < LOD < LOD < LOD 937 
 07-08 * < LOD < LOD 1.13 (1.00-1.31) 1.73 (1.40-2.09) 1289 
 09-10 * < LOD < LOD 1.25 (1.06-1.52) 2.06 (1.59-2.52) 1341 
Females 99-00 * < LOD < LOD < LOD < LOD 983 
 07-08 * < LOD < LOD 1.82 (1.46-2.06) 2.72 (2.19-3.08) 1290 
 09-10 * < LOD < LOD 1.67 (1.46-2.06) 2.94 (2.33-3.97) 1401 
Race/ethnicity        
Mexican Americans 99-00 * < LOD < LOD < LOD < LOD 680 
 07-08 * < LOD < LOD 1.13 (.946-1.46) 1.84 (1.21-2.69) 499 
 09-10 * < LOD < LOD 1.30 (1.13-1.56) 1.84 (1.52-2.10) 600 
Non-Hispanic blacks 99-00 * < LOD < LOD < LOD < LOD 498 
 07-08 * < LOD < LOD .946 (.756-1.09) 1.35 (1.03-1.67) 572 
 09-10 * < LOD < LOD .875 (<LOD-1.06) 1.46 (1.09-1.75) 504 
Non-Hispanic whites 99-00 * < LOD < LOD < LOD < LOD 580 
 07-08 * < LOD < LOD 1.63 (1.32-1.84) 2.47 (1.94-3.06) 1079 
 09-10 * < LOD < LOD 1.63 (1.46-1.89) 2.99 (2.33-3.69) 1197 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary 2-Isopropyl-4-methyl-6-hydroxypyrimidine (1999 - 2010) 
Metabolite of Diazinon 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 * < LOD < LOD < LOD < LOD 1842 
 01-02 * < LOD < LOD < LOD < LOD 3044 
 07-08 * < LOD < LOD .350 (.260-.470) .720 (.530-.890) 2588 
 09-10 * < LOD < LOD .180 (.100-.280) .440 (.310-.660) 2747 
Age group        
6-11 years 99-00 * < LOD < LOD < LOD < LOD 454 
 01-02 * < LOD < LOD < LOD 1.45 (<LOD-3.11) 580 
 07-08 * < LOD < LOD .260 (.160-.510) .580 (.380-1.29) 385 
 09-10 * < LOD < LOD .180 (<LOD-.260) .410 (.210-.480) 386 
12-19 years 99-00 * < LOD < LOD < LOD < LOD 632 
 01-02 * < LOD < LOD < LOD < LOD 829 
 07-08 * < LOD < LOD .320 (.180-.510) .660 (.350-1.24) 390 
 09-10 * < LOD < LOD < LOD .260 (<LOD-.390) 401 
20-59 years 99-00 * < LOD < LOD < LOD < LOD 756 
 01-02 * < LOD < LOD < LOD < LOD 1126 
 07-08 * < LOD < LOD .310 (.220-.500) .670 (.490-.890) 1180 
 09-10 * < LOD < LOD .160 (<LOD-.280) .450 (.280-.810) 1309 
60 years and older 01-02 * < LOD < LOD < LOD < LOD 509 
 07-08 * < LOD < LOD .470 (.320-.670) 1.02 (.600-1.27) 633 
 09-10 * < LOD < LOD .290 (.200-.430) .640 (.350-.860) 651 
Gender        
Males 99-00 * < LOD < LOD < LOD < LOD 894 
 01-02 * < LOD < LOD < LOD < LOD 1427 
 07-08 * < LOD < LOD .390 (.300-.500) .760 (.530-1.02) 1293 
 09-10 * < LOD < LOD .160 (<LOD-.240) .450 (.270-.710) 1343 
Females 99-00 * < LOD < LOD < LOD < LOD 948 
 01-02 * < LOD < LOD < LOD < LOD 1617 
 07-08 * < LOD < LOD .300 (.210-.450) .670 (.510-.830) 1295 
 09-10 * < LOD < LOD .210 (.130-.290) .440 (.310-.600) 1404 
Race/ethnicity        
Mexican Americans 99-00 * < LOD < LOD < LOD < LOD 644 
 01-02 * < LOD < LOD < LOD < LOD 765 
 07-08 * < LOD .110 (<LOD-.160) .350 (.260-.440) .540 (.400-.790) 500 
 09-10 * < LOD < LOD .140 (<LOD-.210) .360 (.210-.570) 602 
Non-Hispanic blacks 99-00 * < LOD < LOD < LOD < LOD 484 
 01-02 * < LOD < LOD < LOD 1.49 (<LOD-2.36) 775 
 07-08 * < LOD .230 (.140-.300) .680 (.460-.990) 1.26 (.880-1.77) 574 
 09-10 * < LOD < LOD .430 (.310-.510) .760 (.460-1.21) 504 
Non-Hispanic whites 99-00 * < LOD < LOD < LOD < LOD 554 
 01-02 * < LOD < LOD < LOD < LOD 1280 
 07-08 * < LOD < LOD .270 (.190-.400) .650 (.440-.880) 1084 
 09-10 * < LOD < LOD .120 (<LOD-.260) .410 (.280-.660) 1200 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 07-08, and 09-10 are 7.2, 0.7, 0.1, and 0.1 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 






Fourth National Report on Human Exposure to Environmental Chemicals, Updated Tables, January 2017 Volume One Page 146
Urinary 2-Isopropyl-4-methyl-6-hydroxypyrimidine (creatinine corrected) (1999 - 2010) 
Metabolite of Diazinon 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 * < LOD < LOD < LOD < LOD 1842 
 01-02 * < LOD < LOD < LOD < LOD 3042 
 07-08 * < LOD < LOD .412 (.333-.508) .731 (.538-1.00) 2586 
 09-10 * < LOD < LOD .313 (.269-.350) .526 (.429-.636) 2747 
Age group        
6-11 years 99-00 * < LOD < LOD < LOD < LOD 454 
 01-02 * < LOD < LOD < LOD 2.72 (<LOD-4.46) 580 
 07-08 * < LOD < LOD .412 (.304-.658) 1.00 (.412-1.59) 385 
 09-10 * < LOD < LOD .333 (<LOD-.438) .438 (.323-.900) 386 
12-19 years 99-00 * < LOD < LOD < LOD < LOD 632 
 01-02 * < LOD < LOD < LOD < LOD 828 
 07-08 * < LOD < LOD .278 (.175-.452) .460 (.276-1.17) 388 
 09-10 * < LOD < LOD < LOD .228 (<LOD-.365) 401 
20-59 years 99-00 * < LOD < LOD < LOD < LOD 756 
 01-02 * < LOD < LOD < LOD < LOD 1126 
 07-08 * < LOD < LOD .383 (.304-.508) .645 (.500-.846) 1180 
 09-10 * < LOD < LOD .304 (<LOD-.350) .526 (.364-.700) 1309 
60 years and older 01-02 * < LOD < LOD < LOD < LOD 508 
 07-08 * < LOD < LOD .594 (.414-.822) 1.05 (.708-1.80) 633 
 09-10 * < LOD < LOD .438 (.333-.551) .773 (.550-1.09) 651 
Gender        
Males 99-00 * < LOD < LOD < LOD < LOD 894 
 01-02 * < LOD < LOD < LOD < LOD 1427 
 07-08 * < LOD < LOD .333 (.286-.457) .677 (.500-.795) 1292 
 09-10 * < LOD < LOD .259 (<LOD-.318) .438 (.318-.613) 1343 
Females 99-00 * < LOD < LOD < LOD < LOD 948 
 01-02 * < LOD < LOD < LOD < LOD 1615 
 07-08 * < LOD < LOD .438 (.368-.632) .822 (.562-1.35) 1294 
 09-10 * < LOD < LOD .347 (.304-.407) .583 (.500-.710) 1404 
Race/ethnicity        
Mexican Americans 99-00 * < LOD < LOD < LOD < LOD 644 
 01-02 * < LOD < LOD < LOD < LOD 765 
 07-08 * < LOD .172 (<LOD-.203) .385 (.260-.483) .636 (.401-.990) 499 
 09-10 * < LOD < LOD .271 (<LOD-.333) .412 (.350-.538) 602 
Non-Hispanic blacks 99-00 * < LOD < LOD < LOD < LOD 484 
 01-02 * < LOD < LOD < LOD 1.89 (<LOD-3.06) 774 
 07-08 * < LOD .202 (.152-.256) .571 (.333-.800) 1.01 (.728-1.47) 573 
 09-10 * < LOD < LOD .318 (.269-.374) .619 (.352-.933) 504 
Non-Hispanic whites 99-00 * < LOD < LOD < LOD < LOD 554 
 01-02 * < LOD < LOD < LOD < LOD 1279 
 07-08 * < LOD < LOD .368 (.292-.484) .700 (.418-1.06) 1084 
 09-10 * < LOD < LOD .304 (<LOD-.368) .525 (.412-.691) 1200 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary para-Nitrophenol (1999 - 2010) 
Metabolite of Ethyl Parathion, Methyl Parathion, and Nitrobenzene 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 * < LOD < LOD 2.50 (1.40-4.50) 5.00 (2.90-11.0) 1989 
 01-02 * < LOD 1.33 (1.20-1.46) 2.69 (2.39-3.01) 3.72 (3.46-4.15) 2975 
 07-08 .673 (.595-.761) .740 (.660-.830) 1.49 (1.32-1.66) 2.77 (2.19-3.45) 4.50 (3.50-5.42) 2564 
 09-10 .454 (.407-.506) .510 (.440-.580) 1.09 (1.00-1.19) 2.18 (1.99-2.34) 3.14 (2.85-3.55) 2744 
Age group        
6-11 years 99-00 * < LOD .940 (<LOD-2.40) 2.67 (1.70-3.80) 4.30 (2.70-6.40) 479 
 01-02 * .790 (<LOD-.910) 1.49 (1.36-1.61) 2.89 (2.22-3.58) 4.10 (3.01-4.74) 565 
 07-08 .803 (.678-.952) .890 (.760-1.01) 1.66 (1.26-1.99) 2.85 (2.10-3.94) 4.37 (2.91-6.75) 383 
 09-10 .506 (.426-.601) .600 (.500-.720) 1.20 (.980-1.43) 2.21 (1.74-2.73) 2.85 (2.28-3.81) 386 
12-19 years 99-00 * < LOD < LOD 3.40 (1.60-5.70) 5.70 (2.60-19.0) 680 
 01-02 * .730 (<LOD-.910) 1.45 (1.32-1.61) 2.66 (2.15-3.11) 3.34 (3.11-4.01) 813 
 07-08 .769 (.614-.962) .850 (.680-1.02) 1.49 (1.28-1.74) 2.79 (1.94-3.45) 3.47 (2.97-4.48) 387 
 09-10 .430 (.375-.493) .520 (.460-.590) .950 (.870-1.09) 1.84 (1.43-2.03) 2.37 (1.84-2.98) 401 
20-59 years 99-00 * < LOD < LOD 2.30 (1.20-5.70) 4.50 (2.30-16.0) 830 
 01-02 * < LOD 1.28 (1.09-1.47) 2.69 (2.32-3.10) 3.72 (3.37-4.24) 1099 
 07-08 .658 (.574-.754) .720 (.640-.840) 1.49 (1.31-1.65) 2.77 (2.10-3.70) 4.68 (3.37-5.56) 1173 
 09-10 .452 (.400-.511) .510 (.420-.590) 1.12 (1.00-1.24) 2.16 (1.91-2.39) 3.27 (2.84-3.58) 1308 
60 years and older 01-02 * < LOD 1.29 (1.07-1.49) 2.66 (2.11-3.39) 4.01 (3.17-7.19) 498 
 07-08 .607 (.512-.720) .610 (.550-.710) 1.41 (1.14-1.76) 2.81 (2.19-3.90) 4.70 (2.90-6.91) 621 
 09-10 .453 (.386-.530) .460 (.380-.580) 1.06 (.970-1.33) 2.42 (1.87-3.00) 3.65 (3.00-4.36) 649 
Gender        
Males 99-00 * < LOD < LOD 2.50 (1.40-4.50) 4.50 (2.50-14.0) 971 
 01-02 * .760 (.450-.880) 1.49 (1.32-1.63) 3.01 (2.66-3.33) 4.13 (3.61-4.92) 1395 
 07-08 .782 (.690-.887) .850 (.740-.980) 1.59 (1.43-1.73) 2.85 (2.19-3.53) 4.52 (3.47-5.01) 1282 
 09-10 .524 (.472-.581) .590 (.490-.670) 1.30 (1.14-1.42) 2.29 (2.07-2.54) 3.29 (2.90-3.73) 1342 
Females 99-00 * < LOD < LOD 2.50 (1.30-5.70) 5.70 (2.90-9.50) 1018 
 01-02 * < LOD 1.18 (1.01-1.37) 2.29 (1.95-2.69) 3.52 (3.16-3.77) 1580 
 07-08 .582 (.510-.664) .640 (.550-.720) 1.32 (1.10-1.59) 2.72 (2.16-3.35) 4.37 (3.09-5.64) 1282 
 09-10 .396 (.352-.446) .440 (.380-.510) .960 (.860-1.06) 2.01 (1.70-2.26) 3.07 (2.62-3.55) 1402 
Race/ethnicity        
Mexican Americans 99-00 * < LOD 1.70 (<LOD-3.50) 5.80 (2.60-24.0) 22.0 (3.60-36.0) 695 
 01-02 * .680 (<LOD-.840) 1.33 (1.08-1.58) 2.61 (1.91-3.41) 3.64 (2.70-5.73) 744 
 07-08 .624 (.542-.720) .700 (.560-.810) 1.37 (1.16-1.52) 2.58 (2.03-3.33) 4.46 (2.79-6.91) 494 
 09-10 .484 (.392-.599) .560 (.440-.710) 1.30 (1.03-1.46) 2.21 (1.78-2.46) 3.07 (2.39-3.73) 602 
Non-Hispanic blacks 99-00 * < LOD 1.20 (<LOD-2.60) 2.90 (1.70-6.00) 4.80 (2.50-9.20) 518 
 01-02 * .850 (<LOD-1.10) 1.76 (1.36-2.15) 3.13 (2.47-4.26) 4.92 (3.75-6.36) 752 
 07-08 .826 (.716-.952) .860 (.760-1.01) 1.71 (1.45-1.92) 3.15 (2.56-3.90) 4.72 (3.91-5.68) 568 
 09-10 .505 (.381-.670) .570 (.400-.820) 1.30 (1.01-1.50) 2.19 (1.80-2.63) 3.49 (2.57-4.28) 504 
Non-Hispanic whites 99-00 * < LOD < LOD 2.10 (<LOD-6.33) 4.20 (2.10-11.0) 603 
 01-02 * < LOD 1.29 (1.14-1.42) 2.70 (2.38-3.10) 3.71 (3.38-4.00) 1259 
 07-08 .623 (.531-.730) .690 (.610-.790) 1.36 (1.19-1.59) 2.51 (1.89-3.08) 3.63 (2.82-5.48) 1075 
 09-10 .440 (.388-.499) .490 (.410-.580) 1.03 (.930-1.12) 2.18 (1.89-2.48) 3.14 (2.67-3.62) 1197 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 07-08, and 09-10 are 0.8, 0.1, 0.1, and 0.1 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary para-Nitrophenol (creatinine corrected) (1999 - 2010) 
Metabolite of Ethyl Parathion, Methyl Parathion, and Nitrobenzene 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 * < LOD < LOD 2.08 (1.33-3.91) 4.25 (2.15-10.2) 1989 
 01-02 * < LOD .987 (.868-1.10) 1.97 (1.86-2.13) 2.98 (2.60-3.33) 2973 
 07-08 .692 (.632-.757) .673 (.624-.737) 1.28 (1.15-1.40) 2.38 (2.11-2.66) 3.57 (2.94-4.39) 2562 
 09-10 .473 (.430-.521) .490 (.438-.531) .923 (.851-1.01) 1.87 (1.60-2.06) 2.62 (2.32-2.91) 2744 
Age group        
6-11 years 99-00 * < LOD .938 (<LOD-1.95) 2.80 (1.94-4.00) 4.20 (3.33-6.70) 479 
 01-02 * .715 (<LOD-.870) 1.60 (1.30-1.82) 2.78 (2.31-3.11) 3.67 (3.11-4.61) 565 
 07-08 1.02 (.892-1.17) 1.02 (.920-1.12) 1.67 (1.46-1.90) 3.13 (2.51-3.64) 3.76 (3.31-4.89) 383 
 09-10 .684 (.598-.784) .717 (.650-.826) 1.30 (1.10-1.54) 2.19 (2.00-2.59) 3.16 (2.33-3.67) 386 
12-19 years 99-00 * < LOD < LOD 1.80 (1.08-3.04) 4.00 (1.57-7.29) 680 
 01-02 * .373 (<LOD-.503) .840 (.790-.951) 1.59 (1.37-1.78) 2.10 (1.78-2.43) 812 
 07-08 .597 (.511-.698) .581 (.497-.697) 1.02 (.891-1.14) 1.64 (1.29-2.17) 2.92 (1.55-4.54) 385 
 09-10 .368 (.319-.426) .413 (.350-.488) .684 (.615-.732) 1.09 (.930-1.48) 1.73 (1.47-2.09) 401 
20-59 years 99-00 * < LOD < LOD 2.00 (1.17-4.25) 4.29 (2.13-12.3) 830 
 01-02 * < LOD .875 (.693-1.07) 1.79 (1.56-2.05) 2.89 (2.35-3.33) 1099 
 07-08 .656 (.595-.724) .635 (.585-.706) 1.22 (1.09-1.34) 2.19 (1.94-2.51) 3.04 (2.56-4.07) 1173 
 09-10 .452 (.410-.498) .453 (.405-.521) .868 (.805-.981) 1.61 (1.48-1.87) 2.34 (2.08-2.67) 1308 
60 years and older 01-02 * < LOD 1.21 (.920-1.56) 2.29 (1.99-2.83) 4.29 (2.51-5.67) 497 
 07-08 .755 (.643-.886) .763 (.638-.909) 1.59 (1.40-1.73) 3.26 (2.46-4.47) 5.43 (3.33-7.09) 621 
 09-10 .537 (.450-.641) .520 (.451-.636) 1.15 (.899-1.59) 2.53 (2.03-3.39) 4.27 (2.98-5.26) 649 
Gender        
Males 99-00 * < LOD < LOD 1.90 (1.01-3.39) 3.39 (1.77-7.55) 971 
 01-02 * .433 (.333-.534) .984 (.869-1.07) 1.89 (1.66-2.09) 2.98 (2.29-3.57) 1395 
 07-08 .650 (.595-.712) .641 (.594-.697) 1.20 (1.08-1.33) 2.11 (1.63-2.49) 3.02 (2.51-3.71) 1281 
 09-10 .466 (.424-.512) .495 (.432-.538) .922 (.843-.985) 1.84 (1.48-2.05) 2.36 (2.21-2.68) 1342 
Females 99-00 * < LOD < LOD 2.26 (1.48-4.88) 6.92 (2.76-14.1) 1018 
 01-02 * < LOD .995 (.801-1.23) 2.08 (1.85-2.32) 3.04 (2.58-3.44) 1578 
 07-08 .735 (.660-.818) .707 (.644-.779) 1.37 (1.21-1.63) 2.67 (2.20-3.25) 4.11 (3.11-5.06) 1281 
 09-10 .480 (.430-.536) .488 (.426-.538) .923 (.824-1.08) 1.93 (1.62-2.17) 2.72 (2.32-3.46) 1402 
Race/ethnicity        
Mexican Americans 99-00 * < LOD 1.55 (<LOD-3.17) 4.86 (2.21-21.9) 17.4 (3.94-47.7) 695 
 01-02 * .389 (<LOD-.546) .935 (.716-1.22) 1.89 (1.43-2.63) 3.23 (2.49-3.84) 744 
 07-08 .638 (.538-.757) .604 (.554-.708) 1.14 (.938-1.40) 2.03 (1.45-3.57) 3.63 (2.05-4.71) 493 
 09-10 .506 (.419-.612) .541 (.480-.621) 1.02 (.854-1.19) 1.73 (1.39-2.15) 2.35 (1.84-3.02) 602 
Non-Hispanic blacks 99-00 * < LOD .683 (<LOD-1.79) 2.07 (1.33-3.71) 3.71 (1.98-7.20) 518 
 01-02 * .438 (<LOD-.640) 1.04 (.847-1.27) 1.84 (1.59-2.30) 2.81 (2.14-4.30) 751 
 07-08 .633 (.565-.708) .634 (.553-.743) 1.07 (.973-1.23) 2.04 (1.64-2.32) 2.66 (2.11-3.54) 567 
 09-10 .382 (.289-.505) .431 (.312-.554) .785 (.671-.874) 1.36 (1.03-1.99) 2.52 (1.73-3.22) 504 
Non-Hispanic whites 99-00 * < LOD < LOD 1.97 (<LOD-4.29) 3.83 (1.97-10.2) 603 
 01-02 * < LOD .984 (.827-1.16) 2.06 (1.89-2.29) 3.11 (2.49-3.57) 1258 
 07-08 .677 (.604-.759) .664 (.604-.761) 1.25 (1.10-1.38) 2.28 (2.00-2.56) 3.23 (2.60-4.00) 1075 
 09-10 .479 (.433-.530) .490 (.433-.538) .923 (.849-1.03) 1.92 (1.60-2.13) 2.62 (2.24-3.04) 1197 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 






Fourth National Report on Human Exposure to Environmental Chemicals, Updated Tables, January 2017 Volume One Page 149
Urinary 3,5,6-Trichloro-2-pyridinol (1999 - 2010) 
Metabolite of Chlorpyrifos and Chlorpyrifos-methyl 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 1.77 (1.46-2.14) 1.70 (1.40-2.20) 3.50 (2.50-5.20) 7.30 (4.80-10.0) 10.0 (7.70-15.0) 1994 
 01-02 1.72 (1.50-1.97) 2.17 (1.81-2.51) 4.87 (4.45-5.24) 8.80 (7.80-9.77) 12.4 (10.7-15.2) 3011 
 07-08 1.29 (1.20-1.39) 1.48 (1.31-1.65) 2.63 (2.39-2.94) 4.55 (4.03-5.14) 6.11 (5.60-6.93) 2588 
 09-10 .779 (.706-.859) 1.03 (.920-1.16) 1.96 (1.80-2.20) 3.34 (2.96-3.68) 4.47 (4.04-5.15) 2747 
Age group        
6-11 years 99-00 2.88 (1.99-4.16) 2.80 (1.60-4.90) 7.09 (3.40-10.0) 12.0 (7.70-17.0) 16.0 (10.0-28.0) 481 
 01-02 2.67 (2.13-3.35) 3.09 (2.50-4.22) 6.36 (4.97-7.97) 10.9 (7.98-15.3) 15.3 (11.5-24.0) 573 
 07-08 1.72 (1.48-2.01) 1.85 (1.49-2.22) 3.18 (2.58-3.68) 4.69 (3.90-5.74) 6.04 (5.12-7.63) 385 
 09-10 1.12 (.899-1.39) 1.46 (1.27-1.64) 2.38 (1.96-2.75) 4.29 (2.67-6.07) 5.81 (4.14-7.16) 386 
12-19 years 99-00 2.37 (1.89-2.97) 2.10 (1.60-3.00) 4.50 (2.90-7.10) 8.10 (5.50-14.0) 12.5 (8.00-24.0) 681 
 01-02 2.71 (2.19-3.35) 3.57 (2.66-4.34) 6.60 (5.61-7.59) 11.3 (8.66-15.1) 18.0 (13.7-23.7) 823 
 07-08 1.54 (1.27-1.86) 1.81 (1.39-2.20) 2.75 (2.34-3.29) 4.70 (3.66-5.72) 6.33 (4.98-7.96) 390 
 09-10 .884 (.793-.985) 1.08 (.960-1.30) 1.89 (1.64-2.28) 3.04 (2.28-4.21) 4.30 (3.14-5.60) 401 
20-59 years 99-00 1.53 (1.29-1.83) 1.50 (1.30-1.80) 2.90 (2.20-4.30) 5.90 (3.90-8.90) 8.90 (6.70-11.0) 832 
 01-02 1.51 (1.32-1.72) 1.91 (1.44-2.26) 4.44 (3.90-4.80) 7.78 (7.00-8.91) 10.9 (9.52-12.4) 1113 
 07-08 1.19 (1.07-1.33) 1.36 (1.22-1.53) 2.55 (2.21-2.98) 4.46 (3.82-5.30) 5.85 (5.40-6.93) 1180 
 09-10 .710 (.634-.795) .970 (.860-1.12) 1.89 (1.70-2.07) 3.14 (2.81-3.49) 4.18 (3.66-4.73) 1309 
60 years and older 01-02 1.51 (1.21-1.89) 1.76 (1.22-2.33) 4.36 (3.54-5.08) 9.11 (6.67-13.0) 13.5 (11.2-15.5) 502 
 07-08 1.31 (1.17-1.47) 1.51 (1.27-1.70) 2.51 (2.34-2.78) 4.64 (3.97-5.81) 6.69 (5.14-8.14) 633 
 09-10 .812 (.710-.929) .990 (.870-1.15) 2.30 (1.73-2.58) 3.90 (3.16-4.67) 5.32 (4.23-6.85) 651 
Gender        
Males 99-00 1.92 (1.60-2.32) 1.90 (1.50-2.40) 3.60 (2.70-5.60) 7.40 (5.04-10.0) 10.0 (7.70-16.0) 972 
 01-02 2.13 (1.82-2.49) 2.67 (2.24-3.16) 5.33 (4.81-6.05) 9.69 (8.45-11.5) 15.0 (11.7-17.7) 1416 
 07-08 1.49 (1.36-1.64) 1.70 (1.49-1.92) 2.85 (2.50-3.17) 4.87 (4.17-5.52) 6.01 (5.56-6.67) 1293 
 09-10 .865 (.775-.965) 1.16 (1.03-1.27) 2.10 (1.87-2.35) 3.50 (2.97-3.93) 4.66 (3.96-5.84) 1343 
Females 99-00 1.63 (1.31-2.02) 1.50 (1.20-2.00) 3.30 (2.30-5.30) 7.20 (4.30-12.0) 11.0 (7.20-16.0) 1022 
 01-02 1.40 (1.21-1.62) 1.63 (1.32-2.01) 4.31 (3.57-4.84) 7.78 (6.52-9.20) 10.9 (8.62-13.2) 1595 
 07-08 1.13 (1.04-1.22) 1.26 (1.13-1.40) 2.41 (2.15-2.79) 4.32 (3.76-4.98) 6.30 (5.27-7.59) 1295 
 09-10 .704 (.631-.786) .940 (.830-1.04) 1.88 (1.63-2.11) 3.22 (2.78-3.72) 4.40 (4.09-4.73) 1404 
Race/ethnicity        
Mexican Americans 99-00 1.61 (1.31-2.00) 1.67 (1.30-2.20) 3.20 (2.60-3.80) 5.10 (3.80-8.40) 7.40 (5.10-17.0) 697 
 01-02 1.98 (1.77-2.21) 2.54 (2.21-2.89) 4.55 (4.09-5.22) 8.94 (7.06-10.4) 11.9 (10.0-15.7) 744 
 07-08 1.13 (.926-1.38) 1.26 (1.06-1.53) 2.34 (1.89-2.94) 4.04 (3.13-4.92) 5.36 (4.37-7.16) 500 
 09-10 .761 (.650-.892) .950 (.850-1.18) 1.90 (1.66-2.11) 3.31 (2.76-4.19) 4.64 (4.19-5.46) 602 
Non-Hispanic blacks 99-00 2.17 (1.59-2.97) 1.90 (1.43-2.80) 4.30 (2.50-8.30) 9.40 (6.40-13.7) 13.0 (9.40-26.0) 521 
 01-02 2.14 (1.61-2.84) 2.85 (2.16-3.38) 5.45 (4.57-6.96) 9.27 (7.21-11.7) 12.9 (9.57-17.5) 776 
 07-08 1.64 (1.36-1.97) 1.86 (1.47-2.24) 3.22 (2.65-4.17) 5.79 (4.85-7.17) 7.97 (6.49-9.58) 574 
 09-10 .918 (.823-1.02) 1.22 (1.06-1.38) 2.24 (2.00-2.52) 3.49 (2.99-4.14) 4.99 (3.93-6.17) 504 
Non-Hispanic whites 99-00 1.76 (1.51-2.05) 1.70 (1.50-2.10) 3.50 (2.50-4.86) 7.10 (4.30-11.0) 10.0 (7.20-14.0) 602 
 01-02 1.67 (1.44-1.94) 2.11 (1.64-2.47) 4.85 (4.38-5.29) 8.91 (7.63-9.97) 12.9 (10.4-15.7) 1267 
 07-08 1.23 (1.16-1.30) 1.44 (1.27-1.58) 2.57 (2.35-2.83) 4.41 (3.89-4.87) 5.69 (5.40-6.14) 1084 
 09-10 .768 (.667-.885) 1.03 (.890-1.18) 1.96 (1.71-2.31) 3.42 (2.93-3.86) 4.46 (3.93-5.32) 1200 
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Urinary 3,5,6-Trichloro-2-pyridinol (creatinine corrected) (1999 - 2010) 
Metabolite of Chlorpyrifos and Chlorpyrifos-methyl 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 1.58 (1.35-1.85) 1.47 (1.24-1.74) 2.85 (2.12-3.59) 5.43 (4.22-6.68) 8.42 (6.25-11.6) 1994 
 01-02 1.75 (1.53-2.00) 1.94 (1.66-2.25) 3.80 (3.13-4.48) 6.53 (5.24-8.23) 9.27 (7.46-12.1) 3009 
 07-08 1.33 (1.22-1.44) 1.34 (1.25-1.48) 2.29 (2.06-2.48) 3.80 (3.44-4.15) 4.91 (4.47-5.83) 2586 
 09-10 .812 (.748-.881) .979 (.917-1.05) 1.66 (1.52-1.80) 2.67 (2.40-2.94) 3.53 (3.15-4.02) 2747 
Age group        
6-11 years 99-00 3.11 (2.31-4.19) 3.20 (2.05-4.80) 6.39 (4.14-8.19) 10.1 (7.26-14.0) 14.1 (10.1-21.0) 481 
 01-02 3.48 (2.80-4.32) 3.76 (3.17-4.36) 6.22 (4.88-8.57) 12.2 (7.24-24.4) 16.9 (12.1-38.0) 573 
 07-08 2.18 (1.89-2.53) 2.21 (1.86-2.66) 3.23 (2.86-3.89) 4.67 (4.23-5.00) 5.94 (4.76-6.58) 385 
 09-10 1.51 (1.28-1.78) 1.77 (1.49-1.95) 2.62 (2.26-2.90) 3.67 (2.93-4.42) 4.42 (3.76-5.95) 386 
12-19 years 99-00 1.60 (1.34-1.91) 1.45 (1.21-1.81) 2.58 (1.98-3.92) 4.83 (3.44-6.16) 6.16 (4.43-10.6) 681 
 01-02 2.09 (1.72-2.55) 2.24 (1.92-2.66) 3.97 (3.30-4.72) 6.33 (5.62-7.89) 10.3 (7.65-15.2) 822 
 07-08 1.19 (1.05-1.34) 1.20 (1.05-1.33) 1.85 (1.61-2.22) 2.66 (2.32-3.62) 4.00 (2.70-5.77) 388 
 09-10 .757 (.675-.850) .861 (.766-.935) 1.34 (1.15-1.55) 2.27 (1.55-2.68) 2.67 (2.13-4.21) 401 
20-59 years 99-00 1.41 (1.23-1.62) 1.33 (1.12-1.58) 2.37 (1.87-3.01) 4.29 (3.53-5.56) 6.42 (5.11-9.02) 832 
 01-02 1.49 (1.30-1.71) 1.64 (1.39-1.88) 3.11 (2.60-3.91) 5.51 (4.33-7.23) 7.44 (5.80-11.0) 1113 
 07-08 1.19 (1.09-1.30) 1.22 (1.10-1.33) 2.04 (1.78-2.32) 3.42 (2.93-3.96) 4.84 (3.96-6.31) 1180 
 09-10 .710 (.644-.784) .875 (.813-.943) 1.47 (1.35-1.62) 2.27 (1.99-2.66) 3.20 (2.75-3.64) 1309 
60 years and older 01-02 1.84 (1.55-2.18) 2.15 (1.71-2.60) 4.08 (3.61-4.84) 7.43 (6.50-8.50) 11.2 (7.95-13.5) 501 
 07-08 1.61 (1.43-1.81) 1.68 (1.48-1.92) 2.88 (2.38-3.46) 4.46 (3.87-4.91) 5.59 (4.64-7.03) 633 
 09-10 .963 (.838-1.11) 1.18 (1.01-1.34) 2.03 (1.87-2.19) 3.14 (2.73-4.02) 4.36 (3.47-5.36) 651 
Gender        
Males 99-00 1.48 (1.27-1.72) 1.44 (1.19-1.68) 2.54 (2.05-3.38) 4.95 (3.84-6.54) 7.63 (5.65-11.0) 972 
 01-02 1.75 (1.51-2.02) 1.93 (1.66-2.24) 3.61 (3.01-4.22) 6.33 (5.08-8.88) 11.3 (7.54-13.5) 1416 
 07-08 1.24 (1.13-1.35) 1.29 (1.15-1.46) 2.12 (1.87-2.34) 3.44 (3.03-3.78) 4.41 (3.82-4.97) 1292 
 09-10 .769 (.712-.831) .930 (.863-.988) 1.55 (1.39-1.70) 2.54 (2.18-2.80) 3.41 (3.01-3.93) 1343 
Females 99-00 1.69 (1.42-2.01) 1.51 (1.25-1.85) 2.97 (2.25-4.02) 5.63 (4.27-7.39) 8.44 (5.79-13.3) 1022 
 01-02 1.75 (1.52-2.02) 1.96 (1.61-2.30) 3.96 (3.16-4.78) 6.58 (5.37-7.95) 8.98 (7.07-11.8) 1593 
 07-08 1.42 (1.30-1.55) 1.40 (1.29-1.53) 2.43 (2.22-2.70) 4.18 (3.73-4.74) 5.77 (4.76-7.03) 1294 
 09-10 .855 (.765-.954) 1.04 (.951-1.14) 1.76 (1.60-1.96) 2.79 (2.40-3.18) 3.68 (3.18-4.10) 1404 
Race/ethnicity        
Mexican Americans 99-00 1.46 (1.20-1.77) 1.44 (1.05-1.93) 2.39 (2.09-2.96) 3.86 (3.24-5.09) 5.85 (3.88-9.57) 697 
 01-02 1.86 (1.64-2.10) 2.06 (1.85-2.30) 3.79 (3.23-4.46) 6.52 (5.73-7.58) 8.71 (7.68-11.0) 744 
 07-08 1.15 (.895-1.46) 1.18 (.941-1.50) 1.97 (1.55-2.38) 3.04 (2.31-4.41) 4.41 (2.92-7.11) 499 
 09-10 .796 (.680-.930) .959 (.821-1.07) 1.58 (1.39-1.76) 2.61 (2.25-2.99) 3.46 (3.16-4.01) 602 
Non-Hispanic blacks 99-00 1.47 (1.09-1.99) 1.33 (.936-1.94) 2.86 (1.58-5.05) 5.91 (4.05-8.93) 9.02 (5.91-13.7) 521 
 01-02 1.58 (1.19-2.08) 1.95 (1.56-2.48) 3.53 (2.84-4.28) 5.60 (4.68-6.40) 7.21 (5.83-9.11) 775 
 07-08 1.25 (1.05-1.49) 1.24 (1.03-1.47) 2.25 (1.86-2.86) 3.91 (3.13-4.68) 5.39 (4.12-8.30) 573 
 09-10 .694 (.613-.786) .813 (.698-.981) 1.41 (1.28-1.62) 2.28 (2.00-2.55) 2.93 (2.55-3.50) 504 
Non-Hispanic whites 99-00 1.66 (1.45-1.91) 1.55 (1.31-1.83) 2.93 (2.09-3.97) 5.56 (4.21-6.75) 8.44 (6.25-12.3) 602 
 01-02 1.81 (1.55-2.11) 2.00 (1.65-2.35) 3.91 (3.03-4.91) 6.94 (5.24-9.22) 10.6 (7.76-12.6) 1266 
 07-08 1.33 (1.22-1.45) 1.37 (1.26-1.53) 2.31 (2.02-2.54) 3.76 (3.40-4.03) 4.73 (4.35-5.68) 1084 
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Urinary Diethylphosphate (DEP) (1999 – 2008) 
Metabolite of Several Organophosphorus Insecticides 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 1.03 (.670-1.58) 1.20 (.750-1.70) 3.20 (2.30-4.80) 7.60 (5.00-12.0) 13.0 (7.70-23.0) 1949 
 01-02 * < LOD 2.90 (2.50-3.26) 6.68 (5.78-7.52) 10.6 (9.14-12.0) 3018 
 03-04 * < LOD 4.56 (3.57-5.83) 10.2 (9.00-11.5) 15.5 (13.5-16.8) 2453 
 05-06 * < LOD 1.46 (.780-2.17) 7.01 (5.67-8.94) 13.3 (10.2-16.0) 2635 
 07-08 * < LOD 2.48 (1.44-3.33) 8.74 (7.51-10.3) 15.3 (13.1-17.8) 2591 
Age group        
6-11 years 99-00 1.32 (.757-2.29) 1.50 (.860-2.60) 4.50 (2.10-7.90) 11.0 (4.80-24.0) 16.0 (8.50-36.0) 471 
 01-02 * .290 (<LOD-1.04) 3.45 (2.36-4.47) 9.56 (6.33-18.0) 20.0 (9.44-38.2) 576 
 03-04 * < LOD 5.13 (2.48-7.94) 10.9 (8.08-15.9) 16.1 (10.9-18.5) 308 
 05-06 * < LOD 1.45 (<LOD-4.51) 8.21 (4.85-13.4) 13.5 (8.36-20.4) 350 
 07-08 * < LOD 4.31 (.420-6.49) 12.9 (9.14-17.7) 20.2 (11.9-37.5) 385 
12-19 years 99-00 1.21 (.758-1.94) 1.40 (.970-2.10) 3.70 (2.40-5.50) 8.00 (4.70-19.0) 20.0 (8.00-27.0) 664 
 01-02 * < LOD 2.86 (1.96-3.95) 7.58 (5.71-9.15) 11.0 (9.35-12.4) 822 
 03-04 * .530 (<LOD-2.32) 5.80 (4.34-7.67) 14.8 (9.12-19.8) 20.8 (14.8-32.7) 701 
 05-06 * < LOD .460 (<LOD-3.69) 9.47 (4.67-14.1) 14.4 (10.2-22.4) 718 
 07-08 * < LOD 3.81 (<LOD-5.42) 10.7 (7.76-14.2) 23.3 (11.3-35.6) 391 
20-59 years 99-00 .955 (.623-1.47) 1.10 (.700-1.60) 3.00 (1.80-4.80) 7.30 (4.70-11.0) 11.0 (6.80-22.0) 814 
 01-02 * < LOD 2.71 (2.34-3.12) 5.79 (5.05-7.21) 10.4 (7.43-12.3) 1122 
 03-04 * < LOD 4.37 (3.02-5.81) 9.74 (8.35-11.3) 14.2 (11.5-16.2) 922 
 05-06 * < LOD 1.13 (<LOD-2.17) 6.15 (4.51-8.24) 11.5 (8.23-15.5) 1092 
 07-08 * < LOD 1.55 (.470-2.48) 7.54 (6.10-8.98) 14.0 (9.62-15.7) 1178 
60 years and older 01-02 * .440 (<LOD-1.63) 3.30 (2.63-4.51) 7.06 (5.17-8.69) 9.41 (8.31-10.6) 498 
 03-04 * 1.80 (<LOD-2.98) 4.73 (3.98-5.91) 10.0 (8.09-11.3) 13.6 (10.6-16.7) 522 
 05-06 * < LOD 2.69 (1.71-3.95) 8.33 (6.60-12.0) 16.3 (12.0-18.7) 475 
 07-08 * < LOD 3.55 (2.80-5.31) 9.86 (7.53-14.2) 17.1 (12.6-22.1) 637 
Gender        
Males 99-00 1.11 (.717-1.73) 1.20 (.810-1.70) 3.80 (2.50-5.00) 8.00 (5.00-19.0) 19.0 (7.20-30.0) 952 
 01-02 * < LOD 3.21 (2.72-3.56) 6.99 (5.83-7.71) 11.5 (9.36-12.1) 1420 
 03-04 * < LOD 5.01 (3.90-6.50) 11.0 (10.1-12.7) 16.2 (14.3-18.8) 1198 
 05-06 * < LOD .770 (<LOD-1.71) 6.82 (5.14-9.54) 13.4 (9.36-16.1) 1246 
 07-08 * < LOD 1.95 (<LOD-3.34) 9.39 (7.90-11.8) 17.0 (13.7-21.5) 1295 
Females 99-00 .954 (.599-1.52) 1.20 (.620-1.70) 2.90 (1.90-4.80) 7.50 (4.60-11.0) 11.0 (7.40-16.0) 997 
 01-02 * .290 (<LOD-.790) 2.63 (2.22-3.03) 6.21 (4.59-8.64) 10.2 (7.52-14.7) 1598 
 03-04 * .110 (<LOD-2.29) 4.29 (3.21-5.80) 9.38 (7.95-10.7) 13.3 (11.2-15.9) 1255 
 05-06 * < LOD 2.15 (1.27-2.76) 7.23 (5.79-9.32) 12.9 (9.64-16.0) 1389 
 07-08 * < LOD 2.76 (1.69-3.62) 7.76 (6.23-10.7) 14.5 (10.7-18.8) 1296 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 05-06, and 07-08 are 0.2, 0.2, 0.1, 0.37,and 0.37 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 1.22 (.740-2.01) 1.20 (.840-1.80) 4.10 (2.20-7.00) 11.0 (6.40-19.0) 18.0 (12.0-27.0) 672 
 01-02 * .600 (<LOD-1.49) 3.07 (2.22-3.83) 6.26 (5.00-7.82) 11.2 (7.82-12.3) 763 
 03-04 * 1.18 (<LOD-2.97) 5.81 (3.99-7.59) 11.0 (8.48-16.1) 16.9 (12.1-24.0) 581 
 05-06 * < LOD < LOD 6.30 (1.57-11.6) 14.9 (5.72-33.5) 695 
 07-08 * < LOD 1.63 (<LOD-3.88) 8.36 (6.44-9.61) 14.8 (8.85-25.1) 501 
Non-Hispanic blacks 99-00 1.56 (1.13-2.14) 1.60 (1.40-1.80) 4.30 (2.90-5.80) 10.0 (5.60-18.0) 18.0 (8.00-27.0) 509 
 01-02 * 1.03 (<LOD-2.33) 4.81 (3.48-6.52) 9.98 (7.39-13.3) 15.1 (9.81-23.4) 756 
 03-04 * 1.04 (<LOD-3.28) 6.29 (5.05-8.44) 11.9 (9.92-15.5) 16.2 (14.1-22.5) 628 
 05-06 * < LOD 2.10 (<LOD-4.57) 8.87 (6.52-12.0) 14.3 (11.2-19.1) 723 
 07-08 * < LOD 3.92 (2.67-5.19) 11.3 (9.44-14.0) 19.5 (14.1-22.0) 574 
Non-Hispanic whites 99-00 .981 (.579-1.66) 1.10 (.490-2.10) 3.30 (2.20-4.90) 7.70 (4.70-14.0) 14.0 (7.60-25.0) 595 
 01-02 * < LOD 2.63 (2.21-3.13) 5.79 (5.05-7.35) 9.90 (8.38-11.7) 1253 
 03-04 * < LOD 4.25 (3.12-5.77) 9.74 (8.37-11.3) 14.4 (12.4-16.0) 1055 
 05-06 * < LOD 1.50 (.900-2.27) 6.82 (5.08-9.74) 13.3 (8.37-16.9) 1007 
 07-08 * < LOD 2.14 (1.27-3.03) 7.57 (6.57-8.97) 14.5 (11.4-16.5) 1086 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 05-06, and 07-08 are 0.2, 0.2, 0.1, 0.37,and 0.37 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 .924 (.608-1.41) .920 (.570-1.40) 2.73 (1.68-4.60) 7.94 (4.40-12.2) 12.2 (8.00-19.6) 1949 
 01-02 * < LOD 2.56 (2.17-2.85) 5.36 (4.75-6.06) 8.72 (7.19-10.3) 3017 
 03-04 * < LOD 4.64 (3.82-5.79) 9.18 (7.85-10.8) 13.1 (10.5-16.1) 2450 
 05-06 * < LOD 2.23 (1.49-3.09) 7.72 (6.26-9.36) 13.5 (11.0-19.0) 2634 
 07-08 * < LOD 3.20 (2.37-4.12) 8.86 (7.52-10.7) 15.7 (11.9-19.8) 2589 
Age group        
6-11 years 99-00 1.43 (.870-2.34) 1.47 (1.02-2.41) 3.94 (2.20-8.57) 10.5 (4.55-20.8) 16.6 (10.5-32.7) 471 
 01-02 * .886 (<LOD-1.76) 4.02 (2.87-5.25) 8.85 (6.88-15.6) 18.4 (9.40-28.8) 576 
 03-04 * < LOD 6.10 (3.79-9.03) 11.9 (9.54-15.2) 16.1 (11.9-28.3) 308 
 05-06 * < LOD 3.09 (<LOD-6.77) 9.50 (5.67-17.6) 20.7 (9.50-26.5) 350 
 07-08 * < LOD 4.67 (2.01-6.96) 17.2 (13.1-20.3) 28.2 (19.3-34.8) 385 
12-19 years 99-00 .818 (.533-1.26) .790 (.560-1.25) 2.35 (1.37-3.75) 5.44 (2.82-14.4) 12.4 (4.66-34.2) 664 
 01-02 * < LOD 2.05 (1.54-2.67) 4.40 (3.40-5.28) 7.28 (5.28-9.75) 821 
 03-04 * .438 (<LOD-2.05) 4.47 (3.90-5.43) 10.1 (7.10-13.5) 14.7 (9.82-26.4) 699 
 05-06 * < LOD 1.27 (<LOD-2.81) 6.74 (4.24-9.87) 11.7 (6.98-16.6) 718 
 07-08 * < LOD 2.86 (<LOD-4.53) 8.56 (5.70-17.0) 17.0 (8.05-23.0) 389 
20-59 years 99-00 .883 (.574-1.36) .860 (.500-1.35) 2.66 (1.54-4.95) 7.37 (4.32-12.1) 12.1 (8.00-17.5) 814 
 01-02 * < LOD 2.28 (2.01-2.56) 4.75 (3.92-5.83) 7.37 (5.93-9.72) 1122 
 03-04 * < LOD 4.29 (2.98-5.71) 8.35 (6.09-11.3) 11.9 (9.02-14.7) 921 
 05-06 * < LOD 1.92 (<LOD-2.95) 6.64 (5.22-9.25) 12.3 (9.25-19.4) 1091 
 07-08 * < LOD 2.38 (1.81-3.27) 7.45 (6.11-9.43) 11.4 (9.22-15.8) 1178 
60+ years 01-02 * 1.00 (<LOD-1.88) 3.29 (2.74-4.14) 6.52 (4.92-8.21) 9.82 (7.05-14.4) 498 
 03-04 * 2.39 (<LOD-3.35) 5.65 (4.36-7.50) 9.44 (8.38-10.5) 13.3 (10.5-18.2) 522 
 05-06 * < LOD 3.75 (2.30-5.14) 9.88 (7.72-12.6) 19.3 (12.6-26.6) 475 
 07-08 * < LOD 5.28 (4.03-6.23) 11.8 (9.36-14.4) 17.7 (13.2-21.9) 637 
Gender        
Males 99-00 .855 (.566-1.29) .820 (.510-1.34) 2.61 (1.76-4.03) 7.69 (4.41-12.1) 12.2 (6.94-23.8) 952 
 01-02 * < LOD 2.20 (1.86-2.64) 4.49 (3.92-5.31) 7.50 (5.79-9.10) 1420 
 03-04 * < LOD 4.20 (3.28-5.30) 8.35 (7.10-10.1) 12.0 (9.33-14.7) 1197 
 05-06 * < LOD 1.16 (<LOD-2.25) 6.24 (4.58-7.63) 10.0 (7.60-17.8) 1246 
 07-08 * < LOD 2.17 (<LOD-3.23) 8.14 (6.35-10.7) 13.6 (9.79-18.6) 1294 
Females 99-00 .996 (.620-1.60) .960 (.540-1.62) 2.81 (1.45-5.85) 8.00 (4.00-13.0) 12.1 (6.67-19.6) 997 
 01-02 * .778 (<LOD-1.31) 2.81 (2.44-3.33) 6.49 (4.95-7.76) 9.61 (7.12-13.6) 1597 
 03-04 * .636 (<LOD-2.84) 5.06 (4.03-6.86) 9.85 (8.25-11.8) 13.8 (10.9-20.3) 1253 
 05-06 * < LOD 3.50 (2.43-4.11) 9.36 (6.91-11.8) 16.5 (12.4-22.3) 1388 
 07-08 * < LOD 4.09 (2.80-4.91) 9.46 (8.43-11.5) 16.5 (13.1-20.9) 1295 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 1.09 (.633-1.89) 1.05 (.650-1.98) 3.78 (2.11-6.46) 9.84 (5.66-15.7) 15.7 (8.61-29.0) 672 
 01-02 * .891 (<LOD-1.41) 2.39 (1.77-3.14) 5.17 (4.10-6.53) 8.04 (6.40-10.9) 763 
 03-04 * 1.07 (<LOD-2.79) 4.94 (3.30-7.01) 9.94 (7.89-13.3) 16.6 (10.1-22.4) 580 
 05-06 * < LOD < LOD 6.26 (3.71-10.1) 14.9 (5.75-37.3) 695 
 07-08 * < LOD 3.19 (<LOD-4.27) 8.56 (6.00-10.3) 13.3 (9.77-15.9) 500 
Non-Hispanic blacks 99-00 1.07 (.773-1.47) 1.18 (.830-1.54) 2.61 (1.89-3.47) 5.98 (3.94-9.56) 11.9 (5.98-22.2) 509 
 01-02 * .797 (<LOD-1.62) 2.98 (2.57-3.61) 6.91 (5.17-8.69) 9.58 (7.82-12.1) 755 
 03-04 * .741 (<LOD-2.21) 4.25 (3.46-5.36) 8.30 (6.57-10.7) 11.7 (10.5-13.2) 627 
 05-06 * < LOD 1.92 (<LOD-3.58) 7.08 (5.16-9.35) 11.4 (8.91-12.3) 722 
 07-08 * < LOD 3.33 (2.33-4.15) 8.72 (7.27-10.2) 16.7 (11.5-19.4) 573 
Non-Hispanic whites 99-00 .932 (.549-1.58) .900 (.430-1.68) 2.87 (1.51-5.88) 8.57 (4.40-14.4) 13.0 (8.21-23.8) 595 
 01-02 * < LOD 2.52 (2.08-2.95) 5.26 (4.57-5.93) 8.26 (6.61-10.8) 1253 
 03-04 * < LOD 4.65 (3.73-5.87) 9.12 (7.79-11.2) 12.7 (10.1-15.7) 1054 
 05-06 * < LOD 2.50 (1.74-3.30) 7.72 (6.24-9.25) 13.9 (10.0-19.5) 1007 
 07-08 * < LOD 3.10 (2.19-4.18) 8.44 (6.84-9.74) 13.6 (10.9-17.5) 1086 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 * .740 (<LOD-1.40) 2.90 (2.10-4.00) 7.90 (6.20-8.90) 14.0 (10.0-19.0) 1949 
 01-02 * < LOD 3.32 (2.90-3.74) 8.40 (7.11-9.23) 13.4 (11.4-14.9) 3017 
 03-04 * < LOD 4.15 (3.39-4.94) 9.54 (7.46-11.9) 15.1 (12.8-18.2) 2494 
 05-06 * < LOD 5.21 (4.15-6.56) 17.2 (13.8-20.5) 29.6 (24.3-35.2) 2635 
 07-08 * < LOD 7.91 (6.64-9.07) 20.8 (18.2-24.4) 35.6 (30.3-39.4) 2593 
Age group        
6-11 years 99-00 1.58 (1.15-2.18) 1.10 (.580-2.20) 4.40 (2.80-6.80) 10.0 (7.80-21.0) 22.0 (15.0-33.0) 471 
 01-02 * .970 (<LOD-2.00) 5.04 (3.31-7.66) 12.2 (9.10-15.1) 18.3 (12.6-41.7) 576 
 03-04 * < LOD 4.53 (3.34-5.96) 11.0 (5.62-17.9) 16.2 (7.46-28.3) 310 
 05-06 * < LOD 9.92 (3.24-20.0) 27.1 (16.5-46.6) 46.6 (27.1-63.0) 350 
 07-08 * < LOD 12.5 (7.22-16.4) 29.7 (20.3-39.1) 43.3 (29.7-62.7) 385 
12-19 years 99-00 * .670 (<LOD-1.80) 3.80 (2.50-4.90) 9.90 (6.20-18.0) 22.0 (13.0-29.0) 664 
 01-02 * .670 (<LOD-1.31) 4.27 (3.41-5.35) 9.27 (7.80-12.3) 14.7 (11.8-21.3) 822 
 03-04 * 1.20 (<LOD-2.27) 4.61 (3.47-6.72) 10.9 (7.90-15.0) 20.9 (12.5-26.8) 717 
 05-06 * < LOD 7.32 (1.35-12.4) 22.6 (16.1-36.1) 44.0 (27.6-54.0) 718 
 07-08 * < LOD 10.0 (7.22-14.5) 25.5 (16.8-35.6) 36.2 (25.5-49.6) 391 
20-59 years 99-00 * .680 (<LOD-1.30) 2.70 (1.80-3.70) 6.60 (5.70-8.10) 9.70 (8.80-14.0) 814 
 01-02 * < LOD 2.95 (2.35-3.41) 6.95 (5.80-8.82) 11.5 (9.66-13.7) 1121 
 03-04 * < LOD 3.75 (2.84-4.88) 8.52 (6.86-10.7) 14.1 (10.8-17.5) 938 
 05-06 * < LOD 4.09 (2.45-6.03) 13.8 (9.82-19.8) 24.6 (19.8-32.8) 1092 
 07-08 * < LOD 6.07 (4.26-7.69) 18.0 (13.6-22.6) 30.3 (23.2-37.9) 1180 
60 years and older 01-02 * .700 (<LOD-1.50) 3.68 (2.91-4.56) 8.93 (6.79-10.7) 14.4 (9.60-19.1) 498 
 03-04 * 2.04 (<LOD-2.63) 4.60 (3.83-5.15) 11.3 (7.68-13.4) 16.3 (12.4-19.4) 529 
 05-06 * < LOD 6.75 (4.75-9.32) 16.8 (11.7-22.1) 26.3 (18.9-38.8) 475 
 07-08 * < LOD 10.8 (8.64-13.0) 24.9 (19.2-32.4) 40.5 (32.5-47.4) 637 
Gender        
Males 99-00 * .670 (<LOD-1.30) 2.90 (2.20-4.00) 7.90 (6.00-9.30) 18.0 (10.0-24.0) 952 
 01-02 * < LOD 3.49 (2.90-4.15) 8.40 (6.95-10.3) 12.8 (11.3-14.7) 1420 
 03-04 * < LOD 4.03 (3.30-4.91) 8.49 (6.82-11.9) 15.1 (11.3-20.0) 1221 
 05-06 * < LOD 4.10 (2.37-6.40) 15.9 (12.4-20.9) 28.1 (22.3-36.7) 1246 
 07-08 * < LOD 7.75 (6.50-9.63) 20.8 (17.6-26.6) 36.1 (27.0-47.4) 1295 
Females 99-00 * .790 (<LOD-1.60) 2.90 (2.00-4.20) 7.80 (5.70-9.00) 11.0 (9.00-18.0) 997 
 01-02 * < LOD 3.06 (2.63-3.63) 8.38 (6.56-9.63) 13.7 (10.9-17.6) 1597 
 03-04 * 1.08 (<LOD-1.92) 4.29 (3.31-5.28) 10.4 (7.64-12.9) 14.8 (13.3-18.0) 1273 
 05-06 * < LOD 6.40 (5.04-7.21) 18.7 (14.6-20.8) 30.9 (24.6-41.1) 1389 
 07-08 * < LOD 7.91 (6.18-9.36) 20.6 (16.5-25.5) 34.2 (26.6-41.5) 1298 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 05-06, and 07-08 are 0.58, 0.5, 0.5, 0.47,and 0.47 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 * 1.10 (<LOD-1.80) 3.80 (2.70-5.30) 9.60 (6.00-16.0) 16.0 (8.90-31.0) 672 
 01-02 * .710 (<LOD-1.52) 3.34 (2.45-4.42) 9.13 (7.29-10.7) 14.4 (11.0-20.6) 763 
 03-04 * < LOD 4.37 (3.12-6.86) 10.3 (7.85-17.4) 22.3 (9.61-31.6) 610 
 05-06 * < LOD 2.65 (<LOD-6.47) 18.9 (13.3-27.9) 39.0 (30.0-47.2) 695 
 07-08 * < LOD 6.85 (3.69-8.82) 20.9 (14.1-26.4) 35.6 (26.3-49.4) 501 
Non-Hispanic blacks 99-00 1.42 (1.16-1.74) 1.00 (.650-1.50) 3.60 (2.50-5.50) 8.90 (6.90-15.0) 21.0 (14.0-24.0) 509 
 01-02 * .890 (<LOD-2.20) 4.71 (3.68-6.62) 10.7 (8.54-13.9) 19.4 (14.7-22.8) 755 
 03-04 * < LOD 5.28 (4.18-6.37) 10.8 (8.33-12.5) 15.8 (12.2-23.4) 631 
 05-06 * < LOD 9.16 (2.74-15.1) 22.7 (18.2-33.7) 42.5 (27.3-61.9) 723 
 07-08 * < LOD 8.67 (6.43-11.1) 23.7 (18.3-28.6) 38.0 (27.7-48.1) 574 
Non-Hispanic whites 99-00 * < LOD 2.90 (1.80-4.20) 7.90 (5.90-9.00) 11.0 (9.00-18.0) 595 
 01-02 * < LOD 3.13 (2.49-3.58) 7.79 (6.67-9.22) 12.5 (10.3-14.7) 1253 
 03-04 * < LOD 3.95 (3.23-4.91) 8.83 (6.56-12.5) 14.8 (11.9-20.0) 1061 
 05-06 * < LOD 5.04 (3.60-6.75) 15.3 (11.8-20.5) 27.8 (20.8-36.7) 1007 
 07-08 * < LOD 7.46 (6.27-9.03) 20.7 (17.5-25.5) 35.6 (28.7-39.1) 1088 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 05-06, and 07-08 are 0.58, 0.5, 0.5, 0.47,and 0.47 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 * .810 (<LOD-1.15) 2.93 (2.11-3.92) 8.50 (6.96-10.4) 16.1 (13.3-17.6) 1949 
 01-02 * < LOD 3.16 (2.69-3.59) 8.00 (7.12-9.28) 12.9 (11.5-15.0) 3016 
 03-04 * < LOD 4.05 (3.50-5.15) 9.96 (8.78-11.2) 15.0 (13.0-18.1) 2491 
 05-06 * < LOD 5.97 (4.75-7.43) 18.0 (15.9-20.5) 27.9 (24.0-32.7) 2634 
 07-08 * < LOD 9.10 (8.08-10.2) 20.0 (18.0-24.2) 33.6 (28.8-40.2) 2591 
Age group        
6-11 years 99-00 1.71 (1.29-2.27) 1.38 (.890-2.38) 4.48 (2.88-7.89) 16.7 (8.21-21.2) 22.1 (19.2-30.1) 471 
 01-02 * 1.93 (<LOD-2.97) 5.99 (4.32-8.28) 12.9 (9.34-18.5) 20.6 (13.3-34.8) 576 
 03-04 * < LOD 6.87 (3.80-9.00) 13.9 (9.68-19.3) 19.6 (13.9-25.9) 310 
 05-06 * < LOD 12.4 (6.71-21.9) 41.2 (23.4-62.2) 71.5 (37.9-107) 350 
 07-08 * < LOD 15.6 (10.8-21.6) 35.3 (27.6-39.2) 54.3 (36.5-67.1) 385 
12-19 years 99-00 * .590 (<LOD-.950) 2.28 (1.70-2.80) 7.78 (4.16-14.4) 16.0 (8.70-35.3) 664 
 01-02 * .913 (<LOD-1.27) 3.29 (2.76-3.78) 6.29 (5.51-7.30) 9.83 (7.94-14.2) 821 
 03-04 * 1.00 (<LOD-1.68) 4.16 (3.37-5.07) 8.81 (7.78-10.2) 12.7 (10.3-17.7) 715 
 05-06 * < LOD 5.89 (2.00-10.1) 18.1 (13.9-24.0) 28.9 (19.9-37.9) 718 
 07-08 * < LOD 9.10 (5.62-10.9) 19.9 (15.5-22.5) 26.1 (19.8-27.2) 389 
20-59 years 99-00 * .760 (<LOD-1.12) 2.88 (1.89-3.99) 8.11 (5.89-10.3) 14.6 (10.4-16.8) 814 
 01-02 * < LOD 2.55 (2.05-3.03) 6.92 (5.85-8.00) 11.5 (9.38-13.6) 1121 
 03-04 * < LOD 3.77 (2.72-4.55) 8.78 (6.68-10.5) 13.5 (11.2-15.6) 937 
 05-06 * < LOD 4.71 (3.22-6.50) 16.3 (13.3-18.7) 24.0 (19.9-27.6) 1091 
 07-08 * < LOD 7.32 (6.02-8.62) 17.2 (13.0-20.0) 28.2 (19.3-40.7) 1180 
60+ years 01-02 * 1.46 (<LOD-2.00) 4.31 (3.44-5.39) 10.6 (7.92-12.0) 14.3 (11.8-18.5) 498 
 03-04 * 2.19 (<LOD-2.69) 5.88 (4.65-7.51) 12.3 (9.79-14.8) 17.4 (13.0-24.2) 529 
 05-06 * < LOD 9.16 (6.36-11.1) 19.7 (13.7-26.4) 30.5 (22.0-46.2) 475 
 07-08 * < LOD 12.9 (10.5-15.3) 29.9 (20.9-38.5) 45.5 (30.5-80.3) 637 
Gender        
Males 99-00 * .620 (<LOD-.940) 2.38 (1.86-3.18) 7.58 (4.64-11.6) 15.2 (9.74-19.5) 952 
 01-02 * < LOD 2.77 (2.32-3.19) 7.06 (5.44-8.80) 11.2 (9.70-12.7) 1420 
 03-04 * < LOD 3.27 (2.55-3.94) 8.58 (6.79-10.4) 12.5 (10.5-15.4) 1220 
 05-06 * < LOD 4.15 (2.16-5.95) 14.7 (11.1-18.0) 21.9 (18.9-26.9) 1246 
 07-08 * < LOD 7.08 (5.54-8.54) 17.5 (15.1-20.4) 28.0 (21.2-35.4) 1294 
Females 99-00 * 1.00 (<LOD-1.71) 3.63 (2.30-5.19) 9.12 (7.82-11.7) 16.4 (11.7-19.7) 997 
 01-02 * < LOD 3.50 (2.86-4.49) 9.09 (7.83-10.8) 15.0 (12.5-17.8) 1596 
 03-04 * 1.67 (<LOD-2.25) 5.28 (4.05-6.49) 11.2 (9.65-13.8) 18.1 (14.8-20.6) 1271 
 05-06 * < LOD 8.22 (6.99-9.20) 22.0 (17.7-24.9) 37.9 (27.0-47.2) 1388 
 07-08 * < LOD 10.7 (9.10-12.4) 24.3 (19.5-28.2) 38.6 (27.2-54.6) 1297 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary Dimethylphosphate (DMP) (creatinine corrected) (1999 – 2008) 
Metabolite of Several Organophosphorus Insecticides 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 * 1.06 (<LOD-1.55) 3.89 (2.54-5.45) 9.41 (7.69-11.5) 16.7 (11.7-23.6) 672 
 01-02 * .947 (<LOD-1.35) 3.18 (2.54-3.80) 8.44 (6.24-10.9) 14.3 (11.4-16.2) 763 
 03-04 * < LOD 4.16 (2.57-6.30) 12.3 (7.50-16.5) 18.8 (15.3-21.5) 609 
 05-06 * < LOD 4.27 (<LOD-8.50) 19.1 (14.9-22.7) 29.9 (23.8-39.0) 695 
 07-08 * < LOD 7.47 (5.57-9.46) 19.9 (16.8-24.7) 29.8 (24.7-33.4) 500 
Non-Hispanic blacks 99-00 .973 (.780-1.21) .690 (.530-1.06) 2.67 (1.89-3.77) 7.07 (5.09-11.4) 14.0 (10.6-19.1) 509 
 01-02 * .851 (<LOD-1.34) 3.36 (2.68-4.22) 7.63 (6.35-9.18) 13.2 (10.1-14.9) 754 
 03-04 * < LOD 3.70 (2.84-4.48) 7.52 (6.59-8.89) 12.7 (8.89-19.3) 630 
 05-06 * < LOD 5.89 (2.56-8.89) 18.7 (13.1-26.4) 29.9 (24.0-38.7) 722 
 07-08 * < LOD 6.75 (4.80-8.65) 20.1 (15.5-25.1) 30.7 (24.2-37.7) 573 
Non-Hispanic whites 99-00 * < LOD 3.15 (1.97-4.32) 8.73 (5.89-13.3) 15.8 (10.0-21.2) 595 
 01-02 * < LOD 3.12 (2.50-3.76) 8.30 (6.91-10.0) 13.6 (11.2-16.9) 1253 
 03-04 * < LOD 4.05 (3.49-5.64) 10.2 (8.83-11.8) 14.8 (12.1-19.2) 1060 
 05-06 * < LOD 5.97 (4.53-8.08) 17.7 (15.2-20.6) 26.3 (23.3-29.3) 1007 
 07-08 * < LOD 9.33 (7.92-10.8) 20.0 (17.5-24.2) 35.1 (27.2-43.9) 1088 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary Diethylthiophosphate (DETP) (1999 – 2008) 
Metabolite of Several Organophosphorus Insecticides 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 * .500 (<LOD-.690) .760 (.620-1.10) 1.40 (1.10-1.80) 2.20 (1.70-2.80) 1949 
 01-02 .484 (.381-.615) .630 (.450-.930) 1.53 (1.33-1.80) 2.57 (2.28-3.01) 3.94 (3.26-4.94) 3016 
 03-04 * < LOD .830 (.710-.960) 1.83 (1.51-2.30) 3.00 (2.39-3.78) 2422 
 05-06 * < LOD .620 (<LOD-.710) 1.43 (1.17-1.84) 2.55 (1.94-3.37) 2634 
 07-08 * < LOD 1.00 (.880-1.16) 2.18 (1.75-2.75) 4.35 (2.95-6.01) 2590 
Age group        
6-11 years 99-00 * .600 (<LOD-.810) .910 (.720-1.30) 1.70 (1.20-3.20) 3.20 (1.70-7.30) 471 
 01-02 .453 (.350-.585) .550 (.350-.850) 1.58 (1.33-2.04) 2.75 (2.22-3.38) 4.08 (2.95-5.16) 575 
 03-04 * < LOD .820 (.580-.970) 1.45 (1.05-2.16) 2.18 (1.45-4.13) 296 
 05-06 * < LOD .700 (<LOD-.950) 1.38 (1.03-2.05) 2.15 (1.37-4.06) 350 
 07-08 * < LOD 1.18 (.990-1.42) 2.93 (2.06-5.58) 6.44 (2.87-13.2) 385 
12-19 years 99-00 * .210 (<LOD-.710) .780 (.600-1.20) 1.50 (1.20-2.30) 2.30 (1.60-4.30) 664 
 01-02 .505 (.388-.657) .690 (.440-.960) 1.61 (1.32-1.94) 2.57 (2.23-3.39) 4.08 (2.73-5.86) 822 
 03-04 * .260 (<LOD-.400) .930 (.750-1.13) 2.14 (1.75-2.89) 3.27 (2.69-4.83) 690 
 05-06 * < LOD .700 (<LOD-.920) 1.42 (1.07-1.94) 2.46 (1.47-4.42) 717 
 07-08 * < LOD 1.04 (.880-1.45) 2.20 (1.58-3.11) 4.02 (2.16-7.07) 390 
20-59 years 99-00 * .490 (<LOD-.670) .740 (.600-.930) 1.30 (.990-1.80) 2.00 (1.50-2.60) 814 
 01-02 .449 (.340-.592) .540 (.380-.880) 1.45 (1.19-1.79) 2.46 (2.11-3.17) 3.83 (2.96-5.34) 1122 
 03-04 * < LOD .800 (.650-.960) 1.76 (1.37-2.32) 2.65 (2.31-3.89) 919 
 05-06 * < LOD .600 (<LOD-.680) 1.42 (1.12-1.77) 2.45 (1.82-3.31) 1092 
 07-08 * < LOD .930 (.780-1.22) 2.16 (1.68-2.76) 4.20 (2.76-5.92) 1179 
60 years and older 01-02 .662 (.571-.768) 1.00 (.740-1.14) 1.77 (1.50-2.10) 2.81 (2.44-3.46) 4.45 (2.93-8.31) 497 
 03-04 * .310 (<LOD-.520) .890 (.740-1.05) 1.99 (1.52-2.67) 3.72 (2.19-6.81) 517 
 05-06 * < LOD .660 (<LOD-.840) 1.62 (1.25-2.31) 3.20 (2.04-4.18) 475 
 07-08 * < LOD .980 (.860-1.16) 2.04 (1.60-3.01) 4.25 (2.76-5.40) 636 
Gender        
Males 99-00 * .510 (<LOD-.700) .790 (.680-1.10) 1.50 (1.20-2.20) 2.70 (1.90-4.10) 952 
 01-02 .495 (.393-.623) .660 (.470-.900) 1.53 (1.37-1.82) 2.68 (2.28-3.34) 3.96 (3.07-5.85) 1419 
 03-04 * .250 (<LOD-.380) .890 (.780-1.04) 2.20 (1.65-2.41) 3.15 (2.42-4.29) 1174 
 05-06 * < LOD .590 (<LOD-.720) 1.48 (1.15-1.97) 2.61 (1.89-3.58) 1246 
 07-08 * < LOD 1.03 (.890-1.25) 2.49 (1.82-3.29) 4.79 (3.44-5.92) 1293 
Females 99-00 * < LOD .720 (.570-1.00) 1.30 (.910-1.60) 1.70 (1.30-3.20) 997 
 01-02 .474 (.360-.624) .620 (.410-.960) 1.51 (1.22-1.86) 2.49 (2.15-3.04) 3.94 (2.82-5.27) 1597 
 03-04 * < LOD .770 (.600-.930) 1.59 (1.24-2.08) 2.67 (2.07-3.81) 1248 
 05-06 * < LOD .630 (.580-.710) 1.43 (1.14-1.77) 2.42 (1.78-3.52) 1388 
 07-08 * < LOD .960 (.840-1.14) 2.00 (1.60-2.50) 4.01 (2.41-6.59) 1297 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 05-06, and 07-08 are 0.09, 0.1, 0.2, 0.56,and 0.56 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Diethylthiophosphate (DETP) (1999 – 2008) 
Metabolite of Several Organophosphorus Insecticides 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 * .570 (<LOD-.780) .840 (.740-.980) 1.50 (1.20-1.90) 2.20 (2.00-2.90) 672 
 01-02 .549 (.403-.749) .710 (.470-.960) 1.40 (1.04-1.97) 2.63 (2.06-3.14) 3.98 (2.75-5.21) 763 
 03-04 * .250 (<LOD-.380) .970 (.720-1.52) 2.35 (1.69-3.83) 4.19 (2.38-8.80) 584 
 05-06 * < LOD .700 (<LOD-.900) 1.42 (.980-2.48) 2.72 (1.42-4.48) 695 
 07-08 * < LOD .970 (.830-1.15) 1.98 (1.60-2.65) 3.46 (2.78-4.46) 500 
Non-Hispanic blacks 99-00 .343 (.201-.584) .570 (<LOD-.750) .820 (.690-1.20) 1.80 (1.30-3.20) 3.60 (2.00-4.80) 509 
 01-02 .755 (.589-.966) 1.17 (.740-1.46) 1.85 (1.73-1.99) 3.54 (2.95-3.87) 5.27 (3.89-6.74) 755 
 03-04 .466 (.384-.564) .430 (.210-.710) 1.08 (.930-1.29) 2.32 (1.74-2.70) 3.25 (2.55-4.83) 605 
 05-06 * < LOD .850 (.640-1.18) 1.74 (1.43-2.27) 2.96 (2.09-4.20) 722 
 07-08 * < LOD 1.23 (.890-1.40) 2.85 (2.05-4.12) 4.81 (4.00-6.59) 574 
Non-Hispanic whites 99-00 * .160 (<LOD-.700) .740 (.580-1.10) 1.30 (.960-1.90) 1.90 (1.50-2.80) 595 
 01-02 .464 (.344-.626) .600 (.410-.950) 1.53 (1.27-1.83) 2.46 (2.15-3.17) 3.75 (2.82-5.54) 1252 
 03-04 * < LOD .750 (.610-.890) 1.75 (1.33-2.20) 2.68 (2.20-3.78) 1044 
 05-06 * < LOD .600 (<LOD-.690) 1.42 (1.04-1.99) 2.56 (1.82-3.70) 1007 
 07-08 * < LOD .910 (.820-1.04) 1.80 (1.56-2.46) 3.52 (2.20-5.61) 1087 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 05-06, and 07-08 are 0.09, 0.1, 0.2, 0.56,and 0.56 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Diethylthiophosphate (DETP) (creatinine corrected) (1999 – 2008) 
Metabolite of Several Organophosphorus Insecticides 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 * .250 (<LOD-.480) .710 (.460-1.07) 1.72 (1.17-2.32) 2.64 (2.08-3.06) 1949 
 01-02 .496 (.388-.636) .569 (.403-.789) 1.42 (1.16-1.79) 3.11 (2.58-3.82) 4.88 (3.78-6.65) 3015 
 03-04 * < LOD .740 (.667-.839) 1.59 (1.32-2.05) 2.87 (2.22-3.77) 2420 
 05-06 * < LOD .956 (<LOD-1.09) 1.88 (1.67-2.21) 2.89 (2.35-3.37) 2633 
 07-08 * < LOD 1.24 (1.15-1.37) 2.46 (1.98-3.11) 3.92 (3.05-5.12) 2588 
Age group        
6-11 years 99-00 * .470 (<LOD-.870) 1.08 (.800-1.32) 1.75 (1.44-2.36) 2.45 (2.04-5.32) 471 
 01-02 .591 (.471-.742) .636 (.397-1.05) 1.63 (1.31-1.94) 3.22 (2.72-4.16) 5.70 (3.84-6.80) 575 
 03-04 * < LOD .869 (.592-1.09) 1.57 (1.08-2.67) 2.67 (1.57-4.05) 296 
 05-06 * < LOD 1.23 (<LOD-1.33) 1.95 (1.60-2.86) 3.97 (1.95-5.88) 350 
 07-08 * < LOD 1.89 (1.32-2.09) 3.74 (2.46-5.55) 6.54 (3.49-16.0) 385 
12-19 years 99-00 * .180 (<LOD-.400) .510 (.320-.820) 1.07 (.720-1.61) 1.97 (1.07-3.92) 664 
 01-02 .393 (.300-.515) .534 (.313-.735) 1.23 (.978-1.53) 2.19 (1.61-3.07) 3.14 (2.25-3.97) 821 
 03-04 * .300 (<LOD-.354) .645 (.559-.734) 1.49 (1.16-1.60) 1.97 (1.57-2.43) 689 
 05-06 * < LOD .710 (<LOD-.889) 1.35 (1.00-2.03) 2.21 (1.35-3.33) 717 
 07-08 * < LOD .902 (.692-1.15) 1.78 (1.15-3.32) 3.32 (1.68-5.48) 388 
20-59 years 99-00 * .250 (<LOD-.460) .680 (.440-1.08) 1.79 (1.08-2.39) 2.75 (2.02-3.22) 814 
 01-02 .447 (.335-.597) .494 (.316-.742) 1.32 (.986-1.71) 2.87 (2.08-3.95) 4.69 (3.20-7.81) 1122 
 03-04 * < LOD .700 (.550-.875) 1.47 (1.11-2.23) 2.82 (2.02-3.81) 918 
 05-06 * < LOD .913 (<LOD-1.13) 1.84 (1.65-2.11) 2.86 (2.25-3.33) 1091 
 07-08 * < LOD 1.24 (1.09-1.40) 2.27 (1.79-3.07) 3.51 (2.59-4.78) 1179 
60+ years 01-02 .821 (.708-.952) .971 (.849-1.10) 2.25 (1.81-2.66) 3.97 (3.33-5.06) 5.51 (4.79-8.07) 497 
 03-04 * .491 (<LOD-.560) .933 (.814-1.17) 2.14 (1.46-3.00) 3.92 (2.28-8.15) 517 
 05-06 * < LOD 1.11 (<LOD-1.38) 2.50 (1.67-3.11) 3.80 (2.86-8.71) 475 
 07-08 * < LOD 1.32 (1.20-1.58) 2.91 (2.25-3.38) 4.49 (3.05-9.80) 636 
Gender        
Males 99-00 * .270 (<LOD-.470) .670 (.520-.840) 1.34 (1.08-2.17) 2.67 (1.67-3.23) 952 
 01-02 .410 (.319-.526) .517 (.342-.721) 1.22 (1.02-1.41) 2.46 (1.71-3.18) 3.67 (2.70-4.71) 1419 
 03-04 * .276 (<LOD-.326) .667 (.560-.804) 1.49 (1.15-1.91) 2.87 (1.74-3.72) 1173 
 05-06 * < LOD .773 (<LOD-.907) 1.42 (1.21-2.00) 2.35 (1.90-3.27) 1246 
 07-08 * < LOD 1.02 (.943-1.09) 1.94 (1.60-2.39) 3.22 (2.50-4.42) 1292 
Females 99-00 * < LOD .790 (.380-1.50) 1.89 (1.07-2.52) 2.52 (1.89-3.75) 997 
 01-02 .597 (.457-.779) .647 (.423-.961) 1.77 (1.34-2.50) 3.82 (2.93-5.14) 6.57 (4.34-9.28) 1596 
 03-04 * < LOD .821 (.700-.946) 1.76 (1.34-2.29) 3.02 (2.25-4.33) 1247 
 05-06 * < LOD 1.17 (1.03-1.38) 2.21 (1.83-2.50) 3.18 (2.50-4.47) 1387 
 07-08 * < LOD 1.47 (1.28-1.72) 2.86 (2.29-3.51) 4.48 (3.30-5.73) 1296 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary Diethylthiophosphate (DETP) (creatinine corrected) (1999 – 2008) 
Metabolite of Several Organophosphorus Insecticides 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 * .330 (<LOD-.790) .830 (.550-1.20) 1.69 (1.20-2.43) 2.71 (1.75-3.78) 672 
 01-02 .520 (.390-.693) .570 (.416-.824) 1.30 (1.05-1.74) 2.58 (1.82-3.72) 3.82 (2.77-6.43) 763 
 03-04 * .329 (<LOD-.414) .824 (.555-1.22) 2.03 (1.26-3.63) 3.74 (2.47-6.18) 584 
 05-06 * < LOD .907 (<LOD-1.10) 1.74 (1.35-2.07) 2.86 (2.02-4.00) 695 
 07-08 * < LOD 1.20 (.989-1.32) 2.20 (1.83-2.86) 3.32 (2.59-5.11) 499 
Non-Hispanic blacks 99-00 .234 (.136-.403) .310 (<LOD-.580) .720 (.510-.850) 1.39 (1.03-2.10) 2.91 (1.49-4.24) 509 
 01-02 .556 (.457-.676) .726 (.565-.938) 1.50 (1.34-1.70) 2.80 (2.35-3.30) 4.00 (3.29-4.99) 754 
 03-04 .321 (.270-.381) .313 (.231-.407) .699 (.561-.831) 1.45 (1.09-1.75) 2.64 (1.71-3.64) 604 
 05-06 * < LOD .720 (.606-.824) 1.48 (1.24-1.73) 2.45 (1.76-3.19) 721 
 07-08 * < LOD 1.07 (.880-1.21) 2.40 (1.85-2.89) 4.12 (3.19-5.67) 573 
Non-Hispanic whites 99-00 * .230 (<LOD-.550) .710 (.390-1.22) 1.88 (1.05-2.58) 2.64 (2.08-3.07) 595 
 01-02 .506 (.373-.687) .579 (.368-.850) 1.51 (1.18-2.00) 3.38 (2.64-4.35) 5.83 (3.95-7.81) 1252 
 03-04 * < LOD .735 (.636-.848) 1.52 (1.20-2.07) 2.69 (2.07-3.97) 1043 
 05-06 * < LOD 1.00 (<LOD-1.21) 2.00 (1.73-2.27) 3.08 (2.50-3.74) 1007 
 07-08 * < LOD 1.24 (1.07-1.39) 2.28 (1.71-3.30) 3.49 (2.56-4.60) 1087 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary Dimethylthiophosphate (DMTP) (1999 – 2008) 
Metabolite of Several Organophosphorus Insecticides 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 1.82 (1.36-2.44) 2.70 (1.40-4.10) 11.0 (8.40-16.0) 38.0 (25.0-41.0) 48.0 (38.0-62.0) 1948 
 01-02 * .580 (<LOD-1.45) 4.23 (3.10-5.88) 17.5 (13.0-22.7) 32.9 (27.2-45.3) 3016 
 03-04 2.25 (1.98-2.56) 2.03 (1.73-2.37) 6.36 (5.11-7.34) 19.6 (16.2-21.5) 35.3 (27.4-45.3) 2494 
 05-06 1.96 (1.74-2.20) 1.71 (1.43-1.94) 5.34 (4.49-6.08) 14.2 (10.5-20.8) 28.2 (22.1-36.0) 2631 
 07-08 2.28 (1.97-2.64) 2.10 (1.77-2.44) 5.90 (4.94-7.01) 18.3 (13.5-23.0) 36.8 (27.8-45.7) 2591 
Age group        
6-11 years 99-00 2.72 (1.93-3.85) 4.20 (2.50-7.20) 20.0 (13.0-29.0) 40.0 (38.0-52.0) 62.0 (40.0-92.0) 471 
 01-02 * 1.46 (.600-2.69) 8.33 (5.75-14.0) 28.4 (19.7-41.4) 45.7 (28.5-74.5) 575 
 03-04 2.79 (2.25-3.45) 2.67 (1.81-3.88) 6.95 (5.64-8.58) 19.4 (10.5-27.4) 30.9 (19.4-76.5) 310 
 05-06 2.70 (2.25-3.26) 2.38 (1.76-3.33) 8.21 (4.96-11.8) 21.4 (12.7-40.7) 40.7 (18.3-90.4) 349 
 07-08 3.43 (2.88-4.09) 3.50 (2.69-4.10) 9.90 (7.14-13.9) 32.0 (19.1-45.7) 52.5 (36.7-67.4) 385 
12-19 years 99-00 2.53 (1.64-3.92) 3.70 (1.70-6.80) 16.0 (11.0-31.0) 38.0 (33.0-58.0) 69.0 (38.0-260) 664 
 01-02 * 1.04 (<LOD-2.12) 4.83 (3.35-6.48) 20.8 (12.2-27.9) 34.9 (23.6-54.7) 822 
 03-04 2.21 (1.81-2.70) 1.83 (1.46-2.16) 5.91 (4.04-8.78) 18.7 (12.2-33.9) 47.1 (22.2-80.8) 717 
 05-06 2.51 (2.00-3.16) 2.53 (1.90-3.02) 6.44 (4.91-8.77) 21.7 (13.1-28.2) 38.5 (25.3-79.2) 717 
 07-08 2.10 (1.68-2.61) 1.82 (1.53-2.31) 5.18 (3.55-7.48) 13.6 (8.16-27.9) 31.5 (12.4-54.5) 391 
20-59 years 99-00 1.59 (1.17-2.16) 2.30 (.830-3.80) 9.10 (7.10-13.0) 38.0 (19.0-39.0) 39.0 (38.0-58.0) 813 
 01-02 * < LOD 3.32 (2.29-4.96) 13.6 (9.50-20.0) 30.0 (20.5-45.3) 1121 
 03-04 1.98 (1.71-2.30) 1.78 (1.48-2.18) 5.11 (4.31-6.53) 16.7 (12.1-20.8) 28.5 (24.1-40.0) 938 
 05-06 1.72 (1.50-1.97) 1.37 (1.20-1.73) 4.25 (3.68-5.22) 12.4 (8.37-19.6) 26.6 (16.4-37.9) 1092 
 07-08 2.03 (1.68-2.46) 1.90 (1.46-2.39) 5.18 (4.24-6.09) 13.3 (10.4-19.2) 30.6 (21.4-44.6) 1179 
60 years and older 01-02 * .860 (<LOD-2.16) 5.85 (3.33-9.56) 19.6 (13.0-27.9) 32.9 (22.7-51.0) 498 
 03-04 3.18 (2.47-4.08) 2.64 (2.16-3.81) 9.63 (6.32-15.5) 25.0 (15.5-45.3) 45.3 (20.9-119) 529 
 05-06 2.18 (1.81-2.63) 2.03 (1.46-2.68) 6.38 (4.62-8.23) 14.0 (9.72-20.9) 25.2 (18.2-37.6) 473 
 07-08 2.91 (2.37-3.58) 2.57 (1.99-3.18) 9.19 (5.54-13.0) 26.2 (19.4-32.5) 42.7 (30.5-54.1) 636 
Gender        
Males 99-00 2.10 (1.48-2.98) 3.50 (2.20-4.80) 14.0 (8.00-24.0) 38.0 (21.0-49.0) 42.0 (38.0-53.0) 952 
 01-02 * .690 (<LOD-1.52) 4.44 (3.32-6.48) 18.3 (12.7-25.6) 31.1 (25.0-43.3) 1420 
 03-04 2.30 (1.95-2.70) 2.15 (1.70-2.53) 6.42 (4.90-7.75) 18.8 (13.3-22.5) 30.0 (23.3-45.3) 1221 
 05-06 1.88 (1.64-2.14) 1.61 (1.28-1.94) 5.38 (3.96-6.38) 13.1 (9.59-20.9) 28.7 (19.5-41.7) 1243 
 07-08 2.33 (2.00-2.71) 2.15 (1.85-2.50) 5.98 (4.78-7.26) 16.7 (11.8-24.7) 31.5 (21.2-48.9) 1293 
Females 99-00 1.59 (1.23-2.06) 2.00 (.690-3.60) 9.70 (7.30-14.0) 38.0 (26.0-39.0) 52.0 (38.0-110) 996 
 01-02 * .430 (<LOD-1.45) 3.81 (2.68-5.85) 16.0 (10.9-22.7) 35.2 (25.0-46.1) 1596 
 03-04 2.21 (1.92-2.55) 1.95 (1.68-2.29) 6.27 (4.93-7.39) 20.4 (16.4-24.0) 36.7 (27.7-47.8) 1273 
 05-06 2.04 (1.79-2.33) 1.75 (1.46-2.13) 5.23 (4.49-6.10) 15.6 (10.9-20.8) 28.1 (20.8-37.9) 1388 
 07-08 2.24 (1.88-2.66) 1.99 (1.57-2.52) 5.85 (4.92-7.31) 18.7 (13.4-26.0) 37.7 (27.0-50.1) 1298 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 05-06, and 07-08 are 0.18, 0.4, 0.5, 0.55,and 0.55 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Dimethylthiophosphate (DMTP) (1999 – 2008) 
Metabolite of Several Organophosphorus Insecticides 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 1.79 (1.05-3.05) 2.00 (.530-4.40) 11.0 (6.70-17.0) 39.0 (32.0-62.0) 140 (46.0-230) 671 
 01-02 * < LOD 3.93 (3.05-5.06) 15.1 (11.1-19.1) 35.6 (22.7-46.0) 763 
 03-04 2.41 (1.88-3.09) 2.54 (1.41-3.98) 6.43 (4.90-8.02) 17.2 (12.0-22.3) 28.9 (19.2-39.8) 610 
 05-06 2.37 (2.07-2.71) 2.26 (1.95-2.68) 5.65 (4.86-6.44) 16.4 (12.9-21.4) 28.3 (23.3-41.4) 693 
 07-08 2.10 (1.83-2.42) 1.98 (1.63-2.31) 5.18 (4.17-6.61) 13.6 (11.5-20.0) 31.0 (20.0-43.5) 501 
Non-Hispanic blacks 99-00 2.13 (1.57-2.88) 3.60 (2.10-4.70) 12.0 (8.80-18.0) 38.0 (20.0-41.0) 41.0 (37.0-110) 509 
 01-02 1.54 (1.15-2.07) 1.18 (.580-1.97) 5.21 (3.11-8.25) 20.0 (13.4-27.2) 39.1 (25.9-62.8) 755 
 03-04 2.13 (1.83-2.48) 1.85 (1.65-2.20) 5.44 (3.87-8.28) 20.4 (15.8-24.9) 31.1 (24.9-51.9) 631 
 05-06 1.94 (1.63-2.31) 1.63 (1.23-2.02) 5.21 (3.93-7.18) 16.8 (13.3-21.6) 28.4 (21.5-40.6) 723 
 07-08 2.12 (1.89-2.38) 1.97 (1.64-2.26) 5.63 (4.15-6.94) 20.8 (12.9-23.9) 33.5 (26.3-47.6) 573 
Non-Hispanic whites 99-00 1.77 (1.23-2.53) 2.70 (.830-4.40) 11.0 (7.50-17.0) 38.0 (17.0-53.0) 48.0 (38.0-69.0) 595 
 01-02 * .540 (<LOD-1.71) 4.21 (2.77-6.48) 18.8 (10.9-25.4) 33.1 (26.6-46.5) 1252 
 03-04 2.31 (2.00-2.66) 2.07 (1.73-2.41) 6.51 (5.12-7.85) 19.8 (15.4-23.3) 36.7 (27.4-47.8) 1061 
 05-06 1.94 (1.67-2.26) 1.76 (1.40-1.99) 5.33 (4.32-6.19) 13.6 (9.80-22.1) 28.9 (20.2-42.8) 1005 
 07-08 2.22 (1.83-2.69) 1.96 (1.57-2.48) 5.84 (4.70-7.68) 17.1 (12.4-24.3) 37.3 (25.9-48.7) 1088 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 05-06, and 07-08 are 0.18, 0.4, 0.5, 0.55,and 0.55 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Dimethylthiophosphate (DMTP) (creatinine corrected) (1999 – 2008) 
Metabolite of Several Organophosphorus Insecticides 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 1.64 (1.22-2.20) 2.12 (1.22-3.35) 9.57 (6.59-15.8) 32.0 (23.9-41.1) 51.0 (39.0-70.1) 1948 
 01-02 * .933 (<LOD-1.40) 4.08 (2.65-6.06) 14.6 (11.5-20.5) 28.9 (24.7-39.4) 3015 
 03-04 2.21 (1.92-2.55) 1.98 (1.69-2.38) 5.96 (5.07-7.16) 19.1 (14.8-22.4) 32.6 (25.8-41.9) 2491 
 05-06 1.99 (1.76-2.26) 1.75 (1.56-1.90) 5.00 (4.16-6.24) 16.8 (11.8-22.1) 30.0 (24.1-38.3) 2630 
 07-08 2.34 (2.05-2.66) 2.00 (1.77-2.31) 5.91 (4.88-7.09) 17.5 (13.9-23.2) 33.7 (25.7-45.9) 2589 
Age group        
6-11 years 99-00 2.95 (2.25-3.86) 5.32 (3.75-6.33) 19.1 (12.2-28.0) 47.0 (32.1-60.3) 66.1 (50.9-95.0) 471 
 01-02 * 2.16 (1.32-3.12) 10.6 (7.84-13.6) 28.7 (18.8-45.0) 48.1 (33.4-71.1) 575 
 03-04 3.40 (2.70-4.28) 3.41 (2.40-4.17) 7.91 (6.43-12.2) 25.2 (16.7-34.2) 36.1 (25.4-67.7) 310 
 05-06 3.35 (2.67-4.21) 2.78 (2.03-3.66) 9.26 (5.67-15.1) 33.4 (16.8-54.3) 71.5 (28.7-161) 349 
 07-08 4.35 (3.78-5.01) 4.26 (3.36-4.75) 14.1 (9.35-16.6) 32.8 (23.8-45.4) 51.3 (41.1-77.9) 385 
12-19 years 99-00 1.71 (1.07-2.75) 2.14 (.890-4.83) 13.5 (6.46-22.6) 36.0 (25.6-51.4) 61.5 (41.7-109) 664 
 01-02 * .933 (<LOD-1.57) 3.56 (2.38-5.57) 12.2 (8.96-16.0) 22.5 (13.2-34.7) 821 
 03-04 1.66 (1.37-2.03) 1.52 (1.19-1.82) 4.38 (3.29-5.66) 13.3 (9.94-20.5) 26.5 (15.5-36.0) 715 
 05-06 1.89 (1.54-2.33) 1.81 (1.38-2.33) 4.55 (3.47-6.17) 14.3 (8.75-27.5) 32.9 (14.3-51.4) 717 
 07-08 1.62 (1.27-2.06) 1.46 (1.19-1.74) 4.14 (3.12-5.52) 11.1 (5.52-20.5) 20.5 (9.61-32.2) 389 
20-59 years 99-00 1.47 (1.07-2.02) 1.90 (.870-3.11) 8.09 (5.19-14.6) 27.0 (19.8-37.6) 47.5 (34.2-70.1) 813 
 01-02 * < LOD 3.16 (1.99-4.62) 11.9 (7.79-17.2) 25.2 (15.9-37.0) 1121 
 03-04 1.88 (1.61-2.19) 1.67 (1.45-1.94) 4.88 (4.20-5.68) 13.9 (10.3-19.7) 30.3 (19.7-38.2) 937 
 05-06 1.72 (1.52-1.96) 1.46 (1.28-1.65) 4.18 (3.14-4.99) 13.2 (9.30-21.9) 25.4 (21.4-30.3) 1091 
 07-08 2.02 (1.73-2.36) 1.79 (1.52-2.05) 4.53 (3.90-5.90) 13.2 (9.47-17.2) 26.7 (17.1-41.8) 1179 
60+ years 01-02 * 1.39 (<LOD-2.40) 6.38 (3.68-9.97) 24.0 (14.9-35.2) 45.5 (26.5-69.7) 498 
 03-04 3.86 (2.99-4.97) 3.18 (2.46-4.84) 11.2 (7.10-18.6) 29.2 (18.6-47.9) 48.2 (24.9-113) 529 
 05-06 2.61 (2.12-3.20) 2.40 (1.75-2.75) 7.66 (5.71-11.3) 19.2 (12.1-31.1) 35.3 (20.5-56.4) 473 
 07-08 3.56 (2.79-4.55) 3.05 (2.31-4.13) 10.6 (6.86-14.8) 31.8 (17.7-50.2) 54.2 (34.1-87.5) 636 
Gender        
Males 99-00 1.61 (1.11-2.34) 2.39 (1.27-3.51) 9.27 (6.00-16.9) 28.9 (19.0-40.4) 41.1 (34.9-52.9) 952 
 01-02 * .778 (<LOD-1.14) 3.82 (2.65-4.98) 13.6 (10.0-17.8) 25.2 (17.2-37.6) 1420 
 03-04 1.88 (1.58-2.23) 1.76 (1.51-2.12) 4.87 (3.87-6.31) 14.4 (9.18-20.4) 25.7 (17.7-36.9) 1220 
 05-06 1.59 (1.37-1.86) 1.33 (1.14-1.57) 4.06 (2.85-5.27) 13.1 (8.56-20.5) 26.0 (17.2-34.2) 1243 
 07-08 1.93 (1.68-2.21) 1.62 (1.42-1.94) 4.36 (3.77-5.50) 14.2 (10.4-17.7) 25.9 (18.2-39.7) 1292 
Females 99-00 1.66 (1.26-2.18) 2.01 (.870-3.33) 10.0 (6.67-16.2) 34.9 (26.2-47.1) 70.1 (39.0-118) 996 
 01-02 * 1.08 (<LOD-1.65) 4.44 (2.55-7.02) 17.4 (11.9-24.8) 38.0 (27.4-51.6) 1595 
 03-04 2.60 (2.23-3.02) 2.24 (1.83-2.63) 7.11 (5.54-10.2) 22.8 (18.9-28.7) 41.6 (29.2-58.9) 1271 
 05-06 2.47 (2.16-2.83) 2.19 (1.83-2.44) 6.07 (4.74-8.34) 20.7 (13.8-25.6) 36.7 (26.1-46.2) 1387 
 07-08 2.81 (2.40-3.29) 2.50 (2.07-2.93) 7.40 (5.83-8.83) 21.9 (16.7-27.4) 41.2 (27.4-60.8) 1297 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary Dimethylthiophosphate (DMTP) (creatinine corrected) (1999 – 2008) 
Metabolite of Several Organophosphorus Insecticides 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 1.60 (.899-2.86) 1.83 (.680-4.23) 10.4 (5.95-16.9) 37.0 (23.1-63.1) 112 (40.5-190) 671 
 01-02 * < LOD 3.55 (2.65-4.68) 13.8 (9.88-22.9) 30.4 (22.9-47.2) 763 
 03-04 2.20 (1.65-2.94) 2.24 (1.70-3.00) 5.95 (4.14-8.68) 15.7 (10.7-20.1) 24.5 (18.9-36.9) 609 
 05-06 2.24 (1.96-2.55) 2.14 (1.89-2.40) 5.19 (4.33-6.18) 14.7 (10.9-20.0) 28.4 (21.5-36.3) 693 
 07-08 2.14 (1.92-2.38) 1.88 (1.61-2.22) 4.84 (4.08-6.48) 13.2 (10.0-18.6) 26.2 (18.6-34.1) 500 
Non-Hispanic blacks 99-00 1.45 (1.03-2.06) 1.75 (1.17-3.06) 8.48 (4.36-13.4) 25.5 (15.4-39.3) 54.4 (25.5-97.6) 509 
 01-02 1.13 (.889-1.44) 1.00 (.693-1.23) 3.62 (2.29-5.41) 12.4 (9.17-17.5) 23.3 (17.4-43.1) 754 
 03-04 1.46 (1.28-1.67) 1.22 (1.06-1.37) 3.90 (2.77-5.34) 12.7 (8.09-18.7) 26.0 (14.6-38.7) 630 
 05-06 1.40 (1.14-1.71) 1.12 (.938-1.37) 3.58 (2.63-5.06) 12.0 (8.44-19.3) 25.6 (17.4-31.2) 722 
 07-08 1.61 (1.45-1.80) 1.38 (1.22-1.61) 4.26 (3.41-5.20) 14.7 (10.7-18.8) 27.5 (20.9-37.4) 572 
Non-Hispanic whites 99-00 1.68 (1.16-2.43) 2.22 (.870-3.51) 9.40 (5.58-17.0) 33.3 (20.6-49.4) 52.9 (39.0-71.1) 595 
 01-02 * .966 (<LOD-1.61) 4.22 (2.41-7.00) 15.9 (11.6-24.1) 33.1 (24.8-45.4) 1252 
 03-04 2.40 (2.05-2.81) 2.12 (1.75-2.53) 6.27 (5.10-8.10) 20.0 (15.3-25.7) 36.2 (25.7-52.7) 1060 
 05-06 2.09 (1.80-2.42) 1.78 (1.56-2.06) 5.14 (4.02-6.91) 16.8 (11.3-23.4) 30.0 (23.4-38.3) 1005 
 07-08 2.40 (1.99-2.90) 2.04 (1.67-2.57) 6.00 (4.64-7.49) 16.9 (13.0-25.3) 37.6 (23.1-54.2) 1088 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary Diethyldithiophosphate (DEDTP) (1999 – 2008) 
Metabolite of Several Organophosphorus Insecticides 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 * .090 (<LOD-.140) .210 (.140-.290) .470 (.380-.640) .870 (.640-1.10) 1949 
 01-02 * < LOD < LOD .610 (.410-.780) .890 (.710-1.32) 3013 
 03-04 * < LOD < LOD < LOD .290 (.160-.510) 2494 
 05-06 * < LOD < LOD < LOD < LOD 2420 
 07-08 * < LOD < LOD < LOD < LOD 2585 
Age group        
6-11 years 99-00 * .090 (<LOD-.160) .190 (.130-.280) .430 (.300-.650) .850 (.470-1.00) 471 
 01-02 * < LOD < LOD .630 (.380-.870) .940 (.690-1.42) 576 
 03-04 * < LOD < LOD < LOD .540 (<LOD-.650) 310 
 05-06 * < LOD < LOD < LOD < LOD 317 
 07-08 * < LOD < LOD < LOD < LOD 383 
12-19 years 99-00 * .080 (<LOD-.180) .260 (.120-.350) .640 (.420-.840) .930 (.720-1.30) 664 
 01-02 * < LOD < LOD .560 (.330-.730) .820 (.610-.990) 822 
 03-04 * < LOD < LOD .150 (<LOD-.350) .450 (.370-.570) 717 
 05-06 * < LOD < LOD < LOD < LOD 660 
 07-08 * < LOD < LOD < LOD < LOD 390 
20-59 years 99-00 * .090 (<LOD-.130) .210 (.130-.290) .450 (.360-.640) .900 (.610-1.10) 814 
 01-02 * < LOD < LOD .620 (.430-.760) .830 (.700-1.32) 1118 
 03-04 * < LOD < LOD < LOD .220 (<LOD-.580) 938 
 05-06 * < LOD < LOD < LOD < LOD 1006 
 07-08 * < LOD < LOD < LOD < LOD 1176 
60 years and older 01-02 * < LOD < LOD .630 (.360-1.08) 1.11 (.610-1.41) 497 
 03-04 * < LOD < LOD < LOD .150 (<LOD-.550) 529 
 05-06 * < LOD < LOD < LOD < LOD 437 
 07-08 * < LOD < LOD < LOD < LOD 636 
Gender        
Males 99-00 * .090 (<LOD-.150) .220 (.140-.310) .490 (.380-.680) .870 (.680-1.10) 952 
 01-02 * < LOD < LOD .600 (.380-.740) .780 (.700-1.03) 1420 
 03-04 * < LOD < LOD < LOD .390 (.160-.540) 1221 
 05-06 * < LOD < LOD < LOD < LOD 1142 
 07-08 * < LOD < LOD < LOD < LOD 1290 
Females 99-00 * .090 (<LOD-.130) .190 (.110-.310) .460 (.320-.840) .870 (.440-1.40) 997 
 01-02 * < LOD < LOD .660 (.460-.880) 1.03 (.700-1.47) 1593 
 03-04 * < LOD < LOD < LOD .230 (<LOD-.600) 1273 
 05-06 * < LOD < LOD < LOD < LOD 1278 
 07-08 * < LOD < LOD < LOD < LOD 1295 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 05-06, and 07-08 are 0.05, 0.1, 0.1, 0.39,and 0.39 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Diethyldithiophosphate (DEDTP) (1999 – 2008) 
Metabolite of Several Organophosphorus Insecticides 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 .130 (.099-.171) .100 (.050-.200) .310 (.230-.390) .650 (.530-.860) 1.10 (.860-1.60) 672 
 01-02 * < LOD .200 (<LOD-.520) .720 (.410-1.12) 1.12 (.700-1.58) 763 
 03-04 * < LOD < LOD .110 (<LOD-.680) .680 (.180-1.15) 610 
 05-06 * < LOD < LOD < LOD < LOD 665 
 07-08 * < LOD < LOD < LOD < LOD 495 
Non-Hispanic blacks 99-00 .117 (.084-.162) .090 (<LOD-.230) .270 (.140-.410) .560 (.400-.830) .870 (.650-1.20) 509 
 01-02 * < LOD < LOD .620 (.440-.800) .810 (.670-.930) 754 
 03-04 * < LOD < LOD < LOD .250 (.110-.540) 631 
 05-06 * < LOD < LOD < LOD < LOD 660 
 07-08 * < LOD < LOD < LOD < LOD 574 
Non-Hispanic whites 99-00 * .080 (<LOD-.160) .190 (.120-.290) .450 (.310-.720) .870 (.510-1.30) 595 
 01-02 * < LOD < LOD .610 (.350-.800) .910 (.660-1.41) 1252 
 03-04 * < LOD < LOD < LOD .240 (.120-.540) 1061 
 05-06 * < LOD < LOD < LOD < LOD 917 
 07-08 * < LOD < LOD < LOD < LOD 1087 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 05-06, and 07-08 are 0.05, 0.1, 0.1, 0.39,and 0.39 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 * .070 (<LOD-.110) .200 (.140-.290) .550 (.390-.700) .860 (.670-1.14) 1949 
 01-02 * < LOD < LOD .604 (.389-.783) 1.08 (.768-1.52) 3012 
 03-04 * < LOD < LOD < LOD .412 (.350-.507) 2491 
 05-06 * < LOD < LOD < LOD < LOD 2419 
 07-08 * < LOD < LOD < LOD < LOD 2583 
Age group        
6-11 years 99-00 * .100 (<LOD-.140) .190 (.150-.270) .570 (.410-.760) 1.03 (.570-1.58) 471 
 01-02 * < LOD < LOD .778 (.606-1.12) 1.36 (1.02-1.86) 576 
 03-04 * < LOD < LOD < LOD .475 (<LOD-.967) 310 
 05-06 * < LOD < LOD < LOD < LOD 317 
 07-08 * < LOD < LOD < LOD < LOD 383 
12-19 years 99-00 * .050 (<LOD-.080) .170 (.100-.220) .440 (.230-.730) .730 (.380-1.09) 664 
 01-02 * < LOD < LOD .359 (.250-.537) .667 (.375-.987) 821 
 03-04 * < LOD < LOD .226 (<LOD-.259) .333 (.241-.600) 715 
 05-06 * < LOD < LOD < LOD < LOD 660 
 07-08 * < LOD < LOD < LOD < LOD 388 
20-59 years 99-00 * .080 (<LOD-.110) .210 (.140-.310) .550 (.360-.730) .860 (.650-1.20) 814 
 01-02 * < LOD < LOD .583 (.379-.740) 1.03 (.699-1.60) 1118 
 03-04 * < LOD < LOD < LOD .400 (<LOD-.537) 937 
 05-06 * < LOD < LOD < LOD < LOD 1005 
 07-08 * < LOD < LOD < LOD < LOD 1176 
60+ years 01-02 * < LOD < LOD .833 (.368-1.28) 1.44 (.853-2.61) 497 
 03-04 * < LOD < LOD < LOD .438 (<LOD-.700) 529 
 05-06 * < LOD < LOD < LOD < LOD 437 
 07-08 * < LOD < LOD < LOD < LOD 636 
Gender        
Males 99-00 * .070 (<LOD-.110) .190 (.140-.230) .410 (.340-.500) .720 (.520-.940) 952 
 01-02 * < LOD < LOD .389 (.309-.658) .768 (.637-1.01) 1420 
 03-04 * < LOD < LOD < LOD .339 (.269-.412) 1220 
 05-06 * < LOD < LOD < LOD < LOD 1142 
 07-08 * < LOD < LOD < LOD < LOD 1289 
Females 99-00 * .090 (<LOD-.120) .220 (.140-.360) .670 (.410-.870) .890 (.660-1.62) 997 
 01-02 * < LOD < LOD .733 (.527-1.03) 1.27 (.868-2.37) 1592 
 03-04 * < LOD < LOD < LOD .500 (<LOD-.604) 1271 
 05-06 * < LOD < LOD < LOD < LOD 1277 
 07-08 * < LOD < LOD < LOD < LOD 1294 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary Diethyldithiophosphate (DEDTP) (creatinine corrected) (1999 – 2008) 
Metabolite of Several Organophosphorus Insecticides 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 .116 (.084-.161) .090 (.060-.170) .300 (.190-.410) .810 (.570-.990) 1.19 (.860-2.66) 672 
 01-02 * < LOD .292 (<LOD-.444) .845 (.487-1.24) 1.29 (.901-1.67) 763 
 03-04 * < LOD < LOD .318 (<LOD-.467) .579 (.404-.940) 609 
 05-06 * < LOD < LOD < LOD < LOD 665 
 07-08 * < LOD < LOD < LOD < LOD 494 
Non-Hispanic blacks 99-00 .080 (.057-.111) .070 (<LOD-.110) .170 (.110-.280) .450 (.300-.580) .700 (.500-1.02) 509 
 01-02 * < LOD < LOD .456 (.362-.593) .769 (.541-1.07) 753 
 03-04 * < LOD < LOD < LOD .269 (.196-.368) 630 
 05-06 * < LOD < LOD < LOD < LOD 659 
 07-08 * < LOD < LOD < LOD < LOD 573 
Non-Hispanic whites 99-00 * .070 (<LOD-.120) .200 (.140-.310) .560 (.380-.730) .880 (.600-1.38) 595 
 01-02 * < LOD < LOD .583 (.368-.868) 1.14 (.682-1.70) 1252 
 03-04 * < LOD < LOD < LOD .389 (.333-.523) 1060 
 05-06 * < LOD < LOD < LOD < LOD 917 
 07-08 * < LOD < LOD < LOD < LOD 1087 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary Dimethyldithiophosphate (DMDTP) (1999 – 2008) 
Metabolite of Several Organophosphorus Insecticides 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 * < LOD 2.30 (1.30-3.90) 13.0 (5.00-17.0) 19.0 (17.0-38.0) 1949 
 01-02 * < LOD .920 (.330-1.30) 2.61 (2.04-3.45) 5.96 (4.41-7.90) 3015 
 03-04 * < LOD .700 (.570-.920) 2.54 (1.64-3.87) 5.74 (3.63-9.85) 2458 
 05-06 * < LOD < LOD 1.96 (1.41-2.59) 3.87 (2.77-6.09) 2635 
 07-08 * < LOD < LOD 2.37 (1.93-2.93) 5.60 (4.62-6.79) 2571 
Age group        
6-11 years 99-00 .691 (.425-1.12) .740 (.080-1.80) 4.30 (2.40-8.60) 17.0 (6.90-37.0) 32.0 (17.0-44.0) 471 
 01-02 * < LOD 1.30 (.750-2.11) 3.53 (2.20-4.50) 7.33 (4.32-9.74) 575 
 03-04 * < LOD .900 (.620-1.14) 2.94 (1.14-5.48) 5.48 (2.94-8.53) 306 
 05-06 * < LOD < LOD 1.84 (.540-3.35) 3.69 (2.67-9.95) 350 
 07-08 * < LOD .950 (<LOD-1.48) 3.80 (2.45-5.70) 6.66 (5.11-9.64) 379 
12-19 years 99-00 * < LOD 2.30 (1.40-4.50) 13.0 (5.40-20.0) 20.0 (17.0-38.0) 664 
 01-02 * < LOD .830 (.400-1.14) 2.52 (1.85-3.07) 4.63 (3.59-5.83) 821 
 03-04 * < LOD .580 (.350-.770) 1.46 (1.12-1.99) 2.67 (1.82-4.49) 699 
 05-06 * < LOD < LOD 2.78 (1.51-3.76) 5.98 (3.03-11.5) 718 
 07-08 * < LOD < LOD 1.45 (.810-2.03) 2.45 (1.65-3.93) 384 
20-59 years 99-00 * < LOD 2.10 (.840-3.60) 11.0 (4.00-17.0) 17.0 (7.70-50.0) 814 
 01-02 * < LOD .840 (<LOD-1.31) 2.32 (1.70-3.40) 4.90 (2.90-9.52) 1122 
 03-04 * < LOD .610 (.350-.800) 2.00 (1.36-3.63) 5.07 (3.62-8.62) 925 
 05-06 * < LOD < LOD 1.71 (.880-2.36) 3.60 (2.40-5.18) 1092 
 07-08 * < LOD < LOD 1.84 (1.34-2.32) 4.27 (2.84-6.79) 1172 
60 years and older 01-02 * < LOD 1.02 (.540-1.37) 3.57 (2.58-5.96) 8.16 (5.04-16.1) 497 
 03-04 * < LOD 1.39 (.720-2.34) 4.09 (2.35-13.4) 13.4 (3.36-33.3) 528 
 05-06 * < LOD < LOD 2.13 (1.67-3.34) 5.12 (2.62-8.17) 475 
 07-08 * < LOD 1.03 (<LOD-1.99) 5.47 (4.31-6.33) 8.89 (6.33-12.2) 636 
Gender        
Males 99-00 * .110 (<LOD-.610) 2.30 (1.20-4.90) 16.0 (5.70-17.0) 19.0 (17.0-38.0) 952 
 01-02 * < LOD .890 (.370-1.28) 2.59 (1.88-3.41) 5.96 (4.47-7.86) 1420 
 03-04 * < LOD .680 (.360-1.01) 2.26 (1.14-4.45) 5.30 (3.20-10.2) 1209 
 05-06 * < LOD < LOD 1.96 (.980-3.04) 4.33 (2.42-7.65) 1246 
 07-08 * < LOD < LOD 2.38 (1.76-3.70) 5.70 (3.80-10.0) 1278 
Females 99-00 * < LOD 2.20 (1.10-3.90) 11.0 (4.20-17.0) 20.0 (13.0-40.0) 997 
 01-02 * < LOD .960 (.250-1.37) 2.61 (1.96-3.68) 5.72 (3.79-9.87) 1595 
 03-04 * < LOD .730 (.590-.970) 2.83 (1.99-3.96) 6.15 (3.91-11.3) 1249 
 05-06 * < LOD < LOD 1.96 (1.49-2.59) 3.75 (2.90-4.60) 1389 
 07-08 * < LOD < LOD 2.34 (1.79-3.12) 5.54 (4.06-6.69) 1293 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 05-06, and 07-08 are 0.08, 0.1, 0.1, 0.51,and 0.51 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Dimethyldithiophosphate (DMDTP) (1999 – 2008) 
Metabolite of Several Organophosphorus Insecticides 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 * .250 (<LOD-.870) 1.90 (1.10-3.00) 5.80 (4.10-9.70) 12.0 (5.90-28.0) 672 
 01-02 * < LOD 1.08 (.780-1.38) 2.80 (2.19-3.54) 4.93 (3.73-7.42) 763 
 03-04 * < LOD .730 (.360-1.21) 2.11 (1.38-3.15) 5.26 (2.31-6.94) 610 
 05-06 * < LOD < LOD 2.04 (1.62-2.96) 5.12 (2.98-10.7) 695 
 07-08 * < LOD < LOD 1.63 (1.18-2.12) 3.88 (2.12-6.07) 491 
Non-Hispanic blacks 99-00 * .330 (<LOD-1.20) 3.20 (1.40-7.00) 14.0 (5.70-30.0) 19.0 (17.0-39.0) 509 
 01-02 * < LOD .640 (<LOD-1.41) 1.96 (1.36-4.15) 4.42 (2.68-8.38) 755 
 03-04 * < LOD .590 (.310-.730) 1.77 (1.05-3.33) 4.77 (2.75-7.80) 604 
 05-06 * < LOD < LOD 2.15 (1.66-2.82) 5.45 (2.82-8.39) 723 
 07-08 * < LOD < LOD 2.04 (1.54-2.65) 4.27 (2.66-7.79) 568 
Non-Hispanic whites 99-00 * < LOD 2.00 (.800-4.00) 13.0 (3.90-20.0) 20.0 (16.0-40.0) 595 
 01-02 * < LOD 1.01 (.180-1.43) 2.74 (1.94-4.18) 6.72 (4.88-8.54) 1252 
 03-04 * < LOD .740 (.540-1.04) 2.66 (1.55-4.56) 5.89 (3.63-11.6) 1056 
 05-06 * < LOD < LOD 1.93 (1.23-2.65) 3.60 (2.71-5.51) 1007 
 07-08 * < LOD < LOD 2.32 (1.75-3.28) 5.60 (4.46-6.88) 1087 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 05-06, and 07-08 are 0.08, 0.1, 0.1, 0.51,and 0.51 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Metabolite of Several Organophosphorus Insecticides 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 * < LOD 1.88 (.970-3.86) 10.1 (5.31-18.3) 21.7 (12.8-33.7) 1949 
 01-02 * < LOD .717 (.389-1.12) 2.80 (2.21-3.96) 6.84 (4.96-8.09) 3014 
 03-04 * < LOD .572 (.411-.772) 2.62 (1.72-4.12) 6.40 (3.85-9.75) 2455 
 05-06 * < LOD < LOD 2.18 (1.64-3.00) 4.62 (3.23-7.12) 2634 
 07-08 * < LOD < LOD 2.63 (2.17-3.08) 6.12 (4.15-8.24) 2569 
Age group        
6-11 years 99-00 .748 (.474-1.18) .790 (.190-1.60) 4.07 (2.31-7.18) 16.2 (8.22-27.0) 30.8 (20.2-38.9) 471 
 01-02 * < LOD 1.36 (.805-2.31) 4.10 (2.67-6.24) 6.98 (4.40-12.8) 575 
 03-04 * < LOD .962 (.584-1.57) 3.39 (2.29-6.15) 7.12 (4.48-7.55) 306 
 05-06 * < LOD < LOD 2.57 (1.39-4.14) 4.50 (3.17-9.35) 350 
 07-08 * < LOD 1.50 (<LOD-1.95) 4.35 (3.05-6.59) 8.01 (4.75-12.9) 379 
12-19 years 99-00 * < LOD 1.52 (.620-3.47) 9.48 (4.04-16.8) 21.5 (9.48-42.3) 664 
 01-02 * < LOD .543 (.306-.773) 2.02 (1.49-2.40) 3.13 (2.51-4.67) 820 
 03-04 * < LOD .361 (.241-.584) 1.02 (.628-1.57) 2.46 (1.33-3.39) 697 
 05-06 * < LOD < LOD 2.05 (1.16-3.56) 4.27 (2.30-8.66) 718 
 07-08 * < LOD < LOD 1.16 (.782-1.85) 1.94 (1.39-3.79) 382 
20-59 years 99-00 * < LOD 1.71 (.850-3.56) 8.50 (4.00-19.1) 20.5 (8.57-40.7) 814 
 01-02 * < LOD .605 (<LOD-1.05) 2.56 (1.64-4.03) 6.33 (3.96-8.17) 1122 
 03-04 * < LOD .451 (.340-.583) 2.17 (1.10-3.64) 5.71 (2.47-10.1) 924 
 05-06 * < LOD < LOD 1.90 (1.44-2.57) 3.69 (2.37-7.07) 1091 
 07-08 * < LOD < LOD 1.99 (1.80-2.32) 4.15 (2.77-6.77) 1172 
60+ years 01-02 * < LOD 1.10 (.631-1.86) 4.89 (3.36-7.82) 13.4 (6.98-19.8) 497 
 03-04 * < LOD 1.55 (.765-2.48) 6.52 (2.73-13.3) 13.3 (5.44-23.0) 528 
 05-06 * < LOD < LOD 3.22 (2.25-4.54) 6.53 (3.70-10.4) 475 
 07-08 * < LOD 1.72 (<LOD-2.58) 5.92 (3.29-8.44) 10.3 (7.25-18.4) 636 
Gender        
Males 99-00 * .150 (<LOD-.370) 1.79 (.840-3.97) 11.0 (4.62-17.4) 18.1 (7.51-44.7) 952 
 01-02 * < LOD .628 (.333-.850) 2.39 (1.75-3.13) 5.37 (4.23-7.29) 1420 
 03-04 * < LOD .467 (.280-.743) 2.03 (.990-3.56) 5.38 (2.29-8.25) 1208 
 05-06 * < LOD < LOD 1.80 (1.14-3.17) 4.14 (2.18-7.15) 1246 
 07-08 * < LOD < LOD 1.89 (1.44-2.71) 4.92 (2.77-8.44) 1277 
Females 99-00 * < LOD 2.06 (.940-4.00) 9.30 (4.96-25.5) 27.0 (9.66-47.5) 997 
 01-02 * < LOD .831 (.412-1.50) 3.35 (2.50-4.96) 7.81 (5.29-11.9) 1594 
 03-04 * < LOD .680 (.538-.887) 3.59 (2.41-5.18) 7.12 (4.13-13.1) 1247 
 05-06 * < LOD < LOD 2.40 (2.00-3.18) 5.25 (3.18-7.60) 1388 
 07-08 * < LOD < LOD 3.05 (2.44-4.00) 7.18 (4.22-11.1) 1292 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 * .270 (<LOD-.660) 1.35 (.860-2.53) 6.55 (3.83-11.8) 16.7 (6.25-38.8) 672 
 01-02 * < LOD .833 (.589-1.15) 2.72 (2.05-3.32) 5.16 (3.69-7.83) 763 
 03-04 * < LOD .651 (.318-1.09) 2.04 (1.10-3.74) 4.50 (2.17-5.88) 609 
 05-06 * < LOD < LOD 2.40 (1.29-4.00) 5.14 (3.45-10.5) 695 
 07-08 * < LOD < LOD 1.97 (1.50-2.77) 4.30 (2.77-6.92) 490 
Non-Hispanic blacks 99-00 * .250 (<LOD-.700) 2.40 (.690-5.44) 9.41 (4.81-17.8) 17.9 (11.5-40.7) 509 
 01-02 * < LOD .403 (<LOD-.847) 1.69 (.793-3.50) 3.50 (2.19-5.91) 754 
 03-04 * < LOD .343 (.242-.477) 1.07 (.727-1.84) 3.21 (1.45-6.07) 603 
 05-06 * < LOD < LOD 1.80 (.990-3.89) 4.95 (2.93-5.59) 722 
 07-08 * < LOD < LOD 1.79 (1.38-2.31) 4.27 (2.44-6.16) 567 
Non-Hispanic whites 99-00 * < LOD 1.77 (.780-4.02) 11.4 (4.07-21.5) 21.5 (11.4-34.8) 595 
 01-02 * < LOD .787 (.389-1.37) 3.42 (2.48-5.24) 7.75 (5.80-9.47) 1252 
 03-04 * < LOD .631 (.412-.897) 3.06 (1.75-5.84) 6.74 (4.42-12.0) 1055 
 05-06 * < LOD < LOD 2.16 (1.64-3.00) 4.14 (2.91-7.59) 1007 
 07-08 * < LOD < LOD 2.74 (2.12-3.58) 5.92 (4.00-9.71) 1087 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary trans-3-(2,2-Dichlorovinyl)-2,2-dimethylcyclopropane carboxylic acid (1999 - 2010) 
Metabolite of Cyfluthrin, trans-Cypermethrin, and trans-Permethrin 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 * < LOD .560 (.480-.700) 1.40 (1.17-1.77) 3.42 (2.39-5.56) 1976 
 01-02 * < LOD .430 (<LOD-.560) 1.18 (.930-1.64) 2.60 (1.85-3.58) 3033 
 07-08 * < LOD < LOD 2.23 (1.58-3.30) 5.23 (3.87-7.05) 2576 
 09-10 * < LOD < LOD 1.29 (.810-1.70) 5.42 (3.26-6.80) 2747 
Age group        
6-11 years 99-00 * < LOD .970 (.700-1.66) 2.91 (1.76-4.19) 4.19 (2.97-11.7) 478 
 01-02 * < LOD .470 (<LOD-.760) 1.39 (1.03-1.68) 2.50 (1.55-3.54) 576 
 07-08 * < LOD < LOD 1.50 (.740-3.01) 4.01 (1.81-10.4) 384 
 09-10 * < LOD < LOD 2.27 (<LOD-5.65) 8.64 (2.27-26.8) 386 
12-19 years 99-00 * < LOD .710 (.520-.860) 2.07 (1.25-3.42) 4.28 (2.12-6.23) 675 
 01-02 * < LOD .490 (<LOD-.670) 1.20 (.800-1.60) 2.01 (1.49-3.77) 826 
 07-08 * < LOD < LOD 2.30 (1.13-3.73) 5.08 (2.36-7.61) 388 
 09-10 * < LOD < LOD < LOD 1.78 (1.05-2.50) 401 
20-59 years 99-00 * < LOD .500 (.400-.620) 1.17 (.910-1.68) 2.94 (1.49-5.56) 823 
 01-02 * < LOD < LOD 1.17 (.850-1.85) 2.56 (1.64-4.66) 1123 
 07-08 * < LOD < LOD 2.15 (1.38-3.55) 5.36 (3.51-7.28) 1174 
 09-10 * < LOD < LOD 1.13 (<LOD-1.83) 5.88 (3.24-7.71) 1309 
60 years and older 01-02 * < LOD .460 (<LOD-.630) 1.13 (.760-2.44) 4.27 (1.20-6.49) 508 
 07-08 * < LOD < LOD 2.33 (.850-4.26) 4.87 (2.75-9.01) 630 
 09-10 * < LOD < LOD 1.66 (1.02-2.68) 6.09 (3.05-10.4) 651 
Gender        
Males 99-00 * < LOD .560 (.500-.670) 1.28 (1.11-1.63) 2.25 (1.55-5.10) 961 
 01-02 * < LOD .420 (<LOD-.500) 1.12 (.860-1.58) 2.44 (1.69-3.70) 1419 
 07-08 * < LOD < LOD 2.20 (1.20-3.76) 5.29 (3.12-7.61) 1289 
 09-10 * < LOD < LOD 1.12 (<LOD-1.83) 4.98 (2.88-7.03) 1343 
Females 99-00 * < LOD .550 (.410-.820) 1.77 (1.07-3.08) 4.19 (3.08-6.81) 1015 
 01-02 * < LOD .440 (<LOD-.630) 1.23 (.910-1.98) 2.62 (1.90-3.58) 1614 
 07-08 * < LOD < LOD 2.27 (1.49-3.51) 5.08 (3.55-6.48) 1287 
 09-10 * < LOD < LOD 1.33 (<LOD-2.12) 5.51 (2.87-9.82) 1404 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 07-08, and 09-10 are 0.4, 0.4, 0.6, and 0.6 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary trans-3-(2,2-Dichlorovinyl)-2,2-dimethylcyclopropane carboxylic acid (1999 - 2010) 
Metabolite of Cyfluthrin, trans-Cypermethrin, and trans-Permethrin 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 * < LOD .470 (.410-.530) 1.23 (.830-1.60) 1.87 (1.49-3.35) 691 
 01-02 * < LOD .410 (<LOD-.510) .860 (.680-1.14) 1.57 (1.08-2.01) 767 
 07-08 * < LOD < LOD 1.37 (<LOD-1.99) 2.89 (1.63-4.19) 495 
 09-10 * < LOD < LOD < LOD 2.32 (1.06-3.76) 602 
Non-Hispanic blacks 99-00 * < LOD .780 (.490-1.13) 1.84 (1.08-4.69) 4.69 (1.41-14.5) 518 
 01-02 * < LOD .590 (.490-.740) 1.26 (1.05-1.70) 2.25 (1.54-3.32) 764 
 07-08 * < LOD < LOD 2.24 (1.26-3.30) 4.25 (3.38-8.10) 569 
 09-10 * < LOD < LOD 1.78 (<LOD-4.06) 5.14 (2.59-8.69) 504 
Non-Hispanic whites 99-00 * < LOD .560 (.460-.730) 1.41 (1.14-2.14) 3.89 (2.14-6.43) 595 
 01-02 * < LOD .410 (<LOD-.580) 1.18 (.850-1.85) 2.64 (1.85-4.27) 1278 
 07-08 * < LOD < LOD 2.24 (1.38-3.76) 5.23 (3.96-6.48) 1082 
 09-10 * < LOD < LOD 1.29 (.690-1.88) 6.13 (3.24-9.30) 1200 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 07-08, and 09-10 are 0.4, 0.4, 0.6, and 0.6 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary trans-3-(2,2-Dichlorovinyl)-2,2-dimethylcyclopropane carboxylic acid (creatinine corrected) 
(1999 - 2010) 
Metabolite of Cyfluthrin, trans-Cypermethrin, and trans-Permethrin 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 * < LOD .700 (.609-.778) 1.56 (1.33-1.87) 2.65 (2.15-3.89) 1976 
 01-02 * < LOD .737 (<LOD-.796) 1.47 (1.32-1.87) 2.62 (2.31-3.11) 3031 
 07-08 * < LOD < LOD 2.90 (2.21-3.81) 5.15 (4.20-6.40) 2574 
 09-10 * < LOD < LOD 2.10 (1.91-2.47) 4.37 (3.73-5.83) 2747 
Age group        
6-11 years 99-00 * < LOD 1.31 (.718-1.74) 2.37 (1.56-5.07) 5.60 (1.91-11.3) 478 
 01-02 * < LOD .903 (<LOD-1.13) 2.16 (1.40-2.61) 2.87 (2.34-3.44) 576 
 07-08 * < LOD < LOD 2.46 (2.07-3.46) 4.18 (2.47-9.69) 384 
 09-10 * < LOD < LOD 2.61 (<LOD-5.87) 6.85 (2.61-38.8) 386 
12-19 years 99-00 * < LOD .525 (.438-.727) 1.42 (.824-2.19) 2.19 (1.34-4.31) 675 
 01-02 * < LOD .528 (<LOD-.657) .966 (.800-1.29) 1.57 (1.07-2.60) 825 
 07-08 * < LOD < LOD 2.06 (1.16-4.97) 5.51 (2.06-7.15) 386 
 09-10 * < LOD < LOD < LOD 1.83 (1.25-2.75) 401 
20-59 years 99-00 * < LOD .700 (.571-.769) 1.33 (1.12-1.87) 2.39 (1.87-3.36) 823 
 01-02 * < LOD < LOD 1.47 (1.22-2.00) 2.55 (2.07-3.11) 1123 
 07-08 * < LOD < LOD 2.87 (2.15-3.82) 5.09 (3.83-6.81) 1174 
 09-10 * < LOD < LOD 2.10 (<LOD-2.63) 4.37 (3.63-6.16) 1309 
60 years and older 01-02 * < LOD .826 (<LOD-.933) 2.00 (1.22-2.80) 3.47 (2.15-6.57) 507 
 07-08 * < LOD < LOD 3.50 (2.21-4.83) 5.85 (3.65-8.56) 630 
 09-10 * < LOD < LOD 2.56 (2.00-3.72) 6.04 (3.82-13.7) 651 
Gender        
Males 99-00 * < LOD .562 (.484-.667) 1.26 (1.07-1.42) 2.15 (1.47-2.74) 961 
 01-02 * < LOD .529 (<LOD-.583) 1.09 (.966-1.35) 2.25 (1.57-2.57) 1419 
 07-08 * < LOD < LOD 2.10 (1.36-3.47) 4.85 (3.20-5.95) 1288 
 09-10 * < LOD < LOD 1.86 (<LOD-2.25) 3.98 (2.63-6.04) 1343 
Females 99-00 * < LOD .875 (.718-1.11) 1.91 (1.48-2.39) 3.67 (2.30-6.28) 1015 
 01-02 * < LOD .903 (<LOD-1.00) 1.90 (1.56-2.15) 3.03 (2.55-3.20) 1612 
 07-08 * < LOD < LOD 3.50 (2.37-4.69) 6.23 (4.20-9.69) 1286 
 09-10 * < LOD < LOD 2.48 (<LOD-2.95) 5.30 (3.54-8.27) 1404 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary trans-3-(2,2-Dichlorovinyl)-2,2-dimethylcyclopropane carboxylic acid (creatinine corrected) 
(1999 - 2010) 
Metabolite of Cyfluthrin, trans-Cypermethrin, and trans-Permethrin 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 * < LOD .583 (.500-.745) 1.35 (1.02-1.65) 2.00 (1.56-2.80) 691 
 01-02 * < LOD .573 (<LOD-.651) 1.08 (.909-1.22) 1.87 (1.39-2.15) 767 
 07-08 * < LOD < LOD 1.87 (<LOD-2.94) 3.20 (2.07-4.16) 494 
 09-10 * < LOD < LOD < LOD 2.57 (2.02-3.50) 602 
Non-Hispanic blacks 99-00 * < LOD .571 (.467-.739) 1.70 (.853-3.13) 3.36 (1.87-8.91) 518 
 01-02 * < LOD .490 (.433-.571) 1.17 (.848-1.56) 2.37 (1.40-2.89) 763 
 07-08 * < LOD < LOD 2.00 (1.56-2.63) 4.85 (2.31-8.30) 568 
 09-10 * < LOD < LOD 1.75 (<LOD-2.25) 3.50 (2.13-6.13) 504 
Non-Hispanic whites 99-00 * < LOD .757 (.695-.848) 1.64 (1.33-2.00) 3.31 (2.00-5.60) 595 
 01-02 * < LOD .778 (<LOD-.848) 1.56 (1.34-2.00) 2.63 (2.30-3.16) 1277 
 07-08 * < LOD < LOD 3.10 (2.21-4.20) 5.34 (4.46-7.21) 1082 
 09-10 * < LOD < LOD 2.46 (1.91-3.00) 4.91 (3.73-7.83) 1200 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary cis-3-(2,2-Dibromovinyl)-2,2-dimethylcyclopropane carboxylic acid (1999 - 2010) 
Metabolite of Deltamethrin 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 * < LOD < LOD < LOD < LOD 1698 
 01-02 * < LOD < LOD < LOD < LOD 3048 
 07-08 * < LOD < LOD < LOD < LOD 2583 
 09-10 * < LOD < LOD < LOD < LOD 2746 
Age group        
6-11 years 99-00 * < LOD < LOD < LOD < LOD 415 
 01-02 * < LOD < LOD < LOD < LOD 580 
 07-08 * < LOD < LOD < LOD < LOD 384 
 09-10 * < LOD < LOD < LOD < LOD 386 
12-19 years 99-00 * < LOD < LOD < LOD < LOD 570 
 01-02 * < LOD < LOD < LOD < LOD 831 
 07-08 * < LOD < LOD < LOD < LOD 389 
 09-10 * < LOD < LOD < LOD < LOD 401 
20-59 years 99-00 * < LOD < LOD < LOD < LOD 713 
 01-02 * < LOD < LOD < LOD < LOD 1128 
 07-08 * < LOD < LOD < LOD < LOD 1177 
 09-10 * < LOD < LOD < LOD < LOD 1308 
60 years and older 01-02 * < LOD < LOD < LOD < LOD 509 
 07-08 * < LOD < LOD < LOD < LOD 633 
 09-10 * < LOD < LOD < LOD < LOD 651 
Gender        
Males 99-00 * < LOD < LOD < LOD < LOD 818 
 01-02 * < LOD < LOD < LOD < LOD 1429 
 07-08 * < LOD < LOD < LOD < LOD 1290 
 09-10 * < LOD < LOD < LOD < LOD 1343 
Females 99-00 * < LOD < LOD < LOD < LOD 880 
 01-02 * < LOD < LOD < LOD < LOD 1619 
 07-08 * < LOD < LOD < LOD < LOD 1293 
 09-10 * < LOD < LOD < LOD < LOD 1403 
Race/ethnicity        
Mexican Americans 99-00 * < LOD < LOD < LOD < LOD 578 
 01-02 * < LOD < LOD < LOD < LOD 767 
 07-08 * < LOD < LOD < LOD < LOD 500 
 09-10 * < LOD < LOD < LOD < LOD 602 
Non-Hispanic blacks 99-00 * < LOD < LOD < LOD < LOD 445 
 01-02 * < LOD < LOD < LOD < LOD 776 
 07-08 * < LOD < LOD < LOD < LOD 572 
 09-10 * < LOD < LOD < LOD < LOD 503 
Non-Hispanic whites 99-00 * < LOD < LOD < LOD < LOD 527 
 01-02 * < LOD < LOD < LOD < LOD 1281 
 07-08 * < LOD < LOD < LOD < LOD 1082 
 09-10 * < LOD < LOD < LOD < LOD 1200 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 07-08, and 09-10 are 0.1, 0.1, 0.5, and 0.5 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary cis-3-(2,2-Dibromovinyl)-2,2-dimethylcyclopropane carboxylic acid (creatinine corrected) 
(1999 - 2010) 
Metabolite of Deltamethrin 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 * < LOD < LOD < LOD < LOD 1698 
 01-02 * < LOD < LOD < LOD < LOD 3046 
 07-08 * < LOD < LOD < LOD < LOD 2581 
 09-10 * < LOD < LOD < LOD < LOD 2746 
Age group        
6-11 years 99-00 * < LOD < LOD < LOD < LOD 415 
 01-02 * < LOD < LOD < LOD < LOD 580 
 07-08 * < LOD < LOD < LOD < LOD 384 
 09-10 * < LOD < LOD < LOD < LOD 386 
12-19 years 99-00 * < LOD < LOD < LOD < LOD 570 
 01-02 * < LOD < LOD < LOD < LOD 830 
 07-08 * < LOD < LOD < LOD < LOD 387 
 09-10 * < LOD < LOD < LOD < LOD 401 
20-59 years 99-00 * < LOD < LOD < LOD < LOD 713 
 01-02 * < LOD < LOD < LOD < LOD 1128 
 07-08 * < LOD < LOD < LOD < LOD 1177 
 09-10 * < LOD < LOD < LOD < LOD 1308 
60 years and older 01-02 * < LOD < LOD < LOD < LOD 508 
 07-08 * < LOD < LOD < LOD < LOD 633 
 09-10 * < LOD < LOD < LOD < LOD 651 
Gender        
Males 99-00 * < LOD < LOD < LOD < LOD 818 
 01-02 * < LOD < LOD < LOD < LOD 1429 
 07-08 * < LOD < LOD < LOD < LOD 1289 
 09-10 * < LOD < LOD < LOD < LOD 1343 
Females 99-00 * < LOD < LOD < LOD < LOD 880 
 01-02 * < LOD < LOD < LOD < LOD 1617 
 07-08 * < LOD < LOD < LOD < LOD 1292 
 09-10 * < LOD < LOD < LOD < LOD 1403 
Race/ethnicity        
Mexican Americans 99-00 * < LOD < LOD < LOD < LOD 578 
 01-02 * < LOD < LOD < LOD < LOD 767 
 07-08 * < LOD < LOD < LOD < LOD 499 
 09-10 * < LOD < LOD < LOD < LOD 602 
Non-Hispanic blacks 99-00 * < LOD < LOD < LOD < LOD 445 
 01-02 * < LOD < LOD < LOD < LOD 775 
 07-08 * < LOD < LOD < LOD < LOD 571 
 09-10 * < LOD < LOD < LOD < LOD 503 
Non-Hispanic whites 99-00 * < LOD < LOD < LOD < LOD 527 
 01-02 * < LOD < LOD < LOD < LOD 1280 
 07-08 * < LOD < LOD < LOD < LOD 1082 
 09-10 * < LOD < LOD < LOD < LOD 1200 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary 4-Fluoro-3-phenoxybenzoic acid (1999 - 2010) 
Metabolite of Cyfluthrin 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 * < LOD < LOD < LOD < LOD 1949 
 01-02 * < LOD < LOD < LOD < LOD 3048 
 07-08 * < LOD < LOD < LOD .140 (<LOD-.210) 2588 
 09-10 * < LOD < LOD < LOD < LOD 2747 
Age group        
6-11 years 99-00 * < LOD < LOD < LOD < LOD 473 
 01-02 * < LOD < LOD < LOD < LOD 580 
 07-08 * < LOD < LOD < LOD .120 (<LOD-.160) 385 
 09-10 * < LOD < LOD < LOD < LOD 386 
12-19 years 99-00 * < LOD < LOD < LOD < LOD 662 
 01-02 * < LOD < LOD < LOD < LOD 831 
 07-08 * < LOD < LOD < LOD < LOD 390 
 09-10 * < LOD < LOD < LOD < LOD 401 
20-59 years 99-00 * < LOD < LOD < LOD < LOD 814 
 01-02 * < LOD < LOD < LOD < LOD 1128 
 07-08 * < LOD < LOD < LOD .170 (<LOD-.290) 1180 
 09-10 * < LOD < LOD < LOD < LOD 1309 
60 years and older 01-02 * < LOD < LOD < LOD < LOD 509 
 07-08 * < LOD < LOD < LOD .120 (<LOD-.260) 633 
 09-10 * < LOD < LOD < LOD .220 (<LOD-.720) 651 
Gender        
Males 99-00 * < LOD < LOD < LOD < LOD 950 
 01-02 * < LOD < LOD < LOD < LOD 1429 
 07-08 * < LOD < LOD < LOD .160 (<LOD-.270) 1293 
 09-10 * < LOD < LOD < LOD < LOD 1343 
Females 99-00 * < LOD < LOD < LOD < LOD 999 
 01-02 * < LOD < LOD < LOD < LOD 1619 
 07-08 * < LOD < LOD < LOD < LOD 1295 
 09-10 * < LOD < LOD < LOD < LOD 1404 
Race/ethnicity        
Mexican Americans 99-00 * < LOD < LOD < LOD < LOD 666 
 01-02 * < LOD < LOD < LOD < LOD 767 
 07-08 * < LOD < LOD < LOD .160 (<LOD-.240) 500 
 09-10 * < LOD < LOD < LOD < LOD 602 
Non-Hispanic blacks 99-00 * < LOD < LOD < LOD < LOD 517 
 01-02 * < LOD < LOD < LOD < LOD 776 
 07-08 * < LOD < LOD < LOD .140 (<LOD-.250) 574 
 09-10 * < LOD < LOD < LOD .250 (<LOD-1.02) 504 
Non-Hispanic whites 99-00 * < LOD < LOD < LOD < LOD 594 
 01-02 * < LOD < LOD < LOD < LOD 1281 
 07-08 * < LOD < LOD < LOD .140 (<LOD-.210) 1084 
 09-10 * < LOD < LOD < LOD < LOD 1200 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 07-08, and 09-10 are 0.2, 0.2, 0.1, and 0.1 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary 4-Fluoro-3-phenoxybenzoic acid (creatinine corrected) (1999 - 2010) 
Metabolite of Cyfluthrin 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 * < LOD < LOD < LOD < LOD 1949 
 01-02 * < LOD < LOD < LOD < LOD 3046 
 07-08 * < LOD < LOD < LOD .350 (<LOD-.412) 2586 
 09-10 * < LOD < LOD < LOD < LOD 2747 
Age group        
6-11 years 99-00 * < LOD < LOD < LOD < LOD 473 
 01-02 * < LOD < LOD < LOD < LOD 580 
 07-08 * < LOD < LOD < LOD .374 (<LOD-.412) 385 
 09-10 * < LOD < LOD < LOD < LOD 386 
12-19 years 99-00 * < LOD < LOD < LOD < LOD 662 
 01-02 * < LOD < LOD < LOD < LOD 830 
 07-08 * < LOD < LOD < LOD < LOD 388 
 09-10 * < LOD < LOD < LOD < LOD 401 
20-59 years 99-00 * < LOD < LOD < LOD < LOD 814 
 01-02 * < LOD < LOD < LOD < LOD 1128 
 07-08 * < LOD < LOD < LOD .368 (<LOD-.467) 1180 
 09-10 * < LOD < LOD < LOD < LOD 1309 
60 years and older 01-02 * < LOD < LOD < LOD < LOD 508 
 07-08 * < LOD < LOD < LOD .389 (<LOD-.476) 633 
 09-10 * < LOD < LOD < LOD .467 (<LOD-.700) 651 
Gender        
Males 99-00 * < LOD < LOD < LOD < LOD 950 
 01-02 * < LOD < LOD < LOD < LOD 1429 
 07-08 * < LOD < LOD < LOD .233 (<LOD-.280) 1292 
 09-10 * < LOD < LOD < LOD < LOD 1343 
Females 99-00 * < LOD < LOD < LOD < LOD 999 
 01-02 * < LOD < LOD < LOD < LOD 1617 
 07-08 * < LOD < LOD < LOD < LOD 1294 
 09-10 * < LOD < LOD < LOD < LOD 1404 
Race/ethnicity        
Mexican Americans 99-00 * < LOD < LOD < LOD < LOD 666 
 01-02 * < LOD < LOD < LOD < LOD 767 
 07-08 * < LOD < LOD < LOD .333 (<LOD-.414) 499 
 09-10 * < LOD < LOD < LOD < LOD 602 
Non-Hispanic blacks 99-00 * < LOD < LOD < LOD < LOD 517 
 01-02 * < LOD < LOD < LOD < LOD 775 
 07-08 * < LOD < LOD < LOD .235 (<LOD-.292) 573 
 09-10 * < LOD < LOD < LOD .333 (<LOD-.788) 504 
Non-Hispanic whites 99-00 * < LOD < LOD < LOD < LOD 594 
 01-02 * < LOD < LOD < LOD < LOD 1280 
 07-08 * < LOD < LOD < LOD .368 (<LOD-.438) 1084 
 09-10 * < LOD < LOD < LOD < LOD 1200 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary 3-Phenoxybenzoic acid (1999 - 2010) 
Metabolite of Cypermethrin, Deltamethrin, and Permethrin 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 .292 (.247-.345) .250 (.190-.320) .730 (.590-.850) 1.75 (1.49-2.16) 4.33 (2.62-6.30) 1998 
 01-02 .318 (.275-.368) .270 (.220-.340) .700 (.570-.810) 1.73 (1.49-2.16) 3.54 (2.69-5.25) 3048 
 07-08 .401 (.350-.460) .390 (.340-.450) 1.10 (.870-1.39) 3.22 (2.55-4.19) 6.63 (4.99-8.24) 2454 
 09-10 .418 (.389-.449) .400 (.350-.460) 1.06 (.970-1.19) 3.12 (2.69-3.77) 6.50 (5.57-8.04) 2723 
Age group        
6-11 years 99-00 .417 (.292-.595) .320 (.210-.490) 1.12 (.700-1.60) 4.18 (2.02-6.54) 8.63 (3.89-71.1) 483 
 01-02 .325 (.260-.406) .300 (.200-.420) .760 (.570-1.05) 1.81 (1.42-2.78) 3.38 (2.25-4.12) 580 
 07-08 .397 (.339-.464) .360 (.280-.410) 1.13 (.780-1.55) 3.40 (2.19-5.87) 9.88 (3.40-17.3) 371 
 09-10 .549 (.389-.774) .480 (.350-.700) 1.43 (1.00-2.15) 4.43 (2.80-8.04) 8.51 (4.12-39.4) 383 
12-19 years 99-00 .336 (.265-.427) .290 (.200-.440) .870 (.620-1.04) 1.93 (1.49-2.90) 4.33 (1.83-11.1) 682 
 01-02 .353 (.288-.434) .300 (.250-.390) .800 (.560-1.13) 1.86 (1.48-2.35) 3.45 (2.14-6.69) 831 
 07-08 .393 (.273-.565) .360 (.200-.640) 1.15 (.720-1.83) 2.96 (2.11-6.73) 7.42 (2.96-12.1) 361 
 09-10 .403 (.346-.470) .410 (.310-.510) .970 (.810-1.29) 2.25 (1.80-3.19) 3.92 (2.55-5.85) 398 
20-59 years 99-00 .267 (.227-.314) .230 (.160-.300) .640 (.510-.820) 1.49 (1.25-1.78) 3.21 (2.04-5.41) 833 
 01-02 .314 (.271-.364) .270 (.220-.340) .670 (.530-.780) 1.65 (1.27-2.34) 3.25 (2.51-6.16) 1128 
 07-08 .427 (.376-.485) .420 (.370-.470) 1.11 (.900-1.39) 3.38 (2.42-4.99) 6.65 (4.86-9.69) 1110 
 09-10 .416 (.382-.454) .390 (.330-.470) 1.07 (.930-1.23) 3.50 (2.67-4.45) 6.95 (5.57-9.31) 1296 
60 years and older 01-02 .303 (.233-.394) .250 (.180-.350) .690 (.490-1.10) 2.03 (1.45-3.68) 5.16 (2.77-6.61) 509 
 07-08 .335 (.270-.416) .300 (.210-.470) 1.05 (.690-1.54) 2.68 (1.84-3.97) 4.70 (2.83-6.43) 612 
 09-10 .382 (.343-.427) .360 (.290-.450) .980 (.860-1.17) 2.56 (2.07-2.88) 5.93 (3.21-8.95) 646 
Gender        
Males 99-00 .273 (.226-.330) .250 (.180-.330) .710 (.570-.820) 1.49 (1.29-1.73) 2.41 (1.92-3.79) 974 
 01-02 .326 (.281-.379) .300 (.230-.360) .690 (.570-.750) 1.60 (1.37-2.15) 3.23 (2.56-5.25) 1429 
 07-08 .419 (.361-.487) .430 (.370-.500) 1.11 (.830-1.48) 3.12 (2.15-4.58) 5.91 (4.19-7.56) 1215 
 09-10 .421 (.391-.454) .400 (.340-.450) 1.07 (.900-1.29) 3.21 (2.51-4.45) 6.50 (5.51-9.07) 1331 
Females 99-00 .311 (.253-.384) .250 (.190-.340) .740 (.510-.990) 2.30 (1.63-3.36) 6.03 (3.27-11.8) 1024 
 01-02 .311 (.260-.371) .250 (.200-.320) .730 (.550-.920) 1.81 (1.53-2.47) 3.76 (2.51-6.55) 1619 
 07-08 .385 (.322-.462) .360 (.290-.450) 1.07 (.820-1.42) 3.30 (2.32-5.30) 6.79 (5.15-9.69) 1239 
 09-10 .415 (.366-.471) .400 (.350-.480) 1.06 (.910-1.26) 2.92 (2.51-3.84) 6.50 (4.89-8.50) 1392 
Race/ethnicity        
Mexican Americans 99-00 .260 (.230-.295) .230 (.190-.270) .600 (.430-.750) 1.35 (1.16-1.53) 2.18 (1.53-3.26) 697 
 01-02 .290 (.233-.361) .260 (.190-.350) .650 (.490-.810) 1.26 (.860-2.17) 2.65 (1.50-3.44) 767 
 07-08 .369 (.302-.451) .400 (.280-.460) .940 (.740-1.15) 2.27 (1.58-3.39) 3.62 (2.70-12.7) 476 
 09-10 .371 (.316-.436) .380 (.300-.480) .830 (.750-1.02) 1.93 (1.55-2.53) 3.70 (2.53-4.81) 596 
Non-Hispanic blacks 99-00 .454 (.352-.586) .450 (.350-.610) 1.13 (.750-1.46) 2.32 (1.45-5.35) 5.35 (2.32-21.1) 524 
 01-02 .507 (.430-.599) .520 (.440-.630) .980 (.840-1.20) 2.03 (1.72-2.52) 3.86 (3.05-5.84) 776 
 07-08 .420 (.353-.501) .430 (.320-.540) 1.12 (.770-1.66) 3.11 (2.44-4.26) 6.13 (4.12-8.39) 533 
 09-10 .464 (.349-.616) .500 (.360-.650) 1.29 (.790-1.94) 2.86 (2.07-4.59) 5.86 (3.42-8.50) 499 
Non-Hispanic whites 99-00 .288 (.233-.355) .240 (.160-.320) .710 (.530-.850) 1.78 (1.41-3.05) 5.34 (2.62-8.43) 603 
 01-02 .297 (.248-.355) .240 (.190-.320) .600 (.490-.780) 1.75 (1.46-2.34) 3.70 (2.52-6.16) 1281 
 07-08 .394 (.329-.470) .380 (.310-.450) 1.09 (.780-1.42) 3.38 (2.42-4.92) 6.53 (5.15-8.24) 1040 
 09-10 .412 (.384-.441) .370 (.330-.420) 1.06 (.920-1.19) 3.83 (2.82-4.46) 8.08 (5.93-11.1) 1192 
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Urinary 3-Phenoxybenzoic acid (creatinine corrected) (1999 - 2010) 
Metabolite of Cypermethrin, Deltamethrin, and Permethrin 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 .261 (.224-.304) .246 (.203-.280) .550 (.459-.629) 1.40 (1.13-1.73) 3.19 (2.16-4.55) 1998 
 01-02 .324 (.284-.371) .290 (.247-.336) .600 (.512-.743) 1.54 (1.26-1.91) 3.35 (2.50-4.92) 3046 
 07-08 .426 (.374-.485) .384 (.333-.450) 1.02 (.886-1.19) 3.08 (2.31-4.04) 5.83 (4.52-7.51) 2452 
 09-10 .438 (.409-.469) .384 (.342-.432) 1.01 (.898-1.13) 2.88 (2.50-3.19) 5.44 (4.52-6.38) 2723 
Age group        
6-11 years 99-00 .450 (.299-.677) .371 (.241-.592) 1.13 (.733-1.62) 3.97 (1.75-8.07) 9.91 (2.43-64.0) 483 
 01-02 .423 (.335-.534) .383 (.296-.500) .864 (.594-1.35) 2.21 (1.61-2.95) 3.32 (2.64-5.40) 580 
 07-08 .511 (.431-.605) .448 (.363-.545) 1.20 (.886-1.83) 3.81 (2.13-7.27) 9.86 (3.81-15.7) 371 
 09-10 .744 (.537-1.03) .667 (.503-.838) 1.87 (1.30-2.60) 4.73 (2.88-9.57) 10.2 (4.48-51.9) 383 
12-19 years 99-00 .227 (.178-.290) .205 (.156-.269) .486 (.379-.732) 1.37 (1.03-1.62) 2.52 (1.41-4.44) 682 
 01-02 .274 (.229-.328) .236 (.189-.313) .539 (.424-.730) 1.11 (.864-1.63) 2.35 (1.36-6.19) 830 
 07-08 .316 (.230-.434) .281 (.191-.425) .869 (.523-1.29) 3.13 (1.47-4.37) 5.41 (3.36-9.20) 359 
 09-10 .347 (.302-.399) .301 (.256-.397) .733 (.575-.903) 1.53 (1.33-2.46) 2.64 (1.76-3.75) 398 
20-59 years 99-00 .246 (.216-.278) .239 (.200-.272) .505 (.405-.590) 1.11 (.861-1.49) 2.53 (1.73-4.09) 833 
 01-02 .311 (.271-.357) .282 (.245-.328) .552 (.444-.673) 1.44 (1.02-1.91) 3.22 (1.91-4.92) 1128 
 07-08 .443 (.384-.510) .401 (.353-.472) 1.01 (.867-1.16) 2.95 (2.22-4.04) 6.29 (4.18-8.05) 1110 
 09-10 .419 (.389-.451) .365 (.326-.421) .993 (.826-1.10) 2.93 (2.35-3.62) 4.72 (4.17-6.15) 1296 
60 years and older 01-02 .372 (.301-.462) .319 (.241-.406) .785 (.541-1.05) 2.16 (1.30-3.50) 4.65 (2.63-6.15) 508 
 07-08 .418 (.351-.498) .363 (.288-.473) 1.06 (.832-1.59) 3.11 (2.22-4.43) 4.93 (3.37-7.62) 612 
 09-10 .455 (.417-.496) .397 (.342-.455) 1.06 (.875-1.30) 2.88 (2.37-3.61) 5.44 (3.77-8.53) 646 
Gender        
Males 99-00 .210 (.173-.253) .195 (.152-.254) .513 (.388-.582) 1.09 (.841-1.41) 1.72 (1.49-2.52) 974 
 01-02 .269 (.233-.310) .239 (.203-.280) .500 (.429-.571) 1.27 (1.05-1.59) 2.95 (1.74-4.00) 1429 
 07-08 .359 (.314-.411) .333 (.291-.392) .840 (.722-1.00) 2.58 (1.58-3.57) 4.42 (3.40-6.46) 1214 
 09-10 .377 (.348-.409) .323 (.295-.368) .865 (.744-1.01) 2.48 (1.98-2.97) 4.72 (3.53-6.45) 1331 
Females 99-00 .323 (.270-.387) .273 (.235-.333) .608 (.477-.743) 1.94 (1.35-3.00) 5.04 (3.19-6.90) 1024 
 01-02 .388 (.331-.455) .344 (.284-.408) .737 (.563-.938) 1.84 (1.46-2.35) 4.43 (2.62-5.59) 1617 
 07-08 .500 (.416-.601) .433 (.355-.540) 1.28 (.995-1.60) 3.56 (2.40-4.93) 7.20 (5.15-9.57) 1238 
 09-10 .505 (.453-.564) .446 (.394-.500) 1.15 (1.00-1.33) 3.19 (2.54-3.73) 5.86 (4.58-8.90) 1392 
Race/ethnicity        
Mexican Americans 99-00 .234 (.202-.272) .219 (.187-.234) .475 (.368-.594) 1.04 (.700-1.39) 1.67 (1.06-3.00) 697 
 01-02 .274 (.230-.328) .242 (.206-.316) .512 (.404-.654) 1.03 (.750-1.67) 1.83 (1.15-2.75) 767 
 07-08 .386 (.320-.466) .379 (.287-.488) .911 (.692-1.24) 1.94 (1.47-2.38) 3.16 (2.08-9.55) 475 
 09-10 .390 (.341-.446) .355 (.305-.438) .696 (.631-.774) 1.62 (1.40-2.15) 3.22 (2.19-3.89) 596 
Non-Hispanic blacks 99-00 .309 (.238-.401) .268 (.224-.353) .636 (.456-.935) 1.49 (1.05-3.43) 3.86 (1.51-7.25) 524 
 01-02 .374 (.308-.455) .357 (.290-.430) .675 (.561-.817) 1.44 (1.20-2.31) 2.91 (2.03-3.76) 775 
 07-08 .335 (.287-.391) .320 (.269-.375) .748 (.621-1.03) 2.30 (1.68-3.35) 4.62 (3.21-6.54) 532 
 09-10 .352 (.281-.442) .360 (.289-.436) .865 (.587-1.21) 1.93 (1.48-2.59) 4.03 (2.43-4.91) 499 
Non-Hispanic whites 99-00 .272 (.225-.329) .250 (.200-.292) .552 (.443-.667) 1.55 (1.09-2.27) 4.02 (2.07-5.49) 603 
 01-02 .321 (.274-.377) .281 (.238-.333) .586 (.468-.811) 1.59 (1.26-2.19) 3.57 (2.25-5.59) 1280 
 07-08 .438 (.369-.519) .368 (.304-.488) 1.00 (.849-1.23) 3.41 (2.41-4.37) 6.29 (4.52-8.37) 1040 
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Urinary Antimony (1999 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 .132 (.120-.145) .130 (.120-.150) .220 (.200-.230) .330 (.300-.350) .430 (.390-.470) 2276 
 01-02 .134 (.126-.142) .130 (.130-.140) .190 (.180-.200) .270 (.250-.310) .350 (.320-.400) 2690 
 03-04 * .080 (<LOD-.090) .130 (.120-.150) .200 (.190-.220) .280 (.250-.320) 2558 
 05-06 .073 (.066-.081) .070 (.070-.080) .120 (.110-.140) .220 (.180-.250) .300 (.270-.360) 2576 
 07-08 .061 (.057-.066) .060 (.060-.060) .100 (.090-.110) .170 (.140-.200) .240 (.220-.260) 2627 
 09-10 .056 (.053-.059) .050 (.050-.060) .090 (.090-.100) .170 (.140-.180) .230 (.200-.280) 2847 
Age group        
6-11 years 99-00 .176 (.154-.200) .190 (.160-.210) .260 (.230-.280) .350 (.300-.400) .440 (.320-.600) 316 
 01-02 .146 (.134-.160) .150 (.130-.160) .200 (.180-.210) .270 (.240-.330) .340 (.280-.440) 368 
 03-04 .099 (.087-.114) .100 (.070-.120) .160 (.120-.200) .240 (.190-.310) .310 (.230-.330) 290 
 05-06 .075 (.063-.088) .080 (.060-.090) .110 (.090-.130) .190 (.120-.260) .240 (.170-.340) 355 
 07-08 .068 (.061-.077) .070 (.060-.080) .110 (.090-.130) .170 (.150-.210) .230 (.180-.280) 394 
 09-10 .069 (.061-.079) .070 (.060-.080) .120 (.100-.150) .220 (.150-.260) .260 (.230-.350) 378 
12-19 years 99-00 .158 (.141-.178) .170 (.150-.180) .240 (.210-.270) .350 (.290-.420) .460 (.350-.510) 663 
 01-02 .169 (.156-.184) .160 (.150-.180) .240 (.220-.260) .350 (.320-.410) .460 (.400-.500) 762 
 03-04 .105 (.095-.115) .100 (.090-.120) .150 (.140-.160) .230 (.200-.270) .290 (.250-.370) 725 
 05-06 .092 (.083-.101) .090 (.080-.100) .140 (.130-.160) .240 (.200-.270) .280 (.250-.320) 701 
 07-08 .079 (.069-.091) .080 (.070-.090) .130 (.110-.140) .210 (.150-.230) .230 (.210-.340) 376 
 09-10 .063 (.056-.071) .060 (.050-.070) .100 (.090-.120) .180 (.150-.210) .270 (.180-.370) 451 
20 years and older 99-00 .123 (.112-.137) .120 (.110-.130) .200 (.180-.220) .310 (.290-.350) .430 (.390-.470) 1297 
 01-02 .128 (.119-.136) .130 (.120-.130) .180 (.170-.190) .250 (.220-.300) .330 (.280-.390) 1560 
 03-04 * .070 (<LOD-.080) .120 (.100-.140) .190 (.170-.210) .270 (.220-.320) 1543 
 05-06 .070 (.064-.078) .070 (.060-.080) .120 (.110-.140) .220 (.180-.270) .320 (.260-.420) 1520 
 07-08 .058 (.054-.062) .060 (.050-.060) .090 (.090-.100) .160 (.130-.190) .240 (.210-.270) 1857 
 09-10 .054 (.051-.057) .050 (.050-.050) .090 (.080-.090) .150 (.140-.180) .220 (.190-.270) 2018 
Gender        
Males 99-00 .143 (.131-.157) .150 (.130-.160) .240 (.220-.260) .350 (.330-.390) .470 (.390-.570) 1132 
 01-02 .145 (.136-.154) .140 (.130-.150) .200 (.190-.210) .310 (.280-.330) .390 (.350-.440) 1335 
 03-04 .095 (.088-.103) .090 (.080-.100) .140 (.130-.160) .220 (.200-.250) .320 (.270-.350) 1281 
 05-06 .085 (.076-.095) .080 (.080-.090) .140 (.120-.160) .250 (.210-.290) .350 (.260-.460) 1271 
 07-08 .068 (.062-.076) .070 (.060-.070) .110 (.100-.120) .210 (.170-.230) .280 (.230-.340) 1327 
 09-10 .060 (.055-.065) .060 (.050-.070) .100 (.090-.110) .170 (.150-.200) .250 (.200-.290) 1397 
Females 99-00 .122 (.109-.137) .120 (.110-.140) .200 (.180-.220) .300 (.280-.340) .400 (.350-.460) 1144 
 01-02 .125 (.117-.133) .120 (.120-.130) .180 (.160-.190) .240 (.220-.280) .320 (.260-.360) 1355 
 03-04 * < LOD .120 (.090-.140) .180 (.150-.220) .230 (.190-.330) 1277 
 05-06 .063 (.057-.071) .060 (.050-.070) .100 (.090-.120) .180 (.150-.230) .270 (.200-.330) 1305 
 07-08 .055 (.052-.058) .050 (.050-.060) .090 (.080-.100) .130 (.120-.150) .200 (.170-.230) 1300 
 09-10 .052 (.049-.056) .050 (.040-.050) .090 (.080-.090) .150 (.130-.170) .220 (.190-.270) 1450 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 05-06, 07-08, and 09-10 are 0.04, 0.04, 0.07, 0.032, 0.032, and 0.032 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Antimony (1999 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 .132 (.108-.161) .140 (.120-.170) .210 (.180-.240) .300 (.260-.390) .430 (.330-.560) 787 
 01-02 .142 (.130-.154) .130 (.130-.150) .200 (.170-.230) .260 (.240-.320) .360 (.300-.400) 683 
 03-04 .093 (.079-.110) .090 (<LOD-.120) .140 (.120-.160) .190 (.160-.260) .270 (.210-.330) 618 
 05-06 .093 (.082-.105) .090 (.080-.100) .150 (.140-.170) .250 (.210-.340) .470 (.270-.850) 652 
 07-08 .069 (.060-.079) .070 (.060-.080) .110 (.100-.120) .190 (.150-.250) .270 (.220-.390) 515 
 09-10 .063 (.060-.067) .060 (.060-.070) .110 (.090-.120) .170 (.150-.200) .250 (.200-.270) 613 
Non-Hispanic blacks 99-00 .175 (.148-.207) .180 (.150-.200) .260 (.230-.300) .400 (.310-.490) .490 (.410-.710) 554 
 01-02 .180 (.164-.197) .170 (.160-.190) .250 (.220-.280) .360 (.320-.410) .460 (.370-.530) 667 
 03-04 .108 (.098-.119) .110 (.100-.120) .160 (.150-.190) .230 (.200-.280) .310 (.250-.360) 723 
 05-06 .088 (.077-.100) .090 (.080-.100) .140 (.130-.170) .210 (.190-.250) .280 (.240-.320) 692 
 07-08 .085 (.079-.092) .080 (.080-.090) .130 (.120-.140) .210 (.180-.250) .290 (.250-.370) 589 
 09-10 .073 (.065-.081) .070 (.060-.080) .120 (.110-.140) .190 (.160-.250) .280 (.220-.350) 544 
Non-Hispanic whites 99-00 .128 (.115-.144) .130 (.110-.140) .210 (.190-.230) .330 (.280-.350) .400 (.360-.500) 768 
 01-02 .126 (.117-.135) .130 (.120-.130) .180 (.170-.190) .250 (.230-.300) .340 (.310-.390) 1132 
 03-04 * .070 (<LOD-.080) .130 (.110-.140) .190 (.170-.210) .280 (.230-.320) 1074 
 05-06 .069 (.062-.077) .070 (.060-.080) .110 (.100-.130) .210 (.170-.260) .300 (.240-.380) 1041 
 07-08 .057 (.052-.063) .060 (.050-.060) .090 (.080-.110) .150 (.130-.200) .230 (.190-.260) 1095 
 09-10 .053 (.050-.057) .050 (.040-.050) .090 (.080-.090) .160 (.130-.190) .230 (.190-.280) 1225 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 05-06, 07-08, and 09-10 are 0.04, 0.04, 0.07, 0.032, 0.032, and 0.032 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Antimony (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * .047 (.042-.052) .083 (.075-.091) .144 (.125-.158) .188 (.169-.222) 2504 
 13-14 .043 (.039-.048) .041 (.036-.046) .076 (.069-.086) .130 (.120-.144) .189 (.170-.214) 2664 
Age group        
6-11 years 11-12 .064 (.059-.069) .059 (.049-.072) .108 (.094-.124) .169 (.152-.188) .206 (.182-.257) 399 
 13-14 .052 (.045-.060) .053 (.046-.065) .096 (.089-.105) .151 (.128-.172) .228 (.168-.254) 402 
12-19 years 11-12 .065 (.057-.073) .065 (.048-.081) .106 (.098-.126) .173 (.137-.202) .218 (.166-.283) 390 
 13-14 .051 (.043-.061) .051 (.041-.062) .088 (.070-.112) .138 (.121-.166) .203 (.152-.235) 451 
20 years and older 11-12 * .044 (<LOD-.051) .076 (.066-.087) .129 (.112-.152) .171 (.158-.228) 1715 
 13-14 .042 (.038-.045) .039 (.033-.043) .071 (.065-.079) .128 (.116-.137) .184 (.161-.215) 1811 
Gender        
Males 11-12 .057 (.052-.063) .052 (.044-.061) .089 (.080-.100) .152 (.124-.169) .196 (.169-.259) 1262 
 13-14 .048 (.044-.052) .046 (.041-.051) .082 (.072-.094) .145 (.129-.161) .213 (.182-.230) 1318 
Females 11-12 * .043 (<LOD-.049) .074 (.068-.082) .131 (.122-.149) .182 (.166-.218) 1242 
 13-14 .040 (.036-.044) .036 (.030-.043) .070 (.062-.078) .122 (.105-.132) .169 (.146-.200) 1346 
Race/ethnicity        
Mexican Americans 11-12 .056 (.051-.062) .053 (.044-.062) .086 (.075-.091) .134 (.110-.164) .174 (.149-.261) 317 
 13-14 .048 (.038-.060) .047 (.033-.057) .082 (.066-.106) .172 (.109-.248) .252 (.170-.432) 453 
Non-Hispanic blacks 11-12 .070 (.063-.079) .068 (.062-.074) .110 (.096-.125) .182 (.148-.229) .254 (.200-.354) 669 
 13-14 .065 (.056-.075) .066 (.060-.070) .111 (.097-.128) .189 (.146-.225) .245 (.218-.303) 581 
Non-Hispanic whites 11-12 * .044 (<LOD-.049) .081 (.069-.095) .143 (.118-.159) .180 (.159-.231) 820 
 13-14 .041 (.037-.045) .037 (.032-.043) .071 (.063-.079) .118 (.104-.130) .167 (.143-.184) 985 
All Hispanics 11-12 * .046 (<LOD-.053) .079 (.066-.088) .128 (.110-.149) .174 (.149-.208) 573 
 13-14 .047 (.040-.055) .045 (.038-.052) .079 (.069-.096) .155 (.116-.218) .231 (.178-.318) 701 
Asians 11-12 * < LOD .066 (.054-.075) .103 (.075-.145) .145 (.100-.194) 353 
 13-14 * .027 (<LOD-.036) .052 (.045-.061) .080 (.065-.098) .099 (.083-.169) 292 
Limit of detection (LOD, see Data Analysis section) for Survey year 11-12 and 13-14 are 0.041 and 0.022. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Antimony (creatinine corrected) (1999 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 .124 (.108-.143) .119 (.102-.143) .185 (.164-.214) .276 (.233-.333) .385 (.333-.430) 2276 
 01-02 .126 (.119-.134) .120 (.115-.126) .173 (.162-.188) .267 (.242-.300) .364 (.320-.414) 2689 
 03-04 * .080 (<LOD-.086) .135 (.119-.143) .208 (.192-.230) .277 (.250-.294) 2558 
 05-06 .072 (.068-.077) .070 (.060-.070) .100 (.100-.110) .160 (.150-.190) .230 (.190-.290) 2576 
 07-08 .064 (.060-.068) .060 (.060-.060) .090 (.080-.100) .140 (.140-.160) .200 (.170-.230) 2627 
 09-10 .060 (.056-.064) .060 (.050-.060) .090 (.080-.090) .140 (.120-.160) .200 (.180-.230) 2847 
Age group        
6-11 years 99-00 .191 (.147-.248) .185 (.156-.220) .250 (.200-.417) .447 (.271-.741) .741 (.333-1.30) 316 
 01-02 .178 (.159-.200) .173 (.150-.193) .228 (.200-.272) .338 (.265-.480) .471 (.313-.727) 368 
 03-04 .116 (.103-.130) .118 (.098-.136) .167 (.146-.187) .256 (.194-.317) .333 (.250-.500) 290 
 05-06 .092 (.081-.104) .090 (.080-.110) .130 (.110-.150) .180 (.150-.210) .220 (.180-.270) 355 
 07-08 .089 (.079-.100) .090 (.070-.100) .120 (.110-.140) .200 (.150-.240) .300 (.200-.370) 394 
 09-10 .094 (.084-.106) .090 (.080-.100) .140 (.120-.160) .200 (.170-.250) .280 (.220-.320) 378 
12-19 years 99-00 .121 (.104-.140) .120 (.095-.146) .176 (.146-.207) .259 (.206-.310) .310 (.228-.421) 663 
 01-02 .121 (.112-.131) .115 (.106-.127) .160 (.138-.186) .224 (.199-.245) .266 (.244-.310) 762 
 03-04 .075 (.068-.082) .068 (.061-.077) .100 (.092-.113) .156 (.126-.173) .193 (.172-.255) 725 
 05-06 .070 (.065-.076) .070 (.060-.080) .100 (.090-.110) .140 (.120-.150) .170 (.150-.250) 701 
 07-08 .062 (.054-.070) .060 (.050-.070) .090 (.070-.100) .120 (.100-.160) .160 (.110-.240) 376 
 09-10 .059 (.053-.066) .060 (.050-.060) .090 (.070-.100) .130 (.110-.170) .180 (.150-.220) 451 
20 years and older 99-00 .118 (.104-.135) .111 (.097-.135) .175 (.149-.209) .263 (.227-.320) .352 (.320-.391) 1297 
 01-02 .122 (.115-.129) .115 (.108-.121) .167 (.153-.181) .265 (.241-.300) .364 (.318-.405) 1559 
 03-04 * .079 (<LOD-.087) .135 (.116-.145) .209 (.195-.233) .278 (.250-.294) 1543 
 05-06 .070 (.066-.075) .060 (.060-.070) .100 (.090-.110) .170 (.150-.190) .250 (.190-.300) 1520 
 07-08 .062 (.058-.066) .060 (.050-.060) .090 (.080-.100) .140 (.130-.160) .200 (.160-.240) 1857 
 09-10 .057 (.053-.061) .050 (.050-.060) .080 (.080-.090) .130 (.120-.140) .190 (.160-.220) 2018 
Gender        
Males 99-00 .112 (.099-.127) .109 (.095-.127) .164 (.146-.181) .226 (.204-.268) .320 (.235-.391) 1132 
 01-02 .114 (.107-.123) .108 (.103-.115) .153 (.138-.171) .228 (.205-.250) .333 (.281-.438) 1334 
 03-04 .080 (.076-.084) .075 (.069-.081) .122 (.111-.132) .192 (.173-.209) .253 (.230-.278) 1281 
 05-06 .070 (.064-.077) .060 (.060-.070) .100 (.090-.120) .160 (.130-.220) .250 (.170-.310) 1271 
 07-08 .061 (.057-.066) .060 (.050-.060) .090 (.080-.100) .140 (.130-.160) .210 (.160-.260) 1327 
 09-10 .055 (.050-.060) .050 (.050-.060) .080 (.070-.100) .130 (.120-.150) .190 (.160-.210) 1397 
Females 99-00 .137 (.117-.161) .131 (.108-.164) .213 (.176-.247) .320 (.263-.417) .429 (.357-.485) 1144 
 01-02 .139 (.131-.148) .132 (.124-.140) .196 (.178-.211) .295 (.267-.317) .371 (.333-.444) 1355 
 03-04 * < LOD .143 (.125-.161) .225 (.188-.261) .288 (.250-.333) 1277 
 05-06 .074 (.070-.078) .070 (.070-.070) .110 (.100-.110) .170 (.150-.190) .220 (.180-.300) 1305 
 07-08 .067 (.062-.071) .060 (.060-.070) .100 (.090-.100) .140 (.130-.160) .200 (.160-.230) 1300 
 09-10 .064 (.060-.069) .060 (.060-.070) .090 (.090-.100) .150 (.130-.170) .220 (.180-.260) 1450 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary Antimony (creatinine corrected) (1999 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 .120 (.107-.135) .114 (.105-.129) .167 (.148-.203) .250 (.209-.315) .333 (.280-.357) 787 
 01-02 .138 (.128-.149) .130 (.117-.143) .182 (.159-.203) .269 (.229-.308) .338 (.308-.429) 682 
 03-04 .086 (.076-.098) .082 (<LOD-.092) .129 (.107-.151) .189 (.154-.238) .238 (.185-.321) 618 
 05-06 .087 (.076-.099) .080 (.070-.080) .120 (.110-.130) .190 (.150-.310) .370 (.200-.800) 652 
 07-08 .069 (.059-.081) .060 (.050-.080) .100 (.080-.120) .160 (.130-.180) .200 (.160-.360) 515 
 09-10 .066 (.063-.071) .060 (.060-.060) .100 (.080-.110) .160 (.130-.190) .240 (.190-.280) 613 
Non-Hispanic blacks 99-00 .114 (.099-.133) .112 (.098-.130) .163 (.144-.183) .236 (.195-.338) .343 (.255-.425) 554 
 01-02 .123 (.113-.134) .115 (.106-.127) .163 (.150-.181) .233 (.208-.267) .300 (.248-.373) 667 
 03-04 .078 (.071-.085) .074 (.069-.082) .109 (.096-.124) .170 (.148-.192) .222 (.179-.257) 723 
 05-06 .064 (.058-.071) .060 (.050-.070) .090 (.080-.090) .130 (.120-.150) .190 (.150-.220) 692 
 07-08 .062 (.059-.066) .060 (.050-.070) .090 (.080-.090) .140 (.120-.160) .180 (.160-.220) 589 
 09-10 .058 (.053-.063) .060 (.050-.060) .080 (.070-.090) .130 (.110-.160) .170 (.150-.190) 544 
Non-Hispanic whites 99-00 .129 (.109-.152) .125 (.102-.152) .195 (.167-.225) .298 (.239-.352) .400 (.333-.444) 768 
 01-02 .127 (.117-.138) .120 (.113-.130) .176 (.159-.198) .280 (.241-.317) .380 (.318-.471) 1132 
 03-04 * .081 (<LOD-.089) .139 (.124-.147) .217 (.200-.238) .286 (.253-.333) 1074 
 05-06 .072 (.068-.077) .070 (.060-.070) .110 (.100-.110) .170 (.150-.190) .230 (.190-.280) 1041 
 07-08 .064 (.060-.069) .060 (.050-.070) .090 (.080-.100) .140 (.140-.160) .210 (.170-.230) 1095 
 09-10 .060 (.055-.065) .060 (.050-.060) .090 (.080-.100) .140 (.120-.170) .200 (.170-.250) 1225 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary Antimony (creatinine corrected) (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * .059 (.055-.063) .092 (.085-.100) .152 (.135-.171) .223 (.181-.261) 2502 
 13-14 .050 (.046-.055) .047 (.044-.051) .073 (.068-.079) .114 (.103-.127) .160 (.145-.172) 2663 
Age group        
6-11 years 11-12 .091 (.081-.102) .091 (.078-.100) .130 (.116-.147) .206 (.153-.283) .308 (.218-.340) 398 
 13-14 .077 (.068-.088) .076 (.067-.084) .114 (.098-.133) .177 (.154-.193) .225 (.191-.238) 402 
12-19 years 11-12 .062 (.055-.069) .058 (.051-.067) .085 (.070-.106) .147 (.115-.181) .222 (.122-.373) 390 
 13-14 .046 (.041-.053) .047 (.039-.052) .064 (.057-.071) .103 (.084-.115) .144 (.109-.172) 451 
20 years and older 11-12 * .056 (<LOD-.060) .088 (.078-.097) .145 (.127-.171) .215 (.179-.240) 1714 
 13-14 .049 (.044-.053) .046 (.043-.049) .070 (.064-.076) .104 (.095-.115) .151 (.130-.170) 1810 
Gender        
Males 11-12 .054 (.050-.058) .051 (.048-.057) .078 (.071-.089) .132 (.120-.151) .186 (.161-.224) 1261 
 13-14 .048 (.043-.053) .045 (.040-.049) .068 (.061-.076) .114 (.099-.123) .163 (.145-.177) 1317 
Females 11-12 * .066 (<LOD-.071) .104 (.094-.112) .165 (.145-.193) .226 (.183-.303) 1241 
 13-14 .053 (.048-.057) .050 (.046-.055) .077 (.071-.084) .114 (.104-.133) .156 (.145-.171) 1346 
Race/ethnicity        
Mexican Americans 11-12 .063 (.059-.067) .061 (.057-.064) .089 (.079-.100) .133 (.121-.153) .183 (.150-.246) 317 
 13-14 .055 (.046-.066) .049 (.043-.057) .076 (.063-.099) .138 (.107-.172) .196 (.137-.381) 453 
Non-Hispanic blacks 11-12 .055 (.049-.060) .052 (.047-.058) .077 (.069-.088) .121 (.104-.147) .175 (.140-.232) 669 
 13-14 .049 (.046-.053) .048 (.044-.052) .068 (.064-.073) .110 (.095-.122) .164 (.133-.221) 581 
Non-Hispanic whites 11-12 * .060 (<LOD-.067) .097 (.088-.108) .161 (.135-.183) .224 (.181-.273) 818 
 13-14 .050 (.044-.056) .047 (.042-.053) .075 (.068-.081) .113 (.098-.127) .156 (.133-.171) 984 
All Hispanics 11-12 * .058 (<LOD-.065) .085 (.073-.097) .132 (.113-.161) .181 (.153-.214) 573 
 13-14 .052 (.047-.059) .047 (.043-.054) .076 (.065-.089) .137 (.107-.164) .196 (.143-.326) 701 
Asians 11-12 * < LOD .087 (.072-.107) .153 (.132-.177) .215 (.171-.290) 353 
 13-14 * .047 (<LOD-.050) .067 (.060-.077) .114 (.087-.145) .160 (.133-.201) 292 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary Total Arsenic (2003 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg /L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 8.30 (7.19-9.57) 7.70 (6.90-8.90) 16.0 (14.1-18.7) 37.4 (31.6-43.5) 65.4 (48.7-83.3) 2557 
 05-06 9.29 (8.05-10.7) 8.65 (7.48-9.99) 17.1 (14.9-20.6) 41.1 (33.3-49.7) 66.7 (53.7-87.0) 2576 
 07-08 8.10 (7.44-8.83) 7.49 (6.90-8.12) 14.9 (13.2-17.0) 33.3 (29.8-38.7) 50.8 (42.3-65.1) 2605 
 09-10 9.28 (8.47-10.2) 8.15 (7.20-8.98) 18.0 (15.3-20.8) 44.6 (39.0-55.1) 85.6 (64.7-114) 2860 
Age group        
6-11 years 03-04 7.08 (5.66-8.84) 6.80 (5.90-7.70) 10.9 (8.90-14.2) 24.6 (13.8-61.8) 46.9 (17.5-178) 290 
 05-06 7.19 (5.81-8.90) 6.96 (5.32-8.88) 11.5 (9.19-16.0) 19.6 (13.1-51.5) 34.1 (19.6-58.5) 355 
 07-08 6.85 (5.98-7.83) 6.40 (5.74-7.23) 10.8 (9.75-12.3) 22.5 (16.9-34.7) 41.0 (21.1-52.8) 390 
 09-10 6.63 (5.74-7.66) 5.94 (5.14-7.19) 10.8 (9.37-12.5) 26.0 (18.2-33.4) 37.7 (27.8-65.6) 378 
12-19 years 03-04 8.55 (7.34-9.97) 8.10 (6.80-9.40) 15.2 (12.2-17.8) 30.5 (23.1-40.4) 46.1 (32.9-62.5) 725 
 05-06 8.19 (6.87-9.77) 7.92 (6.37-9.50) 14.0 (11.6-18.1) 28.2 (22.9-32.9) 41.9 (32.7-48.0) 701 
 07-08 7.09 (6.17-8.14) 6.87 (5.88-7.86) 11.4 (9.41-13.7) 20.4 (16.1-26.6) 38.2 (21.6-53.3) 373 
 09-10 6.45 (5.58-7.47) 6.11 (5.26-6.89) 10.8 (8.59-13.7) 25.9 (16.2-32.9) 38.8 (27.8-55.1) 454 
20 years and older 03-04 8.41 (7.25-9.77) 7.90 (7.00-9.10) 17.0 (15.0-19.7) 40.5 (34.9-46.2) 66.2 (51.2-93.1) 1542 
 05-06 9.76 (8.43-11.3) 9.12 (7.85-10.4) 18.9 (15.8-22.9) 44.2 (35.2-56.1) 71.4 (57.7-98.3) 1520 
 07-08 8.43 (7.70-9.22) 7.94 (7.09-8.67) 16.2 (14.5-18.6) 35.2 (30.4-42.3) 59.0 (44.2-75.6) 1842 
 09-10 10.2 (9.14-11.3) 8.75 (7.95-9.81) 20.4 (17.2-24.1) 52.1 (42.4-66.1) 93.1 (74.2-127) 2028 
Gender        
Males 03-04 9.50 (8.34-10.8) 8.90 (7.70-9.80) 17.6 (15.2-20.1) 41.6 (32.5-52.8) 65.8 (48.7-95.4) 1281 
 05-06 10.1 (8.61-11.8) 8.95 (8.05-10.0) 18.3 (15.5-22.9) 40.8 (31.0-52.6) 63.7 (46.4-78.7) 1271 
 07-08 9.25 (8.28-10.3) 8.50 (7.37-9.53) 17.0 (14.6-19.4) 36.0 (32.1-44.2) 62.5 (44.3-84.6) 1318 
 09-10 10.1 (9.06-11.3) 8.80 (7.80-9.75) 20.4 (16.1-23.9) 47.4 (42.1-64.1) 89.1 (71.6-114) 1401 
Females 03-04 7.30 (6.02-8.84) 6.90 (5.90-8.30) 15.0 (11.3-19.5) 33.4 (26.5-41.7) 60.5 (40.8-77.1) 1276 
 05-06 8.60 (7.38-10.0) 8.18 (6.64-9.97) 15.9 (13.7-19.9) 41.5 (32.2-53.7) 72.6 (54.8-122) 1305 
 07-08 7.14 (6.51-7.82) 6.54 (6.09-7.14) 12.7 (11.6-14.4) 30.1 (26.0-34.0) 49.1 (40.1-57.5) 1287 
 09-10 8.55 (7.44-9.83) 7.63 (6.45-8.62) 15.8 (13.1-19.9) 41.5 (31.7-55.5) 81.5 (54.3-132) 1459 
Race/ethnicity        
Mexican Americans 03-04 9.29 (8.12-10.6) 9.20 (8.10-10.3) 16.2 (13.5-19.9) 34.4 (24.0-60.5) 68.2 (41.3-111) 618 
 05-06 9.55 (8.54-10.7) 9.11 (7.99-10.3) 15.6 (14.0-17.1) 29.2 (21.4-56.8) 67.6 (41.7-81.4) 652 
 07-08 8.98 (8.13-9.92) 8.84 (7.80-9.48) 15.4 (12.3-19.7) 35.2 (25.0-46.0) 53.0 (44.2-77.4) 510 
 09-10 8.47 (7.30-9.84) 7.96 (6.87-9.08) 13.9 (11.3-17.7) 34.7 (25.0-53.2) 60.9 (49.3-78.7) 613 
Non-Hispanic blacks 03-04 11.6 (9.50-14.1) 10.4 (7.90-11.8) 21.5 (14.9-34.4) 43.5 (36.2-61.8) 78.0 (43.6-141) 722 
 05-06 11.0 (8.60-14.0) 9.55 (6.99-13.3) 21.9 (14.9-28.9) 44.9 (31.1-71.4) 82.3 (49.2-164) 692 
 07-08 10.5 (9.40-11.7) 9.21 (8.22-10.4) 18.4 (16.1-21.5) 42.4 (32.9-52.8) 65.6 (45.5-112) 585 
 09-10 10.9 (9.46-12.5) 9.26 (7.70-11.4) 21.7 (17.6-24.2) 49.1 (32.2-81.7) 84.8 (51.3-174) 546 
Non-Hispanic whites 03-04 7.12 (6.13-8.27) 7.00 (6.10-7.90) 13.7 (11.3-15.8) 29.0 (22.6-35.9) 53.1 (38.4-65.6) 1074 
 05-06 8.66 (7.20-10.4) 8.05 (6.52-9.66) 16.3 (13.4-20.6) 40.8 (29.4-50.2) 58.5 (46.0-88.0) 1041 
 07-08 6.98 (6.31-7.71) 6.46 (5.93-7.29) 12.4 (11.3-14.3) 28.3 (21.6-32.6) 42.1 (32.3-50.0) 1088 
 09-10 8.18 (7.46-8.96) 7.24 (6.46-8.21) 14.8 (12.7-17.4) 38.9 (31.7-44.4) 66.3 (49.3-88.7) 1224 
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Urinary Total Arsenic (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg As/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 6.85 (5.85-8.02) 6.09 (5.22-7.12) 13.0 (10.9-16.6) 32.0 (25.9-39.0) 52.5 (41.9-66.2) 2504 
 13-14 6.29 (5.58-7.08) 5.82 (5.10-6.69) 11.7 (10.5-13.2) 26.6 (23.7-30.1) 46.0 (37.5-56.1) 2662 
Age group        
6-11 years 11-12 6.02 (5.03-7.19) 5.50 (4.58-6.56) 10.5 (7.93-14.1) 30.1 (16.7-46.5) 53.0 (37.5-70.3) 399 
 13-14 5.21 (4.57-5.95) 4.78 (4.27-5.57) 8.79 (7.52-10.3) 17.1 (12.4-25.3) 29.0 (17.9-47.7) 402 
12-19 years 11-12 6.01 (4.45-8.11) 5.26 (3.95-7.47) 10.9 (7.74-16.9) 25.9 (16.6-44.0) 44.0 (25.9-153) 390 
 13-14 5.79 (4.96-6.75) 5.33 (4.83-5.91) 9.40 (8.44-11.8) 22.0 (17.4-28.1) 44.1 (27.0-90.8) 451 
20 years and older 11-12 7.09 (6.03-8.33) 6.31 (5.32-7.45) 13.6 (11.3-18.3) 33.2 (26.7-39.5) 52.5 (41.9-77.3) 1715 
 13-14 6.49 (5.72-7.36) 6.12 (5.22-7.06) 12.1 (10.9-14.2) 27.9 (24.1-32.1) 48.0 (37.5-57.5) 1809 
Gender        
Males 11-12 7.69 (6.35-9.31) 6.84 (5.33-8.59) 15.4 (11.7-19.7) 33.5 (27.7-41.9) 56.5 (42.2-78.0) 1262 
 13-14 6.67 (5.97-7.46) 6.37 (5.68-7.12) 11.7 (10.8-13.0) 27.0 (22.3-32.5) 48.5 (33.3-57.5) 1316 
Females 11-12 6.14 (5.22-7.22) 5.42 (4.79-6.25) 11.6 (9.85-13.7) 29.0 (22.5-38.2) 50.6 (37.5-79.8) 1242 
 13-14 5.94 (5.18-6.80) 5.38 (4.68-6.28) 11.2 (9.49-13.7) 26.0 (21.8-31.1) 43.6 (36.0-55.8) 1346 
Race/ethnicity        
Mexican Americans 11-12 7.12 (5.73-8.84) 6.94 (5.34-8.70) 12.2 (9.84-16.5) 24.2 (18.4-35.7) 44.0 (23.8-70.3) 317 
 13-14 5.73 (5.01-6.56) 5.64 (4.93-6.47) 9.19 (8.10-10.2) 17.5 (11.2-36.6) 36.6 (15.4-73.0) 453 
Non-Hispanic blacks 11-12 9.31 (7.19-12.0) 8.18 (6.16-10.8) 17.9 (13.1-25.3) 46.8 (28.8-76.5) 82.1 (53.1-107) 669 
 13-14 8.17 (6.87-9.72) 6.99 (6.01-8.20) 14.9 (10.9-18.2) 30.7 (25.5-38.2) 59.8 (40.0-79.0) 579 
Non-Hispanic whites 11-12 5.89 (4.92-7.06) 5.08 (4.56-6.06) 10.8 (8.48-15.5) 26.3 (20.3-34.9) 43.2 (34.9-56.0) 820 
 13-14 5.67 (4.88-6.59) 5.30 (4.40-6.62) 11.0 (9.16-12.7) 22.4 (17.6-29.9) 39.0 (30.8-50.6) 985 
All Hispanics 11-12 7.62 (6.63-8.76) 7.32 (6.31-8.35) 13.7 (11.7-16.6) 25.8 (21.2-29.8) 45.6 (28.7-55.8) 573 
 13-14 6.16 (5.24-7.22) 5.93 (5.02-6.82) 10.4 (9.11-11.9) 20.2 (14.2-30.1) 37.5 (24.1-57.9) 701 
Asians 11-12 16.7 (14.7-18.9) 14.9 (12.8-19.0) 39.0 (33.2-44.8) 83.2 (61.4-108) 117 (88.4-145) 353 
 13-14 12.1 (10.4-14.1) 11.5 (9.08-13.6) 30.8 (23.2-37.0) 70.7 (52.5-90.8) 126 (79.2-181) 292 
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Urinary Total Arsenic (creatinine corrected) (2003 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg /g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 8.24 (7.07-9.59) 7.04 (5.93-8.51) 14.1 (11.6-17.2) 30.4 (26.0-38.7) 50.4 (40.3-64.5) 2557 
 05-06 9.15 (7.93-10.6) 7.70 (6.55-8.98) 15.2 (11.7-19.4) 35.1 (26.5-44.7) 62.8 (44.7-85.0) 2576 
 07-08 8.46 (7.78-9.21) 7.06 (6.56-7.74) 13.8 (12.5-15.2) 28.9 (24.2-36.7) 49.0 (38.8-70.5) 2605 
 09-10 9.90 (9.06-10.8) 7.90 (6.98-8.97) 17.6 (15.4-20.2) 45.2 (36.6-53.3) 80.8 (60.5-94.4) 2860 
Age group        
6-11 years 03-04 8.25 (6.58-10.3) 7.18 (5.93-9.45) 11.7 (9.10-16.3) 22.2 (12.0-69.5) 40.1 (14.7-188) 290 
 05-06 8.88 (7.05-11.2) 7.87 (6.19-9.42) 11.8 (9.32-18.9) 24.5 (13.0-62.8) 45.4 (22.9-80.9) 355 
 07-08 8.87 (8.06-9.77) 7.53 (6.73-7.88) 13.4 (10.2-16.0) 26.7 (19.9-34.0) 37.2 (28.6-71.4) 390 
 09-10 8.97 (7.93-10.2) 7.42 (6.70-8.32) 11.0 (9.90-14.0) 33.5 (17.0-54.6) 60.8 (36.6-84.9) 378 
12-19 years 03-04 6.11 (5.23-7.13) 5.06 (4.47-6.04) 9.66 (7.44-11.2) 17.8 (12.0-26.0) 27.8 (20.7-35.9) 725 
 05-06 6.30 (5.56-7.14) 5.19 (4.80-6.19) 9.62 (8.12-11.1) 19.4 (13.9-25.8) 28.0 (21.9-33.2) 701 
 07-08 5.50 (4.91-6.16) 4.96 (4.25-5.40) 7.69 (6.09-9.31) 16.8 (10.8-21.1) 22.5 (16.8-29.1) 373 
 09-10 6.06 (5.34-6.87) 4.95 (4.39-5.81) 9.18 (7.00-11.0) 19.2 (14.5-21.3) 28.4 (20.8-35.7) 454 
20 years and older 03-04 8.64 (7.38-10.1) 7.47 (6.20-9.01) 15.4 (12.7-18.8) 33.8 (27.3-41.2) 53.9 (45.4-64.5) 1542 
 05-06 9.75 (8.46-11.2) 8.22 (6.98-9.75) 17.0 (12.8-21.3) 41.0 (29.6-52.5) 68.4 (52.8-89.7) 1520 
 07-08 9.00 (8.20-9.88) 7.55 (6.79-8.53) 14.9 (13.1-17.1) 32.5 (25.8-41.0) 59.4 (41.0-86.2) 1842 
 09-10 10.8 (9.71-12.0) 8.73 (7.69-9.71) 20.1 (16.5-24.2) 50.8 (40.5-59.7) 87.3 (70.0-105) 2028 
Gender        
Males 03-04 8.00 (6.81-9.40) 6.75 (5.66-8.35) 13.7 (11.0-18.0) 28.7 (25.1-36.4) 45.6 (35.3-62.1) 1281 
 05-06 8.26 (7.09-9.63) 7.16 (5.87-8.54) 12.9 (10.2-18.0) 28.8 (22.9-36.3) 46.1 (35.1-66.5) 1271 
 07-08 8.30 (7.49-9.18) 6.79 (6.39-7.61) 13.2 (11.8-15.2) 28.9 (23.5-38.5) 47.7 (35.7-68.1) 1318 
 09-10 9.21 (8.55-9.93) 7.22 (6.43-8.67) 17.0 (14.9-18.6) 41.8 (35.4-47.9) 66.9 (52.0-81.5) 1401 
Females 03-04 8.47 (7.12-10.1) 7.33 (6.10-8.75) 14.4 (11.7-17.7) 32.3 (24.2-46.6) 58.4 (42.8-75.0) 1276 
 05-06 10.1 (8.72-11.7) 8.29 (7.23-9.87) 17.4 (13.0-21.4) 43.8 (29.2-61.5) 74.1 (55.0-96.2) 1305 
 07-08 8.63 (7.91-9.41) 7.13 (6.53-8.33) 14.1 (12.3-16.9) 27.9 (24.1-37.0) 51.4 (39.7-83.3) 1287 
 09-10 10.6 (9.36-12.0) 8.38 (7.40-9.41) 18.6 (14.9-23.9) 50.8 (35.1-72.9) 87.8 (66.8-109) 1459 
Race/ethnicity        
Mexican Americans 03-04 8.61 (7.33-10.1) 7.76 (6.30-9.44) 12.6 (10.2-15.9) 24.0 (17.7-34.8) 42.4 (24.8-62.4) 618 
 05-06 8.98 (7.89-10.2) 7.48 (6.72-8.87) 12.8 (11.0-16.3) 28.1 (21.1-35.5) 49.1 (31.0-108) 652 
 07-08 8.88 (7.71-10.2) 7.38 (6.51-8.63) 14.1 (10.6-17.8) 28.6 (22.5-35.3) 48.2 (31.1-75.7) 510 
 09-10 8.88 (7.87-10.0) 7.62 (6.69-8.45) 13.2 (10.7-17.2) 31.4 (23.7-38.5) 49.8 (37.5-68.9) 613 
Non-Hispanic blacks 03-04 8.31 (6.99-9.88) 6.88 (5.66-8.41) 13.8 (11.5-17.0) 27.6 (17.9-56.0) 54.3 (27.5-120) 722 
 05-06 7.96 (6.40-9.92) 6.48 (5.21-8.30) 13.4 (10.0-18.6) 32.5 (18.7-66.5) 71.4 (35.6-98.8) 692 
 07-08 7.72 (6.98-8.54) 6.60 (6.01-7.56) 13.4 (11.5-15.4) 25.7 (22.1-30.0) 42.7 (31.4-60.3) 585 
 09-10 8.67 (7.54-9.98) 7.26 (5.96-9.02) 15.6 (12.4-21.3) 38.7 (31.5-48.7) 63.9 (43.1-102) 546 
Non-Hispanic whites 03-04 7.50 (6.25-9.01) 6.32 (5.28-7.96) 12.5 (9.86-17.1) 26.8 (21.8-32.0) 40.0 (31.3-53.9) 1074 
 05-06 9.01 (7.57-10.7) 7.68 (6.18-9.56) 14.3 (11.1-20.8) 31.9 (24.1-46.1) 59.4 (37.9-96.2) 1041 
 07-08 7.82 (7.05-8.68) 6.72 (6.00-7.54) 12.5 (11.1-13.9) 24.6 (19.6-32.3) 43.1 (29.1-64.0) 1088 
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Urinary Total Arsenic (creatinine corrected) (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg As/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 7.77 (6.85-8.81) 6.39 (5.57-7.24) 13.7 (11.5-16.5) 30.8 (24.6-38.6) 50.4 (38.2-70.1) 2502 
 13-14 7.27 (6.62-7.99) 6.10 (5.39-6.88) 11.9 (10.5-13.5) 27.6 (23.8-32.8) 52.0 (43.5-60.9) 2661 
Age group        
6-11 years 11-12 8.63 (7.26-10.3) 6.87 (5.84-8.00) 12.3 (9.58-15.5) 27.7 (17.7-57.7) 91.2 (26.2-129) 398 
 13-14 7.78 (7.08-8.54) 6.91 (5.91-7.65) 12.5 (10.3-13.6) 17.7 (16.1-21.1) 29.9 (20.4-52.1) 402 
12-19 years 11-12 5.75 (4.49-7.36) 4.69 (3.70-5.73) 8.73 (6.26-13.3) 22.1 (11.5-52.6) 34.9 (21.1-159) 390 
 13-14 5.24 (4.53-6.06) 4.21 (3.61-4.61) 7.92 (5.75-10.3) 17.6 (12.6-23.0) 30.5 (20.3-54.1) 451 
20 years and older 11-12 8.04 (7.07-9.14) 6.52 (5.88-7.69) 14.8 (12.1-18.8) 32.4 (25.2-39.8) 49.7 (38.2-70.1) 1714 
 13-14 7.58 (6.87-8.36) 6.39 (5.66-7.29) 12.4 (10.9-14.7) 31.0 (26.0-37.9) 54.0 (47.9-66.1) 1808 
Gender        
Males 11-12 7.20 (6.15-8.43) 6.13 (5.18-7.23) 12.5 (10.5-15.2) 28.3 (20.2-34.9) 50.4 (33.3-69.6) 1261 
 13-14 6.69 (6.07-7.38) 5.55 (4.96-6.26) 10.9 (9.50-12.5) 26.0 (19.5-30.6) 47.9 (36.5-55.3) 1315 
Females 11-12 8.35 (7.40-9.42) 6.64 (6.12-7.37) 15.0 (12.2-19.1) 33.1 (26.1-41.4) 50.7 (39.8-79.0) 1241 
 13-14 7.88 (7.03-8.82) 6.67 (5.82-7.78) 13.1 (10.9-15.6) 31.3 (24.9-39.4) 54.1 (46.3-68.3) 1346 
Race/ethnicity        
Mexican Americans 11-12 8.00 (6.85-9.36) 6.91 (6.07-7.98) 11.9 (9.05-14.6) 26.1 (16.7-39.4) 40.8 (24.0-70.1) 317 
 13-14 6.54 (5.70-7.51) 5.83 (5.08-6.54) 8.97 (7.32-11.6) 17.1 (12.6-20.8) 29.2 (15.1-72.2) 453 
Non-Hispanic blacks 11-12 7.24 (5.51-9.51) 5.83 (4.65-7.96) 13.5 (9.02-19.0) 28.8 (21.5-46.3) 55.4 (31.6-87.1) 669 
 13-14 6.23 (5.25-7.39) 4.86 (4.24-6.22) 10.3 (8.03-13.4) 22.7 (17.8-29.1) 37.4 (25.8-70.5) 579 
Non-Hispanic whites 11-12 7.13 (6.05-8.39) 5.72 (5.05-6.70) 12.4 (10.3-15.4) 28.4 (21.7-37.5) 46.5 (33.1-75.8) 818 
 13-14 7.01 (6.25-7.87) 5.87 (5.13-6.88) 11.6 (9.92-13.7) 27.5 (21.6-35.8) 49.5 (40.8-55.3) 984 
All Hispanics 11-12 8.53 (7.74-9.40) 7.60 (6.84-8.42) 12.8 (11.2-14.1) 25.3 (20.8-30.8) 37.5 (28.2-50.6) 573 
 13-14 6.87 (6.08-7.76) 6.26 (5.36-6.89) 10.3 (8.75-11.9) 18.7 (14.3-24.0) 28.7 (18.9-50.7) 701 
Asians 11-12 22.3 (19.1-26.1) 20.1 (16.3-25.2) 39.4 (32.2-61.0) 100 (73.2-129) 162 (114-202) 353 
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Urinary Inorganic-related Arsenic Species (2003 - 2010) 
Sum of arsenic acid, arsenous acid, dimethylarsinic acid, and monomethylarsonic acid** 
Geometric mean and selected percentiles of urine concentrations (in µg As/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 6.52 (6.03-7.04) 6.10 (5.50-6.40) 8.60 (8.00-9.50) 14.0 (12.5-15.4) 19.1 (15.8-22.9) 2572 
 05-06 6.84 (6.35-7.38) 6.40 (5.88-6.85) 9.00 (8.19-10.0) 13.9 (12.0-16.5) 18.5 (15.8-21.7) 2588 
 07-08 6.47 (6.20-6.76) 6.02 (5.74-6.26) 8.55 (8.03-9.22) 12.9 (11.8-14.0) 16.8 (14.7-18.9) 2576 
 09-10 6.56 (6.23-6.90) 5.87 (5.57-6.09) 8.80 (8.14-9.47) 14.6 (12.3-17.2) 20.8 (17.8-24.5) 2852 
Age group        
6-11 years 03-04 6.46 (5.67-7.35) 6.10 (5.80-6.90) 8.50 (7.10-10.0) 12.1 (10.0-14.7) 15.0 (10.7-26.3) 292 
 05-06 6.71 (6.13-7.35) 6.27 (5.44-6.98) 8.46 (7.48-9.72) 13.5 (9.72-16.1) 16.1 (14.0-18.3) 354 
 07-08 6.70 (6.15-7.31) 6.08 (5.77-6.44) 8.78 (7.72-10.3) 13.9 (10.9-16.5) 18.3 (12.2-42.3) 390 
 09-10 6.29 (5.85-6.75) 5.80 (5.11-6.32) 8.34 (7.67-9.07) 13.2 (10.7-14.6) 16.0 (14.0-17.9) 379 
12-19 years 03-04 6.72 (6.08-7.42) 6.10 (5.90-7.00) 8.80 (7.70-10.4) 13.1 (10.6-16.6) 16.7 (14.5-20.3) 729 
 05-06 6.82 (6.18-7.53) 6.38 (5.67-7.45) 8.78 (7.77-10.4) 13.1 (10.9-15.4) 16.4 (13.3-17.7) 703 
 07-08 6.42 (5.89-6.99) 6.34 (5.60-6.95) 8.15 (7.33-9.69) 11.8 (10.5-13.4) 14.6 (12.0-18.1) 366 
 09-10 5.84 (5.43-6.27) 5.31 (4.89-5.85) 7.67 (6.79-8.60) 11.4 (9.66-13.1) 13.9 (11.8-17.0) 453 
20 years and older 03-04 6.49 (6.02-7.00) 6.00 (5.30-6.20) 8.60 (8.10-9.40) 14.1 (12.7-15.6) 19.5 (16.8-24.9) 1550 
 05-06 6.86 (6.34-7.42) 6.43 (5.83-6.87) 9.10 (8.22-10.2) 14.1 (12.0-17.3) 19.9 (15.8-24.0) 1531 
 07-08 6.46 (6.17-6.76) 5.95 (5.71-6.18) 8.57 (8.00-9.40) 13.0 (11.8-14.2) 17.2 (15.0-19.2) 1820 
 09-10 6.70 (6.33-7.10) 5.95 (5.71-6.20) 9.12 (8.20-9.87) 15.4 (12.6-19.6) 23.2 (19.4-27.4) 2020 
Gender        
Males 03-04 7.03 (6.38-7.74) 6.40 (6.00-7.10) 9.20 (8.30-10.5) 14.8 (12.7-18.1) 21.3 (16.0-28.1) 1283 
 05-06 7.10 (6.56-7.68) 6.59 (6.10-7.05) 9.37 (8.22-10.5) 14.3 (11.6-17.7) 18.4 (14.9-23.1) 1276 
 07-08 6.94 (6.54-7.36) 6.44 (6.13-6.87) 9.22 (8.53-9.89) 13.5 (12.4-15.2) 18.3 (14.9-26.4) 1289 
 09-10 6.80 (6.30-7.34) 6.09 (5.71-6.54) 9.06 (8.27-9.89) 15.0 (12.0-20.4) 23.5 (16.3-29.4) 1396 
Females 03-04 6.08 (5.62-6.57) 5.50 (5.10-6.10) 8.10 (7.10-9.10) 12.7 (11.1-14.9) 17.3 (14.6-21.9) 1289 
 05-06 6.60 (6.11-7.14) 6.14 (5.47-6.81) 8.77 (8.06-9.51) 13.3 (11.7-16.2) 18.6 (15.8-22.0) 1312 
 07-08 6.06 (5.81-6.33) 5.66 (5.42-5.84) 7.96 (7.35-8.59) 11.9 (10.7-13.7) 15.8 (14.0-16.8) 1287 
 09-10 6.33 (5.98-6.70) 5.64 (5.21-5.95) 8.36 (7.70-9.60) 14.2 (12.1-16.2) 19.6 (17.8-21.1) 1456 
Race/ethnicity        
Mexican Americans 03-04 7.72 (7.09-8.41) 7.10 (6.50-8.00) 10.1 (9.10-11.8) 15.5 (12.8-20.5) 22.7 (16.5-29.4) 622 
 05-06 7.27 (6.94-7.62) 7.05 (6.69-7.42) 9.83 (9.21-10.5) 12.5 (11.7-14.5) 16.1 (13.9-18.5) 651 
 07-08 7.22 (6.80-7.66) 7.02 (6.43-7.46) 9.89 (9.18-10.3) 12.7 (11.3-14.3) 15.3 (13.6-23.3) 513 
 09-10 6.76 (6.19-7.38) 6.31 (5.48-7.19) 9.12 (8.06-10.3) 14.1 (11.9-16.5) 19.8 (15.8-22.2) 618 
Non-Hispanic blacks 03-04 7.04 (6.42-7.73) 6.50 (6.10-7.30) 9.30 (8.70-10.3) 15.7 (12.3-18.1) 19.4 (17.1-21.4) 725 
 05-06 7.05 (6.36-7.82) 6.48 (5.73-7.16) 8.85 (7.77-9.80) 14.0 (11.0-16.5) 17.9 (14.5-31.0) 695 
 07-08 7.06 (6.76-7.38) 6.45 (6.00-6.81) 9.43 (8.55-10.3) 14.5 (13.3-15.8) 18.5 (15.8-23.5) 586 
 09-10 7.03 (6.44-7.67) 6.28 (5.66-6.92) 9.84 (8.48-11.4) 16.0 (12.7-19.9) 22.2 (17.8-33.5) 543 
Non-Hispanic whites 03-04 5.96 (5.54-6.41) 5.50 (5.10-6.10) 7.70 (7.10-8.50) 12.0 (9.80-13.7) 15.1 (12.8-18.1) 1081 
 05-06 6.55 (5.96-7.20) 6.10 (5.42-6.83) 8.50 (7.74-9.73) 13.3 (11.1-16.2) 17.3 (14.1-21.4) 1050 
 07-08 5.95 (5.69-6.23) 5.66 (5.35-5.96) 7.72 (7.26-8.25) 11.1 (10.3-12.2) 14.0 (12.5-16.1) 1063 
 09-10 5.96 (5.75-6.18) 5.46 (5.22-5.65) 7.89 (7.56-8.19) 11.5 (10.1-13.3) 15.3 (13.3-18.8) 1210 
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Urinary Inorganic-related Arsenic Species (2011 - 2014) 
Sum of arsenic acid, arsenous acid, dimethylarsenic acid, and methylarsonic acid** 
Geometric mean and selected percentiles of urine concentrations (in µg As/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 5.59 (5.24-5.96) 5.15 (4.73-5.56) 7.73 (7.09-8.57) 12.2 (11.1-13.9) 17.2 (14.6-19.9) 2517 
 13-14 4.80 (4.53-5.09) 4.53 (4.18-4.94) 7.22 (6.74-7.70) 11.2 (10.3-12.0) 14.7 (13.5-16.8) 2654 
Age group        
6-11 years 11-12 5.48 (5.05-5.95) 5.36 (4.50-5.98) 7.58 (7.08-8.34) 11.2 (9.93-12.1) 13.4 (11.6-16.2) 401 
 13-14 4.91 (4.44-5.43) 4.59 (4.02-5.00) 7.21 (6.20-8.38) 11.3 (9.91-13.9) 14.2 (11.4-19.6) 397 
12-19 years 11-12 5.37 (4.67-6.17) 5.09 (4.24-6.00) 7.28 (6.27-8.32) 11.1 (8.34-14.9) 15.6 (10.8-23.9) 392 
 13-14 5.09 (4.64-5.57) 5.02 (4.51-5.46) 7.29 (6.53-8.08) 11.9 (9.80-13.7) 14.5 (12.5-15.9) 450 
20 years and older 11-12 5.64 (5.28-6.01) 5.15 (4.71-5.57) 7.83 (7.07-8.88) 12.5 (11.2-14.8) 17.6 (15.2-20.0) 1724 
 13-14 4.75 (4.46-5.05) 4.45 (4.08-4.91) 7.20 (6.63-7.72) 11.2 (10.3-11.8) 14.8 (12.9-17.1) 1807 
Gender        
Males 11-12 6.00 (5.52-6.52) 5.63 (5.11-6.28) 8.31 (7.29-9.94) 13.4 (11.7-16.5) 18.8 (16.7-20.8) 1264 
 13-14 5.02 (4.78-5.28) 4.92 (4.45-5.32) 7.45 (7.09-7.94) 11.4 (10.3-12.1) 14.8 (13.5-16.1) 1308 
Females 11-12 5.23 (4.90-5.58) 4.70 (4.36-5.05) 7.16 (6.47-8.01) 11.6 (10.1-12.9) 14.9 (12.3-20.5) 1253 
 13-14 4.59 (4.26-4.96) 4.29 (3.87-4.69) 6.94 (5.99-7.67) 10.8 (10.0-12.1) 14.7 (12.8-18.3) 1346 
Race/ethnicity        
Mexican Americans 11-12 5.76 (5.37-6.18) 5.26 (5.02-5.77) 7.71 (7.37-8.54) 11.9 (10.1-13.8) 16.8 (12.1-19.9) 317 
 13-14 5.01 (4.77-5.27) 5.14 (4.62-5.52) 7.21 (6.84-7.70) 10.3 (9.54-11.3) 12.4 (11.2-16.2) 455 
Non-Hispanic blacks 11-12 6.20 (5.52-6.97) 5.77 (5.09-6.42) 8.81 (7.43-10.6) 14.4 (12.1-18.0) 20.5 (16.5-25.4) 672 
 13-14 5.58 (5.03-6.20) 5.28 (4.84-5.81) 7.81 (6.82-9.63) 13.4 (10.6-15.7) 19.2 (13.5-25.0) 576 
Non-Hispanic whites 11-12 5.10 (4.79-5.43) 4.69 (4.35-5.11) 7.01 (6.36-7.72) 10.7 (8.90-12.1) 12.9 (11.9-16.0) 825 
 13-14 4.35 (4.02-4.71) 4.12 (3.67-4.47) 6.46 (5.79-7.21) 9.95 (8.65-10.9) 12.3 (10.9-14.0) 980 
All Hispanics 11-12 6.22 (5.52-7.01) 5.72 (5.08-6.51) 8.97 (7.41-11.1) 14.5 (11.4-19.0) 19.9 (15.8-21.6) 574 
 13-14 5.31 (4.87-5.80) 5.34 (4.64-6.01) 7.92 (7.18-8.84) 11.7 (10.5-12.9) 14.8 (12.4-16.2) 703 
Asians 11-12 10.1 (9.11-11.2) 9.53 (8.32-11.1) 17.8 (14.6-19.9) 29.6 (24.5-34.2) 42.3 (33.0-46.4) 356 
 13-14 7.60 (7.10-8.14) 7.69 (6.65-8.90) 13.8 (11.0-14.9) 23.0 (18.3-24.3) 28.0 (23.1-39.4) 291 
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Urinary Inorganic-related Arsenic Species (creatinine corrected) (2003 - 2010) 
Sum of arsenic acid, arsenous acid, dimethylarsinic acid, and monomethylarsonic acid** 
Geometric mean and selected percentiles of urine concentrations (in µg As/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 6.47 (5.84-7.16) 5.95 (5.40-6.62) 9.64 (8.25-11.4) 15.7 (13.3-18.5) 20.0 (17.4-23.9) 2569 
 05-06 6.72 (6.30-7.17) 6.21 (5.81-6.58) 9.75 (8.81-11.0) 16.2 (14.2-18.0) 21.3 (18.7-24.3) 2588 
 07-08 6.75 (6.41-7.12) 6.42 (5.97-6.88) 9.77 (9.03-10.6) 15.5 (14.2-17.0) 21.2 (18.1-23.3) 2576 
 09-10 6.94 (6.55-7.36) 6.55 (6.04-7.00) 10.3 (9.58-11.0) 16.4 (14.9-17.9) 22.5 (19.0-26.5) 2851 
Age group        
6-11 years 03-04 7.52 (6.45-8.77) 6.51 (6.05-8.30) 10.5 (8.06-13.5) 16.8 (12.4-19.7) 19.2 (14.3-41.3) 292 
 05-06 8.28 (7.20-9.52) 7.73 (6.44-8.96) 10.7 (8.86-14.1) 17.4 (13.6-22.1) 24.0 (18.8-26.2) 354 
 07-08 8.81 (7.92-9.80) 8.09 (7.23-9.44) 12.1 (10.8-13.9) 18.3 (15.5-23.4) 24.5 (18.4-37.9) 390 
 09-10 8.47 (7.76-9.25) 7.92 (7.20-8.73) 10.7 (9.71-12.6) 17.0 (13.8-22.3) 24.9 (14.8-42.2) 378 
12-19 years 03-04 4.79 (4.33-5.29) 4.46 (3.98-5.00) 6.31 (5.46-7.44) 8.96 (8.17-11.4) 12.8 (10.2-15.7) 728 
 05-06 5.24 (4.95-5.55) 4.97 (4.61-5.44) 7.23 (6.71-7.72) 10.7 (9.48-11.6) 13.3 (11.5-15.5) 703 
 07-08 5.00 (4.64-5.39) 4.72 (4.47-5.13) 6.68 (5.85-7.49) 9.85 (7.88-11.8) 12.1 (10.2-14.8) 366 
 09-10 5.44 (4.97-5.95) 4.83 (4.46-5.50) 8.10 (6.54-9.23) 12.1 (10.4-15.1) 16.6 (13.6-20.5) 453 
20 years and older 03-04 6.67 (6.00-7.41) 6.12 (5.54-7.03) 10.2 (8.51-12.0) 15.9 (13.8-19.2) 21.2 (18.2-25.5) 1548 
 05-06 6.82 (6.39-7.28) 6.27 (5.80-6.79) 10.3 (9.07-11.5) 16.7 (14.5-18.9) 22.2 (19.3-25.9) 1531 
 07-08 6.87 (6.48-7.29) 6.54 (6.14-7.08) 9.90 (9.10-11.1) 16.2 (14.2-18.0) 21.3 (18.2-24.3) 1820 
 09-10 7.06 (6.61-7.53) 6.67 (6.13-7.09) 10.6 (9.71-11.4) 17.0 (15.0-18.9) 23.3 (19.5-27.5) 2020 
Gender        
Males 03-04 5.93 (5.19-6.78) 5.43 (4.73-6.14) 8.57 (7.19-10.7) 13.7 (11.4-17.4) 19.4 (14.7-25.6) 1283 
 05-06 5.83 (5.41-6.28) 5.43 (5.00-5.90) 8.27 (7.26-9.46) 12.9 (11.3-15.5) 18.0 (14.2-20.4) 1276 
 07-08 6.21 (5.91-6.53) 5.89 (5.47-6.27) 8.87 (8.27-9.71) 14.3 (12.7-16.6) 18.9 (17.0-21.3) 1289 
 09-10 6.17 (5.82-6.54) 5.70 (5.34-6.30) 8.95 (8.40-9.46) 14.3 (12.5-15.8) 18.1 (16.0-22.0) 1395 
Females 03-04 7.02 (6.45-7.64) 6.59 (5.94-7.20) 10.5 (8.95-12.4) 16.8 (14.9-19.1) 20.6 (18.0-25.4) 1285 
 05-06 7.70 (7.22-8.21) 7.11 (6.54-7.73) 11.4 (10.3-13.1) 17.9 (16.2-20.0) 25.7 (22.1-28.5) 1312 
 07-08 7.30 (6.85-7.77) 7.00 (6.44-7.48) 10.4 (9.59-11.5) 16.2 (13.7-20.1) 22.7 (18.9-28.3) 1287 
 09-10 7.77 (7.27-8.31) 7.29 (6.80-7.91) 11.7 (10.9-12.5) 18.9 (16.3-22.0) 26.5 (20.4-34.0) 1456 
Race/ethnicity        
Mexican Americans 03-04 7.16 (6.29-8.15) 6.78 (5.58-8.01) 10.4 (8.19-12.7) 15.6 (13.3-18.9) 20.0 (16.1-29.9) 621 
 05-06 6.83 (6.38-7.32) 6.55 (5.94-7.34) 9.40 (8.51-10.6) 13.6 (11.6-15.9) 16.2 (14.3-20.0) 651 
 07-08 7.19 (6.39-8.10) 7.07 (6.17-7.76) 9.73 (8.28-11.4) 15.4 (12.9-19.2) 21.3 (17.8-24.3) 513 
 09-10 7.04 (6.44-7.69) 6.92 (6.15-7.70) 10.3 (9.19-10.9) 14.7 (13.3-16.2) 18.9 (16.9-20.6) 618 
Non-Hispanic blacks 03-04 5.08 (4.63-5.56) 4.72 (4.34-5.25) 7.04 (6.23-8.00) 10.7 (8.71-14.3) 15.0 (11.4-19.1) 725 
 05-06 5.08 (4.63-5.57) 4.73 (4.33-5.21) 6.82 (6.13-7.61) 10.6 (8.32-13.5) 15.1 (11.2-25.0) 695 
 07-08 5.19 (4.86-5.55) 4.79 (4.41-5.39) 7.28 (6.97-7.97) 11.2 (10.2-12.2) 14.7 (12.2-18.9) 586 
 09-10 5.58 (5.10-6.10) 5.01 (4.58-5.42) 8.50 (6.94-10.4) 13.6 (12.6-15.5) 19.0 (14.6-23.1) 542 
Non-Hispanic whites 03-04 6.28 (5.55-7.10) 5.82 (5.19-6.53) 9.10 (7.74-11.4) 14.8 (11.4-18.8) 19.4 (15.8-23.6) 1079 
 05-06 6.78 (6.30-7.31) 6.26 (5.79-6.78) 10.2 (8.85-11.4) 16.2 (13.8-18.2) 20.8 (17.9-24.6) 1050 
 07-08 6.66 (6.29-7.06) 6.37 (5.73-6.95) 9.64 (8.88-10.2) 14.8 (12.8-16.5) 20.0 (16.5-22.7) 1063 
 09-10 6.61 (6.20-7.05) 6.31 (5.76-6.81) 9.44 (8.75-10.0) 14.7 (13.6-15.8) 18.9 (17.0-22.0) 1210 
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Urinary Inorganic-related Arsenic Species (creatinine corrected) (2011 - 2014) 
Sum of arsenic acid, arsenous acid, dimethylarsenic acid, and methlyarsonic acid** 
Geometric mean and selected percentiles of urine concentrations (in µg As/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 6.31 (6.02-6.63) 6.00 (5.64-6.37) 9.46 (8.88-10.1) 15.1 (13.4-16.5) 19.6 (18.3-20.4) 2516 
 13-14 5.53 (5.24-5.83) 5.28 (4.91-5.61) 8.09 (7.61-8.62) 13.0 (11.9-14.1) 17.4 (15.6-18.8) 2653 
Age group        
6-11 years 11-12 7.77 (7.36-8.20) 7.33 (6.95-8.26) 10.6 (9.74-11.9) 15.9 (14.3-16.8) 20.2 (16.8-22.3) 401 
 13-14 7.38 (6.78-8.04) 6.73 (5.99-8.30) 10.4 (9.30-12.3) 15.4 (14.1-16.8) 17.8 (15.5-19.4) 397 
12-19 years 11-12 5.13 (4.48-5.88) 4.76 (4.40-5.11) 7.40 (5.86-8.81) 11.4 (8.17-16.8) 16.8 (11.4-28.7) 392 
 13-14 4.61 (4.14-5.15) 4.38 (3.92-4.81) 6.57 (5.55-7.69) 9.38 (8.11-11.1) 11.7 (9.46-16.7) 450 
20 years and older 11-12 6.37 (6.08-6.67) 6.09 (5.72-6.52) 9.53 (8.98-10.2) 15.6 (13.6-17.0) 19.6 (18.3-20.4) 1723 
 13-14 5.51 (5.24-5.79) 5.29 (4.95-5.57) 7.95 (7.61-8.52) 12.9 (11.9-14.2) 17.7 (15.6-19.4) 1806 
Gender        
Males 11-12 5.61 (5.24-6.01) 5.27 (4.81-5.87) 8.39 (7.73-9.04) 12.4 (10.6-13.9) 16.8 (13.6-19.1) 1263 
 13-14 5.02 (4.79-5.26) 4.72 (4.44-5.04) 7.04 (6.66-7.54) 11.4 (10.7-12.8) 17.0 (14.2-17.8) 1307 
Females 11-12 7.06 (6.69-7.45) 6.77 (6.30-7.15) 11.0 (10.2-11.9) 16.8 (15.3-19.1) 21.5 (19.4-24.2) 1253 
 13-14 6.06 (5.62-6.54) 5.80 (5.33-6.46) 9.14 (8.21-10.1) 13.9 (12.5-15.5) 18.0 (15.9-19.5) 1346 
Race/ethnicity        
Mexican Americans 11-12 6.48 (6.05-6.94) 6.33 (5.77-6.82) 9.18 (7.97-9.86) 12.4 (11.2-13.3) 16.0 (13.0-19.0) 317 
 13-14 5.71 (5.39-6.06) 5.52 (5.15-5.87) 7.61 (6.97-8.52) 10.9 (9.87-12.4) 13.9 (12.2-15.8) 455 
Non-Hispanic blacks 11-12 4.83 (4.23-5.53) 4.53 (3.92-5.26) 7.30 (6.09-8.27) 10.9 (9.40-13.2) 16.2 (12.6-17.3) 672 
 13-14 4.21 (3.77-4.72) 4.00 (3.42-4.75) 6.13 (5.48-6.97) 8.70 (7.90-10.5) 12.2 (9.92-15.4) 576 
Non-Hispanic whites 11-12 6.13 (5.77-6.50) 5.81 (5.27-6.36) 9.09 (8.41-9.86) 14.3 (12.4-16.2) 18.6 (16.2-19.8) 824 
 13-14 5.36 (4.99-5.76) 5.14 (4.65-5.55) 7.69 (7.04-8.64) 12.5 (11.1-13.9) 16.0 (14.1-18.3) 979 
All Hispanics 11-12 6.96 (6.56-7.38) 6.90 (6.45-7.36) 9.80 (9.30-10.5) 13.4 (12.0-15.9) 17.2 (14.7-20.3) 574 
 13-14 5.93 (5.59-6.28) 5.76 (5.43-6.09) 8.05 (7.53-8.71) 11.9 (10.5-13.0) 15.2 (12.4-19.0) 703 
Asians 11-12 13.6 (11.9-15.4) 13.2 (11.4-14.6) 20.8 (16.5-24.6) 33.9 (24.6-58.3) 58.8 (36.4-71.5) 356 
 13-14 11.8 (10.6-13.2) 11.2 (10.0-12.8) 18.6 (14.7-21.7) 30.3 (23.9-40.3) 44.5 (31.2-48.9) 291 
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Urinary Arsenic (V) acid (2003 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg As/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD 1.10 (<LOD-1.50) 2568 
 05-06 * < LOD < LOD < LOD 1.06 (<LOD-1.43) 2588 
 07-08 * < LOD < LOD < LOD < LOD 2576 
 09-10 * < LOD < LOD < LOD < LOD 2852 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD 1.10 (<LOD-1.30) 292 
 05-06 * < LOD < LOD < LOD < LOD 354 
 07-08 * < LOD < LOD < LOD < LOD 390 
 09-10 * < LOD < LOD < LOD < LOD 379 
12-19 years 03-04 * < LOD < LOD < LOD 1.20 (<LOD-1.60) 728 
 05-06 * < LOD < LOD < LOD 1.00 (<LOD-1.30) 703 
 07-08 * < LOD < LOD < LOD < LOD 366 
 09-10 * < LOD < LOD < LOD < LOD 453 
20 years and older 03-04 * < LOD < LOD < LOD 1.10 (<LOD-1.50) 1548 
 05-06 * < LOD < LOD < LOD 1.09 (<LOD-1.71) 1531 
 07-08 * < LOD < LOD < LOD < LOD 1820 
 09-10 * < LOD < LOD < LOD < LOD 2020 
Gender        
Males 03-04 * < LOD < LOD < LOD 1.20 (<LOD-1.50) 1284 
 05-06 * < LOD < LOD < LOD 1.14 (<LOD-1.71) 1276 
 07-08 * < LOD < LOD < LOD < LOD 1289 
 09-10 * < LOD < LOD < LOD < LOD 1396 
Females 03-04 * < LOD < LOD < LOD 1.10 (<LOD-1.30) 1284 
 05-06 * < LOD < LOD < LOD 1.01 (<LOD-1.22) 1312 
 07-08 * < LOD < LOD < LOD < LOD 1287 
 09-10 * < LOD < LOD < LOD < LOD 1456 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD 1.20 (<LOD-1.60) 621 
 05-06 * < LOD < LOD < LOD < LOD 651 
 07-08 * < LOD < LOD < LOD < LOD 513 
 09-10 * < LOD < LOD < LOD < LOD 618 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD 1.20 (<LOD-1.80) 725 
 05-06 * < LOD < LOD < LOD < LOD 695 
 07-08 * < LOD < LOD < LOD < LOD 586 
 09-10 * < LOD < LOD < LOD < LOD 543 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD 1.10 (<LOD-1.50) 1078 
 05-06 * < LOD < LOD < LOD 1.10 (<LOD-1.74) 1050 
 07-08 * < LOD < LOD < LOD < LOD 1063 
 09-10 * < LOD < LOD < LOD < LOD 1210 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, 07-08 and 09-10 are 1.0, 1.0, 1.0, and 1.0 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Arsenic (V) acid (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg As/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * < LOD < LOD < LOD < LOD 2517 
 13-14 * < LOD < LOD < LOD < LOD 2654 
Age group        
6-11 years 11-12 * < LOD < LOD < LOD < LOD 401 
 13-14 * < LOD < LOD < LOD < LOD 397 
12-19 years 11-12 * < LOD < LOD < LOD < LOD 392 
 13-14 * < LOD < LOD < LOD < LOD 450 
20 years and older 11-12 * < LOD < LOD < LOD < LOD 1724 
 13-14 * < LOD < LOD < LOD < LOD 1807 
Gender        
Males 11-12 * < LOD < LOD < LOD < LOD 1264 
 13-14 * < LOD < LOD < LOD < LOD 1308 
Females 11-12 * < LOD < LOD < LOD < LOD 1253 
 13-14 * < LOD < LOD < LOD < LOD 1346 
Race/ethnicity        
Mexican Americans 11-12 * < LOD < LOD < LOD < LOD 317 
 13-14 * < LOD < LOD < LOD < LOD 455 
Non-Hispanic blacks 11-12 * < LOD < LOD < LOD < LOD 672 
 13-14 * < LOD < LOD < LOD < LOD 576 
Non-Hispanic whites 11-12 * < LOD < LOD < LOD < LOD 825 
 13-14 * < LOD < LOD < LOD < LOD 980 
All Hispanics 11-12 * < LOD < LOD < LOD < LOD 574 
 13-14 * < LOD < LOD < LOD < LOD 703 
Asians 11-12 * < LOD < LOD < LOD < LOD 356 
 13-14 * < LOD < LOD < LOD < LOD 291 
Limit of detection (LOD, see Data Analysis section) for Survey year 11-12 and 13-14 are 0.87 and . 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Arsenic (V) acid (creatinine corrected) (2003 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg As/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD 3.04 (<LOD-3.50) 2568 
 05-06 * < LOD < LOD < LOD 3.23 (<LOD-3.55) 2588 
 07-08 * < LOD < LOD < LOD < LOD 2576 
 09-10 * < LOD < LOD < LOD < LOD 2851 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD 2.80 (<LOD-4.00) 292 
 05-06 * < LOD < LOD < LOD < LOD 354 
 07-08 * < LOD < LOD < LOD < LOD 390 
 09-10 * < LOD < LOD < LOD < LOD 378 
12-19 years 03-04 * < LOD < LOD < LOD 1.75 (<LOD-2.41) 728 
 05-06 * < LOD < LOD < LOD 1.69 (<LOD-2.73) 703 
 07-08 * < LOD < LOD < LOD < LOD 366 
 09-10 * < LOD < LOD < LOD < LOD 453 
20 years and older 03-04 * < LOD < LOD < LOD 3.18 (<LOD-3.70) 1548 
 05-06 * < LOD < LOD < LOD 3.38 (<LOD-3.94) 1531 
 07-08 * < LOD < LOD < LOD < LOD 1820 
 09-10 * < LOD < LOD < LOD < LOD 2020 
Gender        
Males 03-04 * < LOD < LOD < LOD 2.61 (<LOD-3.18) 1284 
 05-06 * < LOD < LOD < LOD 2.14 (<LOD-2.73) 1276 
 07-08 * < LOD < LOD < LOD < LOD 1289 
 09-10 * < LOD < LOD < LOD < LOD 1395 
Females 03-04 * < LOD < LOD < LOD 3.33 (<LOD-3.89) 1284 
 05-06 * < LOD < LOD < LOD 3.55 (<LOD-4.44) 1312 
 07-08 * < LOD < LOD < LOD < LOD 1287 
 09-10 * < LOD < LOD < LOD < LOD 1456 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD 2.69 (<LOD-3.50) 621 
 05-06 * < LOD < LOD < LOD < LOD 651 
 07-08 * < LOD < LOD < LOD < LOD 513 
 09-10 * < LOD < LOD < LOD < LOD 618 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD 1.75 (<LOD-2.19) 725 
 05-06 * < LOD < LOD < LOD < LOD 695 
 07-08 * < LOD < LOD < LOD < LOD 586 
 09-10 * < LOD < LOD < LOD < LOD 542 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD 3.33 (<LOD-3.95) 1078 
 05-06 * < LOD < LOD < LOD 3.38 (<LOD-3.80) 1050 
 07-08 * < LOD < LOD < LOD < LOD 1063 
 09-10 * < LOD < LOD < LOD < LOD 1210 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary Arsenic (V) acid (creatinine corrected) (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg As/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * < LOD < LOD < LOD < LOD 2516 
Age group        
6-11 years 11-12 * < LOD < LOD < LOD < LOD 401 
12-19 years 11-12 * < LOD < LOD < LOD < LOD 392 
20 years and older 11-12 * < LOD < LOD < LOD < LOD 1723 
Gender        
Males 11-12 * < LOD < LOD < LOD < LOD 1263 
Females 11-12 * < LOD < LOD < LOD < LOD 1253 
Race/ethnicity        
Mexican Americans 11-12 * < LOD < LOD < LOD < LOD 317 
Non-Hispanic blacks 11-12 * < LOD < LOD < LOD < LOD 672 
Non-Hispanic whites 11-12 * < LOD < LOD < LOD < LOD 824 
All Hispanics 11-12 * < LOD < LOD < LOD < LOD 574 
Asians 11-12 * < LOD < LOD < LOD < LOD 356 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary Arsenobetaine (2003 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg As/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 1.55 (1.31-1.83) 1.00 (.800-1.40) 5.20 (4.00-6.50) 16.8 (12.7-22.3) 35.0 (27.6-44.6) 2568 
 05-06 1.86 (1.43-2.41) 1.53 (.980-2.26) 6.73 (4.80-8.91) 22.6 (16.5-30.3) 40.6 (30.7-59.4) 2588 
 07-08 * .670 (.510-.910) 4.26 (3.53-4.88) 16.6 (12.5-20.2) 29.5 (22.8-37.1) 2576 
 09-10 1.59 (1.38-1.83) .940 (.720-1.26) 6.18 (4.67-7.87) 23.5 (19.8-30.1) 50.4 (35.7-63.2) 2870 
Age group        
6-11 years 03-04 * < LOD 1.80 (.800-4.00) 8.80 (3.90-29.9) 29.9 (6.20-190) 292 
 05-06 * < LOD 2.22 (.620-5.35) 7.14 (2.34-29.9) 18.9 (5.46-45.0) 354 
 07-08 * < LOD 1.24 (.780-2.42) 6.71 (3.37-8.38) 13.0 (7.22-25.2) 390 
 09-10 * < LOD 1.20 (.590-3.12) 7.98 (5.20-15.7) 19.4 (9.25-47.9) 380 
12-19 years 03-04 * .600 (.400-.800) 3.20 (2.00-4.70) 13.9 (7.20-25.1) 31.8 (17.2-35.8) 728 
 05-06 * .550 (<LOD-1.14) 3.76 (1.95-7.16) 12.4 (9.15-20.4) 25.6 (16.4-32.4) 703 
 07-08 * < LOD 1.72 (.780-2.62) 4.88 (3.49-9.17) 10.4 (6.81-23.6) 366 
 09-10 * < LOD 2.07 (1.26-3.60) 11.0 (5.35-16.7) 17.8 (12.8-24.0) 455 
20 years and older 03-04 1.74 (1.48-2.05) 1.30 (1.00-1.60) 6.10 (4.90-7.10) 18.5 (14.0-23.5) 35.5 (26.8-50.5) 1548 
 05-06 2.20 (1.71-2.84) 1.89 (1.41-2.64) 8.14 (5.86-10.4) 27.6 (18.7-35.7) 43.9 (36.0-67.9) 1531 
 07-08 1.46 (1.28-1.67) .960 (.750-1.22) 5.08 (4.30-6.20) 19.1 (14.3-23.7) 31.7 (23.9-46.1) 1820 
 09-10 1.92 (1.63-2.26) 1.33 (.960-1.91) 7.60 (6.06-9.90) 28.2 (21.9-34.9) 59.5 (45.7-76.7) 2035 
Gender        
Males 03-04 1.66 (1.43-1.93) 1.20 (.900-1.50) 5.80 (4.40-7.10) 18.6 (13.9-23.7) 35.0 (26.8-40.5) 1284 
 05-06 1.83 (1.40-2.40) 1.44 (.920-2.04) 6.63 (5.06-8.66) 23.2 (12.8-33.4) 37.1 (28.5-51.3) 1276 
 07-08 * .910 (.660-1.26) 5.07 (4.01-6.81) 19.1 (13.8-22.6) 30.3 (22.8-46.1) 1289 
 09-10 1.71 (1.48-1.97) .990 (.780-1.33) 7.14 (5.38-9.86) 26.8 (21.5-31.8) 57.4 (36.4-64.6) 1402 
Females 03-04 1.45 (1.17-1.80) .900 (.700-1.40) 4.70 (3.40-6.20) 15.6 (11.1-25.3) 32.7 (21.1-51.3) 1284 
 05-06 1.88 (1.42-2.50) 1.64 (.950-2.51) 6.81 (4.03-9.88) 21.8 (17.3-30.1) 43.3 (33.8-67.9) 1312 
 07-08 * .530 (.410-.650) 3.52 (2.94-4.35) 14.0 (10.9-17.5) 29.5 (19.4-34.0) 1287 
 09-10 1.49 (1.20-1.84) .890 (.590-1.35) 5.54 (3.56-7.74) 21.2 (14.7-32.7) 47.1 (32.5-76.4) 1468 
Race/ethnicity        
Mexican Americans 03-04 1.19 (.871-1.62) .800 (.500-1.30) 3.20 (1.80-5.20) 10.2 (6.70-21.4) 31.4 (16.3-39.1) 621 
 05-06 1.44 (1.23-1.69) 1.04 (.770-1.35) 3.90 (3.03-5.06) 16.8 (11.1-32.0) 41.4 (23.4-57.9) 651 
 07-08 * .560 (<LOD-.910) 3.27 (2.00-5.65) 16.9 (9.73-20.8) 29.6 (19.3-40.5) 513 
 09-10 * .640 (.440-.800) 3.58 (1.80-5.89) 15.5 (7.83-24.6) 31.9 (18.7-44.7) 617 
Non-Hispanic blacks 03-04 2.29 (1.60-3.28) 2.00 (1.20-3.50) 7.70 (5.00-12.0) 23.7 (13.2-38.7) 45.6 (25.1-94.0) 725 
 05-06 2.55 (1.64-3.99) 2.42 (1.15-4.58) 8.74 (6.01-14.4) 23.8 (15.9-48.9) 59.6 (30.5-121) 695 
 07-08 1.58 (1.31-1.90) 1.11 (.750-1.60) 5.88 (4.12-8.13) 21.9 (16.4-24.9) 35.9 (25.4-47.7) 586 
 09-10 1.99 (1.60-2.47) 1.79 (1.05-2.41) 7.61 (5.34-10.0) 25.5 (15.4-37.6) 51.2 (31.0-90.9) 546 
Non-Hispanic whites 03-04 1.37 (1.11-1.68) .800 (.700-1.20) 4.30 (2.50-6.30) 13.3 (9.70-21.4) 29.3 (21.4-35.5) 1078 
 05-06 1.74 (1.27-2.40) 1.41 (.750-2.27) 6.40 (3.93-9.04) 22.4 (14.1-30.1) 38.4 (27.8-66.8) 1050 
 07-08 * .530 (<LOD-.780) 3.63 (3.06-4.38) 12.6 (9.08-17.1) 24.3 (17.6-30.3) 1063 
 09-10 1.43 (1.24-1.65) .800 (.610-1.18) 5.40 (3.77-7.27) 20.6 (17.7-24.5) 41.3 (30.6-59.5) 1226 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, 07-08 and 09-10 are 0.4, 0.4, 0.4, and 0.4 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Arsenobetaine (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg As/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * < LOD 4.62 (3.25-6.25) 18.0 (13.7-23.2) 36.5 (25.7-51.9) 2517 
 13-14 * < LOD 3.70 (2.77-5.00) 15.1 (12.4-19.6) 30.5 (24.2-39.7) 2654 
Age group        
6-11 years 11-12 * < LOD 1.58 (<LOD-4.12) 15.2 (6.60-35.6) 49.6 (20.0-60.1) 401 
 13-14 * < LOD 1.45 (<LOD-2.03) 5.63 (2.82-10.8) 11.7 (6.29-30.8) 397 
12-19 years 11-12 * < LOD 1.82 (<LOD-8.46) 17.6 (6.92-26.5) 32.6 (15.3-100) 392 
 13-14 * < LOD 1.55 (<LOD-2.76) 11.6 (7.52-16.2) 29.8 (13.0-77.9) 450 
20 years and older 11-12 * < LOD 5.26 (4.07-6.58) 18.1 (13.4-24.0) 36.5 (24.4-53.4) 1724 
 13-14 * < LOD 4.35 (3.13-6.09) 17.8 (13.6-21.2) 34.0 (24.5-41.5) 1807 
Gender        
Males 11-12 * < LOD 5.22 (3.38-7.16) 18.4 (13.7-25.9) 41.7 (26.4-60.3) 1264 
 13-14 * < LOD 3.88 (2.95-5.17) 14.7 (10.3-20.6) 30.0 (20.7-41.8) 1308 
Females 11-12 * < LOD 4.18 (2.84-6.11) 17.0 (10.6-22.7) 33.5 (22.1-53.1) 1253 
 13-14 * < LOD 3.53 (2.37-4.95) 16.0 (12.4-21.2) 33.2 (24.3-45.4) 1346 
Race/ethnicity        
Mexican Americans 11-12 * < LOD 3.78 (1.93-5.84) 12.5 (6.11-17.6) 19.3 (12.9-34.7) 317 
 13-14 * < LOD 1.85 (<LOD-2.66) 7.45 (2.97-21.7) 21.3 (7.45-45.8) 455 
Non-Hispanic blacks 11-12 * 1.19 (<LOD-2.91) 7.09 (3.79-13.4) 30.2 (17.2-51.9) 57.9 (36.1-81.5) 672 
 13-14 * 1.25 (<LOD-1.71) 5.04 (3.56-8.35) 21.2 (15.2-26.4) 36.4 (26.4-70.9) 576 
Non-Hispanic whites 11-12 * < LOD 4.07 (2.39-6.12) 16.7 (9.30-22.5) 30.0 (23.2-47.0) 825 
 13-14 * < LOD 3.33 (2.30-5.12) 14.0 (8.82-20.8) 29.4 (20.7-39.7) 980 
All Hispanics 11-12 * < LOD 3.78 (2.65-4.73) 12.2 (7.70-16.8) 19.3 (13.9-37.4) 574 
 13-14 * < LOD 2.30 (1.85-2.81) 9.56 (5.03-14.9) 21.3 (12.0-33.2) 703 
Asians 11-12 5.15 (4.31-6.14) 4.80 (3.76-5.82) 17.3 (13.2-21.3) 46.1 (29.1-74.1) 85.6 (51.8-110) 356 
 13-14 3.74 (3.04-4.60) 2.31 (1.35-4.24) 11.6 (8.96-17.4) 42.1 (27.3-60.7) 79.5 (48.4-123) 291 
Limit of detection (LOD, see Data Analysis section) for Survey year 11-12 and 13-14 are 1.19 and 1.16. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Arsenobetaine (creatinine corrected) (2003 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg As/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 1.54 (1.30-1.82) 1.16 (.959-1.43) 5.00 (3.62-6.91) 16.2 (12.5-20.3) 29.4 (24.0-36.4) 2568 
 05-06 1.82 (1.40-2.37) 1.64 (1.10-2.41) 6.64 (4.48-8.79) 20.3 (14.5-28.1) 37.0 (27.5-58.3) 2588 
 07-08 * 1.00 (.850-1.18) 4.07 (3.36-4.98) 14.7 (11.1-17.8) 27.7 (18.9-45.4) 2576 
 09-10 1.69 (1.45-1.97) 1.23 (.980-1.47) 6.48 (4.90-8.00) 23.6 (18.5-30.7) 49.6 (36.6-61.3) 2869 
Age group        
6-11 years 03-04 * < LOD 2.00 (1.15-4.83) 12.2 (4.13-39.7) 29.6 (6.80-153) 292 
 05-06 * < LOD 2.88 (1.04-6.25) 8.77 (2.88-40.5) 23.6 (6.86-74.8) 354 
 07-08 * < LOD 2.11 (1.27-3.79) 8.98 (4.76-14.8) 16.4 (8.98-23.8) 390 
 09-10 * < LOD 1.70 (1.21-3.02) 9.52 (5.08-20.7) 24.9 (9.81-50.7) 379 
12-19 years 03-04 * .531 (.400-.638) 2.14 (1.39-3.51) 9.29 (4.29-14.7) 17.3 (10.4-28.7) 728 
 05-06 * .620 (<LOD-.800) 2.82 (1.58-4.77) 10.5 (7.03-13.7) 15.4 (11.8-22.3) 703 
 07-08 * < LOD 1.28 (.650-1.72) 5.17 (2.31-6.53) 9.88 (5.72-16.0) 366 
 09-10 * < LOD 2.25 (1.17-3.76) 8.69 (5.03-12.8) 14.0 (9.82-15.5) 455 
20 years and older 03-04 1.79 (1.51-2.12) 1.47 (1.15-1.88) 5.91 (4.32-7.72) 17.2 (13.4-21.8) 30.1 (26.1-36.4) 1548 
 05-06 2.19 (1.70-2.82) 2.13 (1.40-2.83) 7.79 (5.38-10.2) 24.4 (16.6-32.9) 43.1 (30.5-71.4) 1531 
 07-08 1.55 (1.36-1.78) 1.29 (1.13-1.52) 5.27 (3.91-6.40) 16.6 (12.2-21.6) 33.4 (21.0-55.9) 1820 
 09-10 2.03 (1.70-2.42) 1.52 (1.18-2.16) 7.65 (6.04-10.4) 27.7 (22.1-35.9) 57.0 (39.7-71.9) 2035 
Gender        
Males 03-04 1.40 (1.18-1.67) 1.11 (.909-1.28) 4.78 (3.61-6.70) 14.4 (11.1-18.5) 26.5 (18.6-29.9) 1284 
 05-06 1.50 (1.15-1.96) 1.25 (.800-1.93) 5.11 (3.41-7.54) 15.3 (11.2-20.8) 30.5 (19.6-44.0) 1276 
 07-08 * 1.04 (.870-1.25) 4.11 (3.16-5.30) 14.9 (10.1-17.9) 27.0 (17.8-49.2) 1289 
 09-10 1.56 (1.35-1.80) 1.04 (.880-1.34) 6.20 (4.34-7.79) 23.4 (18.7-27.6) 39.2 (32.0-54.8) 1401 
Females 03-04 1.68 (1.37-2.05) 1.25 (.938-1.67) 5.58 (3.50-7.43) 17.2 (12.3-24.5) 32.9 (25.6-46.3) 1284 
 05-06 2.20 (1.65-2.93) 2.04 (1.30-2.92) 7.86 (5.38-10.8) 26.4 (16.6-35.6) 46.2 (30.3-74.3) 1312 
 07-08 * .980 (.800-1.18) 4.06 (3.35-5.29) 14.6 (11.1-17.8) 29.6 (18.2-50.0) 1287 
 09-10 1.83 (1.48-2.26) 1.36 (1.04-1.75) 6.65 (4.68-9.21) 24.1 (16.5-37.3) 57.0 (36.3-71.3) 1468 
Race/ethnicity        
Mexican Americans 03-04 1.10 (.786-1.55) .877 (.612-1.40) 2.93 (1.78-5.21) 8.88 (5.50-15.4) 19.0 (9.64-29.4) 621 
 05-06 1.35 (1.13-1.62) .970 (.810-1.19) 4.21 (2.79-5.68) 16.6 (10.5-21.3) 36.9 (18.4-69.5) 651 
 07-08 * .780 (<LOD-1.21) 3.04 (1.99-5.09) 13.7 (9.09-16.7) 28.9 (16.2-46.7) 513 
 09-10 * .790 (.670-.940) 3.64 (2.28-4.41) 13.5 (7.78-19.1) 26.8 (16.5-42.0) 617 
Non-Hispanic blacks 03-04 1.65 (1.19-2.30) 1.53 (.901-2.45) 5.81 (4.25-7.82) 13.6 (9.76-27.9) 32.9 (13.4-82.1) 725 
 05-06 1.84 (1.20-2.83) 1.71 (.910-2.95) 6.07 (3.83-9.25) 19.4 (10.4-45.2) 47.5 (25.3-62.0) 695 
 07-08 1.16 (.955-1.41) .830 (.620-1.12) 4.44 (3.23-6.58) 14.9 (10.5-17.6) 25.1 (17.4-40.0) 586 
 09-10 1.59 (1.29-1.96) 1.30 (.850-2.04) 5.92 (4.20-8.40) 19.5 (13.5-27.1) 37.9 (26.1-51.7) 545 
Non-Hispanic whites 03-04 1.44 (1.15-1.80) 1.05 (.833-1.36) 4.47 (2.73-6.83) 14.3 (10.9-18.6) 26.5 (18.6-32.0) 1078 
 05-06 1.81 (1.32-2.47) 1.65 (.970-2.55) 6.65 (3.95-9.34) 19.7 (12.6-30.5) 36.6 (25.1-71.4) 1050 
 07-08 * .970 (<LOD-1.18) 3.56 (2.93-4.53) 11.6 (8.98-16.6) 23.8 (15.5-41.7) 1063 
 09-10 1.60 (1.36-1.87) 1.15 (.900-1.43) 5.85 (4.33-7.65) 22.8 (15.6-29.4) 38.5 (32.0-57.0) 1226 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary Arsenobetaine (creatinine corrected) (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg As/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * < LOD 5.63 (4.42-7.22) 18.0 (13.8-26.1) 36.9 (26.9-45.6) 2516 
 13-14 * < LOD 4.91 (3.98-6.31) 16.3 (12.7-21.2) 38.7 (33.3-46.8) 2653 
Age group        
6-11 years 11-12 * < LOD 4.35 (<LOD-6.46) 16.0 (8.00-39.5) 69.0 (16.0-102) 401 
 13-14 * < LOD 3.57 (<LOD-5.38) 9.00 (6.77-11.1) 12.6 (10.1-28.6) 397 
12-19 years 11-12 * < LOD 3.36 (<LOD-8.94) 14.4 (5.56-23.8) 25.9 (13.6-104) 392 
 13-14 * < LOD 2.28 (<LOD-3.15) 9.59 (4.56-16.5) 19.7 (12.2-46.9) 450 
20 years and older 11-12 * < LOD 6.25 (4.78-8.46) 19.3 (14.0-28.4) 35.8 (26.8-44.1) 1723 
 13-14 * < LOD 5.63 (4.54-7.37) 17.8 (14.2-25.2) 44.9 (35.5-52.1) 1806 
Gender        
Males 11-12 * < LOD 4.94 (3.50-6.67) 16.7 (12.6-25.7) 35.7 (23.4-52.8) 1263 
 13-14 * < LOD 4.42 (3.42-5.97) 14.5 (10.7-20.1) 37.8 (24.1-47.7) 1307 
Females 11-12 * < LOD 6.48 (4.79-8.60) 18.8 (15.4-28.1) 37.0 (26.2-46.8) 1253 
 13-14 * < LOD 5.39 (4.56-7.07) 17.8 (13.8-25.8) 41.3 (33.3-53.2) 1346 
Race/ethnicity        
Mexican Americans 11-12 * < LOD 3.87 (2.80-5.76) 12.6 (8.36-22.6) 25.9 (13.4-40.3) 317 
 13-14 * < LOD 2.93 (<LOD-4.10) 7.28 (4.10-14.4) 16.6 (6.84-41.5) 455 
Non-Hispanic blacks 11-12 * 1.50 (<LOD-2.18) 6.00 (2.63-12.4) 20.3 (12.8-30.0) 38.7 (22.6-78.2) 672 
 13-14 * 1.30 (<LOD-1.56) 4.39 (3.28-6.05) 13.7 (10.4-19.3) 29.2 (16.8-60.0) 576 
Non-Hispanic whites 11-12 * < LOD 5.00 (4.06-7.55) 16.8 (12.7-28.7) 35.7 (21.0-45.6) 824 
 13-14 * < LOD 5.08 (3.73-7.46) 16.4 (11.9-24.4) 39.2 (29.3-47.7) 979 
All Hispanics 11-12 * < LOD 4.00 (3.48-4.75) 13.5 (9.17-17.1) 24.9 (16.6-30.9) 574 
 13-14 * < LOD 3.28 (2.56-4.24) 7.95 (5.80-13.7) 17.2 (9.76-29.2) 703 
Asians 11-12 6.90 (5.54-8.60) 6.02 (4.78-7.88) 21.5 (14.0-30.7) 60.4 (42.8-82.0) 95.7 (75.6-120) 356 
 13-14 5.83 (4.56-7.44) 4.08 (3.42-6.68) 17.4 (12.3-28.7) 71.3 (46.4-81.5) 89.3 (80.4-159) 291 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 








Fourth National Report on Human Exposure to Environmental Chemicals, Updated Tables, January 2017 Volume One Page 207
Urinary Arsenocholine (2003 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg As/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 2568 
 05-06 * < LOD < LOD < LOD < LOD 2588 
 07-08 * < LOD < LOD < LOD < LOD 2576 
 09-10 * < LOD < LOD < LOD < LOD 2871 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD < LOD 292 
 05-06 * < LOD < LOD < LOD < LOD 354 
 07-08 * < LOD < LOD < LOD < LOD 390 
 09-10 * < LOD < LOD < LOD < LOD 380 
12-19 years 03-04 * < LOD < LOD < LOD < LOD 728 
 05-06 * < LOD < LOD < LOD < LOD 703 
 07-08 * < LOD < LOD < LOD < LOD 366 
 09-10 * < LOD < LOD < LOD < LOD 456 
20 years and older 03-04 * < LOD < LOD < LOD < LOD 1548 
 05-06 * < LOD < LOD < LOD < LOD 1531 
 07-08 * < LOD < LOD < LOD < LOD 1820 
 09-10 * < LOD < LOD < LOD < LOD 2035 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 1284 
 05-06 * < LOD < LOD < LOD < LOD 1276 
 07-08 * < LOD < LOD < LOD < LOD 1289 
 09-10 * < LOD < LOD < LOD < LOD 1403 
Females 03-04 * < LOD < LOD < LOD < LOD 1284 
 05-06 * < LOD < LOD < LOD < LOD 1312 
 07-08 * < LOD < LOD < LOD < LOD 1287 
 09-10 * < LOD < LOD < LOD < LOD 1468 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 621 
 05-06 * < LOD < LOD < LOD < LOD 651 
 07-08 * < LOD < LOD < LOD < LOD 513 
 09-10 * < LOD < LOD < LOD < LOD 618 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 725 
 05-06 * < LOD < LOD < LOD < LOD 695 
 07-08 * < LOD < LOD < LOD < LOD 586 
 09-10 * < LOD < LOD < LOD < LOD 546 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 1078 
 05-06 * < LOD < LOD < LOD < LOD 1050 
 07-08 * < LOD < LOD < LOD < LOD 1063 
 09-10 * < LOD < LOD < LOD < LOD 1226 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, 07-08 and 09-10 are 0.6, 0.6, 0.6, and 0.6 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Arsenocholine (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg As/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * < LOD < LOD < LOD < LOD 2517 
 13-14 * < LOD < LOD .200 (.140-.250) .320 (.290-.350) 2654 
Age group        
6-11 years 11-12 * < LOD < LOD < LOD < LOD 401 
 13-14 * < LOD < LOD < LOD .260 (<LOD-.750) 397 
12-19 years 11-12 * < LOD < LOD < LOD < LOD 392 
 13-14 * < LOD < LOD .160 (<LOD-.260) .260 (.140-.370) 450 
20 years and older 11-12 * < LOD < LOD < LOD < LOD 1724 
 13-14 * < LOD < LOD .210 (.150-.260) .330 (.290-.370) 1807 
Gender        
Males 11-12 * < LOD < LOD < LOD < LOD 1264 
 13-14 * < LOD < LOD .220 (.130-.290) .340 (.290-.380) 1308 
Females 11-12 * < LOD < LOD < LOD < LOD 1253 
 13-14 * < LOD < LOD .180 (.110-.230) .290 (.220-.360) 1346 
Race/ethnicity        
Mexican Americans 11-12 * < LOD < LOD < LOD < LOD 317 
 13-14 * < LOD < LOD .180 (<LOD-.260) .320 (.220-.390) 455 
Non-Hispanic blacks 11-12 * < LOD < LOD < LOD < LOD 672 
 13-14 * < LOD < LOD .260 (.200-.310) .370 (.310-.410) 576 
Non-Hispanic whites 11-12 * < LOD < LOD < LOD < LOD 825 
 13-14 * < LOD < LOD .160 (<LOD-.250) .280 (.200-.360) 980 
All Hispanics 11-12 * < LOD < LOD < LOD < LOD 574 
 13-14 * < LOD < LOD .180 (<LOD-.270) .330 (.250-.390) 703 
Asians 11-12 * < LOD < LOD .310 (<LOD-.450) .560 (.370-.930) 356 
 13-14 * < LOD .130 (<LOD-.230) .430 (.340-.570) .860 (.480-1.83) 291 
Limit of detection (LOD, see Data Analysis section) for Survey year 11-12 and 13-14 are 0.28 and 0.11. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Arsenocholine (creatinine corrected) (2003 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg As/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 2568 
 05-06 * < LOD < LOD < LOD < LOD 2588 
 07-08 * < LOD < LOD < LOD < LOD 2576 
 09-10 * < LOD < LOD < LOD < LOD 2870 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD < LOD 292 
 05-06 * < LOD < LOD < LOD < LOD 354 
 07-08 * < LOD < LOD < LOD < LOD 390 
 09-10 * < LOD < LOD < LOD < LOD 379 
12-19 years 03-04 * < LOD < LOD < LOD < LOD 728 
 05-06 * < LOD < LOD < LOD < LOD 703 
 07-08 * < LOD < LOD < LOD < LOD 366 
 09-10 * < LOD < LOD < LOD < LOD 456 
20 years and older 03-04 * < LOD < LOD < LOD < LOD 1548 
 05-06 * < LOD < LOD < LOD < LOD 1531 
 07-08 * < LOD < LOD < LOD < LOD 1820 
 09-10 * < LOD < LOD < LOD < LOD 2035 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 1284 
 05-06 * < LOD < LOD < LOD < LOD 1276 
 07-08 * < LOD < LOD < LOD < LOD 1289 
 09-10 * < LOD < LOD < LOD < LOD 1402 
Females 03-04 * < LOD < LOD < LOD < LOD 1284 
 05-06 * < LOD < LOD < LOD < LOD 1312 
 07-08 * < LOD < LOD < LOD < LOD 1287 
 09-10 * < LOD < LOD < LOD < LOD 1468 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 621 
 05-06 * < LOD < LOD < LOD < LOD 651 
 07-08 * < LOD < LOD < LOD < LOD 513 
 09-10 * < LOD < LOD < LOD < LOD 618 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 725 
 05-06 * < LOD < LOD < LOD < LOD 695 
 07-08 * < LOD < LOD < LOD < LOD 586 
 09-10 * < LOD < LOD < LOD < LOD 545 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 1078 
 05-06 * < LOD < LOD < LOD < LOD 1050 
 07-08 * < LOD < LOD < LOD < LOD 1063 
 09-10 * < LOD < LOD < LOD < LOD 1226 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary Arsenocholine (creatinine corrected) (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg As/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * < LOD < LOD < LOD < LOD 2516 
 13-14 * < LOD < LOD .333 (.296-.381) .533 (.444-.615) 2653 
Age group        
6-11 years 11-12 * < LOD < LOD < LOD < LOD 401 
 13-14 * < LOD < LOD < LOD .533 (<LOD-.974) 397 
12-19 years 11-12 * < LOD < LOD < LOD < LOD 392 
 13-14 * < LOD < LOD .229 (<LOD-.276) .308 (.250-.348) 450 
20 years and older 11-12 * < LOD < LOD < LOD < LOD 1723 
 13-14 * < LOD < LOD .351 (.314-.400) .571 (.471-.667) 1806 
Gender        
Males 11-12 * < LOD < LOD < LOD < LOD 1263 
 13-14 * < LOD < LOD .276 (.250-.320) .526 (.338-.603) 1307 
Females 11-12 * < LOD < LOD < LOD < LOD 1253 
 13-14 * < LOD < LOD .381 (.333-.444) .533 (.471-.667) 1346 
Race/ethnicity        
Mexican Americans 11-12 * < LOD < LOD < LOD < LOD 317 
 13-14 * < LOD < LOD .276 (<LOD-.308) .348 (.286-.490) 455 
Non-Hispanic blacks 11-12 * < LOD < LOD < LOD < LOD 672 
 13-14 * < LOD < LOD .235 (.190-.259) .316 (.259-.364) 576 
Non-Hispanic whites 11-12 * < LOD < LOD < LOD < LOD 824 
 13-14 * < LOD < LOD .364 (<LOD-.444) .571 (.444-.667) 979 
All Hispanics 11-12 * < LOD < LOD < LOD < LOD 574 
 13-14 * < LOD < LOD .283 (<LOD-.320) .364 (.308-.444) 703 
Asians 11-12 * < LOD < LOD .952 (<LOD-1.33) 1.43 (.952-2.00) 356 
 13-14 * < LOD .333 (<LOD-.421) .727 (.485-1.14) 1.25 (.800-4.25) 291 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary Arsenous (III) acid (2003 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg As/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 2568 
 05-06 * < LOD < LOD < LOD < LOD 2588 
 07-08 * < LOD < LOD < LOD < LOD 2576 
 09-10 * < LOD < LOD < LOD < LOD 2871 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD < LOD 292 
 05-06 * < LOD < LOD < LOD < LOD 354 
 07-08 * < LOD < LOD < LOD < LOD 390 
 09-10 * < LOD < LOD < LOD < LOD 380 
12-19 years 03-04 * < LOD < LOD < LOD 1.40 (<LOD-1.70) 728 
 05-06 * < LOD < LOD < LOD 1.20 (<LOD-1.40) 703 
 07-08 * < LOD < LOD < LOD < LOD 366 
 09-10 * < LOD < LOD < LOD < LOD 456 
20 years and older 03-04 * < LOD < LOD < LOD < LOD 1548 
 05-06 * < LOD < LOD < LOD < LOD 1531 
 07-08 * < LOD < LOD < LOD < LOD 1820 
 09-10 * < LOD < LOD < LOD < LOD 2035 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 1284 
 05-06 * < LOD < LOD < LOD 1.26 (<LOD-1.73) 1276 
 07-08 * < LOD < LOD < LOD < LOD 1289 
 09-10 * < LOD < LOD < LOD 1.24 (<LOD-1.50) 1403 
Females 03-04 * < LOD < LOD < LOD < LOD 1284 
 05-06 * < LOD < LOD < LOD < LOD 1312 
 07-08 * < LOD < LOD < LOD < LOD 1287 
 09-10 * < LOD < LOD < LOD < LOD 1468 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD 2.00 (<LOD-3.00) 621 
 05-06 * < LOD < LOD < LOD < LOD 651 
 07-08 * < LOD < LOD < LOD 1.20 (<LOD-1.76) 513 
 09-10 * < LOD < LOD < LOD < LOD 618 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD 1.20 (<LOD-1.80) 725 
 05-06 * < LOD < LOD < LOD < LOD 695 
 07-08 * < LOD < LOD < LOD < LOD 586 
 09-10 * < LOD < LOD < LOD < LOD 546 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 1078 
 05-06 * < LOD < LOD < LOD < LOD 1050 
 07-08 * < LOD < LOD < LOD < LOD 1063 
 09-10 * < LOD < LOD < LOD < LOD 1226 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, 07-08 and 09-10 are 1.2, 1.2, 1.2, and 1.2 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Arsenous (III) acid (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg As/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * < LOD .520 (<LOD-.600) .840 (.760-.960) 1.11 (.980-1.27) 2517 
 13-14 .316 (.275-.365) .470 (.360-.560) .730 (.660-.810) 1.00 (.930-1.07) 1.19 (1.12-1.29) 2654 
Age group        
6-11 years 11-12 * < LOD .540 (<LOD-.660) .870 (.710-1.00) 1.03 (.820-1.22) 401 
 13-14 .360 (.278-.466) .540 (.370-.630) .810 (.680-.880) 1.05 (.930-1.13) 1.22 (1.07-1.32) 397 
12-19 years 11-12 * < LOD .610 (.480-.720) .920 (.810-1.14) 1.18 (.980-1.43) 392 
 13-14 .429 (.358-.515) .570 (.490-.630) .830 (.730-.930) 1.12 (1.00-1.28) 1.35 (1.13-1.57) 450 
20 years and older 11-12 * < LOD .500 (<LOD-.570) .830 (.750-.940) 1.11 (.980-1.27) 1724 
 13-14 .299 (.258-.346) .430 (.300-.540) .720 (.650-.790) .970 (.890-1.07) 1.16 (1.08-1.27) 1807 
Gender        
Males 11-12 * < LOD .600 (.520-.680) .980 (.840-1.13) 1.31 (1.11-1.59) 1264 
 13-14 .365 (.306-.436) .540 (.420-.630) .800 (.710-.890) 1.04 (.970-1.12) 1.21 (1.14-1.35) 1308 
Females 11-12 * < LOD < LOD .760 (.600-.840) .940 (.810-1.07) 1253 
 13-14 .276 (.241-.315) .400 (.260-.490) .660 (.600-.730) .940 (.850-1.04) 1.13 (1.05-1.28) 1346 
Race/ethnicity        
Mexican Americans 11-12 * < LOD .570 (.490-.660) .830 (.770-1.03) 1.14 (.880-1.37) 317 
 13-14 .416 (.351-.494) .580 (.460-.700) .870 (.750-.990) 1.08 (1.03-1.18) 1.29 (1.17-1.47) 455 
Non-Hispanic blacks 11-12 * < LOD .520 (<LOD-.680) .880 (.700-1.10) 1.21 (.980-1.57) 672 
 13-14 .416 (.378-.458) .550 (.490-.600) .840 (.730-.900) 1.12 (1.00-1.20) 1.33 (1.18-1.46) 576 
Non-Hispanic whites 11-12 * < LOD < LOD .800 (.640-.900) 1.03 (.830-1.18) 825 
 13-14 .267 (.225-.316) .380 (.170-.520) .670 (.600-.730) .900 (.820-.950) 1.05 (.940-1.21) 980 
All Hispanics 11-12 * < LOD .620 (.510-.760) .910 (.820-1.07) 1.29 (1.07-1.43) 574 
 13-14 .423 (.358-.501) .580 (.460-.700) .880 (.790-.980) 1.11 (1.06-1.18) 1.35 (1.20-1.40) 703 
Asians 11-12 * .510 (<LOD-.610) .900 (.740-.990) 1.32 (1.10-1.63) 1.79 (1.53-2.31) 356 
 13-14 .456 (.393-.528) .600 (.500-.680) .900 (.790-1.09) 1.34 (1.15-1.56) 1.66 (1.37-2.14) 291 
Limit of detection (LOD, see Data Analysis section) for Survey year 11-12 and 13-14 are 0.48 and 0.12. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Arsenous (III) acid (creatinine corrected) (2003 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg As/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 2568 
 05-06 * < LOD < LOD < LOD < LOD 2588 
 07-08 * < LOD < LOD < LOD < LOD 2576 
 09-10 * < LOD < LOD < LOD < LOD 2870 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD < LOD 292 
 05-06 * < LOD < LOD < LOD < LOD 354 
 07-08 * < LOD < LOD < LOD < LOD 390 
 09-10 * < LOD < LOD < LOD < LOD 379 
12-19 years 03-04 * < LOD < LOD < LOD 1.95 (<LOD-2.76) 728 
 05-06 * < LOD < LOD < LOD 2.02 (<LOD-3.04) 703 
 07-08 * < LOD < LOD < LOD < LOD 366 
 09-10 * < LOD < LOD < LOD < LOD 456 
20 years and older 03-04 * < LOD < LOD < LOD < LOD 1548 
 05-06 * < LOD < LOD < LOD < LOD 1531 
 07-08 * < LOD < LOD < LOD < LOD 1820 
 09-10 * < LOD < LOD < LOD < LOD 2035 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 1284 
 05-06 * < LOD < LOD < LOD 2.43 (<LOD-3.15) 1276 
 07-08 * < LOD < LOD < LOD < LOD 1289 
 09-10 * < LOD < LOD < LOD 2.93 (<LOD-3.54) 1402 
Females 03-04 * < LOD < LOD < LOD < LOD 1284 
 05-06 * < LOD < LOD < LOD < LOD 1312 
 07-08 * < LOD < LOD < LOD < LOD 1287 
 09-10 * < LOD < LOD < LOD < LOD 1468 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD 3.08 (<LOD-4.44) 621 
 05-06 * < LOD < LOD < LOD < LOD 651 
 07-08 * < LOD < LOD < LOD 3.54 (<LOD-4.72) 513 
 09-10 * < LOD < LOD < LOD < LOD 618 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD 2.00 (<LOD-2.29) 725 
 05-06 * < LOD < LOD < LOD < LOD 695 
 07-08 * < LOD < LOD < LOD < LOD 586 
 09-10 * < LOD < LOD < LOD < LOD 545 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 1078 
 05-06 * < LOD < LOD < LOD < LOD 1050 
 07-08 * < LOD < LOD < LOD < LOD 1063 
 09-10 * < LOD < LOD < LOD < LOD 1226 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary Arsenous (III) acid (creatinine corrected) (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg As/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * < LOD .791 (<LOD-.850) 1.35 (1.21-1.42) 1.79 (1.55-1.89) 2516 
 13-14 .365 (.311-.427) .387 (.320-.460) .715 (.612-.851) 1.23 (1.05-1.39) 1.62 (1.38-1.85) 2653 
Age group        
6-11 years 11-12 * < LOD 1.03 (<LOD-1.13) 1.54 (1.26-1.79) 2.00 (1.55-2.62) 401 
 13-14 .541 (.415-.706) .578 (.451-.711) 1.03 (.764-1.40) 1.70 (1.22-1.98) 1.94 (1.60-2.92) 397 
12-19 years 11-12 * < LOD .709 (.607-.850) 1.11 (.971-1.31) 1.36 (1.03-2.50) 392 
 13-14 .389 (.335-.452) .390 (.321-.497) .683 (.536-.862) 1.03 (.866-1.37) 1.43 (1.04-1.77) 450 
20 years and older 11-12 * < LOD .773 (<LOD-.850) 1.36 (1.19-1.48) 1.79 (1.55-1.95) 1723 
 13-14 .347 (.296-.407) .366 (.303-.444) .691 (.592-.832) 1.21 (1.00-1.37) 1.56 (1.36-1.82) 1806 
Gender        
Males 11-12 * < LOD .708 (.645-.756) 1.12 (.981-1.25) 1.48 (1.28-1.70) 1263 
 13-14 .366 (.306-.436) .388 (.311-.475) .702 (.592-.825) 1.23 (.942-1.40) 1.59 (1.33-1.86) 1307 
Females 11-12 * < LOD < LOD 1.42 (1.36-1.62) 1.89 (1.70-2.27) 1253 
 13-14 .364 (.311-.426) .387 (.320-.459) .727 (.616-.889) 1.24 (1.05-1.42) 1.65 (1.40-1.91) 1346 
Race/ethnicity        
Mexican Americans 11-12 * < LOD .723 (.630-.850) 1.13 (.919-1.42) 1.55 (1.13-2.20) 317 
 13-14 .475 (.386-.584) .471 (.394-.634) .843 (.692-1.11) 1.50 (1.19-1.79) 1.85 (1.67-2.07) 455 
Non-Hispanic blacks 11-12 * < LOD .514 (<LOD-.586) .919 (.739-1.06) 1.22 (.971-1.64) 672 
 13-14 .314 (.272-.362) .328 (.285-.398) .577 (.483-.673) .878 (.782-.957) 1.05 (.957-1.24) 576 
Non-Hispanic whites 11-12 * < LOD < LOD 1.36 (1.21-1.48) 1.79 (1.51-2.00) 824 
 13-14 .329 (.275-.393) .351 (.278-.433) .653 (.553-.793) 1.17 (.900-1.37) 1.49 (1.30-1.72) 979 
All Hispanics 11-12 * < LOD .762 (.704-.833) 1.21 (1.00-1.48) 1.55 (1.34-1.95) 574 
 13-14 .472 (.388-.575) .482 (.392-.638) .851 (.718-1.05) 1.41 (1.13-1.74) 1.84 (1.65-2.06) 703 
Asians 11-12 * .739 (<LOD-.850) 1.21 (1.06-1.45) 1.96 (1.62-2.43) 2.91 (2.00-3.64) 356 
 13-14 .709 (.590-.854) .779 (.596-.938) 1.22 (1.08-1.33) 1.98 (1.48-3.00) 3.04 (1.98-4.15) 291 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary Dimethylarsinic acid (2003 – 2010) 
Metabolite of Arsenic 
Geometric mean and selected percentiles of urine concentrations (in µg As/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 3.71 (3.33-4.14) 3.90 (3.00-4.00) 6.00 (5.00-7.00) 11.0 (9.20-12.0) 16.0 (13.0-17.8) 2568 
 05-06 3.95 (3.59-4.35) 3.90 (3.46-4.31) 6.17 (5.53-7.04) 10.3 (9.00-12.2) 15.0 (12.2-17.8) 2588 
 07-08 3.67 (3.44-3.91) 3.58 (3.44-3.84) 5.96 (5.44-6.57) 9.78 (8.72-11.2) 13.3 (11.8-15.3) 2576 
 09-10 3.67 (3.43-3.93) 3.50 (3.25-3.76) 6.16 (5.59-6.73) 11.5 (9.35-13.7) 17.4 (14.0-21.0) 2871 
Age group        
6-11 years 03-04 3.73 (3.12-4.45) 4.00 (3.00-4.00) 6.00 (5.00-7.00) 9.00 (7.00-12.0) 12.0 (8.00-22.0) 292 
 05-06 3.96 (3.49-4.49) 3.94 (3.20-4.71) 5.94 (5.01-7.10) 10.5 (7.10-12.1) 13.0 (10.7-15.3) 354 
 07-08 3.86 (3.45-4.32) 3.76 (3.47-4.01) 6.10 (5.29-6.99) 10.4 (7.57-13.9) 15.2 (9.32-39.2) 390 
 09-10 3.53 (3.17-3.92) 3.27 (2.81-3.87) 5.76 (5.07-6.53) 10.7 (7.84-11.9) 12.8 (11.0-14.4) 380 
12-19 years 03-04 3.85 (3.34-4.42) 4.00 (3.00-4.00) 6.00 (5.00-7.10) 9.30 (7.70-12.0) 13.0 (10.0-16.0) 728 
 05-06 3.97 (3.46-4.55) 3.97 (3.31-4.64) 5.74 (5.11-7.10) 9.43 (7.63-11.6) 12.0 (10.7-13.9) 703 
 07-08 3.60 (3.16-4.09) 3.66 (3.24-4.26) 5.53 (4.75-6.72) 8.90 (7.33-9.95) 10.7 (9.08-13.3) 366 
 09-10 3.08 (2.77-3.43) 2.89 (2.64-3.29) 5.05 (4.44-5.77) 7.89 (6.87-10.1) 11.3 (8.75-13.8) 456 
20 years and older 03-04 3.69 (3.31-4.11) 3.70 (3.00-4.00) 6.00 (5.00-7.00) 11.0 (10.0-12.0) 16.0 (13.0-19.0) 1548 
 05-06 3.95 (3.58-4.36) 3.87 (3.46-4.32) 6.30 (5.59-7.28) 10.3 (9.25-13.3) 16.2 (12.5-19.4) 1531 
 07-08 3.66 (3.43-3.91) 3.56 (3.41-3.80) 5.97 (5.44-6.63) 9.89 (8.72-11.4) 13.8 (11.8-15.5) 1820 
 09-10 3.79 (3.51-4.09) 3.60 (3.33-3.87) 6.40 (5.71-7.03) 12.1 (9.52-16.0) 18.2 (15.8-23.6) 2035 
Gender        
Males 03-04 4.12 (3.60-4.71) 4.00 (3.70-4.30) 6.00 (5.60-7.70) 11.0 (9.00-15.0) 17.0 (12.1-22.0) 1284 
 05-06 4.17 (3.79-4.59) 4.04 (3.68-4.43) 6.32 (5.41-7.61) 10.5 (8.68-13.3) 14.8 (11.8-19.2) 1276 
 07-08 4.05 (3.73-4.40) 3.96 (3.63-4.27) 6.53 (5.77-7.15) 10.3 (9.31-12.0) 14.6 (11.6-20.2) 1289 
 09-10 3.89 (3.50-4.32) 3.71 (3.35-4.11) 6.33 (5.80-7.02) 11.6 (8.80-17.3) 19.2 (13.0-24.7) 1403 
Females 03-04 3.37 (3.00-3.78) 3.00 (3.00-4.00) 5.50 (4.80-6.20) 10.0 (8.00-11.0) 14.0 (11.0-17.7) 1284 
 05-06 3.75 (3.37-4.18) 3.70 (3.28-4.21) 6.03 (5.46-6.99) 9.95 (8.81-12.2) 15.5 (11.6-19.0) 1312 
 07-08 3.34 (3.13-3.57) 3.37 (3.15-3.53) 5.48 (5.00-6.05) 8.99 (7.97-10.4) 11.9 (10.7-13.9) 1287 
 09-10 3.48 (3.22-3.76) 3.28 (2.95-3.63) 5.85 (5.21-6.69) 11.5 (9.42-13.3) 16.1 (13.8-17.7) 1468 
Race/ethnicity        
Mexican Americans 03-04 4.72 (4.27-5.22) 4.80 (4.00-5.00) 7.00 (6.00-9.00) 12.0 (10.0-16.0) 17.0 (12.0-25.0) 621 
 05-06 4.43 (4.15-4.72) 4.66 (4.26-5.13) 6.93 (6.38-7.58) 9.51 (8.70-11.1) 13.1 (10.3-15.1) 651 
 07-08 4.36 (4.05-4.69) 4.62 (4.07-5.07) 7.14 (6.23-7.76) 9.67 (8.39-10.8) 11.7 (9.96-17.6) 513 
 09-10 3.90 (3.45-4.40) 3.98 (3.18-4.63) 6.53 (5.61-7.15) 10.7 (8.95-13.2) 16.2 (13.1-19.2) 618 
Non-Hispanic blacks 03-04 4.27 (3.71-4.92) 4.00 (3.50-5.00) 7.00 (6.00-8.00) 11.6 (9.00-15.0) 16.0 (14.0-18.7) 725 
 05-06 4.28 (3.68-4.98) 4.02 (3.37-4.82) 6.42 (5.31-7.36) 10.9 (8.22-13.1) 15.2 (11.5-27.1) 695 
 07-08 4.19 (3.92-4.49) 3.98 (3.63-4.27) 6.69 (5.80-7.43) 11.2 (10.1-12.5) 14.7 (12.1-19.2) 586 
 09-10 4.09 (3.63-4.61) 3.93 (3.31-4.36) 7.13 (5.99-8.63) 12.3 (10.1-17.0) 18.2 (13.7-27.8) 546 
Non-Hispanic whites 03-04 3.27 (2.95-3.62) 3.00 (3.00-3.80) 5.00 (4.60-6.00) 9.00 (7.00-10.0) 12.0 (9.50-15.0) 1078 
 05-06 3.69 (3.28-4.15) 3.60 (3.19-4.08) 5.66 (5.10-6.70) 9.62 (8.11-11.8) 13.9 (10.6-17.8) 1050 
 07-08 3.23 (3.01-3.48) 3.34 (3.04-3.53) 5.14 (4.77-5.59) 8.27 (7.48-9.07) 10.5 (9.25-13.2) 1063 
 09-10 3.21 (3.07-3.37) 3.12 (2.91-3.29) 5.32 (5.00-5.66) 8.65 (7.23-10.1) 12.0 (10.1-14.4) 1226 
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Urinary Dimethylarsinic acid (2011 - 2014) 
Metabolite of Arsenic 
Geometric mean and selected percentiles of urine concentrations (in µg As/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 3.47 (3.18-3.78) 3.37 (3.06-3.66) 5.81 (5.14-6.59) 9.55 (8.43-11.2) 14.0 (11.4-16.5) 2517 
 13-14 3.20 (2.97-3.44) 3.08 (2.73-3.41) 5.15 (4.68-5.69) 8.60 (8.02-9.25) 11.8 (10.6-13.5) 2654 
Age group        
6-11 years 11-12 3.43 (3.06-3.85) 3.53 (2.81-4.05) 5.81 (5.21-6.38) 8.60 (7.55-9.73) 11.4 (9.35-13.7) 401 
 13-14 3.33 (2.95-3.75) 3.12 (2.68-3.56) 5.27 (4.31-6.14) 8.69 (7.44-10.8) 11.8 (8.62-18.5) 397 
12-19 years 11-12 3.27 (2.71-3.94) 3.33 (2.49-4.20) 5.02 (4.33-6.05) 8.53 (6.29-11.1) 11.6 (8.74-17.9) 392 
 13-14 3.30 (2.99-3.63) 3.24 (2.86-3.66) 4.95 (4.53-5.66) 9.02 (6.97-10.6) 11.4 (10.0-13.1) 450 
20 years and older 11-12 3.51 (3.22-3.82) 3.37 (3.05-3.67) 5.91 (5.20-6.83) 9.94 (8.57-11.5) 14.1 (12.2-16.4) 1724 
 13-14 3.17 (2.93-3.43) 3.02 (2.66-3.41) 5.18 (4.68-5.78) 8.53 (7.82-9.21) 11.7 (10.3-14.2) 1807 
Gender        
Males 11-12 3.79 (3.40-4.23) 3.71 (3.33-4.29) 6.27 (5.36-7.61) 10.3 (8.75-12.5) 15.3 (12.5-16.7) 1264 
 13-14 3.31 (3.12-3.51) 3.25 (3.02-3.56) 5.34 (5.03-5.61) 8.56 (8.11-9.30) 11.6 (10.3-12.8) 1308 
Females 11-12 3.19 (2.92-3.48) 3.01 (2.73-3.30) 5.30 (4.61-5.96) 8.96 (7.72-10.5) 12.2 (9.56-17.8) 1253 
 13-14 3.09 (2.81-3.40) 2.81 (2.53-3.23) 4.85 (4.27-5.82) 8.60 (7.56-9.54) 11.9 (10.6-14.6) 1346 
Race/ethnicity        
Mexican Americans 11-12 3.67 (3.33-4.04) 3.58 (3.27-4.18) 5.82 (5.24-6.47) 9.05 (7.91-10.0) 12.1 (9.61-17.4) 317 
 13-14 3.32 (3.10-3.54) 3.45 (2.94-3.84) 5.19 (4.79-5.75) 7.74 (7.22-8.45) 9.94 (8.21-12.7) 455 
Non-Hispanic blacks 11-12 4.05 (3.46-4.74) 4.05 (3.35-4.65) 6.78 (5.46-8.21) 12.0 (10.0-14.2) 17.4 (14.2-19.8) 672 
 13-14 3.83 (3.35-4.39) 3.62 (3.21-4.05) 5.84 (4.60-7.84) 10.2 (8.42-13.2) 15.7 (10.9-20.7) 576 
Non-Hispanic whites 11-12 3.06 (2.82-3.33) 2.97 (2.72-3.29) 4.95 (4.39-5.77) 7.98 (6.92-9.02) 10.5 (8.71-13.0) 825 
 13-14 2.86 (2.59-3.15) 2.69 (2.29-3.10) 4.56 (3.96-5.21) 7.52 (6.61-8.52) 9.62 (8.53-11.3) 980 
All Hispanics 11-12 4.02 (3.45-4.69) 3.96 (3.33-4.68) 6.73 (5.49-8.39) 11.1 (8.53-16.6) 16.8 (12.1-19.7) 574 
 13-14 3.54 (3.16-3.97) 3.61 (3.07-4.11) 5.63 (5.01-6.88) 9.09 (7.80-10.3) 11.8 (9.98-12.9) 703 
Asians 11-12 7.38 (6.50-8.37) 7.52 (6.45-8.74) 14.4 (11.7-17.2) 24.7 (20.3-31.3) 38.6 (28.5-40.5) 356 
 13-14 5.59 (5.13-6.09) 5.62 (5.08-6.53) 11.3 (9.01-12.4) 19.9 (15.6-22.1) 23.6 (19.7-34.6) 291 
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Urinary Dimethylarsinic acid (creatinine corrected) (2003 – 2010) 
Metabolite of Arsenic 
Geometric mean and selected percentiles of urine concentrations (in µg As/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 3.69 (3.24-4.19) 3.37 (2.94-3.91) 5.71 (4.69-6.74) 9.09 (7.61-11.5) 13.0 (10.7-16.0) 2568 
 05-06 3.88 (3.57-4.22) 3.66 (3.39-3.93) 5.71 (5.10-6.43) 9.57 (7.95-10.9) 12.3 (10.6-15.0) 2588 
 07-08 3.83 (3.60-4.07) 3.62 (3.37-3.93) 5.80 (5.33-6.32) 9.01 (8.00-9.97) 11.6 (9.97-14.4) 2576 
 09-10 3.90 (3.64-4.18) 3.53 (3.30-3.80) 6.03 (5.36-6.62) 10.2 (9.15-11.8) 14.9 (12.3-19.2) 2870 
Age group        
6-11 years 03-04 4.34 (3.57-5.28) 4.03 (3.20-4.80) 6.32 (4.65-8.33) 10.3 (7.00-13.9) 13.9 (7.86-21.8) 292 
 05-06 4.89 (4.22-5.65) 4.31 (3.64-5.69) 6.85 (5.71-7.69) 10.0 (7.54-14.7) 14.7 (10.0-18.8) 354 
 07-08 5.07 (4.56-5.64) 4.54 (4.08-4.82) 6.90 (6.14-7.76) 12.0 (8.39-17.1) 20.9 (12.0-40.8) 390 
 09-10 4.77 (4.34-5.23) 4.48 (4.12-4.85) 6.41 (5.66-6.82) 10.0 (7.63-15.3) 16.5 (9.33-27.0) 379 
12-19 years 03-04 2.74 (2.39-3.14) 2.55 (2.27-2.94) 3.77 (3.17-4.44) 5.88 (4.65-6.67) 7.18 (6.16-11.7) 728 
 05-06 3.05 (2.78-3.34) 2.92 (2.55-3.29) 4.25 (3.87-4.84) 6.68 (5.49-8.06) 9.08 (7.11-10.6) 703 
 07-08 2.80 (2.54-3.09) 2.69 (2.37-2.93) 3.91 (3.46-4.56) 6.27 (4.72-8.21) 8.21 (5.77-10.1) 366 
 09-10 2.89 (2.61-3.20) 2.60 (2.36-2.86) 4.08 (3.43-4.80) 6.67 (5.71-8.57) 10.0 (7.61-12.6) 456 
20 years and older 03-04 3.79 (3.34-4.31) 3.48 (3.00-4.00) 5.95 (4.86-7.05) 9.45 (8.00-12.0) 13.5 (11.1-18.6) 1548 
 05-06 3.93 (3.62-4.27) 3.71 (3.42-4.02) 5.82 (5.22-6.47) 9.74 (8.00-11.2) 12.6 (10.9-15.8) 1531 
 07-08 3.89 (3.64-4.16) 3.69 (3.44-4.02) 5.96 (5.47-6.58) 9.10 (8.00-10.0) 11.6 (9.74-14.5) 1820 
 09-10 4.00 (3.70-4.32) 3.61 (3.33-3.90) 6.25 (5.57-6.88) 10.8 (9.23-12.9) 16.1 (12.6-22.2) 2035 
Gender        
Males 03-04 3.48 (2.95-4.10) 3.16 (2.70-3.82) 5.46 (4.17-6.90) 8.59 (6.92-12.0) 12.3 (8.84-18.9) 1284 
 05-06 3.43 (3.13-3.75) 3.24 (2.91-3.63) 5.11 (4.25-6.08) 7.90 (6.65-9.77) 11.0 (9.29-13.0) 1276 
 07-08 3.63 (3.41-3.85) 3.44 (3.22-3.68) 5.33 (5.00-5.82) 8.31 (7.21-10.1) 12.1 (9.73-14.9) 1289 
 09-10 3.54 (3.29-3.80) 3.20 (3.04-3.38) 5.31 (4.80-5.99) 9.24 (7.80-10.8) 13.3 (10.3-16.5) 1402 
Females 03-04 3.89 (3.49-4.34) 3.57 (3.13-4.06) 5.78 (4.95-6.67) 9.32 (8.00-11.5) 13.7 (10.6-18.6) 1284 
 05-06 4.37 (4.03-4.75) 4.03 (3.72-4.51) 6.26 (5.71-6.84) 10.0 (8.50-12.6) 14.4 (11.2-19.3) 1312 
 07-08 4.02 (3.75-4.32) 3.80 (3.46-4.26) 6.15 (5.58-7.06) 9.23 (8.11-10.1) 10.9 (9.52-14.9) 1287 
 09-10 4.28 (3.96-4.63) 4.00 (3.62-4.32) 6.55 (5.98-7.14) 11.0 (9.64-13.2) 17.2 (13.2-24.4) 1468 
Race/ethnicity        
Mexican Americans 03-04 4.38 (3.80-5.05) 4.11 (3.29-4.90) 6.25 (4.84-8.15) 10.3 (8.00-11.8) 12.9 (11.1-15.2) 621 
 05-06 4.16 (3.83-4.52) 4.00 (3.65-4.36) 5.94 (5.40-6.49) 8.69 (7.23-9.65) 10.2 (9.52-13.2) 651 
 07-08 4.34 (3.87-4.88) 4.19 (3.66-4.83) 6.23 (5.31-7.44) 9.14 (8.00-11.0) 12.1 (10.1-15.1) 513 
 09-10 4.06 (3.63-4.54) 3.95 (3.33-4.44) 6.32 (5.36-7.10) 9.23 (8.10-10.6) 11.7 (10.2-14.8) 618 
Non-Hispanic blacks 03-04 3.08 (2.69-3.52) 2.86 (2.60-3.24) 4.34 (3.82-5.05) 7.81 (5.82-9.45) 10.4 (7.61-16.9) 725 
 05-06 3.08 (2.70-3.52) 2.91 (2.52-3.32) 4.21 (3.75-4.91) 7.33 (5.40-10.7) 11.6 (7.66-17.9) 695 
 07-08 3.08 (2.87-3.31) 2.77 (2.56-3.13) 4.74 (4.31-5.22) 7.29 (6.58-8.26) 9.67 (8.26-11.0) 586 
 09-10 3.26 (2.90-3.66) 2.86 (2.47-3.34) 5.10 (4.43-6.06) 10.0 (7.39-11.7) 13.1 (11.1-15.2) 545 
Non-Hispanic whites 03-04 3.44 (2.97-3.98) 3.17 (2.80-3.73) 5.16 (4.03-6.49) 8.00 (6.32-10.9) 11.1 (8.00-15.4) 1078 
 05-06 3.82 (3.47-4.21) 3.64 (3.30-3.93) 5.71 (4.90-6.51) 9.23 (7.26-10.6) 11.6 (9.93-13.9) 1050 
 07-08 3.62 (3.38-3.87) 3.48 (3.20-3.76) 5.38 (4.95-5.80) 8.00 (7.28-8.86) 10.0 (8.96-11.1) 1063 
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Urinary Dimethylarsinic acid (creatinine corrected) (2011 - 2014) 
Metabolite of Arsenic 
Geometric mean and selected percentiles of urine concentrations (in µg As/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 3.92 (3.69-4.16) 3.65 (3.47-3.91) 5.92 (5.40-6.49) 9.86 (8.68-11.3) 13.1 (11.5-15.2) 2516 
 13-14 3.68 (3.46-3.92) 3.47 (3.17-3.79) 5.53 (5.11-5.97) 9.18 (8.11-10.2) 12.7 (11.4-13.6) 2653 
Age group        
6-11 years 11-12 4.86 (4.54-5.21) 4.44 (4.10-4.70) 6.82 (6.15-7.69) 9.77 (8.65-11.5) 13.8 (10.3-15.0) 401 
 13-14 5.00 (4.56-5.50) 4.59 (4.06-5.40) 7.50 (6.62-8.44) 10.8 (9.11-12.3) 13.3 (12.0-14.4) 397 
12-19 years 11-12 3.13 (2.68-3.64) 3.02 (2.48-3.34) 4.51 (3.49-5.62) 7.03 (5.08-10.8) 10.8 (6.13-18.1) 392 
 13-14 2.99 (2.68-3.33) 2.74 (2.57-3.00) 4.32 (3.65-5.28) 6.80 (5.81-7.46) 9.30 (6.94-12.8) 450 
20 years and older 11-12 3.96 (3.75-4.19) 3.73 (3.52-3.94) 6.05 (5.45-6.68) 10.1 (8.97-11.3) 13.1 (11.5-15.5) 1723 
 13-14 3.68 (3.46-3.91) 3.48 (3.21-3.75) 5.47 (5.12-5.89) 9.32 (8.24-10.3) 13.0 (11.3-14.7) 1806 
Gender        
Males 11-12 3.55 (3.27-3.86) 3.34 (3.11-3.69) 5.32 (4.75-6.06) 8.47 (7.35-9.73) 11.0 (9.45-14.1) 1263 
 13-14 3.31 (3.12-3.51) 3.03 (2.92-3.29) 4.79 (4.57-5.05) 8.05 (7.51-9.13) 11.4 (10.3-12.8) 1307 
Females 11-12 4.30 (4.06-4.56) 4.10 (3.85-4.35) 6.68 (5.93-7.36) 10.8 (9.77-12.4) 14.9 (12.4-17.0) 1253 
 13-14 4.08 (3.75-4.44) 3.94 (3.54-4.29) 6.16 (5.64-6.90) 9.84 (8.39-12.0) 13.4 (11.3-15.4) 1346 
Race/ethnicity        
Mexican Americans 11-12 4.12 (3.83-4.44) 4.10 (3.43-4.59) 5.77 (5.29-6.37) 8.06 (7.49-9.54) 10.5 (8.70-14.8) 317 
 13-14 3.78 (3.61-3.96) 3.72 (3.55-3.94) 5.11 (4.81-5.40) 7.29 (6.75-7.94) 9.73 (7.53-11.7) 455 
Non-Hispanic blacks 11-12 3.16 (2.66-3.74) 3.05 (2.41-3.67) 4.98 (4.01-6.08) 8.27 (6.68-9.70) 11.3 (8.87-13.7) 672 
 13-14 2.89 (2.53-3.30) 2.68 (2.33-3.05) 4.40 (3.70-5.00) 6.81 (5.84-8.72) 10.1 (7.41-12.5) 576 
Non-Hispanic whites 11-12 3.68 (3.44-3.93) 3.47 (3.31-3.63) 5.32 (5.04-5.93) 9.07 (7.47-10.3) 11.5 (9.87-13.1) 824 
 13-14 3.52 (3.22-3.84) 3.38 (2.94-3.75) 5.24 (4.70-5.87) 8.64 (7.50-10.1) 12.0 (9.54-13.5) 979 
All Hispanics 11-12 4.50 (4.14-4.89) 4.38 (4.20-4.82) 6.62 (5.91-7.47) 9.46 (8.09-10.6) 13.0 (9.66-16.6) 574 
 13-14 3.95 (3.69-4.23) 3.84 (3.64-4.08) 5.56 (5.12-6.09) 7.92 (6.98-9.33) 11.0 (8.07-14.0) 703 
Asians 11-12 9.89 (8.57-11.4) 9.72 (8.10-11.0) 15.6 (12.4-20.5) 28.6 (20.1-41.1) 45.1 (34.3-57.2) 356 
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Urinary Monomethylarsonic acid (2003 – 2010) 
Metabolite of Arsenic 
Geometric mean and selected percentiles of urine concentrations (in µg As/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD 1.20 (1.00-1.30) 1.90 (1.60-2.10) 2.40 (2.00-2.80) 2567 
 05-06 * < LOD 1.19 (1.05-1.34) 1.72 (1.51-1.94) 2.12 (1.79-2.70) 2588 
 07-08 * < LOD 1.11 (1.00-1.20) 1.61 (1.51-1.69) 2.09 (1.91-2.26) 2576 
 09-10 * < LOD 1.02 (.920-1.10) 1.64 (1.41-1.83) 2.01 (1.82-2.28) 2871 
Age group        
6-11 years 03-04 * < LOD 1.00 (<LOD-1.40) 1.80 (1.30-2.60) 2.30 (1.70-2.90) 292 
 05-06 * < LOD 1.03 (<LOD-1.37) 1.54 (1.37-2.12) 2.12 (1.51-2.73) 354 
 07-08 * < LOD 1.05 (<LOD-1.28) 1.60 (1.32-1.83) 2.04 (1.64-2.86) 390 
 09-10 * < LOD < LOD 1.38 (1.00-1.84) 1.81 (1.26-2.13) 380 
12-19 years 03-04 * < LOD 1.50 (1.10-1.80) 2.20 (1.70-3.00) 2.90 (2.20-3.60) 728 
 05-06 * < LOD 1.31 (1.09-1.46) 1.99 (1.62-2.23) 2.41 (2.04-2.89) 703 
 07-08 * < LOD 1.26 (1.11-1.35) 1.83 (1.54-2.22) 2.31 (1.87-2.90) 366 
 09-10 * < LOD 1.10 (.910-1.25) 1.62 (1.33-1.92) 2.03 (1.74-2.30) 456 
20 years and older 03-04 * < LOD 1.20 (1.00-1.30) 1.80 (1.50-2.10) 2.30 (2.00-2.60) 1547 
 05-06 * < LOD 1.20 (1.05-1.33) 1.70 (1.48-1.90) 2.06 (1.74-2.75) 1531 
 07-08 * < LOD 1.08 (.970-1.17) 1.58 (1.44-1.71) 1.98 (1.82-2.21) 1820 
 09-10 * < LOD 1.02 (.930-1.11) 1.65 (1.42-1.86) 2.03 (1.81-2.35) 2035 
Gender        
Males 03-04 * < LOD 1.30 (1.10-1.60) 2.00 (1.80-2.40) 2.60 (2.10-3.00) 1283 
 05-06 * < LOD 1.31 (1.12-1.49) 1.79 (1.57-2.09) 2.23 (1.85-2.86) 1276 
 07-08 * < LOD 1.24 (1.13-1.35) 1.78 (1.63-1.94) 2.33 (1.97-2.71) 1289 
 09-10 * < LOD 1.07 (.970-1.23) 1.77 (1.47-2.01) 2.19 (1.83-2.68) 1403 
Females 03-04 * < LOD 1.00 (<LOD-1.20) 1.60 (1.30-1.90) 2.10 (1.70-2.60) 1284 
 05-06 * < LOD 1.08 (.920-1.24) 1.57 (1.36-1.90) 2.04 (1.67-2.50) 1312 
 07-08 * < LOD .970 (<LOD-1.06) 1.42 (1.30-1.57) 1.81 (1.68-1.90) 1287 
 09-10 * < LOD .950 (<LOD-1.06) 1.52 (1.27-1.74) 1.89 (1.66-2.12) 1468 
Race/ethnicity        
Mexican Americans 03-04 * < LOD 1.50 (1.20-1.90) 2.20 (1.70-2.80) 2.80 (2.00-4.40) 621 
 05-06 * < LOD 1.19 (1.10-1.32) 1.73 (1.51-1.97) 2.04 (1.67-2.51) 651 
 07-08 * < LOD 1.22 (1.02-1.35) 1.69 (1.43-2.12) 2.32 (1.75-2.85) 513 
 09-10 * < LOD 1.02 (<LOD-1.37) 1.65 (1.38-1.90) 2.02 (1.65-2.33) 618 
Non-Hispanic blacks 03-04 * < LOD 1.10 (<LOD-1.30) 1.80 (1.40-2.00) 2.20 (1.70-2.70) 725 
 05-06 * < LOD 1.02 (.950-1.07) 1.35 (1.29-1.44) 1.70 (1.50-1.88) 695 
 07-08 * < LOD 1.21 (1.09-1.33) 1.79 (1.61-2.05) 2.32 (2.15-2.63) 586 
 09-10 * < LOD 1.02 (<LOD-1.18) 1.51 (1.36-1.84) 1.88 (1.73-2.24) 546 
Non-Hispanic whites 03-04 * < LOD 1.10 (.900-1.30) 1.80 (1.40-2.00) 2.10 (1.80-2.50) 1077 
 05-06 * < LOD 1.22 (1.02-1.39) 1.75 (1.42-2.12) 2.14 (1.72-2.93) 1050 
 07-08 * < LOD 1.04 (.930-1.15) 1.50 (1.37-1.63) 1.91 (1.69-2.09) 1063 
 09-10 * < LOD .940 (<LOD-1.04) 1.45 (1.24-1.76) 1.90 (1.65-2.12) 1226 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, 07-08 and 09-10 are 0.9, 0.9, 0.9, and 0.9 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Monomethylarsonic acid (2011 - 2014) 
Metabolite of Arsenic 
Geometric mean and selected percentiles of urine concentrations (in µg As/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * < LOD < LOD 1.36 (1.17-1.55) 1.83 (1.57-2.07) 2517 
 13-14 .411 (.372-.454) .460 (.390-.530) .810 (.750-.870) 1.22 (1.11-1.33) 1.53 (1.36-1.74) 2654 
Age group        
6-11 years 11-12 * < LOD < LOD 1.21 (.970-1.40) 1.42 (1.24-1.54) 401 
 13-14 * .380 (<LOD-.530) .710 (.600-.850) 1.11 (.920-1.29) 1.47 (1.22-1.52) 397 
12-19 years 11-12 * < LOD .900 (<LOD-1.09) 1.28 (1.09-1.57) 1.59 (1.26-3.30) 392 
 13-14 .506 (.430-.596) .580 (.480-.710) .980 (.820-1.11) 1.28 (1.09-1.58) 1.58 (1.26-1.77) 450 
20 years and older 11-12 * < LOD < LOD 1.41 (1.15-1.67) 1.88 (1.58-2.08) 1724 
 13-14 .406 (.365-.450) .450 (.370-.520) .790 (.740-.850) 1.21 (1.10-1.33) 1.57 (1.36-1.79) 1807 
Gender        
Males 11-12 * < LOD .950 (<LOD-1.14) 1.50 (1.26-1.85) 2.04 (1.79-2.40) 1264 
 13-14 .456 (.408-.510) .520 (.450-.600) .900 (.850-.940) 1.26 (1.18-1.37) 1.57 (1.39-1.74) 1308 
Females 11-12 * < LOD < LOD 1.15 (1.02-1.40) 1.57 (1.41-1.79) 1253 
 13-14 .372 (.336-.412) .400 (.300-.490) .740 (.680-.770) 1.14 (.990-1.33) 1.49 (1.26-1.88) 1346 
Race/ethnicity        
Mexican Americans 11-12 * < LOD < LOD 1.25 (1.04-1.65) 1.85 (1.25-3.26) 317 
 13-14 .406 (.370-.446) .470 (.380-.560) .780 (.750-.860) 1.14 (1.01-1.27) 1.43 (1.17-1.69) 455 
Non-Hispanic blacks 11-12 * < LOD < LOD 1.26 (1.01-1.55) 1.65 (1.34-2.02) 672 
 13-14 .446 (.400-.496) .520 (.430-.600) .820 (.750-.890) 1.23 (1.03-1.39) 1.55 (1.28-1.96) 576 
Non-Hispanic whites 11-12 * < LOD < LOD 1.24 (1.03-1.49) 1.71 (1.34-2.04) 825 
 13-14 .390 (.338-.451) .430 (.320-.530) .780 (.700-.860) 1.17 (1.04-1.31) 1.48 (1.22-1.81) 980 
All Hispanics 11-12 * < LOD .960 (<LOD-1.25) 1.60 (1.32-1.99) 2.38 (1.65-3.29) 574 
 13-14 .443 (.399-.491) .520 (.460-.570) .860 (.770-.950) 1.28 (1.08-1.49) 1.68 (1.32-1.76) 703 
Asians 11-12 * < LOD 1.32 (1.19-1.54) 2.09 (1.71-2.56) 2.76 (2.24-3.64) 356 
 13-14 .499 (.445-.559) .570 (.430-.660) .980 (.790-1.23) 1.58 (1.42-1.80) 2.04 (1.72-2.65) 291 
Limit of detection (LOD, see Data Analysis section) for Survey year 11-12 and 13-14 are 0.89 and 0.2. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Monomethylarsonic acid (creatinine corrected) (2003 – 2010) 
Metabolite of Arsenic 
Geometric mean and selected percentiles of urine concentrations (in µg As/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD 1.33 (1.18-1.54) 2.22 (1.82-2.57) 2.86 (2.40-3.53) 2567 
 05-06 * < LOD 1.28 (1.14-1.52) 2.37 (1.94-2.78) 3.13 (2.67-3.76) 2588 
 07-08 * < LOD 1.31 (1.23-1.42) 2.24 (2.00-2.56) 3.19 (2.78-3.58) 2576 
 09-10 * < LOD 1.36 (1.25-1.45) 2.16 (2.00-2.29) 2.91 (2.67-3.15) 2870 
Age group        
6-11 years 03-04 * < LOD 1.63 (<LOD-1.81) 2.31 (1.88-2.50) 2.52 (2.31-3.07) 292 
 05-06 * < LOD 1.44 (<LOD-1.83) 2.37 (1.65-3.20) 3.13 (2.29-4.92) 354 
 07-08 * < LOD 1.69 (<LOD-2.06) 2.46 (2.09-2.91) 3.20 (2.56-4.32) 390 
 09-10 * < LOD < LOD 2.37 (2.07-2.78) 3.16 (2.55-3.76) 379 
12-19 years 03-04 * < LOD 1.10 (.853-1.23) 1.53 (1.30-1.85) 2.07 (1.71-2.22) 728 
 05-06 * < LOD 1.05 (.930-1.14) 1.56 (1.49-1.73) 1.97 (1.78-2.13) 703 
 07-08 * < LOD .970 (.880-1.07) 1.45 (1.19-1.73) 1.97 (1.49-2.34) 366 
 09-10 * < LOD 1.21 (1.02-1.45) 1.98 (1.60-2.56) 2.56 (1.94-4.57) 456 
20 years and older 03-04 * < LOD 1.36 (1.18-1.58) 2.28 (1.82-2.79) 3.00 (2.43-3.53) 1547 
 05-06 * < LOD 1.31 (1.13-1.58) 2.46 (2.00-2.91) 3.20 (2.78-3.81) 1531 
 07-08 * < LOD 1.32 (1.23-1.45) 2.35 (2.02-2.67) 3.38 (2.78-3.83) 1820 
 09-10 * < LOD 1.36 (1.25-1.45) 2.18 (2.00-2.29) 2.91 (2.78-3.20) 2035 
Gender        
Males 03-04 * < LOD 1.20 (1.05-1.36) 1.88 (1.53-2.34) 2.50 (2.07-3.45) 1283 
 05-06 * < LOD 1.11 (.950-1.28) 1.78 (1.47-2.29) 2.46 (1.88-3.32) 1276 
 07-08 * < LOD 1.18 (1.07-1.26) 2.06 (1.85-2.34) 2.71 (2.46-3.37) 1289 
 09-10 * < LOD 1.16 (1.07-1.25) 1.79 (1.64-1.99) 2.29 (2.08-2.78) 1402 
Females 03-04 * < LOD 1.50 (<LOD-1.77) 2.40 (1.96-2.86) 3.00 (2.61-3.53) 1284 
 05-06 * < LOD 1.58 (1.36-1.76) 2.78 (2.29-3.20) 3.56 (3.05-4.35) 1312 
 07-08 * < LOD 1.45 (<LOD-1.60) 2.41 (1.94-2.91) 3.56 (2.78-4.27) 1287 
 09-10 * < LOD 1.56 (<LOD-1.73) 2.46 (2.29-2.62) 3.37 (2.91-3.56) 1468 
Race/ethnicity        
Mexican Americans 03-04 * < LOD 1.46 (1.11-1.93) 2.30 (1.84-3.00) 3.16 (2.40-3.85) 621 
 05-06 * < LOD 1.19 (1.08-1.35) 1.92 (1.60-2.13) 2.53 (2.06-2.91) 651 
 07-08 * < LOD 1.28 (1.10-1.60) 2.27 (1.64-2.71) 3.05 (2.35-3.76) 513 
 09-10 * < LOD 1.31 (<LOD-1.49) 2.00 (1.73-2.56) 3.05 (2.29-3.56) 618 
Non-Hispanic blacks 03-04 * < LOD .816 (<LOD-.985) 1.37 (1.14-1.61) 1.88 (1.46-2.17) 725 
 05-06 * < LOD .790 (.720-.880) 1.11 (.980-1.34) 1.57 (1.23-1.98) 695 
 07-08 * < LOD .920 (.840-1.06) 1.45 (1.33-1.73) 2.09 (1.73-2.56) 586 
 09-10 * < LOD .970 (<LOD-1.08) 1.73 (1.39-1.94) 2.29 (1.83-2.91) 545 
Non-Hispanic whites 03-04 * < LOD 1.33 (1.15-1.62) 2.28 (1.73-2.86) 2.86 (2.35-3.75) 1077 
 05-06 * < LOD 1.35 (1.16-1.64) 2.50 (2.00-3.05) 3.20 (2.78-3.81) 1050 
 07-08 * < LOD 1.35 (1.23-1.52) 2.37 (2.04-2.78) 3.37 (2.78-4.00) 1063 
 09-10 * < LOD 1.36 (<LOD-1.52) 2.21 (1.99-2.37) 2.91 (2.67-3.20) 1226 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary Monomethylarsonic acid (creatinine corrected) (2011 - 2014) 
Metabolite of Arsenic 
Geometric mean and selected percentiles of urine concentrations (in µg As/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * < LOD < LOD 2.21 (2.03-2.42) 2.86 (2.63-3.32) 2516 
 13-14 .474 (.425-.527) .489 (.424-.556) .812 (.734-.904) 1.27 (1.17-1.40) 1.61 (1.45-1.84) 2653 
Age group        
6-11 years 11-12 * < LOD < LOD 2.55 (2.17-3.15) 3.32 (2.52-4.50) 401 
 13-14 * .543 (<LOD-.667) .933 (.700-1.15) 1.43 (1.08-1.87) 1.71 (1.44-2.22) 397 
12-19 years 11-12 * < LOD 1.07 (<LOD-1.24) 1.75 (1.30-2.42) 2.52 (1.62-7.00) 392 
 13-14 .459 (.397-.530) .462 (.362-.603) .727 (.634-.848) 1.10 (.877-1.50) 1.51 (1.11-2.00) 450 
20 years and older 11-12 * < LOD < LOD 2.25 (2.00-2.42) 2.74 (2.52-3.32) 1723 
 13-14 .471 (.423-.524) .488 (.424-.545) .815 (.740-.900) 1.28 (1.18-1.38) 1.62 (1.44-1.82) 1806 
Gender        
Males 11-12 * < LOD 1.13 (<LOD-1.24) 1.72 (1.58-1.85) 2.31 (1.92-2.67) 1263 
 13-14 .456 (.413-.504) .475 (.421-.535) .772 (.695-.851) 1.20 (1.09-1.30) 1.56 (1.38-1.69) 1307 
Females 11-12 * < LOD < LOD 2.52 (2.27-2.74) 3.32 (2.74-3.94) 1253 
 13-14 .491 (.435-.555) .500 (.424-.583) .842 (.741-1.00) 1.33 (1.18-1.46) 1.68 (1.41-2.08) 1346 
Race/ethnicity        
Mexican Americans 11-12 * < LOD < LOD 1.95 (1.54-2.25) 2.63 (1.85-3.32) 317 
 13-14 .463 (.409-.524) .488 (.438-.554) .743 (.674-.850) 1.20 (1.01-1.33) 1.49 (1.31-1.66) 455 
Non-Hispanic blacks 11-12 * < LOD < LOD 1.38 (1.21-1.62) 1.97 (1.75-2.33) 672 
 13-14 .336 (.296-.382) .329 (.294-.392) .557 (.486-.631) .806 (.735-.910) 1.06 (.910-1.25) 576 
Non-Hispanic whites 11-12 * < LOD < LOD 2.33 (2.03-2.52) 2.86 (2.52-3.50) 824 
 13-14 .481 (.423-.546) .495 (.418-.568) .824 (.733-.933) 1.25 (1.10-1.42) 1.56 (1.36-1.84) 979 
All Hispanics 11-12 * < LOD 1.34 (<LOD-1.48) 2.02 (1.62-2.52) 2.63 (1.97-3.50) 574 
 13-14 .494 (.446-.548) .520 (.467-.586) .819 (.713-.931) 1.31 (1.18-1.50) 1.71 (1.49-1.97) 703 
Asians 11-12 * < LOD 2.06 (1.63-2.33) 3.07 (2.69-3.68) 4.50 (3.43-5.09) 356 
 13-14 .777 (.667-.906) .800 (.623-1.04) 1.33 (1.08-1.61) 1.94 (1.56-2.53) 2.54 (2.00-3.16) 291 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary Trimethylarsine oxide (2003 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg As/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 2568 
 05-06 * < LOD < LOD < LOD < LOD 2588 
 07-08 * < LOD < LOD < LOD < LOD 2576 
 09-10 * < LOD < LOD < LOD < LOD 2871 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD < LOD 292 
 05-06 * < LOD < LOD < LOD < LOD 354 
 07-08 * < LOD < LOD < LOD < LOD 390 
 09-10 * < LOD < LOD < LOD < LOD 380 
12-19 years 03-04 * < LOD < LOD < LOD < LOD 728 
 05-06 * < LOD < LOD < LOD < LOD 703 
 07-08 * < LOD < LOD < LOD < LOD 366 
 09-10 * < LOD < LOD < LOD < LOD 456 
20 years and older 03-04 * < LOD < LOD < LOD < LOD 1548 
 05-06 * < LOD < LOD < LOD < LOD 1531 
 07-08 * < LOD < LOD < LOD < LOD 1820 
 09-10 * < LOD < LOD < LOD < LOD 2035 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 1284 
 05-06 * < LOD < LOD < LOD < LOD 1276 
 07-08 * < LOD < LOD < LOD < LOD 1289 
 09-10 * < LOD < LOD < LOD < LOD 1403 
Females 03-04 * < LOD < LOD < LOD < LOD 1284 
 05-06 * < LOD < LOD < LOD < LOD 1312 
 07-08 * < LOD < LOD < LOD < LOD 1287 
 09-10 * < LOD < LOD < LOD < LOD 1468 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 621 
 05-06 * < LOD < LOD < LOD < LOD 651 
 07-08 * < LOD < LOD < LOD < LOD 513 
 09-10 * < LOD < LOD < LOD < LOD 618 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 725 
 05-06 * < LOD < LOD < LOD < LOD 695 
 07-08 * < LOD < LOD < LOD < LOD 586 
 09-10 * < LOD < LOD < LOD < LOD 546 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 1078 
 05-06 * < LOD < LOD < LOD < LOD 1050 
 07-08 * < LOD < LOD < LOD < LOD 1063 
 09-10 * < LOD < LOD < LOD < LOD 1226 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, 07-08 and 09-10 are 1.0, 1.0, 1.0, and 1.0 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Trimethylarsine oxide (2011 - 2012)‡ 
 
Geometric mean and selected percentiles of urine concentrations (in µg As/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * < LOD < LOD < LOD < LOD 2517 
Age group        
6-11 years 11-12 * < LOD < LOD < LOD .300 (<LOD-.960) 401 
12-19 years 11-12 * < LOD < LOD < LOD < LOD 392 
20 years and older 11-12 * < LOD < LOD < LOD < LOD 1724 
Gender        
Males 11-12 * < LOD < LOD < LOD < LOD 1264 
Females 11-12 * < LOD < LOD < LOD < LOD 1253 
Race/ethnicity        
Mexican Americans 11-12 * < LOD < LOD < LOD < LOD 317 
Non-Hispanic blacks 11-12 * < LOD < LOD < LOD < LOD 672 
Non-Hispanic whites 11-12 * < LOD < LOD < LOD < LOD 825 
All Hispanics 11-12 * < LOD < LOD < LOD < LOD 574 
Asians 11-12 * < LOD < LOD < LOD < LOD 356 
Limit of detection (LOD, see Data Analysis section) for Survey year 11-12 is 0.25. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result.  
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Urinary Trimethylarsine oxide (creatinine corrected) (2003 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg As/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 2568 
 05-06 * < LOD < LOD < LOD < LOD 2588 
 07-08 * < LOD < LOD < LOD < LOD 2576 
 09-10 * < LOD < LOD < LOD < LOD 2870 
Age group        
6-11 years 03-04 * < LOD < LOD < LOD < LOD 292 
 05-06 * < LOD < LOD < LOD < LOD 354 
 07-08 * < LOD < LOD < LOD < LOD 390 
 09-10 * < LOD < LOD < LOD < LOD 379 
12-19 years 03-04 * < LOD < LOD < LOD < LOD 728 
 05-06 * < LOD < LOD < LOD < LOD 703 
 07-08 * < LOD < LOD < LOD < LOD 366 
 09-10 * < LOD < LOD < LOD < LOD 456 
20 years and older 03-04 * < LOD < LOD < LOD < LOD 1548 
 05-06 * < LOD < LOD < LOD < LOD 1531 
 07-08 * < LOD < LOD < LOD < LOD 1820 
 09-10 * < LOD < LOD < LOD < LOD 2035 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 1284 
 05-06 * < LOD < LOD < LOD < LOD 1276 
 07-08 * < LOD < LOD < LOD < LOD 1289 
 09-10 * < LOD < LOD < LOD < LOD 1402 
Females 03-04 * < LOD < LOD < LOD < LOD 1284 
 05-06 * < LOD < LOD < LOD < LOD 1312 
 07-08 * < LOD < LOD < LOD < LOD 1287 
 09-10 * < LOD < LOD < LOD < LOD 1468 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 621 
 05-06 * < LOD < LOD < LOD < LOD 651 
 07-08 * < LOD < LOD < LOD < LOD 513 
 09-10 * < LOD < LOD < LOD < LOD 618 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 725 
 05-06 * < LOD < LOD < LOD < LOD 695 
 07-08 * < LOD < LOD < LOD < LOD 586 
 09-10 * < LOD < LOD < LOD < LOD 545 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 1078 
 05-06 * < LOD < LOD < LOD < LOD 1050 
 07-08 * < LOD < LOD < LOD < LOD 1063 
 09-10 * < LOD < LOD < LOD < LOD 1226 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary Trimethylarsine oxide (creatinine corrected) (2011 - 2012)‡ 
 
Geometric mean and selected percentiles of urine concentrations (in µg As/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * < LOD < LOD < LOD < LOD 2516 
Age group        
6-11 years 11-12 * < LOD < LOD < LOD 1.06 (<LOD-1.39) 401 
12-19 years 11-12 * < LOD < LOD < LOD < LOD 392 
20 years and older 11-12 * < LOD < LOD < LOD < LOD 1723 
Gender        
Males 11-12 * < LOD < LOD < LOD < LOD 1263 
Females 11-12 * < LOD < LOD < LOD < LOD 1253 
Race/ethnicity        
Mexican Americans 11-12 * < LOD < LOD < LOD < LOD 317 
Non-Hispanic blacks 11-12 * < LOD < LOD < LOD < LOD 672 
Non-Hispanic whites 11-12 * < LOD < LOD < LOD < LOD 824 
All Hispanics 11-12 * < LOD < LOD < LOD < LOD 574 
Asians 11-12 * < LOD < LOD < LOD < LOD 356 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result. 
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Urinary Barium (1999 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 1.50 (1.35-1.66) 1.60 (1.50-1.90) 3.10 (2.70-3.40) 5.40 (4.60-6.10) 6.90 (6.20-8.40) 2180 
 01-02 1.52 (1.41-1.65) 1.63 (1.50-1.76) 3.12 (2.77-3.51) 5.24 (4.73-5.84) 7.48 (6.54-8.12) 2690 
 03-04 1.49 (1.36-1.64) 1.51 (1.35-1.72) 2.91 (2.64-3.28) 5.36 (4.86-5.71) 7.54 (6.93-8.63) 2558 
 05-06 1.52 (1.39-1.66) 1.58 (1.44-1.70) 2.99 (2.63-3.41) 5.34 (4.82-5.83) 7.10 (6.46-8.18) 2576 
 07-08 1.56 (1.45-1.69) 1.64 (1.49-1.80) 3.01 (2.72-3.34) 4.93 (4.39-5.69) 7.04 (6.07-8.20) 2627 
 09-10 1.47 (1.34-1.60) 1.48 (1.35-1.62) 2.81 (2.52-3.06) 4.66 (4.34-5.35) 6.78 (5.86-7.76) 2848 
Age group        
6-11 years 99-00 2.15 (1.70-2.72) 2.20 (1.90-2.50) 4.00 (2.60-6.10) 6.40 (5.20-8.30) 8.30 (5.00-76.2) 297 
 01-02 1.80 (1.44-2.26) 2.09 (1.74-2.49) 3.63 (2.86-4.39) 5.37 (4.26-7.38) 6.88 (5.37-8.49) 368 
 03-04 2.21 (1.81-2.71) 2.50 (1.81-2.75) 4.76 (3.80-5.65) 8.63 (5.59-11.8) 11.8 (6.87-14.8) 290 
 05-06 1.73 (1.53-1.97) 1.87 (1.61-2.03) 3.55 (2.41-4.30) 6.21 (4.30-7.32) 7.72 (6.26-8.92) 355 
 07-08 1.75 (1.50-2.04) 1.86 (1.58-2.23) 3.41 (2.85-3.79) 5.57 (4.49-6.59) 7.32 (5.71-9.18) 394 
 09-10 1.49 (1.28-1.74) 1.50 (1.22-1.68) 2.72 (2.19-3.13) 4.63 (4.02-5.37) 6.59 (5.24-7.72) 378 
12-19 years 99-00 1.97 (1.78-2.19) 2.00 (1.70-2.30) 3.50 (3.10-4.00) 5.90 (4.80-7.00) 9.70 (5.90-13.1) 621 
 01-02 2.03 (1.76-2.34) 2.27 (1.96-2.53) 4.11 (3.48-4.72) 6.73 (5.55-7.87) 9.02 (7.25-11.4) 762 
 03-04 2.16 (1.93-2.41) 2.35 (2.06-2.63) 4.11 (3.48-4.71) 7.18 (6.00-8.29) 9.63 (8.15-11.4) 725 
 05-06 2.16 (1.92-2.42) 2.33 (1.99-2.56) 3.80 (3.60-4.21) 6.35 (5.48-7.49) 8.24 (6.06-10.5) 701 
 07-08 2.18 (1.99-2.39) 2.31 (2.07-2.59) 3.62 (3.34-4.10) 6.19 (4.75-7.51) 8.20 (6.22-11.1) 376 
 09-10 1.79 (1.52-2.09) 1.90 (1.46-2.45) 3.25 (2.82-4.14) 5.43 (4.45-6.07) 6.87 (5.73-8.16) 451 
20 years and older 99-00 1.36 (1.24-1.51) 1.50 (1.30-1.70) 2.80 (2.60-3.20) 5.10 (4.30-5.50) 6.40 (5.70-8.40) 1262 
 01-02 1.43 (1.32-1.54) 1.50 (1.39-1.65) 2.85 (2.55-3.27) 4.86 (4.53-5.47) 7.14 (6.08-8.12) 1560 
 03-04 1.34 (1.20-1.50) 1.39 (1.19-1.56) 2.54 (2.21-2.91) 4.61 (3.99-5.30) 6.61 (5.57-7.43) 1543 
 05-06 1.42 (1.28-1.57) 1.43 (1.28-1.63) 2.75 (2.47-3.11) 5.12 (4.45-5.81) 6.83 (6.14-7.90) 1520 
 07-08 1.46 (1.35-1.58) 1.51 (1.39-1.67) 2.79 (2.54-3.15) 4.61 (4.19-5.42) 6.80 (5.50-8.37) 1857 
 09-10 1.42 (1.30-1.55) 1.43 (1.31-1.58) 2.67 (2.36-3.02) 4.58 (4.22-5.14) 6.80 (5.70-8.63) 2019 
Gender        
Males 99-00 1.70 (1.54-1.88) 1.90 (1.80-2.00) 3.20 (3.00-3.60) 5.50 (4.20-6.70) 7.50 (5.90-9.70) 1083 
 01-02 1.64 (1.47-1.82) 1.80 (1.65-1.98) 3.15 (2.76-3.73) 5.52 (4.82-6.35) 7.87 (6.49-9.32) 1335 
 03-04 1.62 (1.47-1.78) 1.69 (1.49-1.85) 3.09 (2.81-3.54) 5.65 (5.14-6.16) 8.56 (6.71-9.67) 1281 
 05-06 1.66 (1.48-1.85) 1.71 (1.50-1.94) 3.21 (2.76-3.79) 5.48 (4.68-6.22) 7.10 (6.18-8.84) 1271 
 07-08 1.62 (1.48-1.77) 1.80 (1.57-1.93) 3.14 (2.79-3.42) 5.00 (4.31-5.70) 6.84 (5.83-7.72) 1327 
 09-10 1.53 (1.35-1.74) 1.57 (1.36-1.82) 3.01 (2.53-3.36) 4.83 (4.25-5.77) 6.81 (5.77-8.76) 1398 
Females 99-00 1.33 (1.15-1.53) 1.50 (1.20-1.60) 2.80 (2.30-3.30) 5.20 (4.20-5.90) 6.80 (5.60-10.4) 1097 
 01-02 1.43 (1.30-1.56) 1.44 (1.29-1.63) 3.11 (2.74-3.43) 4.93 (4.44-5.88) 7.15 (6.32-7.86) 1355 
 03-04 1.38 (1.24-1.54) 1.39 (1.18-1.57) 2.71 (2.41-3.15) 4.95 (4.29-5.51) 6.87 (5.65-8.10) 1277 
 05-06 1.40 (1.27-1.54) 1.42 (1.30-1.63) 2.70 (2.39-3.19) 5.21 (4.65-5.71) 7.09 (6.24-7.94) 1305 
 07-08 1.51 (1.36-1.68) 1.54 (1.38-1.70) 2.84 (2.52-3.37) 4.87 (4.23-6.13) 7.18 (5.94-8.83) 1300 
 09-10 1.40 (1.30-1.51) 1.38 (1.31-1.47) 2.61 (2.41-2.90) 4.58 (4.33-4.95) 6.59 (5.37-7.86) 1450 






Fourth National Report on Human Exposure to Environmental Chemicals, Updated Tables, January 2017 Volume One Page 228
Urinary Barium (1999 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 1.35 (1.25-1.46) 1.40 (1.20-1.50) 2.60 (2.30-2.90) 4.50 (4.10-5.30) 6.30 (5.50-6.80) 692 
 01-02 1.21 (1.06-1.37) 1.25 (1.11-1.46) 2.56 (2.04-2.91) 4.35 (3.65-5.49) 6.43 (5.21-8.22) 683 
 03-04 1.40 (1.15-1.70) 1.45 (1.22-1.73) 2.62 (1.78-3.38) 4.07 (2.95-6.37) 6.01 (4.01-7.88) 618 
 05-06 1.33 (1.24-1.42) 1.36 (1.22-1.50) 2.63 (2.35-2.89) 4.47 (3.80-5.23) 6.21 (5.23-7.00) 652 
 07-08 1.33 (1.16-1.53) 1.37 (1.19-1.48) 2.60 (2.29-2.84) 4.21 (3.53-4.90) 5.79 (4.90-8.00) 515 
 09-10 1.24 (1.07-1.45) 1.18 (1.05-1.40) 2.25 (1.88-2.71) 4.15 (3.55-5.40) 6.35 (5.00-8.75) 613 
Non-Hispanic blacks 99-00 1.34 (1.12-1.62) 1.40 (1.20-1.60) 2.50 (2.30-2.90) 5.10 (3.70-6.60) 7.40 (5.40-13.9) 540 
 01-02 1.30 (1.14-1.48) 1.42 (1.22-1.62) 2.61 (2.31-2.82) 4.30 (3.70-5.18) 5.99 (4.87-7.26) 667 
 03-04 1.27 (1.17-1.39) 1.38 (1.26-1.48) 2.34 (2.05-2.59) 3.77 (3.35-4.36) 5.86 (4.76-7.45) 723 
 05-06 1.25 (1.15-1.37) 1.31 (1.21-1.41) 2.40 (2.22-2.61) 4.24 (3.69-4.83) 6.19 (5.23-6.96) 692 
 07-08 1.17 (1.07-1.28) 1.23 (1.12-1.37) 2.14 (2.01-2.34) 3.70 (3.27-4.00) 5.00 (3.93-5.90) 589 
 09-10 1.22 (1.08-1.38) 1.22 (1.07-1.38) 2.13 (1.91-2.51) 3.76 (3.09-4.88) 5.50 (4.06-7.32) 544 
Non-Hispanic whites 99-00 1.56 (1.36-1.80) 1.80 (1.60-2.00) 3.30 (2.80-3.70) 5.50 (4.50-6.30) 7.50 (6.20-8.80) 765 
 01-02 1.61 (1.46-1.77) 1.68 (1.54-1.85) 3.31 (2.87-3.74) 5.66 (4.94-6.30) 7.73 (6.61-8.49) 1132 
 03-04 1.56 (1.37-1.78) 1.61 (1.28-1.92) 3.12 (2.75-3.70) 5.57 (5.04-6.43) 8.08 (6.87-9.53) 1074 
 05-06 1.59 (1.42-1.78) 1.66 (1.50-1.86) 3.08 (2.63-3.79) 5.50 (4.90-6.08) 7.10 (6.46-8.24) 1041 
 07-08 1.71 (1.55-1.88) 1.82 (1.62-1.97) 3.36 (2.91-3.71) 5.38 (4.51-6.30) 7.18 (6.22-9.05) 1095 
 09-10 1.56 (1.42-1.73) 1.60 (1.40-1.76) 3.00 (2.64-3.36) 4.89 (4.48-5.84) 7.16 (6.12-9.31) 1225 
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Urinary Barium (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 1.19 (1.11-1.28) 1.23 (1.14-1.33) 2.40 (2.24-2.54) 4.04 (3.76-4.35) 5.52 (4.92-5.95) 2504 
 13-14 1.09 (1.03-1.16) 1.10 (.980-1.21) 2.17 (2.05-2.31) 4.01 (3.61-4.28) 5.67 (5.29-6.09) 2664 
Age group        
6-11 years 11-12 1.39 (1.24-1.55) 1.46 (1.21-1.62) 2.96 (2.33-3.52) 4.92 (4.52-5.29) 6.68 (5.25-7.92) 399 
 13-14 1.13 (.962-1.33) 1.20 (.970-1.43) 2.06 (1.73-2.64) 3.48 (2.64-5.02) 5.02 (2.96-9.85) 402 
12-19 years 11-12 1.52 (1.25-1.84) 1.61 (1.24-1.90) 2.98 (2.40-4.03) 5.37 (4.27-6.08) 6.63 (5.53-8.77) 390 
 13-14 1.43 (1.19-1.70) 1.49 (1.10-1.75) 2.78 (2.23-3.49) 5.67 (4.18-6.69) 6.92 (6.14-8.11) 451 
20 years and older 11-12 1.13 (1.06-1.21) 1.19 (1.09-1.27) 2.24 (2.09-2.44) 3.74 (3.39-4.01) 5.05 (4.37-5.78) 1715 
 13-14 1.05 (.989-1.11) 1.03 (.930-1.16) 2.13 (1.93-2.31) 3.88 (3.33-4.25) 5.60 (4.78-5.96) 1811 
Gender        
Males 11-12 1.29 (1.20-1.38) 1.30 (1.24-1.41) 2.52 (2.25-2.71) 4.29 (3.74-4.58) 5.96 (4.49-7.35) 1262 
 13-14 1.20 (1.10-1.31) 1.24 (1.05-1.43) 2.38 (2.09-2.68) 4.27 (3.76-4.95) 5.96 (5.60-6.69) 1318 
Females 11-12 1.11 (.989-1.25) 1.14 (1.00-1.35) 2.33 (2.06-2.57) 3.90 (3.34-4.35) 5.13 (4.44-5.57) 1242 
 13-14 .998 (.940-1.06) .980 (.870-1.12) 2.03 (1.85-2.19) 3.66 (3.21-4.07) 5.19 (4.42-5.74) 1346 
Race/ethnicity        
Mexican Americans 11-12 1.08 (.961-1.22) 1.06 (.910-1.23) 2.10 (1.79-2.57) 3.95 (3.24-4.86) 5.58 (4.10-7.22) 317 
 13-14 .938 (.853-1.03) .870 (.760-1.02) 2.00 (1.61-2.25) 3.15 (2.84-3.53) 4.19 (3.48-4.95) 453 
Non-Hispanic blacks 11-12 .997 (.891-1.12) 1.05 (.910-1.20) 2.08 (1.79-2.29) 3.63 (3.09-4.08) 4.68 (4.02-5.19) 669 
 13-14 .947 (.865-1.04) .940 (.860-1.06) 1.81 (1.59-2.08) 3.48 (2.94-4.01) 4.50 (3.92-5.95) 581 
Non-Hispanic whites 11-12 1.27 (1.17-1.38) 1.32 (1.22-1.43) 2.50 (2.25-2.71) 4.33 (3.63-4.81) 5.57 (4.87-6.35) 820 
 13-14 1.18 (1.10-1.26) 1.20 (1.05-1.35) 2.32 (2.16-2.53) 4.27 (3.74-4.94) 5.99 (5.57-6.44) 985 
All Hispanics 11-12 1.08 (.970-1.19) 1.07 (.940-1.23) 2.15 (1.86-2.47) 3.74 (2.99-4.34) 4.82 (3.96-5.98) 573 
 13-14 .927 (.840-1.03) .890 (.760-1.05) 1.92 (1.72-2.14) 3.15 (2.84-3.53) 4.25 (3.60-4.82) 701 
Asians 11-12 1.16 (1.03-1.30) 1.21 (1.02-1.35) 2.28 (1.94-2.67) 3.90 (3.20-4.47) 5.50 (4.01-6.40) 353 
 13-14 .962 (.831-1.12) .920 (.790-1.13) 1.93 (1.47-2.33) 3.79 (2.95-4.75) 5.67 (4.19-6.61) 292 
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Urinary Barium (creatinine corrected) (1999 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 1.40 (1.26-1.56) 1.41 (1.28-1.54) 2.54 (2.20-2.91) 4.68 (3.85-5.47) 6.33 (5.47-8.09) 2180 
 01-02 1.44 (1.31-1.58) 1.49 (1.35-1.63) 2.76 (2.51-3.03) 4.58 (4.15-4.96) 6.24 (5.28-7.27) 2689 
 03-04 1.48 (1.37-1.60) 1.41 (1.31-1.58) 2.68 (2.44-2.89) 4.92 (4.39-5.45) 7.10 (6.29-7.77) 2558 
 05-06 1.50 (1.40-1.61) 1.48 (1.37-1.61) 2.75 (2.50-3.03) 4.65 (4.09-5.10) 6.38 (5.62-7.56) 2576 
 07-08 1.63 (1.51-1.75) 1.60 (1.51-1.72) 2.92 (2.72-3.16) 4.85 (4.40-5.57) 7.20 (5.94-8.59) 2627 
 09-10 1.56 (1.45-1.68) 1.55 (1.42-1.64) 2.72 (2.54-2.97) 4.69 (4.12-5.16) 6.24 (5.60-7.43) 2848 
Age group        
6-11 years 99-00 2.37 (1.68-3.32) 2.38 (1.84-2.92) 4.47 (2.55-6.46) 10.2 (3.75-22.0) 11.4 (5.46-22.0) 297 
 01-02 2.20 (1.91-2.52) 2.41 (2.19-2.83) 3.91 (3.29-4.51) 5.01 (4.58-6.00) 6.71 (5.20-8.47) 368 
 03-04 2.58 (2.22-2.99) 3.00 (2.35-3.29) 4.45 (3.57-5.54) 6.69 (5.59-7.70) 10.3 (6.53-21.0) 290 
 05-06 2.14 (1.85-2.48) 2.15 (1.76-2.51) 3.83 (3.10-4.73) 6.19 (4.84-7.83) 10.0 (5.76-11.1) 355 
 07-08 2.28 (2.04-2.54) 2.41 (2.05-2.59) 4.43 (3.87-4.70) 6.58 (5.05-9.46) 9.89 (7.13-13.3) 394 
 09-10 2.03 (1.78-2.30) 2.00 (1.77-2.40) 3.33 (2.81-3.79) 5.04 (4.17-7.39) 8.76 (5.93-10.8) 378 
12-19 years 99-00 1.51 (1.34-1.70) 1.40 (1.26-1.59) 2.48 (1.97-3.06) 4.36 (3.23-5.39) 7.62 (4.24-11.4) 621 
 01-02 1.45 (1.33-1.59) 1.56 (1.31-1.77) 2.89 (2.68-3.12) 4.52 (3.84-5.20) 5.55 (4.81-6.10) 762 
 03-04 1.54 (1.36-1.75) 1.59 (1.39-1.87) 2.60 (2.24-3.48) 4.97 (4.34-5.58) 6.47 (5.38-7.77) 725 
 05-06 1.66 (1.50-1.84) 1.73 (1.52-1.93) 3.15 (2.76-3.42) 4.25 (3.88-4.56) 5.00 (4.46-6.68) 701 
 07-08 1.71 (1.52-1.92) 1.70 (1.48-1.96) 3.03 (2.51-3.65) 4.80 (3.96-5.47) 6.17 (4.80-8.12) 376 
 09-10 1.67 (1.48-1.88) 1.66 (1.54-1.84) 2.69 (2.24-3.18) 3.98 (3.40-5.29) 6.42 (4.61-9.33) 451 
20 years and older 99-00 1.30 (1.19-1.42) 1.33 (1.20-1.46) 2.32 (2.08-2.62) 4.29 (3.63-4.96) 5.65 (5.28-6.33) 1262 
 01-02 1.37 (1.24-1.50) 1.40 (1.24-1.52) 2.53 (2.23-2.84) 4.38 (4.02-5.00) 6.55 (5.00-7.64) 1559 
 03-04 1.38 (1.26-1.50) 1.32 (1.22-1.41) 2.39 (2.13-2.70) 4.39 (3.77-5.16) 7.00 (5.45-8.50) 1543 
 05-06 1.42 (1.30-1.54) 1.39 (1.26-1.55) 2.59 (2.33-2.82) 4.53 (3.65-5.40) 6.34 (5.37-7.67) 1520 
 07-08 1.56 (1.44-1.69) 1.55 (1.40-1.66) 2.80 (2.55-3.04) 4.64 (4.05-5.43) 7.20 (5.78-8.65) 1857 
 09-10 1.50 (1.40-1.61) 1.46 (1.38-1.55) 2.67 (2.42-2.92) 4.71 (4.07-5.23) 6.03 (5.53-7.34) 2019 
Gender        
Males 99-00 1.32 (1.22-1.42) 1.36 (1.23-1.47) 2.39 (2.11-2.57) 4.24 (3.48-5.00) 5.61 (4.39-10.2) 1083 
 01-02 1.30 (1.16-1.45) 1.34 (1.19-1.50) 2.46 (2.14-2.83) 4.51 (3.73-4.96) 5.42 (4.81-7.51) 1334 
 03-04 1.36 (1.26-1.47) 1.31 (1.19-1.43) 2.60 (2.37-2.75) 4.36 (3.97-4.72) 6.01 (5.45-6.96) 1281 
 05-06 1.36 (1.23-1.50) 1.38 (1.25-1.52) 2.36 (2.19-2.73) 4.24 (3.65-4.82) 5.69 (4.75-7.36) 1271 
 07-08 1.45 (1.34-1.55) 1.50 (1.32-1.60) 2.59 (2.34-2.79) 4.30 (3.84-4.72) 5.56 (5.05-6.30) 1327 
 09-10 1.40 (1.28-1.52) 1.38 (1.29-1.50) 2.39 (2.13-2.68) 4.05 (3.52-4.71) 5.55 (4.89-6.77) 1398 
Females 99-00 1.49 (1.27-1.74) 1.48 (1.29-1.68) 2.65 (2.13-3.46) 4.91 (3.96-6.38) 7.36 (5.25-11.3) 1097 
 01-02 1.59 (1.45-1.75) 1.64 (1.48-1.79) 2.98 (2.75-3.30) 4.76 (4.38-5.31) 6.97 (5.86-7.52) 1355 
 03-04 1.60 (1.45-1.77) 1.55 (1.35-1.73) 2.78 (2.34-3.25) 5.50 (4.43-6.86) 7.88 (6.28-11.5) 1277 
 05-06 1.65 (1.54-1.76) 1.63 (1.45-1.83) 3.09 (2.71-3.38) 4.87 (4.48-5.65) 7.48 (6.04-10.0) 1305 
 07-08 1.83 (1.63-2.05) 1.74 (1.52-2.06) 3.22 (2.82-3.89) 5.94 (4.57-7.38) 8.15 (7.18-9.49) 1300 
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Urinary Barium (creatinine corrected) (1999 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 1.21 (1.10-1.33) 1.18 (1.05-1.38) 2.39 (2.10-2.59) 4.00 (3.33-4.80) 5.31 (4.80-6.51) 692 
 01-02 1.18 (1.03-1.34) 1.16 (1.00-1.38) 2.33 (1.90-2.61) 3.68 (3.29-4.10) 4.96 (4.24-6.80) 682 
 03-04 1.29 (1.08-1.55) 1.28 (1.03-1.53) 2.25 (1.73-2.97) 3.99 (2.79-5.03) 4.99 (4.24-6.56) 618 
 05-06 1.25 (1.17-1.33) 1.21 (1.09-1.33) 2.27 (1.84-2.61) 3.66 (3.07-4.35) 5.11 (4.00-5.95) 652 
 07-08 1.33 (1.16-1.53) 1.28 (1.14-1.49) 2.40 (1.87-2.90) 4.23 (3.45-4.87) 6.18 (4.75-7.27) 515 
 09-10 1.30 (1.18-1.44) 1.26 (1.14-1.41) 2.33 (1.98-2.79) 3.55 (3.11-4.42) 5.50 (4.27-6.58) 613 
Non-Hispanic blacks 99-00 .881 (.703-1.11) .905 (.710-1.06) 1.64 (1.36-2.00) 3.27 (2.26-4.76) 4.84 (3.57-10.8) 540 
 01-02 .891 (.777-1.02) .921 (.754-1.11) 1.64 (1.44-2.03) 2.86 (2.48-3.37) 4.02 (3.52-4.68) 667 
 03-04 .915 (.832-1.01) .963 (.880-1.04) 1.51 (1.39-1.75) 2.62 (2.29-3.04) 3.76 (3.22-4.72) 723 
 05-06 .909 (.845-.979) .880 (.820-.970) 1.78 (1.56-1.97) 2.99 (2.63-3.14) 3.91 (3.39-4.73) 692 
 07-08 .858 (.807-.913) .850 (.790-.920) 1.53 (1.34-1.61) 2.51 (2.01-3.03) 3.43 (2.83-5.05) 589 
 09-10 .965 (.853-1.09) .930 (.860-1.05) 1.63 (1.40-1.85) 2.92 (2.33-3.34) 3.71 (3.24-4.69) 544 
Non-Hispanic whites 99-00 1.56 (1.38-1.77) 1.55 (1.36-1.74) 2.72 (2.27-3.24) 5.00 (3.81-6.02) 6.60 (5.52-10.2) 765 
 01-02 1.62 (1.49-1.76) 1.66 (1.49-1.82) 3.04 (2.76-3.32) 4.96 (4.55-5.41) 6.74 (5.57-7.64) 1132 
 03-04 1.64 (1.49-1.82) 1.60 (1.40-1.76) 2.88 (2.56-3.26) 5.38 (4.67-6.28) 7.57 (6.69-9.27) 1074 
 05-06 1.65 (1.52-1.80) 1.61 (1.46-1.83) 2.95 (2.70-3.26) 4.82 (4.32-5.65) 7.21 (5.69-8.51) 1041 
 07-08 1.91 (1.74-2.10) 1.85 (1.65-2.09) 3.22 (2.84-3.76) 5.42 (4.55-6.91) 7.81 (6.33-9.45) 1095 
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Urinary Barium (creatinine corrected) (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 1.35 (1.24-1.48) 1.38 (1.27-1.47) 2.44 (2.10-2.84) 4.19 (3.72-4.85) 6.27 (5.20-6.66) 2502 
 13-14 1.26 (1.19-1.34) 1.24 (1.13-1.38) 2.33 (2.18-2.50) 4.06 (3.75-4.26) 5.59 (5.02-6.06) 2663 
Age group        
6-11 years 11-12 1.99 (1.80-2.19) 2.18 (1.70-2.61) 3.72 (3.35-4.03) 5.82 (4.95-6.45) 6.78 (5.98-8.18) 398 
 13-14 1.69 (1.39-2.05) 1.61 (1.24-2.20) 3.10 (2.29-3.80) 5.24 (3.54-7.57) 6.62 (5.03-9.83) 402 
12-19 years 11-12 1.45 (1.24-1.70) 1.42 (1.24-1.78) 2.81 (1.96-3.19) 4.90 (3.82-5.69) 6.29 (4.90-6.57) 390 
 13-14 1.29 (1.18-1.42) 1.36 (1.20-1.59) 2.33 (2.12-2.64) 3.69 (3.24-4.20) 4.80 (4.09-5.05) 451 
20 years and older 11-12 1.29 (1.17-1.41) 1.31 (1.20-1.43) 2.21 (1.95-2.63) 3.83 (3.50-4.31) 5.54 (4.38-6.84) 1714 
 13-14 1.22 (1.16-1.29) 1.18 (1.10-1.28) 2.23 (2.04-2.43) 4.00 (3.69-4.31) 5.59 (5.00-6.11) 1810 
Gender        
Males 11-12 1.20 (1.10-1.32) 1.17 (1.08-1.33) 2.09 (1.85-2.53) 3.72 (3.37-4.22) 5.35 (4.11-6.34) 1261 
 13-14 1.20 (1.13-1.28) 1.16 (1.09-1.30) 2.26 (1.97-2.48) 3.80 (3.39-4.28) 4.79 (4.42-5.24) 1317 
Females 11-12 1.51 (1.36-1.68) 1.51 (1.39-1.67) 2.73 (2.39-3.12) 4.83 (3.88-5.63) 6.52 (5.32-8.33) 1241 
 13-14 1.32 (1.23-1.43) 1.33 (1.17-1.52) 2.42 (2.18-2.72) 4.24 (3.96-4.60) 6.23 (5.29-8.04) 1346 
Race/ethnicity        
Mexican Americans 11-12 1.22 (1.09-1.36) 1.16 (1.02-1.31) 2.20 (1.82-2.71) 4.00 (3.08-4.84) 5.74 (3.94-7.90) 317 
 13-14 1.07 (.985-1.16) 1.02 (.943-1.13) 1.88 (1.68-2.19) 3.53 (2.78-4.32) 4.76 (4.28-5.62) 453 
Non-Hispanic blacks 11-12 .775 (.698-.861) .744 (.664-.918) 1.48 (1.32-1.64) 2.64 (2.24-3.06) 3.56 (3.21-3.86) 669 
 13-14 .721 (.660-.786) .717 (.657-.790) 1.31 (1.18-1.49) 2.42 (1.95-2.85) 3.26 (2.85-4.46) 581 
Non-Hispanic whites 11-12 1.54 (1.38-1.70) 1.53 (1.44-1.64) 2.71 (2.18-3.18) 4.71 (3.82-5.54) 6.45 (5.36-7.63) 818 
 13-14 1.45 (1.38-1.52) 1.46 (1.27-1.63) 2.59 (2.45-2.87) 4.31 (3.99-4.59) 6.06 (5.03-6.79) 984 
All Hispanics 11-12 1.21 (1.09-1.34) 1.19 (1.09-1.28) 2.20 (1.81-2.70) 3.70 (3.10-4.66) 5.17 (3.73-6.49) 573 
 13-14 1.04 (.960-1.12) 1.01 (.935-1.10) 1.86 (1.68-2.00) 3.15 (2.78-3.64) 4.52 (3.76-5.32) 701 
Asians 11-12 1.55 (1.40-1.71) 1.49 (1.35-1.73) 2.86 (2.34-3.33) 5.03 (4.00-5.95) 7.26 (5.03-9.71) 353 
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Urinary Beryllium (1999 – 2010) ‡ 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 * < LOD < LOD < LOD < LOD 2465 
 01-02 * < LOD < LOD < LOD < LOD 2690 
 03-04 * < LOD < LOD < LOD < LOD 2558 
 05-06 * < LOD < LOD < LOD < LOD 2576 
 07-08 * < LOD < LOD < LOD < LOD 2627 
 09-10 * < LOD < LOD < LOD < LOD 2848 
Age group        
6-11 years 99-00 * < LOD < LOD < LOD < LOD 340 
 01-02 * < LOD < LOD < LOD < LOD 368 
 03-04 * < LOD < LOD < LOD < LOD 290 
 05-06 * < LOD < LOD < LOD < LOD 355 
 07-08 * < LOD < LOD < LOD < LOD 394 
 09-10 * < LOD < LOD < LOD < LOD 378 
12-19 years 99-00 * < LOD < LOD < LOD < LOD 719 
 01-02 * < LOD < LOD < LOD .140 (<LOD-.170) 762 
 03-04 * < LOD < LOD < LOD < LOD 725 
 05-06 * < LOD < LOD < LOD < LOD 701 
 07-08 * < LOD < LOD < LOD < LOD 376 
 09-10 * < LOD < LOD < LOD < LOD 451 
20 years and older 99-00 * < LOD < LOD < LOD < LOD 1406 
 01-02 * < LOD < LOD < LOD < LOD 1560 
 03-04 * < LOD < LOD < LOD < LOD 1543 
 05-06 * < LOD < LOD < LOD < LOD 1520 
 07-08 * < LOD < LOD < LOD < LOD 1857 
 09-10 * < LOD < LOD < LOD < LOD 2019 
Gender        
Males 99-00 * < LOD < LOD < LOD < LOD 1227 
 01-02 * < LOD < LOD < LOD .130 (<LOD-.150) 1335 
 03-04 * < LOD < LOD < LOD < LOD 1281 
 05-06 * < LOD < LOD < LOD < LOD 1271 
 07-08 * < LOD < LOD < LOD < LOD 1327 
 09-10 * < LOD < LOD < LOD < LOD 1398 
Females 99-00 * < LOD < LOD < LOD < LOD 1238 
 01-02 * < LOD < LOD < LOD < LOD 1355 
 03-04 * < LOD < LOD < LOD < LOD 1277 
 05-06 * < LOD < LOD < LOD < LOD 1305 
 07-08 * < LOD < LOD < LOD < LOD 1300 
 09-10 * < LOD < LOD < LOD < LOD 1450 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 05-06, 07-08, and 09-10 are 0.13, 0.13, 0.13, 0.072, 0.072, and 0.072 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result.  
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Urinary Beryllium (1999 – 2010) ‡ 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 * < LOD < LOD < LOD < LOD 884 
 01-02 * < LOD < LOD < LOD .130 (<LOD-.160) 683 
 03-04 * < LOD < LOD < LOD < LOD 618 
 05-06 * < LOD < LOD < LOD < LOD 652 
 07-08 * < LOD < LOD < LOD < LOD 515 
 09-10 * < LOD < LOD < LOD < LOD 613 
Non-Hispanic blacks 99-00 * < LOD < LOD < LOD < LOD 568 
 01-02 * < LOD < LOD < LOD < LOD 667 
 03-04 * < LOD < LOD < LOD < LOD 723 
 05-06 * < LOD < LOD < LOD < LOD 692 
 07-08 * < LOD < LOD < LOD < LOD 589 
 09-10 * < LOD < LOD < LOD < LOD 544 
Non-Hispanic whites 99-00 * < LOD < LOD < LOD < LOD 822 
 01-02 * < LOD < LOD < LOD < LOD 1132 
 03-04 * < LOD < LOD < LOD < LOD 1074 
 05-06 * < LOD < LOD < LOD < LOD 1041 
 07-08 * < LOD < LOD < LOD < LOD 1095 
 09-10 * < LOD < LOD < LOD < LOD 1225 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 05-06, 07-08, and 09-10 are 0.13, 0.13, 0.13, 0.072, 0.072, and 0.072 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result.  
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Urinary Beryllium (creatinine corrected) (1999 – 2010) ‡ 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 * < LOD < LOD < LOD < LOD 2465 
 01-02 * < LOD < LOD < LOD < LOD 2689 
 03-04 * < LOD < LOD < LOD < LOD 2558 
 05-06 * < LOD < LOD < LOD < LOD 2576 
 07-08 * < LOD < LOD < LOD < LOD 2627 
 09-10 * < LOD < LOD < LOD < LOD 2848 
Age group        
6-11 years 99-00 * < LOD < LOD < LOD < LOD 340 
 01-02 * < LOD < LOD < LOD < LOD 368 
 03-04 * < LOD < LOD < LOD < LOD 290 
 05-06 * < LOD < LOD < LOD < LOD 355 
 07-08 * < LOD < LOD < LOD < LOD 394 
 09-10 * < LOD < LOD < LOD < LOD 378 
12-19 years 99-00 * < LOD < LOD < LOD < LOD 719 
 01-02 * < LOD < LOD < LOD .231 (<LOD-.273) 762 
 03-04 * < LOD < LOD < LOD < LOD 725 
 05-06 * < LOD < LOD < LOD < LOD 701 
 07-08 * < LOD < LOD < LOD < LOD 376 
 09-10 * < LOD < LOD < LOD < LOD 451 
20 years and older 99-00 * < LOD < LOD < LOD < LOD 1406 
 01-02 * < LOD < LOD < LOD < LOD 1559 
 03-04 * < LOD < LOD < LOD < LOD 1543 
 05-06 * < LOD < LOD < LOD < LOD 1520 
 07-08 * < LOD < LOD < LOD < LOD 1857 
 09-10 * < LOD < LOD < LOD < LOD 2019 
Gender        
Males 99-00 * < LOD < LOD < LOD < LOD 1227 
 01-02 * < LOD < LOD < LOD .281 (<LOD-.333) 1334 
 03-04 * < LOD < LOD < LOD < LOD 1281 
 05-06 * < LOD < LOD < LOD < LOD 1271 
 07-08 * < LOD < LOD < LOD < LOD 1327 
 09-10 * < LOD < LOD < LOD < LOD 1398 
Females 99-00 * < LOD < LOD < LOD < LOD 1238 
 01-02 * < LOD < LOD < LOD < LOD 1355 
 03-04 * < LOD < LOD < LOD < LOD 1277 
 05-06 * < LOD < LOD < LOD < LOD 1305 
 07-08 * < LOD < LOD < LOD < LOD 1300 
 09-10 * < LOD < LOD < LOD < LOD 1450 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result.  
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Urinary Beryllium (creatinine corrected) (1999 – 2010) ‡ 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 * < LOD < LOD < LOD < LOD 884 
 01-02 * < LOD < LOD < LOD .346 (<LOD-.391) 682 
 03-04 * < LOD < LOD < LOD < LOD 618 
 05-06 * < LOD < LOD < LOD < LOD 652 
 07-08 * < LOD < LOD < LOD < LOD 515 
 09-10 * < LOD < LOD < LOD < LOD 613 
Non-Hispanic blacks 99-00 * < LOD < LOD < LOD < LOD 568 
 01-02 * < LOD < LOD < LOD < LOD 667 
 03-04 * < LOD < LOD < LOD < LOD 723 
 05-06 * < LOD < LOD < LOD < LOD 692 
 07-08 * < LOD < LOD < LOD < LOD 589 
 09-10 * < LOD < LOD < LOD < LOD 544 
Non-Hispanic whites 99-00 * < LOD < LOD < LOD < LOD 822 
 01-02 * < LOD < LOD < LOD < LOD 1132 
 03-04 * < LOD < LOD < LOD < LOD 1074 
 05-06 * < LOD < LOD < LOD < LOD 1041 
 07-08 * < LOD < LOD < LOD < LOD 1095 
 09-10 * < LOD < LOD < LOD < LOD 1225 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result.  
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Blood Cadmium (1999 – 2010) 
 
Geometric mean and selected percentiles of blood concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 .412 (.378-.449) .400 (.300-.400) .600 (.500-.700) 1.00 (1.00-1.10) 1.40 (1.30-1.40) 7970 
 01-02 * .300 (.300-.400) .500 (.500-.600) 1.00 (.900-1.10) 1.40 (1.20-1.70) 8945 
 03-04 .304 (.289-.320) .300 (.300-.300) .500 (.500-.600) 1.10 (1.00-1.20) 1.60 (1.50-1.60) 8372 
 05-06 .310 (.294-.327) .270 (.250-.280) .510 (.460-.560) 1.02 (.910-1.13) 1.53 (1.34-1.75) 8407 
 07-08 .315 (.300-.331) .270 (.260-.280) .500 (.460-.560) 1.00 (.900-1.13) 1.52 (1.30-1.77) 8266 
 09-10 .302 (.293-.311) .260 (.250-.270) .480 (.460-.510) .960 (.880-1.01) 1.40 (1.29-1.53) 8793 
Age group        
1-5 years 99-00 * < LOD .300 (<LOD-.400) .400 (.300-.400) .400 (.300-.700) 723 
 01-02 * < LOD < LOD < LOD .300 (.300-.300) 898 
 03-04 * < LOD < LOD .200 (.200-.300) .200 (.200-.400) 910 
 05-06 * < LOD < LOD < LOD .230 (.210-.250) 968 
 07-08 * < LOD < LOD .210 (<LOD-.230) .240 (.220-.260) 817 
 09-10 * < LOD < LOD .200 (<LOD-.210) .220 (.200-.240) 836 
6-11 years 99-00 * < LOD .300 (<LOD-.400) .400 (.300-.500) .500 (.400-.500) 905 
 01-02 * < LOD < LOD .300 (.300-.300) .400 (.400-.400) 1044 
 03-04 * < LOD .200 (<LOD-.200) .300 (.200-.300) .300 (.300-.300) 856 
 05-06 * < LOD < LOD .220 (.200-.240) .260 (.230-.280) 934 
 07-08 * < LOD < LOD .230 (.210-.240) .260 (.240-.280) 1011 
 09-10 * < LOD < LOD .210 (.200-.240) .240 (.220-.280) 1009 
12-19 years 99-00 .333 (.304-.366) .300 (.300-.400) .400 (.400-.500) .800 (.600-1.00) 1.10 (.900-1.20) 2135 
 01-02 * < LOD .300 (.300-.400) .500 (.400-.700) .900 (.700-1.20) 2231 
 03-04 * .200 (<LOD-.200) .300 (.300-.300) .600 (.500-.700) .900 (.800-1.10) 2081 
 05-06 * < LOD .250 (.240-.270) .520 (.410-.680) .960 (.820-1.08) 1996 
 07-08 * < LOD .260 (.240-.270) .520 (.400-.670) .900 (.730-1.19) 1074 
 09-10 * < LOD .240 (.220-.260) .340 (.310-.450) .620 (.460-.850) 1183 
20 years and older 99-00 .468 (.426-.513) .400 (.400-.500) .700 (.600-.800) 1.10 (1.00-1.20) 1.50 (1.40-1.60) 4207 
 01-02 .425 (.400-.452) .400 (.400-.400) .600 (.600-.700) 1.10 (1.00-1.30) 1.60 (1.40-1.90) 4772 
 03-04 .378 (.359-.398) .400 (.300-.400) .600 (.600-.700) 1.20 (1.20-1.30) 1.80 (1.60-1.90) 4525 
 05-06 .373 (.352-.395) .330 (.310-.350) .610 (.570-.660) 1.17 (1.06-1.26) 1.72 (1.53-1.95) 4509 
 07-08 .376 (.354-.399) .330 (.310-.350) .600 (.550-.670) 1.16 (1.02-1.30) 1.70 (1.50-1.96) 5364 
 09-10 .358 (.347-.370) .320 (.310-.330) .580 (.550-.600) 1.10 (1.00-1.18) 1.55 (1.43-1.72) 5765 
Gender        
Males 99-00 .403 (.368-.441) .400 (.300-.400) .600 (.500-.700) 1.00 (.900-1.10) 1.40 (1.30-1.50) 3913 
 01-02 * .300 (<LOD-.300) .500 (.500-.600) 1.00 (.900-1.10) 1.50 (1.20-1.80) 4339 
 03-04 .283 (.266-.300) .300 (.200-.300) .500 (.500-.500) 1.10 (1.00-1.20) 1.60 (1.50-1.60) 4131 
 05-06 * .240 (.220-.260) .470 (.420-.530) 1.02 (.910-1.12) 1.53 (1.27-1.86) 4092 
 07-08 .299 (.283-.317) .250 (.230-.260) .470 (.420-.540) 1.05 (.930-1.19) 1.60 (1.30-1.90) 4147 
 09-10 .279 (.268-.289) .230 (.220-.240) .410 (.390-.460) .920 (.830-1.00) 1.45 (1.30-1.58) 4366 
Females 99-00 .421 (.386-.460) .400 (.400-.400) .600 (.500-.700) 1.00 (1.00-1.10) 1.30 (1.20-1.40) 4057 
 01-02 .382 (.362-.403) .400 (.300-.400) .600 (.500-.600) 1.00 (.900-1.10) 1.40 (1.20-1.70) 4606 
 03-04 .326 (.309-.344) .300 (.300-.300) .600 (.500-.600) 1.10 (1.00-1.20) 1.60 (1.50-1.70) 4241 
 05-06 .329 (.311-.349) .290 (.280-.310) .530 (.480-.580) 1.02 (.870-1.18) 1.54 (1.33-1.79) 4315 
 07-08 .331 (.316-.348) .290 (.280-.310) .530 (.480-.570) .980 (.860-1.10) 1.43 (1.29-1.63) 4119 
 09-10 .326 (.314-.339) .290 (.280-.310) .520 (.490-.550) .960 (.880-1.10) 1.40 (1.20-1.53) 4427 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 05-06, 07-08, and 09-10 are 0.3, 0.3, 0.14, 0.2, 0.2, and 0.2 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Blood Cadmium (1999 – 2010) 
 
Geometric mean and selected percentiles of blood concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 .395 (.367-.424) .400 (.400-.400) .500 (.500-.600) .800 (.700-1.00) 1.20 (.900-1.30) 2742 
 01-02 * < LOD .400 (.400-.500) .600 (.500-.800) 1.00 (.700-1.30) 2268 
 03-04 .235 (.216-.255) .200 (.200-.300) .400 (.300-.400) .600 (.500-.800) 1.00 (.800-1.50) 2085 
 05-06 * .220 (.200-.240) .350 (.300-.400) .580 (.510-.680) .820 (.710-1.00) 2236 
 07-08 * .220 (.210-.230) .350 (.320-.370) .570 (.510-.660) .840 (.690-1.02) 1712 
 09-10 * .220 (.200-.230) .330 (.300-.370) .580 (.500-.670) .800 (.690-.960) 1966 
Non-Hispanic blacks 99-00 .393 (.361-.427) .400 (.300-.400) .600 (.500-.600) 1.00 (.900-1.20) 1.40 (1.20-1.60) 1842 
 01-02 * .300 (<LOD-.300) .500 (.500-.600) 1.00 (.900-1.10) 1.40 (1.20-1.70) 2219 
 03-04 .304 (.275-.337) .300 (.300-.300) .500 (.400-.600) 1.00 (.900-1.20) 1.50 (1.30-1.70) 2292 
 05-06 .307 (.290-.326) .260 (.250-.280) .490 (.440-.570) 1.03 (.880-1.21) 1.50 (1.23-1.79) 2193 
 07-08 .333 (.316-.352) .280 (.270-.300) .550 (.480-.620) 1.20 (1.01-1.36) 1.81 (1.45-2.13) 1746 
 09-10 .328 (.310-.347) .280 (.260-.290) .550 (.490-.640) 1.10 (1.00-1.20) 1.52 (1.38-1.73) 1593 
Non-Hispanic whites 99-00 .420 (.376-.470) .400 (.300-.500) .600 (.500-.700) 1.10 (1.00-1.20) 1.40 (1.30-1.50) 2716 
 01-02 * .300 (.300-.400) .600 (.500-.600) 1.00 (.900-1.20) 1.50 (1.30-1.80) 3806 
 03-04 .313 (.296-.331) .300 (.300-.300) .600 (.500-.600) 1.10 (1.00-1.20) 1.60 (1.50-1.70) 3478 
 05-06 .321 (.300-.343) .270 (.250-.300) .540 (.470-.610) 1.08 (.930-1.23) 1.64 (1.40-1.94) 3310 
 07-08 .321 (.303-.341) .270 (.260-.290) .520 (.470-.580) 1.05 (.920-1.20) 1.55 (1.30-1.80) 3461 
 09-10 .307 (.297-.318) .270 (.260-.280) .490 (.460-.540) .990 (.900-1.10) 1.50 (1.36-1.60) 3760 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 05-06, 07-08, and 09-10 are 0.3, 0.3, 0.14, 0.2, 0.2, and 0.2 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Geometric mean and selected percentiles of blood concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 .279 (.267-.292) .250 (.230-.260) .460 (.430-.490) .960 (.870-1.10) 1.50 (1.30-1.70) 7920 
 13-14 .235 (.224-.247) .210 (.200-.220) .410 (.370-.450) .840 (.730-.940) 1.22 (1.03-1.40) 5215 
Age group        
1-5 years 11-12 * < LOD < LOD .190 (.160-.200) .210 (.190-.240) 713 
 13-14 * < LOD .100 (<LOD-.100) .130 (.120-.140) .150 (.140-.170) 818 
6-11 years 11-12 * < LOD .160 (<LOD-.180) .210 (.190-.230) .240 (.220-.280) 1048 
 13-14 * < LOD .120 (.110-.130) .150 (.140-.170) .190 (.170-.200) 1075 
12-19 years 11-12 * .160 (<LOD-.170) .230 (.210-.240) .340 (.290-.470) .650 (.470-.880) 1129 
 13-14 .134 (.123-.146) .120 (.110-.130) .180 (.160-.190) .280 (.220-.460) .490 (.300-.960) 627 
20 years and older 11-12 .337 (.323-.353) .300 (.290-.320) .550 (.520-.580) 1.14 (1.01-1.28) 1.70 (1.50-1.80) 5030 
 13-14 .297 (.280-.315) .270 (.260-.290) .510 (.450-.570) .940 (.830-1.08) 1.36 (1.17-1.64) 2695 
Gender        
Males 11-12 .255 (.238-.274) .210 (.200-.230) .410 (.360-.480) .940 (.820-1.09) 1.48 (1.20-1.70) 3968 
 13-14 .206 (.192-.221) .180 (.170-.190) .330 (.300-.370) .750 (.610-.940) 1.18 (.940-1.42) 2587 
Females 11-12 .304 (.289-.320) .280 (.260-.300) .490 (.460-.510) .980 (.850-1.16) 1.53 (1.30-1.70) 3952 
 13-14 .267 (.252-.283) .250 (.240-.280) .480 (.440-.530) .890 (.790-.960) 1.29 (1.09-1.53) 2628 
Race/ethnicity        
Mexican Americans 11-12 .217 (.202-.233) .200 (.180-.220) .310 (.290-.340) .550 (.510-.600) .810 (.710-.920) 1077 
 13-14 .182 (.166-.199) .180 (.150-.200) .280 (.250-.310) .490 (.400-.620) .740 (.660-.800) 969 
Non-Hispanic blacks 11-12 .291 (.274-.309) .260 (.240-.270) .470 (.430-.520) 1.07 (.950-1.20) 1.50 (1.40-1.60) 2195 
 13-14 .252 (.225-.281) .220 (.190-.260) .480 (.390-.620) 1.03 (.930-1.17) 1.48 (1.24-1.67) 1119 
Non-Hispanic whites 11-12 .284 (.264-.305) .250 (.230-.270) .470 (.420-.520) 1.02 (.810-1.25) 1.65 (1.30-1.90) 2493 
 13-14 .242 (.227-.257) .220 (.200-.230) .430 (.380-.480) .860 (.700-1.02) 1.30 (1.03-1.65) 1848 
All Hispanics 11-12 .227 (.211-.244) .210 (.190-.230) .330 (.310-.380) .600 (.540-.660) .900 (.760-1.00) 1931 
 13-14 .186 (.170-.204) .180 (.160-.190) .290 (.250-.330) .560 (.450-.680) .800 (.740-.870) 1481 
Asians 11-12 .394 (.355-.437) .390 (.340-.450) .680 (.610-.760) 1.04 (.960-1.18) 1.40 (1.20-1.48) 1005 
 13-14 .339 (.302-.380) .330 (.300-.390) .590 (.540-.660) .900 (.740-1.11) 1.31 (.940-1.46) 510 
Limit of detection (LOD, see Data Analysis section) for Survey year 11-12 and 13-14 are 0.16 and 0.1. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Cadmium (1999 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00** .193 (.169-.220) .232 (.214-.249) .475 (.436-.519) .858 (.763-.980) 1.20 (1.06-1.34) 2257 
 01-02** .210 (.189-.235) .230 (.207-.255) .458 (.423-.482) .839 (.753-.919) 1.20 (1.07-1.28) 2690 
 03-04 .211 (.196-.226) .210 (.200-.230) .450 (.400-.500) .800 (.730-.880) 1.15 (.980-1.26) 2543 
 05-06 .191 (.170-.216) .200 (.170-.220) .400 (.360-.460) .780 (.700-.860) 1.05 (.960-1.17) 2576 
 07-08 .185 (.172-.198) .180 (.170-.200) .380 (.360-.400) .700 (.650-.770) 1.00 (.920-1.12) 2627 
 09-10 .179 (.169-.190) .180 (.170-.200) .370 (.340-.400) .690 (.630-.770) 1.03 (.910-1.13) 2848 
Age group        
6-11 years 99-00** * .078 (.061-.101) .141 (.115-.173) .219 (.178-.233) .279 (.211-.507) 310 
 01-02** .061 (<LOD-.081) .077 (.067-.092) .140 (.112-.160) .219 (.184-.262) .282 (.260-.326) 368 
 03-04 .077 (.065-.090) .080 (.060-.090) .120 (.100-.160) .180 (.160-.310) .310 (.170-.610) 287 
 05-06 .066 (.056-.078) .060 (.050-.080) .110 (.090-.130) .180 (.130-.240) .240 (.160-.290) 355 
 07-08 .064 (.058-.071) .060 (.050-.070) .110 (.090-.130) .180 (.140-.210) .230 (.180-.310) 394 
 09-10 .057 (.053-.061) .060 (.050-.060) .090 (.080-.100) .130 (.120-.160) .170 (.140-.230) 378 
12-19 years 99-00** .092 (.067-.126) .128 (.107-.148) .203 (.183-.232) .329 (.272-.372) .426 (.366-.596) 648 
 01-02** .109 (.087-.136) .135 (.114-.157) .210 (.189-.247) .327 (.289-.366) .452 (.366-.480) 762 
 03-04 .121 (.109-.134) .130 (.110-.150) .200 (.170-.210) .300 (.260-.360) .390 (.330-.490) 724 
 05-06 .099 (.090-.109) .110 (.100-.120) .170 (.150-.190) .240 (.210-.280) .310 (.250-.430) 701 
 07-08 .089 (.080-.100) .080 (.070-.110) .160 (.140-.170) .260 (.200-.300) .330 (.280-.410) 376 
 09-10 .081 (.076-.086) .080 (.070-.080) .140 (.120-.150) .220 (.180-.250) .280 (.240-.300) 451 
20 years and older 99-00** .281 (.253-.313) .306 (.261-.339) .551 (.510-.623) .980 (.836-1.13) 1.32 (1.13-1.57) 1299 
 01-02** .273 (.249-.299) .280 (.261-.308) .545 (.493-.607) .972 (.855-1.06) 1.28 (1.20-1.43) 1560 
 03-04 .260 (.238-.284) .270 (.240-.300) .530 (.470-.580) .890 (.800-.990) 1.25 (1.09-1.46) 1532 
 05-06 .241 (.213-.272) .250 (.220-.290) .490 (.440-.560) .860 (.790-.930) 1.21 (1.06-1.32) 1520 
 07-08 .232 (.215-.251) .240 (.210-.260) .450 (.410-.490) .790 (.730-.870) 1.13 (.990-1.44) 1857 
 09-10 .229 (.213-.245) .230 (.210-.260) .430 (.400-.470) .790 (.700-.910) 1.13 (1.03-1.28) 2019 
Gender        
Males 99-00** .199 (.165-.241) .227 (.193-.263) .462 (.381-.539) .892 (.748-1.15) 1.41 (.980-1.83) 1121 
 01-02** .201 (.177-.229) .223 (.191-.257) .445 (.393-.481) .875 (.741-1.03) 1.22 (1.12-1.38) 1335 
 03-04 .206 (.190-.222) .210 (.190-.230) .440 (.390-.490) .790 (.700-.870) 1.01 (.890-1.25) 1277 
 05-06 .195 (.176-.217) .210 (.190-.230) .400 (.360-.440) .800 (.730-.890) 1.17 (1.01-1.30) 1271 
 07-08 .179 (.162-.197) .180 (.160-.200) .360 (.320-.400) .670 (.540-.780) .950 (.800-1.16) 1327 
 09-10 .170 (.157-.185) .180 (.150-.200) .350 (.310-.380) .650 (.560-.700) .950 (.770-1.14) 1398 
Females 99-00** .187 (.153-.229) .239 (.220-.255) .492 (.456-.540) .818 (.705-.980) 1.10 (1.01-1.19) 1136 
 01-02** .219 (.192-.251) .234 (.202-.265) .466 (.433-.519) .817 (.733-.886) 1.17 (.918-1.36) 1355 
 03-04 .216 (.195-.238) .210 (.200-.240) .450 (.400-.530) .820 (.700-.960) 1.20 (1.02-1.37) 1266 
 05-06 .188 (.160-.221) .190 (.160-.220) .400 (.350-.480) .750 (.640-.860) .980 (.830-1.20) 1305 
 07-08 .191 (.177-.207) .190 (.170-.200) .400 (.370-.430) .740 (.660-.840) 1.09 (.940-1.38) 1300 
 09-10 .188 (.172-.206) .200 (.170-.210) .400 (.360-.440) .740 (.620-.880) 1.07 (.910-1.31) 1450 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 05-06, 07-08, and 09-10 are 0.06, 0.06, 0.06, 0.042, 0.042, and 0.042 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result.  
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Urinary Cadmium (1999 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00** .191 (.157-.233) .202 (.167-.221) .447 (.351-.551) .813 (.686-.977) 1.12 (.886-1.38) 780 
 01-02** .160 (.135-.189) .181 (.171-.198) .322 (.285-.362) .559 (.430-.733) .766 (.633-1.15) 683 
 03-04 .175 (.151-.203) .170 (.150-.210) .350 (.290-.430) .680 (.520-.820) 1.04 (.820-1.20) 614 
 05-06 .173 (.152-.196) .180 (.160-.200) .340 (.300-.380) .560 (.500-.630) .780 (.660-.900) 652 
 07-08 .159 (.139-.181) .170 (.140-.200) .320 (.290-.370) .570 (.510-.620) .710 (.630-.830) 515 
 09-10 .153 (.136-.173) .150 (.130-.170) .300 (.240-.360) .530 (.440-.680) .790 (.610-.840) 613 
Non-Hispanic blacks 99-00** .283 (.208-.387) .316 (.243-.412) .633 (.498-.806) 1.22 (.892-1.38) 1.48 (1.30-1.72) 546 
 01-02** .277 (.229-.336) .302 (.257-.354) .589 (.476-.713) 1.04 (.843-1.38) 1.51 (1.28-1.74) 667 
 03-04 .265 (.237-.295) .270 (.220-.320) .550 (.440-.640) .960 (.810-1.17) 1.52 (1.06-1.82) 717 
 05-06 .236 (.218-.254) .240 (.210-.260) .480 (.420-.530) .830 (.670-.930) 1.04 (.870-1.26) 692 
 07-08 .246 (.218-.277) .260 (.220-.300) .460 (.420-.530) .840 (.690-.980) 1.40 (.900-1.85) 589 
 09-10 .234 (.211-.260) .240 (.220-.270) .450 (.410-.540) .910 (.750-1.06) 1.42 (.990-1.74) 544 
Non-Hispanic whites 99-00** .175 (.148-.206) .220 (.194-.246) .455 (.388-.510) .848 (.714-1.01) 1.17 (.963-1.47) 760 
 01-02** .204 (.179-.231) .221 (.191-.255) .445 (.394-.479) .817 (.717-.875) 1.17 (.989-1.24) 1132 
 03-04 .209 (.192-.226) .200 (.190-.220) .440 (.390-.500) .790 (.700-.860) 1.13 (.940-1.26) 1070 
 05-06 .185 (.159-.216) .200 (.160-.230) .400 (.330-.480) .780 (.670-.920) 1.05 (.940-1.25) 1041 
 07-08 .177 (.161-.195) .170 (.150-.190) .370 (.320-.400) .690 (.620-.780) 1.00 (.880-1.13) 1095 
 09-10 .171 (.158-.186) .180 (.150-.200) .350 (.320-.390) .680 (.590-.780) 1.05 (.880-1.18) 1225 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 05-06, 07-08, and 09-10 are 0.06, 0.06, 0.06, 0.042, 0.042, and 0.042 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result 
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Urinary Cadmium (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 .155 (.143-.169) .153 (.134-.175) .310 (.281-.352) .629 (.590-.670) .874 (.806-1.08) 2504 
 13-14 .124 (.116-.133) .126 (.116-.137) .273 (.243-.302) .576 (.519-.621) .842 (.767-.945) 2664 
Age group        
6-11 years 11-12 * < LOD .070 (.056-.076) .107 (.088-.128) .148 (.118-.200) 399 
 13-14 * < LOD .050 (.044-.059) .087 (.077-.101) .113 (.098-.140) 402 
12-19 years 11-12 * .069 (<LOD-.080) .118 (.100-.152) .218 (.191-.267) .280 (.219-.339) 390 
 13-14 .064 (.055-.075) .063 (.044-.078) .116 (.092-.146) .206 (.146-.292) .292 (.184-.379) 451 
20 years and older 11-12 .194 (.178-.211) .192 (.175-.217) .375 (.336-.417) .715 (.664-.790) 1.08 (.846-1.27) 1715 
 13-14 .156 (.146-.167) .158 (.147-.170) .314 (.279-.359) .654 (.603-.726) .971 (.842-1.08) 1811 
Gender        
Males 11-12 .150 (.136-.166) .152 (.131-.170) .292 (.262-.331) .589 (.518-.675) .832 (.769-.941) 1262 
 13-14 .118 (.110-.126) .123 (.107-.135) .238 (.214-.278) .492 (.394-.617) .777 (.578-1.09) 1318 
Females 11-12 .160 (.142-.181) .153 (.123-.192) .332 (.292-.375) .669 (.607-.741) 1.07 (.798-1.31) 1242 
 13-14 .131 (.118-.145) .132 (.112-.154) .297 (.271-.331) .622 (.553-.719) .896 (.773-1.05) 1346 
Race/ethnicity        
Mexican Americans 11-12 .121 (.112-.132) .115 (.094-.139) .221 (.183-.274) .456 (.386-.547) .643 (.539-.705) 317 
 13-14 .101 (.092-.111) .096 (.079-.109) .219 (.168-.264) .424 (.331-.522) .615 (.439-.785) 453 
Non-Hispanic blacks 11-12 .193 (.172-.216) .199 (.174-.216) .366 (.304-.445) .719 (.594-.831) 1.05 (.825-1.38) 669 
 13-14 .179 (.146-.219) .182 (.136-.239) .387 (.305-.519) .772 (.625-.947) 1.14 (.885-1.37) 581 
Non-Hispanic whites 11-12 .152 (.135-.170) .148 (.123-.183) .303 (.269-.352) .615 (.524-.684) .846 (.759-1.09) 820 
 13-14 .121 (.110-.134) .124 (.106-.140) .267 (.232-.302) .552 (.486-.621) .842 (.692-.987) 985 
All Hispanics 11-12 .133 (.118-.150) .127 (.105-.153) .267 (.207-.325) .546 (.452-.609) .782 (.646-.976) 573 
 13-14 .101 (.092-.111) .096 (.079-.110) .212 (.174-.259) .424 (.340-.501) .617 (.470-.801) 701 
Asians 11-12 .218 (.190-.249) .215 (.172-.251) .453 (.405-.604) .865 (.762-1.23) 1.34 (1.02-1.75) 353 
 13-14 .171 (.146-.201) .172 (.147-.206) .417 (.304-.566) .803 (.664-1.14) 1.19 (.817-1.27) 292 
Limit of detection (LOD, see Data Analysis section) for Survey year 11-12 and 13-14 are 0.056 and 0.036. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Cadmium (creatinine corrected) (1999 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00** .181 (.157-.209) .219 (.199-.238) .423 (.391-.446) .712 (.645-.757) .941 (.826-1.07) 2257 
 01-02** .199 (.181-.218) .212 (.194-.232) .404 (.377-.440) .690 (.630-.754) .919 (.813-.998) 2689 
 03-04 .210 (.201-.219) .208 (.189-.226) .412 (.381-.438) .678 (.650-.716) .940 (.833-1.04) 2543 
 05-06 .189 (.169-.210) .180 (.160-.200) .370 (.310-.430) .650 (.590-.720) .910 (.770-1.08) 2576 
 07-08 .193 (.177-.210) .190 (.180-.210) .370 (.330-.410) .660 (.580-.740) .960 (.840-1.06) 2627 
 09-10 .191 (.184-.199) .180 (.170-.190) .370 (.340-.400) .680 (.630-.730) .910 (.840-1.00) 2848 
Age group        
6-11 years 99-00** * .085 (.063-.107) .148 (.123-.182) .210 (.171-.316) .316 (.184-.607) 310 
 01-02** .075 (<LOD-.094) .100 (.083-.112) .166 (.136-.192) .233 (.206-.281) .318 (.221-.440) 368 
 03-04 .090 (.078-.104) .091 (.075-.104) .126 (.111-.156) .200 (.147-.350) .308 (.178-.415) 287 
 05-06 .081 (.072-.092) .080 (.070-.090) .130 (.110-.140) .170 (.150-.190) .200 (.180-.240) 355 
 07-08 .084 (.076-.092) .080 (.080-.090) .120 (.110-.140) .170 (.150-.240) .260 (.180-.430) 394 
 09-10 .077 (.070-.085) .080 (.070-.090) .110 (.100-.130) .160 (.130-.220) .230 (.140-.280) 378 
12-19 years 99-00** .071 (.051-.098) .093 (.084-.106) .147 (.130-.163) .215 (.204-.240) .283 (.222-.404) 648 
 01-02** .078 (.067-.091) .091 (.085-.101) .137 (.123-.143) .191 (.175-.234) .280 (.234-.321) 762 
 03-04 .086 (.077-.096) .084 (.074-.097) .122 (.113-.135) .176 (.154-.198) .234 (.187-.274) 724 
 05-06 .076 (.071-.081) .080 (.070-.090) .120 (.110-.130) .150 (.140-.180) .210 (.160-.240) 701 
 07-08 .070 (.062-.079) .070 (.070-.080) .110 (.100-.110) .150 (.140-.160) .180 (.160-.210) 376 
 09-10 .076 (.068-.084) .080 (.070-.090) .120 (.100-.130) .160 (.140-.180) .190 (.170-.270) 451 
20 years and older 99-00** .267 (.247-.289) .288 (.261-.304) .484 (.433-.545) .769 (.727-.818) 1.07 (.927-1.17) 1299 
 01-02** .261 (.236-.289) .273 (.247-.303) .481 (.426-.518) .779 (.691-.850) .979 (.874-1.12) 1559 
 03-04 .268 (.255-.281) .270 (.247-.292) .490 (.444-.538) .767 (.688-.830) 1.02 (.909-1.14) 1532 
 05-06 .240 (.216-.267) .230 (.200-.260) .440 (.400-.500) .730 (.660-.820) 1.02 (.850-1.18) 1520 
 07-08 .247 (.227-.270) .240 (.220-.270) .430 (.390-.470) .740 (.670-.840) 1.05 (.930-1.16) 1857 
 09-10 .242 (.232-.253) .230 (.220-.250) .440 (.420-.460) .760 (.700-.820) 1.01 (.910-1.14) 2019 
Gender        
Males 99-00** .154 (.131-.182) .176 (.158-.191) .329 (.293-.382) .617 (.537-.700) .789 (.696-.929) 1121 
 01-02** .159 (.143-.177) .168 (.157-.182) .335 (.304-.364) .536 (.491-.653) .757 (.690-.856) 1334 
 03-04 .173 (.161-.187) .162 (.143-.185) .325 (.300-.352) .591 (.560-.631) .740 (.678-.795) 1277 
 05-06 .160 (.145-.177) .150 (.130-.160) .300 (.260-.340) .620 (.560-.670) .820 (.710-.990) 1271 
 07-08 .160 (.146-.175) .160 (.140-.180) .290 (.260-.330) .520 (.440-.650) .740 (.600-.960) 1327 
 09-10 .155 (.149-.161) .140 (.140-.160) .280 (.250-.300) .540 (.510-.600) .800 (.670-.900) 1398 
Females 99-00** .211 (.170-.261) .267 (.239-.308) .473 (.423-.551) .783 (.690-.917) 1.09 (.813-1.38) 1136 
 01-02** .245 (.216-.278) .263 (.228-.297) .479 (.414-.541) .792 (.687-.884) .985 (.876-1.16) 1355 
 03-04 .252 (.238-.266) .253 (.227-.288) .487 (.438-.533) .802 (.716-.906) 1.06 (.940-1.21) 1266 
 05-06 .220 (.193-.252) .220 (.180-.250) .420 (.370-.470) .690 (.590-.850) .990 (.780-1.31) 1305 
 07-08 .231 (.210-.254) .230 (.200-.270) .440 (.390-.480) .770 (.700-.860) 1.08 (.970-1.16) 1300 
 09-10 .233 (.218-.248) .240 (.220-.260) .450 (.420-.490) .770 (.680-.860) 1.09 (.910-1.19) 1450 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result.  
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Urinary Cadmium (creatinine corrected) (1999 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00** .175 (.137-.223) .181 (.144-.225) .331 (.266-.418) .622 (.441-.828) .856 (.674-1.13) 780 
 01-02** .156 (.136-.178) .170 (.150-.184) .282 (.263-.340) .501 (.388-.614) .693 (.507-.839) 682 
 03-04 .163 (.147-.181) .159 (.140-.183) .296 (.256-.311) .531 (.418-.667) .718 (.562-.950) 614 
 05-06 .162 (.146-.181) .150 (.140-.170) .280 (.220-.340) .480 (.430-.510) .570 (.520-.640) 652 
 07-08 .159 (.141-.178) .160 (.130-.180) .270 (.220-.330) .480 (.370-.620) .720 (.520-.950) 515 
 09-10 .161 (.149-.173) .150 (.130-.170) .280 (.240-.320) .510 (.410-.630) .720 (.540-.890) 613 
Non-Hispanic blacks 99-00** .183 (.140-.240) .202 (.168-.241) .414 (.343-.472) .663 (.516-.827) .873 (.722-.962) 546 
 01-02** .190 (.156-.232) .196 (.174-.225) .387 (.336-.449) .686 (.559-.850) .917 (.725-1.08) 667 
 03-04 .190 (.173-.210) .185 (.168-.207) .338 (.288-.431) .700 (.500-.818) .865 (.708-1.10) 717 
 05-06 .171 (.159-.183) .160 (.140-.180) .320 (.290-.370) .550 (.500-.580) .700 (.610-.730) 692 
 07-08 .180 (.164-.197) .170 (.160-.190) .330 (.290-.390) .600 (.470-.700) .770 (.690-.900) 589 
 09-10 .186 (.170-.203) .180 (.160-.200) .360 (.310-.430) .680 (.570-.760) .860 (.740-1.04) 544 
Non-Hispanic whites 99-00** .175 (.146-.209) .219 (.191-.250) .432 (.387-.470) .729 (.666-.783) 1.00 (.826-1.16) 760 
 01-02** .205 (.184-.229) .224 (.208-.242) .421 (.382-.470) .719 (.668-.784) .931 (.806-1.05) 1132 
 03-04 .220 (.207-.235) .221 (.197-.253) .434 (.398-.476) .687 (.647-.767) 1.00 (.830-1.08) 1070 
 05-06 .193 (.169-.221) .180 (.160-.220) .390 (.310-.480) .680 (.630-.750) .930 (.800-1.07) 1041 
 07-08 .199 (.178-.222) .200 (.180-.230) .380 (.340-.440) .700 (.630-.810) 1.03 (.880-1.13) 1095 
 09-10 .192 (.183-.201) .180 (.170-.200) .390 (.340-.420) .700 (.630-.760) .910 (.840-1.02) 1225 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result.  








Fourth National Report on Human Exposure to Environmental Chemicals, Updated Tables, January 2017 Volume One Page 245
Urinary Cadmium (creatinine corrected) (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 .176 (.165-.187) .172 (.159-.182) .346 (.313-.378) .582 (.551-.639) .907 (.772-.997) 2502 
 13-14 .144 (.136-.152) .138 (.125-.151) .288 (.263-.311) .563 (.487-.621) .800 (.712-.859) 2663 
Age group        
6-11 years 11-12 * < LOD .118 (.107-.129) .168 (.150-.211) .235 (.180-.300) 398 
 13-14 * < LOD .086 (.076-.096) .147 (.119-.167) .175 (.140-.214) 402 
12-19 years 11-12 * .071 (<LOD-.078) .118 (.103-.135) .176 (.153-.204) .250 (.176-.444) 390 
 13-14 .058 (.053-.064) .055 (.045-.068) .092 (.080-.107) .133 (.117-.176) .178 (.133-.233) 451 
20 years and older 11-12 .220 (.204-.237) .213 (.198-.230) .416 (.374-.443) .678 (.594-.772) .977 (.892-1.15) 1714 
 13-14 .182 (.173-.191) .181 (.163-.195) .335 (.306-.368) .626 (.586-.674) .868 (.750-1.00) 1810 
Gender        
Males 11-12 .140 (.127-.156) .136 (.120-.148) .244 (.213-.309) .492 (.424-.554) .713 (.583-.801) 1261 
 13-14 .118 (.108-.128) .107 (.098-.121) .218 (.195-.253) .402 (.349-.471) .613 (.519-.675) 1317 
Females 11-12 .218 (.202-.236) .222 (.200-.243) .430 (.382-.456) .707 (.594-.868) 1.08 (.904-1.22) 1241 
 13-14 .174 (.162-.186) .173 (.151-.204) .355 (.311-.382) .663 (.621-.726) .964 (.844-1.09) 1346 
Race/ethnicity        
Mexican Americans 11-12 .137 (.127-.147) .124 (.105-.144) .244 (.196-.315) .409 (.367-.506) .519 (.406-1.00) 317 
 13-14 .115 (.102-.129) .114 (.096-.128) .216 (.186-.260) .388 (.297-.502) .546 (.463-.729) 453 
Non-Hispanic blacks 11-12 .150 (.135-.166) .139 (.126-.164) .286 (.259-.307) .476 (.416-.659) .761 (.636-.857) 669 
 13-14 .136 (.114-.162) .132 (.100-.170) .281 (.218-.382) .583 (.419-.663) .691 (.616-.833) 581 
Non-Hispanic whites 11-12 .183 (.167-.202) .180 (.158-.200) .370 (.327-.416) .582 (.543-.677) .932 (.725-1.15) 818 
 13-14 .150 (.137-.163) .141 (.126-.165) .290 (.256-.322) .571 (.453-.650) .807 (.673-.957) 984 
All Hispanics 11-12 .149 (.143-.156) .144 (.132-.163) .281 (.244-.320) .471 (.400-.519) .686 (.516-.942) 573 
 13-14 .113 (.100-.127) .112 (.091-.127) .216 (.186-.263) .407 (.327-.498) .569 (.494-.683) 701 
Asians 11-12 .291 (.262-.323) .286 (.223-.342) .610 (.532-.732) 1.03 (.913-1.12) 1.36 (1.07-1.59) 353 
 13-14 .268 (.230-.313) .264 (.219-.309) .609 (.483-.676) .934 (.838-1.09) 1.23 (.910-1.74) 292 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 








Fourth National Report on Human Exposure to Environmental Chemicals, Updated Tables, January 2017 Volume One Page 246
Urinary Cesium (1999 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 4.35 (4.00-4.74) 4.90 (4.40-5.40) 7.10 (6.60-7.70) 9.60 (8.80-10.3) 11.5 (10.2-13.0) 2464 
 01-02 4.81 (4.40-5.26) 5.49 (5.12-5.90) 7.91 (7.47-8.39) 10.4 (9.56-11.4) 12.6 (11.1-13.8) 2690 
 03-04 4.67 (4.39-4.97) 5.14 (4.84-5.49) 7.68 (7.20-8.21) 10.6 (9.55-11.4) 12.7 (11.5-13.9) 2558 
 05-06 4.69 (4.41-4.98) 5.19 (4.91-5.43) 7.68 (7.21-8.09) 10.1 (9.65-10.9) 12.6 (12.0-13.4) 2576 
 07-08 4.42 (4.25-4.60) 4.90 (4.64-5.12) 7.02 (6.79-7.38) 9.46 (9.04-9.86) 11.3 (10.5-11.8) 2627 
 09-10 4.06 (3.87-4.26) 4.47 (4.22-4.66) 6.54 (6.35-6.75) 8.98 (8.25-9.68) 11.0 (10.1-11.6) 2848 
Age group        
6-11 years 99-00 4.87 (4.08-5.81) 5.70 (4.60-6.70) 7.30 (6.70-8.00) 9.00 (7.90-10.1) 9.70 (9.00-10.8) 340 
 01-02 4.87 (4.08-5.82) 5.64 (4.69-6.56) 7.96 (6.77-8.84) 9.88 (8.64-10.6) 11.1 (10.2-12.4) 368 
 03-04 5.21 (4.74-5.71) 5.50 (4.76-6.37) 8.08 (7.10-8.83) 11.5 (8.86-12.9) 12.9 (10.8-13.6) 290 
 05-06 4.74 (4.31-5.21) 5.38 (4.67-5.60) 7.00 (6.38-7.50) 9.30 (8.60-9.95) 11.2 (9.62-12.9) 355 
 07-08 4.58 (4.22-4.96) 5.10 (4.50-5.44) 6.91 (6.45-7.47) 8.25 (7.77-8.93) 9.88 (8.47-10.9) 394 
 09-10 4.21 (3.84-4.62) 4.58 (4.01-5.12) 6.68 (6.25-6.98) 8.28 (7.47-9.11) 9.56 (8.68-11.9) 378 
12-19 years 99-00 4.55 (4.09-5.05) 5.20 (4.40-5.60) 6.90 (6.10-7.80) 8.80 (8.10-9.50) 10.7 (8.90-12.5) 718 
 01-02 5.22 (4.57-5.95) 5.62 (5.16-6.12) 7.55 (7.13-8.04) 9.77 (9.12-11.1) 12.0 (10.0-15.0) 762 
 03-04 5.04 (4.59-5.54) 5.70 (5.16-6.07) 7.53 (6.91-8.37) 9.71 (8.80-10.4) 11.6 (9.92-13.2) 725 
 05-06 4.76 (4.24-5.34) 5.27 (4.80-5.74) 7.50 (6.71-8.04) 9.60 (8.52-10.5) 10.6 (9.68-11.8) 701 
 07-08 4.58 (4.10-5.13) 5.14 (4.30-5.76) 6.93 (6.33-7.37) 9.20 (7.67-9.91) 10.6 (8.91-15.1) 376 
 09-10 3.70 (3.39-4.02) 4.11 (3.54-4.70) 6.17 (5.72-6.47) 8.20 (7.16-8.79) 9.52 (8.66-10.6) 451 
20 years and older 99-00 4.26 (3.94-4.62) 4.80 (4.40-5.30) 7.10 (6.50-7.60) 9.80 (8.90-10.7) 11.7 (10.2-13.4) 1406 
 01-02 4.74 (4.32-5.20) 5.43 (5.05-5.87) 7.97 (7.43-8.52) 10.6 (9.73-11.5) 12.9 (11.2-14.2) 1560 
 03-04 4.56 (4.23-4.90) 5.03 (4.60-5.42) 7.66 (7.01-8.34) 10.7 (9.40-11.5) 12.9 (11.5-14.9) 1543 
 05-06 4.67 (4.38-4.99) 5.14 (4.84-5.44) 7.77 (7.32-8.30) 10.4 (9.72-11.5) 13.2 (12.4-13.9) 1520 
 07-08 4.38 (4.20-4.58) 4.79 (4.59-4.99) 7.12 (6.81-7.52) 9.69 (9.23-10.2) 11.4 (10.6-12.0) 1857 
 09-10 4.10 (3.88-4.34) 4.49 (4.21-4.71) 6.57 (6.33-6.84) 9.26 (8.37-10.1) 11.1 (10.3-11.9) 2019 
Gender        
Males 99-00 4.84 (4.35-5.38) 5.50 (4.60-6.00) 7.50 (7.00-8.20) 9.70 (8.80-11.3) 11.7 (10.3-13.0) 1226 
 01-02 5.34 (4.89-5.84) 6.13 (5.61-6.64) 8.27 (7.84-9.08) 10.8 (10.1-12.1) 12.8 (11.3-15.0) 1335 
 03-04 5.03 (4.73-5.36) 5.59 (5.17-6.00) 7.98 (7.31-8.63) 11.0 (9.53-11.8) 12.9 (11.5-16.1) 1281 
 05-06 5.13 (4.78-5.51) 5.37 (5.03-5.71) 7.92 (7.61-8.41) 10.9 (9.96-11.6) 13.2 (12.4-13.9) 1271 
 07-08 4.77 (4.59-4.96) 5.26 (4.98-5.43) 7.18 (6.93-7.54) 9.68 (8.93-10.6) 11.6 (10.6-12.6) 1327 
 09-10 4.27 (4.00-4.55) 4.70 (4.46-5.00) 6.57 (6.39-6.81) 8.67 (7.91-9.57) 10.7 (9.66-11.3) 1398 
Females 99-00 3.95 (3.63-4.29) 4.50 (4.20-4.90) 6.70 (6.20-7.30) 9.10 (8.30-10.0) 11.2 (9.90-12.9) 1238 
 01-02 4.36 (3.95-4.81) 4.87 (4.45-5.25) 7.33 (6.71-8.01) 9.77 (9.07-11.0) 12.4 (10.4-13.8) 1355 
 03-04 4.35 (4.03-4.70) 4.79 (4.25-5.26) 7.30 (6.87-7.81) 10.2 (9.40-11.0) 12.1 (11.2-13.6) 1277 
 05-06 4.30 (3.98-4.65) 4.89 (4.58-5.25) 7.43 (6.99-7.83) 9.79 (9.30-10.5) 12.1 (10.6-13.1) 1305 
 07-08 4.12 (3.88-4.37) 4.40 (4.17-4.74) 6.84 (6.32-7.36) 9.31 (8.69-9.76) 10.5 (9.93-11.7) 1300 
 09-10 3.88 (3.63-4.14) 4.13 (3.83-4.55) 6.46 (5.95-6.90) 9.29 (8.62-10.0) 11.2 (10.3-12.1) 1450 
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Urinary Cesium (1999 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 4.32 (3.82-4.89) 4.80 (4.30-5.20) 6.70 (6.40-7.20) 9.10 (8.00-9.90) 11.1 (9.60-12.7) 884 
 01-02 4.63 (4.10-5.24) 5.29 (4.59-5.89) 7.08 (6.42-7.99) 9.13 (7.86-11.3) 11.3 (8.81-14.9) 683 
 03-04 4.94 (4.64-5.27) 5.62 (5.01-6.09) 7.86 (7.15-8.46) 10.3 (8.99-11.3) 11.9 (10.7-14.7) 618 
 05-06 4.64 (4.41-4.88) 5.18 (4.91-5.55) 7.29 (6.74-7.73) 9.52 (8.76-9.98) 11.5 (9.88-11.9) 652 
 07-08 4.50 (4.06-4.99) 4.93 (4.40-5.56) 6.98 (6.38-7.49) 9.12 (8.25-9.82) 10.8 (9.45-12.1) 515 
 09-10 4.20 (3.95-4.48) 4.47 (4.16-4.87) 6.49 (6.00-7.01) 8.64 (7.81-9.40) 10.2 (9.15-11.4) 613 
Non-Hispanic blacks 99-00 4.94 (4.33-5.64) 5.40 (4.80-6.40) 7.50 (6.90-8.40) 9.80 (8.80-10.8) 11.6 (9.80-13.1) 568 
 01-02 4.93 (4.70-5.17) 5.33 (5.05-5.64) 7.36 (6.97-7.59) 9.44 (8.71-9.68) 10.7 (10.1-12.3) 667 
 03-04 4.71 (4.47-4.97) 5.12 (4.71-5.49) 7.17 (6.72-7.60) 9.13 (8.52-9.99) 10.7 (9.99-11.4) 723 
 05-06 4.78 (4.42-5.18) 5.26 (5.03-5.44) 7.20 (6.63-7.66) 9.14 (8.26-10.6) 11.0 (9.63-13.7) 692 
 07-08 4.64 (4.29-5.01) 4.90 (4.48-5.31) 6.90 (6.35-7.42) 9.39 (8.29-10.3) 11.3 (9.59-12.6) 589 
 09-10 4.07 (3.82-4.35) 4.68 (4.29-4.84) 6.56 (6.19-7.01) 8.98 (8.12-9.31) 9.97 (9.27-11.3) 544 
Non-Hispanic whites 99-00 4.25 (3.83-4.72) 4.80 (4.20-5.50) 7.20 (6.60-7.90) 9.70 (8.90-10.7) 11.8 (10.3-13.3) 821 
 01-02 4.77 (4.27-5.32) 5.49 (4.99-6.05) 7.98 (7.45-8.61) 10.4 (9.54-11.4) 12.6 (11.0-13.8) 1132 
 03-04 4.56 (4.22-4.94) 5.02 (4.59-5.42) 7.60 (7.00-8.23) 10.7 (9.26-11.8) 12.9 (11.5-14.7) 1074 
 05-06 4.64 (4.25-5.05) 5.19 (4.76-5.49) 7.77 (7.18-8.46) 10.3 (9.62-11.5) 13.1 (12.1-13.9) 1041 
 07-08 4.29 (4.07-4.53) 4.76 (4.48-5.08) 7.02 (6.67-7.49) 9.50 (8.91-9.93) 11.3 (10.3-12.2) 1095 
 09-10 3.96 (3.73-4.20) 4.38 (4.10-4.64) 6.43 (6.15-6.63) 8.62 (7.86-9.29) 10.5 (9.35-11.5) 1225 
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Urinary Cesium (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 3.82 (3.58-4.08) 4.11 (3.90-4.42) 6.31 (5.96-6.63) 8.81 (8.39-9.21) 10.5 (9.76-11.1) 2503 
 13-14 3.94 (3.76-4.12) 4.21 (3.96-4.47) 6.63 (6.36-6.85) 9.31 (8.87-9.80) 11.3 (10.4-11.8) 2664 
Age group        
6-11 years 11-12 3.91 (3.50-4.36) 4.52 (3.75-4.96) 6.71 (6.18-7.16) 8.61 (7.39-9.28) 10.2 (9.02-10.6) 399 
 13-14 4.15 (3.80-4.52) 4.63 (4.05-5.12) 7.11 (6.58-7.54) 9.58 (8.49-10.0) 10.4 (9.92-11.1) 402 
12-19 years 11-12 3.56 (3.08-4.13) 3.96 (3.45-4.56) 5.96 (5.19-6.73) 7.74 (7.17-8.99) 9.55 (7.81-10.6) 390 
 13-14 4.14 (3.72-4.61) 4.55 (4.12-5.08) 6.62 (6.09-7.29) 8.93 (8.19-9.86) 10.9 (9.40-11.8) 451 
20 years and older 11-12 3.85 (3.61-4.10) 4.11 (3.85-4.43) 6.31 (5.94-6.67) 9.08 (8.51-9.44) 10.7 (9.81-11.2) 1714 
 13-14 3.89 (3.70-4.09) 4.09 (3.85-4.36) 6.57 (6.32-6.82) 9.30 (8.67-9.90) 11.3 (10.4-12.2) 1811 
Gender        
Males 11-12 4.20 (3.94-4.47) 4.49 (4.21-4.98) 6.53 (6.15-6.95) 9.08 (8.43-9.55) 10.6 (9.80-11.1) 1261 
 13-14 4.10 (3.84-4.38) 4.47 (4.10-4.88) 6.79 (6.42-7.22) 9.30 (8.56-10.1) 11.1 (9.81-13.1) 1318 
Females 11-12 3.49 (3.16-3.85) 3.75 (3.48-3.99) 5.94 (5.38-6.55) 8.58 (7.58-9.33) 10.3 (9.44-11.2) 1242 
 13-14 3.78 (3.57-4.02) 3.98 (3.60-4.28) 6.35 (5.98-6.75) 9.31 (8.50-9.88) 11.5 (10.1-12.4) 1346 
Race/ethnicity        
Mexican Americans 11-12 3.76 (3.43-4.12) 4.12 (3.61-4.54) 5.50 (5.21-6.21) 7.77 (7.32-8.75) 9.68 (8.07-10.4) 317 
 13-14 3.99 (3.76-4.24) 4.25 (3.65-5.09) 6.53 (6.13-7.18) 9.01 (8.28-9.61) 10.2 (9.01-11.2) 453 
Non-Hispanic blacks 11-12 3.97 (3.68-4.29) 4.49 (4.10-4.88) 6.49 (5.98-6.88) 8.12 (7.56-9.21) 9.59 (8.61-11.0) 669 
 13-14 4.41 (3.97-4.89) 4.83 (4.20-5.38) 6.82 (6.20-7.30) 8.93 (8.01-9.81) 10.7 (9.34-12.2) 581 
Non-Hispanic whites 11-12 3.78 (3.50-4.07) 4.01 (3.75-4.30) 6.30 (5.85-6.85) 9.08 (8.53-9.48) 10.6 (9.88-11.1) 820 
 13-14 3.81 (3.54-4.10) 4.09 (3.70-4.47) 6.62 (6.19-7.06) 9.38 (8.56-10.2) 11.5 (10.1-13.1) 985 
All Hispanics 11-12 3.80 (3.44-4.20) 4.13 (3.65-4.62) 5.87 (5.40-6.34) 7.77 (7.16-8.73) 9.52 (8.08-10.3) 573 
 13-14 4.04 (3.79-4.30) 4.21 (3.70-4.77) 6.65 (6.29-7.17) 9.01 (8.43-9.61) 10.4 (9.30-11.6) 701 
Asians 11-12 4.22 (3.88-4.60) 4.43 (4.00-5.02) 7.42 (6.58-7.92) 10.7 (9.27-11.4) 12.4 (11.1-15.6) 352 
 13-14 3.92 (3.61-4.24) 4.10 (3.43-4.52) 6.41 (5.87-7.48) 9.81 (7.91-11.4) 11.4 (9.11-14.3) 292 
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Urinary Cesium (creatinine corrected) (1999 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 4.10 (3.96-4.25) 4.13 (3.97-4.27) 5.41 (5.21-5.70) 7.14 (6.83-7.50) 8.64 (8.00-9.30) 2464 
 01-02 4.54 (4.30-4.79) 4.44 (4.20-4.64) 6.06 (5.66-6.47) 8.18 (7.62-8.95) 10.2 (8.84-11.7) 2689 
 03-04 4.64 (4.42-4.87) 4.42 (4.21-4.74) 6.11 (5.76-6.48) 8.51 (7.99-9.15) 10.6 (9.75-11.0) 2558 
 05-06 4.62 (4.37-4.88) 4.51 (4.20-4.76) 6.19 (5.90-6.55) 8.84 (8.14-9.24) 10.8 (9.71-12.1) 2576 
 07-08 4.62 (4.42-4.82) 4.58 (4.36-4.79) 6.23 (5.96-6.61) 8.67 (7.79-9.52) 10.6 (9.78-11.2) 2627 
 09-10 4.33 (4.17-4.49) 4.28 (4.12-4.45) 6.00 (5.70-6.23) 8.06 (7.76-8.36) 9.75 (9.05-10.4) 2848 
Age group        
6-11 years 99-00 5.34 (5.03-5.67) 5.42 (5.03-6.04) 6.63 (6.18-7.13) 8.23 (7.13-9.41) 9.90 (7.88-10.1) 340 
 01-02 5.95 (5.48-6.46) 5.91 (5.43-6.53) 7.77 (7.00-8.28) 9.27 (8.35-11.9) 11.9 (9.38-12.3) 368 
 03-04 6.07 (5.63-6.53) 6.02 (5.45-6.49) 8.30 (7.16-8.99) 10.8 (9.15-11.8) 11.9 (10.3-15.8) 290 
 05-06 5.85 (5.41-6.34) 5.74 (5.21-6.41) 7.65 (6.67-9.11) 10.1 (9.38-10.8) 11.6 (10.1-14.9) 355 
 07-08 5.96 (5.53-6.43) 6.12 (5.79-6.55) 7.88 (7.33-8.53) 10.7 (8.91-12.1) 12.5 (10.9-14.1) 394 
 09-10 5.74 (5.30-6.22) 5.58 (5.15-6.12) 7.16 (6.71-7.87) 9.19 (8.13-10.4) 12.2 (8.69-14.8) 378 
12-19 years 99-00 3.43 (3.29-3.58) 3.54 (3.29-3.68) 4.35 (4.17-4.56) 5.31 (4.97-5.79) 6.67 (5.33-8.09) 718 
 01-02 3.73 (3.41-4.08) 3.55 (3.36-3.74) 4.74 (4.40-5.14) 6.10 (5.35-7.63) 8.08 (6.44-9.82) 762 
 03-04 3.60 (3.37-3.85) 3.51 (3.33-3.72) 4.53 (4.24-4.87) 6.08 (5.14-6.94) 7.27 (6.13-9.07) 725 
 05-06 3.66 (3.40-3.93) 3.59 (3.40-3.83) 4.76 (4.30-5.20) 5.93 (5.62-6.62) 7.62 (6.03-8.07) 701 
 07-08 3.58 (3.31-3.88) 3.70 (3.22-3.96) 4.98 (4.60-5.17) 6.36 (5.38-7.28) 7.93 (6.06-9.76) 376 
 09-10 3.46 (3.27-3.65) 3.48 (3.23-3.74) 4.39 (4.16-4.70) 5.54 (5.01-6.32) 6.56 (5.95-7.35) 451 
20 years and older 99-00 4.08 (3.88-4.29) 4.06 (3.85-4.29) 5.39 (5.04-5.85) 7.17 (6.84-7.58) 8.61 (7.91-9.30) 1406 
 01-02 4.54 (4.30-4.78) 4.43 (4.20-4.59) 5.94 (5.64-6.40) 8.15 (7.46-8.97) 10.2 (8.74-11.7) 1559 
 03-04 4.68 (4.46-4.91) 4.47 (4.27-4.80) 6.11 (5.83-6.43) 8.47 (7.76-9.17) 10.5 (9.68-11.2) 1543 
 05-06 4.67 (4.42-4.93) 4.54 (4.25-4.78) 6.24 (5.93-6.66) 8.92 (8.29-9.31) 11.2 (9.71-12.7) 1520 
 07-08 4.67 (4.46-4.88) 4.58 (4.34-4.82) 6.19 (5.93-6.61) 8.65 (7.79-9.52) 10.6 (9.68-11.3) 1857 
 09-10 4.34 (4.17-4.53) 4.28 (4.10-4.49) 6.07 (5.70-6.33) 8.20 (7.81-8.65) 9.80 (9.05-11.1) 2019 
Gender        
Males 99-00 3.78 (3.65-3.91) 3.78 (3.61-3.96) 4.96 (4.72-5.20) 6.50 (6.18-6.70) 7.71 (7.01-8.64) 1226 
 01-02 4.22 (3.96-4.51) 4.10 (3.87-4.41) 5.60 (5.27-6.03) 7.67 (6.90-8.48) 9.46 (8.22-11.5) 1334 
 03-04 4.24 (3.99-4.50) 4.12 (3.89-4.37) 5.66 (5.19-6.06) 7.66 (6.90-8.40) 9.00 (8.36-10.3) 1281 
 05-06 4.21 (3.94-4.50) 4.11 (3.72-4.46) 5.75 (5.14-6.11) 7.68 (6.91-8.78) 9.33 (8.84-9.84) 1271 
 07-08 4.27 (4.04-4.51) 4.19 (4.02-4.42) 5.81 (5.46-6.29) 7.84 (7.20-8.65) 9.61 (8.65-10.2) 1327 
 09-10 3.89 (3.70-4.09) 3.85 (3.60-4.06) 5.29 (4.89-5.69) 7.02 (6.76-7.42) 8.38 (7.87-9.18) 1398 
Females 99-00 4.43 (4.20-4.68) 4.45 (4.14-4.77) 5.92 (5.36-6.47) 7.70 (7.16-8.07) 9.41 (8.00-10.4) 1238 
 01-02 4.86 (4.58-5.16) 4.72 (4.50-5.06) 6.54 (5.93-7.00) 8.50 (7.84-9.79) 10.3 (8.95-12.2) 1355 
 03-04 5.05 (4.77-5.35) 4.77 (4.44-5.14) 6.58 (6.14-7.22) 9.43 (8.56-10.5) 11.3 (10.7-12.3) 1277 
 05-06 5.05 (4.78-5.33) 4.86 (4.57-5.17) 6.72 (6.31-7.23) 9.65 (9.23-10.3) 12.6 (11.0-13.3) 1305 
 07-08 4.98 (4.76-5.20) 4.90 (4.69-5.20) 6.72 (6.20-7.06) 9.50 (8.37-10.5) 11.3 (10.7-12.1) 1300 
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Urinary Cesium (creatinine corrected) (1999 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 3.99 (3.73-4.25) 3.95 (3.65-4.17) 5.09 (4.79-5.39) 6.65 (6.08-7.10) 7.98 (7.20-8.95) 884 
 01-02 4.51 (4.00-5.08) 4.51 (3.82-4.95) 5.91 (5.31-6.64) 7.77 (6.60-10.0) 10.0 (7.60-20.5) 682 
 03-04 4.58 (4.16-5.05) 4.51 (4.10-4.92) 5.74 (5.42-6.09) 7.53 (6.59-8.91) 9.44 (8.24-10.6) 618 
 05-06 4.36 (4.10-4.64) 4.40 (3.97-4.73) 5.69 (5.24-6.22) 7.23 (6.69-7.80) 8.14 (7.65-9.33) 652 
 07-08 4.50 (4.22-4.79) 4.39 (3.96-4.86) 6.07 (5.57-6.59) 7.63 (7.30-7.89) 9.06 (7.89-10.5) 515 
 09-10 4.41 (4.17-4.65) 4.38 (4.04-4.59) 5.70 (5.34-6.07) 7.68 (7.17-8.24) 8.89 (8.50-9.52) 613 
Non-Hispanic blacks 99-00 3.21 (2.90-3.56) 3.26 (3.05-3.44) 4.30 (4.00-4.55) 5.50 (5.00-5.98) 6.33 (5.91-7.04) 568 
 01-02 3.38 (3.19-3.57) 3.35 (3.05-3.60) 4.41 (4.15-4.78) 5.87 (5.63-6.29) 6.75 (6.41-7.03) 667 
 03-04 3.38 (3.21-3.56) 3.30 (3.08-3.50) 4.31 (4.02-4.62) 5.79 (5.12-6.47) 6.98 (6.38-7.18) 723 
 05-06 3.47 (3.34-3.60) 3.40 (3.21-3.60) 4.47 (4.25-4.68) 5.94 (5.52-6.31) 6.95 (6.20-7.51) 692 
 07-08 3.39 (3.21-3.58) 3.33 (3.18-3.54) 4.50 (4.21-4.78) 5.84 (5.41-6.18) 6.87 (5.94-7.58) 589 
 09-10 3.23 (3.05-3.42) 3.20 (2.99-3.46) 4.31 (4.12-4.59) 5.88 (5.30-6.28) 6.69 (6.32-7.89) 544 
Non-Hispanic whites 99-00 4.26 (4.07-4.47) 4.28 (4.05-4.50) 5.66 (5.26-6.05) 7.27 (6.84-7.83) 8.75 (7.93-9.38) 821 
 01-02 4.81 (4.55-5.08) 4.63 (4.42-4.96) 6.33 (5.91-6.68) 8.46 (7.84-9.39) 10.3 (9.04-11.8) 1132 
 03-04 4.81 (4.52-5.12) 4.56 (4.31-4.98) 6.28 (5.95-6.71) 8.63 (7.99-9.28) 10.6 (9.43-11.0) 1074 
 05-06 4.82 (4.50-5.17) 4.68 (4.32-5.04) 6.41 (6.00-6.81) 9.18 (8.67-9.53) 11.0 (9.71-12.7) 1041 
 07-08 4.81 (4.54-5.09) 4.73 (4.42-5.12) 6.43 (6.01-6.80) 9.24 (8.20-9.82) 11.0 (10.2-11.7) 1095 
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Urinary Cesium (creatinine corrected) (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 4.33 (4.13-4.53) 4.27 (4.08-4.50) 5.91 (5.63-6.33) 8.12 (7.43-8.63) 10.2 (8.93-10.7) 2501 
 13-14 4.55 (4.40-4.70) 4.42 (4.24-4.64) 6.37 (6.16-6.58) 8.61 (8.32-8.86) 10.3 (9.67-10.9) 2663 
Age group        
6-11 years 11-12 5.56 (5.16-5.99) 5.47 (5.06-5.98) 7.15 (6.68-7.43) 9.42 (7.88-10.7) 10.7 (9.45-13.0) 398 
 13-14 6.18 (5.90-6.48) 6.25 (5.82-6.83) 8.07 (7.58-8.75) 9.96 (9.24-11.1) 11.6 (9.88-13.4) 402 
12-19 years 11-12 3.41 (3.16-3.67) 3.35 (3.05-3.82) 4.34 (3.95-4.93) 5.30 (5.07-6.17) 6.34 (5.66-6.64) 390 
 13-14 3.75 (3.49-4.03) 3.69 (3.45-3.95) 4.79 (4.36-5.37) 6.79 (5.47-7.52) 7.52 (6.17-9.30) 451 
20 years and older 11-12 4.36 (4.15-4.59) 4.29 (4.10-4.54) 6.00 (5.65-6.45) 8.22 (7.64-8.78) 10.2 (9.47-11.2) 1713 
 13-14 4.53 (4.38-4.69) 4.40 (4.18-4.67) 6.29 (6.15-6.50) 8.61 (8.30-8.86) 10.3 (9.81-10.8) 1810 
Gender        
Males 11-12 3.93 (3.73-4.14) 3.80 (3.63-4.10) 5.31 (4.87-5.91) 7.58 (6.78-8.26) 8.80 (8.28-10.2) 1260 
 13-14 4.10 (3.92-4.29) 4.04 (3.79-4.29) 5.39 (5.10-5.77) 7.55 (6.83-8.11) 8.92 (8.18-10.1) 1317 
Females 11-12 4.74 (4.52-4.97) 4.73 (4.55-4.93) 6.43 (5.91-6.82) 8.55 (8.05-9.48) 11.2 (9.48-12.5) 1241 
 13-14 5.02 (4.86-5.19) 5.00 (4.71-5.23) 7.08 (6.80-7.39) 9.51 (8.67-10.1) 11.3 (10.5-12.3) 1346 
Race/ethnicity        
Mexican Americans 11-12 4.23 (3.96-4.51) 4.14 (3.72-4.53) 5.63 (5.11-5.91) 7.06 (6.41-8.03) 8.78 (7.48-10.3) 317 
 13-14 4.56 (4.37-4.74) 4.40 (4.16-4.78) 6.02 (5.61-6.35) 7.58 (6.91-7.94) 8.92 (7.94-10.0) 453 
Non-Hispanic blacks 11-12 3.09 (2.92-3.27) 3.12 (2.89-3.32) 4.13 (3.90-4.40) 5.31 (4.98-5.63) 6.29 (5.67-6.84) 669 
 13-14 3.35 (3.20-3.52) 3.34 (3.14-3.54) 4.37 (4.14-4.63) 5.82 (5.37-6.27) 7.18 (6.25-7.86) 581 
Non-Hispanic whites 11-12 4.56 (4.29-4.85) 4.50 (4.19-4.80) 6.34 (5.74-6.88) 8.26 (7.86-9.36) 10.3 (9.27-11.5) 818 
 13-14 4.70 (4.56-4.85) 4.56 (4.30-4.84) 6.63 (6.40-6.95) 8.91 (8.37-9.67) 10.5 (9.98-11.3) 984 
All Hispanics 11-12 4.25 (4.00-4.52) 4.25 (3.88-4.49) 5.69 (5.35-5.91) 7.43 (6.61-8.23) 8.67 (8.12-9.70) 573 
 13-14 4.51 (4.34-4.69) 4.43 (4.25-4.64) 5.89 (5.61-6.21) 7.71 (7.12-8.15) 8.93 (8.29-9.52) 701 
Asians 11-12 5.65 (5.13-6.22) 5.40 (5.12-5.95) 7.88 (6.84-9.33) 12.0 (10.1-13.7) 14.7 (12.2-19.4) 352 
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Urinary Cobalt (1999 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 .375 (.336-.419) .410 (.370-.450) .630 (.570-.680) .950 (.890-1.03) 1.32 (1.16-1.48) 2465 
 01-02 .379 (.355-.404) .410 (.380-.430) .610 (.570-.660) .940 (.870-1.00) 1.28 (1.15-1.44) 2690 
 03-04 .316 (.291-.343) .330 (.300-.350) .520 (.490-.550) .820 (.750-.890) 1.16 (1.08-1.26) 2558 
 05-06 .374 (.357-.392) .390 (.370-.410) .600 (.560-.630) .880 (.840-.950) 1.33 (1.17-1.47) 2576 
 07-08 .369 (.351-.389) .380 (.360-.390) .580 (.550-.600) .920 (.840-1.01) 1.32 (1.10-1.43) 2627 
 09-10 .369 (.341-.398) .380 (.350-.400) .600 (.560-.650) .960 (.870-1.06) 1.40 (1.20-1.58) 2848 
Age group        
6-11 years 99-00 .499 (.427-.583) .530 (.450-.640) .750 (.610-.900) 1.03 (.880-1.12) 1.22 (1.03-1.50) 340 
 01-02 .452 (.377-.543) .520 (.430-.610) .710 (.670-.810) 1.07 (.940-1.21) 1.32 (1.17-1.53) 368 
 03-04 .454 (.393-.523) .460 (.410-.520) .750 (.590-.900) 1.24 (.910-1.47) 1.68 (1.26-1.81) 290 
 05-06 .424 (.383-.468) .450 (.410-.490) .660 (.580-.710) .870 (.830-1.04) 1.16 (.910-1.39) 355 
 07-08 .433 (.367-.509) .450 (.360-.550) .700 (.560-.810) .960 (.790-1.28) 1.40 (.880-1.82) 394 
 09-10 .424 (.379-.474) .440 (.400-.490) .670 (.610-.740) .960 (.850-1.10) 1.14 (1.01-1.69) 378 
12-19 years 99-00 .519 (.463-.581) .520 (.490-.570) .820 (.670-.890) 1.17 (1.01-1.47) 1.52 (1.26-2.56) 719 
 01-02 .515 (.469-.564) .520 (.480-.570) .750 (.690-.840) 1.24 (1.07-1.32) 1.59 (1.37-1.99) 762 
 03-04 .461 (.428-.496) .480 (.450-.520) .740 (.650-.800) 1.03 (.940-1.23) 1.60 (1.14-1.92) 725 
 05-06 .510 (.451-.577) .500 (.460-.570) .820 (.690-.980) 1.30 (1.08-1.40) 1.74 (1.39-2.08) 701 
 07-08 .529 (.478-.585) .510 (.450-.570) .820 (.690-.960) 1.36 (1.09-1.53) 1.70 (1.40-1.78) 376 
 09-10 .465 (.406-.533) .460 (.430-.530) .830 (.710-.920) 1.21 (1.05-1.51) 1.56 (1.19-2.11) 451 
20 years and older 99-00 .343 (.305-.386) .370 (.330-.420) .570 (.520-.640) .880 (.810-.980) 1.28 (1.07-1.39) 1406 
 01-02 .352 (.333-.373) .380 (.350-.410) .560 (.520-.590) .860 (.800-.930) 1.15 (1.04-1.42) 1560 
 03-04 .285 (.259-.313) .300 (.270-.330) .460 (.410-.510) .690 (.660-.730) 1.06 (.890-1.14) 1543 
 05-06 .351 (.332-.371) .370 (.350-.390) .550 (.520-.600) .810 (.760-.880) 1.30 (1.05-1.47) 1520 
 07-08 .343 (.326-.362) .350 (.340-.370) .530 (.500-.560) .830 (.750-.920) 1.20 (1.00-1.38) 1857 
 09-10 .351 (.322-.382) .350 (.330-.380) .570 (.520-.630) .890 (.800-1.02) 1.35 (1.12-1.58) 2019 
Gender        
Males 99-00 .371 (.331-.416) .410 (.370-.450) .580 (.540-.640) .820 (.740-.900) 1.01 (.900-1.12) 1227 
 01-02 .367 (.338-.399) .390 (.360-.420) .550 (.520-.600) .790 (.740-.850) 1.05 (.960-1.14) 1335 
 03-04 .294 (.270-.319) .320 (.290-.340) .480 (.440-.500) .670 (.620-.710) .870 (.790-.920) 1281 
 05-06 .369 (.354-.383) .380 (.370-.400) .540 (.510-.570) .760 (.690-.850) 1.06 (.910-1.27) 1271 
 07-08 .350 (.330-.371) .370 (.350-.390) .530 (.500-.560) .750 (.690-.820) 1.00 (.860-1.14) 1327 
 09-10 .336 (.307-.368) .360 (.330-.380) .530 (.480-.570) .750 (.690-.850) .960 (.850-1.12) 1398 
Females 99-00 .379 (.333-.431) .410 (.340-.460) .680 (.590-.790) 1.17 (.930-1.36) 1.50 (1.28-2.05) 1238 
 01-02 .390 (.364-.417) .430 (.400-.450) .670 (.620-.700) 1.06 (.980-1.16) 1.46 (1.22-1.81) 1355 
 03-04 .339 (.308-.372) .340 (.310-.370) .580 (.540-.610) 1.04 (.900-1.13) 1.47 (1.33-1.73) 1277 
 05-06 .379 (.351-.409) .410 (.370-.440) .660 (.620-.700) 1.04 (.900-1.21) 1.54 (1.30-1.93) 1305 
 07-08 .389 (.367-.411) .390 (.360-.410) .650 (.590-.690) 1.08 (.980-1.26) 1.43 (1.34-1.62) 1300 
 09-10 .403 (.364-.447) .400 (.360-.440) .700 (.640-.770) 1.19 (1.05-1.36) 1.68 (1.51-2.11) 1450 
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Urinary Cobalt (1999 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 .418 (.348-.502) .470 (.370-.530) .670 (.630-.770) 1.05 (.950-1.19) 1.47 (1.25-1.67) 884 
 01-02 .398 (.373-.424) .430 (.410-.450) .650 (.600-.710) .950 (.850-1.03) 1.20 (1.06-1.48) 683 
 03-04 .374 (.350-.398) .350 (.340-.390) .580 (.530-.620) 1.09 (.920-1.16) 1.33 (1.16-1.73) 618 
 05-06 .437 (.404-.473) .450 (.420-.500) .680 (.620-.720) 1.11 (.940-1.30) 1.58 (1.33-1.79) 652 
 07-08 .396 (.349-.450) .400 (.330-.480) .610 (.560-.710) .980 (.870-1.08) 1.26 (1.05-1.69) 515 
 09-10 .378 (.351-.407) .380 (.360-.410) .590 (.560-.640) .920 (.860-1.04) 1.24 (1.04-1.58) 613 
Non-Hispanic blacks 99-00 .434 (.405-.465) .430 (.390-.470) .680 (.620-.760) 1.17 (1.04-1.26) 1.45 (1.23-2.04) 568 
 01-02 .435 (.388-.487) .420 (.380-.460) .650 (.540-.810) 1.16 (.850-1.64) 1.75 (1.32-2.22) 667 
 03-04 .380 (.348-.414) .380 (.360-.410) .600 (.540-.680) 1.01 (.890-1.09) 1.28 (1.01-2.03) 723 
 05-06 .412 (.374-.453) .410 (.360-.440) .600 (.560-.670) .930 (.830-1.11) 1.47 (1.12-2.00) 692 
 07-08 .403 (.367-.443) .390 (.360-.420) .620 (.560-.740) 1.06 (.880-1.31) 1.57 (1.22-1.86) 589 
 09-10 .368 (.335-.403) .380 (.340-.400) .590 (.520-.650) .990 (.870-1.15) 1.47 (1.20-1.58) 544 
Non-Hispanic whites 99-00 .369 (.316-.431) .410 (.350-.460) .630 (.550-.700) .930 (.830-1.08) 1.29 (1.02-1.65) 822 
 01-02 .359 (.327-.394) .390 (.360-.430) .590 (.520-.660) .870 (.800-.950) 1.16 (1.04-1.32) 1132 
 03-04 .301 (.270-.334) .310 (.280-.340) .500 (.460-.540) .760 (.690-.850) 1.09 (.950-1.26) 1074 
 05-06 .361 (.340-.384) .380 (.360-.410) .580 (.530-.630) .860 (.800-.940) 1.30 (1.06-1.50) 1041 
 07-08 .358 (.338-.379) .370 (.350-.390) .560 (.520-.600) .900 (.780-1.00) 1.32 (1.02-1.46) 1095 
 09-10 .369 (.335-.408) .370 (.350-.400) .600 (.540-.660) .970 (.850-1.10) 1.40 (1.17-1.64) 1225 
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Urinary Cobalt (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 .326 (.309-.344) .323 (.306-.347) .543 (.510-.577) .860 (.800-.979) 1.27 (1.09-1.45) 2504 
 13-14 .391 (.373-.411) .408 (.382-.435) .687 (.662-.713) 1.04 (.976-1.09) 1.35 (1.23-1.48) 2664 
Age group        
6-11 years 11-12 .397 (.356-.442) .452 (.361-.510) .704 (.616-.772) 1.00 (.846-1.38) 1.42 (1.00-1.78) 399 
 13-14 .447 (.411-.487) .479 (.408-.522) .789 (.718-.877) 1.05 (.991-1.33) 1.55 (1.14-1.84) 402 
12-19 years 11-12 .416 (.358-.484) .429 (.341-.527) .700 (.622-.806) 1.12 (.960-1.30) 1.56 (1.16-1.96) 390 
 13-14 .549 (.462-.653) .602 (.491-.701) .936 (.783-1.05) 1.43 (1.08-1.75) 1.76 (1.49-3.07) 451 
20 years and older 11-12 .307 (.288-.327) .308 (.289-.328) .491 (.457-.534) .800 (.695-.940) 1.16 (.984-1.36) 1715 
 13-14 .367 (.349-.386) .382 (.357-.410) .647 (.614-.673) .930 (.882-1.04) 1.23 (1.17-1.34) 1811 
Gender        
Males 11-12 .317 (.299-.336) .316 (.293-.339) .496 (.452-.547) .715 (.659-.798) .963 (.858-1.03) 1262 
 13-14 .380 (.355-.407) .414 (.374-.452) .641 (.604-.684) .883 (.820-.951) 1.11 (1.04-1.26) 1318 
Females 11-12 .335 (.310-.361) .340 (.308-.382) .591 (.554-.643) 1.07 (.891-1.20) 1.49 (1.30-1.74) 1242 
 13-14 .402 (.374-.432) .398 (.366-.438) .741 (.701-.789) 1.16 (1.06-1.23) 1.50 (1.36-1.75) 1346 
Race/ethnicity        
Mexican Americans 11-12 .350 (.322-.381) .350 (.307-.377) .550 (.490-.598) .891 (.721-1.18) 1.41 (1.14-2.08) 317 
 13-14 .415 (.378-.456) .439 (.400-.482) .686 (.610-.766) .918 (.866-1.09) 1.15 (1.06-1.56) 453 
Non-Hispanic blacks 11-12 .340 (.311-.373) .333 (.304-.358) .519 (.489-.576) .909 (.790-.986) 1.44 (1.06-1.60) 669 
 13-14 .468 (.410-.535) .471 (.402-.561) .796 (.691-.877) 1.26 (1.03-1.39) 1.50 (1.35-1.67) 581 
Non-Hispanic whites 11-12 .320 (.295-.348) .320 (.296-.357) .543 (.485-.591) .858 (.750-.995) 1.20 (1.03-1.35) 820 
 13-14 .374 (.349-.401) .387 (.345-.429) .681 (.638-.723) 1.02 (.930-1.10) 1.34 (1.21-1.56) 985 
All Hispanics 11-12 .338 (.321-.357) .326 (.306-.350) .530 (.490-.583) .891 (.763-1.14) 1.41 (1.10-1.81) 573 
 13-14 .412 (.384-.442) .442 (.409-.481) .674 (.631-.731) .964 (.891-1.07) 1.20 (1.09-1.36) 701 
Asians 11-12 .317 (.282-.357) .323 (.300-.355) .519 (.445-.634) .968 (.723-1.58) 1.78 (.980-2.31) 353 
 13-14 .362 (.315-.416) .354 (.312-.434) .653 (.578-.789) 1.05 (.854-1.25) 1.57 (1.09-2.26) 292 
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Urinary Cobalt (creatinine corrected) (1999 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 .353 (.319-.391) .328 (.302-.365) .515 (.457-.581) .821 (.679-.963) 1.16 (.938-1.50) 2465 
 01-02 .358 (.333-.384) .335 (.313-.360) .523 (.487-.562) .844 (.750-.955) 1.16 (1.00-1.28) 2689 
 03-04 .314 (.303-.325) .290 (.278-.306) .455 (.434-.481) .737 (.703-.781) 1.02 (.911-1.10) 2558 
 05-06 .368 (.353-.384) .340 (.320-.360) .520 (.490-.550) .810 (.750-.920) 1.17 (.990-1.27) 2576 
 07-08 .385 (.366-.406) .360 (.350-.380) .560 (.520-.590) .870 (.760-.990) 1.22 (1.01-1.46) 2627 
 09-10 .393 (.372-.415) .370 (.350-.390) .560 (.530-.600) .890 (.830-.940) 1.29 (1.08-1.49) 2848 
Age group        
6-11 years 99-00 .547 (.467-.640) .554 (.449-.647) .774 (.626-.938) 1.00 (.833-1.49) 1.25 (.895-1.50) 340 
 01-02 .552 (.508-.599) .548 (.503-.609) .756 (.660-.829) 1.00 (.900-1.27) 1.30 (1.03-1.73) 368 
 03-04 .529 (.471-.593) .500 (.463-.543) .689 (.634-.750) 1.04 (.760-1.29) 1.29 (1.04-1.36) 290 
 05-06 .523 (.494-.554) .520 (.480-.570) .720 (.660-.760) .900 (.840-1.04) 1.27 (.980-1.45) 355 
 07-08 .564 (.501-.635) .580 (.500-.630) .760 (.660-.910) 1.12 (.830-1.46) 1.39 (1.06-1.81) 394 
 09-10 .578 (.538-.620) .570 (.530-.620) .760 (.690-.840) 1.06 (.920-1.21) 1.26 (1.06-1.58) 378 
12-19 years 99-00 .391 (.353-.433) .378 (.329-.407) .537 (.469-.595) .824 (.638-1.17) 1.44 (.821-3.54) 719 
 01-02 .368 (.343-.396) .352 (.327-.372) .534 (.471-.611) .851 (.673-.949) 1.06 (.932-1.24) 762 
 03-04 .329 (.304-.355) .316 (.277-.348) .495 (.442-.561) .738 (.630-.847) .952 (.792-1.09) 725 
 05-06 .392 (.360-.427) .360 (.330-.400) .530 (.480-.620) .810 (.720-.920) 1.02 (.870-1.48) 701 
 07-08 .414 (.382-.448) .390 (.340-.450) .610 (.520-.700) .880 (.750-1.13) 1.17 (.890-1.35) 376 
 09-10 .435 (.398-.476) .410 (.370-.470) .610 (.550-.700) .960 (.790-1.07) 1.30 (1.00-1.53) 451 
20 years and older 99-00 .328 (.297-.362) .306 (.280-.328) .471 (.428-.522) .727 (.632-.905) 1.12 (.861-1.36) 1406 
 01-02 .337 (.313-.363) .313 (.294-.337) .475 (.435-.513) .792 (.704-.955) 1.15 (.963-1.33) 1559 
 03-04 .293 (.282-.304) .271 (.257-.286) .400 (.380-.429) .691 (.616-.744) .976 (.829-1.10) 1543 
 05-06 .350 (.334-.367) .320 (.300-.340) .490 (.450-.520) .780 (.690-.940) 1.17 (.970-1.31) 1520 
 07-08 .366 (.348-.384) .340 (.330-.360) .510 (.480-.540) .830 (.720-.960) 1.19 (.980-1.47) 1857 
 09-10 .371 (.350-.394) .340 (.320-.360) .520 (.490-.550) .840 (.750-.930) 1.29 (1.02-1.52) 2019 
Gender        
Males 99-00 .290 (.259-.324) .279 (.248-.301) .402 (.365-.449) .608 (.534-.728) .838 (.667-1.10) 1227 
 01-02 .290 (.272-.310) .278 (.256-.297) .392 (.361-.425) .644 (.574-.707) .848 (.786-.929) 1334 
 03-04 .247 (.237-.259) .234 (.215-.250) .333 (.313-.352) .513 (.476-.585) .700 (.630-.753) 1281 
 05-06 .302 (.289-.317) .290 (.270-.300) .410 (.370-.440) .610 (.580-.640) .770 (.710-.850) 1271 
 07-08 .313 (.298-.329) .300 (.280-.310) .420 (.400-.440) .630 (.580-.680) .830 (.680-1.02) 1327 
 09-10 .306 (.290-.323) .290 (.280-.300) .420 (.390-.450) .630 (.570-.690) .810 (.720-.920) 1398 
Females 99-00 .426 (.378-.479) .407 (.362-.457) .606 (.550-.694) .960 (.781-1.29) 1.50 (1.11-1.83) 1238 
 01-02 .435 (.404-.468) .408 (.382-.438) .635 (.560-.708) 1.00 (.879-1.19) 1.29 (1.12-1.60) 1355 
 03-04 .393 (.378-.409) .361 (.342-.381) .554 (.513-.615) .937 (.850-1.00) 1.29 (1.10-1.33) 1277 
 05-06 .445 (.423-.468) .420 (.400-.440) .630 (.590-.700) .990 (.900-1.17) 1.34 (1.18-1.60) 1305 
 07-08 .470 (.442-.499) .450 (.430-.480) .690 (.630-.750) 1.09 (.930-1.27) 1.46 (1.26-1.69) 1300 
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Urinary Cobalt (creatinine corrected) (1999 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 .386 (.339-.439) .376 (.333-.419) .598 (.500-.669) .898 (.826-1.00) 1.23 (1.11-1.35) 884 
 01-02 .388 (.361-.417) .361 (.333-.394) .591 (.500-.662) .872 (.777-.990) 1.10 (.990-1.27) 682 
 03-04 .346 (.326-.368) .327 (.296-.349) .542 (.487-.594) .850 (.753-.963) 1.14 (.963-1.35) 618 
 05-06 .411 (.388-.436) .380 (.360-.400) .580 (.520-.650) .900 (.820-1.02) 1.19 (1.05-1.35) 652 
 07-08 .396 (.348-.450) .370 (.330-.410) .560 (.470-.690) .900 (.770-1.12) 1.17 (.990-1.54) 515 
 09-10 .396 (.367-.427) .380 (.340-.420) .590 (.530-.650) .930 (.820-1.03) 1.22 (1.04-1.30) 613 
Non-Hispanic blacks 99-00 .282 (.275-.289) .257 (.243-.279) .417 (.378-.462) .723 (.600-.785) .975 (.757-1.60) 568 
 01-02 .298 (.275-.323) .268 (.251-.296) .444 (.393-.505) .728 (.582-.917) 1.03 (.740-1.55) 667 
 03-04 .273 (.248-.300) .259 (.239-.281) .388 (.344-.461) .700 (.563-.842) .964 (.733-1.15) 723 
 05-06 .299 (.281-.318) .280 (.240-.300) .420 (.380-.460) .700 (.570-.780) .950 (.790-1.17) 692 
 07-08 .295 (.277-.314) .270 (.260-.290) .420 (.390-.450) .710 (.570-.860) 1.07 (.850-1.28) 589 
 09-10 .291 (.271-.314) .280 (.240-.310) .420 (.380-.480) .700 (.610-.750) .840 (.750-1.06) 544 
Non-Hispanic whites 99-00 .369 (.324-.421) .352 (.313-.387) .533 (.452-.611) .861 (.667-1.16) 1.25 (.895-1.57) 822 
 01-02 .362 (.331-.396) .343 (.313-.368) .523 (.479-.562) .830 (.736-.983) 1.16 (.983-1.33) 1132 
 03-04 .317 (.301-.334) .291 (.274-.309) .457 (.425-.488) .738 (.683-.804) 1.00 (.857-1.13) 1074 
 05-06 .376 (.357-.395) .350 (.330-.370) .520 (.490-.580) .810 (.710-.950) 1.18 (.950-1.43) 1041 
 07-08 .401 (.380-.423) .380 (.360-.400) .590 (.530-.630) .890 (.760-1.06) 1.27 (.980-1.55) 1095 
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Urinary Cobalt (creatinine corrected) (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 .370 (.349-.391) .347 (.330-.371) .557 (.513-.593) .880 (.768-1.03) 1.29 (1.12-1.46) 2502 
 13-14 .452 (.437-.466) .443 (.427-.454) .656 (.625-.688) .969 (.920-1.03) 1.31 (1.18-1.47) 2663 
Age group        
6-11 years 11-12 .567 (.535-.602) .571 (.526-.611) .778 (.713-.834) 1.19 (.974-1.30) 1.38 (1.10-1.67) 398 
 13-14 .667 (.614-.725) .646 (.593-.704) .914 (.853-.986) 1.26 (1.09-1.40) 1.57 (1.24-2.13) 402 
12-19 years 11-12 .398 (.349-.455) .373 (.316-.441) .585 (.454-.700) .832 (.688-1.09) 1.26 (.830-2.77) 390 
 13-14 .497 (.463-.534) .480 (.446-.525) .692 (.597-.769) .920 (.819-1.10) 1.30 (1.09-1.61) 451 
20 years and older 11-12 .349 (.330-.369) .327 (.300-.341) .508 (.467-.552) .803 (.711-.982) 1.24 (1.10-1.50) 1714 
 13-14 .428 (.412-.444) .417 (.390-.441) .607 (.580-.643) .929 (.853-.994) 1.27 (1.10-1.46) 1810 
Gender        
Males 11-12 .297 (.280-.315) .276 (.254-.294) .426 (.397-.456) .637 (.564-.750) .865 (.748-1.17) 1261 
 13-14 .379 (.362-.398) .368 (.344-.390) .529 (.493-.560) .758 (.689-.852) 1.02 (.871-1.29) 1317 
Females 11-12 .455 (.418-.496) .433 (.407-.466) .660 (.600-.729) 1.10 (.900-1.36) 1.54 (1.28-1.84) 1241 
 13-14 .534 (.515-.553) .532 (.502-.549) .774 (.733-.816) 1.12 (.991-1.27) 1.48 (1.27-1.77) 1346 
Race/ethnicity        
Mexican Americans 11-12 .394 (.357-.435) .374 (.322-.400) .576 (.531-.637) 1.02 (.877-1.24) 1.50 (.988-2.02) 317 
 13-14 .474 (.449-.500) .448 (.425-.473) .669 (.610-.721) .971 (.888-1.03) 1.28 (1.03-1.51) 453 
Non-Hispanic blacks 11-12 .265 (.248-.282) .244 (.222-.267) .401 (.342-.457) .645 (.559-.816) 1.02 (.737-1.41) 669 
 13-14 .356 (.332-.382) .337 (.315-.377) .545 (.490-.624) .841 (.754-.952) 1.08 (.930-1.22) 581 
Non-Hispanic whites 11-12 .387 (.360-.417) .365 (.336-.400) .574 (.513-.615) .860 (.749-1.09) 1.29 (1.04-1.57) 818 
 13-14 .461 (.442-.480) .447 (.430-.469) .669 (.613-.703) .987 (.912-1.13) 1.32 (1.19-1.61) 984 
All Hispanics 11-12 .379 (.351-.409) .361 (.322-.384) .572 (.520-.626) .944 (.809-1.15) 1.33 (1.13-1.91) 573 
 13-14 .460 (.444-.475) .448 (.429-.464) .663 (.619-.703) .952 (.888-1.00) 1.17 (1.03-1.35) 701 
Asians 11-12 .424 (.378-.475) .386 (.329-.457) .659 (.531-.785) 1.18 (.907-1.51) 1.61 (1.14-2.72) 353 
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Serum Copper (2011 - 2014) 
 
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 114 (111-116) 112 (109-114) 130 (127-134) 152 (145-162) 169 (161-183) 2329 
 13-14 115 (112-118) 114 (110-117) 132 (129-135) 155 (150-160) 171 (165-180) 2520 
Age group        
6-11 years 11-12 120 (117-124) 121 (115-126) 135 (130-140) 154 (141-161) 164 (154-175) 316 
 13-14 119 (114-123) 119 (114-123) 132 (127-141) 148 (143-155) 157 (148-175) 339 
12-19 years 11-12 106 (103-110) 103 (99.7-106) 120 (115-125) 143 (130-161) 169 (141-199) 366 
 13-14 106 (103-108) 104 (101-106) 120 (116-125) 141 (132-147) 164 (146-181) 418 
20 years and older 11-12 114 (111-117) 112 (109-115) 131 (127-136) 153 (145-164) 171 (162-184) 1647 
 13-14 116 (113-119) 114 (111-118) 134 (131-136) 157 (150-164) 175 (165-183) 1763 
Gender        
Males 11-12 103 (101-106) 103 (101-105) 116 (114-119) 132 (126-139) 143 (135-155) 1162 
 13-14 103 (99.8-107) 103 (101-106) 117 (113-122) 131 (125-137) 141 (134-148) 1235 
Females 11-12 124 (121-127) 123 (119-125) 142 (137-147) 165 (160-172) 187 (173-207) 1167 
 13-14 127 (124-130) 124 (122-128) 145 (142-149) 168 (162-176) 191 (175-214) 1285 
Race/ethnicity        
Mexican Americans 11-12 111 (107-116) 109 (105-115) 125 (122-131) 144 (137-152) 156 (148-164) 285 
 13-14 116 (113-120) 116 (110-119) 135 (128-142) 157 (147-164) 174 (162-182) 431 
Non-Hispanic blacks 11-12 126 (122-130) 127 (121-130) 147 (142-151) 168 (161-180) 191 (176-214) 620 
 13-14 125 (121-129) 124 (120-128) 147 (143-151) 165 (159-170) 176 (169-188) 516 
Non-Hispanic whites 11-12 113 (110-115) 111 (109-113) 128 (125-132) 150 (141-163) 169 (155-192) 780 
 13-14 113 (110-116) 111 (109-114) 130 (125-133) 150 (144-158) 168 (158-188) 975 
All Hispanics 11-12 112 (108-115) 109 (106-115) 128 (124-132) 145 (139-152) 158 (151-164) 525 
 13-14 117 (113-121) 116 (111-120) 136 (129-142) 157 (148-164) 171 (162-182) 666 
Asians 11-12 105 (102-109) 101 (96.2-107) 120 (114-125) 143 (132-151) 166 (150-198) 323 
 13-14 107 (104-111) 104 (99.8-108) 125 (116-130) 146 (132-162) 162 (145-186) 267 
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Blood Lead (1999 – 2010) 
 
Geometric mean and selected percentiles of blood concentrations (in µg/dL) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 1.66 (1.60-1.72) 1.60 (1.60-1.70) 2.50 (2.40-2.60) 3.80 (3.60-4.00) 5.00 (4.70-5.50) 7970 
 01-02 1.45 (1.39-1.51) 1.40 (1.40-1.50) 2.20 (2.10-2.30) 3.40 (3.20-3.60) 4.50 (4.20-4.70) 8945 
 03-04 1.43 (1.36-1.50) 1.40 (1.30-1.50) 2.10 (2.10-2.20) 3.20 (3.10-3.30) 4.20 (3.90-4.40) 8373 
 05-06 1.29 (1.23-1.36) 1.27 (1.20-1.34) 2.01 (1.91-2.11) 3.05 (2.86-3.22) 3.91 (3.64-4.18) 8407 
 07-08 1.27 (1.21-1.34) 1.22 (1.18-1.30) 1.90 (1.80-2.00) 2.80 (2.67-2.96) 3.70 (3.50-3.90) 8266 
 09-10 1.12 (1.08-1.16) 1.07 (1.03-1.12) 1.70 (1.62-1.77) 2.58 (2.45-2.71) 3.34 (3.14-3.57) 8793 
Age group        
1-5 years 99-00 2.23 (1.96-2.53) 2.20 (1.90-2.50) 3.40 (2.80-3.90) 4.90 (4.00-6.60) 7.00 (6.10-8.30) 723 
 01-02 1.70 (1.55-1.87) 1.60 (1.50-1.80) 2.50 (2.20-2.90) 4.20 (3.50-5.20) 5.80 (4.70-6.90) 898 
 03-04 1.77 (1.60-1.95) 1.70 (1.50-1.90) 2.50 (2.30-2.80) 3.90 (3.30-4.60) 5.10 (4.10-6.60) 911 
 05-06 1.46 (1.36-1.57) 1.43 (1.34-1.55) 2.10 (1.97-2.20) 2.98 (2.72-3.32) 3.80 (3.49-4.54) 968 
 07-08 1.51 (1.37-1.66) 1.43 (1.30-1.60) 2.20 (1.98-2.31) 3.20 (2.65-3.85) 4.10 (3.40-5.19) 817 
 09-10 1.17 (1.08-1.26) 1.15 (1.03-1.27) 1.70 (1.50-1.87) 2.39 (2.08-2.65) 3.37 (2.63-4.11) 836 
6-11 years 99-00 1.51 (1.36-1.66) 1.40 (1.30-1.60) 2.10 (1.80-2.50) 3.30 (2.80-3.80) 4.50 (3.40-6.20) 905 
 01-02 1.25 (1.14-1.36) 1.20 (1.00-1.30) 1.70 (1.60-2.00) 2.80 (2.50-3.10) 3.70 (3.00-4.70) 1044 
 03-04 1.25 (1.12-1.39) 1.20 (1.10-1.40) 1.80 (1.50-2.10) 2.60 (2.10-3.10) 3.30 (2.50-4.60) 856 
 05-06 1.02 (.948-1.10) .970 (.890-1.01) 1.40 (1.28-1.55) 2.06 (1.80-2.72) 3.00 (2.26-3.81) 934 
 07-08 .988 (.914-1.07) .960 (.880-1.07) 1.31 (1.22-1.49) 1.90 (1.70-2.11) 2.50 (2.10-2.88) 1011 
 09-10 .838 (.792-.887) .810 (.740-.840) 1.13 (1.06-1.21) 1.64 (1.45-1.84) 2.01 (1.88-2.25) 1009 
12-19 years 99-00 1.10 (1.04-1.17) 1.10 (1.00-1.20) 1.50 (1.40-1.70) 2.30 (2.10-2.40) 2.90 (2.70-3.00) 2135 
 01-02 .942 (.899-.986) .900 (.900-1.00) 1.30 (1.20-1.40) 2.00 (1.90-2.10) 2.70 (2.40-2.90) 2231 
 03-04 .946 (.878-1.02) .900 (.800-1.00) 1.30 (1.20-1.40) 1.90 (1.70-2.10) 2.60 (2.20-3.00) 2081 
 05-06 .797 (.746-.852) .740 (.690-.790) 1.08 (.990-1.20) 1.69 (1.50-1.85) 2.23 (1.98-2.46) 1996 
 07-08 .800 (.744-.859) .760 (.720-.820) 1.04 (.980-1.16) 1.50 (1.35-1.70) 1.90 (1.70-2.32) 1074 
 09-10 .680 (.636-.727) .660 (.590-.700) .910 (.840-.990) 1.29 (1.19-1.43) 1.72 (1.52-1.86) 1183 
20 years and older 99-00 1.75 (1.68-1.81) 1.70 (1.60-1.80) 2.60 (2.50-2.70) 3.90 (3.70-4.10) 5.20 (4.80-5.60) 4207 
 01-02 1.56 (1.49-1.62) 1.60 (1.50-1.60) 2.30 (2.30-2.40) 3.60 (3.40-3.70) 4.60 (4.30-5.00) 4772 
 03-04 1.52 (1.45-1.60) 1.50 (1.40-1.60) 2.30 (2.20-2.40) 3.30 (3.20-3.50) 4.30 (4.00-4.60) 4525 
 05-06 1.41 (1.34-1.48) 1.41 (1.33-1.48) 2.17 (2.04-2.31) 3.22 (3.05-3.43) 4.12 (3.82-4.38) 4509 
 07-08 1.38 (1.31-1.46) 1.34 (1.26-1.42) 2.06 (1.94-2.18) 3.00 (2.80-3.14) 3.90 (3.68-4.23) 5364 
 09-10 1.23 (1.19-1.28) 1.20 (1.14-1.25) 1.85 (1.78-1.93) 2.77 (2.60-2.93) 3.57 (3.29-3.84) 5765 
Gender        
Males 99-00 2.01 (1.93-2.09) 1.90 (1.90-2.00) 2.90 (2.80-3.00) 4.50 (4.10-4.80) 6.00 (5.50-6.50) 3913 
 01-02 1.78 (1.71-1.86) 1.80 (1.70-1.80) 2.70 (2.50-2.80) 3.90 (3.80-4.10) 5.40 (5.00-5.50) 4339 
 03-04 1.69 (1.62-1.75) 1.60 (1.50-1.70) 2.50 (2.40-2.60) 3.70 (3.40-3.90) 4.80 (4.50-5.20) 4132 
 05-06 1.52 (1.42-1.62) 1.49 (1.41-1.58) 2.30 (2.12-2.51) 3.48 (3.20-3.75) 4.36 (4.04-4.76) 4092 
 07-08 1.47 (1.39-1.56) 1.40 (1.32-1.50) 2.17 (2.00-2.30) 3.21 (3.01-3.53) 4.41 (4.10-4.88) 4147 
 09-10 1.31 (1.25-1.36) 1.26 (1.20-1.32) 1.96 (1.89-2.03) 2.93 (2.72-3.15) 3.84 (3.54-4.39) 4366 
Females 99-00 1.37 (1.32-1.43) 1.30 (1.30-1.40) 2.00 (1.90-2.10) 3.10 (2.90-3.30) 4.00 (3.80-4.20) 4057 
 01-02 1.19 (1.14-1.25) 1.20 (1.10-1.20) 1.80 (1.70-1.90) 2.60 (2.50-2.80) 3.60 (3.10-4.00) 4606 
 03-04 1.22 (1.14-1.31) 1.20 (1.10-1.30) 1.80 (1.70-2.00) 2.70 (2.50-3.00) 3.50 (3.10-3.80) 4241 
 05-06 1.11 (1.05-1.17) 1.06 (.980-1.15) 1.73 (1.61-1.84) 2.59 (2.44-2.74) 3.25 (3.12-3.44) 4315 
 07-08 1.11 (1.06-1.16) 1.09 (1.00-1.14) 1.64 (1.54-1.74) 2.41 (2.35-2.50) 3.00 (2.81-3.20) 4119 
 09-10 .966 (.929-1.01) .940 (.890-.970) 1.43 (1.36-1.53) 2.18 (2.08-2.30) 2.81 (2.63-2.93) 4427 
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Blood Lead (1999 – 2010) 
 
Geometric mean and selected percentiles of blood concentrations (in µg/dL) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 1.83 (1.75-1.91) 1.80 (1.70-1.90) 2.80 (2.60-2.90) 4.20 (3.90-4.60) 5.80 (5.10-6.60) 2742 
 01-02 1.46 (1.34-1.60) 1.50 (1.30-1.60) 2.30 (2.10-2.60) 3.60 (3.40-4.20) 5.40 (4.40-6.70) 2268 
 03-04 1.55 (1.43-1.69) 1.50 (1.40-1.60) 2.30 (2.10-2.50) 3.50 (2.90-4.20) 4.90 (3.90-6.40) 2085 
 05-06 1.29 (1.21-1.38) 1.26 (1.15-1.36) 2.00 (1.87-2.20) 3.16 (2.79-3.58) 4.22 (3.47-5.36) 2236 
 07-08 1.25 (1.15-1.36) 1.20 (1.10-1.31) 1.88 (1.70-2.06) 2.81 (2.60-3.20) 3.92 (3.20-5.00) 1712 
 09-10 1.14 (1.03-1.28) 1.04 (.940-1.18) 1.76 (1.52-1.99) 2.93 (2.63-3.30) 3.92 (3.60-4.69) 1966 
Non-Hispanic blacks 99-00 1.87 (1.75-2.00) 1.80 (1.70-2.00) 2.80 (2.60-3.00) 4.30 (4.00-4.60) 5.70 (5.20-6.10) 1842 
 01-02 1.65 (1.52-1.80) 1.60 (1.40-1.70) 2.60 (2.30-2.90) 4.20 (3.80-4.70) 5.80 (5.30-6.50) 2219 
 03-04 1.69 (1.52-1.89) 1.60 (1.40-1.80) 2.60 (2.20-3.00) 4.10 (3.50-4.70) 5.30 (4.60-6.60) 2293 
 05-06 1.39 (1.26-1.53) 1.31 (1.19-1.45) 2.16 (1.95-2.42) 3.48 (3.19-3.80) 4.65 (4.21-5.14) 2193 
 07-08 1.39 (1.30-1.48) 1.30 (1.20-1.42) 2.10 (2.00-2.20) 3.22 (3.08-3.50) 4.50 (4.00-4.80) 1746 
 09-10 1.24 (1.18-1.30) 1.19 (1.12-1.25) 1.87 (1.76-1.99) 2.90 (2.68-3.18) 3.86 (3.57-4.29) 1593 
Non-Hispanic whites 99-00 1.62 (1.55-1.69) 1.60 (1.50-1.70) 2.40 (2.30-2.50) 3.60 (3.40-3.90) 5.00 (4.40-5.70) 2716 
 01-02 1.43 (1.37-1.48) 1.40 (1.30-1.50) 2.20 (2.10-2.20) 3.20 (3.10-3.40) 4.20 (3.90-4.50) 3806 
 03-04 1.37 (1.32-1.43) 1.30 (1.30-1.40) 2.10 (2.00-2.10) 3.00 (2.80-3.20) 3.90 (3.60-4.30) 3478 
 05-06 1.28 (1.19-1.37) 1.27 (1.17-1.38) 1.97 (1.86-2.14) 2.99 (2.73-3.25) 3.82 (3.41-4.20) 3310 
 07-08 1.24 (1.16-1.33) 1.20 (1.10-1.30) 1.86 (1.72-2.00) 2.70 (2.54-2.90) 3.50 (3.20-3.89) 3461 
 09-10 1.10 (1.04-1.16) 1.07 (1.00-1.15) 1.67 (1.59-1.76) 2.49 (2.35-2.63) 3.14 (2.99-3.36) 3760 
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Blood Lead (2011 - 2014) 
 
Geometric mean and selected percentiles of blood concentrations (in µg/dL) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 .973 (.916-1.04) .930 (.880-.980) 1.52 (1.41-1.61) 2.38 (2.17-2.61) 3.16 (2.77-3.68) 7920 
 13-14 .858 (.813-.906) .830 (.780-.870) 1.32 (1.24-1.42) 2.10 (1.96-2.30) 2.81 (2.49-3.14) 5215 
Age group        
1-5 years 11-12 .970 (.877-1.07) .950 (.870-1.04) 1.34 (1.20-1.65) 2.26 (1.88-2.65) 2.91 (2.41-3.83) 713 
 13-14 .782 (.705-.869) .740 (.680-.800) 1.08 (.940-1.24) 1.58 (1.33-1.90) 2.24 (1.68-2.64) 818 
6-11 years 11-12 .681 (.623-.744) .640 (.600-.700) .930 (.820-1.05) 1.34 (1.14-1.60) 1.89 (1.36-2.94) 1048 
 13-14 .567 (.529-.607) .530 (.500-.570) .760 (.700-.820) 1.13 (1.01-1.23) 1.42 (1.21-1.83) 1075 
12-19 years 11-12 .554 (.511-.601) .530 (.490-.570) .740 (.660-.830) 1.09 (.960-1.19) 1.31 (1.16-1.65) 1129 
 13-14 .506 (.464-.551) .460 (.420-.500) .670 (.600-.750) 1.13 (.870-1.53) 1.69 (1.27-2.06) 627 
20 years and older 11-12 1.09 (1.03-1.16) 1.05 (1.00-1.12) 1.67 (1.56-1.79) 2.56 (2.33-2.77) 3.36 (2.98-3.93) 5030 
 13-14 .967 (.921-1.02) .940 (.900-.980) 1.45 (1.37-1.55) 2.26 (2.09-2.49) 3.03 (2.65-3.55) 2695 
Gender        
Males 11-12 1.13 (1.06-1.21) 1.07 (1.01-1.14) 1.74 (1.63-1.88) 2.73 (2.48-3.01) 3.68 (3.18-4.22) 3968 
 13-14 .994 (.919-1.08) .940 (.890-1.00) 1.48 (1.35-1.61) 2.41 (2.07-2.90) 3.47 (2.89-4.32) 2587 
Females 11-12 .842 (.796-.890) .820 (.780-.860) 1.30 (1.22-1.39) 1.98 (1.83-2.22) 2.59 (2.32-2.94) 3952 
 13-14 .746 (.715-.777) .730 (.700-.760) 1.19 (1.11-1.28) 1.86 (1.69-2.02) 2.33 (2.24-2.42) 2628 
Race/ethnicity        
Mexican Americans 11-12 .838 (.767-.916) .780 (.690-.880) 1.27 (1.15-1.40) 2.05 (1.81-2.36) 3.06 (2.34-3.59) 1077 
 13-14 .746 (.685-.813) .690 (.650-.750) 1.17 (1.10-1.28) 1.88 (1.61-2.04) 2.38 (2.03-2.74) 969 
Non-Hispanic blacks 11-12 .998 (.947-1.05) .910 (.850-.990) 1.53 (1.45-1.60) 2.58 (2.31-2.91) 3.72 (3.04-4.58) 2195 
 13-14 .871 (.787-.963) .830 (.720-.940) 1.39 (1.27-1.48) 2.17 (2.00-2.38) 3.03 (2.48-4.00) 1119 
Non-Hispanic whites 11-12 .993 (.914-1.08) .960 (.880-1.03) 1.56 (1.40-1.73) 2.43 (2.11-2.74) 3.14 (2.67-3.85) 2493 
 13-14 .882 (.820-.950) .870 (.800-.920) 1.34 (1.24-1.48) 2.20 (1.94-2.48) 2.97 (2.43-3.58) 1848 
All Hispanics 11-12 .855 (.793-.922) .820 (.750-.880) 1.27 (1.18-1.39) 2.00 (1.86-2.23) 2.84 (2.41-3.34) 1931 
 13-14 .742 (.695-.793) .690 (.660-.730) 1.14 (1.08-1.24) 1.80 (1.62-1.99) 2.36 (2.03-2.72) 1481 
Asians 11-12 1.15 (1.06-1.24) 1.14 (1.02-1.26) 1.70 (1.56-1.86) 2.56 (2.36-2.72) 3.28 (2.80-3.65) 1005 
 13-14 1.01 (.923-1.11) 1.02 (.900-1.19) 1.48 (1.35-1.66) 2.25 (2.06-2.39) 2.67 (2.37-2.86) 510 








Fourth National Report on Human Exposure to Environmental Chemicals, Updated Tables, January 2017 Volume One Page 262
Urinary Lead (1999 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 .766 (.708-.828) .800 (.800-.900) 1.40 (1.30-1.50) 2.20 (2.00-2.30) 2.90 (2.60-3.30) 2465 
 01-02 .677 (.637-.718) .700 (.700-.800) 1.20 (1.20-1.30) 2.00 (1.90-2.20) 2.70 (2.50-2.80) 2690 
 03-04 .636 (.595-.680) .640 (.580-.690) 1.04 (.960-1.12) 1.73 (1.52-1.86) 2.29 (2.03-2.62) 2558 
 05-06 .554 (.523-.587) .570 (.540-.600) .990 (.910-1.05) 1.58 (1.44-1.73) 2.14 (1.94-2.45) 2576 
 07-08 .493 (.467-.520) .500 (.470-.530) .850 (.790-.910) 1.38 (1.23-1.58) 1.97 (1.75-2.17) 2627 
 09-10 .458 (.441-.476) .470 (.450-.480) .790 (.750-.830) 1.24 (1.11-1.38) 1.65 (1.46-1.84) 2848 
Age group        
6-11 years 99-00 1.07 (.955-1.20) 1.10 (.900-1.30) 1.50 (1.40-1.70) 2.40 (1.80-3.10) 3.40 (2.40-5.00) 340 
 01-02 .753 (.661-.857) .800 (.600-.900) 1.20 (1.10-1.40) 2.10 (1.60-2.40) 2.60 (2.10-3.70) 368 
 03-04 .795 (.671-.941) .790 (.640-.900) 1.35 (.970-1.86) 2.27 (1.62-4.09) 3.33 (2.23-4.41) 290 
 05-06 .508 (.447-.579) .510 (.440-.560) .740 (.620-.980) 1.33 (1.00-1.86) 1.90 (1.33-2.60) 355 
 07-08 .494 (.411-.593) .520 (.410-.590) .790 (.660-.900) 1.23 (.980-1.73) 1.90 (1.51-2.18) 394 
 09-10 .443 (.399-.493) .460 (.430-.490) .710 (.630-.820) 1.09 (.880-1.33) 1.40 (1.06-1.82) 378 
12-19 years 99-00 .659 (.579-.749) .700 (.600-.800) 1.10 (.900-1.30) 1.80 (1.40-2.20) 2.20 (1.90-2.80) 719 
 01-02 .564 (.526-.605) .600 (.500-.600) 1.00 (.800-1.10) 1.60 (1.40-1.70) 2.00 (1.80-2.40) 762 
 03-04 .604 (.553-.660) .630 (.570-.680) .920 (.810-1.02) 1.32 (1.14-1.80) 1.86 (1.44-2.29) 725 
 05-06 .472 (.421-.530) .490 (.450-.540) .780 (.710-.830) 1.19 (1.10-1.45) 1.65 (1.34-1.80) 701 
 07-08 .386 (.346-.431) .380 (.350-.410) .640 (.560-.720) 1.03 (.870-1.24) 1.38 (1.09-1.91) 376 
 09-10 .320 (.283-.361) .320 (.270-.370) .530 (.460-.630) .830 (.710-1.10) 1.16 (.860-1.37) 451 
20 years and older 99-00 .752 (.691-.818) .800 (.700-.900) 1.40 (1.30-1.50) 2.20 (2.00-2.40) 2.90 (2.60-3.30) 1406 
 01-02 .688 (.641-.738) .700 (.700-.800) 1.20 (1.20-1.30) 2.00 (1.90-2.30) 2.80 (2.50-2.90) 1560 
 03-04 .625 (.579-.674) .620 (.560-.700) 1.04 (.960-1.11) 1.70 (1.52-1.80) 2.21 (2.04-2.49) 1543 
 05-06 .574 (.539-.612) .600 (.560-.640) 1.02 (.970-1.13) 1.65 (1.53-1.81) 2.21 (1.99-2.57) 1520 
 07-08 .512 (.485-.540) .530 (.490-.560) .900 (.820-.950) 1.49 (1.29-1.64) 2.01 (1.78-2.33) 1857 
 09-10 .486 (.465-.507) .490 (.470-.520) .830 (.780-.880) 1.32 (1.16-1.46) 1.71 (1.52-2.03) 2019 
Gender        
Males 99-00 .923 (.822-1.04) .900 (.900-1.00) 1.60 (1.40-1.80) 2.50 (2.20-2.90) 3.40 (2.90-3.80) 1227 
 01-02 .808 (.757-.862) .800 (.800-.900) 1.40 (1.30-1.50) 2.50 (2.20-2.70) 3.20 (2.90-3.50) 1335 
 03-04 .731 (.680-.785) .730 (.680-.800) 1.17 (1.07-1.27) 2.03 (1.78-2.22) 2.66 (2.33-2.91) 1281 
 05-06 .672 (.638-.707) .690 (.620-.760) 1.16 (1.04-1.28) 1.78 (1.60-2.00) 2.45 (2.00-2.97) 1271 
 07-08 .560 (.518-.606) .570 (.530-.620) .930 (.840-1.02) 1.63 (1.36-1.97) 2.30 (1.97-3.07) 1327 
 09-10 .527 (.491-.566) .540 (.480-.580) .880 (.820-.960) 1.41 (1.25-1.58) 1.83 (1.62-2.21) 1398 
Females 99-00 .642 (.589-.701) .700 (.600-.800) 1.20 (1.10-1.30) 1.90 (1.60-2.20) 2.40 (2.10-3.00) 1238 
 01-02 .573 (.535-.613) .600 (.600-.600) 1.10 (1.00-1.10) 1.60 (1.50-1.80) 2.20 (1.90-2.40) 1355 
 03-04 .558 (.506-.616) .540 (.480-.620) .920 (.820-1.04) 1.49 (1.24-1.75) 1.82 (1.59-2.30) 1277 
 05-06 .461 (.425-.499) .460 (.430-.510) .810 (.730-.880) 1.27 (1.17-1.46) 1.86 (1.54-2.17) 1305 
 07-08 .436 (.412-.461) .430 (.400-.480) .760 (.690-.830) 1.22 (1.05-1.34) 1.67 (1.44-1.81) 1300 
 09-10 .400 (.378-.424) .420 (.390-.440) .690 (.660-.740) 1.05 (.990-1.13) 1.42 (1.26-1.59) 1450 
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Urinary Lead (1999 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 1.02 (.915-1.13) 1.10 (.900-1.20) 1.80 (1.60-1.90) 2.90 (2.50-3.40) 4.30 (3.10-5.40) 884 
 01-02 .833 (.745-.931) .900 (.700-1.00) 1.50 (1.20-1.70) 2.50 (2.00-2.90) 3.30 (2.70-3.80) 683 
 03-04 .815 (.710-.935) .840 (.700-.990) 1.31 (1.18-1.59) 2.19 (1.86-2.50) 2.66 (2.13-3.97) 618 
 05-06 .729 (.653-.815) .770 (.680-.860) 1.32 (1.15-1.59) 2.22 (1.81-2.64) 3.08 (2.50-4.03) 652 
 07-08 .607 (.528-.698) .610 (.530-.690) .990 (.890-1.21) 1.76 (1.37-2.17) 2.29 (1.82-2.80) 515 
 09-10 .546 (.483-.618) .520 (.460-.580) .930 (.800-1.09) 1.66 (1.34-1.89) 2.16 (1.80-2.87) 613 
Non-Hispanic blacks 99-00 1.11 (1.00-1.23) 1.10 (1.00-1.20) 1.90 (1.50-2.10) 3.00 (2.40-3.50) 4.20 (3.30-5.70) 568 
 01-02 .940 (.833-1.06) .900 (.800-1.00) 1.60 (1.30-1.80) 2.70 (2.10-3.40) 3.70 (2.90-4.80) 667 
 03-04 .848 (.729-.986) .850 (.710-1.00) 1.40 (1.10-1.72) 2.14 (1.78-2.64) 2.82 (2.31-3.89) 723 
 05-06 .666 (.604-.734) .660 (.590-.760) 1.09 (.980-1.18) 1.62 (1.42-1.85) 2.24 (1.65-2.90) 692 
 07-08 .618 (.558-.685) .620 (.560-.690) 1.01 (.920-1.13) 1.56 (1.38-1.90) 2.06 (1.88-2.60) 589 
 09-10 .560 (.522-.601) .550 (.490-.600) .910 (.830-1.01) 1.53 (1.26-1.71) 1.96 (1.68-2.80) 544 
Non-Hispanic whites 99-00 .695 (.625-.773) .700 (.700-.900) 1.30 (1.10-1.40) 2.00 (1.80-2.40) 2.70 (2.30-3.10) 822 
 01-02 .610 (.572-.651) .700 (.600-.700) 1.10 (1.10-1.20) 1.90 (1.70-2.00) 2.40 (2.30-2.60) 1132 
 03-04 .591 (.556-.628) .590 (.540-.650) .960 (.910-.990) 1.52 (1.40-1.75) 2.14 (1.78-2.51) 1074 
 05-06 .520 (.477-.566) .540 (.490-.580) .950 (.820-1.05) 1.53 (1.30-1.76) 2.07 (1.78-2.45) 1041 
 07-08 .452 (.422-.485) .460 (.430-.490) .780 (.700-.880) 1.23 (1.03-1.50) 1.79 (1.58-1.97) 1095 
 09-10 .431 (.406-.458) .450 (.410-.480) .750 (.690-.820) 1.11 (1.05-1.24) 1.51 (1.39-1.67) 1225 
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Urinary Lead (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 .360 (.328-.396) .370 (.340-.400) .650 (.580-.720) 1.05 (.980-1.17) 1.49 (1.26-1.75) 2504 
 13-14 .277 (.257-.298) .290 (.270-.300) .500 (.480-.530) .840 (.780-.900) 1.17 (1.01-1.41) 2664 
Age group        
6-11 years 11-12 .346 (.292-.410) .370 (.300-.440) .610 (.540-.770) 1.12 (.830-1.51) 1.54 (1.28-1.85) 399 
 13-14 .222 (.192-.258) .240 (.200-.270) .390 (.330-.450) .630 (.560-.810) .870 (.710-1.09) 402 
12-19 years 11-12 .259 (.219-.305) .260 (.220-.340) .470 (.380-.530) .720 (.540-.900) .970 (.720-1.17) 390 
 13-14 .201 (.166-.245) .220 (.190-.260) .360 (.290-.440) .550 (.450-.700) .750 (.570-.880) 451 
20 years and older 11-12 .381 (.348-.416) .390 (.360-.420) .680 (.640-.730) 1.11 (1.01-1.21) 1.58 (1.28-1.90) 1715 
 13-14 .297 (.280-.315) .300 (.290-.320) .540 (.510-.580) .900 (.820-.980) 1.27 (1.08-1.55) 1811 
Gender        
Males 11-12 .414 (.367-.466) .420 (.380-.460) .730 (.640-.800) 1.16 (.990-1.47) 1.73 (1.33-2.18) 1262 
 13-14 .315 (.295-.337) .320 (.290-.340) .580 (.520-.620) .940 (.840-1.08) 1.48 (1.15-1.92) 1318 
Females 11-12 .316 (.282-.355) .320 (.290-.360) .580 (.500-.660) .970 (.830-1.14) 1.31 (1.15-1.41) 1242 
 13-14 .245 (.222-.269) .260 (.240-.280) .460 (.430-.480) .720 (.670-.790) 1.00 (.870-1.16) 1346 
Race/ethnicity        
Mexican Americans 11-12 .372 (.320-.431) .380 (.320-.480) .670 (.550-.780) 1.17 (.820-1.58) 1.67 (1.17-2.18) 317 
 13-14 .277 (.240-.319) .290 (.250-.320) .480 (.440-.580) .890 (.690-1.15) 1.21 (.930-1.97) 453 
Non-Hispanic blacks 11-12 .431 (.385-.483) .440 (.370-.520) .730 (.660-.830) 1.15 (1.00-1.39) 1.64 (1.39-1.87) 669 
 13-14 .371 (.320-.429) .380 (.310-.440) .620 (.530-.730) 1.09 (.830-1.34) 1.45 (1.24-1.72) 581 
Non-Hispanic whites 11-12 .346 (.311-.385) .360 (.330-.390) .610 (.540-.700) 1.02 (.920-1.16) 1.38 (1.14-1.85) 820 
 13-14 .267 (.245-.290) .280 (.260-.300) .500 (.450-.540) .820 (.730-.920) 1.16 (.950-1.60) 985 
All Hispanics 11-12 .372 (.327-.423) .370 (.320-.420) .670 (.590-.750) 1.15 (.950-1.31) 1.51 (1.18-2.13) 573 
 13-14 .270 (.239-.305) .280 (.240-.320) .480 (.440-.540) .820 (.690-.930) 1.17 (.940-1.47) 701 
Asians 11-12 .383 (.341-.429) .380 (.350-.460) .690 (.620-.790) 1.15 (.950-1.32) 1.38 (1.21-1.72) 353 
 13-14 .257 (.230-.287) .290 (.240-.350) .470 (.410-.510) .710 (.560-.790) .890 (.750-.980) 292 
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Urinary Lead (creatinine corrected) (1999 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 .721 (.700-.742) .701 (.677-.725) 1.11 (1.05-1.15) 1.70 (1.62-1.85) 2.38 (2.22-2.79) 2465 
 01-02 .639 (.603-.677) .635 (.588-.676) 1.03 (.963-1.08) 1.52 (1.43-1.61) 2.03 (1.89-2.22) 2689 
 03-04 .632 (.603-.662) .622 (.594-.655) .979 (.920-1.03) 1.49 (1.33-1.64) 1.97 (1.73-2.26) 2558 
 05-06 .546 (.520-.573) .530 (.510-.560) .860 (.810-.900) 1.27 (1.15-1.37) 1.71 (1.50-1.89) 2576 
 07-08 .514 (.482-.548) .500 (.460-.530) .800 (.720-.880) 1.30 (1.23-1.42) 1.85 (1.73-1.96) 2627 
 09-10 .488 (.466-.512) .470 (.440-.500) .760 (.710-.810) 1.16 (1.08-1.28) 1.53 (1.41-1.62) 2848 
Age group        
6-11 years 99-00 1.17 (.975-1.41) 1.06 (.918-1.22) 1.55 (1.22-1.97) 2.71 (1.67-4.66) 4.66 (1.97-18.0) 340 
 01-02 .918 (.841-1.00) .870 (.800-.933) 1.27 (1.12-1.43) 2.33 (1.59-3.64) 3.64 (1.89-5.56) 368 
 03-04 .926 (.812-1.06) .914 (.781-1.03) 1.45 (1.17-1.72) 2.14 (1.62-3.47) 3.47 (2.19-5.31) 290 
 05-06 .628 (.563-.701) .590 (.530-.680) .870 (.770-.940) 1.29 (1.03-1.82) 1.96 (1.32-2.42) 355 
 07-08 .643 (.543-.763) .630 (.530-.730) 1.02 (.770-1.24) 1.50 (1.24-2.02) 2.04 (1.70-2.58) 394 
 09-10 .604 (.551-.662) .580 (.520-.650) .870 (.780-1.00) 1.32 (1.09-1.51) 1.60 (1.38-1.75) 378 
12-19 years 99-00 .496 (.460-.535) .469 (.408-.508) .709 (.655-.828) 1.11 (.981-1.28) 1.65 (1.15-2.79) 719 
 01-02 .404 (.380-.428) .375 (.342-.400) .603 (.541-.702) .990 (.882-1.18) 1.41 (1.07-1.63) 762 
 03-04 .432 (.404-.461) .404 (.383-.436) .623 (.551-.730) .938 (.828-1.06) 1.23 (1.09-1.35) 725 
 05-06 .363 (.333-.395) .340 (.310-.360) .510 (.460-.600) .800 (.690-.930) 1.07 (.940-1.23) 701 
 07-08 .302 (.270-.337) .290 (.250-.340) .430 (.400-.490) .670 (.550-.790) .900 (.700-1.09) 376 
 09-10 .299 (.273-.328) .290 (.260-.320) .420 (.370-.490) .620 (.550-.760) .880 (.740-1.01) 451 
20 years and older 99-00 .720 (.683-.758) .712 (.667-.739) 1.10 (1.02-1.18) 1.69 (1.53-1.87) 2.31 (2.15-2.62) 1406 
 01-02 .658 (.617-.703) .652 (.608-.702) 1.05 (.992-1.11) 1.51 (1.40-1.61) 2.00 (1.85-2.19) 1559 
 03-04 .641 (.606-.679) .633 (.605-.670) .988 (.917-1.04) 1.47 (1.28-1.63) 1.94 (1.72-2.12) 1543 
 05-06 .573 (.548-.600) .570 (.530-.600) .890 (.850-.960) 1.32 (1.22-1.41) 1.77 (1.53-1.94) 1520 
 07-08 .545 (.513-.579) .530 (.490-.570) .840 (.760-.910) 1.36 (1.27-1.49) 1.92 (1.78-2.08) 1857 
 09-10 .514 (.489-.539) .500 (.460-.530) .790 (.730-.840) 1.22 (1.10-1.35) 1.57 (1.46-1.71) 2019 
Gender        
Males 99-00 .720 (.679-.763) .693 (.645-.734) 1.10 (.992-1.22) 1.68 (1.50-2.09) 2.43 (2.15-3.03) 1227 
 01-02 .639 (.607-.673) .638 (.586-.686) 1.01 (.957-1.08) 1.55 (1.41-1.61) 2.06 (1.88-2.43) 1334 
 03-04 .615 (.588-.644) .593 (.561-.639) .914 (.862-.977) 1.44 (1.25-1.53) 2.00 (1.71-2.28) 1281 
 05-06 .551 (.522-.582) .530 (.510-.580) .830 (.770-.910) 1.25 (1.13-1.39) 1.77 (1.42-2.20) 1271 
 07-08 .501 (.471-.534) .490 (.450-.530) .750 (.700-.810) 1.29 (1.15-1.49) 1.88 (1.71-1.98) 1327 
 09-10 .481 (.458-.505) .450 (.430-.490) .740 (.690-.800) 1.15 (1.04-1.29) 1.56 (1.37-1.70) 1398 
Females 99-00 .722 (.681-.765) .707 (.667-.746) 1.11 (1.05-1.18) 1.74 (1.50-2.02) 2.38 (2.03-2.88) 1238 
 01-02 .639 (.594-.688) .625 (.571-.682) 1.03 (.946-1.11) 1.50 (1.39-1.61) 1.98 (1.85-2.15) 1355 
 03-04 .648 (.601-.698) .649 (.604-.718) 1.03 (.938-1.10) 1.56 (1.34-1.73) 1.96 (1.72-2.20) 1277 
 05-06 .541 (.507-.577) .530 (.500-.580) .880 (.820-.940) 1.28 (1.12-1.41) 1.64 (1.38-1.91) 1305 
 07-08 .527 (.489-.568) .500 (.470-.550) .840 (.740-.960) 1.34 (1.23-1.47) 1.79 (1.56-2.08) 1300 
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Urinary Lead (creatinine corrected) (1999 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 .940 (.876-1.01) .887 (.796-1.03) 1.43 (1.37-1.58) 2.38 (2.08-2.77) 3.46 (2.78-4.18) 884 
 01-02 .810 (.731-.898) .774 (.702-.893) 1.29 (1.09-1.44) 2.05 (1.75-2.50) 2.78 (2.56-3.33) 682 
 03-04 .755 (.681-.838) .708 (.612-.851) 1.18 (1.09-1.31) 1.86 (1.50-2.26) 2.31 (1.98-2.92) 618 
 05-06 .686 (.638-.737) .680 (.620-.740) 1.00 (.930-1.13) 1.63 (1.39-1.88) 2.20 (1.77-3.20) 652 
 07-08 .607 (.514-.717) .590 (.500-.690) .970 (.770-1.19) 1.56 (1.25-2.07) 2.20 (1.78-2.46) 515 
 09-10 .573 (.526-.623) .540 (.470-.610) .950 (.780-1.06) 1.59 (1.41-1.82) 2.02 (1.82-2.40) 613 
Non-Hispanic blacks 99-00 .722 (.659-.790) .671 (.583-.753) 1.11 (.988-1.20) 2.00 (1.56-2.51) 2.83 (2.20-3.88) 568 
 01-02 .644 (.559-.742) .608 (.510-.710) .962 (.853-1.20) 1.79 (1.36-2.33) 2.75 (2.04-3.98) 667 
 03-04 .609 (.529-.701) .569 (.492-.698) .900 (.793-1.03) 1.48 (1.11-1.97) 2.24 (1.65-2.88) 723 
 05-06 .483 (.459-.508) .470 (.440-.490) .740 (.670-.820) 1.18 (1.06-1.29) 1.60 (1.37-1.85) 692 
 07-08 .452 (.414-.492) .440 (.400-.490) .710 (.610-.780) 1.13 (.930-1.33) 1.57 (1.21-1.88) 589 
 09-10 .444 (.417-.473) .420 (.390-.470) .680 (.600-.740) 1.07 (.940-1.18) 1.51 (1.18-1.65) 544 
Non-Hispanic whites 99-00 .696 (.668-.725) .677 (.645-.718) 1.07 (.997-1.14) 1.66 (1.50-1.83) 2.31 (1.94-2.82) 822 
 01-02 .615 (.579-.654) .621 (.571-.667) 1.00 (.933-1.07) 1.46 (1.37-1.52) 1.88 (1.62-2.03) 1132 
 03-04 .623 (.592-.655) .618 (.587-.657) .971 (.914-1.03) 1.44 (1.25-1.61) 1.85 (1.64-2.10) 1074 
 05-06 .541 (.500-.585) .530 (.490-.580) .850 (.790-.920) 1.24 (1.12-1.37) 1.62 (1.37-1.94) 1041 
 07-08 .506 (.466-.550) .490 (.460-.540) .790 (.700-.880) 1.27 (1.15-1.42) 1.81 (1.59-1.96) 1095 
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Urinary Lead (creatinine corrected) (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 .409 (.380-.440) .396 (.374-.418) .634 (.583-.675) 1.00 (.878-1.16) 1.51 (1.24-1.71) 2502 
 13-14 .320 (.302-.339) .313 (.294-.331) .519 (.491-.554) .823 (.756-.907) 1.16 (1.00-1.30) 2663 
Age group        
6-11 years 11-12 .494 (.430-.567) .459 (.414-.529) .708 (.559-.930) 1.18 (.884-1.56) 1.56 (1.12-2.22) 398 
 13-14 .331 (.297-.370) .313 (.273-.370) .500 (.452-.571) .833 (.667-.938) 1.07 (.905-1.34) 402 
12-19 years 11-12 .247 (.218-.281) .224 (.206-.264) .385 (.317-.429) .541 (.440-.667) .667 (.513-1.03) 390 
 13-14 .182 (.160-.208) .169 (.142-.194) .276 (.225-.330) .457 (.339-.640) .640 (.438-.908) 451 
20 years and older 11-12 .433 (.402-.466) .414 (.389-.437) .660 (.619-.712) 1.05 (.929-1.22) 1.61 (1.28-1.87) 1714 
 13-14 .346 (.331-.363) .337 (.321-.353) .554 (.505-.592) .861 (.789-.935) 1.23 (1.04-1.46) 1810 
Gender        
Males 11-12 .388 (.346-.436) .377 (.338-.418) .590 (.524-.658) .987 (.833-1.17) 1.51 (1.16-1.89) 1261 
 13-14 .315 (.293-.339) .303 (.278-.327) .486 (.440-.541) .758 (.692-.913) 1.16 (.956-1.58) 1317 
Females 11-12 .430 (.405-.457) .416 (.385-.444) .667 (.626-.709) 1.03 (.905-1.21) 1.49 (1.21-1.71) 1241 
 13-14 .325 (.303-.348) .325 (.308-.336) .545 (.500-.580) .864 (.785-.929) 1.18 (.970-1.33) 1346 
Race/ethnicity        
Mexican Americans 11-12 .418 (.370-.471) .409 (.356-.462) .667 (.598-.716) 1.05 (.822-1.25) 1.32 (1.16-1.54) 317 
 13-14 .316 (.283-.352) .319 (.278-.336) .500 (.450-.589) .845 (.720-1.04) 1.16 (.908-1.36) 453 
Non-Hispanic blacks 11-12 .335 (.301-.374) .316 (.269-.357) .529 (.464-.598) .906 (.770-1.07) 1.34 (1.06-1.55) 669 
 13-14 .282 (.251-.317) .275 (.237-.316) .455 (.398-.515) .750 (.611-.920) .977 (.836-1.21) 581 
Non-Hispanic whites 11-12 .419 (.378-.465) .404 (.369-.439) .642 (.559-.722) .966 (.826-1.22) 1.62 (1.16-2.00) 818 
 13-14 .329 (.306-.353) .317 (.293-.344) .541 (.486-.589) .860 (.750-.933) 1.23 (.983-1.60) 984 
All Hispanics 11-12 .416 (.377-.460) .401 (.366-.442) .641 (.561-.694) 1.02 (.851-1.24) 1.40 (1.16-1.65) 573 
 13-14 .301 (.276-.328) .307 (.269-.327) .473 (.438-.508) .795 (.667-.882) 1.07 (.882-1.24) 701 
Asians 11-12 .511 (.453-.577) .512 (.440-.588) .829 (.706-.980) 1.28 (1.05-1.57) 1.61 (1.40-2.22) 353 
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Blood Manganese (2011 - 2014) 
 
Geometric mean and selected percentiles of blood concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 9.35 (9.19-9.51) 9.22 (9.04-9.40) 11.5 (11.3-11.7) 14.4 (14.2-14.6) 16.7 (16.2-17.3) 7920 
 13-14 9.52 (9.35-9.70) 9.41 (9.23-9.62) 11.8 (11.5-12.1) 14.6 (14.2-15.0) 16.7 (15.9-17.3) 5215 
Age group        
1-5 years 11-12 10.7 (10.2-11.2) 10.6 (10.1-11.2) 13.2 (12.6-13.5) 15.3 (14.5-16.8) 18.2 (15.3-19.7) 713 
 13-14 10.9 (10.6-11.1) 10.7 (10.5-11.0) 13.2 (12.6-13.6) 16.1 (14.8-16.9) 18.3 (16.9-19.0) 818 
6-11 years 11-12 10.3 (9.98-10.6) 10.2 (9.83-10.4) 12.6 (12.2-12.8) 14.9 (14.2-15.5) 16.5 (16.0-17.6) 1048 
 13-14 10.2 (9.87-10.6) 10.2 (9.95-10.6) 12.4 (12.0-13.0) 14.8 (14.2-15.6) 16.4 (15.5-17.1) 1075 
12-19 years 11-12 10.1 (9.67-10.5) 9.90 (9.42-10.8) 12.5 (11.7-13.2) 14.8 (14.1-15.4) 16.6 (15.3-17.9) 1129 
 13-14 10.4 (10.0-10.8) 10.1 (9.55-10.6) 13.4 (12.5-13.9) 16.1 (15.0-17.4) 17.9 (16.1-20.3) 627 
20 years and older 11-12 9.09 (8.94-9.24) 8.96 (8.83-9.11) 11.1 (10.9-11.3) 14.1 (13.7-14.5) 16.7 (16.1-17.3) 5030 
 13-14 9.27 (9.11-9.43) 9.22 (9.01-9.39) 11.4 (11.2-11.7) 14.1 (13.9-14.6) 16.2 (15.5-17.0) 2695 
Gender        
Males 11-12 8.74 (8.58-8.91) 8.78 (8.65-8.91) 10.6 (10.3-10.9) 13.0 (12.7-13.4) 14.9 (14.4-15.3) 3968 
 13-14 8.92 (8.76-9.09) 8.96 (8.70-9.19) 10.9 (10.6-11.1) 13.3 (12.9-13.6) 14.7 (14.2-15.2) 2587 
Females 11-12 9.96 (9.75-10.2) 9.72 (9.52-10.0) 12.4 (12.0-12.9) 15.5 (15.2-15.9) 17.8 (17.4-18.4) 3952 
 13-14 10.1 (9.86-10.4) 9.93 (9.57-10.4) 12.6 (12.3-13.0) 15.7 (15.1-16.4) 17.9 (17.0-19.2) 2628 
Race/ethnicity        
Mexican Americans 11-12 10.7 (10.4-11.0) 10.7 (10.3-11.0) 13.2 (12.9-13.5) 16.4 (15.2-17.1) 19.1 (17.7-20.3) 1077 
 13-14 10.9 (10.6-11.3) 11.0 (10.6-11.3) 13.6 (13.1-14.0) 16.4 (15.2-17.4) 18.0 (17.1-19.9) 969 
Non-Hispanic blacks 11-12 8.34 (8.19-8.49) 8.18 (8.04-8.33) 10.1 (9.81-10.4) 12.7 (12.0-13.3) 15.5 (14.5-16.5) 2195 
 13-14 8.23 (8.04-8.43) 8.17 (7.87-8.47) 10.0 (9.72-10.4) 12.5 (12.1-12.8) 14.0 (13.4-15.1) 1119 
Non-Hispanic whites 11-12 9.08 (8.91-9.26) 9.01 (8.79-9.21) 11.1 (10.9-11.3) 13.7 (13.3-14.2) 15.9 (15.2-16.4) 2493 
 13-14 9.27 (9.07-9.48) 9.18 (8.96-9.38) 11.2 (10.9-11.5) 14.0 (13.0-14.5) 15.7 (14.7-17.0) 1848 
All Hispanics 11-12 10.4 (10.1-10.8) 10.3 (9.95-10.7) 12.8 (12.3-13.3) 15.7 (14.9-16.7) 18.3 (17.3-19.2) 1931 
 13-14 10.6 (10.3-10.9) 10.6 (10.4-10.8) 13.2 (12.9-13.5) 16.1 (15.2-16.7) 17.8 (17.1-18.7) 1481 
Asians 11-12 11.9 (11.5-12.4) 11.8 (11.4-12.3) 14.7 (14.1-15.3) 17.6 (16.8-18.4) 19.8 (19.0-21.1) 1005 
 13-14 12.4 (12.0-12.8) 12.6 (12.0-13.0) 15.0 (14.7-15.5) 17.5 (16.8-18.4) 19.4 (18.4-20.4) 510 
Limit of detection (LOD, see Data Analysis section) for Survey year 11-12 and 13-14 are 1.06 and 0.99. 
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Urinary Manganese (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 .123 (.112-.136) .120 (.100-.140) .200 (.180-.230) .300 (.270-.310) .370 (.320-.450) 2504 
 13-14 * < LOD .130 (<LOD-.150) .220 (.200-.230) .300 (.260-.330) 2664 
Age group        
6-11 years 11-12 .143 (.126-.162) .150 (.120-.180) .250 (.210-.300) .340 (.310-.450) .460 (.350-.540) 399 
 13-14 * < LOD .150 (<LOD-.190) .220 (.180-.320) .310 (.220-.460) 402 
12-19 years 11-12 .128 (.107-.153) .120 (.090-.160) .220 (.160-.280) .310 (.250-.420) .430 (.310-.570) 390 
 13-14 * < LOD .140 (.130-.170) .250 (.220-.330) .380 (.300-.520) 451 
20 years and older 11-12 .121 (.109-.134) .120 (.100-.140) .190 (.180-.220) .280 (.250-.300) .350 (.300-.440) 1715 
 13-14 * < LOD .130 (<LOD-.140) .210 (.190-.220) .280 (.240-.320) 1811 
Gender        
Males 11-12 .121 (.108-.136) .120 (.100-.140) .190 (.170-.220) .280 (.250-.310) .350 (.300-.390) 1262 
 13-14 * < LOD < LOD .190 (.160-.210) .240 (.210-.260) 1318 
Females 11-12 .126 (.114-.138) .120 (.100-.140) .210 (.190-.240) .300 (.270-.350) .410 (.340-.520) 1242 
 13-14 * < LOD .150 (.130-.160) .240 (.210-.290) .350 (.300-.400) 1346 
Race/ethnicity        
Mexican Americans 11-12 .129 (.116-.144) .130 (.110-.150) .220 (.190-.250) .300 (.260-.360) .360 (.300-.440) 317 
 13-14 * < LOD .150 (<LOD-.180) .220 (.180-.250) .250 (.220-.410) 453 
Non-Hispanic blacks 11-12 .132 (.116-.150) .140 (.100-.170) .220 (.200-.240) .310 (.280-.360) .380 (.320-.480) 669 
 13-14 * < LOD .150 (.140-.180) .250 (.200-.310) .350 (.290-.410) 581 
Non-Hispanic whites 11-12 .123 (.109-.138) .120 (.100-.140) .200 (.170-.230) .300 (.250-.340) .390 (.300-.510) 820 
 13-14 * < LOD .130 (<LOD-.140) .210 (.180-.240) .290 (.240-.340) 985 
All Hispanics 11-12 .120 (.110-.132) .120 (.100-.150) .200 (.180-.230) .290 (.260-.300) .330 (.300-.380) 573 
 13-14 * < LOD .140 (<LOD-.160) .210 (.190-.240) .250 (.220-.380) 701 
Asians 11-12 .125 (.108-.143) .120 (.090-.160) .220 (.180-.250) .300 (.270-.360) .410 (.300-.490) 353 
 13-14 * < LOD < LOD .190 (.150-.250) .260 (.200-.300) 292 
Limit of detection (LOD, see Data Analysis section) for Survey year 11-12 and 13-14 are 0.08 and 0.13. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Manganese (creatinine corrected) (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 .140 (.126-.155) .139 (.119-.154) .233 (.206-.273) .389 (.354-.444) .548 (.500-.625) 2502 
 13-14 * < LOD .219 (<LOD-.240) .368 (.329-.418) .541 (.438-.657) 2663 
Age group        
6-11 years 11-12 .201 (.175-.231) .197 (.173-.238) .308 (.285-.358) .486 (.388-.600) .633 (.511-.750) 398 
 13-14 * < LOD .297 (<LOD-.400) .495 (.383-.657) .708 (.532-.844) 402 
12-19 years 11-12 .122 (.105-.143) .125 (.099-.150) .200 (.174-.213) .297 (.220-.429) .490 (.271-.814) 390 
 13-14 * < LOD .180 (.148-.204) .279 (.228-.354) .396 (.288-.460) 451 
20 years and older 11-12 .137 (.124-.151) .133 (.117-.148) .232 (.197-.276) .389 (.347-.455) .545 (.487-.600) 1714 
 13-14 * < LOD .217 (<LOD-.237) .355 (.329-.400) .541 (.434-.657) 1810 
Gender        
Males 11-12 .113 (.101-.127) .111 (.098-.127) .182 (.165-.197) .318 (.248-.357) .388 (.349-.487) 1261 
 13-14 * < LOD < LOD .279 (.263-.297) .383 (.317-.460) 1317 
Females 11-12 .171 (.153-.191) .161 (.145-.194) .286 (.250-.324) .500 (.406-.571) .635 (.571-.980) 1241 
 13-14 * < LOD .271 (.237-.307) .438 (.368-.511) .613 (.511-.836) 1346 
Race/ethnicity        
Mexican Americans 11-12 .145 (.125-.169) .139 (.119-.172) .237 (.196-.277) .359 (.300-.419) .439 (.375-.600) 317 
 13-14 * < LOD .212 (<LOD-.233) .341 (.288-.368) .405 (.341-.651) 453 
Non-Hispanic blacks 11-12 .102 (.090-.117) .102 (.085-.117) .172 (.149-.200) .272 (.231-.351) .406 (.351-.547) 669 
 13-14 * < LOD .146 (.133-.155) .242 (.219-.271) .333 (.283-.540) 581 
Non-Hispanic whites 11-12 .148 (.132-.166) .145 (.127-.162) .248 (.212-.300) .410 (.375-.490) .550 (.512-.633) 818 
 13-14 * < LOD .237 (<LOD-.271) .402 (.329-.483) .541 (.484-.700) 984 
All Hispanics 11-12 .135 (.121-.150) .129 (.114-.146) .221 (.190-.250) .356 (.317-.380) .469 (.386-.574) 573 
 13-14 * < LOD .200 (<LOD-.219) .329 (.271-.368) .400 (.345-.541) 701 
Asians 11-12 .167 (.138-.201) .164 (.133-.198) .271 (.219-.360) .462 (.406-.577) .641 (.500-.980) 353 
 13-14 * < LOD < LOD .383 (.341-.484) .514 (.418-.769) 292 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Blood Total Mercury (2003 – 2010) 
 
Geometric mean and selected percentiles of blood concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 .797 (.703-.903) .800 (.700-.900) 1.70 (1.50-1.90) 3.30 (2.90-3.90) 4.90 (4.30-5.50) 8373 
 05-06 .863 (.787-.946) .830 (.760-.920) 1.66 (1.48-1.93) 3.20 (2.87-3.54) 4.64 (4.17-5.25) 8407 
 07-08 .769 (.689-.859) .740 (.660-.830) 1.48 (1.29-1.69) 2.95 (2.46-3.59) 4.64 (3.74-5.79) 8266 
 09-10 .863 (.792-.941) .790 (.730-.880) 1.68 (1.49-1.91) 3.43 (3.07-3.84) 5.13 (4.57-5.67) 8793 
Age group        
1-5 years 03-04 .326 (.285-.372) .300 (.300-.300) .500 (.500-.700) 1.00 (.800-1.60) 1.80 (1.30-2.50) 911 
 05-06 * < LOD .500 (.470-.550) .940 (.820-1.24) 1.43 (1.25-1.59) 968 
 07-08 * < LOD .440 (.380-.540) .830 (.620-1.12) 1.32 (.960-2.40) 817 
 09-10 * < LOD .490 (.430-.590) .890 (.740-1.08) 1.30 (1.08-1.52) 836 
6-11 years 03-04 .419 (.363-.484) .400 (.400-.500) .700 (.700-.900) 1.30 (1.00-1.60) 1.90 (1.40-3.50) 856 
 05-06 * .410 (.330-.460) .740 (.630-1.00) 1.43 (1.21-1.87) 2.34 (1.53-3.42) 934 
 07-08 * .380 (.340-.440) .700 (.600-.790) 1.21 (.970-1.36) 1.56 (1.34-1.80) 1011 
 09-10 * .360 (<LOD-.400) .670 (.590-.770) 1.22 (1.05-1.45) 1.88 (1.43-2.61) 1009 
12-19 years 03-04 .490 (.418-.574) .500 (.400-.600) 1.00 (.800-1.20) 1.80 (1.40-2.30) 2.60 (2.10-3.30) 2081 
 05-06 .513 (.461-.570) .460 (.390-.530) .850 (.740-1.04) 1.66 (1.31-1.98) 2.41 (2.12-2.90) 1996 
 07-08 .469 (.426-.516) .440 (.390-.490) .800 (.670-.970) 1.55 (1.30-1.72) 2.05 (1.77-2.34) 1074 
 09-10 .534 (.473-.602) .450 (.370-.540) .910 (.770-1.11) 2.04 (1.53-2.55) 3.01 (2.53-3.63) 1183 
20 years and older 03-04 .979 (.860-1.12) 1.00 (.800-1.10) 2.00 (1.70-2.30) 3.80 (3.20-4.40) 5.40 (4.60-6.70) 4525 
 05-06 1.06 (.967-1.15) 1.03 (.930-1.15) 1.98 (1.73-2.22) 3.64 (3.33-4.01) 5.31 (4.82-5.67) 4509 
 07-08 .944 (.833-1.07) .890 (.780-1.03) 1.73 (1.47-2.09) 3.41 (2.82-4.17) 5.32 (4.32-6.72) 5364 
 09-10 1.04 (.956-1.14) .970 (.870-1.08) 2.00 (1.80-2.20) 3.96 (3.55-4.27) 5.75 (5.14-6.50) 5765 
Gender        
Males 03-04 .814 (.714-.927) .800 (.700-.900) 1.80 (1.50-2.00) 3.70 (3.20-4.30) 5.40 (4.60-6.50) 4132 
 05-06 .864 (.783-.954) .810 (.720-.940) 1.69 (1.48-2.01) 3.30 (2.86-3.73) 4.83 (4.08-5.45) 4092 
 07-08 .809 (.709-.923) .760 (.670-.850) 1.56 (1.31-1.81) 3.21 (2.72-4.06) 5.16 (4.12-6.97) 4147 
 09-10 .883 (.810-.962) .790 (.730-.870) 1.75 (1.54-2.02) 3.84 (3.35-4.26) 5.65 (5.13-6.34) 4366 
Females 03-04 .781 (.689-.886) .800 (.700-.900) 1.60 (1.40-1.80) 3.00 (2.50-3.50) 4.40 (3.60-5.30) 4241 
 05-06 .864 (.791-.943) .850 (.770-.920) 1.63 (1.44-1.89) 3.09 (2.75-3.46) 4.51 (4.01-5.28) 4315 
 07-08 .748 (.677-.827) .720 (.660-.810) 1.42 (1.24-1.60) 2.70 (2.27-3.27) 3.93 (3.17-5.16) 4119 
 09-10 .845 (.772-.924) .800 (.720-.880) 1.61 (1.43-1.81) 3.13 (2.76-3.48) 4.43 (4.04-5.11) 4427 
Race/ethnicity        
Mexican Americans 03-04 .563 (.472-.672) .600 (.500-.700) 1.00 (.800-1.30) 1.90 (1.60-2.40) 3.00 (2.20-3.80) 2085 
 05-06 .597 (.524-.679) .580 (.490-.670) 1.04 (.870-1.24) 1.70 (1.40-2.12) 2.58 (1.96-3.31) 2236 
 07-08 .594 (.536-.658) .580 (.520-.670) 1.03 (.900-1.17) 1.73 (1.49-2.04) 2.48 (2.10-2.91) 1712 
 09-10 .613 (.571-.659) .580 (.540-.630) 1.01 (.890-1.15) 1.63 (1.47-1.90) 2.45 (2.03-2.93) 1966 
Non-Hispanic blacks 03-04 .877 (.753-1.02) .900 (.800-1.00) 1.60 (1.40-1.80) 3.00 (2.30-4.00) 4.40 (3.30-6.00) 2293 
 05-06 .823 (.697-.972) .800 (.670-.940) 1.50 (1.21-1.92) 2.72 (2.14-3.59) 4.09 (3.22-5.16) 2193 
 07-08 .766 (.711-.825) .780 (.710-.830) 1.32 (1.23-1.42) 2.25 (1.99-2.58) 3.42 (2.74-3.90) 1746 
 09-10 .928 (.805-1.07) .900 (.800-1.02) 1.67 (1.38-1.96) 2.93 (2.20-4.21) 4.56 (3.34-6.69) 1593 
Non-Hispanic whites 03-04 .776 (.655-.919) .800 (.700-.900) 1.70 (1.40-2.00) 3.20 (2.60-3.90) 4.70 (4.00-5.60) 3478 
 05-06 .891 (.801-.992) .870 (.770-1.00) 1.74 (1.50-2.10) 3.37 (2.88-3.76) 4.76 (4.18-5.37) 3310 
 07-08 .743 (.651-.847) .720 (.620-.820) 1.43 (1.18-1.70) 2.79 (2.33-3.41) 4.18 (3.57-4.83) 3461 
 09-10 .856 (.766-.957) .790 (.690-.920) 1.70 (1.46-1.98) 3.43 (2.94-3.94) 4.92 (4.30-5.65) 3760 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, 07-08 and 09-10 are 0.2, 0.33, 0.33, and 0.33 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Blood Total Mercury (2011 - 2014) 
 
Geometric mean and selected percentiles of blood concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 .703 (.617-.801) .640 (.580-.730) 1.38 (1.14-1.72) 2.87 (2.39-3.62) 4.40 (3.50-5.71) 7920 
 13-14 .683 (.621-.751) .620 (.540-.690) 1.29 (1.14-1.46) 2.65 (2.32-3.08) 4.36 (3.65-4.97) 5215 
Age group        
1-5 years 11-12 .262 (.237-.291) .250 (.220-.270) .390 (.340-.450) .680 (.540-.880) .990 (.790-1.21) 713 
 13-14 * < LOD .410 (.370-.450) .810 (.710-.990) 1.21 (1.05-1.48) 818 
6-11 years 11-12 .330 (.287-.379) .320 (.280-.360) .530 (.480-.600) .930 (.780-1.20) 1.40 (1.02-2.17) 1048 
 13-14 * .300 (<LOD-.360) .570 (.470-.680) 1.12 (.980-1.36) 1.62 (1.38-2.19) 1075 
12-19 years 11-12 .411 (.355-.476) .370 (.320-.450) .680 (.590-.800) 1.32 (1.08-1.75) 2.25 (1.46-2.87) 1129 
 13-14 .412 (.367-.463) .350 (.310-.420) .630 (.530-.750) 1.20 (.900-1.67) 1.87 (1.30-2.38) 627 
20 years and older 11-12 .863 (.753-.990) .790 (.690-.940) 1.68 (1.36-2.12) 3.35 (2.71-4.31) 5.02 (3.94-6.96) 5030 
 13-14 .814 (.736-.900) .740 (.650-.850) 1.54 (1.36-1.71) 3.08 (2.73-3.56) 4.88 (4.36-5.21) 2695 
Gender        
Males 11-12 .712 (.623-.815) .650 (.570-.730) 1.40 (1.17-1.72) 3.00 (2.44-3.91) 4.94 (3.50-6.79) 3968 
 13-14 .688 (.617-.767) .620 (.530-.720) 1.30 (1.12-1.54) 2.76 (2.36-3.34) 4.52 (3.65-5.23) 2587 
Females 11-12 .694 (.609-.791) .640 (.580-.740) 1.36 (1.09-1.75) 2.81 (2.28-3.50) 4.03 (3.29-5.08) 3952 
 13-14 .678 (.617-.745) .610 (.530-.700) 1.27 (1.14-1.42) 2.56 (2.17-3.08) 4.15 (3.37-4.93) 2628 
Race/ethnicity        
Mexican Americans 11-12 .483 (.424-.550) .480 (.400-.560) .810 (.720-.900) 1.44 (1.16-1.63) 1.90 (1.57-2.19) 1077 
 13-14 .487 (.433-.547) .430 (.390-.510) .760 (.690-.870) 1.41 (1.14-1.69) 1.98 (1.70-2.38) 969 
Non-Hispanic blacks 11-12 .679 (.542-.852) .630 (.500-.790) 1.24 (.880-1.72) 2.45 (1.84-3.14) 3.80 (2.70-5.37) 2195 
 13-14 .699 (.614-.796) .650 (.570-.750) 1.20 (1.08-1.40) 2.30 (1.65-2.96) 3.34 (2.35-5.93) 1119 
Non-Hispanic whites 11-12 .688 (.582-.813) .630 (.550-.750) 1.38 (1.09-1.82) 2.83 (2.18-3.82) 4.25 (3.02-6.24) 2493 
 13-14 .672 (.598-.755) .620 (.520-.720) 1.30 (1.12-1.51) 2.61 (2.18-3.08) 4.15 (3.35-4.98) 1848 
All Hispanics 11-12 .612 (.527-.710) .590 (.490-.700) 1.08 (.890-1.33) 1.96 (1.60-2.68) 3.03 (2.37-3.86) 1931 
 13-14 .551 (.486-.624) .490 (.420-.580) .910 (.820-1.10) 1.76 (1.44-2.12) 2.59 (2.06-3.14) 1481 
Asians 11-12 1.86 (1.58-2.19) 2.30 (1.84-2.64) 4.32 (3.71-5.21) 7.71 (6.38-8.79) 10.3 (8.85-12.0) 1005 
 13-14 1.72 (1.46-2.03) 1.77 (1.42-2.26) 3.92 (3.35-4.55) 7.78 (6.39-9.16) 9.99 (9.16-13.7) 510 
Limit of detection (LOD, see Data Analysis section) for Survey year 11-12 and 13-14 are 0.16 and 0.28. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Blood Inorganic Mercury (2003 – 2010) 
 
Geometric mean and selected percentiles of blood concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD .600 (.500-.600) .700 (.700-.700) 8147 
 05-06 * < LOD < LOD .540 (.500-.580) .660 (.620-.710) 8371 
 07-08 * < LOD .350 (<LOD-.370) .520 (.500-.540) .650 (.620-.690) 8162 
 09-10 * < LOD < LOD .390 (.360-.430) .510 (.480-.570) 8733 
Age group        
1-5 years 03-04 * < LOD < LOD < LOD .500 (<LOD-.600) 792 
 05-06 * < LOD < LOD .430 (<LOD-.470) .510 (.430-.670) 948 
 07-08 * < LOD < LOD .350 (<LOD-.450) .500 (.410-.550) 726 
 09-10 * < LOD < LOD < LOD .360 (<LOD-.460) 789 
6-11 years 03-04 * < LOD < LOD < LOD .600 (.500-.600) 842 
 05-06 * < LOD < LOD .450 (<LOD-.520) .560 (.470-.640) 932 
 07-08 * < LOD < LOD .380 (.350-.410) .470 (.420-.520) 1010 
 09-10 * < LOD < LOD < LOD .380 (.350-.440) 1006 
12-19 years 03-04 * < LOD < LOD .500 (<LOD-.500) .600 (.500-.600) 2060 
 05-06 * < LOD < LOD .430 (.410-.460) .540 (.480-.590) 1984 
 07-08 * < LOD < LOD .370 (<LOD-.400) .480 (.410-.530) 1069 
 09-10 * < LOD < LOD < LOD .420 (.350-.500) 1184 
20 years and older 03-04 * < LOD < LOD .600 (.500-.600) .700 (.700-.800) 4453 
 05-06 * < LOD < LOD .570 (.530-.610) .690 (.650-.750) 4507 
 07-08 * < LOD .380 (.360-.390) .550 (.530-.570) .700 (.660-.730) 5357 
 09-10 * < LOD < LOD .420 (.390-.450) .540 (.490-.600) 5754 
Gender        
Males 03-04 * < LOD < LOD .500 (.500-.600) .600 (.600-.700) 4015 
 05-06 * < LOD < LOD .480 (.450-.520) .600 (.550-.640) 4076 
 07-08 * < LOD < LOD .500 (.470-.520) .600 (.570-.650) 4093 
 09-10 * < LOD < LOD .370 (<LOD-.420) .500 (.440-.560) 4336 
Females 03-04 * < LOD < LOD .600 (.500-.600) .700 (.700-.800) 4132 
 05-06 * < LOD < LOD .580 (.550-.640) .700 (.670-.780) 4295 
 07-08 * < LOD .380 (.360-.390) .550 (.520-.570) .700 (.670-.740) 4069 
 09-10 * < LOD < LOD .410 (.380-.440) .530 (.490-.600) 4397 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, 07-08, and 09-10 are 0.42, 0.4, 0.35, and 0.35 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Blood Inorganic Mercury (2003 – 2010) 
 
Geometric mean and selected percentiles of blood concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD .500 (.500-.600) .700 (.600-.800) 2007 
 05-06 * < LOD < LOD .530 (.470-.580) .670 (.560-.830) 2224 
 07-08 * < LOD < LOD .430 (.400-.480) .560 (.520-.610) 1685 
 09-10 * < LOD < LOD < LOD .470 (.390-.530) 1947 
Non-Hispanic blacks 03-04 * < LOD < LOD .600 (.500-.600) .700 (.600-.800) 2240 
 05-06 * < LOD < LOD .530 (.470-.600) .670 (.600-.760) 2183 
 07-08 * < LOD < LOD .490 (.450-.530) .610 (.560-.650) 1729 
 09-10 * < LOD < LOD .370 (.350-.390) .480 (.410-.530) 1580 
Non-Hispanic whites 03-04 * < LOD < LOD .600 (.500-.600) .700 (.600-.700) 3406 
 05-06 * < LOD < LOD .540 (.500-.580) .650 (.610-.710) 3298 
 07-08 * < LOD .360 (<LOD-.390) .530 (.500-.550) .660 (.620-.700) 3421 
 09-10 * < LOD < LOD .410 (.370-.450) .520 (.480-.590) 3739 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, 07-08, and 09-10 are 0.42, 0.4, 0.35, and 0.35 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Blood Inorganic Mercury (2011 - 2014) 
 
Geometric mean and selected percentiles of blood concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * < LOD < LOD .440 (.390-.480) .600 (.520-.680) 7841 
 13-14 * < LOD < LOD .410 (.380-.440) .530 (.490-.570) 5175 
Age group        
1-5 years 11-12 * < LOD < LOD < LOD .280 (<LOD-.360) 657 
 13-14 * < LOD < LOD < LOD < LOD 779 
6-11 years 11-12 * < LOD < LOD .280 (<LOD-.320) .360 (.290-.450) 1044 
 13-14 * < LOD < LOD < LOD .340 (<LOD-.420) 1074 
12-19 years 11-12 * < LOD < LOD .280 (<LOD-.350) .400 (.300-.540) 1121 
 13-14 * < LOD < LOD < LOD .360 (.290-.420) 627 
20 years and older 11-12 * < LOD .290 (.270-.310) .470 (.420-.530) .630 (.550-.760) 5019 
 13-14 * < LOD .270 (<LOD-.300) .440 (.410-.470) .560 (.510-.660) 2695 
Gender        
Males 11-12 * < LOD < LOD .420 (.370-.480) .600 (.490-.680) 3925 
 13-14 * < LOD < LOD .400 (.340-.430) .510 (.450-.560) 2570 
Females 11-12 * < LOD .280 (<LOD-.300) .450 (.390-.490) .610 (.520-.700) 3916 
 13-14 * < LOD < LOD .420 (.390-.450) .550 (.510-.590) 2605 
Race/ethnicity        
Mexican Americans 11-12 * < LOD < LOD .390 (.330-.460) .580 (.460-.710) 1058 
 13-14 * < LOD < LOD .380 (.330-.410) .540 (.420-.640) 958 
Non-Hispanic blacks 11-12 * < LOD < LOD .410 (.370-.470) .570 (.480-.670) 2170 
 13-14 * < LOD < LOD .380 (.330-.430) .530 (.440-.630) 1110 
Non-Hispanic whites 11-12 * < LOD .270 (<LOD-.300) .430 (.370-.490) .590 (.480-.690) 2477 
 13-14 * < LOD < LOD .420 (.360-.450) .510 (.460-.570) 1835 
All Hispanics 11-12 * < LOD < LOD .430 (.370-.490) .630 (.540-.760) 1902 
 13-14 * < LOD < LOD .380 (.330-.410) .540 (.440-.650) 1467 
Asians 11-12 * < LOD .350 (.310-.390) .550 (.500-.590) .700 (.630-.760) 997 
 13-14 * < LOD .330 (.270-.390) .570 (.420-.680) .750 (.580-1.10) 508 
Limit of detection (LOD, see Data Analysis section) for Survey year 11-12 and 13-14 are 0.27 and 0.27. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Blood Ethyl Mercury (2011 - 2014) 
 
Geometric mean and selected percentiles of blood concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * < LOD < LOD < LOD < LOD 7841 
 13-14 * < LOD < LOD < LOD < LOD 5175 
Age group        
1-5 years 11-12 * < LOD < LOD < LOD < LOD 657 
 13-14 * < LOD < LOD < LOD < LOD 779 
6-11 years 11-12 * < LOD < LOD < LOD < LOD 1044 
 13-14 * < LOD < LOD < LOD < LOD 1074 
12-19 years 11-12 * < LOD < LOD < LOD < LOD 1121 
 13-14 * < LOD < LOD < LOD < LOD 627 
20 years and older 11-12 * < LOD < LOD < LOD < LOD 5019 
 13-14 * < LOD < LOD < LOD < LOD 2695 
Gender        
Males 11-12 * < LOD < LOD < LOD < LOD 3925 
 13-14 * < LOD < LOD < LOD < LOD 2570 
Females 11-12 * < LOD < LOD < LOD < LOD 3916 
 13-14 * < LOD < LOD < LOD < LOD 2605 
Race/ethnicity        
Mexican Americans 11-12 * < LOD < LOD < LOD < LOD 1058 
 13-14 * < LOD < LOD < LOD < LOD 958 
Non-Hispanic blacks 11-12 * < LOD < LOD < LOD < LOD 2170 
 13-14 * < LOD < LOD < LOD < LOD 1110 
Non-Hispanic whites 11-12 * < LOD < LOD < LOD < LOD 2477 
 13-14 * < LOD < LOD < LOD < LOD 1835 
All Hispanics 11-12 * < LOD < LOD < LOD < LOD 1902 
 13-14 * < LOD < LOD < LOD < LOD 1467 
Asians 11-12 * < LOD < LOD < LOD .160 (<LOD-.280) 997 
 13-14 * < LOD < LOD < LOD < LOD 508 
Limit of detection (LOD, see Data Analysis section) for Survey year 11-12 and 13-14 are 0.16 and 0.16. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Blood Methyl Mercury (2011 - 2014) 
 
Geometric mean and selected percentiles of blood concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 .498 (.423-.587) .480 (.400-.570) 1.25 (.950-1.61) 2.81 (2.29-3.55) 4.43 (3.46-5.49) 7841 
 13-14 .434 (.381-.495) .420 (.340-.510) 1.09 (.940-1.27) 2.62 (2.18-3.04) 4.28 (3.74-4.93) 5175 
Age group        
1-5 years 11-12 * .140 (.120-.170) .270 (.220-.350) .540 (.420-.780) .970 (.590-1.14) 657 
 13-14 * < LOD .260 (.230-.310) .660 (.550-.810) 1.11 (.960-1.48) 779 
6-11 years 11-12 .209 (.182-.241) .180 (.150-.220) .400 (.330-.490) .820 (.630-1.06) 1.34 (.940-1.84) 1044 
 13-14 * .150 (<LOD-.200) .380 (.280-.530) .960 (.700-1.26) 1.58 (1.26-2.11) 1074 
12-19 years 11-12 .276 (.237-.322) .270 (.210-.310) .570 (.460-.670) 1.27 (.870-1.67) 2.15 (1.40-2.81) 1121 
 13-14 .233 (.202-.269) .190 (.140-.260) .480 (.380-.560) 1.02 (.730-1.60) 1.84 (1.20-2.57) 627 
20 years and older 11-12 .624 (.523-.746) .610 (.500-.760) 1.53 (1.18-2.00) 3.28 (2.56-4.31) 4.97 (3.91-6.89) 5019 
 13-14 .541 (.473-.618) .540 (.450-.630) 1.32 (1.17-1.54) 3.05 (2.64-3.60) 4.92 (4.34-5.41) 2695 
Gender        
Males 11-12 .509 (.433-.598) .490 (.400-.590) 1.30 (.990-1.62) 2.84 (2.29-3.68) 4.77 (3.44-6.74) 3925 
 13-14 .448 (.390-.515) .430 (.350-.530) 1.10 (.940-1.37) 2.67 (2.22-3.33) 4.44 (3.88-5.40) 2570 
Females 11-12 .489 (.413-.580) .470 (.380-.560) 1.19 (.900-1.61) 2.72 (2.18-3.46) 3.99 (3.28-4.99) 3916 
 13-14 .422 (.367-.485) .400 (.330-.490) 1.08 (.900-1.22) 2.46 (2.03-2.92) 3.91 (3.32-4.93) 2605 
Race/ethnicity        
Mexican Americans 11-12 .320 (.264-.387) .330 (.260-.410) .610 (.500-.770) 1.23 (.920-1.40) 1.66 (1.33-2.06) 1058 
 13-14 .276 (.239-.318) .260 (.210-.310) .540 (.440-.650) 1.06 (.770-1.43) 1.72 (1.27-2.34) 958 
Non-Hispanic blacks 11-12 .517 (.392-.681) .510 (.380-.660) 1.13 (.750-1.61) 2.37 (1.66-3.08) 3.63 (2.57-5.16) 2170 
 13-14 .481 (.407-.569) .460 (.370-.580) 1.03 (.900-1.22) 2.08 (1.55-2.72) 3.33 (2.15-5.12) 1110 
Non-Hispanic whites 11-12 .478 (.392-.583) .470 (.360-.580) 1.25 (.870-1.69) 2.76 (2.06-3.69) 4.24 (2.92-6.38) 2477 
 13-14 .420 (.357-.495) .420 (.310-.530) 1.10 (.910-1.32) 2.62 (2.07-3.12) 4.01 (3.46-5.00) 1835 
All Hispanics 11-12 .429 (.350-.525) .420 (.340-.520) .890 (.700-1.17) 1.81 (1.39-2.46) 2.94 (2.19-3.71) 1902 
 13-14 .326 (.278-.382) .310 (.250-.350) .680 (.580-.790) 1.50 (1.15-1.89) 2.34 (1.79-3.00) 1467 
Asians 11-12 1.58 (1.29-1.94) 2.16 (1.68-2.55) 4.35 (3.64-5.13) 7.57 (6.21-8.61) 10.5 (8.48-12.5) 997 
 13-14 1.42 (1.16-1.74) 1.71 (1.17-2.07) 3.90 (3.31-4.54) 7.93 (6.42-9.21) 10.8 (9.57-13.6) 508 
Limit of detection (LOD, see Data Analysis section) for Survey year 11-12 and 13-14 are 0.12 and 0.12. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Mercury (2003 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 .447 (.406-.492) .420 (.360-.480) 1.00 (.870-1.14) 2.08 (1.78-2.42) 3.19 (2.76-3.55) 2538 
 05-06 .468 (.426-.514) .460 (.410-.510) 1.03 (.900-1.12) 2.11 (1.88-2.36) 2.94 (2.58-3.26) 2578 
 07-08 .443 (.408-.482) .440 (.400-.470) .880 (.760-1.00) 1.74 (1.62-1.96) 2.66 (2.29-3.08) 2634 
 09-10 * .400 (.360-.450) .850 (.770-.910) 1.53 (1.30-1.81) 2.42 (2.07-2.72) 2865 
Age group        
6-11 years 03-04 .254 (.213-.304) .200 (.160-.250) .440 (.330-.580) 1.16 (.610-1.61) 1.96 (1.13-2.97) 287 
 05-06 .333 (.267-.416) .320 (.250-.390) .650 (.470-.840) 1.32 (.930-1.88) 2.18 (1.28-3.40) 355 
 07-08 .301 (.260-.347) .290 (.230-.340) .520 (.430-.620) 1.03 (.770-1.23) 1.87 (1.03-3.48) 398 
 09-10 * .260 (.220-.320) .510 (.430-.620) 1.03 (.730-1.31) 1.58 (1.18-1.88) 379 
12-19 years 03-04 .358 (.313-.408) .330 (.290-.370) .700 (.530-.840) 1.60 (1.14-2.52) 2.93 (1.88-3.66) 722 
 05-06 .372 (.286-.486) .350 (.270-.470) .740 (.580-.920) 1.61 (.970-2.81) 2.59 (1.40-4.45) 703 
 07-08 .364 (.326-.406) .380 (.320-.450) .590 (.550-.650) 1.24 (.830-1.71) 1.82 (1.41-2.29) 375 
 09-10 * .290 (.230-.360) .530 (.470-.630) 1.09 (.890-1.31) 1.73 (1.28-2.31) 455 
20 years and older 03-04 .495 (.442-.555) .480 (.410-.570) 1.12 (.930-1.29) 2.20 (1.85-2.65) 3.33 (2.76-3.88) 1529 
 05-06 .505 (.468-.545) .510 (.460-.560) 1.11 (1.04-1.16) 2.23 (1.97-2.50) 3.11 (2.64-3.37) 1520 
 07-08 .477 (.435-.523) .470 (.430-.520) .970 (.850-1.10) 1.89 (1.69-2.20) 2.82 (2.33-3.56) 1861 
 09-10 * .450 (.390-.510) .890 (.810-1.00) 1.66 (1.40-2.01) 2.53 (2.21-2.84) 2031 
Gender        
Males 03-04 .433 (.405-.463) .400 (.350-.460) .940 (.840-1.05) 1.88 (1.63-2.18) 2.68 (2.34-3.05) 1266 
 05-06 .464 (.411-.523) .450 (.400-.520) .980 (.860-1.11) 2.03 (1.57-2.48) 3.00 (2.48-3.37) 1270 
 07-08 .457 (.417-.501) .460 (.400-.520) .880 (.780-1.01) 1.68 (1.53-1.77) 2.40 (2.11-2.76) 1326 
 09-10 * .410 (.340-.480) .860 (.750-.950) 1.46 (1.29-1.66) 2.21 (1.93-2.53) 1404 
Females 03-04 .460 (.396-.534) .430 (.330-.530) 1.07 (.870-1.28) 2.26 (1.77-2.90) 3.54 (2.76-4.31) 1272 
 05-06 .472 (.424-.525) .470 (.390-.550) 1.07 (.900-1.19) 2.14 (1.84-2.50) 2.89 (2.60-3.38) 1308 
 07-08 .431 (.388-.478) .430 (.380-.460) .870 (.710-1.05) 1.88 (1.55-2.38) 2.92 (2.27-4.17) 1308 
 09-10 * .390 (.360-.450) .840 (.730-.940) 1.61 (1.29-2.03) 2.61 (2.16-3.12) 1461 
Race/ethnicity        
Mexican Americans 03-04 .416 (.340-.509) .360 (.280-.430) .960 (.700-1.23) 2.19 (1.39-3.24) 3.16 (1.99-6.30) 619 
 05-06 .451 (.369-.551) .420 (.310-.560) 1.01 (.780-1.25) 2.22 (1.48-2.64) 3.00 (2.27-4.01) 651 
 07-08 .409 (.349-.480) .370 (.330-.450) .780 (.700-.950) 1.82 (1.26-1.97) 2.55 (1.87-3.08) 514 
 09-10 * .350 (.280-.430) .670 (.520-.890) 1.53 (1.06-1.84) 2.29 (1.81-2.76) 615 
Non-Hispanic blacks 03-04 .476 (.413-.549) .430 (.360-.530) .890 (.770-1.00) 1.96 (1.60-2.31) 3.09 (2.03-4.89) 713 
 05-06 .453 (.384-.533) .450 (.380-.550) .890 (.710-1.13) 1.78 (1.34-2.29) 2.57 (2.21-3.15) 691 
 07-08 .478 (.411-.556) .460 (.380-.540) .910 (.770-1.06) 1.85 (1.42-2.41) 2.76 (1.97-4.19) 589 
 09-10 * .410 (.340-.490) .840 (.650-1.08) 1.66 (1.34-1.95) 2.64 (1.88-3.30) 546 
Non-Hispanic whites 03-04 .441 (.382-.509) .420 (.330-.520) 1.01 (.840-1.23) 2.08 (1.67-2.46) 3.24 (2.67-3.60) 1066 
 05-06 .459 (.409-.513) .440 (.400-.510) 1.00 (.860-1.12) 2.07 (1.77-2.40) 2.81 (2.47-3.37) 1044 
 07-08 .431 (.378-.493) .430 (.380-.480) .880 (.700-1.07) 1.71 (1.50-2.18) 2.70 (2.18-3.59) 1100 
 09-10 * .390 (.330-.470) .850 (.750-.950) 1.52 (1.26-2.01) 2.42 (1.93-2.85) 1225 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, 07-08 and 09-10 are 0.14, 0.11, 0.08, and 0.08 respectively. 
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Urinary Mercury (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 .324 (.285-.368) .320 (.280-.370) .660 (.580-.770) 1.37 (1.15-1.59) 1.83 (1.62-2.14) 2507 
 13-14 .246 (.221-.273) .200 (.170-.240) .470 (.400-.570) 1.07 (.900-1.22) 1.64 (1.35-1.96) 2666 
Age group        
6-11 years 11-12 .241 (.206-.283) .220 (.190-.270) .450 (.390-.530) .930 (.680-1.36) 1.37 (.990-2.03) 401 
 13-14 * < LOD .220 (.150-.310) .560 (.340-.840) .890 (.640-1.10) 401 
12-19 years 11-12 .257 (.212-.312) .270 (.220-.340) .490 (.390-.600) .840 (.650-1.24) 1.31 (.920-1.75) 390 
 13-14 * < LOD .240 (.200-.310) .560 (.400-.860) 1.02 (.610-1.81) 452 
20 years and older 11-12 .346 (.303-.396) .340 (.290-.400) .720 (.620-.850) 1.49 (1.20-1.67) 1.93 (1.67-2.29) 1716 
 13-14 .274 (.246-.305) .240 (.200-.280) .540 (.450-.630) 1.16 (1.00-1.33) 1.76 (1.44-2.04) 1813 
Gender        
Males 11-12 .342 (.293-.399) .330 (.290-.380) .670 (.580-.810) 1.34 (1.03-1.67) 1.91 (1.54-2.51) 1260 
 13-14 .243 (.219-.268) .200 (.170-.220) .480 (.390-.600) 1.07 (.840-1.33) 1.55 (1.28-1.96) 1319 
Females 11-12 .307 (.262-.360) .300 (.250-.360) .660 (.540-.770) 1.37 (1.17-1.54) 1.82 (1.54-2.14) 1247 
 13-14 .249 (.218-.284) .210 (.170-.260) .470 (.390-.570) 1.07 (.820-1.27) 1.75 (1.25-2.26) 1347 
Race/ethnicity        
Mexican Americans 11-12 .301 (.261-.348) .300 (.200-.400) .620 (.510-.680) 1.25 (.910-1.53) 1.75 (1.32-2.25) 317 
 13-14 .229 (.198-.265) .160 (.150-.210) .450 (.300-.620) 1.12 (.780-1.35) 1.47 (.970-2.38) 454 
Non-Hispanic blacks 11-12 .360 (.316-.410) .360 (.320-.400) .670 (.570-.800) 1.33 (1.06-1.60) 1.99 (1.48-3.06) 671 
 13-14 .279 (.228-.340) .250 (.190-.320) .530 (.400-.690) 1.10 (.900-1.49) 1.82 (1.11-2.48) 580 
Non-Hispanic whites 11-12 .308 (.260-.365) .290 (.260-.360) .630 (.510-.810) 1.37 (1.09-1.64) 1.77 (1.49-2.14) 819 
 13-14 .240 (.211-.271) .200 (.160-.230) .460 (.370-.580) 1.06 (.840-1.24) 1.64 (1.24-2.04) 988 
All Hispanics 11-12 .330 (.299-.364) .330 (.270-.390) .680 (.610-.760) 1.30 (1.15-1.53) 1.98 (1.61-2.42) 574 
 13-14 .239 (.207-.276) .180 (.150-.240) .460 (.360-.620) 1.14 (.800-1.35) 1.57 (1.24-2.15) 702 
Asians 11-12 .430 (.351-.527) .450 (.330-.580) .910 (.750-1.12) 1.69 (1.31-2.06) 2.41 (1.77-3.53) 355 
 13-14 .313 (.269-.363) .270 (.220-.340) .620 (.520-.710) 1.18 (.890-1.66) 1.78 (1.20-3.10) 291 
Limit of detection (LOD, see Data Analysis section) for Survey year 11-12 and 13-14 are 0.05 and 0.13. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Mercury (creatinine corrected) (2003 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 .443 (.404-.486) .447 (.392-.498) .909 (.785-1.00) 1.65 (1.40-1.86) 2.35 (1.88-2.85) 2537 
 05-06 .460 (.414-.511) .450 (.410-.510) .870 (.790-1.00) 1.63 (1.44-1.75) 2.26 (2.12-2.50) 2578 
 07-08 .462 (.425-.502) .450 (.400-.490) .820 (.750-.960) 1.57 (1.38-1.73) 2.32 (2.00-2.89) 2634 
 09-10 * .409 (.367-.459) .793 (.691-.893) 1.43 (1.24-1.67) 2.09 (1.79-2.39) 2865 
Age group        
6-11 years 03-04 .297 (.246-.358) .276 (.208-.347) .485 (.391-.630) 1.25 (.667-1.79) 1.79 (1.11-2.61) 286 
 05-06 .411 (.323-.524) .390 (.290-.500) .710 (.510-.960) 1.30 (.990-2.12) 2.55 (1.38-3.50) 355 
 07-08 .393 (.351-.440) .350 (.300-.440) .630 (.540-.770) 1.15 (.860-1.50) 1.68 (1.18-2.99) 398 
 09-10 * .357 (.306-.406) .632 (.500-.750) 1.04 (.863-1.26) 1.62 (1.19-1.98) 379 
12-19 years 03-04 .255 (.225-.289) .217 (.196-.275) .464 (.376-.535) 1.06 (.714-1.39) 1.67 (1.13-2.03) 722 
 05-06 .286 (.230-.356) .260 (.200-.320) .500 (.380-.660) 1.09 (.660-1.70) 1.76 (1.11-2.67) 703 
 07-08 .284 (.251-.320) .280 (.230-.300) .500 (.400-.550) .890 (.620-1.08) 1.18 (.980-1.36) 375 
 09-10 * .226 (.202-.287) .481 (.429-.553) .917 (.736-1.18) 1.41 (1.12-1.62) 455 
20 years and older 03-04 .508 (.455-.566) .525 (.447-.616) 1.00 (.875-1.09) 1.76 (1.46-2.11) 2.54 (2.04-3.00) 1529 
 05-06 .503 (.461-.549) .510 (.470-.550) .940 (.850-1.07) 1.69 (1.50-1.86) 2.31 (2.12-2.54) 1520 
 07-08 .507 (.463-.555) .500 (.450-.550) .940 (.810-1.02) 1.69 (1.51-2.01) 2.56 (2.09-3.17) 1861 
 09-10 * .454 (.395-.517) .861 (.731-.988) 1.51 (1.29-1.85) 2.15 (1.88-2.57) 2031 
Gender        
Males 03-04 .365 (.333-.400) .362 (.309-.417) .696 (.620-.784) 1.31 (1.18-1.44) 1.87 (1.51-2.30) 1266 
 05-06 .380 (.336-.431) .390 (.330-.440) .740 (.600-.890) 1.27 (1.09-1.47) 1.73 (1.62-1.85) 1270 
 07-08 .408 (.374-.445) .390 (.350-.450) .730 (.650-.810) 1.22 (1.11-1.36) 1.69 (1.54-2.11) 1326 
 09-10 * .337 (.298-.391) .675 (.585-.802) 1.19 (1.06-1.29) 1.50 (1.33-1.78) 1404 
Females 03-04 .532 (.472-.599) .545 (.455-.652) 1.06 (.969-1.21) 1.88 (1.64-2.30) 2.77 (2.12-3.56) 1271 
 05-06 .552 (.494-.617) .540 (.490-.620) 1.09 (.850-1.27) 1.96 (1.72-2.14) 2.78 (2.35-3.17) 1308 
 07-08 .520 (.469-.576) .490 (.460-.540) .960 (.820-1.11) 1.92 (1.58-2.24) 2.83 (2.24-3.50) 1308 
 09-10 * .475 (.423-.552) .890 (.771-1.07) 1.81 (1.43-2.09) 2.57 (2.09-2.94) 1461 
Race/ethnicity        
Mexican Americans 03-04 .384 (.307-.480) .365 (.280-.455) .768 (.619-.990) 1.62 (1.23-2.16) 2.32 (1.78-4.01) 618 
 05-06 .425 (.337-.536) .400 (.310-.490) .840 (.560-1.29) 1.82 (1.30-2.47) 2.63 (2.22-3.20) 651 
 07-08 .409 (.350-.479) .380 (.310-.480) .790 (.690-.850) 1.55 (1.08-1.98) 2.03 (1.55-2.70) 514 
 09-10 * .333 (.272-.400) .660 (.494-.861) 1.29 (1.02-1.54) 1.95 (1.52-2.89) 615 
Non-Hispanic blacks 03-04 .343 (.301-.391) .306 (.265-.368) .587 (.522-.687) 1.28 (.964-1.63) 2.13 (1.41-2.87) 713 
 05-06 .328 (.285-.378) .320 (.270-.370) .610 (.470-.780) 1.15 (.930-1.40) 1.64 (1.29-1.96) 691 
 07-08 .350 (.303-.404) .330 (.280-.380) .590 (.490-.690) 1.10 (.840-1.46) 1.85 (1.13-2.77) 589 
 09-10 * .317 (.259-.393) .582 (.500-.659) 1.05 (.900-1.30) 1.55 (1.18-1.96) 546 
Non-Hispanic whites 03-04 .463 (.400-.537) .476 (.385-.588) .970 (.800-1.07) 1.67 (1.32-2.11) 2.40 (1.88-2.90) 1066 
 05-06 .475 (.426-.531) .490 (.440-.540) .890 (.820-1.02) 1.61 (1.42-1.75) 2.23 (1.98-2.50) 1044 
 07-08 .481 (.423-.546) .480 (.390-.540) .890 (.750-1.03) 1.58 (1.34-2.02) 2.49 (1.89-3.18) 1100 
 09-10 * .434 (.370-.500) .833 (.689-1.04) 1.50 (1.26-1.87) 2.12 (1.80-2.64) 1225 
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Urinary Mercury (creatinine corrected) (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 .367 (.333-.405) .353 (.306-.394) .676 (.623-.754) 1.33 (1.13-1.50) 1.75 (1.49-2.32) 2505 
 13-14 .283 (.260-.309) .270 (.250-.290) .571 (.511-.644) 1.20 (1.05-1.36) 1.61 (1.47-1.81) 2665 
Age group        
6-11 years 11-12 .345 (.298-.398) .306 (.276-.344) .537 (.441-.613) 1.08 (.884-1.43) 1.62 (1.07-2.34) 400 
 13-14 * < LOD .429 (.310-.529) .750 (.563-.897) 1.11 (.713-1.72) 401 
12-19 years 11-12 .246 (.219-.277) .221 (.190-.269) .405 (.368-.453) .735 (.571-1.11) 1.21 (.742-1.49) 390 
 13-14 * < LOD .257 (.200-.281) .580 (.391-.735) .846 (.580-1.07) 452 
20 years and older 11-12 .393 (.351-.439) .383 (.330-.437) .750 (.673-.805) 1.38 (1.17-1.63) 1.95 (1.50-2.48) 1715 
 13-14 .318 (.291-.349) .304 (.281-.333) .644 (.561-.741) 1.32 (1.13-1.47) 1.76 (1.50-1.88) 1812 
Gender        
Males 11-12 .320 (.278-.368) .294 (.267-.358) .558 (.478-.667) 1.11 (.791-1.44) 1.57 (1.21-2.00) 1259 
 13-14 .242 (.223-.263) .231 (.206-.259) .476 (.429-.542) .902 (.779-1.11) 1.31 (1.13-1.49) 1318 
Females 11-12 .418 (.374-.466) .409 (.355-.453) .800 (.706-.900) 1.46 (1.29-1.65) 2.00 (1.63-2.60) 1246 
 13-14 .330 (.297-.367) .315 (.273-.356) .692 (.600-.822) 1.44 (1.18-1.68) 1.83 (1.60-2.12) 1347 
Race/ethnicity        
Mexican Americans 11-12 .339 (.288-.399) .286 (.225-.393) .641 (.433-.789) 1.17 (1.00-1.42) 1.70 (1.31-2.24) 317 
 13-14 .261 (.231-.295) .237 (.209-.273) .516 (.409-.709) 1.04 (.810-1.48) 1.62 (1.11-2.55) 454 
Non-Hispanic blacks 11-12 .280 (.245-.320) .261 (.224-.294) .467 (.411-.529) .896 (.638-1.14) 1.43 (1.10-1.57) 671 
 13-14 .211 (.169-.264) .202 (.152-.269) .409 (.333-.516) .794 (.643-1.10) 1.34 (.880-1.52) 580 
Non-Hispanic whites 11-12 .372 (.323-.428) .364 (.294-.433) .700 (.619-.805) 1.35 (1.05-1.63) 1.75 (1.41-2.48) 817 
 13-14 .295 (.269-.323) .278 (.257-.310) .602 (.516-.689) 1.27 (1.08-1.45) 1.64 (1.46-1.82) 987 
All Hispanics 11-12 .369 (.342-.399) .331 (.283-.384) .674 (.612-.772) 1.24 (1.13-1.44) 1.86 (1.47-2.92) 574 
 13-14 .267 (.237-.300) .237 (.214-.273) .541 (.448-.634) 1.07 (.837-1.36) 1.61 (1.24-1.86) 702 
Asians 11-12 .577 (.473-.705) .562 (.467-.700) 1.16 (.872-1.44) 1.82 (1.54-2.00) 2.29 (1.90-3.12) 355 
 13-14 .488 (.422-.565) .475 (.373-.600) .917 (.779-1.06) 1.88 (1.35-2.19) 2.57 (1.88-4.24) 291 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 45.9 (40.1-52.6) 50.7 (44.6-58.4) 84.9 (78.7-92.3) 135 (125-146) 180 (154-216) 2257 
 01-02 45.0 (42.1-48.0) 52.4 (48.9-55.5) 83.4 (79.1-88.7) 124 (117-130) 165 (145-176) 2690 
 03-04 39.7 (37.7-41.7) 44.5 (41.6-46.7) 78.5 (74.9-82.3) 111 (105-118) 138 (133-146) 2558 
 05-06 45.0 (42.4-47.8) 51.0 (47.2-54.7) 81.5 (77.4-85.8) 127 (117-132) 158 (144-174) 2576 
 07-08 45.2 (43.1-47.3) 49.7 (47.4-52.0) 86.2 (82.3-89.3) 136 (128-142) 163 (154-171) 2627 
 09-10 42.7 (40.8-44.7) 45.2 (43.6-47.3) 79.9 (75.9-83.0) 121 (112-130) 160 (147-180) 2848 
Age group        
6-11 years 99-00 78.2 (61.0-100) 84.8 (67.7-105) 126 (106-147) 178 (147-259) 267 (159-840) 310 
 01-02 63.3 (53.4-75.0) 69.2 (63.0-77.6) 109 (94.5-124) 169 (138-197) 197 (161-291) 368 
 03-04 62.2 (56.7-68.3) 71.3 (55.7-84.1) 108 (92.7-122) 138 (127-152) 181 (138-235) 290 
 05-06 65.6 (56.6-76.0) 73.5 (62.8-85.5) 108 (98.6-115) 154 (130-176) 181 (154-205) 355 
 07-08 69.3 (60.8-79.0) 72.8 (62.1-83.9) 123 (99.9-148) 169 (154-217) 235 (169-282) 394 
 09-10 65.0 (57.8-73.2) 69.7 (61.1-84.2) 123 (103-138) 180 (146-205) 218 (180-263) 378 
12-19 years 99-00 54.3 (47.6-62.0) 60.6 (52.2-70.3) 93.3 (79.9-109) 146 (112-171) 188 (146-216) 648 
 01-02 60.6 (55.5-66.2) 65.7 (58.7-73.1) 97.1 (91.8-108) 145 (129-159) 179 (155-227) 762 
 03-04 52.5 (49.0-56.3) 59.6 (55.5-65.1) 87.3 (84.5-91.4) 118 (105-125) 143 (130-156) 725 
 05-06 59.1 (53.7-65.1) 63.8 (57.9-69.4) 96.6 (86.3-103) 136 (127-147) 173 (148-202) 701 
 07-08 64.1 (58.6-70.2) 68.6 (63.7-80.2) 107 (97.2-118) 149 (125-167) 174 (151-196) 376 
 09-10 52.4 (47.5-57.7) 58.5 (51.4-65.6) 96.2 (85.0-104) 148 (120-170) 178 (151-201) 451 
20 years and older 99-00 41.7 (36.7-47.4) 46.6 (40.5-52.5) 76.7 (73.4-82.2) 126 (114-134) 168 (143-206) 1299 
 01-02 41.1 (38.3-44.1) 47.6 (43.7-51.2) 79.1 (71.9-83.6) 114 (103-124) 150 (130-166) 1560 
 03-04 35.9 (34.0-38.0) 40.3 (37.6-42.1) 71.5 (67.3-75.2) 105 (98.6-111) 133 (119-144) 1543 
 05-06 41.3 (38.7-44.0) 46.0 (41.7-49.6) 75.7 (72.1-80.3) 116 (107-127) 153 (135-171) 1520 
 07-08 40.8 (38.7-43.0) 44.5 (42.2-47.8) 77.7 (74.1-81.2) 123 (114-135) 152 (145-164) 1857 
 09-10 39.6 (37.5-41.8) 42.0 (39.8-43.9) 73.5 (69.0-76.8) 107 (100-113) 144 (130-163) 2019 
Gender        
Males 99-00 52.7 (45.7-60.7) 57.5 (48.5-68.4) 93.2 (83.8-106) 150 (128-187) 215 (161-278) 1121 
 01-02 51.0 (46.6-55.7) 56.9 (52.0-62.6) 88.5 (81.6-96.5) 130 (120-141) 169 (145-194) 1335 
 03-04 45.5 (43.3-47.8) 51.0 (48.1-55.4) 85.8 (82.8-90.7) 119 (112-130) 148 (136-163) 1281 
 05-06 50.9 (48.2-53.9) 56.0 (51.0-60.3) 85.7 (80.3-92.8) 130 (122-136) 161 (145-177) 1271 
 07-08 50.6 (48.1-53.2) 56.7 (52.4-60.6) 93.6 (88.7-98.7) 148 (137-150) 171 (159-178) 1327 
 09-10 46.2 (43.5-49.1) 50.2 (46.4-52.7) 81.8 (77.0-85.9) 127 (113-144) 169 (147-197) 1398 
Females 99-00 40.4 (34.8-46.8) 45.6 (40.4-52.0) 77.3 (71.0-85.7) 119 (105-138) 154 (132-180) 1136 
 01-02 39.9 (37.2-42.9) 45.8 (42.8-49.3) 78.4 (72.6-82.9) 115 (104-128) 158 (130-177) 1355 
 03-04 34.9 (32.2-37.7) 37.9 (33.5-41.6) 67.3 (64.6-72.2) 101 (97.3-108) 127 (114-139) 1277 
 05-06 40.0 (36.4-43.8) 45.6 (40.0-51.0) 75.6 (71.2-82.0) 118 (107-128) 154 (136-179) 1305 
 07-08 40.5 (38.1-43.0) 43.5 (39.0-48.0) 77.0 (72.0-84.5) 123 (114-134) 152 (142-165) 1300 
 09-10 39.6 (36.9-42.4) 41.4 (39.0-43.8) 76.8 (70.7-82.0) 114 (106-127) 151 (135-170) 1450 
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Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 47.0 (42.1-52.4) 53.2 (49.2-59.0) 80.6 (73.7-91.7) 121 (103-139) 152 (120-217) 780 
 01-02 49.3 (46.5-52.3) 55.7 (50.4-61.0) 86.4 (80.8-94.1) 133 (113-155) 177 (142-207) 683 
 03-04 47.0 (43.1-51.1) 54.4 (48.2-59.9) 82.9 (73.2-91.0) 121 (106-143) 152 (141-169) 618 
 05-06 55.1 (51.7-58.7) 58.4 (54.1-63.6) 98.3 (91.5-105) 140 (134-150) 177 (153-200) 652 
 07-08 53.3 (47.6-59.6) 57.3 (49.6-64.3) 90.4 (82.5-97.2) 140 (125-156) 176 (154-191) 515 
 09-10 49.4 (45.9-53.2) 51.1 (46.4-55.4) 81.4 (76.2-85.9) 134 (115-149) 180 (148-231) 613 
Non-Hispanic blacks 99-00 57.7 (51.0-65.2) 62.2 (55.0-71.5) 97.8 (85.0-110) 153 (126-188) 206 (150-274) 546 
 01-02 53.2 (49.9-56.7) 60.3 (55.1-63.8) 90.0 (81.0-101) 132 (121-147) 166 (147-170) 667 
 03-04 46.0 (41.7-50.8) 46.2 (40.9-55.2) 82.3 (73.3-91.3) 117 (109-129) 156 (135-175) 723 
 05-06 48.1 (44.7-51.8) 52.0 (48.3-55.7) 80.0 (71.6-89.4) 125 (112-133) 160 (139-189) 692 
 07-08 51.9 (45.6-59.1) 56.9 (47.5-65.8) 90.3 (83.0-102) 137 (118-158) 168 (147-180) 589 
 09-10 45.8 (41.4-50.8) 52.1 (47.9-55.6) 85.6 (77.7-94.0) 132 (107-166) 184 (152-216) 544 
Non-Hispanic whites 99-00 44.5 (37.0-53.4) 48.5 (41.1-59.8) 85.0 (76.7-96.5) 135 (119-154) 187 (146-223) 760 
 01-02 42.2 (38.5-46.2) 48.9 (44.2-53.2) 80.7 (71.9-85.8) 117 (108-129) 152 (134-180) 1132 
 03-04 37.1 (34.7-39.6) 41.3 (38.1-44.5) 75.2 (69.2-79.6) 107 (99.3-115) 130 (119-142) 1074 
 05-06 42.8 (39.7-46.1) 48.6 (42.3-53.4) 79.0 (73.5-84.0) 123 (108-132) 156 (136-178) 1041 
 07-08 41.7 (39.2-44.5) 46.5 (42.9-49.8) 81.2 (76.6-86.6) 131 (119-142) 153 (149-164) 1095 
 09-10 40.6 (38.1-43.1) 42.6 (39.6-45.3) 75.9 (70.6-81.0) 114 (104-123) 148 (134-166) 1225 
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Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 37.1 (35.1-39.1) 40.0 (37.6-42.2) 69.1 (64.9-74.8) 111 (102-123) 146 (140-160) 2504 
 13-14 33.9 (31.6-36.4) 36.0 (32.1-40.3) 68.0 (63.2-72.9) 105 (98.7-112) 139 (128-156) 2664 
Age group        
6-11 years 11-12 58.4 (51.5-66.2) 65.1 (52.8-74.5) 116 (95.6-129) 168 (145-199) 211 (187-283) 399 
 13-14 51.7 (47.1-56.6) 54.7 (49.3-61.9) 98.2 (82.2-105) 144 (130-164) 182 (159-210) 402 
12-19 years 11-12 46.4 (40.2-53.7) 51.0 (44.2-61.8) 83.6 (70.1-97.7) 141 (106-153) 163 (145-173) 390 
 13-14 48.2 (41.5-55.8) 55.9 (49.0-64.8) 89.3 (80.1-97.2) 128 (105-150) 156 (136-180) 451 
20 years and older 11-12 34.1 (31.8-36.5) 37.3 (33.6-39.8) 63.6 (59.2-69.2) 101 (92.9-109) 136 (120-146) 1715 
 13-14 30.8 (28.5-33.3) 32.7 (28.3-36.0) 61.6 (55.9-67.4) 95.4 (89.3-99.4) 129 (116-137) 1811 
Gender        
Males 11-12 42.5 (38.6-46.9) 45.9 (39.7-52.6) 77.1 (71.2-84.0) 122 (105-135) 146 (136-173) 1262 
 13-14 37.9 (35.2-40.9) 41.3 (38.0-45.9) 73.9 (68.4-79.2) 113 (104-127) 152 (134-173) 1318 
Females 11-12 32.5 (30.0-35.2) 33.7 (30.5-38.7) 61.5 (57.7-66.9) 102 (92.9-117) 148 (121-170) 1242 
 13-14 30.4 (28.2-32.8) 31.7 (26.8-36.0) 62.6 (56.0-67.2) 96.3 (87.1-105) 129 (115-142) 1346 
Race/ethnicity        
Mexican Americans 11-12 44.1 (39.8-49.0) 49.4 (41.6-52.9) 78.8 (72.1-87.0) 117 (102-146) 167 (136-214) 317 
 13-14 40.9 (34.4-48.7) 43.7 (34.8-55.7) 79.3 (64.6-90.8) 119 (96.6-149) 161 (133-205) 453 
Non-Hispanic blacks 11-12 44.4 (41.3-47.7) 48.6 (44.6-51.8) 78.5 (70.8-89.4) 125 (110-139) 158 (138-177) 669 
 13-14 43.8 (39.0-49.2) 49.3 (40.6-55.9) 79.6 (70.0-89.3) 116 (105-132) 150 (124-182) 581 
Non-Hispanic whites 11-12 33.8 (31.4-36.4) 36.9 (32.0-40.2) 64.4 (59.4-69.4) 103 (94.2-117) 141 (125-146) 820 
 13-14 30.5 (27.5-33.8) 32.1 (26.5-37.4) 63.0 (54.7-68.4) 96.7 (88.9-105) 129 (113-143) 985 
All Hispanics 11-12 43.3 (38.9-48.2) 47.6 (40.2-53.7) 81.4 (70.5-90.3) 123 (113-141) 167 (145-184) 573 
 13-14 39.8 (34.7-45.7) 42.5 (34.3-52.5) 78.2 (68.4-86.4) 115 (98.0-134) 150 (134-183) 701 
Asians 11-12 44.2 (38.8-50.4) 49.7 (44.0-55.2) 83.0 (72.0-95.9) 124 (106-157) 166 (126-227) 353 
 13-14 36.0 (31.3-41.4) 34.9 (31.2-40.5) 70.0 (56.1-77.6) 127 (99.4-166) 196 (133-259) 292 
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Urinary Molybdenum (creatinine corrected) (1999 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 43.2 (40.0-46.6) 41.6 (38.5-45.2) 63.5 (59.3-68.8) 108 (97.3-115) 144 (125-171) 2257 
 01-02 42.5 (39.9-45.2) 42.2 (40.1-45.2) 62.0 (58.4-66.4) 98.8 (90.1-109) 130 (120-149) 2689 
 03-04 39.4 (37.6-41.3) 39.2 (37.9-40.7) 58.3 (55.6-61.5) 89.0 (80.5-99.0) 120 (107-135) 2558 
 05-06 44.3 (42.4-46.3) 43.9 (41.8-45.7) 65.9 (61.8-68.6) 97.3 (92.5-103) 132 (125-143) 2576 
 07-08 47.1 (45.8-48.4) 46.3 (44.8-47.7) 72.4 (68.7-74.3) 104 (96.7-111) 137 (127-152) 2627 
 09-10 45.5 (43.2-47.8) 44.4 (41.9-47.4) 67.2 (64.7-69.4) 105 (95.4-121) 143 (129-157) 2848 
Age group        
6-11 years 99-00 85.9 (73.7-100) 79.3 (71.6-88.4) 122 (107-133) 173 (130-243) 214 (154-1040) 310 
 01-02 77.2 (73.1-81.5) 77.6 (71.8-84.5) 109 (99.4-120) 159 (129-170) 185 (165-219) 368 
 03-04 72.5 (65.2-80.7) 73.5 (65.1-79.9) 101 (84.9-117) 132 (107-158) 160 (129-257) 290 
 05-06 81.0 (71.9-91.3) 78.6 (72.1-89.0) 112 (93.7-134) 161 (133-199) 201 (160-261) 355 
 07-08 90.4 (81.8-99.8) 88.2 (79.2-101) 133 (113-147) 206 (159-259) 274 (224-354) 394 
 09-10 88.6 (81.9-95.9) 89.0 (79.2-95.4) 131 (123-148) 174 (154-191) 195 (178-216) 378 
12-19 years 99-00 41.9 (39.3-44.6) 40.5 (37.7-44.4) 57.3 (51.5-62.5) 85.4 (67.4-107) 112 (78.4-185) 648 
 01-02 43.4 (40.8-46.1) 44.1 (40.8-47.2) 60.8 (57.6-63.7) 85.5 (79.7-93.8) 106 (94.8-118) 762 
 03-04 37.5 (35.4-39.8) 38.9 (36.9-41.8) 53.2 (50.3-56.1) 71.9 (64.6-76.9) 81.0 (74.3-102) 725 
 05-06 45.5 (42.5-48.7) 45.7 (41.3-49.2) 64.6 (58.5-71.2) 91.4 (75.3-102) 109 (95.0-131) 701 
 07-08 50.1 (47.2-53.2) 50.1 (44.2-53.4) 71.6 (64.0-79.6) 95.8 (85.1-107) 129 (99.5-138) 376 
 09-10 49.0 (45.3-53.0) 50.7 (44.6-56.2) 67.6 (63.0-73.1) 93.6 (85.8-101) 126 (96.4-134) 451 
20 years and older 99-00 39.6 (36.9-42.6) 38.5 (36.1-41.0) 56.4 (53.5-60.7) 92.5 (83.1-100) 122 (116-147) 1299 
 01-02 39.3 (36.8-42.0) 39.6 (36.4-42.1) 57.2 (52.9-61.0) 86.7 (75.2-96.8) 123 (109-139) 1559 
 03-04 36.9 (35.0-38.9) 37.0 (35.7-38.4) 53.5 (50.0-56.9) 79.8 (75.9-87.5) 118 (101-134) 1543 
 05-06 41.2 (39.3-43.1) 40.5 (38.8-42.7) 59.1 (55.6-62.8) 87.9 (79.7-96.9) 119 (103-132) 1520 
 07-08 43.5 (42.1-44.9) 42.9 (41.3-44.7) 64.9 (61.7-69.9) 94.7 (90.8-97.1) 122 (110-132) 1857 
 09-10 41.9 (40.0-43.9) 41.2 (39.4-43.0) 61.9 (59.0-64.0) 90.4 (84.3-98.5) 127 (115-141) 2019 
Gender        
Males 99-00 40.8 (37.5-44.3) 38.5 (37.2-40.4) 62.4 (55.9-68.4) 101 (83.9-118) 131 (112-179) 1121 
 01-02 40.3 (37.1-43.8) 40.2 (36.3-43.3) 60.5 (54.8-66.3) 91.3 (83.4-106) 123 (107-155) 1334 
 03-04 38.3 (36.1-40.7) 37.8 (36.1-39.3) 56.3 (53.3-59.3) 85.7 (77.2-96.7) 118 (100-139) 1281 
 05-06 41.8 (39.5-44.2) 41.7 (39.2-44.1) 62.1 (58.1-67.4) 94.6 (84.2-101) 126 (112-132) 1271 
 07-08 45.3 (43.8-46.8) 44.6 (42.9-46.7) 72.3 (65.4-74.8) 105 (96.0-118) 135 (126-152) 1327 
 09-10 42.1 (39.6-44.9) 41.3 (38.7-44.2) 63.4 (59.4-67.4) 101 (88.3-121) 139 (123-151) 1398 
Females 99-00 45.5 (41.5-50.0) 44.1 (39.5-48.8) 64.4 (59.5-70.5) 112 (95.2-121) 152 (122-181) 1136 
 01-02 44.6 (42.2-47.1) 45.1 (42.2-46.9) 63.6 (59.5-69.4) 107 (92.5-119) 136 (117-169) 1355 
 03-04 40.5 (38.1-43.0) 41.1 (38.7-43.7) 61.4 (56.8-65.1) 90.1 (82.2-103) 122 (115-142) 1277 
 05-06 46.9 (44.7-49.2) 46.5 (43.9-48.8) 67.2 (63.3-71.7) 103 (93.6-110) 157 (126-173) 1305 
 07-08 48.9 (47.2-50.7) 48.3 (45.7-51.0) 72.6 (69.2-74.4) 103 (93.6-116) 139 (113-177) 1300 
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Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 42.9 (40.6-45.4) 43.2 (40.9-45.6) 61.6 (57.2-65.5) 89.5 (80.0-103) 115 (93.7-137) 780 
 01-02 48.1 (44.3-52.2) 48.4 (44.8-52.3) 71.7 (66.4-76.0) 103 (90.0-120) 129 (109-155) 682 
 03-04 43.5 (40.5-46.8) 43.5 (41.0-46.2) 62.8 (56.8-67.2) 85.9 (79.5-97.0) 112 (97.0-133) 618 
 05-06 51.8 (49.9-53.8) 52.1 (49.7-54.7) 73.5 (69.5-77.4) 106 (99.5-111) 133 (112-151) 652 
 07-08 53.3 (50.2-56.5) 51.9 (47.1-55.3) 77.9 (70.6-82.1) 113 (103-129) 151 (132-185) 515 
 09-10 51.8 (48.9-54.9) 51.4 (48.3-54.8) 74.0 (68.7-78.8) 109 (92.7-125) 148 (125-173) 613 
Non-Hispanic blacks 99-00 37.2 (33.4-41.6) 37.1 (33.0-41.2) 55.9 (49.6-63.3) 88.2 (69.1-112) 119 (88.3-141) 546 
 01-02 36.5 (34.1-39.0) 37.5 (35.1-38.9) 57.1 (49.7-62.4) 78.3 (71.5-92.0) 109 (81.1-127) 667 
 03-04 33.1 (30.5-35.9) 31.7 (30.1-34.7) 47.2 (43.7-52.1) 72.9 (64.6-78.4) 90.5 (78.4-118) 723 
 05-06 34.9 (33.1-36.8) 35.4 (32.7-38.1) 53.5 (49.7-55.8) 81.1 (75.4-89.4) 102 (89.4-119) 692 
 07-08 38.0 (34.8-41.4) 38.7 (34.2-43.0) 57.0 (52.7-60.2) 82.0 (73.2-92.4) 105 (92.0-118) 589 
 09-10 36.3 (32.9-40.1) 37.2 (35.1-39.5) 54.7 (50.3-60.4) 85.2 (68.6-110) 121 (97.1-155) 544 
Non-Hispanic whites 99-00 44.5 (40.2-49.2) 42.1 (38.8-47.3) 65.3 (58.9-71.3) 116 (101-126) 172 (131-195) 760 
 01-02 42.5 (39.3-46.0) 41.9 (39.3-45.6) 61.2 (57.1-67.2) 104 (88.7-120) 138 (120-163) 1132 
 03-04 39.1 (37.2-41.1) 39.3 (37.7-40.8) 58.1 (54.6-61.4) 87.4 (78.9-96.7) 118 (106-134) 1074 
 05-06 44.5 (42.4-46.6) 43.9 (41.7-45.7) 65.0 (59.9-68.5) 97.3 (90.7-105) 132 (119-152) 1041 
 07-08 46.7 (45.0-48.6) 46.1 (43.6-48.4) 72.4 (65.8-75.1) 103 (95.7-113) 135 (120-152) 1095 
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Urinary Molybdenum (creatinine corrected) (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 42.0 (40.4-43.6) 41.0 (38.6-44.4) 62.9 (61.2-65.5) 95.1 (90.9-101) 130 (118-148) 2502 
 13-14 39.1 (37.3-41.1) 39.4 (37.5-41.0) 59.3 (57.1-62.2) 86.9 (83.7-92.5) 117 (108-125) 2663 
Age group        
6-11 years 11-12 83.5 (76.1-91.6) 81.7 (74.3-91.2) 120 (110-129) 178 (146-240) 259 (185-300) 398 
 13-14 77.0 (73.5-80.8) 73.5 (70.0-81.4) 106 (98.4-117) 153 (129-172) 184 (164-225) 402 
12-19 years 11-12 44.4 (40.8-48.4) 43.7 (39.1-48.0) 62.0 (57.8-65.9) 90.4 (76.5-94.8) 109 (92.4-131) 390 
 13-14 43.6 (40.3-47.2) 44.0 (39.1-47.3) 63.2 (59.9-70.8) 90.2 (74.7-107) 113 (95.9-140) 451 
20 years and older 11-12 38.6 (37.1-40.2) 38.5 (36.1-41.0) 57.9 (53.9-61.2) 85.0 (79.5-89.3) 112 (102-123) 1714 
 13-14 35.9 (33.7-38.2) 36.9 (35.1-38.4) 53.4 (50.4-57.1) 79.7 (73.4-83.7) 97.8 (88.5-111) 1810 
Gender        
Males 11-12 39.8 (37.5-42.2) 40.0 (36.0-43.6) 59.5 (56.1-62.9) 88.2 (84.7-96.7) 118 (108-131) 1261 
 13-14 37.9 (35.4-40.6) 38.0 (35.7-40.3) 58.7 (54.5-62.5) 87.7 (82.3-96.4) 119 (104-128) 1317 
Females 11-12 44.2 (41.5-47.0) 43.3 (39.2-45.5) 67.1 (62.8-69.7) 102 (92.4-111) 149 (118-157) 1241 
 13-14 40.4 (38.3-42.6) 40.5 (38.4-43.3) 60.6 (57.1-64.6) 86.8 (82.1-94.4) 116 (104-125) 1346 
Race/ethnicity        
Mexican Americans 11-12 49.6 (43.1-57.1) 48.9 (43.0-56.0) 72.8 (63.6-85.3) 114 (85.7-149) 164 (114-224) 317 
 13-14 46.7 (41.1-53.1) 45.7 (39.0-52.4) 66.9 (60.3-73.0) 103 (83.6-123) 136 (111-205) 453 
Non-Hispanic blacks 11-12 34.5 (32.1-37.1) 34.0 (32.0-36.1) 52.4 (48.0-58.3) 80.7 (70.7-91.7) 104 (87.4-120) 669 
 13-14 33.4 (32.1-34.7) 33.7 (31.4-36.6) 50.1 (46.7-52.9) 74.1 (64.2-81.3) 89.1 (80.9-110) 581 
Non-Hispanic whites 11-12 40.8 (38.4-43.4) 40.0 (37.0-44.6) 61.3 (57.2-64.6) 91.6 (84.9-101) 118 (109-148) 818 
 13-14 37.5 (35.0-40.2) 38.2 (36.1-40.7) 58.2 (53.4-62.8) 84.9 (79.7-91.9) 108 (97.2-119) 984 
All Hispanics 11-12 48.5 (44.5-52.8) 48.7 (44.4-51.9) 71.5 (65.5-76.8) 105 (90.4-122) 146 (112-181) 573 
 13-14 44.4 (40.7-48.6) 44.1 (38.8-48.1) 64.6 (60.3-69.7) 98.0 (85.4-108) 128 (112-160) 701 
Asians 11-12 59.1 (54.2-64.5) 59.5 (51.6-65.2) 91.5 (81.6-102) 158 (137-174) 202 (163-248) 353 
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Urinary Platinum (1999 – 2010) ‡ 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 * < LOD < LOD < LOD < LOD 2465 
 01-02 * < LOD < LOD < LOD < LOD 2690 
 03-04 * < LOD < LOD < LOD < LOD 2558 
 05-06 * < LOD < LOD .009 (<LOD-.012) .014 (.009-.025) 2576 
 07-08 * < LOD < LOD < LOD < LOD 2627 
 09-10 * < LOD < LOD .009 (<LOD-.015) .016 (.009-.049) 2847 
Age group        
6-11 years 99-00 * < LOD < LOD < LOD < LOD 340 
 01-02 * < LOD < LOD < LOD < LOD 368 
 03-04 * < LOD < LOD < LOD < LOD 290 
 05-06 * < LOD < LOD .010 (<LOD-.011) .014 (.010-.020) 355 
 07-08 * < LOD < LOD < LOD .009 (<LOD-.011) 394 
 09-10 * < LOD < LOD .010 (<LOD-.014) .015 (.009-.036) 378 
12-19 years 99-00 * < LOD < LOD < LOD < LOD 719 
 01-02 * < LOD < LOD < LOD < LOD 762 
 03-04 * < LOD < LOD < LOD < LOD 725 
 05-06 * < LOD < LOD < LOD .012 (.009-.019) 701 
 07-08 * < LOD < LOD < LOD .009 (<LOD-.017) 376 
 09-10 * < LOD < LOD .010 (<LOD-.019) .018 (<LOD-.078) 451 
20 years and older 99-00 * < LOD < LOD < LOD < LOD 1406 
 01-02 * < LOD < LOD < LOD < LOD 1560 
 03-04 * < LOD < LOD < LOD < LOD 1543 
 05-06 * < LOD < LOD .009 (<LOD-.014) .014 (.009-.032) 1520 
 07-08 * < LOD < LOD < LOD < LOD 1857 
 09-10 * < LOD < LOD .009 (<LOD-.016) .017 (.009-.049) 2018 
Gender        
Males 99-00 * < LOD < LOD < LOD < LOD 1227 
 01-02 * < LOD < LOD < LOD < LOD 1335 
 03-04 * < LOD < LOD < LOD < LOD 1281 
 05-06 * < LOD < LOD .009 (<LOD-.012) .012 (.009-.020) 1271 
 07-08 * < LOD < LOD < LOD < LOD 1327 
 09-10 * < LOD < LOD .009 (<LOD-.015) .016 (<LOD-.047) 1397 
Females 99-00 * < LOD < LOD < LOD < LOD 1238 
 01-02 * < LOD < LOD < LOD < LOD 1355 
 03-04 * < LOD < LOD < LOD < LOD 1277 
 05-06 * < LOD < LOD .010 (<LOD-.014) .015 (.010-.033) 1305 
 07-08 * < LOD < LOD < LOD .009 (<LOD-.009) 1300 
 09-10 * < LOD < LOD .010 (<LOD-.015) .017 (.009-.051) 1450 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 05-06, 07-08, and 09-10 are 0.04, 0.04, 0.07, 0.009, 0.009, and 0.009 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result.  
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Urinary Platinum (1999 – 2010) ‡ 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 * < LOD < LOD < LOD < LOD 884 
 01-02 * < LOD < LOD < LOD < LOD 683 
 03-04 * < LOD < LOD < LOD < LOD 618 
 05-06 * < LOD < LOD .010 (<LOD-.014) .014 (.009-.023) 652 
 07-08 * < LOD < LOD < LOD .009 (<LOD-.010) 515 
 09-10 * < LOD < LOD < LOD .010 (.009-.012) 613 
Non-Hispanic blacks 99-00 * < LOD < LOD < LOD < LOD 568 
 01-02 * < LOD < LOD < LOD < LOD 667 
 03-04 * < LOD < LOD < LOD < LOD 723 
 05-06 * < LOD < LOD < LOD .011 (.009-.016) 692 
 07-08 * < LOD < LOD < LOD .009 (<LOD-.013) 589 
 09-10 * < LOD < LOD .012 (<LOD-.032) .024 (.009-.103) 544 
Non-Hispanic whites 99-00 * < LOD < LOD < LOD < LOD 822 
 01-02 * < LOD < LOD < LOD < LOD 1132 
 03-04 * < LOD < LOD < LOD < LOD 1074 
 05-06 * < LOD < LOD .009 (<LOD-.012) .013 (.009-.026) 1041 
 07-08 * < LOD < LOD < LOD .009 (<LOD-.009) 1095 
 09-10 * < LOD < LOD .009 (<LOD-.019) .018 (<LOD-.073) 1224 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 05-06, 07-08, and 09-10 are 0.04, 0.04, 0.07, 0.009, 0.009, and 0.009 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result.  
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Urinary Platinum (creatinine corrected) (1999 – 2010) ‡ 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 * < LOD < LOD < LOD < LOD 2465 
 01-02 * < LOD < LOD < LOD < LOD 2689 
 03-04 * < LOD < LOD < LOD < LOD 2558 
 05-06 * < LOD < LOD .021 (<LOD-.023) .029 (.026-.035) 2576 
 07-08 * < LOD < LOD < LOD < LOD 2627 
 09-10 * < LOD < LOD .023 (<LOD-.027) .033 (.026-.046) 2847 
Age group        
6-11 years 99-00 * < LOD < LOD < LOD < LOD 340 
 01-02 * < LOD < LOD < LOD < LOD 368 
 03-04 * < LOD < LOD < LOD < LOD 290 
 05-06 * < LOD < LOD .020 (<LOD-.027) .030 (.021-.050) 355 
 07-08 * < LOD < LOD < LOD .026 (<LOD-.032) 394 
 09-10 * < LOD < LOD .026 (<LOD-.030) .043 (.027-.050) 378 
12-19 years 99-00 * < LOD < LOD < LOD < LOD 719 
 01-02 * < LOD < LOD < LOD < LOD 762 
 03-04 * < LOD < LOD < LOD < LOD 725 
 05-06 * < LOD < LOD < LOD .017 (.012-.026) 701 
 07-08 * < LOD < LOD < LOD .017 (<LOD-.025) 376 
 09-10 * < LOD < LOD .021 (<LOD-.029) .032 (<LOD-.050) 451 
20 years and older 99-00 * < LOD < LOD < LOD < LOD 1406 
 01-02 * < LOD < LOD < LOD < LOD 1559 
 03-04 * < LOD < LOD < LOD < LOD 1543 
 05-06 * < LOD < LOD .022 (<LOD-.025) .030 (.026-.035) 1520 
 07-08 * < LOD < LOD < LOD < LOD 1857 
 09-10 * < LOD < LOD .023 (<LOD-.030) .035 (.024-.050) 2018 
Gender        
Males 99-00 * < LOD < LOD < LOD < LOD 1227 
 01-02 * < LOD < LOD < LOD < LOD 1334 
 03-04 * < LOD < LOD < LOD < LOD 1281 
 05-06 * < LOD < LOD .014 (<LOD-.016) .021 (.016-.025) 1271 
 07-08 * < LOD < LOD < LOD < LOD 1327 
 09-10 * < LOD < LOD .019 (<LOD-.025) .027 (<LOD-.036) 1397 
Females 99-00 * < LOD < LOD < LOD < LOD 1238 
 01-02 * < LOD < LOD < LOD < LOD 1355 
 03-04 * < LOD < LOD < LOD < LOD 1277 
 05-06 * < LOD < LOD .026 (<LOD-.030) .033 (.029-.050) 1305 
 07-08 * < LOD < LOD < LOD .033 (<LOD-.043) 1300 
 09-10 * < LOD < LOD .027 (<LOD-.032) .038 (.030-.054) 1450 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result.  
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Urinary Platinum (creatinine corrected) (1999 – 2010) ‡ 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 * < LOD < LOD < LOD < LOD 884 
 01-02 * < LOD < LOD < LOD < LOD 682 
 03-04 * < LOD < LOD < LOD < LOD 618 
 05-06 * < LOD < LOD .016 (<LOD-.019) .023 (.017-.032) 652 
 07-08 * < LOD < LOD < LOD .025 (<LOD-.033) 515 
 09-10 * < LOD < LOD < LOD .025 (.021-.029) 613 
Non-Hispanic blacks 99-00 * < LOD < LOD < LOD < LOD 568 
 01-02 * < LOD < LOD < LOD < LOD 667 
 03-04 * < LOD < LOD < LOD < LOD 723 
 05-06 * < LOD < LOD < LOD .018 (.014-.022) 692 
 07-08 * < LOD < LOD < LOD .017 (<LOD-.021) 589 
 09-10 * < LOD < LOD .017 (<LOD-.024) .027 (.019-.050) 544 
Non-Hispanic whites 99-00 * < LOD < LOD < LOD < LOD 822 
 01-02 * < LOD < LOD < LOD < LOD 1132 
 03-04 * < LOD < LOD < LOD < LOD 1074 
 05-06 * < LOD < LOD .023 (<LOD-.025) .030 (.027-.035) 1041 
 07-08 * < LOD < LOD < LOD .030 (<LOD-.038) 1095 
 09-10 * < LOD < LOD .025 (<LOD-.032) .036 (<LOD-.058) 1224 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result.  
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Blood Selenium (2011 - 2014) 
 
Geometric mean and selected percentiles of blood concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 190 (187-193) 190 (187-193) 206 (203-210) 223 (219-228) 236 (231-241) 7920 
 13-14 193 (191-195) 193 (190-195) 208 (205-210) 223 (220-228) 235 (232-239) 5215 
Age group        
1-5 years 11-12 167 (164-171) 167 (163-172) 181 (175-187) 196 (187-201) 201 (197-207) 713 
 13-14 168 (166-171) 169 (166-172) 180 (177-183) 192 (187-197) 201 (196-205) 818 
6-11 years 11-12 176 (172-180) 177 (172-181) 189 (185-193) 201 (197-206) 208 (205-215) 1048 
 13-14 180 (177-183) 180 (176-183) 191 (187-195) 204 (198-210) 212 (205-218) 1075 
12-19 years 11-12 189 (184-193) 189 (182-194) 206 (198-211) 220 (212-231) 232 (221-245) 1129 
 13-14 191 (188-194) 192 (188-194) 204 (200-208) 218 (212-222) 224 (220-231) 627 
20 years and older 11-12 193 (190-196) 193 (190-196) 209 (205-213) 227 (222-231) 238 (233-243) 5030 
 13-14 196 (194-198) 196 (193-198) 210 (207-213) 227 (222-232) 238 (235-242) 2695 
Gender        
Males 11-12 192 (189-195) 192 (188-195) 208 (204-213) 227 (221-232) 238 (232-243) 3968 
 13-14 195 (192-197) 195 (193-197) 209 (206-213) 225 (220-231) 235 (230-242) 2587 
Females 11-12 188 (185-191) 188 (186-191) 204 (201-207) 220 (218-224) 233 (227-240) 3952 
 13-14 191 (189-193) 190 (187-193) 205 (202-208) 222 (218-225) 235 (231-238) 2628 
Race/ethnicity        
Mexican Americans 11-12 189 (184-194) 189 (183-195) 205 (200-209) 220 (217-223) 229 (224-233) 1077 
 13-14 191 (188-195) 192 (186-197) 206 (201-210) 221 (214-228) 232 (223-234) 969 
Non-Hispanic blacks 11-12 184 (181-187) 183 (180-187) 199 (196-202) 216 (211-220) 226 (220-233) 2195 
 13-14 190 (187-193) 190 (187-193) 204 (201-209) 222 (219-225) 232 (225-238) 1119 
Non-Hispanic whites 11-12 192 (188-196) 192 (188-196) 208 (204-213) 227 (220-232) 238 (231-245) 2493 
 13-14 194 (191-196) 194 (191-196) 208 (204-211) 224 (219-230) 236 (232-240) 1848 
All Hispanics 11-12 187 (183-191) 188 (183-192) 203 (198-208) 218 (214-222) 228 (223-234) 1931 
 13-14 191 (189-194) 192 (187-196) 206 (203-209) 222 (217-225) 231 (227-234) 1481 
Asians 11-12 193 (189-197) 192 (188-196) 210 (204-215) 227 (223-235) 243 (233-253) 1005 
 13-14 196 (192-201) 194 (189-200) 212 (206-221) 234 (224-245) 251 (237-264) 510 
Limit of detection (LOD, see Data Analysis section) for Survey year 11-12 and 13-14 are 30.0 and 24.5. 
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Serum Selenium (2011 - 2014) 
 
Geometric mean and selected percentiles of serum concentrations (in µg/L) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 127 (125-130) 127 (124-130) 139 (136-142) 151 (148-155) 161 (156-164) 2329 
 13-14 128 (126-130) 127 (126-130) 139 (137-142) 151 (149-153) 159 (156-161) 2519 
Age group        
6-11 years 11-12 117 (115-119) 118 (115-120) 128 (124-130) 133 (132-136) 138 (135-140) 316 
 13-14 118 (115-120) 117 (114-121) 127 (123-131) 135 (130-142) 142 (136-144) 339 
12-19 years 11-12 125 (122-128) 124 (121-127) 136 (130-139) 145 (139-153) 154 (143-178) 366 
 13-14 124 (121-127) 123 (120-126) 134 (128-141) 146 (139-151) 151 (144-157) 418 
20 years and older 11-12 129 (126-132) 129 (125-132) 141 (138-144) 153 (149-157) 163 (158-166) 1647 
 13-14 129 (127-131) 129 (127-131) 141 (138-144) 153 (151-154) 161 (157-162) 1762 
Gender        
Males 11-12 129 (127-132) 129 (126-132) 142 (138-145) 153 (147-162) 163 (155-167) 1162 
 13-14 130 (128-132) 130 (127-132) 144 (141-146) 153 (151-156) 161 (157-162) 1235 
Females 11-12 125 (123-128) 125 (122-129) 137 (134-141) 149 (145-154) 158 (151-166) 1167 
 13-14 125 (124-127) 126 (123-128) 136 (134-139) 147 (145-149) 154 (152-159) 1284 
Race/ethnicity        
Mexican Americans 11-12 126 (124-128) 124 (122-127) 137 (134-140) 151 (142-157) 157 (153-163) 285 
 13-14 129 (125-134) 128 (124-135) 140 (136-146) 153 (147-159) 159 (152-165) 431 
Non-Hispanic blacks 11-12 122 (120-124) 122 (119-124) 132 (130-134) 143 (139-145) 149 (145-157) 620 
 13-14 124 (122-127) 124 (122-127) 135 (131-138) 147 (140-152) 153 (150-160) 516 
Non-Hispanic whites 11-12 129 (126-133) 129 (125-133) 142 (138-145) 154 (149-158) 163 (158-167) 780 
 13-14 128 (125-130) 128 (125-130) 140 (136-143) 151 (148-153) 158 (154-161) 975 
All Hispanics 11-12 125 (123-126) 123 (122-125) 135 (131-140) 149 (144-153) 157 (151-163) 525 
 13-14 129 (126-132) 129 (125-134) 141 (138-145) 153 (148-156) 159 (155-163) 666 
Asians 11-12 126 (123-129) 124 (120-128) 137 (135-140) 152 (143-158) 158 (152-171) 323 
 13-14 130 (126-134) 129 (124-133) 142 (137-147) 159 (151-170) 172 (159-182) 267 
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Urinary Strontium (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 85.8 (80.8-91.1) 90.5 (82.6-98.2) 167 (156-176) 249 (229-269) 321 (288-352) 2503 
 13-14 81.2 (77.6-85.1) 88.1 (83.3-92.7) 151 (142-157) 231 (216-244) 299 (267-342) 2664 
Age group        
6-11 years 11-12 81.9 (69.7-96.2) 91.7 (72.8-106) 179 (135-226) 285 (236-319) 349 (265-466) 399 
 13-14 66.6 (58.6-75.6) 77.8 (67.4-89.2) 133 (119-150) 195 (156-230) 232 (198-255) 402 
12-19 years 11-12 96.8 (82.3-114) 101 (86.4-128) 185 (160-215) 296 (226-348) 350 (274-426) 390 
 13-14 98.1 (85.0-113) 117 (96.6-138) 184 (173-199) 285 (245-311) 369 (294-383) 451 
20 years and older 11-12 84.6 (79.5-90.1) 87.8 (79.9-95.5) 160 (154-171) 239 (222-262) 307 (271-346) 1714 
 13-14 80.7 (76.3-85.3) 86.0 (81.3-90.6) 145 (134-154) 226 (209-244) 298 (260-348) 1811 
Gender        
Males 11-12 95.8 (88.7-103) 102 (95.6-114) 172 (157-189) 255 (215-291) 307 (277-358) 1262 
 13-14 87.8 (82.5-93.4) 94.8 (88.0-102) 158 (147-176) 235 (219-256) 312 (273-344) 1318 
Females 11-12 77.2 (71.5-83.4) 78.3 (72.4-85.2) 156 (140-173) 243 (221-270) 331 (276-355) 1241 
 13-14 75.4 (71.0-80.1) 79.2 (75.8-84.5) 141 (130-151) 221 (190-251) 286 (253-368) 1346 
Race/ethnicity        
Mexican Americans 11-12 85.8 (76.0-96.8) 89.4 (76.1-103) 189 (165-200) 258 (228-266) 302 (260-345) 317 
 13-14 93.0 (80.8-107) 97.0 (83.7-111) 165 (144-201) 248 (209-328) 339 (254-443) 453 
Non-Hispanic blacks 11-12 74.9 (68.0-82.4) 82.8 (75.8-91.3) 143 (132-160) 221 (194-239) 269 (239-298) 669 
 13-14 73.8 (68.7-79.2) 82.0 (77.1-92.4) 132 (123-147) 213 (178-235) 255 (232-292) 581 
Non-Hispanic whites 11-12 87.2 (80.4-94.6) 91.1 (81.0-100) 169 (154-180) 256 (214-296) 343 (278-391) 819 
 13-14 79.8 (75.0-84.8) 85.6 (79.9-92.3) 149 (137-157) 223 (206-251) 298 (254-363) 985 
All Hispanics 11-12 85.6 (74.8-98.0) 89.4 (77.8-108) 170 (151-198) 246 (221-262) 289 (260-325) 573 
 13-14 90.3 (80.5-101) 97.0 (87.0-106) 164 (149-189) 246 (223-278) 326 (255-390) 701 
Asians 11-12 97.0 (85.7-110) 98.4 (84.8-121) 187 (161-206) 280 (239-303) 343 (288-384) 353 
 13-14 85.5 (72.5-101) 93.0 (80.1-105) 159 (132-189) 290 (189-383) 372 (241-534) 292 
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Urinary Strontium (creatinine corrected) (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 97.2 (90.1-105) 99.7 (91.4-110) 156 (143-174) 240 (221-258) 320 (287-341) 2501 
 13-14 93.9 (88.6-99.5) 100 (93.2-105) 150 (142-158) 225 (194-254) 287 (255-324) 2663 
Age group        
6-11 years 11-12 118 (104-133) 124 (105-150) 222 (185-245) 288 (271-338) 354 (299-507) 398 
 13-14 99.3 (84.0-117) 113 (87.2-136) 181 (151-224) 254 (224-303) 303 (255-316) 402 
12-19 years 11-12 92.6 (79.6-108) 95.3 (73.9-119) 150 (122-172) 221 (175-248) 279 (228-320) 390 
 13-14 88.8 (83.7-94.2) 94.9 (88.0-104) 141 (129-151) 203 (181-227) 232 (207-270) 451 
20 years and older 11-12 95.9 (89.0-103) 98.6 (91.0-109) 155 (140-171) 233 (213-255) 315 (278-346) 1713 
 13-14 94.1 (88.5-100) 100 (92.4-105) 148 (140-157) 223 (193-256) 294 (255-339) 1810 
Gender        
Males 11-12 89.5 (82.2-97.5) 91.8 (86.2-101) 142 (130-159) 210 (190-237) 275 (239-314) 1261 
 13-14 87.9 (83.7-92.2) 93.4 (87.8-100) 139 (130-150) 199 (181-228) 253 (207-294) 1317 
Females 11-12 105 (96.6-114) 110 (98.5-117) 178 (152-203) 261 (237-313) 346 (315-371) 1240 
 13-14 100 (92.5-108) 105 (95.4-113) 159 (150-171) 244 (216-288) 325 (278-390) 1346 
Race/ethnicity        
Mexican Americans 11-12 96.5 (88.0-106) 103 (90.3-113) 152 (137-181) 233 (200-274) 283 (258-316) 317 
 13-14 106 (90.8-124) 106 (93.0-125) 173 (140-209) 255 (198-303) 295 (249-402) 453 
Non-Hispanic blacks 11-12 58.2 (53.8-63.0) 64.7 (60.3-68.3) 97.8 (89.3-108) 143 (130-160) 172 (149-216) 669 
 13-14 56.1 (51.9-60.7) 60.4 (55.3-65.1) 91.7 (82.6-104) 135 (125-160) 187 (150-220) 581 
Non-Hispanic whites 11-12 105 (94.3-118) 109 (95.1-118) 168 (148-200) 255 (235-295) 341 (313-367) 817 
 13-14 98.5 (93.0-104) 104 (97.7-110) 150 (142-159) 223 (193-255) 286 (251-314) 984 
All Hispanics 11-12 95.8 (87.5-105) 102 (92.4-112) 150 (136-172) 213 (195-240) 274 (222-315) 573 
 13-14 101 (86.9-117) 103 (89.4-122) 163 (136-198) 248 (195-291) 293 (237-402) 701 
Asians 11-12 130 (120-141) 132 (117-142) 197 (179-217) 295 (246-336) 405 (314-474) 353 
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Urinary Thallium (1999 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 .176 (.162-.192) .200 (.180-.220) .290 (.270-.330) .400 (.370-.420) .450 (.430-.480) 2413 
 01-02 .165 (.154-.177) .190 (.180-.200) .280 (.260-.290) .370 (.350-.390) .440 (.410-.470) 2653 
 03-04 .155 (.145-.165) .170 (.160-.180) .270 (.250-.290) .370 (.340-.400) .440 (.410-.490) 2558 
 05-06 .158 (.151-.165) .180 (.170-.190) .270 (.260-.280) .360 (.350-.390) .430 (.410-.460) 2576 
 07-08 .146 (.139-.153) .160 (.150-.170) .250 (.230-.260) .330 (.320-.360) .400 (.390-.420) 2627 
 09-10 .144 (.137-.152) .160 (.150-.170) .240 (.230-.250) .340 (.310-.360) .410 (.380-.440) 2848 
Age group        
6-11 years 99-00 .201 (.167-.243) .210 (.150-.280) .310 (.250-.350) .410 (.330-.450) .450 (.350-.590) 336 
 01-02 .172 (.147-.202) .200 (.160-.220) .290 (.230-.330) .350 (.340-.370) .390 (.360-.430) 362 
 03-04 .191 (.170-.215) .190 (.170-.230) .300 (.250-.370) .430 (.360-.500) .510 (.430-.690) 290 
 05-06 .174 (.158-.192) .190 (.170-.210) .280 (.250-.300) .380 (.320-.430) .430 (.400-.480) 355 
 07-08 .166 (.150-.185) .170 (.150-.200) .250 (.230-.270) .350 (.310-.410) .420 (.360-.470) 394 
 09-10 .161 (.147-.176) .170 (.150-.200) .280 (.230-.310) .360 (.330-.410) .440 (.400-.460) 378 
12-19 years 99-00 .202 (.181-.225) .220 (.200-.240) .300 (.270-.340) .410 (.390-.430) .470 (.430-.510) 697 
 01-02 .200 (.182-.220) .220 (.190-.250) .310 (.290-.320) .370 (.350-.420) .470 (.400-.500) 746 
 03-04 .201 (.185-.218) .220 (.210-.240) .310 (.290-.320) .410 (.360-.470) .500 (.420-.560) 725 
 05-06 .182 (.165-.200) .210 (.190-.230) .290 (.270-.310) .370 (.350-.400) .430 (.390-.480) 701 
 07-08 .172 (.155-.190) .180 (.160-.210) .270 (.230-.300) .330 (.310-.350) .390 (.340-.420) 376 
 09-10 .150 (.137-.163) .160 (.150-.180) .250 (.240-.270) .340 (.290-.380) .400 (.350-.430) 451 
20 years and older 99-00 .170 (.157-.183) .190 (.180-.210) .290 (.260-.320) .400 (.370-.420) .450 (.420-.480) 1380 
 01-02 .159 (.147-.173) .190 (.170-.200) .270 (.250-.290) .380 (.350-.400) .440 (.410-.490) 1545 
 03-04 .145 (.134-.156) .160 (.150-.170) .250 (.240-.270) .360 (.330-.390) .420 (.390-.460) 1543 
 05-06 .152 (.144-.161) .170 (.160-.180) .260 (.240-.270) .360 (.340-.390) .440 (.400-.470) 1520 
 07-08 .140 (.133-.148) .150 (.140-.160) .240 (.230-.250) .330 (.310-.360) .400 (.380-.440) 1857 
 09-10 .142 (.133-.150) .160 (.150-.170) .240 (.220-.250) .330 (.310-.360) .410 (.370-.440) 2019 
Gender        
Males 99-00 .197 (.179-.217) .220 (.200-.240) .320 (.280-.350) .400 (.370-.440) .450 (.420-.520) 1200 
 01-02 .184 (.173-.196) .210 (.200-.230) .290 (.280-.300) .380 (.360-.400) .430 (.400-.470) 1313 
 03-04 .167 (.156-.178) .190 (.180-.200) .280 (.260-.300) .370 (.340-.400) .430 (.400-.480) 1281 
 05-06 .171 (.163-.179) .190 (.180-.200) .270 (.260-.280) .370 (.360-.390) .430 (.410-.470) 1271 
 07-08 .154 (.148-.161) .170 (.160-.180) .250 (.240-.270) .340 (.320-.360) .390 (.380-.440) 1327 
 09-10 .152 (.140-.164) .170 (.150-.180) .250 (.240-.270) .330 (.310-.360) .410 (.360-.440) 1398 
Females 99-00 .159 (.145-.175) .180 (.150-.200) .270 (.250-.300) .390 (.350-.420) .460 (.410-.490) 1213 
 01-02 .149 (.137-.163) .160 (.150-.180) .260 (.230-.290) .370 (.330-.400) .440 (.400-.500) 1340 
 03-04 .144 (.133-.156) .160 (.140-.170) .250 (.230-.280) .370 (.330-.410) .450 (.410-.510) 1277 
 05-06 .146 (.138-.155) .160 (.150-.180) .260 (.240-.270) .360 (.350-.380) .440 (.400-.460) 1305 
 07-08 .139 (.129-.148) .150 (.130-.160) .240 (.220-.260) .330 (.300-.390) .410 (.380-.430) 1300 
 09-10 .137 (.129-.146) .150 (.140-.160) .230 (.210-.250) .340 (.310-.360) .410 (.380-.450) 1450 








Fourth National Report on Human Exposure to Environmental Chemicals, Updated Tables, January 2017 Volume One Page 297
Urinary Thallium (1999 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 .172 (.150-.196) .200 (.160-.230) .270 (.250-.300) .370 (.320-.420) .450 (.370-.520) 861 
 01-02 .160 (.148-.173) .180 (.160-.200) .260 (.240-.270) .340 (.310-.360) .400 (.350-.440) 675 
 03-04 .171 (.160-.183) .200 (.170-.220) .280 (.260-.310) .360 (.340-.420) .450 (.390-.480) 618 
 05-06 .158 (.149-.167) .180 (.170-.190) .250 (.240-.270) .330 (.300-.360) .400 (.360-.440) 652 
 07-08 .151 (.140-.164) .170 (.150-.180) .250 (.220-.270) .330 (.310-.360) .380 (.350-.390) 515 
 09-10 .147 (.139-.155) .160 (.150-.180) .240 (.210-.260) .310 (.290-.320) .390 (.320-.430) 613 
Non-Hispanic blacks 99-00 .217 (.197-.239) .230 (.220-.260) .350 (.300-.390) .450 (.400-.520) .550 (.460-.630) 561 
 01-02 .202 (.187-.218) .220 (.200-.230) .300 (.270-.340) .410 (.380-.440) .520 (.440-.590) 657 
 03-04 .185 (.167-.206) .190 (.170-.220) .290 (.250-.330) .410 (.330-.490) .490 (.410-.640) 723 
 05-06 .188 (.169-.210) .210 (.180-.230) .300 (.270-.320) .390 (.360-.440) .500 (.430-.530) 692 
 07-08 .171 (.160-.182) .180 (.170-.190) .270 (.250-.290) .350 (.330-.390) .430 (.390-.460) 589 
 09-10 .162 (.148-.177) .180 (.160-.200) .270 (.250-.280) .350 (.330-.400) .450 (.390-.510) 544 
Non-Hispanic whites 99-00 .170 (.153-.188) .200 (.170-.220) .290 (.260-.330) .400 (.360-.420) .450 (.420-.480) 801 
 01-02 .159 (.147-.172) .180 (.170-.200) .270 (.250-.290) .360 (.330-.390) .430 (.390-.460) 1114 
 03-04 .146 (.135-.158) .160 (.150-.170) .260 (.240-.280) .360 (.330-.380) .410 (.380-.460) 1074 
 05-06 .150 (.140-.160) .170 (.160-.180) .260 (.240-.270) .350 (.320-.380) .420 (.390-.450) 1041 
 07-08 .138 (.130-.147) .150 (.130-.160) .240 (.220-.260) .320 (.300-.360) .390 (.350-.440) 1095 
 09-10 .139 (.130-.149) .150 (.140-.170) .240 (.210-.250) .330 (.300-.360) .400 (.360-.430) 1225 








Fourth National Report on Human Exposure to Environmental Chemicals, Updated Tables, January 2017 Volume One Page 298
Urinary Thallium (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 .149 (.138-.160) .157 (.144-.169) .255 (.232-.278) .361 (.334-.377) .434 (.379-.521) 2504 
 13-14 .141 (.132-.150) .154 (.139-.163) .248 (.228-.266) .349 (.338-.370) .421 (.414-.438) 2664 
Age group        
6-11 years 11-12 .157 (.143-.172) .157 (.136-.195) .272 (.232-.308) .365 (.330-.474) .509 (.372-.629) 399 
 13-14 .149 (.131-.170) .163 (.146-.173) .259 (.221-.282) .364 (.331-.400) .438 (.367-.577) 402 
12-19 years 11-12 .155 (.131-.184) .169 (.141-.196) .288 (.240-.301) .376 (.320-.403) .447 (.387-.545) 390 
 13-14 .160 (.136-.188) .170 (.154-.191) .274 (.224-.334) .400 (.324-.507) .495 (.384-.562) 451 
20 years and older 11-12 .147 (.136-.159) .155 (.142-.167) .247 (.223-.274) .356 (.324-.377) .431 (.375-.520) 1715 
 13-14 .137 (.129-.146) .150 (.136-.161) .241 (.222-.262) .340 (.326-.364) .417 (.398-.426) 1811 
Gender        
Males 11-12 .165 (.150-.181) .173 (.151-.195) .272 (.239-.301) .369 (.343-.387) .431 (.381-.524) 1262 
 13-14 .147 (.136-.159) .161 (.151-.171) .258 (.231-.274) .356 (.325-.381) .422 (.400-.455) 1318 
Females 11-12 .135 (.122-.148) .141 (.131-.155) .237 (.208-.260) .348 (.304-.376) .434 (.367-.522) 1242 
 13-14 .135 (.125-.145) .143 (.127-.160) .241 (.214-.262) .348 (.328-.373) .421 (.398-.443) 1346 
Race/ethnicity        
Mexican Americans 11-12 .142 (.135-.150) .162 (.143-.174) .231 (.210-.248) .298 (.268-.321) .344 (.306-.381) 317 
 13-14 .139 (.127-.154) .157 (.137-.175) .247 (.206-.274) .324 (.285-.387) .414 (.324-.511) 453 
Non-Hispanic blacks 11-12 .176 (.150-.206) .184 (.158-.214) .294 (.244-.364) .431 (.370-.503) .524 (.429-.657) 669 
 13-14 .172 (.156-.189) .190 (.170-.213) .271 (.241-.301) .356 (.325-.380) .415 (.375-.433) 581 
Non-Hispanic whites 11-12 .143 (.133-.155) .149 (.135-.166) .245 (.218-.277) .353 (.322-.372) .412 (.367-.522) 820 
 13-14 .132 (.120-.145) .139 (.121-.161) .235 (.203-.265) .340 (.318-.370) .419 (.392-.440) 985 
All Hispanics 11-12 .145 (.134-.157) .158 (.148-.169) .237 (.219-.257) .305 (.289-.340) .381 (.326-.438) 573 
 13-14 .144 (.130-.160) .160 (.138-.178) .251 (.220-.272) .340 (.291-.382) .417 (.365-.473) 701 
Asians 11-12 .177 (.160-.197) .183 (.163-.214) .292 (.255-.319) .417 (.372-.489) .541 (.431-.664) 353 
 13-14 .154 (.140-.169) .159 (.134-.184) .268 (.239-.310) .414 (.368-.438) .502 (.421-.662) 292 
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Urinary Thallium (creatinine corrected) (1999 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 .166 (.159-.173) .168 (.162-.176) .224 (.217-.233) .297 (.273-.319) .366 (.338-.387) 2413 
 01-02 .156 (.151-.162) .156 (.148-.164) .215 (.208-.222) .287 (.278-.300) .349 (.337-.365) 2652 
 03-04 .154 (.149-.158) .153 (.146-.160) .214 (.203-.222) .286 (.274-.304) .350 (.328-.369) 2558 
 05-06 .155 (.149-.162) .150 (.140-.160) .210 (.200-.220) .300 (.290-.320) .370 (.350-.390) 2576 
 07-08 .152 (.147-.158) .150 (.140-.160) .210 (.200-.220) .290 (.280-.310) .370 (.350-.380) 2627 
 09-10 .153 (.145-.162) .150 (.140-.160) .220 (.200-.230) .300 (.280-.320) .370 (.350-.400) 2848 
Age group        
6-11 years 99-00 .221 (.197-.248) .222 (.196-.236) .297 (.229-.356) .375 (.318-.469) .424 (.356-.600) 336 
 01-02 .211 (.198-.226) .207 (.198-.221) .286 (.260-.321) .370 (.333-.402) .412 (.389-.456) 362 
 03-04 .223 (.208-.238) .216 (.198-.229) .306 (.280-.346) .412 (.346-.458) .458 (.400-.532) 290 
 05-06 .215 (.200-.231) .210 (.190-.250) .310 (.270-.320) .360 (.320-.410) .430 (.360-.510) 355 
 07-08 .217 (.201-.234) .220 (.210-.240) .310 (.270-.340) .410 (.370-.440) .470 (.410-.540) 394 
 09-10 .219 (.199-.241) .220 (.200-.260) .300 (.280-.340) .400 (.350-.440) .500 (.390-.600) 378 
12-19 years 99-00 .153 (.146-.160) .154 (.146-.162) .205 (.191-.219) .258 (.231-.278) .321 (.265-.364) 697 
 01-02 .143 (.137-.150) .145 (.135-.152) .196 (.184-.207) .272 (.250-.289) .312 (.299-.333) 746 
 03-04 .143 (.135-.152) .146 (.131-.155) .194 (.179-.208) .254 (.234-.280) .304 (.271-.327) 725 
 05-06 .140 (.133-.147) .140 (.130-.150) .190 (.170-.200) .240 (.220-.270) .290 (.250-.310) 701 
 07-08 .134 (.124-.145) .140 (.120-.150) .190 (.180-.220) .260 (.220-.300) .300 (.250-.370) 376 
 09-10 .140 (.127-.155) .140 (.120-.160) .190 (.170-.220) .260 (.220-.310) .310 (.260-.370) 451 
20 years and older 99-00 .162 (.153-.171) .167 (.155-.176) .218 (.207-.230) .286 (.271-.300) .364 (.325-.389) 1380 
 01-02 .153 (.147-.159) .153 (.144-.161) .210 (.200-.217) .278 (.263-.293) .343 (.313-.362) 1544 
 03-04 .148 (.144-.153) .149 (.141-.156) .206 (.192-.215) .273 (.258-.289) .333 (.306-.353) 1543 
 05-06 .152 (.145-.159) .150 (.140-.160) .210 (.200-.210) .290 (.270-.310) .370 (.350-.400) 1520 
 07-08 .149 (.143-.156) .150 (.140-.160) .210 (.200-.220) .280 (.270-.300) .350 (.330-.380) 1857 
 09-10 .150 (.142-.157) .150 (.140-.160) .210 (.200-.220) .290 (.270-.320) .370 (.330-.400) 2019 
Gender        
Males 99-00 .154 (.147-.161) .156 (.149-.164) .202 (.192-.214) .269 (.254-.297) .338 (.300-.364) 1200 
 01-02 .146 (.140-.153) .148 (.142-.157) .192 (.184-.204) .260 (.246-.278) .307 (.291-.342) 1312 
 03-04 .140 (.135-.146) .142 (.134-.149) .188 (.180-.198) .264 (.235-.286) .317 (.287-.350) 1281 
 05-06 .140 (.134-.147) .140 (.130-.140) .190 (.180-.200) .270 (.240-.300) .320 (.300-.340) 1271 
 07-08 .138 (.131-.145) .130 (.130-.140) .190 (.180-.210) .270 (.250-.290) .330 (.300-.360) 1327 
 09-10 .138 (.129-.148) .130 (.130-.150) .190 (.170-.210) .270 (.240-.300) .330 (.290-.360) 1398 
Females 99-00 .178 (.167-.189) .182 (.169-.197) .244 (.226-.259) .317 (.281-.366) .380 (.333-.462) 1213 
 01-02 .167 (.158-.176) .167 (.153-.180) .233 (.217-.250) .313 (.282-.348) .378 (.348-.402) 1340 
 03-04 .167 (.162-.173) .166 (.157-.177) .235 (.222-.243) .313 (.286-.333) .368 (.340-.412) 1277 
 05-06 .171 (.162-.181) .170 (.160-.180) .230 (.220-.250) .330 (.300-.360) .430 (.370-.490) 1305 
 07-08 .167 (.163-.173) .170 (.160-.180) .230 (.230-.240) .320 (.300-.340) .390 (.360-.430) 1300 
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Urinary Thallium (creatinine corrected) (1999 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 .158 (.147-.170) .160 (.148-.176) .213 (.200-.237) .282 (.266-.304) .343 (.306-.389) 861 
 01-02 .156 (.145-.169) .155 (.145-.167) .204 (.191-.221) .286 (.250-.317) .361 (.301-.424) 674 
 03-04 .159 (.148-.170) .157 (.143-.172) .211 (.187-.241) .293 (.273-.324) .369 (.326-.422) 618 
 05-06 .149 (.139-.158) .150 (.140-.160) .200 (.180-.210) .270 (.240-.290) .320 (.280-.370) 652 
 07-08 .151 (.143-.160) .160 (.130-.170) .200 (.190-.220) .270 (.250-.280) .320 (.290-.370) 515 
 09-10 .154 (.141-.167) .150 (.140-.170) .210 (.180-.230) .280 (.250-.330) .360 (.310-.430) 613 
Non-Hispanic blacks 99-00 .142 (.133-.152) .140 (.129-.151) .200 (.184-.214) .278 (.244-.307) .383 (.286-.462) 561 
 01-02 .138 (.128-.150) .136 (.125-.146) .194 (.170-.212) .256 (.238-.278) .328 (.271-.387) 657 
 03-04 .133 (.122-.145) .128 (.119-.143) .185 (.171-.200) .255 (.237-.269) .323 (.267-.377) 723 
 05-06 .137 (.128-.145) .130 (.130-.140) .190 (.180-.200) .240 (.220-.290) .320 (.270-.370) 692 
 07-08 .125 (.118-.132) .130 (.120-.130) .170 (.160-.180) .230 (.210-.260) .280 (.250-.330) 589 
 09-10 .128 (.120-.137) .120 (.110-.130) .180 (.160-.210) .250 (.230-.280) .310 (.270-.350) 544 
Non-Hispanic whites 99-00 .169 (.160-.179) .173 (.167-.181) .227 (.215-.240) .300 (.272-.329) .364 (.333-.377) 801 
 01-02 .161 (.155-.167) .161 (.153-.171) .222 (.214-.231) .292 (.278-.304) .348 (.330-.383) 1114 
 03-04 .154 (.148-.160) .153 (.143-.162) .214 (.200-.223) .283 (.271-.304) .333 (.313-.363) 1074 
 05-06 .156 (.148-.164) .150 (.140-.160) .210 (.200-.230) .300 (.280-.320) .360 (.330-.400) 1041 
 07-08 .154 (.146-.164) .160 (.140-.170) .220 (.210-.230) .300 (.280-.320) .370 (.340-.390) 1095 
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Urinary Thallium (creatinine corrected) (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 .168 (.157-.180) .167 (.156-.178) .235 (.216-.253) .337 (.310-.365) .425 (.369-.497) 2502 
 13-14 .162 (.155-.171) .161 (.151-.169) .236 (.228-.245) .338 (.321-.351) .429 (.405-.444) 2663 
Age group        
6-11 years 11-12 .223 (.209-.238) .216 (.200-.241) .301 (.275-.336) .395 (.371-.440) .486 (.422-.568) 398 
 13-14 .222 (.199-.249) .227 (.215-.255) .318 (.279-.360) .429 (.386-.458) .502 (.457-.537) 402 
12-19 years 11-12 .149 (.134-.165) .147 (.130-.169) .200 (.180-.218) .276 (.235-.321) .339 (.268-.500) 390 
 13-14 .145 (.133-.158) .141 (.131-.160) .213 (.182-.231) .276 (.237-.301) .315 (.283-.361) 451 
20 years and older 11-12 .166 (.155-.179) .164 (.154-.175) .233 (.212-.250) .333 (.298-.367) .436 (.365-.510) 1714 
 13-14 .160 (.153-.168) .157 (.148-.165) .229 (.222-.241) .333 (.313-.352) .429 (.394-.457) 1810 
Gender        
Males 11-12 .154 (.142-.167) .155 (.144-.165) .211 (.197-.233) .292 (.258-.326) .353 (.312-.385) 1261 
 13-14 .147 (.137-.158) .141 (.133-.150) .206 (.194-.222) .295 (.272-.315) .368 (.341-.414) 1317 
Females 11-12 .183 (.172-.195) .180 (.168-.193) .261 (.240-.286) .382 (.349-.420) .480 (.422-.510) 1241 
 13-14 .179 (.172-.187) .180 (.171-.190) .264 (.248-.274) .374 (.352-.402) .439 (.416-.482) 1346 
Race/ethnicity        
Mexican Americans 11-12 .160 (.150-.170) .163 (.141-.175) .222 (.198-.245) .295 (.276-.326) .359 (.302-.440) 317 
 13-14 .159 (.151-.168) .151 (.142-.162) .218 (.194-.230) .313 (.282-.350) .409 (.350-.457) 453 
Non-Hispanic blacks 11-12 .137 (.119-.157) .137 (.113-.159) .208 (.174-.244) .284 (.248-.334) .348 (.293-.406) 669 
 13-14 .131 (.125-.137) .126 (.117-.138) .181 (.171-.189) .254 (.232-.276) .324 (.265-.421) 581 
Non-Hispanic whites 11-12 .173 (.161-.186) .171 (.161-.181) .235 (.213-.261) .337 (.309-.373) .453 (.357-.521) 818 
 13-14 .163 (.151-.176) .163 (.149-.176) .242 (.226-.255) .338 (.309-.362) .430 (.390-.482) 984 
All Hispanics 11-12 .162 (.150-.176) .158 (.142-.174) .221 (.198-.250) .304 (.278-.347) .370 (.316-.440) 573 
 13-14 .161 (.153-.170) .154 (.145-.164) .222 (.208-.238) .318 (.294-.344) .386 (.350-.432) 701 
Asians 11-12 .237 (.219-.256) .228 (.206-.250) .337 (.297-.367) .526 (.442-.586) .663 (.557-.830) 353 
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Urinary Tin (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 .621 (.569-.678) .530 (.470-.590) 1.16 (.990-1.35) 2.94 (2.43-3.44) 4.74 (4.07-5.90) 2504 
 13-14 .433 (.374-.500) .380 (.330-.440) .930 (.790-1.16) 2.30 (2.02-2.67) 4.14 (3.12-5.46) 2664 
Age group        
6-11 years 11-12 1.17 (.985-1.39) 1.12 (.820-1.43) 2.61 (2.24-2.95) 5.07 (3.44-7.29) 8.05 (5.07-12.7) 399 
 13-14 .867 (.702-1.07) .850 (.650-1.15) 2.16 (1.67-2.92) 5.16 (3.23-6.49) 7.25 (5.03-9.48) 402 
12-19 years 11-12 .585 (.497-.688) .470 (.380-.610) 1.21 (.880-1.60) 2.68 (1.92-3.65) 4.18 (3.19-4.93) 390 
 13-14 .404 (.320-.511) .370 (.290-.490) .940 (.690-1.21) 2.02 (1.41-2.86) 3.19 (2.28-4.14) 451 
20 years and older 11-12 .585 (.521-.656) .510 (.450-.580) 1.02 (.870-1.24) 2.58 (2.09-3.40) 4.46 (3.46-5.97) 1715 
 13-14 .406 (.352-.469) .360 (.320-.410) .830 (.730-1.00) 2.16 (1.73-2.38) 3.40 (2.80-4.84) 1811 
Gender        
Males 11-12 .622 (.550-.704) .530 (.470-.590) 1.11 (.930-1.28) 3.02 (2.27-3.84) 4.89 (3.65-6.72) 1262 
 13-14 .414 (.360-.476) .360 (.320-.420) .840 (.720-1.01) 2.25 (1.70-2.81) 4.47 (3.15-5.57) 1318 
Females 11-12 .620 (.558-.690) .550 (.460-.620) 1.22 (.990-1.45) 2.77 (2.29-3.36) 4.59 (3.98-5.54) 1242 
 13-14 .451 (.376-.541) .410 (.350-.470) 1.05 (.830-1.34) 2.36 (1.97-2.92) 3.90 (2.99-5.21) 1346 
Race/ethnicity        
Mexican Americans 11-12 .644 (.527-.786) .580 (.430-.700) 1.08 (.830-1.43) 2.66 (1.88-4.41) 5.54 (3.10-8.30) 317 
 13-14 .410 (.314-.536) .360 (.270-.490) .890 (.680-1.24) 2.25 (1.39-3.26) 4.40 (2.31-6.11) 453 
Non-Hispanic blacks 11-12 .950 (.825-1.09) .860 (.740-1.00) 1.86 (1.63-2.16) 4.22 (3.28-5.55) 7.73 (4.93-12.4) 669 
 13-14 .729 (.570-.932) .720 (.520-.880) 1.50 (1.18-1.93) 3.60 (2.82-5.03) 6.79 (4.85-9.94) 581 
Non-Hispanic whites 11-12 .579 (.513-.654) .490 (.430-.570) 1.03 (.830-1.28) 2.72 (2.08-3.62) 4.53 (3.41-6.03) 820 
 13-14 .402 (.341-.473) .350 (.310-.410) .840 (.700-1.06) 2.20 (1.84-2.39) 3.39 (2.67-5.18) 985 
All Hispanics 11-12 .642 (.575-.717) .570 (.460-.640) 1.23 (.990-1.41) 2.77 (2.12-3.29) 4.57 (3.56-6.54) 573 
 13-14 .432 (.355-.526) .410 (.330-.490) .910 (.750-1.17) 2.25 (1.61-2.93) 4.22 (2.67-5.80) 701 
Asians 11-12 .477 (.433-.526) .400 (.350-.460) .820 (.690-1.01) 2.00 (1.34-2.39) 2.58 (2.21-3.90) 353 
 13-14 .270 (.216-.337) .230 (.170-.310) .570 (.400-.750) 1.31 (.810-1.83) 2.02 (1.54-3.56) 292 
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Urinary Tin (creatinine corrected) (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 .705 (.653-.761) .624 (.567-.678) 1.24 (1.11-1.34) 2.54 (2.29-2.80) 4.50 (3.76-5.33) 2502 
 13-14 .499 (.436-.570) .438 (.389-.510) .995 (.826-1.14) 2.25 (1.99-2.64) 3.72 (3.17-4.48) 2663 
Age group        
6-11 years 11-12 1.67 (1.46-1.90) 1.60 (1.44-1.73) 2.83 (2.61-3.31) 5.61 (4.50-7.22) 7.91 (6.11-12.1) 398 
 13-14 1.29 (1.07-1.57) 1.36 (1.00-1.64) 2.82 (2.22-3.25) 5.93 (3.80-7.26) 7.82 (6.17-13.4) 402 
12-19 years 11-12 .559 (.475-.659) .484 (.411-.543) 1.03 (.725-1.39) 1.97 (1.43-2.49) 2.80 (2.00-3.74) 390 
 13-14 .366 (.304-.441) .347 (.254-.455) .735 (.600-.870) 1.45 (1.16-1.77) 2.21 (1.48-3.03) 451 
20 years and older 11-12 .665 (.599-.737) .593 (.537-.663) 1.11 (.956-1.30) 2.32 (1.94-2.67) 4.04 (3.00-5.09) 1714 
 13-14 .473 (.414-.539) .417 (.372-.475) .882 (.737-1.05) 1.96 (1.74-2.33) 3.32 (2.83-3.91) 1810 
Gender        
Males 11-12 .584 (.524-.651) .515 (.436-.576) .966 (.875-1.12) 2.29 (1.86-2.80) 4.17 (2.80-5.55) 1261 
 13-14 .412 (.356-.477) .353 (.302-.406) .740 (.606-.949) 1.96 (1.64-2.30) 3.30 (2.73-4.65) 1317 
Females 11-12 .843 (.772-.920) .764 (.676-.857) 1.42 (1.21-1.72) 2.70 (2.51-3.19) 4.81 (3.50-5.59) 1241 
 13-14 .599 (.515-.697) .557 (.491-.608) 1.19 (1.00-1.37) 2.58 (2.00-3.19) 4.00 (3.20-5.50) 1346 
Race/ethnicity        
Mexican Americans 11-12 .724 (.599-.874) .640 (.482-.785) 1.23 (1.00-1.72) 3.28 (2.27-4.17) 5.29 (3.28-7.22) 317 
 13-14 .468 (.372-.588) .394 (.294-.554) .833 (.712-1.27) 2.19 (1.73-3.01) 3.29 (2.24-7.09) 453 
Non-Hispanic blacks 11-12 .739 (.648-.842) .684 (.553-.802) 1.52 (1.27-1.79) 3.19 (2.66-3.91) 5.28 (3.47-7.90) 669 
 13-14 .555 (.459-.670) .495 (.401-.600) 1.10 (.989-1.40) 2.80 (2.04-3.62) 4.99 (3.31-7.26) 581 
Non-Hispanic whites 11-12 .701 (.636-.772) .624 (.557-.683) 1.22 (1.06-1.39) 2.50 (2.06-2.79) 4.22 (2.94-5.35) 818 
 13-14 .494 (.418-.584) .438 (.380-.527) .970 (.787-1.16) 2.09 (1.76-2.73) 3.63 (2.83-5.50) 984 
All Hispanics 11-12 .719 (.638-.810) .640 (.543-.739) 1.23 (1.06-1.41) 3.18 (2.32-3.74) 4.51 (3.63-6.13) 573 
 13-14 .482 (.409-.568) .401 (.337-.485) .866 (.725-1.17) 2.31 (1.91-3.10) 4.04 (2.88-5.03) 701 
Asians 11-12 .638 (.560-.727) .543 (.503-.667) 1.00 (.867-1.17) 1.96 (1.49-2.36) 3.03 (2.23-3.58) 353 
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Urinary Tungsten (1999 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 .093 (.087-.100) .090 (.080-.090) .180 (.160-.190) .320 (.280-.370) .500 (.430-.550) 2338 
 01-02 .082 (.073-.092) .070 (.060-.090) .160 (.140-.180) .300 (.260-.350) .460 (.370-.560) 2652 
 03-04 .071 (.064-.078) .070 (.060-.080) .130 (.120-.140) .270 (.230-.300) .400 (.330-.480) 2558 
 05-06 .085 (.079-.092) .090 (.080-.090) .170 (.150-.180) .310 (.280-.340) .470 (.400-.520) 2576 
 07-08 .099 (.093-.105) .100 (.090-.110) .190 (.180-.200) .360 (.320-.380) .500 (.440-.570) 2627 
 09-10 .081 (.075-.087) .080 (.070-.090) .160 (.150-.170) .310 (.270-.330) .460 (.370-.540) 2847 
Age group        
6-11 years 99-00 .158 (.123-.204) .160 (.120-.220) .270 (.220-.350) .510 (.380-.560) .620 (.510-.950) 320 
 01-02 .137 (.110-.170) .140 (.110-.170) .260 (.200-.350) .460 (.360-.690) .770 (.510-1.53) 363 
 03-04 .130 (.111-.151) .140 (.120-.150) .240 (.190-.290) .410 (.290-.500) .500 (.370-.630) 290 
 05-06 .142 (.121-.166) .140 (.120-.170) .230 (.210-.290) .430 (.330-.610) .640 (.440-.850) 355 
 07-08 .160 (.138-.186) .150 (.130-.170) .310 (.240-.390) .510 (.450-.580) .810 (.560-1.15) 394 
 09-10 .151 (.126-.180) .150 (.110-.200) .310 (.230-.400) .560 (.400-.770) .770 (.560-1.04) 378 
12-19 years 99-00 .113 (.097-.132) .110 (.090-.130) .210 (.180-.250) .360 (.310-.440) .530 (.380-.800) 679 
 01-02 .113 (.095-.135) .110 (.090-.130) .210 (.180-.260) .400 (.310-.520) .570 (.430-.790) 744 
 03-04 .105 (.090-.122) .100 (.090-.120) .190 (.160-.230) .350 (.290-.460) .530 (.350-1.00) 725 
 05-06 .131 (.108-.158) .130 (.100-.160) .250 (.200-.310) .430 (.360-.530) .620 (.410-1.04) 701 
 07-08 .150 (.136-.167) .160 (.140-.180) .250 (.220-.290) .470 (.350-.660) .660 (.430-1.05) 376 
 09-10 .101 (.089-.115) .100 (.080-.120) .210 (.190-.240) .360 (.300-.460) .540 (.440-.650) 451 
20 years and older 99-00 .084 (.078-.091) .080 (.070-.090) .160 (.130-.180) .280 (.260-.320) .450 (.360-.520) 1339 
 01-02 .073 (.065-.082) .060 (.050-.070) .140 (.110-.160) .260 (.210-.310) .380 (.310-.490) 1545 
 03-04 .062 (.056-.068) .060 (.050-.070) .110 (.100-.120) .210 (.180-.250) .360 (.270-.430) 1543 
 05-06 .075 (.070-.081) .080 (.070-.080) .140 (.130-.160) .250 (.220-.310) .410 (.340-.470) 1520 
 07-08 .088 (.081-.095) .090 (.080-.100) .170 (.150-.190) .310 (.280-.340) .450 (.390-.500) 1857 
 09-10 .073 (.068-.079) .080 (.070-.080) .150 (.130-.160) .260 (.230-.300) .370 (.330-.460) 2018 
Gender        
Males 99-00 .107 (.096-.120) .100 (.090-.120) .210 (.190-.230) .390 (.310-.470) .530 (.470-.650) 1160 
 01-02 .088 (.074-.105) .080 (.060-.100) .170 (.140-.220) .330 (.260-.390) .490 (.380-.580) 1307 
 03-04 .081 (.071-.093) .080 (.070-.090) .140 (.130-.170) .300 (.250-.340) .430 (.340-.560) 1281 
 05-06 .095 (.090-.101) .090 (.080-.100) .180 (.160-.190) .340 (.310-.380) .480 (.420-.610) 1271 
 07-08 .109 (.102-.116) .110 (.100-.130) .210 (.190-.240) .380 (.350-.450) .550 (.450-.660) 1327 
 09-10 .090 (.082-.098) .090 (.080-.100) .170 (.150-.190) .320 (.290-.350) .500 (.410-.550) 1398 
Females 99-00 .082 (.077-.087) .070 (.060-.080) .150 (.130-.160) .270 (.240-.300) .400 (.320-.470) 1178 
 01-02 .076 (.069-.084) .060 (.060-.080) .150 (.120-.170) .280 (.230-.330) .430 (.340-.560) 1345 
 03-04 .062 (.056-.069) .060 (.050-.070) .110 (.100-.120) .220 (.190-.250) .370 (.270-.460) 1277 
 05-06 .077 (.069-.085) .080 (.070-.090) .160 (.150-.170) .280 (.250-.320) .440 (.350-.510) 1305 
 07-08 .090 (.083-.098) .090 (.080-.100) .170 (.160-.180) .300 (.270-.350) .460 (.420-.550) 1300 
 09-10 .074 (.067-.081) .070 (.070-.080) .150 (.130-.170) .280 (.240-.330) .400 (.320-.600) 1449 
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Urinary Tungsten (1999 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 .113 (.095-.133) .110 (.090-.130) .200 (.160-.250) .400 (.300-.520) .550 (.420-.830) 790 
 01-02 .101 (.093-.109) .100 (.090-.110) .190 (.170-.210) .370 (.310-.430) .570 (.450-.670) 680 
 03-04 .086 (.073-.100) .080 (.070-.100) .170 (.120-.220) .360 (.230-.620) .640 (.410-.800) 618 
 05-06 .102 (.088-.118) .100 (.080-.110) .200 (.170-.220) .450 (.310-.650) .730 (.510-1.04) 652 
 07-08 .106 (.084-.135) .110 (.080-.150) .210 (.170-.270) .400 (.250-.670) .580 (.400-1.12) 515 
 09-10 .099 (.089-.109) .090 (.090-.100) .200 (.170-.220) .380 (.340-.470) .540 (.480-.580) 613 
Non-Hispanic blacks 99-00 .113 (.101-.126) .100 (.090-.130) .210 (.180-.250) .370 (.290-.460) .560 (.420-.810) 562 
 01-02 .096 (.080-.116) .090 (.070-.120) .160 (.130-.250) .310 (.270-.400) .460 (.400-.590) 649 
 03-04 .092 (.082-.104) .090 (.080-.110) .160 (.150-.180) .300 (.250-.330) .470 (.340-.550) 723 
 05-06 .101 (.088-.116) .110 (.090-.120) .190 (.160-.220) .320 (.280-.370) .450 (.340-.650) 692 
 07-08 .120 (.099-.146) .120 (.090-.160) .240 (.200-.290) .390 (.340-.440) .540 (.460-.690) 589 
 09-10 .093 (.086-.100) .100 (.090-.110) .180 (.160-.200) .290 (.270-.340) .400 (.320-.590) 543 
Non-Hispanic whites 99-00 .092 (.084-.100) .080 (.070-.100) .180 (.160-.200) .320 (.270-.380) .470 (.380-.550) 802 
 01-02 .076 (.066-.088) .060 (.050-.080) .150 (.120-.180) .290 (.230-.360) .430 (.330-.620) 1117 
 03-04 .065 (.058-.073) .060 (.060-.070) .120 (.100-.130) .230 (.190-.290) .380 (.320-.410) 1074 
 05-06 .082 (.075-.089) .080 (.080-.090) .160 (.140-.180) .300 (.250-.340) .430 (.380-.480) 1041 
 07-08 .093 (.087-.101) .100 (.090-.110) .180 (.160-.190) .330 (.290-.370) .470 (.410-.570) 1095 
 09-10 .077 (.070-.083) .080 (.070-.090) .150 (.140-.170) .280 (.250-.310) .400 (.330-.540) 1225 
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Urinary Tungsten (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 .074 (.067-.082) .069 (.062-.076) .143 (.127-.170) .284 (.235-.361) .434 (.354-.522) 2491 
 13-14 .059 (.052-.065) .058 (.050-.068) .129 (.113-.146) .241 (.220-.264) .380 (.337-.436) 2664 
Age group        
6-11 years 11-12 .136 (.120-.155) .138 (.123-.162) .272 (.229-.301) .448 (.391-.504) .583 (.498-.691) 398 
 13-14 .111 (.097-.127) .114 (.098-.130) .224 (.184-.245) .367 (.322-.449) .606 (.436-.758) 402 
12-19 years 11-12 .107 (.088-.130) .112 (.083-.141) .212 (.175-.269) .371 (.308-.458) .506 (.399-.647) 388 
 13-14 .093 (.081-.106) .094 (.082-.107) .182 (.161-.207) .364 (.316-.406) .559 (.406-.774) 451 
20 years and older 11-12 .066 (.058-.074) .060 (.055-.067) .121 (.104-.144) .237 (.194-.315) .374 (.274-.493) 1705 
 13-14 .051 (.045-.058) .050 (.042-.059) .111 (.092-.129) .213 (.178-.238) .320 (.264-.380) 1811 
Gender        
Males 11-12 .084 (.074-.095) .080 (.068-.094) .164 (.136-.200) .343 (.260-.408) .471 (.388-.537) 1254 
 13-14 .065 (.057-.074) .066 (.054-.076) .141 (.121-.159) .256 (.230-.295) .380 (.321-.468) 1318 
Females 11-12 .066 (.060-.073) .060 (.054-.067) .131 (.115-.145) .247 (.212-.294) .361 (.284-.463) 1237 
 13-14 .053 (.048-.059) .053 (.043-.063) .119 (.104-.129) .226 (.197-.244) .359 (.313-.441) 1346 
Race/ethnicity        
Mexican Americans 11-12 .097 (.082-.114) .097 (.071-.115) .198 (.150-.282) .434 (.356-.534) .691 (.473-.827) 314 
 13-14 .069 (.057-.083) .072 (.054-.090) .150 (.114-.207) .280 (.216-.395) .515 (.350-.648) 453 
Non-Hispanic blacks 11-12 .102 (.087-.119) .096 (.082-.120) .184 (.145-.245) .387 (.282-.496) .537 (.391-.808) 669 
 13-14 .085 (.073-.099) .085 (.071-.096) .166 (.151-.194) .350 (.310-.422) .493 (.424-.676) 581 
Non-Hispanic whites 11-12 .068 (.060-.076) .063 (.056-.070) .130 (.113-.153) .260 (.212-.327) .370 (.307-.463) 810 
 13-14 .053 (.046-.062) .054 (.043-.065) .117 (.096-.139) .215 (.172-.255) .328 (.243-.468) 985 
All Hispanics 11-12 .082 (.072-.092) .072 (.061-.094) .162 (.136-.197) .371 (.294-.433) .534 (.422-.692) 570 
 13-14 .064 (.056-.073) .065 (.054-.076) .145 (.119-.169) .264 (.217-.350) .411 (.346-.585) 701 
Asians 11-12 .067 (.058-.077) .066 (.052-.078) .135 (.115-.168) .252 (.206-.319) .401 (.260-.635) 353 
 13-14 .052 (.040-.069) .047 (.030-.067) .119 (.074-.188) .290 (.168-.593) .537 (.290-.700) 292 






Fourth National Report on Human Exposure to Environmental Chemicals, Updated Tables, January 2017 Volume One Page 307
Urinary Tungsten (creatinine corrected) (1999 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 .087 (.080-.095) .080 (.075-.086) .146 (.136-.158) .270 (.206-.333) .383 (.302-.459) 2338 
 01-02 .078 (.069-.087) .074 (.064-.084) .138 (.122-.154) .255 (.216-.300) .359 (.315-.436) 2651 
 03-04 .070 (.063-.078) .065 (.059-.074) .117 (.107-.133) .215 (.179-.253) .333 (.255-.439) 2558 
 05-06 .084 (.080-.089) .080 (.080-.080) .140 (.130-.150) .250 (.210-.290) .350 (.290-.440) 2576 
 07-08 .103 (.096-.111) .100 (.090-.110) .170 (.160-.190) .320 (.290-.360) .470 (.410-.540) 2627 
 09-10 .086 (.080-.093) .080 (.070-.090) .150 (.130-.160) .270 (.230-.310) .400 (.340-.470) 2847 
Age group        
6-11 years 99-00 .174 (.150-.201) .169 (.136-.198) .293 (.216-.333) .439 (.331-.667) .667 (.452-.880) 320 
 01-02 .168 (.144-.197) .158 (.139-.190) .275 (.231-.326) .412 (.333-.554) .634 (.436-1.28) 363 
 03-04 .151 (.131-.174) .144 (.119-.167) .250 (.205-.283) .333 (.278-.484) .484 (.333-.739) 290 
 05-06 .175 (.152-.202) .160 (.140-.180) .270 (.220-.320) .560 (.330-.790) .790 (.470-1.18) 355 
 07-08 .209 (.185-.235) .200 (.180-.240) .340 (.290-.370) .540 (.450-.660) .780 (.620-.910) 394 
 09-10 .205 (.177-.239) .200 (.160-.230) .330 (.290-.440) .620 (.450-.850) .930 (.690-1.08) 378 
12-19 years 99-00 .084 (.078-.091) .079 (.074-.084) .138 (.124-.158) .231 (.180-.287) .339 (.237-.465) 679 
 01-02 .081 (.071-.092) .081 (.072-.091) .148 (.122-.167) .250 (.208-.301) .359 (.272-.431) 744 
 03-04 .075 (.065-.086) .071 (.061-.082) .122 (.098-.148) .197 (.167-.308) .379 (.197-.582) 725 
 05-06 .101 (.086-.117) .100 (.080-.110) .170 (.140-.200) .300 (.200-.370) .370 (.300-.770) 701 
 07-08 .118 (.104-.132) .120 (.110-.130) .180 (.160-.210) .340 (.230-.550) .530 (.310-.810) 376 
 09-10 .094 (.085-.106) .090 (.080-.110) .150 (.120-.180) .270 (.210-.290) .370 (.280-.500) 451 
20 years and older 99-00 .080 (.072-.089) .075 (.067-.082) .130 (.116-.146) .218 (.179-.301) .347 (.245-.426) 1339 
 01-02 .070 (.063-.079) .067 (.058-.075) .119 (.099-.139) .216 (.176-.267) .333 (.253-.431) 1544 
 03-04 .063 (.057-.071) .059 (.053-.065) .105 (.094-.117) .181 (.155-.215) .279 (.217-.370) 1543 
 05-06 .075 (.071-.079) .070 (.070-.080) .120 (.110-.130) .210 (.200-.220) .290 (.240-.360) 1520 
 07-08 .093 (.087-.101) .090 (.080-.100) .160 (.140-.170) .280 (.250-.310) .420 (.350-.490) 1857 
 09-10 .078 (.072-.084) .070 (.070-.080) .130 (.120-.140) .220 (.190-.260) .340 (.270-.400) 2018 
Gender        
Males 99-00 .083 (.074-.094) .073 (.063-.086) .146 (.126-.165) .279 (.198-.386) .439 (.329-.605) 1160 
 01-02 .071 (.060-.083) .065 (.056-.077) .125 (.098-.153) .255 (.203-.306) .364 (.300-.431) 1306 
 03-04 .068 (.059-.079) .062 (.054-.071) .111 (.098-.133) .216 (.170-.284) .341 (.240-.500) 1281 
 05-06 .078 (.073-.083) .070 (.070-.080) .130 (.120-.150) .240 (.200-.300) .360 (.300-.440) 1271 
 07-08 .097 (.090-.106) .090 (.090-.110) .170 (.150-.180) .310 (.280-.360) .440 (.410-.480) 1327 
 09-10 .082 (.074-.089) .070 (.070-.080) .140 (.120-.150) .250 (.220-.310) .440 (.320-.500) 1398 
Females 99-00 .091 (.085-.098) .084 (.080-.091) .145 (.136-.158) .265 (.200-.301) .339 (.300-.381) 1178 
 01-02 .085 (.077-.094) .083 (.075-.091) .143 (.130-.161) .258 (.216-.317) .353 (.317-.538) 1345 
 03-04 .072 (.065-.079) .069 (.063-.078) .121 (.108-.138) .211 (.176-.237) .333 (.261-.439) 1277 
 05-06 .090 (.085-.096) .080 (.080-.090) .150 (.140-.160) .250 (.210-.290) .350 (.260-.530) 1305 
 07-08 .109 (.100-.118) .100 (.090-.120) .180 (.160-.210) .330 (.290-.360) .520 (.400-.590) 1300 
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Urinary Tungsten (creatinine corrected) (1999 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 .106 (.093-.120) .100 (.086-.116) .184 (.152-.214) .329 (.267-.392) .497 (.354-.727) 790 
 01-02 .098 (.090-.108) .089 (.081-.100) .164 (.143-.187) .294 (.258-.375) .555 (.410-.797) 679 
 03-04 .079 (.065-.096) .073 (.054-.093) .136 (.103-.197) .300 (.233-.426) .482 (.344-.823) 618 
 05-06 .096 (.083-.111) .090 (.080-.090) .160 (.150-.180) .330 (.250-.420) .670 (.360-.890) 652 
 07-08 .106 (.083-.137) .110 (.080-.140) .200 (.160-.270) .400 (.260-.710) .610 (.310-1.12) 515 
 09-10 .103 (.096-.111) .100 (.090-.110) .180 (.160-.200) .330 (.290-.390) .480 (.390-.540) 613 
Non-Hispanic blacks 99-00 .073 (.064-.083) .071 (.061-.081) .124 (.109-.154) .201 (.188-.222) .360 (.217-.465) 562 
 01-02 .066 (.056-.077) .060 (.049-.079) .109 (.090-.125) .199 (.153-.285) .340 (.250-.414) 649 
 03-04 .066 (.059-.074) .067 (.055-.075) .105 (.095-.120) .186 (.150-.224) .317 (.214-.358) 723 
 05-06 .073 (.065-.082) .070 (.060-.080) .120 (.110-.140) .210 (.190-.260) .320 (.260-.390) 692 
 07-08 .088 (.076-.102) .090 (.070-.100) .150 (.140-.160) .240 (.220-.300) .380 (.270-.630) 589 
 09-10 .074 (.067-.080) .070 (.060-.080) .120 (.110-.140) .210 (.180-.250) .310 (.220-.410) 543 
Non-Hispanic whites 99-00 .091 (.083-.100) .082 (.077-.088) .150 (.136-.169) .279 (.200-.354) .385 (.302-.462) 802 
 01-02 .078 (.068-.088) .073 (.061-.085) .139 (.121-.157) .253 (.209-.308) .353 (.286-.453) 1117 
 03-04 .069 (.060-.078) .063 (.057-.071) .116 (.104-.133) .199 (.167-.237) .299 (.222-.439) 1074 
 05-06 .085 (.080-.090) .080 (.080-.090) .140 (.130-.160) .240 (.210-.280) .340 (.280-.420) 1041 
 07-08 .104 (.096-.114) .100 (.090-.110) .180 (.160-.200) .310 (.280-.360) .460 (.390-.530) 1095 
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Urinary Tungsten (creatinine corrected) (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 .084 (.076-.093) .077 (.072-.085) .140 (.123-.161) .260 (.209-.323) .402 (.294-.536) 2489 
 13-14 .068 (.061-.075) .065 (.058-.072) .124 (.111-.136) .224 (.195-.251) .332 (.303-.377) 2663 
Age group        
6-11 years 11-12 .194 (.174-.217) .183 (.159-.214) .312 (.256-.407) .500 (.421-.652) .687 (.515-.863) 397 
 13-14 .166 (.152-.181) .166 (.149-.176) .249 (.229-.295) .400 (.327-.518) .673 (.457-.764) 402 
12-19 years 11-12 .103 (.091-.116) .099 (.086-.111) .164 (.144-.181) .288 (.203-.324) .381 (.286-.656) 388 
 13-14 .084 (.073-.097) .089 (.071-.101) .144 (.127-.162) .246 (.195-.293) .327 (.293-.492) 451 
20 years and older 11-12 .074 (.067-.083) .069 (.064-.075) .121 (.104-.138) .215 (.170-.263) .334 (.233-.458) 1704 
 13-14 .060 (.054-.066) .057 (.051-.062) .105 (.092-.117) .186 (.163-.212) .286 (.227-.357) 1810 
Gender        
Males 11-12 .079 (.068-.090) .075 (.064-.085) .131 (.112-.150) .261 (.180-.327) .400 (.276-.539) 1253 
 13-14 .065 (.057-.073) .065 (.054-.075) .121 (.103-.135) .199 (.179-.248) .316 (.278-.377) 1317 
Females 11-12 .090 (.083-.097) .079 (.075-.088) .150 (.134-.165) .257 (.223-.324) .404 (.314-.544) 1236 
 13-14 .071 (.065-.077) .065 (.059-.072) .127 (.116-.137) .240 (.220-.261) .342 (.311-.383) 1346 
Race/ethnicity        
Mexican Americans 11-12 .110 (.090-.134) .102 (.071-.142) .192 (.150-.270) .381 (.263-.633) .633 (.396-.729) 314 
 13-14 .079 (.067-.093) .073 (.059-.093) .146 (.115-.172) .287 (.211-.369) .471 (.338-.602) 453 
Non-Hispanic blacks 11-12 .079 (.068-.092) .072 (.060-.083) .129 (.102-.151) .246 (.168-.411) .440 (.253-.669) 669 
 13-14 .064 (.056-.074) .059 (.050-.071) .118 (.105-.127) .233 (.193-.275) .342 (.296-.430) 581 
Non-Hispanic whites 11-12 .082 (.072-.094) .076 (.068-.088) .135 (.113-.164) .247 (.183-.324) .353 (.250-.515) 808 
 13-14 .066 (.058-.075) .064 (.056-.072) .118 (.100-.141) .200 (.167-.257) .307 (.227-.395) 984 
All Hispanics 11-12 .092 (.078-.108) .079 (.068-.100) .164 (.134-.184) .312 (.263-.404) .473 (.367-.664) 570 
 13-14 .072 (.064-.080) .068 (.058-.079) .133 (.115-.148) .240 (.200-.320) .391 (.319-.549) 701 
Asians 11-12 .089 (.075-.107) .082 (.073-.103) .152 (.129-.181) .296 (.207-.413) .449 (.299-.824) 353 
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Urinary Uranium (1999 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 .008 (.007-.009) .007 (.006-.008) .013 (.010-.017) .027 (.021-.038) .046 (.037-.056) 2464 
 01-02 .009 (.007-.010) .008 (.007-.009) .014 (.012-.018) .030 (.023-.039) .046 (.034-.062) 2690 
 03-04 .008 (.007-.008) .007 (.006-.007) .011 (.010-.013) .021 (.017-.026) .031 (.026-.037) 2557 
 05-06 .006 (.005-.006) .005 (.005-.006) .010 (.009-.012) .019 (.016-.022) .033 (.023-.041) 2576 
 07-08 .007 (.006-.008) .007 (.005-.008) .013 (.011-.015) .024 (.018-.033) .039 (.026-.057) 2627 
 09-10 .007 (.006-.008) .007 (.006-.008) .013 (.011-.015) .022 (.019-.030) .036 (.029-.044) 2848 
Age group        
6-11 years 99-00 .009 (.007-.011) .007 (.006-.009) .013 (.009-.022) .032 (.019-.048) .048 (.033-.066) 340 
 01-02 .008 (.007-.010) .008 (.006-.010) .014 (.010-.020) .026 (.020-.036) .040 (.025-.049) 368 
 03-04 .008 (.007-.009) .007 (.006-.009) .012 (.009-.016) .020 (.016-.026) .028 (.020-.039) 289 
 05-06 .006 (.005-.007) .005 (.004-.007) .010 (.008-.011) .015 (.012-.031) .031 (.013-.051) 355 
 07-08 .007 (.006-.008) .006 (.005-.008) .012 (.009-.016) .021 (.016-.027) .030 (.022-.039) 394 
 09-10 .006 (.005-.008) .006 (.005-.008) .012 (.009-.014) .018 (.013-.034) .033 (.016-.052) 378 
12-19 years 99-00 .009 (.008-.011) .009 (.008-.010) .015 (.012-.018) .026 (.020-.043) .044 (.028-.072) 719 
 01-02 .010 (.008-.012) .010 (.008-.012) .017 (.013-.023) .030 (.022-.042) .042 (.027-.088) 762 
 03-04 .010 (.009-.011) .009 (.008-.010) .015 (.012-.018) .028 (.023-.036) .038 (.036-.053) 725 
 05-06 .007 (.006-.008) .007 (.006-.008) .013 (.011-.015) .023 (.018-.032) .034 (.027-.045) 701 
 07-08 .009 (.007-.011) .008 (.007-.011) .016 (.014-.020) .029 (.022-.056) .056 (.027-.156) 376 
 09-10 .008 (.007-.010) .008 (.006-.010) .014 (.011-.018) .023 (.020-.038) .040 (.024-.059) 451 
20 years and older 99-00 .008 (.006-.009) .007 (.005-.008) .013 (.010-.017) .027 (.021-.040) .046 (.036-.056) 1405 
 01-02 .009 (.007-.010) .008 (.007-.009) .014 (.012-.017) .031 (.022-.040) .046 (.034-.065) 1560 
 03-04 * .006 (.005-.007) .011 (.009-.012) .019 (.016-.026) .029 (.024-.038) 1543 
 05-06 .006 (.005-.006) .005 (.005-.006) .010 (.008-.012) .019 (.015-.022) .032 (.022-.041) 1520 
 07-08 .007 (.005-.008) .006 (.005-.008) .013 (.010-.015) .024 (.017-.035) .039 (.026-.052) 1857 
 09-10 .007 (.006-.008) .007 (.006-.008) .013 (.011-.015) .023 (.019-.030) .036 (.029-.044) 2019 
Gender        
Males 99-00 .009 (.008-.011) .008 (.007-.010) .015 (.012-.021) .036 (.024-.046) .053 (.040-.067) 1227 
 01-02 .009 (.008-.011) .009 (.007-.010) .015 (.013-.021) .033 (.024-.045) .047 (.035-.065) 1335 
 03-04 .008 (.007-.009) .007 (.006-.008) .013 (.011-.016) .023 (.019-.027) .031 (.027-.035) 1280 
 05-06 .006 (.006-.007) .006 (.005-.006) .011 (.009-.012) .019 (.015-.022) .030 (.021-.043) 1271 
 07-08 .007 (.006-.009) .007 (.006-.009) .014 (.013-.016) .026 (.021-.037) .046 (.030-.056) 1327 
 09-10 .007 (.006-.009) .007 (.006-.009) .014 (.012-.017) .024 (.020-.034) .040 (.032-.046) 1398 
Females 99-00 .007 (.006-.008) .006 (.005-.007) .012 (.009-.015) .023 (.016-.033) .036 (.026-.050) 1237 
 01-02 .008 (.007-.010) .008 (.006-.009) .014 (.011-.017) .027 (.019-.037) .041 (.029-.063) 1355 
 03-04 * .006 (.005-.007) .010 (.009-.011) .018 (.013-.027) .031 (.022-.039) 1277 
 05-06 .005 (.005-.006) .005 (.004-.006) .010 (.008-.011) .019 (.016-.023) .034 (.025-.040) 1305 
 07-08 .006 (.005-.008) .006 (.005-.007) .011 (.009-.015) .024 (.016-.033) .035 (.022-.067) 1300 
 09-10 .007 (.006-.008) .007 (.006-.008) .012 (.011-.014) .022 (.017-.029) .033 (.023-.045) 1450 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 05-06, 07-08, and 09-10 are 0.004, 0.004, 0.005, 0.002, 0.002, and 0.002 respectively. 
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Urinary Uranium (1999 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 .017 (.012-.023) .016 (.011-.021) .033 (.020-.054) .060 (.040-.127) .114 (.054-.279) 883 
 01-02 .013 (.010-.016) .012 (.009-.016) .022 (.017-.030) .040 (.031-.054) .055 (.046-.069) 683 
 03-04 .014 (.011-.017) .013 (.009-.018) .024 (.017-.034) .041 (.028-.073) .064 (.039-.158) 618 
 05-06 .008 (.007-.009) .009 (.007-.010) .014 (.013-.017) .025 (.021-.033) .042 (.028-.051) 652 
 07-08 .009 (.008-.011) .009 (.008-.010) .017 (.014-.022) .032 (.026-.039) .047 (.032-.073) 515 
 09-10 .009 (.008-.011) .009 (.008-.011) .018 (.015-.021) .034 (.027-.040) .046 (.039-.055) 613 
Non-Hispanic blacks 99-00 .009 (.007-.011) .008 (.006-.010) .014 (.010-.020) .028 (.018-.049) .052 (.030-.067) 568 
 01-02 .008 (.007-.009) .008 (.007-.009) .012 (.011-.015) .021 (.017-.027) .030 (.023-.037) 667 
 03-04 .008 (.008-.009) .007 (.007-.008) .012 (.011-.013) .021 (.017-.027) .031 (.023-.045) 722 
 05-06 .006 (.005-.007) .006 (.005-.007) .010 (.009-.011) .016 (.014-.020) .023 (.018-.031) 692 
 07-08 .007 (.006-.009) .007 (.006-.008) .013 (.010-.016) .024 (.016-.038) .038 (.025-.055) 589 
 09-10 .008 (.007-.010) .008 (.007-.010) .014 (.012-.016) .027 (.017-.044) .044 (.027-.074) 544 
Non-Hispanic whites 99-00 .007 (.006-.009) .007 (.006-.007) .012 (.009-.016) .023 (.017-.037) .043 (.027-.051) 822 
 01-02 .008 (.007-.009) .007 (.006-.009) .013 (.011-.016) .026 (.019-.035) .037 (.029-.050) 1132 
 03-04 * .006 (.005-.007) .010 (.009-.012) .018 (.015-.023) .027 (.020-.036) 1074 
 05-06 .005 (.005-.006) .005 (.004-.006) .010 (.008-.012) .018 (.014-.022) .033 (.021-.043) 1041 
 07-08 .006 (.005-.008) .006 (.005-.008) .013 (.009-.016) .023 (.015-.039) .038 (.022-.086) 1095 
 09-10 .006 (.005-.007) .006 (.005-.007) .012 (.011-.014) .021 (.017-.027) .032 (.023-.041) 1225 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 05-06, 07-08, and 09-10 are 0.004, 0.004, 0.005, 0.002, 0.002, and 0.002 respectively. 
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Urinary Uranium (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 .006 (.005-.007) .006 (.005-.007) .011 (.008-.014) .019 (.015-.025) .031 (.023-.043) 2504 
 13-14 .005 (.004-.006) .005 (.004-.005) .010 (.008-.013) .023 (.015-.038) .039 (.023-.066) 2664 
Age group        
6-11 years 11-12 .006 (.005-.007) .006 (.005-.008) .011 (.009-.013) .019 (.013-.024) .025 (.020-.037) 399 
 13-14 .005 (.004-.007) .005 (.004-.006) .010 (.007-.017) .023 (.015-.034) .034 (.019-.061) 402 
12-19 years 11-12 .007 (.006-.009) .007 (.005-.008) .012 (.009-.017) .021 (.014-.032) .033 (.021-.052) 390 
 13-14 .006 (.005-.007) .005 (.004-.006) .010 (.007-.016) .023 (.013-.047) .046 (.020-.096) 451 
20 years and older 11-12 .006 (.005-.007) .005 (.004-.007) .011 (.008-.013) .019 (.015-.025) .031 (.023-.043) 1715 
 13-14 .005 (.004-.006) .005 (.004-.005) .010 (.008-.012) .023 (.015-.035) .038 (.023-.066) 1811 
Gender        
Males 11-12 .007 (.005-.008) .006 (.005-.007) .011 (.009-.014) .020 (.014-.032) .034 (.022-.045) 1262 
 13-14 .005 (.004-.006) .005 (.004-.005) .010 (.008-.014) .024 (.014-.041) .040 (.023-.077) 1318 
Females 11-12 .006 (.005-.007) .005 (.004-.006) .010 (.008-.013) .019 (.015-.025) .029 (.024-.042) 1242 
 13-14 .005 (.004-.006) .005 (.004-.005) .010 (.008-.012) .022 (.015-.033) .036 (.022-.065) 1346 
Race/ethnicity        
Mexican Americans 11-12 .007 (.006-.009) .007 (.006-.009) .013 (.010-.016) .023 (.015-.033) .031 (.017-.054) 317 
 13-14 .008 (.006-.009) .008 (.006-.011) .015 (.012-.020) .028 (.022-.040) .043 (.028-.058) 453 
Non-Hispanic blacks 11-12 .006 (.005-.008) .006 (.005-.008) .011 (.008-.014) .019 (.014-.028) .029 (.022-.042) 669 
 13-14 .005 (.005-.006) .005 (.005-.006) .009 (.008-.011) .017 (.013-.023) .025 (.016-.046) 581 
Non-Hispanic whites 11-12 .006 (.005-.007) .006 (.004-.007) .011 (.008-.014) .021 (.015-.029) .034 (.023-.045) 820 
 13-14 .005 (.004-.006) .004 (.003-.005) .009 (.006-.016) .023 (.011-.046) .040 (.019-.098) 985 
All Hispanics 11-12 .006 (.005-.007) .005 (.005-.007) .011 (.008-.014) .018 (.013-.030) .030 (.018-.047) 573 
 13-14 .007 (.006-.008) .007 (.005-.008) .013 (.011-.018) .026 (.019-.034) .040 (.026-.057) 701 
Asians 11-12 .005 (.005-.006) .005 (.004-.005) .009 (.007-.013) .016 (.014-.020) .021 (.016-.040) 353 
 13-14 .005 (.004-.008) .005 (.003-.007) .011 (.006-.025) .031 (.011-.068) .051 (.025-.101) 292 
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Urinary Uranium (creatinine corrected) (1999 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 .007 (.006-.009) .007 (.006-.009) .013 (.010-.016) .024 (.019-.030) .034 (.027-.053) 2464 
 01-02 .008 (.007-.010) .007 (.006-.009) .014 (.011-.018) .026 (.020-.034) .040 (.028-.058) 2689 
 03-04 .008 (.007-.008) .007 (.006-.008) .012 (.010-.014) .021 (.017-.025) .029 (.023-.039) 2557 
 05-06 .006 (.005-.006) .005 (.005-.006) .009 (.008-.010) .017 (.014-.020) .026 (.020-.039) 2576 
 07-08 .007 (.006-.009) .006 (.005-.008) .012 (.009-.016) .024 (.016-.038) .038 (.025-.065) 2627 
 09-10 .007 (.006-.008) .007 (.006-.008) .012 (.010-.013) .020 (.017-.024) .029 (.024-.035) 2848 
Age group        
6-11 years 99-00 .009 (.007-.012) .008 (.006-.011) .015 (.010-.024) .030 (.016-.044) .037 (.030-.077) 340 
 01-02 .010 (.008-.011) .010 (.008-.012) .015 (.013-.019) .027 (.018-.032) .033 (.027-.048) 368 
 03-04 .009 (.008-.010) .008 (.007-.010) .013 (.011-.017) .024 (.016-.039) .033 (.022-.050) 289 
 05-06 .007 (.006-.008) .006 (.005-.008) .010 (.008-.014) .018 (.013-.035) .034 (.018-.048) 355 
 07-08 .009 (.007-.011) .008 (.007-.010) .014 (.010-.022) .026 (.016-.053) .042 (.023-.065) 394 
 09-10 .009 (.007-.010) .008 (.007-.010) .014 (.011-.016) .020 (.015-.030) .029 (.022-.033) 378 
12-19 years 99-00 .007 (.006-.008) .006 (.005-.008) .010 (.009-.014) .020 (.014-.030) .030 (.019-.074) 719 
 01-02 .007 (.006-.008) .007 (.006-.008) .012 (.009-.016) .020 (.015-.026) .026 (.020-.042) 762 
 03-04 .007 (.006-.008) .006 (.005-.007) .010 (.008-.013) .019 (.015-.027) .034 (.022-.041) 725 
 05-06 .006 (.005-.007) .005 (.005-.006) .009 (.007-.012) .017 (.013-.022) .023 (.019-.026) 701 
 07-08 .007 (.006-.009) .006 (.005-.008) .012 (.009-.016) .025 (.013-.050) .033 (.022-.077) 376 
 09-10 .007 (.006-.009) .007 (.006-.008) .011 (.010-.013) .017 (.014-.021) .025 (.017-.038) 451 
20 years and older 99-00 .007 (.006-.009) .007 (.006-.009) .013 (.010-.016) .024 (.019-.029) .034 (.025-.051) 1405 
 01-02 .008 (.007-.010) .007 (.006-.009) .014 (.011-.019) .027 (.020-.039) .043 (.030-.063) 1559 
 03-04 * .007 (.006-.008) .012 (.010-.014) .020 (.017-.024) .028 (.022-.038) 1543 
 05-06 .006 (.005-.006) .005 (.005-.006) .009 (.008-.010) .016 (.014-.019) .026 (.020-.039) 1520 
 07-08 .007 (.006-.008) .006 (.005-.008) .012 (.009-.016) .024 (.016-.036) .037 (.025-.065) 1857 
 09-10 .007 (.006-.008) .007 (.006-.008) .012 (.010-.013) .020 (.017-.025) .029 (.024-.036) 2019 
Gender        
Males 99-00 .007 (.006-.009) .006 (.005-.008) .011 (.009-.015) .021 (.017-.028) .035 (.024-.056) 1227 
 01-02 .007 (.006-.008) .007 (.006-.008) .012 (.010-.015) .022 (.018-.028) .033 (.025-.047) 1334 
 03-04 .007 (.006-.008) .006 (.006-.007) .010 (.009-.012) .019 (.015-.024) .026 (.019-.039) 1280 
 05-06 .005 (.005-.005) .005 (.004-.005) .008 (.007-.009) .014 (.013-.016) .021 (.016-.031) 1271 
 07-08 .007 (.005-.008) .006 (.005-.007) .012 (.009-.015) .022 (.016-.031) .032 (.024-.056) 1327 
 09-10 .007 (.006-.008) .006 (.006-.007) .011 (.010-.012) .019 (.015-.023) .028 (.022-.033) 1398 
Females 99-00 .008 (.007-.010) .007 (.006-.010) .013 (.010-.017) .025 (.019-.033) .034 (.027-.054) 1237 
 01-02 .009 (.008-.011) .009 (.007-.011) .016 (.012-.021) .029 (.021-.042) .045 (.031-.067) 1355 
 03-04 * .008 (.007-.009) .013 (.011-.016) .022 (.018-.028) .031 (.025-.041) 1277 
 05-06 .006 (.006-.007) .006 (.005-.006) .010 (.009-.011) .019 (.015-.024) .035 (.022-.041) 1305 
 07-08 .008 (.006-.009) .007 (.006-.008) .013 (.010-.018) .026 (.016-.043) .042 (.024-.083) 1300 
 09-10 .008 (.007-.009) .008 (.006-.009) .013 (.011-.015) .021 (.017-.027) .031 (.024-.041) 1450 
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Urinary Uranium (creatinine corrected) (1999 – 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 .015 (.011-.022) .015 (.011-.020) .029 (.016-.058) .059 (.027-.146) .100 (.042-.270) 883 
 01-02 .012 (.010-.016) .012 (.009-.016) .021 (.015-.028) .033 (.024-.053) .050 (.034-.080) 682 
 03-04 .013 (.010-.016) .013 (.009-.017) .022 (.016-.029) .035 (.026-.051) .051 (.034-.061) 618 
 05-06 .008 (.007-.009) .007 (.006-.008) .013 (.010-.015) .022 (.016-.031) .035 (.025-.060) 652 
 07-08 .009 (.008-.012) .009 (.007-.011) .017 (.014-.021) .031 (.021-.048) .042 (.027-.097) 515 
 09-10 .010 (.009-.011) .010 (.008-.011) .016 (.013-.018) .026 (.022-.030) .036 (.030-.044) 613 
Non-Hispanic blacks 99-00 .006 (.004-.007) .005 (.004-.006) .008 (.006-.013) .017 (.011-.029) .028 (.018-.048) 568 
 01-02 .005 (.005-.006) .005 (.005-.006) .008 (.007-.010) .013 (.011-.014) .017 (.014-.029) 667 
 03-04 .006 (.005-.006) .005 (.005-.006) .009 (.008-.009) .013 (.012-.015) .018 (.014-.024) 722 
 05-06 .004 (.004-.005) .004 (.003-.005) .006 (.006-.007) .011 (.009-.015) .017 (.012-.021) 692 
 07-08 .005 (.005-.006) .005 (.004-.006) .009 (.007-.011) .014 (.011-.017) .018 (.014-.041) 589 
 09-10 .006 (.005-.008) .006 (.005-.007) .010 (.008-.012) .018 (.013-.021) .023 (.018-.044) 544 
Non-Hispanic whites 99-00 .007 (.006-.009) .007 (.006-.009) .012 (.010-.015) .021 (.017-.027) .030 (.024-.050) 822 
 01-02 .008 (.007-.009) .007 (.006-.009) .013 (.011-.016) .025 (.018-.032) .034 (.025-.051) 1132 
 03-04 * .007 (.006-.008) .011 (.010-.013) .019 (.015-.024) .027 (.020-.040) 1074 
 05-06 .006 (.005-.006) .005 (.005-.006) .009 (.008-.010) .016 (.013-.020) .024 (.019-.039) 1041 
 07-08 .007 (.006-.009) .006 (.005-.008) .012 (.009-.019) .025 (.015-.043) .039 (.024-.081) 1095 
 09-10 .007 (.006-.008) .007 (.006-.008) .012 (.010-.013) .018 (.015-.024) .028 (.021-.035) 1225 
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Urinary Uranium (creatinine corrected) (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 .007 (.006-.008) .007 (.006-.008) .011 (.009-.014) .021 (.015-.026) .029 (.023-.037) 2502 
 13-14 .006 (.005-.007) .005 (.004-.006) .010 (.008-.013) .020 (.013-.038) .039 (.021-.064) 2663 
Age group        
6-11 years 11-12 .009 (.007-.011) .008 (.007-.010) .013 (.011-.017) .023 (.014-.031) .031 (.018-.080) 398 
 13-14 .008 (.006-.010) .006 (.005-.009) .012 (.009-.019) .028 (.018-.045) .045 (.022-.081) 402 
12-19 years 11-12 .007 (.005-.009) .006 (.005-.009) .010 (.008-.013) .016 (.013-.026) .026 (.015-.059) 390 
 13-14 .005 (.004-.007) .004 (.004-.005) .009 (.005-.015) .021 (.011-.045) .038 (.018-.051) 451 
20 years and older 11-12 .007 (.006-.008) .006 (.005-.008) .011 (.009-.014) .021 (.015-.027) .029 (.022-.041) 1714 
 13-14 .006 (.005-.007) .005 (.004-.006) .010 (.008-.013) .020 (.014-.036) .039 (.020-.065) 1810 
Gender        
Males 11-12 .006 (.005-.007) .006 (.005-.007) .009 (.007-.013) .017 (.012-.026) .027 (.017-.052) 1261 
 13-14 .005 (.004-.006) .005 (.004-.005) .009 (.006-.012) .019 (.011-.039) .034 (.018-.061) 1317 
Females 11-12 .008 (.007-.009) .007 (.006-.009) .013 (.010-.016) .022 (.020-.026) .030 (.026-.036) 1241 
 13-14 .007 (.006-.008) .006 (.005-.007) .011 (.009-.013) .024 (.016-.042) .046 (.025-.067) 1346 
Race/ethnicity        
Mexican Americans 11-12 .008 (.006-.011) .008 (.006-.011) .013 (.010-.018) .021 (.014-.030) .027 (.019-.046) 317 
 13-14 .009 (.007-.011) .008 (.007-.010) .014 (.011-.020) .025 (.020-.042) .042 (.025-.061) 453 
Non-Hispanic blacks 11-12 .005 (.004-.006) .005 (.004-.006) .008 (.006-.009) .013 (.009-.019) .019 (.014-.030) 669 
 13-14 .004 (.004-.005) .004 (.004-.004) .006 (.005-.007) .011 (.008-.016) .017 (.011-.026) 581 
Non-Hispanic whites 11-12 .007 (.006-.009) .007 (.006-.008) .012 (.010-.016) .022 (.018-.028) .031 (.023-.057) 818 
 13-14 .006 (.004-.008) .005 (.004-.007) .010 (.007-.015) .021 (.011-.055) .039 (.019-.082) 984 
All Hispanics 11-12 .007 (.005-.008) .007 (.005-.009) .011 (.009-.014) .018 (.013-.026) .025 (.019-.034) 573 
 13-14 .008 (.006-.009) .007 (.006-.009) .013 (.010-.018) .023 (.019-.035) .042 (.022-.061) 701 
Asians 11-12 .007 (.006-.008) .007 (.006-.008) .012 (.010-.013) .019 (.015-.032) .033 (.018-.048) 353 
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Serum Zinc (2011 - 2014) 
 
Geometric mean and selected percentiles of serum concentrations (in µg/dL) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 81.9 (80.9-82.9) 81.8 (80.8-82.9) 91.5 (89.8-93.1) 101 (99.1-104) 109 (105-112) 2329 
 13-14 80.4 (78.2-82.6) 80.7 (78.4-82.9) 90.5 (88.0-93.1) 101 (97.7-104) 109 (104-113) 2519 
Age group        
6-11 years 11-12 81.3 (79.4-83.2) 82.0 (79.2-83.7) 90.3 (86.3-93.4) 101 (93.7-106) 106 (101-114) 316 
 13-14 79.3 (77.4-81.3) 79.4 (77.7-81.0) 88.5 (84.5-91.5) 97.4 (91.4-103) 103 (96.2-114) 339 
12-19 years 11-12 83.0 (81.5-84.5) 81.9 (79.4-85.0) 94.4 (89.6-96.0) 103 (99.1-105) 106 (103-115) 366 
 13-14 82.8 (80.1-85.6) 84.1 (79.8-87.6) 94.8 (89.4-98.3) 103 (100-108) 110 (102-118) 418 
20 years and older 11-12 81.8 (80.7-83.0) 81.7 (80.6-82.9) 91.3 (89.3-93.4) 101 (98.6-104) 109 (105-114) 1647 
 13-14 80.1 (77.9-82.5) 80.5 (78.2-82.5) 90.2 (87.3-92.9) 101 (97.0-105) 109 (103-114) 1762 
Gender        
Males 11-12 84.2 (82.7-85.8) 83.9 (82.4-85.4) 94.0 (91.9-96.4) 104 (101-109) 112 (108-117) 1162 
 13-14 82.6 (80.2-85.0) 83.1 (80.6-85.6) 93.3 (90.4-96.3) 105 (100-109) 113 (107-119) 1235 
Females 11-12 79.8 (78.7-81.0) 79.7 (78.2-81.1) 88.5 (87.3-90.2) 99.6 (95.5-103) 105 (103-108) 1167 
 13-14 78.3 (76.1-80.6) 78.7 (76.0-81.3) 87.5 (84.9-90.1) 97.5 (93.0-102) 103 (101-108) 1284 
Race/ethnicity        
Mexican Americans 11-12 81.4 (77.2-85.7) 81.8 (76.4-86.4) 89.6 (86.5-96.4) 101 (94.3-110) 110 (100-119) 285 
 13-14 81.0 (77.6-84.5) 80.8 (77.1-85.8) 92.1 (88.1-98.6) 102 (100-110) 113 (103-119) 431 
Non-Hispanic blacks 11-12 79.7 (77.9-81.5) 79.4 (77.8-81.3) 90.9 (87.0-93.3) 101 (95.7-106) 108 (103-111) 620 
 13-14 79.1 (75.8-82.5) 78.4 (74.6-83.0) 88.4 (85.8-91.8) 102 (95.1-105) 109 (103-114) 516 
Non-Hispanic whites 11-12 82.8 (81.3-84.2) 82.9 (81.1-84.5) 92.2 (89.8-94.5) 102 (98.0-105) 109 (103-117) 780 
 13-14 80.5 (77.9-83.2) 81.2 (78.7-83.3) 90.4 (87.5-93.3) 101 (96.8-103) 109 (102-113) 975 
All Hispanics 11-12 80.4 (78.1-82.7) 80.1 (77.5-83.1) 88.8 (86.4-92.4) 100 (96.2-106) 109 (101-116) 525 
 13-14 81.7 (78.3-85.2) 81.8 (78.4-85.6) 92.2 (87.3-99.5) 103 (99.9-109) 113 (104-123) 666 
Asians 11-12 81.2 (79.0-83.6) 81.0 (78.6-83.7) 91.3 (88.7-95.1) 101 (97.9-107) 110 (103-114) 323 
 13-14 78.4 (75.8-81.1) 78.0 (74.8-83.2) 89.7 (85.8-93.0) 100 (96.0-106) 109 (103-112) 266 
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Urinary Nitrate (2001 - 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in mg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 01-02 48.2 (46.2-50.3) 49.0 (46.0-52.0) 78.0 (73.0-83.0) 100 (100-130) 140 (130-150) 1617 
 05-06 42.7 (39.6-46.1) 47.8 (44.4-51.2) 74.6 (69.8-79.4) 108 (101-114) 133 (125-144) 7697 
 07-08 46.3 (44.6-48.1) 50.3 (48.4-52.0) 76.0 (72.7-79.1) 110 (104-116) 138 (132-146) 7629 
 09-10 40.7 (38.9-42.7) 43.3 (41.1-45.8) 68.7 (65.5-72.5) 98.5 (93.4-102) 126 (114-137) 2844 
Age group        
6-11 years 01-02 62.2 (53.8-71.8) 68.0 (58.0-79.0) 94.0 (84.0-100) 130 (100-160) 150 (120-380) 374 
 05-06 51.2 (47.4-55.4) 54.7 (51.9-58.2) 79.2 (72.8-87.2) 113 (101-128) 141 (120-158) 1054 
 07-08 55.2 (51.7-58.9) 60.2 (56.1-64.3) 84.5 (80.1-92.5) 117 (107-135) 149 (132-189) 1143 
 09-10 46.8 (43.2-50.6) 50.3 (45.5-58.2) 73.2 (70.2-79.1) 98.7 (86.7-112) 119 (98.0-186) 377 
12-19 years 01-02 57.4 (53.5-61.6) 66.0 (60.0-69.0) 91.0 (86.0-95.0) 120 (100-130) 150 (130-160) 827 
 05-06 52.5 (48.5-56.8) 57.5 (52.3-62.6) 84.2 (79.9-88.4) 119 (111-124) 144 (129-153) 2106 
 07-08 55.5 (51.5-59.7) 56.8 (51.9-61.5) 84.1 (76.2-94.5) 119 (107-133) 144 (133-162) 1135 
 09-10 44.6 (41.0-48.4) 48.0 (43.3-54.9) 75.2 (70.0-79.4) 106 (91.6-119) 133 (106-163) 452 
20 years and older 01-02 45.4 (43.3-47.5) 49.0 (46.0-52.0) 78.0 (73.0-83.0) 100 (100-130) 140 (130-150) 1617 
 05-06 40.5 (37.4-43.9) 45.0 (41.3-48.3) 71.7 (67.1-77.4) 105 (98.0-113) 129 (122-142) 4537 
 07-08 44.2 (42.5-45.9) 48.1 (46.0-49.7) 73.2 (70.1-76.5) 107 (101-113) 135 (128-146) 5351 
 09-10 39.6 (37.4-41.9) 42.3 (39.4-44.8) 66.4 (62.3-71.9) 97.2 (91.9-102) 124 (113-144) 2015 
Gender        
Males 01-02 57.5 (54.6-60.6) 63.0 (59.0-67.0) 89.0 (83.0-94.0) 130 (100-140) 150 (140-170) 1335 
 05-06 48.4 (44.6-52.6) 52.7 (48.3-57.8) 79.4 (72.8-86.5) 110 (103-121) 136 (123-152) 3765 
 07-08 51.9 (49.9-54.1) 56.1 (53.8-58.0) 79.5 (75.7-83.5) 112 (105-119) 137 (131-149) 3839 
 09-10 44.9 (41.8-48.2) 46.0 (43.1-49.7) 73.3 (67.9-77.1) 105 (95.6-112) 133 (117-159) 1401 
Females 01-02 40.7 (38.4-43.2) 43.0 (41.0-48.0) 72.0 (68.0-76.0) 100 (98.0-120) 130 (120-150) 1483 
 05-06 37.9 (35.1-40.8) 42.0 (38.2-46.0) 69.2 (65.5-73.4) 104 (96.6-110) 130 (124-140) 3932 
 07-08 41.4 (39.3-43.7) 43.9 (41.5-46.3) 71.3 (67.5-74.8) 108 (99.8-115) 138 (132-149) 3790 
 09-10 37.1 (34.9-39.5) 40.3 (36.4-43.9) 65.9 (62.0-69.8) 92.2 (88.4-98.5) 117 (101-130) 1443 
Race/ethnicity        
Mexican Americans 01-02 53.2 (48.7-58.2) 59.0 (52.0-66.0) 84.0 (79.0-91.0) 120 (100-150) 160 (130-180) 707 
 05-06 47.8 (44.7-51.2) 52.4 (49.9-56.2) 77.9 (75.1-83.1) 113 (104-120) 148 (133-156) 1972 
 07-08 48.7 (45.0-52.6) 51.9 (47.4-56.7) 75.6 (69.7-81.3) 111 (100-122) 148 (127-164) 1505 
 09-10 41.3 (39.3-43.5) 43.5 (41.2-46.4) 66.4 (61.0-73.9) 92.6 (86.5-99.7) 111 (94.4-132) 611 
Non-Hispanic blacks 01-02 53.8 (47.8-60.5) 58.0 (51.0-64.0) 84.0 (77.0-93.0) 120 (100-130) 140 (130-170) 680 
 05-06 45.9 (42.1-50.0) 50.4 (46.6-54.9) 75.0 (68.8-80.8) 101 (95.3-110) 127 (114-148) 2078 
 07-08 47.5 (45.0-50.3) 50.3 (48.6-52.5) 74.7 (71.9-77.3) 105 (97.1-116) 134 (125-150) 1707 
 09-10 39.0 (36.5-41.7) 44.1 (41.6-46.3) 65.4 (61.5-69.6) 94.2 (86.6-101) 121 (101-141) 544 
Non-Hispanic whites 01-02 46.3 (44.1-48.6) 51.0 (47.0-53.0) 81.0 (78.0-85.0) 120 (100-130) 140 (130-150) 1228 
 05-06 41.2 (37.6-45.2) 46.2 (41.3-50.6) 73.3 (67.3-80.1) 107 (98.2-115) 129 (122-142) 3056 
 07-08 45.0 (42.7-47.5) 49.2 (46.1-52.6) 75.5 (70.5-80.0) 108 (101-116) 134 (128-140) 3190 
 09-10 39.8 (37.2-42.6) 42.1 (39.1-45.2) 68.4 (63.0-73.5) 95.6 (89.8-100) 119 (106-131) 1215 
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Urinary Nitrate (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in mg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 41.8 (39.7-44.1) 44.5 (42.3-47.2) 71.5 (68.1-76.4) 108 (99.3-116) 133 (119-156) 2467 
 13-14 40.8 (38.8-42.9) 42.2 (39.6-45.7) 72.2 (67.8-78.7) 107 (101-112) 136 (123-151) 2644 
Age group        
6-11 years 11-12 47.4 (43.3-52.0) 54.1 (49.2-61.3) 78.6 (74.3-84.0) 99.8 (93.2-113) 121 (104-141) 394 
 13-14 44.7 (41.0-48.8) 47.3 (42.3-51.7) 79.2 (68.9-86.0) 119 (95.8-138) 151 (124-189) 398 
12-19 years 11-12 43.3 (37.4-50.1) 50.4 (39.8-58.3) 71.5 (66.5-78.0) 107 (91.9-121) 135 (108-183) 384 
 13-14 46.5 (40.8-53.0) 51.1 (42.5-59.3) 83.4 (72.9-89.6) 112 (92.5-120) 122 (115-134) 449 
20 years and older 11-12 41.0 (38.7-43.5) 43.4 (40.8-46.2) 70.1 (66.1-75.7) 110 (98.7-117) 135 (117-164) 1689 
 13-14 39.6 (37.6-41.8) 40.7 (38.2-44.1) 70.2 (64.2-76.1) 107 (101-111) 136 (120-153) 1797 
Gender        
Males 11-12 46.9 (43.3-50.8) 48.4 (43.6-53.0) 76.2 (69.9-81.7) 114 (101-124) 150 (116-175) 1251 
 13-14 43.6 (40.1-47.4) 45.3 (41.0-50.6) 73.1 (64.3-83.5) 108 (99.8-113) 141 (118-157) 1313 
Females 11-12 37.4 (34.4-40.7) 41.2 (36.4-46.0) 67.9 (60.6-73.7) 101 (89.8-114) 120 (113-145) 1216 
 13-14 38.2 (36.1-40.5) 39.2 (37.5-41.7) 71.4 (67.8-74.8) 107 (99.8-112) 134 (120-141) 1331 
Race/ethnicity        
Mexican Americans 11-12 41.1 (36.9-45.8) 45.9 (40.4-51.3) 65.9 (61.8-70.9) 89.8 (78.4-108) 112 (89.8-159) 313 
 13-14 42.0 (36.0-49.0) 45.3 (35.4-56.6) 72.0 (61.7-83.4) 111 (93.0-134) 136 (111-163) 451 
Non-Hispanic blacks 11-12 44.9 (41.5-48.6) 47.6 (41.6-52.3) 73.8 (67.8-79.8) 107 (97.1-117) 139 (116-150) 663 
 13-14 46.4 (42.4-50.9) 50.0 (44.9-54.4) 73.6 (66.4-80.6) 105 (92.1-119) 135 (107-172) 574 
Non-Hispanic whites 11-12 41.0 (38.0-44.1) 43.6 (39.6-47.9) 71.9 (66.7-78.0) 110 (96.1-117) 132 (115-169) 810 
 13-14 39.3 (36.6-42.3) 40.2 (37.6-43.9) 71.9 (64.5-80.9) 107 (95.9-111) 128 (114-145) 976 
All Hispanics 11-12 41.0 (36.7-45.7) 44.4 (40.2-48.9) 67.2 (60.9-73.9) 95.3 (82.9-113) 120 (97.0-159) 566 
 13-14 41.1 (36.8-45.8) 44.4 (39.0-50.5) 70.0 (62.7-76.7) 107 (94.2-116) 138 (120-153) 699 
Asians 11-12 50.2 (43.7-57.6) 50.8 (45.8-57.5) 84.0 (72.1-91.9) 146 (121-171) 238 (142-380) 341 
 13-14 44.4 (38.9-50.7) 45.2 (36.6-53.0) 91.6 (76.2-99.5) 150 (114-183) 189 (139-282) 291 
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Urinary Nitrate (creatinine corrected) (2001 - 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in mg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 01-02 49.8 (47.7-51.9) 46.9 (44.2-49.6) 63.8 (61.2-67.7) 90.9 (84.3-98.8) 120 (111-128) 1616 
 05-06 42.6 (40.2-45.1) 42.4 (40.1-44.7) 59.7 (55.8-64.1) 85.5 (81.3-91.3) 113 (106-118) 7697 
 07-08 47.7 (45.9-49.7) 46.0 (44.0-48.3) 66.5 (62.4-70.5) 98.0 (92.3-102) 127 (119-135) 7628 
 09-10 43.7 (42.1-45.3) 42.3 (41.0-43.7) 60.2 (57.6-63.0) 88.5 (83.3-96.1) 115 (104-127) 2843 
Age group        
6-11 years 01-02 72.0 (66.1-78.4) 66.0 (62.6-70.4) 87.0 (80.2-97.7) 129 (96.5-144) 144 (130-235) 374 
 05-06 60.8 (57.4-64.5) 57.3 (53.6-60.6) 76.5 (70.9-82.1) 109 (95.0-123) 134 (121-164) 1054 
 07-08 70.2 (65.7-74.9) 65.9 (62.4-69.5) 89.0 (83.2-96.5) 128 (112-152) 173 (140-216) 1143 
 09-10 64.2 (58.8-70.0) 60.2 (56.3-63.3) 80.7 (68.9-96.1) 107 (96.1-124) 127 (105-202) 376 
12-19 years 01-02 44.8 (43.4-46.2) 43.8 (42.6-45.0) 56.2 (52.2-59.7) 73.2 (65.2-85.1) 93.4 (79.0-104) 826 
 05-06 39.8 (37.8-41.9) 38.1 (36.3-40.3) 51.8 (47.7-56.0) 70.6 (63.1-78.8) 88.9 (79.4-103) 2106 
 07-08 43.4 (41.3-45.5) 40.5 (38.6-43.5) 56.0 (52.7-59.2) 76.6 (69.0-86.2) 98.0 (85.4-121) 1134 
 09-10 41.7 (39.3-44.4) 39.7 (38.3-41.7) 54.0 (48.4-57.4) 73.4 (61.0-86.1) 88.5 (71.0-117) 452 
20 years and older 01-02 48.3 (45.9-50.9) 46.9 (44.2-49.6) 63.8 (61.2-67.7) 90.9 (84.3-98.8) 120 (111-128) 1616 
 05-06 41.4 (38.9-43.9) 41.0 (38.8-43.7) 58.6 (54.8-63.1) 85.3 (80.2-91.0) 111 (105-116) 4537 
 07-08 46.5 (44.6-48.4) 44.7 (42.5-47.0) 65.0 (60.7-69.2) 96.1 (90.0-102) 125 (117-132) 5351 
 09-10 42.2 (40.3-44.2) 41.0 (39.6-42.5) 58.6 (55.4-62.2) 87.7 (81.0-98.5) 116 (103-133) 2015 
Gender        
Males 01-02 47.6 (44.7-50.7) 46.1 (43.4-48.7) 61.3 (58.0-64.5) 86.7 (77.1-97.3) 114 (97.3-125) 1335 
 05-06 40.1 (37.5-42.9) 39.5 (36.7-42.8) 55.3 (51.6-59.5) 77.2 (70.7-83.0) 95.9 (89.6-102) 3765 
 07-08 44.6 (42.8-46.6) 42.8 (40.7-45.1) 60.6 (58.1-64.4) 85.6 (81.1-91.3) 111 (101-121) 3839 
 09-10 41.0 (38.9-43.1) 39.1 (37.6-40.6) 54.6 (52.2-58.1) 83.3 (74.6-90.0) 103 (96.1-122) 1400 
Females 01-02 51.9 (49.9-54.1) 51.2 (48.4-53.0) 69.1 (66.7-71.2) 100 (91.7-111) 129 (118-140) 1481 
 05-06 45.1 (42.8-47.6) 45.0 (42.4-47.4) 64.4 (60.0-69.6) 96.8 (87.8-105) 128 (117-134) 3932 
 07-08 51.0 (48.9-53.2) 50.0 (47.5-52.7) 72.3 (67.8-76.8) 107 (101-116) 146 (129-163) 3789 
 09-10 46.5 (44.4-48.7) 46.5 (44.8-48.4) 64.2 (60.5-69.4) 96.6 (83.3-106) 121 (106-152) 1443 
Race/ethnicity        
Mexican Americans 01-02 50.9 (45.7-56.8) 48.1 (44.9-51.4) 67.4 (60.3-77.6) 97.3 (85.7-117) 135 (100-161) 707 
 05-06 44.6 (42.6-46.7) 44.0 (42.2-45.3) 60.4 (58.1-62.9) 89.9 (82.0-95.4) 120 (111-128) 1972 
 07-08 48.7 (45.1-52.7) 47.0 (43.5-50.5) 64.8 (59.7-69.9) 93.5 (88.9-101) 128 (108-156) 1505 
 09-10 43.4 (40.5-46.5) 42.2 (39.7-45.9) 58.2 (54.7-61.3) 86.2 (77.1-92.5) 104 (90.8-122) 611 
Non-Hispanic blacks 01-02 38.7 (36.3-41.3) 38.0 (34.6-41.3) 53.5 (50.3-57.4) 70.3 (64.9-79.3) 91.7 (78.9-100) 679 
 05-06 32.9 (30.9-35.0) 31.9 (29.8-34.1) 45.4 (41.5-49.6) 64.0 (60.1-68.0) 81.2 (75.3-89.6) 2078 
 07-08 35.9 (34.2-37.7) 34.8 (33.3-36.6) 49.0 (44.8-53.6) 69.1 (63.5-77.4) 87.8 (78.1-97.4) 1706 
 09-10 31.4 (28.9-34.0) 32.2 (29.7-34.5) 43.3 (40.8-47.3) 59.9 (54.8-69.7) 77.1 (62.2-98.3) 543 
Non-Hispanic whites 01-02 51.4 (49.4-53.4) 49.1 (46.9-51.5) 66.9 (64.2-69.4) 95.2 (87.7-100) 124 (115-132) 1227 
 05-06 43.7 (40.8-46.8) 43.9 (40.8-46.8) 61.4 (56.5-66.2) 85.5 (80.6-91.9) 110 (102-116) 3056 
 07-08 49.0 (46.7-51.4) 47.4 (44.9-50.5) 68.2 (63.3-73.1) 98.3 (91.2-105) 126 (118-135) 3190 





Fourth National Report on Human Exposure to Environmental Chemicals, Updated Tables, January 2017 Volume One Page 320
Urinary Nitrate (creatinine corrected) (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in mg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 47.8 (45.3-50.4) 46.0 (43.7-49.2) 67.4 (62.6-71.5) 103 (88.7-117) 137 (117-153) 2465 
 13-14 47.2 (45.2-49.4) 46.3 (43.2-49.4) 66.2 (62.9-70.2) 97.3 (91.0-104) 123 (116-133) 2643 
Age group        
6-11 years 11-12 68.0 (63.3-73.1) 66.4 (60.9-68.7) 87.3 (81.2-95.6) 122 (110-132) 144 (124-156) 393 
 13-14 67.1 (62.3-72.2) 63.2 (59.4-67.1) 83.6 (72.4-95.2) 118 (99.1-145) 159 (110-230) 398 
12-19 years 11-12 42.2 (39.6-44.9) 41.5 (38.7-43.8) 54.0 (51.2-57.7) 69.1 (63.6-77.1) 86.9 (69.1-104) 384 
 13-14 42.2 (39.7-44.8) 41.9 (37.2-44.7) 52.8 (47.9-58.1) 69.2 (61.0-82.0) 85.6 (72.6-107) 449 
20 years and older 11-12 46.8 (44.0-49.8) 44.9 (41.7-47.9) 66.8 (60.5-73.0) 105 (87.4-122) 142 (116-165) 1688 
 13-14 46.3 (44.2-48.5) 45.2 (42.5-48.2) 66.0 (62.8-70.2) 97.4 (90.5-105) 123 (113-136) 1796 
Gender        
Males 11-12 44.1 (41.8-46.6) 43.8 (40.8-45.9) 59.8 (57.0-62.4) 87.1 (76.9-98.4) 109 (98.4-120) 1250 
 13-14 43.7 (41.4-46.2) 42.5 (38.9-45.6) 59.8 (55.7-65.5) 84.0 (78.6-94.3) 110 (99.1-128) 1312 
Females 11-12 51.6 (47.9-55.5) 50.0 (45.8-54.0) 76.5 (68.9-85.1) 120 (98.1-143) 151 (132-170) 1215 
 13-14 50.9 (48.2-53.7) 50.5 (47.1-53.5) 71.6 (67.8-75.7) 107 (95.6-113) 135 (118-156) 1331 
Race/ethnicity        
Mexican Americans 11-12 46.4 (41.0-52.6) 43.6 (38.9-49.7) 62.4 (52.7-78.0) 86.4 (72.1-124) 110 (84.0-203) 313 
 13-14 48.1 (43.4-53.2) 48.3 (46.0-50.9) 67.3 (62.1-72.0) 99.3 (83.0-116) 128 (100-169) 451 
Non-Hispanic blacks 11-12 35.0 (33.2-36.9) 34.3 (32.1-36.3) 47.5 (44.0-51.3) 69.2 (62.2-78.1) 89.3 (77.1-102) 663 
 13-14 35.5 (33.4-37.8) 33.8 (32.0-35.9) 46.2 (43.5-49.7) 67.3 (60.4-75.0) 87.3 (76.6-95.6) 574 
Non-Hispanic whites 11-12 50.1 (47.2-53.2) 49.0 (45.7-52.3) 68.9 (63.8-79.4) 107 (91.1-129) 144 (121-154) 808 
 13-14 48.6 (46.3-50.9) 47.9 (44.8-51.4) 67.8 (62.9-72.5) 97.4 (89.5-105) 122 (109-136) 975 
All Hispanics 11-12 45.8 (42.4-49.5) 44.1 (41.7-46.2) 61.5 (55.4-69.3) 85.2 (78.5-95.6) 115 (86.4-159) 566 
 13-14 45.9 (43.1-48.9) 46.1 (43.1-48.3) 65.5 (61.0-68.6) 95.4 (85.0-105) 126 (105-137) 699 
Asians 11-12 67.2 (61.9-72.9) 62.9 (56.3-68.8) 106 (93.3-118) 178 (153-216) 247 (203-318) 341 
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Urinary Perchlorate (2001 - 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 01-02 3.72 (3.46-4.01) 3.70 (3.40-3.90) 6.20 (5.60-6.90) 10.0 (8.90-12.0) 14.0 (12.0-18.0) 1618 
 03-04 3.39 (3.08-3.73) 3.50 (3.00-4.00) 5.80 (5.20-6.70) 10.0 (8.80-12.0) 14.0 (13.0-16.0) 2522 
 05-06 3.47 (3.20-3.76) 3.62 (3.35-3.98) 6.10 (5.67-6.52) 9.76 (9.19-10.5) 13.4 (12.4-14.6) 7697 
 07-08 3.88 (3.60-4.18) 3.96 (3.59-4.30) 7.10 (6.50-7.74) 12.0 (11.2-13.0) 17.3 (16.1-18.8) 7629 
 09-10 3.38 (3.19-3.58) 3.44 (3.17-3.61) 5.95 (5.66-6.35) 10.1 (9.20-10.6) 13.8 (12.2-15.4) 2844 
Age group        
6-11 years 01-02 5.19 (4.44-6.05) 5.50 (4.60-6.70) 8.50 (7.20-10.0) 13.0 (9.80-20.0) 20.0 (13.0-24.0) 374 
 03-04 4.54 (3.85-5.36) 4.80 (4.20-5.50) 8.30 (6.00-10.0) 14.0 (9.20-17.0) 17.0 (12.0-30.0) 314 
 05-06 4.64 (4.15-5.18) 4.81 (4.26-5.38) 7.67 (6.71-8.60) 11.6 (10.0-12.7) 14.1 (12.4-16.3) 1054 
 07-08 4.88 (4.31-5.53) 4.86 (4.22-5.93) 9.11 (7.84-10.3) 14.4 (12.1-16.9) 18.9 (16.1-23.2) 1143 
 09-10 4.47 (3.88-5.15) 5.03 (3.84-5.98) 7.98 (6.86-9.68) 12.2 (10.1-15.7) 16.2 (11.2-24.5) 377 
12-19 years 01-02 4.00 (3.62-4.42) 4.60 (4.00-5.00) 7.10 (6.60-7.70) 10.0 (9.70-12.0) 14.0 (12.0-18.0) 828 
 03-04 3.81 (3.35-4.33) 4.00 (3.40-4.60) 6.70 (5.80-7.40) 10.0 (8.20-13.0) 14.0 (10.0-19.0) 721 
 05-06 4.14 (3.77-4.53) 4.25 (3.94-4.65) 7.00 (6.41-7.69) 10.9 (9.71-12.4) 15.6 (12.4-17.9) 2106 
 07-08 4.50 (4.06-4.97) 4.73 (4.39-5.05) 7.93 (6.89-8.89) 13.0 (11.1-15.4) 17.7 (15.8-20.2) 1135 
 09-10 3.36 (2.89-3.91) 3.33 (2.86-3.98) 6.21 (5.22-7.82) 10.7 (8.58-13.2) 15.1 (12.0-19.4) 452 
20 years and older 01-02 3.53 (3.24-3.84) 3.70 (3.40-3.90) 6.20 (5.60-6.90) 10.0 (8.90-12.0) 14.0 (12.0-18.0) 1618 
 03-04 3.21 (2.89-3.56) 3.40 (2.80-3.80) 5.50 (4.90-6.40) 9.50 (8.30-10.0) 13.0 (12.0-15.0) 1487 
 05-06 3.27 (3.01-3.55) 3.42 (3.14-3.72) 5.75 (5.33-6.21) 9.38 (8.73-9.86) 13.1 (12.2-14.5) 4537 
 07-08 3.70 (3.43-3.99) 3.69 (3.42-4.09) 6.75 (6.09-7.38) 11.6 (10.8-12.7) 16.8 (15.4-18.7) 5351 
 09-10 3.29 (3.08-3.51) 3.28 (3.00-3.59) 5.68 (5.47-6.05) 9.55 (8.72-10.3) 13.3 (11.2-15.2) 2015 
Gender        
Males 01-02 4.41 (4.13-4.70) 4.60 (4.40-4.80) 7.40 (6.70-8.30) 12.0 (10.0-13.0) 15.0 (12.0-20.0) 1335 
 03-04 3.95 (3.56-4.37) 4.10 (3.60-4.60) 6.70 (5.90-7.90) 12.0 (9.70-13.0) 15.0 (14.0-18.0) 1229 
 05-06 3.93 (3.64-4.25) 4.07 (3.77-4.38) 6.50 (6.11-6.92) 10.4 (9.65-11.6) 14.7 (13.2-16.3) 3765 
 07-08 4.40 (4.13-4.70) 4.42 (4.12-4.78) 7.90 (7.16-8.46) 13.3 (12.0-14.4) 18.6 (17.0-19.7) 3839 
 09-10 3.66 (3.40-3.95) 3.74 (3.36-4.00) 6.21 (5.70-6.65) 10.2 (9.10-11.2) 14.6 (11.9-18.2) 1401 
Females 01-02 3.17 (2.89-3.48) 3.30 (2.80-3.60) 5.70 (5.20-6.30) 9.70 (8.60-12.0) 14.0 (12.0-18.0) 1485 
 03-04 2.93 (2.62-3.28) 3.00 (2.60-3.40) 5.10 (4.60-5.80) 8.60 (7.20-10.0) 12.0 (9.20-16.0) 1293 
 05-06 3.08 (2.80-3.38) 3.24 (2.96-3.51) 5.55 (5.14-6.07) 9.20 (8.22-10.3) 12.4 (11.3-14.2) 3932 
 07-08 3.42 (3.11-3.76) 3.44 (3.10-3.79) 6.41 (5.95-7.01) 10.8 (10.0-12.0) 16.0 (14.1-17.9) 3790 
 09-10 3.13 (2.93-3.34) 3.11 (2.83-3.37) 5.83 (5.36-6.28) 9.73 (8.44-10.6) 13.2 (11.0-15.4) 1443 
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Urinary Perchlorate (2001 - 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 01-02 4.23 (3.65-4.90) 4.60 (3.90-5.20) 7.40 (6.10-8.80) 13.0 (9.90-14.0) 15.0 (13.0-19.0) 708 
 03-04 3.96 (3.63-4.32) 4.20 (3.70-4.60) 6.50 (5.60-7.90) 12.0 (9.50-13.0) 16.0 (13.0-18.0) 617 
 05-06 4.02 (3.77-4.28) 4.16 (3.84-4.46) 6.93 (6.62-7.26) 11.3 (10.4-12.0) 15.7 (14.6-16.8) 1972 
 07-08 4.20 (3.95-4.46) 4.38 (4.08-4.65) 7.32 (6.73-7.95) 12.1 (10.9-14.0) 16.7 (15.0-17.7) 1505 
 09-10 3.98 (3.51-4.51) 3.99 (3.45-4.54) 7.27 (6.06-8.20) 11.3 (9.97-13.4) 17.2 (12.0-24.5) 611 
Non-Hispanic blacks 01-02 3.69 (3.22-4.23) 3.90 (3.30-4.30) 6.20 (5.30-7.30) 9.70 (8.20-13.0) 16.0 (12.0-21.0) 681 
 03-04 3.38 (3.05-3.74) 3.40 (3.00-3.70) 5.70 (4.80-6.60) 9.00 (7.90-12.0) 14.0 (9.80-18.0) 652 
 05-06 3.48 (3.19-3.80) 3.54 (3.24-3.94) 5.95 (5.33-6.65) 9.99 (9.02-11.0) 14.4 (12.8-15.7) 2078 
 07-08 3.82 (3.37-4.33) 3.82 (3.37-4.48) 6.96 (6.18-7.97) 12.0 (10.6-13.8) 17.2 (14.3-20.6) 1707 
 09-10 2.98 (2.74-3.26) 2.94 (2.64-3.27) 5.31 (4.88-5.99) 9.06 (7.90-10.2) 12.7 (9.23-17.3) 544 
Non-Hispanic whites 01-02 3.70 (3.35-4.08) 3.90 (3.60-4.30) 6.60 (6.00-7.40) 10.0 (9.20-12.0) 15.0 (12.0-19.0) 1228 
 03-04 3.43 (3.04-3.86) 3.50 (2.90-4.20) 5.90 (5.10-7.10) 9.90 (8.50-12.0) 14.0 (12.0-16.0) 1092 
 05-06 3.42 (3.08-3.80) 3.59 (3.23-4.04) 6.05 (5.52-6.55) 9.62 (8.90-10.5) 13.2 (11.9-14.8) 3056 
 07-08 3.84 (3.52-4.18) 3.93 (3.48-4.36) 7.07 (6.37-7.77) 11.7 (10.8-12.7) 16.8 (15.3-18.4) 3190 
 09-10 3.40 (3.21-3.61) 3.48 (3.17-3.68) 5.94 (5.60-6.40) 9.69 (8.78-10.3) 13.6 (11.2-15.5) 1215 
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Urinary Perchlorate (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 2.96 (2.79-3.14) 3.01 (2.82-3.24) 5.46 (5.11-5.71) 9.11 (8.46-9.78) 12.8 (11.4-14.2) 2467 
 13-14 2.63 (2.44-2.83) 2.62 (2.40-2.83) 4.76 (4.51-5.08) 7.92 (7.26-8.57) 10.6 (9.43-11.9) 2644 
Age group        
6-11 years 11-12 3.89 (3.45-4.39) 4.31 (3.67-4.86) 6.41 (5.88-7.17) 10.6 (8.97-12.8) 14.9 (12.7-18.5) 394 
 13-14 3.37 (2.96-3.84) 3.56 (2.95-4.14) 5.61 (4.95-7.08) 9.38 (7.52-10.6) 12.1 (9.70-21.2) 398 
12-19 years 11-12 2.77 (2.33-3.30) 2.82 (2.39-3.60) 5.15 (4.28-5.71) 7.54 (6.40-8.68) 10.8 (7.54-13.3) 384 
 13-14 2.86 (2.42-3.37) 2.91 (2.47-3.45) 5.11 (3.96-6.69) 9.43 (7.11-10.9) 13.9 (9.83-24.0) 449 
20 years and older 11-12 2.90 (2.71-3.10) 2.95 (2.75-3.14) 5.30 (4.94-5.73) 9.16 (8.46-10.3) 12.8 (11.2-14.6) 1689 
 13-14 2.53 (2.34-2.73) 2.44 (2.25-2.76) 4.57 (4.22-4.93) 7.67 (6.94-8.29) 10.2 (8.93-11.7) 1797 
Gender        
Males 11-12 3.32 (3.05-3.61) 3.43 (3.22-3.67) 5.79 (5.45-6.58) 10.3 (8.70-10.8) 13.3 (11.7-14.6) 1251 
 13-14 2.73 (2.47-3.03) 2.85 (2.58-3.13) 4.84 (4.53-5.33) 8.18 (6.97-9.43) 11.0 (9.87-13.4) 1313 
Females 11-12 2.65 (2.44-2.87) 2.64 (2.40-2.96) 4.86 (4.20-5.52) 8.21 (7.78-8.86) 11.7 (10.6-13.2) 1216 
 13-14 2.53 (2.36-2.70) 2.40 (2.21-2.62) 4.67 (4.14-5.21) 7.81 (7.00-8.45) 9.83 (8.73-11.7) 1331 
Race/ethnicity        
Mexican Americans 11-12 3.46 (2.97-4.02) 3.47 (2.83-3.90) 6.06 (4.99-7.38) 10.5 (7.19-16.4) 15.3 (10.1-24.2) 313 
 13-14 3.02 (2.67-3.42) 3.08 (2.70-3.42) 4.95 (4.55-5.75) 8.69 (6.98-11.5) 12.6 (8.71-18.8) 451 
Non-Hispanic blacks 11-12 2.92 (2.69-3.16) 2.91 (2.64-3.27) 5.48 (4.72-5.96) 9.02 (8.11-10.8) 12.2 (11.3-14.7) 663 
 13-14 2.75 (2.47-3.06) 2.81 (2.49-3.06) 4.76 (4.17-5.42) 7.78 (6.82-8.59) 11.9 (7.92-15.1) 574 
Non-Hispanic whites 11-12 2.93 (2.75-3.13) 3.07 (2.81-3.31) 5.44 (5.04-5.73) 8.70 (8.05-10.4) 12.7 (10.8-14.2) 810 
 13-14 2.57 (2.39-2.77) 2.52 (2.29-2.81) 4.73 (4.37-5.11) 7.70 (7.02-8.29) 9.54 (8.80-10.8) 976 
All Hispanics 11-12 3.15 (2.81-3.52) 2.99 (2.52-3.50) 5.49 (4.67-6.27) 9.51 (7.38-11.6) 13.2 (10.4-18.4) 566 
 13-14 2.84 (2.51-3.21) 2.82 (2.56-3.16) 4.84 (4.39-5.72) 8.67 (7.00-11.0) 12.6 (9.82-18.8) 699 
Asians 11-12 2.81 (2.44-3.24) 2.82 (2.36-3.22) 5.48 (4.82-6.39) 9.48 (7.86-12.3) 15.1 (10.3-23.6) 341 
 13-14 2.42 (1.97-2.97) 2.36 (1.76-3.27) 5.02 (3.91-6.25) 9.29 (7.70-10.4) 12.1 (10.2-14.0) 291 
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Urinary Perchlorate (creatinine corrected) (2001 - 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 01-02 3.74 (3.51-3.99) 3.44 (3.18-3.79) 5.70 (5.27-6.18) 9.47 (7.88-10.8) 12.9 (10.7-14.9) 1617 
 03-04 3.31 (3.04-3.59) 3.18 (2.90-3.45) 5.19 (4.80-5.55) 8.86 (7.69-10.0) 12.4 (11.2-14.5) 2519 
 05-06 3.46 (3.27-3.66) 3.37 (3.17-3.59) 5.42 (5.08-5.86) 8.56 (8.19-9.17) 11.6 (10.4-13.4) 7697 
 07-08 4.00 (3.69-4.33) 3.89 (3.59-4.26) 6.59 (6.10-7.13) 10.9 (10.1-11.8) 15.7 (14.6-16.8) 7628 
 09-10 3.62 (3.48-3.77) 3.51 (3.37-3.72) 5.84 (5.57-6.10) 9.42 (8.73-10.3) 13.1 (11.4-14.1) 2843 
Age group        
6-11 years 01-02 6.01 (5.49-6.57) 6.10 (5.37-6.67) 8.68 (7.72-10.6) 13.6 (11.6-17.3) 18.6 (13.7-23.7) 374 
 03-04 5.52 (4.86-6.28) 5.34 (4.92-5.78) 7.64 (6.67-10.5) 13.5 (9.66-21.3) 21.3 (12.0-46.9) 314 
 05-06 5.51 (5.06-6.00) 5.66 (5.08-6.22) 8.39 (7.61-9.25) 12.3 (10.3-13.6) 15.4 (14.3-17.0) 1054 
 07-08 6.21 (5.52-6.99) 6.34 (5.56-7.10) 9.78 (8.63-11.3) 14.7 (13.3-16.0) 20.6 (16.4-25.0) 1143 
 09-10 6.14 (5.51-6.84) 6.10 (5.40-6.94) 10.3 (7.79-13.3) 16.2 (14.1-17.6) 20.2 (15.8-25.5) 376 
12-19 years 01-02 3.10 (2.77-3.46) 3.04 (2.67-3.53) 4.75 (4.20-5.48) 7.50 (6.82-8.26) 10.4 (7.90-14.1) 827 
 03-04 2.85 (2.59-3.14) 2.83 (2.62-3.17) 4.39 (3.88-4.67) 6.63 (5.56-7.82) 8.62 (7.24-11.4) 719 
 05-06 3.14 (2.89-3.41) 3.17 (2.87-3.40) 4.86 (4.32-5.41) 7.30 (6.40-8.43) 9.54 (8.46-11.0) 2106 
 07-08 3.52 (3.27-3.78) 3.43 (3.07-3.80) 5.62 (5.13-6.11) 8.84 (7.70-9.73) 12.6 (10.4-15.8) 1134 
 09-10 3.15 (2.87-3.45) 3.05 (2.75-3.50) 4.79 (4.14-5.74) 8.20 (6.29-8.96) 9.70 (8.73-11.0) 452 
20 years and older 01-02 3.64 (3.37-3.93) 3.44 (3.18-3.79) 5.70 (5.27-6.18) 9.47 (7.88-10.8) 12.9 (10.7-14.9) 1617 
 03-04 3.18 (2.90-3.49) 3.02 (2.74-3.33) 4.94 (4.53-5.35) 8.64 (7.18-10.0) 11.7 (10.3-15.2) 1486 
 05-06 3.34 (3.15-3.53) 3.24 (3.08-3.45) 5.12 (4.82-5.45) 8.24 (7.67-8.64) 11.4 (10.0-13.0) 4537 
 07-08 3.88 (3.57-4.22) 3.77 (3.49-4.14) 6.35 (5.85-6.91) 10.5 (9.64-11.5) 15.4 (13.6-16.9) 5351 
 09-10 3.50 (3.33-3.68) 3.44 (3.23-3.61) 5.59 (5.20-5.94) 8.91 (7.93-9.70) 12.2 (10.5-13.7) 2015 
Gender        
Males 01-02 3.57 (3.36-3.79) 3.42 (3.17-3.67) 5.62 (5.22-6.12) 9.24 (7.87-10.3) 12.2 (10.9-13.3) 1335 
 03-04 3.23 (2.96-3.52) 3.09 (2.83-3.33) 5.00 (4.60-5.55) 8.00 (6.86-10.2) 12.5 (10.2-15.3) 1228 
 05-06 3.25 (3.08-3.44) 3.16 (2.99-3.36) 4.98 (4.71-5.37) 8.07 (7.60-8.58) 11.0 (10.0-12.9) 3765 
 07-08 3.78 (3.47-4.12) 3.64 (3.28-4.03) 6.29 (5.72-6.85) 10.3 (9.28-11.3) 14.4 (13.1-15.5) 3839 
 09-10 3.34 (3.19-3.51) 3.25 (2.98-3.48) 5.21 (4.95-5.77) 9.08 (7.91-9.90) 13.1 (10.4-15.0) 1400 
Females 01-02 3.92 (3.57-4.30) 3.79 (3.36-4.31) 6.33 (5.65-7.00) 10.6 (8.64-12.6) 14.0 (11.8-17.0) 1483 
 03-04 3.38 (3.02-3.78) 3.28 (2.90-3.61) 5.24 (4.73-6.00) 9.40 (7.24-11.4) 12.4 (10.7-15.2) 1291 
 05-06 3.67 (3.43-3.93) 3.58 (3.31-3.91) 5.86 (5.39-6.19) 9.21 (8.35-9.77) 12.1 (10.5-14.5) 3932 
 07-08 4.22 (3.90-4.56) 4.16 (3.81-4.55) 6.89 (6.40-7.54) 11.5 (10.4-12.6) 16.6 (14.5-18.6) 3789 
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Urinary Perchlorate (creatinine corrected) (2001 - 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 01-02 3.96 (3.39-4.63) 3.71 (3.15-4.69) 6.18 (5.06-8.13) 10.9 (8.78-14.0) 15.3 (12.2-18.6) 708 
 03-04 3.59 (3.32-3.88) 3.45 (3.10-3.68) 5.69 (4.82-6.45) 9.77 (8.00-11.2) 13.5 (11.2-20.0) 616 
 05-06 3.75 (3.56-3.95) 3.60 (3.42-3.81) 5.97 (5.53-6.48) 9.83 (9.19-10.4) 12.7 (11.3-14.5) 1972 
 07-08 4.20 (3.96-4.46) 4.17 (3.81-4.58) 6.95 (6.33-7.73) 11.8 (10.4-12.3) 15.7 (14.4-17.6) 1505 
 09-10 4.18 (3.73-4.69) 4.09 (3.68-4.53) 6.94 (5.71-7.74) 10.3 (8.91-13.3) 16.2 (11.9-19.8) 611 
Non-Hispanic blacks 01-02 2.66 (2.35-3.01) 2.66 (2.22-2.97) 4.24 (3.69-5.20) 7.18 (6.17-8.80) 11.0 (8.73-12.7) 680 
 03-04 2.33 (2.11-2.57) 2.24 (2.02-2.47) 3.60 (3.22-4.13) 6.54 (4.91-8.47) 9.02 (6.84-11.8) 651 
 05-06 2.50 (2.32-2.69) 2.40 (2.24-2.61) 3.97 (3.69-4.26) 6.71 (6.30-7.13) 9.41 (8.53-10.4) 2078 
 07-08 2.89 (2.60-3.21) 2.76 (2.47-3.17) 4.92 (4.36-5.54) 8.63 (7.43-9.78) 11.8 (10.6-13.6) 1706 
 09-10 2.40 (2.19-2.63) 2.35 (2.11-2.55) 3.81 (3.60-4.18) 6.31 (5.58-6.94) 8.31 (6.69-10.6) 543 
Non-Hispanic whites 01-02 3.95 (3.64-4.29) 3.73 (3.39-4.22) 6.19 (5.73-6.64) 10.0 (8.67-11.2) 13.3 (11.8-16.0) 1227 
 03-04 3.53 (3.16-3.94) 3.35 (3.01-3.68) 5.29 (4.81-5.96) 9.23 (7.61-11.0) 12.8 (11.0-16.5) 1091 
 05-06 3.63 (3.36-3.91) 3.51 (3.20-3.85) 5.60 (5.10-6.10) 8.58 (7.98-9.42) 11.8 (10.0-14.3) 3056 
 07-08 4.17 (3.83-4.54) 4.06 (3.71-4.52) 6.63 (6.18-7.23) 10.8 (9.86-11.8) 15.5 (14.0-16.8) 3190 
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Urinary Perchlorate (creatinine corrected) (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 3.38 (3.17-3.60) 3.28 (2.99-3.60) 5.55 (5.21-5.92) 9.20 (8.31-10.1) 14.7 (11.1-17.4) 2465 
 13-14 3.04 (2.80-3.30) 2.98 (2.76-3.24) 4.89 (4.56-5.37) 7.96 (7.25-8.67) 10.7 (9.68-12.4) 2643 
Age group        
6-11 years 11-12 5.56 (5.05-6.12) 5.25 (4.75-5.95) 8.57 (7.57-9.95) 14.3 (10.4-17.4) 18.0 (13.8-27.3) 393 
 13-14 5.06 (4.43-5.76) 4.83 (3.90-5.66) 7.71 (6.31-9.13) 11.0 (9.14-15.4) 15.4 (11.5-28.3) 398 
12-19 years 11-12 2.70 (2.50-2.91) 2.87 (2.46-3.22) 3.92 (3.80-4.14) 5.73 (4.55-7.76) 8.14 (5.97-8.43) 384 
 13-14 2.59 (2.32-2.89) 2.41 (2.05-2.74) 4.06 (3.34-4.56) 6.33 (4.96-8.11) 8.66 (7.05-12.0) 449 
20 years and older 11-12 3.31 (3.07-3.56) 3.16 (2.85-3.54) 5.53 (5.16-5.88) 9.16 (8.03-10.2) 14.8 (10.1-18.8) 1688 
 13-14 2.95 (2.72-3.20) 2.92 (2.72-3.19) 4.71 (4.45-5.21) 7.59 (6.77-8.35) 10.4 (9.02-11.7) 1796 
Gender        
Males 11-12 3.12 (2.84-3.42) 2.99 (2.64-3.34) 4.84 (4.41-5.41) 8.38 (7.08-9.92) 14.7 (9.56-20.0) 1250 
 13-14 2.74 (2.51-2.99) 2.65 (2.32-2.91) 4.48 (4.00-4.81) 7.09 (6.32-8.25) 10.6 (8.16-13.1) 1312 
Females 11-12 3.64 (3.41-3.89) 3.61 (3.18-3.96) 6.10 (5.66-6.45) 9.86 (8.80-10.9) 14.7 (11.6-17.7) 1215 
 13-14 3.36 (3.08-3.67) 3.36 (3.06-3.60) 5.54 (4.86-5.92) 8.59 (7.75-9.45) 11.4 (10.0-13.1) 1331 
Race/ethnicity        
Mexican Americans 11-12 3.90 (3.21-4.75) 3.67 (3.17-4.42) 6.31 (5.16-7.92) 10.9 (8.38-14.4) 17.8 (11.7-28.1) 313 
 13-14 3.46 (3.09-3.87) 3.24 (2.84-3.76) 5.57 (4.61-6.31) 9.16 (7.57-11.6) 12.4 (9.27-18.1) 451 
Non-Hispanic blacks 11-12 2.28 (2.10-2.46) 2.12 (1.99-2.31) 3.74 (3.20-4.03) 6.79 (5.15-8.44) 9.35 (7.57-12.2) 663 
 13-14 2.10 (1.86-2.37) 1.92 (1.81-2.24) 3.39 (3.07-3.92) 5.42 (4.81-7.36) 9.21 (6.46-15.5) 574 
Non-Hispanic whites 11-12 3.58 (3.36-3.81) 3.50 (3.16-3.82) 5.72 (5.28-6.10) 9.22 (8.19-10.3) 14.8 (10.2-17.7) 808 
 13-14 3.17 (3.00-3.36) 3.13 (2.91-3.34) 4.94 (4.63-5.56) 7.88 (7.08-8.49) 10.4 (9.45-11.4) 975 
All Hispanics 11-12 3.52 (2.95-4.20) 3.31 (2.68-4.11) 5.83 (4.67-7.08) 9.91 (8.03-12.1) 15.2 (11.7-19.4) 566 
 13-14 3.17 (2.88-3.49) 3.01 (2.78-3.29) 5.11 (4.55-5.66) 8.41 (7.35-9.46) 12.3 (9.18-15.6) 699 
Asians 11-12 3.76 (3.41-4.15) 3.84 (3.45-4.12) 6.00 (5.25-7.04) 11.2 (8.22-18.8) 21.2 (12.6-33.6) 341 
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Urinary Thiocyanate (2001 - 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in mg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 01-02 1.52 (1.44-1.61) 1.50 (1.40-1.60) 3.60 (3.00-4.10) 7.90 (6.90-9.00) 12.0 (10.0-13.0) 1617 
 05-06 1.23 (1.12-1.35) 1.18 (1.08-1.31) 2.55 (2.31-2.83) 6.11 (5.10-6.85) 9.04 (8.14-9.93) 7697 
 07-08 1.35 (1.26-1.45) 1.32 (1.23-1.42) 2.77 (2.47-3.13) 6.36 (5.39-7.33) 9.54 (8.58-11.1) 7629 
 09-10 1.15 (1.08-1.24) 1.12 (1.04-1.18) 2.27 (2.11-2.45) 5.39 (4.61-6.37) 8.92 (7.59-9.83) 2844 
Age group        
6-11 years 01-02 1.35 (1.20-1.51) 1.50 (1.30-1.70) 2.50 (1.90-3.00) 3.70 (3.30-4.10) 4.90 (3.90-5.60) 374 
 05-06 .980 (.892-1.08) 1.03 (.916-1.15) 1.72 (1.55-1.92) 2.65 (2.31-3.09) 3.45 (2.96-4.21) 1054 
 07-08 1.10 (.989-1.22) 1.12 (1.02-1.24) 1.88 (1.68-2.07) 2.92 (2.48-3.52) 4.08 (3.35-5.30) 1143 
 09-10 .847 (.760-.945) .855 (.762-1.02) 1.51 (1.31-1.82) 2.27 (2.00-2.45) 2.64 (2.30-3.09) 377 
12-19 years 01-02 1.59 (1.43-1.77) 1.50 (1.40-1.70) 2.90 (2.50-3.30) 5.30 (4.30-7.40) 7.70 (5.90-10.0) 826 
 05-06 1.24 (1.11-1.39) 1.29 (1.15-1.47) 2.27 (1.99-2.62) 3.84 (3.18-4.65) 6.07 (4.76-6.95) 2106 
 07-08 1.29 (1.15-1.46) 1.35 (1.14-1.53) 2.39 (2.06-2.69) 3.93 (3.36-4.57) 6.14 (4.55-7.27) 1135 
 09-10 .978 (.869-1.10) 1.01 (.927-1.18) 1.76 (1.68-1.99) 2.96 (2.51-3.78) 4.48 (3.05-6.62) 452 
20 years and older 01-02 1.54 (1.43-1.65) 1.50 (1.40-1.60) 3.60 (3.00-4.10) 7.90 (6.90-9.00) 12.0 (10.0-13.0) 1617 
 05-06 1.26 (1.14-1.40) 1.19 (1.08-1.34) 2.82 (2.50-3.15) 6.87 (6.06-7.58) 9.79 (8.78-10.7) 4537 
 07-08 1.39 (1.29-1.50) 1.34 (1.25-1.46) 3.11 (2.68-3.57) 7.21 (6.05-8.31) 10.8 (8.99-12.0) 5351 
 09-10 1.22 (1.13-1.32) 1.15 (1.07-1.23) 2.53 (2.31-2.93) 6.32 (5.11-7.59) 9.72 (8.62-11.4) 2015 
Gender        
Males 01-02 1.86 (1.67-2.07) 1.80 (1.60-2.10) 4.00 (3.40-4.90) 8.40 (7.00-10.0) 12.0 (10.0-13.0) 1335 
 05-06 1.49 (1.36-1.64) 1.44 (1.27-1.62) 3.10 (2.82-3.56) 6.90 (6.13-7.64) 9.93 (8.99-10.7) 3765 
 07-08 1.61 (1.50-1.72) 1.60 (1.50-1.71) 3.32 (2.96-3.77) 7.27 (6.01-8.22) 10.9 (9.04-12.3) 3839 
 09-10 1.33 (1.22-1.46) 1.23 (1.15-1.36) 2.71 (2.29-3.10) 5.81 (5.01-7.19) 9.25 (7.85-10.0) 1401 
Females 01-02 1.26 (1.16-1.36) 1.30 (1.00-1.40) 2.50 (2.40-2.80) 6.00 (5.20-6.70) 8.70 (7.20-10.0) 1482 
 05-06 1.02 (.920-1.13) .995 (.886-1.13) 2.07 (1.86-2.25) 4.61 (3.81-5.98) 8.04 (7.26-8.78) 3932 
 07-08 1.14 (1.04-1.24) 1.09 (.991-1.19) 2.31 (2.06-2.62) 5.51 (4.58-6.52) 8.59 (7.36-9.85) 3790 
 09-10 1.00 (.894-1.13) .982 (.842-1.10) 1.95 (1.59-2.29) 4.63 (3.59-6.33) 8.79 (6.44-10.0) 1443 
Race/ethnicity        
Mexican Americans 01-02 1.14 (.977-1.33) 1.20 (.940-1.40) 2.20 (1.80-2.60) 3.90 (3.00-4.90) 5.70 (4.20-6.60) 707 
 05-06 .823 (.744-.912) .844 (.763-.937) 1.51 (1.36-1.71) 2.70 (2.26-3.22) 4.48 (3.49-5.40) 1972 
 07-08 .993 (.926-1.06) 1.04 (.987-1.11) 1.88 (1.75-2.02) 3.30 (2.98-3.52) 4.56 (3.92-5.43) 1505 
 09-10 .877 (.787-.977) .917 (.800-1.02) 1.62 (1.34-1.92) 2.97 (2.57-3.83) 5.06 (4.06-5.56) 611 
Non-Hispanic blacks 01-02 1.91 (1.72-2.11) 2.00 (1.80-2.20) 3.90 (3.30-4.90) 7.60 (6.20-10.0) 10.0 (7.00-15.0) 679 
 05-06 1.50 (1.32-1.72) 1.51 (1.36-1.68) 3.13 (2.56-3.81) 6.94 (5.66-8.09) 10.3 (8.01-12.4) 2078 
 07-08 1.73 (1.61-1.86) 1.73 (1.61-1.86) 3.78 (3.53-4.23) 8.29 (7.25-9.07) 12.8 (11.2-14.5) 1707 
 09-10 1.34 (1.21-1.48) 1.29 (1.15-1.49) 2.67 (2.36-3.32) 6.82 (6.01-8.08) 12.1 (7.67-14.1) 544 
Non-Hispanic whites 01-02 1.56 (1.45-1.68) 1.50 (1.40-1.70) 3.40 (2.80-3.80) 7.20 (6.30-8.50) 12.0 (8.90-13.0) 1228 
 05-06 1.30 (1.18-1.44) 1.25 (1.12-1.40) 2.74 (2.46-3.01) 6.53 (5.57-7.31) 9.43 (8.58-10.4) 3056 
 07-08 1.42 (1.29-1.56) 1.41 (1.28-1.53) 2.98 (2.52-3.44) 6.67 (5.24-8.14) 9.71 (8.32-11.9) 3190 
 09-10 1.27 (1.18-1.36) 1.18 (1.13-1.26) 2.44 (2.27-2.72) 5.95 (4.62-7.69) 9.59 (8.53-11.3) 1215 
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Urinary Thiocyanate (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in mg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 1.09 (1.01-1.17) 1.05 (.973-1.17) 2.23 (2.04-2.43) 4.69 (4.03-5.64) 7.16 (5.66-8.20) 2467 
 13-14 1.04 (.963-1.13) 1.00 (.884-1.12) 2.10 (1.84-2.40) 4.75 (3.82-5.42) 7.90 (6.56-8.66) 2643 
Age group        
6-11 years 11-12 .897 (.816-.987) .982 (.847-1.11) 1.54 (1.35-1.74) 2.23 (1.93-3.02) 3.03 (2.34-4.45) 394 
 13-14 .906 (.777-1.06) .972 (.779-1.17) 1.57 (1.34-1.88) 2.44 (2.08-2.89) 3.31 (2.26-4.85) 398 
12-19 years 11-12 .983 (.802-1.21) .954 (.788-1.13) 1.73 (1.31-2.42) 3.48 (2.44-5.01) 5.86 (3.48-8.47) 384 
 13-14 1.01 (.875-1.18) .981 (.837-1.21) 1.86 (1.49-2.41) 3.20 (2.48-4.79) 5.37 (3.28-7.96) 449 
20 years and older 11-12 1.13 (1.05-1.21) 1.10 (1.01-1.21) 2.42 (2.18-2.86) 5.35 (4.36-6.21) 7.38 (6.43-8.45) 1689 
 13-14 1.06 (.972-1.16) 1.00 (.877-1.13) 2.26 (1.95-2.62) 5.17 (4.44-5.93) 8.38 (7.16-9.76) 1796 
Gender        
Males 11-12 1.27 (1.18-1.38) 1.24 (1.10-1.37) 2.43 (2.11-2.97) 4.91 (3.99-6.43) 7.30 (5.96-8.51) 1251 
 13-14 1.16 (1.07-1.26) 1.13 (.991-1.26) 2.35 (2.00-2.74) 4.93 (4.33-5.80) 8.12 (6.35-10.8) 1313 
Females 11-12 .931 (.815-1.07) .924 (.797-1.07) 1.95 (1.61-2.27) 4.36 (3.63-5.37) 6.83 (5.51-8.20) 1216 
 13-14 .938 (.849-1.04) .903 (.771-1.04) 1.81 (1.53-2.10) 4.30 (3.40-5.36) 7.43 (5.52-8.43) 1330 
Race/ethnicity        
Mexican Americans 11-12 .892 (.730-1.09) .936 (.734-1.16) 1.66 (1.38-1.94) 3.03 (1.90-4.79) 4.24 (2.64-5.25) 313 
 13-14 .824 (.719-.944) .877 (.749-.992) 1.51 (1.29-1.87) 2.51 (2.31-3.21) 3.96 (2.51-6.35) 451 
Non-Hispanic blacks 11-12 1.29 (1.12-1.48) 1.25 (1.14-1.40) 2.37 (2.01-2.92) 5.75 (4.50-7.28) 9.91 (7.40-12.7) 663 
 13-14 1.58 (1.42-1.76) 1.37 (1.30-1.54) 3.33 (2.81-3.93) 8.53 (6.12-9.87) 14.1 (9.87-15.2) 574 
Non-Hispanic whites 11-12 1.16 (1.06-1.26) 1.12 (.996-1.28) 2.43 (2.16-2.92) 5.11 (4.03-6.43) 7.30 (5.87-8.45) 810 
 13-14 1.06 (.949-1.19) 1.02 (.861-1.19) 2.20 (1.78-2.67) 4.53 (3.60-5.61) 7.91 (6.16-8.89) 975 
All Hispanics 11-12 .865 (.733-1.02) .876 (.734-1.02) 1.57 (1.38-1.82) 3.42 (2.20-4.37) 4.84 (3.85-6.40) 566 
 13-14 .849 (.753-.957) .891 (.757-.993) 1.51 (1.31-1.84) 2.93 (2.32-4.55) 5.32 (3.09-6.84) 699 
Asians 11-12 .646 (.571-.731) .715 (.624-.765) 1.19 (1.02-1.47) 2.51 (1.82-2.71) 3.19 (2.61-4.11) 341 
 13-14 .555 (.478-.644) .567 (.503-.640) .983 (.817-1.20) 1.99 (1.47-2.37) 3.17 (2.12-4.08) 291 
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Urinary Thiocyanate (creatinine corrected) (2001 - 2010) 
 
Geometric mean and selected percentiles of urine concentrations (in mg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 01-02 1.53 (1.43-1.64) 1.47 (1.37-1.61) 3.35 (2.95-3.74) 7.34 (6.67-7.81) 10.3 (8.81-11.3) 1616 
 05-06 1.23 (1.13-1.33) 1.15 (1.05-1.27) 2.44 (2.18-2.68) 5.67 (5.16-6.28) 8.23 (7.71-8.98) 7697 
 07-08 1.39 (1.28-1.51) 1.33 (1.22-1.43) 2.72 (2.42-3.04) 6.11 (5.25-7.30) 9.59 (8.03-11.5) 7628 
 09-10 1.24 (1.15-1.34) 1.13 (1.04-1.21) 2.31 (2.11-2.58) 5.78 (4.64-6.63) 9.13 (7.28-11.2) 2843 
Age group        
6-11 years 01-02 1.56 (1.35-1.80) 1.55 (1.35-1.82) 2.67 (2.33-3.13) 4.46 (3.79-5.20) 5.33 (4.58-6.16) 374 
 05-06 1.16 (1.06-1.28) 1.18 (1.06-1.34) 2.03 (1.81-2.32) 3.15 (2.83-3.43) 4.25 (3.49-4.58) 1054 
 07-08 1.40 (1.27-1.54) 1.42 (1.24-1.59) 2.28 (2.02-2.53) 3.74 (3.29-4.26) 5.23 (4.39-6.65) 1143 
 09-10 1.16 (1.04-1.30) 1.12 (1.02-1.23) 1.90 (1.58-2.26) 2.96 (2.47-3.57) 3.92 (3.04-4.67) 376 
12-19 years 01-02 1.23 (1.12-1.35) 1.14 (1.08-1.24) 2.12 (1.78-2.45) 3.88 (3.28-4.91) 5.75 (3.93-8.13) 825 
 05-06 .941 (.867-1.02) .937 (.855-1.03) 1.69 (1.51-1.86) 2.95 (2.43-3.64) 4.15 (3.64-5.00) 2106 
 07-08 1.01 (.910-1.12) 1.04 (.906-1.17) 1.75 (1.60-1.92) 2.94 (2.49-3.54) 4.69 (3.64-5.44) 1134 
 09-10 .917 (.858-.980) .875 (.784-.972) 1.53 (1.36-1.79) 2.90 (2.26-3.84) 4.86 (3.49-5.10) 452 
20 years and older 01-02 1.59 (1.47-1.71) 1.47 (1.37-1.61) 3.35 (2.95-3.74) 7.34 (6.67-7.81) 10.3 (8.81-11.3) 1616 
 05-06 1.29 (1.17-1.42) 1.20 (1.08-1.33) 2.68 (2.37-3.10) 6.43 (5.88-7.07) 8.99 (8.23-10.2) 4537 
 07-08 1.46 (1.34-1.59) 1.37 (1.27-1.47) 3.00 (2.69-3.45) 7.02 (5.82-8.26) 10.5 (8.63-12.9) 5351 
 09-10 1.30 (1.19-1.43) 1.17 (1.08-1.26) 2.63 (2.31-3.05) 6.41 (5.42-7.83) 9.88 (8.30-12.1) 2015 
Gender        
Males 01-02 1.51 (1.37-1.67) 1.42 (1.31-1.59) 3.33 (3.00-3.67) 6.38 (5.81-6.92) 8.51 (7.41-9.72) 1335 
 05-06 1.24 (1.12-1.37) 1.18 (1.05-1.32) 2.61 (2.26-3.01) 5.67 (5.00-6.43) 8.17 (7.15-9.13) 3765 
 07-08 1.38 (1.28-1.50) 1.32 (1.23-1.42) 2.77 (2.42-3.08) 6.13 (5.47-6.97) 9.27 (7.82-11.1) 3839 
 09-10 1.22 (1.09-1.36) 1.12 (1.02-1.24) 2.47 (2.14-2.96) 5.78 (4.51-6.67) 8.72 (6.88-11.3) 1400 
Females 01-02 1.55 (1.43-1.69) 1.45 (1.33-1.58) 2.79 (2.42-3.25) 7.07 (5.86-7.69) 10.0 (8.18-11.1) 1480 
 05-06 1.22 (1.12-1.33) 1.13 (1.04-1.24) 2.27 (2.00-2.54) 5.62 (4.91-6.37) 8.40 (7.20-10.5) 3932 
 07-08 1.40 (1.27-1.55) 1.34 (1.19-1.45) 2.69 (2.40-3.03) 6.07 (4.89-7.80) 9.88 (7.93-12.1) 3789 
 09-10 1.26 (1.12-1.42) 1.14 (1.01-1.26) 2.15 (1.88-2.74) 5.80 (4.17-7.29) 9.24 (6.88-12.0) 1443 
Race/ethnicity        
Mexican Americans 01-02 1.07 (.898-1.27) 1.06 (.819-1.29) 1.97 (1.51-2.50) 3.62 (2.86-4.52) 5.10 (3.52-7.33) 707 
 05-06 .768 (.685-.861) .773 (.684-.881) 1.37 (1.20-1.59) 2.44 (2.19-2.85) 3.66 (3.28-4.27) 1972 
 07-08 .995 (.923-1.07) 1.03 (.918-1.14) 1.88 (1.71-2.05) 3.27 (2.77-3.76) 4.59 (3.86-5.59) 1505 
 09-10 .921 (.845-1.01) .912 (.849-.985) 1.57 (1.38-1.90) 3.09 (2.79-3.63) 4.24 (3.72-5.62) 611 
Non-Hispanic blacks 01-02 1.37 (1.18-1.59) 1.37 (1.18-1.61) 2.80 (2.21-3.43) 5.67 (4.17-6.74) 7.64 (5.91-11.3) 678 
 05-06 1.08 (.972-1.20) 1.05 (.972-1.16) 2.15 (1.84-2.57) 4.77 (3.93-5.61) 6.91 (5.84-7.80) 2078 
 07-08 1.31 (1.21-1.41) 1.25 (1.18-1.36) 2.81 (2.55-3.24) 6.19 (5.29-6.77) 8.74 (7.44-9.59) 1706 
 09-10 1.07 (.963-1.19) .993 (.888-1.08) 2.14 (1.87-2.49) 5.39 (3.94-6.76) 7.74 (6.56-11.3) 543 
Non-Hispanic whites 01-02 1.67 (1.55-1.80) 1.55 (1.42-1.73) 3.29 (3.00-3.73) 7.09 (6.38-7.95) 10.3 (8.78-11.1) 1227 
 05-06 1.38 (1.25-1.52) 1.30 (1.14-1.44) 2.78 (2.48-3.12) 6.31 (5.67-7.08) 9.00 (8.13-10.5) 3056 
 07-08 1.55 (1.40-1.70) 1.45 (1.32-1.58) 2.96 (2.56-3.53) 7.03 (5.71-8.56) 10.9 (8.70-13.1) 3190 
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Urinary Thiocyanate (creatinine corrected) (2011 - 2014) 
 
Geometric mean and selected percentiles of urine concentrations (in mg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 1.24 (1.18-1.31) 1.19 (1.11-1.28) 2.20 (2.12-2.37) 5.10 (4.05-5.98) 8.53 (6.73-10.9) 2465 
 13-14 1.21 (1.13-1.29) 1.15 (1.06-1.23) 2.19 (1.96-2.53) 4.66 (4.14-5.35) 8.07 (7.12-9.33) 2642 
Age group        
6-11 years 11-12 1.28 (1.16-1.40) 1.27 (1.12-1.39) 2.11 (1.89-2.34) 3.11 (2.69-4.13) 4.73 (3.62-5.77) 393 
 13-14 1.36 (1.18-1.57) 1.41 (1.19-1.62) 2.34 (1.92-2.62) 3.39 (2.69-4.29) 5.02 (3.23-7.47) 398 
12-19 years 11-12 .958 (.831-1.10) .949 (.803-1.19) 1.49 (1.35-1.89) 2.82 (2.12-3.30) 3.77 (2.97-4.91) 384 
 13-14 .919 (.810-1.04) .926 (.721-1.06) 1.45 (1.28-1.64) 2.70 (2.33-3.40) 4.33 (2.71-8.41) 449 
20 years and older 11-12 1.29 (1.22-1.35) 1.21 (1.12-1.31) 2.41 (2.19-2.67) 5.70 (4.69-7.11) 9.90 (7.75-11.3) 1688 
 13-14 1.24 (1.15-1.34) 1.17 (1.08-1.27) 2.31 (2.03-2.75) 5.11 (4.54-6.09) 8.83 (7.82-10.2) 1795 
Gender        
Males 11-12 1.20 (1.11-1.29) 1.16 (1.06-1.28) 2.16 (2.07-2.48) 5.00 (3.77-6.42) 7.75 (6.10-10.4) 1250 
 13-14 1.17 (1.09-1.25) 1.14 (1.03-1.24) 2.10 (1.92-2.49) 5.08 (4.41-5.70) 8.07 (6.68-9.68) 1312 
Females 11-12 1.28 (1.17-1.40) 1.22 (1.11-1.38) 2.20 (2.01-2.59) 5.10 (3.89-6.02) 10.4 (6.32-14.0) 1215 
 13-14 1.25 (1.14-1.38) 1.16 (1.06-1.25) 2.23 (1.89-2.60) 4.36 (3.83-5.14) 7.86 (6.32-9.96) 1330 
Race/ethnicity        
Mexican Americans 11-12 1.01 (.831-1.22) .935 (.790-1.20) 1.90 (1.45-2.32) 3.28 (2.53-3.73) 4.49 (3.46-6.12) 313 
 13-14 .943 (.828-1.07) .917 (.853-1.03) 1.58 (1.27-1.87) 2.94 (2.27-3.92) 4.62 (3.15-5.41) 451 
Non-Hispanic blacks 11-12 1.00 (.901-1.12) .958 (.892-1.04) 1.96 (1.71-2.23) 3.72 (3.31-4.55) 6.36 (4.89-7.76) 663 
 13-14 1.21 (1.07-1.36) 1.04 (.979-1.19) 2.26 (2.01-3.17) 6.42 (5.00-7.69) 9.44 (7.73-10.7) 574 
Non-Hispanic whites 11-12 1.41 (1.31-1.52) 1.35 (1.23-1.46) 2.66 (2.21-2.91) 5.78 (4.49-7.41) 10.4 (7.41-12.8) 808 
 13-14 1.31 (1.20-1.43) 1.27 (1.17-1.38) 2.43 (2.03-2.86) 4.88 (4.20-6.30) 8.53 (7.38-10.4) 974 
All Hispanics 11-12 .968 (.826-1.13) .923 (.805-1.11) 1.76 (1.45-2.07) 3.26 (2.53-3.76) 5.10 (3.76-6.40) 566 
 13-14 .949 (.836-1.08) .913 (.829-1.03) 1.64 (1.34-1.89) 3.11 (2.34-4.24) 4.98 (3.12-8.34) 699 
Asians 11-12 .864 (.775-.964) .868 (.767-.993) 1.44 (1.30-1.63) 2.31 (1.96-2.81) 3.69 (2.60-5.35) 341 
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Serum Perfluorobutane sulfonic acid (PFBuS) (2003 – 2010) 
 
Geometric mean and selected percentiles of serum concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 2094 
 05-06 * < LOD < LOD < LOD .100 (<LOD-.200) 2120 
 07-08 * < LOD < LOD < LOD < LOD 2100 
 09-10 * < LOD < LOD < LOD < LOD 2233 
Age group        
12-19 years 03-04 * < LOD < LOD < LOD < LOD 640 
 05-06 * < LOD < LOD < LOD .100 (<LOD-.100) 640 
 07-08 * < LOD < LOD < LOD < LOD 357 
 09-10 * < LOD < LOD < LOD < LOD 364 
20 years and older 03-04 * < LOD < LOD < LOD < LOD 1454 
 05-06 * < LOD < LOD < LOD .100 (<LOD-.200) 1480 
 07-08 * < LOD < LOD < LOD < LOD 1743 
 09-10 * < LOD < LOD < LOD < LOD 1869 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 1053 
 05-06 * < LOD < LOD < LOD .100 (<LOD-.200) 1048 
 07-08 * < LOD < LOD < LOD < LOD 1059 
 09-10 * < LOD < LOD < LOD < LOD 1075 
Females 03-04 * < LOD < LOD < LOD < LOD 1041 
 05-06 * < LOD < LOD < LOD .100 (<LOD-.200) 1072 
 07-08 * < LOD < LOD < LOD < LOD 1041 
 09-10 * < LOD < LOD < LOD < LOD 1158 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, 07-08, and 09-10 are 0.4, 0.1, 0.1, and 0.1 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Serum Perfluorobutane sulfonic acid (PFBuS) (2003 – 2010) 
 
Geometric mean and selected percentiles of serum concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 485 
 05-06 * < LOD < LOD < LOD .100 (<LOD-.200) 499 
 07-08 * < LOD < LOD < LOD < LOD 391 
 09-10 * < LOD < LOD < LOD < LOD 461 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 538 
 05-06 * < LOD < LOD < LOD .100 (<LOD-.100) 544 
 07-08 * < LOD < LOD < LOD < LOD 419 
 09-10 * < LOD < LOD < LOD < LOD 391 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 962 
 05-06 * < LOD < LOD < LOD .100 (<LOD-.400) 935 
 07-08 * < LOD < LOD < LOD < LOD 931 
 09-10 * < LOD < LOD < LOD < LOD 1031 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, 07-08, and 09-10 are 0.4, 0.1, 0.1, and 0.1 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Serum Perfluorobutane sulfonic acid (PFBuS) (2011 - 2014) 
 
Geometric mean and selected percentiles of serum concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * < LOD < LOD < LOD < LOD 1904 
 13-14 * < LOD < LOD < LOD < LOD 2168 
Age group        
12-19 years 11-12 * < LOD < LOD < LOD < LOD 344 
 13-14 * < LOD < LOD < LOD < LOD 402 
20 years and older 11-12 * < LOD < LOD < LOD < LOD 1560 
 13-14 * < LOD < LOD < LOD < LOD 1766 
Gender        
Males 11-12 * < LOD < LOD < LOD < LOD 966 
 13-14 * < LOD < LOD < LOD < LOD 1032 
Females 11-12 * < LOD < LOD < LOD < LOD 938 
 13-14 * < LOD < LOD < LOD < LOD 1136 
Race/ethnicity        
Mexican Americans 11-12 * < LOD < LOD < LOD < LOD 211 
 13-14 * < LOD < LOD < LOD < LOD 332 
Non-Hispanic blacks 11-12 * < LOD < LOD < LOD < LOD 485 
 13-14 * < LOD < LOD < LOD < LOD 455 
Non-Hispanic whites 11-12 * < LOD < LOD < LOD < LOD 666 
 13-14 * < LOD < LOD < LOD < LOD 862 
All Hispanics 11-12 * < LOD < LOD < LOD < LOD 406 
 13-14 * < LOD < LOD < LOD < LOD 537 
Asians 11-12 * < LOD < LOD < LOD < LOD 291 
 13-14 * < LOD < LOD < LOD < LOD 236 
Limit of detection (LOD, see Data Analysis section) for Survey year 11-12 and 13-14 are 0.1 and 0.1. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Serum Perfluorodecanoic acid (PFDeA) (1999 – 2010) 
 
Geometric mean and selected percentiles of serum concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 * < LOD .200 (<LOD-.300) .400 (.300-.700) .600 (.400-1.10) 1562 
 03-04 * < LOD .300 (<LOD-.500) .600 (.400-1.10) .900 (.500-1.80) 2094 
 05-06 .355 (.297-.423) .300 (.300-.400) .500 (.400-.700) .900 (.600-1.60) 1.50 (.900-2.60) 2120 
 07-08 .286 (.264-.309) .300 (.300-.300) .400 (.400-.500) .700 (.600-.700) .900 (.800-1.00) 2100 
 09-10 .279 (.258-.303) .300 (.300-.300) .400 (.400-.500) .700 (.600-.800) .900 (.800-1.10) 2233 
Age group        
12-19 years 99-00 * < LOD < LOD .300 (.200-.400) .400 (.300-.600) 543 
 03-04 * < LOD < LOD .500 (<LOD-1.00) .800 (.300-1.20) 640 
 05-06 .295 (.258-.338) .300 (.200-.300) .500 (.400-.500) .600 (.500-.800) .800 (.600-1.60) 640 
 07-08 .231 (.214-.248) .200 (.200-.300) .300 (.300-.400) .500 (.400-.500) .600 (.500-.700) 357 
 09-10 .220 (.198-.245) .200 (.200-.200) .300 (.300-.300) .400 (.400-.600) .600 (.400-.800) 364 
20 years and older 99-00 * < LOD .300 (.200-.300) .400 (.300-.800) .600 (.400-1.50) 1019 
 03-04 * < LOD .400 (<LOD-.500) .700 (.400-1.00) .900 (.500-1.80) 1454 
 05-06 .364 (.303-.438) .300 (.300-.400) .500 (.400-.700) 1.00 (.600-1.70) 1.50 (.900-2.60) 1480 
 07-08 .295 (.271-.321) .300 (.300-.300) .400 (.400-.500) .700 (.600-.800) .900 (.800-1.10) 1743 
 09-10 .289 (.265-.314) .300 (.300-.300) .400 (.400-.500) .700 (.600-.800) .900 (.800-1.20) 1869 
Gender        
Males 99-00 * < LOD .300 (.200-.300) .400 (.300-.700) .500 (.300-1.90) 743 
 03-04 * < LOD .400 (<LOD-.500) .800 (.400-1.40) 1.10 (.600-2.10) 1053 
 05-06 .381 (.318-.456) .400 (.300-.400) .600 (.400-.800) 1.00 (.600-2.20) 1.70 (1.00-2.60) 1048 
 07-08 .306 (.283-.331) .300 (.300-.300) .400 (.400-.500) .700 (.600-.800) .900 (.800-1.20) 1059 
 09-10 .289 (.264-.318) .300 (.300-.300) .400 (.400-.500) .600 (.500-.800) .800 (.600-1.20) 1075 
Females 99-00 * < LOD .200 (<LOD-.300) .400 (.300-.800) .600 (.400-1.40) 819 
 03-04 * < LOD .300 (<LOD-.400) .500 (.400-.800) .800 (.500-1.20) 1041 
 05-06 .331 (.277-.396) .300 (.300-.400) .500 (.400-.600) .900 (.600-1.40) 1.30 (.800-2.30) 1072 
 07-08 .267 (.245-.292) .300 (.200-.300) .400 (.400-.500) .600 (.500-.800) .800 (.700-1.10) 1041 
 09-10 .270 (.248-.295) .300 (.200-.300) .400 (.400-.500) .700 (.600-.800) 1.00 (.800-1.10) 1158 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 03-04, 05-06, 07-08, and 09-10 are 0.2, 0.3, 0.2, 0.2, and 0.1 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 * < LOD < LOD .300 (<LOD-.300) .300 (.200-1.50) 584 
 03-04 * < LOD < LOD .500 (.400-.500) .600 (.500-.800) 485 
 05-06 .283 (.245-.327) .300 (.200-.300) .400 (.300-.500) .600 (.500-1.00) 1.00 (.500-2.40) 499 
 07-08 .253 (.222-.289) .200 (.200-.300) .400 (.300-.500) .600 (.400-.700) .600 (.500-1.40) 391 
 09-10 .242 (.215-.272) .200 (.200-.300) .400 (.300-.400) .500 (.500-.600) .700 (.600-.800) 461 
Non-Hispanic blacks 99-00 * .200 (<LOD-.300) .400 (.200-.700) .800 (.500-1.20) 1.10 (.600-2.30) 303 
 03-04 * < LOD .400 (<LOD-.700) .800 (.400-1.50) 1.00 (.500-3.10) 538 
 05-06 .405 (.309-.531) .400 (.300-.500) .600 (.400-.900) 1.20 (.600-2.90) 2.30 (1.10-3.70) 544 
 07-08 .331 (.298-.368) .300 (.300-.400) .500 (.400-.600) .800 (.600-.900) 1.00 (.800-1.50) 419 
 09-10 .336 (.298-.379) .300 (.300-.300) .500 (.400-.600) .800 (.600-1.00) 1.10 (.800-2.60) 391 
Non-Hispanic whites 99-00 * < LOD .300 (<LOD-.300) .400 (.300-.600) .500 (.400-.800) 519 
 03-04 * < LOD .300 (<LOD-.500) .600 (.400-1.00) .900 (.500-1.80) 962 
 05-06 .350 (.294-.417) .300 (.300-.400) .500 (.400-.700) .900 (.600-1.50) 1.40 (.800-2.30) 935 
 07-08 .276 (.254-.301) .300 (.200-.300) .400 (.400-.500) .600 (.500-.700) .900 (.700-.900) 931 
 09-10 .270 (.240-.304) .300 (.200-.300) .400 (.300-.500) .600 (.500-.800) .800 (.600-1.10) 1031 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 03-04, 05-06, 07-08, and 09-10 are 0.2, 0.3, 0.2, 0.2, and 0.1 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 .199 (.181-.220) .190 (.170-.210) .300 (.270-.340) .480 (.420-.580) .690 (.600-.770) 1904 
 13-14 .185 (.165-.208) .200 (.200-.200) .300 (.300-.300) .500 (.400-.600) .700 (.600-.900) 2168 
Age group        
12-19 years 11-12 .146 (.126-.168) .150 (.120-.170) .200 (.180-.230) .290 (.240-.340) .360 (.290-.560) 344 
 13-14 .136 (.122-.152) .100 (.100-.200) .200 (.200-.200) .300 (.200-.400) .400 (.300-.500) 402 
20 years and older 11-12 .209 (.189-.230) .200 (.180-.230) .320 (.280-.370) .510 (.440-.590) .730 (.630-.850) 1560 
 13-14 .193 (.171-.218) .200 (.200-.200) .300 (.300-.400) .500 (.400-.600) .800 (.600-.900) 1766 
Gender        
Males 11-12 .206 (.184-.232) .200 (.180-.230) .310 (.260-.370) .440 (.380-.550) .620 (.480-.810) 966 
 13-14 .198 (.175-.225) .200 (.200-.200) .300 (.300-.400) .500 (.400-.700) .800 (.600-1.00) 1032 
Females 11-12 .193 (.177-.211) .190 (.170-.210) .290 (.260-.340) .530 (.410-.640) .690 (.640-.830) 938 
 13-14 .174 (.155-.195) .200 (.100-.200) .300 (.200-.300) .500 (.400-.500) .700 (.500-.900) 1136 
Race/ethnicity        
Mexican Americans 11-12 .176 (.150-.205) .170 (.150-.200) .260 (.210-.300) .380 (.300-.530) .530 (.360-.600) 211 
 13-14 .145 (.125-.169) .100 (.100-.200) .200 (.200-.300) .300 (.200-.500) .400 (.300-1.40) 332 
Non-Hispanic blacks 11-12 .214 (.193-.237) .200 (.180-.220) .330 (.280-.380) .590 (.420-.850) .880 (.670-1.06) 485 
 13-14 .200 (.162-.246) .200 (.200-.200) .300 (.200-.500) .600 (.400-.900) .900 (.700-1.20) 455 
Non-Hispanic whites 11-12 .193 (.171-.219) .190 (.170-.220) .290 (.260-.340) .440 (.360-.590) .620 (.480-.740) 666 
 13-14 .184 (.158-.213) .200 (.200-.200) .300 (.200-.400) .500 (.400-.500) .700 (.500-.800) 862 
All Hispanics 11-12 .182 (.156-.212) .170 (.150-.200) .270 (.210-.330) .430 (.330-.530) .540 (.440-.760) 406 
 13-14 .150 (.135-.167) .200 (.100-.200) .200 (.200-.300) .300 (.300-.400) .400 (.300-1.00) 537 
Asians 11-12 .367 (.308-.438) .350 (.280-.420) .670 (.510-.870) 1.35 (.870-2.05) 2.05 (1.19-2.52) 291 
 13-14 .360 (.294-.439) .400 (.300-.500) .700 (.500-.900) 1.50 (1.00-2.10) 2.20 (1.60-3.30) 236 
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(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 * < LOD < LOD < LOD < LOD 1562 
 03-04 * < LOD < LOD < LOD < LOD 2094 
 05-06 * < LOD < LOD < LOD < LOD 2120 
 07-08 * < LOD < LOD < LOD < LOD 2100 
 09-10 * < LOD < LOD < LOD < LOD 2233 
Age group        
12-19 years 99-00 * < LOD < LOD < LOD < LOD 543 
 03-04 * < LOD < LOD < LOD < LOD 640 
 05-06 * < LOD < LOD < LOD < LOD 640 
 07-08 * < LOD < LOD < LOD < LOD 357 
 09-10 * < LOD < LOD < LOD < LOD 364 
20 years and older 99-00 * < LOD < LOD < LOD < LOD 1019 
 03-04 * < LOD < LOD < LOD < LOD 1454 
 05-06 * < LOD < LOD < LOD < LOD 1480 
 07-08 * < LOD < LOD < LOD < LOD 1743 
 09-10 * < LOD < LOD < LOD .100 (<LOD-.100) 1869 
Gender        
Males 99-00 * < LOD < LOD < LOD < LOD 743 
 03-04 * < LOD < LOD < LOD < LOD 1053 
 05-06 * < LOD < LOD < LOD < LOD 1048 
 07-08 * < LOD < LOD < LOD < LOD 1059 
 09-10 * < LOD < LOD < LOD < LOD 1075 
Females 99-00 * < LOD < LOD < LOD < LOD 819 
 03-04 * < LOD < LOD < LOD < LOD 1041 
 05-06 * < LOD < LOD < LOD < LOD 1072 
 07-08 * < LOD < LOD < LOD < LOD 1041 
 09-10 * < LOD < LOD < LOD .100 (<LOD-.100) 1158 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 03-04, 05-06, 07-08, and 09-10 are 0.2, 1.0, 0.2, 0.2, and 0.1 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Geometric mean and selected percentiles of serum concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 * < LOD < LOD < LOD < LOD 584 
 03-04 * < LOD < LOD < LOD < LOD 485 
 05-06 * < LOD < LOD < LOD < LOD 499 
 07-08 * < LOD < LOD < LOD < LOD 391 
 09-10 * < LOD < LOD < LOD < LOD 461 
Non-Hispanic blacks 99-00 * < LOD < LOD < LOD < LOD 303 
 03-04 * < LOD < LOD < LOD < LOD 538 
 05-06 * < LOD < LOD < LOD < LOD 544 
 07-08 * < LOD < LOD < LOD < LOD 419 
 09-10 * < LOD < LOD < LOD .100 (<LOD-.400) 391 
Non-Hispanic whites 99-00 * < LOD < LOD < LOD < LOD 519 
 03-04 * < LOD < LOD < LOD < LOD 962 
 05-06 * < LOD < LOD < LOD < LOD 935 
 07-08 * < LOD < LOD < LOD < LOD 931 
 09-10 * < LOD < LOD < LOD < LOD 1031 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 03-04, 05-06, 07-08, and 09-10 are 0.2, 1.0, 0.2, 0.2, and 0.1 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * < LOD < LOD < LOD .140 (<LOD-.240) 1904 
 13-14 * < LOD < LOD .100 (<LOD-.200) .200 (.100-.300) 2168 
Age group        
12-19 years 11-12 * < LOD < LOD < LOD < LOD 344 
 13-14 * < LOD < LOD .100 (<LOD-.200) .200 (<LOD-.300) 402 
20 years and older 11-12 * < LOD < LOD < LOD .150 (<LOD-.280) 1560 
 13-14 * < LOD < LOD .100 (<LOD-.200) .200 (.100-.300) 1766 
Gender        
Males 11-12 * < LOD < LOD < LOD .140 (<LOD-.240) 966 
 13-14 * < LOD < LOD .100 (<LOD-.200) .200 (.100-.300) 1032 
Females 11-12 * < LOD < LOD < LOD .130 (<LOD-.280) 938 
 13-14 * < LOD < LOD .100 (<LOD-.200) .200 (.100-.300) 1136 
Race/ethnicity        
Mexican Americans 11-12 * < LOD < LOD < LOD .110 (<LOD-.230) 211 
 13-14 * < LOD < LOD .200 (<LOD-.300) .300 (.200-.300) 332 
Non-Hispanic blacks 11-12 * < LOD < LOD < LOD .110 (<LOD-.160) 485 
 13-14 * < LOD < LOD .100 (<LOD-.200) .200 (.100-.300) 455 
Non-Hispanic whites 11-12 * < LOD < LOD < LOD .130 (<LOD-.290) 666 
 13-14 * < LOD < LOD .100 (<LOD-.200) .200 (<LOD-.300) 862 
All Hispanics 11-12 * < LOD < LOD < LOD .110 (<LOD-.150) 406 
 13-14 * < LOD < LOD .200 (.100-.300) .300 (.200-.300) 537 
Asians 11-12 * < LOD < LOD .180 (.130-.350) .360 (.180-.440) 291 
 13-14 * < LOD .100 (<LOD-.200) .200 (.200-.500) .300 (.200-.500) 236 
Limit of detection (LOD, see Data Analysis section) for Survey year 11-12 and 13-14 are 0.1 and 0.1. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 * < LOD < LOD .500 (<LOD-.600) .700 (.500-1.00) 1562 
 03-04 * < LOD < LOD < LOD .400 (<LOD-.500) 2094 
 05-06 * < LOD < LOD < LOD .700 (<LOD-1.70) 2120 
 07-08 * < LOD < LOD < LOD .500 (.400-.600) 2100 
 09-10 * < LOD < LOD .200 (.100-.200) .200 (.200-.300) 2233 
Age group        
12-19 years 99-00 * < LOD < LOD .800 (.600-1.10) 1.20 (.800-1.80) 543 
 03-04 * < LOD < LOD .400 (<LOD-.600) .600 (.500-.900) 640 
 05-06 * < LOD < LOD .700 (<LOD-1.10) 1.10 (.600-2.70) 640 
 07-08 * < LOD < LOD .500 (<LOD-.600) .600 (.500-.700) 357 
 09-10 * < LOD .100 (.100-.200) .200 (.200-.400) .400 (.200-.500) 364 
20 years and older 99-00 * < LOD < LOD < LOD .600 (<LOD-.900) 1019 
 03-04 * < LOD < LOD < LOD < LOD 1454 
 05-06 * < LOD < LOD < LOD .600 (<LOD-2.10) 1480 
 07-08 * < LOD < LOD < LOD .500 (<LOD-.500) 1743 
 09-10 * < LOD < LOD .100 (.100-.200) .200 (.200-.200) 1869 
Gender        
Males 99-00 * < LOD < LOD .500 (<LOD-.600) .700 (.500-1.00) 743 
 03-04 * < LOD < LOD < LOD .300 (<LOD-.400) 1053 
 05-06 * < LOD < LOD .400 (<LOD-1.00) .800 (<LOD-2.10) 1048 
 07-08 * < LOD < LOD < LOD .600 (.400-.700) 1059 
 09-10 * < LOD < LOD .200 (.100-.200) .200 (.200-.300) 1075 
Females 99-00 * < LOD < LOD .500 (<LOD-.700) .700 (<LOD-1.20) 819 
 03-04 * < LOD < LOD < LOD .400 (.300-.600) 1041 
 05-06 * < LOD < LOD < LOD .600 (<LOD-1.30) 1072 
 07-08 * < LOD < LOD < LOD .500 (.400-.500) 1041 
 09-10 * < LOD < LOD .200 (.100-.200) .200 (.200-.300) 1158 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 03-04, 05-06, 07-08, and 09-10 are 0.4, 0.3, 0.4, 0.4, and 0.1 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 * < LOD < LOD .500 (<LOD-.900) .900 (.500-1.30) 584 
 03-04 * < LOD < LOD < LOD .500 (<LOD-.900) 485 
 05-06 * < LOD < LOD < LOD .500 (<LOD-1.50) 499 
 07-08 * < LOD < LOD < LOD .500 (<LOD-.500) 391 
 09-10 * < LOD < LOD .200 (.100-.200) .200 (.200-.300) 461 
Non-Hispanic blacks 99-00 * < LOD < LOD < LOD .600 (<LOD-1.20) 303 
 03-04 * < LOD < LOD < LOD < LOD 538 
 05-06 * < LOD < LOD < LOD .500 (<LOD-1.80) 544 
 07-08 * < LOD < LOD < LOD .600 (.400-.700) 419 
 09-10 * < LOD < LOD .100 (.100-.200) .200 (.200-.200) 391 
Non-Hispanic whites 99-00 * < LOD < LOD .400 (<LOD-.600) .600 (.500-.900) 519 
 03-04 * < LOD < LOD < LOD .300 (<LOD-.500) 962 
 05-06 * < LOD < LOD < LOD .800 (<LOD-2.10) 935 
 07-08 * < LOD < LOD < LOD .500 (.400-.700) 931 
 09-10 * < LOD < LOD .200 (.100-.200) .200 (.200-.300) 1031 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 03-04, 05-06, 07-08, and 09-10 are 0.4, 0.3, 0.4, 0.4, and 0.1 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Geometric mean and selected percentiles of serum concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * < LOD < LOD .140 (.120-.170) .220 (.180-.260) 1904 
 13-14 * < LOD < LOD .100 (<LOD-.100) .200 (.100-.200) 2168 
Age group        
12-19 years 11-12 * < LOD .100 (<LOD-.130) .160 (.130-.200) .190 (.160-.270) 344 
 13-14 * < LOD < LOD .200 (.100-.200) .200 (.100-.600) 402 
20 years and older 11-12 * < LOD < LOD .140 (.120-.180) .220 (.160-.280) 1560 
 13-14 * < LOD < LOD .100 (<LOD-.100) .100 (.100-.200) 1766 
Gender        
Males 11-12 * < LOD < LOD .140 (.120-.200) .220 (.180-.270) 966 
 13-14 * < LOD < LOD .100 (<LOD-.100) .100 (.100-.200) 1032 
Females 11-12 * < LOD < LOD .140 (.110-.180) .200 (.140-.360) 938 
 13-14 * < LOD < LOD .100 (<LOD-.100) .200 (.100-.300) 1136 
Race/ethnicity        
Mexican Americans 11-12 * < LOD < LOD .130 (<LOD-.180) .170 (.120-.230) 211 
 13-14 * < LOD < LOD < LOD .100 (<LOD-.300) 332 
Non-Hispanic blacks 11-12 * < LOD < LOD .130 (.100-.150) .180 (.140-.230) 485 
 13-14 * < LOD < LOD .100 (<LOD-.100) .100 (<LOD-.200) 455 
Non-Hispanic whites 11-12 * < LOD < LOD .150 (.120-.190) .230 (.160-.290) 666 
 13-14 * < LOD < LOD .100 (<LOD-.100) .200 (.100-.200) 862 
All Hispanics 11-12 * < LOD < LOD .140 (.100-.180) .190 (.160-.230) 406 
 13-14 * < LOD < LOD < LOD .100 (<LOD-.300) 537 
Asians 11-12 * < LOD < LOD .160 (.120-.220) .230 (.180-.310) 291 
 13-14 * < LOD < LOD .100 (<LOD-.100) .100 (.100-.200) 236 
Limit of detection (LOD, see Data Analysis section) for Survey year 11-12 and 13-14 are 0.1 and 0.1. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Geometric mean and selected percentiles of serum concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 2.13 (1.91-2.38) 2.10 (1.80-2.30) 3.40 (3.10-4.00) 5.80 (5.20-6.90) 8.70 (7.00-10.0) 1562 
 03-04 1.93 (1.73-2.16) 1.90 (1.70-2.10) 3.30 (2.80-3.90) 5.90 (4.80-7.20) 8.30 (7.10-9.70) 2094 
 05-06 1.67 (1.42-1.98) 1.80 (1.50-2.10) 3.20 (2.60-4.00) 5.40 (4.40-7.10) 8.30 (5.80-11.9) 2120 
 07-08 1.95 (1.76-2.17) 2.00 (1.80-2.10) 3.50 (3.10-4.00) 5.90 (4.90-8.30) 9.80 (6.10-15.2) 2100 
 09-10 1.66 (1.51-1.82) 1.70 (1.50-1.90) 3.00 (2.60-3.30) 4.80 (4.40-5.30) 6.90 (5.90-7.60) 2233 
Age group        
12-19 years 99-00 2.69 (2.14-3.39) 2.50 (2.00-3.70) 5.00 (3.60-6.50) 8.00 (5.80-12.9) 12.9 (6.90-16.4) 543 
 03-04 2.44 (2.05-2.90) 2.40 (1.80-3.20) 4.90 (4.00-6.30) 9.50 (6.80-12.5) 13.3 (9.90-19.6) 640 
 05-06 2.09 (1.74-2.52) 2.40 (2.00-2.90) 4.30 (3.70-5.40) 9.50 (6.40-13.1) 14.1 (9.80-17.8) 640 
 07-08 2.40 (2.09-2.75) 2.30 (1.80-2.70) 4.30 (3.70-5.70) 9.90 (6.50-12.5) 15.9 (11.1-21.5) 357 
 09-10 2.03 (1.77-2.33) 1.90 (1.60-2.10) 3.80 (3.20-4.20) 8.10 (6.30-9.70) 12.3 (8.60-19.0) 364 
20 years and older 99-00 2.05 (1.85-2.27) 2.00 (1.80-2.30) 3.30 (3.00-3.70) 5.40 (4.90-5.90) 8.20 (6.70-9.50) 1019 
 03-04 1.86 (1.67-2.08) 1.80 (1.60-2.10) 3.00 (2.60-3.60) 5.50 (4.50-6.70) 7.60 (6.30-9.40) 1454 
 05-06 1.62 (1.37-1.92) 1.70 (1.50-2.10) 3.10 (2.50-3.80) 5.20 (4.20-6.50) 7.20 (5.10-11.6) 1480 
 07-08 1.90 (1.69-2.13) 1.90 (1.70-2.10) 3.30 (2.90-3.90) 5.80 (4.50-8.00) 9.00 (5.60-15.0) 1743 
 09-10 1.61 (1.45-1.79) 1.70 (1.50-1.90) 2.90 (2.50-3.30) 4.50 (4.00-5.20) 6.00 (5.40-7.10) 1869 
Gender        
Males 99-00 2.61 (2.27-3.00) 2.60 (2.20-3.00) 4.10 (3.50-4.70) 6.60 (5.30-9.40) 10.5 (6.90-15.0) 743 
 03-04 2.17 (1.87-2.51) 2.10 (1.80-2.40) 3.40 (2.80-4.50) 6.10 (4.60-8.10) 8.50 (6.50-10.5) 1053 
 05-06 2.08 (1.76-2.45) 2.20 (1.80-2.70) 3.70 (3.20-4.60) 6.40 (4.80-9.30) 9.50 (6.70-13.7) 1048 
 07-08 2.63 (2.36-2.94) 2.60 (2.40-2.80) 4.20 (3.80-4.90) 7.30 (5.50-11.0) 11.4 (7.10-18.1) 1059 
 09-10 2.21 (1.99-2.46) 2.20 (1.90-2.50) 3.40 (3.00-4.00) 5.50 (5.00-6.40) 7.80 (6.50-9.90) 1075 
Females 99-00 1.79 (1.56-2.06) 1.70 (1.50-2.10) 2.80 (2.30-3.50) 5.10 (4.10-6.70) 8.00 (5.70-9.00) 819 
 03-04 1.72 (1.56-1.91) 1.60 (1.40-1.80) 2.90 (2.50-3.50) 5.80 (4.60-7.10) 8.20 (6.70-10.0) 1041 
 05-06 1.37 (1.15-1.63) 1.50 (1.20-1.70) 2.80 (2.20-3.30) 4.60 (3.90-5.80) 6.60 (5.60-9.30) 1072 
 07-08 1.46 (1.30-1.64) 1.40 (1.30-1.50) 2.60 (2.20-3.10) 4.70 (3.80-6.10) 7.50 (5.00-12.5) 1041 
 09-10 1.26 (1.14-1.40) 1.30 (1.20-1.40) 2.20 (2.00-2.60) 4.00 (3.50-4.50) 5.40 (4.70-6.50) 1158 
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Serum Perfluorohexane sulfonic acid (PFHxS) (1999 – 2010) 
 
Geometric mean and selected percentiles of serum concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 1.47 (1.13-1.92) 1.50 (1.00-2.00) 2.80 (1.80-3.80) 4.50 (3.30-6.90) 6.70 (4.60-9.50) 584 
 03-04 1.42 (1.17-1.72) 1.50 (1.20-1.70) 2.30 (1.90-2.90) 4.30 (3.10-5.10) 5.50 (4.00-8.90) 485 
 05-06 1.25 (.884-1.76) 1.60 (1.20-2.10) 2.80 (2.50-3.40) 4.30 (3.60-5.20) 6.00 (4.60-7.20) 499 
 07-08 1.65 (1.46-1.86) 1.70 (1.40-1.90) 3.00 (2.70-3.40) 5.00 (3.70-6.10) 6.70 (5.20-10.7) 391 
 09-10 1.01 (.835-1.22) 1.10 (.800-1.30) 1.80 (1.50-2.20) 3.10 (2.50-3.70) 4.00 (3.20-5.30) 461 
Non-Hispanic blacks 99-00 2.14 (1.58-2.89) 2.10 (1.40-3.00) 3.40 (2.70-5.00) 6.70 (3.90-10.7) 10.7 (6.80-14.3) 303 
 03-04 1.92 (1.62-2.26) 1.90 (1.60-2.20) 3.50 (2.80-4.60) 6.00 (5.00-7.10) 8.30 (6.30-12.0) 538 
 05-06 1.53 (1.13-2.07) 1.70 (1.40-2.20) 3.30 (2.50-4.10) 5.40 (3.90-7.50) 7.50 (5.30-11.0) 544 
 07-08 1.98 (1.55-2.52) 2.10 (1.80-2.50) 3.90 (2.80-5.40) 7.90 (4.20-12.5) 11.1 (5.90-17.2) 419 
 09-10 1.44 (1.26-1.64) 1.40 (1.20-1.70) 2.60 (2.10-3.00) 4.40 (3.80-5.20) 6.50 (4.60-8.20) 391 
Non-Hispanic whites 99-00 2.30 (2.06-2.56) 2.30 (1.90-2.60) 3.60 (3.20-4.20) 5.90 (5.30-7.00) 8.40 (7.00-9.70) 519 
 03-04 2.01 (1.77-2.27) 1.90 (1.70-2.20) 3.30 (2.80-4.10) 6.10 (4.70-7.80) 8.20 (6.90-10.1) 962 
 05-06 1.79 (1.48-2.17) 1.80 (1.50-2.20) 3.30 (2.70-4.30) 5.60 (4.60-8.20) 9.40 (6.10-13.1) 935 
 07-08 2.13 (1.89-2.41) 2.10 (1.80-2.40) 3.70 (3.20-4.20) 6.40 (5.30-9.00) 10.5 (6.50-15.6) 931 
 09-10 1.93 (1.77-2.10) 2.00 (1.80-2.20) 3.30 (2.90-3.70) 5.30 (4.80-5.60) 7.30 (6.20-8.80) 1031 
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Serum Perfluorohexane sulfonic acid (PFHxS) (2011 - 2014) 
 
Geometric mean and selected percentiles of serum concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 1.28 (1.15-1.43) 1.27 (1.11-1.45) 2.26 (2.01-2.61) 3.85 (3.28-4.61) 5.44 (4.61-6.82) 1904 
 13-14 1.35 (1.20-1.52) 1.40 (1.20-1.60) 2.40 (2.20-2.70) 4.10 (3.60-4.80) 5.60 (4.70-7.10) 2168 
Age group        
12-19 years 11-12 1.28 (1.08-1.51) 1.13 (.920-1.45) 2.17 (1.53-2.79) 4.53 (2.76-5.72) 6.45 (4.21-9.34) 344 
 13-14 1.27 (1.06-1.53) 1.10 (.900-1.40) 2.10 (1.50-2.90) 4.10 (2.50-6.30) 6.30 (4.00-9.40) 402 
20 years and older 11-12 1.28 (1.14-1.43) 1.28 (1.13-1.47) 2.29 (2.02-2.62) 3.76 (3.17-4.61) 5.05 (4.61-6.44) 1560 
 13-14 1.36 (1.21-1.53) 1.40 (1.30-1.60) 2.50 (2.20-2.80) 4.10 (3.60-4.80) 5.50 (4.80-7.10) 1766 
Gender        
Males 11-12 1.68 (1.50-1.89) 1.73 (1.46-2.03) 2.75 (2.37-3.28) 4.46 (3.76-5.09) 6.90 (4.99-8.59) 966 
 13-14 1.84 (1.59-2.12) 1.90 (1.60-2.10) 3.00 (2.50-3.40) 4.60 (4.00-5.70) 6.30 (5.20-8.80) 1032 
Females 11-12 .989 (.876-1.12) .970 (.880-1.07) 1.71 (1.39-2.05) 2.96 (2.23-4.28) 4.61 (3.00-5.61) 938 
 13-14 1.01 (.909-1.12) 1.00 (.900-1.10) 1.80 (1.60-2.10) 3.40 (2.80-4.10) 4.90 (3.80-5.90) 1136 
Race/ethnicity        
Mexican Americans 11-12 .927 (.771-1.12) .980 (.690-1.28) 1.56 (1.22-2.06) 2.26 (1.95-2.54) 2.78 (2.26-4.78) 211 
 13-14 .973 (.866-1.09) 1.10 (1.00-1.10) 1.60 (1.40-1.80) 2.40 (2.10-2.70) 2.90 (2.60-4.30) 332 
Non-Hispanic blacks 11-12 1.13 (1.03-1.23) 1.10 (1.01-1.22) 2.10 (1.84-2.35) 3.44 (2.86-4.15) 4.97 (3.68-6.89) 485 
 13-14 1.16 (1.00-1.33) 1.20 (1.00-1.40) 2.20 (1.80-2.70) 3.60 (2.90-5.10) 5.60 (3.80-9.80) 455 
Non-Hispanic whites 11-12 1.46 (1.28-1.66) 1.41 (1.20-1.69) 2.50 (2.10-3.00) 4.30 (3.47-4.99) 5.62 (4.70-7.60) 666 
 13-14 1.53 (1.28-1.83) 1.50 (1.30-1.90) 2.70 (2.20-3.30) 4.80 (3.80-5.70) 5.90 (4.80-9.30) 862 
All Hispanics 11-12 .904 (.737-1.11) .950 (.730-1.23) 1.66 (1.36-2.06) 2.54 (2.06-3.15) 3.59 (2.52-5.42) 406 
 13-14 1.00 (.875-1.14) 1.10 (1.00-1.20) 1.80 (1.50-2.00) 2.70 (2.20-3.60) 3.90 (2.90-4.50) 537 
Asians 11-12 .942 (.791-1.12) .980 (.820-1.20) 1.69 (1.41-1.94) 2.62 (2.13-3.50) 3.72 (2.75-5.98) 291 
 13-14 1.15 (.948-1.40) 1.20 (.900-1.60) 2.20 (1.70-2.70) 3.30 (2.60-4.20) 4.40 (3.30-5.90) 236 
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Serum Perfluorononanoic acid (PFNA) (1999-2010) 
 
Geometric mean and selected percentiles of serum concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 .551 (.456-.666) .600 (.500-.700) .900 (.700-1.00) 1.30 (1.00-1.90) 1.80 (1.30-2.40) 1562 
 03-04 .966 (.816-1.14) 1.00 (.900-1.10) 1.50 (1.20-1.80) 2.30 (1.60-4.30) 3.20 (1.80-7.70) 2094 
 05-06 1.09 (.909-1.29) 1.10 (.900-1.20) 1.70 (1.30-2.10) 2.60 (1.80-4.20) 3.60 (2.50-5.70) 2120 
 07-08 1.22 (1.12-1.32) 1.23 (1.15-1.31) 1.72 (1.56-1.89) 2.62 (2.30-2.87) 3.28 (2.95-3.77) 2100 
 09-10 1.26 (1.11-1.44) 1.23 (1.07-1.31) 1.80 (1.48-2.13) 2.71 (1.97-4.26) 3.77 (2.30-7.22) 2233 
Age group        
12-19 years 99-00 .473 (.406-.551) .500 (.400-.600) .700 (.600-.800) .900 (.800-1.10) 1.20 (.900-1.40) 543 
 03-04 .852 (.697-1.04) .800 (.700-1.00) 1.20 (1.00-1.60) 1.90 (1.20-3.70) 2.80 (1.30-6.30) 640 
 05-06 .929 (.782-1.10) .900 (.800-1.10) 1.40 (1.10-1.80) 2.00 (1.60-2.70) 2.70 (2.10-3.40) 640 
 07-08 1.16 (1.04-1.30) 1.15 (.980-1.31) 1.56 (1.31-1.97) 2.05 (1.64-2.71) 2.54 (2.13-3.28) 357 
 09-10 1.10 (.950-1.27) 1.07 (.900-1.23) 1.48 (1.31-1.80) 2.21 (1.48-2.95) 2.62 (1.89-4.84) 364 
20 years and older 99-00 .566 (.464-.690) .600 (.500-.700) .900 (.700-1.20) 1.40 (1.00-1.90) 1.90 (1.40-2.40) 1019 
 03-04 .984 (.835-1.16) 1.00 (.900-1.10) 1.50 (1.20-1.80) 2.40 (1.60-4.40) 3.40 (1.80-8.40) 1454 
 05-06 1.11 (.929-1.33) 1.10 (1.00-1.20) 1.70 (1.30-2.20) 2.60 (1.80-4.40) 3.90 (2.50-5.80) 1480 
 07-08 1.23 (1.13-1.33) 1.23 (1.15-1.31) 1.72 (1.64-1.89) 2.62 (2.38-2.95) 3.36 (3.03-3.77) 1743 
 09-10 1.29 (1.13-1.47) 1.23 (1.15-1.39) 1.80 (1.56-2.21) 2.71 (1.97-4.67) 3.94 (2.38-8.36) 1869 
Gender        
Males 99-00 .604 (.510-.716) .600 (.500-.700) .900 (.800-1.10) 1.30 (1.10-1.80) 1.70 (1.30-2.40) 743 
 03-04 1.09 (.912-1.30) 1.10 (.900-1.20) 1.60 (1.40-1.90) 2.40 (1.70-5.00) 4.00 (1.80-8.70) 1053 
 05-06 1.19 (.993-1.43) 1.20 (1.00-1.30) 1.80 (1.40-2.50) 2.90 (1.80-4.60) 3.90 (2.50-6.70) 1048 
 07-08 1.36 (1.27-1.47) 1.31 (1.23-1.39) 1.89 (1.72-2.05) 2.87 (2.54-3.12) 3.53 (3.12-4.18) 1059 
 09-10 1.37 (1.17-1.59) 1.31 (1.15-1.48) 1.80 (1.56-2.30) 2.79 (1.89-4.84) 4.10 (2.21-12.1) 1075 
Females 99-00 .508 (.409-.632) .500 (.400-.600) .800 (.600-1.00) 1.30 (.900-2.00) 1.80 (1.30-2.60) 819 
 03-04 .861 (.721-1.03) .900 (.800-1.00) 1.30 (1.00-1.70) 2.20 (1.40-3.40) 3.00 (1.70-6.10) 1041 
 05-06 .992 (.833-1.18) .900 (.800-1.10) 1.50 (1.20-1.90) 2.40 (1.70-3.50) 3.10 (2.10-5.70) 1072 
 07-08 1.09 (.985-1.21) 1.07 (.980-1.23) 1.56 (1.48-1.72) 2.21 (1.97-2.54) 2.79 (2.54-3.53) 1041 
 09-10 1.17 (1.05-1.31) 1.15 (.980-1.23) 1.72 (1.39-2.05) 2.62 (1.97-3.77) 3.53 (2.30-6.15) 1158 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 03-04, 05-06, 07-08, and 09-10 are 0.1, 0.1, 0.1, 0.082, and 0.082 respectively. 
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Geometric mean and selected percentiles of serum concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 .341 (.292-.398) .400 (.300-.400) .500 (.400-.700) .700 (.600-.900) .900 (.700-1.30) 584 
 03-04 .689 (.586-.809) .700 (.600-.900) 1.10 (.900-1.40) 1.60 (1.30-2.00) 2.00 (1.60-2.80) 485 
 05-06 .821 (.710-.951) .800 (.700-.900) 1.20 (1.10-1.40) 1.60 (1.30-2.30) 2.30 (1.50-3.20) 499 
 07-08 1.10 (.967-1.25) 1.15 (.980-1.31) 1.56 (1.39-1.80) 2.13 (1.80-2.71) 2.71 (2.13-3.28) 391 
 09-10 .993 (.906-1.09) .980 (.900-1.07) 1.39 (1.31-1.56) 2.05 (1.80-2.38) 2.46 (2.21-3.03) 461 
Non-Hispanic blacks 99-00 .764 (.606-.964) .700 (.600-1.00) 1.30 (.800-1.80) 1.90 (1.50-2.50) 2.50 (1.90-2.90) 303 
 03-04 1.14 (.834-1.54) 1.10 (.900-1.40) 1.70 (1.20-2.90) 3.20 (1.50-6.50) 4.70 (2.10-9.30) 538 
 05-06 1.17 (.916-1.50) 1.20 (.900-1.40) 1.60 (1.30-2.50) 2.60 (1.70-5.60) 4.40 (2.40-8.20) 544 
 07-08 1.35 (1.23-1.48) 1.39 (1.23-1.48) 1.89 (1.72-2.13) 2.79 (2.30-3.36) 3.36 (2.79-4.67) 419 
 09-10 1.42 (1.29-1.56) 1.39 (1.23-1.56) 1.97 (1.80-2.30) 2.79 (2.38-3.36) 3.36 (2.62-4.84) 391 
Non-Hispanic whites 99-00 .566 (.467-.687) .600 (.500-.700) .900 (.700-1.10) 1.30 (1.00-1.90) 1.70 (1.30-2.30) 519 
 03-04 .963 (.826-1.12) .900 (.900-1.10) 1.50 (1.20-1.70) 2.30 (1.60-3.60) 3.00 (1.80-6.20) 962 
 05-06 1.10 (.914-1.31) 1.10 (.900-1.20) 1.70 (1.30-2.10) 2.60 (1.80-4.20) 3.50 (2.40-5.70) 935 
 07-08 1.22 (1.10-1.34) 1.23 (1.15-1.31) 1.72 (1.48-1.89) 2.54 (2.13-3.03) 3.20 (2.79-3.85) 931 
 09-10 1.28 (1.08-1.51) 1.23 (1.07-1.39) 1.80 (1.48-2.21) 2.62 (1.80-5.08) 3.85 (2.05-10.8) 1031 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 03-04, 05-06, 07-08, and 09-10 are 0.1, 0.1, 0.1, 0.082, and 0.082 respectively. 









Fourth National Report on Human Exposure to Environmental Chemicals, Updated Tables, January 2017 Volume One Page 348
Serum Perfluorononanoic acid (PFNA) (2011 - 2014) 
 
Geometric mean and selected percentiles of serum concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 .881 (.801-.968) .860 (.750-.960) 1.30 (1.13-1.45) 1.96 (1.68-2.21) 2.54 (2.28-2.89) 1904 
 13-14 .675 (.613-.742) .700 (.600-.800) 1.00 (.900-1.20) 1.60 (1.40-1.70) 2.00 (1.80-2.30) 2168 
Age group        
12-19 years 11-12 .741 (.638-.861) .680 (.620-.810) 1.00 (.800-1.33) 1.67 (1.12-2.06) 2.06 (1.51-3.07) 344 
 13-14 .599 (.492-.730) .500 (.500-.600) .800 (.600-1.30) 1.50 (.800-2.80) 2.00 (1.00-3.40) 402 
20 years and older 11-12 .903 (.823-.992) .890 (.800-.980) 1.34 (1.16-1.48) 2.00 (1.71-2.33) 2.64 (2.37-3.03) 1560 
 13-14 .685 (.625-.752) .700 (.600-.800) 1.00 (1.00-1.20) 1.60 (1.40-1.70) 2.00 (1.80-2.30) 1766 
Gender        
Males 11-12 .946 (.836-1.07) .930 (.810-1.09) 1.36 (1.18-1.52) 1.89 (1.61-2.37) 2.57 (2.14-3.12) 966 
 13-14 .763 (.682-.854) .800 (.700-.800) 1.10 (1.00-1.30) 1.70 (1.50-1.80) 2.20 (1.80-2.40) 1032 
Females 11-12 .824 (.762-.890) .770 (.700-.870) 1.19 (1.00-1.44) 2.00 (1.69-2.28) 2.52 (2.20-2.76) 938 
 13-14 .600 (.549-.657) .600 (.500-.700) .900 (.900-1.00) 1.50 (1.30-1.60) 1.90 (1.70-2.10) 1136 
Race/ethnicity        
Mexican Americans 11-12 .810 (.631-1.04) .790 (.580-1.10) 1.17 (.840-1.66) 1.74 (1.19-2.47) 2.36 (1.66-2.85) 211 
 13-14 .538 (.452-.641) .500 (.500-.600) .800 (.600-.900) 1.10 (.800-1.70) 1.60 (1.10-2.10) 332 
Non-Hispanic blacks 11-12 .939 (.842-1.05) .950 (.870-1.00) 1.35 (1.18-1.59) 2.03 (1.60-3.03) 3.12 (1.89-5.08) 485 
 13-14 .665 (.564-.783) .700 (.600-.800) 1.10 (.900-1.30) 1.70 (1.30-2.10) 2.20 (1.80-2.50) 455 
Non-Hispanic whites 11-12 .864 (.766-.975) .850 (.710-.980) 1.26 (1.04-1.45) 1.83 (1.54-2.21) 2.37 (2.00-3.14) 666 
 13-14 .699 (.621-.786) .700 (.600-.800) 1.10 (1.00-1.20) 1.60 (1.40-1.80) 2.00 (1.70-2.40) 862 
All Hispanics 11-12 .850 (.699-1.03) .840 (.660-1.00) 1.21 (.970-1.67) 1.99 (1.51-2.53) 2.53 (2.07-2.85) 406 
 13-14 .549 (.484-.622) .600 (.500-.600) .800 (.700-.900) 1.10 (.900-1.50) 1.60 (1.20-2.10) 537 
Asians 11-12 1.18 (.996-1.40) 1.18 (.970-1.49) 1.94 (1.56-2.38) 2.96 (2.52-3.50) 3.72 (3.04-4.31) 291 
 13-14 .893 (.789-1.01) .900 (.800-1.10) 1.50 (1.20-1.60) 2.20 (1.80-2.80) 3.10 (2.40-4.20) 236 
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Serum Perfluorooctanoic acid (PFOA) (1999 – 2010) 
 
Geometric mean and selected percentiles of serum concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 5.21 (4.72-5.74) 5.20 (4.80-5.90) 6.90 (6.30-7.80) 9.40 (8.20-11.1) 11.9 (10.9-13.5) 1562 
 03-04 3.95 (3.65-4.27) 4.10 (3.80-4.40) 5.80 (5.30-6.40) 7.80 (6.70-9.60) 9.80 (7.40-14.1) 2094 
 05-06 3.92 (3.48-4.42) 4.20 (3.80-4.50) 6.20 (5.40-7.20) 9.00 (7.40-11.2) 11.3 (8.80-14.5) 2120 
 07-08 4.12 (4.01-4.24) 4.30 (4.20-4.50) 5.90 (5.70-6.20) 7.90 (7.50-8.30) 9.60 (8.90-10.1) 2100 
 09-10 3.07 (2.81-3.36) 3.20 (2.90-3.50) 4.60 (4.10-5.10) 6.00 (5.30-7.20) 7.50 (6.20-9.70) 2233 
Age group        
12-19 years 99-00 5.46 (4.98-5.99) 5.60 (4.90-6.10) 6.90 (6.20-7.70) 9.40 (7.70-11.0) 11.6 (10.2-12.5) 543 
 03-04 3.89 (3.47-4.35) 4.00 (3.50-4.50) 5.40 (4.60-6.10) 7.00 (5.60-9.20) 8.60 (5.90-12.6) 640 
 05-06 3.59 (3.26-3.96) 3.80 (3.30-4.20) 5.40 (4.60-5.90) 6.90 (6.30-7.90) 8.40 (7.30-10.1) 640 
 07-08 3.91 (3.71-4.12) 4.00 (3.70-4.40) 5.00 (4.70-5.50) 6.10 (5.70-6.70) 7.30 (6.20-8.00) 357 
 09-10 2.74 (2.46-3.05) 2.90 (2.60-3.10) 3.80 (3.30-4.20) 4.80 (4.10-5.30) 5.00 (4.40-7.20) 364 
20 years and older 99-00 5.16 (4.66-5.72) 5.20 (4.70-5.70) 7.00 (6.30-7.80) 9.40 (8.20-11.1) 12.0 (10.8-14.0) 1019 
 03-04 3.96 (3.67-4.27) 4.10 (3.90-4.40) 5.90 (5.40-6.50) 7.80 (6.80-9.60) 9.90 (7.60-14.2) 1454 
 05-06 3.97 (3.51-4.49) 4.20 (3.80-4.60) 6.40 (5.40-7.50) 9.30 (7.40-11.9) 11.6 (9.00-14.8) 1480 
 07-08 4.15 (4.02-4.30) 4.30 (4.20-4.60) 6.10 (5.80-6.50) 8.10 (7.70-8.70) 9.80 (9.00-10.4) 1743 
 09-10 3.12 (2.84-3.43) 3.30 (3.00-3.60) 4.70 (4.20-5.30) 6.40 (5.40-7.50) 7.70 (6.30-10.2) 1869 
Gender        
Males 99-00 5.71 (5.17-6.31) 6.00 (5.40-6.50) 7.70 (6.80-8.70) 10.6 (9.00-11.8) 12.1 (11.2-13.1) 743 
 03-04 4.47 (4.07-4.91) 4.60 (4.30-5.00) 6.30 (5.70-7.20) 8.40 (6.80-12.5) 10.7 (7.40-17.5) 1053 
 05-06 4.69 (4.23-5.20) 4.90 (4.40-5.40) 7.20 (6.10-8.00) 9.90 (8.00-12.2) 12.2 (9.60-15.2) 1048 
 07-08 4.80 (4.55-5.06) 4.90 (4.60-5.20) 6.70 (6.30-7.10) 8.70 (8.10-9.30) 10.1 (9.50-11.1) 1059 
 09-10 3.53 (3.22-3.87) 3.70 (3.40-4.00) 4.90 (4.50-5.40) 6.80 (5.40-8.00) 7.90 (6.40-10.2) 1075 
Females 99-00 4.80 (4.32-5.34) 4.70 (4.40-5.20) 6.30 (5.60-7.10) 8.30 (7.50-9.90) 11.3 (9.20-14.4) 819 
 03-04 3.50 (3.21-3.82) 3.60 (3.30-3.90) 5.20 (4.70-5.80) 7.10 (6.30-8.20) 8.60 (7.40-10.6) 1041 
 05-06 3.31 (2.89-3.79) 3.50 (3.10-4.00) 5.20 (4.40-6.00) 7.90 (6.10-9.70) 10.1 (7.50-14.2) 1072 
 07-08 3.55 (3.38-3.73) 3.70 (3.50-3.90) 5.20 (4.80-5.60) 7.00 (6.50-7.50) 8.30 (7.20-9.90) 1041 
 09-10 2.69 (2.45-2.96) 2.70 (2.50-3.00) 4.10 (3.60-4.70) 5.60 (5.10-6.50) 6.90 (5.80-8.40) 1158 
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Serum Perfluorooctanoic acid (PFOA) (1999 – 2010) 
 
Geometric mean and selected percentiles of serum concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 3.89 (3.58-4.21) 4.20 (3.80-4.60) 5.80 (5.20-6.30) 7.70 (6.40-8.00) 8.20 (7.70-8.90) 584 
 03-04 3.11 (2.84-3.40) 3.30 (3.10-3.70) 4.50 (4.20-5.20) 6.70 (5.70-7.30) 7.60 (6.70-10.5) 485 
 05-06 2.62 (2.33-2.95) 2.80 (2.50-3.30) 4.30 (3.80-4.70) 5.80 (5.30-6.70) 7.40 (5.90-8.10) 499 
 07-08 3.54 (3.35-3.75) 3.80 (3.50-4.00) 5.20 (4.90-5.60) 6.60 (6.20-7.10) 7.60 (6.80-9.00) 391 
 09-10 2.26 (2.00-2.54) 2.40 (2.10-2.60) 3.60 (3.10-3.80) 4.60 (4.00-5.30) 5.40 (4.50-6.60) 461 
Non-Hispanic blacks 99-00 4.78 (4.10-5.57) 4.80 (3.80-5.90) 6.40 (5.90-7.50) 9.00 (7.40-11.5) 11.5 (9.20-14.0) 303 
 03-04 3.37 (2.99-3.79) 3.70 (3.20-4.20) 5.20 (4.40-6.30) 7.70 (5.30-11.6) 9.60 (6.50-13.9) 538 
 05-06 3.27 (2.61-4.08) 3.70 (3.00-4.20) 5.50 (4.40-6.80) 8.10 (6.00-11.3) 10.4 (7.80-12.3) 544 
 07-08 3.86 (3.57-4.16) 4.00 (3.50-4.30) 5.90 (5.20-6.50) 7.80 (7.10-8.70) 9.20 (8.50-10.1) 419 
 09-10 2.74 (2.47-3.04) 2.80 (2.60-3.00) 4.00 (3.70-4.40) 5.50 (5.00-6.20) 6.70 (5.60-9.40) 391 
Non-Hispanic whites 99-00 5.61 (5.06-6.23) 5.60 (4.90-6.20) 7.30 (6.50-8.20) 10.3 (8.40-12.1) 13.0 (11.0-14.9) 519 
 03-04 4.18 (3.85-4.53) 4.30 (3.90-4.70) 6.00 (5.50-6.70) 7.90 (7.20-9.20) 9.90 (7.60-13.3) 962 
 05-06 4.27 (3.80-4.81) 4.40 (4.00-5.00) 6.60 (5.60-7.80) 9.60 (7.40-12.2) 11.6 (8.80-14.8) 935 
 07-08 4.38 (4.20-4.56) 4.60 (4.30-4.70) 6.10 (5.80-6.60) 8.20 (7.80-8.80) 9.90 (9.30-10.6) 931 
 09-10 3.36 (3.06-3.69) 3.50 (3.20-3.90) 4.80 (4.40-5.40) 6.60 (5.40-7.80) 7.80 (6.20-10.5) 1031 
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Serum Perfluorooctanoic acid (PFOA) (2011 - 2014)‡  
 
Geometric mean and selected percentiles of serum concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 2.08 (1.95-2.22) 2.08 (1.96-2.26) 3.03 (2.76-3.27) 4.35 (3.82-4.85) 5.68 (5.02-6.49) 1904 
 13-14‡ 1.94 (1.76-2.14) 2.07 (1.87-2.20) 3.07 (2.67-3.37) 4.27 (3.57-5.17) 5.57 (4.60-6.27) 2165 
Age group        
12-19 years 11-12 1.80 (1.71-1.91) 1.74 (1.67-1.89) 2.41 (2.17-2.62) 2.93 (2.68-3.19) 3.59 (2.93-4.25) 344 
 13-14‡ 1.66 (1.50-1.84) 1.67 (1.37-1.97) 2.20 (1.97-2.57) 2.87 (2.57-3.40) 3.47 (2.87-4.37) 401 
20 years and older 11-12 2.12 (1.98-2.28) 2.16 (2.01-2.33) 3.15 (2.90-3.36) 4.64 (3.93-5.25) 5.94 (5.34-7.45) 1560 
 13-14‡ 1.98 (1.79-2.19) 2.07 (1.90-2.27) 3.17 (2.77-3.47) 4.47 (3.70-5.27) 5.60 (4.67-6.40) 1764 
Gender        
Males 11-12 2.37 (2.22-2.53) 2.38 (2.26-2.56) 3.25 (3.00-3.56) 4.61 (4.11-5.02) 5.62 (4.85-6.20) 966 
 13-14‡ 2.29 (2.09-2.50) 2.37 (2.17-2.57) 3.27 (2.87-3.60) 4.67 (3.77-5.60) 5.67 (4.67-6.27) 1031 
Females 11-12 1.84 (1.68-2.01) 1.78 (1.62-1.98) 2.65 (2.34-3.14) 3.91 (3.36-4.99) 5.68 (4.33-8.45) 938 
 13-14‡ 1.66 (1.48-1.87) 1.67 (1.47-1.87) 2.67 (2.27-3.07) 3.77 (3.37-4.70) 5.07 (4.07-6.70) 1134 
Race/ethnicity        
Mexican Americans 11-12 1.66 (1.37-2.02) 1.71 (1.32-2.23) 2.43 (1.98-2.98) 3.38 (2.43-4.48) 4.08 (2.98-6.15) 211 
 13-14‡ 1.36 (1.25-1.47) 1.37 (1.27-1.47) 1.97 (1.87-2.10) 2.70 (2.40-3.10) 3.17 (2.57-3.77) 332 
Non-Hispanic blacks 11-12 1.80 (1.71-1.90) 1.94 (1.76-2.09) 2.82 (2.65-2.95) 3.94 (3.51-4.40) 5.11 (4.40-5.79) 485 
 13-14‡ 1.52 (1.34-1.73) 1.67 (1.37-1.97) 2.57 (2.17-2.97) 3.60 (3.07-4.50) 4.60 (3.40-5.77) 455 
Non-Hispanic whites 11-12 2.25 (2.05-2.47) 2.25 (1.98-2.48) 3.21 (2.90-3.50) 4.68 (3.95-5.35) 6.20 (5.34-7.74) 666 
 13-14‡ 2.20 (1.91-2.52) 2.27 (1.97-2.67) 3.37 (2.77-3.77) 4.77 (3.77-5.67) 5.77 (4.80-6.87) 861 
All Hispanics 11-12 1.70 (1.48-1.95) 1.79 (1.59-1.95) 2.46 (2.15-2.91) 3.60 (2.95-4.48) 4.70 (3.87-5.94) 406 
 13-14‡ 1.45 (1.33-1.59) 1.47 (1.37-1.67) 2.10 (1.97-2.40) 3.07 (2.67-3.27) 3.47 (3.17-3.97) 537 
Asians 11-12 2.08 (1.83-2.36) 2.21 (2.04-2.27) 2.92 (2.55-3.45) 4.66 (3.42-5.79) 5.79 (4.93-8.91) 291 
 13-14‡ 1.97 (1.75-2.23) 1.87 (1.67-2.27) 2.97 (2.47-3.57) 4.67 (3.97-5.77) 5.90 (5.00-6.40) 234 
Limit of detection (LOD, see Data Analysis section) for Survey year 11-12 is 0.1. 








Fourth National Report on Human Exposure to Environmental Chemicals, Updated Tables, January 2017 Volume One Page 352
Serum n-Perfluorooctanoic acid (n-PFOA) (2013 - 2014) 
Linear PFOA isomer 
Geometric mean and selected percentiles of serum concentrations (in µg/L) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 13-14 1.83 (1.65-2.03) 1.90 (1.80-2.10) 2.90 (2.60-3.20) 4.10 (3.50-5.10) 5.30 (4.40-6.00) 2165 
Age group        
12-19 years 13-14 1.56 (1.41-1.74) 1.60 (1.30-1.80) 2.10 (1.90-2.50) 2.70 (2.30-3.40) 3.40 (2.70-4.80) 401 
20 years and older 13-14 1.87 (1.68-2.08) 2.00 (1.80-2.20) 3.00 (2.70-3.30) 4.40 (3.60-5.10) 5.40 (4.60-6.20) 1764 
Gender        
Males 13-14 2.18 (1.98-2.39) 2.30 (2.10-2.50) 3.20 (2.80-3.50) 4.60 (3.70-5.30) 5.40 (4.60-5.90) 1031 
Females 13-14 1.55 (1.37-1.75) 1.60 (1.40-1.80) 2.60 (2.20-2.90) 3.70 (3.30-4.70) 4.80 (3.90-6.60) 1134 
Race/ethnicity        
Mexican Americans 13-14 1.27 (1.16-1.38) 1.30 (1.20-1.40) 1.90 (1.80-2.00) 2.60 (2.30-3.10) 3.10 (2.50-3.70) 332 
Non-Hispanic blacks 13-14 1.41 (1.23-1.62) 1.60 (1.30-1.90) 2.50 (2.10-2.80) 3.50 (2.90-4.40) 4.40 (3.30-5.70) 455 
Non-Hispanic whites 13-14 2.08 (1.80-2.41) 2.20 (1.90-2.60) 3.20 (2.70-3.60) 4.60 (3.60-5.50) 5.60 (4.70-6.70) 861 
All Hispanics 13-14 1.35 (1.23-1.49) 1.40 (1.30-1.60) 2.00 (1.90-2.30) 2.90 (2.50-3.10) 3.40 (3.10-3.70) 537 
Asians 13-14 1.87 (1.65-2.12) 1.80 (1.60-2.20) 2.90 (2.40-3.50) 4.60 (3.90-5.70) 5.70 (4.70-6.80) 234 
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Serum branched Perfluorooctanoic acid (Sb-PFOA) (2013 - 2014) 
Branched isomers of PFOA 
Geometric mean and selected percentiles of serum concentrations (in µg/L) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 13-14 * < LOD < LOD .200 (.100-.200) .200 (.200-.300) 2165 
Age group        
12-19 years 13-14 * < LOD .100 (<LOD-.100) .200 (.100-.200) .200 (.100-.400) 401 
20 years and older 13-14 * < LOD < LOD .100 (.100-.200) .200 (.200-.300) 1764 
Gender        
Males 13-14 * < LOD < LOD .200 (.100-.200) .200 (.200-.400) 1031 
Females 13-14 * < LOD < LOD .100 (.100-.200) .200 (.200-.300) 1134 
Race/ethnicity        
Mexican Americans 13-14 * < LOD < LOD .100 (<LOD-.200) .200 (.100-.200) 332 
Non-Hispanic blacks 13-14 * < LOD < LOD .100 (<LOD-.200) .200 (.100-.300) 455 
Non-Hispanic whites 13-14 * < LOD < LOD .200 (.100-.200) .200 (.200-.500) 861 
All Hispanics 13-14 * < LOD < LOD .100 (<LOD-.200) .200 (.100-.300) 537 
Asians 13-14 * < LOD < LOD .100 (<LOD-.400) .200 (<LOD-3.00) 234 
Limit of detection (LOD, see Data Analysis section) for Survey year 13-14 is 0.1. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Serum Perfluorooctane sulfonic acid (PFOS) (1999 – 2010) 
 
Geometric mean and selected percentiles of serum concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 30.4 (27.1-33.9) 30.2 (27.8-33.9) 43.7 (37.5-47.3) 57.0 (50.2-71.7) 75.7 (58.1-97.5) 1562 
 03-04 20.7 (19.2-22.3) 21.2 (19.8-22.4) 30.0 (27.5-33.0) 41.3 (35.6-50.0) 54.6 (44.0-66.5) 2094 
 05-06 17.1 (16.0-18.2) 17.5 (16.8-18.6) 27.2 (24.9-29.6) 39.4 (34.9-43.1) 47.5 (42.7-56.8) 2120 
 07-08 13.2 (12.2-14.2) 13.6 (12.8-14.7) 21.0 (18.9-23.3) 32.6 (29.4-36.3) 40.5 (35.4-47.4) 2100 
 09-10 9.32 (8.13-10.7) 9.70 (8.50-10.8) 14.8 (12.9-17.3) 23.7 (18.3-30.2) 32.0 (22.6-48.5) 2233 
Age group        
12-19 years 99-00 29.1 (26.2-32.4) 29.5 (26.9-34.2) 39.0 (35.9-45.0) 52.7 (46.0-56.2) 57.4 (52.7-66.5) 543 
 03-04 19.3 (17.5-21.4) 19.9 (17.8-22.0) 27.1 (23.7-30.2) 36.5 (28.6-45.6) 42.6 (35.1-52.1) 640 
 05-06 15.0 (14.3-15.7) 14.9 (13.6-16.6) 22.7 (19.7-24.9) 30.6 (27.8-34.1) 38.5 (33.0-44.6) 640 
 07-08 11.3 (10.3-12.3) 11.3 (10.3-13.0) 15.9 (15.1-17.7) 21.7 (17.7-28.2) 28.0 (22.0-32.2) 357 
 09-10 6.84 (5.81-8.06) 6.90 (6.00-8.40) 10.7 (8.90-12.5) 14.4 (12.4-18.1) 18.1 (13.5-26.0) 364 
20 years and older 99-00 30.6 (27.1-34.4) 30.3 (27.9-33.9) 44.4 (37.9-48.0) 58.0 (50.1-75.7) 78.0 (59.9-107) 1019 
 03-04 20.9 (19.3-22.5) 21.4 (19.8-22.8) 30.4 (28.1-33.0) 42.7 (35.7-53.3) 57.8 (45.7-69.4) 1454 
 05-06 17.4 (16.2-18.7) 18.0 (17.1-19.4) 27.8 (25.3-30.8) 40.2 (35.6-44.5) 49.6 (42.8-60.7) 1480 
 07-08 13.5 (12.4-14.6) 14.0 (13.0-15.5) 21.7 (19.5-24.6) 33.9 (29.9-39.0) 42.8 (37.3-50.3) 1743 
 09-10 9.72 (8.45-11.2) 10.1 (8.90-11.2) 15.7 (13.4-18.4) 25.3 (19.3-32.9) 34.1 (23.4-52.7) 1869 
Gender        
Males 99-00 33.4 (29.6-37.6) 34.9 (31.1-37.9) 46.3 (41.2-51.6) 58.4 (50.2-78.3) 78.3 (58.0-108) 743 
 03-04 23.2 (21.1-25.6) 23.9 (22.4-25.5) 32.2 (28.8-35.9) 45.3 (35.5-62.7) 62.7 (43.8-81.8) 1053 
 05-06 20.5 (19.4-21.8) 21.3 (20.0-22.5) 31.4 (27.9-33.7) 43.3 (38.7-49.7) 54.3 (43.5-80.7) 1048 
 07-08 16.3 (15.0-17.7) 17.0 (15.7-17.8) 23.9 (21.6-26.9) 36.4 (33.5-41.1) 45.3 (40.4-53.1) 1059 
 09-10 11.5 (9.93-13.3) 11.8 (10.6-12.9) 16.8 (14.3-20.4) 25.7 (19.4-39.7) 37.4 (22.5-72.3) 1075 
Females 99-00 28.0 (24.6-31.8) 27.8 (24.5-30.2) 39.0 (32.7-46.0) 55.4 (46.3-70.2) 75.7 (56.1-98.4) 819 
 03-04 18.4 (17.0-20.0) 18.2 (16.9-19.8) 27.4 (23.8-30.2) 39.8 (34.4-42.6) 46.6 (42.3-61.5) 1041 
 05-06 14.4 (13.3-15.4) 14.6 (13.5-15.9) 23.3 (21.1-25.3) 34.2 (30.6-37.7) 42.8 (38.0-46.5) 1072 
 07-08 10.7 (9.70-11.7) 10.7 (9.80-11.7) 17.2 (15.4-19.1) 28.7 (21.7-32.5) 33.6 (29.9-41.6) 1041 
 09-10 7.65 (6.73-8.71) 7.80 (6.70-9.00) 12.0 (10.8-14.4) 21.1 (16.4-26.9) 28.8 (22.3-34.1) 1158 
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Serum Perfluorooctane sulfonic acid (PFOS) (1999 – 2010)  
 
Geometric mean and selected percentiles of serum concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 22.7 (19.8-25.9) 23.7 (20.8-27.2) 33.0 (27.9-39.7) 41.9 (36.7-54.5) 53.6 (41.3-72.0) 584 
 03-04 14.7 (13.0-16.6) 15.9 (13.4-17.9) 21.2 (18.7-23.5) 28.1 (24.1-35.0) 35.5 (28.9-38.5) 485 
 05-06 11.2 (10.3-12.2) 11.6 (9.90-13.3) 17.2 (15.4-19.3) 24.9 (22.0-30.3) 31.9 (26.4-40.6) 499 
 07-08 10.6 (9.47-11.9) 10.8 (9.70-12.2) 17.1 (14.9-19.2) 26.3 (20.7-30.4) 31.5 (25.7-36.1) 391 
 09-10 6.23 (5.28-7.36) 6.10 (5.10-8.10) 11.2 (8.50-14.1) 16.8 (14.9-18.8) 20.4 (17.5-22.7) 461 
Non-Hispanic blacks 99-00 32.9 (26.0-41.6) 32.0 (23.9-45.8) 50.6 (37.4-62.2) 69.3 (60.9-75.9) 81.5 (68.0-129) 303 
 03-04 21.6 (19.1-24.4) 22.1 (19.6-24.9) 32.3 (28.1-36.2) 43.8 (37.2-57.3) 57.7 (43.8-78.4) 538 
 05-06 18.4 (15.6-21.8) 19.0 (16.7-22.3) 27.6 (24.3-35.5) 45.9 (34.4-58.1) 57.9 (45.0-84.4) 544 
 07-08 15.0 (12.6-17.8) 15.2 (12.9-17.7) 25.8 (21.0-33.3) 42.7 (31.5-57.3) 57.3 (43.4-79.2) 419 
 09-10 9.11 (7.93-10.5) 9.50 (8.20-11.2) 16.0 (13.4-17.4) 23.0 (20.5-26.1) 28.7 (25.7-39.7) 391 
Non-Hispanic whites 99-00 32.3 (29.5-35.3) 32.8 (29.5-36.0) 45.1 (40.4-47.4) 56.3 (51.7-70.0) 78.0 (58.0-98.4) 519 
 03-04 21.4 (19.9-23.1) 22.0 (20.5-23.0) 30.2 (27.7-33.3) 41.7 (35.7-49.6) 56.3 (44.0-70.0) 962 
 05-06 18.1 (17.1-19.1) 18.6 (17.3-19.8) 28.3 (26.1-30.8) 39.7 (35.6-43.3) 46.6 (42.7-54.3) 935 
 07-08 13.7 (12.7-14.8) 14.3 (13.2-15.5) 21.1 (18.7-23.7) 32.9 (29.7-36.0) 40.4 (36.1-44.9) 931 
 09-10 10.2 (8.69-11.9) 10.4 (9.20-11.5) 15.6 (13.0-18.7) 24.7 (17.5-35.1) 33.1 (20.7-56.7) 1031 
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Serum Perfluorooctane sulfonic acid (PFOS) (2011 - 2014)‡ 
 
Geometric mean and selected percentiles of serum concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 6.31 (5.84-6.82) 6.53 (5.99-7.13) 10.5 (9.78-11.1) 15.7 (14.7-17.5) 21.7 (19.3-23.9) 1904 
 13-14‡ 4.99 (4.50-5.52) 5.20 (4.80-5.70) 8.70 (7.90-9.40) 13.9 (11.9-15.5) 18.5 (15.4-22.0) 2165 
Age group        
12-19 years 11-12 4.16 (3.70-4.68) 4.11 (3.48-4.65) 5.90 (5.14-7.25) 9.05 (6.49-10.8) 10.8 (8.52-14.2) 344 
 13-14‡ 3.54 (3.17-3.96) 3.60 (3.10-4.20) 5.20 (4.60-6.20) 7.80 (7.00-8.90) 9.30 (7.90-11.7) 401 
20 years and older 11-12 6.71 (6.24-7.20) 7.07 (6.65-7.52) 11.0 (10.4-11.9) 17.0 (15.3-18.5) 22.7 (20.4-24.8) 1560 
 13-14‡ 5.22 (4.70-5.81) 5.60 (5.10-6.00) 9.10 (8.20-10.2) 14.5 (12.9-16.1) 19.5 (15.8-23.0) 1764 
Gender        
Males 11-12 7.91 (7.19-8.70) 8.31 (7.35-9.15) 12.5 (11.4-13.5) 19.3 (15.7-21.4) 24.1 (22.2-28.5) 966 
 13-14‡ 6.36 (5.62-7.20) 6.40 (5.70-7.30) 10.2 (8.70-11.5) 15.5 (13.2-19.8) 22.1 (16.7-26.9) 1031 
Females 11-12 5.10 (4.70-5.53) 5.27 (4.67-5.64) 8.57 (7.87-9.30) 12.5 (11.0-14.9) 17.5 (14.9-20.5) 938 
 13-14‡ 3.96 (3.60-4.35) 4.00 (3.60-4.60) 7.20 (6.40-7.70) 11.8 (9.70-13.6) 15.1 (13.9-17.3) 1134 
Race/ethnicity        
Mexican Americans 11-12 4.79 (4.07-5.64) 5.18 (3.92-6.33) 7.91 (6.18-9.48) 10.5 (8.50-12.6) 12.1 (10.0-14.4) 211 
 13-14‡ 3.47 (2.90-4.16) 3.70 (3.00-4.40) 5.20 (4.60-6.40) 8.80 (6.40-10.3) 10.8 (9.20-11.8) 332 
Non-Hispanic blacks 11-12 6.35 (5.41-7.46) 6.57 (5.71-7.65) 11.3 (9.74-13.9) 21.8 (13.9-31.3) 30.7 (21.6-45.1) 485 
 13-14‡ 5.32 (4.12-6.88) 5.30 (4.30-6.80) 10.2 (7.60-13.7) 17.4 (12.4-24.5) 24.5 (16.3-39.7) 455 
Non-Hispanic whites 11-12 6.71 (6.15-7.32) 6.83 (6.07-7.73) 10.7 (9.89-12.2) 15.7 (14.8-18.1) 21.3 (18.7-23.5) 666 
 13-14‡ 5.31 (4.72-5.98) 5.70 (5.10-6.40) 8.90 (8.20-9.90) 14.1 (12.2-15.6) 18.0 (15.5-20.4) 861 
All Hispanics 11-12 4.63 (3.86-5.55) 5.18 (4.41-6.19) 8.10 (6.64-9.78) 11.0 (9.96-12.6) 13.4 (11.5-16.1) 406 
 13-14‡ 3.51 (3.09-3.98) 3.70 (3.20-4.20) 5.50 (4.90-6.40) 8.80 (8.00-9.70) 10.8 (9.70-12.1) 537 
Asians 11-12 7.10 (5.80-8.68) 7.53 (5.96-9.25) 12.6 (10.8-17.0) 24.6 (19.1-33.3) 35.1 (26.4-42.3) 291 
 13-14‡ 6.18 (5.08-7.52) 6.30 (5.00-7.90) 13.2 (9.40-15.4) 23.8 (15.2-33.9) 33.6 (20.1-69.0) 234 
Limit of detection (LOD, see Data Analysis section) for Survey year 11-12 is 0.2. 
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Serum n-Perfluorooctane sulfonic acid (n-PFOS) (2013 - 2014) 
Linear PFOS isomer 
Geometric mean and selected percentiles of serum concentrations (in µg/L) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 13-14 3.45 (3.10-3.85) 3.50 (3.20-3.90) 6.00 (5.20-6.60) 9.90 (8.50-11.3) 14.0 (11.0-16.7) 2165 
Age group        
12-19 years 13-14 2.59 (2.29-2.93) 2.70 (2.30-2.90) 3.90 (3.40-4.80) 6.20 (4.80-7.00) 7.10 (6.20-8.60) 401 
20 years and older 13-14 3.59 (3.21-4.02) 3.70 (3.40-4.10) 6.30 (5.50-7.20) 10.3 (9.10-12.3) 15.1 (11.9-17.7) 1764 
Gender        
Males 13-14 4.26 (3.74-4.86) 4.20 (3.70-4.80) 6.60 (6.00-7.90) 10.8 (9.30-15.1) 15.4 (12.1-20.2) 1031 
Females 13-14 2.83 (2.56-3.13) 2.90 (2.60-3.20) 4.90 (4.40-5.60) 8.50 (7.30-9.90) 11.6 (9.90-13.0) 1134 
Race/ethnicity        
Mexican Americans 13-14 2.38 (1.99-2.84) 2.40 (2.10-2.80) 3.50 (3.00-3.90) 6.10 (3.90-8.00) 7.90 (6.20-8.90) 332 
Non-Hispanic blacks 13-14 4.02 (3.03-5.34) 4.00 (3.00-5.50) 7.50 (5.30-10.9) 14.4 (9.00-20.3) 19.3 (14.4-32.6) 455 
Non-Hispanic whites 13-14 3.58 (3.17-4.06) 3.70 (3.40-4.20) 6.10 (5.40-6.70) 10.0 (8.60-11.0) 13.0 (10.8-15.1) 861 
All Hispanics 13-14 2.43 (2.14-2.76) 2.50 (2.10-2.80) 3.90 (3.30-4.50) 6.20 (4.90-7.60) 8.00 (7.10-8.80) 537 
Asians 13-14 4.79 (3.83-5.99) 4.60 (4.00-6.20) 9.90 (8.00-12.5) 19.2 (12.4-32.5) 31.1 (17.0-64.8) 234 
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Serum branched Perfluoromethylheptane sulfonic acid (Sm-PFOS) (2013 - 2014) 
Perfluoromethylheptane sulfonic acid isomers 
Geometric mean and selected percentiles of serum concentrations (in µg/L) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 13-14 1.39 (1.25-1.55) 1.50 (1.40-1.60) 2.70 (2.50-2.90) 4.00 (3.60-4.50) 5.10 (4.60-5.80) 2165 
Age group        
12-19 years 13-14 .897 (.800-1.01) 1.00 (.800-1.10) 1.40 (1.20-1.50) 1.90 (1.50-2.10) 2.30 (1.80-3.00) 401 
20 years and older 13-14 1.47 (1.32-1.65) 1.60 (1.50-1.80) 2.90 (2.60-3.10) 4.20 (3.70-4.70) 5.30 (4.70-6.00) 1764 
Gender        
Males 13-14 1.94 (1.72-2.19) 2.10 (1.80-2.40) 3.20 (2.90-3.60) 4.60 (4.00-5.60) 5.90 (4.90-7.00) 1031 
Females 13-14 1.01 (.914-1.12) 1.10 (.900-1.20) 1.90 (1.70-2.10) 3.30 (3.00-3.60) 4.20 (3.70-4.70) 1134 
Race/ethnicity        
Mexican Americans 13-14 1.00 (.823-1.23) 1.10 (.900-1.30) 1.70 (1.50-2.20) 2.70 (2.20-3.20) 3.70 (2.90-4.20) 332 
Non-Hispanic blacks 13-14 1.15 (.942-1.40) 1.20 (1.00-1.50) 2.40 (1.90-3.00) 4.40 (3.40-5.20) 5.50 (4.50-7.00) 455 
Non-Hispanic whites 13-14 1.61 (1.41-1.82) 1.70 (1.50-2.00) 3.00 (2.70-3.20) 4.20 (3.70-4.90) 5.50 (4.80-6.00) 861 
All Hispanics 13-14 .987 (.859-1.13) 1.00 (.900-1.20) 1.80 (1.60-2.10) 2.70 (2.40-3.20) 3.50 (2.90-4.00) 537 
Asians 13-14 1.10 (.955-1.28) 1.20 (1.00-1.40) 2.30 (1.60-2.70) 3.50 (2.50-4.50) 4.40 (3.50-7.20) 234 
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Serum Perfluorooctane sulfonamide (PFOSA) (1999 – 2010) 
 
Geometric mean and selected percentiles of serum concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 .355 (.296-.426) .400 (.300-.400) .700 (.500-.800) 1.00 (.900-1.40) 1.40 (1.00-2.00) 1562 
 03-04 * .100 (.100-.100) .100 (.100-.100) .300 (.200-.300) .300 (.300-.400) 2094 
 05-06 * < LOD .100 (<LOD-.200) .200 (.200-.300) .300 (.200-.500) 2120 
 07-08 * < LOD < LOD < LOD < LOD 2100 
 09-10 * < LOD < LOD < LOD < LOD 2233 
Age group        
12-19 years 99-00 .429 (.370-.498) .400 (.400-.500) .700 (.700-.900) 1.10 (.900-1.40) 1.60 (1.10-2.90) 543 
 03-04 * .100 (.100-.100) .100 (.100-.200) .300 (.200-.300) .300 (.200-.500) 640 
 05-06 * < LOD < LOD .200 (.100-.300) .300 (.200-.500) 640 
 07-08 * < LOD < LOD < LOD < LOD 357 
 09-10 * < LOD < LOD < LOD < LOD 364 
20 years and older 99-00 .344 (.283-.418) .300 (.300-.400) .600 (.500-.800) 1.00 (.800-1.40) 1.40 (1.00-2.00) 1019 
 03-04 * .100 (.100-.100) .100 (.100-.100) .300 (.200-.300) .300 (.300-.400) 1454 
 05-06 * < LOD .100 (<LOD-.200) .200 (.200-.300) .300 (.200-.500) 1480 
 07-08 * < LOD < LOD < LOD < LOD 1743 
 09-10 * < LOD < LOD < LOD < LOD 1869 
Gender        
Males 99-00 .351 (.289-.426) .400 (.300-.400) .600 (.500-.700) .900 (.700-1.30) 1.30 (.900-1.90) 743 
 03-04 * .100 (.100-.100) .100 (.100-.100) .300 (.200-.300) .300 (.200-.500) 1053 
 05-06 * < LOD .100 (.100-.200) .200 (.200-.300) .300 (.200-.600) 1048 
 07-08 * < LOD < LOD < LOD < LOD 1059 
 09-10 * < LOD < LOD < LOD < LOD 1075 
Females 99-00 .358 (.298-.431) .300 (.300-.500) .700 (.500-.900) 1.10 (.900-1.40) 1.50 (1.20-2.00) 819 
 03-04 * .100 (.100-.100) .100 (.100-.200) .300 (.200-.300) .300 (.300-.500) 1041 
 05-06 * < LOD .100 (<LOD-.100) .200 (.200-.300) .300 (.200-.400) 1072 
 07-08 * < LOD < LOD < LOD < LOD 1041 
 09-10 * < LOD < LOD < LOD < LOD 1158 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 03-04, 05-06, 07-08, and 09-10 are 0.05, 0.1, 0.1, 0.1, and 0.1 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Serum Perfluorooctane sulfonamide (PFOSA) (1999 -2010) 
 
Geometric mean and selected percentiles of serum concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 .285 (.245-.332) .300 (.200-.400) .500 (.400-.600) .800 (.700-1.00) 1.10 (.800-1.60) 584 
 03-04 * .100 (.100-.100) .100 (.100-.100) .100 (.100-.100) .200 (.100-.300) 485 
 05-06 * < LOD < LOD .200 (<LOD-.300) .200 (<LOD-5.00) 499 
 07-08 * < LOD < LOD < LOD < LOD 391 
 09-10 * < LOD < LOD < LOD < LOD 461 
Non-Hispanic blacks 99-00 .347 (.289-.417) .300 (.300-.400) .600 (.500-.800) 1.00 (.700-1.70) 1.70 (.900-2.60) 303 
 03-04 * .100 (.100-.100) .100 (.100-.200) .300 (.200-.300) .300 (.200-.500) 538 
 05-06 * < LOD < LOD .200 (.100-.200) .200 (.200-.400) 544 
 07-08 * < LOD < LOD < LOD < LOD 419 
 09-10 * < LOD < LOD < LOD < LOD 391 
Non-Hispanic whites 99-00 .382 (.305-.479) .400 (.300-.500) .700 (.600-.900) 1.10 (.900-1.40) 1.50 (1.10-2.00) 519 
 03-04 * .100 (.100-.100) .100 (.100-.200) .300 (.200-.300) .300 (.300-.500) 962 
 05-06 * < LOD .100 (.100-.200) .200 (.200-.300) .300 (.200-.500) 935 
 07-08 * < LOD < LOD < LOD < LOD 931 
 09-10 * < LOD < LOD < LOD < LOD 1031 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 03-04, 05-06, 07-08, and 09-10 are 0.05, 0.1, 0.1, 0.1, and 0.1 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Serum Perfluorooctane sulfonamide (PFOSA) (2011 - 2012)‡ 
 
Geometric mean and selected percentiles of serum concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * < LOD < LOD < LOD < LOD 1904 
Age group        
12-19 years 11-12 * < LOD < LOD < LOD < LOD 344 
20 years and older 11-12 * < LOD < LOD < LOD < LOD 1560 
Gender        
Males 11-12 * < LOD < LOD < LOD < LOD 966 
Females 11-12 * < LOD < LOD < LOD < LOD 938 
Race/ethnicity        
Mexican Americans 11-12 * < LOD < LOD < LOD < LOD 211 
Non-Hispanic blacks 11-12 * < LOD < LOD < LOD < LOD 485 
Non-Hispanic whites 11-12 * < LOD < LOD < LOD < LOD 666 
All Hispanics 11-12 * < LOD < LOD < LOD < LOD 406 
Asians 11-12 * < LOD < LOD < LOD < LOD 291 
Limit of detection (LOD, see Data Analysis section) for Survey year 11-12 is 0.1. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result. 
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Serum 2-(N-Ethyl-perfluorooctane sulfonamido) acetic acid (Et-PFOSA-AcOH) (1999 – 2010) 
 
Geometric mean and selected percentiles of serum concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 .642 (.596-.691) .600 (.500-.700) 1.10 (1.00-1.20) 1.60 (1.50-1.80) 2.30 (1.90-2.70) 1562 
 03-04 * < LOD < LOD < LOD < LOD 2094 
 05-06 * < LOD < LOD < LOD .300 (<LOD-.300) 2120 
 07-08 * < LOD < LOD < LOD < LOD 2100 
 09-10 * < LOD < LOD < LOD .100 (<LOD-.100) 2233 
Age group        
12-19 years 99-00 .826 (.764-.893) .800 (.700-.800) 1.20 (1.10-1.30) 1.70 (1.50-2.00) 2.40 (1.90-3.30) 543 
 03-04 * < LOD < LOD < LOD < LOD 640 
 05-06 * < LOD < LOD < LOD .200 (<LOD-.400) 640 
 07-08 * < LOD < LOD < LOD < LOD 357 
 09-10 * < LOD < LOD < LOD < LOD 364 
20 years and older 99-00 .614 (.569-.663) .600 (.500-.700) 1.00 (.900-1.10) 1.60 (1.50-1.80) 2.30 (1.80-2.70) 1019 
 03-04 * < LOD < LOD < LOD < LOD 1454 
 05-06 * < LOD < LOD < LOD .300 (<LOD-.300) 1480 
 07-08 * < LOD < LOD < LOD < LOD 1743 
 09-10 * < LOD < LOD < LOD .100 (<LOD-.100) 1869 
Gender        
Males 99-00 .619 (.572-.671) .600 (.500-.700) 1.00 (.900-1.10) 1.50 (1.30-1.80) 1.90 (1.60-2.90) 743 
 03-04 * < LOD < LOD < LOD < LOD 1053 
 05-06 * < LOD < LOD < LOD .300 (.200-.300) 1048 
 07-08 * < LOD < LOD < LOD < LOD 1059 
 09-10 * < LOD < LOD < LOD .100 (<LOD-.100) 1075 
Females 99-00 .662 (.599-.732) .700 (.500-.700) 1.10 (1.00-1.20) 1.70 (1.50-2.20) 2.50 (2.00-2.80) 819 
 03-04 * < LOD < LOD < LOD < LOD 1041 
 05-06 * < LOD < LOD < LOD .300 (<LOD-.300) 1072 
 07-08 * < LOD < LOD < LOD < LOD 1041 
 09-10 * < LOD < LOD < LOD .100 (<LOD-.100) 1158 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 03-04, 05-06, 07-08, and 09-10 are 0.2, 0.4, 0.2, 0.2, and 0.1 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Serum 2-(N-Ethyl-perfluorooctane sulfonamido) acetic acid (Et-PFOSA-AcOH) (1999 – 2010) 
 
Geometric mean and selected percentiles of serum concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 .577 (.477-.698) .600 (.400-.700) 1.00 (.800-1.20) 1.70 (1.30-2.00) 2.50 (1.90-3.00) 584 
 03-04 * < LOD < LOD < LOD < LOD 485 
 05-06 * < LOD < LOD < LOD < LOD 499 
 07-08 * < LOD < LOD < LOD < LOD 391 
 09-10 * < LOD < LOD < LOD < LOD 461 
Non-Hispanic blacks 99-00 .555 (.476-.646) .500 (.500-.600) .900 (.700-1.00) 1.50 (1.20-1.90) 2.20 (1.40-3.20) 303 
 03-04 * < LOD < LOD < LOD .400 (<LOD-.500) 538 
 05-06 * < LOD < LOD < LOD < LOD 544 
 07-08 * < LOD < LOD < LOD < LOD 419 
 09-10 * < LOD < LOD < LOD < LOD 391 
Non-Hispanic whites 99-00 .660 (.606-.717) .700 (.600-.700) 1.10 (1.00-1.20) 1.70 (1.50-1.90) 2.40 (1.90-2.80) 519 
 03-04 * < LOD < LOD < LOD < LOD 962 
 05-06 * < LOD < LOD < LOD .300 (.200-.400) 935 
 07-08 * < LOD < LOD < LOD < LOD 931 
 09-10 * < LOD < LOD < LOD .100 (<LOD-.200) 1031 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 03-04, 05-06, 07-08, and 09-10 are 0.2, 0.4, 0.2, 0.2, and 0.1 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Serum 2-(N-Ethyl-perfluorooctane sulfonamido) acetic acid (Et-PFOSA-AcOH) (2011 - 2012)‡ 
 
Geometric mean and selected percentiles of serum concentrations (in µg/L) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * < LOD < LOD < LOD .110 (<LOD-.130) 1904 
Age group        
12-19 years 11-12 * < LOD < LOD < LOD < LOD 344 
20 years and older 11-12 * < LOD < LOD < LOD .110 (<LOD-.150) 1560 
Gender        
Males 11-12 * < LOD < LOD < LOD .110 (<LOD-.140) 966 
Females 11-12 * < LOD < LOD < LOD .100 (<LOD-.130) 938 
Race/ethnicity        
Mexican Americans 11-12 * < LOD < LOD < LOD .100 (<LOD-.160) 211 
Non-Hispanic blacks 11-12 * < LOD < LOD < LOD < LOD 485 
Non-Hispanic whites 11-12 * < LOD < LOD < LOD .120 (<LOD-.140) 666 
All Hispanics 11-12 * < LOD < LOD < LOD < LOD 406 
Asians 11-12 * < LOD < LOD < LOD .110 (<LOD-.200) 291 
Limit of detection (LOD, see Data Analysis section) for Survey year 11-12 is 0.1. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result.  
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Serum 2-(N-Methyl-perfluorooctane sulfonamido) acetic acid (Me-PFOSA-AcOH) (1999 – 2010) 
 
Geometric mean and selected percentiles of serum concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 .846 (.738-.970) .870 (.780-.960) 1.40 (1.13-1.66) 2.18 (1.83-2.62) 2.79 (2.44-3.23) 1562 
 03-04 * < LOD .610 (<LOD-.610) .870 (.780-.960) 1.13 (.960-1.31) 2094 
 05-06 .410 (.372-.451) .440 (.350-.440) .700 (.610-.780) 1.22 (1.13-1.22) 1.57 (1.48-1.74) 2120 
 07-08 .303 (.277-.330) .300 (.300-.300) .500 (.400-.600) 1.00 (.800-1.00) 1.30 (1.20-1.40) 2100 
 09-10 .198 (.184-.213) .200 (.200-.200) .300 (.300-.300) .700 (.600-.700) 1.00 (.900-1.00) 2233 
Age group        
12-19 years 99-00 1.17 (1.03-1.34) 1.22 (1.05-1.31) 1.83 (1.31-2.18) 2.70 (2.18-3.05) 3.23 (2.79-4.10) 543 
 03-04 * < LOD .610 (<LOD-.700) .960 (.780-1.13) 1.31 (1.05-1.57) 640 
 05-06 .432 (.380-.490) .440 (.350-.520) .780 (.610-.870) 1.13 (.960-1.31) 1.48 (1.13-1.66) 640 
 07-08 .340 (.305-.379) .300 (.300-.400) .600 (.500-.600) 1.00 (.800-1.50) 1.60 (1.00-2.00) 357 
 09-10 .235 (.203-.273) .300 (.200-.300) .400 (.300-.500) .700 (.500-.900) .900 (.600-1.70) 364 
20 years and older 99-00 .800 (.693-.923) .780 (.700-.960) 1.31 (1.13-1.57) 2.09 (1.74-2.44) 2.70 (2.27-3.14) 1019 
 03-04 * < LOD .610 (<LOD-.610) .870 (.780-.960) 1.05 (.960-1.40) 1454 
 05-06 .406 (.369-.448) .440 (.350-.440) .700 (.610-.780) 1.22 (1.13-1.31) 1.66 (1.48-1.74) 1480 
 07-08 .297 (.270-.327) .300 (.300-.300) .500 (.400-.600) 1.00 (.800-1.00) 1.20 (1.10-1.40) 1743 
 09-10 .193 (.178-.210) .200 (.200-.200) .300 (.300-.300) .700 (.600-.800) 1.00 (.900-1.00) 1869 
Gender        
Males 99-00 .885 (.756-1.04) .870 (.780-1.05) 1.40 (1.13-1.74) 2.27 (2.01-2.79) 2.79 (2.44-3.66) 743 
 03-04 * < LOD .610 (<LOD-.610) .960 (.780-1.05) 1.13 (.960-1.48) 1053 
 05-06 .435 (.400-.472) .440 (.350-.440) .780 (.700-.870) 1.22 (1.13-1.31) 1.66 (1.40-1.74) 1048 
 07-08 .307 (.281-.334) .300 (.300-.300) .500 (.400-.600) .900 (.800-1.00) 1.30 (1.10-1.40) 1059 
 09-10 .200 (.187-.214) .200 (.200-.200) .300 (.300-.400) .700 (.600-.800) 1.00 (.800-1.10) 1075 
Females 99-00 .813 (.717-.923) .780 (.700-.960) 1.31 (1.13-1.66) 2.01 (1.74-2.35) 2.62 (2.27-3.23) 819 
 03-04 * < LOD < LOD .870 (.780-.960) .960 (.870-1.57) 1041 
 05-06 .387 (.342-.438) .350 (.350-.440) .700 (.610-.780) 1.13 (1.05-1.31) 1.57 (1.40-1.83) 1072 
 07-08 .299 (.267-.334) .300 (.300-.300) .500 (.400-.600) 1.00 (.800-1.10) 1.30 (1.10-1.70) 1041 
 09-10 .196 (.178-.216) .200 (.200-.200) .300 (.300-.300) .600 (.500-.800) 1.00 (.800-1.00) 1158 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 03-04, 05-06, 07-08, and 09-10 are 0.174, 0.523, 0.174, 0.174, and 0.087 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Serum 2-(N-Methyl-perfluorooctane sulfonamido) acetic acid (Me-PFOSA-AcOH) (1999 – 2010) 
 
Geometric mean and selected percentiles of serum concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 .668 (.545-.817) .700 (.520-.780) 1.13 (.870-1.31) 1.83 (1.40-2.35) 2.35 (1.74-3.92) 584 
 03-04 * < LOD < LOD .610 (<LOD-.780) .780 (<LOD-1.13) 485 
 05-06 .292 (.245-.348) .260 (.260-.350) .440 (.350-.700) .780 (.610-1.05) 1.05 (.870-1.22) 499 
 07-08 * .200 (<LOD-.200) .300 (.300-.300) .500 (.400-.800) .800 (.500-1.10) 391 
 09-10 .139 (.118-.163) .100 (.100-.200) .300 (.200-.300) .500 (.400-.600) .700 (.500-1.00) 461 
Non-Hispanic blacks 99-00 .989 (.853-1.15) 1.05 (.780-1.22) 1.57 (1.31-1.83) 2.35 (1.92-2.79) 3.14 (2.27-4.27) 303 
 03-04 * < LOD .700 (<LOD-.780) .960 (.780-1.22) 1.31 (.960-1.57) 538 
 05-06 .418 (.361-.486) .440 (.350-.520) .700 (.610-.870) 1.22 (1.05-1.48) 1.66 (1.48-2.01) 544 
 07-08 .330 (.304-.357) .300 (.300-.300) .500 (.500-.700) 1.00 (.800-1.20) 1.40 (1.20-1.70) 419 
 09-10 .193 (.166-.225) .200 (.200-.200) .300 (.300-.400) .600 (.400-.800) .900 (.600-1.10) 391 
Non-Hispanic whites 99-00 .883 (.758-1.03) .870 (.780-1.05) 1.40 (1.22-1.74) 2.18 (1.92-2.70) 2.79 (2.44-3.66) 519 
 03-04 * < LOD .610 (<LOD-.700) .870 (.780-.960) 1.13 (.960-1.40) 962 
 05-06 .428 (.380-.483) .440 (.350-.520) .780 (.700-.870) 1.22 (1.13-1.31) 1.66 (1.40-1.83) 935 
 07-08 .332 (.296-.372) .300 (.300-.300) .600 (.500-.700) 1.00 (.800-1.10) 1.30 (1.10-1.60) 931 
 09-10 .216 (.201-.232) .200 (.200-.300) .300 (.300-.400) .700 (.600-.800) 1.00 (.900-1.10) 1031 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 03-04, 05-06, 07-08, and 09-10 are 0.174, 0.523, 0.174, 0.174, and 0.087 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Serum 2-(N-Methyl-perfluorooctane sulfonamido) acetic acid (Me-PFOSA-AcOH) (2011 - 2014) 
 
Geometric mean and selected percentiles of serum concentrations (in µg/L) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * .100 (<LOD-.160) .250 (.200-.310) .500 (.440-.530) .690 (.580-.850) 1904 
 13-14 * < LOD .200 (.200-.200) .400 (.300-.500) .600 (.500-.900) 2168 
Age group        
12-19 years 11-12 .134 (.110-.163) .110 (.090-.170) .260 (.170-.350) .420 (.350-.480) .510 (.420-.850) 344 
 13-14 * .100 (<LOD-.100) .200 (.200-.300) .500 (.400-.500) .600 (.500-.900) 402 
20 years and older 11-12 * .100 (<LOD-.160) .250 (.200-.310) .510 (.460-.550) .700 (.640-.840) 1560 
 13-14 * < LOD .200 (.200-.200) .400 (.300-.500) .600 (.500-1.00) 1766 
Gender        
Males 11-12 * .110 (<LOD-.160) .270 (.190-.350) .490 (.390-.660) .720 (.510-1.06) 966 
 13-14 * < LOD .200 (.200-.200) .400 (.300-.500) .600 (.400-.900) 1032 
Females 11-12 * .100 (<LOD-.160) .250 (.200-.300) .510 (.410-.540) .690 (.560-.810) 938 
 13-14 * < LOD .200 (.200-.200) .400 (.300-.600) .700 (.500-1.10) 1136 
Race/ethnicity        
Mexican Americans 11-12 * < LOD .220 (.160-.310) .440 (.310-.590) .590 (.390-.970) 211 
 13-14 * < LOD .100 (<LOD-.100) .200 (.100-.500) .500 (.300-.500) 332 
Non-Hispanic blacks 11-12 * .100 (<LOD-.150) .240 (.170-.340) .520 (.390-.660) .780 (.580-1.06) 485 
 13-14 * < LOD .200 (.100-.300) .400 (.200-1.00) .800 (.400-1.60) 455 
Non-Hispanic whites 11-12 * .120 (<LOD-.170) .280 (.230-.340) .510 (.460-.580) .700 (.600-.990) 666 
 13-14 * .100 (<LOD-.100) .200 (.200-.300) .500 (.400-.500) .700 (.500-1.00) 862 
All Hispanics 11-12 * < LOD .170 (.130-.230) .350 (.260-.450) .510 (.380-.740) 406 
 13-14 * < LOD .100 (<LOD-.100) .200 (.200-.300) .300 (.200-.500) 537 
Asians 11-12 * < LOD .170 (.130-.260) .370 (.300-.520) .580 (.420-.860) 291 
 13-14 * < LOD .100 (<LOD-.200) .200 (.100-.400) .400 (.200-.600) 236 
Limit of detection (LOD, see Data Analysis section) for Survey year 11-12 and 13-14 are 0.087 and 0.1, respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Serum Perfluoroundecanoic acid (PFUA) (1999 – 2010) 
 
Geometric mean and selected percentiles of serum concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 * < LOD < LOD .300 (<LOD-.400) .400 (.300-.700) 1562 
 03-04 * < LOD < LOD < LOD .600 (<LOD-1.30) 2094 
 05-06 * < LOD .300 (.200-.400) .500 (.400-.800) .700 (.600-1.20) 2120 
 07-08 * < LOD .200 (<LOD-.300) .400 (.300-.500) .600 (.500-.800) 2100 
 09-10 .172 (.151-.196) .200 (.100-.200) .300 (.200-.400) .600 (.400-.800) .900 (.600-1.10) 2233 
Age group        
12-19 years 99-00 * < LOD < LOD < LOD .200 (<LOD-.300) 543 
 03-04 * < LOD < LOD < LOD .300 (<LOD-1.10) 640 
 05-06 * < LOD < LOD .300 (.200-.500) .500 (.300-.900) 640 
 07-08 * < LOD < LOD .200 (<LOD-.200) .300 (.200-.300) 357 
 09-10 * .100 (<LOD-.100) .200 (.100-.200) .300 (.200-.600) .400 (.200-.900) 364 
20 years and older 99-00 * < LOD < LOD .300 (<LOD-.500) .500 (.300-.700) 1019 
 03-04 * < LOD < LOD .300 (<LOD-.600) .600 (<LOD-1.40) 1454 
 05-06 * < LOD .300 (.200-.400) .500 (.400-.800) .800 (.600-1.10) 1480 
 07-08 * < LOD .200 (.200-.300) .400 (.300-.600) .600 (.500-.900) 1743 
 09-10 .182 (.160-.207) .200 (.200-.200) .300 (.300-.400) .600 (.400-.800) .900 (.700-1.20) 1869 
Gender        
Males 99-00 * < LOD < LOD .300 (<LOD-.500) .500 (.300-.600) 743 
 03-04 * < LOD < LOD .400 (<LOD-1.00) .700 (<LOD-2.30) 1053 
 05-06 * < LOD .300 (.200-.400) .600 (.400-.700) .800 (.600-1.10) 1048 
 07-08 * < LOD .200 (<LOD-.300) .400 (.300-.500) .700 (.500-1.00) 1059 
 09-10 .170 (.147-.196) .200 (.100-.200) .300 (.200-.400) .500 (.400-.900) .800 (.500-1.20) 1075 
Females 99-00 * < LOD < LOD .300 (<LOD-.400) .400 (.200-.800) 819 
 03-04 * < LOD < LOD < LOD .400 (<LOD-.700) 1041 
 05-06 * < LOD .300 (<LOD-.400) .500 (.400-.700) .700 (.500-1.10) 1072 
 07-08 * < LOD .200 (<LOD-.200) .400 (.300-.500) .600 (.400-.700) 1041 
 09-10 .175 (.153-.199) .200 (.100-.200) .300 (.200-.400) .600 (.400-.800) .900 (.700-1.20) 1158 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 03-04, 05-06, 07-08, and 09-10 are 0.2, 0.3, 0.2, 0.2, and 0.1 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Serum Perfluoroundecanoic acid (PFUA) (1999 – 2010) 
 
Geometric mean and selected percentiles of serum concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 * < LOD < LOD < LOD < LOD 584 
 03-04 * < LOD < LOD < LOD < LOD 485 
 05-06 * < LOD < LOD .300 (<LOD-.700) .500 (.300-1.00) 499 
 07-08 * < LOD < LOD .300 (<LOD-.400) .300 (<LOD-1.40) 391 
 09-10 * .100 (.100-.100) .200 (.200-.200) .300 (.300-.400) .400 (.300-.600) 461 
Non-Hispanic blacks 99-00 * < LOD .300 (<LOD-.500) .600 (.300-1.00) .900 (.600-1.80) 303 
 03-04 * < LOD < LOD .600 (<LOD-1.40) .900 (.300-2.90) 538 
 05-06 * < LOD .300 (<LOD-.500) .600 (.400-1.50) 1.20 (.600-2.70) 544 
 07-08 * < LOD .300 (.200-.400) .500 (.400-.700) .800 (.600-1.20) 419 
 09-10 .237 (.199-.283) .200 (.200-.200) .400 (.300-.500) .800 (.500-1.10) 1.30 (.800-1.80) 391 
Non-Hispanic whites 99-00 * < LOD < LOD .200 (<LOD-.300) .300 (<LOD-.800) 519 
 03-04 * < LOD < LOD < LOD .500 (<LOD-.900) 962 
 05-06 * < LOD .300 (.200-.400) .500 (.400-.700) .600 (.400-1.50) 935 
 07-08 * < LOD .200 (<LOD-.200) .300 (.300-.500) .500 (.400-.600) 931 
 09-10 .162 (.136-.193) .200 (.100-.200) .300 (.200-.400) .500 (.300-.800) .800 (.500-1.00) 1031 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 03-04, 05-06, 07-08, and 09-10 are 0.2, 0.3, 0.2, 0.2, and 0.1 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Serum Perfluoroundecanoic acid (PFUA) (2011 - 2014) 
 
Geometric mean and selected percentiles of serum concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * .120 (.100-.140) .220 (.180-.250) .380 (.310-.520) .620 (.440-.790) 1904 
 13-14 * < LOD .200 (.100-.200) .300 (.200-.400) .500 (.400-.600) 2168 
Age group        
12-19 years 11-12 * < LOD .110 (<LOD-.140) .180 (.140-.220) .250 (.190-.390) 344 
 13-14 * < LOD < LOD .200 (.100-.200) .200 (.200-.300) 402 
20 years and older 11-12 .146 (.129-.165) .130 (.110-.150) .230 (.190-.280) .420 (.330-.530) .660 (.490-.840) 1560 
 13-14 * < LOD .200 (.100-.200) .300 (.300-.500) .500 (.400-.700) 1766 
Gender        
Males 11-12 * .120 (.100-.150) .220 (.180-.260) .340 (.290-.480) .590 (.390-.820) 966 
 13-14 * < LOD .200 (.100-.200) .300 (.200-.500) .500 (.400-.700) 1032 
Females 11-12 * .120 (.100-.140) .210 (.180-.270) .420 (.320-.540) .650 (.520-.740) 938 
 13-14 * < LOD .200 (.100-.200) .300 (.200-.400) .500 (.400-.600) 1136 
Race/ethnicity        
Mexican Americans 11-12 * < LOD .150 (.130-.180) .230 (.190-.300) .310 (.230-.330) 211 
 13-14 * < LOD < LOD .200 (.100-.300) .200 (.100-.600) 332 
Non-Hispanic blacks 11-12 .164 (.135-.199) .140 (.110-.190) .260 (.200-.390) .530 (.350-.840) .840 (.520-1.26) 485 
 13-14 * .100 (<LOD-.200) .200 (.100-.400) .500 (.300-.700) .700 (.500-.900) 455 
Non-Hispanic whites 11-12 * .110 (<LOD-.140) .200 (.160-.240) .330 (.280-.410) .450 (.330-.690) 666 
 13-14 * < LOD .200 (.100-.200) .300 (.200-.400) .400 (.300-.600) 862 
All Hispanics 11-12 * .110 (<LOD-.130) .180 (.160-.210) .310 (.230-.390) .420 (.300-.630) 406 
 13-14 * < LOD .100 (<LOD-.100) .200 (.100-.200) .200 (.100-.600) 537 
Asians 11-12 .338 (.277-.412) .330 (.220-.510) .840 (.630-1.01) 1.38 (1.02-2.33) 2.40 (1.33-3.41) 291 
 13-14 .274 (.231-.326) .300 (.200-.400) .600 (.400-.800) 1.00 (.900-1.20) 1.50 (1.00-2.40) 236 
Limit of detection (LOD, see Data Analysis section) for Survey year 11-12 and 13-14 are 0.1 and 0.1. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Mono-benzyl phthalate (MBzP) (1999 – 2010) 
Metabolite of Benzylbutyl phthalate (BzBP) 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 11.0 (9.88-12.3) 12.2 (11.0-13.6) 25.5 (23.5-28.6) 48.3 (39.8-59.3) 74.4 (68.1-83.4) 2541 
 01-02 10.8 (10.0-11.7) 11.4 (10.7-12.5) 27.4 (24.8-29.7) 58.2 (51.3-63.5) 87.6 (73.7-102) 2782 
 03-04 9.89 (9.12-10.7) 10.3 (9.22-11.8) 23.3 (21.7-25.2) 47.9 (41.3-54.4) 72.6 (61.4-90.2) 2605 
 05-06 8.32 (7.28-9.51) 8.93 (7.78-10.4) 20.7 (18.2-23.7) 44.6 (37.6-52.8) 67.1 (57.4-77.7) 2548 
 07-08 7.24 (6.47-8.09) 8.42 (7.20-9.50) 18.3 (16.6-20.4) 37.3 (31.3-43.3) 58.8 (48.7-69.1) 2604 
 09-10 6.46 (5.76-7.24) 6.70 (5.97-7.49) 15.4 (13.4-17.1) 31.0 (26.8-36.1) 48.3 (43.1-55.4) 2749 
Age group        
6-11 years 99-00 28.4 (23.7-34.0) 29.0 (24.3-35.0) 59.0 (40.2-70.6) 92.8 (70.6-154) 154 (77.8-287) 328 
 01-02 24.1 (21.0-27.6) 26.6 (19.2-31.2) 49.3 (44.4-66.8) 120 (83.7-137) 169 (132-237) 393 
 03-04 24.4 (20.3-29.2) 25.2 (21.7-28.7) 45.9 (36.3-66.5) 105 (79.1-154) 184 (105-263) 342 
 05-06 21.3 (19.2-23.7) 23.5 (19.4-26.6) 46.1 (37.1-56.9) 78.6 (64.3-104) 116 (88.4-137) 356 
 07-08 15.4 (12.3-19.3) 17.6 (13.8-20.8) 33.8 (27.0-47.5) 69.9 (51.3-104) 131 (69.9-221) 389 
 09-10 11.6 (9.51-14.1) 12.6 (10.4-14.5) 28.4 (20.2-37.8) 63.9 (47.4-76.8) 87.8 (65.4-212) 415 
12-19 years 99-00 18.4 (15.7-21.6) 20.4 (16.1-25.1) 36.9 (31.5-42.1) 63.7 (48.4-82.6) 90.2 (67.5-122) 752 
 01-02 16.7 (14.3-19.6) 17.9 (15.3-22.3) 40.0 (34.1-45.3) 81.1 (66.1-95.5) 122 (96.3-143) 742 
 03-04 15.9 (14.0-18.1) 17.9 (16.1-19.6) 35.9 (28.7-46.5) 64.7 (51.2-86.3) 110 (71.9-136) 729 
 05-06 14.2 (11.9-16.9) 14.8 (11.5-18.3) 31.8 (24.2-41.0) 62.6 (44.0-85.0) 94.2 (67.7-134) 702 
 07-08 11.6 (9.56-14.2) 14.6 (11.5-16.6) 27.2 (22.0-31.5) 46.7 (35.4-58.3) 63.9 (54.7-102) 401 
 09-10 10.6 (8.75-12.9) 11.9 (10.1-15.4) 24.8 (21.9-29.2) 43.1 (36.0-45.8) 56.1 (44.7-74.3) 420 
20 years and older 99-00 8.96 (7.83-10.3) 9.94 (8.71-11.2) 21.0 (18.1-23.8) 37.4 (31.6-45.0) 62.1 (39.4-85.5) 1461 
 01-02 9.16 (8.40-9.98) 10.0 (9.22-10.7) 22.9 (20.5-24.1) 47.1 (38.7-54.9) 71.8 (59.6-87.1) 1647 
 03-04 8.22 (7.42-9.11) 8.71 (7.78-9.72) 19.4 (17.0-21.2) 39.0 (33.9-44.3) 57.2 (47.9-68.3) 1534 
 05-06 6.87 (6.00-7.86) 7.34 (6.41-8.71) 17.1 (14.5-19.7) 34.0 (28.3-43.4) 56.9 (45.9-66.7) 1490 
 07-08 6.18 (5.40-7.08) 7.13 (6.12-8.06) 15.5 (13.4-17.6) 30.5 (25.2-37.7) 49.5 (40.3-63.9) 1814 
 09-10 5.61 (4.97-6.34) 5.95 (5.17-6.61) 12.7 (10.9-14.8) 25.6 (21.5-29.4) 39.6 (34.2-47.7) 1914 
Gender        
Males 99-00 11.6 (10.1-13.4) 12.7 (10.9-14.4) 25.5 (22.7-29.0) 50.0 (43.1-62.8) 77.8 (69.3-93.4) 1215 
 01-02 11.2 (9.78-12.9) 11.5 (10.5-13.3) 26.6 (23.8-31.0) 56.4 (45.7-70.1) 87.5 (63.5-132) 1371 
 03-04 10.5 (9.50-11.6) 10.9 (9.50-12.6) 23.3 (21.2-25.6) 47.2 (38.6-57.3) 72.6 (56.6-94.8) 1250 
 05-06 9.47 (8.20-10.9) 10.2 (8.78-12.2) 23.3 (19.3-25.9) 51.6 (39.8-61.6) 71.0 (61.6-83.2) 1270 
 07-08 7.80 (6.96-8.74) 8.64 (7.49-10.0) 17.6 (15.8-20.4) 33.8 (28.4-41.3) 49.3 (41.5-62.1) 1294 
 09-10 6.93 (6.07-7.92) 6.98 (6.21-7.80) 15.6 (13.3-17.6) 33.0 (27.4-37.8) 49.0 (40.4-62.8) 1399 
Females 99-00 10.5 (9.17-12.0) 11.6 (10.2-13.8) 25.8 (22.2-29.8) 45.9 (38.7-59.3) 73.9 (60.6-83.4) 1326 
 01-02 10.5 (9.40-11.7) 11.1 (9.94-12.9) 27.4 (23.3-31.5) 58.6 (49.2-66.0) 88.0 (73.2-103) 1411 
 03-04 9.33 (8.53-10.2) 9.58 (8.71-11.2) 24.0 (21.2-26.1) 48.3 (42.3-52.1) 72.5 (60.8-86.3) 1355 
 05-06 7.34 (6.30-8.55) 7.70 (6.55-9.36) 18.4 (15.6-22.2) 39.5 (33.0-46.3) 62.1 (48.0-73.7) 1278 
 07-08 6.73 (5.77-7.85) 7.99 (6.41-9.36) 18.8 (15.4-22.5) 40.1 (32.2-50.9) 64.4 (51.1-78.8) 1310 
 09-10 6.04 (5.38-6.77) 6.36 (5.18-7.47) 15.3 (12.9-16.9) 29.3 (24.5-36.9) 47.7 (38.0-60.4) 1350 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 05-06, 07-08, and 09-10 are 0.576, 0.216, 0.072, 0.216, 0.216, and 0.216 respectively. 
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Urinary Mono-benzyl phthalate (MBzP) (1999 – 2010) 
Metabolite of Benzylbutyl phthalate (BzBP) 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 10.0 (8.69-11.6) 11.3 (9.65-12.2) 23.8 (19.8-26.0) 48.6 (40.0-60.5) 71.1 (58.0-108) 814 
 01-02 9.49 (7.75-11.6) 10.7 (7.78-13.3) 21.2 (18.9-27.4) 50.7 (38.2-61.5) 68.2 (50.6-116) 677 
 03-04 10.7 (9.52-12.0) 11.2 (9.72-13.2) 23.3 (19.9-25.5) 51.4 (35.0-66.5) 71.9 (62.3-104) 652 
 05-06 8.95 (7.12-11.3) 10.2 (8.57-11.9) 20.1 (14.3-31.0) 43.1 (33.9-49.8) 59.8 (43.6-77.3) 637 
 07-08 7.87 (6.39-9.68) 9.43 (6.91-11.5) 18.7 (14.1-25.3) 38.0 (30.2-47.5) 60.4 (40.5-73.9) 531 
 09-10 7.58 (6.42-8.96) 7.39 (6.33-9.00) 17.1 (14.3-20.3) 33.8 (26.5-43.5) 54.5 (34.4-79.7) 566 
Non-Hispanic blacks 99-00 16.6 (14.9-18.4) 16.6 (14.8-18.4) 35.5 (31.7-40.0) 68.2 (57.6-93.4) 99.1 (76.6-174) 603 
 01-02 17.1 (15.1-19.4) 17.4 (14.3-20.2) 36.4 (29.9-45.3) 72.6 (62.2-91.3) 103 (91.2-129) 703 
 03-04 13.6 (11.8-15.7) 14.4 (11.1-17.7) 31.5 (28.0-35.3) 58.2 (50.4-76.0) 86.2 (71.8-124) 699 
 05-06 11.9 (9.03-15.7) 12.7 (10.1-17.1) 26.1 (21.0-35.0) 60.6 (47.2-74.6) 83.2 (74.6-102) 678 
 07-08 9.37 (8.28-10.6) 9.72 (8.35-11.7) 21.4 (18.4-24.8) 46.9 (34.3-61.6) 71.3 (63.7-89.6) 597 
 09-10 8.98 (7.67-10.5) 9.14 (7.76-10.5) 21.0 (16.4-24.7) 38.9 (30.3-52.6) 67.4 (51.3-80.7) 516 
Non-Hispanic whites 99-00 10.3 (9.12-11.6) 11.6 (10.3-13.4) 24.5 (22.0-27.6) 42.3 (36.9-53.4) 73.9 (53.4-83.4) 912 
 01-02 10.1 (9.12-11.1) 10.5 (9.65-11.2) 25.6 (23.2-28.4) 55.2 (47.6-65.0) 87.5 (67.1-112) 1216 
 03-04 9.25 (8.30-10.3) 9.50 (8.42-11.5) 22.0 (20.0-25.3) 45.9 (38.6-52.1) 65.9 (54.9-87.9) 1088 
 05-06 7.67 (6.61-8.90) 8.06 (6.98-10.1) 19.8 (17.1-23.5) 43.4 (32.4-52.5) 65.8 (52.5-76.8) 1038 
 07-08 7.10 (6.33-7.97) 8.14 (7.06-9.29) 17.9 (16.5-20.3) 37.7 (31.0-44.2) 57.0 (46.0-68.6) 1077 
 09-10 6.07 (5.24-7.03) 6.31 (5.54-7.23) 14.7 (12.4-16.7) 29.5 (23.4-36.9) 44.6 (34.9-64.1) 1206 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 05-06, 07-08, and 09-10 are 0.576, 0.216, 0.072, 0.216, 0.216, and 0.216 respectively. 
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Urinary Mono-benzyl phthalate (MBzP) (2011 - 2012) 
Metabolite of Benzylbutyl phthalate (BzBP) 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 4.52 (4.17-4.90) 4.40 (4.10-5.00) 10.7 (9.80-12.2) 21.7 (20.2-24.4) 35.9 (29.2-41.7) 2489 
Age group        
6-11 years 11-12 8.62 (7.22-10.3) 8.50 (6.60-10.4) 21.6 (15.8-26.2) 50.7 (31.4-71.7) 75.2 (51.3-124) 396 
12-19 years 11-12 6.62 (5.28-8.30) 7.30 (4.80-10.2) 17.0 (13.3-20.2) 31.5 (24.1-39.2) 42.6 (33.4-65.3) 388 
20 years and older 11-12 3.98 (3.60-4.39) 4.00 (3.70-4.40) 9.70 (8.10-10.5) 19.2 (17.0-21.0) 28.0 (22.4-37.0) 1705 
Gender        
Males 11-12 4.80 (4.25-5.41) 4.80 (4.20-5.40) 11.1 (9.80-12.7) 22.4 (19.9-25.7) 37.0 (28.0-58.3) 1259 
Females 11-12 4.27 (3.81-4.77) 4.20 (3.80-4.90) 10.5 (9.50-12.3) 21.6 (19.7-24.4) 33.9 (27.4-42.0) 1230 
Race/ethnicity        
Mexican Americans 11-12 5.11 (4.03-6.48) 5.10 (3.90-6.60) 11.3 (7.60-16.9) 20.4 (14.7-28.8) 29.1 (19.9-69.3) 316 
Non-Hispanic blacks 11-12 7.43 (6.14-8.98) 7.50 (6.40-9.00) 16.4 (13.4-20.1) 33.9 (24.3-48.6) 54.9 (42.7-76.1) 665 
Non-Hispanic whites 11-12 4.14 (3.84-4.46) 4.10 (3.80-4.40) 10.1 (8.50-11.4) 20.2 (17.9-22.9) 30.4 (24.8-38.2) 813 
All Hispanics 11-12 4.80 (4.03-5.72) 4.90 (4.00-5.70) 11.3 (8.40-14.8) 22.4 (17.6-29.8) 33.6 (22.4-45.5) 571 
Asians 11-12 2.99 (2.44-3.67) 2.90 (2.40-3.50) 7.20 (5.20-9.50) 15.1 (11.2-21.5) 27.7 (17.5-45.9) 352 
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Urinary Mono-benzyl phthalate (MBzP) (creatinine corrected) (1999 – 2010) 
Metabolite of Benzylbutyl phthalate (BzBP) 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 10.0 (9.33-10.8) 9.60 (9.22-10.3) 18.1 (16.8-19.6) 36.1 (29.9-42.3) 55.7 (50.1-62.1) 2541 
 01-02 10.2 (9.50-10.9) 9.71 (9.12-10.4) 19.1 (17.8-20.9) 39.5 (35.3-42.1) 65.1 (53.6-73.2) 2782 
 03-04 9.29 (8.76-9.86) 9.04 (8.07-9.82) 17.7 (16.0-19.0) 33.1 (29.5-37.1) 50.4 (44.9-57.5) 2605 
 05-06 8.11 (7.28-9.04) 8.24 (7.37-8.98) 15.3 (13.9-17.4) 30.2 (26.4-35.1) 47.4 (42.7-53.3) 2548 
 07-08 7.29 (6.71-7.93) 7.20 (6.57-8.17) 14.3 (13.1-15.4) 28.3 (24.4-31.8) 42.6 (36.3-49.1) 2604 
 09-10 6.74 (6.06-7.50) 6.40 (5.63-7.30) 12.4 (11.3-13.8) 24.0 (20.4-26.6) 34.1 (30.5-41.4) 2749 
Age group        
6-11 years 99-00 28.8 (24.2-34.3) 27.8 (21.7-36.9) 52.9 (40.8-71.4) 75.1 (64.4-102) 102 (71.8-124) 328 
 01-02 27.4 (24.8-30.3) 26.9 (24.3-30.4) 48.9 (40.2-57.9) 96.7 (83.3-127) 140 (86.9-219) 393 
 03-04 25.8 (21.9-30.3) 23.2 (20.1-29.1) 43.7 (36.1-57.2) 97.8 (61.6-154) 165 (71.8-286) 342 
 05-06 23.5 (21.1-26.2) 25.5 (20.5-29.5) 47.1 (35.8-57.8) 77.6 (62.8-94.3) 104 (85.8-130) 356 
 07-08 19.0 (16.0-22.5) 20.7 (15.6-27.0) 35.4 (32.3-40.0) 67.2 (51.9-91.5) 118 (74.3-159) 389 
 09-10 15.1 (12.7-18.0) 14.6 (12.0-17.2) 29.3 (25.9-37.6) 66.5 (45.3-84.1) 92.2 (67.1-163) 415 
12-19 years 99-00 12.4 (11.1-14.0) 12.3 (10.5-14.6) 20.4 (17.5-25.1) 35.8 (27.9-49.9) 50.4 (35.7-59.0) 752 
 01-02 12.9 (11.3-14.8) 13.0 (11.3-15.0) 24.4 (21.1-27.8) 48.7 (40.2-61.9) 72.0 (58.1-88.6) 742 
 03-04 11.9 (11.1-12.8) 12.2 (11.1-13.1) 21.6 (18.0-25.6) 37.5 (29.3-44.5) 56.0 (39.5-82.6) 729 
 05-06 10.6 (9.14-12.2) 10.5 (8.33-13.0) 18.5 (15.9-23.7) 35.8 (28.1-46.0) 48.8 (41.3-65.3) 702 
 07-08 9.06 (7.76-10.6) 9.39 (8.12-11.1) 16.7 (13.8-21.0) 32.1 (22.0-45.9) 48.4 (32.3-55.6) 401 
 09-10 8.54 (7.36-9.90) 8.73 (7.44-10.8) 14.9 (13.2-17.5) 24.9 (21.6-28.9) 32.5 (25.7-42.7) 420 
20 years and older 99-00 8.47 (7.73-9.27) 8.68 (8.01-9.26) 14.5 (13.2-16.8) 24.9 (22.0-29.4) 41.1 (29.7-53.2) 1461 
 01-02 8.66 (8.08-9.28) 8.47 (8.00-9.00) 15.6 (14.3-17.1) 30.5 (25.8-34.7) 46.8 (39.0-56.4) 1647 
 03-04 7.90 (7.39-8.45) 7.58 (6.98-8.37) 14.2 (13.1-15.4) 26.3 (25.0-28.2) 40.2 (33.7-44.9) 1534 
 05-06 6.89 (6.20-7.66) 7.10 (6.60-7.71) 13.1 (12.1-14.2) 22.4 (19.9-25.5) 34.6 (28.9-43.1) 1490 
 07-08 6.35 (5.74-7.03) 6.41 (5.65-7.15) 12.3 (11.1-13.6) 21.8 (19.1-25.7) 32.6 (28.7-40.5) 1814 
 09-10 5.94 (5.31-6.66) 5.67 (5.03-6.53) 10.8 (9.18-12.5) 19.2 (16.6-23.5) 29.1 (24.2-33.4) 1914 
Gender        
Males 99-00 9.14 (8.51-9.82) 8.96 (8.32-9.39) 17.1 (15.5-18.8) 32.0 (25.5-41.0) 52.9 (34.9-71.8) 1215 
 01-02 9.13 (8.18-10.2) 8.55 (7.85-9.53) 17.4 (15.1-19.0) 35.3 (31.5-40.4) 57.8 (43.8-74.7) 1371 
 03-04 8.25 (7.60-8.95) 7.99 (7.01-9.03) 15.2 (14.0-17.0) 28.4 (24.6-35.8) 45.3 (37.4-59.8) 1250 
 05-06 7.61 (6.65-8.70) 7.57 (6.65-8.91) 14.3 (13.0-16.6) 30.0 (25.5-34.5) 43.7 (36.2-48.2) 1270 
 07-08 6.57 (5.91-7.31) 6.66 (5.68-7.46) 12.8 (11.3-14.8) 24.4 (21.2-29.5) 36.3 (30.6-45.5) 1294 
 09-10 6.21 (5.56-6.94) 5.88 (5.13-6.74) 11.6 (10.1-12.9) 21.3 (18.8-24.1) 32.2 (27.6-35.6) 1399 
Females 99-00 11.0 (9.96-12.1) 10.6 (9.60-11.5) 18.6 (17.3-21.1) 40.6 (33.7-43.6) 57.9 (43.3-84.2) 1326 
 01-02 11.3 (10.2-12.4) 10.8 (9.97-11.9) 21.2 (18.6-24.5) 42.1 (35.9-50.0) 69.0 (50.0-83.4) 1411 
 03-04 10.4 (9.65-11.2) 9.97 (9.20-10.9) 20.1 (17.8-22.6) 37.4 (31.2-43.4) 52.9 (45.8-65.0) 1355 
 05-06 8.63 (7.84-9.51) 8.67 (8.12-9.26) 15.9 (14.8-18.3) 32.0 (26.3-41.4) 52.3 (45.2-62.8) 1278 
 07-08 8.07 (7.29-8.93) 8.37 (7.20-9.16) 15.5 (13.9-18.0) 31.5 (27.5-34.2) 48.3 (40.2-54.9) 1310 
 09-10 7.29 (6.47-8.21) 6.90 (5.90-8.04) 13.6 (11.9-15.3) 25.6 (21.9-30.4) 38.8 (30.7-47.3) 1350 
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Urinary Mono-benzyl phthalate (MBzP) (creatinine corrected) (1999 – 2010) 
Metabolite of Benzylbutyl phthalate (BzBP) 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 9.10 (8.20-10.1) 8.60 (7.87-9.53) 17.4 (15.5-19.1) 33.5 (30.2-38.7) 49.1 (40.6-67.5) 814 
 01-02 8.95 (7.69-10.4) 8.55 (7.16-10.7) 17.1 (14.1-20.9) 33.6 (26.3-44.4) 51.5 (36.8-86.5) 677 
 03-04 9.66 (8.41-11.1) 9.00 (8.25-9.66) 17.3 (15.1-20.0) 38.2 (27.6-46.7) 56.0 (41.1-89.8) 652 
 05-06 8.05 (6.69-9.69) 8.38 (7.48-8.91) 16.0 (12.6-20.2) 31.0 (22.4-40.6) 45.7 (31.3-54.2) 637 
 07-08 7.68 (6.13-9.62) 8.06 (6.42-10.3) 15.5 (12.5-19.2) 29.1 (21.9-36.9) 42.9 (33.5-51.8) 531 
 09-10 7.53 (6.52-8.69) 7.29 (6.30-8.18) 13.3 (11.6-16.3) 32.3 (23.3-43.6) 52.2 (33.0-66.1) 566 
Non-Hispanic blacks 99-00 10.7 (9.75-11.7) 9.83 (8.76-10.9) 19.4 (16.2-22.9) 40.5 (28.4-54.7) 62.5 (46.4-71.9) 603 
 01-02 12.0 (10.5-13.7) 11.3 (9.84-13.9) 24.1 (19.1-27.4) 43.3 (38.7-50.0) 77.7 (54.4-83.4) 703 
 03-04 9.65 (8.46-11.0) 9.81 (8.32-11.2) 17.4 (15.8-20.7) 36.0 (29.6-41.6) 53.8 (42.5-65.2) 699 
 05-06 8.38 (6.44-10.9) 8.24 (6.72-10.6) 16.1 (12.8-21.5) 34.1 (25.8-43.9) 52.3 (39.9-62.9) 678 
 07-08 7.28 (6.51-8.14) 7.07 (5.97-8.28) 14.7 (12.2-16.0) 25.8 (22.6-31.5) 42.3 (32.6-50.3) 597 
 09-10 6.50 (5.49-7.70) 6.50 (5.38-7.45) 11.7 (9.80-14.9) 23.9 (17.0-31.8) 34.4 (25.8-48.9) 516 
Non-Hispanic whites 99-00 10.0 (9.16-11.0) 9.66 (9.25-10.7) 18.2 (16.6-19.8) 38.3 (27.9-46.7) 56.1 (48.5-65.0) 912 
 01-02 9.97 (9.24-10.8) 9.33 (8.69-10.3) 18.5 (17.1-20.1) 38.2 (33.5-42.1) 64.2 (49.7-78.5) 1216 
 03-04 9.14 (8.48-9.84) 8.97 (7.77-9.93) 17.6 (15.6-19.2) 30.2 (28.1-35.2) 47.2 (41.4-57.3) 1088 
 05-06 8.08 (7.17-9.10) 8.35 (7.31-9.49) 15.2 (13.7-17.4) 29.9 (25.1-36.5) 47.4 (40.0-57.1) 1038 
 07-08 7.42 (6.90-7.97) 7.38 (6.65-8.23) 14.0 (12.9-15.4) 28.3 (24.2-32.3) 44.5 (36.3-52.4) 1077 
 09-10 6.83 (6.08-7.67) 6.37 (5.58-7.34) 12.6 (11.1-14.5) 24.0 (19.5-27.6) 33.4 (27.9-44.6) 1206 
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Urinary Mono-benzyl phthalate (MBzP) (creatinine corrected) (2011 - 2012) 
Metabolite of Benzylbutyl phthalate (BzBP) 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 5.15 (4.80-5.52) 4.96 (4.62-5.35) 9.49 (8.71-10.5) 17.4 (16.2-19.1) 26.7 (24.3-30.0) 2487 
Age group        
6-11 years 11-12 12.5 (10.8-14.5) 11.9 (10.0-14.3) 24.1 (18.5-28.9) 53.2 (35.9-67.4) 81.0 (54.1-97.7) 395 
12-19 years 11-12 6.45 (5.81-7.16) 6.23 (5.39-7.54) 11.7 (10.1-13.2) 18.3 (15.2-22.1) 25.5 (20.3-39.9) 388 
20 years and older 11-12 4.52 (4.18-4.89) 4.46 (4.05-4.76) 8.08 (7.50-8.83) 15.1 (12.9-16.8) 21.6 (18.5-24.5) 1704 
Gender        
Males 11-12 4.49 (4.01-5.04) 4.26 (3.91-4.73) 8.46 (7.56-9.10) 15.4 (13.8-18.3) 24.7 (18.3-37.0) 1258 
Females 11-12 5.87 (5.43-6.35) 5.65 (5.00-6.43) 10.5 (9.45-12.1) 19.7 (16.4-23.3) 28.7 (24.5-34.8) 1229 
Race/ethnicity        
Mexican Americans 11-12 5.76 (4.41-7.51) 5.86 (5.00-7.08) 10.2 (8.61-13.1) 17.8 (12.4-34.6) 28.3 (17.1-50.2) 316 
Non-Hispanic blacks 11-12 5.78 (4.83-6.92) 5.30 (4.49-6.16) 10.5 (8.68-13.6) 21.1 (17.4-27.5) 35.3 (25.2-53.4) 665 
Non-Hispanic whites 11-12 5.04 (4.67-5.44) 4.82 (4.44-5.37) 9.11 (8.18-10.7) 16.6 (15.1-18.5) 24.7 (21.4-28.7) 811 
All Hispanics 11-12 5.38 (4.45-6.51) 5.29 (4.55-6.14) 9.63 (7.95-12.7) 18.4 (13.9-34.6) 35.6 (18.4-49.3) 571 
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Urinary Mono-n-butyl phthalate (MnBP) (1999 – 2010) 
Metabolite of Dibutyl phthalate (DBP) and Benzylbutyl phthalate (BzBP) 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 24.6 (22.1-27.4) 26.0 (23.6-29.2) 51.6 (44.5-60.3) 98.6 (90.2-114) 150 (121-169) 2541 
 01-02 18.9 (17.4-20.6) 20.4 (19.2-21.8) 40.4 (36.5-44.2) 73.6 (65.3-85.6) 108 (94.1-122) 2782 
 03-04 21.1 (19.8-22.5) 23.2 (21.2-24.8) 42.7 (38.5-47.2) 80.7 (70.2-93.9) 122 (104-137) 2605 
 05-06 19.6 (18.2-21.3) 20.6 (18.6-23.0) 40.4 (36.4-44.9) 71.5 (66.5-79.5) 107 (96.3-124) 2548 
 07-08 18.9 (17.2-20.7) 20.0 (18.1-21.9) 39.1 (34.5-43.4) 72.4 (64.5-77.7) 110 (94.5-120) 2604 
 09-10 14.6 (13.2-16.2) 15.9 (14.3-17.3) 30.5 (27.2-33.3) 54.4 (49.7-59.1) 75.9 (67.5-86.8) 2749 
Age group        
6-11 years 99-00 41.4 (35.6-48.0) 40.0 (36.2-49.2) 75.5 (59.1-92.8) 124 (98.4-159) 166 (127-279) 328 
 01-02 31.1 (26.6-36.5) 32.4 (25.6-37.1) 62.1 (51.3-76.9) 107 (84.3-136) 159 (110-290) 393 
 03-04 36.3 (30.7-42.9) 36.7 (28.5-47.5) 71.3 (56.9-87.2) 137 (107-162) 191 (150-243) 342 
 05-06 30.5 (27.5-33.8) 32.3 (27.8-35.0) 57.4 (46.8-65.4) 93.4 (75.6-130) 136 (108-181) 356 
 07-08 26.9 (22.5-32.1) 28.7 (21.3-38.0) 53.6 (45.6-63.6) 85.6 (71.4-102) 119 (91.6-150) 389 
 09-10 21.7 (19.0-24.8) 23.3 (20.8-26.2) 44.9 (39.1-49.7) 83.8 (59.6-121) 124 (92.3-173) 415 
12-19 years 99-00 36.0 (30.8-42.1) 36.3 (30.6-44.9) 68.6 (55.9-79.7) 119 (90.2-159) 165 (121-227) 752 
 01-02 25.1 (21.6-29.2) 26.7 (22.0-32.7) 52.6 (48.4-60.4) 92.4 (72.7-121) 148 (106-185) 742 
 03-04 26.7 (24.1-29.5) 28.2 (25.2-33.1) 52.0 (45.3-60.9) 97.5 (74.7-116) 134 (110-158) 729 
 05-06 27.5 (24.3-31.3) 29.0 (23.7-36.6) 57.2 (48.7-64.9) 88.6 (75.1-105) 125 (96.2-154) 702 
 07-08 26.2 (22.5-30.6) 27.3 (22.1-32.8) 51.7 (46.2-63.8) 111 (77.7-132) 149 (103-188) 401 
 09-10 18.9 (16.1-22.2) 22.3 (19.4-24.4) 37.2 (31.3-43.4) 61.7 (52.8-73.2) 81.4 (68.9-86.3) 420 
20 years and older 99-00 21.6 (19.0-24.5) 23.1 (19.7-26.1) 46.3 (36.9-53.6) 95.0 (78.7-111) 143 (117-161) 1461 
 01-02 17.0 (15.4-18.8) 19.1 (17.1-20.4) 35.1 (31.6-40.2) 64.8 (57.3-79.7) 95.4 (84.6-113) 1647 
 03-04 19.0 (17.7-20.5) 20.7 (18.9-22.9) 38.4 (35.7-42.7) 74.7 (64.1-82.6) 108 (90.7-127) 1534 
 05-06 17.7 (16.0-19.6) 18.4 (16.6-20.6) 36.7 (32.5-41.4) 65.1 (55.4-74.3) 101 (84.3-121) 1490 
 07-08 17.2 (15.6-19.1) 18.6 (16.7-20.3) 34.5 (31.5-39.1) 63.8 (56.4-72.5) 98.3 (83.0-115) 1814 
 09-10 13.5 (12.0-15.1) 14.5 (13.0-16.0) 28.1 (24.1-32.0) 50.0 (44.1-56.1) 68.9 (60.6-77.3) 1914 
Gender        
Males 99-00 22.0 (20.1-24.1) 23.2 (20.4-26.3) 43.1 (36.6-49.5) 84.4 (71.3-96.2) 116 (97.8-132) 1215 
 01-02 17.7 (16.0-19.6) 19.3 (17.3-21.0) 34.5 (30.3-40.6) 62.1 (54.1-75.5) 95.2 (75.5-117) 1371 
 03-04 20.0 (18.1-22.0) 21.1 (19.0-24.0) 39.4 (35.5-43.4) 65.5 (59.0-73.0) 95.9 (79.8-111) 1250 
 05-06 19.8 (18.4-21.4) 20.7 (19.0-23.0) 38.5 (34.6-42.0) 63.8 (56.8-72.0) 96.2 (79.0-113) 1270 
 07-08 18.4 (16.8-20.3) 19.0 (17.3-21.3) 36.0 (32.5-40.4) 60.9 (52.8-68.8) 88.3 (72.6-110) 1294 
 09-10 14.5 (13.0-16.3) 15.4 (13.7-16.9) 28.4 (25.9-31.2) 51.7 (44.3-54.8) 68.9 (58.9-78.0) 1399 
Females 99-00 27.3 (23.6-31.5) 30.0 (25.9-33.3) 59.7 (51.6-69.6) 120 (98.3-145) 167 (143-223) 1326 
 01-02 20.2 (18.2-22.4) 21.7 (19.7-24.3) 46.7 (43.1-51.1) 85.0 (72.7-92.5) 121 (106-136) 1411 
 03-04 22.2 (21.2-23.3) 24.4 (23.4-25.8) 47.3 (42.7-53.0) 95.9 (79.9-114) 137 (122-156) 1355 
 05-06 19.5 (17.2-22.0) 20.4 (17.1-24.7) 42.3 (36.7-52.0) 83.2 (71.0-90.2) 124 (101-137) 1278 
 07-08 19.3 (17.2-21.7) 20.8 (18.1-23.2) 42.5 (35.6-50.6) 83.7 (68.6-109) 132 (109-151) 1310 
 09-10 14.7 (13.1-16.5) 16.4 (13.9-19.3) 32.7 (29.9-37.1) 57.7 (52.7-63.9) 86.2 (68.9-113) 1350 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 05-06, 07-08, and 09-10 are 0.9, 1.1, 0.4, 0.6, 0.6, and 0.4 respectively. 
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Urinary Mono-n-butyl phthalate (MnBP) (1999 – 2010) 
Metabolite of Dibutyl phthalate (DBP) and Benzylbutyl phthalate (BzBP) 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 23.4 (21.8-25.1) 26.3 (23.9-28.1) 48.1 (41.2-56.7) 92.2 (78.9-101) 117 (104-131) 814 
 01-02 20.1 (16.6-24.5) 23.1 (18.0-26.5) 42.1 (34.0-51.5) 77.1 (62.9-92.5) 112 (84.6-143) 677 
 03-04 24.1 (19.8-29.5) 26.9 (20.2-32.0) 47.4 (38.0-58.5) 85.6 (61.7-117) 127 (99.8-165) 652 
 05-06 22.4 (18.6-27.0) 23.5 (19.0-29.0) 45.4 (37.1-55.4) 90.2 (71.1-119) 132 (106-174) 637 
 07-08 22.2 (18.5-26.7) 22.4 (17.8-27.1) 43.8 (36.2-50.4) 76.4 (59.8-106) 145 (85.6-223) 531 
 09-10 17.2 (15.3-19.4) 17.3 (14.3-20.9) 34.3 (31.4-38.8) 56.1 (47.7-67.9) 80.0 (65.1-107) 566 
Non-Hispanic blacks 99-00 37.0 (31.9-42.9) 38.7 (33.4-44.5) 78.2 (58.7-91.8) 118 (108-143) 167 (143-197) 603 
 01-02 29.6 (26.6-33.1) 31.5 (28.7-34.1) 58.3 (51.2-63.4) 93.2 (79.5-121) 138 (110-184) 703 
 03-04 30.1 (28.4-31.9) 31.5 (29.7-34.1) 64.1 (58.3-67.1) 106 (94.8-119) 144 (115-168) 699 
 05-06 27.1 (23.1-31.8) 28.5 (25.0-31.2) 53.1 (39.9-65.8) 105 (77.3-135) 143 (118-183) 678 
 07-08 25.0 (21.9-28.4) 25.8 (22.0-30.4) 52.4 (43.9-59.5) 91.2 (75.6-106) 114 (96.8-148) 597 
 09-10 21.9 (19.2-25.0) 23.2 (20.0-26.3) 42.4 (37.1-47.5) 69.1 (59.4-84.2) 103 (74.8-134) 516 
Non-Hispanic whites 99-00 21.8 (19.3-24.6) 23.2 (19.5-27.5) 46.3 (37.5-53.3) 90.2 (74.7-106) 142 (111-161) 912 
 01-02 17.6 (16.0-19.3) 19.2 (17.0-21.0) 36.6 (32.4-42.6) 69.2 (59.2-87.6) 107 (89.8-123) 1216 
 03-04 18.9 (17.6-20.3) 20.7 (18.9-22.8) 38.4 (35.5-42.7) 71.3 (60.1-80.0) 101 (90.7-124) 1088 
 05-06 17.8 (16.2-19.5) 18.6 (16.9-20.7) 37.8 (33.1-42.1) 65.4 (55.4-73.9) 95.9 (79.5-113) 1038 
 07-08 17.8 (16.2-19.5) 18.9 (17.2-20.9) 36.7 (32.3-41.4) 68.0 (58.9-77.2) 110 (86.5-120) 1077 
 09-10 13.0 (11.6-14.5) 14.1 (12.7-15.8) 26.6 (23.4-31.0) 48.8 (42.2-54.3) 67.5 (57.6-76.5) 1206 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 05-06, 07-08, and 09-10 are 0.9, 1.1, 0.4, 0.6, 0.6, and 0.4 respectively. 
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Urinary Mono-n-butyl phthalate (MnBP) (2011 - 2012) 
Metabolite of Dibutyl phthalate (DBP) and Benzylbutyl phthalate (BzBP) 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 7.61 (6.64-8.72) 9.20 (8.10-10.1) 20.0 (17.8-22.1) 35.5 (31.3-41.8) 55.0 (44.3-68.5) 2489 
Age group        
6-11 years 11-12 11.1 (8.73-14.2) 14.9 (10.8-17.1) 25.7 (23.2-32.1) 58.6 (39.6-71.4) 97.0 (59.3-163) 396 
12-19 years 11-12 9.69 (7.91-11.9) 12.2 (10.0-14.7) 24.7 (21.0-30.7) 44.2 (36.1-56.9) 60.7 (51.3-83.4) 388 
20 years and older 11-12 7.04 (6.04-8.21) 8.20 (7.20-9.60) 18.2 (15.7-20.7) 31.8 (27.3-38.3) 46.4 (37.7-64.3) 1705 
Gender        
Males 11-12 8.14 (7.03-9.43) 9.20 (8.50-10.1) 20.1 (17.6-23.2) 34.0 (29.7-43.1) 56.9 (38.5-75.1) 1259 
Females 11-12 7.14 (6.05-8.41) 9.00 (7.10-10.6) 19.7 (17.5-21.9) 36.1 (30.3-43.1) 51.8 (44.3-68.0) 1230 
Race/ethnicity        
Mexican Americans 11-12 8.96 (7.58-10.6) 10.1 (7.70-13.1) 20.6 (15.2-26.4) 35.8 (29.1-45.4) 50.3 (38.9-83.4) 316 
Non-Hispanic blacks 11-12 13.2 (11.2-15.6) 15.3 (13.3-17.9) 29.7 (26.4-32.8) 53.1 (43.6-67.3) 76.4 (60.3-100) 665 
Non-Hispanic whites 11-12 6.47 (5.66-7.39) 7.60 (6.70-8.50) 17.1 (15.2-18.4) 30.3 (25.9-33.4) 43.1 (32.3-59.3) 813 
All Hispanics 11-12 9.78 (8.15-11.7) 11.0 (8.80-14.4) 23.3 (20.0-27.0) 38.9 (31.8-50.6) 60.5 (45.4-93.3) 571 
Asians 11-12 6.77 (5.05-9.06) 8.20 (5.80-10.8) 18.9 (13.5-29.1) 40.5 (29.1-58.6) 64.3 (45.9-104) 352 
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Urinary Mono-n-butyl phthalate (MnBP) (creatinine corrected) (1999 – 2010) 
Metabolite of Dibutyl phthalate (DBP) and Benzylbutyl phthalate (BzBP) 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 22.4 (20.6-24.4) 21.9 (19.8-24.3) 38.9 (35.0-41.8) 68.3 (60.3-78.3) 97.7 (81.4-131) 2541 
 01-02 17.8 (16.7-19.0) 17.4 (16.3-18.4) 30.3 (28.1-32.3) 52.4 (47.4-61.0) 81.3 (71.0-92.5) 2782 
 03-04 19.8 (18.5-21.2) 19.3 (17.7-20.8) 33.9 (30.9-38.5) 59.0 (52.9-68.1) 91.6 (74.1-115) 2605 
 05-06 19.2 (18.0-20.4) 18.3 (16.8-19.8) 30.8 (29.0-33.0) 50.8 (47.8-56.6) 77.8 (67.2-94.8) 2548 
 07-08 19.0 (17.7-20.5) 18.8 (17.2-20.0) 31.4 (28.7-34.1) 52.0 (46.4-59.5) 77.1 (64.2-88.6) 2604 
 09-10 15.3 (14.0-16.6) 14.4 (13.4-15.8) 23.6 (21.7-25.2) 38.7 (34.1-45.8) 57.4 (49.8-69.9) 2749 
Age group        
6-11 years 99-00 41.9 (37.4-47.1) 39.1 (34.3-49.0) 65.9 (56.7-80.0) 108 (71.2-179) 159 (102-263) 328 
 01-02 35.4 (31.7-39.6) 35.1 (29.3-38.9) 55.4 (50.1-62.3) 84.0 (69.0-113) 147 (93.8-235) 393 
 03-04 38.4 (33.8-43.6) 39.0 (34.7-42.6) 59.3 (52.9-68.1) 104 (83.6-119) 137 (108-198) 342 
 05-06 33.6 (30.8-36.6) 33.9 (30.6-37.4) 50.6 (45.0-58.3) 78.5 (66.8-111) 128 (73.4-172) 356 
 07-08 33.1 (27.6-39.7) 34.2 (27.5-41.3) 51.9 (42.6-63.8) 81.8 (61.3-101) 109 (83.1-159) 389 
 09-10 28.3 (25.0-32.0) 26.7 (24.0-31.1) 47.8 (39.4-53.9) 78.6 (59.8-101) 130 (98.9-156) 415 
12-19 years 99-00 24.3 (21.2-27.8) 23.7 (20.6-27.4) 37.6 (31.6-43.8) 63.3 (52.4-76.4) 88.1 (61.5-142) 752 
 01-02 19.4 (17.3-21.7) 20.3 (17.5-22.3) 34.9 (30.5-37.9) 53.4 (45.2-73.9) 89.7 (60.3-106) 742 
 03-04 20.0 (18.7-21.3) 19.8 (18.2-21.7) 30.7 (27.9-34.8) 52.7 (43.4-65.4) 74.4 (56.0-90.9) 729 
 05-06 20.5 (19.0-22.2) 21.2 (18.8-22.9) 31.9 (29.6-33.8) 49.3 (42.1-56.4) 70.2 (52.0-108) 702 
 07-08 20.4 (18.4-22.6) 21.9 (18.7-25.7) 33.8 (30.0-38.5) 50.7 (42.4-64.0) 72.4 (50.7-84.5) 401 
 09-10 15.2 (13.8-16.8) 15.3 (13.8-18.4) 22.5 (21.1-24.8) 31.8 (28.2-34.6) 42.3 (33.8-51.2) 420 
20 years and older 99-00 20.4 (18.6-22.4) 19.5 (18.1-21.4) 34.9 (30.3-40.0) 62.4 (53.4-72.1) 91.0 (70.4-135) 1461 
 01-02 16.1 (15.0-17.3) 15.5 (14.2-16.5) 26.3 (24.2-28.6) 44.2 (38.7-51.1) 71.6 (61.2-85.6) 1647 
 03-04 18.3 (17.0-19.6) 17.7 (16.6-19.2) 31.0 (27.4-34.0) 53.3 (46.5-64.2) 83.8 (65.3-114) 1534 
 05-06 17.8 (16.4-19.2) 16.8 (15.6-18.4) 28.1 (25.3-30.9) 46.1 (41.5-53.0) 74.3 (55.4-94.8) 1490 
 07-08 17.7 (16.3-19.2) 17.2 (15.7-18.8) 28.2 (25.8-30.5) 46.7 (42.0-53.3) 71.8 (57.8-89.5) 1814 
 09-10 14.3 (13.0-15.7) 13.5 (12.5-14.8) 21.6 (20.0-23.8) 34.5 (30.1-40.2) 50.9 (42.2-67.7) 1914 
Gender        
Males 99-00 17.3 (16.1-18.6) 17.0 (15.5-18.8) 28.6 (25.8-32.1) 49.3 (42.6-53.5) 64.7 (57.3-71.5) 1215 
 01-02 14.4 (13.5-15.4) 13.7 (12.9-14.9) 22.9 (20.8-24.6) 39.9 (35.6-44.0) 60.0 (50.5-76.2) 1371 
 03-04 15.7 (14.5-16.9) 14.8 (13.6-16.0) 25.4 (23.6-28.1) 41.4 (37.0-47.5) 59.4 (50.3-81.5) 1250 
 05-06 15.9 (15.1-16.8) 15.4 (14.2-16.4) 24.9 (23.1-27.0) 38.6 (35.7-42.3) 51.2 (46.1-63.5) 1270 
 07-08 15.5 (14.4-16.8) 14.7 (13.4-16.3) 24.9 (22.6-27.6) 40.8 (35.2-44.9) 55.2 (46.1-65.2) 1294 
 09-10 13.0 (12.0-14.2) 12.8 (11.7-13.6) 19.9 (18.1-21.2) 30.3 (28.4-33.2) 45.3 (39.7-53.8) 1399 
Females 99-00 28.6 (25.3-32.3) 28.8 (25.5-30.5) 50.6 (41.9-56.3) 84.3 (69.2-106) 134 (93.6-155) 1326 
 01-02 21.7 (19.6-23.9) 21.6 (19.7-23.6) 35.8 (33.0-38.7) 64.9 (58.9-70.2) 91.5 (81.4-103) 1411 
 03-04 24.8 (22.9-26.8) 24.1 (21.6-26.8) 42.9 (39.2-48.9) 74.9 (64.2-86.6) 117 (83.6-139) 1355 
 05-06 22.9 (20.9-25.1) 21.5 (19.4-24.6) 37.1 (33.3-41.9) 67.2 (56.8-74.4) 99.6 (77.8-128) 1278 
 07-08 23.1 (21.0-25.5) 22.8 (20.9-25.2) 38.0 (32.7-43.1) 62.7 (52.1-78.5) 89.8 (76.2-126) 1310 
 09-10 17.8 (16.0-19.7) 17.6 (15.1-19.4) 27.1 (24.4-30.3) 47.8 (37.9-53.8) 70.6 (53.8-91.5) 1350 
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Urinary Mono-n-butyl phthalate (MnBP) (creatinine corrected) (1999 – 2010) 
Metabolite of Dibutyl phthalate (DBP) and Benzylbutyl phthalate (BzBP) 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 21.2 (19.3-23.3) 20.0 (18.2-22.9) 40.1 (32.6-44.3) 63.6 (57.5-70.1) 82.9 (73.9-100) 814 
 01-02 19.0 (16.2-22.2) 19.2 (16.3-21.9) 33.7 (28.3-39.6) 61.0 (43.9-84.0) 86.7 (60.6-128) 677 
 03-04 21.8 (17.7-26.8) 20.4 (17.4-24.0) 37.6 (29.6-50.1) 75.3 (55.6-92.0) 96.3 (76.4-164) 652 
 05-06 20.1 (17.8-22.8) 19.1 (16.4-23.0) 34.3 (29.2-42.6) 64.8 (54.6-75.9) 98.1 (70.2-154) 637 
 07-08 21.7 (17.7-26.5) 20.9 (16.4-27.1) 36.9 (29.1-46.7) 59.5 (47.1-88.9) 102 (63.4-161) 531 
 09-10 17.1 (15.5-18.8) 15.0 (14.0-16.3) 27.4 (23.6-31.6) 51.0 (42.9-69.6) 88.1 (59.8-100) 566 
Non-Hispanic blacks 99-00 23.9 (21.3-26.8) 25.0 (20.7-28.1) 42.2 (35.9-49.6) 70.0 (61.1-83.9) 96.2 (83.9-105) 603 
 01-02 20.8 (18.8-23.1) 20.2 (19.2-22.8) 34.5 (30.9-36.8) 62.8 (50.6-74.6) 85.6 (72.1-99.0) 703 
 03-04 21.4 (19.5-23.4) 22.0 (19.6-24.8) 35.4 (31.6-42.7) 65.7 (54.0-75.3) 94.0 (71.1-128) 699 
 05-06 19.1 (16.4-22.1) 18.5 (16.2-20.7) 30.1 (24.9-39.5) 54.6 (42.0-81.3) 84.7 (51.3-125) 678 
 07-08 19.4 (17.3-21.7) 19.2 (16.8-22.0) 30.5 (27.0-36.5) 50.7 (42.8-60.4) 78.3 (59.3-125) 597 
 09-10 15.9 (14.5-17.4) 15.3 (13.5-18.6) 24.9 (22.6-27.2) 37.6 (33.8-45.4) 51.2 (44.7-70.6) 516 
Non-Hispanic whites 99-00 21.3 (19.1-23.8) 20.5 (18.6-23.2) 36.4 (31.5-41.0) 67.1 (56.7-78.4) 97.7 (73.5-142) 912 
 01-02 17.4 (16.2-18.6) 16.5 (15.3-17.8) 29.0 (26.6-32.2) 51.1 (46.0-60.0) 81.4 (68.1-99.0) 1216 
 03-04 18.6 (17.3-20.1) 17.9 (16.7-19.8) 31.6 (27.7-37.8) 53.3 (48.2-61.5) 81.5 (64.2-108) 1088 
 05-06 18.7 (17.5-19.9) 17.9 (16.3-19.5) 29.7 (27.5-32.0) 48.7 (42.2-55.4) 74.3 (58.3-94.5) 1038 
 07-08 18.5 (17.3-19.9) 18.1 (16.6-19.6) 30.4 (27.3-33.3) 50.9 (43.6-61.0) 75.8 (62.6-88.0) 1077 
 09-10 14.6 (13.5-15.7) 13.9 (13.2-15.0) 22.1 (20.3-24.2) 35.3 (30.9-40.6) 52.5 (45.8-63.0) 1206 
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Urinary Mono-n-butyl phthalate (MnBP) (creatinine corrected) (2011 - 2012) 
Metabolite of Dibutyl phthalate (DBP) and Benzylbutyl phthalate (BzBP) 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 8.66 (7.79-9.62) 9.04 (8.30-9.92) 15.8 (15.0-17.3) 27.9 (24.2-30.9) 41.2 (33.0-51.8) 2487 
Age group        
6-11 years 11-12 15.9 (13.0-19.5) 17.7 (15.0-20.6) 29.8 (24.8-34.4) 51.2 (38.4-66.4) 73.3 (47.3-114) 395 
12-19 years 11-12 9.44 (8.71-10.2) 10.5 (8.61-12.7) 15.7 (14.9-17.8) 28.1 (22.0-30.0) 37.0 (29.2-46.7) 388 
20 years and older 11-12 8.00 (7.09-9.01) 8.32 (7.64-9.12) 14.6 (13.0-16.0) 23.4 (21.4-27.9) 36.2 (29.4-47.3) 1704 
Gender        
Males 11-12 7.61 (6.65-8.69) 8.07 (7.54-8.85) 13.7 (11.9-15.5) 22.7 (19.3-26.3) 34.6 (24.1-53.0) 1258 
Females 11-12 9.81 (8.86-10.9) 10.3 (9.18-11.5) 18.1 (16.8-19.7) 31.8 (28.1-34.6) 44.8 (38.4-54.6) 1229 
Race/ethnicity        
Mexican Americans 11-12 10.1 (8.62-11.8) 10.7 (8.62-12.9) 17.6 (14.2-19.7) 32.6 (24.7-46.4) 55.9 (35.1-76.6) 316 
Non-Hispanic blacks 11-12 10.3 (8.80-12.0) 11.1 (9.27-12.6) 19.1 (17.0-21.5) 31.7 (25.7-37.0) 43.5 (34.0-56.0) 665 
Non-Hispanic whites 11-12 7.85 (6.92-8.91) 8.13 (7.43-8.99) 14.5 (13.0-15.9) 22.9 (21.4-27.9) 34.6 (27.9-46.4) 811 
All Hispanics 11-12 11.0 (9.71-12.3) 11.2 (10.3-12.5) 19.3 (15.8-24.9) 36.1 (28.8-47.4) 55.6 (42.1-65.6) 571 
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Urinary Mono-isobutyl phthalate (MiBP) (2001 – 2010) 
Metabolite of Di-isobutyl phthalate (DiBP) 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 01-02 2.71 (2.49-2.94) 2.70 (2.40-3.00) 5.70 (5.30-6.10) 12.0 (11.4-12.7) 17.9 (16.3-19.8) 2782 
 03-04 3.80 (3.40-4.25) 4.20 (3.70-4.80) 8.40 (7.40-9.50) 15.0 (13.1-17.3) 21.3 (18.6-26.0) 2605 
 05-06 5.20 (4.64-5.83) 5.80 (5.40-6.60) 11.9 (10.6-13.3) 21.3 (18.7-23.7) 31.6 (27.1-37.2) 2548 
 07-08 7.15 (6.59-7.77) 8.00 (7.50-8.60) 15.3 (13.9-16.9) 27.2 (24.6-30.4) 39.1 (35.4-43.8) 2604 
 09-10 7.64 (6.88-8.49) 8.30 (7.24-9.27) 15.8 (14.5-17.4) 27.6 (24.7-31.7) 41.3 (35.6-47.5) 2749 
Age group        
6-11 years 01-02 4.22 (3.28-5.43) 4.40 (3.20-6.20) 10.7 (7.30-13.4) 18.6 (14.2-22.0) 23.4 (20.4-27.8) 393 
 03-04 6.56 (5.24-8.22) 7.00 (5.10-9.10) 12.8 (9.40-17.7) 24.3 (19.6-34.5) 40.6 (29.3-48.5) 342 
 05-06 8.53 (7.67-9.48) 9.00 (8.20-10.3) 15.8 (13.7-19.2) 33.2 (27.5-38.4) 49.1 (33.2-54.4) 356 
 07-08 10.7 (8.94-12.8) 11.4 (8.90-13.2) 21.1 (16.6-27.2) 35.9 (30.2-44.7) 55.4 (36.4-75.5) 389 
 09-10 10.2 (9.10-11.4) 10.9 (9.45-12.2) 20.8 (18.8-23.6) 35.7 (28.8-46.9) 55.4 (41.2-75.4) 415 
12-19 years 01-02 3.48 (2.90-4.17) 3.80 (2.90-4.40) 7.40 (6.00-9.00) 14.5 (11.7-18.6) 22.3 (16.2-33.4) 742 
 03-04 4.55 (3.73-5.55) 5.60 (4.50-6.30) 10.1 (8.00-11.4) 17.1 (13.3-20.9) 22.7 (18.5-29.1) 729 
 05-06 7.46 (6.53-8.51) 7.90 (6.90-9.80) 16.2 (13.6-19.3) 29.2 (23.6-31.3) 34.1 (30.1-49.9) 702 
 07-08 10.2 (8.53-12.3) 10.5 (8.40-12.9) 22.3 (17.0-26.9) 41.6 (32.9-48.1) 56.2 (44.6-82.7) 401 
 09-10 10.7 (9.54-12.1) 12.3 (10.7-13.6) 20.2 (17.3-22.2) 36.1 (28.3-46.0) 49.8 (42.3-60.2) 420 
20 years and older 01-02 2.46 (2.30-2.63) 2.40 (2.20-2.70) 5.10 (4.80-5.50) 10.6 (9.40-12.0) 16.3 (13.6-18.5) 1647 
 03-04 3.46 (3.11-3.84) 3.90 (3.40-4.30) 7.50 (6.70-8.50) 13.3 (11.5-16.5) 19.9 (16.0-25.0) 1534 
 05-06 4.65 (4.07-5.30) 5.40 (4.70-6.00) 10.6 (9.50-12.0) 18.7 (16.0-21.9) 29.0 (22.1-34.4) 1490 
 07-08 6.47 (5.91-7.09) 7.50 (6.70-8.00) 14.1 (12.5-16.1) 24.5 (21.3-27.7) 34.2 (27.9-39.5) 1814 
 09-10 7.03 (6.26-7.90) 7.55 (6.66-8.57) 14.6 (12.8-16.6) 25.7 (23.2-28.5) 38.6 (31.4-43.6) 1914 
Gender        
Males 01-02 2.73 (2.50-2.97) 2.80 (2.40-3.20) 5.60 (5.00-6.10) 11.6 (10.1-12.6) 16.6 (13.6-20.1) 1371 
 03-04 4.07 (3.56-4.66) 4.30 (3.80-5.10) 9.20 (7.50-10.2) 16.0 (13.3-18.5) 22.7 (17.3-30.3) 1250 
 05-06 5.65 (5.08-6.29) 6.20 (5.60-6.90) 11.9 (10.7-13.3) 22.1 (18.7-26.5) 32.3 (25.5-39.8) 1270 
 07-08 7.52 (6.84-8.26) 8.30 (7.70-9.40) 15.2 (13.6-17.2) 25.0 (21.7-28.4) 38.3 (27.3-44.2) 1294 
 09-10 7.80 (6.96-8.74) 8.48 (7.44-9.16) 15.3 (14.0-17.0) 26.2 (23.2-30.9) 39.1 (31.1-46.4) 1399 
Females 01-02 2.68 (2.44-2.96) 2.60 (2.30-3.00) 5.80 (5.30-6.50) 12.6 (11.0-14.7) 18.7 (16.3-24.0) 1411 
 03-04 3.56 (3.19-3.97) 4.10 (3.50-4.50) 8.00 (7.10-9.10) 14.2 (12.5-16.6) 20.5 (17.9-23.0) 1355 
 05-06 4.80 (4.15-5.55) 5.50 (4.70-6.60) 11.9 (10.1-13.6) 19.6 (17.0-24.1) 29.8 (24.6-35.9) 1278 
 07-08 6.82 (6.21-7.49) 7.40 (6.50-8.30) 15.5 (14.5-16.9) 29.1 (27.0-32.9) 39.8 (36.2-46.7) 1310 
 09-10 7.50 (6.68-8.43) 8.07 (6.94-9.62) 16.4 (14.0-18.9) 29.1 (25.3-33.5) 45.0 (36.0-52.7) 1350 
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Urinary Mono-isobutyl phthalate (MiBP) (2001 – 2010) 
Metabolite of Di-isobutyl phthalate (DiBP) 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 01-02 3.26 (2.72-3.91) 3.40 (2.70-4.30) 7.20 (6.20-9.30) 12.2 (11.2-14.7) 18.4 (14.1-25.6) 677 
 03-04 4.81 (3.85-6.02) 5.10 (4.00-6.70) 10.2 (8.20-12.6) 18.3 (13.5-24.5) 26.0 (19.0-38.5) 652 
 05-06 6.88 (5.58-8.48) 7.30 (6.00-8.90) 14.5 (11.5-17.5) 26.3 (20.7-34.1) 40.4 (33.8-46.8) 637 
 07-08 9.30 (8.12-10.6) 10.2 (9.40-11.1) 17.4 (15.9-18.8) 31.9 (24.0-39.2) 47.6 (34.2-58.2) 531 
 09-10 9.34 (8.22-10.6) 9.97 (8.31-11.6) 18.8 (16.0-21.8) 31.7 (25.6-37.2) 46.4 (37.3-54.0) 566 
Non-Hispanic blacks 01-02 4.90 (4.46-5.37) 5.30 (4.60-6.00) 10.7 (9.20-12.0) 18.3 (16.1-20.1) 25.5 (20.7-31.3) 703 
 03-04 6.67 (5.97-7.46) 6.90 (6.30-7.50) 12.6 (10.9-14.7) 25.7 (17.7-31.0) 33.5 (27.3-43.9) 699 
 05-06 8.37 (7.06-9.91) 8.70 (7.50-10.2) 16.1 (13.8-19.7) 30.1 (22.1-37.2) 41.4 (30.1-67.7) 678 
 07-08 10.7 (9.08-12.5) 12.5 (10.5-14.8) 23.1 (21.7-25.0) 38.9 (32.4-43.5) 47.6 (44.5-57.0) 597 
 09-10 14.0 (11.9-16.4) 15.4 (12.9-17.8) 27.5 (22.4-34.1) 47.6 (34.4-65.6) 66.0 (46.3-85.2) 516 
Non-Hispanic whites 01-02 2.33 (2.10-2.59) 2.30 (1.90-2.60) 4.90 (4.40-5.30) 9.60 (8.30-11.6) 15.6 (13.0-18.6) 1216 
 03-04 3.17 (2.82-3.56) 3.50 (3.00-4.00) 6.80 (5.90-7.90) 12.5 (10.6-14.5) 17.6 (14.7-20.8) 1088 
 05-06 4.41 (3.86-5.04) 5.00 (4.20-5.70) 10.3 (9.10-11.5) 18.7 (16.3-21.1) 28.8 (22.1-32.2) 1038 
 07-08 6.32 (5.78-6.93) 7.20 (6.40-7.90) 13.6 (12.4-14.9) 24.3 (20.1-27.3) 33.8 (27.0-39.5) 1077 
 09-10 6.34 (5.65-7.10) 6.92 (6.08-7.90) 12.9 (11.7-14.5) 21.6 (19.1-24.2) 29.6 (26.0-34.3) 1206 
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Urinary Mono-isobutyl phthalate (MiBP) (2011 - 2012) 
Metabolite of Di-isobutyl phthalate (DiBP) 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 6.00 (5.41-6.65) 6.30 (5.80-6.90) 13.0 (11.9-14.5) 25.4 (22.3-29.7) 36.5 (33.4-41.0) 2489 
Age group        
6-11 years 11-12 8.28 (6.93-9.91) 9.40 (6.90-11.6) 18.6 (14.1-23.6) 31.8 (26.0-38.2) 43.1 (33.6-66.5) 396 
12-19 years 11-12 7.73 (6.74-8.86) 8.10 (6.90-9.60) 19.0 (14.5-23.0) 34.2 (25.3-38.5) 43.3 (36.5-45.4) 388 
20 years and older 11-12 5.57 (4.92-6.31) 6.00 (5.40-6.60) 12.2 (10.6-13.6) 23.6 (19.4-27.8) 34.4 (31.1-39.2) 1705 
Gender        
Males 11-12 6.54 (5.70-7.51) 6.60 (5.70-7.50) 13.6 (11.7-15.8) 27.6 (21.8-35.1) 39.3 (33.6-46.9) 1259 
Females 11-12 5.52 (4.95-6.15) 6.10 (5.60-6.80) 12.7 (11.3-14.5) 24.1 (21.2-26.3) 32.7 (30.2-36.5) 1230 
Race/ethnicity        
Mexican Americans 11-12 6.71 (5.77-7.82) 6.60 (5.30-8.40) 12.4 (10.5-15.2) 23.7 (15.5-31.2) 33.4 (23.7-54.7) 316 
Non-Hispanic blacks 11-12 9.88 (8.55-11.4) 10.4 (8.90-12.5) 19.7 (16.5-23.6) 36.5 (30.8-41.2) 49.9 (41.2-67.8) 665 
Non-Hispanic whites 11-12 5.23 (4.71-5.82) 5.50 (4.90-6.00) 11.7 (9.40-13.3) 23.7 (17.6-28.8) 34.2 (28.6-37.7) 813 
All Hispanics 11-12 7.22 (5.89-8.87) 7.70 (5.70-10.0) 13.7 (11.4-18.2) 24.8 (18.8-32.4) 33.4 (23.9-64.8) 571 
Asians 11-12 5.70 (4.35-7.46) 6.20 (4.30-8.70) 13.8 (9.80-21.2) 27.8 (19.9-39.3) 40.1 (27.8-65.3) 352 
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Urinary Mono-isobutyl phthalate (MiBP) (creatinine corrected) (2001 – 2010) 
Metabolite of Di-isobutyl phthalate (DiBP) 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 01-02 2.54 (2.36-2.73) 2.46 (2.26-2.68) 4.54 (4.20-4.86) 8.02 (7.78-8.66) 12.0 (10.8-13.5) 2782 
 03-04 3.57 (3.18-4.00) 3.57 (3.15-4.08) 6.21 (5.36-7.17) 10.9 (9.47-12.7) 15.4 (12.8-18.6) 2605 
 05-06 5.07 (4.68-5.50) 5.07 (4.74-5.45) 8.81 (8.08-9.55) 15.2 (13.4-16.5) 21.3 (18.3-24.3) 2548 
 07-08 7.21 (6.76-7.70) 7.25 (6.77-7.81) 12.1 (11.2-13.3) 19.5 (17.2-21.5) 27.8 (24.9-31.3) 2604 
 09-10 7.98 (7.34-8.68) 7.86 (7.12-8.52) 12.4 (11.2-14.1) 20.1 (17.3-23.0) 26.8 (23.7-32.8) 2749 
Age group        
6-11 years 01-02 4.81 (3.89-5.94) 5.18 (4.13-6.32) 9.20 (7.03-11.7) 15.2 (11.1-24.3) 24.3 (13.9-40.3) 393 
 03-04 6.94 (5.79-8.31) 7.03 (5.29-8.95) 11.8 (9.56-15.1) 18.6 (15.1-25.1) 28.7 (21.8-36.9) 342 
 05-06 9.39 (8.56-10.3) 9.46 (8.50-10.3) 15.3 (13.0-18.1) 25.2 (21.6-30.1) 37.9 (28.0-65.5) 356 
 07-08 13.2 (11.1-15.5) 12.9 (10.5-15.7) 21.9 (17.8-26.0) 35.5 (28.3-43.5) 52.6 (41.4-58.3) 389 
 09-10 13.2 (11.8-14.9) 12.6 (11.0-14.7) 20.9 (18.7-24.9) 35.3 (28.6-46.1) 53.0 (39.1-95.1) 415 
12-19 years 01-02 2.68 (2.29-3.15) 2.83 (2.39-3.33) 4.79 (4.04-5.51) 7.62 (6.18-10.2) 12.8 (8.76-15.6) 742 
 03-04 3.41 (2.86-4.05) 3.69 (2.99-4.31) 5.75 (4.69-7.04) 9.32 (7.17-12.0) 13.5 (9.52-20.1) 729 
 05-06 5.56 (5.05-6.11) 5.82 (5.20-6.53) 9.05 (8.06-10.4) 14.3 (13.4-16.5) 20.3 (17.7-26.8) 702 
 07-08 7.95 (6.96-9.09) 8.30 (6.89-9.76) 13.7 (11.3-15.7) 21.3 (16.3-28.4) 28.7 (20.5-62.6) 401 
 09-10 8.63 (7.97-9.34) 8.94 (7.87-9.78) 12.7 (11.7-14.9) 19.5 (16.5-25.3) 28.8 (20.6-53.4) 420 
20 years and older 01-02 2.33 (2.20-2.46) 2.26 (2.08-2.43) 3.89 (3.65-4.25) 7.31 (7.00-7.78) 10.6 (9.46-11.3) 1647 
 03-04 3.32 (3.00-3.68) 3.33 (3.00-3.81) 5.59 (4.93-6.51) 9.84 (8.65-11.2) 13.5 (11.4-16.0) 1534 
 05-06 4.66 (4.23-5.13) 4.62 (4.36-5.03) 8.00 (7.23-8.78) 13.5 (11.6-15.7) 18.2 (16.1-23.0) 1490 
 07-08 6.65 (6.21-7.12) 6.73 (6.29-7.20) 11.1 (10.2-12.1) 17.1 (15.6-18.6) 23.8 (21.0-26.7) 1814 
 09-10 7.45 (6.81-8.15) 7.24 (6.69-7.89) 11.6 (10.4-12.6) 17.7 (15.1-21.9) 23.8 (20.7-28.8) 1914 
Gender        
Males 01-02 2.22 (2.09-2.35) 2.18 (1.97-2.37) 3.76 (3.58-4.11) 7.38 (6.64-7.95) 11.1 (10.1-12.5) 1371 
 03-04 3.20 (2.80-3.66) 3.19 (2.74-3.56) 5.84 (4.79-6.56) 10.0 (8.27-12.2) 13.9 (11.5-19.1) 1250 
 05-06 4.54 (4.19-4.92) 4.45 (4.21-4.81) 7.95 (6.95-8.73) 13.4 (11.6-15.8) 18.5 (16.7-19.8) 1270 
 07-08 6.33 (5.91-6.79) 6.36 (5.93-6.77) 10.4 (9.43-11.3) 16.4 (15.0-19.7) 24.1 (21.1-27.7) 1294 
 09-10 6.99 (6.44-7.59) 6.70 (6.26-7.21) 10.6 (9.80-11.5) 17.5 (15.4-19.8) 23.4 (20.9-27.3) 1399 
Females 01-02 2.88 (2.61-3.18) 2.85 (2.52-3.18) 5.14 (4.67-5.89) 8.66 (8.02-10.1) 13.7 (11.1-15.0) 1411 
 03-04 3.96 (3.56-4.42) 4.00 (3.57-4.45) 6.73 (5.64-7.80) 11.6 (10.2-13.0) 15.7 (13.0-18.7) 1355 
 05-06 5.64 (5.04-6.32) 5.86 (5.39-6.39) 9.61 (8.85-10.6) 15.8 (14.3-18.1) 24.3 (18.7-32.5) 1278 
 07-08 8.18 (7.46-8.96) 8.70 (7.78-9.47) 13.9 (12.2-15.2) 21.3 (18.3-25.3) 31.6 (26.4-34.7) 1310 









Fourth National Report on Human Exposure to Environmental Chemicals, Updated Tables, January 2017 Volume One Page 387
Urinary Mono-isobutyl phthalate (MiBP) (creatinine corrected) (2001 – 2010) 
Metabolite of Di-isobutyl phthalate (DiBP) 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 01-02 3.07 (2.58-3.66) 2.98 (2.53-3.82) 5.82 (4.91-6.99) 10.6 (8.28-13.3) 16.0 (12.6-19.4) 677 
 03-04 4.34 (3.47-5.43) 4.47 (3.53-5.24) 7.75 (6.33-9.69) 13.1 (11.9-16.8) 23.3 (17.9-26.1) 652 
 05-06 6.19 (5.24-7.31) 6.17 (5.59-7.02) 10.9 (9.61-12.3) 18.6 (17.1-21.5) 28.3 (23.7-36.2) 637 
 07-08 9.07 (7.87-10.5) 8.94 (8.07-10.3) 14.6 (12.4-18.0) 25.9 (21.1-32.4) 36.1 (28.0-42.3) 531 
 09-10 9.27 (8.37-10.3) 8.95 (8.00-10.0) 14.6 (12.8-17.3) 25.6 (23.1-28.2) 40.6 (28.7-47.4) 566 
Non-Hispanic blacks 01-02 3.44 (3.20-3.69) 3.52 (2.95-3.81) 6.11 (5.03-7.04) 10.6 (8.94-12.4) 15.6 (12.6-19.7) 703 
 03-04 4.74 (4.07-5.51) 4.65 (4.10-5.30) 7.81 (6.38-10.0) 15.2 (10.8-18.4) 19.9 (15.7-28.7) 699 
 05-06 5.88 (5.12-6.76) 5.86 (5.03-7.03) 9.74 (8.21-11.3) 14.9 (12.0-19.9) 21.4 (14.9-29.7) 678 
 07-08 8.28 (7.20-9.52) 8.96 (8.33-9.71) 14.4 (12.9-15.7) 21.6 (20.3-24.3) 29.6 (24.3-37.7) 597 
 09-10 10.1 (8.76-11.7) 10.5 (9.41-11.6) 15.2 (12.9-19.2) 24.1 (19.3-32.2) 33.2 (26.3-42.0) 516 
Non-Hispanic whites 01-02 2.31 (2.11-2.52) 2.20 (2.01-2.43) 3.80 (3.53-4.39) 7.30 (6.72-7.78) 10.7 (9.62-12.6) 1216 
 03-04 3.13 (2.76-3.54) 3.17 (2.76-3.72) 5.28 (4.55-6.21) 8.92 (7.64-10.3) 11.8 (10.2-15.1) 1088 
 05-06 4.64 (4.25-5.07) 4.58 (4.35-4.91) 8.28 (7.45-9.01) 13.7 (12.2-15.6) 18.8 (16.9-22.2) 1038 
 07-08 6.60 (6.14-7.10) 6.70 (6.26-7.08) 10.9 (10.0-12.1) 17.0 (15.2-20.5) 24.9 (20.5-29.1) 1077 
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Urinary Mono-isobutyl phthalate (MiBP) (creatinine corrected) (2011 - 2012) 
Metabolite of Di-isobutyl phthalate (DiBP) 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 6.83 (6.30-7.40) 6.77 (6.19-7.27) 11.6 (10.9-12.6) 19.4 (17.5-22.6) 27.5 (24.5-31.6) 2487 
Age group        
6-11 years 11-12 11.8 (10.2-13.6) 12.2 (10.4-14.2) 18.5 (16.2-22.4) 31.1 (24.5-46.3) 46.4 (30.8-70.0) 395 
12-19 years 11-12 7.53 (6.81-8.32) 7.61 (6.84-8.26) 11.7 (10.9-13.8) 19.9 (14.9-24.8) 25.6 (20.6-33.5) 388 
20 years and older 11-12 6.34 (5.83-6.89) 6.19 (5.56-6.85) 10.8 (9.54-11.6) 18.1 (15.5-20.1) 25.2 (23.3-29.9) 1704 
Gender        
Males 11-12 6.13 (5.47-6.86) 5.91 (5.12-6.88) 10.7 (8.81-12.2) 17.6 (14.6-22.4) 25.8 (22.2-33.3) 1258 
Females 11-12 7.58 (7.03-8.17) 7.57 (6.94-7.90) 12.8 (11.6-13.8) 21.2 (18.5-24.5) 28.5 (25.2-31.6) 1229 
Race/ethnicity        
Mexican Americans 11-12 7.57 (6.49-8.81) 7.00 (5.61-8.77) 12.3 (9.74-15.2) 18.4 (15.2-30.8) 33.1 (18.0-61.6) 316 
Non-Hispanic blacks 11-12 7.69 (6.69-8.83) 7.83 (6.73-8.89) 13.2 (10.6-15.4) 20.6 (17.1-26.9) 30.9 (24.5-35.8) 665 
Non-Hispanic whites 11-12 6.36 (5.68-7.12) 6.12 (5.43-6.93) 11.0 (9.52-11.8) 18.5 (14.8-22.9) 25.8 (21.2-33.8) 811 
All Hispanics 11-12 8.09 (6.94-9.43) 8.02 (6.80-9.43) 13.0 (10.6-15.9) 21.0 (15.6-30.5) 30.5 (20.5-45.0) 571 
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Urinary Mono-cyclohexyl phthalate (MCHP) (1999 – 2010) ‡ 
Metabolite of Dicyclohexyl phthalate (DCHP) 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 * < LOD < LOD < LOD 2.21 (<LOD-3.42) 2541 
 01-02 * < LOD < LOD .804 (.603-1.01) 1.01 (.804-1.21) 2782 
 03-04 * < LOD < LOD < LOD .603 (.402-.804) 2605 
 05-06 * < LOD < LOD < LOD < LOD 2548 
 07-08 * < LOD < LOD < LOD < LOD 2604 
 09-10 * < LOD < LOD < LOD < LOD 2749 
Age group        
6-11 years 99-00 * < LOD < LOD 2.01 (<LOD-2.21) 3.42 (2.01-7.64) 328 
 01-02 * < LOD < LOD .804 (.603-1.01) 1.21 (1.01-1.41) 393 
 03-04 * < LOD < LOD .603 (<LOD-.804) 1.01 (.603-1.01) 342 
 05-06 * < LOD < LOD < LOD < LOD 356 
 07-08 * < LOD < LOD < LOD < LOD 389 
 09-10 * < LOD < LOD < LOD .960 (.640-1.57) 415 
12-19 years 99-00 * < LOD < LOD 2.01 (<LOD-3.02) 3.42 (2.01-5.03) 752 
 01-02 * < LOD < LOD .804 (.603-1.01) 1.01 (.804-1.21) 742 
 03-04 * < LOD < LOD .402 (<LOD-.603) .804 (.603-1.21) 729 
 05-06 * < LOD < LOD < LOD < LOD 702 
 07-08 * < LOD < LOD < LOD < LOD 401 
 09-10 * < LOD < LOD < LOD < LOD 420 
20 years and older 99-00 * < LOD < LOD < LOD < LOD 1461 
 01-02 * < LOD < LOD .804 (<LOD-1.01) 1.01 (.804-1.21) 1647 
 03-04 * < LOD < LOD < LOD .603 (.402-.603) 1534 
 05-06 * < LOD < LOD < LOD < LOD 1490 
 07-08 * < LOD < LOD < LOD < LOD 1814 
 09-10 * < LOD < LOD < LOD < LOD 1914 
Gender        
Males 99-00 * < LOD < LOD < LOD 2.21 (<LOD-4.02) 1215 
 01-02 * < LOD < LOD .804 (.603-1.01) 1.01 (.804-1.21) 1371 
 03-04 * < LOD < LOD < LOD .603 (.603-.804) 1250 
 05-06 * < LOD < LOD < LOD < LOD 1270 
 07-08 * < LOD < LOD < LOD < LOD 1294 
 09-10 * < LOD < LOD < LOD < LOD 1399 
Females 99-00 * < LOD < LOD < LOD 2.21 (<LOD-3.82) 1326 
 01-02 * < LOD < LOD .804 (<LOD-.804) 1.01 (.804-1.01) 1411 
 03-04 * < LOD < LOD < LOD .603 (.402-1.01) 1355 
 05-06 * < LOD < LOD < LOD < LOD 1278 
 07-08 * < LOD < LOD < LOD < LOD 1310 
 09-10 * < LOD < LOD < LOD < LOD 1350 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 05-06, 07-08, and 09-10 are 1.81, 0.603, 0.402, 0.603, 0.603 and 0.402 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result.  
**To correct for inadequate purity in the analytical standards, all results and LODs have been adjusted by a factor of 2.01 for survey periods 1999-2008 compared with results previously released. 
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Urinary Mono-cyclohexyl phthalate (MCHP) (1999 – 2010) ‡ 
Metabolite of Dicyclohexyl phthalate (DCHP) 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 * < LOD < LOD < LOD < LOD 814 
 01-02 * < LOD < LOD .804 (<LOD-1.01) 1.01 (.603-1.41) 677 
 03-04 * < LOD < LOD < LOD .603 (.402-1.01) 652 
 05-06 * < LOD < LOD < LOD < LOD 637 
 07-08 * < LOD < LOD < LOD < LOD 531 
 09-10 * < LOD < LOD < LOD .440 (<LOD-.640) 566 
Non-Hispanic blacks 99-00 * < LOD < LOD < LOD 2.21 (1.81-2.41) 603 
 01-02 * < LOD < LOD .804 (.603-1.01) 1.01 (.804-1.41) 703 
 03-04 * < LOD < LOD .603 (.402-.603) .804 (.603-1.01) 699 
 05-06 * < LOD < LOD < LOD < LOD 678 
 07-08 * < LOD < LOD < LOD < LOD 597 
 09-10 * < LOD < LOD < LOD .480 (<LOD-.620) 516 
Non-Hispanic whites 99-00 * < LOD < LOD < LOD 2.01 (<LOD-3.42) 912 
 01-02 * < LOD < LOD .804 (<LOD-.804) 1.01 (.804-1.21) 1216 
 03-04 * < LOD < LOD < LOD .603 (.402-.804) 1088 
 05-06 * < LOD < LOD < LOD < LOD 1038 
 07-08 * < LOD < LOD < LOD < LOD 1077 
 09-10 * < LOD < LOD < LOD < LOD 1206 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 05-06, 07-08, and 09-10 are 1.81, 0.603, 0.402, 0.603, 0.603 and 0.402 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result.  
**To correct for inadequate purity in the analytical standards, all results and LODs have been adjusted by a factor of 2.01 for survey periods 1999-2008 compared with results previously released. 
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Urinary Mono-cyclohexyl phthalate (MCHP) (creatinine corrected) (1999 – 2010) ‡ 
Metabolite of Dicyclohexyl phthalate (DCHP) 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 * < LOD < LOD < LOD 6.03 (<LOD-6.69) 2541 
 01-02 * < LOD < LOD 1.23 (1.07-1.39) 1.83 (1.55-2.01) 2782 
 03-04 * < LOD < LOD < LOD .905 (.804-1.01) 2605 
 05-06 * < LOD < LOD < LOD < LOD 2548 
 07-08 * < LOD < LOD < LOD < LOD 2604 
 09-10 * < LOD < LOD < LOD < LOD 2749 
Age group        
6-11 years 99-00 * < LOD < LOD 3.10 (<LOD-4.70) 5.67 (3.10-12.9) 328 
 01-02 * < LOD < LOD 1.39 (1.03-1.49) 1.89 (1.39-2.35) 393 
 03-04 * < LOD < LOD .744 (<LOD-1.07) 1.07 (.704-1.67) 342 
 05-06 * < LOD < LOD < LOD < LOD 356 
 07-08 * < LOD < LOD < LOD < LOD 389 
 09-10 * < LOD < LOD < LOD 1.80 (1.34-2.55) 415 
12-19 years 99-00 * < LOD < LOD 2.45 (<LOD-3.10) 3.36 (2.73-3.66) 752 
 01-02 * < LOD < LOD .945 (.764-1.33) 1.55 (1.07-2.37) 742 
 03-04 * < LOD < LOD .442 (<LOD-.543) .764 (.482-1.25) 729 
 05-06 * < LOD < LOD < LOD < LOD 702 
 07-08 * < LOD < LOD < LOD < LOD 401 
 09-10 * < LOD < LOD < LOD < LOD 420 
20 years and older 99-00 * < LOD < LOD < LOD < LOD 1461 
 01-02 * < LOD < LOD 1.27 (<LOD-1.39) 1.83 (1.55-2.11) 1647 
 03-04 * < LOD < LOD < LOD .905 (.804-1.01) 1534 
 05-06 * < LOD < LOD < LOD < LOD 1490 
 07-08 * < LOD < LOD < LOD < LOD 1814 
 09-10 * < LOD < LOD < LOD < LOD 1914 
Gender        
Males 99-00 * < LOD < LOD < LOD 4.30 (<LOD-6.35) 1215 
 01-02 * < LOD < LOD 1.03 (.844-1.33) 1.77 (1.35-2.13) 1371 
 03-04 * < LOD < LOD < LOD .663 (.583-1.01) 1250 
 05-06 * < LOD < LOD < LOD < LOD 1270 
 07-08 * < LOD < LOD < LOD < LOD 1294 
 09-10 * < LOD < LOD < LOD < LOD 1399 
Females 99-00 * < LOD < LOD < LOD 6.69 (<LOD-7.10) 1326 
 01-02 * < LOD < LOD 1.35 (<LOD-1.55) 1.83 (1.61-2.21) 1411 
 03-04 * < LOD < LOD < LOD 1.01 (.844-1.19) 1355 
 05-06 * < LOD < LOD < LOD < LOD 1278 
 07-08 * < LOD < LOD < LOD < LOD 1310 
 09-10 * < LOD < LOD < LOD < LOD 1350 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result.  
**To correct for inadequate purity in the analytical standards, all results and LODs have been adjusted by a factor of 2.01 for survey periods 1999-2008 compared with results previously released. 
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Urinary Mono-cyclohexyl phthalate (MCHP) (creatinine corrected) (1999 – 2010) ‡ 
Metabolite of Dicyclohexyl phthalate (DCHP) 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 * < LOD < LOD < LOD < LOD 814 
 01-02 * < LOD < LOD 1.19 (<LOD-1.39) 1.91 (1.59-2.23) 677 
 03-04 * < LOD < LOD < LOD .784 (.623-1.13) 652 
 05-06 * < LOD < LOD < LOD < LOD 637 
 07-08 * < LOD < LOD < LOD < LOD 531 
 09-10 * < LOD < LOD < LOD 1.20 (<LOD-1.56) 566 
Non-Hispanic blacks 99-00 * < LOD < LOD < LOD 2.87 (2.25-3.50) 603 
 01-02 * < LOD < LOD .824 (.724-.985) 1.19 (1.01-1.43) 703 
 03-04 * < LOD < LOD .503 (.342-.623) .663 (.523-.945) 699 
 05-06 * < LOD < LOD < LOD < LOD 678 
 07-08 * < LOD < LOD < LOD < LOD 597 
 09-10 * < LOD < LOD < LOD .880 (<LOD-1.08) 516 
Non-Hispanic whites 99-00 * < LOD < LOD < LOD 6.35 (<LOD-7.10) 912 
 01-02 * < LOD < LOD 1.27 (<LOD-1.49) 1.83 (1.55-2.13) 1216 
 03-04 * < LOD < LOD < LOD .965 (.844-1.07) 1088 
 05-06 * < LOD < LOD < LOD < LOD 1038 
 07-08 * < LOD < LOD < LOD < LOD 1077 
 09-10 * < LOD < LOD < LOD < LOD 1206 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result.  
**To correct for inadequate purity in the analytical standards, all results and LODs have been adjusted by a factor of 2.01 for survey periods 1999-2008 compared with results previously released. 








Fourth National Report on Human Exposure to Environmental Chemicals, Updated Tables, January 2017 Volume One Page 393
Urinary Mono-ethyl phthalate (MEP) (1999 – 2010) 
Metabolite of Diethyl phthalate (DEP) 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 118 (103-135) 108 (90.0-132) 300 (244-355) 830 (664-977) 1870 (1420-2490) 2536 
 01-02 117 (105-131) 112 (93.0-128) 307 (274-348) 813 (688-947) 1650 (1230-2130) 2782 
 03-04 127 (112-145) 115 (99.9-137) 332 (302-366) 909 (769-1150) 1780 (1420-2180) 2605 
 05-06 108 (95.5-123) 102 (83.4-121) 284 (257-323) 750 (707-825) 1410 (1140-1830) 2548 
 07-08 90.4 (80.3-102) 81.1 (70.8-93.5) 239 (205-272) 605 (493-713) 1180 (821-1760) 2604 
 09-10 64.4 (58.3-71.2) 54.9 (50.5-62.7) 163 (145-187) 485 (374-604) 988 (805-1180) 2749 
Age group        
6-11 years 99-00 60.3 (49.4-73.6) 49.8 (41.0-61.8) 130 (85.2-164) 249 (192-481) 499 (250-703) 328 
 01-02 56.2 (47.0-67.2) 47.5 (40.9-61.1) 121 (93.7-143) 297 (208-420) 533 (377-717) 393 
 03-04 62.9 (54.3-72.9) 53.9 (46.4-67.9) 130 (112-159) 344 (195-377) 546 (358-949) 342 
 05-06 55.7 (45.7-67.9) 47.9 (38.3-61.6) 111 (73.9-147) 289 (173-368) 522 (326-719) 356 
 07-08 49.0 (42.4-56.6) 45.2 (38.5-53.3) 108 (80.5-135) 193 (155-227) 296 (214-359) 389 
 09-10 35.2 (31.2-39.8) 33.0 (29.8-37.8) 68.7 (54.3-80.9) 151 (114-207) 288 (205-530) 415 
12-19 years 99-00 139 (105-183) 127 (92.8-169) 372 (276-540) 994 (694-1420) 2150 (1020-2920) 752 
 01-02 130 (105-161) 121 (97.9-150) 316 (256-429) 835 (649-974) 1360 (969-2020) 742 
 03-04 148 (123-178) 146 (109-194) 367 (285-459) 828 (642-1030) 1520 (900-2180) 729 
 05-06 126 (108-146) 114 (96.4-134) 315 (256-390) 765 (636-1060) 1360 (1030-1680) 702 
 07-08 98.6 (79.1-123) 97.4 (68.3-130) 214 (173-330) 477 (356-705) 821 (511-1270) 401 
 09-10 64.0 (50.1-81.8) 53.9 (39.0-75.4) 151 (101-228) 354 (260-497) 662 (371-1190) 420 
20 years and older 99-00 125 (108-145) 119 (92.6-146) 318 (257-389) 882 (666-1100) 2300 (1470-3060) 1456 
 01-02 126 (113-141) 120 (101-140) 329 (291-374) 888 (702-1100) 1800 (1420-2420) 1647 
 03-04 135 (116-157) 124 (104-145) 351 (311-415) 1050 (807-1370) 1970 (1480-2510) 1534 
 05-06 114 (99.0-132) 111 (87.1-131) 299 (268-346) 782 (724-901) 1480 (1140-2080) 1490 
 07-08 95.3 (85.4-106) 84.7 (75.6-97.8) 264 (235-299) 673 (539-823) 1470 (913-1920) 1814 
 09-10 69.0 (61.8-76.9) 60.5 (54.0-68.7) 183 (159-207) 557 (445-712) 1110 (875-1350) 1914 
Gender        
Males 99-00 118 (98.5-142) 102 (78.3-130) 345 (246-429) 948 (672-1500) 2310 (1400-3010) 1214 
 01-02 120 (103-139) 113 (91.8-131) 331 (276-398) 957 (703-1390) 2040 (1390-2900) 1371 
 03-04 130 (114-148) 113 (97.8-133) 354 (296-432) 1000 (801-1370) 1920 (1460-2300) 1250 
 05-06 107 (92.1-124) 95.9 (75.8-120) 279 (227-340) 757 (651-855) 1470 (923-1930) 1270 
 07-08 92.8 (80.1-107) 81.0 (70.4-93.3) 245 (194-298) 659 (481-867) 1450 (851-1900) 1294 
 09-10 61.0 (54.2-68.6) 52.8 (45.4-58.3) 157 (126-202) 436 (342-586) 965 (768-1170) 1399 
Females 99-00 118 (102-136) 115 (91.3-139) 280 (231-335) 652 (581-813) 1470 (903-2560) 1322 
 01-02 115 (101-131) 110 (91.5-128) 282 (255-329) 692 (580-867) 1230 (982-1650) 1411 
 03-04 125 (106-148) 120 (90.9-145) 316 (258-372) 830 (639-1080) 1710 (1190-2260) 1355 
 05-06 110 (92.8-130) 109 (86.8-130) 291 (252-346) 734 (671-871) 1310 (1140-1900) 1278 
 07-08 88.2 (77.8-99.9) 82.4 (67.6-101) 233 (202-264) 553 (462-703) 1050 (713-1680) 1310 
 09-10 67.8 (60.3-76.4) 59.6 (52.4-73.7) 164 (148-192) 548 (392-675) 988 (777-1340) 1350 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 05-06, 07-08, and 09-10 are 0.792, 0.594, 0.264, 0.528, 0.462, and 0.396 respectively. 
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Urinary Mono-ethyl phthalate (MEP) (1999 – 2010) 
Metabolite of Diethyl phthalate (DEP) 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 119 (103-138) 115 (96.5-138) 291 (257-357) 842 (561-996) 1130 (966-1410) 813 
 01-02 149 (129-173) 145 (125-174) 349 (293-435) 984 (690-1390) 1730 (1010-2940) 677 
 03-04 176 (158-196) 164 (140-202) 394 (345-454) 1080 (873-1440) 2010 (1470-2840) 652 
 05-06 163 (130-203) 161 (124-186) 384 (310-466) 1030 (682-1830) 1930 (1170-3330) 637 
 07-08 122 (105-141) 111 (82.0-144) 314 (270-372) 850 (604-971) 1180 (971-1520) 531 
 09-10 82.2 (70.0-96.5) 72.6 (59.6-84.0) 199 (142-254) 586 (415-869) 1300 (818-1760) 566 
Non-Hispanic blacks 99-00 213 (182-249) 202 (169-231) 521 (419-626) 1250 (932-1500) 2380 (1410-3060) 603 
 01-02 233 (214-253) 235 (191-269) 563 (468-718) 1430 (1070-1630) 2340 (1860-3350) 703 
 03-04 236 (205-272) 202 (167-273) 626 (507-760) 1650 (1220-1970) 2880 (1840-3900) 699 
 05-06 219 (189-254) 199 (163-253) 522 (440-700) 1450 (1070-1900) 2610 (1900-3600) 678 
 07-08 168 (145-195) 165 (132-202) 415 (343-493) 994 (711-1260) 1920 (1090-3370) 597 
 09-10 156 (130-188) 137 (113-159) 405 (276-543) 1190 (841-1570) 1930 (1430-3380) 516 
Non-Hispanic whites 99-00 101 (87.6-116) 88.4 (71.0-104) 242 (189-318) 651 (527-882) 1630 (1050-2560) 908 
 01-02 104 (92.8-117) 96.8 (78.8-117) 273 (241-297) 672 (598-813) 1530 (1030-1800) 1216 
 03-04 110 (95.4-128) 97.8 (82.4-115) 276 (242-315) 801 (630-975) 1480 (1050-2170) 1088 
 05-06 91.3 (80.3-104) 84.2 (69.4-111) 232 (196-278) 600 (500-715) 1140 (757-1550) 1038 
 07-08 78.9 (70.4-88.5) 68.9 (59.8-80.1) 199 (175-233) 506 (429-650) 880 (670-1500) 1077 
 09-10 52.1 (48.1-56.5) 45.1 (40.0-51.6) 127 (106-140) 309 (259-394) 768 (468-988) 1206 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 05-06, 07-08, and 09-10 are 0.792, 0.594, 0.264, 0.528, 0.462, and 0.396 respectively. 
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Urinary Mono-ethyl phthalate (MEP) (2011 - 2012) 
Metabolite of Diethyl phthalate (DEP) 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 37.9 (33.0-43.5) 31.1 (27.3-37.9) 96.4 (83.7-114) 277 (227-367) 570 (419-738) 2489 
Age group        
6-11 years 11-12 23.4 (18.7-29.2) 24.5 (18.9-28.7) 49.8 (38.4-70.6) 112 (85.0-165) 199 (139-277) 396 
12-19 years 11-12 36.2 (27.9-47.0) 30.6 (24.0-40.4) 86.7 (59.0-129) 216 (155-256) 378 (254-642) 388 
20 years and older 11-12 40.2 (34.9-46.5) 32.0 (27.6-40.9) 105 (93.7-119) 315 (253-406) 688 (460-801) 1705 
Gender        
Males 11-12 38.1 (33.3-43.7) 29.6 (26.1-35.9) 93.8 (75.3-118) 262 (227-369) 566 (371-875) 1259 
Females 11-12 37.7 (30.6-46.4) 32.5 (25.2-45.3) 101 (82.8-118) 295 (207-406) 596 (447-727) 1230 
Race/ethnicity        
Mexican Americans 11-12 49.5 (39.3-62.3) 39.3 (34.0-47.0) 120 (69.8-163) 375 (259-561) 874 (394-1420) 316 
Non-Hispanic blacks 11-12 89.2 (77.9-102) 82.1 (71.0-93.2) 196 (166-229) 524 (381-669) 942 (653-1790) 665 
Non-Hispanic whites 11-12 30.4 (26.0-35.6) 25.4 (20.1-29.2) 77.6 (64.2-92.9) 221 (166-290) 460 (290-697) 813 
All Hispanics 11-12 55.5 (44.2-69.6) 47.6 (38.0-59.6) 132 (99.9-180) 406 (334-537) 809 (461-1240) 571 
Asians 11-12 23.3 (17.9-30.3) 18.8 (13.9-28.3) 60.7 (38.6-89.5) 166 (109-289) 405 (175-1080) 352 
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Urinary Mono-ethyl phthalate (MEP) (creatinine corrected) (1999 – 2010) 
Metabolite of Diethyl phthalate (DEP) 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 107 (98.0-118) 93.0 (85.4-104) 237 (203-278) 598 (497-781) 1290 (1100-1530) 2536 
 01-02 110 (99.3-122) 97.4 (87.9-107) 256 (218-287) 640 (532-778) 1220 (959-1450) 2782 
 03-04 120 (107-133) 101 (90.1-117) 298 (254-332) 733 (587-853) 1350 (1080-1680) 2605 
 05-06 106 (95.3-117) 92.3 (80.9-104) 242 (211-286) 625 (528-711) 1140 (942-1310) 2548 
 07-08 91.1 (82.6-101) 75.3 (68.6-83.5) 204 (185-231) 547 (433-680) 987 (821-1190) 2604 
 09-10 67.2 (60.5-74.7) 56.1 (48.9-66.8) 150 (128-172) 433 (373-524) 850 (709-999) 2749 
Age group        
6-11 years 99-00 61.1 (51.4-72.7) 52.5 (43.3-72.4) 109 (83.6-137) 225 (145-365) 412 (264-517) 328 
 01-02 64.0 (54.4-75.2) 53.6 (43.7-69.4) 117 (88.8-148) 338 (191-529) 556 (338-874) 393 
 03-04 66.6 (57.5-77.1) 57.4 (43.9-74.7) 119 (95.6-134) 310 (205-394) 474 (310-877) 342 
 05-06 61.3 (49.6-75.8) 50.1 (42.7-61.0) 107 (76.2-145) 279 (167-441) 512 (366-1210) 356 
 07-08 60.4 (53.9-67.7) 52.8 (42.4-64.2) 108 (96.3-134) 205 (166-237) 278 (228-386) 389 
 09-10 45.9 (41.0-51.3) 39.0 (34.7-41.8) 73.0 (63.2-87.2) 168 (125-234) 296 (182-590) 415 
12-19 years 99-00 93.7 (78.6-112) 80.7 (61.4-103) 240 (181-326) 580 (446-834) 1160 (661-1320) 752 
 01-02 100 (83.0-121) 92.4 (73.1-119) 218 (164-270) 533 (389-729) 878 (573-1220) 742 
 03-04 111 (93.1-132) 99.1 (81.2-121) 240 (193-320) 522 (389-714) 969 (651-1470) 729 
 05-06 93.6 (80.5-109) 85.3 (69.0-104) 201 (174-238) 500 (389-635) 813 (590-1110) 702 
 07-08 76.7 (61.8-95.1) 72.8 (53.3-91.3) 161 (108-218) 334 (213-491) 547 (334-866) 401 
 09-10 51.4 (40.8-64.9) 46.6 (31.2-68.8) 108 (84.2-137) 236 (150-393) 419 (268-524) 420 
20 years and older 99-00 118 (107-131) 102 (89.5-117) 257 (222-298) 669 (530-965) 1430 (1180-2210) 1456 
 01-02 119 (108-132) 105 (96.3-120) 277 (240-321) 702 (583-871) 1400 (1010-1840) 1647 
 03-04 130 (115-147) 117 (96.8-133) 338 (279-417) 815 (652-1060) 1510 (1170-2110) 1534 
 05-06 115 (103-128) 100 (87.6-117) 278 (233-309) 700 (574-803) 1220 (972-1530) 1490 
 07-08 97.9 (89.6-107) 78.7 (73.2-87.7) 236 (208-266) 624 (518-759) 1100 (875-1380) 1814 
 09-10 73.0 (65.1-81.9) 62.5 (52.4-72.8) 173 (149-195) 523 (407-662) 989 (810-1120) 1914 
Gender        
Males 99-00 92.8 (82.0-105) 79.0 (70.8-88.2) 214 (165-274) 661 (457-978) 1290 (965-1920) 1214 
 01-02 97.6 (85.8-111) 83.2 (72.6-96.8) 232 (186-280) 729 (554-974) 1400 (980-2000) 1371 
 03-04 102 (91.9-113) 83.7 (71.0-99.0) 258 (225-307) 704 (562-896) 1320 (1060-1590) 1250 
 05-06 85.7 (75.4-97.4) 73.0 (61.0-90.2) 204 (172-231) 504 (368-673) 898 (607-1240) 1270 
 07-08 78.1 (68.5-89.1) 65.5 (57.0-73.8) 181 (162-216) 490 (390-625) 936 (662-1190) 1294 
 09-10 54.7 (48.3-62.0) 43.3 (38.2-54.2) 125 (97.7-153) 314 (262-436) 792 (570-935) 1399 
Females 99-00 123 (109-139) 104 (93.7-118) 249 (203-326) 543 (460-770) 1270 (770-2250) 1322 
 01-02 123 (110-139) 113 (97.4-124) 269 (235-312) 568 (470-725) 944 (784-1330) 1411 
 03-04 139 (119-163) 120 (97.8-143) 335 (250-418) 741 (587-923) 1490 (951-2200) 1355 
 05-06 129 (116-144) 106 (97.4-121) 293 (247-333) 759 (629-920) 1370 (1150-1730) 1278 
 07-08 106 (95.5-117) 88.5 (77.6-98.6) 227 (188-278) 610 (491-727) 1040 (759-1520) 1310 
 09-10 81.9 (72.7-92.2) 69.9 (57.2-80.9) 178 (151-214) 523 (407-661) 987 (716-1220) 1350 
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Urinary Mono-ethyl phthalate (MEP) (creatinine corrected) (1999 2010) 
Metabolite of Diethyl phthalate (DEP) 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 108 (93.9-125) 102 (89.8-115) 252 (207-312) 538 (444-643) 875 (643-1270) 813 
 01-02 141 (120-165) 131 (108-160) 304 (261-378) 714 (568-1090) 1280 (928-1740) 677 
 03-04 159 (141-179) 154 (133-178) 352 (275-439) 815 (631-1060) 1500 (1190-2070) 652 
 05-06 146 (123-173) 125 (107-157) 324 (235-425) 767 (600-1020) 1410 (926-2510) 637 
 07-08 119 (100-140) 105 (81.9-142) 260 (224-306) 616 (502-750) 1230 (628-2160) 531 
 09-10 81.6 (70.9-93.8) 64.9 (56.3-72.7) 170 (131-254) 523 (324-792) 945 (685-1510) 566 
Non-Hispanic blacks 99-00 137 (121-156) 130 (109-151) 292 (257-333) 682 (503-1120) 1270 (810-1710) 603 
 01-02 163 (149-179) 150 (122-178) 367 (316-408) 818 (634-979) 1380 (1020-1850) 703 
 03-04 167 (148-189) 140 (124-162) 409 (314-522) 1010 (793-1300) 1710 (1420-2310) 699 
 05-06 154 (131-181) 134 (113-160) 360 (311-412) 919 (590-1290) 1700 (1070-2030) 678 
 07-08 131 (115-148) 121 (105-132) 280 (224-334) 614 (489-843) 1100 (836-1780) 597 
 09-10 113 (89.0-143) 92.7 (77.5-121) 236 (180-338) 722 (443-1210) 1300 (890-2240) 516 
Non-Hispanic whites 99-00 98.3 (88.9-109) 84.5 (72.9-93.7) 206 (158-255) 565 (432-916) 1290 (975-1810) 908 
 01-02 103 (93.5-114) 89.6 (82.1-98.9) 223 (190-265) 607 (470-765) 1050 (874-1440) 1216 
 03-04 109 (95.3-125) 88.9 (79.2-105) 254 (223-320) 652 (548-876) 1270 (922-1830) 1088 
 05-06 96.1 (86.5-107) 84.5 (71.2-97.6) 211 (189-242) 532 (450-686) 993 (828-1240) 1038 
 07-08 82.4 (74.7-90.9) 66.4 (58.5-73.8) 185 (158-219) 523 (397-640) 871 (708-1040) 1077 
 09-10 58.6 (53.2-64.4) 49.1 (41.4-56.8) 125 (110-146) 366 (278-437) 706 (515-965) 1206 
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Urinary Mono-ethyl phthalate (MEP) (creatinine corrected) (2011 - 2012) 
Metabolite of Diethyl phthalate (DEP) 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 43.2 (38.5-48.5) 34.4 (30.5-39.2) 94.2 (79.5-111) 263 (198-368) 541 (398-777) 2487 
Age group        
6-11 years 11-12 33.4 (26.7-41.6) 29.2 (23.0-36.7) 59.7 (39.8-99.6) 123 (90.0-172) 177 (144-353) 395 
12-19 years 11-12 35.3 (30.5-40.9) 29.4 (22.8-37.3) 61.1 (46.7-94.5) 157 (122-223) 262 (163-549) 388 
20 years and older 11-12 45.8 (40.4-52.0) 35.4 (32.2-42.3) 101 (86.9-124) 328 (235-405) 634 (432-1010) 1704 
Gender        
Males 11-12 35.8 (31.7-40.4) 29.3 (25.0-33.6) 77.3 (60.9-92.4) 203 (156-293) 455 (271-703) 1258 
Females 11-12 51.8 (44.5-60.4) 40.7 (34.0-49.9) 111 (89.2-132) 339 (249-415) 646 (436-1020) 1229 
Race/ethnicity        
Mexican Americans 11-12 55.7 (47.0-66.1) 41.6 (34.5-52.5) 122 (85.3-164) 335 (223-549) 736 (398-1080) 316 
Non-Hispanic blacks 11-12 69.4 (59.9-80.4) 57.7 (49.7-67.4) 141 (124-168) 404 (274-571) 973 (609-1220) 665 
Non-Hispanic whites 11-12 37.0 (31.9-43.0) 29.1 (25.0-33.0) 80.4 (62.3-98.6) 230 (152-346) 481 (314-704) 811 
All Hispanics 11-12 62.1 (52.3-73.8) 51.2 (42.6-57.4) 138 (101-187) 393 (257-484) 739 (398-1400) 571 
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Urinary Mono-2-ethylhexyl phthalate (MEHP) (1999 – 2010) 
Metabolite of Di-2-ethylhexyl phthalate (DEHP) 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 3.43 (3.19-3.69) 3.20 (3.00-3.60) 7.60 (6.80-8.40) 14.9 (13.5-17.4) 23.8 (19.2-28.6) 2541 
 01-02 4.27 (3.80-4.79) 4.20 (3.70-4.90) 9.80 (8.40-11.6) 23.0 (19.1-27.9) 39.2 (31.8-50.0) 2782 
 03-04 2.34 (2.10-2.62) 1.90 (1.70-2.40) 5.30 (4.50-6.60) 15.1 (11.4-20.6) 31.0 (21.4-42.0) 2605 
 05-06 3.04 (2.78-3.32) 2.50 (2.10-2.80) 6.30 (5.70-7.10) 17.7 (14.0-22.5) 39.7 (28.6-52.1) 2548 
 07-08 2.64 (2.29-3.05) 2.20 (1.80-2.50) 5.40 (4.30-6.90) 14.1 (11.2-20.2) 27.6 (19.8-39.8) 2604 
 09-10 1.59 (1.41-1.79) 1.51 (1.33-1.71) 3.52 (2.99-4.00) 7.54 (5.96-9.54) 14.1 (9.91-21.1) 2749 
Age group        
6-11 years 99-00 5.12 (4.42-5.92) 4.90 (3.70-6.40) 11.1 (8.30-13.6) 19.0 (13.8-36.1) 35.3 (15.6-130) 328 
 01-02 4.41 (3.90-5.00) 4.40 (4.10-5.30) 9.30 (7.90-11.7) 19.7 (14.6-25.9) 31.4 (21.8-47.9) 393 
 03-04 2.84 (2.10-3.84) 2.70 (1.80-4.10) 6.40 (4.40-9.60) 13.9 (7.80-27.6) 27.6 (11.3-64.7) 342 
 05-06 3.10 (2.78-3.47) 3.00 (2.60-3.30) 6.20 (5.10-7.10) 14.1 (9.40-19.3) 19.7 (14.7-36.6) 356 
 07-08 2.39 (2.05-2.80) 2.20 (1.70-2.90) 4.50 (3.70-6.20) 8.70 (6.40-13.9) 15.1 (10.6-24.1) 389 
 09-10 1.64 (1.45-1.85) 1.71 (1.26-2.02) 3.50 (3.09-3.94) 5.95 (4.56-7.56) 8.92 (6.94-12.9) 415 
12-19 years 99-00 3.75 (3.24-4.35) 3.70 (2.90-4.60) 8.10 (6.40-9.40) 15.3 (11.4-20.5) 22.8 (19.1-29.2) 752 
 01-02 4.57 (3.96-5.27) 4.50 (3.70-5.10) 11.0 (9.50-14.4) 23.0 (17.7-32.7) 42.5 (25.9-57.5) 742 
 03-04 2.77 (2.25-3.41) 2.50 (2.00-3.00) 6.40 (4.50-8.60) 18.6 (10.2-35.6) 40.6 (20.7-58.4) 729 
 05-06 3.72 (3.04-4.56) 3.20 (2.40-4.10) 8.80 (6.20-13.3) 22.6 (13.8-43.4) 48.7 (23.1-62.9) 702 
 07-08 2.99 (2.39-3.75) 2.30 (1.80-2.70) 6.00 (4.40-9.90) 21.1 (11.8-32.8) 37.6 (24.8-74.1) 401 
 09-10 1.82 (1.52-2.16) 1.66 (1.42-1.94) 3.98 (3.35-4.73) 9.53 (6.27-14.0) 17.6 (9.54-27.4) 420 
20 years and older 99-00 3.21 (2.94-3.51) 3.00 (2.70-3.40) 7.30 (6.40-8.00) 14.5 (12.1-17.0) 22.7 (17.5-27.0) 1461 
 01-02 4.20 (3.63-4.86) 4.10 (3.50-5.00) 9.50 (8.10-11.9) 23.5 (18.0-29.8) 39.5 (30.3-57.1) 1647 
 03-04 2.23 (2.03-2.44) 1.70 (1.50-2.00) 5.10 (4.50-6.00) 15.1 (10.9-19.7) 29.5 (20.4-40.0) 1534 
 05-06 2.94 (2.68-3.21) 2.30 (1.90-2.70) 6.20 (5.60-6.70) 17.7 (13.6-24.5) 41.5 (28.6-54.1) 1490 
 07-08 2.62 (2.27-3.02) 2.10 (1.80-2.50) 5.40 (4.20-7.10) 14.4 (11.2-20.2) 27.3 (19.2-40.6) 1814 
 09-10 1.55 (1.36-1.78) 1.44 (1.25-1.68) 3.40 (2.88-4.03) 7.39 (5.94-9.58) 14.6 (9.91-21.1) 1914 
Gender        
Males 99-00 3.68 (3.31-4.10) 3.40 (2.90-3.90) 8.00 (7.40-8.80) 16.0 (14.0-19.0) 25.3 (19.5-36.7) 1215 
 01-02 4.31 (3.84-4.83) 4.30 (3.70-5.10) 9.70 (8.30-11.2) 23.0 (16.9-29.8) 37.9 (29.9-48.4) 1371 
 03-04 2.56 (2.26-2.90) 2.20 (1.70-2.60) 6.00 (4.60-7.70) 17.2 (11.3-26.3) 33.3 (24.9-55.5) 1250 
 05-06 3.40 (3.01-3.85) 2.80 (2.40-3.30) 7.00 (5.70-9.00) 22.6 (15.0-35.8) 49.8 (35.2-67.4) 1270 
 07-08 2.77 (2.35-3.27) 2.30 (1.90-2.80) 5.50 (4.20-7.60) 14.4 (11.2-20.5) 28.9 (19.2-40.0) 1294 
 09-10 1.83 (1.63-2.05) 1.77 (1.63-1.91) 3.97 (3.49-4.51) 8.63 (6.94-11.9) 18.0 (12.6-29.0) 1399 
Females 99-00 3.21 (2.91-3.54) 3.10 (2.80-3.50) 7.10 (5.90-8.50) 13.6 (12.1-17.2) 21.9 (15.6-28.5) 1326 
 01-02 4.23 (3.67-4.86) 4.10 (3.50-5.00) 9.80 (8.40-12.2) 23.0 (19.5-28.4) 43.5 (31.4-53.7) 1411 
 03-04 2.15 (1.92-2.42) 1.80 (1.50-2.10) 4.90 (4.10-5.70) 13.2 (10.0-18.1) 27.8 (17.5-40.7) 1355 
 05-06 2.72 (2.49-2.98) 2.10 (1.90-2.40) 6.00 (5.20-6.80) 13.9 (11.7-17.5) 30.8 (21.9-36.2) 1278 
 07-08 2.52 (2.18-2.92) 2.00 (1.70-2.40) 5.10 (4.20-6.30) 14.1 (9.50-21.4) 26.4 (19.2-42.1) 1310 
 09-10 1.39 (1.21-1.60) 1.30 (1.12-1.53) 3.00 (2.51-3.62) 6.48 (5.45-8.09) 10.3 (8.33-14.9) 1350 
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Urinary Mono-2-ethylhexyl phthalate (MEHP) (1999 – 2010) 
Metabolite of Di-2-ethylhexyl phthalate (DEHP) 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 3.49 (3.16-3.85) 3.50 (3.10-3.90) 7.00 (5.70-8.60) 13.3 (10.7-18.7) 23.9 (17.4-27.3) 814 
 01-02 4.32 (3.75-4.98) 4.70 (3.80-5.70) 10.1 (8.50-11.4) 19.6 (16.6-23.0) 28.5 (24.2-39.9) 677 
 03-04 2.35 (1.87-2.96) 2.20 (1.50-3.00) 5.10 (4.30-6.60) 11.2 (7.50-16.5) 18.5 (11.6-38.2) 652 
 05-06 2.99 (2.50-3.57) 2.30 (1.70-3.30) 5.70 (4.70-7.60) 18.4 (12.1-30.6) 36.4 (26.2-63.8) 637 
 07-08 2.89 (2.38-3.50) 2.60 (2.00-3.10) 5.30 (4.40-8.20) 16.9 (10.3-27.3) 30.2 (22.9-34.3) 531 
 09-10 2.08 (1.84-2.36) 2.10 (1.86-2.40) 4.44 (3.73-5.63) 9.67 (6.89-16.0) 17.9 (13.1-24.3) 566 
Non-Hispanic blacks 99-00 4.82 (3.92-5.93) 5.20 (4.10-5.80) 9.50 (7.60-11.4) 19.5 (12.9-26.5) 29.5 (18.6-60.3) 603 
 01-02 6.60 (5.57-7.82) 6.70 (5.40-8.10) 15.4 (13.0-18.7) 32.9 (26.5-41.4) 52.6 (41.0-84.0) 703 
 03-04 3.61 (3.07-4.23) 3.50 (3.00-4.00) 8.50 (7.10-11.4) 22.9 (16.5-28.6) 35.2 (29.3-49.1) 699 
 05-06 4.09 (3.51-4.75) 3.70 (3.10-4.10) 9.10 (6.90-11.9) 22.5 (17.4-40.7) 59.3 (34.5-86.7) 678 
 07-08 3.30 (2.98-3.64) 3.20 (2.70-3.60) 7.20 (6.30-8.90) 15.3 (13.3-20.2) 25.5 (19.2-38.1) 597 
 09-10 2.08 (1.79-2.41) 2.05 (1.70-2.42) 4.79 (3.80-5.95) 10.1 (7.50-14.4) 16.4 (9.60-38.4) 516 
Non-Hispanic whites 99-00 3.16 (2.89-3.46) 2.80 (2.50-3.10) 7.40 (6.30-8.40) 14.5 (12.2-17.4) 22.4 (16.9-28.5) 912 
 01-02 3.85 (3.37-4.40) 3.70 (3.10-4.40) 8.70 (7.80-9.90) 20.9 (17.3-25.9) 37.9 (29.9-49.5) 1216 
 03-04 2.14 (1.92-2.39) 1.70 (1.40-1.90) 4.80 (4.00-5.80) 13.6 (9.50-20.0) 31.0 (18.1-48.9) 1088 
 05-06 2.83 (2.59-3.10) 2.20 (1.80-2.60) 5.90 (5.30-6.90) 17.0 (13.3-21.6) 36.3 (26.6-51.0) 1038 
 07-08 2.44 (2.07-2.88) 2.00 (1.70-2.30) 4.90 (3.70-6.20) 13.1 (8.70-20.1) 25.0 (15.8-42.1) 1077 
 09-10 1.41 (1.22-1.62) 1.30 (1.12-1.57) 3.04 (2.53-3.60) 6.12 (5.23-7.65) 11.8 (7.63-21.1) 1206 
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Urinary Mono-2-ethylhexyl phthalate (MEHP) (2011 - 2012) 
Metabolite of Di-2-ethylhexyl phthalate (DEHP) 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 1.36 (1.25-1.49) 1.40 (1.20-1.50) 3.00 (2.70-3.30) 6.00 (5.30-6.40) 8.70 (7.60-9.70) 2489 
Age group        
6-11 years 11-12 1.41 (1.23-1.61) 1.50 (1.20-1.80) 2.90 (2.50-3.40) 5.30 (4.10-7.10) 7.60 (6.30-8.80) 396 
12-19 years 11-12 1.58 (1.33-1.87) 1.50 (1.00-2.30) 3.90 (3.10-4.40) 6.80 (5.20-10.3) 12.5 (8.90-14.3) 388 
20 years and older 11-12 1.33 (1.19-1.48) 1.30 (1.10-1.50) 2.90 (2.50-3.20) 5.90 (5.10-6.40) 8.30 (7.10-9.60) 1705 
Gender        
Males 11-12 1.51 (1.33-1.70) 1.50 (1.20-1.80) 3.10 (2.60-3.90) 6.10 (5.50-7.00) 9.20 (7.70-11.3) 1259 
Females 11-12 1.24 (1.14-1.34) 1.20 (1.00-1.40) 2.90 (2.50-3.10) 5.60 (4.90-6.30) 8.10 (6.80-9.20) 1230 
Race/ethnicity        
Mexican Americans 11-12 1.49 (1.16-1.91) 1.50 (1.00-1.90) 3.40 (2.50-4.30) 6.60 (5.10-8.90) 9.60 (6.60-12.9) 316 
Non-Hispanic blacks 11-12 1.89 (1.67-2.13) 2.00 (1.60-2.40) 4.00 (3.40-4.90) 8.00 (6.20-9.70) 11.3 (9.60-14.9) 665 
Non-Hispanic whites 11-12 1.21 (1.07-1.37) 1.10 (.900-1.50) 2.70 (2.20-3.10) 4.90 (4.20-6.10) 6.70 (6.00-8.30) 813 
All Hispanics 11-12 1.61 (1.40-1.83) 1.70 (1.30-2.00) 3.90 (3.10-4.70) 7.30 (6.30-8.70) 11.6 (9.20-12.9) 571 
Asians 11-12 1.69 (1.44-1.98) 1.70 (1.30-1.90) 3.60 (2.80-4.40) 7.80 (6.60-11.4) 13.8 (10.0-17.8) 352 
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Urinary Mono-2-ethylhexyl phthalate (MEHP) (creatinine corrected) (1999 – 2010) 
Metabolite of Di-2-ethylhexyl phthalate (DEHP) 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 3.12 (2.95-3.31) 3.08 (2.82-3.27) 5.88 (5.38-6.25) 10.8 (9.62-12.5) 18.9 (15.0-21.8) 2541 
 01-02 4.00 (3.58-4.48) 3.90 (3.44-4.47) 7.94 (7.22-9.02) 18.0 (15.3-21.5) 32.8 (25.2-42.9) 2782 
 03-04 2.20 (2.01-2.41) 1.89 (1.68-2.19) 4.31 (3.84-4.74) 10.8 (8.72-13.8) 25.4 (16.7-34.7) 2605 
 05-06 2.96 (2.72-3.23) 2.61 (2.37-2.86) 5.69 (5.00-6.47) 13.7 (11.4-17.8) 30.1 (21.2-35.2) 2548 
 07-08 2.66 (2.37-2.99) 2.36 (2.11-2.67) 5.15 (4.35-6.00) 11.8 (8.89-15.6) 21.9 (14.6-33.4) 2604 
 09-10 1.66 (1.45-1.90) 1.52 (1.36-1.77) 3.09 (2.69-3.60) 6.28 (4.98-8.48) 11.2 (8.33-19.1) 2749 
Age group        
6-11 years 99-00 5.19 (4.55-5.93) 5.37 (4.52-5.95) 9.11 (8.06-11.4) 21.6 (11.5-41.9) 41.9 (13.5-86.2) 328 
 01-02 5.03 (4.47-5.65) 5.38 (4.51-6.21) 9.90 (7.87-11.5) 21.1 (13.8-28.8) 31.4 (24.3-40.7) 393 
 03-04 3.00 (2.30-3.93) 2.80 (1.93-4.09) 5.86 (4.69-7.70) 14.3 (8.54-24.4) 28.7 (14.1-45.3) 342 
 05-06 3.42 (3.08-3.79) 3.26 (2.63-3.92) 6.18 (5.40-6.85) 11.3 (8.96-17.4) 20.7 (11.3-31.8) 356 
 07-08 2.95 (2.49-3.49) 2.80 (2.17-3.33) 5.42 (3.95-6.51) 10.6 (7.47-14.0) 15.6 (10.6-23.7) 389 
 09-10 2.13 (1.90-2.40) 2.08 (1.88-2.33) 3.69 (3.13-4.20) 5.83 (4.80-7.95) 8.89 (5.88-20.1) 415 
12-19 years 99-00 2.53 (2.14-2.99) 2.35 (2.05-2.76) 5.83 (4.38-6.29) 9.66 (7.41-11.5) 12.1 (10.5-17.3) 752 
 01-02 3.53 (3.09-4.03) 3.67 (2.89-4.48) 7.47 (6.51-8.67) 15.2 (11.7-21.9) 25.2 (17.7-32.8) 742 
 03-04 2.07 (1.74-2.48) 1.88 (1.60-2.23) 4.25 (3.19-5.62) 11.6 (6.83-23.2) 24.8 (11.6-37.9) 729 
 05-06 2.77 (2.27-3.38) 2.43 (2.03-2.87) 5.24 (4.06-7.75) 15.2 (9.86-23.2) 27.1 (16.0-43.7) 702 
 07-08 2.33 (1.90-2.86) 2.00 (1.67-2.57) 4.33 (3.55-6.23) 12.6 (8.31-16.3) 21.9 (12.0-45.7) 401 
 09-10 1.46 (1.20-1.77) 1.33 (1.09-1.61) 2.85 (2.24-3.63) 7.47 (4.31-11.6) 13.2 (8.11-20.9) 420 
20 years and older 99-00 3.03 (2.83-3.25) 2.98 (2.73-3.23) 5.55 (4.90-6.06) 10.0 (8.60-12.9) 17.5 (13.8-22.1) 1461 
 01-02 3.97 (3.49-4.52) 3.82 (3.26-4.38) 7.79 (7.00-9.00) 18.3 (15.3-21.8) 34.5 (23.1-47.9) 1647 
 03-04 2.14 (1.98-2.31) 1.84 (1.63-2.08) 4.14 (3.78-4.40) 10.5 (8.38-12.9) 25.6 (15.9-36.3) 1534 
 05-06 2.94 (2.69-3.23) 2.60 (2.36-2.83) 5.67 (4.77-6.52) 13.8 (11.3-18.1) 33.1 (21.9-47.4) 1490 
 07-08 2.69 (2.39-3.02) 2.36 (2.14-2.66) 5.20 (4.38-6.04) 11.8 (8.94-16.6) 22.1 (13.5-37.1) 1814 
 09-10 1.65 (1.43-1.90) 1.51 (1.34-1.75) 3.04 (2.63-3.60) 6.24 (4.98-8.61) 11.1 (8.03-19.4) 1914 
Gender        
Males 99-00 2.89 (2.60-3.22) 2.76 (2.52-2.96) 5.58 (4.71-6.08) 10.3 (9.35-12.4) 21.6 (14.1-27.7) 1215 
 01-02 3.50 (3.08-3.99) 3.33 (2.83-3.90) 7.00 (6.49-7.77) 16.2 (12.8-20.9) 31.6 (20.5-49.4) 1371 
 03-04 2.01 (1.82-2.21) 1.71 (1.46-1.89) 4.14 (3.49-4.81) 10.4 (7.68-16.2) 23.3 (15.1-41.1) 1250 
 05-06 2.73 (2.43-3.07) 2.30 (2.12-2.61) 5.08 (4.29-6.14) 14.3 (11.2-20.5) 31.0 (21.5-50.9) 1270 
 07-08 2.33 (2.03-2.68) 2.00 (1.71-2.34) 4.36 (3.71-5.41) 11.6 (8.33-14.2) 20.2 (14.6-26.3) 1294 
 09-10 1.64 (1.45-1.85) 1.52 (1.39-1.74) 3.06 (2.70-3.60) 6.53 (5.18-9.49) 13.0 (8.65-22.2) 1399 
Females 99-00 3.36 (3.11-3.63) 3.33 (2.91-3.80) 6.15 (5.55-6.77) 11.1 (9.11-14.0) 17.3 (12.4-24.6) 1326 
 01-02 4.54 (4.02-5.13) 4.47 (3.85-5.14) 9.28 (7.94-10.3) 20.3 (16.6-24.4) 34.7 (27.1-42.0) 1411 
 03-04 2.40 (2.15-2.69) 2.16 (1.84-2.40) 4.40 (3.97-4.89) 10.9 (8.27-16.0) 27.0 (17.5-34.6) 1355 
 05-06 3.20 (2.89-3.55) 2.89 (2.58-3.17) 6.07 (5.00-7.00) 13.3 (10.4-16.3) 28.2 (18.2-37.4) 1278 
 07-08 3.02 (2.70-3.38) 2.76 (2.36-3.02) 5.57 (4.90-6.50) 12.1 (8.64-18.2) 24.7 (14.8-44.4) 1310 
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Urinary Mono-2-ethylhexyl phthalate (MEHP) (creatinine corrected) (1999 – 2010) 
Metabolite of Di-2-ethylhexyl phthalate (DEHP) 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 3.16 (2.72-3.68) 3.15 (2.52-3.81) 5.88 (4.86-7.24) 11.6 (9.63-13.1) 15.7 (12.6-23.1) 814 
 01-02 4.07 (3.60-4.61) 4.18 (3.82-4.90) 7.80 (6.64-9.49) 16.4 (13.6-18.9) 24.9 (19.8-28.7) 677 
 03-04 2.12 (1.74-2.59) 1.94 (1.50-2.42) 4.06 (3.29-4.93) 9.38 (5.72-15.4) 16.8 (9.86-38.6) 652 
 05-06 2.69 (2.36-3.07) 2.41 (2.04-2.73) 4.82 (4.09-6.05) 14.3 (10.0-16.9) 27.2 (16.3-40.1) 637 
 07-08 2.82 (2.38-3.34) 2.45 (2.08-2.89) 5.00 (4.14-6.86) 12.3 (9.58-20.7) 29.0 (17.0-50.3) 531 
 09-10 2.07 (1.83-2.34) 1.89 (1.69-2.31) 4.06 (3.50-4.98) 8.38 (6.08-11.3) 13.9 (9.70-20.0) 566 
Non-Hispanic blacks 99-00 3.11 (2.59-3.73) 3.13 (2.50-3.61) 5.84 (4.43-7.32) 10.2 (8.05-15.6) 18.4 (11.6-35.2) 603 
 01-02 4.63 (3.96-5.42) 4.59 (3.97-5.02) 9.93 (7.95-12.4) 21.2 (16.0-33.2) 39.9 (27.7-48.1) 703 
 03-04 2.56 (2.24-2.92) 2.28 (2.02-2.78) 5.17 (4.48-6.83) 13.2 (10.5-16.2) 27.5 (18.4-36.0) 699 
 05-06 2.87 (2.45-3.38) 2.41 (2.09-2.78) 5.72 (4.40-7.29) 15.0 (12.0-20.6) 54.4 (18.4-84.0) 678 
 07-08 2.56 (2.26-2.90) 2.40 (2.17-2.73) 4.77 (4.07-5.76) 11.4 (8.75-15.4) 18.0 (16.1-26.3) 597 
 09-10 1.51 (1.22-1.86) 1.48 (1.14-1.93) 2.87 (2.26-3.69) 5.73 (3.69-10.7) 10.7 (5.61-19.1) 516 
Non-Hispanic whites 99-00 3.09 (2.84-3.36) 3.08 (2.73-3.47) 5.87 (5.11-6.67) 10.6 (8.95-13.5) 20.0 (14.0-24.6) 912 
 01-02 3.81 (3.34-4.35) 3.67 (3.11-4.33) 7.78 (6.74-9.35) 17.0 (14.1-21.8) 32.8 (21.5-46.9) 1216 
 03-04 2.12 (1.91-2.35) 1.82 (1.60-2.13) 4.11 (3.49-4.42) 10.7 (7.42-15.1) 27.0 (15.1-37.4) 1088 
 05-06 2.98 (2.77-3.21) 2.66 (2.43-2.93) 5.73 (5.00-6.47) 13.4 (11.3-17.8) 27.7 (19.5-37.4) 1038 
 07-08 2.55 (2.20-2.94) 2.26 (1.97-2.67) 4.90 (3.99-5.92) 11.0 (7.80-14.8) 20.5 (11.9-30.2) 1077 
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Urinary Mono-2-ethylhexyl phthalate (MEHP) (creatinine corrected) (2011 - 2012) 
Metabolite of Di-2-ethylhexyl phthalate (DEHP) 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 1.55 (1.43-1.68) 1.46 (1.33-1.67) 2.73 (2.50-2.92) 4.91 (4.55-5.52) 8.47 (6.72-9.86) 2487 
Age group        
6-11 years 11-12 2.02 (1.81-2.25) 2.07 (1.75-2.44) 3.45 (2.82-4.06) 5.26 (4.60-5.89) 7.15 (5.89-8.17) 395 
12-19 years 11-12 1.53 (1.33-1.78) 1.40 (1.12-1.88) 2.79 (2.20-3.88) 5.00 (4.11-6.94) 9.86 (5.00-11.1) 388 
20 years and older 11-12 1.51 (1.39-1.64) 1.46 (1.28-1.58) 2.59 (2.38-2.84) 4.81 (4.35-5.51) 8.49 (6.18-11.2) 1704 
Gender        
Males 11-12 1.41 (1.28-1.56) 1.36 (1.19-1.58) 2.52 (2.21-2.83) 4.58 (3.77-5.46) 7.19 (6.16-8.79) 1258 
Females 11-12 1.70 (1.56-1.85) 1.58 (1.43-1.75) 2.86 (2.63-3.18) 5.36 (4.64-5.89) 8.89 (6.67-13.2) 1229 
Race/ethnicity        
Mexican Americans 11-12 1.68 (1.36-2.06) 1.67 (1.21-2.06) 2.91 (2.46-3.50) 6.23 (4.32-9.05) 11.3 (5.67-18.3) 316 
Non-Hispanic blacks 11-12 1.47 (1.29-1.67) 1.44 (1.26-1.75) 2.75 (2.37-3.14) 5.16 (4.17-7.05) 8.69 (6.07-12.1) 665 
Non-Hispanic whites 11-12 1.47 (1.29-1.68) 1.45 (1.25-1.65) 2.51 (2.17-2.84) 4.43 (3.77-5.00) 6.77 (5.00-9.54) 811 
All Hispanics 11-12 1.80 (1.63-1.98) 1.79 (1.59-2.00) 3.32 (2.86-3.76) 6.37 (5.67-8.07) 11.3 (7.79-14.4) 571 
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Urinary Mono-(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP) (2001 – 2010) 
Metabolite of Di-2-ethylhexyl phthalate (DEHP) 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 01-02 20.0 (17.8-22.5) 20.1 (17.8-22.4) 43.6 (38.0-49.7) 92.3 (77.0-108) 192 (131-256) 2782 
 03-04 21.7 (19.3-24.4) 21.2 (18.7-24.1) 49.1 (40.5-56.9) 121 (91.3-164) 266 (165-383) 2605 
 05-06 25.5 (23.0-28.2) 23.8 (21.5-26.8) 55.1 (50.2-61.0) 153 (132-180) 306 (240-421) 2548 
 07-08 22.1 (18.7-26.0) 20.7 (17.6-23.7) 48.2 (39.8-61.8) 123 (83.7-181) 238 (171-336) 2604 
 09-10 12.9 (11.3-14.7) 12.9 (11.4-14.8) 25.8 (22.1-30.3) 53.2 (41.7-75.2) 103 (74.2-149) 2749 
Age group        
6-11 years 01-02 33.6 (29.7-37.9) 32.9 (26.9-39.1) 66.9 (49.7-74.0) 127 (103-148) 216 (137-280) 393 
 03-04 36.9 (28.4-47.9) 36.5 (26.5-47.0) 77.4 (49.1-103) 164 (79.9-350) 318 (164-400) 342 
 05-06 34.9 (30.8-39.6) 35.7 (31.3-40.7) 68.9 (56.5-76.0) 140 (101-169) 206 (133-401) 356 
 07-08 28.6 (23.4-34.8) 27.0 (20.1-36.4) 56.1 (45.4-67.8) 113 (76.5-218) 242 (109-351) 389 
 09-10 15.0 (13.2-17.1) 17.0 (14.1-19.8) 28.9 (24.4-37.4) 49.3 (41.2-70.2) 75.1 (55.2-117) 415 
12-19 years 01-02 24.9 (21.3-29.1) 25.3 (22.9-31.3) 50.6 (40.7-64.5) 107 (78.5-148) 216 (117-330) 742 
 03-04 28.3 (23.0-34.8) 29.8 (25.9-33.9) 56.9 (45.4-73.7) 157 (84.1-299) 317 (176-553) 729 
 05-06 34.8 (28.0-43.3) 32.5 (27.1-42.2) 79.5 (66.9-103) 213 (131-384) 424 (232-836) 702 
 07-08 29.8 (22.5-39.3) 26.6 (20.0-35.4) 66.7 (43.7-96.6) 224 (101-417) 417 (209-615) 401 
 09-10 15.3 (12.4-18.8) 14.9 (12.0-18.0) 28.8 (22.7-41.0) 70.2 (41.0-110) 117 (61.0-215) 420 
20 years and older 01-02 18.1 (15.7-20.9) 17.8 (14.7-20.7) 39.8 (32.7-48.0) 86.2 (65.7-107) 175 (110-279) 1647 
 03-04 19.5 (17.7-21.5) 18.4 (16.6-21.0) 41.9 (36.9-51.2) 107 (88.2-136) 225 (148-384) 1534 
 05-06 23.4 (21.1-25.9) 21.4 (19.5-23.7) 48.6 (43.7-55.1) 148 (121-172) 306 (238-421) 1490 
 07-08 20.5 (17.4-24.1) 19.6 (17.1-22.2) 46.3 (37.2-59.9) 110 (75.0-169) 214 (157-303) 1814 
 09-10 12.4 (10.7-14.3) 12.5 (10.8-14.3) 24.5 (21.1-29.3) 52.5 (40.1-72.6) 104 (72.6-151) 1914 
Gender        
Males 01-02 22.0 (19.5-24.7) 21.2 (19.4-24.2) 48.0 (41.4-54.4) 94.2 (80.8-110) 212 (130-256) 1371 
 03-04 24.1 (20.9-27.9) 22.9 (19.2-27.9) 51.0 (40.5-59.8) 133 (94.8-220) 317 (162-470) 1250 
 05-06 29.6 (26.0-33.8) 27.2 (22.9-31.0) 63.1 (54.3-71.9) 180 (143-263) 494 (285-626) 1270 
 07-08 23.2 (19.4-27.8) 20.8 (18.1-24.5) 46.0 (39.2-57.3) 132 (85.4-190) 277 (162-349) 1294 
 09-10 15.2 (13.1-17.6) 14.6 (12.9-16.4) 29.5 (24.6-36.2) 71.0 (50.3-93.5) 128 (90.6-181) 1399 
Females 01-02 18.3 (15.7-21.4) 18.2 (14.9-22.1) 39.8 (34.3-46.0) 86.0 (69.4-115) 170 (119-273) 1411 
 03-04 19.7 (17.4-22.2) 19.4 (16.7-22.8) 46.4 (37.5-54.4) 103 (84.1-148) 214 (140-318) 1355 
 05-06 22.0 (19.2-25.2) 21.4 (19.5-23.4) 47.1 (42.6-54.3) 135 (113-156) 232 (186-300) 1278 
 07-08 21.0 (17.8-24.8) 19.9 (16.8-23.3) 51.0 (39.9-64.6) 121 (76.9-183) 223 (171-336) 1310 
 09-10 11.0 (9.58-12.8) 11.6 (9.73-13.5) 22.5 (19.2-27.2) 42.8 (33.2-59.1) 82.2 (53.1-116) 1350 
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Urinary Mono-(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP) (2001 – 2010) 
Metabolite of Di-2-ethylhexyl phthalate (DEHP) 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 01-02 18.5 (16.2-21.1) 19.1 (16.3-21.6) 36.3 (31.6-44.0) 79.9 (66.4-93.9) 123 (100-161) 677 
 03-04 18.9 (15.4-23.4) 19.8 (17.6-22.3) 37.5 (30.0-45.6) 72.2 (52.4-115) 116 (71.6-327) 652 
 05-06 23.0 (18.0-29.3) 19.9 (15.7-23.9) 47.8 (34.8-65.3) 136 (84.6-223) 244 (157-520) 637 
 07-08 22.7 (18.5-27.7) 19.8 (17.5-23.8) 43.6 (33.5-66.6) 104 (82.8-157) 238 (158-282) 531 
 09-10 15.3 (12.9-18.2) 15.8 (13.3-18.3) 31.5 (26.6-39.2) 64.5 (46.4-94.9) 108 (70.7-153) 566 
Non-Hispanic blacks 01-02 29.8 (26.1-34.1) 30.9 (27.2-34.3) 61.9 (52.6-69.4) 126 (108-157) 276 (157-339) 703 
 03-04 30.8 (26.8-35.5) 29.1 (25.3-32.3) 65.6 (53.7-76.3) 154 (113-178) 275 (174-401) 699 
 05-06 34.8 (30.3-39.9) 30.2 (27.6-33.2) 73.8 (61.0-96.7) 206 (156-275) 395 (274-547) 678 
 07-08 25.7 (23.1-28.6) 25.8 (22.4-28.9) 55.9 (47.1-64.7) 121 (99.1-150) 184 (137-255) 597 
 09-10 15.5 (12.8-18.8) 15.7 (13.4-17.7) 30.4 (24.4-35.7) 54.5 (37.7-84.1) 94.6 (51.5-229) 516 
Non-Hispanic whites 01-02 19.1 (16.7-21.9) 19.2 (16.9-21.4) 41.7 (35.3-50.7) 91.1 (75.6-110) 212 (130-275) 1216 
 03-04 20.8 (18.6-23.3) 19.7 (17.2-22.5) 47.5 (39.4-56.1) 120 (91.3-165) 270 (155-403) 1088 
 05-06 24.3 (21.9-26.9) 23.0 (21.1-26.0) 54.6 (48.4-61.0) 148 (121-172) 302 (221-421) 1038 
 07-08 21.3 (17.6-25.8) 20.2 (16.5-24.1) 46.7 (36.1-65.2) 123 (75.1-203) 277 (161-373) 1077 
 09-10 12.2 (10.5-14.1) 12.3 (10.5-14.2) 24.4 (20.7-29.1) 51.7 (37.7-77.1) 104 (72.6-151) 1206 
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Urinary Mono-(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP) (2011 - 2012) 
Metabolite of Di-2-ethylhexyl phthalate (DEHP) 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 7.91 (7.47-8.36) 8.30 (7.50-9.00) 16.0 (14.4-17.4) 29.0 (25.8-32.5) 43.1 (40.6-47.2) 2489 
Age group        
6-11 years 11-12 10.5 (8.82-12.4) 11.8 (10.4-14.2) 23.3 (19.9-26.1) 39.5 (30.6-50.3) 55.4 (41.8-68.5) 396 
12-19 years 11-12 8.55 (6.93-10.6) 8.80 (6.80-10.6) 18.3 (14.3-23.2) 36.0 (27.4-46.6) 56.7 (38.1-99.8) 388 
20 years and older 11-12 7.58 (7.03-8.16) 8.00 (7.20-8.90) 15.0 (13.5-16.9) 26.7 (23.8-30.6) 41.5 (34.7-46.2) 1705 
Gender        
Males 11-12 8.71 (7.98-9.51) 9.40 (7.80-10.6) 16.4 (14.2-19.5) 31.1 (26.7-35.8) 46.2 (41.5-55.4) 1259 
Females 11-12 7.20 (6.77-7.66) 7.60 (6.90-8.20) 15.5 (14.4-17.1) 27.6 (25.0-30.5) 40.7 (35.1-46.4) 1230 
Race/ethnicity        
Mexican Americans 11-12 9.13 (7.22-11.5) 9.60 (7.30-11.7) 17.7 (12.7-24.7) 32.1 (24.8-37.7) 50.2 (36.4-56.3) 316 
Non-Hispanic blacks 11-12 11.3 (10.1-12.7) 11.2 (10.2-12.7) 22.1 (17.4-26.8) 38.8 (34.9-47.9) 56.2 (46.8-65.1) 665 
Non-Hispanic whites 11-12 7.20 (6.73-7.70) 7.40 (6.80-8.30) 14.6 (12.9-17.2) 25.0 (23.4-27.9) 36.6 (30.6-42.9) 813 
All Hispanics 11-12 9.28 (8.07-10.7) 9.40 (7.70-10.8) 18.8 (15.3-22.9) 37.5 (32.1-43.9) 53.8 (46.3-70.6) 571 
Asians 11-12 6.85 (5.53-8.48) 6.70 (5.40-7.90) 15.1 (11.5-18.6) 31.8 (22.5-41.9) 64.2 (35.7-82.8) 352 
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Urinary Mono-(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP) (creatinine corrected) (2001 – 2010) 
Metabolite of Di-2-ethylhexyl phthalate (DEHP) 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 01-02 18.8 (17.0-20.7) 16.6 (14.9-18.5) 32.2 (27.8-37.1) 71.1 (58.7-88.3) 143 (101-200) 2782 
 03-04 20.4 (18.7-22.3) 17.7 (16.3-19.6) 35.8 (30.5-43.3) 93.5 (74.0-128) 182 (134-262) 2605 
 05-06 24.8 (22.4-27.5) 21.4 (19.1-23.4) 46.1 (40.0-52.1) 117 (97.8-148) 235 (197-272) 2548 
 07-08 22.2 (19.4-25.5) 19.3 (17.4-22.1) 40.5 (34.1-50.3) 99.3 (69.7-134) 179 (135-252) 2604 
 09-10 13.5 (11.6-15.6) 11.9 (10.5-13.9) 22.3 (18.6-26.4) 44.0 (35.3-61.0) 86.3 (59.2-131) 2749 
Age group        
6-11 years 01-02 38.2 (34.3-42.6) 34.3 (29.9-38.9) 60.6 (51.9-76.4) 107 (96.3-147) 211 (122-313) 393 
 03-04 39.0 (31.1-48.9) 36.6 (25.3-49.3) 65.6 (49.8-91.3) 129 (77.1-253) 211 (123-708) 342 
 05-06 38.5 (34.2-43.3) 37.0 (32.9-40.3) 65.5 (55.4-71.9) 115 (85.1-165) 213 (119-333) 356 
 07-08 35.2 (29.1-42.5) 31.4 (25.6-37.8) 53.5 (44.8-72.3) 139 (79.9-230) 258 (141-303) 389 
 09-10 19.6 (17.3-22.2) 18.6 (16.5-21.5) 34.2 (27.3-40.4) 55.4 (44.0-64.8) 72.1 (56.3-140) 415 
12-19 years 01-02 19.2 (17.0-21.8) 17.8 (15.6-20.0) 34.9 (29.2-42.7) 73.4 (58.4-80.7) 102 (86.6-160) 742 
 03-04 21.2 (18.1-24.7) 18.6 (16.9-21.7) 38.7 (29.7-53.4) 103 (62.7-209) 212 (100-358) 729 
 05-06 26.0 (21.2-31.7) 23.7 (18.8-28.4) 49.4 (37.4-74.0) 131 (79.0-228) 278 (132-375) 702 
 07-08 23.2 (18.1-29.6) 20.0 (14.6-23.9) 46.1 (31.5-66.3) 148 (66.6-234) 234 (146-373) 401 
 09-10 12.3 (9.73-15.5) 10.5 (8.95-13.3) 20.9 (14.2-31.0) 45.3 (28.9-91.9) 110 (44.6-200) 420 
20 years and older 01-02 17.1 (15.2-19.3) 15.0 (13.3-16.7) 27.7 (23.2-34.0) 63.7 (48.3-86.9) 137 (84.4-203) 1647 
 03-04 18.8 (17.5-20.2) 16.3 (15.4-17.5) 31.6 (28.1-35.3) 83.8 (67.2-106) 171 (129-246) 1534 
 05-06 23.4 (21.1-26.0) 19.4 (17.6-21.8) 42.5 (37.6-49.2) 115 (93.1-153) 235 (184-298) 1490 
 07-08 21.0 (18.5-24.0) 18.5 (16.3-20.2) 38.1 (30.9-49.2) 94.3 (62.6-126) 164 (120-235) 1814 
 09-10 13.1 (11.3-15.2) 11.5 (10.1-13.4) 20.9 (17.7-25.1) 40.6 (32.4-64.9) 86.3 (59.2-131) 1914 
Gender        
Males 01-02 17.9 (16.2-19.7) 15.4 (13.8-17.9) 32.2 (27.8-36.8) 73.4 (55.3-91.8) 137 (97.7-224) 1371 
 03-04 18.9 (17.1-20.9) 17.1 (15.2-18.6) 32.7 (26.6-41.6) 93.4 (68.8-123) 193 (108-291) 1250 
 05-06 23.8 (21.0-26.9) 20.2 (17.5-23.3) 44.8 (38.5-54.1) 129 (92.5-166) 251 (202-352) 1270 
 07-08 19.6 (16.8-22.7) 16.8 (14.6-20.0) 34.8 (28.7-41.8) 90.3 (65.2-119) 164 (111-258) 1294 
 09-10 13.6 (11.7-15.9) 11.6 (10.5-13.1) 22.9 (17.8-27.4) 52.8 (39.1-74.3) 103 (73.3-173) 1399 
Females 01-02 19.7 (17.3-22.4) 17.6 (15.4-19.5) 32.1 (26.8-38.6) 70.5 (57.8-93.7) 156 (93.7-201) 1411 
 03-04 21.9 (19.7-24.5) 18.7 (16.8-20.9) 39.3 (33.8-46.9) 94.3 (72.8-136) 171 (146-261) 1355 
 05-06 25.9 (23.2-28.8) 22.5 (19.6-25.5) 47.3 (40.5-52.3) 108 (88.8-131) 202 (157-278) 1278 
 07-08 25.2 (22.1-28.6) 22.1 (19.6-24.4) 47.4 (38.5-56.1) 112 (84.6-150) 190 (162-268) 1310 
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Urinary Mono-(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP) (creatinine corrected) (2001 – 2010) 
Metabolite of Di-2-ethylhexyl phthalate (DEHP) 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 01-02 17.4 (15.9-19.1) 15.7 (14.4-17.5) 30.6 (26.0-34.7) 65.9 (50.6-83.9) 103 (75.5-128) 677 
 03-04 17.1 (14.3-20.4) 15.4 (13.2-17.7) 29.3 (23.8-36.8) 57.3 (45.7-97.6) 105 (70.1-195) 652 
 05-06 20.7 (17.2-25.0) 17.5 (15.3-21.3) 37.3 (30.9-45.7) 99.9 (67.6-159) 181 (110-357) 637 
 07-08 22.1 (17.7-27.7) 18.8 (15.2-23.4) 38.6 (28.3-54.9) 91.4 (61.0-170) 197 (141-282) 531 
 09-10 15.2 (12.9-17.8) 14.6 (12.8-16.2) 27.0 (21.3-33.3) 60.0 (42.3-77.7) 94.8 (66.4-142) 566 
Non-Hispanic blacks 01-02 20.9 (18.8-23.3) 19.7 (17.5-21.8) 38.3 (32.1-46.0) 93.5 (69.2-123) 164 (130-183) 703 
 03-04 21.9 (20.1-23.8) 19.5 (17.3-22.6) 40.1 (35.8-45.3) 102 (75.5-122) 164 (133-269) 699 
 05-06 24.5 (21.2-28.2) 18.9 (17.1-22.8) 46.1 (37.9-59.7) 128 (100-158) 308 (158-399) 678 
 07-08 20.0 (18.1-22.0) 18.3 (16.5-19.2) 36.9 (27.9-46.7) 85.5 (65.8-103) 136 (107-227) 597 
 09-10 11.2 (8.71-14.5) 10.5 (8.26-13.5) 18.9 (13.6-25.3) 32.9 (22.3-58.4) 47.2 (33.6-153) 516 
Non-Hispanic whites 01-02 18.9 (17.0-21.0) 16.3 (14.8-18.4) 32.1 (27.3-37.3) 70.8 (56.9-93.7) 177 (98.0-242) 1216 
 03-04 20.5 (18.5-22.8) 17.8 (16.2-19.7) 35.3 (29.7-44.9) 96.2 (75.8-136) 211 (136-283) 1088 
 05-06 25.6 (23.1-28.2) 22.4 (19.6-24.5) 47.6 (40.7-54.1) 119 (98.2-148) 231 (181-297) 1038 
 07-08 22.2 (18.7-26.3) 19.5 (16.7-23.0) 40.4 (32.1-54.8) 99.1 (68.1-145) 179 (129-258) 1077 
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Urinary Mono-(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP) (creatinine corrected) (2011 - 2012) 
Metabolite of Di-2-ethylhexyl phthalate (DEHP) 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 8.99 (8.55-9.46) 8.46 (7.90-9.27) 14.1 (13.5-14.9) 25.3 (23.1-27.8) 37.7 (32.9-45.3) 2487 
Age group        
6-11 years 11-12 14.9 (12.9-17.2) 14.8 (13.0-18.2) 26.5 (22.9-28.2) 42.6 (30.9-46.5) 58.1 (43.2-75.1) 395 
12-19 years 11-12 8.33 (7.38-9.41) 7.60 (6.41-8.29) 12.6 (10.4-15.5) 28.7 (20.1-37.2) 53.9 (31.7-68.8) 388 
20 years and older 11-12 8.61 (8.17-9.07) 8.20 (7.63-8.94) 13.5 (12.6-14.1) 22.5 (20.1-25.3) 32.0 (28.1-39.3) 1704 
Gender        
Males 11-12 8.15 (7.67-8.66) 7.80 (7.18-8.21) 12.2 (11.5-13.2) 24.2 (20.9-25.9) 37.2 (29.5-50.2) 1258 
Females 11-12 9.89 (9.16-10.7) 9.64 (8.33-11.1) 15.6 (14.7-17.3) 27.0 (23.9-28.8) 37.7 (33.2-44.4) 1229 
Race/ethnicity        
Mexican Americans 11-12 10.3 (8.35-12.7) 9.10 (7.02-12.5) 18.6 (14.4-21.1) 30.4 (25.1-36.0) 49.6 (30.4-114) 316 
Non-Hispanic blacks 11-12 8.80 (7.84-9.87) 8.12 (7.37-8.96) 14.7 (12.4-17.8) 28.2 (20.7-37.4) 46.2 (29.7-57.5) 665 
Non-Hispanic whites 11-12 8.74 (8.02-9.53) 8.36 (7.62-9.58) 13.5 (12.5-14.5) 23.1 (19.7-25.9) 32.7 (27.8-42.9) 811 
All Hispanics 11-12 10.4 (9.42-11.5) 9.29 (8.14-10.5) 18.7 (16.7-21.1) 30.5 (27.1-35.6) 49.6 (33.4-67.9) 571 
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Urinary Mono-(2-ethyl-5-oxohexyl) phthalate (MEOHP) (2001 – 2010) 
Metabolite of Di-2-ethylhexyl phthalate (DEHP) 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 01-02 13.5 (12.0-15.0) 14.0 (12.5-15.1) 29.6 (25.2-34.0) 59.9 (50.4-70.9) 120 (87.2-156) 2782 
 03-04 14.5 (13.0-16.1) 14.4 (12.4-16.7) 31.4 (27.4-36.6) 76.7 (59.4-102) 157 (106-232) 2605 
 05-06 16.2 (14.6-18.0) 15.1 (13.5-17.1) 35.5 (32.1-40.3) 94.8 (78.5-112) 183 (147-250) 2548 
 07-08 12.2 (10.3-14.3) 11.3 (10.0-13.3) 27.1 (21.8-33.8) 64.2 (47.3-93.6) 130 (93.6-177) 2604 
 09-10 8.02 (7.11-9.06) 8.02 (7.27-9.04) 16.1 (13.8-19.0) 32.5 (25.2-41.8) 55.7 (41.8-80.9) 2749 
Age group        
6-11 years 01-02 23.3 (20.9-26.1) 22.9 (18.5-28.1) 46.5 (38.1-52.0) 81.6 (64.7-109) 142 (93.9-178) 393 
 03-04 25.1 (19.6-32.3) 25.8 (19.3-31.4) 51.1 (32.1-76.5) 97.9 (58.8-197) 197 (97.6-261) 342 
 05-06 23.0 (20.3-26.1) 24.5 (19.9-27.6) 44.3 (38.1-52.3) 83.8 (63.6-115) 126 (77.3-253) 356 
 07-08 16.9 (13.9-20.6) 16.6 (12.4-22.6) 34.5 (26.2-40.9) 64.4 (46.9-129) 137 (63.8-179) 389 
 09-10 9.78 (8.72-11.0) 11.1 (8.87-12.7) 20.0 (17.1-21.6) 35.4 (24.8-41.4) 48.4 (36.0-74.0) 415 
12-19 years 01-02 17.5 (15.1-20.3) 18.6 (16.2-20.7) 35.0 (27.7-42.1) 70.7 (52.2-104) 118 (74.0-174) 742 
 03-04 19.5 (16.0-23.7) 20.3 (18.4-23.5) 37.8 (32.6-44.6) 110 (54.6-168) 212 (103-326) 729 
 05-06 23.0 (18.7-28.4) 22.1 (18.0-26.2) 50.7 (42.7-62.2) 134 (82.3-240) 263 (134-511) 702 
 07-08 16.9 (12.8-22.3) 15.9 (11.9-19.3) 38.2 (24.0-55.5) 121 (58.1-258) 258 (120-354) 401 
 09-10 10.0 (8.32-12.1) 9.82 (7.96-12.3) 19.0 (15.9-23.5) 40.0 (26.7-61.5) 68.4 (32.6-154) 420 
20 years and older 01-02 12.0 (10.5-13.9) 12.3 (10.4-14.1) 26.0 (21.6-32.1) 52.3 (41.8-68.3) 116 (74.9-160) 1647 
 03-04 12.9 (11.8-14.1) 12.4 (10.9-14.5) 27.0 (25.0-30.9) 68.9 (55.0-86.5) 139 (92.7-216) 1534 
 05-06 14.7 (13.2-16.4) 13.4 (12.2-15.1) 31.9 (28.2-36.2) 91.6 (74.6-104) 182 (138-247) 1490 
 07-08 11.1 (9.48-13.1) 10.7 (9.30-12.3) 25.5 (20.2-31.4) 59.8 (42.3-88.9) 108 (80.0-155) 1814 
 09-10 7.59 (6.64-8.68) 7.55 (6.69-8.58) 15.3 (12.6-18.6) 30.6 (24.1-41.5) 54.9 (41.8-81.0) 1914 
Gender        
Males 01-02 14.5 (13.0-16.2) 14.6 (13.1-16.2) 31.6 (25.6-34.7) 60.4 (52.3-71.4) 129 (84.4-167) 1371 
 03-04 15.6 (13.6-17.9) 14.7 (12.7-18.1) 31.8 (27.2-39.5) 83.8 (59.4-134) 185 (96.2-277) 1250 
 05-06 18.3 (16.0-20.9) 16.3 (14.7-19.7) 39.3 (33.4-48.1) 104 (80.7-140) 258 (180-337) 1270 
 07-08 12.5 (10.5-15.0) 11.3 (9.80-13.4) 26.1 (21.8-32.2) 61.8 (46.8-98.1) 139 (83.7-189) 1294 
 09-10 9.14 (8.01-10.4) 8.76 (7.87-9.88) 18.2 (14.8-21.0) 39.3 (27.5-50.9) 69.6 (50.0-109) 1399 
Females 01-02 12.5 (10.8-14.6) 13.1 (11.2-15.0) 28.1 (23.7-33.5) 57.5 (45.8-72.7) 115 (81.8-147) 1411 
 03-04 13.4 (11.9-15.1) 13.7 (11.4-16.4) 29.5 (26.1-36.6) 68.6 (53.7-88.1) 143 (88.2-210) 1355 
 05-06 14.4 (12.6-16.5) 13.8 (12.5-15.7) 32.5 (29.3-36.4) 81.7 (68.6-104) 159 (114-182) 1278 
 07-08 11.8 (10.0-14.0) 11.7 (9.80-13.5) 27.9 (21.3-37.5) 64.2 (43.9-93.6) 122 (92.0-191) 1310 
 09-10 7.09 (6.17-8.14) 7.35 (6.13-8.67) 15.2 (12.1-17.5) 27.1 (21.6-36.9) 48.2 (31.3-67.1) 1350 
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Urinary Mono-(2-ethyl-5-oxohexyl) phthalate (MEOHP) (2001 – 2010) 
Metabolite of Di-2-ethylhexyl phthalate (DEHP) 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 01-02 13.1 (11.6-14.9) 13.4 (11.6-15.0) 25.5 (21.6-30.8) 56.6 (40.6-70.3) 77.3 (70.5-101) 677 
 03-04 12.8 (10.5-15.5) 13.6 (11.4-15.6) 25.3 (20.4-29.9) 46.6 (32.3-70.8) 76.0 (51.6-153) 652 
 05-06 14.8 (11.7-18.8) 12.8 (10.5-16.1) 30.9 (22.6-42.9) 79.1 (51.7-131) 152 (92.9-276) 637 
 07-08 12.6 (10.5-15.1) 11.4 (10.4-12.9) 25.1 (18.7-37.2) 53.4 (43.2-91.7) 118 (88.4-147) 531 
 09-10 9.57 (8.10-11.3) 9.65 (8.17-11.3) 19.2 (16.3-23.3) 39.0 (30.9-54.7) 64.6 (43.0-95.3) 566 
Non-Hispanic blacks 01-02 19.6 (17.1-22.5) 20.1 (17.9-22.4) 39.0 (34.8-44.2) 80.5 (71.4-97.4) 153 (102-228) 703 
 03-04 20.2 (17.7-23.0) 20.1 (17.0-22.5) 40.0 (33.9-46.9) 92.6 (68.8-130) 173 (104-247) 699 
 05-06 21.8 (18.9-25.2) 18.8 (16.8-21.0) 46.0 (38.0-59.1) 130 (104-168) 243 (159-304) 678 
 07-08 14.2 (12.7-15.9) 14.0 (12.7-16.3) 30.5 (25.8-35.9) 64.2 (52.1-76.1) 110 (71.9-136) 597 
 09-10 9.57 (8.17-11.2) 9.64 (8.15-11.1) 19.8 (16.5-22.1) 31.4 (25.5-44.0) 50.9 (31.4-129) 516 
Non-Hispanic whites 01-02 12.8 (11.2-14.6) 13.2 (11.6-14.6) 28.5 (23.6-34.0) 58.6 (48.8-70.9) 126 (83.7-172) 1216 
 03-04 13.8 (12.4-15.4) 13.4 (11.3-16.3) 31.0 (27.0-36.3) 77.6 (59.4-102) 161 (98.7-241) 1088 
 05-06 15.5 (13.9-17.3) 15.0 (13.3-16.5) 35.3 (30.1-40.8) 92.6 (74.6-111) 182 (134-247) 1038 
 07-08 11.7 (9.66-14.2) 11.0 (9.20-13.6) 26.9 (20.2-35.1) 64.2 (43.4-108) 137 (90.0-197) 1077 
 09-10 7.59 (6.60-8.73) 7.55 (6.81-8.63) 15.7 (12.9-18.6) 29.1 (22.9-46.5) 55.7 (41.5-83.5) 1206 
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Urinary Mono-(2-ethyl-5-oxohexyl) phthalate (MEOHP) (2011 - 2012) 
Metabolite of Di-2-ethylhexyl phthalate (DEHP) 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 5.08 (4.78-5.41) 5.30 (4.90-5.80) 10.3 (9.40-11.5) 18.4 (17.0-19.5) 26.5 (23.7-30.2) 2489 
Age group        
6-11 years 11-12 6.96 (5.86-8.28) 8.10 (6.90-9.70) 14.6 (12.8-17.1) 26.1 (22.6-28.4) 34.7 (27.9-42.5) 396 
12-19 years 11-12 5.70 (4.64-7.01) 5.70 (4.60-7.30) 12.2 (10.5-13.7) 22.2 (19.1-29.5) 35.1 (23.0-46.8) 388 
20 years and older 11-12 4.83 (4.45-5.23) 5.10 (4.70-5.60) 9.60 (8.50-10.8) 16.7 (14.5-18.6) 23.0 (20.8-26.5) 1705 
Gender        
Males 11-12 5.50 (5.07-5.95) 5.70 (5.10-6.30) 10.5 (8.90-12.2) 18.7 (16.9-21.2) 28.1 (23.4-34.3) 1259 
Females 11-12 4.71 (4.39-5.07) 5.00 (4.70-5.60) 10.2 (9.20-11.1) 18.1 (15.8-19.3) 25.4 (21.9-29.6) 1230 
Race/ethnicity        
Mexican Americans 11-12 5.86 (4.69-7.33) 5.90 (4.40-7.50) 11.6 (8.40-14.4) 20.5 (15.4-25.4) 31.5 (22.5-35.1) 316 
Non-Hispanic blacks 11-12 7.30 (6.48-8.22) 7.40 (6.70-8.00) 14.0 (11.5-16.0) 26.0 (21.1-32.1) 36.9 (30.8-48.2) 665 
Non-Hispanic whites 11-12 4.62 (4.31-4.96) 4.90 (4.50-5.50) 9.50 (8.40-10.8) 16.1 (13.8-18.6) 21.2 (19.0-25.9) 813 
All Hispanics 11-12 5.94 (5.17-6.83) 6.00 (4.80-7.30) 11.8 (9.70-14.0) 22.5 (19.8-25.8) 34.3 (26.2-39.8) 571 
Asians 11-12 4.39 (3.63-5.31) 4.20 (3.30-5.20) 9.40 (7.20-11.3) 19.0 (15.0-27.8) 36.8 (25.4-52.4) 352 
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Urinary Mono-(2-ethyl-5-oxohexyl) phthalate (MEOHP) (creatinine corrected) (2001 – 2010) 
Metabolite of Di-2-ethylhexyl phthalate (DEHP) 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 01-02 12.6 (11.5-13.9) 11.2 (10.2-12.3) 21.3 (18.3-23.8) 45.2 (37.1-58.1) 87.0 (68.0-124) 2782 
 03-04 13.6 (12.4-14.8) 12.1 (11.0-12.9) 24.3 (20.9-27.8) 63.0 (47.8-75.8) 118 (94.1-153) 2605 
 05-06 15.8 (14.2-17.5) 13.5 (12.4-14.7) 28.9 (26.0-33.8) 77.7 (62.4-91.1) 144 (118-172) 2548 
 07-08 12.3 (10.7-14.0) 11.0 (9.72-12.2) 22.3 (18.4-27.9) 52.9 (37.9-74.6) 107 (74.8-136) 2604 
 09-10 8.37 (7.31-9.59) 7.44 (6.71-8.42) 13.5 (11.5-15.7) 25.9 (21.4-34.6) 47.7 (34.6-67.8) 2749 
Age group        
6-11 years 01-02 26.6 (24.0-29.4) 22.8 (20.3-25.0) 43.3 (33.6-47.1) 74.7 (69.0-91.9) 131 (83.0-183) 393 
 03-04 26.6 (21.4-33.0) 25.3 (17.8-32.4) 43.6 (34.2-63.2) 77.1 (63.0-118) 121 (76.3-435) 342 
 05-06 25.4 (22.5-28.6) 24.4 (21.4-26.4) 42.7 (36.0-46.9) 70.4 (52.8-117) 136 (77.2-195) 356 
 07-08 20.8 (17.1-25.4) 18.5 (15.6-21.5) 35.0 (26.4-46.0) 84.1 (47.2-137) 145 (84.8-187) 389 
 09-10 12.7 (11.4-14.2) 12.6 (11.5-14.1) 20.8 (16.5-25.1) 33.3 (29.5-44.1) 45.5 (33.7-74.5) 415 
12-19 years 01-02 13.5 (12.0-15.2) 12.0 (10.8-14.3) 23.4 (20.0-28.5) 48.4 (39.2-54.9) 70.5 (55.0-97.2) 742 
 03-04 14.6 (12.6-16.9) 12.7 (11.6-14.4) 25.5 (20.7-33.8) 67.9 (42.3-143) 153 (61.8-209) 729 
 05-06 17.2 (14.1-20.9) 15.3 (12.5-18.6) 32.5 (25.7-41.3) 84.2 (49.1-147) 163 (93.1-250) 702 
 07-08 13.2 (10.3-16.7) 11.1 (9.08-13.5) 25.9 (18.9-35.6) 86.3 (39.4-128) 132 (84.3-203) 401 
 09-10 8.06 (6.57-9.88) 7.05 (6.16-8.25) 13.3 (9.53-18.3) 24.8 (17.8-47.9) 55.2 (23.6-110) 420 
20 years and older 01-02 11.4 (10.2-12.8) 10.1 (8.89-11.4) 17.5 (15.2-21.8) 38.4 (30.5-52.5) 84.3 (53.3-128) 1647 
 03-04 12.4 (11.5-13.3) 11.0 (10.0-12.0) 20.9 (18.6-22.8) 53.9 (40.7-70.2) 109 (88.6-130) 1534 
 05-06 14.8 (13.3-16.4) 12.4 (11.2-13.5) 26.7 (23.8-31.3) 76.3 (61.0-89.9) 144 (106-170) 1490 
 07-08 11.4 (10.0-13.0) 10.0 (9.15-11.2) 20.8 (16.7-25.6) 47.3 (33.2-65.3) 87.4 (62.7-136) 1814 
 09-10 8.04 (6.99-9.24) 7.19 (6.36-8.00) 12.7 (10.7-14.7) 24.3 (19.7-34.6) 47.4 (33.7-67.3) 1914 
Gender        
Males 01-02 11.8 (10.7-13.0) 10.2 (8.93-11.7) 21.2 (18.5-23.3) 46.1 (35.3-58.7) 84.2 (69.6-104) 1371 
 03-04 12.3 (11.1-13.5) 11.1 (10.0-12.0) 21.6 (17.6-26.9) 59.1 (45.4-72.0) 120 (72.0-162) 1250 
 05-06 14.7 (12.9-16.7) 12.6 (10.9-14.3) 27.1 (23.3-35.6) 79.5 (59.6-96.9) 147 (120-190) 1270 
 07-08 10.5 (9.08-12.2) 9.25 (8.08-10.6) 18.9 (15.9-23.1) 46.7 (32.6-62.4) 86.4 (56.5-144) 1294 
 09-10 8.19 (7.15-9.38) 7.07 (6.59-7.55) 13.4 (10.8-15.8) 30.2 (21.7-41.2) 52.1 (41.2-82.3) 1399 
Females 01-02 13.5 (11.9-15.2) 12.0 (10.8-13.7) 21.5 (18.0-25.6) 44.8 (36.8-61.6) 92.3 (61.0-139) 1411 
 03-04 14.9 (13.4-16.7) 12.7 (11.4-14.2) 26.6 (21.8-30.6) 65.6 (48.0-90.1) 118 (97.0-157) 1355 
 05-06 16.9 (15.1-19.0) 14.7 (13.2-16.5) 30.3 (26.6-34.7) 76.4 (57.6-97.2) 137 (106-170) 1278 
 07-08 14.2 (12.5-16.0) 12.5 (11.5-13.8) 25.9 (21.2-31.0) 61.1 (40.9-84.1) 114 (84.3-142) 1310 
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Urinary Mono-(2-ethyl-5-oxohexyl) phthalate (MEOHP) (creatinine corrected) (2001 – 2010) 
Metabolite of Di-2-ethylhexyl phthalate (DEHP) 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 01-02 12.4 (11.4-13.5) 11.0 (10.5-12.3) 20.9 (18.5-24.4) 44.6 (33.4-56.2) 65.9 (53.1-83.1) 677 
 03-04 11.5 (9.81-13.6) 10.7 (9.04-12.3) 18.8 (15.6-24.6) 39.1 (31.8-53.9) 63.0 (47.2-121) 652 
 05-06 13.3 (11.1-16.1) 11.4 (9.58-13.6) 24.0 (19.4-30.4) 61.2 (45.6-85.9) 102 (69.9-200) 637 
 07-08 12.3 (10.0-15.0) 10.6 (8.57-14.1) 21.7 (16.1-28.7) 53.1 (32.7-85.2) 113 (79.7-149) 531 
 09-10 9.50 (8.16-11.1) 8.72 (8.13-9.61) 16.6 (12.9-20.5) 35.4 (24.4-46.6) 56.7 (40.9-82.3) 566 
Non-Hispanic blacks 01-02 13.8 (12.3-15.4) 13.1 (12.0-14.2) 23.9 (20.0-29.3) 58.3 (45.3-79.7) 101 (81.3-124) 703 
 03-04 14.3 (13.1-15.6) 13.3 (11.3-15.5) 24.8 (21.7-27.7) 61.2 (46.8-76.6) 105 (79.7-152) 699 
 05-06 15.3 (13.2-17.8) 11.6 (9.87-14.6) 29.1 (24.7-38.5) 77.1 (61.9-113) 172 (99.8-251) 678 
 07-08 11.0 (9.94-12.2) 9.90 (9.16-11.1) 20.6 (16.6-23.5) 42.2 (33.8-58.6) 75.8 (57.2-124) 597 
 09-10 6.92 (5.60-8.57) 6.49 (5.12-8.24) 11.4 (9.09-14.1) 19.2 (14.9-27.3) 28.1 (19.8-61.1) 516 
Non-Hispanic whites 01-02 12.7 (11.4-14.0) 11.1 (9.90-12.3) 20.8 (18.0-23.9) 45.7 (35.9-64.9) 96.0 (68.5-161) 1216 
 03-04 13.7 (12.2-15.3) 12.0 (10.5-12.9) 24.9 (20.7-28.6) 69.5 (51.4-95.3) 124 (90.3-182) 1088 
 05-06 16.3 (14.8-18.0) 14.0 (12.9-15.7) 30.8 (27.3-34.8) 79.3 (66.0-93.8) 139 (117-163) 1038 
 07-08 12.2 (10.3-14.5) 11.0 (9.38-13.1) 22.3 (17.4-30.4) 51.4 (35.7-77.7) 107 (74.6-139) 1077 
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Urinary Mono-(2-ethyl-5-oxohexyl) phthalate (MEOHP) (creatinine corrected) (2011 - 2012) 
Metabolite of Di-2-ethylhexyl phthalate (DEHP) 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 5.78 (5.51-6.06) 5.51 (5.12-5.83) 8.99 (8.41-9.83) 15.6 (14.3-16.8) 23.4 (19.6-28.0) 2487 
Age group        
6-11 years 11-12 9.93 (8.63-11.4) 9.89 (8.25-11.4) 16.5 (14.3-18.9) 25.6 (22.9-30.2) 34.5 (27.9-41.9) 395 
12-19 years 11-12 5.55 (4.95-6.23) 5.21 (4.81-5.61) 8.54 (7.09-11.1) 16.3 (12.9-21.3) 31.6 (16.8-35.3) 388 
20 years and older 11-12 5.48 (5.23-5.74) 5.19 (4.89-5.56) 8.39 (7.95-8.98) 13.9 (12.8-15.3) 19.3 (16.6-25.4) 1704 
Gender        
Males 11-12 5.14 (4.86-5.43) 4.86 (4.55-5.12) 7.83 (7.29-8.24) 14.7 (12.7-16.1) 22.6 (18.1-29.7) 1258 
Females 11-12 6.48 (6.07-6.91) 6.34 (5.71-6.91) 10.0 (9.34-11.0) 16.5 (14.7-18.6) 23.5 (19.5-27.9) 1229 
Race/ethnicity        
Mexican Americans 11-12 6.61 (5.43-8.05) 6.00 (4.83-7.45) 11.3 (8.87-13.9) 18.9 (15.8-22.8) 28.1 (18.2-60.8) 316 
Non-Hispanic blacks 11-12 5.68 (5.11-6.32) 5.31 (4.71-5.70) 9.33 (7.79-10.8) 16.9 (13.6-23.4) 29.4 (18.8-39.2) 665 
Non-Hispanic whites 11-12 5.61 (5.17-6.08) 5.41 (4.90-5.99) 8.42 (7.84-9.61) 14.3 (12.5-15.8) 20.5 (16.6-25.4) 811 
All Hispanics 11-12 6.66 (6.05-7.33) 6.04 (5.49-6.74) 11.3 (10.0-13.5) 18.9 (16.9-21.0) 30.2 (20.8-41.9) 571 
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Urinary Mono-(2-ethyl-5-carboxypentyl) phthalate (MECPP) (2003 – 2010) 
Metabolite of Di-2-ethylhexyl phthalate (DEHP) 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 34.7 (31.0-38.9) 33.0 (29.1-37.4) 71.8 (61.7-84.8) 168 (133-240) 339 (235-506) 2605 
 05-06 38.6 (34.7-42.9) 35.6 (31.1-40.3) 79.7 (70.9-92.9) 211 (180-246) 386 (311-484) 2548 
 07-08 33.3 (28.7-38.6) 31.2 (27.1-36.0) 69.5 (55.8-86.3) 153 (120-216) 308 (220-397) 2604 
 09-10 20.7 (18.5-23.3) 20.4 (18.1-23.5) 39.9 (34.9-45.5) 78.4 (67.2-95.5) 127 (99.5-199) 2749 
Age group        
6-11 years 03-04 58.2 (44.7-75.6) 51.6 (39.2-67.6) 112 (71.4-182) 314 (124-524) 391 (238-781) 342 
 05-06 57.4 (50.2-65.7) 53.5 (42.7-67.2) 94.7 (83.2-108) 200 (154-247) 297 (196-548) 356 
 07-08 46.6 (39.2-55.3) 44.1 (34.9-54.7) 92.7 (64.7-112) 156 (117-278) 357 (176-441) 389 
 09-10 27.7 (24.7-31.2) 29.4 (25.4-33.2) 48.5 (39.0-60.2) 87.1 (64.4-102) 118 (87.1-202) 415 
12-19 years 03-04 44.6 (36.8-54.0) 42.7 (38.4-47.6) 86.5 (67.3-108) 220 (120-397) 448 (235-808) 729 
 05-06 52.9 (43.0-65.2) 46.7 (39.4-61.6) 114 (85.6-173) 314 (195-515) 560 (324-1180) 702 
 07-08 44.3 (35.2-55.9) 38.9 (28.9-49.3) 97.3 (64.3-127) 247 (140-456) 476 (231-977) 401 
 09-10 26.2 (22.4-30.6) 25.7 (21.2-30.0) 50.1 (38.3-57.7) 90.3 (58.2-162) 147 (83.9-349) 420 
20 years and older 03-04 31.3 (28.6-34.4) 29.2 (26.2-33.0) 63.5 (56.5-73.9) 157 (130-187) 312 (199-457) 1534 
 05-06 35.1 (31.5-39.0) 31.3 (28.1-35.7) 72.7 (65.4-82.4) 193 (163-237) 377 (285-460) 1490 
 07-08 30.7 (26.4-35.8) 29.2 (24.3-34.4) 63.2 (51.6-80.0) 145 (109-206) 286 (182-378) 1814 
 09-10 19.4 (17.0-22.0) 18.8 (15.7-22.3) 37.7 (32.8-44.0) 76.9 (63.1-92.8) 126 (96.1-197) 1914 
Gender        
Males 03-04 37.9 (33.1-43.5) 34.7 (30.0-39.5) 73.7 (60.8-91.9) 187 (133-300) 388 (222-660) 1250 
 05-06 43.6 (38.1-49.8) 39.7 (31.9-46.2) 87.0 (76.8-103) 260 (188-308) 460 (347-670) 1270 
 07-08 34.4 (29.3-40.5) 31.5 (27.3-35.7) 65.1 (52.1-87.4) 161 (120-217) 321 (213-422) 1294 
 09-10 23.4 (20.7-26.4) 23.0 (20.2-25.6) 44.9 (40.1-51.0) 87.1 (70.3-110) 162 (107-288) 1399 
Females 03-04 31.9 (28.1-36.2) 31.3 (27.5-35.8) 69.3 (58.9-81.9) 154 (128-199) 312 (182-441) 1355 
 05-06 34.3 (30.4-38.6) 31.7 (28.0-36.6) 71.0 (63.0-85.3) 192 (156-217) 309 (251-386) 1278 
 07-08 32.3 (27.8-37.5) 31.0 (26.4-38.3) 73.0 (56.9-90.2) 147 (112-220) 297 (185-420) 1310 
 09-10 18.5 (16.2-21.0) 18.8 (15.8-22.4) 34.7 (29.3-41.5) 72.9 (56.3-93.2) 111 (90.3-146) 1350 
Race/ethnicity        
Mexican Americans 03-04 31.9 (27.1-37.6) 31.5 (26.8-37.4) 57.4 (45.9-71.8) 116 (86.0-162) 175 (133-355) 652 
 05-06 39.4 (30.3-51.2) 34.2 (24.1-47.1) 74.6 (54.0-111) 220 (124-338) 394 (222-673) 637 
 07-08 36.7 (30.6-44.0) 31.3 (27.0-35.7) 71.9 (54.9-91.7) 162 (123-241) 321 (209-477) 531 
 09-10 26.2 (22.5-30.4) 25.8 (22.3-29.8) 51.0 (41.3-57.4) 92.6 (74.5-122) 160 (113-245) 566 
Non-Hispanic blacks 03-04 42.6 (37.0-49.2) 38.3 (33.8-46.9) 82.5 (68.7-103) 191 (146-246) 339 (244-468) 699 
 05-06 46.6 (41.3-52.5) 40.3 (35.6-46.1) 96.3 (76.6-132) 256 (208-347) 455 (328-528) 678 
 07-08 35.0 (31.1-39.4) 35.6 (30.7-38.8) 71.6 (59.1-84.5) 151 (113-192) 235 (184-338) 597 
 09-10 21.9 (18.6-25.7) 22.3 (18.2-25.6) 40.5 (35.7-47.1) 77.0 (61.1-97.1) 127 (76.0-268) 516 
Non-Hispanic whites 03-04 33.8 (30.1-37.9) 32.1 (27.6-37.5) 72.4 (62.0-87.7) 167 (133-240) 354 (220-560) 1088 
 05-06 37.0 (33.4-41.0) 35.4 (30.4-40.9) 79.7 (70.0-93.3) 203 (174-237) 380 (284-484) 1038 
 07-08 32.0 (26.7-38.3) 30.4 (24.5-38.0) 67.6 (52.5-90.9) 145 (105-244) 316 (197-476) 1077 
 09-10 19.6 (17.2-22.2) 19.3 (16.4-23.1) 39.3 (33.0-45.3) 75.0 (61.9-95.7) 120 (95.5-197) 1206 
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Urinary Mono-(2-ethyl-5-carboxypentyl) phthalate (MECPP) (2011 - 2012) 
Metabolite of Di-2-ethylhexyl phthalate (DEHP) 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 12.9 (12.0-13.9) 13.5 (12.4-14.8) 25.3 (23.6-26.7) 43.9 (40.0-51.1) 68.9 (60.4-75.2) 2489 
Age group        
6-11 years 11-12 18.8 (16.1-21.9) 21.6 (17.3-24.1) 36.8 (31.5-41.4) 63.5 (51.5-71.5) 81.5 (68.1-95.1) 396 
12-19 years 11-12 14.3 (11.3-18.0) 14.0 (11.6-17.5) 28.4 (23.5-36.8) 59.3 (47.1-70.2) 74.6 (59.3-135) 388 
20 years and older 11-12 12.2 (11.3-13.3) 13.0 (11.4-14.4) 23.8 (21.8-25.8) 40.2 (36.9-43.9) 61.8 (52.1-73.6) 1705 
Gender        
Males 11-12 14.3 (13.0-15.6) 14.6 (12.7-16.4) 24.7 (23.1-27.6) 45.7 (40.2-54.9) 71.5 (59.8-88.4) 1259 
Females 11-12 11.8 (10.8-12.9) 12.4 (11.2-13.7) 25.6 (23.4-26.6) 42.3 (37.4-49.5) 64.9 (54.4-76.8) 1230 
Race/ethnicity        
Mexican Americans 11-12 15.8 (12.7-19.6) 14.9 (12.7-18.3) 28.1 (22.6-34.3) 51.3 (42.5-71.3) 72.6 (56.6-109) 316 
Non-Hispanic blacks 11-12 16.4 (14.5-18.5) 16.2 (14.4-18.8) 30.7 (26.0-36.6) 60.9 (47.5-69.9) 78.1 (68.2-96.7) 665 
Non-Hispanic whites 11-12 11.8 (10.9-12.9) 12.5 (11.0-14.6) 23.8 (21.8-25.7) 39.9 (34.8-44.2) 55.8 (47.1-76.8) 813 
All Hispanics 11-12 16.0 (14.0-18.2) 15.2 (12.9-18.2) 30.1 (24.5-37.8) 59.8 (50.0-68.9) 76.0 (70.2-104) 571 
Asians 11-12 12.0 (10.2-14.2) 11.7 (10.2-13.7) 23.6 (19.5-27.7) 51.1 (36.5-70.0) 80.5 (58.7-138) 352 
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Urinary Mono-(2-ethyl-5-carboxypentyl) phthalate (MECPP) (creatinine corrected) (2003 – 2010) 
Metabolite of Di-2-ethylhexyl phthalate (DEHP) 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 32.6 (29.6-36.0) 27.0 (24.3-30.6) 54.6 (48.0-63.5) 139 (109-186) 251 (192-356) 2605 
 05-06 37.6 (33.7-42.0) 32.2 (29.5-37.0) 67.5 (58.2-80.8) 168 (139-209) 290 (261-328) 2548 
 07-08 33.6 (29.7-38.0) 29.1 (25.8-32.2) 58.7 (49.6-68.8) 138 (109-164) 233 (178-319) 2604 
 09-10 21.6 (19.0-24.7) 19.2 (16.8-22.1) 33.7 (30.0-40.0) 69.4 (54.0-84.3) 121 (85.1-184) 2749 
Age group        
6-11 years 03-04 61.5 (49.0-77.2) 52.2 (41.6-73.8) 104 (74.2-140) 210 (111-500) 372 (192-988) 342 
 05-06 63.2 (55.6-71.9) 54.2 (48.1-63.6) 92.8 (82.6-111) 160 (124-247) 312 (172-480) 356 
 07-08 57.4 (49.2-66.9) 49.6 (42.7-61.5) 94.2 (79.5-122) 185 (138-294) 376 (188-404) 389 
 09-10 36.1 (32.4-40.3) 33.6 (32.3-36.8) 55.4 (43.9-66.9) 88.7 (69.2-113) 121 (90.6-224) 415 
12-19 years 03-04 33.4 (28.7-38.7) 27.1 (23.9-32.0) 55.0 (43.8-83.8) 168 (92.5-289) 294 (159-387) 729 
 05-06 39.5 (32.5-47.8) 33.9 (27.9-41.0) 72.7 (56.9-96.7) 197 (106-327) 385 (216-531) 702 
 07-08 34.5 (28.1-42.3) 28.0 (23.2-35.0) 65.9 (47.5-85.9) 159 (90.1-233) 246 (159-489) 401 
 09-10 21.1 (17.4-25.5) 18.2 (15.6-20.7) 33.2 (25.5-43.3) 64.9 (42.7-158) 158 (58.4-246) 420 
20 years and older 03-04 30.1 (27.7-32.7) 25.1 (22.9-27.6) 49.1 (44.1-55.2) 126 (101-154) 237 (191-315) 1534 
 05-06 35.2 (31.2-39.6) 29.8 (26.1-33.3) 60.8 (54.2-74.0) 167 (131-206) 279 (247-322) 1490 
 07-08 31.5 (27.8-35.8) 27.8 (24.1-30.8) 53.1 (45.0-65.4) 128 (101-155) 214 (162-319) 1814 
 09-10 20.5 (17.9-23.5) 18.2 (15.9-20.5) 31.7 (27.4-36.8) 65.0 (52.1-80.6) 118 (81.3-173) 1914 
Gender        
Males 03-04 29.8 (26.8-33.1) 23.5 (21.4-27.1) 50.7 (42.2-61.7) 132 (98.0-191) 248 (159-422) 1250 
 05-06 35.0 (30.7-39.9) 29.0 (25.7-32.1) 69.3 (54.2-82.9) 172 (141-210) 301 (249-376) 1270 
 07-08 29.0 (25.3-33.2) 25.1 (21.7-28.8) 47.6 (40.8-57.4) 120 (91.7-157) 210 (157-331) 1294 
 09-10 21.0 (18.4-23.9) 18.4 (16.1-20.4) 33.1 (29.2-38.5) 70.2 (53.4-94.6) 125 (92.8-210) 1399 
Females 03-04 35.5 (31.6-40.0) 30.6 (26.4-35.5) 58.3 (48.8-71.8) 144 (108-192) 251 (192-349) 1355 
 05-06 40.3 (36.2-44.9) 36.7 (31.6-40.0) 66.1 (58.2-83.7) 168 (127-206) 279 (240-341) 1278 
 07-08 38.7 (34.5-43.3) 32.8 (30.0-36.4) 67.8 (58.5-80.0) 147 (117-176) 266 (176-379) 1310 
 09-10 22.3 (19.3-25.7) 20.5 (17.2-23.9) 34.9 (30.0-41.7) 67.0 (53.5-80.8) 104 (80.8-170) 1350 
Race/ethnicity        
Mexican Americans 03-04 28.8 (25.4-32.6) 24.7 (22.4-26.3) 46.7 (39.0-56.3) 94.7 (73.2-137) 152 (118-238) 652 
 05-06 35.5 (28.7-43.7) 29.8 (25.5-34.9) 61.5 (48.4-86.2) 165 (105-201) 278 (181-501) 637 
 07-08 35.8 (29.1-44.0) 30.6 (23.2-38.6) 64.1 (47.2-84.8) 151 (92.3-240) 286 (198-402) 531 
 09-10 26.0 (22.5-30.0) 23.8 (21.3-27.0) 40.1 (35.0-52.3) 88.8 (69.5-104) 148 (100-203) 566 
Non-Hispanic blacks 03-04 30.3 (27.7-33.2) 27.0 (23.2-30.7) 51.1 (41.6-64.0) 135 (100-161) 212 (173-252) 699 
 05-06 32.7 (28.9-37.1) 27.1 (22.4-31.5) 62.4 (53.1-76.0) 166 (119-260) 370 (231-429) 678 
 07-08 27.2 (24.3-30.5) 23.5 (21.9-26.1) 49.1 (37.7-58.6) 103 (85.9-132) 178 (140-259) 597 
 09-10 15.9 (12.6-19.9) 14.5 (11.5-18.8) 26.3 (19.5-32.9) 48.0 (32.6-66.4) 70.7 (46.1-209) 516 
Non-Hispanic whites 03-04 33.4 (29.5-37.7) 27.0 (23.5-31.6) 56.8 (48.6-69.4) 145 (109-198) 294 (193-385) 1088 
 05-06 39.0 (34.9-43.4) 34.3 (30.3-39.1) 69.5 (59.5-83.7) 182 (143-214) 284 (237-324) 1038 
 07-08 33.4 (28.4-39.3) 29.2 (25.1-34.6) 57.7 (46.6-72.4) 138 (101-166) 233 (164-338) 1077 
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Urinary Mono-(2-ethyl-5-carboxypentyl) phthalate (MECPP) (creatinine corrected) (2011 - 2012) 
Metabolite of Di-2-ethylhexyl phthalate (DEHP) 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 14.7 (13.8-15.7) 14.1 (12.9-15.1) 22.7 (21.1-25.3) 38.9 (34.5-44.3) 59.8 (54.5-63.5) 2487 
Age group        
6-11 years 11-12 26.8 (23.6-30.3) 26.2 (22.6-29.4) 41.5 (36.5-47.2) 63.5 (57.5-70.7) 84.4 (71.3-107) 395 
12-19 years 11-12 13.9 (11.7-16.5) 12.5 (10.7-15.5) 22.2 (16.5-29.2) 41.4 (30.3-60.8) 70.9 (46.9-92.9) 388 
20 years and older 11-12 13.9 (13.0-14.8) 13.3 (12.4-14.4) 21.3 (19.5-22.8) 33.9 (30.6-39.0) 53.7 (42.9-63.2) 1704 
Gender        
Males 11-12 13.3 (12.6-14.1) 12.5 (11.6-13.3) 20.1 (17.8-21.6) 35.0 (31.0-38.8) 56.4 (46.4-62.4) 1258 
Females 11-12 16.2 (14.6-18.0) 15.8 (14.1-17.7) 25.8 (22.2-29.4) 44.1 (37.6-50.8) 63.2 (54.3-72.4) 1229 
Race/ethnicity        
Mexican Americans 11-12 17.8 (14.6-21.6) 15.3 (12.7-19.8) 28.4 (21.9-39.0) 53.4 (44.7-62.9) 80.0 (52.4-115) 316 
Non-Hispanic blacks 11-12 12.8 (11.3-14.4) 11.8 (10.6-13.0) 20.8 (18.0-25.0) 40.4 (29.6-50.3) 59.4 (46.2-75.6) 665 
Non-Hispanic whites 11-12 14.3 (13.1-15.7) 13.9 (12.6-15.2) 21.8 (19.7-24.6) 34.3 (30.1-42.2) 54.9 (42.9-60.9) 811 
All Hispanics 11-12 17.9 (16.2-19.7) 15.7 (14.1-18.1) 30.0 (25.8-33.4) 53.4 (44.8-64.0) 80.0 (59.0-107) 571 
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Urinary Mono-(carboxynonyl) phthalate (MCNP) (2005 – 2010) 
Metabolite of Di-isodecyl phthalate (DiDP) 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 05-06 2.73 (2.50-2.98) 2.70 (2.40-3.00) 5.30 (4.80-5.90) 10.2 (8.80-11.9) 17.5 (14.0-21.4) 2548 
 07-08 2.42 (2.17-2.71) 2.40 (2.20-2.70) 4.70 (4.20-5.30) 9.20 (8.00-10.6) 16.1 (12.3-21.0) 2604 
 09-10 2.88 (2.58-3.22) 2.91 (2.51-3.26) 5.52 (4.83-6.30) 10.6 (9.14-12.6) 16.8 (13.9-22.1) 2749 
Age group        
6-11 years 05-06 4.54 (3.94-5.24) 4.70 (4.00-5.60) 8.10 (6.80-9.60) 14.6 (10.8-19.1) 22.8 (16.7-35.3) 356 
 07-08 3.15 (2.65-3.74) 3.40 (2.90-3.80) 5.40 (4.60-6.80) 9.10 (7.40-12.3) 14.9 (9.10-24.8) 389 
 09-10 3.45 (2.95-4.03) 3.59 (3.04-4.34) 6.39 (5.39-7.41) 9.65 (8.75-11.2) 14.5 (10.4-23.2) 415 
12-19 years 05-06 3.18 (2.74-3.68) 3.30 (2.90-3.80) 6.00 (4.70-7.20) 10.3 (7.60-13.7) 16.5 (11.5-21.5) 702 
 07-08 2.86 (2.59-3.16) 2.70 (2.40-2.90) 5.10 (4.30-5.70) 10.3 (8.90-13.0) 16.8 (10.7-32.4) 401 
 09-10 3.02 (2.61-3.51) 3.05 (2.41-3.65) 5.11 (4.49-6.43) 11.0 (7.24-14.6) 16.9 (10.9-32.0) 420 
20 years and older 05-06 2.51 (2.27-2.78) 2.40 (2.20-2.70) 4.90 (4.40-5.40) 9.50 (7.90-11.9) 17.0 (13.1-21.5) 1490 
 07-08 2.29 (2.04-2.58) 2.30 (2.00-2.50) 4.50 (4.00-5.10) 9.10 (7.60-10.7) 16.1 (12.2-21.4) 1814 
 09-10 2.81 (2.49-3.16) 2.80 (2.44-3.09) 5.52 (4.69-6.45) 10.7 (8.95-13.5) 17.3 (13.5-23.7) 1914 
Gender        
Males 05-06 3.16 (2.82-3.54) 3.00 (2.70-3.50) 5.90 (5.10-6.90) 11.0 (8.80-14.0) 19.5 (14.0-28.0) 1270 
 07-08 2.75 (2.50-3.03) 2.60 (2.40-2.90) 5.10 (4.50-5.70) 9.50 (8.00-12.2) 19.4 (12.4-29.1) 1294 
 09-10 3.14 (2.80-3.53) 3.11 (2.72-3.61) 5.75 (5.13-6.56) 10.4 (9.14-11.5) 15.1 (12.5-20.5) 1399 
Females 05-06 2.37 (2.13-2.65) 2.30 (2.00-2.70) 4.80 (4.30-5.30) 9.30 (7.60-11.5) 14.7 (13.1-18.2) 1278 
 07-08 2.14 (1.84-2.49) 2.20 (1.80-2.60) 4.40 (3.80-4.90) 9.00 (7.30-10.3) 14.1 (10.8-18.5) 1310 
 09-10 2.66 (2.32-3.04) 2.60 (2.21-2.98) 5.21 (4.43-6.17) 11.6 (8.88-14.8) 17.5 (14.6-23.4) 1350 
Race/ethnicity        
Mexican Americans 05-06 2.72 (2.40-3.08) 2.70 (2.40-3.20) 4.90 (4.30-5.70) 9.00 (7.00-12.4) 14.4 (9.00-26.8) 637 
 07-08 2.37 (2.15-2.62) 2.30 (2.10-2.60) 4.30 (3.70-5.10) 8.40 (6.50-10.5) 12.3 (8.40-16.2) 531 
 09-10 2.35 (2.15-2.57) 2.51 (2.18-2.69) 4.35 (3.83-4.83) 7.72 (6.56-9.53) 11.0 (8.09-14.1) 566 
Non-Hispanic blacks 05-06 3.18 (2.75-3.67) 3.20 (2.70-3.80) 5.90 (4.90-7.30) 13.0 (9.50-14.6) 19.2 (14.6-30.5) 678 
 07-08 2.89 (2.64-3.17) 2.90 (2.50-3.10) 5.60 (4.80-6.20) 11.9 (9.10-15.4) 21.7 (17.9-28.9) 597 
 09-10 3.51 (2.92-4.22) 3.64 (2.97-4.24) 6.94 (5.75-8.47) 13.2 (10.2-17.5) 20.8 (13.5-41.7) 516 
Non-Hispanic whites 05-06 2.67 (2.39-2.98) 2.60 (2.30-2.90) 5.30 (4.70-6.10) 10.1 (8.20-12.6) 17.6 (12.6-24.3) 1038 
 07-08 2.42 (2.09-2.81) 2.40 (2.10-2.70) 4.70 (4.10-5.60) 9.10 (7.60-11.6) 14.9 (10.5-29.1) 1077 
 09-10 2.98 (2.61-3.40) 2.96 (2.53-3.48) 5.59 (4.78-6.57) 10.7 (8.83-14.3) 16.6 (12.6-23.7) 1206 
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Urinary Mono-(carboxynonyl) phthalate (MCNP) (2011 - 2012) 
Metabolite of Di-isodecyl phthalate (DiDP) 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 2.49 (2.31-2.68) 2.40 (2.10-2.60) 4.60 (4.20-5.30) 8.90 (8.00-10.6) 15.2 (11.4-20.0) 2489 
Age group        
6-11 years 11-12 2.51 (2.15-2.93) 2.70 (2.00-3.00) 4.50 (3.80-5.40) 7.60 (6.60-8.90) 12.9 (7.90-15.4) 396 
12-19 years 11-12 2.65 (2.24-3.13) 2.50 (2.20-3.00) 5.00 (4.00-6.30) 9.10 (7.70-10.5) 12.2 (10.3-18.0) 388 
20 years and older 11-12 2.46 (2.24-2.71) 2.30 (2.10-2.60) 4.60 (4.10-5.30) 9.00 (7.70-11.4) 16.9 (11.4-22.2) 1705 
Gender        
Males 11-12 2.81 (2.52-3.14) 2.60 (2.30-3.10) 5.40 (4.60-6.20) 9.80 (8.10-14.3) 18.8 (10.7-22.9) 1259 
Females 11-12 2.21 (2.03-2.40) 2.20 (1.90-2.40) 4.10 (3.70-4.60) 8.50 (7.70-9.90) 12.0 (10.8-13.7) 1230 
Race/ethnicity        
Mexican Americans 11-12 2.22 (1.87-2.64) 2.10 (1.70-2.30) 3.70 (3.10-4.30) 7.20 (4.80-11.0) 17.8 (7.90-28.5) 316 
Non-Hispanic blacks 11-12 3.02 (2.82-3.25) 2.90 (2.70-3.20) 6.00 (5.00-7.20) 10.2 (8.90-12.5) 17.3 (12.5-21.0) 665 
Non-Hispanic whites 11-12 2.55 (2.31-2.82) 2.50 (2.10-2.80) 4.80 (4.10-5.60) 9.00 (7.70-11.4) 15.2 (10.3-20.8) 813 
All Hispanics 11-12 2.27 (2.04-2.53) 2.10 (1.80-2.40) 3.80 (3.40-4.50) 7.90 (6.30-10.4) 16.1 (10.8-21.0) 571 
Asians 11-12 1.56 (1.33-1.83) 1.40 (1.20-1.50) 2.90 (2.30-4.10) 7.30 (5.90-8.50) 11.2 (8.10-20.0) 352 
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Urinary Mono-(carboxynonyl) phthalate (MCNP) (creatinine corrected) (2005 – 2010) 
Metabolite of Di-isodecyl phthalate (DiDP) 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 05-06 2.66 (2.43-2.91) 2.48 (2.29-2.71) 4.48 (4.05-4.85) 8.67 (7.17-9.71) 13.2 (10.8-17.5) 2548 
 07-08 2.44 (2.25-2.65) 2.21 (2.00-2.36) 4.00 (3.68-4.44) 8.31 (6.96-9.04) 12.8 (11.2-15.1) 2604 
 09-10 3.01 (2.74-3.31) 2.79 (2.48-3.10) 5.04 (4.47-5.66) 9.76 (8.41-11.2) 15.5 (12.8-18.9) 2749 
Age group        
6-11 years 05-06 5.00 (4.45-5.63) 5.06 (4.18-5.76) 7.48 (6.70-8.84) 16.1 (12.5-18.9) 23.5 (16.1-31.7) 356 
 07-08 3.88 (3.34-4.50) 3.82 (3.17-4.18) 6.07 (5.14-7.00) 11.2 (9.01-13.6) 18.2 (12.6-27.0) 389 
 09-10 4.49 (4.01-5.03) 4.33 (3.95-4.82) 7.30 (6.41-8.54) 11.2 (9.74-13.6) 14.9 (12.7-23.1) 415 
12-19 years 05-06 2.37 (2.04-2.75) 2.18 (1.91-2.52) 3.64 (2.94-4.55) 6.26 (5.15-8.70) 10.7 (7.57-14.1) 702 
 07-08 2.23 (2.07-2.40) 1.96 (1.83-2.08) 3.68 (3.08-3.83) 6.39 (4.88-9.01) 10.0 (7.26-13.5) 401 
 09-10 2.43 (2.10-2.81) 2.17 (1.79-2.54) 3.94 (3.23-4.87) 7.67 (5.32-11.2) 12.8 (8.43-14.4) 420 
20 years and older 05-06 2.52 (2.29-2.78) 2.37 (2.14-2.57) 4.05 (3.77-4.51) 7.90 (6.46-9.40) 12.0 (9.71-16.7) 1490 
 07-08 2.36 (2.15-2.58) 2.14 (1.91-2.32) 3.88 (3.44-4.29) 8.21 (6.67-9.00) 12.3 (11.0-15.3) 1814 
 09-10 2.97 (2.69-3.29) 2.72 (2.43-3.03) 4.93 (4.32-5.62) 9.68 (7.90-11.6) 15.6 (11.9-22.5) 1914 
Gender        
Males 05-06 2.53 (2.28-2.82) 2.36 (2.14-2.56) 4.38 (3.74-5.04) 7.41 (6.47-8.88) 13.0 (9.40-19.6) 1270 
 07-08 2.32 (2.11-2.55) 2.12 (1.90-2.32) 3.88 (3.50-4.29) 7.13 (5.78-9.15) 11.4 (9.68-15.5) 1294 
 09-10 2.82 (2.55-3.12) 2.56 (2.28-2.96) 4.73 (4.19-5.49) 8.68 (7.21-10.2) 13.4 (11.2-15.4) 1399 
Females 05-06 2.79 (2.47-3.15) 2.65 (2.34-2.95) 4.51 (4.03-5.15) 9.41 (6.82-11.6) 13.5 (10.7-19.7) 1278 
 07-08 2.57 (2.33-2.83) 2.27 (2.03-2.57) 4.13 (3.78-4.82) 8.71 (7.41-9.50) 13.5 (12.0-16.0) 1310 
 09-10 3.20 (2.88-3.57) 2.98 (2.72-3.28) 5.40 (4.70-6.23) 10.6 (8.39-13.8) 16.9 (12.5-27.3) 1350 
Race/ethnicity        
Mexican Americans 05-06 2.45 (2.13-2.81) 2.32 (2.14-2.60) 4.04 (3.64-4.58) 6.96 (5.73-8.14) 11.0 (7.89-19.1) 637 
 07-08 2.32 (2.10-2.56) 2.10 (1.90-2.34) 4.12 (3.54-4.68) 6.89 (5.73-7.67) 9.75 (7.69-11.7) 531 
 09-10 2.33 (2.08-2.62) 2.12 (1.80-2.66) 3.80 (3.27-4.58) 7.02 (5.44-9.66) 11.3 (8.09-13.0) 566 
Non-Hispanic blacks 05-06 2.24 (1.96-2.55) 1.97 (1.78-2.37) 3.60 (3.25-4.24) 7.82 (6.38-10.4) 12.1 (10.1-17.4) 678 
 07-08 2.25 (2.05-2.47) 2.00 (1.88-2.17) 3.88 (3.50-4.27) 8.18 (6.25-10.4) 14.9 (9.31-20.4) 597 
 09-10 2.54 (2.24-2.88) 2.46 (2.02-2.96) 4.52 (4.20-5.13) 8.51 (6.35-10.9) 11.3 (9.81-16.0) 516 
Non-Hispanic whites 05-06 2.81 (2.51-3.14) 2.57 (2.33-2.85) 4.62 (4.10-5.19) 9.26 (7.00-10.8) 13.5 (10.3-23.5) 1038 
 07-08 2.53 (2.23-2.86) 2.26 (1.98-2.57) 4.11 (3.66-4.70) 8.51 (6.59-10.2) 13.3 (10.7-17.6) 1077 
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Urinary Mono-(carboxynonyl) phthalate (MCNP) (creatinine corrected) (2011 - 2012) 
Metabolite of Di-isodecyl phthalate (DiDP) 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 2.83 (2.57-3.11) 2.50 (2.28-2.80) 4.59 (4.13-5.29) 9.36 (7.85-11.1) 14.6 (11.9-16.8) 2487 
Age group        
6-11 years 11-12 3.55 (3.13-4.03) 3.16 (2.73-3.94) 5.25 (4.55-6.45) 9.15 (6.64-14.3) 14.7 (10.0-16.8) 395 
12-19 years 11-12 2.58 (2.16-3.09) 2.34 (1.96-3.04) 4.67 (3.38-6.13) 7.74 (5.97-11.3) 12.0 (7.74-15.6) 388 
20 years and older 11-12 2.79 (2.51-3.10) 2.43 (2.21-2.77) 4.46 (4.02-5.27) 9.73 (7.85-11.7) 14.9 (11.8-17.5) 1704 
Gender        
Males 11-12 2.63 (2.42-2.86) 2.37 (2.17-2.54) 4.43 (3.83-4.92) 8.49 (6.61-10.0) 12.5 (9.58-15.5) 1258 
Females 11-12 3.03 (2.65-3.46) 2.70 (2.30-3.21) 4.82 (4.18-5.80) 10.7 (8.66-12.1) 15.6 (12.3-17.6) 1229 
Race/ethnicity        
Mexican Americans 11-12 2.50 (2.21-2.83) 2.18 (2.02-2.42) 3.73 (3.00-4.38) 8.00 (5.46-10.7) 13.2 (8.49-18.8) 316 
Non-Hispanic blacks 11-12 2.35 (2.19-2.53) 2.20 (2.06-2.39) 3.99 (3.56-4.38) 6.95 (6.17-8.18) 12.1 (9.30-15.7) 665 
Non-Hispanic whites 11-12 3.09 (2.75-3.47) 2.75 (2.36-3.25) 5.05 (4.35-5.89) 10.4 (8.08-12.3) 15.3 (11.9-17.6) 811 
All Hispanics 11-12 2.54 (2.37-2.73) 2.25 (2.06-2.42) 3.92 (3.54-4.41) 8.20 (6.72-9.71) 13.9 (10.0-16.8) 571 
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Urinary Mono-isononyl phthalate (MiNP) (1999 – 2010) 
Metabolite of Di-isononyl phthalate (DiNP) 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 * < LOD < LOD < LOD 5.39 (<LOD-21.3) 2541 
 01-02 * < LOD < LOD < LOD < LOD 2782 
 03-04 * < LOD < LOD < LOD 1.54 (<LOD-2.00) 2605 
 05-06 * < LOD < LOD 1.69 (<LOD-2.00) 3.54 (2.31-6.16) 2548 
 07-08 * < LOD < LOD 1.54 (<LOD-1.69) 3.08 (2.16-4.16) 2604 
 09-10 * < LOD 1.80 (1.49-2.13) 5.62 (4.48-7.28) 14.6 (10.7-18.3) 2749 
Age group        
6-11 years 99-00 * < LOD < LOD < LOD 9.55 (<LOD-34.7) 328 
 01-02 * < LOD < LOD < LOD < LOD 393 
 03-04 * < LOD < LOD 1.54 (<LOD-2.31) 2.62 (1.85-4.77) 342 
 05-06 * < LOD < LOD 1.69 (<LOD-2.00) 2.16 (2.00-2.62) 356 
 07-08 * < LOD < LOD 1.39 (<LOD-2.00) 2.16 (1.54-3.85) 389 
 09-10 * < LOD 1.72 (1.09-2.94) 5.30 (3.08-8.98) 13.1 (5.33-21.5) 415 
12-19 years 99-00 * < LOD < LOD < LOD 3.54 (<LOD-31.3) 752 
 01-02 * < LOD < LOD < LOD 1.39 (<LOD-1.69) 742 
 03-04 * < LOD < LOD < LOD 2.16 (<LOD-2.77) 729 
 05-06 * < LOD < LOD 2.16 (<LOD-4.31) 5.39 (2.00-12.2) 702 
 07-08 * < LOD < LOD 2.46 (1.39-5.39) 5.54 (2.46-8.01) 401 
 09-10 * < LOD 2.20 (1.42-3.96) 10.7 (4.87-17.1) 20.6 (14.8-36.1) 420 
20 years and older 99-00 * < LOD < LOD < LOD 4.77 (<LOD-20.3) 1461 
 01-02 * < LOD < LOD < LOD < LOD 1647 
 03-04 * < LOD < LOD < LOD < LOD 1534 
 05-06 * < LOD < LOD 1.54 (<LOD-2.00) 3.54 (2.16-6.47) 1490 
 07-08 * < LOD < LOD 1.39 (<LOD-1.69) 2.77 (1.85-3.85) 1814 
 09-10 * < LOD 1.76 (1.43-2.11) 5.44 (4.31-6.64) 12.9 (8.32-17.9) 1914 
Gender        
Males 99-00 * < LOD < LOD < LOD 7.55 (<LOD-29.1) 1215 
 01-02 * < LOD < LOD < LOD < LOD 1371 
 03-04 * < LOD < LOD < LOD 1.54 (<LOD-2.77) 1250 
 05-06 * < LOD < LOD 2.00 (1.39-2.93) 4.00 (3.23-6.31) 1270 
 07-08 * < LOD < LOD 1.54 (<LOD-2.16) 3.23 (2.31-4.93) 1294 
 09-10 * < LOD 2.06 (1.74-2.68) 7.19 (5.62-10.5) 17.1 (11.7-27.6) 1399 
Females 99-00 * < LOD < LOD < LOD 3.85 (<LOD-10.5) 1326 
 01-02 * < LOD < LOD < LOD 1.39 (<LOD-1.69) 1411 
 03-04 * < LOD < LOD < LOD < LOD 1355 
 05-06 * < LOD < LOD 1.39 (<LOD-1.54) 2.62 (1.85-4.31) 1278 
 07-08 * < LOD < LOD 1.39 (<LOD-1.69) 2.77 (2.00-3.70) 1310 
 09-10 * < LOD 1.52 (1.12-1.91) 4.70 (3.80-5.47) 12.3 (6.61-16.5) 1350 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 05-06, 07-08, and 09-10 are 1.23, 1.23, 1.54, 1.23, 1.23, and 0.77 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result. 
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Urinary Mono-isononyl phthalate (MiNP) (1999 – 2010) 
Metabolite of Di-isononyl phthalate (DiNP) 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 * < LOD < LOD < LOD 2.31 (<LOD-4.31) 814 
 01-02 * < LOD < LOD < LOD 1.54 (<LOD-2.16) 677 
 03-04 * < LOD < LOD < LOD < LOD 652 
 05-06 * < LOD < LOD 1.54 (<LOD-2.00) 4.31 (2.00-8.62) 637 
 07-08 * < LOD < LOD 1.39 (<LOD-2.93) 3.08 (2.00-3.85) 531 
 09-10 * < LOD 1.52 (1.19-1.91) 5.11 (3.77-7.67) 12.9 (6.27-22.2) 566 
Non-Hispanic blacks 99-00 * < LOD < LOD 3.54 (<LOD-21.3) 10.5 (<LOD-46.5) 603 
 01-02 * < LOD < LOD < LOD 1.54 (<LOD-2.62) 703 
 03-04 * < LOD < LOD < LOD 2.00 (1.54-3.08) 699 
 05-06 * < LOD < LOD 2.00 (1.54-2.77) 5.70 (3.54-8.62) 678 
 07-08 * < LOD < LOD 1.69 (<LOD-2.31) 3.70 (2.16-5.70) 597 
 09-10 * < LOD 2.14 (1.79-2.56) 6.05 (4.48-10.5) 17.1 (8.32-21.9) 516 
Non-Hispanic whites 99-00 * < LOD < LOD < LOD 5.39 (<LOD-24.6) 912 
 01-02 * < LOD < LOD < LOD < LOD 1216 
 03-04 * < LOD < LOD < LOD < LOD 1088 
 05-06 * < LOD < LOD 1.54 (<LOD-2.16) 3.23 (1.85-6.47) 1038 
 07-08 * < LOD < LOD 1.39 (<LOD-2.00) 2.77 (1.69-4.93) 1077 
 09-10 * < LOD 1.83 (1.40-2.53) 5.67 (4.59-8.07) 14.7 (10.3-21.5) 1206 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 05-06, 07-08, and 09-10 are 1.23, 1.23, 1.54, 1.23, 1.23, and 0.77 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result. 
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Urinary Mono-isononyl phthalate (MiNP) (2011 - 2012) 
Metabolite of Di-isononyl phthalate (DiNP) 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * .800 (.600-.900) 2.60 (2.00-3.20) 8.80 (6.80-12.5) 18.6 (13.3-28.3) 2489 
Age group        
6-11 years 11-12 * .700 (<LOD-1.10) 1.90 (1.50-2.50) 4.40 (2.50-6.20) 6.20 (4.40-11.4) 396 
12-19 years 11-12 1.36 (1.12-1.65) .900 (.800-1.20) 2.80 (2.20-4.00) 13.1 (5.90-23.4) 24.9 (17.8-90.6) 388 
20 years and older 11-12 * .700 (.600-.800) 2.70 (2.00-3.40) 9.60 (7.30-13.0) 18.4 (13.1-32.1) 1705 
Gender        
Males 11-12 1.26 (1.12-1.42) .900 (.800-1.10) 3.10 (2.60-3.70) 9.30 (7.20-12.8) 20.0 (12.5-39.6) 1259 
Females 11-12 * .700 (<LOD-.800) 2.10 (1.70-2.80) 8.20 (4.50-14.4) 18.4 (14.9-26.9) 1230 
Race/ethnicity        
Mexican Americans 11-12 * .700 (<LOD-1.10) 2.30 (1.50-3.20) 5.30 (3.70-7.70) 16.8 (5.60-31.2) 316 
Non-Hispanic blacks 11-12 1.40 (1.19-1.65) 1.00 (.900-1.20) 3.20 (2.40-4.30) 13.1 (7.70-19.5) 24.1 (15.3-36.8) 665 
Non-Hispanic whites 11-12 * .700 (<LOD-.900) 2.60 (1.90-3.40) 9.20 (6.30-12.6) 17.5 (13.0-33.5) 813 
All Hispanics 11-12 * .800 (.600-1.00) 2.40 (1.80-3.30) 6.20 (4.40-9.30) 17.9 (10.4-24.9) 571 
Asians 11-12 * .700 (<LOD-.800) 2.30 (1.40-3.60) 6.50 (5.30-9.80) 19.1 (7.80-25.9) 352 
Limit of detection (LOD, see Data Analysis section) for Survey year 11-12 is 0.6. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Mono-isononyl phthalate (MiNP) (creatinine corrected) (1999 – 2010) 
Metabolite of Di-isononyl phthalate (DiNP) 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 * < LOD < LOD < LOD 6.61 (<LOD-12.8) 2541 
 01-02 * < LOD < LOD < LOD < LOD 2782 
 03-04 * < LOD < LOD < LOD 4.50 (<LOD-4.90) 2605 
 05-06 * < LOD < LOD 3.20 (<LOD-3.82) 5.16 (3.99-5.67) 2548 
 07-08 * < LOD < LOD 3.35 (<LOD-3.96) 5.05 (4.15-6.22) 2604 
 09-10 * < LOD 2.16 (1.91-2.41) 5.40 (4.21-7.00) 11.8 (9.59-14.2) 2749 
Age group        
6-11 years 99-00 * < LOD < LOD < LOD 9.24 (<LOD-21.9) 328 
 01-02 * < LOD < LOD < LOD < LOD 393 
 03-04 * < LOD < LOD 3.71 (<LOD-4.82) 5.04 (3.71-7.19) 342 
 05-06 * < LOD < LOD 2.37 (<LOD-2.93) 3.03 (2.54-5.16) 356 
 07-08 * < LOD < LOD 3.35 (<LOD-5.33) 5.33 (3.11-7.26) 389 
 09-10 * < LOD 2.53 (1.93-3.09) 6.61 (3.77-9.73) 10.7 (6.70-21.7) 415 
12-19 years 99-00 * < LOD < LOD < LOD 3.08 (<LOD-11.8) 752 
 01-02 * < LOD < LOD < LOD 3.19 (<LOD-5.13) 742 
 03-04 * < LOD < LOD < LOD 3.03 (<LOD-3.99) 729 
 05-06 * < LOD < LOD 2.66 (<LOD-3.59) 3.99 (2.97-5.28) 702 
 07-08 * < LOD < LOD 2.56 (2.10-3.23) 3.68 (2.90-6.84) 401 
 09-10 * < LOD 2.14 (1.40-3.40) 7.58 (4.06-11.2) 13.2 (10.2-23.4) 420 
20 years and older 99-00 * < LOD < LOD < LOD 7.11 (<LOD-12.4) 1461 
 01-02 * < LOD < LOD < LOD < LOD 1647 
 03-04 * < LOD < LOD < LOD < LOD 1534 
 05-06 * < LOD < LOD 3.37 (<LOD-4.19) 5.17 (4.17-6.11) 1490 
 07-08 * < LOD < LOD 3.48 (<LOD-4.15) 5.45 (4.15-6.39) 1814 
 09-10 * < LOD 2.12 (1.86-2.35) 5.00 (3.91-6.67) 11.7 (8.29-14.5) 1914 
Gender        
Males 99-00 * < LOD < LOD < LOD 6.53 (<LOD-15.7) 1215 
 01-02 * < LOD < LOD < LOD < LOD 1371 
 03-04 * < LOD < LOD < LOD 3.56 (<LOD-4.54) 1250 
 05-06 * < LOD < LOD 2.51 (1.96-3.51) 3.99 (2.79-5.61) 1270 
 07-08 * < LOD < LOD 2.42 (<LOD-2.95) 3.96 (3.23-5.05) 1294 
 09-10 * < LOD 1.91 (1.59-2.37) 5.54 (4.14-7.89) 12.9 (9.90-18.8) 1399 
Females 99-00 * < LOD < LOD < LOD 6.61 (<LOD-11.8) 1326 
 01-02 * < LOD < LOD < LOD 4.20 (<LOD-4.40) 1411 
 03-04 * < LOD < LOD < LOD < LOD 1355 
 05-06 * < LOD < LOD 3.67 (<LOD-4.39) 5.37 (4.88-6.27) 1278 
 07-08 * < LOD < LOD 4.08 (<LOD-4.84) 5.81 (4.36-7.26) 1310 
 09-10 * < LOD 2.35 (2.01-2.49) 5.40 (4.13-7.00) 10.8 (7.58-14.9) 1350 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result. 
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Urinary Mono-isononyl phthalate (MiNP) (creatinine corrected) (1999 – 2010) 
Metabolite of Di-isononyl phthalate (DiNP) 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 * < LOD < LOD < LOD 5.44 (<LOD-7.70) 814 
 01-02 * < LOD < LOD < LOD 3.70 (<LOD-4.20) 677 
 03-04 * < LOD < LOD < LOD < LOD 652 
 05-06 * < LOD < LOD 2.71 (<LOD-3.73) 4.88 (3.73-6.27) 637 
 07-08 * < LOD < LOD 2.81 (<LOD-3.23) 3.96 (3.23-5.13) 531 
 09-10 * < LOD 1.74 (1.42-2.35) 4.35 (3.10-9.92) 11.5 (8.42-19.1) 566 
Non-Hispanic blacks 99-00 * < LOD < LOD 3.13 (<LOD-8.18) 6.61 (<LOD-22.1) 603 
 01-02 * < LOD < LOD < LOD 2.71 (<LOD-3.30) 703 
 03-04 * < LOD < LOD < LOD 3.37 (2.57-3.85) 699 
 05-06 * < LOD < LOD 2.22 (1.83-2.59) 4.39 (2.83-6.75) 678 
 07-08 * < LOD < LOD 2.49 (<LOD-3.35) 4.19 (3.11-4.62) 597 
 09-10 * < LOD 1.51 (1.25-1.80) 4.00 (2.90-5.61) 8.97 (5.15-15.1) 516 
Non-Hispanic whites 99-00 * < LOD < LOD < LOD 8.39 (<LOD-15.4) 912 
 01-02 * < LOD < LOD < LOD < LOD 1216 
 03-04 * < LOD < LOD < LOD < LOD 1088 
 05-06 * < LOD < LOD 3.37 (<LOD-3.99) 4.88 (3.99-5.41) 1038 
 07-08 * < LOD < LOD 3.60 (<LOD-4.15) 5.45 (3.96-6.96) 1077 
 09-10 * < LOD 2.41 (2.08-2.70) 6.00 (4.23-8.05) 12.9 (10.4-16.6) 1206 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result. 








Fourth National Report on Human Exposure to Environmental Chemicals, Updated Tables, January 2017 Volume One Page 430
Urinary Mono-isononyl phthalate (MiNP) (creatinine corrected) (2011 - 2012) 
Metabolite of Di-isononyl phthalate (DiNP) 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * 1.08 (.921-1.25) 2.69 (2.25-3.26) 7.88 (5.88-11.3) 17.6 (11.6-26.6) 2487 
Age group        
6-11 years 11-12 * 1.13 (<LOD-1.40) 2.44 (1.84-2.98) 4.20 (3.27-7.88) 7.88 (4.00-15.2) 395 
12-19 years 11-12 1.33 (1.05-1.68) 1.01 (.818-1.40) 2.72 (1.94-3.89) 10.6 (4.63-17.6) 33.0 (11.8-53.5) 388 
20 years and older 11-12 * 1.09 (.876-1.30) 2.78 (2.22-3.33) 8.23 (5.95-11.4) 18.1 (11.4-33.8) 1704 
Gender        
Males 11-12 1.18 (1.04-1.33) .982 (.778-1.16) 2.50 (2.15-3.06) 7.88 (5.65-11.4) 15.6 (10.1-24.1) 1258 
Females 11-12 * 1.21 (<LOD-1.40) 2.86 (2.18-3.88) 7.73 (5.20-13.0) 20.1 (11.4-33.8) 1229 
Race/ethnicity        
Mexican Americans 11-12 * .942 (<LOD-1.13) 2.04 (1.65-2.50) 4.68 (3.19-13.8) 17.1 (8.39-42.6) 316 
Non-Hispanic blacks 11-12 1.09 (.915-1.29) .896 (.750-1.05) 2.31 (1.73-3.33) 7.45 (5.19-10.7) 15.2 (9.60-22.5) 665 
Non-Hispanic whites 11-12 * 1.15 (<LOD-1.38) 3.06 (2.35-3.60) 8.23 (5.91-11.9) 20.1 (11.4-33.8) 811 
All Hispanics 11-12 * 1.02 (.875-1.20) 2.18 (1.90-2.46) 6.67 (4.00-9.25) 14.9 (10.1-29.7) 571 
Asians 11-12 * 1.21 (<LOD-1.49) 2.70 (2.00-3.50) 6.75 (4.62-10.1) 14.9 (8.75-21.5) 352 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary Mono-(carboxyoctyl) phthalate (MCOP) (2005 – 2010) 
Metabolite of Di-isononyl phthalate (DiNP) 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 05-06 5.39 (4.68-6.22) 5.10 (4.40-6.00) 10.9 (9.10-13.1) 25.5 (19.1-35.4) 54.4 (32.5-85.2) 2548 
 07-08 6.79 (5.83-7.92) 6.40 (5.60-7.40) 14.9 (12.1-18.2) 34.6 (25.2-43.8) 63.0 (41.8-80.0) 2604 
 09-10 12.6 (10.4-15.2) 11.8 (9.26-14.7) 33.1 (25.8-40.2) 83.3 (61.2-113) 160 (117-191) 2749 
Age group        
6-11 years 05-06 8.52 (7.19-10.1) 8.90 (7.60-9.90) 15.0 (11.3-19.3) 26.4 (19.9-37.3) 40.3 (26.4-61.6) 356 
 07-08 10.8 (9.25-12.6) 10.7 (9.10-13.1) 19.8 (15.8-24.5) 33.8 (26.1-50.3) 59.9 (33.5-79.5) 389 
 09-10 15.0 (10.8-20.7) 14.2 (9.15-20.7) 34.7 (18.6-56.5) 74.6 (41.6-135) 120 (74.6-340) 415 
12-19 years 05-06 6.61 (5.42-8.06) 6.30 (5.20-7.30) 11.9 (9.60-16.0) 28.4 (18.2-58.7) 63.2 (28.4-106) 702 
 07-08 9.25 (7.33-11.7) 8.10 (6.80-10.3) 20.8 (15.4-28.7) 60.5 (29.6-79.4) 79.4 (49.7-166) 401 
 09-10 16.1 (12.3-20.9) 14.5 (11.6-17.0) 39.8 (22.5-61.2) 96.8 (66.7-191) 209 (135-263) 420 
20 years and older 05-06 4.96 (4.27-5.76) 4.50 (3.90-5.20) 9.70 (8.20-12.3) 25.1 (18.2-35.7) 54.4 (30.8-88.5) 1490 
 07-08 6.15 (5.20-7.29) 5.80 (5.00-6.60) 13.2 (10.5-16.8) 32.0 (23.0-41.8) 61.2 (38.9-80.0) 1814 
 09-10 11.9 (9.89-14.3) 11.0 (8.58-13.7) 32.1 (25.8-39.0) 83.7 (56.0-114) 158 (109-188) 1914 
Gender        
Males 05-06 6.24 (5.25-7.42) 5.70 (4.70-6.90) 12.1 (10.2-15.1) 30.8 (19.0-58.8) 66.4 (33.8-122) 1270 
 07-08 7.14 (6.10-8.36) 6.60 (5.70-7.70) 15.6 (12.4-19.3) 35.7 (24.7-43.2) 61.2 (40.1-89.1) 1294 
 09-10 14.0 (11.6-16.8) 13.4 (10.5-15.6) 36.0 (27.5-45.9) 92.9 (66.1-134) 168 (111-217) 1399 
Females 05-06 4.69 (4.14-5.30) 4.50 (4.00-5.20) 9.30 (8.20-11.1) 21.5 (17.5-27.0) 41.7 (28.1-61.7) 1278 
 07-08 6.48 (5.49-7.65) 6.20 (5.40-7.40) 14.3 (12.0-17.0) 32.6 (24.8-47.0) 64.8 (47.0-73.3) 1310 
 09-10 11.4 (9.17-14.1) 10.6 (8.05-13.7) 29.6 (20.8-38.4) 70.4 (50.1-113) 146 (85.2-188) 1350 
Race/ethnicity        
Mexican Americans 05-06 5.77 (4.84-6.87) 5.20 (4.50-5.70) 9.90 (8.50-12.0) 23.6 (14.9-49.7) 54.4 (23.0-185) 637 
 07-08 6.83 (6.23-7.49) 6.20 (5.60-6.80) 12.9 (11.3-14.9) 29.1 (25.2-33.8) 52.0 (36.8-61.2) 531 
 09-10 9.96 (7.99-12.4) 8.59 (6.21-12.1) 20.3 (15.8-32.6) 59.3 (44.0-69.5) 86.2 (63.2-136) 566 
Non-Hispanic blacks 05-06 6.08 (5.60-6.61) 6.00 (5.10-6.70) 11.4 (10.4-13.0) 24.5 (20.3-28.1) 50.0 (32.0-70.3) 678 
 07-08 7.55 (6.21-9.17) 7.00 (6.00-8.00) 16.6 (12.0-22.9) 40.3 (25.5-51.9) 60.4 (41.8-97.8) 597 
 09-10 12.6 (9.85-16.1) 11.0 (7.35-16.2) 34.5 (26.5-42.1) 82.4 (63.8-109) 137 (83.3-188) 516 
Non-Hispanic whites 05-06 5.25 (4.40-6.27) 5.00 (4.10-6.20) 11.1 (8.60-13.6) 25.5 (17.7-43.5) 56.1 (28.1-88.5) 1038 
 07-08 6.81 (5.48-8.46) 6.40 (5.20-7.90) 15.1 (11.0-20.8) 35.7 (23.2-62.0) 64.7 (39.4-89.0) 1077 
 09-10 13.4 (10.7-16.8) 12.9 (10.1-16.1) 34.8 (27.5-43.4) 88.9 (64.4-136) 168 (113-220) 1206 
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Urinary Mono-(carboxyoctyl) phthalate (MCOP) (2011 - 2012) 
Metabolite of Di-isononyl phthalates (DiNP) 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 19.7 (17.4-22.3) 18.7 (15.6-21.3) 50.0 (43.0-61.8) 123 (98.3-160) 214 (180-275) 2489 
Age group        
6-11 years 11-12 18.3 (15.7-21.4) 17.0 (14.7-19.8) 35.2 (30.2-46.4) 88.2 (63.1-108) 144 (90.7-249) 396 
12-19 years 11-12 21.7 (17.2-27.3) 20.7 (16.0-25.8) 51.4 (35.9-68.0) 160 (80.4-261) 289 (174-421) 388 
20 years and older 11-12 19.6 (17.0-22.6) 18.6 (14.7-21.5) 51.4 (43.4-66.1) 127 (103-165) 199 (178-273) 1705 
Gender        
Males 11-12 22.8 (19.9-26.1) 20.2 (16.6-22.1) 59.8 (50.0-67.5) 155 (120-184) 255 (184-379) 1259 
Females 11-12 17.1 (14.7-19.9) 16.3 (13.5-20.4) 43.3 (35.3-58.6) 103 (75.4-138) 180 (119-259) 1230 
Race/ethnicity        
Mexican Americans 11-12 17.1 (14.8-19.9) 14.4 (11.5-20.5) 38.1 (33.9-46.6) 96.7 (70.3-133) 174 (98.9-251) 316 
Non-Hispanic blacks 11-12 24.1 (21.0-27.5) 22.4 (19.0-25.1) 58.2 (45.7-75.9) 165 (102-220) 273 (206-306) 665 
Non-Hispanic whites 11-12 20.1 (17.2-23.4) 19.5 (15.6-21.8) 52.8 (43.1-68.0) 123 (94.0-166) 196 (166-275) 813 
All Hispanics 11-12 18.5 (15.3-22.2) 15.8 (11.9-21.1) 42.3 (35.3-55.1) 104 (77.9-153) 221 (133-297) 571 
Asians 11-12 12.2 (10.0-14.8) 11.0 (8.40-13.8) 36.7 (25.6-47.1) 81.9 (66.1-127) 135 (91.9-204) 352 
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Urinary Mono-(carboxyoctyl) phthalate (MCOP) (creatinine corrected) (2005 – 2010) 
Metabolite of Di-isononyl phthalate (DiNP) 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 05-06 5.26 (4.54-6.10) 4.53 (3.95-5.11) 9.25 (7.64-11.2) 24.0 (17.1-30.8) 40.2 (30.3-55.2) 2548 
 07-08 6.85 (6.05-7.75) 5.94 (5.19-6.67) 12.6 (10.8-14.4) 30.6 (23.4-38.5) 50.2 (40.0-60.0) 2604 
 09-10 13.1 (11.1-15.5) 11.6 (9.69-13.8) 29.3 (23.7-36.2) 72.3 (55.0-93.8) 119 (89.1-147) 2749 
Age group        
6-11 years 05-06 9.38 (8.08-10.9) 8.48 (7.66-10.1) 14.8 (12.2-18.7) 30.3 (20.0-38.8) 40.1 (28.2-57.3) 356 
 07-08 13.3 (11.4-15.5) 11.6 (9.90-14.2) 23.1 (16.2-32.5) 44.2 (27.0-64.1) 60.3 (44.2-110) 389 
 09-10 19.5 (14.7-25.9) 18.6 (11.7-26.9) 35.9 (25.7-56.9) 87.8 (43.7-132) 139 (80.1-312) 415 
12-19 years 05-06 4.93 (4.10-5.93) 4.32 (3.61-4.89) 7.44 (5.93-11.0) 19.4 (12.4-31.8) 34.7 (24.1-58.3) 702 
 07-08 7.20 (5.94-8.73) 6.28 (4.79-8.08) 12.6 (10.0-20.7) 32.7 (22.6-56.9) 56.9 (31.4-103) 401 
 09-10 12.9 (10.5-15.8) 11.5 (8.38-15.1) 26.3 (19.2-37.9) 74.8 (43.5-120) 125 (101-167) 420 
20 years and older 05-06 4.97 (4.26-5.81) 4.17 (3.68-4.77) 8.58 (7.23-10.6) 23.4 (15.5-31.8) 41.1 (29.2-55.9) 1490 
 07-08 6.32 (5.49-7.27) 5.31 (4.77-6.05) 11.8 (9.27-13.9) 27.5 (19.5-36.8) 47.7 (34.4-60.9) 1814 
 09-10 12.6 (10.7-14.8) 10.9 (9.42-12.7) 28.5 (23.3-35.9) 69.5 (52.5-89.4) 113 (81.9-153) 1914 
Gender        
Males 05-06 5.01 (4.21-5.97) 4.29 (3.75-5.03) 8.44 (7.17-10.9) 21.6 (15.1-35.4) 44.6 (25.7-85.9) 1270 
 07-08 6.01 (5.29-6.84) 5.14 (4.54-6.26) 11.5 (9.32-13.6) 24.5 (19.2-31.0) 43.2 (31.2-54.9) 1294 
 09-10 12.5 (10.6-14.7) 11.4 (9.29-13.9) 28.6 (23.5-36.6) 67.2 (52.0-85.9) 106 (82.2-138) 1399 
Females 05-06 5.51 (4.75-6.39) 4.73 (4.23-5.32) 9.55 (8.26-12.2) 24.7 (17.3-30.3) 39.3 (30.3-45.0) 1278 
 07-08 7.76 (6.84-8.81) 6.52 (5.95-7.39) 13.7 (11.9-16.5) 35.3 (26.6-44.2) 57.7 (43.5-74.4) 1310 
 09-10 13.7 (11.5-16.4) 11.8 (9.80-14.4) 29.5 (22.8-37.9) 75.3 (54.2-110) 123 (93.8-197) 1350 
Race/ethnicity        
Mexican Americans 05-06 5.19 (4.38-6.14) 4.50 (3.64-5.29) 8.04 (7.13-10.1) 19.5 (12.3-37.7) 43.6 (20.9-93.4) 637 
 07-08 6.66 (5.97-7.44) 5.29 (4.69-6.20) 11.6 (10.4-13.0) 25.7 (20.9-29.8) 38.3 (30.8-58.3) 531 
 09-10 9.89 (7.75-12.6) 8.53 (6.98-10.0) 20.9 (12.8-28.3) 51.6 (34.2-72.3) 89.4 (59.3-125) 566 
Non-Hispanic blacks 05-06 4.28 (3.86-4.74) 3.67 (3.26-4.09) 7.60 (6.80-8.81) 17.1 (13.2-21.5) 31.8 (22.5-43.7) 678 
 07-08 5.87 (4.82-7.13) 5.37 (4.16-6.50) 11.1 (8.68-15.2) 28.1 (17.7-37.2) 40.2 (32.0-57.8) 597 
 09-10 9.11 (7.52-11.0) 7.62 (5.84-10.8) 19.8 (15.5-26.5) 47.6 (36.9-57.7) 77.8 (57.0-104) 516 
Non-Hispanic whites 05-06 5.53 (4.61-6.63) 4.81 (4.13-5.56) 10.0 (7.63-13.3) 25.2 (16.3-34.5) 39.3 (26.8-59.7) 1038 
 07-08 7.11 (5.91-8.56) 6.27 (5.09-7.50) 13.0 (10.4-16.3) 31.1 (21.3-43.2) 54.2 (40.2-64.1) 1077 
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Urinary Mono-(carboxyoctyl) phthalate (MCOP) (creatinine corrected) (2011 - 2012) 
Metabolite of Di-isononyl phthalates (DiNP) 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 22.4 (19.4-25.8) 20.4 (17.0-24.4) 54.1 (42.0-62.1) 118 (92.5-144) 194 (144-239) 2487 
Age group        
6-11 years 11-12 25.9 (22.8-29.6) 22.1 (18.7-25.8) 42.3 (32.7-54.2) 116 (56.9-161) 161 (117-259) 395 
12-19 years 11-12 21.1 (16.6-26.9) 16.9 (13.7-20.2) 45.6 (28.8-63.4) 120 (73.7-209) 238 (117-396) 388 
20 years and older 11-12 22.2 (19.1-25.8) 20.8 (16.7-25.1) 55.3 (42.0-64.5) 118 (92.2-144) 194 (136-250) 1704 
Gender        
Males 11-12 21.3 (18.9-23.9) 20.0 (16.1-23.2) 54.2 (45.8-58.8) 112 (90.3-144) 189 (136-222) 1258 
Females 11-12 23.5 (19.4-28.5) 20.8 (16.6-26.2) 53.7 (38.3-68.5) 121 (86.8-156) 194 (135-290) 1229 
Race/ethnicity        
Mexican Americans 11-12 19.3 (16.8-22.2) 16.3 (12.8-20.7) 35.7 (26.8-55.5) 81.9 (70.6-115) 136 (81.1-384) 316 
Non-Hispanic blacks 11-12 18.7 (16.5-21.3) 16.1 (14.1-19.6) 40.0 (32.6-51.6) 102 (76.4-134) 154 (132-201) 665 
Non-Hispanic whites 11-12 24.3 (20.4-29.0) 21.9 (18.1-27.5) 58.8 (48.3-71.3) 127 (101-161) 203 (146-284) 811 
All Hispanics 11-12 20.7 (18.0-23.7) 18.3 (15.5-21.7) 38.7 (31.2-53.0) 90.7 (79.3-117) 163 (121-276) 571 









Fourth National Report on Human Exposure to Environmental Chemicals, Updated Tables, January 2017 Volume One Page 435
Urinary Mono-methyl phthalate (MMP) (2001 – 2010) 
Metabolite of Dimethyl phthalate (DMP) 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 01-02 1.15 (.985-1.34) 1.50 (1.30-1.80) 3.30 (2.90-3.70) 6.00 (5.10-7.50) 9.80 (8.00-12.5) 2782 
 03-04 * 1.30 (<LOD-1.70) 3.90 (3.00-4.90) 9.70 (7.70-12.2) 16.3 (12.0-20.4) 2605 
 05-06 * < LOD 2.50 (1.90-3.40) 7.40 (6.10-8.60) 12.4 (10.8-14.7) 2548 
 07-08 * < LOD 2.20 (1.80-2.70) 6.50 (4.70-8.30) 11.3 (8.40-16.3) 2604 
 09-10 * .940 (.670-1.21) 2.89 (2.51-3.28) 6.72 (5.76-8.16) 12.0 (9.29-15.3) 2749 
Age group        
6-11 years 01-02 1.45 (1.13-1.87) 1.90 (1.40-2.80) 4.00 (3.40-4.90) 7.20 (6.00-8.00) 11.8 (7.60-20.8) 393 
 03-04 2.10 (1.67-2.63) 1.70 (1.20-2.40) 4.30 (2.80-6.40) 9.50 (6.40-18.8) 18.8 (9.40-33.4) 342 
 05-06 * < LOD 4.00 (3.30-4.80) 10.6 (7.40-13.4) 15.4 (10.6-30.6) 356 
 07-08 * 1.20 (<LOD-1.60) 3.70 (3.00-5.30) 8.00 (6.50-8.70) 12.1 (8.30-35.8) 389 
 09-10 2.13 (1.83-2.47) 2.36 (1.72-2.92) 4.83 (3.85-5.61) 10.8 (8.59-16.7) 22.3 (11.4-25.8) 415 
12-19 years 01-02 1.59 (1.28-1.96) 2.10 (1.80-2.50) 3.90 (3.30-4.70) 8.50 (5.30-10.5) 13.0 (9.60-17.8) 742 
 03-04 * 1.50 (1.00-2.20) 4.40 (3.00-7.00) 13.3 (7.40-20.9) 21.8 (17.8-31.5) 729 
 05-06 * < LOD 3.70 (2.70-4.60) 8.60 (7.00-9.50) 12.4 (9.30-20.7) 702 
 07-08 * < LOD 2.30 (1.70-3.20) 6.70 (4.20-8.90) 12.0 (7.90-17.4) 401 
 09-10 1.45 (1.12-1.89) 1.37 (.870-1.98) 3.33 (2.76-4.53) 7.68 (5.27-11.7) 12.0 (7.33-19.6) 420 
20 years and older 01-02 1.06 (.904-1.25) 1.40 (1.10-1.60) 3.10 (2.50-3.50) 5.60 (4.60-7.10) 9.20 (7.40-12.3) 1647 
 03-04 * 1.20 (<LOD-1.50) 3.80 (2.80-4.90) 9.30 (7.10-11.8) 14.3 (10.8-19.9) 1534 
 05-06 * < LOD 2.20 (1.60-2.80) 6.90 (5.30-8.40) 11.9 (9.50-14.7) 1490 
 07-08 * < LOD 2.00 (1.60-2.50) 6.00 (4.20-8.30) 11.1 (8.10-17.3) 1814 
 09-10 * .750 (<LOD-1.02) 2.59 (2.19-2.90) 6.30 (5.22-7.60) 10.5 (8.49-14.2) 1914 
Gender        
Males 01-02 1.17 (.962-1.43) 1.50 (1.30-1.90) 3.30 (2.90-4.00) 5.90 (4.80-7.90) 9.20 (7.10-13.5) 1371 
 03-04 * 1.30 (1.00-1.80) 4.00 (3.20-5.20) 10.0 (7.30-13.5) 17.7 (11.8-20.4) 1250 
 05-06 * < LOD 2.40 (1.80-3.50) 7.40 (5.70-9.20) 13.4 (11.0-15.7) 1270 
 07-08 * < LOD 2.40 (1.80-3.20) 6.90 (4.70-8.70) 10.3 (8.20-17.2) 1294 
 09-10 * 1.04 (.730-1.40) 2.92 (2.60-3.47) 6.53 (5.38-8.66) 11.4 (8.86-13.9) 1399 
Females 01-02 1.13 (.973-1.31) 1.40 (1.10-1.70) 3.30 (2.80-3.70) 6.40 (5.00-7.80) 10.3 (8.20-16.2) 1411 
 03-04 * 1.20 (<LOD-1.60) 3.60 (2.80-4.70) 9.50 (7.70-12.2) 15.3 (11.7-22.9) 1355 
 05-06 * < LOD 2.60 (1.80-3.40) 7.40 (5.10-9.30) 12.0 (9.30-16.0) 1278 
 07-08 * < LOD 2.10 (1.70-2.50) 6.20 (4.30-8.20) 12.0 (7.90-16.1) 1310 
 09-10 * .840 (.600-1.09) 2.81 (2.30-3.25) 6.81 (5.49-8.27) 13.5 (8.91-16.8) 1350 
Limit of detection (LOD, see Data Analysis section) for Survey years 01-02, 03-04, 05-06,07-08, and 09-10 are 0.2, 1.0, 1.1,1.1, and 0.5 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Mono-methyl phthalate (MMP) (2001 – 2010) 
Metabolite of Dimethyl phthalate (DMP) 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 01-02 1.21 (1.02-1.45) 1.60 (1.30-1.70) 3.30 (2.70-4.00) 5.60 (4.70-7.30) 8.60 (6.40-15.2) 677 
 03-04 * 1.40 (1.10-1.80) 4.00 (2.50-6.30) 9.60 (7.30-13.4) 15.0 (11.4-18.8) 652 
 05-06 * < LOD 3.10 (2.20-4.30) 7.30 (5.90-9.40) 11.3 (8.50-18.0) 637 
 07-08 * < LOD 2.50 (1.30-3.70) 6.40 (4.20-11.1) 12.1 (6.80-16.3) 531 
 09-10 1.36 (1.22-1.51) 1.26 (.970-1.53) 3.67 (2.97-4.16) 8.30 (6.51-9.24) 12.0 (9.36-18.2) 566 
Non-Hispanic blacks 01-02 1.64 (1.37-1.98) 2.10 (1.70-2.70) 4.40 (3.60-5.10) 8.30 (6.20-10.1) 11.0 (9.50-13.4) 703 
 03-04 2.16 (1.64-2.84) 1.70 (1.00-2.80) 5.10 (3.70-7.00) 11.4 (7.30-17.3) 17.8 (10.2-39.4) 699 
 05-06 * < LOD 3.70 (2.40-4.70) 8.20 (6.10-10.6) 13.0 (10.6-15.8) 678 
 07-08 * < LOD 2.40 (1.50-3.40) 6.10 (4.10-8.80) 10.6 (6.70-16.4) 597 
 09-10 1.71 (1.32-2.21) 1.89 (1.33-2.66) 4.11 (3.38-5.12) 7.87 (5.90-12.5) 14.2 (8.47-17.0) 516 
Non-Hispanic whites 01-02 1.08 (.906-1.29) 1.40 (1.10-1.70) 3.20 (2.50-3.60) 5.60 (4.70-6.70) 9.70 (7.10-14.0) 1216 
 03-04 * 1.20 (<LOD-1.60) 3.60 (2.80-4.80) 9.70 (7.50-12.2) 16.5 (12.0-20.4) 1088 
 05-06 * < LOD 2.30 (1.70-2.80) 7.40 (5.50-8.80) 12.5 (10.4-15.0) 1038 
 07-08 * < LOD 2.10 (1.70-2.60) 6.80 (4.30-8.50) 11.2 (8.00-18.7) 1077 
 09-10 * .690 (<LOD-.930) 2.37 (1.95-2.85) 6.17 (5.23-8.04) 12.3 (8.97-15.9) 1206 
Limit of detection (LOD, see Data Analysis section) for Survey years 01-02, 03-04, 05-06,07-08, and 09-10 are 0.2, 1.0, 1.1,1.1, and 0.5 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Mono-methyl phthalate (MMP) (2011 - 2012) 
Metabolite of Dimethyl phthalate (DMP) 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * 1.00 (.800-1.20) 3.00 (2.60-3.50) 7.00 (6.30-8.10) 11.8 (10.3-14.8) 2489 
Age group        
6-11 years 11-12 2.33 (1.78-3.04) 2.20 (1.50-3.30) 6.40 (5.70-7.70) 15.6 (9.60-24.1) 27.7 (14.8-157) 396 
12-19 years 11-12 1.41 (1.09-1.81) 1.10 (.800-1.70) 3.80 (2.20-6.00) 9.90 (5.90-14.0) 14.8 (10.4-28.4) 388 
20 years and older 11-12 * .800 (.600-1.10) 2.60 (2.30-2.90) 6.10 (4.90-6.90) 9.80 (8.60-11.7) 1705 
Gender        
Males 11-12 1.34 (1.16-1.55) 1.20 (.900-1.60) 3.40 (2.80-4.10) 8.50 (6.90-9.10) 12.9 (10.1-18.6) 1259 
Females 11-12 * .800 (.600-.900) 2.50 (2.20-2.90) 6.30 (5.00-7.30) 10.5 (8.80-13.6) 1230 
Race/ethnicity        
Mexican Americans 11-12 1.39 (1.10-1.76) 1.40 (1.00-1.80) 3.80 (2.50-5.40) 6.90 (5.00-9.40) 9.60 (6.90-14.5) 316 
Non-Hispanic blacks 11-12 1.51 (1.30-1.77) 1.40 (1.10-1.60) 4.30 (3.10-5.20) 8.90 (6.80-13.0) 16.6 (9.90-24.8) 665 
Non-Hispanic whites 11-12 * .700 (<LOD-1.10) 2.50 (2.00-3.10) 6.30 (4.80-8.20) 10.7 (8.90-16.0) 813 
All Hispanics 11-12 1.54 (1.27-1.87) 1.50 (1.20-1.90) 4.00 (2.90-5.70) 8.00 (5.90-10.7) 11.4 (9.40-14.8) 571 
Asians 11-12 1.33 (1.13-1.57) 1.20 (.800-1.60) 3.50 (2.90-4.20) 7.50 (5.20-10.6) 14.1 (9.00-20.1) 352 
Limit of detection (LOD, see Data Analysis section) for Survey year 11-12 is 0.5. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Mono-methyl phthalate (MMP) (creatinine corrected) (2001 – 2010) 
Metabolite of Dimethyl phthalate (DMP) 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 01-02 1.08 (.936-1.25) 1.33 (1.13-1.55) 2.62 (2.36-2.97) 5.00 (3.97-6.02) 8.00 (6.07-11.0) 2782 
 03-04 * 1.53 (<LOD-1.79) 3.45 (2.76-4.37) 7.95 (5.83-11.8) 13.5 (11.3-18.1) 2605 
 05-06 * < LOD 2.85 (2.52-3.25) 6.53 (5.49-7.67) 12.2 (9.74-14.3) 2548 
 07-08 * < LOD 2.79 (2.31-3.25) 5.68 (4.77-7.36) 10.8 (8.00-13.6) 2604 
 09-10 * 1.18 (1.03-1.38) 2.56 (2.29-2.92) 5.55 (4.81-6.54) 10.6 (7.70-13.1) 2749 
Age group        
6-11 years 01-02 1.65 (1.28-2.14) 2.32 (1.72-2.86) 3.97 (3.27-4.71) 7.20 (5.99-9.41) 13.2 (7.60-22.5) 393 
 03-04 2.22 (1.75-2.81) 1.88 (1.49-2.60) 4.96 (2.81-6.49) 9.67 (6.15-14.6) 16.2 (12.1-34.5) 342 
 05-06 * < LOD 4.59 (3.09-6.35) 11.0 (8.07-15.0) 18.6 (10.4-21.9) 356 
 07-08 * 2.05 (<LOD-2.33) 4.56 (3.85-5.36) 9.06 (6.63-11.4) 13.6 (10.4-36.0) 389 
 09-10 2.77 (2.44-3.15) 2.85 (2.46-3.29) 5.24 (4.34-6.18) 14.7 (9.87-16.6) 20.5 (14.7-27.7) 415 
12-19 years 01-02 1.23 (1.01-1.48) 1.51 (1.32-1.82) 2.84 (2.52-3.33) 5.36 (3.68-6.39) 7.27 (5.64-11.4) 742 
 03-04 * 1.34 (1.12-1.73) 3.19 (2.26-4.43) 7.84 (4.95-12.1) 13.3 (9.49-19.1) 729 
 05-06 * < LOD 2.80 (2.15-3.55) 5.65 (4.33-6.52) 12.4 (6.45-18.9) 702 
 07-08 * < LOD 2.00 (1.63-2.63) 4.32 (3.10-6.05) 7.25 (4.77-10.8) 401 
 09-10 1.17 (.907-1.51) 1.18 (.930-1.49) 2.24 (1.81-2.62) 4.17 (3.09-6.47) 7.33 (4.56-15.9) 420 
20 years and older 01-02 1.00 (.868-1.16) 1.21 (1.05-1.40) 2.44 (2.14-2.68) 4.53 (3.49-6.02) 7.72 (5.52-11.4) 1647 
 03-04 * 1.52 (<LOD-1.79) 3.39 (2.69-4.31) 7.69 (5.40-11.8) 13.3 (10.1-18.9) 1534 
 05-06 * < LOD 2.76 (2.44-3.12) 6.09 (5.00-7.75) 11.2 (9.17-13.4) 1490 
 07-08 * < LOD 2.75 (2.26-3.25) 5.58 (4.33-7.59) 10.4 (7.09-14.8) 1814 
 09-10 * 1.09 (<LOD-1.23) 2.34 (2.02-2.69) 5.16 (4.25-6.39) 9.53 (7.07-12.1) 1914 
Gender        
Males 01-02 .954 (.794-1.15) 1.17 (1.02-1.40) 2.37 (2.03-2.75) 4.18 (3.45-5.64) 6.42 (4.94-9.59) 1371 
 03-04 * 1.35 (1.15-1.52) 2.95 (2.26-4.09) 7.11 (5.00-10.2) 11.8 (9.05-13.3) 1250 
 05-06 * < LOD 2.19 (1.89-2.50) 5.03 (4.09-6.45) 10.2 (7.75-13.4) 1270 
 07-08 * < LOD 2.33 (1.92-2.88) 4.88 (3.85-7.25) 8.56 (6.25-13.8) 1294 
 09-10 * 1.02 (.850-1.21) 2.49 (2.00-2.86) 5.23 (4.25-6.84) 9.51 (7.20-12.4) 1399 
Females 01-02 1.21 (1.06-1.38) 1.45 (1.23-1.82) 2.87 (2.58-3.06) 5.56 (4.55-7.14) 10.0 (7.20-15.3) 1411 
 03-04 * 1.83 (<LOD-2.10) 3.87 (3.04-4.96) 9.41 (6.41-13.6) 16.5 (12.5-23.5) 1355 
 05-06 * < LOD 3.47 (3.00-4.11) 7.67 (6.00-9.75) 13.2 (9.75-18.7) 1278 
 07-08 * < LOD 3.12 (2.72-3.71) 6.50 (5.20-8.67) 11.7 (8.56-14.8) 1310 
 09-10 * 1.35 (1.16-1.57) 2.76 (2.34-3.18) 5.77 (4.94-7.22) 11.3 (8.29-15.5) 1350 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary Mono-methyl phthalate (MMP) (creatinine corrected) (2001 – 2010) 
Metabolite of Dimethyl phthalate (DMP) 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 01-02 1.14 (.975-1.34) 1.48 (1.30-1.63) 2.50 (2.20-2.94) 4.19 (3.77-5.76) 8.47 (5.58-12.5) 677 
 03-04 * 1.36 (1.15-1.71) 3.56 (2.45-4.90) 7.53 (5.62-9.64) 12.5 (9.44-16.9) 652 
 05-06 * < LOD 2.86 (2.07-3.67) 6.48 (4.21-8.24) 11.5 (6.94-21.7) 637 
 07-08 * < LOD 2.59 (2.06-3.39) 5.65 (3.60-8.13) 9.40 (6.06-13.9) 531 
 09-10 1.35 (1.19-1.53) 1.37 (1.13-1.67) 3.13 (2.61-3.57) 6.18 (5.33-8.40) 10.7 (8.33-15.2) 566 
Non-Hispanic blacks 01-02 1.15 (.949-1.40) 1.39 (1.29-1.67) 2.70 (2.36-2.95) 4.87 (4.21-5.93) 8.09 (5.86-11.0) 703 
 03-04 1.53 (1.21-1.94) 1.40 (1.07-1.75) 3.14 (2.26-4.37) 7.50 (4.29-14.6) 13.7 (7.70-20.7) 699 
 05-06 * < LOD 2.59 (1.87-3.28) 5.20 (4.53-6.29) 8.50 (6.79-10.3) 678 
 07-08 * < LOD 2.10 (1.69-2.44) 4.22 (2.94-5.74) 7.36 (4.88-8.79) 597 
 09-10 1.24 (.983-1.56) 1.35 (1.08-1.58) 2.69 (2.22-3.23) 4.94 (4.03-6.54) 8.18 (5.74-15.5) 516 
Non-Hispanic whites 01-02 1.07 (.914-1.26) 1.30 (1.05-1.58) 2.62 (2.32-2.99) 5.22 (3.68-6.82) 8.26 (6.07-12.6) 1216 
 03-04 * 1.56 (<LOD-1.89) 3.50 (2.71-4.67) 8.10 (6.00-11.9) 13.6 (11.3-18.9) 1088 
 05-06 * < LOD 2.98 (2.60-3.39) 7.19 (5.58-9.51) 13.4 (10.4-16.6) 1038 
 07-08 * < LOD 2.89 (2.26-3.67) 6.01 (4.63-8.57) 11.7 (7.47-15.6) 1077 
 09-10 * 1.13 (<LOD-1.29) 2.48 (2.06-2.80) 5.38 (4.44-6.76) 10.9 (7.68-13.8) 1206 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary Mono-methyl phthalate (MMP) (creatinine corrected) (2011 - 2012) 
Metabolite of Dimethyl phthalate (DMP) 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * 1.32 (1.16-1.49) 2.84 (2.52-3.24) 6.13 (5.42-7.43) 11.0 (9.44-12.9) 2487 
Age group        
6-11 years 11-12 3.31 (2.57-4.25) 2.97 (2.14-3.89) 7.73 (5.56-8.53) 17.3 (12.4-24.2) 30.2 (17.3-171) 395 
12-19 years 11-12 1.37 (1.12-1.68) 1.16 (.959-1.46) 2.86 (1.88-4.29) 7.68 (4.95-10.0) 12.2 (7.68-24.6) 388 
20 years and older 11-12 * 1.26 (1.05-1.40) 2.57 (2.33-2.82) 5.29 (4.43-5.93) 9.31 (7.26-10.2) 1704 
Gender        
Males 11-12 1.25 (1.09-1.44) 1.23 (.957-1.49) 2.74 (2.35-3.16) 5.88 (5.08-7.73) 10.0 (8.33-12.9) 1258 
Females 11-12 * 1.38 (1.23-1.52) 2.92 (2.57-3.29) 6.17 (5.44-8.08) 12.2 (8.98-15.4) 1229 
Race/ethnicity        
Mexican Americans 11-12 1.57 (1.19-2.06) 1.57 (1.06-2.14) 3.44 (2.44-5.26) 7.26 (4.28-12.2) 11.8 (7.39-22.4) 316 
Non-Hispanic blacks 11-12 1.18 (1.01-1.38) 1.20 (.955-1.45) 2.64 (2.19-3.33) 6.50 (4.30-9.78) 11.1 (6.93-18.0) 665 
Non-Hispanic whites 11-12 * 1.23 (<LOD-1.45) 2.52 (2.13-3.04) 5.75 (4.69-6.54) 10.0 (8.08-12.9) 811 
All Hispanics 11-12 1.73 (1.44-2.08) 1.79 (1.48-2.14) 3.55 (2.82-4.89) 7.73 (5.54-10.9) 12.7 (8.51-19.8) 571 
Asians 11-12 1.79 (1.52-2.10) 1.75 (1.50-2.07) 3.91 (3.49-4.37) 8.75 (6.61-10.3) 11.5 (10.0-15.0) 352 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary Mono-(3-carboxypropyl) phthalate (MCPP) (2001 – 2010) 
Metabolite of Di-n-octyl phthalate (DOP) and of several high molecular weight phthalates 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 01-02 2.75 (2.49-3.04) 3.10 (2.80-3.30) 5.70 (5.10-6.40) 10.0 (8.90-11.3) 14.6 (12.7-17.5) 2782 
 03-04 2.91 (2.79-3.04) 3.10 (3.00-3.30) 5.70 (5.20-6.10) 10.2 (9.20-11.8) 15.3 (13.8-16.2) 2605 
 05-06 2.05 (1.87-2.26) 2.10 (1.90-2.40) 4.40 (4.00-4.80) 8.90 (7.60-10.1) 13.1 (10.6-17.4) 2548 
 07-08 2.76 (2.52-3.04) 2.70 (2.50-3.00) 5.80 (5.20-6.50) 11.1 (9.70-13.1) 18.1 (15.4-22.3) 2604 
 09-10 3.02 (2.58-3.53) 3.10 (2.57-3.65) 6.44 (5.44-7.70) 13.4 (11.4-16.5) 22.3 (19.5-26.2) 2749 
Age group        
6-11 years 01-02 6.11 (5.46-6.84) 6.70 (5.40-7.50) 11.8 (10.2-13.3) 20.1 (17.8-23.1) 24.7 (22.2-31.6) 393 
 03-04 6.86 (5.80-8.11) 7.10 (6.00-8.90) 12.7 (10.4-16.4) 22.0 (17.2-27.7) 29.2 (22.3-36.6) 342 
 05-06 4.82 (4.09-5.68) 4.90 (4.30-5.90) 8.50 (6.70-10.4) 13.1 (10.3-17.9) 17.9 (12.6-34.5) 356 
 07-08 6.01 (4.80-7.53) 6.40 (5.10-8.00) 11.3 (8.40-15.9) 20.3 (13.2-27.3) 23.9 (19.1-34.1) 389 
 09-10 4.54 (3.74-5.52) 4.86 (3.71-6.49) 9.08 (7.14-11.2) 14.4 (10.8-20.3) 20.3 (14.3-51.9) 415 
12-19 years 01-02 3.71 (3.18-4.33) 4.00 (3.40-4.70) 7.10 (6.10-8.10) 11.5 (9.50-12.7) 14.1 (11.8-19.0) 742 
 03-04 3.72 (3.33-4.15) 4.10 (3.50-4.60) 7.20 (5.80-8.40) 11.0 (9.50-13.6) 15.4 (13.4-17.9) 729 
 05-06 2.96 (2.52-3.46) 3.10 (2.50-3.60) 5.90 (4.80-7.30) 11.8 (9.10-14.5) 17.0 (12.7-21.5) 702 
 07-08 3.81 (3.15-4.61) 4.00 (3.20-4.70) 8.20 (6.90-9.40) 13.3 (11.1-17.1) 24.1 (13.8-25.6) 401 
 09-10 3.65 (2.88-4.64) 3.74 (2.90-4.74) 7.16 (5.48-9.32) 15.9 (10.8-25.8) 32.3 (20.9-54.3) 420 
20 years and older 01-02 2.37 (2.11-2.66) 2.60 (2.20-3.00) 4.80 (4.30-5.40) 8.10 (7.20-9.50) 12.0 (10.1-14.2) 1647 
 03-04 2.53 (2.41-2.66) 2.80 (2.60-2.90) 4.90 (4.50-5.20) 8.10 (7.50-8.90) 13.2 (10.8-14.3) 1534 
 05-06 1.76 (1.60-1.93) 1.70 (1.60-2.00) 3.60 (3.20-4.10) 7.10 (6.10-8.40) 11.3 (9.60-13.6) 1490 
 07-08 2.41 (2.18-2.67) 2.50 (2.20-2.60) 5.00 (4.60-5.50) 9.60 (8.00-11.1) 15.6 (12.9-19.9) 1814 
 09-10 2.80 (2.40-3.28) 2.88 (2.42-3.39) 6.00 (5.04-7.15) 13.1 (10.8-16.4) 21.8 (18.7-27.9) 1914 
Gender        
Males 01-02 2.89 (2.64-3.17) 3.10 (2.80-3.40) 5.70 (5.00-6.80) 9.90 (8.70-12.0) 14.2 (12.4-18.1) 1371 
 03-04 3.25 (3.01-3.52) 3.30 (3.00-3.60) 6.00 (5.60-6.80) 11.8 (10.1-13.6) 16.0 (14.2-20.0) 1250 
 05-06 2.32 (2.11-2.54) 2.40 (2.00-2.70) 4.70 (4.30-5.20) 9.60 (7.90-11.8) 14.5 (11.5-22.3) 1270 
 07-08 3.02 (2.70-3.39) 2.90 (2.60-3.30) 5.80 (5.10-6.60) 12.3 (10.1-15.3) 21.3 (16.7-28.5) 1294 
 09-10 3.37 (2.86-3.96) 3.42 (2.91-4.04) 7.09 (6.04-8.32) 15.5 (12.9-18.7) 23.6 (19.9-33.0) 1399 
Females 01-02 2.62 (2.29-2.99) 3.00 (2.50-3.30) 5.70 (5.00-6.30) 10.0 (8.50-11.5) 14.7 (11.2-20.3) 1411 
 03-04 2.63 (2.44-2.83) 3.00 (2.60-3.20) 5.20 (4.70-5.80) 9.20 (8.20-10.3) 13.4 (11.0-16.2) 1355 
 05-06 1.83 (1.59-2.10) 1.80 (1.60-2.10) 4.00 (3.30-4.60) 8.00 (6.60-9.50) 12.1 (9.50-14.7) 1278 
 07-08 2.54 (2.30-2.79) 2.60 (2.30-3.00) 5.90 (5.00-6.80) 10.5 (9.10-12.3) 15.4 (13.3-21.5) 1310 
 09-10 2.72 (2.29-3.22) 2.79 (2.25-3.40) 5.78 (4.67-7.20) 12.6 (9.86-15.9) 20.7 (15.9-29.7) 1350 
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Urinary Mono-(3-carboxypropyl) phthalate (MCPP) (2001 – 2010) 
Metabolite of Di-n-octyl phthalate (DOP) and of several high molecular weight phthalates 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 01-02 2.67 (2.26-3.16) 3.00 (2.30-3.50) 5.30 (4.40-5.90) 9.20 (7.30-12.4) 13.6 (10.4-18.7) 677 
 03-04 3.08 (2.86-3.32) 3.10 (2.80-3.40) 5.50 (4.80-6.10) 9.90 (7.90-12.6) 13.7 (11.5-19.8) 652 
 05-06 2.24 (1.71-2.94) 2.20 (1.60-3.10) 4.50 (3.30-6.50) 9.40 (6.50-13.1) 14.1 (9.90-25.4) 637 
 07-08 2.66 (2.37-3.00) 2.70 (2.40-3.20) 5.00 (4.30-5.70) 8.80 (7.60-11.2) 14.5 (11.5-17.8) 531 
 09-10 2.31 (1.95-2.74) 2.32 (1.92-2.93) 5.11 (4.44-5.58) 8.95 (7.39-11.3) 14.8 (11.1-23.2) 566 
Non-Hispanic blacks 01-02 3.09 (2.81-3.40) 3.30 (2.90-3.60) 6.30 (5.50-6.50) 10.9 (9.10-13.0) 15.1 (13.5-22.4) 703 
 03-04 3.30 (3.01-3.62) 3.20 (2.90-3.60) 6.10 (5.50-6.90) 11.6 (9.30-13.4) 20.1 (13.6-25.5) 699 
 05-06 2.28 (2.03-2.57) 2.40 (2.10-2.80) 4.50 (3.80-5.60) 8.70 (7.10-10.3) 13.3 (10.4-16.5) 678 
 07-08 2.94 (2.50-3.44) 2.90 (2.50-3.40) 5.80 (4.90-6.80) 12.2 (8.50-17.1) 21.1 (13.7-42.4) 597 
 09-10 3.38 (2.66-4.31) 3.35 (2.49-4.56) 6.92 (5.86-8.97) 13.6 (10.2-21.0) 22.9 (17.9-28.7) 516 
Non-Hispanic whites 01-02 2.72 (2.40-3.08) 3.00 (2.60-3.30) 5.80 (4.80-6.80) 10.3 (8.90-11.9) 15.8 (12.6-19.5) 1216 
 03-04 2.87 (2.73-3.02) 3.10 (2.90-3.30) 5.60 (5.00-6.00) 10.1 (9.10-12.0) 15.2 (13.4-16.1) 1088 
 05-06 1.97 (1.81-2.15) 2.00 (1.80-2.20) 4.20 (3.80-4.60) 8.70 (6.80-10.3) 13.1 (10.0-17.5) 1038 
 07-08 2.84 (2.51-3.21) 2.90 (2.50-3.40) 6.10 (5.30-7.00) 11.4 (9.70-14.0) 18.1 (14.0-24.1) 1077 
 09-10 3.17 (2.65-3.79) 3.16 (2.60-3.87) 6.86 (5.72-8.32) 14.5 (12.6-17.8) 23.6 (18.9-35.7) 1206 
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Urinary Mono-(3-carboxypropyl) phthalate (MCPP) (2011 - 2012) 
Metabolite of Di-n-octyl phthalate (DOP) and of several high molecular weight phthalates 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 3.01 (2.59-3.50) 2.70 (2.40-3.10) 6.60 (5.60-7.90) 16.9 (13.1-23.1) 34.4 (21.3-51.8) 2489 
Age group        
6-11 years 11-12 3.38 (2.87-3.97) 3.20 (2.70-4.10) 6.80 (5.50-8.50) 11.0 (9.40-14.1) 20.7 (13.7-34.2) 396 
12-19 years 11-12 3.26 (2.59-4.12) 3.00 (2.20-4.10) 6.80 (5.80-9.90) 22.2 (13.1-38.4) 45.0 (24.6-58.9) 388 
20 years and older 11-12 2.94 (2.46-3.50) 2.60 (2.30-3.00) 6.50 (5.40-7.70) 16.9 (12.8-23.5) 34.4 (19.8-56.3) 1705 
Gender        
Males 11-12 3.52 (2.94-4.22) 2.80 (2.50-3.50) 7.30 (5.90-10.0) 18.7 (13.0-33.2) 48.0 (22.1-106) 1259 
Females 11-12 2.58 (2.24-2.97) 2.50 (2.20-2.80) 6.00 (4.80-7.00) 15.5 (11.2-19.8) 27.8 (17.7-40.2) 1230 
Race/ethnicity        
Mexican Americans 11-12 2.58 (2.12-3.13) 2.40 (2.10-2.80) 4.50 (3.60-6.00) 12.2 (6.60-22.2) 22.2 (12.2-50.7) 316 
Non-Hispanic blacks 11-12 3.55 (3.13-4.02) 3.00 (2.70-3.30) 6.80 (5.60-8.10) 19.7 (13.4-25.0) 30.9 (25.0-39.8) 665 
Non-Hispanic whites 11-12 3.03 (2.54-3.62) 2.80 (2.30-3.30) 6.70 (5.50-8.80) 16.9 (12.8-24.4) 37.2 (18.3-51.8) 813 
All Hispanics 11-12 2.79 (2.19-3.56) 2.40 (2.10-2.70) 5.70 (4.20-7.80) 16.3 (9.00-33.7) 35.1 (14.9-115) 571 
Asians 11-12 2.24 (1.66-3.01) 2.00 (1.50-2.60) 4.60 (3.60-6.90) 11.5 (7.70-25.7) 33.2 (11.5-74.3) 352 
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Urinary Mono-(3-carboxypropyl) phthalate (MCPP) (creatinine corrected) (2001 – 2010) 
Metabolite of Di-n-octyl phthalate (DOP) and of several high molecular weight phthalates 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 01-02 2.58 (2.35-2.83) 2.47 (2.25-2.76) 4.08 (3.87-4.48) 7.24 (6.58-8.00) 11.4 (10.0-12.5) 2782 
 03-04 2.74 (2.56-2.93) 2.60 (2.42-2.79) 4.39 (3.94-4.86) 7.70 (6.65-8.60) 10.7 (9.53-11.9) 2605 
 05-06 2.00 (1.82-2.20) 1.86 (1.67-2.06) 3.55 (3.14-4.00) 6.80 (5.77-7.95) 10.3 (8.68-12.7) 2548 
 07-08 2.79 (2.63-2.96) 2.53 (2.37-2.70) 4.76 (4.33-5.16) 9.70 (8.52-10.9) 14.8 (12.7-17.0) 2604 
 09-10 3.15 (2.77-3.59) 2.94 (2.55-3.38) 5.71 (4.88-6.72) 11.8 (10.5-13.5) 18.8 (16.0-21.9) 2749 
Age group        
6-11 years 01-02 6.96 (6.29-7.70) 7.08 (5.83-7.87) 11.2 (9.15-14.0) 20.7 (15.5-22.3) 26.4 (20.7-27.0) 393 
 03-04 7.25 (6.43-8.18) 7.06 (5.93-7.59) 11.2 (9.38-12.4) 19.1 (14.4-25.6) 26.9 (19.3-29.0) 342 
 05-06 5.31 (4.57-6.17) 5.06 (4.57-5.79) 8.78 (7.50-10.0) 13.7 (10.2-21.3) 21.3 (13.2-36.7) 356 
 07-08 7.41 (5.87-9.34) 6.81 (5.50-9.05) 11.6 (9.43-14.1) 20.2 (12.7-39.2) 30.4 (16.5-68.9) 389 
 09-10 5.92 (5.09-6.88) 5.94 (5.09-6.92) 9.47 (8.38-10.3) 15.5 (10.7-23.7) 22.7 (13.6-47.2) 415 
12-19 years 01-02 2.86 (2.52-3.25) 2.94 (2.50-3.36) 4.59 (4.03-5.23) 6.69 (6.30-7.25) 9.55 (8.03-10.7) 742 
 03-04 2.78 (2.54-3.05) 2.75 (2.53-2.99) 4.55 (4.05-5.15) 6.61 (6.15-7.20) 8.24 (7.00-10.2) 729 
 05-06 2.20 (1.90-2.55) 2.07 (1.76-2.46) 3.67 (2.99-4.39) 6.84 (5.35-8.67) 9.67 (7.12-11.4) 702 
 07-08 2.96 (2.59-3.38) 2.95 (2.51-3.62) 5.04 (4.33-6.00) 8.18 (6.75-10.4) 10.9 (9.38-15.1) 401 
 09-10 2.94 (2.40-3.60) 2.67 (2.26-3.28) 4.68 (4.04-5.56) 10.8 (7.30-17.8) 21.4 (15.6-29.9) 420 
20 years and older 01-02 2.24 (2.03-2.47) 2.20 (2.00-2.40) 3.51 (3.11-3.95) 5.39 (4.82-6.18) 7.71 (6.71-9.28) 1647 
 03-04 2.43 (2.27-2.61) 2.38 (2.19-2.56) 3.70 (3.33-4.08) 6.09 (5.38-7.06) 8.79 (7.84-9.56) 1534 
 05-06 1.76 (1.60-1.94) 1.67 (1.47-1.86) 2.96 (2.60-3.38) 5.55 (4.61-6.46) 8.46 (7.00-10.3) 1490 
 07-08 2.48 (2.33-2.64) 2.26 (2.14-2.36) 4.00 (3.68-4.39) 8.03 (7.11-9.09) 12.7 (11.1-14.8) 1814 
 09-10 2.97 (2.60-3.39) 2.75 (2.38-3.22) 5.25 (4.45-6.31) 11.3 (9.63-13.2) 18.1 (15.4-21.6) 1914 
Gender        
Males 01-02 2.35 (2.17-2.56) 2.20 (2.02-2.42) 3.76 (3.45-4.20) 7.17 (6.27-8.06) 11.5 (9.28-15.1) 1371 
 03-04 2.55 (2.39-2.72) 2.36 (2.22-2.47) 4.14 (3.52-4.86) 7.84 (6.80-8.79) 11.6 (10.2-13.5) 1250 
 05-06 1.86 (1.70-2.03) 1.70 (1.53-1.88) 3.33 (2.92-3.70) 6.70 (5.59-8.33) 10.7 (8.72-14.2) 1270 
 07-08 2.54 (2.34-2.76) 2.32 (2.10-2.50) 4.17 (3.80-4.81) 8.91 (7.37-11.2) 14.7 (12.9-17.5) 1294 
 09-10 3.02 (2.61-3.49) 2.82 (2.43-3.36) 5.51 (4.70-6.36) 10.9 (9.84-12.1) 18.5 (13.7-23.7) 1399 
Females 01-02 2.81 (2.48-3.18) 2.76 (2.46-3.02) 4.39 (3.97-4.92) 7.66 (6.17-8.69) 11.0 (8.62-15.9) 1411 
 03-04 2.93 (2.68-3.20) 2.89 (2.58-3.23) 4.53 (4.09-5.00) 7.58 (6.44-8.57) 10.0 (8.60-11.6) 1355 
 05-06 2.15 (1.88-2.45) 2.00 (1.72-2.44) 3.77 (3.15-4.47) 6.90 (5.62-8.43) 10.0 (8.14-12.5) 1278 
 07-08 3.04 (2.84-3.25) 2.80 (2.50-3.11) 5.08 (4.64-5.52) 10.3 (8.67-11.3) 15.0 (11.8-17.8) 1310 









Fourth National Report on Human Exposure to Environmental Chemicals, Updated Tables, January 2017 Volume One Page 445
Urinary Mono-(3-carboxypropyl) phthalate (MCPP) (creatinine corrected) (2001 – 2010) 
Metabolite of Di-n-octyl phthalate (DOP) and of several high molecular weight phthalates 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 01-02 2.52 (2.21-2.88) 2.37 (2.07-2.73) 4.29 (3.73-5.00) 7.36 (5.58-10.3) 11.4 (8.36-14.5) 677 
 03-04 2.78 (2.56-3.02) 2.63 (2.30-2.96) 4.32 (3.66-4.96) 8.14 (6.72-10.3) 12.8 (9.37-17.1) 652 
 05-06 2.02 (1.62-2.51) 1.79 (1.42-2.53) 3.85 (2.74-5.22) 7.00 (5.40-8.82) 10.2 (7.64-16.4) 637 
 07-08 2.60 (2.26-2.99) 2.45 (2.05-3.10) 4.31 (3.49-5.22) 8.31 (6.67-9.76) 12.9 (9.50-15.5) 531 
 09-10 2.29 (1.92-2.74) 2.08 (1.76-2.60) 4.29 (3.61-5.05) 9.02 (7.16-11.4) 13.7 (10.9-17.8) 566 
Non-Hispanic blacks 01-02 2.17 (2.02-2.33) 2.07 (1.88-2.28) 3.68 (3.25-4.07) 6.73 (5.46-7.70) 10.0 (8.27-13.1) 703 
 03-04 2.34 (2.13-2.58) 2.17 (1.99-2.45) 3.96 (3.33-4.43) 6.93 (6.03-8.80) 13.4 (9.32-15.9) 699 
 05-06 1.61 (1.42-1.81) 1.58 (1.38-1.77) 2.76 (2.27-3.37) 5.63 (4.33-7.59) 8.68 (6.86-10.4) 678 
 07-08 2.28 (1.96-2.65) 2.11 (1.72-2.35) 3.91 (3.33-4.56) 7.97 (5.58-12.8) 16.4 (8.21-57.0) 597 
 09-10 2.45 (2.02-2.97) 2.26 (1.81-2.84) 4.14 (3.35-5.19) 8.02 (6.24-11.3) 14.7 (9.92-19.7) 516 
Non-Hispanic whites 01-02 2.69 (2.42-3.00) 2.57 (2.25-2.94) 4.19 (3.87-4.79) 7.63 (6.58-8.45) 11.8 (10.0-14.7) 1216 
 03-04 2.83 (2.60-3.09) 2.65 (2.43-2.96) 4.55 (3.90-5.16) 7.79 (6.59-8.79) 10.6 (9.43-11.3) 1088 
 05-06 2.08 (1.92-2.24) 1.95 (1.76-2.12) 3.60 (3.26-4.00) 6.47 (5.56-7.93) 10.3 (7.95-13.1) 1038 
 07-08 2.96 (2.72-3.23) 2.70 (2.50-2.93) 5.06 (4.35-5.77) 10.3 (8.61-11.5) 15.1 (12.3-19.3) 1077 
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Urinary Mono-(3-carboxypropyl) phthalate (MCPP) (creatinine corrected) (2011 - 2012) 
Metabolite of Di-n-octyl phthalate (DOP) and of several high molecular weight phthalates 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 3.42 (2.93-3.99) 2.86 (2.44-3.33) 6.00 (4.95-7.75) 15.8 (10.8-23.6) 36.6 (18.8-65.9) 2487 
Age group        
6-11 years 11-12 4.79 (4.18-5.49) 4.19 (3.60-4.67) 7.26 (5.81-8.61) 15.7 (8.97-26.7) 28.2 (16.4-39.8) 395 
12-19 years 11-12 3.18 (2.50-4.04) 2.44 (1.82-3.31) 5.59 (3.85-8.33) 26.6 (8.44-45.7) 45.7 (17.4-80.0) 388 
20 years and older 11-12 3.33 (2.83-3.93) 2.69 (2.34-3.16) 5.97 (4.78-7.89) 15.7 (10.7-22.1) 32.2 (17.1-69.6) 1704 
Gender        
Males 11-12 3.29 (2.80-3.86) 2.67 (2.35-3.07) 6.00 (4.86-7.58) 15.7 (10.1-25.0) 41.5 (17.2-89.9) 1258 
Females 11-12 3.55 (2.95-4.27) 3.00 (2.44-3.65) 6.05 (4.80-8.45) 15.8 (9.78-25.7) 33.7 (16.2-65.9) 1229 
Race/ethnicity        
Mexican Americans 11-12 2.91 (2.34-3.61) 2.50 (2.14-2.92) 4.88 (3.49-6.11) 11.5 (6.42-24.4) 24.4 (9.94-78.7) 316 
Non-Hispanic blacks 11-12 2.76 (2.42-3.15) 2.27 (1.96-2.65) 4.82 (3.77-6.23) 11.8 (8.36-15.1) 22.9 (15.3-31.9) 665 
Non-Hispanic whites 11-12 3.67 (3.06-4.42) 3.08 (2.58-3.93) 6.92 (5.14-9.10) 16.3 (11.2-27.0) 36.8 (17.6-69.6) 811 
All Hispanics 11-12 3.13 (2.50-3.92) 2.45 (2.14-2.73) 5.31 (4.04-6.73) 15.1 (7.09-36.6) 34.6 (11.9-128) 571 
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Urinary Mono-n-octyl phthalate (MOP) (1999 – 2010)‡ 
Metabolite of Di-n-octyl phthalate (DOP) 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 * < LOD < LOD 2.69 (2.02-3.36) 4.87 (3.86-5.71) 2541 
 01-02 * < LOD < LOD < LOD < LOD 2782 
 03-04 * < LOD < LOD < LOD < LOD 2605 
 05-06 * < LOD < LOD < LOD < LOD 2548 
 07-08 * < LOD < LOD < LOD < LOD 2604 
 09-10 * < LOD < LOD < LOD < LOD 2749 
Age group        
6-11 years 99-00 * < LOD < LOD 3.70 (<LOD-5.88) 5.38 (2.86-8.40) 328 
 01-02 * < LOD < LOD < LOD < LOD 393 
 03-04 * < LOD < LOD < LOD < LOD 342 
 05-06 * < LOD < LOD < LOD < LOD 356 
 07-08 * < LOD < LOD < LOD < LOD 389 
 09-10 * < LOD < LOD < LOD < LOD 415 
12-19 years 99-00 * < LOD < LOD 2.86 (<LOD-4.20) 4.70 (3.36-7.06) 752 
 01-02 * < LOD < LOD < LOD < LOD 742 
 03-04 * < LOD < LOD < LOD < LOD 729 
 05-06 * < LOD < LOD < LOD < LOD 702 
 07-08 * < LOD < LOD < LOD < LOD 401 
 09-10 * < LOD < LOD < LOD < LOD 420 
20 years and older 99-00 * < LOD < LOD 2.52 (1.85-3.19) 4.87 (3.53-5.88) 1461 
 01-02 * < LOD < LOD < LOD < LOD 1647 
 03-04 * < LOD < LOD < LOD < LOD 1534 
 05-06 * < LOD < LOD < LOD < LOD 1490 
 07-08 * < LOD < LOD < LOD < LOD 1814 
 09-10 * < LOD < LOD < LOD < LOD 1914 
Gender        
Males 99-00 * < LOD < LOD 2.69 (1.85-3.70) 4.70 (3.36-5.88) 1215 
 01-02 * < LOD < LOD < LOD < LOD 1371 
 03-04 * < LOD < LOD < LOD < LOD 1250 
 05-06 * < LOD < LOD < LOD < LOD 1270 
 07-08 * < LOD < LOD < LOD < LOD 1294 
 09-10 * < LOD < LOD < LOD < LOD 1399 
Females 99-00 * < LOD < LOD 2.52 (2.02-3.53) 5.21 (3.70-6.38) 1326 
 01-02 * < LOD < LOD < LOD < LOD 1411 
 03-04 * < LOD < LOD < LOD < LOD 1355 
 05-06 * < LOD < LOD < LOD < LOD 1278 
 07-08 * < LOD < LOD < LOD < LOD 1310 
 09-10 * < LOD < LOD < LOD < LOD 1350 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 05-06, 07-08, and 09-10 are 1.51, 1.68, 1.68, 1.85, 1.85 and 0.84 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result.  
**To correct for inadequate purity in the analytical standards, all results and LODs have been adjusted by a factor of 1.68 for survey periods 1999-2008 compared with results previously reported. 
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Urinary Mono-n-octyl phthalate (MOP) (1999 – 2010) ‡ 
Metabolite of Di-n-octyl phthalate (DOP) 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 * < LOD < LOD 1.85 (<LOD-2.35) 2.69 (2.35-4.37) 814 
 01-02 * < LOD < LOD < LOD < LOD 677 
 03-04 * < LOD < LOD < LOD < LOD 652 
 05-06 * < LOD < LOD < LOD < LOD 637 
 07-08 * < LOD < LOD < LOD < LOD 531 
 09-10 * < LOD < LOD < LOD < LOD 566 
Non-Hispanic blacks 99-00 * < LOD < LOD 3.19 (<LOD-5.04) 5.04 (3.70-6.89) 603 
 01-02 * < LOD < LOD < LOD < LOD 703 
 03-04 * < LOD < LOD < LOD < LOD 699 
 05-06 * < LOD < LOD < LOD < LOD 678 
 07-08 * < LOD < LOD < LOD < LOD 597 
 09-10 * < LOD < LOD < LOD < LOD 516 
Non-Hispanic whites 99-00 * < LOD < LOD 2.69 (2.02-3.53) 5.04 (3.86-5.88) 912 
 01-02 * < LOD < LOD < LOD < LOD 1216 
 03-04 * < LOD < LOD < LOD < LOD 1088 
 05-06 * < LOD < LOD < LOD < LOD 1038 
 07-08 * < LOD < LOD < LOD < LOD 1077 
 09-10 * < LOD < LOD < LOD < LOD 1206 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 05-06, 07-08, and 09-10 are 1.51, 1.68, 1.68, 1.85, 1.85 and 0.84 respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result.  
**To correct for inadequate purity in the analytical standards, all results and LODs have been adjusted by a factor of 1.68 for survey periods 1999-2008 compared with results previously reported. 
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Urinary Mono-n-octyl phthalate (MOP) (creatinine corrected) (1999 – 2010) ‡ 
Metabolite of Di-n-octyl phthalate (DOP) 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 * < LOD < LOD 4.03 (3.48-4.38) 5.93 (4.96-7.21) 2541 
 01-02 * < LOD < LOD < LOD < LOD 2782 
 03-04 * < LOD < LOD < LOD < LOD 2605 
 05-06 * < LOD < LOD < LOD < LOD 2548 
 07-08 * < LOD < LOD < LOD < LOD 2604 
 09-10 * < LOD < LOD < LOD < LOD 2749 
Age group        
6-11 years 99-00 * < LOD < LOD 3.73 (<LOD-6.30) 6.30 (3.31-17.2) 328 
 01-02 * < LOD < LOD < LOD < LOD 393 
 03-04 * < LOD < LOD < LOD < LOD 342 
 05-06 * < LOD < LOD < LOD < LOD 356 
 07-08 * < LOD < LOD < LOD < LOD 389 
 09-10 * < LOD < LOD < LOD < LOD 415 
12-19 years 99-00 * < LOD < LOD 2.50 (<LOD-2.87) 3.16 (2.59-5.59) 752 
 01-02 * < LOD < LOD < LOD < LOD 742 
 03-04 * < LOD < LOD < LOD < LOD 729 
 05-06 * < LOD < LOD < LOD < LOD 702 
 07-08 * < LOD < LOD < LOD < LOD 401 
 09-10 * < LOD < LOD < LOD < LOD 420 
20 years and older 99-00 * < LOD < LOD 4.37 (3.48-4.89) 5.93 (5.04-7.76) 1461 
 01-02 * < LOD < LOD < LOD < LOD 1647 
 03-04 * < LOD < LOD < LOD < LOD 1534 
 05-06 * < LOD < LOD < LOD < LOD 1490 
 07-08 * < LOD < LOD < LOD < LOD 1814 
 09-10 * < LOD < LOD < LOD < LOD 1914 
Gender        
Males 99-00 * < LOD < LOD 3.06 (2.59-3.48) 4.30 (3.26-5.80) 1215 
 01-02 * < LOD < LOD < LOD < LOD 1371 
 03-04 * < LOD < LOD < LOD < LOD 1250 
 05-06 * < LOD < LOD < LOD < LOD 1270 
 07-08 * < LOD < LOD < LOD < LOD 1294 
 09-10 * < LOD < LOD < LOD < LOD 1399 
Females 99-00 * < LOD < LOD 5.04 (4.20-5.96) 7.21 (5.59-10.5) 1326 
 01-02 * < LOD < LOD < LOD < LOD 1411 
 03-04 * < LOD < LOD < LOD < LOD 1355 
 05-06 * < LOD < LOD < LOD < LOD 1278 
 07-08 * < LOD < LOD < LOD < LOD 1310 
 09-10 * < LOD < LOD < LOD < LOD 1350 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result. 
**To correct for inadequate purity in the analytical standards, all results and LODs have been adjusted by a factor of 1.68 for survey periods 1999-2008 compared with results previously reported..  
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Urinary Mono-n-octyl phthalate (MOP) (creatinine corrected) (1999 – 2010) ‡ 
Metabolite of Di-n-octyl phthalate (DOP) 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 * < LOD < LOD 3.06 (<LOD-4.70) 5.59 (4.37-6.72) 814 
 01-02 * < LOD < LOD < LOD < LOD 677 
 03-04 * < LOD < LOD < LOD < LOD 652 
 05-06 * < LOD < LOD < LOD < LOD 637 
 07-08 * < LOD < LOD < LOD < LOD 531 
 09-10 * < LOD < LOD < LOD < LOD 566 
Non-Hispanic blacks 99-00 * < LOD < LOD 2.28 (<LOD-3.26) 3.73 (2.52-5.49) 603 
 01-02 * < LOD < LOD < LOD < LOD 703 
 03-04 * < LOD < LOD < LOD < LOD 699 
 05-06 * < LOD < LOD < LOD < LOD 678 
 07-08 * < LOD < LOD < LOD < LOD 597 
 09-10 * < LOD < LOD < LOD < LOD 516 
Non-Hispanic whites 99-00 * < LOD < LOD 4.38 (3.60-5.17) 6.12 (5.29-8.40) 912 
 01-02 * < LOD < LOD < LOD < LOD 1216 
 03-04 * < LOD < LOD < LOD < LOD 1088 
 05-06 * < LOD < LOD < LOD < LOD 1038 
 07-08 * < LOD < LOD < LOD < LOD 1077 
 09-10 * < LOD < LOD < LOD < LOD 1206 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result.  
**To correct for inadequate purity in the analytical standards, all results and LODs have been adjusted by a factor of 1.68 for survey periods 1999-2008 compared with results previously reported. 
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Urinary Cyclohexane-1,2-dicarboxylic acid-mono(hydroxy-isononyl) ester (MHNCH) (2011 - 2012) 
Metabolite of Di(isononyl) cyclohexane-1,2-dicarboxylate (DINCH) 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * < LOD < LOD .600 (.500-.800) 1.10 (.900-1.20) 2489 
Age group        
6-11 years 11-12 * < LOD .800 (.600-1.10) 1.90 (1.20-2.70) 4.10 (1.90-6.00) 396 
12-19 years 11-12 * < LOD .400 (<LOD-.600) .900 (.600-1.30) 1.30 (.900-2.50) 388 
20 years and older 11-12 * < LOD < LOD .500 (.400-.600) .800 (.700-.900) 1705 
Gender        
Males 11-12 * < LOD < LOD .700 (.600-1.00) 1.10 (.800-1.70) 1259 
Females 11-12 * < LOD < LOD .600 (.500-.700) .900 (.800-1.10) 1230 
Race/ethnicity        
Mexican Americans 11-12 * < LOD .400 (<LOD-.500) .800 (.600-1.10) 1.30 (.800-2.70) 316 
Non-Hispanic blacks 11-12 * < LOD .500 (<LOD-.500) .900 (.700-1.10) 1.20 (1.10-1.50) 665 
Non-Hispanic whites 11-12 * < LOD < LOD .600 (.500-.700) .900 (.700-1.10) 813 
All Hispanics 11-12 * < LOD < LOD .700 (.600-.900) 1.10 (.800-1.60) 571 
Asians 11-12 * < LOD < LOD 1.00 (.700-1.50) 2.00 (1.20-5.50) 352 
Limit of detection (LOD, see Data Analysis section) for Survey year 11-12 is 0.4. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary Cyclohexane-1,2-dicarboxylic acid-mono(hydroxy-isononyl) ester (MHNCH) 
(creatinine corrected) (2011 - 2012) 
Metabolite of Di(isononyl) cyclohexane-1,2-dicarboxylate (DINCH) 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * < LOD < LOD 1.12 (1.01-1.22) 1.57 (1.39-1.87) 2487 
Age group        
6-11 years 11-12 * < LOD 1.27 (1.04-1.40) 2.22 (1.65-3.11) 3.81 (2.38-6.64) 395 
12-19 years 11-12 * < LOD .581 (<LOD-.700) 1.00 (.778-1.33) 1.57 (1.04-2.86) 388 
20 years and older 11-12 * < LOD < LOD 1.03 (.933-1.12) 1.39 (1.17-1.65) 1704 
Gender        
Males 11-12 * < LOD < LOD .916 (.778-1.08) 1.39 (1.08-1.59) 1258 
Females 11-12 * < LOD < LOD 1.22 (1.12-1.40) 1.91 (1.47-2.55) 1229 
Race/ethnicity        
Mexican Americans 11-12 * < LOD .667 (<LOD-.755) 1.22 (.903-1.47) 1.61 (1.27-2.76) 316 
Non-Hispanic blacks 11-12 * < LOD .449 (<LOD-.528) .848 (.757-.952) 1.23 (1.02-1.57) 665 
Non-Hispanic whites 11-12 * < LOD < LOD 1.12 (1.00-1.22) 1.56 (1.22-2.00) 811 
All Hispanics 11-12 * < LOD < LOD 1.12 (.824-1.47) 1.54 (1.27-1.87) 571 
Asians 11-12 * < LOD < LOD 1.89 (1.33-2.22) 3.57 (2.00-7.00) 352 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary Daidzein (1999 – 2010) ‡ 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 75.1 (61.9-91.1) 69.8 (57.8-82.6) 229 (184-298) 538 (471-702) 1320 (1020-1540) 2553 
 01-02 51.7 (46.6-57.5) 52.3 (48.9-57.4) 192 (151-226) 577 (447-725) 1250 (863-1640) 2794 
 03-04 66.7 (60.4-73.7) 62.0 (54.1-69.7) 195 (171-219) 590 (500-675) 1070 (893-1330) 2594 
 05-06 66.5 (59.7-74.1) 58.8 (51.0-67.7) 204 (187-226) 648 (485-745) 1180 (1000-1350) 2528 
 07-08 67.1 (60.2-74.8) 57.6 (49.1-66.0) 203 (182-222) 747 (551-994) 1740 (1210-2240) 2424 
 09-10 69.3 (61.6-77.9) 57.2 (48.8-64.3) 228 (190-262) 753 (671-880) 1850 (1380-2480) 2792 
Age group        
6-11 years 99-00 90.5 (75.1-109) 101 (70.3-138) 257 (172-430) 510 (437-840) 1130 (657-1740) 330 
 01-02 84.9 (71.6-101) 72.7 (56.3-97.0) 261 (155-385) 605 (437-989) 1060 (645-1500) 396 
 03-04 84.9 (71.6-101) 66.8 (55.4-92.8) 229 (151-314) 574 (371-654) 818 (625-1060) 341 
 05-06 94.1 (74.3-119) 74.0 (56.0-95.9) 287 (149-471) 1010 (557-1600) 1870 (1040-3830) 351 
 07-08 105 (80.2-137) 90.6 (61.4-123) 277 (183-431) 1370 (491-2190) 2190 (1340-3500) 360 
 09-10 109 (88.1-135) 98.5 (75.4-119) 461 (262-605) 1000 (730-1520) 1900 (1120-2800) 371 
12-19 years 99-00 123 (91.4-166) 124 (85.6-168) 326 (227-454) 833 (445-1490) 1460 (861-2410) 753 
 01-02 69.3 (52.6-91.3) 70.2 (52.5-87.5) 255 (185-344) 774 (573-984) 1360 (922-1950) 744 
 03-04 89.0 (75.2-105) 78.0 (59.0-104) 248 (197-332) 808 (500-968) 1200 (900-1790) 729 
 05-06 94.4 (76.0-117) 77.1 (59.7-103) 286 (200-416) 836 (530-1170) 1390 (929-2220) 693 
 07-08 79.7 (64.4-98.6) 76.0 (52.2-107) 256 (189-300) 828 (396-1100) 1220 (874-2070) 375 
 09-10 94.2 (74.1-120) 82.9 (60.8-116) 295 (201-395) 1020 (690-1210) 1390 (1150-2500) 447 
20 years and older 99-00 67.6 (55.4-82.4) 60.9 (49.3-74.1) 215 (167-239) 518 (459-573) 1320 (978-1540) 1470 
 01-02 46.4 (41.4-52.0) 49.1 (40.8-53.4) 176 (133-216) 520 (396-703) 1210 (771-1900) 1654 
 03-04 61.9 (55.2-69.4) 57.9 (48.7-68.5) 180 (150-214) 554 (416-695) 1110 (857-1360) 1524 
 05-06 60.5 (53.4-68.7) 54.0 (46.8-63.8) 197 (169-209) 512 (427-664) 1100 (795-1270) 1484 
 07-08 62.2 (55.0-70.4) 51.7 (44.3-60.3) 189 (169-211) 686 (514-939) 1640 (1060-2500) 1689 
 09-10 63.0 (54.7-72.5) 49.3 (43.0-59.8) 203 (168-250) 701 (572-856) 1980 (1220-2780) 1974 
Gender        
Males 99-00 88.9 (71.4-111) 80.6 (66.6-112) 262 (198-355) 587 (501-989) 1540 (989-2080) 1220 
 01-02 49.8 (42.8-57.9) 50.8 (46.0-55.0) 190 (137-240) 498 (386-694) 920 (717-1380) 1375 
 03-04 73.8 (63.4-85.9) 65.2 (56.1-76.4) 214 (156-311) 709 (535-900) 1200 (969-1380) 1244 
 05-06 73.9 (65.3-83.6) 66.4 (53.8-78.5) 210 (180-241) 694 (471-823) 1180 (979-1400) 1252 
 07-08 72.7 (62.2-85.0) 63.4 (49.3-76.5) 210 (174-259) 706 (520-1180) 2010 (1210-3520) 1198 
 09-10 68.8 (59.0-80.3) 55.0 (46.0-65.0) 207 (168-257) 674 (559-840) 1430 (1160-2370) 1377 
Females 99-00 64.1 (52.9-77.6) 57.8 (45.0-73.2) 199 (150-244) 476 (389-722) 1220 (566-1700) 1333 
 01-02 53.6 (48.1-59.8) 55.7 (49.8-62.7) 199 (149-234) 642 (511-816) 1470 (1170-1980) 1419 
 03-04 60.7 (53.6-68.8) 57.4 (49.1-67.6) 175 (159-201) 466 (381-622) 884 (654-1380) 1350 
 05-06 60.1 (52.5-68.9) 52.5 (45.0-61.1) 200 (166-231) 587 (420-717) 1140 (811-1440) 1276 
 07-08 62.2 (54.4-71.0) 52.2 (44.4-58.7) 191 (169-217) 752 (476-905) 1570 (994-2180) 1226 
 09-10 69.8 (60.7-80.3) 60.2 (46.1-71.1) 249 (200-309) 840 (694-973) 2140 (1210-2910) 1415 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 05-06, 07-08, and 09-10 are 0.5, 1.6, 0.3, 0.4, 0.4, and 0.4 respectively. 
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Urinary Daidzein (1999 – 2010) ‡ 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 78.9 (59.8-104) 66.2 (48.4-87.1) 254 (170-402) 806 (534-1020) 1360 (968-2780) 816 
 01-02 39.2 (28.5-54.0) 39.9 (28.8-59.9) 169 (100-291) 515 (388-669) 896 (613-1480) 679 
 03-04 57.4 (50.2-65.7) 45.5 (35.2-53.3) 178 (130-236) 686 (487-934) 1390 (934-1650) 653 
 05-06 60.6 (53.3-68.9) 54.1 (44.3-65.2) 193 (155-239) 671 (424-966) 1350 (966-1550) 634 
 07-08 60.5 (46.6-78.6) 45.8 (34.4-67.3) 206 (143-313) 815 (510-1010) 1410 (994-2010) 520 
 09-10 60.6 (48.8-75.2) 48.8 (38.6-74.3) 219 (142-283) 622 (495-853) 1190 (884-1570) 604 
Non-Hispanic blacks 99-00 91.9 (71.9-118) 103 (81.6-133) 286 (243-377) 553 (459-824) 1190 (640-1900) 607 
 01-02 66.1 (48.2-90.7) 72.9 (52.8-97.3) 255 (182-393) 757 (448-1400) 1410 (757-2480) 706 
 03-04 75.0 (56.1-100) 66.0 (50.7-86.6) 241 (151-340) 622 (408-875) 1190 (660-2300) 699 
 05-06 81.3 (71.6-92.4) 76.5 (64.7-97.1) 254 (199-331) 676 (463-874) 1210 (760-1790) 662 
 07-08 84.0 (63.3-111) 69.8 (43.4-102) 338 (248-419) 1080 (735-1500) 2180 (1230-2610) 562 
 09-10 77.2 (64.6-92.1) 69.9 (58.1-82.6) 229 (192-281) 711 (534-1080) 1350 (894-3480) 534 
Non-Hispanic whites 99-00 74.4 (61.5-89.9) 66.9 (56.2-78.2) 216 (157-298) 512 (438-745) 1360 (989-1710) 917 
 01-02 48.6 (43.8-54.0) 49.8 (42.8-54.2) 171 (137-204) 504 (389-658) 1140 (774-1620) 1222 
 03-04 65.8 (58.6-74.0) 62.0 (52.8-71.9) 191 (165-215) 572 (416-722) 1070 (823-1330) 1079 
 05-06 62.0 (54.4-70.7) 54.2 (46.9-64.1) 200 (164-216) 581 (430-717) 1040 (811-1310) 1039 
 07-08 63.6 (56.8-71.2) 56.7 (46.2-65.0) 180 (158-212) 603 (455-832) 1430 (915-2170) 993 
 09-10 68.3 (58.2-80.2) 55.0 (45.5-66.8) 219 (168-284) 726 (584-887) 1740 (1150-2510) 1186 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 05-06, 07-08, and 09-10 are 0.5, 1.6, 0.3, 0.4, 0.4, and 0.4 respectively. 
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Urinary Daidzein (creatinine corrected) (1999 – 2010) ‡ 
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(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 68.5 (55.9-83.9) 65.1 (52.8-80.8) 204 (156-249) 560 (471-629) 944 (836-1150) 2553 
 01-02 48.5 (43.7-54.0) 48.3 (43.1-56.5) 166 (140-196) 500 (391-608) 957 (801-1180) 2794 
 03-04 62.5 (58.3-67.0) 56.1 (50.0-63.5) 164 (144-187) 502 (429-591) 1060 (825-1150) 2594 
 05-06 64.8 (58.7-71.6) 52.4 (47.4-59.7) 184 (162-209) 564 (461-679) 1070 (896-1310) 2528 
 07-08 67.5 (60.5-75.2) 55.6 (47.4-64.0) 197 (178-217) 672 (538-897) 1400 (1070-2250) 2424 
 09-10 74.2 (67.0-82.2) 55.9 (51.6-61.7) 219 (184-272) 790 (688-1090) 1920 (1550-2390) 2791 
Age group        
6-11 years 99-00 92.6 (76.3-112) 93.1 (71.2-114) 251 (157-324) 552 (363-838) 1070 (781-2150) 330 
 01-02 96.4 (79.0-118) 85.9 (60.3-127) 275 (159-395) 655 (452-733) 938 (683-1140) 396 
 03-04 90.4 (77.2-106) 72.8 (58.1-99.5) 201 (152-240) 454 (329-638) 702 (526-1200) 341 
 05-06 104 (83.1-130) 73.8 (59.5-96.7) 305 (175-453) 1040 (686-1830) 2430 (1190-3630) 351 
 07-08 128 (101-164) 106 (80.0-141) 307 (197-429) 1420 (543-2630) 2630 (1380-3670) 360 
 09-10 149 (124-179) 128 (91.0-162) 500 (346-601) 1230 (814-1530) 2150 (1450-3070) 370 
12-19 years 99-00 83.1 (58.4-118) 85.6 (53.8-126) 207 (138-386) 628 (295-1060) 1000 (628-2380) 753 
 01-02 53.4 (40.8-70.0) 50.9 (38.3-77.6) 181 (142-248) 549 (385-718) 1030 (622-1360) 744 
 03-04 66.6 (55.7-79.6) 56.4 (43.9-74.6) 179 (151-217) 517 (370-753) 877 (617-1240) 729 
 05-06 70.0 (56.9-86.2) 55.1 (42.9-74.3) 203 (149-263) 545 (338-845) 914 (659-1750) 693 
 07-08 61.3 (51.5-72.9) 61.9 (39.9-75.0) 191 (144-217) 470 (295-645) 821 (544-1110) 375 
 09-10 88.6 (71.3-110) 76.5 (53.6-107) 249 (177-312) 689 (522-969) 1410 (823-2740) 447 
20 years and older 99-00 63.8 (51.5-79.1) 59.3 (48.7-75.0) 194 (151-234) 554 (471-624) 908 (783-1180) 1470 
 01-02 43.9 (39.4-48.9) 43.8 (37.4-53.3) 153 (125-186) 428 (348-590) 946 (728-1220) 1654 
 03-04 59.2 (54.3-64.5) 51.7 (46.4-62.6) 155 (131-185) 501 (404-658) 1090 (808-1240) 1524 
 05-06 60.7 (54.3-67.8) 50.6 (43.1-59.5) 171 (151-199) 483 (434-609) 1030 (847-1200) 1484 
 07-08 63.9 (56.0-72.9) 49.2 (42.6-57.7) 187 (164-216) 675 (514-904) 1340 (962-2780) 1689 
 09-10 67.1 (59.4-75.7) 50.3 (44.2-55.5) 194 (168-232) 775 (613-1120) 1980 (1550-2640) 1974 
Gender        
Males 99-00 69.7 (54.7-88.8) 70.2 (51.3-84.3) 198 (147-276) 623 (494-836) 1050 (884-1290) 1220 
 01-02 40.5 (34.8-47.1) 41.7 (34.5-47.9) 139 (107-179) 348 (260-553) 788 (585-947) 1375 
 03-04 57.7 (49.4-67.3) 48.9 (41.6-58.2) 160 (126-205) 467 (368-600) 919 (665-1200) 1244 
 05-06 59.5 (53.3-66.3) 51.0 (43.2-57.6) 164 (134-203) 467 (403-612) 927 (781-1100) 1252 
 07-08 61.3 (52.5-71.7) 48.7 (41.5-63.2) 178 (141-205) 585 (412-845) 1290 (907-2810) 1198 
 09-10 62.8 (54.8-72.1) 49.9 (42.6-57.3) 174 (145-196) 613 (497-790) 1740 (1170-2570) 1376 
Females 99-00 67.4 (54.8-82.9) 62.7 (51.1-80.9) 207 (152-250) 509 (356-624) 850 (610-1410) 1333 
 01-02 57.6 (50.8-65.2) 59.5 (48.1-73.4) 191 (159-227) 615 (536-722) 1180 (924-1430) 1419 
 03-04 67.4 (60.8-74.9) 65.1 (54.6-73.4) 165 (143-191) 564 (409-699) 1090 (757-1370) 1350 
 05-06 70.4 (61.3-80.8) 57.1 (45.1-71.7) 194 (169-216) 609 (463-887) 1200 (957-1750) 1276 
 07-08 73.8 (64.9-84.0) 63.0 (52.1-77.2) 223 (190-259) 763 (577-1000) 1410 (1070-1990) 1226 
 09-10 87.2 (77.9-97.7) 64.1 (55.6-76.7) 292 (240-336) 972 (800-1230) 2280 (1560-2880) 1415 
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(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 72.5 (59.1-88.9) 64.2 (47.1-91.1) 243 (176-310) 677 (468-1080) 1380 (753-2690) 816 
 01-02 36.9 (27.8-49.0) 37.1 (24.8-57.9) 146 (101-225) 441 (307-596) 722 (565-1160) 679 
 03-04 51.8 (45.0-59.6) 47.7 (35.9-58.3) 159 (117-209) 502 (354-686) 1130 (779-1390) 653 
 05-06 54.7 (45.6-65.7) 47.2 (35.7-61.1) 174 (136-219) 558 (380-617) 925 (642-1140) 634 
 07-08 59.5 (44.1-80.1) 41.1 (27.4-76.1) 200 (150-288) 715 (502-1060) 1410 (1090-1860) 520 
 09-10 63.7 (52.5-77.1) 49.2 (37.9-65.4) 213 (167-273) 614 (487-861) 1380 (865-1940) 604 
Non-Hispanic blacks 99-00 59.1 (46.5-75.1) 67.6 (52.1-87.1) 172 (134-207) 381 (316-533) 802 (562-1010) 607 
 01-02 46.4 (33.7-63.8) 49.8 (35.5-69.7) 169 (104-249) 504 (263-773) 939 (542-1530) 706 
 03-04 53.1 (42.5-66.4) 44.7 (28.6-72.1) 147 (121-191) 415 (275-538) 727 (538-1040) 699 
 05-06 57.0 (50.3-64.5) 48.5 (40.3-59.7) 157 (124-221) 467 (370-654) 913 (603-1290) 662 
 07-08 65.0 (48.7-86.6) 53.0 (36.0-80.6) 240 (171-292) 728 (520-937) 1330 (800-2670) 562 
 09-10 62.1 (53.0-72.8) 55.7 (42.7-65.0) 179 (157-223) 576 (457-690) 956 (710-1840) 533 
Non-Hispanic whites 99-00 72.8 (60.3-88.0) 67.5 (55.3-81.5) 207 (160-249) 560 (442-659) 908 (742-1350) 917 
 01-02 48.1 (43.4-53.3) 47.0 (42.0-56.0) 163 (137-191) 463 (375-627) 957 (805-1220) 1222 
 03-04 64.9 (59.8-70.3) 58.2 (50.4-66.3) 165 (138-204) 516 (385-667) 1090 (786-1250) 1079 
 05-06 65.2 (57.9-73.3) 52.7 (46.5-60.7) 184 (155-211) 564 (443-737) 1070 (894-1390) 1039 
 07-08 66.2 (58.4-75.1) 57.7 (46.0-65.5) 187 (160-216) 604 (474-763) 1210 (907-1670) 993 
 09-10 76.6 (67.1-87.4) 56.7 (51.2-64.1) 225 (173-306) 809 (617-1180) 1920 (1410-2470) 1186 
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(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 26.6 (21.9-32.3) 34.0 (29.4-38.7) 78.8 (62.6-95.5) 165 (135-215) 266 (215-335) 2527 
 01-02 35.7 (32.5-39.3) 39.4 (36.3-43.4) 89.2 (80.7-96.9) 181 (162-205) 253 (223-308) 2794 
 03-04 39.5 (36.1-43.3) 44.9 (40.6-50.3) 106 (97.2-115) 242 (212-264) 367 (311-423) 2594 
 05-06 37.7 (33.2-42.9) 42.4 (39.4-47.2) 106 (95.5-120) 244 (226-266) 379 (305-440) 2528 
 07-08 36.8 (32.0-42.4) 43.5 (37.8-49.2) 109 (92.1-124) 238 (199-294) 429 (279-723) 2424 
 09-10 39.5 (36.3-43.1) 44.5 (41.0-48.5) 107 (98.4-120) 264 (226-288) 545 (446-651) 2792 
Age group        
6-11 years 99-00 26.5 (17.1-41.0) 29.4 (21.2-44.2) 78.7 (44.2-109) 215 (91.1-279) 276 (131-458) 327 
 01-02 33.6 (29.8-37.8) 35.5 (29.4-43.7) 78.1 (63.8-87.0) 152 (113-171) 203 (167-327) 396 
 03-04 42.0 (34.5-51.1) 42.1 (34.4-49.2) 91.4 (74.4-110) 199 (126-289) 312 (217-525) 341 
 05-06 33.2 (26.1-42.3) 38.5 (34.7-43.2) 70.4 (55.7-91.7) 129 (99.1-162) 181 (129-366) 351 
 07-08 38.5 (30.1-49.3) 42.9 (31.3-55.3) 80.4 (62.7-118) 181 (119-318) 318 (186-439) 360 
 09-10 38.6 (33.9-44.0) 39.9 (32.5-44.2) 88.8 (67.7-106) 195 (131-265) 277 (210-380) 371 
12-19 years 99-00 29.8 (23.8-37.2) 34.0 (27.4-42.0) 84.4 (59.1-101) 166 (112-234) 253 (182-337) 744 
 01-02 35.3 (30.5-40.9) 37.7 (34.8-43.4) 84.2 (72.1-96.9) 165 (128-206) 238 (169-343) 744 
 03-04 45.1 (39.4-51.6) 46.3 (38.7-56.9) 99.5 (84.9-109) 191 (161-269) 325 (275-415) 729 
 05-06 39.1 (34.0-45.0) 41.1 (36.8-46.5) 92.0 (80.2-109) 193 (151-238) 265 (231-303) 693 
 07-08 37.3 (29.5-47.2) 45.8 (32.2-54.1) 97.9 (73.4-126) 199 (151-253) 293 (212-483) 375 
 09-10 37.5 (30.4-46.2) 38.3 (32.5-50.7) 98.0 (72.3-119) 184 (122-286) 315 (177-820) 447 
20 years and older 99-00 26.1 (21.8-31.3) 34.3 (29.8-38.7) 78.3 (63.5-94.8) 160 (132-196) 263 (189-335) 1456 
 01-02 36.1 (31.8-41.0) 40.4 (36.0-45.7) 91.2 (79.3-105) 190 (161-220) 256 (224-312) 1654 
 03-04 38.4 (34.2-43.0) 44.9 (40.1-51.9) 112 (98.8-125) 255 (215-274) 398 (320-448) 1524 
 05-06 38.1 (32.7-44.4) 43.8 (39.0-49.5) 116 (103-130) 266 (242-281) 413 (326-479) 1484 
 07-08 36.5 (31.2-42.8) 43.5 (37.6-49.3) 116 (97.5-130) 247 (194-326) 473 (300-757) 1689 
 09-10 40.0 (36.2-44.1) 47.6 (42.2-53.0) 114 (101-130) 277 (230-366) 596 (460-746) 1974 
Gender        
Males 99-00 25.3 (19.5-32.7) 33.0 (28.0-38.0) 72.6 (54.7-94.3) 149 (109-219) 258 (169-286) 1206 
 01-02 35.2 (31.8-39.1) 40.5 (36.8-44.8) 90.6 (82.3-103) 184 (158-198) 263 (223-338) 1375 
 03-04 39.7 (36.2-43.6) 45.1 (40.5-51.1) 102 (92.9-115) 231 (186-266) 361 (268-460) 1244 
 05-06 40.4 (32.8-49.8) 46.2 (38.9-52.3) 107 (90.6-127) 264 (227-289) 413 (287-496) 1252 
 07-08 33.1 (28.6-38.2) 39.8 (34.7-43.3) 91.8 (78.6-116) 216 (180-242) 378 (238-738) 1198 
 09-10 37.4 (30.9-45.3) 41.7 (35.5-48.4) 94.7 (78.9-111) 227 (173-312) 476 (366-664) 1377 
Females 99-00 27.9 (23.4-33.3) 36.0 (29.9-40.3) 84.4 (71.8-97.9) 177 (146-219) 280 (219-375) 1321 
 01-02 36.2 (32.2-40.7) 38.5 (35.3-43.4) 87.0 (75.6-98.5) 175 (152-212) 248 (220-283) 1419 
 03-04 39.3 (33.8-45.5) 44.9 (38.3-53.0) 110 (97.3-124) 250 (203-294) 398 (309-464) 1350 
 05-06 35.4 (30.3-41.2) 41.1 (35.6-45.4) 106 (94.2-123) 225 (186-267) 352 (268-477) 1276 
 07-08 40.7 (33.0-50.2) 48.4 (39.3-58.1) 123 (101-145) 258 (206-336) 479 (311-757) 1226 
 09-10 41.7 (37.6-46.3) 48.9 (41.6-56.7) 123 (111-140) 277 (243-304) 553 (448-778) 1415 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 05-06, 07-08, and 09-10 are 0.8, 1.5, 0.3, 0.04, 0.04, and 0.04 respectively. 
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(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 21.7 (19.5-24.1) 28.0 (24.7-34.7) 70.4 (60.8-78.8) 143 (117-169) 213 (169-256) 791 
 01-02 30.5 (25.7-36.3) 34.0 (29.0-39.2) 75.9 (58.8-89.7) 159 (119-202) 244 (192-298) 679 
 03-04 33.1 (26.4-41.6) 38.7 (31.2-47.6) 95.2 (78.1-115) 198 (125-307) 307 (186-480) 653 
 05-06 38.1 (32.2-45.1) 40.6 (34.6-47.6) 102 (86.8-123) 262 (177-359) 383 (289-511) 634 
 07-08 28.2 (24.8-32.0) 29.7 (26.7-33.4) 70.8 (59.9-83.8) 173 (139-208) 305 (207-456) 520 
 09-10 27.9 (24.5-31.7) 31.1 (28.8-36.7) 75.5 (66.6-85.5) 157 (120-192) 255 (174-408) 604 
Non-Hispanic blacks 99-00 25.8 (21.7-30.7) 31.2 (24.4-35.9) 66.0 (50.2-86.7) 157 (122-193) 260 (185-336) 608 
 01-02 35.0 (28.9-42.3) 38.7 (33.2-49.2) 83.7 (70.0-103) 169 (132-191) 225 (175-339) 706 
 03-04 40.4 (34.9-46.7) 47.1 (40.4-53.7) 100 (81.3-123) 212 (157-254) 293 (232-417) 699 
 05-06 34.7 (30.1-40.1) 38.4 (32.6-44.7) 85.1 (70.9-109) 190 (137-242) 269 (245-364) 662 
 07-08 34.4 (26.9-44.0) 38.9 (28.9-48.5) 95.7 (78.5-126) 202 (147-252) 327 (232-514) 562 
 09-10 32.4 (27.3-38.4) 35.7 (30.4-42.3) 98.5 (76.2-126) 211 (178-245) 307 (221-546) 534 
Non-Hispanic whites 99-00 29.2 (24.0-35.4) 37.6 (31.3-43.8) 85.8 (68.3-99.4) 171 (138-228) 270 (187-375) 915 
 01-02 35.6 (31.8-40.0) 40.4 (36.1-44.7) 89.6 (78.5-101) 175 (153-198) 254 (214-337) 1222 
 03-04 39.8 (35.5-44.7) 45.8 (38.9-54.9) 109 (95.8-126) 255 (206-267) 365 (294-424) 1079 
 05-06 37.3 (31.2-44.6) 42.6 (37.1-50.1) 108 (94.0-127) 243 (219-267) 371 (285-456) 1039 
 07-08 39.1 (31.5-48.5) 46.8 (39.3-55.5) 116 (91.8-140) 257 (188-369) 444 (269-839) 993 
 09-10 44.1 (39.0-49.9) 51.7 (44.2-56.7) 114 (100-129) 277 (236-311) 596 (414-778) 1186 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 05-06, 07-08, and 09-10 are 0.8, 1.5, 0.3, 0.04, 0.04, and 0.04 respectively. 
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(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 24.2 (20.3-28.9) 29.9 (25.0-34.7) 70.5 (59.6-82.1) 146 (124-177) 240 (199-320) 2527 
 01-02 33.5 (30.7-36.7) 37.6 (33.0-42.1) 79.2 (72.6-87.3) 149 (136-164) 224 (197-250) 2794 
 03-04 37.0 (33.6-40.7) 41.7 (37.9-45.4) 95.9 (85.6-106) 194 (171-213) 294 (247-368) 2594 
 05-06 36.8 (32.7-41.4) 41.0 (35.9-46.3) 103 (94.3-114) 204 (174-219) 323 (280-424) 2528 
 07-08 37.0 (32.3-42.3) 42.1 (36.8-48.1) 103 (87.1-117) 224 (164-328) 395 (292-634) 2424 
 09-10 42.3 (38.9-46.1) 47.1 (44.9-49.8) 108 (101-117) 281 (234-333) 522 (415-602) 2791 
Age group        
6-11 years 99-00 27.0 (18.6-39.3) 33.7 (21.8-43.7) 62.7 (43.0-108) 168 (81.6-290) 290 (150-411) 327 
 01-02 38.1 (32.5-44.7) 39.3 (30.8-53.1) 78.3 (66.6-103) 188 (147-244) 304 (242-389) 396 
 03-04 44.7 (37.4-53.5) 46.6 (38.5-58.3) 93.3 (73.9-125) 177 (128-205) 215 (181-413) 341 
 05-06 36.6 (28.9-46.4) 37.8 (32.3-46.5) 75.6 (60.9-105) 156 (109-219) 223 (165-326) 351 
 07-08 47.2 (37.5-59.4) 48.0 (38.0-65.2) 86.3 (67.9-178) 230 (181-297) 335 (230-854) 360 
 09-10 52.6 (45.0-61.4) 54.3 (39.8-64.5) 104 (79.5-139) 235 (145-335) 336 (239-413) 370 
12-19 years 99-00 20.1 (16.7-24.2) 24.1 (19.6-30.1) 55.1 (42.6-71.7) 99.5 (91.5-116) 158 (121-177) 744 
 01-02 27.2 (23.3-31.8) 28.7 (24.9-34.9) 62.7 (54.9-71.0) 104 (84.2-139) 152 (111-225) 744 
 03-04 33.8 (30.3-37.7) 34.8 (33.2-38.8) 67.6 (64.1-73.9) 130 (107-164) 221 (138-324) 729 
 05-06 29.0 (25.2-33.3) 31.4 (27.8-36.1) 68.8 (57.7-80.7) 131 (113-160) 167 (160-216) 693 
 07-08 28.7 (22.3-36.9) 33.8 (25.1-43.3) 73.4 (52.9-99.3) 131 (100-207) 207 (128-280) 375 
 09-10 35.3 (29.5-42.1) 37.8 (29.7-44.1) 81.7 (66.9-101) 170 (111-303) 306 (170-763) 447 
20 years and older 99-00 24.7 (20.6-29.5) 30.6 (26.0-34.8) 73.0 (62.5-84.5) 157 (129-184) 242 (199-344) 1456 
 01-02 34.2 (30.3-38.5) 39.6 (32.5-45.3) 84.1 (73.8-93.3) 152 (136-169) 224 (193-250) 1654 
 03-04 36.7 (32.5-41.4) 42.0 (37.1-47.8) 103 (91.8-111) 205 (173-239) 327 (256-431) 1524 
 05-06 38.2 (33.1-44.0) 43.1 (36.4-49.4) 111 (96.0-128) 216 (187-242) 358 (291-475) 1484 
 07-08 37.5 (32.2-43.7) 42.5 (36.8-49.9) 109 (90.7-134) 242 (167-372) 447 (328-718) 1689 
 09-10 42.6 (39.0-46.4) 48.3 (46.0-51.1) 113 (103-128) 303 (252-355) 579 (461-747) 1974 
Gender        
Males 99-00 19.8 (15.4-25.4) 25.4 (20.0-31.4) 55.1 (46.4-64.2) 122 (94.6-168) 199 (145-282) 1206 
 01-02 28.7 (26.0-31.7) 31.4 (27.0-36.8) 71.3 (64.2-78.0) 136 (114-160) 212 (179-259) 1375 
 03-04 31.1 (27.5-35.0) 34.8 (32.3-38.5) 78.0 (68.8-92.7) 165 (128-211) 249 (187-361) 1244 
 05-06 32.5 (26.7-39.5) 34.2 (29.5-41.1) 90.9 (75.2-102) 192 (147-235) 311 (218-490) 1252 
 07-08 27.9 (23.9-32.6) 33.0 (28.5-38.6) 79.3 (72.4-87.1) 164 (122-234) 259 (172-499) 1198 
 09-10 34.2 (27.9-42.0) 39.0 (33.0-45.6) 80.9 (69.7-103) 197 (150-253) 345 (235-494) 1376 
Females 99-00 29.3 (25.0-34.4) 35.4 (29.5-41.6) 85.2 (74.5-92.3) 165 (141-201) 321 (226-370) 1321 
 01-02 38.9 (34.9-43.3) 43.9 (39.3-48.7) 88.3 (74.7-102) 157 (139-174) 235 (180-304) 1419 
 03-04 43.6 (38.3-49.7) 49.0 (43.4-57.7) 109 (98.8-123) 215 (178-270) 377 (278-443) 1350 
 05-06 41.4 (36.1-47.4) 48.2 (41.8-55.7) 116 (98.0-131) 210 (183-231) 376 (235-470) 1276 
 07-08 48.4 (40.6-57.6) 53.2 (44.2-62.9) 128 (105-154) 300 (215-388) 529 (372-759) 1226 
 09-10 52.1 (46.7-58.1) 59.4 (49.4-66.2) 139 (121-156) 384 (311-450) 694 (526-938) 1415 
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Urinary Enterodiol (creatinine corrected) (1999 – 2010) ‡ 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 19.6 (17.3-22.2) 23.5 (19.7-28.7) 60.6 (49.8-77.7) 134 (114-154) 193 (154-227) 791 
 01-02 28.7 (24.5-33.7) 31.0 (27.0-37.3) 64.1 (55.0-77.5) 133 (94.4-183) 223 (143-337) 679 
 03-04 29.9 (23.8-37.4) 34.0 (26.5-42.8) 74.1 (62.0-101) 176 (118-234) 241 (189-364) 653 
 05-06 34.4 (28.3-41.8) 35.3 (30.7-40.0) 84.6 (71.2-110) 200 (145-271) 315 (221-515) 634 
 07-08 27.7 (24.5-31.3) 29.5 (23.9-33.8) 75.9 (61.3-88.2) 169 (124-198) 240 (178-387) 520 
 09-10 29.3 (25.8-33.3) 33.6 (29.5-38.0) 72.3 (61.4-82.7) 157 (116-193) 265 (193-351) 604 
Non-Hispanic blacks 99-00 16.6 (13.9-19.7) 18.8 (14.4-22.9) 47.3 (37.7-55.8) 113 (85.9-145) 169 (131-272) 608 
 01-02 24.5 (19.7-30.6) 27.0 (22.6-33.3) 57.5 (48.2-73.2) 117 (92.2-143) 157 (118-246) 706 
 03-04 28.6 (24.5-33.4) 30.4 (26.1-36.1) 68.3 (53.4-87.5) 126 (96.3-191) 203 (153-227) 699 
 05-06 24.3 (20.5-28.9) 25.3 (22.1-30.4) 68.6 (50.3-86.0) 125 (110-147) 190 (139-245) 662 
 07-08 26.6 (20.8-34.0) 30.0 (23.6-38.0) 62.9 (51.9-80.8) 139 (102-191) 257 (156-459) 562 
 09-10 26.1 (22.1-30.8) 29.7 (25.5-35.9) 73.9 (56.7-88.3) 153 (115-191) 252 (191-339) 533 
Non-Hispanic whites 99-00 28.6 (24.3-33.6) 34.4 (28.9-39.3) 75.8 (65.3-87.2) 163 (130-197) 252 (203-363) 915 
 01-02 35.3 (31.6-39.4) 40.9 (34.3-46.8) 83.3 (74.7-90.3) 152 (136-173) 225 (189-275) 1222 
 03-04 39.3 (34.4-44.8) 45.5 (38.4-53.0) 105 (90.2-116) 202 (168-234) 299 (244-374) 1079 
 05-06 39.2 (33.3-46.1) 45.0 (39.4-50.2) 111 (96.2-124) 210 (175-235) 331 (277-439) 1039 
 07-08 40.7 (32.7-50.6) 46.4 (38.6-56.7) 109 (86.3-138) 240 (154-384) 424 (257-802) 993 
 09-10 49.5 (43.6-56.1) 53.5 (48.3-59.0) 123 (106-140) 325 (252-384) 572 (414-766) 1186 
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Urinary Enterolactone (1999 – 2010) ‡ 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 239 (200-286) 315 (245-381) 726 (595-879) 1970 (1440-2370) 2800 (2500-3140) 2548 
 01-02 259 (233-287) 350 (314-389) 807 (739-873) 1590 (1440-1820) 2720 (1870-3430) 2794 
 03-04 298 (265-334) 395 (331-464) 900 (819-969) 1790 (1560-2040) 2620 (2360-2880) 2594 
 05-06 283 (245-327) 385 (338-460) 935 (824-1060) 1850 (1710-2040) 2880 (2480-3160) 2528 
 07-08 242 (211-277) 311 (263-371) 876 (741-1010) 1740 (1480-2050) 2910 (2170-3320) 2424 
 09-10 215 (193-240) 267 (229-306) 734 (659-853) 1760 (1490-2090) 2690 (2220-3160) 2792 
Age group        
6-11 years 99-00 308 (219-432) 356 (243-474) 721 (520-1320) 1730 (973-2840) 2840 (1700-3590) 331 
 01-02 288 (245-339) 329 (271-412) 680 (566-794) 1380 (929-1620) 2200 (1420-2550) 396 
 03-04 384 (287-513) 414 (299-567) 926 (589-1190) 1660 (1140-2280) 2360 (1700-3440) 341 
 05-06 300 (242-373) 399 (280-546) 851 (667-984) 1390 (1000-1770) 1910 (1390-2460) 351 
 07-08 255 (203-320) 314 (247-418) 706 (547-882) 1340 (897-1610) 1730 (1150-2600) 360 
 09-10 255 (206-316) 275 (209-346) 666 (552-749) 1480 (1180-1720) 1870 (1500-2870) 371 
12-19 years 99-00 250 (191-327) 317 (242-410) 672 (454-888) 1760 (973-2480) 2920 (1950-4330) 746 
 01-02 267 (231-308) 321 (255-399) 729 (617-856) 1480 (1230-1800) 2180 (1560-3440) 744 
 03-04 314 (267-369) 400 (333-468) 866 (736-1050) 1690 (1410-2080) 2620 (2000-2890) 729 
 05-06 292 (245-348) 393 (350-492) 877 (681-1010) 1620 (1470-1800) 2360 (1780-2960) 693 
 07-08 250 (203-309) 281 (217-444) 832 (645-1000) 1450 (1100-2030) 2390 (1450-3320) 375 
 09-10 194 (154-244) 229 (181-318) 632 (479-735) 1340 (812-2040) 2190 (1340-2960) 447 
20 years and older 99-00 230 (193-274) 310 (242-375) 734 (599-888) 2000 (1490-2390) 2790 (2510-3540) 1471 
 01-02 254 (223-289) 357 (314-397) 835 (760-914) 1660 (1460-1890) 2840 (1890-3610) 1654 
 03-04 286 (253-324) 394 (311-465) 900 (824-960) 1820 (1560-2060) 2630 (2350-3100) 1524 
 05-06 280 (238-330) 379 (332-460) 958 (843-1110) 1970 (1760-2310) 3130 (2540-3570) 1484 
 07-08 239 (205-280) 311 (258-374) 923 (746-1090) 1800 (1480-2370) 3000 (2210-4030) 1689 
 09-10 215 (189-243) 272 (228-320) 768 (666-930) 1850 (1590-2140) 2770 (2350-3690) 1974 
Gender        
Males 99-00 254 (212-304) 351 (266-418) 778 (579-1050) 2000 (1580-2400) 2730 (2430-3350) 1219 
 01-02 262 (233-295) 340 (314-387) 873 (769-957) 1810 (1490-2470) 3050 (1990-4070) 1375 
 03-04 314 (280-351) 425 (376-477) 938 (840-1060) 1760 (1540-2050) 2620 (2060-3230) 1244 
 05-06 301 (247-368) 421 (341-515) 1000 (854-1150) 2020 (1730-2330) 3130 (2660-3340) 1252 
 07-08 245 (215-278) 321 (261-389) 882 (714-1030) 1620 (1420-2050) 2700 (2000-3360) 1198 
 09-10 210 (173-256) 254 (207-324) 718 (583-870) 1670 (1300-2110) 2680 (1850-4060) 1377 
Females 99-00 226 (180-284) 287 (236-339) 684 (560-799) 1890 (1200-2460) 2830 (2100-4330) 1329 
 01-02 255 (226-288) 357 (298-397) 759 (680-840) 1450 (1190-1700) 2200 (1710-2950) 1419 
 03-04 283 (233-343) 371 (278-465) 859 (706-984) 1810 (1440-2170) 2630 (2210-3440) 1350 
 05-06 267 (220-324) 359 (318-445) 874 (716-1030) 1770 (1440-2020) 2660 (2040-3270) 1276 
 07-08 240 (196-293) 301 (234-394) 875 (747-1030) 1870 (1510-2200) 2920 (2160-3510) 1226 
 09-10 220 (196-247) 281 (237-325) 749 (662-868) 1850 (1520-2220) 2690 (2350-3200) 1415 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 05-06, 07-08, and 09-10 are 0.6, 1.9, 0.3, 0.1, 0.1, and 0.1 respectively. 
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Urinary Enterolactone (1999 – 2010) ‡ 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 212 (169-265) 281 (230-335) 631 (539-732) 1650 (950-2210) 2690 (2380-3350) 813 
 01-02 275 (221-342) 347 (312-395) 778 (671-913) 1520 (1090-1920) 2340 (1610-2990) 679 
 03-04 275 (239-316) 376 (316-435) 849 (744-958) 1560 (1320-1860) 2240 (1860-3100) 653 
 05-06 359 (311-415) 420 (364-515) 914 (750-1080) 1710 (1340-2060) 2660 (1950-3180) 634 
 07-08 227 (182-283) 320 (240-385) 747 (634-876) 1520 (1300-1740) 2070 (1650-2840) 520 
 09-10 198 (166-237) 265 (215-303) 642 (524-752) 1290 (981-1640) 1930 (1380-2280) 604 
Non-Hispanic blacks 99-00 262 (196-349) 363 (293-440) 759 (629-925) 1730 (1000-2420) 2500 (1870-3280) 605 
 01-02 278 (226-342) 418 (341-479) 769 (686-853) 1450 (1160-1840) 2000 (1540-2420) 706 
 03-04 328 (285-378) 437 (362-526) 942 (768-1110) 1580 (1360-1820) 2280 (1880-2640) 699 
 05-06 276 (237-322) 411 (346-483) 924 (827-1050) 1660 (1430-2040) 2620 (2220-3080) 662 
 07-08 252 (185-343) 362 (272-452) 902 (700-1120) 1820 (1320-2100) 2350 (1920-3160) 562 
 09-10 187 (140-250) 267 (180-346) 777 (543-945) 1410 (1150-1810) 1920 (1580-2340) 534 
Non-Hispanic whites 99-00 247 (196-311) 317 (240-403) 752 (616-955) 2040 (1600-2450) 3000 (2460-3880) 917 
 01-02 267 (235-303) 357 (307-397) 834 (750-923) 1630 (1420-1890) 2780 (1820-3740) 1222 
 03-04 299 (254-352) 396 (299-488) 900 (789-996) 1810 (1510-2140) 2680 (2310-3230) 1079 
 05-06 274 (228-329) 373 (318-460) 923 (745-1080) 1800 (1610-2020) 2910 (2360-3220) 1039 
 07-08 265 (218-322) 328 (266-409) 926 (733-1130) 1790 (1420-2580) 3030 (2050-4310) 993 
 09-10 236 (210-265) 293 (244-334) 765 (660-899) 1900 (1590-2310) 2990 (2210-4300) 1186 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 05-06, 07-08, and 09-10 are 0.6, 1.9, 0.3, 0.1, 0.1, and 0.1 respectively. 
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Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 218 (184-260) 284 (247-336) 733 (613-869) 1580 (1290-1830) 2250 (1860-2830) 2548 
 01-02 243 (220-268) 324 (293-360) 756 (668-858) 1430 (1250-1580) 2120 (1720-2450) 2794 
 03-04 279 (245-317) 371 (324-430) 810 (697-911) 1590 (1350-1910) 2400 (2000-2890) 2594 
 05-06 276 (237-321) 382 (329-448) 856 (775-975) 1640 (1480-1840) 2650 (2240-3380) 2528 
 07-08 243 (211-281) 345 (292-402) 826 (733-946) 1650 (1390-2050) 2730 (2080-3510) 2424 
 09-10 230 (206-258) 301 (268-342) 779 (695-882) 1800 (1540-2090) 2820 (2400-3420) 2791 
Age group        
6-11 years 99-00 315 (238-416) 384 (266-435) 704 (495-1110) 1580 (1110-2010) 2100 (1580-3040) 331 
 01-02 327 (274-391) 349 (263-478) 738 (603-994) 1420 (1140-1800) 2020 (1420-2940) 396 
 03-04 409 (310-540) 470 (354-632) 904 (669-1150) 1480 (1090-2420) 2300 (1480-2690) 341 
 05-06 331 (268-408) 459 (325-528) 778 (637-1010) 1480 (1130-1750) 1820 (1430-2510) 351 
 07-08 313 (255-384) 402 (309-484) 766 (725-824) 1310 (1020-1590) 1650 (1310-2220) 360 
 09-10 346 (283-424) 416 (323-471) 753 (607-904) 1440 (1100-2000) 2290 (1440-3340) 370 
12-19 years 99-00 169 (133-214) 210 (172-264) 486 (371-615) 1150 (742-1540) 1850 (1310-2350) 746 
 01-02 206 (178-239) 255 (223-293) 619 (466-753) 1110 (869-1480) 1500 (1140-2080) 744 
 03-04 235 (202-273) 285 (255-307) 631 (533-744) 1230 (993-1350) 1510 (1240-2230) 729 
 05-06 216 (184-254) 297 (255-336) 627 (514-701) 1010 (853-1170) 1410 (1150-1700) 693 
 07-08 192 (149-248) 273 (197-373) 540 (477-676) 936 (708-1220) 1620 (936-3420) 375 
 09-10 182 (147-226) 228 (176-295) 514 (362-809) 1140 (817-1530) 1740 (1140-3160) 447 
20 years and older 99-00 217 (181-261) 288 (249-350) 785 (653-923) 1640 (1330-1890) 2310 (1890-3110) 1471 
 01-02 240 (213-271) 331 (300-375) 786 (672-915) 1460 (1300-1630) 2180 (1890-2470) 1654 
 03-04 274 (236-318) 377 (316-448) 823 (697-937) 1700 (1430-1980) 2480 (2040-3100) 1524 
 05-06 281 (236-335) 399 (326-491) 942 (831-1040) 1730 (1570-2200) 2930 (2350-3530) 1484 
 07-08 246 (210-287) 350 (291-418) 906 (784-1040) 1810 (1420-2360) 2820 (2320-3570) 1689 
 09-10 229 (203-257) 300 (271-346) 828 (727-939) 1920 (1640-2350) 3070 (2530-3760) 1974 
Gender        
Males 99-00 199 (170-234) 263 (228-309) 664 (490-828) 1380 (1200-1710) 2030 (1780-2480) 1219 
 01-02 213 (191-238) 287 (255-316) 682 (601-764) 1350 (1090-1580) 1980 (1570-2550) 1375 
 03-04 245 (215-280) 330 (288-372) 729 (676-808) 1330 (1160-1580) 2040 (1590-2380) 1244 
 05-06 243 (196-300) 336 (279-418) 800 (707-897) 1500 (1270-1680) 2200 (1890-2480) 1252 
 07-08 206 (176-241) 303 (251-358) 715 (594-859) 1410 (1080-1850) 2140 (1560-3060) 1198 
 09-10 192 (157-235) 261 (210-310) 650 (543-766) 1440 (1170-1670) 2300 (1540-3220) 1376 
Females 99-00 238 (191-297) 303 (260-379) 819 (662-968) 1720 (1390-2010) 2550 (1940-3390) 1329 
 01-02 274 (241-312) 356 (313-407) 833 (710-1000) 1490 (1320-1670) 2150 (1890-2410) 1419 
 03-04 314 (257-385) 414 (327-510) 866 (704-1090) 1840 (1460-2280) 2840 (2220-3910) 1350 
 05-06 313 (261-375) 419 (337-529) 954 (809-1060) 1840 (1550-2320) 3100 (2350-4580) 1276 
 07-08 285 (234-346) 396 (327-469) 966 (843-1060) 1910 (1560-2410) 3040 (2730-3740) 1226 
 09-10 274 (244-309) 362 (305-416) 907 (789-1100) 2200 (1730-2810) 3570 (2800-4200) 1415 
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Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 194 (165-228) 254 (225-282) 605 (519-695) 1340 (969-1740) 2100 (1620-2790) 813 
 01-02 259 (213-314) 362 (296-409) 730 (586-905) 1240 (1010-1490) 1630 (1240-2540) 679 
 03-04 248 (217-282) 350 (310-403) 724 (657-826) 1320 (1020-1560) 1820 (1460-2170) 653 
 05-06 324 (267-393) 379 (315-471) 773 (679-953) 1560 (1290-1680) 2060 (1630-2560) 634 
 07-08 223 (185-268) 312 (267-379) 733 (642-871) 1330 (1110-1580) 1860 (1620-2160) 520 
 09-10 208 (174-249) 284 (214-322) 624 (505-728) 1270 (1090-1460) 1870 (1460-2130) 604 
Non-Hispanic blacks 99-00 168 (125-226) 214 (173-274) 546 (411-732) 1130 (874-1450) 1590 (1120-2560) 605 
 01-02 195 (155-245) 302 (257-331) 562 (470-629) 985 (821-1130) 1490 (1080-1730) 706 
 03-04 233 (197-274) 303 (276-347) 621 (512-707) 1050 (917-1350) 1550 (1170-2220) 699 
 05-06 193 (167-223) 286 (252-331) 630 (556-729) 1120 (967-1230) 1490 (1220-1650) 662 
 07-08 195 (144-264) 291 (191-408) 659 (564-741) 1220 (993-1360) 1480 (1350-2060) 562 
 09-10 150 (113-200) 256 (183-328) 539 (457-659) 927 (757-1160) 1310 (1000-1720) 533 
Non-Hispanic whites 99-00 241 (194-300) 323 (279-388) 828 (674-997) 1780 (1390-2020) 2490 (1930-3340) 917 
 01-02 264 (232-301) 339 (299-393) 833 (719-944) 1530 (1340-1880) 2410 (1940-2800) 1222 
 03-04 294 (246-353) 399 (326-488) 836 (707-980) 1660 (1330-2040) 2500 (1990-3350) 1079 
 05-06 288 (238-347) 403 (326-500) 926 (809-1050) 1700 (1500-2200) 2930 (2230-3710) 1039 
 07-08 276 (225-337) 386 (318-467) 911 (736-1100) 1870 (1370-2730) 2850 (2200-3640) 993 
 09-10 264 (233-299) 329 (290-385) 895 (779-1030) 2140 (1640-2780) 3420 (2740-3990) 1186 
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Urinary Equol (1999 – 2010) ‡ 
Metabolite of Daidzein 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 8.37 (7.21-9.72) 8.02 (6.27-9.90) 17.2 (15.2-19.8) 35.0 (28.9-41.6) 53.7 (40.1-74.2) 2182 
 01-02 9.17 (7.76-10.8) 9.00 (7.40-10.5) 19.6 (16.6-23.5) 42.1 (34.3-51.5) 73.5 (53.6-89.2) 2794 
 03-04 8.02 (7.07-9.10) 8.00 (6.80-9.40) 18.2 (15.2-20.8) 36.6 (31.3-40.0) 64.9 (45.4-97.9) 2590 
 05-06 8.40 (7.63-9.24) 8.61 (7.89-9.17) 18.1 (16.4-20.4) 37.6 (33.9-41.8) 64.5 (54.8-85.3) 2527 
 07-08 7.29 (6.21-8.57) 7.18 (6.18-8.44) 15.3 (12.5-18.5) 30.7 (24.5-43.2) 65.9 (50.7-131) 2424 
 09-10 7.82 (6.91-8.85) 7.39 (6.59-8.34) 17.1 (14.9-18.9) 38.0 (33.9-42.4) 68.6 (52.4-95.6) 2792 
Age group        
6-11 years 99-00 10.5 (7.65-14.3) 11.7 (5.43-18.6) 24.9 (17.5-29.5) 34.4 (29.5-53.3) 56.1 (30.1-149) 272 
 01-02 12.2 (10.2-14.6) 13.7 (11.1-16.2) 26.2 (17.9-37.9) 50.4 (35.0-84.3) 85.4 (50.4-159) 396 
 03-04 12.4 (9.71-15.8) 12.1 (8.40-17.8) 24.4 (20.1-31.2) 46.7 (33.5-82.3) 85.8 (44.9-118) 341 
 05-06 13.3 (11.3-15.7) 13.5 (12.1-16.8) 26.5 (20.8-34.1) 45.6 (39.3-69.6) 70.3 (44.7-144) 351 
 07-08 10.9 (8.38-14.3) 11.3 (8.60-13.2) 22.0 (15.8-27.5) 55.9 (24.2-77.8) 73.3 (59.5-115) 360 
 09-10 13.4 (9.85-18.4) 12.7 (9.01-16.7) 28.5 (22.6-41.8) 68.0 (45.3-179) 242 (68.0-598) 371 
12-19 years 99-00 10.9 (8.64-13.8) 10.8 (8.52-13.4) 22.3 (16.0-34.9) 42.9 (34.1-71.3) 71.6 (48.1-210) 657 
 01-02 10.2 (8.50-12.1) 10.5 (8.20-12.5) 20.5 (16.8-24.8) 43.1 (30.1-56.1) 70.0 (46.3-99.2) 744 
 03-04 10.6 (8.97-12.4) 10.5 (8.70-12.2) 22.6 (19.3-26.4) 39.9 (34.8-45.1) 61.9 (45.1-113) 729 
 05-06 11.6 (10.3-13.0) 11.4 (9.25-12.3) 23.2 (20.3-28.8) 46.3 (37.2-64.0) 81.8 (50.1-146) 693 
 07-08 8.47 (7.19-9.98) 7.91 (6.79-9.30) 16.0 (12.8-19.0) 32.7 (24.5-43.2) 65.6 (33.6-148) 375 
 09-10 11.4 (8.90-14.6) 9.60 (7.57-14.1) 24.6 (19.6-29.6) 48.0 (35.9-112) 220 (69.4-701) 447 
20 years and older 99-00 7.79 (6.79-8.94) 7.43 (5.71-8.85) 16.0 (13.6-18.1) 33.1 (24.4-39.7) 52.2 (36.3-93.9) 1253 
 01-02 8.70 (7.29-10.4) 8.00 (6.20-10.2) 18.6 (15.0-22.3) 41.3 (34.1-47.4) 73.5 (53.9-89.0) 1654 
 03-04 7.28 (6.37-8.33) 7.20 (6.00-8.70) 16.0 (14.2-19.2) 33.9 (28.2-38.9) 63.0 (41.3-121) 1520 
 05-06 7.58 (6.82-8.42) 7.57 (7.01-8.30) 16.6 (14.9-18.2) 33.6 (29.1-42.6) 58.1 (50.6-89.0) 1483 
 07-08 6.82 (5.70-8.17) 6.75 (5.70-7.98) 14.3 (11.6-18.3) 28.9 (23.6-41.9) 65.8 (47.7-135) 1689 
 09-10 6.97 (6.07-8.00) 6.72 (5.78-7.75) 15.0 (13.1-17.1) 33.2 (28.4-38.3) 57.7 (44.6-75.4) 1974 
Gender        
Males 99-00 9.15 (7.37-11.4) 8.44 (6.36-11.2) 19.0 (15.9-24.0) 35.6 (29.2-54.8) 71.3 (39.7-166) 1042 
 01-02 9.41 (7.99-11.1) 9.20 (7.70-10.8) 20.1 (16.7-26.1) 43.1 (32.4-53.1) 61.7 (51.8-81.5) 1375 
 03-04 8.56 (7.54-9.72) 8.70 (7.20-10.2) 19.0 (15.9-21.6) 38.0 (31.9-44.2) 72.6 (45.4-100) 1240 
 05-06 9.13 (7.99-10.4) 9.42 (8.16-10.8) 20.0 (16.7-23.8) 39.4 (33.8-45.3) 63.1 (52.0-88.1) 1252 
 07-08 7.58 (6.40-8.97) 7.74 (6.62-8.80) 15.5 (12.5-18.2) 32.7 (24.5-41.9) 65.6 (47.7-133) 1198 
 09-10 8.20 (7.14-9.42) 8.18 (6.86-9.67) 18.4 (15.2-21.3) 39.3 (31.4-48.0) 70.7 (53.4-112) 1377 
Females 99-00 7.70 (6.79-8.75) 7.57 (5.79-9.04) 15.6 (12.7-18.9) 33.6 (26.7-37.7) 48.2 (37.1-62.9) 1140 
 01-02 8.94 (7.38-10.8) 8.60 (6.70-10.7) 19.0 (15.6-22.9) 41.6 (33.3-51.5) 79.8 (56.6-122) 1419 
 03-04 7.55 (6.44-8.84) 7.30 (6.20-9.00) 16.9 (14.7-19.8) 33.8 (28.3-40.0) 60.3 (42.5-116) 1350 
 05-06 7.75 (6.85-8.78) 7.57 (6.87-8.37) 16.7 (15.0-18.0) 35.6 (30.9-43.1) 69.2 (51.7-125) 1275 
 07-08 7.03 (5.84-8.47) 6.75 (5.85-7.85) 15.1 (12.3-19.0) 30.0 (24.4-48.3) 76.3 (49.5-163) 1226 
 09-10 7.47 (6.33-8.81) 6.75 (5.70-7.85) 15.4 (13.1-18.5) 36.4 (29.4-45.3) 65.2 (46.4-130) 1415 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 05-06, 07-08, and 09-10 are 3.0, 3.3, 0.3, 0.06, 0.06, and 0.06 respectively. 
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Urinary Equol (1999 – 2010) ‡ 
Metabolite of Daidzein 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 5.24 (4.77-5.76) 4.51 (3.65-5.18) 9.48 (7.96-10.3) 18.5 (14.5-22.6) 30.9 (21.6-48.4) 726 
 01-02 7.22 (6.04-8.62) 6.50 (4.40-9.10) 14.2 (11.3-20.1) 31.4 (21.1-41.0) 42.4 (38.1-60.2) 679 
 03-04 6.08 (5.08-7.28) 5.70 (4.70-6.80) 12.5 (9.80-15.4) 26.1 (18.1-39.7) 43.6 (34.3-88.2) 653 
 05-06 6.04 (5.31-6.87) 6.13 (5.28-7.35) 13.3 (11.2-14.7) 25.2 (19.6-33.4) 47.6 (33.6-67.1) 634 
 07-08 5.52 (5.02-6.07) 5.15 (4.71-5.86) 11.4 (10.1-14.0) 23.2 (20.2-30.3) 39.9 (30.7-60.9) 520 
 09-10 5.07 (4.51-5.71) 5.13 (4.45-5.74) 11.1 (8.72-13.0) 20.2 (17.1-29.7) 46.3 (29.7-75.4) 604 
Non-Hispanic blacks 99-00 6.73 (5.20-8.71) 6.24 (3.86-10.0) 15.1 (12.7-17.6) 27.6 (19.4-35.6) 36.4 (28.9-49.4) 514 
 01-02 7.15 (6.06-8.43) 6.10 (4.70-7.60) 14.7 (12.0-18.7) 30.9 (22.8-41.9) 45.7 (36.1-90.5) 706 
 03-04 7.35 (6.16-8.79) 7.90 (6.00-9.60) 16.5 (14.2-18.3) 32.0 (25.1-37.5) 47.0 (37.8-68.2) 696 
 05-06 6.96 (5.89-8.22) 6.37 (5.44-7.95) 15.1 (11.7-20.2) 30.1 (23.8-39.4) 48.8 (38.7-64.9) 662 
 07-08 6.73 (5.28-8.59) 6.69 (5.17-8.19) 15.2 (11.9-18.5) 31.3 (21.7-50.7) 72.0 (36.1-402) 562 
 09-10 5.59 (4.98-6.27) 5.98 (5.37-6.48) 12.2 (10.8-14.2) 25.0 (21.6-31.0) 43.3 (32.4-53.7) 534 
Non-Hispanic whites 99-00 9.26 (7.80-11.0) 8.98 (6.73-11.9) 19.0 (16.1-22.8) 36.2 (30.1-45.4) 56.1 (42.1-89.4) 758 
 01-02 9.91 (7.95-12.4) 10.0 (7.30-12.6) 22.0 (17.4-27.4) 44.4 (35.1-57.5) 74.4 (55.1-107) 1222 
 03-04 8.52 (7.26-10.0) 8.80 (7.10-10.3) 19.3 (15.4-23.0) 37.7 (31.7-44.2) 73.1 (46.7-120) 1078 
 05-06 9.05 (8.08-10.1) 9.49 (8.47-10.4) 19.4 (16.6-23.2) 39.2 (33.9-45.1) 69.2 (52.2-130) 1038 
 07-08 8.01 (6.45-9.93) 8.19 (6.59-9.49) 16.1 (12.5-21.7) 32.7 (24.1-55.9) 79.5 (47.7-152) 993 
 09-10 9.45 (8.04-11.1) 9.15 (7.87-10.2) 19.3 (17.5-22.4) 41.3 (35.4-48.7) 75.4 (52.4-189) 1186 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 05-06, 07-08, and 09-10 are 3.0, 3.3, 0.3, 0.06, 0.06, and 0.06 respectively. 
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Urinary Equol (creatinine corrected) (1999 – 2010) ‡ 
 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 7.70 (6.82-8.70) 7.96 (6.87-9.35) 16.2 (13.2-18.6) 30.6 (26.9-35.1) 50.3 (41.8-67.3) 2182 
 01-02 8.60 (7.26-10.2) 7.98 (6.62-9.76) 17.6 (14.8-21.8) 37.8 (30.3-46.3) 62.6 (50.0-85.0) 2794 
 03-04 7.52 (6.83-8.29) 7.29 (6.56-8.18) 14.6 (13.3-15.7) 27.8 (24.7-31.9) 50.6 (39.9-75.0) 2590 
 05-06 8.18 (7.33-9.14) 7.92 (7.01-8.76) 15.9 (14.2-17.4) 32.7 (29.9-35.1) 69.1 (48.4-105) 2527 
 07-08 7.33 (6.34-8.48) 6.91 (6.13-7.86) 14.4 (12.2-16.7) 28.9 (23.5-37.4) 60.9 (40.5-93.1) 2424 
 09-10 8.38 (7.52-9.33) 7.70 (6.80-8.69) 16.6 (15.3-18.1) 36.3 (30.5-44.5) 73.4 (54.2-122) 2791 
Age group        
6-11 years 99-00 10.3 (7.83-13.5) 11.4 (7.46-16.3) 22.6 (14.7-27.2) 32.7 (25.5-46.0) 47.8 (32.7-150) 272 
 01-02 13.9 (11.2-17.2) 14.0 (10.6-17.0) 28.8 (19.6-39.8) 54.4 (34.9-99.8) 88.2 (56.8-186) 396 
 03-04 13.2 (10.9-15.9) 13.2 (9.19-17.5) 24.2 (20.6-28.0) 41.6 (35.2-64.1) 93.5 (45.4-117) 341 
 05-06 14.7 (12.6-17.1) 15.3 (13.8-17.4) 26.2 (21.2-34.4) 48.0 (40.6-70.3) 88.9 (55.4-267) 351 
 07-08 13.4 (10.8-16.6) 13.1 (10.6-15.2) 22.6 (16.9-32.8) 45.2 (28.8-84.4) 72.8 (45.8-199) 360 
 09-10 18.3 (13.5-24.7) 15.7 (11.5-19.3) 42.0 (28.1-54.1) 84.1 (63.5-183) 232 (98.4-498) 370 
12-19 years 99-00 7.61 (6.17-9.39) 8.02 (6.72-9.29) 14.0 (11.4-20.4) 27.5 (20.8-38.3) 47.4 (27.5-149) 657 
 01-02 7.83 (6.68-9.17) 7.77 (6.29-9.13) 17.4 (14.9-19.2) 31.9 (25.3-41.7) 54.3 (33.0-76.7) 744 
 03-04 7.91 (6.59-9.49) 8.11 (6.80-9.09) 14.5 (11.8-17.5) 30.1 (21.0-38.2) 40.6 (32.6-66.9) 729 
 05-06 8.61 (7.54-9.83) 8.03 (7.00-9.21) 16.3 (13.4-19.0) 31.8 (25.3-37.6) 62.0 (37.0-129) 693 
 07-08 6.51 (5.69-7.46) 5.83 (4.78-6.71) 12.6 (10.5-16.4) 28.7 (20.8-35.3) 50.4 (30.7-72.7) 375 
 09-10 10.7 (8.50-13.5) 8.95 (7.40-10.3) 20.6 (15.9-23.3) 46.3 (31.3-101) 215 (58.9-919) 447 
20 years and older 99-00 7.45 (6.60-8.41) 7.63 (6.35-9.22) 15.3 (12.7-17.7) 30.8 (25.0-37.2) 53.2 (41.2-71.8) 1253 
 01-02 8.23 (6.93-9.79) 7.52 (5.97-9.56) 16.6 (14.0-20.7) 36.4 (29.3-42.9) 58.7 (47.9-85.0) 1654 
 03-04 6.98 (6.30-7.73) 6.76 (6.05-7.65) 13.6 (12.5-14.8) 24.6 (21.9-29.4) 42.8 (35.7-81.6) 1520 
 05-06 7.60 (6.72-8.59) 7.43 (6.63-8.21) 14.1 (12.4-16.4) 30.1 (23.9-34.9) 65.9 (42.7-123) 1483 
 07-08 7.00 (5.90-8.31) 6.64 (5.73-7.57) 13.2 (11.2-16.2) 26.4 (21.6-38.4) 57.7 (38.4-97.0) 1689 
 09-10 7.43 (6.61-8.34) 6.97 (6.09-8.08) 15.0 (13.5-16.7) 29.2 (25.3-34.5) 54.7 (41.4-75.7) 1974 
Gender        
Males 99-00 7.01 (5.93-8.29) 7.32 (5.63-8.78) 13.8 (11.7-17.6) 29.3 (21.4-41.8) 54.1 (35.8-81.0) 1042 
 01-02 7.66 (6.39-9.18) 7.43 (5.81-9.16) 16.2 (14.0-19.4) 32.9 (27.9-40.4) 54.3 (37.8-67.1) 1375 
 03-04 6.71 (6.02-7.47) 6.63 (5.78-7.29) 13.3 (11.9-15.5) 25.7 (23.1-30.3) 51.1 (37.1-76.7) 1240 
 05-06 7.35 (6.40-8.43) 7.03 (5.90-8.67) 14.9 (12.0-18.3) 31.4 (26.8-34.0) 57.6 (42.7-83.5) 1252 
 07-08 6.39 (5.52-7.41) 6.10 (5.28-6.85) 12.2 (10.6-14.3) 25.7 (20.4-33.0) 48.4 (35.3-77.1) 1198 
 09-10 7.49 (6.54-8.59) 6.90 (5.98-8.20) 15.7 (14.1-17.3) 32.4 (25.3-44.1) 73.4 (44.2-130) 1376 
Females 99-00 8.41 (7.33-9.66) 8.71 (7.33-10.1) 17.7 (15.1-20.0) 31.6 (27.5-37.2) 46.3 (41.0-56.5) 1140 
 01-02 9.60 (7.99-11.5) 8.66 (6.97-10.6) 19.2 (15.7-23.7) 41.7 (32.3-55.9) 85.0 (61.7-115) 1419 
 03-04 8.38 (7.39-9.51) 8.29 (7.03-9.28) 15.1 (14.0-16.6) 30.6 (25.0-32.5) 45.4 (38.7-102) 1350 
 05-06 9.07 (8.04-10.2) 8.49 (7.90-9.22) 16.7 (15.3-18.1) 34.3 (29.9-40.7) 85.1 (48.4-144) 1275 
 07-08 8.35 (6.98-9.99) 7.97 (6.83-9.31) 16.0 (13.4-20.0) 32.8 (23.7-46.1) 67.5 (41.6-167) 1226 
 09-10 9.34 (7.98-10.9) 8.44 (7.24-9.76) 17.4 (15.1-20.4) 39.6 (30.7-54.2) 72.9 (51.6-158) 1415 
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Urinary Equol (creatinine corrected) (1999 – 2010) ‡ 
Metabolite of Daidzein 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 4.89 (4.36-5.47) 4.73 (3.90-5.27) 8.85 (8.18-9.91) 22.3 (16.5-26.8) 37.1 (25.3-57.6) 726 
 01-02 6.79 (5.82-7.92) 6.81 (5.55-8.04) 14.9 (11.7-17.8) 29.1 (22.9-36.0) 41.3 (31.4-47.1) 679 
 03-04 5.48 (4.60-6.54) 4.72 (3.95-5.78) 10.1 (7.76-13.4) 24.4 (17.2-30.9) 35.6 (27.6-102) 653 
 05-06 5.45 (4.84-6.14) 5.00 (4.37-5.85) 9.94 (8.80-12.4) 22.3 (19.3-30.0) 39.4 (30.0-61.9) 634 
 07-08 5.42 (4.82-6.09) 4.87 (4.28-5.66) 10.9 (9.21-12.2) 20.9 (17.0-26.9) 34.9 (26.9-60.9) 520 
 09-10 5.33 (4.60-6.18) 5.00 (4.17-6.16) 9.49 (8.54-11.2) 19.6 (15.1-35.6) 48.5 (30.3-126) 604 
Non-Hispanic blacks 99-00 4.36 (3.41-5.57) 4.57 (2.94-6.23) 10.2 (7.96-12.0) 17.1 (14.8-19.8) 26.0 (19.6-32.0) 514 
 01-02 5.01 (4.26-5.89) 4.48 (3.80-5.42) 11.0 (8.80-13.0) 22.7 (16.5-29.3) 35.4 (24.8-46.7) 706 
 03-04 5.23 (4.44-6.16) 5.28 (4.67-6.10) 10.3 (8.61-12.3) 20.2 (17.1-23.8) 29.4 (23.9-42.3) 696 
 05-06 4.88 (4.11-5.78) 4.72 (3.55-6.00) 9.40 (7.54-12.0) 21.5 (16.8-24.4) 31.6 (24.4-51.4) 662 
 07-08 5.21 (4.11-6.61) 4.73 (3.77-6.22) 9.81 (7.77-12.7) 19.3 (14.7-28.8) 50.6 (24.2-314) 562 
 09-10 4.50 (4.03-5.01) 4.57 (3.80-5.29) 9.76 (8.00-11.3) 18.4 (15.6-22.3) 26.8 (22.8-29.7) 533 
Non-Hispanic whites 99-00 9.13 (7.85-10.6) 9.51 (7.63-11.2) 18.0 (15.2-21.6) 35.4 (29.5-41.3) 56.5 (46.0-73.0) 758 
 01-02 9.81 (7.93-12.1) 9.17 (7.06-12.2) 19.8 (15.4-25.6) 41.3 (30.7-55.9) 66.4 (56.8-85.0) 1222 
 03-04 8.40 (7.50-9.41) 8.17 (7.13-9.19) 15.6 (14.1-17.1) 30.6 (25.0-32.8) 56.8 (38.0-107) 1078 
 05-06 9.51 (8.48-10.7) 9.17 (8.06-10.5) 17.1 (15.0-19.4) 34.5 (31.0-40.6) 77.7 (48.4-129) 1038 
 07-08 8.33 (6.76-10.3) 7.94 (6.62-9.61) 15.7 (12.5-20.4) 30.7 (23.4-46.1) 65.2 (38.9-144) 993 
 09-10 10.6 (9.17-12.2) 9.69 (8.74-10.8) 20.5 (17.8-22.5) 44.2 (33.4-60.8) 84.1 (60.3-187) 1186 
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Urinary Genistein (1999 – 2010) ‡ 
 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 24.4 (19.7-30.3) 27.0 (22.5-32.8) 93.6 (75.8-118) 284 (244-331) 563 (413-709) 2557 
 01-02 33.0 (30.1-36.2) 29.0 (26.8-31.8) 92.5 (77.9-109) 306 (240-372) 619 (523-719) 2794 
 03-04 31.1 (29.0-33.3) 26.2 (23.9-29.7) 87.8 (78.8-102) 286 (239-313) 528 (402-610) 2594 
 05-06 28.7 (25.8-32.0) 26.0 (20.9-29.7) 81.0 (73.3-92.4) 261 (232-308) 523 (422-591) 2528 
 07-08 31.3 (27.3-35.8) 25.7 (22.8-28.9) 89.7 (73.4-109) 309 (227-411) 665 (527-999) 2424 
 09-10 32.5 (29.3-36.2) 28.2 (23.2-33.1) 102 (88.8-120) 356 (295-428) 691 (530-1060) 2792 
Age group        
6-11 years 99-00 27.6 (21.1-36.1) 31.9 (18.1-42.6) 104 (67.6-151) 220 (151-315) 376 (272-725) 331 
 01-02 39.2 (33.4-46.0) 31.7 (25.8-39.6) 94.1 (62.3-158) 258 (190-426) 502 (258-830) 396 
 03-04 33.6 (27.8-40.6) 29.3 (23.1-37.8) 79.4 (56.7-111) 193 (146-274) 351 (207-376) 341 
 05-06 38.6 (29.8-49.9) 34.6 (25.3-42.5) 109 (76.6-181) 367 (252-568) 629 (367-2390) 351 
 07-08 43.7 (32.6-58.5) 34.3 (22.1-56.4) 139 (82.5-194) 505 (251-763) 840 (505-2200) 360 
 09-10 46.1 (37.8-56.3) 38.4 (30.7-46.9) 167 (96.9-253) 467 (280-616) 958 (528-1210) 371 
12-19 years 99-00 43.7 (34.2-55.7) 45.4 (34.3-60.5) 138 (93.7-179) 319 (245-464) 547 (321-777) 754 
 01-02 34.1 (27.2-42.8) 29.0 (26.1-32.9) 90.6 (71.5-113) 278 (216-363) 470 (360-687) 744 
 03-04 34.7 (29.3-41.0) 29.0 (23.4-37.6) 111 (69.3-141) 304 (206-376) 530 (358-671) 729 
 05-06 34.1 (28.8-40.5) 26.9 (20.5-35.6) 90.5 (76.1-115) 307 (209-394) 486 (372-982) 693 
 07-08 35.2 (28.5-43.5) 28.4 (23.7-34.5) 111 (63.7-138) 279 (160-483) 538 (320-954) 375 
 09-10 39.2 (29.5-52.0) 34.4 (23.5-47.1) 141 (77.0-188) 373 (242-520) 620 (445-1160) 447 
20 years and older 99-00 21.9 (17.6-27.2) 24.0 (21.7-28.4) 86.2 (67.5-108) 293 (235-343) 566 (412-744) 1472 
 01-02 32.1 (28.8-35.8) 28.8 (25.4-33.4) 93.4 (77.3-110) 312 (235-389) 627 (537-790) 1654 
 03-04 30.2 (27.8-32.8) 25.9 (22.3-29.8) 87.8 (77.9-103) 296 (239-321) 557 (412-653) 1524 
 05-06 27.0 (23.9-30.6) 25.0 (19.8-28.8) 77.4 (66.7-89.5) 244 (190-308) 518 (413-591) 1484 
 07-08 29.6 (25.4-34.5) 24.7 (21.3-28.4) 84.1 (68.0-98.0) 278 (207-422) 671 (512-1150) 1689 
 09-10 30.5 (26.7-34.8) 26.3 (20.3-31.7) 97.5 (77.3-115) 327 (281-425) 691 (523-1110) 1974 
Gender        
Males 99-00 29.8 (22.2-40.0) 31.9 (26.3-37.2) 108 (79.1-151) 335 (257-440) 709 (437-981) 1222 
 01-02 32.2 (27.9-37.2) 29.5 (25.4-33.7) 91.2 (73.4-103) 239 (190-331) 474 (335-719) 1375 
 03-04 33.7 (29.6-38.4) 27.3 (23.4-33.0) 92.6 (68.6-124) 310 (228-351) 562 (443-653) 1244 
 05-06 32.1 (28.6-36.0) 29.1 (22.7-33.8) 90.2 (77.5-101) 269 (216-340) 494 (394-591) 1252 
 07-08 33.3 (27.7-40.0) 26.2 (22.3-31.2) 98.0 (71.9-119) 316 (220-477) 723 (501-1510) 1198 
 09-10 33.5 (29.3-38.2) 28.8 (23.6-35.5) 89.8 (74.7-114) 351 (286-425) 623 (476-967) 1377 
Females 99-00 20.3 (17.0-24.2) 23.1 (20.1-26.3) 84.7 (59.6-105) 242 (203-288) 446 (339-619) 1335 
 01-02 33.7 (30.9-36.8) 28.7 (26.0-32.3) 97.0 (79.9-118) 387 (253-500) 666 (598-807) 1419 
 03-04 28.7 (25.5-32.4) 25.0 (22.4-28.4) 85.0 (71.2-106) 256 (218-308) 467 (356-620) 1350 
 05-06 25.9 (22.3-29.9) 22.4 (17.9-27.4) 74.5 (61.0-87.0) 246 (195-329) 526 (398-657) 1276 
 07-08 29.5 (25.1-34.6) 24.6 (22.2-28.4) 83.5 (63.7-109) 296 (194-432) 661 (448-964) 1226 
 09-10 31.7 (27.6-36.4) 27.0 (21.8-32.1) 115 (101-129) 371 (290-489) 826 (523-1530) 1415 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 05-06, 07-08, and 09-10 are 0.3, 0.8, 0.3, 1.0, 0.2, and 0.2 respectively. 
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(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 31.1 (25.1-38.5) 30.0 (25.1-37.3) 117 (82.9-179) 328 (248-494) 573 (419-1180) 819 
 01-02 28.3 (22.0-36.4) 25.6 (19.6-32.5) 74.8 (48.8-111) 225 (174-314) 424 (323-523) 679 
 03-04 31.1 (27.5-35.2) 25.2 (19.1-32.6) 83.2 (63.6-120) 319 (252-537) 653 (537-851) 653 
 05-06 27.6 (24.4-31.2) 26.6 (21.5-30.2) 77.0 (63.3-87.3) 255 (187-319) 412 (320-568) 634 
 07-08 30.5 (24.3-38.4) 24.0 (18.9-30.2) 86.8 (68.0-123) 318 (210-414) 603 (414-1130) 520 
 09-10 28.7 (23.7-34.7) 24.2 (18.4-32.3) 84.8 (57.8-120) 257 (197-327) 484 (334-623) 604 
Non-Hispanic blacks 99-00 26.7 (19.2-37.0) 32.9 (24.4-41.5) 103 (84.8-137) 257 (213-367) 495 (329-926) 608 
 01-02 37.6 (27.4-51.6) 35.3 (23.6-49.5) 95.5 (71.1-142) 378 (192-530) 598 (375-1120) 706 
 03-04 32.3 (24.0-43.4) 27.4 (18.8-44.9) 84.8 (60.5-113) 279 (163-412) 514 (323-852) 699 
 05-06 31.0 (26.7-36.1) 27.9 (23.0-34.9) 92.3 (69.3-106) 265 (187-355) 458 (371-643) 662 
 07-08 36.2 (29.3-44.7) 27.3 (22.6-36.8) 124 (84.3-157) 395 (310-530) 912 (567-1490) 562 
 09-10 33.5 (29.0-38.6) 27.8 (23.2-36.4) 99.6 (79.3-120) 321 (218-392) 625 (410-1010) 534 
Non-Hispanic whites 99-00 23.6 (19.1-29.3) 25.6 (21.7-32.0) 91.4 (68.0-122) 288 (227-353) 566 (395-734) 917 
 01-02 30.9 (27.8-34.4) 27.6 (24.6-30.8) 89.7 (71.1-105) 278 (226-365) 626 (485-755) 1222 
 03-04 30.8 (28.2-33.6) 26.2 (22.6-31.0) 93.6 (78.8-112) 279 (225-313) 504 (376-610) 1079 
 05-06 26.9 (23.6-30.6) 23.8 (19.0-29.1) 77.2 (66.2-87.9) 244 (198-316) 518 (391-609) 1039 
 07-08 29.3 (25.2-34.0) 25.2 (22.1-28.5) 84.1 (65.8-102) 235 (182-346) 620 (446-840) 993 
 09-10 31.9 (27.4-37.2) 28.3 (21.3-34.6) 102 (75.4-125) 334 (280-450) 691 (501-1060) 1186 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 05-06, 07-08, and 09-10 are 0.3, 0.8, 0.3, 1.0, 0.2, and 0.2 respectively. 
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(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 22.3 (17.7-28.1) 23.8 (18.8-28.9) 84.7 (67.2-105) 222 (182-279) 381 (334-497) 2557 
 01-02 30.9 (28.5-33.6) 25.9 (23.4-29.2) 83.3 (72.2-96.3) 256 (211-296) 427 (375-490) 2794 
 03-04 29.1 (27.3-31.0) 24.5 (21.3-27.4) 77.7 (67.3-90.9) 231 (203-279) 510 (388-619) 2594 
 05-06 28.0 (25.3-31.0) 23.2 (20.3-26.4) 72.0 (63.1-85.2) 242 (197-280) 577 (406-734) 2528 
 07-08 31.4 (27.3-36.1) 23.7 (21.0-27.7) 85.2 (70.3-99.5) 264 (214-375) 751 (464-1130) 2424 
 09-10 34.9 (31.6-38.4) 25.4 (22.8-30.0) 100 (83.3-124) 367 (313-424) 863 (612-1090) 2791 
Age group        
6-11 years 99-00 28.3 (21.1-37.9) 27.8 (15.8-41.3) 94.3 (60.5-145) 209 (148-317) 490 (279-895) 331 
 01-02 44.5 (37.0-53.5) 37.9 (29.7-49.0) 112 (76.5-146) 252 (173-371) 504 (252-713) 396 
 03-04 35.8 (29.7-43.0) 35.4 (24.9-43.2) 78.6 (60.9-119) 172 (130-243) 297 (168-618) 341 
 05-06 42.5 (33.1-54.6) 34.1 (23.7-41.9) 138 (89.5-195) 414 (256-850) 1040 (429-1590) 351 
 07-08 53.5 (41.5-69.0) 44.2 (33.0-63.9) 149 (83.2-224) 451 (236-937) 940 (411-1800) 360 
 09-10 62.8 (52.5-75.1) 47.8 (36.7-63.0) 200 (144-249) 493 (405-644) 875 (551-1140) 370 
12-19 years 99-00 29.4 (22.3-38.8) 32.0 (23.8-41.6) 83.2 (64.1-104) 184 (130-295) 336 (184-816) 754 
 01-02 26.3 (21.3-32.5) 21.0 (17.8-26.5) 66.2 (47.9-91.5) 200 (149-298) 321 (261-435) 744 
 03-04 25.9 (21.8-30.9) 21.8 (17.0-29.1) 65.6 (51.0-83.1) 201 (145-313) 366 (297-455) 729 
 05-06 25.3 (22.1-29.0) 19.6 (16.4-24.0) 76.5 (51.4-91.6) 164 (130-249) 368 (213-520) 693 
 07-08 27.1 (23.1-31.7) 23.7 (17.8-29.3) 77.7 (56.2-95.3) 159 (125-264) 324 (214-568) 375 
 09-10 36.8 (28.5-47.7) 27.6 (20.4-40.1) 102 (67.5-174) 371 (234-455) 848 (424-1100) 447 
20 years and older 99-00 20.6 (16.3-26.2) 21.6 (17.7-26.2) 83.1 (64.9-107) 234 (190-287) 381 (325-562) 1472 
 01-02 30.4 (27.6-33.4) 24.8 (21.9-30.0) 83.1 (68.5-99.0) 269 (208-328) 435 (374-518) 1654 
 03-04 28.9 (26.7-31.3) 24.0 (20.1-27.4) 78.5 (66.1-92.9) 253 (209-302) 542 (399-673) 1524 
 05-06 27.1 (24.3-30.3) 23.0 (19.7-26.8) 70.3 (61.2-81.3) 233 (184-275) 575 (349-762) 1484 
 07-08 30.4 (25.8-35.8) 22.8 (19.9-25.9) 81.2 (63.2-99.5) 263 (205-423) 842 (464-1310) 1689 
 09-10 32.5 (28.9-36.5) 23.1 (20.5-28.2) 91.9 (72.8-116) 340 (295-409) 863 (590-1150) 1974 
Gender        
Males 99-00 23.3 (16.8-32.3) 23.8 (17.5-32.2) 86.2 (64.7-115) 236 (178-330) 523 (323-889) 1222 
 01-02 26.2 (23.1-29.8) 22.0 (19.4-26.0) 67.6 (57.4-78.1) 186 (144-237) 350 (278-418) 1375 
 03-04 26.4 (22.8-30.5) 21.5 (17.3-26.2) 70.0 (51.1-90.5) 203 (159-235) 415 (346-600) 1244 
 05-06 25.8 (23.4-28.4) 22.8 (19.3-26.4) 65.0 (54.6-82.2) 207 (154-261) 431 (305-628) 1252 
 07-08 28.1 (23.4-33.7) 20.9 (17.6-24.8) 76.1 (58.9-92.9) 249 (174-369) 634 (370-1130) 1198 
 09-10 30.6 (27.3-34.3) 23.5 (20.7-27.5) 78.7 (63.0-101) 313 (241-370) 631 (453-1020) 1376 
Females 99-00 21.3 (17.5-26.0) 23.2 (17.5-29.3) 83.1 (57.2-106) 211 (154-283) 357 (283-398) 1335 
 01-02 36.2 (32.8-39.9) 29.6 (25.2-34.3) 107 (88.4-129) 321 (269-355) 547 (427-729) 1419 
 03-04 31.9 (28.7-35.5) 27.1 (23.6-31.6) 87.1 (71.1-102) 278 (209-324) 548 (363-763) 1350 
 05-06 30.3 (25.8-35.5) 23.5 (19.8-29.1) 81.3 (67.4-104) 271 (208-406) 658 (444-894) 1276 
 07-08 35.0 (30.1-40.8) 27.7 (23.0-34.7) 95.6 (80.3-107) 290 (220-506) 842 (506-1350) 1226 
 09-10 39.6 (35.2-44.5) 29.4 (23.9-35.5) 131 (101-151) 430 (340-542) 944 (670-1540) 1415 
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(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 28.4 (23.3-34.7) 27.9 (22.5-35.0) 109 (91.5-137) 257 (209-380) 562 (257-981) 819 
 01-02 26.6 (21.6-32.9) 21.0 (16.1-28.9) 61.6 (50.6-76.8) 205 (147-270) 372 (271-479) 679 
 03-04 28.0 (24.8-31.8) 23.5 (18.5-28.1) 69.2 (52.3-92.8) 254 (187-390) 608 (417-764) 653 
 05-06 24.9 (22.1-28.0) 21.7 (17.8-23.8) 72.4 (56.2-90.2) 202 (140-274) 338 (275-648) 634 
 07-08 30.0 (23.2-38.8) 22.5 (16.5-30.5) 88.3 (55.4-127) 287 (210-373) 583 (385-921) 520 
 09-10 30.1 (25.4-35.7) 23.2 (19.0-30.5) 79.2 (60.6-108) 262 (192-353) 601 (371-818) 604 
Non-Hispanic blacks 99-00 17.1 (12.4-23.7) 19.5 (15.7-26.1) 59.5 (43.1-93.7) 179 (132-245) 299 (222-446) 608 
 01-02 26.4 (19.3-36.1) 22.7 (16.4-33.6) 69.4 (42.2-115) 217 (139-317) 384 (217-747) 706 
 03-04 22.8 (18.1-28.8) 19.6 (14.3-27.1) 55.0 (39.6-78.1) 182 (107-240) 311 (210-514) 699 
 05-06 21.7 (18.8-25.1) 18.6 (14.9-21.6) 55.3 (42.6-78.7) 157 (124-235) 351 (235-543) 662 
 07-08 28.0 (22.5-34.9) 20.8 (15.9-25.9) 91.2 (63.7-112) 252 (184-413) 668 (310-1530) 562 
 09-10 26.9 (23.7-30.6) 19.5 (17.6-23.1) 78.0 (58.1-107) 245 (158-341) 505 (341-879) 533 
Non-Hispanic whites 99-00 23.2 (18.5-29.0) 24.9 (19.0-31.7) 86.1 (68.4-105) 232 (178-295) 381 (325-523) 917 
 01-02 30.6 (28.2-33.2) 25.4 (22.7-29.5) 82.0 (68.3-96.3) 248 (207-320) 427 (365-518) 1222 
 03-04 30.4 (27.9-33.0) 26.2 (21.5-31.4) 79.6 (69.1-99.6) 238 (195-321) 534 (352-688) 1079 
 05-06 28.2 (25.1-31.8) 23.5 (19.8-29.0) 71.7 (58.9-89.6) 242 (192-305) 615 (423-802) 1039 
 07-08 30.5 (25.8-36.0) 23.7 (20.2-28.3) 80.1 (63.4-96.6) 256 (185-369) 651 (412-1010) 993 
 09-10 35.8 (31.2-41.0) 25.6 (22.5-32.7) 107 (78.5-140) 398 (304-448) 881 (576-1300) 1186 
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(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 4.39 (3.37-5.73) 4.98 (3.65-6.77) 22.7 (18.7-30.1) 100 (74.8-141) 222 (182-250) 2271 
 01-02 4.08 (3.53-4.73) 3.30 (2.70-4.20) 19.8 (16.7-24.6) 96.0 (70.1-135) 260 (161-437) 2794 
 03-04 4.91 (4.34-5.55) 4.60 (4.00-5.20) 23.6 (18.6-27.2) 95.9 (70.7-122) 230 (185-342) 2581 
 05-06 4.71 (4.17-5.31) 3.80 (3.10-4.30) 22.5 (19.7-26.6) 101 (86.4-124) 266 (200-385) 2528 
 07-08 4.65 (4.02-5.39) 3.40 (2.90-4.20) 23.0 (17.9-29.8) 132 (98.2-181) 328 (236-501) 2424 
 09-10 4.73 (4.08-5.48) 3.60 (2.90-4.30) 21.8 (16.8-28.4) 125 (99.2-156) 394 (237-615) 2792 
Age group        
6-11 years 99-00 5.60 (3.85-8.15) 7.52 (3.43-15.2) 36.2 (20.3-45.0) 78.7 (43.4-191) 176 (74.8-264) 287 
 01-02 6.19 (4.51-8.49) 5.90 (3.80-9.30) 26.9 (15.7-52.1) 122 (61.5-215) 281 (161-466) 396 
 03-04 6.33 (4.30-9.30) 6.10 (3.50-10.6) 24.0 (17.0-33.8) 70.8 (51.4-122) 138 (80.9-256) 341 
 05-06 7.20 (5.20-9.96) 6.20 (4.00-11.0) 37.8 (24.2-55.2) 145 (83.9-295) 386 (201-516) 351 
 07-08 7.50 (5.43-10.4) 5.40 (3.90-9.70) 34.5 (16.5-52.6) 133 (79.9-275) 490 (133-3020) 360 
 09-10 7.85 (6.20-9.94) 7.00 (4.30-11.7) 34.9 (27.7-49.6) 153 (89.1-199) 263 (167-467) 371 
12-19 years 99-00 6.04 (3.76-9.70) 7.60 (5.13-13.5) 36.6 (22.0-57.3) 107 (63.4-165) 194 (107-238) 667 
 01-02 5.92 (4.46-7.87) 5.20 (3.70-7.60) 33.6 (18.0-56.8) 125 (91.2-172) 299 (172-435) 744 
 03-04 6.37 (4.95-8.18) 5.30 (3.80-8.10) 33.9 (18.2-50.5) 110 (82.2-198) 257 (175-415) 729 
 05-06 8.50 (6.48-11.2) 8.10 (5.50-11.6) 41.3 (33.6-49.6) 105 (80.2-213) 385 (139-829) 693 
 07-08 4.74 (3.00-7.48) 3.80 (2.20-7.20) 20.6 (11.2-34.6) 105 (29.5-357) 328 (78.1-638) 375 
 09-10 6.40 (4.93-8.31) 5.30 (4.00-7.70) 26.8 (16.6-47.8) 117 (77.8-165) 377 (156-965) 447 
20 years and older 99-00 4.05 (3.12-5.26) 4.46 (3.31-5.64) 19.8 (16.0-26.5) 101 (80.8-150) 228 (179-259) 1317 
 01-02 3.65 (3.08-4.32) 2.80 (2.30-3.70) 17.0 (13.9-22.4) 81.5 (63.0-128) 260 (135-526) 1654 
 03-04 4.56 (4.02-5.17) 4.40 (3.60-4.90) 22.0 (17.8-25.6) 94.0 (67.6-131) 230 (187-398) 1511 
 05-06 4.09 (3.51-4.77) 3.20 (2.60-4.00) 17.9 (14.9-22.3) 91.2 (72.3-124) 248 (182-302) 1484 
 07-08 4.41 (3.72-5.22) 3.20 (2.40-4.20) 23.0 (17.5-30.7) 133 (93.3-187) 320 (206-589) 1689 
 09-10 4.28 (3.59-5.11) 3.00 (2.40-3.90) 19.3 (14.9-27.0) 127 (95.2-159) 438 (225-681) 1974 
Gender        
Males 99-00 4.97 (3.71-6.66) 5.62 (4.12-8.73) 29.1 (19.8-42.9) 121 (74.1-190) 235 (177-332) 1087 
 01-02 3.81 (3.08-4.71) 3.30 (2.60-4.50) 17.4 (13.2-24.6) 82.8 (58.4-116) 194 (123-324) 1375 
 03-04 4.90 (3.93-6.12) 4.60 (3.40-5.50) 23.0 (16.6-30.1) 92.9 (70.7-129) 222 (159-332) 1240 
 05-06 4.93 (4.13-5.89) 4.00 (3.40-5.50) 22.3 (16.7-28.1) 90.8 (63.5-137) 235 (171-311) 1252 
 07-08 4.49 (3.67-5.49) 3.10 (2.50-4.10) 22.1 (14.5-33.7) 117 (81.4-194) 293 (195-589) 1198 
 09-10 4.39 (3.46-5.59) 3.30 (2.40-4.40) 18.1 (14.5-24.3) 99.2 (65.2-142) 293 (153-615) 1377 
Females 99-00 3.92 (2.97-5.16) 4.22 (3.18-5.51) 19.4 (14.1-26.1) 83.8 (61.1-114) 192 (123-250) 1184 
 01-02 4.36 (3.64-5.23) 3.40 (2.50-4.60) 21.3 (16.8-29.2) 107 (70.6-199) 394 (230-746) 1419 
 03-04 4.91 (4.26-5.66) 4.60 (3.90-5.50) 23.9 (18.1-27.4) 99.3 (63.5-155) 283 (160-433) 1341 
 05-06 4.50 (3.90-5.20) 3.30 (2.70-4.30) 22.8 (17.9-28.3) 121 (83.2-168) 284 (182-499) 1276 
 07-08 4.82 (4.03-5.75) 3.90 (2.90-5.30) 24.6 (18.1-33.9) 137 (99.3-195) 362 (236-468) 1226 
 09-10 5.09 (4.19-6.18) 3.90 (2.70-5.00) 28.5 (18.4-42.8) 152 (110-230) 494 (309-766) 1415 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 05-06, 07-08, and 09-10 are 0.2, 0.4, 0.2, 0.2, 0.2, and 0.2 respectively. 
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(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 2.41 (1.55-3.73) 2.14 (1.31-3.37) 21.0 (10.6-30.5) 97.6 (59.7-140) 191 (122-320) 721 
 01-02 2.44 (1.51-3.94) 1.40 (.500-3.40) 13.1 (5.80-27.6) 66.4 (33.5-102) 152 (75.8-265) 679 
 03-04 2.54 (1.86-3.48) 1.90 (1.00-3.40) 14.4 (9.00-18.1) 62.3 (40.3-99.5) 146 (99.5-254) 652 
 05-06 3.04 (2.29-4.05) 2.10 (1.40-2.90) 14.5 (8.20-24.7) 62.8 (39.1-104) 158 (87.0-246) 634 
 07-08 3.16 (2.40-4.15) 2.50 (1.50-3.30) 14.7 (10.5-20.7) 84.9 (52.1-152) 211 (159-340) 520 
 09-10 3.44 (2.78-4.27) 2.70 (2.10-3.50) 15.2 (10.6-21.2) 93.1 (63.5-114) 216 (127-294) 604 
Non-Hispanic blacks 99-00 5.74 (4.55-7.24) 8.71 (5.82-10.9) 33.5 (22.1-52.4) 108 (78.3-156) 192 (149-255) 538 
 01-02 5.35 (4.00-7.14) 5.30 (2.90-7.30) 32.7 (22.0-52.4) 128 (75.9-216) 308 (150-436) 706 
 03-04 5.49 (4.05-7.46) 4.20 (3.30-6.10) 26.1 (13.4-49.0) 117 (86.2-166) 221 (177-354) 698 
 05-06 5.83 (4.49-7.58) 4.90 (3.90-6.30) 32.6 (21.2-46.7) 110 (72.4-189) 297 (162-398) 662 
 07-08 6.63 (4.50-9.75) 5.80 (3.90-9.10) 40.8 (23.6-63.3) 183 (119-230) 347 (199-822) 562 
 09-10 5.03 (3.75-6.74) 4.30 (2.90-6.00) 27.0 (16.7-35.9) 120 (80.5-168) 293 (168-464) 534 
Non-Hispanic whites 99-00 4.50 (3.26-6.22) 4.99 (3.43-7.10) 22.5 (17.1-34.4) 103 (72.0-152) 228 (177-259) 826 
 01-02 4.13 (3.43-4.96) 3.40 (2.60-4.40) 17.9 (15.5-23.8) 98.7 (67.4-153) 260 (153-526) 1222 
 03-04 5.27 (4.63-5.99) 5.30 (4.40-6.00) 24.2 (18.8-28.5) 99.5 (67.6-149) 246 (183-409) 1070 
 05-06 4.72 (4.09-5.45) 3.80 (3.20-4.70) 21.9 (17.5-27.6) 97.7 (72.3-142) 246 (181-363) 1039 
 07-08 4.67 (3.88-5.62) 3.50 (2.80-4.60) 21.3 (16.9-27.8) 113 (79.9-193) 357 (193-628) 993 
 09-10 4.95 (4.20-5.84) 3.70 (2.90-4.50) 20.4 (16.0-30.1) 139 (97.5-156) 471 (206-766) 1186 
Limit of detection (LOD, see Data Analysis section) for Survey years 99-00, 01-02, 03-04, 05-06, 07-08, and 09-10 are 0.2, 0.4, 0.2, 0.2, 0.2, and 0.2 respectively. 
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Urinary O-Desmethylangolensin (creatinine corrected) (1999 – 2010) ‡ 
Metabolite of Daidzein 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 99-00 4.03 (2.97-5.45) 4.44 (3.10-6.35) 21.8 (15.3-31.6) 90.4 (62.9-122) 167 (140-218) 2271 
 01-02 3.83 (3.32-4.43) 3.24 (2.55-4.12) 18.9 (16.1-23.2) 85.2 (65.1-117) 281 (149-412) 2794 
 03-04 4.58 (4.20-5.01) 4.09 (3.53-4.59) 19.6 (17.4-22.6) 92.9 (76.5-120) 201 (183-261) 2581 
 05-06 4.59 (4.04-5.21) 3.70 (3.12-4.42) 20.7 (18.4-22.8) 95.6 (78.0-129) 215 (180-325) 2528 
 07-08 4.68 (4.04-5.41) 3.51 (3.06-4.02) 22.5 (16.7-30.5) 125 (94.8-164) 350 (199-523) 2424 
 09-10 5.07 (4.38-5.87) 3.78 (3.06-4.61) 23.6 (19.3-29.7) 138 (101-185) 433 (285-547) 2791 
Age group        
6-11 years 99-00 6.00 (4.04-8.91) 7.15 (3.94-16.6) 28.8 (14.3-45.0) 83.3 (45.0-167) 179 (88.2-262) 287 
 01-02 7.03 (5.05-9.77) 6.49 (4.24-11.6) 29.9 (16.3-54.1) 101 (75.3-199) 305 (134-464) 396 
 03-04 6.73 (4.55-9.97) 5.97 (4.09-8.28) 27.7 (15.6-42.3) 86.1 (45.2-135) 149 (84.3-189) 341 
 05-06 7.93 (5.73-11.0) 7.15 (3.90-11.3) 40.9 (27.5-55.9) 164 (85.8-280) 346 (215-497) 351 
 07-08 9.20 (6.70-12.6) 6.81 (5.05-10.7) 31.1 (20.1-58.9) 164 (100-296) 465 (175-2310) 360 
 09-10 10.7 (8.43-13.6) 9.58 (5.71-13.9) 43.0 (31.3-63.3) 201 (111-260) 330 (226-478) 370 
12-19 years 99-00 4.13 (2.33-7.35) 5.71 (2.82-11.5) 26.0 (14.7-44.4) 71.4 (40.8-122) 122 (75.2-262) 667 
 01-02 4.57 (3.44-6.07) 3.88 (2.82-5.32) 26.0 (18.0-35.9) 95.0 (61.4-129) 259 (129-331) 744 
 03-04 4.76 (3.71-6.11) 4.26 (3.13-5.97) 22.8 (14.3-39.2) 86.4 (49.0-149) 185 (101-261) 729 
 05-06 6.30 (4.89-8.13) 5.69 (3.44-8.40) 28.0 (22.5-37.1) 89.0 (58.5-138) 258 (103-686) 693 
 07-08 3.64 (2.28-5.83) 2.99 (1.91-5.69) 18.3 (7.73-24.0) 75.3 (21.4-200) 199 (69.4-664) 375 
 09-10 6.02 (4.74-7.65) 5.71 (3.30-7.53) 23.6 (16.0-36.8) 109 (59.2-189) 287 (132-558) 447 
20 years and older 99-00 3.82 (2.84-5.13) 3.90 (2.69-5.73) 20.2 (12.9-29.2) 96.5 (61.8-133) 172 (140-252) 1317 
 01-02 3.46 (2.95-4.04) 2.74 (2.03-3.64) 16.8 (13.7-20.3) 78.9 (58.2-124) 281 (143-467) 1654 
 03-04 4.35 (3.96-4.78) 3.75 (3.23-4.35) 18.6 (15.7-22.6) 95.2 (76.5-131) 228 (192-284) 1511 
 05-06 4.10 (3.51-4.79) 3.35 (2.57-4.30) 17.4 (14.0-20.6) 89.3 (64.5-140) 197 (160-332) 1484 
 07-08 4.52 (3.82-5.36) 3.13 (2.55-3.92) 22.7 (16.1-32.4) 130 (89.1-183) 353 (189-641) 1689 
 09-10 4.56 (3.83-5.42) 3.29 (2.42-4.07) 21.2 (16.2-26.8) 139 (95.3-212) 437 (246-634) 1974 
Gender        
Males 99-00 3.95 (2.79-5.58) 4.50 (2.88-6.50) 24.5 (13.8-40.5) 96.5 (62.4-122) 210 (125-265) 1087 
 01-02 3.10 (2.48-3.86) 2.87 (2.00-3.96) 15.0 (10.4-19.7) 60.7 (41.5-90.2) 154 (96.4-301) 1375 
 03-04 3.83 (3.10-4.73) 3.33 (2.41-4.35) 15.6 (13.9-18.9) 76.2 (51.1-99.5) 193 (124-255) 1240 
 05-06 3.97 (3.33-4.72) 3.49 (2.73-4.33) 17.7 (14.1-21.4) 68.3 (55.8-85.8) 165 (140-216) 1252 
 07-08 3.79 (3.10-4.63) 2.79 (2.33-3.49) 18.2 (12.4-25.7) 86.7 (59.2-153) 264 (139-432) 1198 
 09-10 4.02 (3.10-5.19) 3.19 (2.13-4.58) 17.3 (12.3-21.7) 86.2 (59.8-137) 317 (140-485) 1376 
Females 99-00 4.10 (3.00-5.61) 4.17 (2.91-6.35) 20.4 (14.4-27.2) 86.0 (49.1-145) 155 (100-205) 1184 
 01-02 4.68 (3.87-5.68) 3.74 (2.77-4.88) 26.8 (18.7-34.0) 111 (70.3-205) 399 (175-739) 1419 
 03-04 5.45 (4.71-6.30) 4.82 (4.09-5.92) 24.3 (19.6-28.9) 106 (78.5-163) 255 (193-343) 1341 
 05-06 5.27 (4.56-6.09) 4.00 (3.07-5.49) 24.1 (19.8-31.1) 140 (96.8-166) 325 (197-613) 1276 
 07-08 5.72 (4.75-6.88) 4.23 (3.33-5.71) 29.0 (20.4-43.2) 164 (105-213) 394 (212-743) 1226 
 09-10 6.35 (5.34-7.57) 4.42 (3.46-5.79) 34.1 (25.4-43.5) 199 (139-248) 504 (350-761) 1415 
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Urinary O-Desmethylangolensin (creatinine corrected) (1999 – 2010) ‡ 
Metabolite of Daidzein 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 99-00 2.19 (1.49-3.24) 1.88 (1.15-3.10) 16.6 (11.3-25.8) 71.2 (52.3-113) 136 (90.5-251) 721 
 01-02 2.30 (1.48-3.57) 1.45 (.769-3.37) 11.8 (4.91-23.6) 46.7 (31.4-87.8) 108 (54.7-218) 679 
 03-04 2.30 (1.68-3.15) 1.65 (.845-3.06) 13.2 (6.63-21.2) 51.6 (36.9-75.4) 125 (84.1-165) 652 
 05-06 2.75 (1.92-3.93) 1.69 (1.04-2.99) 12.8 (7.27-24.9) 53.0 (33.3-93.2) 135 (72.6-204) 634 
 07-08 3.10 (2.26-4.27) 2.22 (1.42-3.32) 16.0 (8.84-23.8) 82.0 (45.8-145) 215 (98.9-467) 520 
 09-10 3.62 (2.92-4.50) 2.71 (1.82-4.92) 13.5 (10.8-19.6) 76.5 (54.2-128) 226 (113-461) 604 
Non-Hispanic blacks 99-00 3.65 (2.90-4.60) 5.22 (3.59-6.75) 23.8 (17.6-32.1) 67.1 (52.1-79.7) 116 (81.9-239) 538 
 01-02 3.75 (2.76-5.10) 3.57 (2.14-5.48) 22.8 (14.5-30.4) 78.5 (46.5-175) 218 (98.5-339) 706 
 03-04 3.89 (3.03-4.99) 3.12 (1.96-4.96) 16.9 (11.3-26.7) 80.0 (58.6-104) 159 (120-255) 698 
 05-06 4.09 (3.13-5.34) 4.22 (2.49-5.71) 20.1 (13.5-24.5) 69.9 (44.8-151) 225 (90.2-369) 662 
 07-08 5.13 (3.47-7.57) 4.22 (2.84-7.71) 27.0 (15.6-44.5) 133 (81.9-182) 308 (164-485) 562 
 09-10 4.06 (3.11-5.28) 3.61 (2.41-5.07) 22.4 (12.9-30.2) 95.1 (59.2-142) 208 (133-418) 533 
Non-Hispanic whites 99-00 4.42 (3.12-6.27) 4.68 (3.05-7.23) 22.3 (15.3-37.9) 102 (57.6-148) 177 (140-215) 826 
 01-02 4.08 (3.41-4.89) 3.51 (2.45-4.57) 21.2 (16.3-27.4) 96.4 (69.8-126) 300 (153-464) 1222 
 03-04 5.18 (4.70-5.70) 4.58 (3.89-5.39) 21.6 (17.4-27.7) 103 (77.7-149) 225 (185-271) 1070 
 05-06 4.96 (4.33-5.69) 3.97 (3.26-4.67) 21.5 (17.3-26.2) 101 (74.5-142) 227 (183-332) 1039 
 07-08 4.86 (4.00-5.91) 3.85 (3.06-4.57) 22.2 (15.1-32.4) 124 (84.2-180) 355 (175-728) 993 
 09-10 5.55 (4.77-6.47) 3.88 (3.19-4.87) 23.8 (19.2-32.5) 146 (97.6-248) 461 (330-739) 1186 
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Urinary 2-Hydroxyfluorene (2003 – 2010) 
Metabolite of Fluorene 
Geometric mean and selected percentiles of urine concentrations (in ng/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 304 (262-354) 280 (242-319) 679 (561-815) 1850 (1430-2190) 2670 (2230-3130) 2521 
 05-06 316 (297-338) 272 (243-296) 661 (605-743) 2060 (1600-2420) 3150 (2670-3730) 2431 
 07-08 303 (271-338) 259 (231-293) 618 (489-817) 1630 (1340-2020) 2510 (2100-2890) 2581 
 09-10 240 (222-259) 211 (195-227) 480 (449-530) 1190 (1040-1410) 2200 (1880-2490) 2747 
Age group        
6-11 years 03-04 209 (183-239) 228 (189-259) 341 (295-411) 576 (423-728) 763 (613-827) 338 
 05-06 201 (184-221) 195 (170-223) 352 (306-402) 497 (436-618) 709 (536-833) 343 
 07-08 233 (205-264) 239 (194-280) 400 (326-454) 620 (484-714) 851 (695-1000) 382 
 09-10 172 (153-192) 170 (160-181) 278 (251-320) 458 (356-622) 743 (486-966) 416 
12-19 years 03-04 281 (245-321) 292 (259-323) 502 (445-601) 1000 (753-1320) 1480 (1320-1930) 707 
 05-06 283 (258-311) 272 (247-300) 482 (425-540) 1080 (843-1250) 1750 (1100-2820) 670 
 07-08 287 (243-339) 255 (217-293) 541 (434-631) 963 (774-1350) 1510 (1050-2120) 395 
 09-10 231 (196-273) 203 (179-235) 418 (339-535) 784 (645-1230) 1880 (765-2410) 420 
20 years and older 03-04 323 (272-383) 290 (247-334) 832 (653-1020) 2090 (1680-2460) 2920 (2410-3650) 1476 
 05-06 340 (311-371) 284 (252-317) 813 (705-917) 2410 (1880-2820) 3460 (2820-4160) 1418 
 07-08 314 (276-357) 267 (231-306) 699 (518-1020) 1790 (1470-2220) 2700 (2190-3270) 1804 
 09-10 250 (230-272) 220 (201-238) 537 (476-599) 1370 (1130-1650) 2330 (1990-2700) 1911 
Gender        
Males 03-04 385 (333-446) 338 (300-415) 900 (739-1150) 2120 (1770-2450) 2930 (2490-3390) 1213 
 05-06 376 (345-410) 332 (302-364) 823 (658-1030) 2160 (1660-2570) 3120 (2570-3560) 1213 
 07-08 366 (334-402) 306 (280-348) 756 (613-983) 1740 (1430-2130) 2650 (2130-3270) 1280 
 09-10 275 (250-304) 234 (215-259) 536 (464-635) 1390 (1130-1710) 2350 (1990-2550) 1399 
Females 03-04 243 (204-290) 226 (184-269) 490 (405-617) 1400 (907-1930) 2310 (1740-3070) 1308 
 05-06 268 (234-307) 227 (199-270) 528 (445-638) 1910 (1020-2830) 3180 (2180-4590) 1218 
 07-08 252 (219-289) 216 (192-236) 505 (387-629) 1470 (1050-1960) 2330 (1770-2840) 1301 
 09-10 210 (189-232) 189 (170-213) 442 (389-506) 1050 (849-1270) 2090 (1370-2520) 1348 
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Urinary 2-Hydroxyfluorene (2003 – 2010) 
Metabolite of Fluorene 
Geometric mean and selected percentiles of urine concentrations (in ng/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 03-04 248 (215-286) 235 (203-293) 502 (412-580) 1100 (771-1330) 1640 (1250-2240) 629 
 05-06 233 (200-271) 216 (180-247) 413 (334-488) 901 (704-1080) 1360 (1060-1950) 615 
 07-08 248 (226-273) 240 (215-261) 418 (355-496) 801 (643-979) 1300 (933-1680) 523 
 09-10 214 (181-254) 197 (156-245) 385 (286-483) 860 (635-1130) 1800 (1070-2350) 566 
Non-Hispanic blacks 03-04 432 (360-519) 380 (314-462) 856 (695-1330) 2200 (1830-2650) 2970 (2310-4680) 666 
 05-06 404 (346-471) 330 (307-377) 805 (626-1090) 2190 (1610-2930) 3160 (2530-4330) 657 
 07-08 387 (333-450) 325 (281-403) 879 (724-1040) 1940 (1500-2550) 3170 (2290-5120) 590 
 09-10 371 (317-433) 354 (314-401) 808 (620-1080) 1710 (1330-2280) 2580 (2090-3390) 517 
Non-Hispanic whites 03-04 306 (254-369) 274 (230-332) 708 (555-878) 1950 (1540-2390) 2920 (2400-3500) 1035 
 05-06 319 (290-350) 270 (237-315) 705 (626-829) 2180 (1700-2540) 3390 (2670-4250) 972 
 07-08 307 (261-362) 257 (221-308) 629 (452-995) 1720 (1260-2190) 2580 (2070-3020) 1070 
 09-10 228 (206-252) 199 (182-220) 457 (409-506) 1150 (921-1440) 2120 (1650-2550) 1203 
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Urinary 2-Hydroxyfluorene (2011 - 2012) 
Metabolite of Fluorene 
Geometric mean and selected percentiles of urine concentrations (in ng/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 240 (219-263) 215 (199-231) 498 (444-576) 1380 (1110-1570) 2340 (1920-2620) 2492 
Age group        
6-11 years 11-12 161 (146-177) 176 (166-194) 301 (259-332) 485 (390-595) 615 (522-736) 397 
12-19 years 11-12 233 (198-274) 224 (180-275) 476 (386-567) 888 (679-1100) 1370 (1030-1950) 389 
20 years and older 11-12 252 (227-279) 217 (201-242) 574 (474-637) 1530 (1320-1830) 2420 (2180-2920) 1706 
Gender        
Males 11-12 280 (245-320) 244 (210-286) 584 (457-689) 1460 (1180-1830) 2390 (2050-3100) 1258 
Females 11-12 207 (182-236) 180 (157-209) 425 (360-525) 1210 (810-1580) 2260 (1620-2420) 1234 
Race/ethnicity        
Mexican Americans 11-12 238 (184-307) 220 (180-252) 475 (306-747) 1030 (584-1780) 1510 (829-2920) 317 
Non-Hispanic blacks 11-12 342 (306-381) 321 (304-349) 641 (549-734) 1480 (1150-1890) 2390 (1970-3040) 664 
Non-Hispanic whites 11-12 227 (210-246) 199 (173-221) 480 (386-580) 1410 (1110-1620) 2350 (1790-2920) 814 
All Hispanics 11-12 251 (210-301) 228 (204-260) 514 (421-646) 1050 (785-1510) 1810 (1260-2410) 573 
Asians 11-12 154 (126-190) 137 (111-175) 326 (217-408) 563 (467-903) 1100 (691-1490) 352 
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Urinary 2-Hydroxyfluorene (creatinine corrected) (2003 – 2010) 
Metabolite of Fluorene 
Geometric mean and selected percentiles of urine concentrations (in ng/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 286 (256-320) 221 (200-249) 495 (429-629) 1510 (1150-1800) 2070 (1850-2390) 2521 
 05-06 308 (288-330) 227 (209-245) 567 (509-658) 1730 (1540-1850) 2450 (2020-2930) 2431 
 07-08 304 (272-339) 234 (211-260) 526 (403-711) 1500 (1140-1780) 2150 (1850-2500) 2581 
 09-10 250 (237-264) 193 (179-208) 392 (353-434) 1170 (1050-1290) 1840 (1620-1990) 2747 
Age group        
6-11 years 03-04 221 (199-246) 217 (188-238) 305 (270-356) 462 (370-535) 695 (465-807) 338 
 05-06 224 (207-243) 219 (197-254) 320 (288-365) 451 (384-523) 527 (450-720) 343 
 07-08 287 (255-324) 262 (240-292) 407 (355-503) 721 (555-849) 864 (757-956) 382 
 09-10 224 (207-242) 208 (186-232) 324 (296-336) 448 (361-677) 710 (448-1290) 416 
12-19 years 03-04 213 (189-240) 189 (172-211) 310 (275-377) 649 (512-778) 937 (762-1320) 707 
 05-06 214 (201-227) 189 (178-197) 286 (266-320) 607 (516-769) 1190 (803-1430) 670 
 07-08 223 (200-249) 204 (176-236) 351 (270-419) 592 (504-683) 900 (683-1080) 395 
 09-10 186 (168-206) 154 (139-171) 251 (214-320) 569 (366-831) 858 (605-1190) 420 
20 years and older 03-04 310 (274-350) 233 (203-269) 659 (494-835) 1730 (1420-1940) 2310 (1930-2590) 1476 
 05-06 339 (313-367) 241 (216-262) 754 (629-891) 1870 (1750-2110) 2830 (2250-3200) 1418 
 07-08 321 (282-365) 234 (210-269) 633 (438-873) 1650 (1360-2060) 2390 (2090-2690) 1804 
 09-10 265 (249-282) 199 (185-215) 463 (400-511) 1360 (1190-1490) 1970 (1750-2230) 1911 
Gender        
Males 03-04 302 (271-337) 242 (218-272) 635 (494-758) 1510 (1200-1700) 1940 (1700-2310) 1213 
 05-06 302 (278-328) 233 (212-259) 610 (510-744) 1480 (1240-1680) 1920 (1680-2390) 1213 
 07-08 308 (283-336) 239 (218-261) 615 (464-764) 1480 (1200-1640) 2120 (1780-2390) 1280 
 09-10 247 (229-266) 188 (171-214) 417 (350-491) 1190 (955-1420) 1770 (1400-2220) 1399 
Females 03-04 271 (235-314) 208 (183-244) 415 (352-521) 1530 (991-1890) 2220 (1730-2590) 1308 
 05-06 314 (284-347) 217 (198-247) 526 (437-622) 1900 (1680-2240) 2930 (2310-3280) 1218 
 07-08 300 (257-350) 225 (201-265) 461 (347-683) 1510 (929-2100) 2250 (1630-2770) 1301 









Fourth National Report on Human Exposure to Environmental Chemicals, Updated Tables, January 2017 Volume One Page 481
Urinary 2-Hydroxyfluorene (creatinine corrected) (2003 – 2010) 
Metabolite of Fluorene 
Geometric mean and selected percentiles of urine concentrations (in ng/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 03-04 224 (197-255) 198 (178-227) 370 (306-432) 745 (562-1030) 1200 (745-1730) 629 
 05-06 210 (190-232) 179 (155-205) 294 (250-368) 624 (439-834) 1000 (720-1190) 615 
 07-08 244 (216-275) 214 (187-238) 364 (301-438) 718 (582-824) 958 (775-1480) 523 
 09-10 213 (181-250) 171 (150-207) 316 (244-462) 667 (534-852) 1180 (846-1470) 566 
Non-Hispanic blacks 03-04 306 (259-360) 245 (207-295) 609 (430-756) 1390 (939-1870) 1880 (1510-2430) 666 
 05-06 284 (250-322) 222 (202-245) 502 (350-714) 1230 (941-1760) 1880 (1510-2440) 657 
 07-08 299 (254-351) 237 (198-287) 602 (468-768) 1370 (1050-1910) 2220 (1570-2990) 590 
 09-10 269 (241-300) 214 (193-244) 501 (383-653) 1220 (1010-1410) 1620 (1280-1950) 517 
Non-Hispanic whites 03-04 303 (265-346) 225 (198-259) 561 (450-765) 1620 (1420-1940) 2310 (1940-2540) 1035 
 05-06 335 (307-366) 242 (216-270) 687 (561-806) 1840 (1650-2060) 2800 (2070-3260) 972 
 07-08 319 (274-372) 238 (205-290) 579 (393-841) 1620 (1180-2090) 2340 (1940-2640) 1070 
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(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 273 (255-292) 211 (196-228) 439 (374-495) 1340 (1120-1570) 2110 (1930-2250) 2490 
Age group        
6-11 years 11-12 231 (213-251) 222 (201-243) 309 (268-371) 474 (379-567) 584 (515-702) 396 
12-19 years 11-12 225 (205-248) 205 (180-242) 307 (266-368) 733 (454-877) 966 (733-1150) 389 
20 years and older 11-12 286 (266-309) 211 (195-229) 484 (420-615) 1630 (1320-1820) 2230 (2000-2630) 1705 
Gender        
Males 11-12 262 (233-296) 201 (183-228) 439 (342-576) 1320 (1060-1630) 2040 (1710-2200) 1257 
Females 11-12 284 (255-316) 218 (199-242) 439 (338-527) 1370 (920-1820) 2220 (1820-2570) 1233 
Race/ethnicity        
Mexican Americans 11-12 267 (222-322) 221 (183-264) 440 (283-647) 1020 (515-1500) 1350 (937-2460) 317 
Non-Hispanic blacks 11-12 266 (241-294) 228 (203-244) 461 (339-619) 971 (841-1090) 1460 (1090-1930) 664 
Non-Hispanic whites 11-12 276 (260-293) 208 (189-228) 445 (374-501) 1600 (1310-1820) 2220 (1950-2630) 812 
All Hispanics 11-12 281 (248-319) 225 (199-255) 445 (337-553) 1110 (642-1460) 1550 (1170-2180) 573 
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(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 01-02 134 (115-155) 111 (96.0-126) 253 (207-349) 959 (666-1300) 1620 (1390-1900) 2745 
 03-04 126 (108-148) 103 (90.4-118) 302 (231-404) 1090 (934-1270) 1740 (1400-2070) 2502 
 05-06 124 (115-134) 99.1 (88.5-110) 304 (268-365) 1060 (830-1210) 1780 (1500-1910) 2398 
 07-08 116 (103-132) 92.9 (85.7-100) 258 (203-341) 821 (681-1050) 1380 (1170-1630) 2581 
 09-10 95.0 (87.9-103) 78.0 (71.0-84.0) 192 (174-208) 623 (501-741) 1050 (941-1270) 2744 
Age group        
6-11 years 01-02 106 (94.8-119) 106 (91.0-124) 174 (145-200) 287 (235-358) 385 (306-455) 387 
 03-04 89.2 (77.3-103) 92.3 (79.7-103) 151 (113-172) 238 (184-331) 343 (241-423) 336 
 05-06 81.7 (73.6-90.7) 80.6 (68.3-98.9) 140 (122-174) 235 (189-272) 287 (242-345) 336 
 07-08 98.0 (85.8-112) 94.2 (84.3-106) 178 (149-198) 302 (239-332) 458 (247-752) 382 
 09-10 73.8 (66.7-81.7) 74.0 (65.0-82.0) 113 (103-129) 194 (164-249) 308 (202-453) 416 
12-19 years 01-02 129 (103-161) 113 (97.0-137) 222 (177-266) 542 (325-1070) 1210 (680-2130) 733 
 03-04 116 (100-134) 114 (94.7-133) 214 (181-269) 476 (317-748) 924 (609-1410) 701 
 05-06 119 (107-133) 112 (94.4-126) 212 (181-229) 588 (436-659) 986 (609-1800) 661 
 07-08 114 (95.5-136) 93.7 (77.4-114) 218 (168-258) 494 (341-740) 830 (725-1020) 400 
 09-10 96.0 (79.7-116) 85.0 (65.0-104) 178 (139-215) 394 (257-643) 798 (550-1030) 420 
20 years and older 01-02 138 (119-161) 111 (94.0-129) 311 (228-429) 1130 (823-1400) 1850 (1470-2080) 1625 
 03-04 134 (112-160) 105 (86.5-125) 408 (300-537) 1240 (1050-1480) 1910 (1620-2290) 1465 
 05-06 131 (118-145) 101 (86.2-117) 394 (308-448) 1220 (968-1510) 1900 (1620-2050) 1401 
 07-08 119 (103-138) 91.4 (83.5-100) 302 (205-449) 992 (745-1200) 1550 (1230-1820) 1799 
 09-10 97.5 (90.1-106) 79.0 (71.0-84.0) 217 (185-253) 711 (542-820) 1230 (978-1490) 1908 
Gender        
Males 01-02 163 (137-194) 134 (115-155) 352 (242-481) 1110 (721-1500) 1850 (1390-2190) 1346 
 03-04 165 (140-194) 133 (108-162) 458 (313-681) 1270 (1030-1530) 1920 (1580-2120) 1205 
 05-06 155 (138-174) 127 (118-136) 420 (304-510) 1130 (887-1330) 1810 (1440-2050) 1196 
 07-08 146 (131-162) 115 (103-132) 330 (262-450) 944 (748-1190) 1530 (1160-1940) 1284 
 09-10 111 (99.3-124) 87.0 (75.0-102) 214 (183-272) 718 (549-806) 1190 (982-1390) 1397 
Females 01-02 111 (95.0-130) 94.0 (83.0-108) 204 (169-250) 796 (498-1040) 1390 (1250-1670) 1399 
 03-04 98.2 (81.2-119) 80.5 (66.7-101) 195 (163-272) 842 (530-1200) 1590 (1180-1800) 1297 
 05-06 99.9 (87.0-115) 78.2 (68.3-88.3) 225 (176-278) 961 (558-1390) 1720 (1300-2020) 1202 
 07-08 93.9 (81.2-109) 77.2 (70.4-83.8) 192 (134-276) 688 (457-1090) 1280 (1030-1590) 1297 
 09-10 82.0 (74.7-90.0) 69.0 (62.0-77.0) 174 (155-194) 514 (388-677) 958 (757-1370) 1347 
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(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 01-02 108 (87.1-134) 99.0 (81.0-119) 190 (144-255) 476 (302-641) 718 (476-1140) 662 
 03-04 93.4 (79.6-110) 83.4 (67.0-96.9) 190 (150-252) 520 (388-726) 1030 (688-1320) 622 
 05-06 82.5 (71.0-95.8) 71.8 (60.2-83.9) 143 (116-173) 435 (265-716) 763 (565-1020) 596 
 07-08 90.4 (79.6-103) 81.2 (74.5-92.4) 160 (136-192) 363 (259-513) 674 (454-1180) 529 
 09-10 77.8 (67.1-90.1) 65.0 (51.0-80.0) 149 (108-207) 390 (296-470) 750 (464-1020) 564 
Non-Hispanic blacks 01-02 203 (169-244) 162 (135-188) 449 (308-830) 1420 (1130-1780) 2350 (1520-3000) 692 
 03-04 194 (156-242) 156 (124-184) 466 (297-869) 1480 (1170-1810) 2180 (1620-2830) 665 
 05-06 170 (143-202) 134 (121-149) 345 (246-558) 1300 (929-1760) 1880 (1550-2370) 652 
 07-08 164 (142-190) 133 (112-157) 393 (303-494) 1290 (963-1420) 1770 (1330-2660) 587 
 09-10 163 (134-198) 144 (120-167) 389 (255-670) 1100 (804-1360) 1670 (1230-2010) 517 
Non-Hispanic whites 01-02 130 (108-157) 108 (93.0-127) 246 (202-352) 948 (621-1320) 1620 (1320-1990) 1207 
 03-04 128 (106-155) 104 (86.2-124) 311 (233-452) 1210 (1010-1410) 1870 (1430-2290) 1025 
 05-06 123 (111-137) 96.8 (85.4-112) 343 (275-420) 1060 (760-1260) 1870 (1390-2050) 966 
 07-08 118 (98.0-141) 91.6 (81.6-103) 274 (195-403) 857 (646-1190) 1370 (1050-1740) 1066 
 09-10 89.5 (80.7-99.4) 73.0 (64.0-84.0) 174 (156-194) 545 (403-732) 973 (806-1280) 1202 
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Urinary 3-Hydroxyfluorene (2011 - 2012) 
Metabolite of Fluorene 
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(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 93.6 (85.2-103) 77.0 (70.0-85.0) 195 (166-226) 688 (505-851) 1240 (946-1690) 2488 
Age group        
6-11 years 11-12 69.9 (63.1-77.3) 77.0 (66.0-91.0) 132 (118-145) 203 (178-229) 244 (224-270) 397 
12-19 years 11-12 91.7 (77.7-108) 86.0 (73.0-109) 182 (153-208) 398 (269-681) 801 (473-1050) 389 
20 years and older 11-12 97.0 (87.0-108) 76.0 (67.0-85.0) 221 (172-271) 809 (614-968) 1410 (1090-1810) 1702 
Gender        
Males 11-12 112 (95.1-132) 92.0 (78.0-108) 225 (167-302) 857 (517-1030) 1630 (969-1990) 1257 
Females 11-12 78.8 (68.1-91.1) 66.0 (58.0-76.0) 166 (135-205) 556 (399-715) 1030 (804-1340) 1231 
Race/ethnicity        
Mexican Americans 11-12 86.4 (64.9-115) 75.0 (58.0-95.0) 176 (114-289) 426 (229-949) 835 (311-1640) 315 
Non-Hispanic blacks 11-12 143 (128-159) 122 (109-137) 281 (220-335) 879 (639-1140) 1600 (1190-1980) 663 
Non-Hispanic whites 11-12 88.9 (82.3-96.0) 70.0 (63.0-78.0) 183 (155-223) 700 (515-837) 1220 (857-1930) 813 
All Hispanics 11-12 92.6 (75.9-113) 77.0 (68.0-97.0) 199 (148-258) 473 (300-835) 946 (543-1330) 571 
Asians 11-12 57.8 (47.9-69.8) 49.0 (41.0-64.0) 126 (96.0-151) 230 (184-373) 555 (295-781) 352 
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(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 01-02 125 (108-144) 94.4 (83.3-106) 220 (174-303) 754 (622-873) 1060 (909-1290) 2745 
 03-04 119 (106-134) 86.6 (76.8-97.3) 256 (201-337) 856 (668-1060) 1330 (1130-1590) 2502 
 05-06 121 (111-131) 84.5 (77.5-93.4) 245 (203-297) 930 (806-1020) 1280 (1150-1400) 2398 
 07-08 117 (104-132) 84.6 (76.8-98.5) 226 (177-310) 789 (601-1000) 1230 (1040-1410) 2581 
 09-10 99.2 (93.0-106) 76.0 (69.7-84.0) 157 (144-180) 568 (521-662) 988 (914-1070) 2744 
Age group        
6-11 years 01-02 119 (103-137) 110 (96.7-121) 153 (135-197) 265 (206-377) 382 (254-631) 387 
 03-04 94.6 (84.3-106) 92.4 (83.1-98.5) 130 (115-154) 202 (168-282) 311 (197-435) 336 
 05-06 90.7 (82.6-99.6) 90.3 (80.1-99.7) 130 (119-142) 210 (167-242) 290 (237-353) 336 
 07-08 120 (105-138) 108 (92.3-127) 186 (150-215) 330 (231-401) 419 (304-918) 382 
 09-10 96.3 (89.9-103) 89.5 (82.4-96.5) 130 (120-145) 228 (173-262) 304 (235-430) 416 
12-19 years 01-02 99.3 (81.6-121) 81.9 (74.2-92.6) 144 (109-197) 390 (214-700) 711 (372-1380) 733 
 03-04 88.1 (78.0-99.6) 79.0 (72.5-83.2) 137 (114-170) 319 (225-440) 586 (356-880) 701 
 05-06 90.1 (84.3-96.3) 73.8 (70.0-81.7) 133 (112-153) 381 (323-426) 618 (437-819) 661 
 07-08 88.5 (78.9-99.2) 74.8 (65.2-84.6) 141 (118-185) 317 (242-449) 515 (338-656) 400 
 09-10 77.2 (68.4-87.1) 64.1 (57.0-72.7) 103 (87.0-138) 257 (211-368) 475 (355-600) 420 
20 years and older 01-02 131 (113-151) 94.4 (81.0-108) 279 (195-367) 862 (727-923) 1210 (1010-1350) 1625 
 03-04 128 (113-146) 88.2 (76.8-104) 364 (242-484) 1020 (828-1240) 1500 (1290-1710) 1465 
 05-06 131 (119-144) 85.9 (77.1-98.5) 334 (251-476) 1020 (931-1180) 1380 (1220-1550) 1401 
 07-08 122 (106-142) 83.9 (76.0-99.9) 276 (186-389) 926 (710-1110) 1320 (1150-1500) 1799 
 09-10 103 (96.3-111) 76.2 (69.6-85.9) 185 (157-213) 710 (600-779) 1070 (966-1120) 1908 
Gender        
Males 01-02 132 (111-156) 100 (88.5-117) 260 (194-361) 745 (560-914) 1130 (862-1380) 1346 
 03-04 129 (114-147) 95.8 (82.5-111) 338 (226-456) 833 (672-1010) 1220 (980-1510) 1205 
 05-06 125 (112-139) 92.4 (84.3-103) 272 (215-404) 784 (660-936) 1100 (874-1310) 1196 
 07-08 123 (111-136) 92.3 (80.8-105) 282 (227-354) 791 (675-969) 1110 (989-1330) 1284 
 09-10 99.4 (90.3-110) 74.3 (65.3-85.9) 167 (149-199) 616 (494-739) 948 (736-1140) 1397 
Females 01-02 119 (104-136) 88.9 (78.6-103) 179 (156-227) 777 (604-888) 1030 (923-1270) 1399 
 03-04 110 (93.4-129) 81.7 (69.5-91.5) 183 (132-285) 920 (488-1270) 1460 (1130-1750) 1297 
 05-06 117 (105-130) 77.6 (71.9-90.2) 203 (160-290) 1040 (836-1240) 1400 (1220-1780) 1202 
 07-08 112 (95.7-131) 82.1 (72.7-96.8) 180 (132-265) 789 (450-1140) 1240 (1050-1500) 1297 
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(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 01-02 101 (84.2-121) 84.0 (74.8-97.2) 159 (124-214) 364 (227-598) 604 (357-1230) 662 
 03-04 84.8 (73.1-98.4) 68.8 (60.0-80.2) 170 (119-213) 353 (319-435) 668 (353-1050) 622 
 05-06 74.0 (66.0-83.1) 59.9 (52.5-69.7) 112 (88.0-136) 282 (217-410) 585 (320-763) 596 
 07-08 88.1 (75.3-103) 72.7 (62.2-84.1) 141 (107-184) 366 (232-536) 568 (397-722) 529 
 09-10 77.3 (67.1-89.1) 61.6 (52.6-72.6) 126 (96.0-160) 344 (252-479) 609 (373-905) 564 
Non-Hispanic blacks 01-02 143 (118-173) 110 (90.7-133) 316 (186-525) 849 (622-1230) 1240 (882-1430) 692 
 03-04 138 (114-167) 106 (91.7-117) 316 (203-475) 948 (554-1310) 1310 (963-1710) 665 
 05-06 119 (103-138) 87.4 (78.4-97.0) 214 (154-388) 711 (523-1000) 1100 (838-1380) 652 
 07-08 128 (109-150) 94.1 (82.2-110) 309 (204-433) 829 (715-981) 1310 (981-1640) 587 
 09-10 118 (102-137) 87.1 (73.8-104) 260 (173-397) 729 (559-860) 958 (784-1190) 517 
Non-Hispanic whites 01-02 128 (108-152) 94.7 (83.4-109) 223 (171-323) 816 (642-914) 1150 (910-1410) 1207 
 03-04 127 (110-145) 89.8 (79.5-103) 305 (211-403) 975 (768-1170) 1460 (1270-1700) 1025 
 05-06 130 (117-144) 91.1 (81.0-104) 290 (229-426) 973 (836-1180) 1380 (1130-1570) 966 
 07-08 122 (103-145) 89.3 (76.2-108) 244 (166-377) 895 (579-1110) 1250 (1080-1470) 1066 
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(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 107 (99.8-114) 80.6 (76.7-83.3) 185 (155-225) 753 (588-826) 1170 (1040-1330) 2486 
Age group        
6-11 years 11-12 100 (90.6-111) 93.3 (86.2-106) 138 (120-168) 210 (176-256) 281 (220-349) 396 
12-19 years 11-12 88.6 (78.9-99.5) 79.4 (70.0-88.4) 122 (109-173) 273 (223-392) 519 (329-698) 389 
20 years and older 11-12 110 (102-119) 78.3 (73.1-83.1) 220 (177-262) 832 (754-1030) 1230 (1100-1530) 1701 
Gender        
Males 11-12 105 (90.1-122) 78.7 (70.5-86.7) 195 (137-279) 754 (493-1010) 1200 (894-1470) 1256 
Females 11-12 108 (94.7-123) 81.8 (75.0-88.9) 181 (144-235) 702 (439-964) 1130 (960-1380) 1230 
Race/ethnicity        
Mexican Americans 11-12 96.7 (77.8-120) 78.0 (63.7-91.3) 149 (121-220) 535 (219-765) 765 (510-1110) 315 
Non-Hispanic blacks 11-12 111 (101-121) 86.8 (81.3-95.1) 217 (183-267) 610 (456-758) 932 (753-1100) 663 
Non-Hispanic whites 11-12 108 (102-114) 80.0 (75.0-85.4) 199 (163-230) 822 (644-1040) 1230 (1100-1560) 811 
All Hispanics 11-12 103 (89.2-120) 82.9 (73.1-94.6) 163 (130-219) 554 (301-749) 839 (610-1110) 571 
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(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 267 (234-305) 269 (233-313) 541 (463-620) 929 (839-1060) 1390 (1130-1600) 2504 
 05-06 308 (289-328) 300 (271-325) 609 (563-652) 1270 (1090-1420) 1820 (1560-2110) 2422 
 07-08 337 (310-367) 327 (295-367) 677 (582-769) 1300 (1060-1490) 1960 (1670-2420) 2608 
 09-10 255 (239-272) 253 (229-273) 514 (464-557) 981 (911-1060) 1510 (1290-1700) 2747 
Age group        
6-11 years 03-04 209 (184-238) 216 (173-240) 331 (267-458) 594 (446-809) 853 (553-1500) 333 
 05-06 184 (162-209) 190 (153-210) 324 (261-397) 657 (448-783) 823 (671-1220) 342 
 07-08 242 (208-282) 229 (196-280) 449 (326-580) 791 (565-1040) 1090 (787-1610) 389 
 09-10 164 (144-186) 150 (132-182) 291 (254-351) 518 (424-727) 809 (522-1220) 416 
12-19 years 03-04 253 (216-297) 271 (215-324) 506 (413-560) 894 (773-988) 1210 (929-1510) 698 
 05-06 266 (245-290) 278 (253-314) 528 (454-574) 842 (738-1020) 1290 (1070-1510) 668 
 07-08 308 (255-371) 295 (241-374) 583 (459-736) 1050 (829-1290) 1400 (1080-1870) 401 
 09-10 237 (203-278) 235 (186-303) 475 (398-544) 813 (663-954) 1100 (846-1580) 420 
20 years and older 03-04 277 (240-320) 279 (237-335) 583 (476-656) 979 (842-1140) 1490 (1140-1770) 1473 
 05-06 335 (309-363) 323 (292-349) 653 (593-729) 1360 (1180-1610) 1950 (1650-2530) 1412 
 07-08 355 (323-390) 352 (311-384) 716 (629-835) 1410 (1170-1670) 2160 (1770-2780) 1818 
 09-10 271 (251-291) 267 (245-296) 546 (496-596) 1060 (960-1130) 1590 (1340-1900) 1911 
Gender        
Males 03-04 330 (291-374) 330 (285-372) 632 (583-709) 1090 (898-1370) 1720 (1360-2250) 1208 
 05-06 355 (325-387) 334 (296-387) 693 (608-783) 1310 (1150-1620) 2000 (1670-2560) 1208 
 07-08 401 (365-441) 394 (356-442) 778 (661-897) 1420 (1260-1580) 2120 (1770-2820) 1294 
 09-10 286 (261-313) 283 (255-317) 555 (492-632) 985 (900-1060) 1580 (1320-1750) 1399 
Females 03-04 218 (188-253) 226 (191-253) 439 (357-521) 833 (697-973) 1100 (955-1310) 1296 
 05-06 269 (242-299) 257 (230-297) 503 (426-580) 1090 (845-1400) 1610 (1400-1920) 1214 
 07-08 286 (260-313) 271 (246-299) 557 (474-671) 1110 (914-1400) 1830 (1400-2400) 1314 
 09-10 228 (213-244) 223 (208-244) 464 (432-501) 964 (850-1080) 1470 (1240-1700) 1348 
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Urinary 9-Hydroxyfluorene (2003 – 2010) 
Metabolite of Fluorene 
Geometric mean and selected percentiles of urine concentrations (in ng/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 03-04 229 (200-261) 232 (197-274) 435 (362-492) 773 (561-1010) 1030 (849-1170) 614 
 05-06 232 (204-264) 221 (186-262) 407 (361-435) 738 (596-840) 1030 (788-1470) 614 
 07-08 267 (246-288) 259 (236-285) 476 (430-515) 859 (732-1100) 1470 (1070-1980) 532 
 09-10 214 (187-246) 197 (158-245) 416 (331-495) 854 (723-1040) 1520 (1040-2060) 566 
Non-Hispanic blacks 03-04 382 (310-471) 357 (287-478) 717 (549-843) 1260 (1050-1600) 1880 (1540-2330) 661 
 05-06 416 (360-481) 406 (366-450) 716 (593-943) 1430 (1010-2250) 2310 (1590-3410) 655 
 07-08 426 (376-482) 423 (356-477) 817 (693-978) 1490 (1200-1950) 2260 (1870-3040) 597 
 09-10 377 (339-419) 363 (339-421) 745 (626-878) 1240 (1110-1460) 2120 (1430-2680) 517 
Non-Hispanic whites 03-04 265 (225-312) 265 (227-324) 558 (452-660) 939 (826-1130) 1450 (1090-1770) 1038 
 05-06 306 (279-335) 296 (257-331) 613 (548-669) 1290 (1150-1450) 1730 (1530-2140) 966 
 07-08 345 (302-394) 338 (286-398) 700 (564-849) 1380 (1030-1690) 2040 (1570-2650) 1080 
 09-10 252 (232-273) 254 (225-274) 485 (448-544) 934 (833-1060) 1480 (1220-1700) 1203 
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Urinary 9-Hydroxyfluorene (2011 - 2012) 
Metabolite of Fluorene 
Geometric mean and selected percentiles of urine concentrations (in ng/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 245 (226-265) 244 (226-259) 501 (447-560) 1080 (934-1190) 1550 (1310-1840) 2491 
Age group        
6-11 years 11-12 147 (124-176) 140 (119-161) 308 (235-441) 661 (471-845) 1030 (684-1350) 397 
12-19 years 11-12 210 (176-249) 213 (163-270) 428 (318-576) 796 (619-961) 1010 (856-1340) 388 
20 years and older 11-12 265 (244-287) 257 (236-284) 537 (472-613) 1180 (1040-1310) 1700 (1330-2140) 1706 
Gender        
Males 11-12 278 (254-304) 270 (248-296) 566 (481-672) 1150 (978-1310) 1650 (1310-2280) 1258 
Females 11-12 217 (193-244) 212 (187-243) 438 (386-511) 966 (786-1220) 1440 (1140-1860) 1233 
Race/ethnicity        
Mexican Americans 11-12 204 (155-268) 194 (152-228) 391 (277-508) 853 (528-1620) 1650 (538-14400) 317 
Non-Hispanic blacks 11-12 356 (311-406) 357 (310-398) 677 (579-847) 1350 (1030-1660) 1940 (1570-2420) 664 
Non-Hispanic whites 11-12 238 (219-260) 244 (221-262) 492 (436-564) 1070 (886-1190) 1400 (1230-1710) 814 
All Hispanics 11-12 225 (190-267) 208 (184-239) 455 (373-528) 914 (719-1310) 1560 (940-2090) 572 
Asians 11-12 168 (135-209) 164 (127-197) 304 (230-427) 762 (469-988) 1200 (790-1820) 352 
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Urinary 9-Hydroxyfluorene (creatinine corrected) (2003 – 2010) 
Metabolite of Fluorene 
Geometric mean and selected percentiles of urine concentrations (in ng/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 252 (230-276) 233 (205-266) 412 (371-461) 729 (609-905) 1100 (918-1390) 2504 
 05-06 301 (281-322) 270 (252-290) 511 (460-575) 1040 (908-1230) 1510 (1360-1750) 2422 
 07-08 339 (309-372) 303 (277-333) 562 (493-645) 1110 (908-1300) 1660 (1430-1960) 2608 
 09-10 266 (254-279) 242 (224-262) 442 (417-466) 838 (775-894) 1250 (1160-1360) 2747 
Age group        
6-11 years 03-04 223 (200-247) 208 (176-264) 343 (299-389) 548 (433-689) 866 (533-958) 333 
 05-06 205 (180-234) 195 (176-209) 309 (272-371) 590 (402-668) 866 (620-1300) 342 
 07-08 298 (256-346) 280 (249-331) 463 (399-576) 817 (576-1130) 1130 (862-1230) 389 
 09-10 214 (192-237) 185 (169-203) 331 (275-365) 568 (400-848) 1020 (539-1650) 416 
12-19 years 03-04 192 (172-215) 182 (161-200) 323 (286-360) 484 (412-696) 738 (571-1110) 698 
 05-06 201 (183-220) 194 (173-223) 325 (283-343) 511 (397-666) 848 (521-941) 668 
 07-08 239 (204-280) 235 (190-283) 381 (312-462) 596 (479-722) 768 (660-1090) 401 
 09-10 191 (175-207) 181 (162-199) 293 (257-338) 521 (376-604) 691 (534-938) 420 
20 years and older 03-04 267 (242-294) 243 (219-280) 446 (392-490) 788 (641-994) 1280 (991-1560) 1473 
 05-06 336 (314-358) 304 (284-323) 573 (506-650) 1200 (1000-1360) 1720 (1490-1900) 1412 
 07-08 363 (330-399) 314 (293-351) 618 (533-738) 1200 (1030-1450) 1770 (1570-2040) 1818 
 09-10 287 (272-302) 265 (243-288) 484 (450-514) 909 (832-986) 1340 (1230-1460) 1911 
Gender        
Males 03-04 260 (238-283) 236 (209-269) 429 (382-480) 739 (591-952) 1300 (916-1800) 1208 
 05-06 286 (266-308) 258 (235-291) 498 (422-576) 993 (858-1180) 1410 (1240-1730) 1208 
 07-08 338 (308-372) 303 (269-338) 575 (516-626) 1150 (987-1300) 1690 (1420-1940) 1294 
 09-10 257 (240-275) 228 (206-258) 445 (402-489) 816 (747-932) 1260 (1070-1420) 1399 
Females 03-04 244 (217-275) 227 (198-269) 396 (342-467) 717 (569-905) 1020 (905-1280) 1296 
 05-06 316 (287-348) 278 (253-303) 532 (466-623) 1100 (840-1370) 1610 (1360-1840) 1214 
 07-08 340 (306-377) 303 (274-335) 555 (451-683) 1030 (852-1330) 1620 (1330-2040) 1314 
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Metabolite of Fluorene 
Geometric mean and selected percentiles of urine concentrations (in ng/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 03-04 209 (188-232) 195 (181-209) 335 (293-379) 541 (447-722) 793 (569-1440) 614 
 05-06 208 (194-224) 201 (180-220) 304 (270-342) 502 (425-584) 663 (527-919) 614 
 07-08 260 (236-285) 244 (226-259) 388 (348-419) 654 (527-858) 1160 (775-1640) 532 
 09-10 213 (186-243) 186 (161-214) 312 (285-378) 727 (524-1070) 1410 (1030-2360) 566 
Non-Hispanic blacks 03-04 271 (225-326) 258 (207-308) 460 (344-562) 777 (630-919) 1040 (856-1300) 661 
 05-06 293 (258-332) 261 (230-297) 449 (377-554) 851 (635-1080) 1480 (925-2070) 655 
 07-08 331 (289-379) 293 (257-333) 542 (489-620) 990 (805-1250) 1550 (1160-2470) 597 
 09-10 273 (256-292) 253 (224-279) 445 (403-489) 793 (626-887) 1170 (887-1540) 517 
Non-Hispanic whites 03-04 263 (235-294) 243 (211-285) 438 (386-485) 773 (607-1020) 1300 (967-1710) 1038 
 05-06 323 (296-353) 293 (266-322) 570 (496-650) 1180 (962-1360) 1630 (1370-1840) 966 
 07-08 359 (316-407) 314 (280-366) 605 (497-750) 1170 (935-1420) 1740 (1460-2040) 1080 
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Urinary 9-Hydroxyfluorene (creatinine corrected) (2011 - 2012) 
Metabolite of Fluorene 
Geometric mean and selected percentiles of urine concentrations (in ng/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 279 (261-298) 248 (229-270) 490 (431-544) 934 (875-1010) 1370 (1140-1660) 2489 
Age group        
6-11 years 11-12 212 (183-247) 191 (163-225) 328 (274-365) 544 (413-928) 1000 (688-1450) 396 
12-19 years 11-12 203 (182-225) 188 (173-207) 323 (273-380) 538 (430-644) 804 (595-876) 388 
20 years and older 11-12 301 (279-325) 271 (244-301) 561 (480-620) 1030 (918-1140) 1480 (1180-2010) 1705 
Gender        
Males 11-12 260 (241-281) 226 (205-251) 450 (395-540) 908 (794-1010) 1260 (1000-1650) 1257 
Females 11-12 297 (269-329) 270 (229-322) 505 (436-581) 984 (914-1100) 1480 (1140-1850) 1232 
Race/ethnicity        
Mexican Americans 11-12 229 (186-283) 187 (162-235) 376 (311-430) 750 (430-1630) 1480 (511-5650) 317 
Non-Hispanic blacks 11-12 277 (244-314) 256 (231-294) 447 (399-540) 823 (640-1040) 1240 (918-1460) 664 
Non-Hispanic whites 11-12 290 (268-314) 257 (227-290) 542 (451-614) 961 (875-1080) 1350 (1130-1660) 812 
All Hispanics 11-12 252 (217-293) 220 (186-267) 415 (343-492) 1000 (520-1330) 1390 (787-3250) 572 
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Urinary 1-Hydroxyphenanthrene (2001 – 2010)  
Metabolite of Phenanthrene 
Geometric mean and selected percentiles of urine concentrations (in ng/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 01-02 140 (125-158) 141 (130-154) 266 (229-312) 476 (426-539) 684 (581-763) 2741 
 03-04 156 (140-173) 166 (150-179) 287 (263-321) 464 (423-508) 625 (538-745) 2496 
 05-06 152 (143-161) 151 (138-163) 275 (257-303) 493 (428-549) 669 (580-852) 2449 
 07-08 139 (130-149) 140 (127-154) 252 (228-272) 442 (402-481) 683 (577-760) 2608 
 09-10 131 (124-140) 133 (126-141) 235 (222-251) 402 (367-451) 567 (488-659) 2746 
Age group        
6-11 years 01-02 119 (104-137) 121 (98.0-142) 228 (182-249) 357 (265-501) 501 (367-661) 387 
 03-04 138 (124-154) 131 (111-161) 222 (200-275) 397 (304-500) 615 (384-916) 328 
 05-06 111 (101-123) 110 (96.9-121) 176 (150-240) 320 (251-375) 381 (329-540) 345 
 07-08 121 (105-139) 120 (96.5-154) 200 (174-235) 334 (247-401) 405 (278-557) 389 
 09-10 103 (90.7-116) 105 (89.0-119) 156 (142-172) 261 (226-320) 363 (283-628) 416 
12-19 years 01-02 133 (110-162) 131 (110-153) 238 (198-303) 431 (376-546) 579 (439-820) 733 
 03-04 158 (141-178) 171 (138-193) 300 (262-333) 470 (437-537) 654 (563-745) 692 
 05-06 144 (132-157) 154 (130-175) 260 (236-286) 425 (383-496) 666 (496-845) 677 
 07-08 136 (122-152) 144 (128-164) 219 (199-283) 374 (315-415) 503 (392-607) 401 
 09-10 133 (117-151) 124 (106-142) 244 (212-269) 410 (296-510) 511 (414-742) 420 
20 years and older 01-02 145 (127-164) 145 (133-164) 274 (237-329) 499 (440-565) 713 (595-819) 1621 
 03-04 157 (141-176) 167 (152-182) 296 (264-337) 469 (430-513) 625 (534-783) 1476 
 05-06 159 (147-172) 156 (141-172) 287 (265-328) 516 (438-615) 744 (580-996) 1427 
 07-08 142 (132-153) 141 (125-158) 258 (241-280) 470 (417-531) 733 (622-856) 1818 
 09-10 135 (126-144) 140 (131-148) 245 (223-265) 412 (377-462) 579 (497-672) 1910 
Gender        
Males 01-02 150 (133-169) 145 (132-164) 284 (235-348) 501 (424-593) 713 (575-845) 1344 
 03-04 176 (161-194) 182 (167-198) 321 (283-363) 492 (459-536) 662 (541-929) 1196 
 05-06 169 (156-183) 166 (153-180) 289 (265-334) 519 (438-593) 791 (562-1080) 1222 
 07-08 153 (140-167) 152 (137-171) 268 (251-292) 448 (406-488) 722 (566-813) 1294 
 09-10 139 (129-149) 140 (127-153) 244 (222-260) 399 (363-457) 565 (469-664) 1398 
Females 01-02 132 (115-152) 137 (121-151) 254 (221-297) 464 (390-520) 654 (538-769) 1397 
 03-04 138 (122-156) 144 (126-164) 263 (240-294) 430 (404-469) 589 (489-680) 1300 
 05-06 137 (123-152) 136 (117-153) 260 (234-297) 460 (391-553) 648 (540-809) 1227 
 07-08 128 (120-136) 128 (117-139) 230 (205-258) 432 (373-500) 663 (527-740) 1314 
 09-10 125 (116-135) 129 (119-136) 231 (214-246) 405 (332-489) 581 (470-689) 1348 
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(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 01-02 117 (90.8-152) 116 (88.0-147) 214 (157-306) 369 (254-583) 549 (342-847) 664 
 03-04 138 (120-158) 152 (129-175) 246 (213-291) 413 (311-492) 518 (352-896) 611 
 05-06 125 (104-151) 129 (107-151) 223 (174-276) 376 (298-460) 523 (399-617) 621 
 07-08 118 (108-129) 108 (103-119) 194 (172-216) 341 (271-437) 491 (417-738) 532 
 09-10 116 (107-126) 112 (100-126) 195 (168-245) 391 (294-509) 603 (432-825) 565 
Non-Hispanic blacks 01-02 150 (127-179) 145 (126-170) 287 (243-327) 493 (423-629) 713 (568-975) 690 
 03-04 183 (152-219) 178 (148-213) 350 (268-423) 551 (455-645) 797 (588-1050) 661 
 05-06 162 (148-177) 155 (141-173) 307 (259-349) 517 (408-695) 753 (545-1110) 658 
 07-08 142 (129-158) 141 (128-163) 264 (234-302) 448 (401-511) 613 (522-722) 597 
 09-10 148 (130-167) 161 (135-181) 269 (234-312) 410 (346-489) 536 (435-658) 517 
Non-Hispanic whites 01-02 144 (125-166) 144 (131-162) 276 (241-330) 489 (436-552) 661 (550-793) 1204 
 03-04 159 (140-180) 167 (151-185) 296 (267-330) 474 (421-534) 641 (516-843) 1036 
 05-06 156 (143-170) 155 (137-173) 279 (251-322) 500 (414-606) 743 (570-1050) 982 
 07-08 146 (133-159) 149 (132-174) 261 (235-292) 453 (405-503) 725 (590-836) 1080 
 09-10 133 (123-144) 136 (128-143) 235 (214-259) 409 (357-462) 570 (470-689) 1203 
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Metabolite of Phenanthrene 
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(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 126 (117-135) 126 (115-134) 240 (219-254) 426 (365-463) 565 (493-682) 2492 
Age group        
6-11 years 11-12 98.6 (87.8-111) 100 (89.0-115) 199 (144-240) 323 (270-405) 473 (327-549) 397 
12-19 years 11-12 119 (103-138) 132 (108-157) 219 (192-252) 332 (284-365) 438 (344-505) 389 
20 years and older 11-12 130 (121-140) 128 (119-138) 248 (221-270) 450 (372-499) 589 (495-759) 1706 
Gender        
Males 11-12 133 (121-146) 132 (115-149) 246 (221-271) 434 (365-476) 589 (466-781) 1258 
Females 11-12 119 (109-131) 117 (107-128) 232 (212-249) 408 (334-471) 557 (465-682) 1234 
Race/ethnicity        
Mexican Americans 11-12 115 (91.3-146) 112 (94.0-131) 214 (156-260) 371 (260-572) 572 (284-1390) 317 
Non-Hispanic blacks 11-12 141 (129-155) 140 (129-156) 244 (221-268) 439 (366-503) 609 (495-849) 664 
Non-Hispanic whites 11-12 126 (117-136) 128 (114-141) 245 (219-261) 428 (352-475) 557 (456-733) 814 
All Hispanics 11-12 125 (108-146) 123 (105-138) 239 (207-260) 391 (321-502) 544 (439-826) 573 
Asians 11-12 91.3 (75.3-111) 88.0 (65.0-114) 173 (134-238) 303 (260-387) 447 (315-597) 352 
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Urinary 1-Hydroxyphenanthrene  (creatinine corrected) (2001 – 2010) 
Metabolite of Phenanthrene 
Geometric mean and selected percentiles of urine concentrations (in ng/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 01-02 132 (118-147) 125 (113-141) 210 (191-231) 344 (310-385) 464 (404-539) 2741 
 03-04 146 (138-155) 141 (133-150) 222 (205-244) 352 (330-384) 487 (416-546) 2496 
 05-06 147 (138-157) 140 (130-148) 229 (211-247) 372 (339-406) 502 (446-600) 2449 
 07-08 140 (130-151) 137 (124-151) 221 (207-236) 345 (319-372) 457 (407-522) 2608 
 09-10 137 (132-143) 130 (125-136) 206 (194-221) 328 (304-346) 448 (395-489) 2746 
Age group        
6-11 years 01-02 133 (116-153) 126 (110-147) 188 (165-225) 344 (245-437) 467 (364-598) 387 
 03-04 145 (129-163) 138 (121-155) 205 (169-240) 315 (244-456) 477 (313-803) 328 
 05-06 124 (114-134) 115 (103-133) 191 (162-210) 275 (230-340) 368 (321-396) 345 
 07-08 149 (132-169) 139 (127-158) 221 (191-264) 334 (275-410) 424 (332-796) 389 
 09-10 134 (121-148) 122 (113-133) 184 (161-209) 290 (241-437) 489 (290-845) 416 
12-19 years 01-02 103 (87.9-121) 97.3 (81.4-117) 158 (131-192) 240 (198-322) 354 (235-531) 733 
 03-04 119 (108-130) 115 (101-131) 176 (157-197) 275 (230-331) 345 (269-496) 692 
 05-06 108 (97.5-119) 108 (95.9-116) 163 (148-180) 268 (199-330) 372 (262-609) 677 
 07-08 106 (94.9-117) 106 (90.0-116) 158 (147-171) 243 (197-303) 324 (250-407) 401 
 09-10 107 (99.6-115) 102 (94.4-112) 150 (130-164) 227 (190-273) 316 (228-491) 420 
20 years and older 01-02 137 (122-153) 132 (117-145) 223 (200-243) 351 (319-395) 476 (421-541) 1621 
 03-04 151 (142-161) 147 (134-157) 237 (212-253) 365 (335-397) 500 (422-580) 1476 
 05-06 158 (147-170) 151 (137-163) 244 (224-265) 397 (362-420) 554 (478-666) 1427 
 07-08 145 (135-157) 142 (127-156) 229 (214-251) 354 (336-383) 495 (420-560) 1818 
 09-10 143 (137-149) 139 (132-144) 221 (203-235) 333 (316-356) 455 (407-500) 1910 
Gender        
Males 01-02 122 (108-137) 116 (104-131) 194 (173-218) 321 (262-395) 455 (348-642) 1344 
 03-04 138 (131-146) 130 (117-143) 201 (187-227) 335 (301-391) 437 (392-550) 1196 
 05-06 135 (126-145) 125 (117-132) 208 (187-229) 341 (300-385) 498 (391-634) 1222 
 07-08 129 (117-141) 126 (112-141) 207 (191-223) 327 (290-344) 410 (354-487) 1294 
 09-10 125 (117-132) 118 (109-130) 188 (176-206) 288 (266-324) 397 (332-500) 1398 
Females 01-02 142 (125-160) 136 (118-156) 226 (199-256) 355 (323-399) 473 (421-541) 1397 
 03-04 154 (142-168) 150 (138-160) 241 (212-269) 364 (323-425) 505 (418-635) 1300 
 05-06 160 (149-172) 152 (136-166) 251 (229-275) 398 (367-428) 509 (435-638) 1227 
 07-08 152 (140-165) 148 (133-162) 231 (213-262) 373 (329-411) 478 (409-577) 1314 
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(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 01-02 110 (88.6-136) 101 (85.5-131) 162 (138-203) 275 (187-452) 400 (268-755) 664 
 03-04 124 (111-140) 122 (107-136) 183 (159-242) 304 (246-392) 392 (318-437) 611 
 05-06 112 (99.2-126) 109 (87.1-129) 170 (145-201) 259 (228-307) 353 (297-414) 621 
 07-08 115 (102-129) 107 (96.7-118) 159 (143-183) 287 (218-344) 424 (324-520) 532 
 09-10 116 (104-129) 104 (93.1-114) 163 (141-203) 312 (225-471) 502 (329-860) 565 
Non-Hispanic blacks 01-02 106 (88.7-127) 102 (92.4-111) 172 (141-203) 274 (224-356) 384 (308-598) 690 
 03-04 129 (112-148) 125 (107-143) 199 (173-239) 337 (279-395) 428 (374-536) 661 
 05-06 114 (106-121) 107 (98.6-114) 179 (163-189) 301 (229-370) 449 (321-771) 658 
 07-08 111 (98.8-124) 109 (90.0-126) 181 (153-201) 293 (257-338) 385 (338-446) 597 
 09-10 107 (102-113) 98.5 (94.1-108) 165 (149-179) 258 (240-283) 328 (283-386) 517 
Non-Hispanic whites 01-02 142 (126-161) 137 (119-153) 228 (206-247) 363 (321-406) 476 (411-552) 1204 
 03-04 156 (146-168) 149 (138-158) 239 (214-255) 373 (335-426) 515 (426-649) 1036 
 05-06 164 (152-176) 154 (141-165) 247 (228-268) 398 (366-428) 554 (466-739) 982 
 07-08 152 (139-166) 152 (135-167) 236 (217-258) 354 (330-383) 464 (407-551) 1080 
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(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 143 (134-153) 134 (126-143) 218 (200-247) 357 (320-410) 519 (473-554) 2490 
Age group        
6-11 years 11-12 142 (131-155) 137 (123-150) 206 (175-217) 292 (255-363) 450 (272-678) 396 
12-19 years 11-12 115 (101-132) 117 (87.0-144) 172 (153-213) 254 (215-303) 310 (254-359) 389 
20 years and older 11-12 148 (138-159) 137 (128-146) 232 (206-260) 377 (337-459) 543 (500-583) 1705 
Gender        
Males 11-12 125 (118-132) 117 (107-124) 188 (172-207) 297 (272-360) 437 (364-522) 1257 
Females 11-12 163 (148-180) 152 (138-175) 250 (217-281) 406 (340-494) 549 (500-664) 1233 
Race/ethnicity        
Mexican Americans 11-12 130 (111-152) 117 (102-133) 191 (148-235) 373 (231-676) 497 (337-837) 317 
Non-Hispanic blacks 11-12 110 (100-121) 110 (96.1-122) 168 (147-197) 273 (238-319) 387 (322-453) 664 
Non-Hispanic whites 11-12 154 (143-165) 143 (133-154) 234 (207-265) 368 (335-450) 543 (478-593) 812 
All Hispanics 11-12 140 (125-157) 128 (117-141) 214 (184-244) 357 (274-481) 504 (383-792) 573 
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(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 01-02 54.0 (46.0-63.5) 58.0 (50.0-68.0) 117 (102-140) 240 (201-271) 332 (299-377) 2742 
 03-04 59.3 (52.5-66.9) 62.2 (55.4-69.7) 117 (105-129) 206 (180-235) 291 (252-336) 2512 
 05-06 65.3 (60.9-70.0) 63.3 (58.5-68.6) 126 (111-139) 234 (203-254) 314 (282-383) 2410 
 07-08 63.6 (58.8-68.7) 62.9 (58.0-68.7) 117 (104-130) 204 (184-223) 300 (256-367) 2572 
 09-10 64.1 (60.3-68.0) 64.0 (58.0-69.0) 114 (108-122) 204 (185-228) 281 (260-310) 2744 
Age group        
6-11 years 01-02 40.5 (34.3-47.7) 46.0 (37.0-57.0) 87.0 (71.0-101) 170 (133-207) 257 (195-320) 387 
 03-04 45.3 (40.0-51.3) 48.1 (41.9-56.8) 72.7 (63.2-89.4) 135 (104-176) 225 (136-299) 337 
 05-06 42.1 (38.4-46.1) 40.1 (36.4-47.2) 70.4 (58.1-83.2) 110 (89.2-132) 152 (112-213) 341 
 07-08 48.1 (41.8-55.4) 46.4 (41.7-54.6) 80.3 (68.2-95.4) 144 (98.8-184) 184 (122-229) 382 
 09-10 44.6 (39.3-50.7) 44.0 (39.0-51.0) 71.0 (60.0-80.0) 112 (89.0-131) 167 (112-260) 416 
12-19 years 01-02 49.5 (37.3-65.7) 52.0 (41.0-68.0) 108 (93.0-122) 210 (145-270) 281 (214-524) 733 
 03-04 58.0 (50.7-66.2) 62.5 (54.5-71.6) 104 (88.8-132) 198 (166-215) 258 (199-318) 707 
 05-06 60.4 (55.4-65.8) 62.4 (56.3-67.1) 114 (93.8-133) 175 (156-195) 250 (198-291) 664 
 07-08 59.4 (52.9-66.7) 60.5 (51.5-67.0) 97.4 (81.2-121) 160 (133-204) 223 (175-264) 398 
 09-10 60.6 (53.0-69.3) 62.0 (51.0-68.0) 109 (90.0-126) 170 (130-230) 230 (155-443) 420 
20 years and older 01-02 56.8 (48.1-66.9) 60.0 (52.0-73.0) 126 (104-152) 249 (207-292) 342 (308-398) 1622 
 03-04 61.5 (53.7-70.4) 64.9 (57.2-73.5) 125 (111-138) 216 (187-250) 310 (259-389) 1468 
 05-06 69.6 (63.6-76.2) 67.3 (61.5-75.3) 137 (118-154) 251 (215-280) 348 (298-446) 1405 
 07-08 66.2 (60.8-72.1) 65.9 (60.4-71.2) 123 (109-136) 218 (195-251) 334 (272-412) 1792 
 09-10 67.3 (63.1-71.8) 68.0 (61.0-75.0) 120 (114-127) 218 (199-244) 296 (266-324) 1908 
Gender        
Males 01-02 62.1 (53.3-72.5) 67.0 (58.0-80.0) 136 (109-161) 274 (245-303) 367 (329-414) 1345 
 03-04 72.3 (64.4-81.3) 71.6 (65.8-83.3) 138 (123-150) 240 (200-279) 337 (279-428) 1211 
 05-06 76.5 (70.3-83.3) 72.9 (67.4-81.3) 141 (122-156) 254 (219-296) 383 (289-555) 1204 
 07-08 75.8 (70.3-81.8) 73.5 (67.6-81.4) 136 (126-149) 229 (199-256) 354 (276-408) 1277 
 09-10 72.1 (66.6-78.1) 72.0 (62.0-79.0) 124 (112-139) 227 (198-253) 310 (271-357) 1397 
Females 01-02 47.4 (39.1-57.5) 50.0 (41.0-60.0) 105 (88.0-129) 200 (171-240) 294 (236-357) 1397 
 03-04 49.0 (42.4-56.6) 52.5 (45.3-58.7) 95.4 (84.1-110) 166 (146-202) 247 (202-291) 1301 
 05-06 56.0 (50.2-62.5) 54.4 (49.5-61.0) 107 (94.7-125) 206 (173-245) 275 (248-343) 1206 
 07-08 53.7 (48.9-59.0) 53.0 (48.9-59.2) 97.0 (87.0-111) 173 (146-207) 280 (206-327) 1295 
 09-10 57.2 (53.2-61.4) 57.0 (52.0-64.0) 108 (98.0-114) 189 (161-214) 253 (214-301) 1347 
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(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 01-02 46.8 (32.7-66.8) 51.0 (36.0-73.0) 97.0 (72.0-140) 191 (122-332) 303 (187-652) 665 
 03-04 53.9 (46.7-62.1) 60.1 (50.8-68.6) 104 (89.5-115) 164 (144-187) 200 (187-219) 627 
 05-06 54.6 (45.0-66.3) 56.2 (47.1-67.7) 96.2 (84.4-108) 164 (120-202) 213 (175-294) 612 
 07-08 58.2 (53.9-62.7) 59.3 (50.8-63.0) 98.6 (92.5-113) 167 (141-193) 252 (192-395) 528 
 09-10 57.6 (51.3-64.8) 56.0 (45.0-64.0) 95.0 (80.0-116) 190 (153-234) 303 (228-479) 566 
Non-Hispanic blacks 01-02 71.1 (58.0-87.1) 74.0 (66.0-90.0) 152 (124-182) 262 (217-311) 374 (284-560) 690 
 03-04 81.9 (68.2-98.3) 74.1 (61.0-102) 164 (125-199) 282 (217-375) 390 (289-574) 660 
 05-06 77.3 (69.0-86.6) 75.3 (65.8-83.5) 141 (114-172) 267 (202-340) 363 (275-546) 641 
 07-08 72.8 (65.2-81.3) 70.7 (62.6-80.2) 127 (115-149) 251 (206-284) 367 (284-455) 597 
 09-10 80.1 (71.2-90.0) 86.0 (77.0-98.0) 139 (123-164) 224 (190-265) 295 (252-367) 517 
Non-Hispanic whites 01-02 53.1 (43.6-64.6) 57.0 (48.0-68.0) 117 (99.0-144) 242 (199-286) 333 (303-385) 1204 
 03-04 58.1 (49.9-67.6) 60.5 (52.1-71.0) 115 (97.9-133) 209 (172-259) 299 (251-358) 1034 
 05-06 65.2 (59.4-71.5) 63.7 (57.0-70.4) 130 (109-144) 244 (206-261) 343 (282-439) 974 
 07-08 63.3 (56.6-70.8) 64.0 (56.4-71.1) 121 (102-135) 203 (174-234) 298 (238-410) 1050 
 09-10 62.9 (57.5-68.7) 63.0 (55.0-69.0) 112 (101-121) 200 (165-242) 279 (242-310) 1200 
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(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 60.8 (56.8-65.2) 60.0 (56.0-65.0) 113 (105-123) 214 (187-242) 288 (263-317) 2489 
Age group        
6-11 years 11-12 39.6 (34.3-45.6) 39.0 (33.0-46.0) 78.0 (61.0-96.0) 133 (109-153) 173 (133-237) 397 
12-19 years 11-12 56.5 (49.8-64.1) 62.0 (53.0-70.0) 105 (88.0-114) 162 (134-183) 212 (169-248) 389 
20 years and older 11-12 64.5 (60.0-69.4) 64.0 (57.0-68.0) 121 (107-132) 233 (198-263) 311 (271-340) 1703 
Gender        
Males 11-12 70.3 (63.9-77.4) 69.0 (63.0-77.0) 130 (115-143) 246 (198-288) 339 (277-384) 1257 
Females 11-12 53.0 (48.7-57.5) 52.0 (50.0-56.0) 100 (89.0-109) 184 (158-210) 259 (216-282) 1232 
Race/ethnicity        
Mexican Americans 11-12 56.3 (43.9-72.1) 56.0 (46.0-69.0) 97.0 (79.0-140) 180 (128-276) 276 (175-508) 317 
Non-Hispanic blacks 11-12 78.9 (72.3-86.2) 75.0 (68.0-81.0) 145 (122-166) 246 (212-297) 368 (286-436) 663 
Non-Hispanic whites 11-12 58.3 (54.7-62.2) 58.0 (53.0-64.0) 109 (100-121) 204 (169-243) 282 (247-312) 812 
All Hispanics 11-12 62.2 (52.7-73.4) 62.0 (53.0-75.0) 112 (99.0-134) 202 (175-248) 268 (214-416) 573 
Asians 11-12 50.3 (40.5-62.4) 50.0 (39.0-58.0) 96.0 (78.0-118) 187 (126-240) 257 (193-338) 352 
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(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 01-02 50.6 (43.3-59.2) 52.5 (46.4-59.6) 91.4 (78.7-108) 164 (138-200) 233 (206-275) 2742 
 03-04 55.4 (51.1-60.0) 52.3 (48.8-55.8) 85.8 (79.4-97.0) 150 (128-174) 212 (180-252) 2512 
 05-06 63.1 (58.9-67.5) 57.0 (53.3-61.9) 101 (92.8-110) 178 (157-194) 245 (209-295) 2410 
 07-08 64.0 (58.9-69.4) 60.3 (55.3-66.5) 98.2 (87.5-108) 163 (151-179) 229 (199-248) 2572 
 09-10 66.9 (64.5-69.3) 62.2 (58.9-65.2) 97.7 (94.7-103) 166 (155-176) 228 (212-251) 2744 
Age group        
6-11 years 01-02 45.3 (38.8-52.8) 50.0 (40.0-57.8) 85.9 (69.6-100) 144 (105-217) 234 (138-397) 387 
 03-04 47.9 (43.6-52.7) 46.6 (41.0-51.4) 66.3 (60.3-72.8) 106 (81.0-125) 183 (108-295) 337 
 05-06 45.9 (42.0-50.1) 43.6 (38.4-48.7) 65.8 (56.1-85.2) 101 (85.4-110) 116 (101-135) 341 
 07-08 59.7 (51.2-69.4) 56.5 (49.4-65.2) 85.1 (73.1-107) 134 (105-187) 187 (121-437) 382 
 09-10 58.2 (52.3-64.9) 54.7 (49.3-60.5) 76.6 (69.6-93.8) 124 (104-145) 170 (134-320) 416 
12-19 years 01-02 38.4 (29.6-49.7) 38.5 (30.6-48.7) 64.9 (52.4-84.0) 117 (86.7-167) 173 (128-305) 733 
 03-04 43.6 (39.3-48.5) 40.8 (37.7-45.0) 70.6 (55.8-84.7) 106 (88.2-123) 127 (115-176) 707 
 05-06 44.5 (39.9-49.7) 42.7 (38.9-47.1) 66.1 (58.0-73.7) 111 (80.0-129) 146 (115-232) 664 
 07-08 46.1 (42.0-50.5) 47.0 (39.7-53.0) 69.7 (62.0-78.0) 100 (83.0-113) 127 (105-188) 398 
 09-10 48.7 (45.1-52.6) 46.5 (43.0-50.8) 67.8 (59.2-73.3) 97.0 (77.3-137) 140 (103-186) 420 
20 years and older 01-02 53.7 (46.2-62.4) 55.6 (49.4-62.7) 94.6 (84.1-112) 173 (145-201) 241 (209-287) 1622 
 03-04 58.7 (53.6-64.2) 54.8 (50.7-60.9) 91.6 (83.5-105) 164 (139-182) 227 (183-291) 1468 
 05-06 69.1 (64.1-74.6) 63.6 (58.4-67.8) 111 (102-123) 191 (168-216) 267 (232-316) 1405 
 07-08 67.8 (62.4-73.8) 64.1 (57.6-71.6) 105 (95.5-119) 177 (160-194) 239 (211-255) 1792 
 09-10 71.2 (68.4-74.2) 66.2 (61.9-72.5) 107 (101-113) 177 (164-195) 237 (220-258) 1908 
Gender        
Males 01-02 50.4 (43.3-58.5) 52.5 (47.2-59.2) 91.4 (78.6-103) 176 (140-208) 245 (206-349) 1345 
 03-04 56.6 (52.5-61.0) 52.3 (48.1-57.1) 84.7 (79.2-96.4) 157 (132-180) 227 (184-284) 1211 
 05-06 61.2 (56.7-65.9) 55.7 (50.0-59.3) 102 (89.3-111) 161 (137-194) 244 (190-310) 1204 
 07-08 64.0 (59.3-69.1) 59.8 (55.3-64.1) 99.7 (90.5-108) 172 (152-191) 229 (211-243) 1277 
 09-10 64.7 (61.1-68.6) 60.8 (55.1-66.7) 97.7 (89.1-111) 162 (150-179) 229 (202-251) 1397 
Females 01-02 50.9 (42.7-60.7) 52.8 (45.5-61.0) 91.6 (75.0-115) 158 (133-183) 214 (200-245) 1397 
 03-04 54.3 (48.7-60.5) 52.3 (47.0-57.2) 88.1 (76.4-101) 146 (118-179) 202 (175-246) 1301 
 05-06 65.0 (60.0-70.3) 60.5 (55.1-65.3) 101 (91.6-113) 184 (165-201) 256 (224-312) 1206 
 07-08 63.9 (57.8-70.7) 61.5 (54.0-69.3) 95.8 (83.7-115) 159 (140-189) 229 (186-256) 1295 
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(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 01-02 43.7 (31.9-59.8) 44.0 (34.3-58.8) 80.8 (59.8-115) 146 (103-245) 245 (144-394) 665 
 03-04 48.8 (42.5-55.9) 50.1 (42.4-58.8) 79.5 (68.1-86.1) 124 (96.2-149) 155 (127-206) 627 
 05-06 48.7 (43.0-55.2) 46.0 (39.4-56.2) 75.1 (62.9-85.8) 111 (94.5-138) 146 (121-178) 612 
 07-08 56.7 (51.1-62.8) 55.0 (47.7-62.2) 83.7 (76.2-90.4) 133 (107-180) 198 (145-233) 528 
 09-10 57.2 (50.0-65.4) 49.7 (45.0-55.8) 80.0 (65.2-103) 162 (118-212) 282 (195-402) 566 
Non-Hispanic blacks 01-02 50.2 (40.5-62.2) 49.7 (44.3-56.0) 87.7 (72.6-103) 174 (127-224) 257 (178-459) 690 
 03-04 57.7 (49.7-67.1) 53.1 (45.7-63.5) 90.2 (77.6-116) 165 (131-189) 224 (173-357) 660 
 05-06 54.3 (49.7-59.3) 47.7 (45.4-51.3) 84.8 (71.3-97.8) 150 (116-192) 211 (167-298) 641 
 07-08 56.6 (50.4-63.6) 51.2 (46.6-55.9) 95.5 (77.7-107) 154 (136-178) 212 (188-232) 597 
 09-10 58.1 (54.5-61.9) 55.7 (51.4-59.7) 87.6 (80.8-96.5) 150 (135-164) 191 (164-210) 517 
Non-Hispanic whites 01-02 52.5 (43.8-62.9) 54.8 (47.7-61.9) 92.7 (80.5-113) 170 (140-204) 233 (202-293) 1204 
 03-04 57.0 (51.6-62.9) 52.7 (48.7-57.0) 88.5 (79.0-102) 159 (126-187) 239 (180-296) 1034 
 05-06 67.9 (62.6-73.7) 60.9 (56.5-66.5) 111 (101-123) 191 (162-224) 274 (231-323) 974 
 07-08 65.9 (59.4-73.3) 62.8 (55.1-72.0) 100 (87.2-119) 166 (147-190) 229 (197-252) 1050 
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(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 69.2 (65.5-73.1) 62.2 (59.1-66.9) 106 (97.4-116) 182 (167-202) 248 (218-293) 2487 
Age group        
6-11 years 11-12 56.8 (50.8-63.6) 54.7 (48.8-60.0) 78.9 (68.8-95.3) 121 (105-148) 180 (131-200) 396 
12-19 years 11-12 54.6 (49.9-59.6) 52.4 (44.9-64.0) 81.4 (70.8-92.6) 112 (103-147) 163 (121-203) 389 
20 years and older 11-12 73.3 (69.2-77.7) 65.3 (60.9-70.0) 116 (105-127) 200 (178-215) 280 (221-336) 1702 
Gender        
Males 11-12 65.9 (61.8-70.3) 58.2 (54.6-61.2) 104 (96.9-113) 181 (159-202) 248 (192-385) 1256 
Females 11-12 72.5 (66.9-78.6) 67.9 (62.7-73.4) 108 (94.7-125) 187 (165-206) 248 (213-293) 1231 
Race/ethnicity        
Mexican Americans 11-12 63.3 (53.1-75.4) 55.2 (47.3-66.7) 93.2 (78.0-108) 173 (116-237) 243 (166-600) 317 
Non-Hispanic blacks 11-12 61.4 (56.1-67.1) 59.2 (52.6-65.4) 90.8 (84.4-98.9) 162 (124-192) 227 (187-272) 663 
Non-Hispanic whites 11-12 70.9 (67.0-74.9) 64.0 (59.3-68.8) 110 (101-120) 187 (167-203) 248 (206-293) 810 
All Hispanics 11-12 69.6 (61.1-79.3) 61.2 (53.1-70.4) 104 (91.3-123) 180 (144-237) 256 (202-455) 573 
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(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 01-02 105 (92.5-118) 105 (92.0-118) 200 (179-225) 401 (336-480) 649 (542-747) 2741 
 03-04 115 (104-128) 118 (107-129) 219 (201-237) 424 (351-487) 647 (509-788) 2426 
 05-06 103 (96.1-109) 99.8 (90.3-107) 200 (185-210) 399 (365-429) 593 (463-746) 2448 
 07-08 97.6 (91.6-104) 97.8 (90.9-106) 178 (164-195) 319 (283-353) 490 (426-557) 2601 
 09-10 71.7 (67.1-76.7) 71.0 (67.0-76.0) 130 (121-140) 248 (225-265) 354 (303-412) 2746 
Age group        
6-11 years 01-02 105 (91.1-122) 109 (82.0-138) 195 (160-231) 298 (245-346) 412 (319-545) 387 
 03-04 116 (99.9-134) 107 (93.0-135) 205 (170-223) 333 (241-435) 472 (322-881) 325 
 05-06 89.6 (79.6-101) 84.0 (72.6-103) 154 (123-176) 245 (193-316) 316 (245-569) 345 
 07-08 100 (85.9-117) 102 (83.4-126) 175 (144-183) 251 (194-328) 348 (239-862) 389 
 09-10 66.2 (58.1-75.4) 69.0 (60.0-75.0) 110 (98.0-126) 198 (145-229) 285 (198-417) 416 
12-19 years 01-02 104 (87.3-125) 107 (90.0-122) 201 (165-231) 329 (255-445) 459 (331-631) 733 
 03-04 120 (103-141) 127 (107-149) 221 (195-262) 366 (327-424) 564 (391-730) 677 
 05-06 105 (96.5-113) 104 (97.3-116) 193 (166-217) 323 (275-383) 453 (377-604) 676 
 07-08 103 (92.9-114) 103 (89.5-116) 173 (146-195) 293 (246-352) 371 (323-436) 401 
 09-10 77.5 (67.2-89.3) 75.0 (65.0-85.0) 136 (115-168) 237 (184-315) 320 (243-452) 420 
20 years and older 01-02 105 (91.7-119) 105 (89.0-118) 201 (180-231) 433 (366-515) 683 (597-806) 1621 
 03-04 114 (103-128) 118 (105-130) 221 (203-243) 450 (353-505) 696 (511-885) 1424 
 05-06 104 (95.3-113) 101 (89.6-113) 206 (188-223) 419 (384-466) 657 (481-832) 1427 
 07-08 96.5 (89.3-104) 96.9 (87.3-106) 183 (163-201) 331 (285-393) 535 (432-624) 1811 
 09-10 71.5 (66.8-76.6) 71.0 (67.0-75.0) 131 (121-147) 250 (233-279) 370 (308-435) 1910 
Gender        
Males 01-02 122 (107-138) 117 (106-132) 224 (188-278) 474 (372-597) 734 (597-1010) 1344 
 03-04 137 (122-154) 135 (119-157) 251 (221-287) 487 (398-579) 754 (606-913) 1167 
 05-06 125 (114-137) 119 (107-136) 227 (204-261) 427 (395-491) 768 (520-951) 1222 
 07-08 117 (109-127) 115 (103-130) 209 (191-229) 352 (322-390) 557 (462-674) 1290 
 09-10 82.6 (76.0-89.7) 79.0 (73.0-85.0) 147 (126-169) 263 (242-302) 412 (344-466) 1399 
Females 01-02 90.8 (77.7-106) 93.0 (80.0-108) 184 (155-207) 328 (291-399) 518 (434-649) 1397 
 03-04 97.7 (86.5-110) 100 (86.6-114) 193 (170-210) 351 (287-445) 531 (447-647) 1259 
 05-06 84.6 (75.6-94.5) 82.4 (73.1-92.5) 159 (143-176) 363 (285-404) 480 (421-577) 1226 
 07-08 81.9 (76.8-87.3) 81.7 (74.7-91.0) 148 (134-173) 272 (237-326) 439 (355-501) 1311 
 09-10 62.7 (57.9-67.8) 64.0 (58.0-69.0) 119 (109-131) 223 (189-253) 311 (255-379) 1347 
Limit of detection (LOD, see Data Analysis section) for Survey years 01-02, 03-04, 05-06,07-08, and 09-10 are 3.6, 5.0, 5.0,5.0, and 10.0 respectively. 
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(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 01-02 83.5 (64.1-109) 84.0 (64.0-111) 144 (117-198) 259 (193-430) 454 (253-1140) 664 
 03-04 92.7 (81.3-106) 92.8 (84.1-111) 164 (133-204) 317 (236-374) 436 (338-501) 576 
 05-06 77.0 (64.1-92.5) 74.8 (60.0-90.8) 138 (110-162) 260 (191-312) 366 (299-471) 620 
 07-08 79.1 (71.4-87.7) 75.3 (66.4-85.2) 133 (118-154) 250 (176-330) 414 (302-511) 529 
 09-10 56.9 (50.7-63.8) 54.0 (45.0-63.0) 96.0 (79.0-114) 193 (145-244) 317 (240-484) 566 
Non-Hispanic blacks 01-02 145 (122-172) 135 (120-163) 281 (228-346) 516 (414-684) 957 (609-1410) 690 
 03-04 167 (141-198) 160 (136-198) 315 (243-414) 548 (457-688) 870 (590-1220) 668 
 05-06 138 (120-159) 125 (113-147) 260 (211-329) 466 (365-671) 716 (491-1100) 658 
 07-08 129 (115-145) 129 (112-148) 237 (205-266) 427 (349-514) 657 (514-839) 596 
 09-10 103 (89.1-118) 110 (94.0-123) 196 (168-220) 310 (248-422) 456 (368-544) 517 
Non-Hispanic whites 01-02 104 (90.8-120) 106 (92.0-120) 199 (177-224) 401 (331-495) 649 (518-747) 1204 
 03-04 114 (100-129) 117 (104-128) 220 (201-235) 443 (333-511) 702 (505-915) 1000 
 05-06 101 (93.6-110) 101 (89.3-112) 200 (181-213) 402 (368-434) 657 (449-829) 982 
 07-08 97.0 (87.7-107) 97.9 (87.3-111) 179 (155-202) 315 (270-355) 468 (371-590) 1077 
 09-10 69.6 (63.3-76.5) 70.0 (65.0-75.0) 121 (110-137) 235 (203-263) 322 (255-410) 1203 
Limit of detection (LOD, see Data Analysis section) for Survey years 01-02, 03-04, 05-06,07-08, and 09-10 are 3.6, 5.0, 5.0,5.0, and 10.0 respectively. 
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(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 61.9 (57.2-67.0) 62.0 (57.0-66.0) 127 (115-136) 235 (201-280) 377 (289-479) 2491 
Age group        
6-11 years 11-12 55.3 (48.4-63.2) 60.0 (48.0-73.0) 104 (92.0-122) 192 (169-248) 287 (214-413) 397 
12-19 years 11-12 63.6 (55.1-73.5) 65.0 (57.0-76.0) 125 (115-144) 198 (169-235) 296 (200-389) 389 
20 years and older 11-12 62.4 (57.2-68.1) 61.0 (54.0-67.0) 130 (111-144) 251 (206-296) 413 (295-499) 1705 
Gender        
Males 11-12 72.3 (63.9-81.7) 68.0 (60.0-78.0) 145 (127-168) 273 (205-392) 475 (296-651) 1258 
Females 11-12 53.4 (48.3-59.0) 55.0 (48.0-59.0) 105 (93.0-126) 207 (175-235) 297 (251-364) 1233 
Race/ethnicity        
Mexican Americans 11-12 54.8 (42.1-71.2) 54.0 (46.0-69.0) 103 (79.0-139) 197 (128-364) 308 (139-1270) 317 
Non-Hispanic blacks 11-12 92.6 (84.3-102) 98.0 (84.0-105) 185 (164-202) 348 (261-441) 519 (428-611) 664 
Non-Hispanic whites 11-12 58.2 (54.3-62.4) 58.0 (50.0-64.0) 119 (102-132) 221 (184-265) 325 (265-475) 813 
All Hispanics 11-12 61.3 (51.2-73.3) 61.0 (54.0-72.0) 123 (101-149) 230 (172-308) 377 (244-452) 573 
Asians 11-12 50.0 (39.8-62.9) 47.0 (37.0-59.0) 106 (69.0-141) 213 (136-278) 282 (215-400) 352 
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Metabolite of Phenanthrene 
Geometric mean and selected percentiles of urine concentrations (in ng/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 01-02 98.0 (87.4-110) 86.5 (78.8-97.1) 158 (142-174) 299 (252-342) 428 (365-621) 2741 
 03-04 108 (101-115) 99.5 (91.9-106) 172 (158-189) 321 (273-363) 497 (406-566) 2426 
 05-06 99.5 (93.6-106) 88.1 (83.8-93.5) 164 (151-175) 326 (273-364) 443 (402-525) 2448 
 07-08 98.1 (91.3-106) 91.3 (81.8-100) 159 (141-174) 273 (246-301) 380 (333-442) 2601 
 09-10 74.9 (71.8-78.1) 68.4 (63.8-73.1) 114 (110-118) 207 (192-224) 281 (257-326) 2746 
Age group        
6-11 years 01-02 118 (103-135) 114 (94.9-131) 173 (150-201) 289 (238-368) 410 (308-544) 387 
 03-04 124 (110-138) 119 (110-129) 165 (145-202) 283 (231-402) 484 (269-710) 325 
 05-06 99.6 (89.4-111) 93.5 (85.7-107) 146 (118-165) 232 (171-292) 292 (232-352) 345 
 07-08 123 (107-142) 120 (105-143) 183 (159-200) 230 (201-382) 382 (222-948) 389 
 09-10 86.3 (77.7-95.9) 77.9 (69.6-90.6) 129 (110-136) 194 (161-252) 290 (193-484) 416 
12-19 years 01-02 81.1 (70.1-93.8) 78.0 (66.7-89.4) 116 (96.5-144) 205 (153-275) 283 (198-511) 733 
 03-04 90.3 (81.5-100) 84.9 (76.1-93.9) 139 (116-160) 212 (193-231) 295 (225-429) 677 
 05-06 78.2 (70.9-86.3) 72.5 (66.7-82.1) 111 (98.8-121) 183 (141-262) 291 (211-465) 676 
 07-08 80.0 (73.6-86.9) 74.4 (67.0-87.5) 117 (110-126) 188 (151-223) 243 (213-284) 401 
 09-10 62.3 (57.4-67.6) 60.5 (55.7-64.1) 88.8 (78.2-98.0) 123 (105-182) 190 (124-228) 420 
20 years and older 01-02 98.9 (88.3-111) 85.3 (78.3-96.6) 164 (147-183) 320 (273-356) 488 (379-774) 1621 
 03-04 109 (102-117) 99.1 (91.7-106) 180 (161-198) 343 (282-385) 523 (417-608) 1424 
 05-06 103 (96.3-111) 90.3 (84.4-97.8) 177 (161-200) 350 (319-387) 506 (426-538) 1427 
 07-08 98.8 (91.2-107) 90.3 (80.2-100) 163 (140-184) 290 (262-321) 388 (338-464) 1811 
 09-10 75.8 (72.4-79.3) 69.0 (63.6-73.6) 118 (113-124) 220 (200-239) 297 (260-341) 1910 
Gender        
Males 01-02 98.6 (87.7-111) 87.1 (79.5-98.2) 159 (138-188) 310 (245-368) 505 (356-761) 1344 
 03-04 107 (98.2-116) 99.2 (87.4-109) 169 (154-184) 305 (261-343) 491 (383-592) 1167 
 05-06 100 (92.6-109) 89.2 (81.5-97.0) 166 (147-184) 326 (260-365) 430 (364-553) 1222 
 07-08 98.9 (91.2-107) 91.3 (81.3-101) 166 (146-184) 288 (263-310) 382 (321-449) 1290 
 09-10 74.1 (69.7-78.8) 66.4 (59.5-73.8) 117 (108-126) 217 (193-234) 296 (245-351) 1399 
Females 01-02 97.5 (84.9-112) 86.4 (76.9-100) 158 (139-178) 292 (245-333) 410 (352-583) 1397 
 03-04 109 (99.6-119) 100 (88.9-110) 176 (155-202) 328 (265-398) 497 (380-594) 1259 
 05-06 98.7 (91.6-106) 87.3 (80.4-95.1) 160 (144-177) 332 (284-375) 446 (393-518) 1226 
 07-08 97.4 (89.6-106) 90.9 (79.4-102) 150 (131-181) 262 (223-305) 377 (299-446) 1311 
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Metabolite of Phenanthrene 
Geometric mean and selected percentiles of urine concentrations (in ng/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 01-02 78.2 (62.4-98.0) 70.8 (56.2-87.4) 130 (92.9-171) 224 (173-321) 333 (224-656) 664 
 03-04 83.8 (75.1-93.6) 79.5 (72.9-87.0) 137 (111-165) 224 (188-274) 305 (247-406) 576 
 05-06 68.8 (61.0-77.7) 61.3 (51.5-73.2) 96.9 (82.9-122) 175 (159-206) 291 (200-387) 620 
 07-08 77.1 (68.5-86.7) 71.6 (63.1-78.8) 113 (99.6-133) 200 (160-227) 275 (230-334) 529 
 09-10 56.5 (49.6-64.3) 48.4 (42.7-57.0) 82.4 (67.4-97.4) 170 (119-252) 265 (201-417) 566 
Non-Hispanic blacks 01-02 102 (85.8-122) 91.9 (79.8-108) 160 (133-202) 296 (234-475) 673 (347-1260) 690 
 03-04 117 (102-135) 106 (89.4-126) 186 (157-217) 346 (264-439) 530 (373-772) 668 
 05-06 97.0 (86.6-109) 85.7 (77.3-94.1) 141 (125-172) 271 (217-366) 443 (283-623) 658 
 07-08 101 (88.7-114) 91.3 (80.9-104) 176 (143-208) 297 (238-360) 411 (344-512) 596 
 09-10 74.3 (67.8-81.5) 69.4 (61.4-78.2) 122 (103-140) 194 (176-230) 264 (223-330) 517 
Non-Hispanic whites 01-02 103 (91.5-117) 89.4 (80.2-102) 167 (148-193) 324 (272-368) 447 (365-738) 1204 
 03-04 112 (104-121) 103 (97.2-108) 183 (161-200) 346 (276-402) 544 (417-690) 1000 
 05-06 106 (98.8-114) 93.6 (86.4-102) 178 (160-206) 348 (317-387) 506 (416-551) 982 
 07-08 101 (91.1-112) 96.5 (83.5-107) 163 (137-190) 280 (243-317) 378 (316-447) 1077 
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Urinary 3-Hydroxyphenanthrene (creatinine corrected) (2011 - 2012) 
Metabolite of Phenanthrene 
Geometric mean and selected percentiles of urine concentrations (in ng/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 70.5 (66.7-74.6) 62.6 (58.5-67.3) 118 (104-128) 226 (201-247) 325 (271-366) 2489 
Age group        
6-11 years 11-12 79.6 (71.8-88.3) 73.9 (65.0-84.2) 116 (100-131) 170 (140-220) 238 (168-383) 396 
12-19 years 11-12 61.5 (56.0-67.6) 55.7 (47.0-69.0) 89.0 (83.2-101) 150 (121-196) 229 (173-243) 389 
20 years and older 11-12 71.0 (66.9-75.4) 61.6 (58.3-67.0) 123 (110-139) 246 (209-258) 334 (278-409) 1704 
Gender        
Males 11-12 67.8 (61.9-74.2) 60.4 (52.2-68.5) 117 (99.1-130) 222 (188-246) 320 (243-474) 1257 
Females 11-12 73.2 (67.0-80.0) 64.2 (59.7-72.1) 120 (99.2-138) 238 (187-271) 325 (276-362) 1232 
Race/ethnicity        
Mexican Americans 11-12 61.6 (50.6-75.0) 54.2 (44.9-66.7) 91.4 (75.2-118) 204 (110-343) 303 (195-556) 317 
Non-Hispanic blacks 11-12 72.1 (66.5-78.1) 68.3 (60.5-77.5) 117 (106-134) 202 (163-245) 311 (239-388) 664 
Non-Hispanic whites 11-12 70.8 (66.7-75.2) 62.0 (56.8-67.4) 121 (105-131) 238 (200-254) 325 (258-383) 811 
All Hispanics 11-12 68.6 (60.2-78.1) 61.8 (54.3-73.2) 104 (88.1-126) 206 (150-291) 343 (225-500) 573 
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Urinary 4-Hydroxyphenanthrene (2003 – 2006)‡ 
Metabolite of Phenanthrene 
Geometric mean and selected percentiles of urine concentrations (in ng/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 25.1 (22.6-27.9) 25.9 (22.5-29.6) 53.7 (47.4-59.7) 96.8 (85.0-116) 152 (118-176) 2443 
 05-06 29.3 (26.7-32.2) 29.2 (25.1-31.8) 56.9 (50.1-66.1) 108 (93.1-124) 157 (134-176) 2131 
Age group        
6-11 years 03-04 25.2 (22.3-28.4) 26.3 (22.8-30.0) 45.7 (38.6-53.3) 95.5 (61.7-137) 138 (95.1-202) 321 
 05-06 20.4 (17.7-23.4) 20.2 (17.6-23.8) 35.1 (27.4-41.6) 59.6 (43.3-93.0) 96.1 (62.2-155) 307 
12-19 years 03-04 23.7 (20.3-27.6) 25.8 (20.5-31.4) 49.9 (45.2-53.0) 77.4 (67.2-95.1) 123 (94.6-142) 683 
 05-06 26.6 (23.0-30.8) 27.6 (22.4-31.2) 50.9 (43.5-56.8) 79.4 (71.1-89.9) 108 (89.9-140) 568 
20 years and older 03-04 25.3 (22.4-28.6) 25.8 (22.4-29.5) 54.8 (48.6-61.9) 101 (87.1-120) 163 (117-197) 1439 
 05-06 31.1 (28.1-34.3) 30.7 (26.4-33.7) 62.9 (52.6-75.1) 119 (97.1-140) 165 (138-188) 1256 
Gender        
Males 03-04 30.0 (26.5-34.0) 29.6 (25.5-35.1) 60.4 (53.4-68.7) 110 (90.6-130) 169 (118-211) 1180 
 05-06 31.9 (28.6-35.5) 30.7 (25.0-36.8) 60.3 (49.7-72.7) 111 (92.3-134) 153 (119-226) 1064 
Females 03-04 21.1 (18.7-23.8) 21.3 (18.3-25.3) 46.5 (41.6-53.3) 88.4 (73.5-103) 136 (106-157) 1263 
 05-06 27.1 (23.4-31.4) 26.6 (22.7-31.1) 54.0 (41.9-66.9) 107 (82.6-140) 165 (120-189) 1067 
Race/ethnicity        
Mexican Americans 03-04 23.5 (20.9-26.3) 24.4 (21.4-29.4) 46.1 (40.1-53.0) 80.5 (60.9-94.1) 99.7 (80.2-154) 607 
 05-06 24.5 (20.3-29.6) 24.8 (20.2-31.3) 43.7 (37.2-54.5) 81.2 (62.8-94.4) 112 (82.6-134) 466 
Non-Hispanic blacks 03-04 35.4 (29.6-42.3) 37.1 (29.8-46.1) 71.4 (60.3-83.3) 123 (104-145) 167 (133-215) 657 
 05-06 36.8 (31.8-42.5) 33.6 (29.7-42.0) 66.0 (56.0-80.5) 130 (98.0-168) 190 (133-276) 612 
Non-Hispanic whites 03-04 24.4 (21.5-27.7) 25.2 (21.8-29.1) 51.5 (45.1-58.5) 97.9 (77.4-127) 163 (113-202) 1021 
 05-06 28.6 (25.2-32.4) 28.6 (24.5-31.9) 55.5 (47.3-69.3) 108 (90.9-136) 163 (134-188) 890 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04 and 05-06 are 5.0 and 5.0 respectively. 
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Urinary 4-Hydroxyphenanthrene (2011 - 2012) 
Metabolite of Phenanthrene 
Geometric mean and selected percentiles of urine concentrations (in ng/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 20.5 (19.3-21.8) 19.0 (18.0-21.0) 36.0 (34.0-40.0) 74.0 (62.0-82.0) 99.0 (88.0-114) 2487 
Age group        
6-11 years 11-12 17.1 (15.6-18.8) 16.0 (13.0-19.0) 32.0 (25.0-37.0) 54.0 (46.0-59.0) 72.0 (56.0-96.0) 397 
12-19 years 11-12 20.4 (18.1-23.0) 18.0 (17.0-23.0) 34.0 (31.0-42.0) 57.0 (47.0-75.0) 84.0 (57.0-120) 389 
20 years and older 11-12 21.0 (19.6-22.4) 20.0 (18.0-21.0) 38.0 (35.0-42.0) 78.0 (69.0-87.0) 101 (89.0-128) 1701 
Gender        
Males 11-12 21.6 (19.8-23.7) 22.0 (18.0-24.0) 38.0 (34.0-43.0) 74.0 (63.0-83.0) 99.0 (85.0-124) 1255 
Females 11-12 19.5 (18.1-21.1) 18.0 (16.0-19.0) 36.0 (33.0-40.0) 74.0 (59.0-82.0) 98.0 (87.0-114) 1232 
Race/ethnicity        
Mexican Americans 11-12 19.7 (16.2-24.0) 18.0 (15.0-22.0) 34.0 (27.0-45.0) 65.0 (40.0-96.0) 91.0 (53.0-130) 317 
Non-Hispanic blacks 11-12 28.4 (26.0-31.0) 28.0 (25.0-31.0) 50.0 (44.0-57.0) 90.0 (75.0-109) 122 (103-136) 662 
Non-Hispanic whites 11-12 19.4 (18.3-20.5) 18.0 (16.0-20.0) 35.0 (32.0-38.0) 73.0 (57.0-81.0) 94.0 (82.0-114) 812 
All Hispanics 11-12 21.0 (18.5-23.8) 20.0 (17.0-23.0) 38.0 (32.0-46.0) 68.0 (52.0-88.0) 91.0 (69.0-122) 573 
Asians 11-12 16.8 (14.7-19.1) 15.0 (13.0-17.0) 30.0 (25.0-33.0) 55.0 (37.0-86.0) 91.0 (53.0-110) 351 
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Urinary 4-Hydroxyphenanthrene (creatinine corrected) (2003 – 2006)‡ 
Metabolite of Phenanthrene 
Geometric mean and selected percentiles of urine concentrations (in ng/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 23.3 (21.7-25.0) 22.7 (20.5-24.9) 42.0 (38.6-44.6) 74.3 (66.3-85.4) 114 (102-130) 2443 
 05-06 28.9 (26.6-31.4) 26.9 (24.1-29.4) 48.4 (43.9-53.7) 88.3 (77.5-102) 127 (106-145) 2131 
Age group        
6-11 years 03-04 26.3 (23.7-29.2) 24.8 (21.6-28.6) 43.3 (35.2-48.8) 72.9 (56.3-113) 126 (79.3-173) 321 
 05-06 22.9 (19.8-26.5) 21.7 (20.0-24.8) 36.2 (27.8-43.7) 50.0 (42.7-79.3) 79.3 (50.0-98.3) 307 
12-19 years 03-04 17.7 (15.9-19.8) 16.7 (15.7-18.4) 31.4 (26.0-37.1) 47.9 (40.7-54.1) 61.7 (51.7-86.0) 683 
 05-06 20.1 (18.2-22.2) 19.0 (16.5-22.9) 30.0 (28.3-33.0) 48.7 (41.0-63.5) 79.4 (53.8-98.2) 568 
20 years and older 03-04 24.0 (22.0-26.2) 23.3 (21.1-25.4) 43.5 (39.4-48.1) 79.0 (66.8-100) 121 (104-138) 1439 
 05-06 31.4 (29.0-34.1) 29.4 (26.9-32.4) 54.6 (48.0-61.6) 102 (86.4-109) 139 (115-166) 1256 
Gender        
Males 03-04 23.4 (21.6-25.4) 22.7 (20.3-24.9) 40.9 (35.9-45.7) 72.7 (61.5-86.8) 112 (100-126) 1180 
 05-06 26.1 (23.8-28.7) 24.1 (22.2-28.2) 44.3 (40.0-51.1) 74.3 (61.6-87.7) 102 (87.3-120) 1064 
Females 03-04 23.2 (21.2-25.5) 22.8 (19.7-26.0) 42.5 (38.3-46.2) 75.1 (63.4-94.0) 119 (93.1-139) 1263 
 05-06 31.8 (28.7-35.3) 28.9 (25.8-31.8) 54.2 (46.0-63.2) 103 (85.4-127) 145 (119-174) 1067 
Race/ethnicity        
Mexican Americans 03-04 21.2 (18.8-23.8) 20.7 (19.1-22.9) 35.9 (29.8-40.7) 59.0 (43.3-87.5) 83.4 (60.9-139) 607 
 05-06 22.5 (20.1-25.3) 21.6 (18.8-27.1) 34.7 (31.4-41.5) 54.5 (48.2-61.6) 81.3 (59.8-86.1) 466 
Non-Hispanic blacks 03-04 25.0 (21.6-28.9) 25.3 (23.1-28.8) 42.0 (37.4-51.4) 75.0 (61.6-87.9) 102 (79.2-137) 657 
 05-06 25.8 (23.0-29.0) 24.5 (22.0-26.8) 39.4 (36.2-44.7) 68.5 (59.8-88.6) 103 (80.0-146) 612 
Non-Hispanic whites 03-04 23.7 (21.5-26.2) 22.4 (19.4-25.4) 43.6 (38.8-47.3) 82.2 (68.5-101) 126 (103-143) 1021 
 05-06 30.5 (27.3-34.1) 28.5 (25.0-31.6) 53.0 (45.5-61.5) 102 (83.0-115) 138 (112-174) 890 
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Urinary 4-Hydroxyphenanthrene (creatinine corrected) (2011 - 2012) 
Metabolite of Phenanthrene 
Geometric mean and selected percentiles of urine concentrations (in ng/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 23.3 (22.4-24.2) 22.0 (20.9-22.9) 36.9 (33.8-40.0) 65.0 (60.0-76.3) 106 (85.9-121) 2485 
Age group        
6-11 years 11-12 24.4 (22.1-26.9) 23.7 (21.5-25.9) 36.2 (31.9-39.1) 55.0 (47.9-69.7) 78.9 (57.1-126) 396 
12-19 years 11-12 19.7 (17.7-21.9) 19.7 (17.2-21.7) 28.4 (26.3-34.7) 46.6 (38.5-57.9) 64.9 (46.1-78.9) 389 
20 years and older 11-12 23.8 (22.6-25.0) 22.1 (20.9-23.3) 38.4 (34.2-43.8) 70.5 (60.0-88.8) 115 (91.4-136) 1700 
Gender        
Males 11-12 20.3 (19.3-21.4) 19.4 (18.5-20.6) 31.4 (28.4-35.4) 57.7 (53.3-63.8) 79.6 (63.8-111) 1254 
Females 11-12 26.6 (24.9-28.5) 24.5 (22.9-26.2) 41.8 (37.4-46.6) 78.9 (66.7-88.8) 117 (95.7-142) 1231 
Race/ethnicity        
Mexican Americans 11-12 22.2 (19.1-25.8) 20.9 (19.2-23.6) 35.5 (29.6-42.1) 59.7 (43.2-67.6) 67.6 (48.0-183) 317 
Non-Hispanic blacks 11-12 22.1 (20.3-24.0) 21.3 (19.7-23.4) 34.9 (30.8-38.8) 53.5 (49.0-61.3) 74.5 (63.7-84.7) 662 
Non-Hispanic whites 11-12 23.5 (22.1-24.9) 22.0 (20.3-23.4) 37.3 (32.3-43.7) 70.5 (60.0-81.6) 111 (88.8-142) 810 
All Hispanics 11-12 23.5 (21.2-25.9) 22.9 (20.7-25.5) 37.4 (33.0-41.8) 60.1 (45.5-79.6) 90.7 (60.1-133) 573 
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Urinary 1-Hydroxypyrene (2003 – 2010) 
Metabolite of Pyrene 
Geometric mean and selected percentiles of urine concentrations (in ng/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 89.2 (79.8-99.7) 91.3 (83.5-98.8) 189 (168-208) 389 (345-459) 569 (493-676) 2515 
 05-06 98.3 (91.0-106) 94.0 (85.5-102) 206 (181-227) 440 (373-521) 673 (585-829) 2415 
 07-08 118 (108-129) 118 (107-133) 233 (208-263) 439 (392-487) 675 (543-844) 2581 
 09-10 119 (110-130) 118 (109-129) 231 (213-251) 451 (401-509) 675 (580-822) 2746 
Age group        
6-11 years 03-04 112 (96.9-130) 119 (99.0-143) 193 (163-229) 351 (233-484) 514 (336-680) 333 
 05-06 103 (91.3-117) 99.8 (91.7-105) 170 (139-206) 342 (222-413) 469 (353-786) 342 
 07-08 146 (127-168) 149 (131-171) 231 (203-288) 395 (293-557) 569 (395-1060) 387 
 09-10 147 (125-174) 143 (127-164) 245 (203-312) 443 (312-681) 756 (383-2410) 415 
12-19 years 03-04 119 (103-137) 115 (98.0-145) 244 (213-274) 506 (359-608) 705 (636-788) 705 
 05-06 118 (104-134) 108 (93.2-132) 218 (179-266) 409 (332-557) 837 (481-992) 667 
 07-08 149 (130-170) 145 (118-165) 282 (228-343) 452 (399-515) 614 (476-843) 401 
 09-10 152 (132-174) 156 (130-175) 280 (237-305) 414 (348-543) 642 (452-910) 420 
20 years and older 03-04 82.8 (73.0-93.8) 83.8 (75.6-92.4) 177 (155-203) 387 (337-437) 553 (483-644) 1477 
 05-06 94.9 (86.3-104) 89.1 (79.8-100) 208 (173-245) 476 (368-563) 677 (563-913) 1406 
 07-08 111 (100-123) 114 (95.7-129) 226 (199-258) 446 (370-506) 719 (525-904) 1793 
 09-10 113 (103-122) 110 (103-119) 222 (199-244) 452 (401-531) 674 (559-837) 1911 
Gender        
Males 03-04 108 (96.0-122) 111 (98.7-121) 227 (197-265) 459 (387-518) 644 (526-811) 1214 
 05-06 114 (104-125) 108 (98.4-119) 235 (196-279) 465 (386-585) 793 (634-980) 1208 
 07-08 134 (120-150) 131 (113-155) 260 (229-293) 474 (409-560) 748 (554-956) 1279 
 09-10 128 (114-143) 128 (114-141) 230 (205-251) 465 (393-555) 713 (559-923) 1398 
Females 03-04 74.0 (64.3-85.1) 75.3 (66.3-83.9) 158 (143-173) 334 (258-407) 502 (389-604) 1301 
 05-06 84.8 (74.5-96.5) 80.0 (69.8-89.9) 173 (148-213) 421 (313-521) 617 (534-677) 1207 
 07-08 105 (94.7-116) 111 (92.6-123) 213 (194-227) 387 (342-444) 580 (486-769) 1302 
 09-10 112 (101-125) 109 (98.0-124) 231 (209-260) 425 (390-495) 652 (566-780) 1348 
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Urinary 1-Hydroxypyrene (2003 – 2010) 
Metabolite of Pyrene 
Geometric mean and selected percentiles of urine concentrations (in ng/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 03-04 89.4 (78.6-102) 92.4 (79.8-113) 173 (153-191) 331 (281-415) 495 (404-548) 623 
 05-06 95.6 (81.0-113) 92.3 (80.1-112) 179 (149-220) 332 (261-455) 490 (367-756) 611 
 07-08 119 (110-129) 117 (104-132) 196 (170-230) 380 (289-494) 593 (485-755) 531 
 09-10 134 (122-147) 134 (116-154) 245 (198-314) 453 (392-591) 706 (551-975) 566 
Non-Hispanic blacks 03-04 128 (105-157) 127 (111-157) 296 (226-356) 552 (399-669) 702 (569-935) 663 
 05-06 116 (98.5-137) 108 (91.0-124) 230 (185-332) 517 (401-639) 743 (559-1060) 653 
 07-08 136 (122-153) 142 (122-160) 282 (250-320) 548 (480-610) 752 (617-871) 592 
 09-10 165 (146-188) 170 (142-201) 321 (280-392) 656 (557-727) 989 (727-1370) 516 
Non-Hispanic whites 03-04 84.6 (73.3-97.8) 85.2 (75.2-97.4) 182 (156-213) 386 (336-463) 566 (464-748) 1040 
 05-06 94.9 (85.4-106) 91.3 (80.3-104) 203 (170-235) 399 (351-538) 677 (563-899) 968 
 07-08 116 (102-131) 117 (102-136) 235 (198-287) 436 (364-500) 719 (473-981) 1059 
 09-10 108 (96.3-122) 107 (99.0-118) 209 (176-239) 398 (329-474) 603 (495-739) 1203 
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Urinary 1-Hydroxypyrene (2011 - 2012) 
Metabolite of Pyrene 
Geometric mean and selected percentiles of urine concentrations (in ng/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 111 (101-123) 113 (99.0-124) 217 (196-254) 437 (373-501) 635 (538-784) 2487 
Age group        
6-11 years 11-12 130 (111-153) 127 (107-160) 252 (202-301) 386 (362-462) 521 (431-693) 397 
12-19 years 11-12 131 (110-156) 141 (117-159) 247 (199-331) 451 (331-547) 555 (454-716) 387 
20 years and older 11-12 107 (96.2-119) 104 (95.0-118) 208 (181-244) 443 (373-504) 685 (543-882) 1703 
Gender        
Males 11-12 122 (107-139) 121 (103-131) 231 (198-276) 494 (380-606) 756 (547-1020) 1255 
Females 11-12 102 (92.6-113) 104 (92.0-117) 209 (183-243) 384 (340-447) 543 (443-652) 1232 
Race/ethnicity        
Mexican Americans 11-12 127 (104-157) 129 (112-157) 225 (191-262) 435 (262-685) 685 (342-1060) 316 
Non-Hispanic blacks 11-12 140 (123-160) 138 (117-168) 292 (246-335) 476 (384-685) 779 (596-1070) 662 
Non-Hispanic whites 11-12 104 (94.6-113) 102 (94.0-116) 199 (176-231) 447 (349-513) 606 (504-803) 812 
All Hispanics 11-12 131 (114-152) 136 (119-156) 248 (209-279) 416 (329-501) 654 (440-873) 572 
Asians 11-12 85.6 (72.3-101) 78.0 (65.0-94.0) 175 (124-218) 301 (243-359) 373 (325-571) 352 
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Urinary 1-Hydroxypyrene (creatinine corrected) (2003 – 2010) 
Metabolite of Pyrene 
Geometric mean and selected percentiles of urine concentrations (in ng/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 83.4 (77.4-90.0) 79.9 (72.6-86.9) 149 (133-167) 279 (236-343) 424 (352-474) 2515 
 05-06 95.1 (89.1-102) 85.5 (81.0-91.1) 173 (161-184) 338 (292-371) 492 (427-550) 2415 
 07-08 119 (110-129) 113 (103-127) 200 (180-224) 364 (321-411) 527 (467-587) 2581 
 09-10 125 (116-134) 117 (109-126) 202 (187-222) 366 (337-401) 530 (485-583) 2746 
Age group        
6-11 years 03-04 119 (102-138) 112 (98.2-137) 185 (156-225) 336 (227-440) 475 (336-566) 333 
 05-06 115 (102-128) 105 (94.7-116) 181 (145-217) 285 (242-385) 407 (308-517) 342 
 07-08 180 (156-206) 171 (145-197) 255 (233-316) 457 (329-593) 604 (457-1320) 387 
 09-10 192 (164-225) 181 (161-203) 283 (232-355) 471 (356-836) 812 (405-2030) 415 
12-19 years 03-04 89.4 (77.7-103) 81.5 (74.3-93.0) 146 (123-187) 269 (196-364) 364 (251-611) 705 
 05-06 88.7 (78.7-99.9) 80.9 (73.8-92.3) 146 (115-176) 250 (199-358) 400 (252-682) 667 
 07-08 116 (105-127) 112 (98.3-127) 178 (154-202) 301 (245-349) 405 (321-558) 401 
 09-10 122 (111-133) 121 (108-133) 176 (155-198) 262 (211-337) 371 (280-421) 420 
20 years and older 03-04 79.1 (73.2-85.4) 73.5 (66.7-82.3) 142 (127-160) 278 (236-331) 424 (349-472) 1477 
 05-06 94.1 (87.1-102) 82.5 (75.8-89.3) 177 (163-194) 352 (294-397) 502 (444-558) 1406 
 07-08 114 (105-125) 106 (95.3-124) 194 (173-217) 364 (317-415) 510 (456-591) 1793 
 09-10 119 (111-128) 109 (104-118) 199 (178-220) 365 (336-407) 530 (481-606) 1911 
Gender        
Males 03-04 84.8 (77.3-93.1) 82.8 (72.7-91.0) 163 (145-175) 290 (241-352) 416 (353-513) 1214 
 05-06 91.6 (84.3-99.6) 84.6 (76.9-95.5) 169 (152-182) 308 (268-364) 492 (426-589) 1208 
 07-08 113 (102-125) 109 (94.3-124) 193 (176-214) 379 (308-440) 549 (456-629) 1279 
 09-10 115 (104-126) 105 (93.9-116) 184 (168-205) 362 (317-419) 546 (452-708) 1398 
Females 03-04 82.1 (73.5-91.7) 78.3 (69.2-86.8) 137 (119-169) 274 (215-350) 440 (313-479) 1301 
 05-06 98.7 (91.7-106) 86.8 (78.5-92.8) 175 (156-195) 345 (295-390) 482 (395-558) 1207 
 07-08 125 (114-137) 119 (104-135) 203 (179-238) 348 (302-405) 503 (425-619) 1302 
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Urinary 1-Hydroxypyrene (creatinine corrected) (2003 – 2010) 
Metabolite of Pyrene 
Geometric mean and selected percentiles of urine concentrations (in ng/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 03-04 81.2 (73.9-89.2) 80.9 (70.4-91.7) 146 (122-167) 247 (221-301) 372 (321-460) 623 
 05-06 84.9 (76.4-94.2) 78.4 (67.7-91.2) 132 (118-145) 237 (203-287) 374 (279-482) 611 
 07-08 116 (107-125) 105 (96.5-116) 173 (156-188) 296 (250-367) 501 (395-629) 531 
 09-10 133 (118-150) 119 (105-140) 216 (178-266) 388 (295-527) 643 (464-1180) 566 
Non-Hispanic blacks 03-04 90.7 (77.3-106) 92.6 (76.6-106) 171 (140-211) 325 (226-433) 451 (301-680) 663 
 05-06 81.2 (70.7-93.2) 74.9 (65.6-84.8) 140 (113-173) 295 (206-403) 477 (324-643) 653 
 07-08 106 (93.1-121) 104 (93.4-123) 201 (162-249) 352 (302-464) 537 (384-662) 592 
 09-10 120 (109-131) 115 (103-123) 206 (185-226) 390 (323-476) 567 (471-757) 516 
Non-Hispanic whites 03-04 83.1 (75.1-91.9) 76.3 (69.0-86.6) 146 (127-174) 285 (238-360) 438 (360-506) 1040 
 05-06 99.3 (91.2-108) 90.6 (82.2-99.5) 188 (169-200) 358 (305-395) 495 (427-555) 968 
 07-08 120 (108-134) 113 (97.7-135) 206 (178-237) 379 (300-438) 510 (438-617) 1059 
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Urinary 1-Hydroxypyrene (creatinine corrected) (2011 - 2012) 
Metabolite of Pyrene 
Geometric mean and selected percentiles of urine concentrations (in ng/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 127 (119-137) 119 (110-128) 215 (193-241) 395 (356-449) 542 (464-703) 2485 
Age group        
6-11 years 11-12 187 (165-212) 181 (153-213) 276 (232-317) 415 (356-477) 500 (450-671) 396 
12-19 years 11-12 126 (110-144) 121 (102-143) 194 (156-256) 313 (252-396) 409 (325-480) 387 
20 years and older 11-12 122 (114-131) 112 (103-122) 207 (189-227) 411 (356-464) 589 (466-793) 1702 
Gender        
Males 11-12 114 (103-127) 106 (95.0-115) 196 (170-230) 378 (296-452) 506 (394-804) 1254 
Females 11-12 141 (130-154) 133 (124-143) 232 (209-262) 422 (364-464) 589 (464-748) 1231 
Race/ethnicity        
Mexican Americans 11-12 143 (123-166) 136 (116-153) 225 (176-270) 385 (267-525) 512 (374-829) 316 
Non-Hispanic blacks 11-12 109 (94.8-126) 114 (95.2-138) 191 (166-233) 330 (276-396) 453 (411-556) 662 
Non-Hispanic whites 11-12 127 (117-138) 113 (104-126) 218 (192-249) 415 (356-465) 580 (464-793) 810 
All Hispanics 11-12 147 (133-162) 144 (127-158) 244 (200-262) 395 (295-458) 525 (436-600) 572 
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Urinary 1-Hydroxynaphthalene (1-Naphthol) (2003 – 2010) 
Metabolite of Naphthalene 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 2.68 (2.36-3.05) 2.26 (1.98-2.65) 7.66 (6.27-9.42) 18.5 (15.5-20.9) 26.1 (23.0-33.6) 2595 
 05-06 2.64 (2.39-2.92) 1.94 (1.69-2.24) 8.45 (7.05-9.98) 29.9 (23.2-37.1) 48.1 (41.3-65.6) 2385 
 07-08 2.58 (2.19-3.03) 1.98 (1.75-2.28) 6.87 (5.00-8.76) 17.2 (13.0-22.2) 29.2 (22.2-41.1) 2496 
 09-10 2.05 (1.88-2.25) 1.74 (1.57-1.91) 5.19 (4.29-6.20) 14.2 (12.1-16.7) 23.9 (20.9-27.6) 2747 
Age group        
6-11 years 03-04 1.54 (1.36-1.75) 1.33 (1.11-1.68) 2.79 (2.18-3.52) 5.78 (4.11-8.20) 10.5 (5.87-17.0) 340 
 05-06 1.19 (1.01-1.40) 1.03 (.775-1.29) 2.16 (1.70-2.73) 8.10 (3.87-10.7) 11.0 (7.29-44.1) 336 
 07-08 1.54 (1.28-1.85) 1.50 (1.22-1.68) 3.09 (2.17-3.80) 5.94 (4.16-9.29) 9.36 (4.68-14.3) 370 
 09-10 1.17 (1.03-1.34) 1.10 (.869-1.27) 2.31 (1.85-2.56) 5.38 (2.93-7.30) 7.77 (5.40-11.4) 416 
12-19 years 03-04 1.96 (1.68-2.28) 1.67 (1.50-1.97) 4.19 (3.10-5.40) 10.5 (8.43-14.3) 20.9 (13.5-26.1) 727 
 05-06 1.71 (1.49-1.96) 1.36 (1.11-1.70) 3.76 (3.11-4.37) 14.1 (9.09-23.5) 25.8 (12.4-46.2) 655 
 07-08 1.84 (1.49-2.26) 1.51 (1.19-2.01) 4.03 (2.55-5.75) 10.0 (6.70-13.5) 14.8 (12.0-21.3) 386 
 09-10 1.59 (1.18-2.15) 1.28 (.943-2.12) 3.94 (2.39-5.58) 9.24 (5.98-14.9) 17.0 (11.3-21.5) 420 
20 years and older 03-04 3.02 (2.58-3.52) 2.65 (2.20-3.20) 9.42 (7.32-11.5) 20.6 (16.5-23.4) 29.4 (23.4-37.4) 1528 
 05-06 3.10 (2.74-3.51) 2.33 (2.03-2.82) 10.5 (8.18-13.3) 34.5 (26.7-43.4) 55.1 (42.2-80.4) 1394 
 07-08 2.88 (2.37-3.49) 2.27 (1.83-2.80) 8.19 (6.01-10.7) 19.6 (15.0-25.5) 33.0 (23.6-54.9) 1740 
 09-10 2.27 (2.05-2.52) 1.91 (1.66-2.14) 6.19 (4.84-7.25) 16.1 (13.2-18.6) 26.3 (21.9-30.7) 1911 
Gender        
Males 03-04 3.17 (2.82-3.56) 2.84 (2.37-3.39) 8.79 (7.13-11.0) 19.6 (16.1-22.2) 25.8 (22.5-30.6) 1243 
 05-06 2.97 (2.63-3.35) 2.37 (1.98-2.97) 8.76 (7.14-10.7) 28.9 (21.7-33.0) 44.1 (36.0-52.3) 1197 
 07-08 2.94 (2.58-3.36) 2.37 (2.05-2.93) 7.75 (5.87-9.83) 15.9 (13.8-21.3) 28.2 (21.4-36.8) 1239 
 09-10 2.30 (2.03-2.61) 1.93 (1.63-2.20) 6.32 (4.32-7.67) 15.3 (12.8-17.8) 23.9 (21.6-27.6) 1399 
Females 03-04 2.29 (1.94-2.72) 1.85 (1.50-2.31) 6.38 (4.45-8.81) 17.9 (14.0-21.5) 28.5 (21.5-37.4) 1352 
 05-06 2.36 (2.01-2.77) 1.59 (1.42-1.82) 7.35 (5.57-10.2) 33.6 (21.6-43.9) 56.8 (41.6-101) 1188 
 07-08 2.27 (1.85-2.79) 1.58 (1.32-1.97) 5.26 (4.03-7.73) 17.7 (11.9-24.8) 32.0 (21.3-78.9) 1257 
 09-10 1.84 (1.60-2.12) 1.56 (1.39-1.72) 4.50 (3.65-5.34) 12.6 (10.2-16.6) 24.0 (17.7-31.5) 1348 
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Urinary 1-Hydroxynaphthalene (1-Naphthol) (2003 – 2010) 
Metabolite of Naphthalene 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 03-04 1.95 (1.73-2.19) 1.65 (1.37-2.04) 4.38 (3.52-5.30) 11.6 (9.04-15.5) 20.1 (14.9-22.5) 651 
 05-06 1.54 (1.30-1.83) 1.29 (1.09-1.55) 3.72 (2.68-4.43) 11.8 (8.10-15.6) 22.2 (15.2-34.0) 607 
 07-08 1.61 (1.38-1.89) 1.48 (1.23-1.66) 3.38 (2.58-4.04) 8.75 (6.12-11.9) 16.1 (8.19-29.4) 506 
 09-10 1.71 (1.43-2.04) 1.50 (1.36-1.80) 3.38 (2.55-5.27) 10.7 (6.93-14.3) 17.6 (13.7-23.3) 566 
Non-Hispanic blacks 03-04 3.36 (2.80-4.02) 2.65 (2.17-3.46) 7.80 (6.52-10.8) 21.9 (17.0-29.2) 35.4 (27.0-48.9) 677 
 05-06 3.42 (2.83-4.14) 2.67 (2.20-3.43) 11.9 (9.12-14.6) 29.9 (24.4-41.0) 56.4 (42.8-71.6) 641 
 07-08 2.88 (2.48-3.35) 2.41 (2.12-2.91) 8.15 (5.31-10.7) 19.3 (13.7-27.1) 31.6 (21.3-42.4) 574 
 09-10 3.06 (2.58-3.64) 3.04 (2.38-3.49) 9.21 (7.41-10.3) 19.3 (15.7-23.2) 29.6 (24.2-38.8) 517 
Non-Hispanic whites 03-04 2.78 (2.40-3.22) 2.29 (1.93-2.81) 8.63 (6.65-10.8) 19.8 (15.9-22.5) 27.1 (23.2-35.1) 1074 
 05-06 2.72 (2.30-3.21) 1.98 (1.56-2.43) 8.66 (6.73-11.3) 32.5 (22.6-42.2) 51.3 (41.0-85.5) 952 
 07-08 2.79 (2.23-3.50) 2.08 (1.74-2.69) 7.52 (4.97-10.4) 18.7 (12.6-26.9) 32.2 (22.5-62.0) 1022 
 09-10 2.00 (1.78-2.26) 1.70 (1.49-1.94) 4.77 (3.97-5.70) 13.2 (10.3-17.7) 23.9 (19.5-30.8) 1203 
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Urinary 1-Hydroxynaphthalene (1-Naphthol) (2011 - 2012) 
Metabolite of Naphthalene 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 1.67 (1.52-1.84) 1.41 (1.26-1.59) 3.90 (3.25-5.05) 13.1 (10.9-15.7) 22.1 (19.0-26.6) 2492 
Age group        
6-11 years 11-12 .960 (.803-1.15) .970 (.727-1.20) 2.01 (1.63-2.51) 4.02 (3.11-7.07) 7.99 (5.05-12.6) 397 
12-19 years 11-12 1.16 (.895-1.50) 1.04 (.843-1.33) 2.34 (1.77-3.34) 8.38 (3.43-15.0) 14.6 (8.38-22.4) 389 
20 years and older 11-12 1.88 (1.71-2.06) 1.59 (1.40-1.73) 5.05 (3.98-5.82) 14.7 (12.4-17.9) 23.7 (19.8-34.2) 1706 
Gender        
Males 11-12 1.89 (1.66-2.15) 1.62 (1.36-1.78) 4.57 (3.25-5.91) 13.5 (10.6-19.0) 22.9 (16.7-36.7) 1258 
Females 11-12 1.49 (1.20-1.84) 1.21 (.997-1.52) 3.51 (2.67-5.12) 12.9 (8.54-16.4) 21.1 (17.7-24.6) 1234 
Race/ethnicity        
Mexican Americans 11-12 1.27 (.962-1.68) 1.15 (.805-1.46) 2.92 (1.79-4.58) 7.97 (4.82-13.3) 14.2 (7.97-20.2) 317 
Non-Hispanic blacks 11-12 2.14 (1.85-2.47) 1.78 (1.51-2.01) 5.17 (3.73-6.71) 14.9 (11.2-19.5) 22.8 (16.8-42.9) 664 
Non-Hispanic whites 11-12 1.70 (1.53-1.90) 1.47 (1.28-1.65) 4.20 (3.15-5.43) 13.6 (10.9-17.4) 22.4 (17.7-33.4) 814 
All Hispanics 11-12 1.35 (1.12-1.64) 1.13 (.896-1.41) 3.17 (2.39-4.46) 9.30 (6.34-11.6) 16.1 (11.3-20.9) 573 
Asians 11-12 1.29 (1.01-1.66) 1.16 (.885-1.50) 3.00 (2.02-4.61) 8.61 (5.33-11.5) 15.5 (10.6-21.9) 352 
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Urinary 1-Hydroxynaphthalene (1-Naphthol) (creatinine corrected) (2003 – 2010) 
Metabolite of Naphthalene 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 2.52 (2.28-2.79) 2.10 (1.87-2.40) 6.56 (5.43-8.18) 15.1 (13.5-17.4) 21.8 (18.2-25.4) 2595 
 05-06 2.56 (2.29-2.86) 1.79 (1.57-2.06) 7.57 (5.89-9.40) 24.7 (20.4-31.0) 39.6 (34.1-53.0) 2385 
 07-08 2.59 (2.19-3.06) 1.98 (1.67-2.40) 6.25 (4.69-8.22) 16.1 (13.6-18.8) 25.3 (20.9-32.8) 2496 
 09-10 2.14 (1.99-2.32) 1.69 (1.59-1.86) 4.68 (4.21-5.52) 13.5 (12.3-14.9) 21.2 (19.0-22.9) 2747 
Age group        
6-11 years 03-04 1.63 (1.43-1.86) 1.36 (1.18-1.74) 2.77 (2.27-3.20) 5.70 (3.99-8.95) 10.2 (5.70-16.4) 340 
 05-06 1.30 (1.09-1.55) 1.09 (.938-1.33) 2.21 (1.99-2.81) 6.15 (3.33-10.3) 10.3 (6.82-28.0) 336 
 07-08 1.87 (1.57-2.24) 1.67 (1.35-2.15) 3.31 (2.61-4.65) 7.37 (5.13-8.83) 9.99 (8.06-11.3) 370 
 09-10 1.53 (1.35-1.73) 1.39 (1.17-1.63) 2.66 (2.36-2.95) 5.58 (4.36-7.62) 9.32 (5.73-17.2) 416 
12-19 years 03-04 1.47 (1.26-1.71) 1.20 (1.02-1.39) 2.84 (2.49-4.08) 7.56 (5.47-9.12) 10.8 (9.12-13.4) 727 
 05-06 1.29 (1.14-1.45) .995 (.854-1.10) 2.70 (2.27-3.35) 8.76 (5.83-10.8) 12.5 (9.37-19.6) 655 
 07-08 1.39 (1.18-1.65) 1.13 (.833-1.58) 3.21 (2.02-3.63) 6.95 (4.79-8.41) 9.93 (7.84-11.9) 386 
 09-10 1.28 (1.03-1.60) .992 (.735-1.36) 2.54 (1.87-3.77) 7.54 (4.63-9.68) 10.5 (7.54-17.5) 420 
20 years and older 03-04 2.90 (2.59-3.25) 2.52 (2.12-3.06) 8.21 (6.45-9.81) 16.9 (14.4-19.8) 24.2 (20.0-27.2) 1528 
 05-06 3.08 (2.72-3.50) 2.32 (1.91-2.73) 10.1 (7.67-13.9) 29.8 (23.9-34.1) 46.4 (39.1-57.3) 1394 
 07-08 2.96 (2.43-3.60) 2.36 (1.89-2.78) 7.42 (5.75-10.2) 18.5 (14.9-22.6) 27.9 (22.3-45.0) 1740 
 09-10 2.41 (2.21-2.63) 1.92 (1.71-2.10) 5.83 (4.84-6.84) 15.4 (13.5-16.7) 22.7 (20.2-27.0) 1911 
Gender        
Males 03-04 2.49 (2.25-2.75) 2.14 (1.86-2.59) 6.56 (5.50-8.01) 13.5 (12.3-14.4) 18.3 (16.6-20.7) 1243 
 05-06 2.38 (2.11-2.68) 1.89 (1.59-2.21) 6.45 (4.94-9.21) 19.2 (16.1-22.4) 31.7 (22.1-38.4) 1197 
 07-08 2.48 (2.21-2.77) 2.07 (1.74-2.39) 6.17 (5.07-7.52) 13.8 (11.9-16.0) 20.7 (16.7-24.0) 1239 
 09-10 2.07 (1.82-2.35) 1.67 (1.48-1.94) 5.07 (3.82-6.48) 12.6 (10.4-14.9) 18.6 (15.3-21.9) 1399 
Females 03-04 2.56 (2.22-2.95) 2.04 (1.73-2.44) 6.68 (5.00-8.85) 17.5 (13.5-21.7) 24.7 (19.8-30.6) 1352 
 05-06 2.75 (2.37-3.19) 1.75 (1.47-2.06) 8.05 (6.08-11.8) 31.5 (24.7-39.5) 54.2 (40.8-64.5) 1188 
 07-08 2.71 (2.13-3.43) 1.94 (1.58-2.50) 6.31 (4.29-9.32) 18.9 (13.8-23.7) 32.8 (22.3-104) 1257 
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Urinary 1-Hydroxynaphthalene (1-Naphthol) (creatinine corrected) (2003 – 2010) 
Metabolite of Naphthalene 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 03-04 1.75 (1.59-1.93) 1.50 (1.26-1.69) 3.24 (2.90-4.25) 8.55 (7.15-12.0) 17.5 (13.5-21.4) 651 
 05-06 1.37 (1.15-1.64) 1.08 (.940-1.38) 2.83 (2.13-3.82) 9.50 (5.95-12.6) 18.8 (12.0-21.6) 607 
 07-08 1.59 (1.29-1.95) 1.29 (1.03-1.57) 3.09 (2.17-5.05) 7.58 (5.43-10.8) 11.8 (7.86-26.1) 506 
 09-10 1.70 (1.46-1.98) 1.41 (1.24-1.61) 3.38 (2.48-4.56) 7.83 (6.02-11.6) 15.7 (10.9-19.3) 566 
Non-Hispanic blacks 03-04 2.36 (2.03-2.76) 2.00 (1.59-2.41) 5.90 (4.44-6.81) 13.8 (9.01-18.7) 20.9 (17.1-30.3) 677 
 05-06 2.40 (1.99-2.89) 1.98 (1.52-2.51) 7.17 (5.28-8.85) 20.6 (15.4-29.2) 39.2 (29.2-54.3) 641 
 07-08 2.22 (1.87-2.64) 1.87 (1.47-2.42) 6.06 (4.34-7.94) 13.6 (10.6-17.0) 21.3 (14.1-31.8) 574 
 09-10 2.22 (1.96-2.52) 2.13 (1.64-2.52) 5.89 (4.70-7.22) 13.0 (10.3-14.9) 18.2 (14.5-28.9) 517 
Non-Hispanic whites 03-04 2.75 (2.45-3.08) 2.33 (1.94-2.87) 8.03 (6.32-9.26) 16.6 (14.4-18.9) 23.5 (20.3-26.0) 1074 
 05-06 2.84 (2.41-3.36) 1.99 (1.60-2.54) 8.65 (5.95-12.6) 28.2 (20.8-35.0) 43.1 (38.4-59.0) 952 
 07-08 2.90 (2.33-3.61) 2.16 (1.71-2.78) 7.30 (5.00-10.2) 18.4 (14.8-22.3) 27.3 (22.3-50.8) 1022 
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Urinary 1-Hydroxynaphthalene (1-Naphthol) (creatinine corrected) (2011 - 2012) 
Metabolite of Naphthalene 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 1.90 (1.73-2.10) 1.51 (1.35-1.67) 4.15 (3.49-5.23) 13.4 (10.4-15.6) 20.4 (15.8-26.7) 2490 
Age group        
6-11 years 11-12 1.38 (1.18-1.61) 1.21 (.971-1.58) 2.36 (1.96-2.83) 4.78 (3.72-6.59) 8.90 (5.68-10.0) 396 
12-19 years 11-12 1.12 (.927-1.35) .936 (.729-1.21) 2.02 (1.43-3.03) 5.22 (3.42-7.72) 8.11 (5.61-17.2) 389 
20 years and older 11-12 2.14 (1.93-2.36) 1.69 (1.49-1.87) 5.35 (4.44-6.53) 15.3 (13.0-17.5) 22.4 (16.4-38.0) 1705 
Gender        
Males 11-12 1.77 (1.53-2.05) 1.43 (1.16-1.69) 3.80 (2.92-5.93) 12.2 (9.34-14.7) 18.8 (14.2-25.5) 1257 
Females 11-12 2.04 (1.68-2.47) 1.62 (1.30-1.90) 4.42 (3.31-6.05) 15.3 (12.4-18.0) 21.6 (18.0-30.0) 1233 
Race/ethnicity        
Mexican Americans 11-12 1.43 (1.14-1.80) 1.18 (.841-1.71) 3.03 (1.94-4.75) 7.88 (5.68-10.6) 11.8 (8.45-18.9) 317 
Non-Hispanic blacks 11-12 1.66 (1.46-1.90) 1.29 (1.11-1.47) 4.01 (3.05-5.22) 10.5 (8.56-12.7) 16.4 (12.2-25.5) 664 
Non-Hispanic whites 11-12 2.07 (1.87-2.30) 1.66 (1.47-1.81) 4.97 (3.58-6.10) 15.0 (12.7-17.5) 22.4 (15.8-39.3) 812 
All Hispanics 11-12 1.51 (1.27-1.81) 1.21 (.961-1.59) 3.35 (2.33-4.61) 9.08 (6.82-11.3) 15.1 (10.7-20.1) 573 
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Urinary 2-Hydroxynaphthalene (2-Naphthol) (2001 – 2010) 
Metabolite of Naphthalene 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 01-02 2.47 (2.11-2.89) 2.28 (1.93-2.67) 5.68 (4.58-6.83) 14.7 (12.8-19.5) 26.0 (22.5-29.7) 2748 
 03-04 3.18 (2.76-3.67) 2.96 (2.50-3.50) 7.50 (6.19-9.69) 17.3 (14.5-22.1) 25.8 (22.6-27.7) 2575 
 05-06 3.63 (3.36-3.92) 3.44 (3.11-3.80) 8.55 (7.84-9.42) 20.2 (17.0-24.1) 33.1 (28.6-38.2) 2446 
 07-08 3.83 (3.37-4.36) 3.66 (3.24-4.12) 8.44 (6.67-10.3) 17.3 (14.8-21.9) 26.7 (23.0-30.8) 2531 
 09-10 3.55 (3.23-3.91) 3.49 (3.15-3.85) 7.81 (7.07-8.55) 15.8 (14.0-17.6) 23.8 (21.5-26.9) 2747 
Age group        
6-11 years 01-02 1.69 (1.56-1.84) 1.70 (1.40-1.95) 3.01 (2.58-3.47) 5.41 (3.89-6.70) 7.72 (6.30-9.54) 387 
 03-04 2.11 (1.80-2.47) 2.14 (1.79-2.59) 3.57 (3.14-4.38) 5.58 (5.05-6.38) 9.71 (5.23-20.0) 339 
 05-06 2.16 (1.94-2.41) 2.09 (1.95-2.33) 3.96 (3.09-4.46) 5.64 (5.00-9.68) 10.6 (7.21-13.3) 345 
 07-08 2.70 (2.38-3.06) 2.59 (2.13-2.95) 4.66 (4.05-5.23) 8.73 (5.91-10.7) 11.5 (9.16-14.8) 376 
 09-10 2.40 (2.04-2.83) 2.49 (2.12-3.02) 4.89 (3.80-6.27) 9.61 (7.65-11.6) 12.8 (10.4-22.2) 416 
12-19 years 01-02 2.22 (1.70-2.90) 2.15 (1.74-2.53) 4.39 (3.15-6.11) 11.0 (6.99-20.4) 22.5 (13.9-28.4) 735 
 03-04 3.04 (2.68-3.46) 2.91 (2.51-3.50) 5.29 (4.67-6.59) 12.4 (8.53-16.8) 17.6 (15.1-25.9) 721 
 05-06 3.46 (3.04-3.95) 3.30 (2.87-3.78) 6.75 (5.87-7.49) 14.5 (10.3-20.8) 23.9 (14.7-33.1) 677 
 07-08 4.29 (3.49-5.28) 4.34 (3.73-5.32) 8.74 (6.57-10.8) 17.1 (13.0-22.5) 24.0 (19.6-29.7) 387 
 09-10 3.93 (3.25-4.75) 3.98 (3.37-5.26) 7.76 (6.63-9.35) 12.8 (10.7-16.0) 19.8 (13.4-22.1) 420 
20 years and older 01-02 2.62 (2.22-3.10) 2.44 (1.94-2.95) 6.38 (5.11-8.11) 17.6 (14.0-21.1) 28.1 (23.3-33.7) 1626 
 03-04 3.37 (2.86-3.96) 3.18 (2.59-3.96) 8.77 (7.21-11.3) 19.2 (16.0-23.2) 26.6 (23.4-28.8) 1515 
 05-06 3.88 (3.51-4.29) 3.77 (3.25-4.33) 9.58 (8.77-10.6) 23.0 (18.6-28.8) 37.0 (29.2-39.5) 1424 
 07-08 3.91 (3.41-4.50) 3.68 (3.20-4.32) 9.17 (6.82-11.0) 18.5 (15.1-23.6) 28.6 (23.8-33.5) 1768 
 09-10 3.66 (3.27-4.08) 3.54 (3.14-4.00) 8.17 (7.41-9.09) 17.4 (15.0-19.7) 25.6 (22.1-32.1) 1911 
Gender        
Males 01-02 2.75 (2.36-3.22) 2.51 (2.09-2.97) 6.06 (4.82-7.81) 16.9 (11.9-23.0) 28.1 (20.8-35.6) 1349 
 03-04 3.52 (3.09-4.01) 3.37 (2.91-3.88) 8.52 (6.96-10.5) 18.4 (15.3-22.6) 26.1 (22.2-27.9) 1233 
 05-06 4.03 (3.65-4.44) 3.85 (3.25-4.34) 9.49 (7.84-11.3) 19.7 (16.7-23.1) 32.9 (25.5-38.2) 1221 
 07-08 4.25 (3.77-4.78) 4.20 (3.74-4.52) 9.30 (7.35-10.8) 17.5 (14.5-22.7) 26.0 (20.9-32.6) 1256 
 09-10 3.72 (3.30-4.20) 3.52 (3.14-4.12) 7.43 (6.76-8.41) 15.5 (13.7-18.0) 25.2 (21.0-27.2) 1399 
Females 01-02 2.22 (1.86-2.66) 2.06 (1.65-2.48) 5.24 (3.89-6.44) 13.9 (12.3-17.7) 25.3 (19.7-28.3) 1399 
 03-04 2.89 (2.42-3.45) 2.60 (2.14-3.16) 6.80 (5.14-9.21) 16.6 (12.7-21.3) 23.9 (22.1-27.6) 1342 
 05-06 3.28 (2.83-3.80) 3.18 (2.64-3.61) 7.83 (6.77-9.00) 21.3 (14.5-29.2) 35.0 (26.7-39.6) 1225 
 07-08 3.47 (2.99-4.03) 3.18 (2.65-3.74) 7.64 (5.97-10.0) 17.1 (13.6-21.9) 26.7 (21.6-30.8) 1275 
 09-10 3.40 (3.09-3.74) 3.44 (3.07-3.82) 8.14 (7.12-9.07) 16.3 (13.6-18.6) 23.7 (20.8-30.7) 1348 
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Urinary 2-Hydroxynaphthalene (2-Naphthol) (2001 – 2010) 
Metabolite of Naphthalene 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 01-02 2.70 (2.36-3.08) 2.71 (2.35-3.26) 5.14 (4.36-6.15) 9.64 (8.15-10.6) 14.3 (10.4-18.7) 665 
 03-04 3.13 (2.71-3.63) 3.11 (2.57-3.85) 6.74 (5.60-8.28) 14.5 (10.4-15.6) 18.0 (15.5-20.5) 648 
 05-06 4.52 (4.12-4.96) 4.79 (4.13-5.43) 8.96 (7.84-9.81) 17.3 (12.4-23.3) 28.7 (20.0-32.7) 621 
 07-08 4.69 (4.07-5.41) 4.50 (3.93-5.58) 8.60 (6.77-11.3) 16.4 (12.6-20.9) 24.0 (19.1-29.7) 515 
 09-10 4.47 (3.90-5.13) 4.56 (3.72-5.88) 9.63 (8.51-10.7) 16.6 (13.4-19.5) 23.6 (18.7-28.4) 566 
Non-Hispanic blacks 01-02 3.97 (3.47-4.54) 3.46 (3.10-4.02) 9.29 (6.82-13.2) 22.8 (16.0-29.1) 33.0 (25.9-38.7) 692 
 03-04 4.69 (3.81-5.77) 4.23 (3.18-5.54) 10.3 (7.67-13.1) 21.5 (17.4-26.1) 30.7 (23.0-40.6) 673 
 05-06 4.99 (4.41-5.65) 4.63 (3.93-5.62) 11.6 (9.37-14.3) 22.6 (20.0-26.9) 31.9 (27.6-38.5) 657 
 07-08 4.90 (4.42-5.44) 4.81 (4.33-5.19) 10.1 (8.05-12.3) 22.1 (17.2-26.3) 28.6 (25.0-36.6) 587 
 09-10 5.23 (4.45-6.16) 5.42 (4.51-6.80) 11.1 (9.18-13.3) 22.1 (17.9-26.0) 30.9 (26.0-35.1) 517 
Non-Hispanic whites 01-02 2.19 (1.76-2.72) 1.91 (1.61-2.42) 4.97 (3.71-6.78) 14.1 (10.7-20.2) 25.9 (20.7-30.0) 1207 
 03-04 3.07 (2.57-3.66) 2.65 (2.19-3.43) 7.61 (5.77-10.3) 18.5 (14.5-23.2) 26.3 (23.2-28.7) 1062 
 05-06 3.25 (2.90-3.64) 2.98 (2.71-3.33) 7.90 (6.69-9.36) 19.3 (15.8-24.7) 34.0 (25.5-38.3) 980 
 07-08 3.60 (2.98-4.35) 3.34 (2.61-4.17) 8.04 (5.73-10.7) 17.1 (11.8-23.8) 26.4 (20.4-35.6) 1044 
 09-10 3.17 (2.79-3.62) 3.12 (2.81-3.51) 6.75 (6.06-7.81) 14.1 (12.3-17.6) 22.3 (19.7-26.5) 1203 
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Urinary 2-Hydroxynaphthalene (2-Naphthol) (2011 - 2012) 
Metabolite of Naphthalene 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 4.14 (3.73-4.61) 4.18 (3.83-4.76) 9.74 (8.22-10.8) 19.7 (17.7-21.2) 28.1 (24.1-30.3) 2492 
Age group        
6-11 years 11-12 3.13 (2.66-3.69) 3.34 (2.75-4.53) 6.49 (5.77-8.10) 11.9 (11.1-16.5) 20.3 (14.8-26.5) 397 
12-19 years 11-12 4.33 (3.47-5.40) 4.03 (3.18-5.36) 9.34 (7.14-11.7) 20.8 (14.7-26.6) 27.3 (20.8-61.5) 389 
20 years and older 11-12 4.25 (3.78-4.77) 4.26 (3.84-4.96) 10.4 (8.45-11.4) 20.0 (17.7-22.2) 28.5 (23.6-31.2) 1706 
Gender        
Males 11-12 4.26 (3.82-4.76) 4.20 (3.62-5.09) 8.93 (7.61-10.7) 18.3 (14.7-22.4) 27.7 (21.0-32.9) 1258 
Females 11-12 4.03 (3.50-4.65) 4.16 (3.72-4.83) 10.4 (8.56-11.9) 20.5 (17.8-23.0) 28.3 (24.1-31.2) 1234 
Race/ethnicity        
Mexican Americans 11-12 5.86 (5.13-6.70) 5.41 (4.82-6.55) 12.7 (9.57-16.6) 22.5 (17.5-25.1) 27.5 (22.7-37.3) 317 
Non-Hispanic blacks 11-12 6.65 (5.66-7.80) 6.87 (5.70-8.56) 14.0 (11.8-15.1) 23.6 (20.3-28.4) 37.0 (25.4-47.1) 664 
Non-Hispanic whites 11-12 3.54 (3.17-3.96) 3.59 (3.09-4.06) 7.55 (6.80-9.06) 17.8 (13.4-20.5) 26.2 (20.5-29.2) 814 
All Hispanics 11-12 5.69 (4.90-6.61) 5.49 (4.60-6.61) 12.6 (10.1-15.7) 22.8 (18.4-24.7) 27.9 (23.0-42.3) 573 
Asians 11-12 2.91 (2.37-3.56) 2.97 (2.06-3.86) 6.33 (5.29-8.33) 13.5 (10.8-17.0) 20.6 (14.2-26.6) 352 
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Urinary 2-Hydroxynaphthalene (2-Naphthol) (creatinine corrected) (2001 – 2010) 
Metabolite of Naphthalene 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 01-02 2.31 (1.98-2.68) 1.94 (1.67-2.30) 4.73 (3.82-5.86) 11.5 (9.98-13.1) 16.7 (14.1-19.2) 2748 
 03-04 2.99 (2.67-3.34) 2.56 (2.20-2.97) 6.34 (5.01-7.87) 14.1 (11.8-16.3) 19.9 (16.0-23.8) 2575 
 05-06 3.52 (3.29-3.77) 3.08 (2.67-3.40) 7.24 (6.45-8.27) 17.0 (14.8-18.8) 23.9 (21.9-27.2) 2446 
 07-08 3.86 (3.44-4.33) 3.44 (3.04-3.91) 7.08 (6.01-8.63) 15.3 (12.9-18.3) 20.7 (18.8-23.9) 2531 
 09-10 3.71 (3.47-3.97) 3.33 (3.08-3.70) 6.69 (6.29-7.15) 13.8 (12.7-15.0) 19.9 (17.8-21.7) 2747 
Age group        
6-11 years 01-02 1.89 (1.74-2.07) 1.83 (1.72-1.94) 3.11 (2.51-3.47) 5.04 (4.38-5.54) 6.49 (5.27-12.4) 387 
 03-04 2.24 (1.89-2.65) 2.04 (1.66-2.44) 3.54 (2.85-3.91) 5.95 (4.14-8.51) 8.72 (7.56-12.0) 339 
 05-06 2.40 (2.10-2.75) 2.27 (2.00-2.58) 3.68 (3.15-4.43) 6.10 (4.84-7.04) 7.82 (6.31-13.8) 345 
 07-08 3.33 (2.98-3.73) 3.35 (2.90-3.71) 5.23 (4.32-6.78) 8.00 (6.79-9.92) 10.5 (8.00-14.5) 376 
 09-10 3.13 (2.73-3.60) 3.08 (2.54-3.60) 5.01 (4.19-6.23) 9.79 (7.04-12.5) 13.8 (10.9-18.9) 416 
12-19 years 01-02 1.72 (1.35-2.19) 1.51 (1.34-1.83) 2.75 (2.08-4.07) 7.18 (4.07-10.9) 11.1 (7.86-17.4) 735 
 03-04 2.28 (2.06-2.52) 2.03 (1.77-2.35) 3.78 (3.20-4.47) 7.84 (6.13-9.11) 10.5 (9.10-12.5) 721 
 05-06 2.59 (2.37-2.84) 2.31 (2.03-2.62) 4.58 (3.99-5.02) 8.47 (6.98-10.5) 11.9 (10.1-15.2) 677 
 07-08 3.30 (2.74-3.96) 3.13 (2.43-4.08) 5.73 (4.88-6.79) 9.85 (7.56-12.0) 12.5 (9.91-18.6) 387 
 09-10 3.16 (2.79-3.58) 3.00 (2.58-3.67) 5.43 (4.70-6.35) 8.73 (7.59-9.98) 12.5 (9.61-14.2) 420 
20 years and older 01-02 2.48 (2.13-2.89) 2.08 (1.68-2.60) 5.63 (4.46-6.94) 12.4 (10.9-13.9) 17.7 (15.2-20.6) 1626 
 03-04 3.23 (2.87-3.64) 2.91 (2.36-3.41) 7.54 (6.20-9.10) 15.6 (13.1-17.9) 21.8 (17.2-24.0) 1515 
 05-06 3.87 (3.59-4.17) 3.40 (3.08-3.75) 9.20 (7.93-10.5) 19.0 (17.4-21.3) 27.2 (22.3-29.7) 1424 
 07-08 4.02 (3.55-4.55) 3.47 (3.07-4.04) 7.75 (6.17-9.83) 17.5 (13.9-19.8) 22.7 (20.2-25.5) 1768 
 09-10 3.87 (3.57-4.20) 3.47 (3.18-3.87) 7.26 (6.69-7.99) 14.9 (13.3-16.8) 21.2 (19.2-22.8) 1911 
Gender        
Males 01-02 2.23 (1.90-2.61) 1.86 (1.63-2.10) 4.79 (3.51-6.12) 11.4 (8.95-14.3) 15.8 (13.1-19.2) 1349 
 03-04 2.77 (2.50-3.06) 2.36 (2.13-2.81) 6.31 (5.08-7.36) 12.8 (11.3-14.6) 16.4 (14.6-18.3) 1233 
 05-06 3.23 (3.00-3.48) 2.83 (2.53-3.14) 6.75 (5.62-8.10) 13.8 (12.3-16.2) 18.9 (17.4-21.3) 1221 
 07-08 3.58 (3.24-3.95) 3.13 (2.70-3.57) 6.79 (5.79-8.10) 14.4 (12.2-17.2) 19.6 (18.3-20.9) 1256 
 09-10 3.34 (3.04-3.67) 2.92 (2.54-3.37) 6.19 (5.44-6.84) 13.2 (11.1-15.4) 18.1 (14.9-21.7) 1399 
Females 01-02 2.38 (2.05-2.77) 1.99 (1.66-2.56) 4.73 (3.79-6.00) 11.5 (10.3-12.8) 17.4 (13.7-21.5) 1399 
 03-04 3.21 (2.76-3.73) 2.68 (2.20-3.26) 6.43 (4.74-8.58) 16.0 (11.5-19.9) 22.5 (18.1-25.0) 1342 
 05-06 3.83 (3.39-4.33) 3.21 (2.72-3.76) 8.08 (6.43-9.74) 20.8 (17.0-24.7) 29.0 (24.9-34.2) 1225 
 07-08 4.15 (3.57-4.83) 3.59 (3.19-4.18) 7.40 (5.88-9.63) 16.8 (12.9-20.2) 22.7 (20.0-25.5) 1275 
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Urinary 2-Hydroxynaphthalene (2-Naphthol) (creatinine corrected) (2001 – 2010) 
Metabolite of Naphthalene 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Race/ethnicity        
Mexican Americans 01-02 2.52 (2.23-2.85) 2.35 (2.01-2.95) 4.65 (3.97-5.21) 7.32 (6.05-8.09) 12.1 (7.82-15.3) 665 
 03-04 2.83 (2.44-3.28) 2.57 (2.20-3.23) 5.00 (4.10-5.95) 10.3 (6.79-13.0) 13.3 (11.0-15.5) 648 
 05-06 4.05 (3.77-4.35) 4.03 (3.65-4.36) 7.05 (6.30-8.05) 12.6 (9.53-15.1) 17.4 (13.4-20.6) 621 
 07-08 4.58 (3.97-5.28) 4.38 (3.55-5.02) 7.59 (6.30-9.38) 14.2 (11.6-16.4) 19.1 (16.0-24.7) 515 
 09-10 4.44 (4.02-4.90) 4.30 (3.79-5.03) 7.80 (7.28-8.47) 12.9 (11.1-14.6) 18.8 (13.8-22.8) 566 
Non-Hispanic blacks 01-02 2.79 (2.39-3.27) 2.41 (2.04-2.77) 5.98 (4.84-6.98) 11.6 (9.09-15.3) 17.4 (12.2-23.4) 692 
 03-04 3.31 (2.70-4.04) 3.06 (2.31-3.86) 6.92 (5.12-9.33) 12.8 (10.4-16.5) 18.6 (15.7-22.1) 673 
 05-06 3.51 (3.16-3.89) 3.10 (2.59-3.53) 6.71 (5.33-8.04) 12.3 (10.3-16.1) 19.7 (16.1-25.0) 657 
 07-08 3.80 (3.47-4.15) 3.45 (3.08-3.90) 6.73 (5.57-8.41) 13.1 (11.3-14.9) 19.2 (14.8-26.5) 587 
 09-10 3.80 (3.47-4.15) 3.37 (3.10-3.85) 7.27 (6.54-8.32) 13.4 (10.8-16.8) 18.7 (13.4-23.5) 517 
Non-Hispanic whites 01-02 2.16 (1.78-2.62) 1.74 (1.44-2.18) 4.34 (3.32-6.09) 11.9 (9.93-14.3) 16.9 (13.8-20.6) 1207 
 03-04 3.03 (2.65-3.46) 2.46 (2.10-2.98) 7.14 (5.09-8.91) 15.6 (13.3-17.6) 21.9 (17.1-24.1) 1062 
 05-06 3.40 (3.08-3.77) 2.73 (2.39-3.26) 7.45 (6.10-9.65) 17.9 (15.3-20.7) 24.9 (21.3-29.0) 980 
 07-08 3.75 (3.18-4.43) 3.28 (2.60-4.08) 6.91 (5.53-9.51) 16.8 (12.8-19.8) 22.2 (19.4-25.5) 1044 
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Urinary 2-Hydroxynaphthalene (2-Naphthol) (creatinine corrected) (2011 - 2012) 
Metabolite of Naphthalene 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 4.72 (4.39-5.08) 4.32 (4.00-4.78) 9.30 (8.40-10.1) 17.6 (15.5-18.7) 23.4 (20.2-25.9) 2490 
Age group        
6-11 years 11-12 4.50 (3.93-5.16) 4.18 (3.68-4.96) 7.81 (6.44-9.37) 14.6 (11.2-17.1) 19.2 (15.3-22.6) 396 
12-19 years 11-12 4.19 (3.61-4.86) 3.82 (3.26-4.63) 6.97 (5.26-8.92) 12.9 (9.70-14.9) 20.5 (12.9-32.1) 389 
20 years and older 11-12 4.84 (4.48-5.22) 4.50 (4.07-4.98) 9.88 (9.07-11.0) 18.1 (16.4-19.4) 24.0 (20.8-26.7) 1705 
Gender        
Males 11-12 4.01 (3.61-4.44) 3.71 (3.23-4.19) 7.61 (6.50-8.89) 14.2 (12.1-15.8) 19.6 (17.4-22.3) 1257 
Females 11-12 5.53 (5.01-6.11) 5.22 (4.62-5.94) 11.4 (9.85-12.8) 19.1 (17.4-22.6) 25.9 (21.6-31.0) 1233 
Race/ethnicity        
Mexican Americans 11-12 6.59 (5.61-7.75) 6.22 (5.54-7.60) 11.6 (9.38-14.3) 20.1 (14.3-26.3) 26.3 (18.5-44.9) 317 
Non-Hispanic blacks 11-12 5.17 (4.58-5.85) 5.26 (4.59-6.16) 9.33 (8.09-10.7) 15.3 (13.5-17.3) 19.6 (17.9-22.0) 664 
Non-Hispanic whites 11-12 4.32 (3.96-4.70) 3.81 (3.40-4.21) 8.89 (7.40-10.0) 17.6 (14.5-18.7) 21.9 (18.7-27.7) 812 
All Hispanics 11-12 6.37 (5.80-7.00) 6.04 (5.65-6.77) 11.6 (9.85-13.3) 19.2 (15.8-23.8) 25.9 (21.9-30.4) 573 
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Blood 1,1,1-Trichloroethane (Methyl chloroform) (2003 - 2008) 
 
Geometric mean and selected percentiles of whole blood concentrations (in ng/mL) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 1345 
 05-06 * < LOD < LOD < LOD < LOD 3085 
 07-08 * < LOD < LOD < LOD < LOD 2907 
Age group        
12-19 years 05-06 * < LOD < LOD < LOD < LOD 911 
 07-08 * < LOD < LOD < LOD < LOD 469 
20-59 years 03-04 * < LOD < LOD < LOD < LOD 1345 
 05-06 * < LOD < LOD < LOD < LOD 1524 
 07-08 * < LOD < LOD < LOD < LOD 1565 
60 years and older 05-06 * < LOD < LOD < LOD .014 (<LOD-.021) 650 
 07-08 * < LOD < LOD < LOD < LOD 873 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 660 
 05-06 * < LOD < LOD < LOD < LOD 1464 
 07-08 * < LOD < LOD < LOD < LOD 1442 
Females 03-04 * < LOD < LOD < LOD < LOD 685 
 05-06 * < LOD < LOD < LOD < LOD 1621 
 07-08 * < LOD < LOD < LOD < LOD 1465 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 267 
 05-06 * < LOD < LOD < LOD < LOD 762 
 07-08 * < LOD < LOD < LOD < LOD 575 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 289 
 05-06 * < LOD < LOD < LOD < LOD 791 
 07-08 * < LOD < LOD < LOD < LOD 581 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 688 
 05-06 * < LOD < LOD < LOD < LOD 1303 
 07-08 * < LOD < LOD < LOD < LOD 1291 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, and 07-08 are 0.048, 0.01, and 0.01, respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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1,1,1,2-Tetrachloroethane (2007 - 2008) 
 
Geometric mean and selected percentiles of whole blood concentrations (in ng/mL) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 07-08 * < LOD < LOD < LOD < LOD 2750 
Age group        
12-19 years 07-08 * < LOD < LOD < LOD < LOD 452 
20-59 years 07-08 * < LOD < LOD < LOD < LOD 1493 
60 years and older 07-08 * < LOD < LOD < LOD < LOD 805 
Gender        
Males 07-08 * < LOD < LOD < LOD < LOD 1365 
Females 07-08 * < LOD < LOD < LOD < LOD 1385 
Race/ethnicity        
Mexican Americans 07-08 * < LOD < LOD < LOD < LOD 556 
Non-Hispanic blacks 07-08 * < LOD < LOD < LOD < LOD 546 
Non-Hispanic whites 07-08 * < LOD < LOD < LOD < LOD 1197 
Limit of detection (LOD, see Data Analysis section) for Survey year 07-08 is 0.04. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Blood 1,1,2,2-Tetrachloroethane (2003 - 2008) 
 
Geometric mean and selected percentiles of whole blood concentrations (in ng/mL) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 1235 
 05-06 * < LOD < LOD < LOD < LOD 3131 
 07-08 * < LOD < LOD < LOD < LOD 2922 
Age group        
12-19 years 05-06 * < LOD < LOD < LOD < LOD 924 
 07-08 * < LOD < LOD < LOD < LOD 464 
20-59 years 03-04 * < LOD < LOD < LOD < LOD 1235 
 05-06 * < LOD < LOD < LOD < LOD 1542 
 07-08 * < LOD < LOD < LOD < LOD 1575 
60 years and older 05-06 * < LOD < LOD < LOD < LOD 665 
 07-08 * < LOD < LOD < LOD < LOD 883 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 613 
 05-06 * < LOD < LOD < LOD < LOD 1484 
 07-08 * < LOD < LOD < LOD < LOD 1447 
Females 03-04 * < LOD < LOD < LOD < LOD 622 
 05-06 * < LOD < LOD < LOD < LOD 1647 
 07-08 * < LOD < LOD < LOD < LOD 1475 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 250 
 05-06 * < LOD < LOD < LOD < LOD 753 
 07-08 * < LOD < LOD < LOD < LOD 554 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 282 
 05-06 * < LOD < LOD < LOD < LOD 823 
 07-08 * < LOD < LOD < LOD < LOD 594 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 606 
 05-06 * < LOD < LOD < LOD < LOD 1323 
 07-08 * < LOD < LOD < LOD < LOD 1310 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, and 07-08 are 0.01, 0.01, and 0.01, respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 






Fourth National Report on Human Exposure to Environmental Chemicals, Updated Tables, January 2017 Volume One Page 538
Blood 1,1,2-Trichloroethane (2003 - 2008) 
 
Geometric mean and selected percentiles of whole blood concentrations (in ng/mL) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 1354 
 05-06 * < LOD < LOD < LOD < LOD 3165 
 07-08 * < LOD < LOD < LOD < LOD 2701 
Age group        
12-19 years 05-06 * < LOD < LOD < LOD < LOD 936 
 07-08 * < LOD < LOD < LOD < LOD 436 
20-59 years 03-04 * < LOD < LOD < LOD < LOD 1354 
 05-06 * < LOD < LOD < LOD < LOD 1556 
 07-08 * < LOD < LOD < LOD < LOD 1458 
60 years and older 05-06 * < LOD < LOD < LOD < LOD 673 
 07-08 * < LOD < LOD < LOD < LOD 807 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 664 
 05-06 * < LOD < LOD < LOD < LOD 1499 
 07-08 * < LOD < LOD < LOD < LOD 1338 
Females 03-04 * < LOD < LOD < LOD < LOD 690 
 05-06 * < LOD < LOD < LOD < LOD 1666 
 07-08 * < LOD < LOD < LOD < LOD 1363 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 267 
 05-06 * < LOD < LOD < LOD < LOD 777 
 07-08 * < LOD < LOD < LOD < LOD 534 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 297 
 05-06 * < LOD < LOD < LOD < LOD 824 
 07-08 * < LOD < LOD < LOD < LOD 572 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 686 
 05-06 * < LOD < LOD < LOD < LOD 1331 
 07-08 * < LOD < LOD < LOD < LOD 1183 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, and 07-08 are 0.01, 0.01, and 0.01, respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Blood 1,2,3-Trichloropropane (2007 - 2008) 
 
Geometric mean and selected percentiles of whole blood concentrations (in ng/mL) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 07-08 * < LOD < LOD < LOD < LOD 2592 
Age group        
12-19 years 07-08 * < LOD < LOD < LOD < LOD 413 
20-59 years 07-08 * < LOD < LOD < LOD < LOD 1398 
60 years and older 07-08 * < LOD < LOD < LOD < LOD 781 
Gender        
Males 07-08 * < LOD < LOD < LOD < LOD 1284 
Females 07-08 * < LOD < LOD < LOD < LOD 1308 
Race/ethnicity        
Mexican Americans 07-08 * < LOD < LOD < LOD < LOD 518 
Non-Hispanic blacks 07-08 * < LOD < LOD < LOD < LOD 541 
Non-Hispanic whites 07-08 * < LOD < LOD < LOD < LOD 1133 
Limit of detection (LOD, see Data Analysis section) for Survey year 07-08 is 0.04. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Blood 1,1-Dichloroethane (2003 - 2008) 
 
Geometric mean and selected percentiles of whole blood concentrations (in ng/mL) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 1367 
 05-06 * < LOD < LOD < LOD < LOD 3193 
 07-08 * < LOD < LOD < LOD < LOD 2800 
Age group        
12-19 years 05-06 * < LOD < LOD < LOD < LOD 941 
 07-08 * < LOD < LOD < LOD < LOD 446 
20-59 years 03-04 * < LOD < LOD < LOD < LOD 1367 
 05-06 * < LOD < LOD < LOD < LOD 1569 
 07-08 * < LOD < LOD < LOD < LOD 1505 
60 years and older 05-06 * < LOD < LOD < LOD < LOD 683 
 07-08 * < LOD < LOD < LOD < LOD 849 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 670 
 05-06 * < LOD < LOD < LOD < LOD 1510 
 07-08 * < LOD < LOD < LOD < LOD 1380 
Females 03-04 * < LOD < LOD < LOD < LOD 697 
 05-06 * < LOD < LOD < LOD < LOD 1683 
 07-08 * < LOD < LOD < LOD < LOD 1420 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 267 
 05-06 * < LOD < LOD < LOD < LOD 778 
 07-08 * < LOD < LOD < LOD < LOD 548 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 300 
 05-06 * < LOD < LOD < LOD < LOD 832 
 07-08 * < LOD < LOD < LOD < LOD 577 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 695 
 05-06 * < LOD < LOD < LOD < LOD 1347 
 07-08 * < LOD < LOD < LOD < LOD 1239 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, and 07-08 are 0.01, 0.01, and 0.01, respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Blood 1,1 - Dichloroethene (Vinylidene chloride) (2003 - 2008) 
 
Geometric mean and selected percentiles of whole blood concentrations (in ng/mL) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 1367 
 05-06 * < LOD < LOD < LOD < LOD 3163 
 07-08 * < LOD < LOD < LOD < LOD 2810 
Age group        
12-19 years 05-06 * < LOD < LOD < LOD < LOD 931 
 07-08 * < LOD < LOD < LOD < LOD 447 
20-59 years 03-04 * < LOD < LOD < LOD < LOD 1367 
 05-06 * < LOD < LOD < LOD < LOD 1555 
 07-08 * < LOD < LOD < LOD < LOD 1503 
60 years and older 05-06 * < LOD < LOD < LOD < LOD 677 
 07-08 * < LOD < LOD < LOD < LOD 860 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 670 
 05-06 * < LOD < LOD < LOD < LOD 1502 
 07-08 * < LOD < LOD < LOD < LOD 1398 
Females 03-04 * < LOD < LOD < LOD < LOD 697 
 05-06 * < LOD < LOD < LOD < LOD 1661 
 07-08 * < LOD < LOD < LOD < LOD 1412 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 267 
 05-06 * < LOD < LOD < LOD < LOD 774 
 07-08 * < LOD < LOD < LOD < LOD 525 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 300 
 05-06 * < LOD < LOD < LOD < LOD 823 
 07-08 * < LOD < LOD < LOD < LOD 584 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 695 
 05-06 * < LOD < LOD < LOD < LOD 1332 
 07-08 * < LOD < LOD < LOD < LOD 1255 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, and 07-08 are 0.009, 0.009, and 0.009, respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Blood 1,2-Dibromo-3-chloropropane (DBCP) (2003 - 2008) 
 
Geometric mean and selected percentiles of whole blood concentrations (in ng/mL) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 1170 
 05-06 * < LOD < LOD < LOD < LOD 2998 
 07-08 * < LOD < LOD < LOD < LOD 2837 
Age group        
12-19 years 05-06 * < LOD < LOD < LOD < LOD 875 
 07-08 * < LOD < LOD < LOD < LOD 469 
20-59 years 03-04 * < LOD < LOD < LOD < LOD 1170 
 05-06 * < LOD < LOD < LOD < LOD 1485 
 07-08 * < LOD < LOD < LOD < LOD 1522 
60 years and older 05-06 * < LOD < LOD < LOD < LOD 638 
 07-08 * < LOD < LOD < LOD < LOD 846 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 568 
 05-06 * < LOD < LOD < LOD < LOD 1409 
 07-08 * < LOD < LOD < LOD < LOD 1397 
Females 03-04 * < LOD < LOD < LOD < LOD 602 
 05-06 * < LOD < LOD < LOD < LOD 1589 
 07-08 * < LOD < LOD < LOD < LOD 1440 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 234 
 05-06 * < LOD < LOD < LOD < LOD 752 
 07-08 * < LOD < LOD < LOD < LOD 565 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 239 
 05-06 * < LOD < LOD < LOD < LOD 737 
 07-08 * < LOD < LOD < LOD < LOD 586 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 603 
 05-06 * < LOD < LOD < LOD < LOD 1287 
 07-08 * < LOD < LOD < LOD < LOD 1231 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, and 07-08 are 0.1, 0.1, and 0.1, respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Blood 1,2-Dibromoethane (2007 - 2008) 
 
Geometric mean and selected percentiles of whole blood concentrations (in ng/mL) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 07-08 * < LOD < LOD < LOD < LOD 2577 
Age group        
12-19 years 07-08 * < LOD < LOD < LOD < LOD 409 
20-59 years 07-08 * < LOD < LOD < LOD < LOD 1389 
60 years and older 07-08 * < LOD < LOD < LOD < LOD 779 
Gender        
Males 07-08 * < LOD < LOD < LOD < LOD 1270 
Females 07-08 * < LOD < LOD < LOD < LOD 1307 
Race/ethnicity        
Mexican Americans 07-08 * < LOD < LOD < LOD < LOD 471 
Non-Hispanic blacks 07-08 * < LOD < LOD < LOD < LOD 532 
Non-Hispanic whites 07-08 * < LOD < LOD < LOD < LOD 1165 
Limit of detection (LOD, see Data Analysis section) for Survey year 07-08 is 0.015. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Blood 1,2-Dichlorobenzene (o-Dichlorobenzene) (2003 - 2008) 
 
Geometric mean and selected percentiles of whole blood concentrations (in ng/mL) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 1327 
 05-06 * < LOD < LOD < LOD < LOD 3083 
 07-08 * < LOD < LOD < LOD < LOD 2803 
Age group        
12-19 years 05-06 * < LOD < LOD < LOD < LOD 921 
 07-08 * < LOD < LOD < LOD < LOD 455 
20-59 years 03-04 * < LOD < LOD < LOD < LOD 1327 
 05-06 * < LOD < LOD < LOD < LOD 1523 
 07-08 * < LOD < LOD < LOD < LOD 1510 
60 years and older 05-06 * < LOD < LOD < LOD < LOD 639 
 07-08 * < LOD < LOD < LOD < LOD 838 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 647 
 05-06 * < LOD < LOD < LOD < LOD 1457 
 07-08 * < LOD < LOD < LOD < LOD 1388 
Females 03-04 * < LOD < LOD < LOD < LOD 680 
 05-06 * < LOD < LOD < LOD < LOD 1626 
 07-08 * < LOD < LOD < LOD < LOD 1415 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 250 
 05-06 * < LOD < LOD < LOD < LOD 766 
 07-08 * < LOD < LOD < LOD < LOD 544 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 291 
 05-06 * < LOD < LOD < LOD < LOD 801 
 07-08 * < LOD < LOD < LOD < LOD 579 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 682 
 05-06 * < LOD < LOD < LOD < LOD 1288 
 07-08 * < LOD < LOD < LOD < LOD 1237 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, and 07-08 are 0.1, 0.1, and 0.025, respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Blood 1,2-Dichloroethane (Ethylene dichloride) (2003 - 2008) 
 
Geometric mean and selected percentiles of whole blood concentrations (in ng/mL) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 1346 
 05-06 * < LOD < LOD < LOD < LOD 3082 
 07-08 * < LOD < LOD < LOD < LOD 2767 
Age group        
12-19 years 05-06 * < LOD < LOD < LOD < LOD 906 
 07-08 * < LOD < LOD < LOD < LOD 443 
20-59 years 03-04 * < LOD < LOD < LOD < LOD 1346 
 05-06 * < LOD < LOD < LOD < LOD 1520 
 07-08 * < LOD < LOD < LOD < LOD 1484 
60 years and older 05-06 * < LOD < LOD < LOD < LOD 656 
 07-08 * < LOD < LOD < LOD < LOD 840 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 661 
 05-06 * < LOD < LOD < LOD < LOD 1452 
 07-08 * < LOD < LOD < LOD < LOD 1375 
Females 03-04 * < LOD < LOD < LOD < LOD 685 
 05-06 * < LOD < LOD < LOD < LOD 1630 
 07-08 * < LOD < LOD < LOD < LOD 1392 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 267 
 05-06 * < LOD < LOD < LOD < LOD 763 
 07-08 * < LOD < LOD < LOD < LOD 533 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 289 
 05-06 * < LOD < LOD < LOD < LOD 795 
 07-08 * < LOD < LOD < LOD < LOD 554 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 689 
 05-06 * < LOD < LOD < LOD < LOD 1297 
 07-08 * < LOD < LOD < LOD < LOD 1244 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, and 07-08 are 0.01, 0.01, and 0.01, respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Blood cis-1,2-Dichloroethene (2003 - 2008) 
 
Geometric mean and selected percentiles of whole blood concentrations (in ng/mL) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 1366 
 05-06 * < LOD < LOD < LOD < LOD 3140 
 07-08 * < LOD < LOD < LOD < LOD 2897 
Age group        
12-19 years 05-06 * < LOD < LOD < LOD < LOD 924 
 07-08 * < LOD < LOD < LOD < LOD 463 
20-59 years 03-04 * < LOD < LOD < LOD < LOD 1366 
 05-06 * < LOD < LOD < LOD < LOD 1539 
 07-08 * < LOD < LOD < LOD < LOD 1556 
60 years and older 05-06 * < LOD < LOD < LOD < LOD 677 
 07-08 * < LOD < LOD < LOD < LOD 878 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 669 
 05-06 * < LOD < LOD < LOD < LOD 1481 
 07-08 * < LOD < LOD < LOD < LOD 1432 
Females 03-04 * < LOD < LOD < LOD < LOD 697 
 05-06 * < LOD < LOD < LOD < LOD 1659 
 07-08 * < LOD < LOD < LOD < LOD 1465 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 267 
 05-06 * < LOD < LOD < LOD < LOD 757 
 07-08 * < LOD < LOD < LOD < LOD 576 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 300 
 05-06 * < LOD < LOD < LOD < LOD 822 
 07-08 * < LOD < LOD < LOD < LOD 591 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 694 
 05-06 * < LOD < LOD < LOD < LOD 1329 
 07-08 * < LOD < LOD < LOD < LOD 1283 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, and 07-08 are 0.01, 0.01, and 0.01, respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Blood trans-1,2-Dichloroethene (2003 - 2008) 
 
Geometric mean and selected percentiles of whole blood concentrations (in ng/mL) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 1367 
 05-06 * < LOD < LOD < LOD < LOD 3193 
 07-08 * < LOD < LOD < LOD < LOD 2843 
Age group        
12-19 years 05-06 * < LOD < LOD < LOD < LOD 941 
 07-08 * < LOD < LOD < LOD < LOD 468 
20-59 years 03-04 * < LOD < LOD < LOD < LOD 1367 
 05-06 * < LOD < LOD < LOD < LOD 1569 
 07-08 * < LOD < LOD < LOD < LOD 1524 
60 years and older 05-06 * < LOD < LOD < LOD < LOD 683 
 07-08 * < LOD < LOD < LOD < LOD 851 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 670 
 05-06 * < LOD < LOD < LOD < LOD 1511 
 07-08 * < LOD < LOD < LOD < LOD 1415 
Females 03-04 * < LOD < LOD < LOD < LOD 697 
 05-06 * < LOD < LOD < LOD < LOD 1682 
 07-08 * < LOD < LOD < LOD < LOD 1428 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 267 
 05-06 * < LOD < LOD < LOD < LOD 779 
 07-08 * < LOD < LOD < LOD < LOD 574 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 300 
 05-06 * < LOD < LOD < LOD < LOD 832 
 07-08 * < LOD < LOD < LOD < LOD 580 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 695 
 05-06 * < LOD < LOD < LOD < LOD 1346 
 07-08 * < LOD < LOD < LOD < LOD 1249 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, and 07-08 are 0.01, 0.01, and 0.01, respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Blood 1,2-Dichloropropane (2003 - 2008) 
 
Geometric mean and selected percentiles of whole blood concentrations (in ng/mL) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 1364 
 05-06 * < LOD < LOD < LOD < LOD 3120 
 07-08 * < LOD < LOD < LOD < LOD 2840 
Age group        
12-19 years 05-06 * < LOD < LOD < LOD < LOD 918 
 07-08 * < LOD < LOD < LOD < LOD 469 
20-59 years 03-04 * < LOD < LOD < LOD < LOD 1364 
 05-06 * < LOD < LOD < LOD < LOD 1536 
 07-08 * < LOD < LOD < LOD < LOD 1524 
60 years and older 05-06 * < LOD < LOD < LOD < LOD 666 
 07-08 * < LOD < LOD < LOD < LOD 847 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 667 
 05-06 * < LOD < LOD < LOD < LOD 1478 
 07-08 * < LOD < LOD < LOD < LOD 1413 
Females 03-04 * < LOD < LOD < LOD < LOD 697 
 05-06 * < LOD < LOD < LOD < LOD 1642 
 07-08 * < LOD < LOD < LOD < LOD 1427 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 267 
 05-06 * < LOD < LOD < LOD < LOD 755 
 07-08 * < LOD < LOD < LOD < LOD 562 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 300 
 05-06 * < LOD < LOD < LOD < LOD 811 
 07-08 * < LOD < LOD < LOD < LOD 582 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 692 
 05-06 * < LOD < LOD < LOD < LOD 1322 
 07-08 * < LOD < LOD < LOD < LOD 1245 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, and 07-08 are 0.008, 0.008, and 0.01, respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 






Fourth National Report on Human Exposure to Environmental Chemicals, Updated Tables, January 2017 Volume One Page 549
Blood 1,3-Dichlorobenzene (m-Dichlorobenzene) (2003 - 2008) 
 
Geometric mean and selected percentiles of whole blood concentrations (in ng/mL) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 1334 
 05-06 * < LOD < LOD < LOD < LOD 3148 
 07-08 * < LOD < LOD < LOD < LOD 2484 
Age group        
12-19 years 05-06 * < LOD < LOD < LOD < LOD 928 
 07-08 * < LOD < LOD < LOD < LOD 405 
20-59 years 03-04 * < LOD < LOD < LOD < LOD 1334 
 05-06 * < LOD < LOD < LOD < LOD 1545 
 07-08 * < LOD < LOD < LOD < LOD 1345 
60 years and older 05-06 * < LOD < LOD < LOD < LOD 675 
 07-08 * < LOD < LOD < LOD < LOD 734 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 659 
 05-06 * < LOD < LOD < LOD < LOD 1491 
 07-08 * < LOD < LOD < LOD < LOD 1217 
Females 03-04 * < LOD < LOD < LOD < LOD 675 
 05-06 * < LOD < LOD < LOD < LOD 1657 
 07-08 * < LOD < LOD < LOD < LOD 1267 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 266 
 05-06 * < LOD < LOD < LOD < LOD 774 
 07-08 * < LOD < LOD < LOD < LOD 483 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 279 
 05-06 * < LOD < LOD < LOD < LOD 809 
 07-08 * < LOD < LOD < LOD < LOD 534 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 686 
 05-06 * < LOD < LOD < LOD < LOD 1330 
 07-08 * < LOD < LOD < LOD < LOD 1072 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, and 07-08 are 0.05, 0.05, and 0.025, respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Blood 1,4-Dichlorobenzene (Paradichlorobenzene) (2001 - 2008) 
 
Geometric mean and selected percentiles of whole blood concentrations (in ng/mL) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 01-02 * < LOD .300 (.190-.550) 1.19 (.610-2.90) 4.10 (1.40-7.60) 807 
 03-04 * < LOD .320 (.250-.400) 1.10 (.710-1.60) 3.30 (1.70-5.10) 1322 
 05-06 * .085 (.085-.085) .218 (.180-.260) .917 (.643-1.31) 3.59 (1.80-5.50) 3126 
 07-08 * .054 (.043-.071) .186 (.138-.262) .869 (.543-1.35) 2.69 (1.52-7.13) 2330 
Age group        
12-19 years 05-06 * .085 (.085-.085) .220 (.160-.280) .960 (.560-2.00) 4.27 (2.37-6.10) 926 
 07-08 .118 (.089-.155) .074 (.049-.109) .244 (.147-.520) 1.11 (.743-2.10) 4.16 (1.18-20.1) 379 
20-59 years 01-02 * < LOD .300 (.190-.550) 1.19 (.610-2.90) 4.10 (1.40-7.60) 807 
 03-04 * < LOD .320 (.250-.400) 1.10 (.710-1.60) 3.30 (1.70-5.10) 1322 
 05-06 * .085 (.085-.085) .220 (.170-.260) .910 (.540-1.50) 3.77 (1.50-7.33) 1537 
 07-08 * .052 (<LOD-.071) .184 (.121-.266) .788 (.464-1.49) 2.67 (1.36-7.58) 1250 
60 years and older 05-06 * .085 (.085-.085) .207 (.158-.313) .877 (.525-1.80) 3.06 (1.50-4.20) 663 
 07-08 * .055 (<LOD-.072) .169 (.120-.280) .768 (.461-1.16) 2.28 (.936-7.84) 698 
Gender        
Males 01-02 * < LOD .270 (.180-.530) .900 (.570-2.90) 3.60 (1.10-7.20) 390 
 03-04 * < LOD .320 (.250-.380) .770 (.580-1.20) 1.90 (1.20-4.00) 651 
 05-06 * .085 (.085-.085) .230 (.188-.290) .950 (.603-1.50) 3.50 (1.50-7.20) 1479 
 07-08 .102 (.081-.126) .065 (.052-.080) .205 (.156-.274) .833 (.497-1.33) 2.14 (1.05-8.40) 1133 
Females 01-02 * < LOD .360 (.190-.620) 1.20 (.620-3.90) 4.10 (1.68-8.30) 417 
 03-04 * < LOD .350 (.220-.450) 1.40 (.810-2.10) 4.10 (2.20-5.90) 671 
 05-06 * .085 (.085-.085) .180 (.140-.240) .865 (.522-1.70) 3.59 (2.10-5.18) 1647 
 07-08 * .048 (<LOD-.065) .155 (.108-.268) .894 (.537-1.61) 3.11 (1.68-8.10) 1197 
Race/ethnicity        
Mexican Americans 01-02 .331 (.246-.446) .180 (<LOD-.260) .790 (.400-1.30) 6.00 (1.30-16.0) 16.0 (6.20-33.0) 217 
 03-04 .381 (.256-.566) .210 (.140-.400) .730 (.370-2.90) 6.20 (2.90-9.30) 10.0 (6.30-19.0) 262 
 05-06 .412 (.309-.549) .210 (.150-.290) 1.20 (.680-2.97) 8.80 (3.80-16.0) 16.0 (8.10-33.0) 772 
 07-08 .251 (.119-.529) .179 (.059-.420) .864 (.304-4.30) 7.76 (2.14-17.8) 19.0 (10.5-23.4) 459 
Non-Hispanic blacks 01-02 .558 (.376-.827) .360 (.260-.560) 1.80 (.710-3.90) 6.30 (1.40-29.0) 15.0 (3.60-51.0) 136 
 03-04 .423 (.292-.613) .340 (.200-.480) .980 (.550-1.50) 4.10 (1.60-9.20) 11.0 (2.50-19.0) 297 
 05-06 .381 (.272-.532) .230 (.160-.330) .860 (.500-1.70) 5.24 (2.00-11.5) 12.7 (8.41-21.0) 805 
 07-08 .235 (.181-.303) .151 (.112-.200) .688 (.410-1.04) 3.76 (2.14-9.10) 12.7 (6.00-21.3) 502 
Non-Hispanic whites 01-02 * < LOD .200 (<LOD-.380) .570 (.300-1.20) 1.19 (.570-3.70) 396 
 03-04 * < LOD .200 (.160-.260) .490 (.370-.720) .940 (.690-2.00) 658 
 05-06 * .085 (.085-.085) .134 (.085-.180) .438 (.260-.670) 1.16 (.520-2.30) 1319 
 07-08 * .043 (<LOD-.055) .095 (.081-.137) .377 (.291-.486) .898 (.543-1.49) 1015 
Limit of detection (LOD, see Data Analysis section) for Survey years 01-02, 03-04, 05-06, and 07-08 are 0.12, 0.12, 0.011, and 0.04, respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Blood 2,5-Dimethylfuran (2003 - 2008) 
 
Geometric mean and selected percentiles of whole blood concentrations (in ng/mL) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD .016 (<LOD-.032) .100 (.083-.110) .140 (.120-.180) 1213 
 05-06 * < LOD < LOD .100 (.069-.120) .160 (.130-.180) 3160 
 07-08 * < LOD < LOD .087 (.056-.118) .148 (.129-.168) 2745 
Age group        
12-19 years 05-06 * < LOD < LOD .013 (<LOD-.029) .049 (.020-.069) 930 
 07-08 * < LOD < LOD < LOD .028 (<LOD-.077) 449 
20-59 years 03-04 * < LOD .016 (<LOD-.032) .100 (.083-.110) .140 (.120-.180) 1213 
 05-06 * < LOD .013 (<LOD-.035) .120 (.097-.144) .170 (.140-.210) 1553 
 07-08 * < LOD < LOD .113 (.079-.146) .169 (.147-.209) 1471 
60 years and older 05-06 * < LOD < LOD .069 (.027-.100) .140 (.106-.160) 677 
 07-08 * < LOD < LOD .014 (<LOD-.061) .086 (.061-.137) 825 
Gender        
Males 03-04 * < LOD .019 (<LOD-.034) .094 (.071-.110) .130 (.110-.190) 598 
 05-06 * < LOD < LOD .110 (.079-.130) .160 (.130-.190) 1490 
 07-08 * < LOD < LOD .101 (.056-.130) .154 (.133-.187) 1358 
Females 03-04 * < LOD .012 (<LOD-.048) .110 (.071-.120) .150 (.120-.210) 615 
 05-06 * < LOD < LOD .094 (.062-.120) .158 (.120-.180) 1670 
 07-08 * < LOD < LOD .081 (.042-.110) .142 (.101-.176) 1387 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD .012 (<LOD-.020) .038 (.013-.054) 237 
 05-06 * < LOD < LOD .015 (<LOD-.029) .033 (.020-.055) 778 
 07-08 * < LOD < LOD .012 (<LOD-.019) .032 (.019-.048) 557 
Non-Hispanic blacks 03-04 * < LOD .042 (.019-.063) .110 (.079-.170) .170 (.099-.220) 258 
 05-06 * < LOD .012 (<LOD-.030) .085 (.058-.110) .130 (.095-.180) 825 
 07-08 * < LOD < LOD .081 (.058-.102) .148 (.093-.160) 557 
Non-Hispanic whites 03-04 * < LOD .021 (<LOD-.043) .110 (.087-.120) .150 (.120-.200) 624 
 05-06 * < LOD < LOD .118 (.091-.140) .170 (.140-.230) 1325 
 07-08 * < LOD < LOD .111 (.077-.142) .165 (.146-.191) 1215 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, and 07-08 are 0.012, 0.011, and 0.011, respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Blood Benzene (2001 - 2008) 
 
Geometric mean and selected percentiles of whole blood concentrations (in ng/mL) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 01-02 * .030 (<LOD-.050) .100 (.060-.140) .190 (.140-.290) .320 (.190-.480) 837 
 03-04 * .027 (.025-.031) .064 (.050-.084) .170 (.150-.190) .260 (.210-.320) 1345 
 05-06 * .026 (<LOD-.030) .056 (.047-.072) .220 (.157-.260) .310 (.264-.370) 3091 
 07-08 * < LOD .041 (.028-.062) .198 (.156-.246) .294 (.246-.380) 2685 
Age group        
12-19 years 05-06 * .024 (<LOD-.028) .039 (.031-.056) .089 (.066-.110) .120 (.092-.180) 912 
 07-08 * < LOD < LOD .053 (.029-.088) .106 (.056-.159) 426 
20-59 years 01-02 * .030 (<LOD-.050) .100 (.060-.140) .190 (.140-.290) .320 (.190-.480) 837 
 03-04 * .027 (.025-.031) .064 (.050-.084) .170 (.150-.190) .260 (.210-.320) 1345 
 05-06 * .028 (.025-.032) .072 (.053-.100) .240 (.200-.290) .340 (.300-.390) 1513 
 07-08 * < LOD .075 (.037-.126) .243 (.187-.290) .328 (.280-.416) 1445 
60 years and older 05-06 * < LOD .042 (.036-.048) .180 (.100-.230) .270 (.200-.340) 666 
 07-08 * < LOD < LOD .120 (.065-.158) .213 (.150-.279) 814 
Gender        
Males 01-02 * .030 (<LOD-.050) .110 (.060-.160) .230 (.150-.370) .370 (.210-.510) 403 
 03-04 .039 (.035-.043) .030 (.027-.035) .069 (.053-.084) .160 (.140-.180) .240 (.190-.320) 654 
 05-06 * .028 (.025-.032) .066 (.051-.083) .230 (.165-.280) .330 (.260-.440) 1459 
 07-08 * < LOD .056 (.036-.095) .216 (.172-.274) .303 (.252-.398) 1330 
Females 01-02 * .030 (<LOD-.050) .100 (.060-.130) .180 (.120-.240) .250 (.170-.330) 434 
 03-04 * .025 (<LOD-.029) .057 (.040-.090) .180 (.150-.220) .290 (.220-.420) 691 
 05-06 * .024 (<LOD-.028) .049 (.040-.067) .200 (.150-.230) .290 (.250-.340) 1632 
 07-08 * < LOD .030 (<LOD-.045) .182 (.109-.240) .285 (.220-.368) 1355 
Race/ethnicity        
Mexican Americans 01-02 * .030 (<LOD-.070) .070 (.030-.170) .140 (.060-.360) .230 (.130-.370) 227 
 03-04 * .027 (<LOD-.035) .041 (.034-.057) .077 (.058-.110) .130 (.084-.320) 254 
 05-06 * < LOD .036 (.031-.045) .060 (.048-.086) .096 (.072-.140) 744 
 07-08 * < LOD < LOD .053 (.038-.076) .092 (.056-.120) 522 
Non-Hispanic blacks 01-02 * < LOD .060 (<LOD-.160) .180 (.090-.300) .250 (.160-.480) 137 
 03-04 .043 (.033-.058) .029 (<LOD-.054) .092 (.055-.140) .210 (.140-.290) .320 (.240-.460) 302 
 05-06 * .026 (<LOD-.034) .077 (.051-.110) .180 (.150-.221) .280 (.220-.360) 812 
 07-08 * < LOD .075 (.056-.093) .180 (.136-.284) .318 (.240-.512) 556 
Non-Hispanic whites 01-02 * .030 (<LOD-.060) .110 (.070-.160) .210 (.140-.340) .330 (.190-.510) 411 
 03-04 * .028 (.025-.033) .068 (.053-.088) .180 (.150-.200) .280 (.210-.330) 687 
 05-06 * .027 (<LOD-.031) .069 (.049-.091) .240 (.190-.280) .330 (.270-.390) 1309 
 07-08 * < LOD .051 (.028-.107) .226 (.182-.276) .313 (.276-.388) 1210 
Limit of detection (LOD, see Data Analysis section) for Survey years 01-02, 03-04, 05-06, and 07-08 are 0.024, 0.024, 0.024, and 0.024, respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Blood Chlorobenzene (Monochlorobenzene) (2003 - 2008) 
 
Geometric mean and selected percentiles of whole blood concentrations (in ng/mL) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 1366 
 05-06 * < LOD < LOD < LOD < LOD 3072 
 07-08 * < LOD < LOD < LOD < LOD 2749 
Age group        
12-19 years 05-06 * < LOD < LOD < LOD < LOD 910 
 07-08 * < LOD < LOD < LOD < LOD 434 
20-59 years 03-04 * < LOD < LOD < LOD < LOD 1366 
 05-06 * < LOD < LOD < LOD < LOD 1495 
 07-08 * < LOD < LOD < LOD < LOD 1487 
60 years and older 05-06 * < LOD < LOD < LOD < LOD 667 
 07-08 * < LOD < LOD < LOD < LOD 828 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 669 
 05-06 * < LOD < LOD < LOD < LOD 1453 
 07-08 * < LOD < LOD < LOD < LOD 1358 
Females 03-04 * < LOD < LOD < LOD < LOD 697 
 05-06 * < LOD < LOD < LOD < LOD 1619 
 07-08 * < LOD < LOD < LOD < LOD 1391 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 267 
 05-06 * < LOD < LOD < LOD < LOD 740 
 07-08 * < LOD < LOD < LOD < LOD 524 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 300 
 05-06 * < LOD < LOD < LOD < LOD 817 
 07-08 * < LOD < LOD < LOD < LOD 568 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 694 
 05-06 * < LOD < LOD < LOD < LOD 1287 
 07-08 * < LOD < LOD < LOD < LOD 1227 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, and 07-08 are 0.011, 0.011, and 0.011, respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Blood Dibromomethane (2003 - 2008) 
 
Geometric mean and selected percentiles of whole blood concentrations (in ng/mL) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 1355 
 05-06 * < LOD < LOD < LOD < LOD 3152 
 07-08 * < LOD < LOD < LOD < LOD 2712 
Age group        
12-19 years 05-06 * < LOD < LOD < LOD < LOD 929 
 07-08 * < LOD < LOD < LOD < LOD 427 
20-59 years 03-04 * < LOD < LOD < LOD < LOD 1355 
 05-06 * < LOD < LOD < LOD < LOD 1554 
 07-08 * < LOD < LOD < LOD < LOD 1461 
60 years and older 05-06 * < LOD < LOD < LOD < LOD 669 
 07-08 * < LOD < LOD < LOD < LOD 824 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 666 
 05-06 * < LOD < LOD < LOD < LOD 1494 
 07-08 * < LOD < LOD < LOD < LOD 1345 
Females 03-04 * < LOD < LOD < LOD < LOD 689 
 05-06 * < LOD < LOD < LOD < LOD 1658 
 07-08 * < LOD < LOD < LOD < LOD 1367 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 267 
 05-06 * < LOD < LOD < LOD < LOD 778 
 07-08 * < LOD < LOD < LOD < LOD 510 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 292 
 05-06 * < LOD < LOD < LOD < LOD 816 
 07-08 * < LOD < LOD < LOD < LOD 556 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 693 
 05-06 * < LOD < LOD < LOD < LOD 1324 
 07-08 * < LOD < LOD < LOD < LOD 1236 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, and 07-08 are 0.03, 0.03, and 0.03, respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Blood Dichloromethane (Methylene chloride) (2003 - 2008) 
 
Geometric mean and selected percentiles of whole blood concentrations (in ng/mL) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 1165 
 05-06 * < LOD < LOD < LOD < LOD 2852 
 07-08 * < LOD < LOD < LOD < LOD 2569 
Age group        
12-19 years 05-06 * < LOD < LOD < LOD < LOD 837 
 07-08 * < LOD < LOD < LOD < LOD 416 
20-59 years 03-04 * < LOD < LOD < LOD < LOD 1165 
 05-06 * < LOD < LOD < LOD < LOD 1400 
 07-08 * < LOD < LOD < LOD < LOD 1369 
60 years and older 05-06 * < LOD < LOD < LOD < LOD 615 
 07-08 * < LOD < LOD < LOD < LOD 784 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 568 
 05-06 * < LOD < LOD < LOD < LOD 1338 
 07-08 * < LOD < LOD < LOD < LOD 1279 
Females 03-04 * < LOD < LOD < LOD < LOD 597 
 05-06 * < LOD < LOD < LOD < LOD 1514 
 07-08 * < LOD < LOD < LOD < LOD 1290 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 225 
 05-06 * < LOD < LOD < LOD < LOD 731 
 07-08 * < LOD < LOD < LOD < LOD 521 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 245 
 05-06 * < LOD < LOD < LOD < LOD 729 
 07-08 * < LOD < LOD < LOD < LOD 476 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 607 
 05-06 * < LOD < LOD < LOD < LOD 1186 
 07-08 * < LOD < LOD < LOD < LOD 1154 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, and 07-08 are 0.07, 0.25, and 0.25, respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Blood Ethylbenzene (2001 - 2008) 
 
Geometric mean and selected percentiles of whole blood concentrations (in ng/mL) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 01-02 .034 (.029-.039) .030 (.030-.040) .050 (.050-.070) .090 (.070-.120) .140 (.090-.180) 879 
 03-04 .035 (.033-.037) .032 (.030-.036) .053 (.048-.057) .083 (.077-.088) .110 (.098-.120) 1299 
 05-06 .038 (.036-.041) .035 (.033-.037) .059 (.052-.067) .100 (.093-.114) .140 (.122-.160) 3119 
 07-08 * < LOD .038 (.031-.047) .083 (.071-.098) .122 (.099-.143) 2750 
Age group        
12-19 years 05-06 .032 (.030-.034) .031 (.029-.033) .046 (.042-.049) .070 (.058-.085) .096 (.075-.120) 909 
 07-08 * < LOD .026 (<LOD-.035) .051 (.036-.059) .068 (.057-.090) 448 
20-59 years 01-02 .034 (.029-.039) .030 (.030-.040) .050 (.050-.070) .090 (.070-.120) .140 (.090-.180) 879 
 03-04 .035 (.033-.037) .032 (.030-.036) .053 (.048-.057) .083 (.077-.088) .110 (.098-.120) 1299 
 05-06 .040 (.037-.043) .037 (.034-.039) .062 (.054-.073) .110 (.098-.126) .150 (.130-.180) 1539 
 07-08 * < LOD .045 (.036-.056) .094 (.077-.114) .131 (.112-.160) 1473 
60 years and older 05-06 .037 (.033-.040) .033 (.030-.036) .056 (.046-.068) .098 (.090-.110) .130 (.110-.160) 671 
 07-08 * < LOD .032 (.026-.038) .062 (.050-.083) .100 (.074-.123) 829 
Gender        
Males 01-02 .035 (.029-.041) .030 (<LOD-.040) .060 (.040-.070) .100 (.070-.150) .150 (.090-.220) 419 
 03-04 .037 (.034-.041) .036 (.031-.040) .057 (.051-.065) .086 (.078-.099) .110 (.094-.130) 625 
 05-06 .042 (.039-.044) .038 (.036-.041) .067 (.057-.074) .114 (.099-.131) .160 (.136-.180) 1474 
 07-08 * < LOD .044 (.037-.056) .090 (.077-.105) .128 (.102-.154) 1356 
Females 01-02 .033 (.028-.038) .030 (.030-.040) .050 (.040-.060) .080 (.060-.120) .130 (.070-.180) 460 
 03-04 .032 (.030-.034) .030 (.027-.033) .048 (.041-.053) .081 (.071-.089) .100 (.091-.120) 674 
 05-06 .035 (.032-.038) .032 (.029-.035) .052 (.047-.061) .093 (.081-.103) .120 (.106-.150) 1645 
 07-08 * < LOD .032 (.027-.043) .074 (.058-.092) .116 (.089-.134) 1394 
Race/ethnicity        
Mexican Americans 01-02 * .030 (<LOD-.040) .040 (.040-.060) .070 (.050-.110) .120 (.070-.210) 220 
 03-04 .031 (.027-.036) .029 (<LOD-.035) .044 (.035-.048) .064 (.051-.074) .091 (.066-.170) 253 
 05-06 .032 (.028-.036) .030 (.026-.036) .047 (.039-.057) .072 (.051-.093) .086 (.073-.120) 752 
 07-08 * < LOD .029 (.025-.036) .050 (.040-.068) .072 (.059-.100) 557 
Non-Hispanic blacks 01-02 .032 (.027-.038) .030 (<LOD-.040) .050 (.030-.070) .080 (.060-.130) .130 (.070-.240) 159 
 03-04 .032 (.027-.038) .030 (<LOD-.037) .050 (.037-.066) .079 (.065-.100) .110 (.084-.130) 281 
 05-06 .037 (.035-.040) .034 (.030-.038) .057 (.052-.064) .095 (.085-.100) .120 (.104-.140) 809 
 07-08 * < LOD .048 (.037-.053) .086 (.066-.105) .117 (.089-.170) 559 
Non-Hispanic whites 01-02 .035 (.029-.043) .030 (<LOD-.040) .060 (.050-.070) .090 (.070-.140) .150 (.090-.190) 432 
 03-04 .036 (.034-.038) .034 (.030-.038) .055 (.050-.061) .087 (.081-.092) .110 (.098-.130) 669 
 05-06 .039 (.037-.042) .036 (.033-.038) .061 (.053-.072) .110 (.095-.120) .150 (.125-.180) 1326 
 07-08 * < LOD .040 (.031-.053) .090 (.075-.112) .128 (.105-.154) 1190 
Limit of detection (LOD, see Data Analysis section) for Survey years 01-02, 03-04, 05-06, and 07-08 are 0.024, 0.024, 0.024, and 0.024, respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Blood Furan (2007 - 2008) 
 
Geometric mean and selected percentiles of whole blood concentrations (in ng/mL) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 07-08 * < LOD < LOD .042 (<LOD-.065) .089 (.068-.106) 2758 
Age group        
12-19 years 07-08 * < LOD < LOD < LOD < LOD 450 
20-59 years 07-08 * < LOD < LOD .066 (.032-.088) .099 (.082-.128) 1455 
60 years and older 07-08 * < LOD < LOD < LOD .052 (<LOD-.084) 853 
Gender        
Males 07-08 * < LOD < LOD .051 (<LOD-.074) .091 (.062-.121) 1367 
Females 07-08 * < LOD < LOD .038 (<LOD-.063) .087 (.050-.102) 1391 
Race/ethnicity        
Mexican Americans 07-08 * < LOD < LOD < LOD < LOD 540 
Non-Hispanic blacks 07-08 * < LOD < LOD .039 (.026-.050) .083 (.050-.099) 575 
Non-Hispanic whites 07-08 * < LOD < LOD .056 (<LOD-.083) .098 (.080-.124) 1206 
Limit of detection (LOD, see Data Analysis section) for Survey year 07-08 is 0.025. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Blood Hexachloroethane (2003 - 2008) 
 
Geometric mean and selected percentiles of whole blood concentrations (in ng/mL) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 1366 
 05-06 * < LOD < LOD < LOD < LOD 3155 
 07-08 * < LOD < LOD < LOD < LOD 2627 
Age group        
12-19 years 05-06 * < LOD < LOD < LOD < LOD 930 
 07-08 * < LOD < LOD < LOD < LOD 419 
20-59 years 03-04 * < LOD < LOD < LOD < LOD 1366 
 05-06 * < LOD < LOD < LOD < LOD 1547 
 07-08 * < LOD < LOD < LOD < LOD 1417 
60 years and older 05-06 * < LOD < LOD < LOD < LOD 678 
 07-08 * < LOD < LOD < LOD < LOD 791 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 669 
 05-06 * < LOD < LOD < LOD < LOD 1495 
 07-08 * < LOD < LOD < LOD < LOD 1285 
Females 03-04 * < LOD < LOD < LOD < LOD 697 
 05-06 * < LOD < LOD < LOD < LOD 1660 
 07-08 * < LOD < LOD < LOD < LOD 1342 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 267 
 05-06 * < LOD < LOD < LOD < LOD 758 
 07-08 * < LOD < LOD < LOD < LOD 506 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 300 
 05-06 * < LOD < LOD < LOD < LOD 830 
 07-08 * < LOD < LOD < LOD < LOD 531 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 694 
 05-06 * < LOD < LOD < LOD < LOD 1335 
 07-08 * < LOD < LOD < LOD < LOD 1191 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, and 07-08 are 0.011, 0.011, and 0.011, respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Blood Isopropylbenzene (Cumene) (2007 - 2008) 
 
Geometric mean and selected percentiles of whole blood concentrations (in ng/mL) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 07-08 * < LOD < LOD < LOD < LOD 2752 
Age group        
12-19 years 07-08 * < LOD < LOD < LOD < LOD 448 
20-59 years 07-08 * < LOD < LOD < LOD < LOD 1479 
60 years and older 07-08 * < LOD < LOD < LOD < LOD 825 
Gender        
Males 07-08 * < LOD < LOD < LOD < LOD 1369 
Females 07-08 * < LOD < LOD < LOD < LOD 1383 
Race/ethnicity        
Mexican Americans 07-08 * < LOD < LOD < LOD < LOD 518 
Non-Hispanic blacks 07-08 * < LOD < LOD < LOD < LOD 544 
Non-Hispanic whites 07-08 * < LOD < LOD < LOD < LOD 1251 
Limit of detection (LOD, see Data Analysis section) for Survey year 07-08 is 0.04. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Blood Methyl-tert-Butyl Ether (MTBE) (2001 - 2008) 
 
Geometric mean and selected percentiles of whole blood concentrations (in pg/mL) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 01-02 16.4 (4.77-56.7) 27.7 (7.29-64.9) 73.8 (35.5-127) 132 (64.0-278) 188 (109-339) 672 
 03-04 11.0 (5.98-20.1) 10.0 (4.60-25.1) 45.0 (16.0-98.0) 110 (70.0-180) 170 (110-340) 1307 
 05-06 6.16 (2.94-12.9) 4.60 (1.80-15.0) 20.0 (5.20-73.0) 75.0 (22.0-140) 110 (49.0-250) 3080 
 07-08 * < LOD < LOD 3.50 (2.00-7.83) 7.27 (3.40-22.3) 2964 
Age group        
12-19 years 05-06 5.85 (2.61-13.1) 4.20 (1.40-18.0) 18.0 (4.60-75.0) 70.0 (18.0-140) 110 (62.0-180) 911 
 07-08 * < LOD < LOD 3.74 (1.90-8.47) 8.43 (3.10-19.0) 476 
20-59 years 01-02 16.4 (4.77-56.7) 27.7 (7.29-64.9) 73.8 (35.5-127) 132 (64.0-278) 188 (109-339) 672 
 03-04 11.0 (5.98-20.1) 10.0 (4.60-25.1) 45.0 (16.0-98.0) 110 (70.0-180) 170 (110-340) 1307 
 05-06 6.26 (3.05-12.9) 4.80 (2.00-14.0) 20.0 (5.50-70.0) 71.0 (21.0-150) 110 (46.0-250) 1512 
 07-08 * < LOD < LOD 3.16 (1.90-5.10) 5.10 (2.87-19.0) 1597 
60 years and older 05-06 6.00 (2.67-13.5) 3.80 (1.60-14.0) 22.0 (4.00-94.0) 86.0 (19.0-180) 120 (55.0-290) 657 
 07-08 * < LOD 1.80 (<LOD-3.10) 6.00 (2.70-14.5) 14.0 (5.25-28.0) 891 
Gender        
Males 01-02 16.9 (4.96-57.7) 27.9 (6.82-64.6) 75.0 (35.5-131) 132 (54.9-307) 167 (109-417) 334 
 03-04 12.2 (6.29-23.6) 11.0 (4.80-29.0) 55.0 (18.0-110) 130 (79.0-200) 200 (110-470) 641 
 05-06 6.24 (3.07-12.7) 4.60 (1.90-15.0) 20.0 (5.90-69.0) 73.0 (25.0-120) 110 (52.0-230) 1462 
 07-08 * < LOD 1.40 (<LOD-2.21) 3.40 (1.93-8.40) 7.27 (3.00-26.0) 1481 
Females 01-02 16.0 (4.12-61.8) 26.6 (5.93-74.6) 72.7 (32.6-132) 142 (73.5-255) 194 (92.3-336) 338 
 03-04 9.88 (5.62-17.4) 8.90 (4.30-23.0) 38.0 (14.0-85.0) 94.0 (58.0-160) 140 (90.0-250) 666 
 05-06 6.08 (2.81-13.1) 4.50 (1.70-14.0) 19.0 (4.90-79.0) 76.0 (20.0-160) 110 (48.0-250) 1618 
 07-08 * < LOD < LOD 3.50 (1.90-8.40) 7.30 (3.60-16.5) 1483 
Race/ethnicity        
Mexican Americans 01-02 23.3 (4.96-110) 33.4 (2.92-187) 91.3 (26.1-255) 225 (80.6-339) 273 (182-358) 166 
 03-04 11.6 (5.35-25.3) 12.0 (3.80-29.0) 32.0 (14.0-80.0) 80.0 (38.0-190) 160 (74.0-220) 245 
 05-06 7.61 (2.99-19.3) 5.40 (2.00-33.0) 30.0 (4.60-90.0) 67.0 (26.0-190) 100 (45.0-330) 735 
 07-08 * < LOD 1.71 (<LOD-2.90) 4.10 (2.19-9.60) 8.80 (5.20-11.5) 559 
Non-Hispanic blacks 01-02 14.9 (6.11-36.4) 26.4 (3.11-55.6) 52.6 (30.0-86.8) 87.4 (38.6-155) 120 (70.0-155) 119 
 03-04 9.63 (4.83-19.2) 10.0 (3.50-28.0) 32.8 (11.0-85.0) 77.0 (36.0-160) 140 (61.0-210) 285 
 05-06 9.14 (3.16-26.5) 5.70 (1.80-50.0) 48.0 (5.00-150) 120 (46.0-280) 180 (88.0-460) 820 
 07-08 * < LOD 1.90 (<LOD-3.80) 3.50 (2.40-7.27) 5.80 (3.50-15.3) 587 
Non-Hispanic whites 01-02 16.0 (4.13-62.4) 27.9 (4.71-74.6) 72.7 (33.3-132) 132 (59.6-249) 165 (92.8-366) 333 
 03-04 11.5 (5.51-23.8) 11.0 (4.00-33.5) 59.0 (14.0-120) 120 (73.0-230) 180 (110-430) 673 
 05-06 5.55 (2.47-12.5) 4.00 (<LOD-15.0) 16.0 (4.30-75.0) 70.0 (15.0-150) 110 (40.0-250) 1291 
 07-08 * < LOD < LOD 3.30 (1.42-12.0) 7.10 (2.59-31.0) 1349 
Limit of detection (LOD, see Data Analysis section) for Survey years 01-02, 03-04, 05-06, and 07-08 are 0.232, 2.0, 1.4, and 1.4, respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Blood Nitrobenzene (2003 - 2008) 
 
Geometric mean and selected percentiles of whole blood concentrations (in ng/mL) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 03-04 * < LOD < LOD < LOD < LOD 1066 
 05-06 * < LOD < LOD < LOD < LOD 3144 
 07-08 * < LOD < LOD < LOD < LOD 2764 
Age group        
12-19 years 05-06 * < LOD < LOD < LOD < LOD 926 
 07-08 * < LOD < LOD < LOD < LOD 437 
20-59 years 03-04 * < LOD < LOD < LOD < LOD 1066 
 05-06 * < LOD < LOD < LOD < LOD 1549 
 07-08 * < LOD < LOD < LOD < LOD 1499 
60 years and older 05-06 * < LOD < LOD < LOD < LOD 669 
 07-08 * < LOD < LOD < LOD < LOD 828 
Gender        
Males 03-04 * < LOD < LOD < LOD < LOD 529 
 05-06 * < LOD < LOD < LOD < LOD 1491 
 07-08 * < LOD < LOD < LOD < LOD 1362 
Females 03-04 * < LOD < LOD < LOD < LOD 537 
 05-06 * < LOD < LOD < LOD < LOD 1653 
 07-08 * < LOD < LOD < LOD < LOD 1402 
Race/ethnicity        
Mexican Americans 03-04 * < LOD < LOD < LOD < LOD 206 
 05-06 * < LOD < LOD < LOD < LOD 773 
 07-08 * < LOD < LOD < LOD < LOD 525 
Non-Hispanic blacks 03-04 * < LOD < LOD < LOD < LOD 205 
 05-06 * < LOD < LOD < LOD < LOD 816 
 07-08 * < LOD < LOD < LOD < LOD 568 
Non-Hispanic whites 03-04 * < LOD < LOD < LOD < LOD 564 
 05-06 * < LOD < LOD < LOD < LOD 1322 
 07-08 * < LOD < LOD < LOD < LOD 1248 
Limit of detection (LOD, see Data Analysis section) for Survey years 03-04, 05-06, and 07-08 are 0.3, 0.3, and 0.32, respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Blood Nitromethane (2007 - 2008) 
 
Geometric mean and selected percentiles of whole blood concentrations (in pg/mL) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 07-08 685 (643-729) 668 (618-714) 864 (790-926) 1080 (1020-1160) 1320 (1200-1420) 2766 
Age group        
12-19 years 07-08 590 (554-629) 590 (552-628) 717 (676-798) 883 (819-986) 998 (919-1080) 451 
20-59 years 07-08 688 (650-728) 675 (628-719) 866 (798-921) 1050 (1000-1120) 1260 (1120-1360) 1495 
60 years and older 07-08 739 (670-816) 692 (600-816) 960 (840-1110) 1340 (1210-1490) 1600 (1390-1950) 820 
Gender        
Males 07-08 679 (639-722) 664 (620-712) 853 (785-912) 1050 (993-1130) 1260 (1130-1420) 1384 
Females 07-08 690 (645-738) 670 (612-721) 871 (786-948) 1100 (1040-1200) 1370 (1260-1480) 1382 
Race/ethnicity        
Mexican Americans 07-08 689 (632-752) 667 (606-736) 845 (759-961) 1080 (982-1160) 1260 (1120-1560) 535 
Non-Hispanic blacks 07-08 754 (714-796) 720 (673-792) 929 (870-1010) 1220 (1120-1320) 1500 (1340-1640) 545 
Non-Hispanic whites 07-08 666 (619-716) 648 (597-704) 834 (756-919) 1040 (993-1150) 1270 (1160-1420) 1289 
Limit of detection (LOD, see Data Analysis section) for Survey year 07-08 is 65.0. 
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Blood Styrene (2001 - 2008) 
 
Geometric mean and selected percentiles of whole blood concentrations (in ng/mL) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 01-02 * < LOD .080 (.050-.100) .130 (.090-.200) .200 (.140-.260) 950 
 03-04 * < LOD .050 (.044-.061) .089 (.081-.097) .120 (.110-.130) 1245 
 05-06 * < LOD .047 (.042-.056) .099 (.086-.113) .135 (.120-.160) 2808 
 07-08 * < LOD .045 (.036-.056) .096 (.083-.109) .130 (.115-.151) 2719 
Age group        
12-19 years 05-06 * < LOD .039 (.031-.049) .058 (.050-.071) .072 (.059-.089) 827 
 07-08 * < LOD .031 (<LOD-.035) .047 (.039-.061) .074 (.049-.085) 448 
20-59 years 01-02 * < LOD .080 (.050-.100) .130 (.090-.200) .200 (.140-.260) 950 
 03-04 * < LOD .050 (.044-.061) .089 (.081-.097) .120 (.110-.130) 1245 
 05-06 * < LOD .051 (.044-.065) .110 (.094-.120) .150 (.120-.180) 1380 
 07-08 * < LOD .055 (.041-.076) .109 (.094-.130) .151 (.130-.172) 1459 
60 years and older 05-06 * < LOD .041 (.033-.055) .083 (.072-.110) .130 (.100-.150) 601 
 07-08 * < LOD .034 (.031-.039) .065 (.055-.079) .094 (.080-.103) 812 
Gender        
Males 01-02 * < LOD .080 (.050-.110) .140 (.100-.230) .220 (.140-.340) 445 
 03-04 * < LOD .056 (.045-.068) .089 (.081-.100) .120 (.095-.150) 608 
 05-06 * < LOD .052 (.043-.067) .110 (.096-.120) .142 (.120-.170) 1326 
 07-08 * < LOD .051 (.041-.069) .102 (.086-.123) .144 (.117-.169) 1344 
Females 01-02 * < LOD .070 (.050-.100) .120 (.090-.180) .180 (.120-.260) 505 
 03-04 * < LOD .048 (.040-.060) .090 (.074-.100) .110 (.097-.140) 637 
 05-06 * < LOD .045 (.038-.052) .087 (.077-.100) .129 (.107-.150) 1482 
 07-08 * < LOD .038 (.031-.051) .087 (.071-.102) .127 (.104-.149) 1375 
Race/ethnicity        
Mexican Americans 01-02 * < LOD .050 (.030-.070) .090 (.070-.110) .120 (.090-.470) 225 
 03-04 * < LOD < LOD .049 (.033-.066) .062 (.048-.100) 241 
 05-06 * < LOD .035 (<LOD-.047) .060 (.042-.092) .092 (.064-.110) 603 
 07-08 * < LOD .030 (<LOD-.035) .049 (.042-.060) .067 (.055-.084) 510 
Non-Hispanic blacks 01-02 * .040 (<LOD-.080) .100 (.040-.180) .180 (.110-.350) .300 (.170-1.00) 192 
 03-04 * < LOD .060 (.047-.077) .100 (.077-.130) .130 (.110-.160) 264 
 05-06 * < LOD .056 (.047-.064) .100 (.079-.120) .145 (.115-.180) 781 
 07-08 * < LOD .047 (.040-.055) .098 (.077-.112) .137 (.110-.192) 554 
Non-Hispanic whites 01-02 * .030 (<LOD-.050) .080 (.050-.110) .130 (.090-.210) .200 (.130-.260) 462 
 03-04 * < LOD .056 (.046-.067) .096 (.083-.110) .130 (.110-.140) 646 
 05-06 * < LOD .049 (.043-.058) .103 (.087-.120) .140 (.120-.174) 1217 
 07-08 * < LOD .049 (.037-.069) .104 (.090-.118) .143 (.127-.158) 1218 
Limit of detection (LOD, see Data Analysis section) for Survey years 01-02, 03-04, 05-06, and 07-08 are 0.03, 0.03, 0.03, and 0.03, respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Blood Tetrachloroethene (Perchloroethylene) (2001 - 2008) 
 
Geometric mean and selected percentiles of whole blood concentrations (in ng/mL) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 01-02 * < LOD .050 (<LOD-.060) .100 (.070-.150) .190 (.130-.260) 978 
 03-04 * < LOD < LOD .076 (.060-.097) .140 (.091-.300) 1317 
 05-06 * < LOD < LOD .070 (.056-.088) .126 (.098-.170) 2940 
 07-08 * < LOD < LOD .056 (.049-.061) .094 (.075-.125) 2735 
Age group        
12-19 years 05-06 * < LOD < LOD .049 (<LOD-.062) .079 (.057-.106) 865 
 07-08 * < LOD < LOD < LOD .066 (<LOD-.082) 446 
20-59 years 01-02 * < LOD .050 (<LOD-.060) .100 (.070-.150) .190 (.130-.260) 978 
 03-04 * < LOD < LOD .076 (.060-.097) .140 (.091-.300) 1317 
 05-06 * < LOD < LOD .074 (.056-.100) .130 (.098-.199) 1458 
 07-08 * < LOD < LOD .056 (.050-.066) .102 (.076-.158) 1482 
60 years and older 05-06 * < LOD < LOD .071 (.054-.092) .113 (.092-.190) 617 
 07-08 * < LOD < LOD .057 (<LOD-.070) .095 (.065-.151) 806 
Gender        
Males 01-02 * < LOD .050 (<LOD-.060) .110 (.070-.170) .210 (.170-.340) 457 
 03-04 * < LOD < LOD .082 (.060-.140) .230 (.097-.410) 639 
 05-06 * < LOD < LOD .085 (.062-.126) .172 (.113-.300) 1404 
 07-08 * < LOD < LOD .059 (.053-.071) .136 (.095-.191) 1351 
Females 01-02 * < LOD .050 (<LOD-.060) .100 (.070-.140) .150 (.100-.220) 521 
 03-04 * < LOD < LOD .069 (.050-.091) .120 (.085-.180) 678 
 05-06 * < LOD < LOD .056 (.049-.071) .090 (.070-.130) 1536 
 07-08 * < LOD < LOD .050 (<LOD-.059) .073 (.061-.112) 1384 
Race/ethnicity        
Mexican Americans 01-02 * < LOD < LOD .060 (<LOD-.070) .070 (.060-.230) 226 
 03-04 * < LOD < LOD .049 (<LOD-.097) .100 (.054-.180) 248 
 05-06 * < LOD < LOD .069 (.056-.074) .130 (.073-.284) 713 
 07-08 * < LOD < LOD .061 (<LOD-.081) .112 (.072-.190) 544 
Non-Hispanic blacks 01-02 * < LOD < LOD .070 (.050-.110) .110 (.060-.190) 195 
 03-04 * < LOD < LOD .086 (.050-.220) .220 (.082-.360) 284 
 05-06 * < LOD < LOD .074 (.057-.112) .120 (.069-.280) 776 
 07-08 * < LOD < LOD .060 (<LOD-.095) .106 (.074-.149) 549 
Non-Hispanic whites 01-02 * < LOD .050 (<LOD-.070) .110 (.090-.170) .210 (.150-.260) 487 
 03-04 * < LOD < LOD .072 (.060-.091) .140 (.085-.330) 686 
 05-06 * < LOD < LOD .070 (.053-.090) .130 (.092-.180) 1229 
 07-08 * < LOD < LOD .053 (<LOD-.059) .080 (.069-.112) 1219 
Limit of detection (LOD, see Data Analysis section) for Survey years 01-02, 03-04, 05-06, and 07-08 are 0.048, 0.048, 0.048, and 0.048, respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 






Fourth National Report on Human Exposure to Environmental Chemicals, Updated Tables, January 2017 Volume One Page 565
Blood Tetrachloromethane (Carbon tetrachloride) (2001 - 2008) 
 
Geometric mean and selected percentiles of whole blood concentrations (in ng/mL) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 01-02 * < LOD .010 (<LOD-.010) .010 (<LOD-.140) .020 (.010-.050) 742 
 03-04 * < LOD < LOD < LOD < LOD 1362 
 05-06 * < LOD < LOD < LOD < LOD 2979 
 07-08 * < LOD < LOD < LOD < LOD 2812 
Age group        
12-19 years 05-06 * < LOD < LOD < LOD < LOD 882 
 07-08 * < LOD < LOD < LOD < LOD 456 
20-59 years 01-02 * < LOD .010 (<LOD-.010) .010 (<LOD-.140) .020 (.010-.050) 742 
 03-04 * < LOD < LOD < LOD < LOD 1362 
 05-06 * < LOD < LOD < LOD < LOD 1476 
 07-08 * < LOD < LOD < LOD < LOD 1526 
60 years and older 05-06 * < LOD < LOD < LOD < LOD 621 
 07-08 * < LOD < LOD < LOD < LOD 830 
Gender        
Males 01-02 * < LOD .010 (<LOD-.010) .010 (<LOD-.140) .010 (.010-.040) 364 
 03-04 * < LOD < LOD < LOD < LOD 667 
 05-06 * < LOD < LOD < LOD < LOD 1419 
 07-08 * < LOD < LOD < LOD < LOD 1388 
Females 01-02 * < LOD .010 (<LOD-.010) .010 (<LOD-.090) .040 (.010-.080) 378 
 03-04 * < LOD < LOD < LOD < LOD 695 
 05-06 * < LOD < LOD < LOD < LOD 1560 
 07-08 * < LOD < LOD < LOD < LOD 1424 
Race/ethnicity        
Mexican Americans 01-02 * < LOD < LOD .010 (<LOD-.750) .020 (.010-.050) 193 
 03-04 * < LOD < LOD < LOD < LOD 266 
 05-06 * < LOD < LOD < LOD < LOD 740 
 07-08 * < LOD < LOD < LOD < LOD 555 
Non-Hispanic blacks 01-02 * < LOD .010 (<LOD-.010) .010 (<LOD-.020) .010 (<LOD-.020) 132 
 03-04 * < LOD < LOD < LOD < LOD 299 
 05-06 * < LOD < LOD < LOD < LOD 779 
 07-08 * < LOD < LOD < LOD < LOD 562 
Non-Hispanic whites 01-02 * < LOD .010 (<LOD-.010) .010 (<LOD-.140) .030 (.010-.080) 366 
 03-04 * < LOD < LOD < LOD < LOD 692 
 05-06 * < LOD < LOD < LOD < LOD 1237 
 07-08 * < LOD < LOD < LOD < LOD 1249 
Limit of detection (LOD, see Data Analysis section) for Survey years 01-02, 03-04, 05-06, and 07-08 are 0.01, 0.005, 0.005, and 0.005, respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Blood Toluene (2001 - 2008) 
 
Geometric mean and selected percentiles of whole blood concentrations (in ng/mL) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 01-02 .156 (.122-.198) .160 (.120-.220) .340 (.260-.430) .670 (.480-.950) 1.06 (.700-1.43) 954 
 03-04 .114 (.100-.129) .096 (.087-.110) .220 (.180-.260) .430 (.380-.550) .680 (.560-.880) 1336 
 05-06 .137 (.123-.152) .120 (.110-.130) .230 (.200-.262) .550 (.481-.640) .814 (.702-.937) 3050 
 07-08 .103 (.090-.119) .083 (.072-.098) .192 (.148-.256) .511 (.411-.608) .735 (.634-.888) 2731 
Age group        
12-19 years 05-06 .110 (.098-.122) .100 (.094-.120) .170 (.150-.180) .280 (.240-.310) .400 (.300-.610) 907 
 07-08 .067 (.057-.080) .061 (.053-.073) .100 (.078-.133) .205 (.141-.287) .318 (.228-.388) 439 
20-59 years 01-02 .156 (.122-.198) .160 (.120-.220) .340 (.260-.430) .670 (.480-.950) 1.06 (.700-1.43) 954 
 03-04 .114 (.100-.129) .096 (.087-.110) .220 (.180-.260) .430 (.380-.550) .680 (.560-.880) 1336 
 05-06 .147 (.133-.163) .120 (.110-.137) .260 (.210-.340) .594 (.505-.720) .900 (.730-1.10) 1505 
 07-08 .115 (.098-.135) .090 (.076-.110) .257 (.174-.339) .589 (.508-.692) .839 (.702-.976) 1483 
60 years and older 05-06 .124 (.100-.154) .114 (.097-.138) .190 (.167-.230) .520 (.370-.600) .720 (.600-.814) 638 
 07-08 .094 (.084-.105) .078 (.070-.091) .143 (.126-.173) .370 (.277-.479) .610 (.424-.742) 809 
Gender        
Males 01-02 .165 (.130-.209) .170 (.120-.230) .360 (.260-.520) .780 (.580-1.06) 1.22 (.850-1.43) 450 
 03-04 .128 (.112-.148) .110 (.096-.130) .250 (.190-.310) .500 (.380-.660) .730 (.590-1.10) 647 
 05-06 .152 (.139-.166) .130 (.120-.140) .280 (.240-.330) .640 (.550-.720) .920 (.790-1.10) 1441 
 07-08 .118 (.103-.135) .091 (.078-.113) .256 (.191-.311) .563 (.483-.663) .816 (.689-.928) 1370 
Females 01-02 .147 (.114-.190) .150 (.110-.220) .320 (.240-.390) .550 (.400-.740) .810 (.530-1.63) 504 
 03-04 .101 (.086-.118) .085 (.070-.100) .190 (.150-.230) .410 (.340-.500) .580 (.480-.750) 689 
 05-06 .124 (.107-.144) .110 (.097-.130) .190 (.170-.230) .470 (.380-.550) .690 (.550-.880) 1609 
 07-08 .091 (.078-.106) .074 (.065-.087) .151 (.119-.209) .444 (.297-.589) .679 (.533-.853) 1360 
Race/ethnicity        
Mexican Americans 01-02 .136 (.106-.176) .140 (.080-.210) .270 (.210-.340) .550 (.400-.980) .990 (.500-1.30) 219 
 03-04 .084 (.074-.096) .076 (.064-.091) .120 (.100-.170) .280 (.170-.410) .400 (.310-.620) 253 
 05-06 .110 (.097-.125) .110 (.096-.120) .160 (.140-.170) .240 (.220-.290) .340 (.290-.460) 737 
 07-08 .079 (.068-.093) .075 (.059-.094) .117 (.106-.142) .220 (.169-.292) .339 (.253-.409) 539 
Non-Hispanic blacks 01-02 .137 (.089-.210) .150 (.070-.200) .310 (.200-.460) .690 (.390-1.19) 1.15 (.660-1.69) 194 
 03-04 .105 (.077-.144) .095 (.070-.130) .200 (.130-.330) .440 (.290-.620) .620 (.480-.710) 297 
 05-06 .139 (.120-.161) .120 (.099-.140) .230 (.190-.290) .450 (.370-.550) .670 (.550-.830) 796 
 07-08 .108 (.097-.120) .083 (.076-.097) .220 (.179-.265) .463 (.380-.554) .663 (.486-.899) 567 
Non-Hispanic whites 01-02 .165 (.125-.217) .170 (.120-.240) .350 (.270-.450) .710 (.450-1.12) 1.14 (.710-1.63) 467 
 03-04 .123 (.110-.139) .100 (.092-.120) .240 (.210-.280) .500 (.400-.590) .750 (.590-.940) 685 
 05-06 .144 (.125-.166) .130 (.110-.140) .260 (.210-.330) .600 (.510-.710) .880 (.760-.990) 1291 
 07-08 .110 (.094-.128) .086 (.073-.102) .223 (.162-.310) .582 (.479-.693) .832 (.706-.974) 1200 
Limit of detection (LOD, see Data Analysis section) for Survey years 01-02, 03-04, 05-06, and 07-08 are 0.025, 0.025, 0.025, and 0.025, respectively. 
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Blood Trichloroethene (Trichloroethylene) (2001 - 2008) 
 
Geometric mean and selected percentiles of whole blood concentrations (in ng/mL) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 01-02 * < LOD < LOD < LOD < LOD 922 
 03-04 * < LOD < LOD < LOD < LOD 1228 
 05-06 * < LOD < LOD < LOD < LOD 3178 
 07-08 * < LOD < LOD < LOD < LOD 2952 
Age group        
12-19 years 05-06 * < LOD < LOD < LOD < LOD 937 
 07-08 * < LOD < LOD < LOD < LOD 473 
20-59 years 01-02 * < LOD < LOD < LOD < LOD 922 
 03-04 * < LOD < LOD < LOD < LOD 1228 
 05-06 * < LOD < LOD < LOD < LOD 1562 
 07-08 * < LOD < LOD < LOD < LOD 1592 
60 years and older 05-06 * < LOD < LOD < LOD < LOD 679 
 07-08 * < LOD < LOD < LOD < LOD 887 
Gender        
Males 01-02 * < LOD < LOD < LOD < LOD 434 
 03-04 * < LOD < LOD < LOD < LOD 604 
 05-06 * < LOD < LOD < LOD < LOD 1504 
 07-08 * < LOD < LOD < LOD < LOD 1466 
Females 01-02 * < LOD < LOD < LOD < LOD 488 
 03-04 * < LOD < LOD < LOD < LOD 624 
 05-06 * < LOD < LOD < LOD < LOD 1674 
 07-08 * < LOD < LOD < LOD < LOD 1486 
Race/ethnicity        
Mexican Americans 01-02 * < LOD < LOD < LOD < LOD 228 
 03-04 * < LOD < LOD < LOD < LOD 224 
 05-06 * < LOD < LOD < LOD < LOD 773 
 07-08 * < LOD < LOD < LOD < LOD 572 
Non-Hispanic blacks 01-02 * < LOD < LOD < LOD < LOD 191 
 03-04 * < LOD < LOD < LOD < LOD 266 
 05-06 * < LOD < LOD < LOD < LOD 828 
 07-08 * < LOD < LOD < LOD < LOD 583 
Non-Hispanic whites 01-02 * < LOD < LOD < LOD < LOD 441 
 03-04 * < LOD < LOD < LOD < LOD 644 
 05-06 * < LOD < LOD < LOD < LOD 1341 
 07-08 * < LOD < LOD < LOD < LOD 1329 
Limit of detection (LOD, see Data Analysis section) for Survey years 01-02, 03-04, 05-06, and 07-08 are 0.012, 0.012, 0.012, and 0.012, respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Blood m- and p-Xylene (2001 - 2008) 
 
Geometric mean and selected percentiles of whole blood concentrations (in ng/mL) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 01-02 .156 (.124-.198) .150 (.110-.200) .280 (.190-.430) .500 (.370-.690) .670 (.500-.890) 962 
 03-04 .136 (.123-.150) .130 (.120-.150) .200 (.190-.210) .280 (.260-.300) .340 (.310-.400) 1346 
 05-06 .132 (.122-.143) .120 (.110-.130) .190 (.170-.210) .301 (.270-.330) .410 (.360-.450) 3133 
 07-08 .079 (.069-.090) .072 (.061-.086) .130 (.108-.156) .231 (.200-.281) .343 (.281-.410) 2823 
Age group        
12-19 years 05-06 .118 (.106-.130) .120 (.110-.120) .160 (.150-.170) .220 (.190-.270) .330 (.240-.380) 923 
 07-08 .067 (.059-.076) .061 (.052-.074) .099 (.080-.125) .181 (.138-.205) .216 (.182-.282) 447 
20-59 years 01-02 .156 (.124-.198) .150 (.110-.200) .280 (.190-.430) .500 (.370-.690) .670 (.500-.890) 962 
 03-04 .136 (.123-.150) .130 (.120-.150) .200 (.190-.210) .280 (.260-.300) .340 (.310-.400) 1346 
 05-06 .137 (.127-.147) .130 (.120-.140) .200 (.180-.220) .320 (.280-.350) .430 (.360-.480) 1542 
 07-08 .083 (.072-.097) .076 (.065-.089) .143 (.116-.173) .256 (.210-.308) .379 (.290-.468) 1520 
60 years and older 05-06 .126 (.112-.142) .120 (.100-.130) .184 (.150-.220) .303 (.240-.360) .400 (.335-.463) 668 
 07-08 .073 (.063-.085) .068 (.055-.082) .113 (.097-.134) .209 (.179-.243) .308 (.255-.361) 854 
Gender        
Males 01-02 .155 (.121-.200) .140 (.110-.190) .280 (.180-.440) .510 (.350-.700) .700 (.500-.890) 455 
 03-04 .149 (.134-.166) .140 (.130-.170) .220 (.200-.230) .290 (.270-.320) .380 (.300-.490) 654 
 05-06 .145 (.135-.157) .130 (.130-.147) .220 (.190-.240) .340 (.310-.370) .460 (.430-.490) 1480 
 07-08 .088 (.077-.101) .080 (.068-.095) .153 (.128-.178) .260 (.224-.308) .392 (.305-.470) 1395 
Females 01-02 .157 (.124-.199) .150 (.110-.220) .270 (.190-.410) .480 (.360-.650) .650 (.460-.890) 507 
 03-04 .124 (.112-.138) .130 (.110-.140) .180 (.160-.200) .270 (.240-.300) .340 (.290-.390) 692 
 05-06 .120 (.109-.132) .110 (.100-.123) .170 (.151-.197) .260 (.220-.320) .340 (.300-.420) 1653 
 07-08 .071 (.061-.083) .066 (.054-.080) .110 (.091-.142) .201 (.169-.253) .296 (.240-.362) 1426 
Race/ethnicity        
Mexican Americans 01-02 .134 (.097-.184) .130 (.090-.180) .240 (.150-.370) .400 (.290-.540) .540 (.380-1.10) 223 
 03-04 .132 (.109-.160) .120 (.110-.150) .180 (.140-.230) .250 (.220-.320) .360 (.260-.490) 257 
 05-06 .108 (.093-.125) .110 (.098-.120) .150 (.130-.170) .220 (.170-.290) .270 (.220-.370) 755 
 07-08 .075 (.066-.084) .071 (.061-.085) .104 (.094-.120) .181 (.134-.240) .260 (.210-.410) 548 
Non-Hispanic blacks 01-02 .147 (.107-.202) .140 (.090-.220) .280 (.160-.460) .470 (.330-.850) .590 (.420-1.08) 198 
 03-04 .117 (.094-.146) .120 (.099-.140) .170 (.140-.220) .270 (.210-.330) .330 (.260-.450) 297 
 05-06 .131 (.120-.144) .120 (.110-.140) .190 (.170-.210) .280 (.250-.320) .350 (.320-.392) 823 
 07-08 .085 (.070-.103) .082 (.063-.103) .138 (.120-.160) .233 (.180-.294) .326 (.242-.420) 571 
Non-Hispanic whites 01-02 .163 (.124-.214) .160 (.110-.220) .300 (.190-.480) .520 (.370-.740) .700 (.510-.960) 468 
 03-04 .141 (.128-.155) .140 (.130-.150) .210 (.190-.220) .290 (.270-.310) .350 (.330-.400) 690 
 05-06 .136 (.125-.147) .130 (.120-.140) .200 (.180-.220) .324 (.280-.350) .430 (.368-.480) 1323 
 07-08 .080 (.069-.094) .072 (.058-.088) .138 (.109-.173) .248 (.209-.300) .371 (.290-.457) 1265 
Limit of detection (LOD, see Data Analysis section) for Survey years 01-02, 03-04, 05-06, and 07-08 are 0.034, 0.034, 0.034, and 0.034, respectively. 
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Blood o-Xylene (2001 - 2008) 
 
Geometric mean and selected percentiles of whole blood concentrations (in ng/mL) for the U.S. population from the National 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 01-02 * < LOD .070 (.050-.080) .100 (.080-.130) .130 (.110-.180) 981 
 03-04 * < LOD .051 (<LOD-.057) .072 (.066-.079) .090 (.081-.097) 1365 
 05-06 .037 (.034-.040) .035 (.032-.039) .053 (.047-.061) .083 (.072-.094) .110 (.094-.120) 3153 
 07-08 * < LOD .039 (.033-.047) .062 (.051-.076) .086 (.068-.128) 2835 
Age group        
12-19 years 05-06 .032 (.030-.034) .031 (.029-.034) .044 (.040-.049) .062 (.053-.075) .088 (.072-.100) 929 
 07-08 * < LOD .033 (.026-.044) .048 (.039-.080) .066 (.048-.180) 457 
20-59 years 01-02 * < LOD .070 (.050-.080) .100 (.080-.130) .130 (.110-.180) 981 
 03-04 * < LOD .051 (<LOD-.057) .072 (.066-.079) .090 (.081-.097) 1365 
 05-06 .038 (.034-.041) .036 (.032-.039) .055 (.048-.062) .083 (.073-.094) .110 (.093-.120) 1547 
 07-08 * .025 (<LOD-.030) .040 (.034-.048) .065 (.053-.079) .086 (.069-.140) 1524 
60 years and older 05-06 .038 (.033-.044) .036 (.032-.042) .054 (.046-.065) .092 (.065-.115) .115 (.094-.150) 677 
 07-08 * < LOD .038 (.031-.049) .061 (.052-.078) .091 (.068-.118) 854 
Gender        
Males 01-02 * < LOD .070 (.050-.090) .110 (.080-.140) .150 (.110-.180) 465 
 03-04 * < LOD .057 (.050-.060) .074 (.068-.084) .096 (.084-.110) 667 
 05-06 .040 (.036-.045) .038 (.033-.041) .058 (.050-.070) .092 (.082-.100) .120 (.100-.140) 1487 
 07-08 * .026 (<LOD-.031) .042 (.037-.048) .069 (.059-.083) .098 (.078-.146) 1407 
Females 01-02 * < LOD .060 (.050-.080) .100 (.070-.130) .120 (.100-.180) 516 
 03-04 * < LOD < LOD .067 (.059-.076) .085 (.074-.095) 698 
 05-06 .034 (.032-.037) .034 (.031-.036) .049 (.044-.054) .072 (.060-.086) .094 (.078-.110) 1666 
 07-08 * < LOD .036 (.029-.044) .056 (.046-.070) .076 (.056-.120) 1428 
Race/ethnicity        
Mexican Americans 01-02 * < LOD .060 (<LOD-.080) .090 (.080-.110) .120 (.090-.270) 227 
 03-04 * < LOD .052 (<LOD-.067) .074 (.067-.080) .100 (.075-.130) 265 
 05-06 .030 (.027-.033) .029 (.026-.031) .040 (.036-.045) .057 (.050-.069) .079 (.062-.097) 777 
 07-08 * .025 (<LOD-.028) .032 (.030-.038) .060 (.038-.140) .121 (.052-.210) 561 
Non-Hispanic blacks 01-02 * < LOD .050 (<LOD-.070) .100 (.080-.110) .110 (.100-.160) 197 
 03-04 * < LOD < LOD .065 (.055-.078) .084 (.068-.100) 301 
 05-06 .035 (.033-.038) .034 (.031-.038) .049 (.045-.054) .073 (.064-.077) .088 (.078-.100) 824 
 07-08 * .027 (<LOD-.035) .041 (.032-.054) .066 (.045-.130) .100 (.054-.470) 573 
Non-Hispanic whites 01-02 * < LOD .070 (.050-.090) .110 (.080-.140) .140 (.110-.180) 483 
 03-04 * < LOD .052 (<LOD-.058) .073 (.066-.082) .090 (.081-.100) 694 
 05-06 .039 (.035-.043) .037 (.033-.041) .056 (.049-.064) .087 (.074-.100) .110 (.096-.130) 1319 
 07-08 * < LOD .040 (.033-.048) .063 (.052-.079) .086 (.069-.117) 1242 
Limit of detection (LOD, see Data Analysis section) for Survey years 01-02, 03-04, 05-06, and 07-08 are 0.049, 0.049, 0.024, and 0.024, respectively. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary N-Acetyl-S-(2-carboxyethyl)-L-cysteine (2011 - 2012) 
Metabolite of Acrolein 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 96.5 (88.6-105) 100 (93.6-109) 195 (179-215) 354 (320-405) 494 (432-603) 2466 
Age group        
6-11 years 11-12 77.5 (68.2-87.9) 79.2 (62.6-98.4) 158 (136-181) 257 (217-330) 358 (267-528) 394 
12-19 years 11-12 81.8 (64.8-103) 94.2 (70.7-109) 159 (122-205) 279 (217-322) 414 (315-473) 384 
20 years and older 11-12 101 (92.3-111) 104 (94.6-118) 205 (184-228) 377 (324-432) 527 (445-685) 1688 
Gender        
Males 11-12 116 (106-128) 118 (107-126) 216 (191-252) 381 (343-448) 528 (474-620) 1251 
Females 11-12 80.5 (71.5-90.7) 82.3 (71.2-94.6) 178 (156-195) 321 (262-386) 447 (371-654) 1215 
Race/ethnicity        
Mexican Americans 11-12 90.3 (77.9-105) 88.2 (82.2-101) 158 (130-187) 270 (199-343) 399 (270-615) 313 
Non-Hispanic blacks 11-12 142 (129-156) 150 (135-163) 260 (238-288) 404 (350-468) 581 (491-665) 662 
Non-Hispanic whites 11-12 93.0 (82.6-105) 96.7 (87.5-109) 193 (166-222) 367 (310-416) 494 (431-642) 810 
All Hispanics 11-12 88.6 (76.2-103) 91.4 (77.7-109) 161 (130-190) 291 (228-341) 411 (325-512) 566 
Asians 11-12 73.2 (66.7-80.2) 77.6 (67.6-86.3) 135 (123-161) 257 (198-314) 366 (286-476) 341 
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Urinary N-Acetyl-S-(2-carboxyethyl)-L-cysteine (creatinine corrected) (2011 - 2012) 
Metabolite of Acrolein 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 110 (103-118) 103 (96.3-107) 176 (162-190) 311 (266-359) 454 (369-538) 2464 
Age group        
6-11 years 11-12 111 (102-120) 108 (98.5-119) 176 (163-191) 248 (226-295) 338 (253-357) 393 
12-19 years 11-12 79.6 (71.0-89.3) 75.3 (66.5-83.5) 116 (95.6-138) 175 (141-249) 249 (163-345) 384 
20 years and older 11-12 116 (107-125) 107 (102-113) 185 (172-196) 346 (284-404) 509 (409-633) 1687 
Gender        
Males 11-12 109 (102-117) 98.1 (88.7-110) 172 (153-190) 309 (262-361) 434 (359-531) 1250 
Females 11-12 111 (100-123) 105 (98.3-112) 180 (166-194) 320 (253-407) 493 (353-744) 1214 
Race/ethnicity        
Mexican Americans 11-12 102 (88.4-118) 96.0 (85.2-109) 153 (129-184) 232 (185-330) 337 (221-512) 313 
Non-Hispanic blacks 11-12 111 (103-118) 108 (102-114) 173 (154-187) 267 (231-297) 352 (284-428) 662 
Non-Hispanic whites 11-12 114 (104-125) 105 (95.4-112) 187 (165-207) 351 (289-410) 531 (423-629) 808 
All Hispanics 11-12 99.1 (89.2-110) 95.0 (85.8-103) 151 (138-163) 231 (206-272) 324 (235-397) 566 
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Urinary N-Acetyl-S-(3-hydroxypropyl)-L-cysteine (2011 - 2012) 
Metabolite of Acrolein 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 296 (273-321) 277 (251-306) 575 (509-652) 1270 (1110-1490) 2080 (1790-2630) 2466 
Age group        
6-11 years 11-12 222 (199-248) 224 (194-270) 452 (378-518) 697 (600-808) 894 (795-1090) 394 
12-19 years 11-12 252 (203-313) 249 (190-338) 499 (391-620) 900 (653-1160) 1470 (876-1970) 384 
20 years and older 11-12 313 (289-339) 290 (265-321) 616 (555-702) 1430 (1250-1620) 2440 (2040-2900) 1688 
Gender        
Males 11-12 355 (327-386) 330 (297-355) 622 (548-724) 1300 (1110-1740) 2170 (1880-3170) 1251 
Females 11-12 248 (220-280) 217 (195-250) 524 (450-615) 1200 (976-1610) 1940 (1690-2630) 1215 
Race/ethnicity        
Mexican Americans 11-12 290 (243-346) 294 (241-374) 549 (458-620) 952 (742-1110) 1380 (952-1930) 313 
Non-Hispanic blacks 11-12 372 (326-425) 353 (315-391) 727 (592-841) 1440 (1140-1820) 2210 (1820-2670) 662 
Non-Hispanic whites 11-12 281 (251-314) 256 (228-290) 558 (482-648) 1300 (1030-1640) 2300 (1770-2900) 810 
All Hispanics 11-12 280 (245-321) 280 (225-345) 523 (469-581) 969 (768-1140) 1400 (975-2020) 566 
Asians 11-12 329 (303-357) 316 (264-394) 731 (577-852) 1220 (976-1490) 1690 (1350-2560) 341 
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Urinary N-Acetyl-S-(3-hydroxypropyl)-L-cysteine (creatinine corrected) (2011 - 2012) 
Metabolite of Acrolein 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 338 (314-363) 276 (259-297) 545 (501-590) 1220 (1030-1410) 2190 (1800-2730) 2464 
Age group        
6-11 years 11-12 316 (295-339) 304 (273-329) 478 (415-519) 706 (573-826) 1020 (737-1240) 393 
12-19 years 11-12 246 (213-284) 222 (186-273) 361 (302-452) 584 (466-816) 868 (584-1220) 384 
20 years and older 11-12 357 (333-383) 286 (263-307) 612 (563-664) 1450 (1190-1750) 2690 (2110-3030) 1687 
Gender        
Males 11-12 334 (309-360) 271 (256-296) 521 (462-589) 1090 (884-1370) 1870 (1490-2600) 1250 
Females 11-12 342 (306-381) 284 (250-318) 564 (501-622) 1380 (1040-1750) 2440 (1910-2990) 1214 
Race/ethnicity        
Mexican Americans 11-12 327 (277-386) 294 (255-347) 482 (421-578) 816 (651-1000) 1090 (815-1840) 313 
Non-Hispanic blacks 11-12 290 (264-318) 241 (219-284) 434 (395-517) 923 (772-1130) 1370 (1110-1790) 662 
Non-Hispanic whites 11-12 343 (312-378) 272 (253-296) 551 (492-622) 1450 (1090-1800) 2690 (1920-3060) 808 
All Hispanics 11-12 314 (282-349) 286 (251-313) 484 (446-533) 850 (754-967) 1150 (947-1600) 566 





Fourth National Report on Human Exposure to Environmental Chemicals, Updated Tables, January 2017 Volume One Page 574
Urinary N-Acetyl-S-(2-carbamoylethyl)-L-cysteine (2011 - 2012) 
Metabolite of Acrylamide 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 46.6 (43.6-49.9) 45.9 (43.1-48.9) 88.4 (82.8-95.9) 170 (155-195) 276 (211-370) 2466 
Age group        
6-11 years 11-12 39.6 (36.0-43.5) 44.5 (40.0-51.5) 69.8 (60.5-82.2) 111 (96.8-126) 139 (122-187) 394 
12-19 years 11-12 53.5 (45.2-63.4) 49.8 (41.9-66.3) 119 (95.2-142) 168 (158-202) 279 (168-439) 384 
20 years and older 11-12 46.5 (42.6-50.7) 45.2 (42.4-49.0) 85.8 (79.9-97.4) 181 (154-208) 285 (221-384) 1688 
Gender        
Males 11-12 55.6 (50.8-60.9) 53.4 (48.8-59.8) 101 (84.9-116) 177 (157-215) 276 (220-382) 1251 
Females 11-12 39.3 (35.4-43.7) 38.7 (34.9-42.8) 75.3 (67.1-84.6) 158 (127-195) 272 (193-382) 1215 
Race/ethnicity        
Mexican Americans 11-12 48.6 (41.6-56.9) 51.5 (42.7-59.8) 87.7 (75.1-108) 143 (108-195) 195 (143-274) 313 
Non-Hispanic blacks 11-12 59.3 (54.0-65.0) 55.8 (49.9-62.2) 115 (93.8-141) 234 (178-276) 349 (293-419) 662 
Non-Hispanic whites 11-12 46.4 (42.0-51.3) 45.1 (41.4-49.6) 87.6 (78.5-101) 168 (151-202) 285 (195-420) 810 
All Hispanics 11-12 43.4 (37.3-50.5) 45.6 (38.7-52.2) 80.0 (69.1-91.1) 143 (112-186) 192 (163-264) 566 
Asians 11-12 31.8 (27.6-36.6) 33.3 (29.0-39.7) 58.4 (50.1-71.9) 109 (78.3-145) 153 (131-200) 341 
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Urinary N-Acetyl-S-(2-carbamoylethyl)-L-cysteine (creatinine corrected) (2011 - 2012) 
Metabolite of Acrylamide 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 53.3 (50.3-56.4) 49.5 (47.4-51.7) 82.0 (76.6-89.4) 146 (127-168) 199 (167-237) 2464 
Age group        
6-11 years 11-12 56.8 (53.5-60.4) 52.8 (50.9-56.2) 77.9 (70.3-84.6) 119 (105-143) 173 (121-202) 393 
12-19 years 11-12 52.1 (46.3-58.7) 48.2 (42.5-53.3) 81.1 (66.5-94.7) 133 (105-203) 203 (128-366) 384 
20 years and older 11-12 53.1 (49.7-56.6) 49.0 (46.0-52.0) 83.1 (76.6-91.5) 150 (129-173) 199 (162-262) 1687 
Gender        
Males 11-12 52.3 (49.0-55.8) 48.4 (43.4-54.6) 82.5 (73.5-92.8) 145 (124-159) 187 (159-230) 1250 
Females 11-12 54.3 (49.5-59.6) 50.3 (46.8-53.7) 82.0 (73.7-93.9) 155 (127-175) 210 (170-283) 1214 
Race/ethnicity        
Mexican Americans 11-12 54.9 (45.6-66.1) 53.2 (45.3-61.0) 86.8 (69.9-104) 137 (104-183) 183 (135-215) 313 
Non-Hispanic blacks 11-12 46.2 (42.7-50.0) 43.2 (41.0-46.4) 74.7 (66.4-80.8) 134 (110-156) 175 (148-210) 662 
Non-Hispanic whites 11-12 56.8 (52.7-61.2) 51.7 (48.5-55.3) 88.1 (79.3-98.1) 159 (129-186) 215 (170-306) 808 
All Hispanics 11-12 48.6 (41.8-56.3) 46.4 (42.0-50.7) 76.5 (65.7-87.6) 122 (101-143) 173 (127-215) 566 
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Urinary N-Acetyl-S-(2-carbamoyl-2-hydroxyethyl)-L-cysteine (2011 - 2012) 
Metabolite of Acrylamide 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 15.4 (14.5-16.3) 14.7 (13.7-15.6) 24.6 (22.5-26.9) 44.2 (41.8-48.0) 64.1 (54.1-78.0) 2466 
Age group        
6-11 years 11-12 15.3 (14.0-16.6) 15.9 (13.9-18.2) 23.9 (21.8-26.3) 38.1 (31.0-45.1) 50.9 (36.5-60.8) 394 
12-19 years 11-12 16.6 (14.5-19.0) 16.4 (12.0-20.4) 27.8 (22.9-35.5) 49.0 (38.5-65.4) 68.0 (52.0-85.0) 384 
20 years and older 11-12 15.2 (14.3-16.3) 14.3 (13.0-15.7) 24.1 (21.8-26.7) 43.5 (39.7-49.0) 64.5 (52.2-85.2) 1688 
Gender        
Males 11-12 16.6 (15.3-18.0) 16.1 (14.5-17.7) 26.3 (24.1-29.7) 43.6 (39.7-48.8) 63.4 (52.5-74.8) 1251 
Females 11-12 14.3 (13.3-15.3) 12.8 (11.5-14.4) 22.4 (21.0-25.4) 44.8 (36.6-50.6) 66.5 (50.7-88.9) 1215 
Race/ethnicity        
Mexican Americans 11-12 15.9 (14.2-17.9) 16.5 (15.1-17.9) 25.2 (21.9-30.2) 38.7 (30.2-51.9) 51.9 (38.7-71.5) 313 
Non-Hispanic blacks 11-12 17.6 (16.0-19.4) 16.8 (15.2-19.6) 29.2 (24.5-34.7) 53.0 (45.4-62.6) 74.8 (64.0-90.8) 662 
Non-Hispanic whites 11-12 15.5 (14.2-16.8) 14.5 (13.0-16.4) 25.0 (21.7-28.8) 44.9 (40.9-49.0) 66.3 (50.6-91.7) 810 
All Hispanics 11-12 14.8 (13.4-16.3) 15.0 (12.9-15.9) 23.4 (20.8-26.5) 37.9 (30.2-50.1) 51.9 (41.2-64.2) 566 
Asians 11-12 * < LOD 17.2 (14.5-19.0) 24.1 (22.4-26.8) 29.9 (25.5-41.7) 341 
Limit of detection (LOD, see Data Analysis section) for Survey year 11-12 is 9.4. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary N-Acetyl-S-(2-carbamoyl-2-hydroxyethyl)-L-cysteine (creatinine corrected) (2011 - 2012) 
Metabolite of Acrylamide 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 17.6 (16.6-18.6) 16.6 (15.9-17.5) 26.6 (24.6-27.7) 39.3 (36.6-44.3) 59.8 (50.0-66.5) 2464 
Age group        
6-11 years 11-12 21.8 (20.1-23.7) 20.1 (19.0-21.5) 29.5 (27.6-32.2) 42.3 (36.6-52.6) 57.6 (40.0-76.1) 393 
12-19 years 11-12 16.2 (14.2-18.4) 14.8 (13.2-16.2) 21.9 (19.0-26.6) 39.7 (29.6-67.7) 69.5 (37.5-95.0) 384 
20 years and older 11-12 17.4 (16.4-18.4) 16.6 (15.6-17.5) 26.6 (24.6-27.7) 39.1 (36.5-44.1) 59.1 (44.6-66.7) 1687 
Gender        
Males 11-12 15.6 (14.7-16.5) 14.8 (14.1-15.5) 22.9 (20.7-24.9) 36.0 (33.3-38.5) 46.0 (39.1-55.4) 1250 
Females 11-12 19.7 (18.3-21.2) 19.0 (17.5-20.3) 28.8 (27.0-31.6) 47.5 (38.9-59.5) 66.7 (58.2-73.9) 1214 
Race/ethnicity        
Mexican Americans 11-12 18.0 (15.5-20.8) 17.5 (14.9-20.3) 24.9 (21.3-30.2) 35.1 (28.9-45.5) 48.4 (33.4-62.0) 313 
Non-Hispanic blacks 11-12 13.7 (12.6-15.0) 13.5 (12.1-14.6) 21.0 (18.9-23.8) 34.0 (29.3-37.4) 42.1 (38.9-44.3) 662 
Non-Hispanic whites 11-12 18.9 (17.7-20.2) 17.7 (16.6-19.0) 27.7 (26.6-28.9) 41.6 (36.9-54.1) 63.9 (55.6-70.0) 808 
All Hispanics 11-12 16.5 (14.8-18.5) 16.0 (13.9-18.5) 23.5 (20.4-27.7) 35.0 (30.6-39.8) 44.3 (35.1-55.4) 566 
Asians 11-12 * < LOD 22.0 (18.8-24.1) 31.7 (27.0-37.3) 44.3 (31.8-51.2) 341 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary N-Acetyl-S-(2-cyanoethyl)-L-cysteine (2011 - 2012) 
Metabolite of Acrylonitrile 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 3.40 (2.97-3.90) 1.71 (1.61-1.86) 5.42 (4.03-8.55) 136 (100-172) 276 (238-323) 2466 
Age group        
6-11 years 11-12 1.47 (1.35-1.60) 1.38 (1.30-1.58) 2.44 (2.18-2.90) 4.27 (3.15-5.40) 6.71 (4.26-9.62) 394 
12-19 years 11-12 2.65 (2.07-3.39) 1.68 (1.36-2.13) 3.79 (2.90-5.85) 40.6 (9.71-88.9) 135 (43.9-276) 384 
20 years and older 11-12 3.87 (3.32-4.52) 1.78 (1.61-1.98) 10.3 (5.71-19.9) 164 (131-203) 310 (239-385) 1688 
Gender        
Males 11-12 4.27 (3.60-5.06) 2.14 (1.92-2.35) 9.79 (5.39-17.1) 166 (117-207) 294 (217-439) 1251 
Females 11-12 2.73 (2.16-3.46) 1.42 (1.26-1.61) 3.72 (2.83-5.55) 118 (74.4-142) 260 (142-310) 1215 
Race/ethnicity        
Mexican Americans 11-12 2.51 (1.88-3.36) 1.61 (1.31-1.87) 3.50 (2.74-6.61) 51.6 (12.6-105) 105 (38.8-174) 313 
Non-Hispanic blacks 11-12 5.02 (3.99-6.32) 2.63 (2.16-3.11) 9.18 (5.27-24.4) 166 (123-228) 339 (234-429) 662 
Non-Hispanic whites 11-12 3.46 (2.95-4.07) 1.63 (1.47-1.82) 6.33 (3.97-12.6) 146 (117-203) 280 (228-350) 810 
All Hispanics 11-12 2.57 (2.01-3.28) 1.57 (1.41-1.79) 3.49 (2.78-5.42) 58.5 (17.3-105) 158 (74.3-253) 566 
Asians 11-12 1.90 (1.65-2.21) 1.40 (1.24-1.65) 2.73 (2.18-3.10) 12.3 (4.53-48.4) 91.4 (24.4-133) 341 
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Urinary N-Acetyl-S-(2-cyanoethyl)-L-cysteine (creatinine corrected) (2011 - 2012) 
Metabolite of Acrylonitrile 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 3.89 (3.44-4.40) 1.83 (1.73-1.93) 5.28 (4.08-7.59) 157 (119-194) 256 (224-300) 2464 
Age group        
6-11 years 11-12 2.11 (1.91-2.33) 2.00 (1.81-2.22) 2.95 (2.53-3.59) 5.00 (3.92-5.78) 6.31 (5.74-7.95) 393 
12-19 years 11-12 2.58 (2.10-3.18) 1.73 (1.51-1.88) 3.28 (2.35-5.84) 19.3 (7.61-58.9) 157 (17.6-228) 384 
20 years and older 11-12 4.43 (3.85-5.09) 1.82 (1.66-2.00) 8.86 (5.46-20.6) 188 (151-224) 292 (238-339) 1687 
Gender        
Males 11-12 4.02 (3.34-4.83) 1.76 (1.61-1.93) 7.71 (4.18-20.2) 153 (116-220) 238 (220-278) 1250 
Females 11-12 3.77 (3.01-4.73) 1.87 (1.71-2.09) 4.37 (3.22-6.59) 158 (86.4-228) 292 (229-315) 1214 
Race/ethnicity        
Mexican Americans 11-12 2.84 (2.20-3.66) 1.65 (1.49-1.86) 3.52 (2.40-7.27) 41.8 (20.0-93.2) 128 (39.4-345) 313 
Non-Hispanic blacks 11-12 3.91 (3.18-4.81) 1.92 (1.74-2.10) 7.14 (3.58-33.5) 120 (92.2-139) 199 (145-241) 662 
Non-Hispanic whites 11-12 4.25 (3.67-4.92) 1.85 (1.74-1.97) 6.40 (4.02-13.7) 200 (157-230) 292 (238-342) 808 
All Hispanics 11-12 2.88 (2.37-3.49) 1.62 (1.53-1.78) 3.38 (2.65-4.56) 54.1 (31.6-91.7) 146 (67.8-230) 566 
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Urinary N-Acetyl-S-(2-hydroxyethyl)-L-cysteine (2011 - 2012) 
Metabolite of Acrylonitrile, Ethylene oxide, and Vinyl chloride 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * .697 (.618-.792) 1.33 (1.21-1.46) 2.77 (2.39-3.47) 4.61 (3.96-5.26) 2466 
Age group        
6-11 years 11-12 .904 (.800-1.02) .888 (.740-.961) 1.42 (1.22-1.75) 2.42 (2.05-2.96) 3.44 (2.59-3.82) 394 
12-19 years 11-12 .963 (.841-1.10) .898 (.697-1.00) 1.57 (1.26-1.95) 2.82 (2.17-4.01) 4.53 (3.66-5.54) 384 
20 years and older 11-12 * .678 (<LOD-.766) 1.28 (1.09-1.47) 2.81 (2.32-3.57) 4.86 (4.01-5.73) 1688 
Gender        
Males 11-12 * .694 (<LOD-.829) 1.29 (1.12-1.47) 2.51 (2.00-3.04) 3.96 (3.16-5.04) 1251 
Females 11-12 * .714 (<LOD-.852) 1.38 (1.19-1.63) 3.38 (2.59-3.84) 5.08 (3.84-6.49) 1215 
Race/ethnicity        
Mexican Americans 11-12 .907 (.792-1.04) .788 (.693-.910) 1.40 (1.12-1.68) 2.94 (2.14-3.66) 3.91 (3.57-4.82) 313 
Non-Hispanic blacks 11-12 1.08 (.965-1.21) .976 (.835-1.14) 1.81 (1.51-2.16) 3.57 (2.71-5.26) 6.40 (4.81-7.41) 662 
Non-Hispanic whites 11-12 * .669 (<LOD-.766) 1.24 (1.08-1.41) 2.72 (2.17-3.47) 4.55 (3.75-5.54) 810 
All Hispanics 11-12 * .730 (.647-.817) 1.32 (1.10-1.59) 2.61 (2.16-3.45) 3.91 (2.94-5.25) 566 
Asians 11-12 * < LOD .977 (.858-1.06) 1.75 (1.22-2.05) 2.51 (1.90-3.58) 341 
Limit of detection (LOD, see Data Analysis section) for Survey year 11-12 is 0.6. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary N-Acetyl-S-(2-hydroxyethyl)-L-cysteine (creatinine corrected) (2011 - 2012) 
Metabolite of Acrylonitrile, Ethylene oxide, and Vinyl chloride 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * .941 (.883-1.01) 1.70 (1.57-1.82) 3.11 (2.81-3.43) 4.75 (3.86-5.69) 2464 
Age group        
6-11 years 11-12 1.28 (1.13-1.44) 1.29 (1.11-1.43) 2.00 (1.70-2.36) 2.95 (2.46-3.48) 3.86 (2.83-5.26) 393 
12-19 years 11-12 .938 (.853-1.03) .883 (.753-.959) 1.52 (1.22-1.87) 2.69 (2.10-4.11) 4.71 (2.92-6.06) 384 
20 years and older 11-12 * .912 (<LOD-1.00) 1.63 (1.51-1.83) 3.23 (2.85-3.57) 5.15 (3.94-5.74) 1687 
Gender        
Males 11-12 * .744 (<LOD-.846) 1.33 (1.17-1.54) 2.49 (2.29-2.65) 3.66 (3.03-4.41) 1250 
Females 11-12 * 1.12 (<LOD-1.21) 1.96 (1.74-2.23) 3.80 (2.93-5.26) 5.50 (3.95-8.67) 1214 
Race/ethnicity        
Mexican Americans 11-12 1.02 (.885-1.19) .964 (.865-1.11) 1.71 (1.43-1.96) 3.02 (2.23-4.21) 4.51 (3.14-5.45) 313 
Non-Hispanic blacks 11-12 .841 (.774-.913) .749 (.674-.861) 1.50 (1.28-1.65) 2.83 (2.43-3.24) 4.00 (3.35-4.43) 662 
Non-Hispanic whites 11-12 * .986 (<LOD-1.06) 1.70 (1.57-1.91) 3.25 (2.65-3.86) 5.15 (3.41-6.58) 808 
All Hispanics 11-12 * .918 (.831-1.05) 1.60 (1.38-1.83) 2.76 (2.22-3.41) 4.35 (3.11-5.19) 566 
Asians 11-12 * < LOD 1.46 (1.28-1.88) 2.49 (1.93-3.26) 3.59 (2.50-6.06) 341 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary N-Acetyl-S-(phenyl)-L-cysteine (2011 - 2012) 
Metabolite of Benzene 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * < LOD 1.07 (.985-1.14) 1.95 (1.72-2.30) 3.01 (2.65-3.32) 2466 
Age group        
6-11 years 11-12 * < LOD 1.28 (1.10-1.52) 2.36 (1.93-2.63) 2.98 (2.40-3.67) 394 
12-19 years 11-12 * < LOD 1.12 (.963-1.41) 1.96 (1.57-2.52) 2.81 (2.03-3.27) 384 
20 years and older 11-12 * < LOD 1.02 (.943-1.12) 1.91 (1.63-2.40) 3.05 (2.56-3.45) 1688 
Gender        
Males 11-12 * .645 (<LOD-.765) 1.20 (1.07-1.28) 2.12 (1.76-2.51) 3.11 (2.65-3.76) 1251 
Females 11-12 * < LOD .964 (.834-1.07) 1.91 (1.56-2.38) 2.84 (2.12-3.32) 1215 
Race/ethnicity        
Mexican Americans 11-12 * .661 (<LOD-.958) 1.44 (.995-1.68) 2.54 (1.75-2.93) 2.96 (2.52-5.19) 313 
Non-Hispanic blacks 11-12 * < LOD 1.05 (.963-1.16) 1.84 (1.59-2.11) 2.62 (2.19-3.06) 662 
Non-Hispanic whites 11-12 * < LOD 1.04 (.931-1.13) 1.92 (1.61-2.40) 3.08 (2.44-3.50) 810 
All Hispanics 11-12 * < LOD 1.20 (1.00-1.45) 2.26 (1.75-2.62) 2.85 (2.49-3.33) 566 
Asians 11-12 * < LOD .932 (.806-1.09) 1.84 (1.45-2.16) 2.56 (2.13-3.48) 341 
Limit of detection (LOD, see Data Analysis section) for Survey year 11-12 is 0.6. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary N-Acetyl-S-(phenyl)-L-cysteine (creatinine corrected) (2011 - 2012) 
Metabolite of Benzene 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * < LOD 1.29 (1.18-1.41) 2.10 (1.86-2.37) 3.03 (2.62-3.53) 2464 
Age group        
6-11 years 11-12 * < LOD 1.95 (1.64-2.24) 2.68 (2.44-3.45) 3.58 (2.66-4.71) 393 
12-19 years 11-12 * < LOD 1.14 (.942-1.41) 1.70 (1.29-2.23) 2.35 (1.70-4.39) 384 
20 years and older 11-12 * < LOD 1.26 (1.15-1.39) 2.02 (1.77-2.42) 3.03 (2.50-3.53) 1687 
Gender        
Males 11-12 * .704 (<LOD-.771) 1.12 (1.00-1.25) 1.89 (1.64-2.21) 2.55 (2.23-2.98) 1250 
Females 11-12 * < LOD 1.46 (1.30-1.62) 2.35 (2.02-2.73) 3.46 (2.73-4.71) 1214 
Race/ethnicity        
Mexican Americans 11-12 * .883 (<LOD-.986) 1.45 (1.15-1.82) 2.15 (1.66-3.04) 3.04 (1.93-5.59) 313 
Non-Hispanic blacks 11-12 * < LOD .847 (.742-.924) 1.35 (1.18-1.57) 1.88 (1.57-2.36) 662 
Non-Hispanic whites 11-12 * < LOD 1.36 (1.22-1.46) 2.23 (1.92-2.55) 3.26 (2.55-4.15) 808 
All Hispanics 11-12 * < LOD 1.34 (1.11-1.64) 1.93 (1.68-2.62) 2.68 (2.04-3.39) 566 
Asians 11-12 * < LOD 1.46 (1.27-1.66) 2.23 (1.91-3.03) 3.03 (2.37-4.95) 341 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary N-Acetyl-S-(n-propyl)-L-cysteine (2011 - 2012) 
Metabolite of 1-Bromopropane 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 4.08 (3.67-4.52) 3.70 (3.18-4.14) 10.3 (8.86-11.8) 26.5 (23.0-29.9) 43.7 (37.0-60.9) 2396 
Age group        
6-11 years 11-12 2.44 (2.15-2.78) 1.74 (1.44-2.30) 5.09 (4.38-6.26) 12.1 (8.91-20.7) 24.8 (15.7-32.0) 387 
12-19 years 11-12 3.13 (2.41-4.08) 2.46 (1.50-4.28) 7.10 (4.72-10.3) 18.1 (11.1-31.5) 31.6 (18.1-49.3) 366 
20 years and older 11-12 4.48 (4.00-5.02) 4.10 (3.64-4.63) 11.4 (9.69-13.8) 28.9 (24.6-33.1) 49.7 (36.1-72.4) 1643 
Gender        
Males 11-12 4.27 (3.73-4.89) 3.75 (3.13-4.51) 10.4 (8.86-12.2) 28.4 (23.0-33.9) 48.9 (33.1-72.9) 1218 
Females 11-12 3.90 (3.44-4.41) 3.58 (2.85-4.23) 10.2 (8.23-12.7) 24.8 (20.2-30.2) 43.0 (32.4-52.3) 1178 
Race/ethnicity        
Mexican Americans 11-12 5.51 (4.37-6.95) 5.59 (4.13-8.24) 14.3 (11.1-20.8) 29.0 (22.3-40.5) 40.5 (28.2-60.8) 293 
Non-Hispanic blacks 11-12 5.15 (4.24-6.27) 4.52 (3.51-5.67) 13.1 (10.3-16.4) 38.3 (27.3-52.2) 66.0 (43.0-93.2) 655 
Non-Hispanic whites 11-12 3.52 (3.10-3.99) 3.09 (2.38-3.75) 8.33 (6.46-10.5) 21.7 (17.5-27.4) 39.6 (25.8-61.8) 795 
All Hispanics 11-12 5.18 (4.34-6.20) 5.16 (4.22-6.36) 12.9 (11.1-17.2) 28.9 (24.0-34.9) 43.5 (33.7-60.8) 544 
Asians 11-12 6.94 (5.71-8.45) 6.33 (4.70-9.11) 20.9 (16.9-27.0) 42.2 (32.8-58.0) 69.7 (48.9-98.7) 316 
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Urinary N-Acetyl-S-(n-propyl)-L-cysteine (creatinine corrected) (2011 - 2012) 
Metabolite of 1-Bromopropane 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 4.64 (4.23-5.09) 4.19 (3.69-4.72) 11.3 (9.46-12.8) 28.8 (24.2-32.7) 46.1 (36.4-58.4) 2394 
Age group        
6-11 years 11-12 3.39 (3.01-3.82) 3.15 (2.58-3.87) 6.54 (5.46-7.71) 14.0 (10.7-17.1) 21.5 (14.5-30.0) 386 
12-19 years 11-12 3.08 (2.31-4.10) 2.59 (1.74-4.24) 7.14 (4.29-10.6) 15.6 (9.44-23.4) 23.8 (15.6-43.1) 366 
20 years and older 11-12 5.10 (4.61-5.64) 4.72 (4.17-5.32) 12.7 (11.1-13.9) 31.2 (25.1-40.0) 50.3 (37.9-64.4) 1642 
Gender        
Males 11-12 4.01 (3.59-4.47) 3.59 (3.24-4.03) 9.20 (7.62-11.1) 24.6 (19.2-31.0) 40.0 (33.8-47.6) 1217 
Females 11-12 5.34 (4.58-6.24) 4.88 (4.12-6.06) 12.9 (10.6-16.2) 30.3 (25.1-37.1) 50.3 (36.7-65.1) 1177 
Race/ethnicity        
Mexican Americans 11-12 6.14 (5.18-7.29) 5.61 (3.86-8.70) 15.0 (12.5-21.8) 32.4 (22.7-45.2) 46.3 (27.4-67.1) 293 
Non-Hispanic blacks 11-12 4.02 (3.29-4.91) 3.76 (2.94-4.71) 9.20 (6.72-12.9) 28.1 (17.7-45.7) 56.6 (33.4-72.3) 655 
Non-Hispanic whites 11-12 4.30 (3.80-4.87) 3.83 (3.27-4.54) 9.88 (8.31-12.1) 25.6 (19.1-31.0) 42.2 (29.3-54.5) 793 
All Hispanics 11-12 5.76 (5.02-6.61) 5.44 (4.25-6.61) 13.8 (11.9-16.3) 30.9 (24.8-37.6) 45.8 (34.7-63.0) 544 
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Urinary N-Acetyl-S-(3,4-dihydroxybutyl)-L-cysteine (2011 - 2012) 
Metabolite of 1,3-Butadiene 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 252 (235-271) 271 (254-296) 454 (421-482) 650 (608-711) 848 (751-939) 2466 
Age group        
6-11 years 11-12 255 (227-286) 273 (239-334) 450 (401-494) 731 (533-884) 903 (583-1430) 394 
12-19 years 11-12 256 (220-298) 273 (224-340) 506 (414-529) 651 (606-687) 729 (651-882) 384 
20 years and older 11-12 252 (232-273) 271 (247-299) 450 (412-481) 647 (597-742) 848 (751-944) 1688 
Gender        
Males 11-12 299 (273-326) 328 (288-368) 487 (458-528) 697 (623-809) 927 (770-1180) 1251 
Females 11-12 214 (196-234) 224 (207-249) 407 (370-426) 604 (554-636) 776 (639-879) 1215 
Race/ethnicity        
Mexican Americans 11-12 248 (213-290) 275 (220-334) 442 (387-472) 571 (502-694) 730 (592-881) 313 
Non-Hispanic blacks 11-12 316 (291-343) 356 (308-385) 517 (479-563) 751 (666-820) 916 (843-1030) 662 
Non-Hispanic whites 11-12 249 (229-270) 265 (231-292) 454 (409-502) 665 (607-745) 876 (721-1000) 810 
All Hispanics 11-12 244 (212-280) 267 (229-317) 437 (384-476) 562 (503-648) 715 (597-813) 566 
Asians 11-12 186 (164-210) 212 (186-238) 328 (288-393) 481 (425-547) 602 (518-726) 341 
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Urinary N-Acetyl-S-(3,4-dihydroxybutyl)-L-cysteine (creatinine corrected) (2011 - 2012) 
Metabolite of 1,3-Butadiene 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 288 (275-302) 283 (271-297) 374 (360-389) 488 (460-518) 583 (549-623) 2464 
Age group        
6-11 years 11-12 366 (341-393) 366 (334-386) 459 (431-507) 622 (561-648) 728 (631-746) 393 
12-19 years 11-12 249 (232-268) 249 (235-259) 304 (274-341) 389 (341-410) 418 (394-462) 384 
20 years and older 11-12 287 (273-302) 281 (270-298) 370 (357-389) 484 (457-518) 563 (539-623) 1687 
Gender        
Males 11-12 281 (266-295) 275 (261-284) 369 (350-389) 476 (449-515) 558 (509-651) 1250 
Females 11-12 296 (279-314) 292 (275-309) 378 (355-402) 505 (473-530) 588 (549-623) 1214 
Race/ethnicity        
Mexican Americans 11-12 280 (236-333) 280 (242-327) 364 (327-400) 473 (400-555) 555 (474-625) 313 
Non-Hispanic blacks 11-12 246 (231-263) 236 (225-252) 316 (291-338) 423 (376-461) 501 (454-551) 662 
Non-Hispanic whites 11-12 305 (289-321) 300 (284-312) 395 (378-415) 514 (473-554) 623 (549-655) 808 
All Hispanics 11-12 273 (244-304) 270 (244-297) 353 (329-381) 455 (415-484) 522 (461-585) 566 
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Urinary N-Acetyl-S-(1-hydroxymethyl-2-propenyl)-L-cysteine (2011 - 2012) 
Metabolite of 1,3-Butadiene 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * < LOD < LOD < LOD < LOD 2466 
Age group        
6-11 years 11-12 * < LOD < LOD < LOD < LOD 394 
12-19 years 11-12 * < LOD < LOD < LOD < LOD 384 
20 years and older 11-12 * < LOD < LOD < LOD < LOD 1688 
Gender        
Males 11-12 * < LOD < LOD < LOD < LOD 1251 
Females 11-12 * < LOD < LOD < LOD < LOD 1215 
Race/ethnicity        
Mexican Americans 11-12 * < LOD < LOD < LOD < LOD 313 
Non-Hispanic blacks 11-12 * < LOD < LOD < LOD < LOD 662 
Non-Hispanic whites 11-12 * < LOD < LOD < LOD < LOD 810 
All Hispanics 11-12 * < LOD < LOD < LOD < LOD 566 
Asians 11-12 * < LOD < LOD < LOD < LOD 341 
Limit of detection (LOD, see Data Analysis section) for Survey year 11-12 is 0.7. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary N-Acetyl-S-(1-hydroxymethyl-2-propenyl)-L-cysteine (creatinine corrected) (2011 - 2012) 
Metabolite of 1,3-Butadiene 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * < LOD < LOD < LOD < LOD 2464 
Age group        
6-11 years 11-12 * < LOD < LOD < LOD < LOD 393 
12-19 years 11-12 * < LOD < LOD < LOD < LOD 384 
20 years and older 11-12 * < LOD < LOD < LOD < LOD 1687 
Gender        
Males 11-12 * < LOD < LOD < LOD < LOD 1250 
Females 11-12 * < LOD < LOD < LOD < LOD 1214 
Race/ethnicity        
Mexican Americans 11-12 * < LOD < LOD < LOD < LOD 313 
Non-Hispanic blacks 11-12 * < LOD < LOD < LOD < LOD 662 
Non-Hispanic whites 11-12 * < LOD < LOD < LOD < LOD 808 
All Hispanics 11-12 * < LOD < LOD < LOD < LOD 566 
Asians 11-12 * < LOD < LOD < LOD < LOD 341 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary N-Acetyl-S-(2-hydroxy-3-butenyl)-L-cysteine (2011 - 2012) 
Metabolite of 1,3-Butadiene 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * < LOD < LOD .985 (<LOD-1.33) 2.53 (2.03-3.34) 2466 
Age group        
6-11 years 11-12 * < LOD < LOD < LOD < LOD 394 
12-19 years 11-12 * < LOD < LOD < LOD 1.51 (.882-2.12) 384 
20 years and older 11-12 * < LOD < LOD 1.21 (.931-1.88) 3.23 (2.20-4.26) 1688 
Gender        
Males 11-12 * < LOD < LOD .931 (<LOD-1.25) 2.21 (1.33-3.23) 1251 
Females 11-12 * < LOD < LOD 1.07 (<LOD-1.76) 2.90 (2.20-3.79) 1215 
Race/ethnicity        
Mexican Americans 11-12 * < LOD < LOD .785 (<LOD-1.24) 1.25 (.785-3.39) 313 
Non-Hispanic blacks 11-12 * < LOD < LOD .855 (<LOD-1.23) 2.71 (1.32-4.34) 662 
Non-Hispanic whites 11-12 * < LOD < LOD 1.16 (.714-1.76) 2.90 (2.11-4.26) 810 
All Hispanics 11-12 * < LOD < LOD .711 (<LOD-1.23) 1.45 (.914-2.97) 566 
Asians 11-12 * < LOD < LOD < LOD < LOD 341 
Limit of detection (LOD, see Data Analysis section) for Survey year 11-12 is 0.7. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary N-Acetyl-S-(2-hydroxy-3-butenyl)-L-cysteine (creatinine corrected) (2011 - 2012) 
Metabolite of 1,3-Butadiene 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * < LOD < LOD 2.15 (<LOD-2.65) 3.70 (2.75-5.20) 2464 
Age group        
6-11 years 11-12 * < LOD < LOD < LOD < LOD 393 
12-19 years 11-12 * < LOD < LOD < LOD 2.61 (1.65-3.09) 384 
20 years and older 11-12 * < LOD < LOD 2.32 (1.98-2.86) 4.27 (2.91-5.68) 1687 
Gender        
Males 11-12 * < LOD < LOD 1.71 (<LOD-2.06) 2.91 (2.12-3.51) 1250 
Females 11-12 * < LOD < LOD 2.65 (<LOD-3.30) 4.67 (3.06-6.21) 1214 
Race/ethnicity        
Mexican Americans 11-12 * < LOD < LOD 1.71 (<LOD-2.32) 2.32 (1.71-4.76) 313 
Non-Hispanic blacks 11-12 * < LOD < LOD 1.44 (<LOD-1.57) 2.06 (1.65-2.70) 662 
Non-Hispanic whites 11-12 * < LOD < LOD 2.48 (1.98-2.91) 4.48 (2.91-5.67) 808 
All Hispanics 11-12 * < LOD < LOD 1.98 (<LOD-2.32) 2.61 (2.15-3.30) 566 
Asians 11-12 * < LOD < LOD < LOD < LOD 341 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 




Fourth National Report on Human Exposure to Environmental Chemicals, Updated Tables, January 2017 Volume One Page 592
Urinary N-Acetyl-S-(4-hydroxy-2-butenyl)-L-cysteine (2011 - 2012) 
Metabolite of 1,3-Butadiene 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 10.3 (9.31-11.5) 9.74 (8.96-10.7) 20.2 (17.7-23.5) 56.3 (48.6-68.2) 119 (90.2-142) 2466 
Age group        
6-11 years 11-12 8.29 (7.47-9.19) 8.73 (7.22-10.1) 16.8 (13.8-19.7) 28.7 (21.2-37.8) 37.8 (28.2-45.1) 394 
12-19 years 11-12 8.05 (6.29-10.3) 9.52 (6.38-12.4) 17.3 (14.6-19.4) 30.9 (21.5-51.0) 51.0 (27.3-105) 384 
20 years and older 11-12 11.0 (9.86-12.2) 10.0 (9.01-11.1) 21.9 (18.6-26.0) 69.2 (56.2-86.2) 128 (115-152) 1688 
Gender        
Males 11-12 12.4 (11.4-13.5) 11.5 (10.7-12.8) 21.5 (19.0-25.9) 57.0 (46.6-75.1) 120 (78.0-157) 1251 
Females 11-12 8.66 (7.27-10.3) 7.70 (6.64-9.01) 18.1 (15.4-22.6) 56.2 (40.3-81.2) 118 (82.7-146) 1215 
Race/ethnicity        
Mexican Americans 11-12 9.25 (7.14-12.0) 9.85 (7.95-12.0) 19.3 (16.2-25.7) 40.2 (32.7-47.7) 48.9 (36.2-126) 313 
Non-Hispanic blacks 11-12 13.4 (12.0-15.0) 12.9 (11.7-14.1) 26.0 (23.6-29.1) 63.6 (46.9-76.3) 121 (82.1-153) 662 
Non-Hispanic whites 11-12 10.2 (8.84-11.8) 9.23 (8.04-10.8) 20.1 (16.3-24.5) 63.0 (50.8-86.2) 121 (90.9-144) 810 
All Hispanics 11-12 9.22 (7.64-11.1) 9.36 (8.12-10.7) 18.6 (16.6-21.9) 40.5 (32.7-48.3) 60.4 (45.9-94.8) 566 
Asians 11-12 7.81 (6.82-8.94) 8.43 (7.18-9.42) 15.4 (13.3-18.0) 26.3 (22.2-38.8) 59.9 (31.3-104) 341 
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Urinary N-Acetyl-S-(4-hydroxy-2-butenyl)-L-cysteine (creatinine corrected) (2011 - 2012) 
Metabolite of 1,3-Butadiene 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 11.8 (10.7-13.0) 9.76 (8.88-10.8) 18.2 (16.2-20.7) 60.4 (50.5-73.2) 108 (77.1-151) 2464 
Age group        
6-11 years 11-12 11.8 (10.9-12.9) 11.7 (10.8-12.6) 16.6 (14.9-19.7) 26.3 (21.2-32.3) 34.0 (27.0-48.5) 393 
12-19 years 11-12 7.84 (6.60-9.31) 7.83 (6.69-9.04) 11.8 (10.7-14.3) 21.9 (15.4-34.5) 38.4 (23.0-64.3) 384 
20 years and older 11-12 12.5 (11.4-13.8) 9.81 (8.78-11.1) 20.2 (18.1-22.9) 74.9 (60.4-86.0) 130 (88.8-174) 1687 
Gender        
Males 11-12 11.6 (10.8-12.6) 9.81 (8.82-10.9) 18.3 (16.0-21.2) 55.2 (39.6-75.1) 84.7 (77.1-108) 1250 
Females 11-12 11.9 (10.2-14.0) 9.73 (8.41-11.2) 17.9 (14.3-24.1) 63.4 (40.0-102) 135 (92.4-171) 1214 
Race/ethnicity        
Mexican Americans 11-12 10.4 (7.98-13.7) 9.90 (8.41-11.5) 18.0 (15.0-20.4) 34.1 (24.1-55.1) 59.0 (32.9-115) 313 
Non-Hispanic blacks 11-12 10.5 (9.64-11.4) 9.14 (8.01-10.0) 18.0 (15.8-21.1) 42.6 (34.5-46.9) 70.8 (52.3-81.0) 662 
Non-Hispanic whites 11-12 12.5 (11.1-14.1) 9.89 (8.78-11.2) 18.7 (15.8-22.6) 75.6 (54.9-94.4) 136 (81.9-179) 808 
All Hispanics 11-12 10.3 (8.79-12.1) 9.47 (8.53-10.6) 16.0 (14.8-18.5) 34.4 (24.6-50.3) 63.7 (39.6-93.7) 566 
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Urinary 2-Thioxothiazolidine-4-carboxylic acid (2011 - 2012) 
Metabolite of Carbon disulfide 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 8.88 (8.00-9.85) 6.91 (6.32-7.70) 18.7 (15.2-23.3) 52.9 (40.4-66.1) 109 (74.8-144) 2466 
Age group        
6-11 years 11-12 6.70 (5.87-7.64) 5.03 (4.17-5.87) 11.2 (8.82-15.1) 38.3 (25.3-51.9) 59.7 (42.5-90.3) 394 
12-19 years 11-12 7.28 (5.89-9.00) 5.94 (4.13-7.81) 14.1 (8.39-22.2) 40.3 (22.5-64.6) 92.1 (40.3-137) 384 
20 years and older 11-12 9.44 (8.35-10.7) 7.48 (6.59-8.26) 20.6 (15.8-26.3) 57.9 (43.7-70.6) 118 (91.7-146) 1688 
Gender        
Males 11-12 10.3 (9.03-11.8) 7.87 (7.02-9.01) 24.3 (18.0-30.0) 63.6 (47.9-96.5) 123 (100-155) 1251 
Females 11-12 7.69 (6.88-8.59) 5.99 (5.15-6.60) 14.8 (11.7-19.2) 38.0 (29.3-54.1) 74.8 (51.0-133) 1215 
Race/ethnicity        
Mexican Americans 11-12 7.73 (6.58-9.08) 6.12 (4.96-6.96) 16.7 (9.52-23.7) 43.9 (33.8-60.5) 66.5 (53.5-104) 313 
Non-Hispanic blacks 11-12 12.2 (10.4-14.3) 10.5 (8.16-13.1) 26.8 (22.2-30.8) 64.2 (52.5-75.9) 125 (75.9-175) 662 
Non-Hispanic whites 11-12 8.56 (7.39-9.91) 6.61 (5.74-7.78) 17.0 (12.4-24.5) 47.9 (35.3-71.0) 111 (66.8-157) 810 
All Hispanics 11-12 7.37 (6.41-8.47) 5.42 (4.76-6.85) 14.5 (10.7-20.1) 40.2 (31.0-56.3) 67.4 (56.3-98.0) 566 
Asians 11-12 12.6 (10.3-15.5) 8.97 (7.38-11.3) 32.3 (21.7-46.9) 121 (69.0-177) 220 (129-532) 341 
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Urinary 2-Thioxothiazolidine-4-carboxylic acid (creatinine corrected) (2011 - 2012) 
Metabolite of Carbon disulfide 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 10.1 (9.09-11.3) 8.23 (7.21-9.15) 19.9 (17.0-22.9) 53.6 (42.7-65.0) 105 (82.0-136) 2464 
Age group        
6-11 years 11-12 9.35 (8.13-10.7) 7.49 (6.31-9.88) 17.3 (14.6-20.4) 42.0 (30.1-54.5) 91.4 (51.9-127) 393 
12-19 years 11-12 7.09 (5.81-8.65) 5.68 (5.06-6.54) 13.0 (7.92-25.0) 32.2 (27.4-45.4) 54.4 (30.3-93.0) 384 
20 years and older 11-12 10.8 (9.52-12.2) 8.82 (7.64-9.93) 21.2 (17.8-25.3) 56.9 (46.3-73.3) 127 (81.5-170) 1687 
Gender        
Males 11-12 9.68 (8.63-10.9) 7.54 (6.37-9.01) 20.4 (17.4-23.9) 54.4 (43.8-71.0) 107 (78.4-143) 1250 
Females 11-12 10.6 (9.25-12.1) 8.70 (7.49-9.61) 19.0 (15.5-24.2) 50.9 (39.4-69.0) 104 (69.0-144) 1214 
Race/ethnicity        
Mexican Americans 11-12 8.73 (7.11-10.7) 6.86 (5.37-9.57) 18.6 (11.5-25.9) 34.7 (26.0-57.5) 59.4 (32.9-186) 313 
Non-Hispanic blacks 11-12 9.53 (8.34-10.9) 7.75 (6.86-9.39) 18.4 (15.4-21.3) 54.3 (36.5-69.0) 103 (73.1-136) 662 
Non-Hispanic whites 11-12 10.4 (8.97-12.1) 8.36 (7.01-9.88) 20.7 (15.7-26.8) 53.7 (41.0-79.5) 107 (78.4-146) 808 
All Hispanics 11-12 8.25 (6.92-9.83) 6.52 (5.57-8.23) 16.7 (11.2-20.6) 38.2 (29.3-52.6) 63.9 (52.6-104) 566 
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Urinary N-Acetyl-S-(3-hydroxypropyl-1-methyl)-L-cysteine (2011 - 2012) 
Metabolite of Crotonaldehyde 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 443 (417-471) 419 (383-446) 806 (735-856) 2000 (1720-2340) 3700 (3100-4230) 2466 
Age group        
6-11 years 11-12 318 (291-347) 347 (312-400) 569 (501-629) 861 (762-937) 1190 (871-1500) 394 
12-19 years 11-12 350 (292-421) 360 (301-439) 631 (532-750) 1130 (858-2190) 2200 (1100-4040) 384 
20 years and older 11-12 477 (448-507) 439 (392-470) 874 (809-970) 2350 (2000-2730) 4160 (3580-4450) 1688 
Gender        
Males 11-12 507 (470-546) 467 (425-502) 848 (746-982) 2010 (1520-2660) 3840 (3010-4320) 1251 
Females 11-12 390 (349-435) 352 (304-413) 733 (630-834) 2000 (1360-2490) 3520 (2980-4190) 1215 
Race/ethnicity        
Mexican Americans 11-12 389 (320-474) 393 (300-496) 767 (655-856) 1330 (990-1800) 2350 (1460-3010) 313 
Non-Hispanic blacks 11-12 511 (454-576) 480 (446-525) 794 (691-899) 2190 (1530-2690) 3350 (2650-4850) 662 
Non-Hispanic whites 11-12 449 (411-492) 422 (366-456) 834 (706-930) 2120 (1680-2660) 3880 (3290-4370) 810 
All Hispanics 11-12 398 (348-455) 384 (333-451) 751 (651-838) 1460 (1080-2060) 2600 (1910-3270) 566 
Asians 11-12 336 (294-383) 339 (313-384) 588 (521-694) 1140 (944-1580) 1830 (1160-3090) 341 
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Urinary N-Acetyl-S-(3-hydroxypropyl-1-methyl)-L-cysteine (creatinine corrected) (2011 - 2012) 
Metabolite of Crotonaldehyde 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 506 (473-540) 398 (370-419) 683 (613-760) 2050 (1720-2490) 3970 (3220-5200) 2464 
Age group        
6-11 years 11-12 450 (421-480) 425 (395-449) 534 (501-611) 843 (635-1110) 1100 (785-1970) 393 
12-19 years 11-12 341 (300-388) 308 (257-336) 431 (376-502) 909 (534-1430) 1430 (763-2400) 384 
20 years and older 11-12 543 (508-581) 408 (385-432) 760 (693-920) 2610 (2020-3280) 4700 (3510-5830) 1687 
Gender        
Males 11-12 476 (442-511) 377 (351-405) 654 (600-770) 1780 (1480-2170) 3170 (2350-4230) 1250 
Females 11-12 536 (483-596) 410 (379-444) 698 (605-855) 2700 (1570-3800) 4700 (3350-5710) 1214 
Race/ethnicity        
Mexican Americans 11-12 439 (361-535) 362 (320-424) 581 (479-698) 1430 (1090-1850) 2240 (1660-4310) 313 
Non-Hispanic blacks 11-12 399 (364-437) 322 (293-360) 536 (471-641) 1450 (1050-1780) 2070 (1800-2680) 662 
Non-Hispanic whites 11-12 548 (506-594) 411 (388-444) 730 (628-932) 2700 (1720-3550) 4700 (3280-6190) 808 
All Hispanics 11-12 445 (395-502) 361 (325-405) 607 (519-712) 1650 (1220-2020) 2700 (1850-3440) 566 
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Urinary 2-Aminothiazoline-4-carboxylic acid (2011 - 2012) 
Metabolite of Cyanide 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 110 (101-120) 120 (106-133) 234 (212-249) 410 (364-441) 558 (500-622) 2466 
Age group        
6-11 years 11-12 247 (227-270) 270 (239-308) 482 (394-583) 718 (641-835) 911 (749-1090) 394 
12-19 years 11-12 118 (97.2-143) 133 (100-159) 266 (232-334) 435 (347-562) 583 (435-923) 384 
20 years and older 11-12 99.8 (90.3-110) 106 (98.9-121) 201 (181-228) 348 (304-407) 483 (393-545) 1688 
Gender        
Males 11-12 92.0 (84.1-101) 98.4 (82.4-109) 191 (169-211) 361 (314-386) 493 (414-586) 1251 
Females 11-12 131 (116-148) 147 (131-162) 275 (246-303) 447 (401-515) 589 (514-757) 1215 
Race/ethnicity        
Mexican Americans 11-12 135 (109-168) 144 (106-184) 271 (191-374) 501 (364-671) 728 (537-872) 313 
Non-Hispanic blacks 11-12 142 (124-163) 163 (122-201) 315 (264-383) 534 (485-604) 728 (651-816) 662 
Non-Hispanic whites 11-12 99.5 (91.2-109) 107 (99.0-125) 202 (182-229) 356 (331-391) 482 (419-553) 810 
All Hispanics 11-12 135 (117-156) 139 (114-170) 268 (212-310) 483 (374-589) 671 (537-835) 566 
Asians 11-12 114 (100-131) 114 (102-130) 225 (181-290) 424 (335-520) 543 (440-671) 341 
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Urinary 2-Aminothiazoline-4-carboxylic acid (creatinine corrected) (2011 - 2012) 
Metabolite of Cyanide 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 126 (118-134) 135 (123-147) 249 (228-272) 413 (380-438) 539 (489-588) 2464 
Age group        
6-11 years 11-12 352 (323-384) 375 (329-418) 540 (472-628) 742 (634-859) 926 (747-1000) 393 
12-19 years 11-12 115 (101-131) 125 (113-151) 214 (183-240) 338 (255-438) 438 (307-591) 384 
20 years and older 11-12 114 (105-123) 120 (111-134) 221 (201-241) 363 (336-379) 444 (411-514) 1687 
Gender        
Males 11-12 86.4 (79.1-94.3) 80.2 (73.1-91.6) 169 (142-199) 328 (298-375) 471 (426-539) 1250 
Females 11-12 181 (166-196) 189 (171-204) 312 (286-337) 440 (413-489) 577 (520-624) 1214 
Race/ethnicity        
Mexican Americans 11-12 153 (121-192) 178 (149-215) 300 (228-353) 438 (363-539) 585 (450-800) 313 
Non-Hispanic blacks 11-12 111 (98.4-125) 125 (106-147) 245 (212-276) 396 (325-458) 504 (445-544) 662 
Non-Hispanic whites 11-12 121 (113-131) 123 (112-136) 230 (217-256) 413 (373-440) 539 (458-605) 808 
All Hispanics 11-12 152 (130-177) 178 (153-201) 286 (253-331) 423 (359-483) 568 (454-749) 566 
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Urinary N-Acetyl-S-(N-methylcarbamoyl)-L-cysteine (2011 - 2012) 
Metabolite of N,N-Dimethylformamide 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 123 (114-132) 121 (110-129) 257 (224-290) 496 (428-588) 755 (626-902) 2466 
Age group        
6-11 years 11-12 52.2 (47.1-57.9) 56.8 (50.4-62.7) 98.4 (86.8-106) 141 (111-170) 170 (124-193) 394 
12-19 years 11-12 77.7 (65.3-92.3) 75.0 (62.1-91.8) 145 (125-162) 248 (199-367) 397 (324-506) 384 
20 years and older 11-12 144 (134-156) 145 (131-160) 296 (268-324) 583 (502-625) 869 (689-1010) 1688 
Gender        
Males 11-12 136 (123-149) 134 (117-156) 257 (222-300) 481 (397-592) 786 (589-1010) 1251 
Females 11-12 111 (99.8-124) 106 (95.3-122) 255 (202-296) 512 (406-625) 747 (611-939) 1215 
Race/ethnicity        
Mexican Americans 11-12 86.7 (73.4-102) 84.3 (69.8-103) 171 (143-187) 259 (211-336) 416 (281-652) 313 
Non-Hispanic blacks 11-12 108 (97.1-120) 103 (93.6-117) 204 (173-224) 419 (321-509) 620 (520-705) 662 
Non-Hispanic whites 11-12 139 (127-153) 140 (124-160) 296 (268-323) 560 (468-625) 864 (637-1010) 810 
All Hispanics 11-12 94.4 (77.6-115) 96.1 (77.7-114) 185 (141-230) 331 (254-402) 475 (374-646) 566 
Asians 11-12 70.7 (61.3-81.6) 68.4 (58.5-81.3) 143 (116-178) 266 (209-356) 465 (327-554) 341 
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Urinary N-Acetyl-S-(N-methylcarbamoyl)-L-cysteine (creatinine corrected) (2011 - 2012) 
Metabolite of N,N-Dimethylformamide 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 140 (131-150) 129 (120-138) 248 (231-280) 482 (404-578) 757 (615-860) 2464 
Age group        
6-11 years 11-12 74.9 (71.1-78.9) 72.8 (69.6-76.6) 97.5 (88.5-110) 135 (116-147) 152 (126-196) 393 
12-19 years 11-12 75.6 (66.7-85.8) 68.6 (56.9-89.7) 107 (95.5-126) 169 (149-192) 234 (175-324) 384 
20 years and older 11-12 165 (153-177) 156 (145-169) 299 (275-324) 578 (469-664) 795 (697-891) 1687 
Gender        
Males 11-12 127 (116-140) 121 (107-135) 218 (183-260) 408 (337-527) 632 (489-746) 1250 
Females 11-12 154 (140-168) 138 (128-153) 285 (241-322) 610 (435-713) 821 (757-885) 1214 
Race/ethnicity        
Mexican Americans 11-12 97.9 (82.8-116) 87.4 (79.8-96.2) 150 (121-182) 255 (189-340) 394 (250-962) 313 
Non-Hispanic blacks 11-12 84.0 (77.2-91.4) 76.6 (68.2-84.9) 137 (117-156) 258 (229-293) 390 (313-469) 662 
Non-Hispanic whites 11-12 170 (159-183) 158 (141-175) 315 (275-335) 615 (476-745) 821 (755-891) 808 
All Hispanics 11-12 106 (92.7-120) 96.0 (87.5-107) 163 (141-200) 299 (240-382) 443 (368-496) 566 
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Urinary Phenylglyoxylic acid (2011 - 2012) 
Metabolite of Ethylbenzene and Styrene 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 177 (165-191) 199 (184-212) 334 (314-359) 491 (451-559) 706 (630-789) 2466 
Age group        
6-11 years 11-12 161 (148-176) 184 (161-202) 282 (255-312) 393 (347-456) 508 (393-594) 394 
12-19 years 11-12 173 (152-197) 193 (165-222) 341 (307-392) 468 (423-579) 662 (505-872) 384 
20 years and older 11-12 180 (165-197) 203 (184-219) 341 (314-369) 514 (448-596) 732 (653-842) 1688 
Gender        
Males 11-12 201 (179-226) 225 (198-248) 369 (329-411) 540 (468-588) 789 (592-900) 1251 
Females 11-12 157 (143-172) 171 (157-193) 298 (273-332) 447 (412-518) 660 (502-771) 1215 
Race/ethnicity        
Mexican Americans 11-12 149 (123-181) 166 (141-185) 279 (209-347) 423 (347-505) 505 (431-706) 313 
Non-Hispanic blacks 11-12 217 (198-237) 229 (204-255) 369 (342-390) 570 (489-647) 771 (683-937) 662 
Non-Hispanic whites 11-12 180 (165-196) 205 (184-220) 340 (316-365) 493 (439-585) 726 (578-861) 810 
All Hispanics 11-12 154 (130-183) 169 (146-192) 283 (233-359) 442 (393-558) 604 (464-711) 566 
Asians 11-12 139 (120-160) 161 (131-187) 266 (221-302) 398 (330-489) 518 (410-617) 341 
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Urinary Phenylglyoxylic acid (creatinine corrected) (2011 - 2012) 
Metabolite of Ethylbenzene and Styrene 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 202 (189-217) 206 (195-219) 285 (269-301) 401 (377-426) 518 (468-568) 2464 
Age group        
6-11 years 11-12 231 (219-244) 239 (221-256) 310 (297-323) 411 (377-436) 467 (416-502) 393 
12-19 years 11-12 168 (150-189) 181 (167-193) 239 (212-256) 285 (261-336) 368 (285-550) 384 
20 years and older 11-12 205 (191-220) 207 (195-220) 288 (272-310) 413 (384-442) 536 (482-602) 1687 
Gender        
Males 11-12 189 (174-205) 194 (178-207) 270 (244-299) 400 (367-418) 517 (481-538) 1250 
Females 11-12 217 (199-235) 223 (202-239) 291 (274-318) 404 (366-460) 536 (448-598) 1214 
Race/ethnicity        
Mexican Americans 11-12 168 (135-210) 177 (160-198) 240 (220-265) 311 (267-413) 413 (311-520) 313 
Non-Hispanic blacks 11-12 169 (160-179) 171 (158-180) 233 (221-243) 308 (291-334) 395 (355-431) 662 
Non-Hispanic whites 11-12 220 (207-234) 224 (210-233) 304 (281-336) 426 (395-481) 562 (481-660) 808 
All Hispanics 11-12 173 (150-199) 179 (164-197) 243 (226-265) 317 (295-344) 390 (354-476) 566 











Fourth National Report on Human Exposure to Environmental Chemicals, Updated Tables, January 2017 Volume One Page 604
Urinary N-Acetyl-S-(2-hydroxypropyl)-L-cysteine (2011 - 2012) 
Metabolite of Propylene oxide 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 58.4 (53.4-63.9) 56.0 (50.5-59.7) 110 (102-118) 226 (200-259) 456 (330-572) 2466 
Age group        
6-11 years 11-12 45.2 (39.8-51.4) 44.3 (38.7-54.1) 74.7 (67.2-95.1) 142 (116-174) 235 (161-292) 394 
12-19 years 11-12 47.1 (38.4-57.7) 47.5 (39.0-58.2) 86.8 (72.4-107) 149 (107-192) 205 (150-371) 384 
20 years and older 11-12 62.1 (56.1-68.6) 58.7 (53.7-61.8) 120 (109-130) 259 (220-305) 523 (364-699) 1688 
Gender        
Males 11-12 63.3 (56.7-70.6) 59.7 (54.3-65.6) 112 (95.2-129) 195 (175-256) 370 (259-494) 1251 
Females 11-12 54.1 (46.7-62.6) 48.9 (42.5-58.2) 108 (91.2-124) 250 (221-297) 536 (305-808) 1215 
Race/ethnicity        
Mexican Americans 11-12 60.1 (50.6-71.4) 58.2 (46.6-67.7) 98.0 (82.7-113) 184 (148-325) 375 (202-911) 313 
Non-Hispanic blacks 11-12 68.0 (60.3-76.7) 65.0 (60.1-72.6) 117 (106-130) 220 (188-260) 333 (270-386) 662 
Non-Hispanic whites 11-12 58.4 (52.1-65.5) 54.3 (46.6-59.9) 113 (100-125) 238 (196-292) 523 (325-716) 810 
All Hispanics 11-12 55.7 (48.0-64.7) 52.8 (45.2-61.4) 95.4 (77.8-121) 184 (151-268) 350 (253-429) 566 
Asians 11-12 45.0 (38.0-53.4) 44.6 (39.8-53.1) 88.5 (74.2-109) 181 (144-214) 370 (201-585) 341 
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Urinary N-Acetyl-S-(2-hydroxypropyl)-L-cysteine (creatinine corrected) (2011 - 2012) 
Metabolite of Propylene oxide 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 66.6 (60.7-73.1) 56.4 (53.0-59.0) 101 (93.6-113) 221 (192-262) 403 (346-574) 2464 
Age group        
6-11 years 11-12 64.4 (58.0-71.4) 59.1 (53.5-61.9) 92.4 (82.1-102) 161 (116-216) 233 (161-344) 393 
12-19 years 11-12 45.8 (41.3-50.9) 41.5 (38.0-44.2) 61.5 (56.8-76.4) 98.2 (79.7-139) 156 (115-215) 384 
20 years and older 11-12 70.8 (63.9-78.4) 58.3 (54.5-62.8) 112 (97.9-129) 258 (221-304) 493 (363-782) 1687 
Gender        
Males 11-12 59.4 (54.4-64.8) 53.1 (49.7-56.9) 86.7 (79.7-97.9) 161 (133-207) 262 (216-368) 1250 
Females 11-12 74.5 (63.0-88.1) 59.8 (52.7-66.1) 125 (99.0-146) 300 (223-381) 594 (346-1610) 1214 
Race/ethnicity        
Mexican Americans 11-12 67.9 (59.4-77.5) 55.1 (51.9-62.8) 95.9 (81.5-116) 207 (148-256) 350 (185-1660) 313 
Non-Hispanic blacks 11-12 53.0 (47.3-59.5) 48.2 (42.8-55.0) 81.3 (73.9-89.5) 149 (122-171) 223 (171-304) 662 
Non-Hispanic whites 11-12 71.3 (64.1-79.4) 58.3 (53.5-62.1) 111 (96.8-129) 262 (203-327) 488 (347-782) 808 
All Hispanics 11-12 62.3 (56.3-69.0) 53.0 (50.7-57.1) 86.9 (78.2-102) 176 (136-233) 295 (193-532) 566 
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Urinary N-Acetyl-S-(phenyl-2-hydroxyethyl)-L-cysteine** (2011 - 2012) 
Metabolite of Styrene 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * < LOD .933 (.843-1.04) 1.90 (1.74-2.17) 3.20 (2.75-3.63) 2466 
Age group        
6-11 years 11-12 * < LOD .929 (<LOD-1.12) 1.98 (1.42-3.06) 3.21 (1.98-5.67) 394 
12-19 years 11-12 * < LOD .882 (<LOD-1.11) 1.88 (1.42-2.16) 2.50 (1.90-4.61) 384 
20 years and older 11-12 * < LOD .942 (.819-1.08) 1.91 (1.66-2.32) 3.26 (2.71-3.93) 1688 
Gender        
Males 11-12 * < LOD .988 (.820-1.19) 2.06 (1.80-2.70) 3.60 (2.71-5.41) 1251 
Females 11-12 * < LOD .887 (.807-.987) 1.75 (1.58-1.85) 2.95 (2.27-3.26) 1215 
Race/ethnicity        
Mexican Americans 11-12 * < LOD .887 (.706-1.09) 1.69 (1.51-1.93) 2.39 (1.73-3.87) 313 
Non-Hispanic blacks 11-12 * < LOD 1.40 (1.23-1.58) 3.02 (2.39-3.56) 4.14 (3.56-5.65) 662 
Non-Hispanic whites 11-12 * < LOD .807 (<LOD-.920) 1.79 (1.57-1.93) 2.95 (2.13-3.57) 810 
All Hispanics 11-12 * < LOD 1.04 (.865-1.26) 1.93 (1.69-2.39) 2.99 (2.24-3.69) 566 
Asians 11-12 * < LOD < LOD 1.34 (1.01-1.73) 1.95 (1.35-2.83) 341 
Limit of detection (LOD, see Data Analysis section) for Survey year 11-12 is 0.7. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result.  
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Urinary N-Acetyl-S-(phenyl-2-hydroxyethyl)-L-cysteine** (creatinine corrected) (2011 - 2012) 
Metabolite of Styrene 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * < LOD 1.34 (1.27-1.41) 2.28 (2.06-2.61) 3.34 (2.75-4.13) 2464 
Age group        
6-11 years 11-12 * < LOD 1.64 (<LOD-1.83) 2.61 (2.06-3.45) 3.81 (2.90-5.50) 393 
12-19 years 11-12 * < LOD 1.15 (<LOD-1.30) 1.96 (1.38-2.61) 3.09 (1.85-5.50) 384 
20 years and older 11-12 * < LOD 1.34 (1.27-1.43) 2.36 (2.06-2.64) 3.34 (2.75-4.13) 1687 
Gender        
Males 11-12 * < LOD 1.13 (1.05-1.24) 1.96 (1.71-2.17) 2.91 (2.61-3.34) 1250 
Females 11-12 * < LOD 1.60 (1.40-1.77) 2.48 (2.17-2.85) 3.81 (2.75-4.88) 1214 
Race/ethnicity        
Mexican Americans 11-12 * < LOD 1.21 (1.10-1.38) 2.23 (1.77-2.61) 2.69 (2.29-3.30) 313 
Non-Hispanic blacks 11-12 * < LOD 1.17 (1.05-1.26) 1.89 (1.72-2.38) 2.91 (2.47-3.54) 662 
Non-Hispanic whites 11-12 * < LOD 1.34 (<LOD-1.48) 2.35 (1.98-2.75) 3.45 (2.82-4.31) 808 
All Hispanics 11-12 * < LOD 1.36 (1.20-1.46) 2.19 (1.98-2.59) 2.75 (2.61-3.09) 566 
Asians 11-12 * < LOD < LOD 2.36 (1.71-3.30) 3.54 (2.61-4.95) 341 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
* Not calculated: proportion of results below limit of detection was too high to provide a valid result. 
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Urinary Mandelic acid (2011 - 2012) 
Metabolite of Styrene 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 146 (134-160) 152 (140-169) 263 (236-297) 424 (386-466) 589 (510-677) 2466 
Age group        
6-11 years 11-12 111 (103-120) 113 (103-131) 195 (173-223) 311 (235-359) 384 (317-478) 394 
12-19 years 11-12 130 (114-149) 140 (121-164) 236 (201-288) 335 (293-404) 421 (356-638) 384 
20 years and older 11-12 153 (138-170) 159 (141-180) 275 (245-312) 452 (414-499) 638 (533-766) 1688 
Gender        
Males 11-12 170 (155-186) 176 (150-196) 285 (245-327) 452 (388-542) 677 (536-934) 1251 
Females 11-12 126 (112-143) 135 (120-147) 245 (210-272) 410 (351-454) 510 (431-619) 1215 
Race/ethnicity        
Mexican Americans 11-12 143 (126-162) 153 (139-170) 236 (202-259) 317 (288-354) 419 (327-903) 313 
Non-Hispanic blacks 11-12 186 (169-205) 189 (164-216) 296 (267-348) 507 (447-560) 730 (587-845) 662 
Non-Hispanic whites 11-12 141 (125-158) 146 (135-162) 260 (220-308) 430 (386-483) 574 (498-665) 810 
All Hispanics 11-12 145 (124-169) 153 (135-176) 255 (205-296) 337 (296-482) 485 (356-903) 566 
Asians 11-12 122 (108-137) 128 (114-146) 210 (181-254) 335 (280-395) 448 (349-594) 341 
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Urinary Mandelic acid (creatinine corrected) (2011 - 2012) 
Metabolite of Styrene 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 167 (155-179) 158 (146-168) 232 (215-251) 363 (328-392) 513 (440-608) 2464 
Age group        
6-11 years 11-12 158 (147-171) 161 (149-174) 223 (199-246) 289 (252-306) 337 (294-389) 393 
12-19 years 11-12 127 (115-139) 125 (110-137) 173 (147-199) 225 (215-233) 291 (225-323) 384 
20 years and older 11-12 175 (162-188) 162 (150-178) 247 (225-271) 394 (366-433) 564 (475-622) 1687 
Gender        
Males 11-12 159 (150-170) 148 (138-158) 221 (190-249) 349 (316-392) 482 (420-564) 1250 
Females 11-12 174 (158-192) 166 (150-184) 245 (220-281) 382 (335-423) 531 (410-622) 1214 
Race/ethnicity        
Mexican Americans 11-12 161 (142-183) 148 (135-167) 208 (187-223) 290 (262-333) 391 (290-657) 313 
Non-Hispanic blacks 11-12 145 (135-156) 141 (128-155) 193 (181-211) 294 (262-335) 440 (345-493) 662 
Non-Hispanic whites 11-12 172 (156-189) 162 (144-184) 247 (224-283) 389 (354-452) 559 (452-659) 808 
All Hispanics 11-12 162 (148-178) 152 (143-163) 209 (190-230) 307 (262-350) 400 (325-525) 566 
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Urinary N-Acetyl-S-(trichlorovinyl)-L-cysteine (2011 - 2012) 
Metabolite of Tetrachloroethene 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * < LOD < LOD < LOD < LOD 2466 
Age group        
6-11 years 11-12 * < LOD < LOD < LOD < LOD 394 
12-19 years 11-12 * < LOD < LOD < LOD < LOD 384 
20 years and older 11-12 * < LOD < LOD < LOD < LOD 1688 
Gender        
Males 11-12 * < LOD < LOD < LOD < LOD 1251 
Females 11-12 * < LOD < LOD < LOD < LOD 1215 
Race/ethnicity        
Mexican Americans 11-12 * < LOD < LOD < LOD < LOD 313 
Non-Hispanic blacks 11-12 * < LOD < LOD < LOD < LOD 662 
Non-Hispanic whites 11-12 * < LOD < LOD < LOD < LOD 810 
All Hispanics 11-12 * < LOD < LOD < LOD < LOD 566 
Asians 11-12 * < LOD < LOD < LOD < LOD 341 
Limit of detection (LOD, see Data Analysis section) for Survey year 11-12 is 3.0. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary N-Acetyl-S-(trichlorovinyl)-L-cysteine (creatinine corrected) (2011 - 2012) 
Metabolite of Tetrachloroethene 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * < LOD < LOD < LOD < LOD 2464 
Age group        
6-11 years 11-12 * < LOD < LOD < LOD < LOD 393 
12-19 years 11-12 * < LOD < LOD < LOD < LOD 384 
20 years and older 11-12 * < LOD < LOD < LOD < LOD 1687 
Gender        
Males 11-12 * < LOD < LOD < LOD < LOD 1250 
Females 11-12 * < LOD < LOD < LOD < LOD 1214 
Race/ethnicity        
Mexican Americans 11-12 * < LOD < LOD < LOD < LOD 313 
Non-Hispanic blacks 11-12 * < LOD < LOD < LOD < LOD 662 
Non-Hispanic whites 11-12 * < LOD < LOD < LOD < LOD 808 
All Hispanics 11-12 * < LOD < LOD < LOD < LOD 566 
Asians 11-12 * < LOD < LOD < LOD < LOD 341 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary N-Acetyl-S-(benzyl)-L-cysteine (2011 - 2012) 
Metabolite of Toluene 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 6.47 (6.12-6.83) 6.45 (6.01-6.88) 12.3 (10.9-13.7) 23.6 (20.4-27.2) 37.9 (32.1-45.9) 2466 
Age group        
6-11 years 11-12 6.11 (5.37-6.96) 6.63 (5.60-7.34) 11.4 (9.82-14.2) 23.1 (16.9-25.3) 29.7 (24.9-48.2) 394 
12-19 years 11-12 6.51 (5.53-7.65) 6.66 (5.73-7.56) 12.8 (10.1-16.9) 23.2 (17.8-33.4) 36.5 (23.9-66.0) 384 
20 years and older 11-12 6.50 (6.02-7.02) 6.31 (5.84-7.01) 12.3 (10.5-14.7) 23.7 (20.1-28.4) 38.7 (31.9-53.9) 1688 
Gender        
Males 11-12 6.81 (6.34-7.31) 6.83 (6.09-7.65) 12.5 (11.1-14.0) 23.6 (19.3-29.8) 39.7 (29.9-62.7) 1251 
Females 11-12 6.15 (5.56-6.82) 6.15 (5.77-6.64) 12.1 (9.98-14.5) 23.2 (19.5-28.7) 35.4 (29.7-53.9) 1215 
Race/ethnicity        
Mexican Americans 11-12 5.76 (4.82-6.87) 5.87 (5.02-6.50) 9.68 (7.99-12.3) 19.1 (15.9-23.6) 29.9 (19.1-42.8) 313 
Non-Hispanic blacks 11-12 11.0 (10.1-11.9) 10.6 (9.57-11.9) 21.6 (17.8-24.8) 39.7 (34.2-45.5) 68.3 (52.3-95.4) 662 
Non-Hispanic whites 11-12 5.90 (5.57-6.25) 5.92 (5.35-6.47) 10.9 (10.0-12.1) 19.5 (17.7-23.2) 32.1 (25.3-39.3) 810 
All Hispanics 11-12 6.52 (5.53-7.70) 6.17 (5.50-7.39) 12.2 (9.53-15.4) 23.2 (18.3-31.6) 39.1 (24.7-56.9) 566 
Asians 11-12 5.25 (4.39-6.28) 5.30 (4.17-6.82) 10.8 (8.50-12.9) 20.5 (16.9-26.1) 35.8 (23.1-51.5) 341 
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Urinary N-Acetyl-S-(benzyl)-L-cysteine (creatinine corrected) (2011 - 2012) 
Metabolite of Toluene 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 7.39 (7.07-7.72) 6.68 (6.36-7.00) 12.2 (11.1-13.1) 21.0 (19.3-23.9) 36.4 (29.2-44.7) 2464 
Age group        
6-11 years 11-12 8.78 (8.11-9.50) 7.88 (7.00-8.46) 12.8 (11.8-14.1) 24.5 (18.2-29.5) 33.1 (23.7-56.4) 393 
12-19 years 11-12 6.34 (5.51-7.29) 5.73 (4.72-6.94) 10.0 (8.30-12.3) 17.4 (13.3-20.2) 25.7 (17.7-32.4) 384 
20 years and older 11-12 7.42 (6.98-7.89) 6.70 (6.23-7.24) 12.5 (11.1-13.7) 21.9 (19.1-25.1) 39.4 (30.1-49.1) 1687 
Gender        
Males 11-12 6.40 (6.04-6.78) 5.78 (5.41-6.09) 9.52 (8.74-10.5) 17.7 (15.3-21.7) 29.5 (21.3-39.6) 1250 
Females 11-12 8.49 (7.86-9.17) 7.62 (7.11-8.30) 14.2 (12.7-15.5) 24.7 (22.2-27.0) 40.4 (31.4-49.1) 1214 
Race/ethnicity        
Mexican Americans 11-12 6.50 (5.31-7.96) 5.99 (4.63-8.22) 10.4 (8.29-12.9) 17.9 (12.9-23.5) 24.1 (20.0-30.6) 313 
Non-Hispanic blacks 11-12 8.56 (7.91-9.26) 7.73 (6.92-8.43) 14.4 (13.0-15.8) 26.0 (22.5-31.9) 46.9 (31.9-63.2) 662 
Non-Hispanic whites 11-12 7.21 (6.86-7.58) 6.49 (5.91-6.98) 11.8 (10.0-13.1) 19.7 (17.3-24.5) 37.9 (25.7-50.1) 808 
All Hispanics 11-12 7.30 (6.38-8.36) 6.67 (5.87-7.70) 11.4 (10.2-12.9) 21.9 (19.1-24.4) 30.4 (24.6-35.3) 566 
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Urinary N-Acetyl-S-(1,2-dichlorovinyl)-L-cysteine (2011 - 2012) 
Metabolite of Trichloroethene 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * < LOD < LOD < LOD < LOD 2466 
Age group        
6-11 years 11-12 * < LOD < LOD < LOD < LOD 394 
12-19 years 11-12 * < LOD < LOD < LOD < LOD 384 
20 years and older 11-12 * < LOD < LOD < LOD < LOD 1688 
Gender        
Males 11-12 * < LOD < LOD < LOD < LOD 1251 
Females 11-12 * < LOD < LOD < LOD < LOD 1215 
Race/ethnicity        
Mexican Americans 11-12 * < LOD < LOD < LOD < LOD 313 
Non-Hispanic blacks 11-12 * < LOD < LOD < LOD < LOD 662 
Non-Hispanic whites 11-12 * < LOD < LOD < LOD < LOD 810 
All Hispanics 11-12 * < LOD < LOD < LOD < LOD 566 
Asians 11-12 * < LOD < LOD < LOD < LOD 341 
Limit of detection (LOD, see Data Analysis section) for Survey year 11-12 is 12.6. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary N-Acetyl-S-(1,2-dichlorovinyl)-L-cysteine (creatinine corrected) (2011 - 2012) 
Metabolite of Trichloroethene 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * < LOD < LOD < LOD < LOD 2464 
Age group        
6-11 years 11-12 * < LOD < LOD < LOD < LOD 393 
12-19 years 11-12 * < LOD < LOD < LOD < LOD 384 
20 years and older 11-12 * < LOD < LOD < LOD < LOD 1687 
Gender        
Males 11-12 * < LOD < LOD < LOD < LOD 1250 
Females 11-12 * < LOD < LOD < LOD < LOD 1214 
Race/ethnicity        
Mexican Americans 11-12 * < LOD < LOD < LOD < LOD 313 
Non-Hispanic blacks 11-12 * < LOD < LOD < LOD < LOD 662 
Non-Hispanic whites 11-12 * < LOD < LOD < LOD < LOD 808 
All Hispanics 11-12 * < LOD < LOD < LOD < LOD 566 
Asians 11-12 * < LOD < LOD < LOD < LOD 341 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary N-Acetyl-S-(2,2-dichlorovinyl)-L-cysteine (2011 - 2012) 
Metabolite of Trichloroethene 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * < LOD < LOD < LOD < LOD 2466 
Age group        
6-11 years 11-12 * < LOD < LOD < LOD < LOD 394 
12-19 years 11-12 * < LOD < LOD < LOD < LOD 384 
20 years and older 11-12 * < LOD < LOD < LOD < LOD 1688 
Gender        
Males 11-12 * < LOD < LOD < LOD < LOD 1251 
Females 11-12 * < LOD < LOD < LOD < LOD 1215 
Race/ethnicity        
Mexican Americans 11-12 * < LOD < LOD < LOD < LOD 313 
Non-Hispanic blacks 11-12 * < LOD < LOD < LOD < LOD 662 
Non-Hispanic whites 11-12 * < LOD < LOD < LOD < LOD 810 
All Hispanics 11-12 * < LOD < LOD < LOD < LOD 566 
Asians 11-12 * < LOD < LOD < LOD < LOD 341 
Limit of detection (LOD, see Data Analysis section) for Survey year 11-12 is 6.5. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 






Fourth National Report on Human Exposure to Environmental Chemicals, Updated Tables, January 2017 Volume One Page 617
Urinary N-Acetyl-S-(2,2-dichlorovinyl)-L-cysteine (creatinine corrected) (2011 - 2012) 
Metabolite of Trichloroethene 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * < LOD < LOD < LOD < LOD 2464 
Age group        
6-11 years 11-12 * < LOD < LOD < LOD < LOD 393 
12-19 years 11-12 * < LOD < LOD < LOD < LOD 384 
20 years and older 11-12 * < LOD < LOD < LOD < LOD 1687 
Gender        
Males 11-12 * < LOD < LOD < LOD < LOD 1250 
Females 11-12 * < LOD < LOD < LOD < LOD 1214 
Race/ethnicity        
Mexican Americans 11-12 * < LOD < LOD < LOD < LOD 313 
Non-Hispanic blacks 11-12 * < LOD < LOD < LOD < LOD 662 
Non-Hispanic whites 11-12 * < LOD < LOD < LOD < LOD 808 
All Hispanics 11-12 * < LOD < LOD < LOD < LOD 566 
Asians 11-12 * < LOD < LOD < LOD < LOD 341 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary N-Acetyl-S-(dimethylphenyl)-L-cysteine (2011 - 2012) 
Metabolite of Xylene 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * < LOD < LOD < LOD < LOD 2466 
Age group        
6-11 years 11-12 * < LOD < LOD < LOD < LOD 394 
12-19 years 11-12 * < LOD < LOD < LOD < LOD 384 
20 years and older 11-12 * < LOD < LOD < LOD < LOD 1688 
Gender        
Males 11-12 * < LOD < LOD < LOD < LOD 1251 
Females 11-12 * < LOD < LOD < LOD < LOD 1215 
Race/ethnicity        
Mexican Americans 11-12 * < LOD < LOD < LOD < LOD 313 
Non-Hispanic blacks 11-12 * < LOD < LOD < LOD < LOD 662 
Non-Hispanic whites 11-12 * < LOD < LOD < LOD < LOD 810 
All Hispanics 11-12 * < LOD < LOD < LOD < LOD 566 
Asians 11-12 * < LOD < LOD < LOD < LOD 341 
Limit of detection (LOD, see Data Analysis section) for Survey year 11-12 is 0.5. 
< LOD means less than the limit of detection, which may vary for some chemicals by year and by individual sample. 
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Urinary N-Acetyl-S-(dimethylphenyl)-L-cysteine (creatinine corrected) (2011 - 2012) 
Metabolite of Xylene 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 * < LOD < LOD < LOD < LOD 2464 
Age group        
6-11 years 11-12 * < LOD < LOD < LOD < LOD 393 
12-19 years 11-12 * < LOD < LOD < LOD < LOD 384 
20 years and older 11-12 * < LOD < LOD < LOD < LOD 1687 
Gender        
Males 11-12 * < LOD < LOD < LOD < LOD 1250 
Females 11-12 * < LOD < LOD < LOD < LOD 1214 
Race/ethnicity        
Mexican Americans 11-12 * < LOD < LOD < LOD < LOD 313 
Non-Hispanic blacks 11-12 * < LOD < LOD < LOD < LOD 662 
Non-Hispanic whites 11-12 * < LOD < LOD < LOD < LOD 808 
All Hispanics 11-12 * < LOD < LOD < LOD < LOD 566 
Asians 11-12 * < LOD < LOD < LOD < LOD 341 
< LOD means less than the limit of detection for the urine levels not corrected for creatinine. 
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Urinary 2-Methylhippuric acid (2011 - 2012) 
Metabolite of Xylene 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 32.8 (29.8-36.1) 30.4 (27.4-34.1) 76.1 (69.2-88.9) 161 (133-192) 221 (195-276) 2466 
Age group        
6-11 years 11-12 21.9 (19.6-24.4) 19.4 (16.6-23.4) 45.4 (35.8-54.9) 97.4 (61.8-114) 122 (97.2-168) 394 
12-19 years 11-12 31.0 (26.4-36.4) 27.7 (24.7-34.5) 68.3 (56.7-75.9) 146 (104-166) 173 (161-227) 384 
20 years and older 11-12 34.6 (30.9-38.6) 32.8 (28.6-37.2) 83.2 (72.6-94.5) 170 (134-206) 232 (200-327) 1688 
Gender        
Males 11-12 37.7 (32.3-44.0) 33.0 (28.5-38.9) 86.8 (72.9-104) 180 (147-224) 269 (195-407) 1251 
Females 11-12 28.6 (25.3-32.4) 28.5 (25.4-32.5) 69.2 (58.5-82.6) 135 (113-151) 197 (159-227) 1215 
Race/ethnicity        
Mexican Americans 11-12 30.5 (24.7-37.7) 29.1 (24.9-34.1) 62.3 (51.0-72.0) 129 (84.1-171) 198 (133-250) 313 
Non-Hispanic blacks 11-12 35.6 (31.2-40.6) 33.0 (28.2-40.7) 78.4 (66.9-97.5) 155 (131-192) 212 (181-269) 662 
Non-Hispanic whites 11-12 33.5 (30.0-37.3) 31.5 (27.5-35.9) 82.6 (70.5-94.5) 166 (134-204) 232 (188-351) 810 
All Hispanics 11-12 29.2 (25.0-34.1) 26.5 (22.5-32.3) 64.9 (51.0-72.7) 131 (92.5-166) 198 (144-227) 566 
Asians 11-12 26.2 (21.5-32.0) 26.3 (20.9-33.8) 56.4 (47.4-75.4) 114 (79.4-155) 165 (126-195) 341 
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Urinary 2-Methylhippuric acid (creatinine corrected) (2011 - 2012) 
Metabolite of Xylene 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 37.5 (33.9-41.4) 35.2 (31.5-39.3) 77.9 (69.0-87.6) 159 (140-184) 248 (187-303) 2464 
Age group        
6-11 years 11-12 31.2 (27.5-35.3) 26.9 (24.1-31.9) 48.5 (44.9-61.0) 101 (70.9-155) 173 (102-209) 393 
12-19 years 11-12 30.2 (25.4-35.9) 29.6 (22.7-38.6) 54.5 (47.6-68.9) 103 (74.3-160) 175 (106-277) 384 
20 years and older 11-12 39.5 (35.5-43.9) 37.4 (33.6-42.1) 87.0 (77.3-96.9) 168 (142-201) 270 (190-331) 1687 
Gender        
Males 11-12 35.5 (30.8-40.8) 34.3 (28.6-39.8) 75.0 (62.5-86.4) 144 (121-171) 251 (161-336) 1250 
Females 11-12 39.5 (35.2-44.2) 36.4 (31.2-41.1) 83.7 (69.0-97.2) 170 (146-198) 245 (187-301) 1214 
Race/ethnicity        
Mexican Americans 11-12 34.5 (27.7-42.9) 29.3 (24.1-36.1) 62.9 (49.1-76.1) 127 (88.8-175) 188 (109-300) 313 
Non-Hispanic blacks 11-12 27.7 (24.7-31.1) 26.2 (20.8-32.6) 58.9 (49.8-71.3) 104 (87.5-120) 146 (114-182) 662 
Non-Hispanic whites 11-12 40.9 (36.9-45.4) 39.4 (34.3-43.6) 88.3 (76.3-99.7) 180 (146-233) 281 (201-333) 808 
All Hispanics 11-12 32.7 (28.7-37.1) 27.6 (25.2-32.6) 60.8 (52.1-70.1) 127 (98.5-142) 170 (139-238) 566 
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Urinary 3-and 4-Methylhippuric acid (2011 - 2012) 
Metabolite of Xylene 
Geometric mean and selected percentiles of urine concentrations (in µg/L) for the U.S. population from the National Health 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 221 (202-241) 212 (197-229) 563 (485-624) 1190 (1000-1410) 1710 (1520-2040) 2466 
Age group        
6-11 years 11-12 152 (134-172) 136 (107-180) 311 (254-368) 616 (441-747) 889 (644-1140) 394 
12-19 years 11-12 214 (185-248) 209 (176-238) 499 (374-592) 1210 (879-1570) 1680 (1510-2100) 384 
20 years and older 11-12 231 (209-256) 222 (206-249) 601 (523-667) 1230 (1050-1470) 1740 (1560-2050) 1688 
Gender        
Males 11-12 251 (217-290) 224 (203-264) 590 (477-708) 1340 (1050-1590) 1720 (1470-2260) 1251 
Females 11-12 195 (173-220) 202 (176-215) 547 (431-602) 1020 (866-1230) 1650 (1470-1890) 1215 
Race/ethnicity        
Mexican Americans 11-12 178 (141-224) 165 (118-224) 388 (288-446) 879 (569-1110) 1230 (886-2120) 313 
Non-Hispanic blacks 11-12 257 (226-293) 246 (200-275) 600 (495-725) 1270 (1090-1440) 1830 (1490-2060) 662 
Non-Hispanic whites 11-12 231 (209-256) 221 (205-251) 599 (499-681) 1250 (1050-1510) 1720 (1510-2190) 810 
All Hispanics 11-12 176 (141-219) 161 (118-215) 400 (294-498) 886 (597-1230) 1290 (935-1920) 566 
Asians 11-12 141 (109-183) 128 (96.4-185) 346 (251-486) 760 (598-1030) 1160 (892-1610) 341 
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Urinary 3-and 4-Methylhippuric acid (creatinine corrected) (2011 - 2012) 
Metabolite of Xylene 
Geometric mean and selected percentiles of urine concentrations (in µg/g of creatinine) for the U.S. population from the 




(95% conf. interval) 
50th Percentile 
(95% conf. interval) 
75th Percentile 
(95% conf. interval) 
90th Percentile 
(95% conf. interval) 
95th Percentile 
(95% conf. interval) 
Sample 
size 
Total 11-12 252 (232-275) 212 (185-241) 565 (510-617) 1050 (982-1130) 1540 (1370-1690) 2464 
Age group        
6-11 years 11-12 218 (192-247) 189 (153-230) 302 (258-376) 603 (477-669) 911 (603-1200) 393 
12-19 years 11-12 208 (178-244) 175 (136-227) 459 (314-585) 812 (660-982) 1130 (864-1500) 384 
20 years and older 11-12 264 (242-288) 227 (195-253) 612 (545-692) 1120 (1050-1220) 1610 (1420-1940) 1687 
Gender        
Males 11-12 236 (209-266) 197 (170-229) 511 (462-549) 930 (806-1030) 1420 (1110-1870) 1250 
Females 11-12 269 (244-297) 226 (189-253) 631 (551-723) 1170 (1040-1360) 1660 (1470-1830) 1214 
Race/ethnicity        
Mexican Americans 11-12 201 (159-253) 144 (127-179) 415 (284-515) 798 (595-1020) 1050 (792-1920) 313 
Non-Hispanic blacks 11-12 201 (180-223) 182 (143-219) 442 (387-496) 763 (640-856) 1030 (841-1360) 662 
Non-Hispanic whites 11-12 283 (262-306) 245 (214-287) 648 (553-723) 1210 (1050-1360) 1690 (1470-2050) 808 
All Hispanics 11-12 197 (168-230) 145 (128-175) 415 (284-492) 792 (660-942) 1040 (870-1350) 566 
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Chemical, matrix, units 1999-2000
 
2001-2002 2003-2004 2005-2006 2007-2008 2009-2010 2011-2012 2013-2014




Cotinine in serum, ng/mL 0.05
NNAL in urine, pg/mL

















































Insect Repellent and Metabolites in urine, μg/L
N,N-Diethyl-meta -toluamide (DEET)








































































































































































Appendix C. Limit of Detection Table 
The analytical limit of detection (LOD) for each of the different chemical measurements is presented in the table below. The LOD is the concentration at which 
the measurement has a 95% probability of being greater than zero (Taylor, 1987).  As analytical methods improve, LODs will often change. For this reason, LOD 
results are reported by survey periods (e.g., 1999-2000, 2001-2002, etc.).
Reference: Taylor JK. Quality Assurance of Chemical Measurements. Chelsea (MI): Lewis Publishing. 1987.
_________________________________________________________________________________________________
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Chemical, matrix, units 1999-2000 2001-2002 2003-2004 2005-2006 2007-2008 2009-2010 2011-2012 2013-2014
Carbamate Pesticide Metabolites in urine, μg/L
Carbofuranphenol 0.4
2-isopropoxyphenol 1.1
Organochlorine Pesticides and Metabolites in urine, μg/L
2,4,5-Trichlorophenol
2,4,6-Trichlorophenol
















Pyrethroid Metabolites in urine, μg/L
trans -3-(2,2-Dichlorovinyl)-2,2-dimethylcyclopropane carboxylic 0.1acid




Antimony in urine, μg/L 0.04
Arsenic, Total in urine, μg/L
    Arsenic (V) Acid in urine, μg As/L
    Arsenobetaine in urine, μg As/L
    Arsenocholine in urine, μg As/L
    Arsenous (III) Acid in urine, μg As/L
    Dimethylarsinic Acid in urine, μg As/L
    Monomethylarsonic Acid in urine, μg As/L
Inorganic-related Arsenic Species, in urine, μg As/g
    Trimethylarsine oxide in urine, μg As/L
Barium in urine, μg/L 0.12
Beryllium in urine, μg/L 0.13
Cadmium in blood, μg/L 0.3
Cadmium in urine, μg/L 0.06
Cesium in urine, μg/L 0.14
Cobalt in urine, μg/L 0.07
Copper in serum, μg/dL
Lead in blood, μg/dL 0.3
Lead in urine, μg/L 0.1
Manganese in blood, μg/L
Manganese in urine, μg/L
Mercury, Total in blood, μg/L
       Mercury, Inorganic in blood, μg/L
    Mercury, Ethyl in blood, μg/L
    Mercury, Methyl in blood, μg/L
Mercury in urine, μg/L
Molybdenum in urine, μg/L 0.8
Platinum in urine, μg/L 0.04
Selenium in blood, μg/L
Selenium in serum, μg/L
Strontium in urine, μg/L
Thallium in urine, μg/L 0.02
Tin in urine, μg/L
Tungsten in urine, μg/L 0.04
Uranium in urine, μg/L 0.004
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Chemical, matrix, units 1999-2000 2001-2002 2003-2004 2005-2006 2007-2008 2009-2010 2011-2012 2013-2014




Perfluoroalkyl and Polyfluoroalkyl Substances: Surfactants in serum, μg/L
Perfluorobutane sulfonic acid (PFBuS)
Perfluorodecanoic acid (PFDeA) 0.2
Perfluorododecanoic acid (PFDoA) 0.2
Perfluoroheptanoic acid (PFHpA) 0.4
Perfluorohexane sulfonic acid (PFHxS) 0.1
Perfluorononanoic acid (PFNA) 0.1
Perfluorooctanoic acid (PFOA) 0.1
n-Perfluorooctanoic acid (n-PFOA) 
Branched Perfluorooctanoic acid isomers (Sb-PFOA) 
Perfluorooctane sulfonic acid (PFOS)  0.2
n-Perfluorooctane sulfonic acid (n-PFOS) 
Perfluoromethylheptane sulfonic acid isomers (Sm-PFOS)
Perfluorooctane sulfonamide (PFOSA) 0.05
2-(N-Ethyl-perfluorooctane sulfonamido) 0.2acetic acid (Et-PFOSA-AcOH) 
 2-(N-Methyl-perfluorooctane sulfonamido) 0.174acetic acid (Me-PFOSA-AcOH)
Perfluoroundecanoic acid (PFUA) 0.2
Phthalate and Phthalate Alternatives Metabolites in urine, μg/L
Mono-benzyl phthalate (MBzP) 0.576
Mono-n -butyl phthalate (MnBP) 0.9
Mono-isobutyl phthalate (MiBP)
Mono-cyclohexyl phthalate (MCHP) 1.81
Mono-ethyl phthalate (MEP) 0.792









Mono-n -octyl phthalate (MOP) 1.51
Cyclohexane-1,2-dicarboxylic mono hydroxyisononyl ester 
(MHNCH)
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Chemical, matrix, units 1999-2000 2001-2002 2003-2004 2005-2006 2007-2008 2009-2010 2011-2012 2013-2014







1,1-Dichloroethene (Vinylidene chloride) 
1,2-Dibromo-3-chloropropane (DBCP) 
1,2-Dibromoethane
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Chemical, matrix, units 1999-2000 2001-2002 2003-2004 2005-2006 2007-2008 2009-2010 2011-2012 2013-2014




Heptachlor epoxide 10.5 7.8
Oxychlordane 14.5 10.5 7.8
trans -Nonachlor 14.5 10.5 7.8
p,p' -DDT 20.7 17.4 7.8
p,p' -DDE 18.6 8.3 7.8
o,p' -DDT 17.4 7.8
Hexachlorobenzene 118 31.4 7.8
beta -Hexachlorocyclohexane 9.36 6.76 7.8
gamma -Hexachlorocyclohexane 14.5 10.5 7.8
Mirex 14.6 10.5 7.8
Polybrominated Diphenyl Ethers and PBB 153 (Pooled Samples after 2004) in serum, ng/g lipid
2,2',4’-Tribromodiphenyl ether (BDE 17) 1
2,4,4’-Tribromodiphenyl ether (BDE 28) 0.8
2,2’,4,4’-Tetrabromodiphenyl ether (BDE 47) 4.2
2,3',4,4'-Tetrabromodiphenyl ether (BDE 66) 1
2,2’,3,4,4’-Pentabromodiphenyl ether (BDE 85) 2.4
2,2’,4,4’,5-Pentabromodiphenyl ether (BDE 99) 5
2,2’,4,4’,6-Pentabromodiphenyl ether (BDE 100) 1.4
2,2’,4,4’,5,5’-Hexabromodiphenyl ether (BDE 153) 2.2
2,2’,4,4’,5,6’-Hexabromodiphenyl ether (BDE 154) 0.8
2,2’,3,4,4’,5’,6-Heptabromodiphenyl ether (BDE 183) 1.7
2,2',3,3',4,4',5,5',6,6'-Decabromodiphenyl ether (BDE 209)
2,2’,4,4’,5,5’-Hexabromobiphenyl (PBB 153) 0.8
Polychlorinated Dibenzo-p-dioxins (Pooled Samples) in serum, pg/g lipid
1,2,3,4,6,7,8-Heptachlorodibenzo-p -dioxin (HpCDD) 55.9 10.3 13
1,2,3,4,7,8-Hexachlorodibenzo-p -dioxin (HxCDD) 9 11.9
1,2,3,6,7,8-Hexachlorodibenzo-p -dioxin (HxCDD) 20.1 9.1 12.3
1,2,3,7,8,9-Hexachlorodibenzo-p -dioxin (HxCDD) 20.3 9.3 12.3
1,2,3,4,6,7,8,9-Octachlorodibenzo-p -dioxin (OCDD) 329 319 218
1,2,3,7,8-Pentachlorodibenzo-p -dioxin (PeCDD) 14.2 6 4.5
2,3,7,8-Tetrachlorodibenzo-p -dioxin (TCDD) 12.1 5.8 3.8
Polychlorinated Dibenzofurans (Pooled Samples after 2004) in serum, pg/g lipid
1,2,3,4,6,7,8-Heptachlorodibenzofuran (HpCDF) 13.5 7 8.6
1,2,3,4,7,8,9-Heptachlorodibenzofuran (HpCDF) 7 8.6
1,2,3,4,7,8-Hexachlorodibenzofuran (HxCDF) 12.7 6.5 7.4
1,2,3,6,7,8-Hexachlorodibenzofuran (HxCDF) 12.6 6.1 7.9
1,2,3,7,8,9-Hexachlorodibenzofuran (HxCDF) 12.7 6 8.3
2,3,4,6,7,8-Hexachlorodibenzofuran (HxCDF) 12.9 5.8 8.2
1,2,3,4,6,7,8,9-Octachlorodibenzofuran (OCDF) 35.6 21 12
1,2,3,7,8-Pentachlorodibenzofuran (PeCDF) 13.2 5.8 7.1
2,3,4,7,8-Pentachlorodibenzofuran (PeCDF) 12.7 5.5 6.8
2,3,7,8-Tetrachlorodibenzofuran (TCDF) 11.9 5.2 6
Dioxin-like Polychlorinated Biphenyls: Coplanar PCBs (Pooled Samples after 2004) in serum, pg/
3,4,4',5-Tetrachlorobiphenyl (PCB 81) 68.4 26.8 13.1
3,3',4,4',5-Pentachlorobiphenyl (PCB 126) 23.2 10.8 13.9
3,3',4,4',5,5'-Hexachlorobiphenyl (PCB 169) 27 11 15.9
Dioxin-like Polychlorinated Biphenyls: mono-ortho-substituted PCBs (Pooled Samples after 2004)
2,3,3',4,4'-Pentachlorobiphenyl (PCB 105) 12.4 10.5 0.4
2,3,3',4,4'-Pentachlorobiphenyl (PCB 114)
2,3',4,4',5-Pentachlorobiphenyl (PCB 118) 12.5 10.5 0.6
2',3,4,4',5-Pentachlorobiphenyl (PCB 123)
2,3,3',4,4',5-Hexachlorobiphenyl (PCB 156) 12.5 10.5 0.4
2,3,3',4,4',5'-Hexachlorobiphenyl (PCB 157) 12.5 10.5 0.4
2,3',4,4',5,5'-Hexachlorobiphenyl (PCB 167) 12.4 10.5 0.4
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Chemical, matrix, units 1999-2000 2001-2002 2003-2004 2005-2006 2007-2008 2009-2010 2011-2012 2013-2014
Polychlorinated Biphenyls: Non-Dioxin-Like (Pooled Samples after 2004) 
2,4,4'-Trichlorobiphenyl (PCB 28) 32.4
2,2'3,5'-Tetrachloro biphenyl (PCB 44)
2,2',4,5'-Tetrachloro biphenyl (PCB 49)
2,2',5,5'-Tetrachlorobiphenyl (PCB 52) 12.5
2,3',4,4'-Tetrachlorobiphenyl (PCB 66) 12.4
2,4,4',5-Tetrachlorobiphenyl (PCB 74) 12.4
2,2',3,4,5'-Pentachlorobiphenyl (PCB 87) 
2,2',4,4',5-Pentachlorobiphenyl (PCB 99) 12.5
2,2',4,5,5'-Pentachlorobiphenyl (PCB 101) 25.7
2,3,3’,4’,6-Pentachlorobiphenyl (PCB 110)
2,2',3,3',4,4'-Hexachlorobiphenyl (PCB 128) 12.4
2,2',3,4,4',5' and 2,3,3’,4,4’,6-Hexachlorobiphenyl (PCB 138 & 41.1158) 
2,2',3,4',5,5'-Hexachlorobiphenyl (PCB 146) 12.4
2,2’,3,4’,5’,6-Hexachlorobiphenyl (PCB 149) 10.5
2,2’,3,5,5’,6-Hexachlorobiphenyl (PCB 151)
2,2',4,4',5,5'-Hexachlorobiphenyl (PCB 153) 55.6
2,2',3,3',4,4',5-Heptachlorobiphenyl (PCB 170) 17.2
2,2',3,3',4,5,5'-Heptachlorobiphenyl (PCB 172) 12.5
2,2',3,3',4,5',6'-Heptachlorobiphenyl (PCB 177) 12.5
2,2',3,3',5,5',6-Heptachlorobiphenyl (PCB 178) 12.4
2,2',3,4,4',5,5'-Heptachlorobiphenyl (PCB 180) 28.2
2,2',3,4,4',5',6-Heptachlorobiphenyl (PCB 183) 12.4
2,2',3,4',5,5',6-Heptachlorobiphenyl (PCB 187) 12.4
2,2’,3,3’,4,4’,5,5’-Octachlorobiphenyl (PCB 194)
2,2’,3,3’,4,4’,5,6-Octachlorobiphenyl (PCB 195)
2,2’,3,3’,4,4’,5,6’ and 2,2’,3,4,4’,5,5’,6-Octachlorobiphenyl (PCB 
196 & 203)
2,2’,3,3’,4,5,5’,6-Octachlorobiphenyl (PCB 199) 
2,2’,3,3’,4,4’,5,5’,6-Nonachlorobiphenyl (PCB 206)
2,2',3,3',4,4',5,5',6,6'-Decachlorobiphenyl (PCB 209)
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Appendix D. References for Biomonitoring Analytical Methods 
 
Adducts of Hemoglobin 
 
Vesper HW, Bernert JT, Ospina M, Meyers T, Ingham L, Smith A, et al. Assessment of the 
relation between biomarkers for smoking and biomarkers for acrylamide exposure in humans. 
Cancer Epidemiol Biomarkers Prev 2007;16(11):2471-8. 
 
Vesper HW, Slimani N, Hallmans G, Tjonneland A, Agudo A, Benetou V, et al. Cross-sectional 
study on acrylamide hemoglobin adducts in subpopulations from the European Prospective 
Investigation into Cancer and Nutrition (EPIC) study. J Agric Food Chem 2008; 56 (15):6046–
53. 
 




Bernert JT, McGuffey JE, Morrison MA, Pirkle JL. Comparison of serum and salivary cotinine 
measurements by a sensitive high-performance liquid chromatography/tandem mass spectrometry 
method as an indicator of exposure to tobacco smoke among smokers and nonsmokers. J Anal 
Toxicol 2000;24:333-9. 
 
Bernert JT, Turner WE, Pirkle JL, Sosnoff CS, Akins JR, Waldrep MK, et al. Development and 
validation of sensitive method for determination of serum cotinine in smokers and nonsmokers by 





Xia Y, Bernert JT. Stability of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3- 
pyridyl)-1-butanol (NNAL) in urine samples stored at various temperatures. J Anal Toxicol 
2010:34:411-5. 
 
Xia Y, McGuffey JE, Bhattacharyya S, Sellergren B, Yilmaz E, Wang L, et al. Analysis of the 
tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in urine by 
extraction on a molecularly imprinted polymer column and liquid chromatography/atmospheric 
pressure ionization tandem mass spectrometry. Anal Chem. 2005;77(23):7639-45. 
 
Personal Care and Consumer Product Chemicals and Metabolites 
 
Ye X, Kuklenyik Z, Needham LL, Calafat AM. Automated on-line column-switching 
HPLCMS/MS method with peak focusing for the determination of nine environmental phenols in 
urine. Anal Chem 2005;77:5407-13. 
 
Ye X, Kuklenyik Z, Bishop AM, Needham LL, Calafat AM. Quantification of the urinary 
concentrations of parabens in humans by on-line solid phase extraction-high performance liquid 
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Fungicides and Metabolites 
Bravo R, Caltabiano LM, Fernandez C, Smith KD, Gallegos M, Whitehead RD, et al. 
Quantification of phenolic metabolites of environmental chemicals in human urine using gas 
chromatography-tandem mass spectrometry and isotope dilution quantification. J Chromatog B 
2005;820(2):229-236. 
 
Hill RH Jr, Shealy DB, Head SL, Williams CC, Bailey SL, Gregg M, et al. Determination of 
pesticide metabolites in human urine using isotope dilution technique and tandem mass 
spectrometry. J Anal Toxicol 1995;19(5):323-329. 
 
Montesano MA, Olsson AO, Kuklenyik P, Needham LL, Bradman AS, Barr DB. Method for 
determination of acephate, methamidophos, omethoate, dimethoate, ethylenethiourea and 
propylenethiourea in human urine using high-performance liquid chromatography-atmospheric 
pressure chemical ionization tandem mass spectrometry. J Expo Sci Environ Epidemiol. 
2007;17(4):321-30. 
 
Herbicides and Metabolites 
Atrazine 
 
Kuklenyik Z, Panuwet P, Jayatilaka NK, Pirkle JL, Calafat AM. Two-dimensional high 
performance liquid chromatography separation and tandem mass spectrometry detection of 
atrazine and its metabolic and hydrolysis products in urine. J Chromatogr B Analyt Technol 
Biomed Life Sci. 2012 Jul 15;901:1-8.  
 
2,4-D and 2,4,5-T 
 
Davis MD, Wade EL, Restrepo PR, Roman-Esteva W, Bravo R, Kuklenyik P, Calafat AM. 
Semiautomated solid phase extraction method for the mass spectrometric quantification of 12 
specific metabolites of organophosphorus pesticides, synthetic pyrethroids, and select herbicides 
in human urine. J Chromatogr B 2013;929:18-26. (NHANES 2007-2008 and later) 
 
Olsson AO, Baker SE, Nguyen JV, Romanoff LC, Udunka SO, Walker RD, et al. A liquid 
chromatography-tandem mass spectrometry multiresidue method for quantification of specific 
metabolites of organophosphorus pesticides, synthetic pyrethroids, selected herbicides, and DEET 




Nguyen JV, Olsson AO, Bravo R, Needham LL, Barr DB. Quantification of atrazine, phenylurea, 
and sulfonylurea herbicide metabolites in urine by high-performance liquid 
chromatographytandem mass spectrometry. J Anal Toxicol. 2007;31(4):181-6. 
 
Baker SE, Olsson AO, Needham LL, Barr DB. High-performance liquid chromatography-tandem 
mass spectrometry method for quantifying sulfonylurea herbicides in human urine: reconsidering 
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Insect Repellent and Metabolites (DEET) 
Kuklenyik P, Baker SE, Bishop AM, Morales-A P, Calafat AM. On-line solid phase extraction-
high performance liquid chromatography-isotope dilution-tandem mass spectrometry approach to 




Bravo R, Caltabiano LM, Fernandez C, Smith KD, Gallegos M, Whitehead RD, et al. 
Quantification of phenolic metabolites of environmental chemicals in human urine using gas 
chromatography-tandem mass spectrometry and isotope dilution quantification. J Chromatog B 
2005;820(2):229-236. 
 
Hill RH Jr, Shealy DB, Head SL, Williams CC, Bailey SL, Gregg M, et al. Determination of 
pesticide metabolites in human urine using isotope dilution technique and tandem mass 
spectrometry. J Anal Toxicol 1995;19(5):323-329. 
 
Organochlorine Pesticide Metabolites   
Ye X, Kuklenyik Z, Needham LL, Calafat AM. Automated on-line column-switching 
HPLCMS/MS method with peak focusing for the determination of nine environmental phenols in 
urine. Anal Chem 2005;77:5407-13.  
Organophosphate Insecticides: Specific Metabolites 
Bravo R, Caltabiano LM, Fernandez C, Smith KD, Gallegos M, Whitehead RD, et al. 
Quantification of phenolic metabolites of environmental chemicals in human urine using gas 
chromatography-tandem mass spectrometry and isotope dilution quantification. J Chromatog B 
2005;820(2):229-36. 
 
Hill RH Jr, Shealy DB, Head SL, Williams CC, Bailey SL, Gregg M, et al. Determination of 
pesticide metabolites in human urine using isotope dilution technique and tandem mass 
spectrometry. J Anal Toxicol 1995;19(5):323-9. 
 
Olsson AO, Baker SE, Nguyen JV, Romanoff LC, Udunka SO, Walker RD, et al. A liquid 
chromatography-tandem mass spectrometry multiresidue method for quantification of specific 
metabolites of organophosphorus pesticides, synthetic pyrethroids, selected herbicides, and DEET 
in human urine. Anal Chem 2004;76(9):2453-61. 
 
Organophosphate Insecticides: Dialkyl Phosphate Metabolites 
Bravo R, Caltabiano LM, Weerasekera G, Whitehead RD, Fernandez C, Needham LL, et al. 
Measurement of dialkyl phosphate metabolites of organophosphorus pesticides in human urine 
using lyophilization with gas chromatography-tandem mass spectrometry and isotope dilution 
quantification. J Expo Anal Environ Epidemiol 2004;14:249-259. 
 
Bravo R, Driskell WJ, Whitehead RD Jr, Needham LL, Barr DB. Quantitation of dialkyl 
phosphate metabolites of organophosphate pesticides in human urine using GC-MS-MS with 
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Pyrethroids 
 
Davis MD, Wade EL, Restrepo PR, Roman-Esteva W, Bravo R, Kuklenyik P, Calafat AM. 
Semiautomated solid phase extraction method for the mass spectrometric quantification of 12 
specific metabolites of organophosphorus pesticides, synthetic pyrethroids, and select herbicides 
in human urine. J Chromatogr B 2013;929:18-26. (NHANES 2007-2008 and later) 
 
Olsson AO, Baker SE, Nguyen JV, Romanoff LC, Udunka SO, Walker RD, et al. A liquid 
chromatography-tandem mass spectrometry multiresidue method for quantification of specific 
metabolites of organophosphorus pesticides, synthetic pyrethroids, selected herbicides, and DEET 
in human urine. Anal Chem 2004;76(9):2453-2461. 
  
Metals and Metalloids 
Caldwell KL, Hartel J, Jarrett J, Jones RL. Inductively coupled plasma mass spectrometry to 
measure multiple toxic elements in urine in NHANES 1999-2000. Atomic Spectroscopy. 
2005;26(1):1-7. 
 
Chen HP, Paschal DC, Miller DT, Morrow JC. Determination of total and inorganic mercury in 
whole blood by on-line digestion with flow injection. Atomic Spectroscopy 1998;19:176-179. 
 
Jarrett JM, Jones RL, Caldwell KL, Verdon CP. Total urine arsenic measurements using 
inductively coupled plasma mass spectrometry with a dynamic reaction cell. Atomic 
Spectroscopy 2007;28(4):113-122. 
 
Sommer YL, Verdon CP, Fresquez MR, Ward CD, Wood EB, Pan Y, et al. Measurement of 
mercury species in human blood using triple spike isotope dilution with SPME-GC-ICP-DRCMS. 
Anal Bioanal Chem 2014;406(20):5039-47.  
 
Stoeppler M, Brandt K. Determination of cadmium in whole blood and urine by electrothermal 
atomic-absorption spectrophotometry. Fresnius A Anal Chem 1980;300:372-380. 
 
Verdon CP, Caldwell KL, Fresques MR, Jones RL. Determination of seven arsenic compounds in 
urine by HPLC-ICP-DRC-MS: a CDC population biomonitoring method. Anal Bioanal Chem 
2008;393(3):939-947. 
 
Perchlorate and Other Anions 
Valentin-Blasini L, Blount BC, Delinsky A. Quantification of iodide and sodium-iodide 
symporter inhibitors in human urine using ion chromatography tandem mass spectrometry. J 
Chrom A 2007;1155(1):40-46. 
 
Valentin-Blasini L, Mauldin JP, Maple D and Blount BC. Analysis of perchlorate in human urine 
using ion chromatography and electrospray tandem mass spectrometry. Anal Chem 
2005;77(8):2475-2481. 
 
Perfluoroalkyl and Polyfluoroalkyl Substances: Surfactants  
 
Kato K, Basden BJ, Needham LL, Calafat AM. Improved selectivity for the analysis of maternal 
serum and cord serum for polyfluoroalkyl chemicals. J Chromatogr A 2011;1218(15):2133-2137.  
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Kuklenyik Z, Needham LL, Calafat AM. Measurement of 18 perfluorinated organic acids and 
amides in human serum using on-line solid-phase extraction. Anal Chem 2005;77:6085-6091. 
 
Kuklenyik Z, Reich JA, Tully JS, Needham LL, Calafat AM. Automated solid-phase extraction 
and measurement of perfluorinated organic acids and amides in human serum and milk. Environ 
Sci Technol. 2004 Jul 1;38(13):3698-704. 
 
 
Phthalate and Phthalate Alternative Metabolites 
Blount BC, Milgram KE, Silva M, Malek N, Reidy J, Needham LL, et al. Quantitative detection 
of eight phthalate metabolites in human urine using HPLC-APCI-MS/MS. Anal Chem 
2000;72:4127-4134. 
 
Kato K, Silva MJ, Needham LL, Calafat AM. Determination of 16 phthalate metabolites in urine 
using automated sample preparation and on-line preconcentration/high-performance liquid 
chromatography/tandem mass spectrometry. Anal Chem 2005;77(9):2985-91. (NHANES 2003- 
2004) 
 
Silva MJ, Jia T, Samandar E, Preau JL, Calafat AM. Environmental exposure to plasticizer 1,2- 
cyclohexane dicarboxylic acid, diisononyl ester (DINCH) in US adults (2000-2012). Environ Res 
2013; 126: 159-163. (NHANES 2011-2014)  
 
Silva MJ, Malek NA, Hodge CC, Reidy JA, Kato K, Barr DB, et al. Improved quantitative 
detection of 11 urinary phthalate metabolites in humans using liquid chromatographyatmospheric 
pressure chemical ionization tandem mass spectrometry. J Chromatogr B 2003;789:393-404. 
(NHANES 1999-2000)  
 
Silva MJ, Samandar E, Preau JL, Reidy JA, Needham LL, Calafat AM. Quantification of 22 
phthalate metabolites in human urine. J Chromatogr B 2007;860:106-12. (NHANES 2005-2012)  
 
Silva MJ, Slakman AR, Reidy JA, Preau JLJ, Herbert AR, Samandar E, et al. Analysis of human 
urine for 15 phthalate metabolites using automated solid-phase extraction. J Chromatogr B 
2004;805:161-7. (NHANES 2001-2002) 
 
Phytoestrogens and Metabolites 
Valentin-Blasini L, Blount BC, Rogers HS, Needham LL. HPLC-MS/MS method for the 
measurement of seven phytoestrogens in human serum and urine. J Expo Anal Environ Epidemiol 
2000;10:799-807. 
 
Parker DL, Rybak ME, Pfeiffer CM. Phytoestrogen biomonitoring: an extractionless LC-MS/MS 
method for measuring urinary isoflavones and lignans by use of atmospheric pressure 
photoionization (APPI). Anal Bioanal Chem 2012;402:1123-1136. (NHANES 2005-2006 and 
later)  
 
Rybak ME, Parker DL, Pfeiffer CM. Determination of urinary phytoestrogens by HPLC–MS/MS: 
A comparison of atmospheric pressure chemical ionization (APCI) and electrospray ionization 
(ESI). J Chromatogr R 2008;861:145-150. (NHANES 2003-2004)  
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Kuklenyik Z, Ye X, Reich JA, Needham LL, Calafat AM. Automated on-line and off-line solid 
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Polycyclic Aromatic Hydrocarbon Metabolites 
Li Z, Romanoff LC, Trinidad DA, Hussain N, Jones RS, Porter EN, et al. Measurement of urinary 
Monohydroxy polycyclic aromatic hydrocarbons using automated liquid-liquid extraction and gas 
chromatography/isotope dilution high-resolution mass spectrometry. Anal Chem 2006;78:5744-
51. 
 
Romanoff LC, Li Z, Young KJ, Blakely NC III, Patterson DG, Sandau CD. Automated solid-
phase extraction method for measuring urinary polycyclic aromatic hydrocarbon metabolites in 
human biomonitoring using isotope-dilution gas chromatography high-resolution mass 
spectrometry. J Chromatog B 2006;835:47-54. 
 
Smith CJ, Huang WL, Walcott CJ, Turner WE, Grainger J, Patterson DG Jr. Quantification of 
monohydroxy-PAH metabolites in urine by solid-phase extraction with isotope dilution GC-
HRMS. Anal Bioanal Chem 2002;372:216-220. 
 
Volatile Organic Compounds (VOCs), including Disinfection By-Products  
Blount BC, Kobelski RJ, McElprang DO, Ashley DL, Morrow JC, Chambers DM, et al. 
Quantification of  31 volatile organic compounds in whole blood using solid-phase 
microextraction and gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol 
Biomed Life Sci 2006;832: 292-301. 
 
Alwis KU, Blount BC, Silva LK, Smith MM, Loose KH. Method for quantifying nitromethane in 
blood as a potential biomarker of halonitromethane exposure. Environ Sci Technol 2008;42 (7): 
2522-7. 
 
Bonin MA, Silva LK, Smith MM, Ashley DL, Blount BC. Measurement of trihalomethanes and 
methyl tert-butyl ether in whole blood using gas chromatography with high-resolution mass 
spectrometry. J Anal Toxicol 2005;29(2):81-9. 
 
Chambers DM, Blount BC, McElprang DO, Waterhouse MG, Morrow J. Picogram measurement 
of volatile n-alkanes (n-hexane through n-dodecane) in blood using solid-phase microextraction 
to assess nonoccupational petroleum-based fuel exposure. Anal Chem 2008;80(12): 4666-74. 
 
Chambers DM, McElprang DO, Mauldin JP, Hughes TM, Blount BC. Identification and 
elimination of polysiloxane curing agent interference encountered in the quantification of low 
picogram per milliliter methyl tert-butyl ether in blood by solid-phase microextraction headspace 
analysis. Anal Chem 2005;77 (9): 2912-9. 
 
Chambers DM, McElprang DO, Waterhouse MG, Blount BC. An improved approach for accurate 
quantitation of benzene, toluene, ethylbenzene, xylene, and styrene in blood. Anal Chem 2006;78 
(15): 5375-83. 
 
Chambers DM, Ocariz JM, McGuirk MF, Bount BC. Impact of cigarette smoking on volatile 
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Volatile Organic Compound (VOC) Metabolites  
 
Alwis KU, Blount BC, Britt AS, Patel D, Ashley DL. Simultaneous analysis of 28 urinary VOC 
metabolites using ultra high performance liquid chromatography coupled with electrospray 
ionization tandem mass spectrometry (UPLC-ESI/MSMS). Anal Chim Acta 2012;750:152-60. 
 
Polybrominated Diphenyl Ethers and PBB 153 (Pooled and Individual Samples)  
 
Jones R, Edenfield E, Anderson S, Zhang Y, Sjodin A. Semi-automated extraction and cleanup 
method for measuring persistent organic pollutants in human serum. Organohalogen Compounds 
2012;74: 97-8.  
 
Sjodin A, Jones RS, Lapeza CR, Focant JF, McGahee EE III, Patterson DG. Semiautomated high-
throughput extraction and cleanup method for the measurement of polybrominated diphenyl 
ethers, polybrominated biphenyls, and polychlorinated biphenyls in human serum. Anal Chem 
2004;76:1921-7. 
 
Organochlorine Pesticides and Metabolites, and Non-dioxin-like and mono-ortho-
substituted Polychlorinated Biphenyls (Pooled and Individual Samples)  
 
Barr JB, Maggio VL, Barr DB, Turner WE, Sjodin A, Sandau CD, et al. New high-resolution 
mass spectrometric approach for the measurement of polychlorinated biphenyls and 
organochlorine pesticides in human serum. J Chromatog B 2003;794:137-48.  
 
Jones R, Edenfield E, Anderson S, Zhang Y and Sjodin A. Semi-automated extraction and 
cleanup method for measuring persistent organic pollutants in human serum. Organohalogen 
Compounds 2012;74:97-8.  
 
Sjodin A, Jones RS, Lapeza CR, Focant JF, McGahee EE III, Patterson DG. Semiautomated high-
throughput extraction and cleanup method for the measurement of polybrominated diphenyl 
ethers, polybrominated biphenyls, and polychlorinated biphenyls in human serum. Anal Chem 
2004;76:1921-7. 
 
Patterson DG Jr., Alexander LR, Turner WE, Isaacs SG, Needham LL. The development and 
application of a high resolution mass spectrometry method for measuring polychlorinated 
dibenzo-p-dioxins and dibenzofurans in serum. In: Clement RE, Sui KM, Hill HH Jr., eds. 
Instrumentation for trace organic monitoring. Chelsea, MI: Lewis Publishers; 1990. pp. 119-53. 
 
Patterson DG Jr., Hampton L, Lapeza CR Jr., Belser WT, Green V, Alexander L, et al. High 
resolution gas chromatographic/high resolution mass spectrometric analysis of human serum on a 
whole weight and lipid basis for 2,3,7,8 TCDD. Anal Chem 1987;59:2000-5. 
 
Patterson, DG Jr., Wong L-Y, Turner WE, Caudill SP, DiPietro ES, McClure PC, et al.  Levels in 
the U.S. population of those persistent organic pollutants (2003-2004) included in the Stockholm 
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Polychlorinated Dibenzo-p-dioxins and Dibenzofurans (Pooled and Individual 
Samples), and Coplanar Polychlorinated Biphenyls (Pooled and Individual Samples) 
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application of a high resolution mass spectrometry method for measuring polychlorinated 
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Instrumentation for Trace Organic Monitoring. Chelsea, MI: Lewis Publishers; 1990. pp. 119-53. 
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Technol 2009;43(4):1211-8. 
 
Turner WE, DiPietro E, Cash TP, McClure PC, Patterson DG Jr., Shirkhan H. An improved SPE 
extraction and automated sample cleanup method for serum PCDDs, PCDFs, and coplanar 
PCBs.  Organohalogen Compounds 1994; 19: 31-5. 
 
Turner WE, Whitfield WE, Cash TP, DiPietro ES, Anderson CJ, McClure PC, et al.  Same 
sample cleanup for PCDDs/PCDFs/cPCBs, PCNs and PBDDs/PBDFs in human serum and 
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